{"meta":{"query_hash":"efd139ecc9ad","filters":{"venue":"British Journal of Haematology"},"cohort_total":778,"direct_labels_cover":1,"predictions_cover":778,"exported":778,"export_cap":100000,"truncated":false,"label_status":"direct model label, unvalidated","prediction_status":"machine_predicted_unvalidated (Codex and Gemma teacher distillation)","score_status":"score_only:v0-immature-baseline","snapshot":{"source":"OpenAlex, pinned release, all 482 partitions","release":"2026-06-24","frame_built":"2026-07-12"},"permalink":"https://metacan.xera.ac/q/efd139ecc9ad","api":"https://metacan.xera.ac/api/v1/cohort?venue=British+Journal+of+Haematology"},"results":[{"id":"W1487233123","doi":"10.1111/j.1365-2141.2009.07910.x","title":"15‐deoxy‐Δ<sup>12,14</sup>‐PGJ<sub>2</sub> induces cell cycle arrest and apoptosis of haematopoietic progenitors","year":2009,"lang":"en","type":"letter","venue":"British Journal of Haematology","topic":"Peroxisome Proliferator-Activated Receptors","field":"Biochemistry, Genetics and Molecular Biology","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"Agencia Nacional de Promoción Científica y Tecnológica; Consejo Nacional de Investigaciones Científicas y Técnicas","keywords":"Haematopoiesis; Apoptosis; Progenitor cell; Cell biology; Cell cycle checkpoint; Cell cycle; Biology; Physics; Stem cell; Genetics","score_opus":0.006472575781169075,"score_gpt":0.2089922071717555,"score_spread":0.20251963139058643,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1487233123","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.985036,0.006334389,0.0019817064,0.00018711315,0.00012514245,0.000059755585,0.0012513477,0.00010676547,0.004917813],"genre_scores_gemma":[0.9835827,0.0030493513,0.0015047427,0.00028987086,0.00003584269,0.00008396691,0.002071766,0.000029546363,0.00935219],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99984646,0.000021888261,0.000017386788,0.00002389218,0.000046262478,0.000044116696],"domain_scores_gemma":[0.99991083,0.000015391293,0.000021474292,0.000014729003,0.000008821188,0.000028810171],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010997877,0.00032959765,0.000279286,0.0003401317,0.0001360733,0.0003134936,0.00015568176,0.00019799627,0.0024290655],"category_scores_gemma":[0.00008198216,0.0001493386,0.00033339128,0.00020472443,0.00018603748,0.00015561185,0.00022594181,0.0007770112,0.00086247583],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007632775,0.00014396284,0.0005308729,0.00012260092,0.000019597037,0.00027979026,0.000038430255,0.00018571159,0.99221474,0.00021333402,0.00029450175,0.005193203],"study_design_scores_gemma":[0.00005444087,0.0010388929,0.007951226,0.000013447511,0.000023464665,0.0003563443,0.000058833804,0.00057433196,0.98236966,0.00014205292,0.0074094683,0.000007848195],"about_ca_topic_score_codex":0.0009821025,"about_ca_topic_score_gemma":0.0014831248,"teacher_disagreement_score":0.0024290655,"about_ca_system_score_codex":0.0002259711,"about_ca_system_score_gemma":0.00039417954,"threshold_uncertainty_score":0.00812602},"labels":[],"label_agreement":null},{"id":"W1493859144","doi":"10.1111/j.1365-2141.2011.08973.x","title":"Platelet apoptosis in paediatric immune thrombocytopenia is ameliorated by intravenous immunoglobulin","year":2011,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":59,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Mount Sinai Hospital; Hospital for Sick Children","funders":"","keywords":"Platelet; Medicine; Phosphatidylserine; Apoptosis; Flow cytometry; Immunology; Antibody; Immune thrombocytopenia; Immune system; Platelet activation; Platelet membrane glycoprotein; Chemotherapy; Gastroenterology; Internal medicine; Biology","score_opus":0.01482268090958412,"score_gpt":0.2393378797339692,"score_spread":0.2245151988243851,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1493859144","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99749964,0.0019323666,0.00019774935,0.000025533463,0.000004220511,0.000008597617,0.000035513927,0.000007686448,0.00028870266],"genre_scores_gemma":[0.9985292,0.0009820774,0.00022018197,0.000025233336,0.000009509361,0.000012286514,0.00012721188,0.0000021224607,0.000092299706],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99971586,0.0001002754,0.000030219344,0.000032913093,0.000072210714,0.000048425827],"domain_scores_gemma":[0.99953413,0.00010103184,0.00025360167,0.00002342699,0.00003693278,0.000050971223],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002650124,0.00022575469,0.00042625214,0.00032283145,0.00012638331,0.0002714355,0.00014884942,0.00029044593,0.00046792044],"category_scores_gemma":[0.0014360783,0.0001370864,0.00020646164,0.00040526208,0.00030164068,0.00019309162,0.0002805157,0.00039693544,0.00009837838],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0062008672,0.0002441909,0.8439544,0.00043991426,0.0001480406,0.010883733,0.00082523236,0.0005896824,0.06618511,0.0002802697,0.0005478002,0.06970078],"study_design_scores_gemma":[0.0001562382,0.0036936924,0.9596704,0.000040608575,0.00012090147,0.025023002,0.00028341744,0.0004910829,0.00887049,0.00013651299,0.001506277,0.000007234923],"about_ca_topic_score_codex":0.00047034127,"about_ca_topic_score_gemma":0.0003229235,"teacher_disagreement_score":0.00047034127,"about_ca_system_score_codex":0.00024189265,"about_ca_system_score_gemma":0.00014316852,"threshold_uncertainty_score":0.0017550588},"labels":[],"label_agreement":null},{"id":"W1499879695","doi":"10.1111/bjh.13567","title":"Splenic lymphocyte subtypes in immune thrombocytopenia: increased presence of a subtype of B‐regulatory cells","year":2015,"lang":"en","type":"letter","venue":"British Journal of Haematology","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Toronto; Canadian Blood Services; St. Michael's Hospital","funders":"National Center for Research Resources; National Cancer Institute; National Institutes of Health; China Scholarship Council; National Center for Advancing Translational Sciences; Canadian Blood Services","keywords":"FOXP3; Immunology; CD38; Regulatory B cells; Antigen; Population; CD8; Immune system; CD19; Antibody; Lymphocyte; Medicine; Biology; Interleukin 10; CD34; Stem cell","score_opus":0.015290587012916872,"score_gpt":0.25283158674740547,"score_spread":0.23754099973448858,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1499879695","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9953945,0.0022887138,0.00059858203,0.000022886166,0.0000072938137,0.000009248037,0.00004805734,0.000023983444,0.0016066849],"genre_scores_gemma":[0.9986124,0.00048734935,0.00044159274,0.000034438617,0.000015376028,0.00001054543,0.00010770709,0.0000072555063,0.0002833534],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99987304,0.00003067167,0.000016730568,0.000028608505,0.000024904995,0.000026108228],"domain_scores_gemma":[0.99985707,0.00003361603,0.000038432216,0.000020137817,0.000021944761,0.000028901275],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00024891074,0.00027139904,0.00023316186,0.0012100091,0.00022036713,0.00031087833,0.0001673603,0.00027573196,0.0027698209],"category_scores_gemma":[0.0002731739,0.00017937142,0.00019209339,0.00033664456,0.00025226682,0.0002790502,0.00030901848,0.00039377448,0.00039729945],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0030450677,0.00017724176,0.23049186,0.0003934403,0.00009336404,0.0041099302,0.00088758155,0.00019716748,0.715338,0.00027239916,0.00033691782,0.04465692],"study_design_scores_gemma":[0.00030226714,0.002368138,0.8065199,0.00014661805,0.00034016423,0.0563476,0.0017566462,0.0018111434,0.121233836,0.0006105653,0.008532906,0.00003020002],"about_ca_topic_score_codex":0.00026829247,"about_ca_topic_score_gemma":0.00025860016,"teacher_disagreement_score":0.0027698209,"about_ca_system_score_codex":0.00009937385,"about_ca_system_score_gemma":0.000057652418,"threshold_uncertainty_score":0.009266019},"labels":[],"label_agreement":null},{"id":"W1512582735","doi":"10.1046/j.1365-2141.2001.02632.x","title":"Which children with fever and neutropenia can be safely treated as outpatients?","year":2001,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Neutropenia and Cancer Infections","field":"Medicine","cited_by":39,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Neutropenia; Medicine; Cancer; Leukopenia; Chemotherapy; Febrile neutropenia; Intensive care medicine; Internal medicine; Pediatrics","score_opus":0.010532309746658839,"score_gpt":0.2519400703507211,"score_spread":0.24140776060406224,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1512582735","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.34501946,0.37494183,0.0047712047,0.20907208,0.005840074,0.00070350006,0.0019627986,0.00049840065,0.05719066],"genre_scores_gemma":[0.7294288,0.22801667,0.0077555142,0.018572718,0.005566257,0.0006641153,0.0017597296,0.00015345421,0.008082669],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99950457,0.0001158865,0.000057912614,0.000057848694,0.000088872745,0.00017488396],"domain_scores_gemma":[0.9987197,0.00019988767,0.00030575768,0.00003108445,0.00012876838,0.00061480264],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007054291,0.00029181986,0.00065994065,0.00076419476,0.00098752,0.0015338069,0.00070226984,0.0013769692,0.010952344],"category_scores_gemma":[0.004280602,0.00022956995,0.000653804,0.00070654735,0.0006481008,0.002754561,0.0009803781,0.0012067184,0.0017692938],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00067523884,0.0005946637,0.22478543,0.0015691175,0.00006289685,0.009507286,0.0018715254,0.00015886905,0.00073216215,0.0039161197,0.07712007,0.67900664],"study_design_scores_gemma":[0.0007212731,0.0023918815,0.43034026,0.013636584,0.00041027,0.07340039,0.04319298,0.00042680374,0.0011787296,0.020987628,0.41305453,0.00025860383],"about_ca_topic_score_codex":0.0045089666,"about_ca_topic_score_gemma":0.0108170705,"teacher_disagreement_score":0.010952344,"about_ca_system_score_codex":0.0011767598,"about_ca_system_score_gemma":0.0030583194,"threshold_uncertainty_score":0.036639273},"labels":[],"label_agreement":null},{"id":"W1526709380","doi":"10.1111/j.1365-2141.2005.05879.x","title":"Atypical presentation of acute promyelocytic leukaemia","year":2005,"lang":"en","type":"letter","venue":"British Journal of Haematology","topic":"Retinoids in leukemia and cellular processes","field":"Biochemistry, Genetics and Molecular Biology","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McGill University Health Centre; Montreal Children's Hospital","funders":"Core Research for Evolutional Science and Technology","keywords":"Medicine; Pathology; CD99; Immunohistochemistry","score_opus":0.007593307816003039,"score_gpt":0.2513434094097791,"score_spread":0.24375010159377608,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1526709380","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9684988,0.0069064777,0.0049651223,0.0016745611,0.00024029073,0.00015073219,0.00035123143,0.00037609506,0.016836815],"genre_scores_gemma":[0.9957814,0.0010678177,0.0013062032,0.00045336806,0.00038853902,0.000022342634,0.000120795805,0.000022411607,0.0008371184],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.99924976,0.00011949761,0.00007958359,0.00016274006,0.00011284,0.00027562943],"domain_scores_gemma":[0.9987361,0.00030565454,0.00039544643,0.00011569617,0.000093360206,0.00035378154],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00032958886,0.0016338566,0.0008934474,0.0016540218,0.0011024221,0.0013278845,0.00081438414,0.002696729,0.002652411],"category_scores_gemma":[0.003464457,0.00062895904,0.00044075647,0.0014225941,0.0009445407,0.001319744,0.0011976714,0.0014508236,0.0013302527],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000060972696,0.000014958254,0.014264143,0.000044644195,0.000005474673,0.9815653,0.00011635938,0.0000735119,0.0014861643,0.00023834806,0.00033361965,0.0017964591],"study_design_scores_gemma":[0.0000051550915,0.00002407204,0.0028654945,0.000008641886,0.0000039519655,0.99624014,0.000060737682,0.00008796047,0.00018784577,0.00014791152,0.00036477763,0.0000033146678],"about_ca_topic_score_codex":0.0004953879,"about_ca_topic_score_gemma":0.0007627099,"teacher_disagreement_score":0.002696729,"about_ca_system_score_codex":0.0005394989,"about_ca_system_score_gemma":0.00038658563,"threshold_uncertainty_score":0.008873165},"labels":[],"label_agreement":null},{"id":"W1531745986","doi":"10.1111/j.1365-2141.2000.02238.x","title":"A history of pernicious anaemia","year":2000,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Porphyrin Metabolism and Disorders","field":"Biochemistry, Genetics and Molecular Biology","cited_by":39,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Pernicious anaemia; Intrinsic factor; Medicine; pernicious anemia; Atrophic gastritis; Vitamin B12; Pediatrics; Psychiatry; Stomach; Gastritis; Gastroenterology; Anemia; Internal medicine","score_opus":0.0052898358066272855,"score_gpt":0.20775318019208647,"score_spread":0.20246334438545918,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1531745986","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0004122225,0.9759267,0.00021464947,0.0080544045,0.008991021,0.000005509504,0.000028252123,0.000020523086,0.0063467906],"genre_scores_gemma":[0.0076499777,0.9446809,0.0004337263,0.017585479,0.021180278,0.000021733975,0.00011114204,0.000032787324,0.008304019],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9991721,0.00026352805,0.00010842816,0.00013867141,0.00024428626,0.0000730384],"domain_scores_gemma":[0.9982722,0.00083893863,0.00017066965,0.00006745737,0.00045735767,0.0001933793],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00084493984,0.00071559247,0.0012251525,0.0028002877,0.00095586944,0.0018787795,0.00079873105,0.0019679319,0.0056757987],"category_scores_gemma":[0.003548592,0.00035159293,0.0006150796,0.0022075535,0.0014041488,0.0026476851,0.001257355,0.0042723035,0.0039183153],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018150204,0.00009199531,0.0014326061,0.005669127,0.00010330801,0.0039814506,0.0015100271,0.00025589042,0.00087484054,0.016630447,0.54041207,0.42885673],"study_design_scores_gemma":[0.000005516706,0.000036285404,0.0006448176,0.0024711045,0.000023525434,0.0060692886,0.00012239469,0.000018412728,0.00006177984,0.002513294,0.9880173,0.000016205642],"about_ca_topic_score_codex":0.001915983,"about_ca_topic_score_gemma":0.0022652852,"teacher_disagreement_score":0.0056757987,"about_ca_system_score_codex":0.0014978154,"about_ca_system_score_gemma":0.001553963,"threshold_uncertainty_score":0.018987417},"labels":[],"label_agreement":null},{"id":"W1536143313","doi":"10.1111/j.1365-2141.2010.08477.x","title":"Renal dysfunction in patients with thalassaemia","year":2011,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":109,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; Toronto General Hospital","funders":"National Heart, Lung, and Blood Institute","keywords":"Deferasirox; Medicine; Hypercalciuria; Renal function; Creatinine; Albuminuria; Urology; Internal medicine; Nephrotoxicity; Thalassemia; Gastroenterology; Urinary system; Kidney","score_opus":0.008040433559071004,"score_gpt":0.19957076767612902,"score_spread":0.19153033411705803,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1536143313","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98682654,0.009329991,0.0002873701,0.0010443719,0.000042776937,0.000012161431,0.0003345351,0.000016348476,0.00210568],"genre_scores_gemma":[0.9979538,0.0014735224,0.00009721343,0.00014274604,0.000049020637,0.000004079912,0.00012459938,0.000001421803,0.00015356959],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99958664,0.00015668935,0.000047910533,0.000059779864,0.000096633354,0.000052359574],"domain_scores_gemma":[0.9990361,0.00027291983,0.0004170235,0.000047983845,0.000071775205,0.00015410487],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005449698,0.00016391953,0.00050205545,0.0004873052,0.00036109262,0.0006080423,0.00018099428,0.00038753412,0.0014906994],"category_scores_gemma":[0.0032103565,0.00011377977,0.00029858662,0.0009833837,0.00027588842,0.00035831126,0.00030128748,0.0006119536,0.00023731918],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003106963,0.000049689934,0.9833385,0.00009778079,0.000090696034,0.00064835406,0.00016916479,0.00016169118,0.00025938888,0.00008173904,0.00056314585,0.014229164],"study_design_scores_gemma":[0.000017352118,0.00028747102,0.9942411,0.00006374487,0.000080715436,0.003401504,0.0001855592,0.00044166643,0.000060946677,0.00043471038,0.00077537826,0.000009710514],"about_ca_topic_score_codex":0.00216512,"about_ca_topic_score_gemma":0.0018467377,"teacher_disagreement_score":0.00216512,"about_ca_system_score_codex":0.00026540458,"about_ca_system_score_gemma":0.0003267889,"threshold_uncertainty_score":0.004986942},"labels":[],"label_agreement":null},{"id":"W1547137195","doi":"10.1111/j.1365-2141.2005.05494.x","title":"Bone marrow biopsy in thrombocytopenic or anticoagulated patients","year":2005,"lang":"en","type":"letter","venue":"British Journal of Haematology","topic":"Hematological disorders and diagnostics","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Medicine; Biopsy; Bone marrow; Hematology; Warfarin; Surgery; Adverse effect; Trephine; Internal medicine","score_opus":0.025771347831330726,"score_gpt":0.2843715951081158,"score_spread":0.2586002472767851,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1547137195","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97982943,0.00984338,0.00026829803,0.0013565448,0.00008409313,0.00009067835,0.000220576,0.000022891945,0.0082841115],"genre_scores_gemma":[0.99290943,0.0045046518,0.00053006166,0.0010906592,0.00009648878,0.000035176905,0.00017656163,0.000004008746,0.0006530333],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.9995016,0.00018736326,0.00008351736,0.000046209574,0.00011516484,0.00006613392],"domain_scores_gemma":[0.99894816,0.0002515763,0.0004159958,0.00003069472,0.000090505644,0.00026318146],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00056797086,0.00013690769,0.00026135647,0.0008469223,0.0005249245,0.00049489184,0.00021985338,0.0005974356,0.0033140979],"category_scores_gemma":[0.0029672242,0.00014742797,0.00014723031,0.0008819847,0.0002861019,0.0004006355,0.00035567183,0.00048045017,0.00061872636],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00047952955,0.0001166387,0.96261233,0.00017697195,0.000018513658,0.008614054,0.00048162843,0.000049995702,0.0012710752,0.00010273568,0.002250502,0.023825966],"study_design_scores_gemma":[0.00006601397,0.0010429287,0.94611365,0.00033515313,0.000041917716,0.0442513,0.0014737324,0.00024328567,0.0005366711,0.00021138658,0.0056698234,0.000014088279],"about_ca_topic_score_codex":0.0018562885,"about_ca_topic_score_gemma":0.002746875,"teacher_disagreement_score":0.0033140979,"about_ca_system_score_codex":0.00024521444,"about_ca_system_score_gemma":0.00032927256,"threshold_uncertainty_score":0.011086822},"labels":[],"label_agreement":null},{"id":"W1547731352","doi":"10.1111/j.1365-2141.2011.09012.x","title":"UK guidelines on the management of iron deficiency in pregnancy","year":2012,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Iron Metabolism and Disorders","field":"Medicine","cited_by":607,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Thomas Hospital","funders":"University Hospitals of Leicester NHS Trust; NHS Blood and Transplant","keywords":"Medicine; Guideline; Pregnancy; Malnutrition; Iron deficiency; Intensive care medicine; Public health; Food fortification; Health care; Developed country; Environmental health; Pediatrics; Anemia; Economic growth; Population; Nursing; Psychiatry","score_opus":0.034419341831717506,"score_gpt":0.30794246076016285,"score_spread":0.27352311892844533,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1547731352","genre_codex":"other","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.003486906,0.3591367,0.013934906,0.18623704,0.017951587,0.003717231,0.0092014605,0.0017583414,0.4045758],"genre_scores_gemma":[0.038549397,0.5023567,0.106278606,0.106434435,0.0062505812,0.009987897,0.029121041,0.0005093164,0.20051198],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99563473,0.0017141192,0.00096758606,0.00011469129,0.0013021926,0.0002667614],"domain_scores_gemma":[0.9933207,0.002091676,0.0008679911,0.0001851226,0.0031173043,0.00041727212],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0028409963,0.0008719175,0.0011673422,0.002473576,0.00077192223,0.0012710117,0.0021418813,0.0044090413,0.017744169],"category_scores_gemma":[0.015800577,0.00053061446,0.0011594627,0.002132138,0.00058340444,0.00083698105,0.0012321415,0.0035217516,0.009505083],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000064359694,0.00009795421,0.0005416579,0.0014225346,0.000016160418,0.00090430776,0.00020718621,0.00029635913,0.0002681222,0.002522103,0.77629745,0.21736188],"study_design_scores_gemma":[0.000104133986,0.000071615446,0.0026613884,0.007197144,0.000030304285,0.0024379897,0.00011037104,0.00016341133,0.00013849838,0.0020533183,0.98500466,0.000027242519],"about_ca_topic_score_codex":0.018882107,"about_ca_topic_score_gemma":0.028640984,"teacher_disagreement_score":0.018882107,"about_ca_system_score_codex":0.0023644844,"about_ca_system_score_gemma":0.005271866,"threshold_uncertainty_score":0.059360087},"labels":[],"label_agreement":null},{"id":"W1550825447","doi":"10.1111/j.1365-2141.2007.06803.x","title":"Mixed haematopoietic chimerism for sickle cell disease prevents intravascular haemolysis","year":2007,"lang":"en","type":"letter","venue":"British Journal of Haematology","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":54,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Institute of Allergy and Infectious Diseases; National Institutes of Health; National Heart, Lung, and Blood Institute; Leading Edge Endowment Fund","keywords":"Haemolysis; Haematopoiesis; Medicine; Immunology; Disease; Hemolysis; Internal medicine; Stem cell; Biology; Genetics","score_opus":0.012745762413536742,"score_gpt":0.2426172938335001,"score_spread":0.22987153141996333,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1550825447","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9983664,0.00054979837,0.00056471076,0.00002054124,0.000009887294,0.000021120895,0.000035139623,0.000018378505,0.00041408723],"genre_scores_gemma":[0.99923086,0.000108079905,0.0003957197,0.000024855934,0.0000045661786,0.000011620336,0.000065624954,0.0000028067523,0.0001558974],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9998209,0.000048772927,0.000016072167,0.000042980515,0.000044289874,0.000026996768],"domain_scores_gemma":[0.99981767,0.000040296698,0.00003076154,0.00003951831,0.000017016057,0.00005475361],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00031630177,0.00016755637,0.00032019752,0.0002548098,0.0002790672,0.00024878213,0.0001892576,0.00023304562,0.0010050366],"category_scores_gemma":[0.0006015819,0.00010176803,0.00019456791,0.00011010186,0.00025309145,0.000111689296,0.0002490615,0.00033193716,0.00015436574],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0077257315,0.002543863,0.10996084,0.0002923622,0.0002290265,0.005635567,0.0011172212,0.0017213213,0.7165637,0.0012154339,0.0009951009,0.15199979],"study_design_scores_gemma":[0.0017737901,0.0844126,0.5872424,0.000105052895,0.0008069471,0.06548651,0.0006059016,0.0083115585,0.23419146,0.0006661346,0.01633458,0.00006316373],"about_ca_topic_score_codex":0.0003785659,"about_ca_topic_score_gemma":0.0004287785,"teacher_disagreement_score":0.0010050366,"about_ca_system_score_codex":0.00017019211,"about_ca_system_score_gemma":0.00017873578,"threshold_uncertainty_score":0.0033621192},"labels":[],"label_agreement":null},{"id":"W1559360333","doi":"10.1111/j.1365-2141.2011.08701.x","title":"Low prevalence of <i>JAK2</i> V617F mutation in patients with first unprovoked venous thromboembolism","year":2011,"lang":"en","type":"letter","venue":"British Journal of Haematology","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of British Columbia; McMaster University; Université de Montréal; Western University; Hôpital du Sacré-Cœur de Montréal; McGill University; Ottawa Hospital; Dalhousie University; University of Ottawa","funders":"Canadian Institutes of Health Research","keywords":"JAK2 V617F; Venous thromboembolism; Medicine; Internal medicine; Mutation; Genetics; Thrombosis; Biology; Gene","score_opus":0.008621205634112651,"score_gpt":0.21588955584631903,"score_spread":0.20726835021220638,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1559360333","genre_codex":"review","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"editorial","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.058638666,0.9367467,0.00034343541,0.0006897108,0.00012254271,0.000055156153,0.0015145446,0.000010780102,0.0018784497],"genre_scores_gemma":[0.69899154,0.29645872,0.0006272669,0.0018824163,0.00030843122,0.000076898075,0.0013806487,0.000013316485,0.00026080955],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9940865,0.001692646,0.0018566089,0.001027358,0.00116304,0.00017386861],"domain_scores_gemma":[0.9755475,0.013370761,0.008723631,0.00054995425,0.0015472186,0.00026107946],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0044312086,0.00029524858,0.0027314215,0.0031271337,0.00021597577,0.0012096295,0.0006939046,0.0010623113,0.0024132633],"category_scores_gemma":[0.024847278,0.0004006785,0.0034404523,0.0038073978,0.00040912436,0.0010701626,0.0004697178,0.00069045596,0.00022252562],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0027796559,0.000103933344,0.5714856,0.17897432,0.04003452,0.0016624151,0.0006964266,0.0002771178,0.0018351285,0.00057092955,0.005872585,0.1957074],"study_design_scores_gemma":[0.00084124075,0.00067866815,0.8386187,0.063410886,0.06679798,0.00896542,0.00053420063,0.00033930104,0.0007162233,0.0007225673,0.018283421,0.00009135592],"about_ca_topic_score_codex":0.0039707175,"about_ca_topic_score_gemma":0.008369829,"teacher_disagreement_score":0.0044312086,"about_ca_system_score_codex":0.00049127935,"about_ca_system_score_gemma":0.0013327599,"threshold_uncertainty_score":0.023434699},"labels":[],"label_agreement":null},{"id":"W1564251925","doi":"10.1046/j.1365-2141.2002.03585.x","title":"Shwachman–Diamond Syndrome","year":2002,"lang":"en","type":"review","venue":"British Journal of Haematology","topic":"Blood disorders and treatments","field":"Biochemistry, Genetics and Molecular Biology","cited_by":212,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children; University of Toronto","funders":"","keywords":"Medicine; Intensive care medicine","score_opus":0.020498756971110327,"score_gpt":0.2810316291733023,"score_spread":0.260532872202192,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1564251925","genre_codex":"empirical","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8748128,0.029012505,0.00911583,0.0029975364,0.0007623345,0.00048820587,0.002479061,0.00068598,0.07964567],"genre_scores_gemma":[0.97631663,0.0047901804,0.0020803942,0.0008480059,0.00014074142,0.00006510204,0.00065939425,0.00003306099,0.015066562],"study_design_codex":"case_report","study_design_gemma":"not_applicable","domain_scores_codex":[0.99976724,0.00001545111,0.000014038484,0.0000695372,0.00007127399,0.00006243483],"domain_scores_gemma":[0.9997718,0.000056145946,0.000048658432,0.000010437299,0.000037145008,0.000075792144],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000113566355,0.0010689272,0.00051243446,0.0013050311,0.000850716,0.00035959948,0.00046779623,0.0009053905,0.008791146],"category_scores_gemma":[0.0008578239,0.0001765437,0.00025446457,0.0008784441,0.0006705898,0.00042090833,0.0008475326,0.0006480434,0.0009012806],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00048014254,0.00015763812,0.07217904,0.0008881211,0.00027403288,0.6780075,0.0015106836,0.0009724913,0.053812277,0.024896193,0.027276307,0.13954568],"study_design_scores_gemma":[0.00009922799,0.00015986334,0.04075079,0.00024178847,0.00009225017,0.8847686,0.0003431652,0.0005422878,0.004275473,0.004239079,0.06443253,0.00005492793],"about_ca_topic_score_codex":0.003958749,"about_ca_topic_score_gemma":0.0042957054,"teacher_disagreement_score":0.008791146,"about_ca_system_score_codex":0.00034997484,"about_ca_system_score_gemma":0.00047920176,"threshold_uncertainty_score":0.029409349},"labels":[],"label_agreement":null},{"id":"W1566407278","doi":"10.1111/bjh.13613","title":"Distinctive genotypes in infants with T‐cell acute lymphoblastic leukaemia","year":2015,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":37,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Institut National Du Cancer; Fundação Carlos Chagas Filho de Amparo à Pesquisa do Estado do Rio de Janeiro; Conselho Nacional de Desenvolvimento Científico e Tecnológico; Lady Tata Memorial Trust; Kay Kendall Leukaemia Fund; CNIB; Leukaemia and Lymphoma Research; European Hematology Association","keywords":"CDKN2A; PTEN; Genotype; Biology; Genetics; In utero; Cancer; Fetus; Gene; Pregnancy","score_opus":0.013813976408568221,"score_gpt":0.2699230648654331,"score_spread":0.25610908845686486,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1566407278","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99940753,0.00013570477,0.00010269904,0.000007057961,0.000002420272,0.0000038073028,0.00007369323,0.000006224602,0.00026088173],"genre_scores_gemma":[0.9993217,0.00019162678,0.00019598464,0.000009140181,0.000005279523,0.0000069552334,0.00017589325,0.0000065661065,0.000086817345],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99964404,0.00007847267,0.000052374067,0.00006256853,0.00007469927,0.00008776671],"domain_scores_gemma":[0.99943703,0.00017942283,0.00018750918,0.000045821656,0.00004568918,0.0001045058],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001772087,0.00032049225,0.00039336365,0.001022774,0.00030403506,0.00039005166,0.00017922063,0.00026376187,0.00086002995],"category_scores_gemma":[0.0016363839,0.00020070023,0.000190989,0.0007350018,0.00029925295,0.00016541366,0.0004124046,0.00020203214,0.00022228301],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00045056012,0.00003375062,0.9490944,0.000045173532,0.000035571014,0.018566959,0.000656658,0.0001499545,0.0196663,0.000090130845,0.00015583674,0.011054722],"study_design_scores_gemma":[0.00001006634,0.000237924,0.93645066,0.000015139107,0.00005419894,0.05940392,0.0004283392,0.0001548523,0.0022346354,0.00010401448,0.00089368876,0.000012572515],"about_ca_topic_score_codex":0.000887377,"about_ca_topic_score_gemma":0.0008479434,"teacher_disagreement_score":0.001022774,"about_ca_system_score_codex":0.0001290636,"about_ca_system_score_gemma":0.000118483425,"threshold_uncertainty_score":0.0028771162},"labels":[],"label_agreement":null},{"id":"W1570354759","doi":"10.1111/j.1365-2141.2010.08412.x","title":"Pathophysiology and management of chronic immune thrombocytopenia: focusing on what matters","year":2010,"lang":"en","type":"review","venue":"British Journal of Haematology","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":54,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Canadian Blood Services","funders":"Canadian Institutes of Health Research","keywords":"Immune thrombocytopenia; Medicine; Thrombopoietin; Pathophysiology; Intensive care medicine; Mechanism (biology); Immunology; Disease; Romiplostim; Clinical trial; Eltrombopag; Platelet; Pathogenesis; Immune system; Autoimmune disease; Bioinformatics; Antibody; Internal medicine; Biology; Stem cell","score_opus":0.020955932384401733,"score_gpt":0.3110593357585867,"score_spread":0.29010340337418494,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1570354759","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000053620417,0.99924254,0.000048826278,0.0003321789,0.00011508614,0.000002230337,0.0000027471472,0.0000019009816,0.00020082256],"genre_scores_gemma":[0.00048241895,0.99879646,0.00013665017,0.00022616537,0.0001963346,0.0000036627102,0.000006024885,6.1157e-7,0.00015159429],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9997236,0.00008309382,0.000054353914,0.000035253426,0.00008449602,0.000019178256],"domain_scores_gemma":[0.99956244,0.0002143949,0.00009808676,0.000010918462,0.00008391878,0.000030270314],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00073735655,0.00090932805,0.002086422,0.0017340461,0.0002878568,0.0009932815,0.00092119747,0.0015330826,0.0018691185],"category_scores_gemma":[0.0010898251,0.00021233919,0.0004913428,0.0019561148,0.00071562344,0.0015651546,0.00059695233,0.002196328,0.001123459],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008439581,0.00007077183,0.00029135126,0.025282262,0.00013860945,0.00039022963,0.00009973786,0.0003294053,0.00076307345,0.0032148326,0.02582289,0.94351244],"study_design_scores_gemma":[0.0000774373,0.00025480124,0.0031795905,0.02787243,0.00039307005,0.00839506,0.00037066994,0.00025340635,0.00049848657,0.006904393,0.9517533,0.00004735331],"about_ca_topic_score_codex":0.0013039191,"about_ca_topic_score_gemma":0.0019286006,"teacher_disagreement_score":0.002086422,"about_ca_system_score_codex":0.0006222308,"about_ca_system_score_gemma":0.0010105304,"threshold_uncertainty_score":0.0062528253},"labels":[],"label_agreement":null},{"id":"W1582919185","doi":"10.1111/j.1365-2141.2010.08191.x","title":"Modern management of severe platelet function disorders","year":2010,"lang":"en","type":"review","venue":"British Journal of Haematology","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":98,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Thomas Hospital","funders":"","keywords":"Intensive care medicine; Medicine; Intervention (counseling); Platelet; Case management; Internal medicine; Psychiatry","score_opus":0.01805168487697095,"score_gpt":0.2924483891965691,"score_spread":0.2743967043195982,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1582919185","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00025763002,0.9977192,0.00020305734,0.00034369246,0.00018105407,0.0000061983196,0.000013217698,0.000008817306,0.0012670604],"genre_scores_gemma":[0.0012349623,0.9975084,0.00035921583,0.00019734359,0.00027651808,0.000008191709,0.000034735946,0.0000013963719,0.0003792744],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.999749,0.000044231023,0.000044941527,0.000032930006,0.000109377754,0.000019533263],"domain_scores_gemma":[0.9997801,0.00009010458,0.000046023197,0.000008020914,0.0000550804,0.000020709293],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00041153785,0.0007696236,0.00125021,0.0019406048,0.0002553507,0.0006384176,0.0008377219,0.0008275771,0.0024247447],"category_scores_gemma":[0.000650094,0.000199712,0.0004374468,0.0011868875,0.00031862894,0.00075134146,0.0005640112,0.0017200239,0.0016359867],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006170817,0.00007237908,0.00020445143,0.009584141,0.00007969942,0.00080566446,0.00005165665,0.00028159647,0.0015445605,0.0012784796,0.022236975,0.9637987],"study_design_scores_gemma":[0.000060891696,0.00019102485,0.0032137574,0.0071335733,0.0001899063,0.015190181,0.000099065066,0.00016727558,0.0009077835,0.0029226218,0.96989125,0.000032545548],"about_ca_topic_score_codex":0.00058936916,"about_ca_topic_score_gemma":0.00097430043,"teacher_disagreement_score":0.0024247447,"about_ca_system_score_codex":0.0004014965,"about_ca_system_score_gemma":0.0006057526,"threshold_uncertainty_score":0.008111596},"labels":[],"label_agreement":null},{"id":"W1584887708","doi":"10.1111/j.1365-2141.2011.08586.x","title":"Regulation of the adaptor molecule LAT2, an <i>in vivo</i> target gene of AML1/ETO (<i>RUNX1/RUNX1T1</i>), during myeloid differentiation","year":2011,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"National Cancer Institute; Albert-Ludwigs-Universität Freiburg","keywords":"RUNX1; Biology; Myeloid; RUNX1T1; Downregulation and upregulation; Cancer research; Transcription factor; Retinoic acid; Molecular biology; Immunology; Gene expression; Gene; Genetics","score_opus":0.016897106971341534,"score_gpt":0.24438462493283045,"score_spread":0.22748751796148892,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1584887708","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.997593,0.00049702026,0.0006749909,0.00003972709,0.000009253166,0.000007746912,0.0002688314,0.000036086924,0.00087340357],"genre_scores_gemma":[0.9964365,0.00030331235,0.00041161646,0.00003277342,0.0000067548362,0.00001968727,0.00060694985,0.000012071255,0.002170316],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.999894,0.000019868417,0.000007526616,0.000023248791,0.000021295913,0.000033985234],"domain_scores_gemma":[0.99993706,0.000008265923,0.000021980617,0.0000057098678,0.0000077515615,0.000019319585],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00006611737,0.00021298684,0.00013423864,0.00013354169,0.00014336892,0.00035147864,0.0000747277,0.00014286836,0.001135682],"category_scores_gemma":[0.00006698721,0.0001229825,0.00014743514,0.00011812064,0.00015355463,0.00012579093,0.00018198967,0.00029572356,0.00051246915],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000050888684,0.0000041906806,0.00028312273,0.0000055486,0.0000010321271,0.00002845863,0.000008933265,0.000013622888,0.99937564,0.000028654547,0.000011810468,0.0001880571],"study_design_scores_gemma":[0.000011722871,0.00014445894,0.0252137,0.0000031080292,0.000011655916,0.0004094553,0.000055845037,0.00063380523,0.97099364,0.000034696208,0.0024847405,0.0000032249854],"about_ca_topic_score_codex":0.00027495148,"about_ca_topic_score_gemma":0.0005586263,"teacher_disagreement_score":0.001135682,"about_ca_system_score_codex":0.00022634523,"about_ca_system_score_gemma":0.00009068748,"threshold_uncertainty_score":0.0037992},"labels":[],"label_agreement":null},{"id":"W1590498065","doi":"10.1111/j.1365-2141.2011.08810.x","title":"<i>NUP98‐HOXA9</i>‐transgenic zebrafish develop a myeloproliferative neoplasm and provide new insight into mechanisms of myeloid leukaemogenesis","year":2011,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Zebrafish Biomedical Research Applications","field":"Biochemistry, Genetics and Molecular Biology","cited_by":70,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Izaak Walton Killam Health Centre; Dalhousie University","funders":"Canadian Institutes of Health Research","keywords":"Myeloproliferative neoplasm; Zebrafish; Haematopoiesis; Biology; Myeloid; Cancer research; Transgene; Embryonic stem cell; Progenitor cell; Carcinogenesis; Myeloproliferative Disorders; Downregulation and upregulation; Stem cell; Myelofibrosis; Immunology; Cell biology; Bone marrow; Cancer; Genetics; Gene","score_opus":0.016232276563186456,"score_gpt":0.2497178839117989,"score_spread":0.23348560734861243,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1590498065","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9861384,0.0007383281,0.008671981,0.00016227565,0.000025765537,0.000040378774,0.0010120799,0.0002916494,0.0029191808],"genre_scores_gemma":[0.9853866,0.00046045356,0.0046722903,0.00004906982,0.0000055423466,0.000034896402,0.0007586009,0.000077576115,0.008555036],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99994195,0.0000032739613,0.0000061148326,0.000019359997,0.0000194004,0.00000985282],"domain_scores_gemma":[0.99992836,0.0000071770587,0.00002922823,0.000008228225,0.000008465712,0.000018608667],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000075310665,0.00032333352,0.000110898756,0.0001937914,0.00018391378,0.00016765865,0.0001965678,0.00028160604,0.0023368094],"category_scores_gemma":[0.00005205944,0.0001598319,0.00016288886,0.00006698069,0.00024810538,0.000229961,0.00022246322,0.00045324746,0.00061780005],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000136700755,0.000002106838,0.0001898694,0.000008798725,0.0000011235966,0.000048200553,0.000006094367,0.000016924747,0.99919814,0.000057061192,0.000019950938,0.00043810834],"study_design_scores_gemma":[0.000009797784,0.00009336356,0.01240384,0.000008965691,0.00001798956,0.000761296,0.000026360633,0.00073654886,0.98059225,0.000076978635,0.00526682,0.000005669581],"about_ca_topic_score_codex":0.0008779667,"about_ca_topic_score_gemma":0.00229669,"teacher_disagreement_score":0.0023368094,"about_ca_system_score_codex":0.00022443435,"about_ca_system_score_gemma":0.00014156569,"threshold_uncertainty_score":0.007817388},"labels":[],"label_agreement":null},{"id":"W1613302221","doi":"10.1111/j.1365-2141.2011.08588.x","title":"<scp>l</scp>‐asparaginase loaded red blood cells in refractory or relapsing acute lymphoblastic leukaemia in children and adults: results of the GRASPALL 2005‐01 randomized trial","year":2011,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":131,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hotel Dieu Hospital","funders":"","keywords":"Asparaginase; Medicine; Randomization; Adverse effect; Internal medicine; Gastroenterology; Randomized controlled trial; Refractory (planetary science); Immunology; Lymphoblastic Leukemia; Leukemia; Biology","score_opus":0.012036325153233041,"score_gpt":0.24650577653568884,"score_spread":0.23446945138245578,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1613302221","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.987399,0.009050258,0.00022581531,0.0007407561,0.00020393534,0.0008023359,0.00055543386,0.00006700037,0.0009554562],"genre_scores_gemma":[0.98950243,0.0053551733,0.00070322276,0.0011063172,0.00027386667,0.0011875075,0.00078806194,0.000021477097,0.0010618609],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9992267,0.00051173544,0.00005438029,0.00007677821,0.000055488286,0.00007483796],"domain_scores_gemma":[0.99887246,0.00031296955,0.0003232851,0.00006159933,0.000044029985,0.00038563856],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016730631,0.00083852303,0.002158686,0.00028846972,0.00022059162,0.0009001147,0.00060476817,0.0012281833,0.0026854582],"category_scores_gemma":[0.0014746969,0.0003505674,0.0018613329,0.0004528493,0.0007663479,0.00056943303,0.0002965754,0.0022920095,0.00036219918],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.96301425,0.0020435643,0.0025495903,0.000855677,0.0014406553,0.000115083705,0.00006949997,0.00033641435,0.0025937497,0.0001348616,0.0013014248,0.025545212],"study_design_scores_gemma":[0.9295634,0.061210375,0.0061618765,0.00007436767,0.00088687026,0.00012930408,0.0000364536,0.0002874594,0.0005128119,0.00010669413,0.0010169831,0.000013378939],"about_ca_topic_score_codex":0.0012800168,"about_ca_topic_score_gemma":0.0028132375,"teacher_disagreement_score":0.0026854582,"about_ca_system_score_codex":0.0008763619,"about_ca_system_score_gemma":0.0010249638,"threshold_uncertainty_score":0.008983731},"labels":[],"label_agreement":null},{"id":"W1616213856","doi":"10.1111/j.1365-2141.2010.08262.x","title":"Development of target‐specific treatments in multiple myeloma","year":2010,"lang":"en","type":"review","venue":"British Journal of Haematology","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":24,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"National Institutes of Health; National Cancer Institute; Celgene; Bristol-Myers Squibb","keywords":"Thalidomide; Bortezomib; Multiple myeloma; Arsenic trioxide; Cancer research; Lenalidomide; Medicine; Histone deacetylase; Protein kinase B; Pharmacology; Panobinostat; Monoclonal antibody; Immunology; Biology; Apoptosis; Histone; Signal transduction; Antibody; Cell biology","score_opus":0.07596536851419747,"score_gpt":0.3565687772379315,"score_spread":0.280603408723734,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1616213856","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00014432063,0.9981129,0.0002087332,0.00016589735,0.00015480805,0.000008302242,0.000015663441,0.000011122901,0.0011781821],"genre_scores_gemma":[0.000682738,0.99805534,0.0003075399,0.00017393165,0.00012386739,0.000008447711,0.0000309499,0.0000017726964,0.0006154419],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.999801,0.000034249708,0.00002548579,0.000034724162,0.00008617818,0.00001841926],"domain_scores_gemma":[0.99981505,0.00007528007,0.000031728556,0.000009690589,0.000047132384,0.000021181013],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00060857454,0.0009438971,0.0016674339,0.0022691523,0.00030881347,0.0008121951,0.00094854494,0.0011131014,0.004343761],"category_scores_gemma":[0.000481244,0.0003880983,0.00053737086,0.0019310704,0.0005583692,0.0013470016,0.0006903585,0.0022550956,0.0038299304],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007397526,0.00011103075,0.000101689024,0.009179692,0.000078153425,0.00020095102,0.000041902942,0.00037974358,0.003598628,0.0032074987,0.017863227,0.96516365],"study_design_scores_gemma":[0.000041054533,0.0001368153,0.00062083884,0.0017364,0.00008987382,0.0012752218,0.00003165295,0.00008408762,0.0010812639,0.0022051167,0.9926813,0.000016365131],"about_ca_topic_score_codex":0.00076945935,"about_ca_topic_score_gemma":0.001280504,"teacher_disagreement_score":0.004343761,"about_ca_system_score_codex":0.0005602591,"about_ca_system_score_gemma":0.000692062,"threshold_uncertainty_score":0.014531314},"labels":[],"label_agreement":null},{"id":"W1741176048","doi":"10.1111/j.1365-2141.2011.08872.x","title":"T cells of patients with myelodysplastic syndrome are frequently derived from the malignant clone","year":2011,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Vancouver General Hospital; University of British Columbia; BC Cancer Agency; BC Children's Hospital","funders":"National Institute of Dental and Craniofacial Research; Canadian Institutes of Health Research; Michael Smith Health Research BC; Genome Canada; Leukemia and Lymphoma Society","keywords":"Biology; Progenitor cell; Stem cell; CD34; clone (Java method); Myeloid; Myelodysplastic syndromes; Cancer research; Immunology; Bone marrow; Molecular biology; Genetics; DNA","score_opus":0.01710947392432581,"score_gpt":0.22225848332022255,"score_spread":0.20514900939589675,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1741176048","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9979159,0.0006152353,0.00043714882,0.00003403569,0.0000046190394,0.000013495406,0.00040654137,0.000015945468,0.0005570515],"genre_scores_gemma":[0.9973779,0.0005082873,0.0007451625,0.000052315372,0.0000101281885,0.000020958652,0.0006024409,0.000005060746,0.0006778246],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9999026,0.00000813895,0.000007985434,0.000035036534,0.000027129807,0.000018989069],"domain_scores_gemma":[0.99994314,0.00001495302,0.000018131586,0.000003820257,0.000008278895,0.000011746904],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000044667784,0.00023003973,0.00021915894,0.0005450501,0.00026388714,0.00019870889,0.00007085833,0.00023512976,0.0016902376],"category_scores_gemma":[0.00020466316,0.00012729818,0.00012734444,0.0004442965,0.00014965478,0.00011710412,0.00013913022,0.00018438364,0.0003942393],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008796318,0.000067792025,0.3546799,0.0001654282,0.000057889338,0.0043919766,0.0007817875,0.00015841445,0.60955054,0.00012702486,0.00049785106,0.028641785],"study_design_scores_gemma":[0.000028500986,0.00059117435,0.9260833,0.00001843387,0.000083399755,0.019735565,0.00043233114,0.0003447635,0.04618035,0.00017973712,0.0063112085,0.000011333689],"about_ca_topic_score_codex":0.00048323307,"about_ca_topic_score_gemma":0.00084481906,"teacher_disagreement_score":0.0016902376,"about_ca_system_score_codex":0.00008925668,"about_ca_system_score_gemma":0.00009429269,"threshold_uncertainty_score":0.0056543946},"labels":[],"label_agreement":null},{"id":"W1798928306","doi":"10.1046/j.1365-2141.2003.03929.x","title":"Novel therapies for multiple myeloma","year":2002,"lang":"en","type":"review","venue":"British Journal of Haematology","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":74,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"U.S. Public Health Service","keywords":"Stromal cell; Cancer research; Bortezomib; Multiple myeloma; Tumor microenvironment; Growth factor; Medicine; Extracellular matrix; Bone marrow; Immunology; Biology; Cell biology; Internal medicine; Receptor","score_opus":0.10477212268443684,"score_gpt":0.3753771102808782,"score_spread":0.27060498759644136,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1798928306","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.014598634,0.87733316,0.010131746,0.014826118,0.005259091,0.00032079723,0.0005802963,0.00041859964,0.07653162],"genre_scores_gemma":[0.108979136,0.7515538,0.023401888,0.0244195,0.0045068995,0.00076425454,0.0015213187,0.00015686624,0.08469637],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99973625,0.000055511286,0.000015162488,0.00004592761,0.0001128788,0.000034268858],"domain_scores_gemma":[0.9998685,0.000031515825,0.000023632418,0.000012794688,0.000036620622,0.000026939848],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004761143,0.0005581356,0.0006258234,0.0007696988,0.00037966765,0.0007696383,0.00061992434,0.0009020976,0.015852628],"category_scores_gemma":[0.0004911939,0.00013150857,0.0007461605,0.00047582688,0.0003586785,0.00082084525,0.0009438535,0.002375139,0.0044579073],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00056769146,0.00052709697,0.00057153445,0.0031570508,0.00017183233,0.00074568845,0.00016230172,0.0003705898,0.021704668,0.017321182,0.059126664,0.89557374],"study_design_scores_gemma":[0.00025877627,0.0006706061,0.001017256,0.00064078934,0.000097506614,0.0020196328,0.0000423826,0.00022642704,0.0035964518,0.0060056164,0.98540825,0.00001628309],"about_ca_topic_score_codex":0.00042580807,"about_ca_topic_score_gemma":0.0012996905,"teacher_disagreement_score":0.015852628,"about_ca_system_score_codex":0.00061874435,"about_ca_system_score_gemma":0.00041275818,"threshold_uncertainty_score":0.05303234},"labels":[],"label_agreement":null},{"id":"W1829668511","doi":"10.1111/bjh.13631","title":"<scp>RNA</scp> editing in acute myeloid leukaemia with normal karyotype","year":2015,"lang":"en","type":"letter","venue":"British Journal of Haematology","topic":"RNA regulation and disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"Ministère de l'Education Nationale, de l'Enseignement Superieur et de la Recherche","keywords":"NPM1; RNA editing; RNA; Karyotype; Myeloid leukemia; Biology; Sanger sequencing; Intron; Mutation; Medicine; Molecular biology; Cancer research; Genetics; Gene; Chromosome","score_opus":0.008262122444222825,"score_gpt":0.2297694973531748,"score_spread":0.22150737490895198,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1829668511","genre_codex":"empirical","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"editorial","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9972277,0.0008716038,0.00076118537,0.000038955503,0.000006426858,0.000023022774,0.00036566317,0.000021361699,0.00068402785],"genre_scores_gemma":[0.9981122,0.00031442786,0.00076023984,0.000027420348,0.000016140864,0.00001907084,0.0005203996,0.0000075421635,0.00022248014],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.9996885,0.000067424226,0.00003096317,0.000092198774,0.00008082593,0.0000400999],"domain_scores_gemma":[0.9996971,0.00008531075,0.00013850194,0.000027448676,0.000020942378,0.000030712923],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00025004247,0.0001477387,0.00024761198,0.00064196036,0.0001836439,0.00037417604,0.00012243104,0.00022617416,0.0013991232],"category_scores_gemma":[0.0007253326,0.00007522446,0.00015438486,0.0005477348,0.0002749088,0.00010694231,0.00017476949,0.00016432078,0.0004177988],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0029214742,0.00008537579,0.6120649,0.00027831132,0.000091751775,0.008805752,0.0004091372,0.00068077695,0.31409922,0.0003661586,0.0009084795,0.059288714],"study_design_scores_gemma":[0.00003413607,0.000636982,0.9554937,0.000024001032,0.00006596657,0.016809175,0.00021462693,0.0013854298,0.020375004,0.0004947445,0.0044532274,0.000013098309],"about_ca_topic_score_codex":0.00043622253,"about_ca_topic_score_gemma":0.00047728347,"teacher_disagreement_score":0.0013991232,"about_ca_system_score_codex":0.00017219695,"about_ca_system_score_gemma":0.00012984844,"threshold_uncertainty_score":0.004680574},"labels":[],"label_agreement":null},{"id":"W1874071964","doi":"10.1111/bjh.13634","title":"Evaluation of the International Prognostic Score (IPS‐7) and a Simpler Prognostic Score (IPS‐3) for advanced Hodgkin lymphoma in the modern era","year":2015,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":76,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency; Princess Margaret Cancer Centre","funders":"ECOG-ACRIN Cancer Research Group; National Cancer Institute; U.S. Department of Health and Human Services; National Institutes of Health; American College of Radiology Imaging Network; American Cancer Society","keywords":"Medicine; Internal medicine; Univariate; International Prognostic Index; Oncology; Multivariate analysis; Univariate analysis; Framingham Risk Score; Risk stratification; Stage (stratigraphy); Proportional hazards model; Prognostic model; Prognostic variable; Multivariate statistics; Overall survival; Lymphoma; Disease; Rituximab; Machine learning","score_opus":0.07048132621520345,"score_gpt":0.32302799265549303,"score_spread":0.25254666644028956,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1874071964","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99673754,0.00068924384,0.0014787533,0.00016736427,0.000019167475,0.000054231165,0.00037282528,0.000010222517,0.00047070664],"genre_scores_gemma":[0.9967865,0.00015372752,0.0017697845,0.000046431673,0.00005147219,0.00006033891,0.0010046229,0.000005813773,0.00012140928],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9976332,0.0014276586,0.00015544906,0.00017484743,0.00049564015,0.000113087495],"domain_scores_gemma":[0.9913532,0.005161372,0.001859201,0.00055624713,0.00048338584,0.0005866353],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.010660238,0.0005709883,0.0008718591,0.0009313662,0.0001499536,0.0009723253,0.0004757434,0.0003798476,0.0012619374],"category_scores_gemma":[0.014333453,0.00012722767,0.001054988,0.0010198856,0.00048604986,0.0010413001,0.000955797,0.0009754764,0.00019768708],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008060884,0.00020419859,0.9377263,0.000087397355,0.0007415616,0.000112988884,0.00010099245,0.0050922083,0.0007332556,0.00054701953,0.0007162694,0.045877],"study_design_scores_gemma":[0.0010812879,0.008009525,0.94032276,0.000057275895,0.0007361833,0.0005326929,0.00015268837,0.04335931,0.0008887861,0.0028327396,0.0019761429,0.000050676597],"about_ca_topic_score_codex":0.00048773576,"about_ca_topic_score_gemma":0.00062511844,"teacher_disagreement_score":0.010660238,"about_ca_system_score_codex":0.0005134575,"about_ca_system_score_gemma":0.0007541613,"threshold_uncertainty_score":0.05637735},"labels":[],"label_agreement":null},{"id":"W1878883003","doi":"10.1046/j.1365-2141.2003.03883.x","title":"Disseminated fusariosis in a patient with acute leukaemia","year":2002,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Antifungal resistance and susceptibility","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; Vancouver Hospital and Health Sciences Centre","funders":"","keywords":"Medicine; Skin biopsy; White blood cell; Bone marrow; Vincristine; Cytarabine; Leukemia; Absolute neutrophil count; Pathology; Induction chemotherapy; Amphotericin B; Rash; Biopsy; Chemotherapy; Surgery; Gastroenterology; Internal medicine; Dermatology; Cyclophosphamide; Neutropenia","score_opus":0.009444974156630393,"score_gpt":0.23954477623084594,"score_spread":0.23009980207421554,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1878883003","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9900718,0.0019178337,0.0005367954,0.0012998673,0.000106499734,0.00005956935,0.00010118622,0.000050875406,0.0058557326],"genre_scores_gemma":[0.99830914,0.00048188522,0.00013897446,0.00037373696,0.0001716279,0.000007237279,0.000056435445,0.0000057690113,0.0004551943],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.99971455,0.000040772047,0.000024421233,0.000058891306,0.000039749055,0.00012153667],"domain_scores_gemma":[0.99946207,0.0001437919,0.000097957825,0.00003411086,0.000041711955,0.00022036057],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003005857,0.0009576438,0.0007545901,0.0009212598,0.0017667599,0.0008813811,0.0002789446,0.0016138715,0.002314766],"category_scores_gemma":[0.0020288832,0.0005083917,0.00038296726,0.0007196019,0.00067611056,0.0009120534,0.00061777356,0.0011212901,0.00064212043],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00026727404,0.00013275728,0.09305285,0.000058803587,0.000023351093,0.8976729,0.0010382303,0.00013702188,0.002131389,0.00023817296,0.0008013141,0.004446001],"study_design_scores_gemma":[0.00010512269,0.00065105635,0.0648787,0.000046881465,0.000053072923,0.9293463,0.0005295843,0.00042615633,0.00039202307,0.00038364553,0.0031663454,0.000021021247],"about_ca_topic_score_codex":0.0012783015,"about_ca_topic_score_gemma":0.0013465266,"teacher_disagreement_score":0.002314766,"about_ca_system_score_codex":0.0005048039,"about_ca_system_score_gemma":0.00033698126,"threshold_uncertainty_score":0.0077437162},"labels":[],"label_agreement":null},{"id":"W1884535370","doi":"10.1111/j.1365-2141.2011.08921.x","title":"Guidelines for the diagnosis and management of hereditary spherocytosis – 2011 update","year":2011,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Erythrocyte Function and Pathophysiology","field":"Medicine","cited_by":419,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children; University of Toronto","funders":"British Society for Haematology","keywords":"Hereditary spherocytosis; Splenectomy; Asymptomatic; Spherocytosis; Concomitant; Medicine; Gallstones; General surgery; Pathology; Surgery; Internal medicine","score_opus":0.0994798348855256,"score_gpt":0.3165964413920471,"score_spread":0.21711660650652154,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1884535370","genre_codex":"review","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0048475186,0.6974532,0.0263903,0.15381995,0.02418529,0.00099205,0.0046986984,0.0013974573,0.08621553],"genre_scores_gemma":[0.019706288,0.7211146,0.11229238,0.05712212,0.017898625,0.0016773698,0.019865122,0.00039761583,0.049925916],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99784243,0.00060704164,0.0006078657,0.000109675486,0.0007212982,0.00011167333],"domain_scores_gemma":[0.99386203,0.0013271607,0.00072487496,0.00012848483,0.0035863305,0.00037116712],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0026107982,0.0012320277,0.0018513632,0.0043928977,0.000501073,0.0010830284,0.0027550876,0.0040873634,0.008393203],"category_scores_gemma":[0.008137442,0.0005380979,0.0013865208,0.0021086852,0.00055238494,0.0014911402,0.0011234055,0.0040588747,0.0068500554],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007133003,0.0002152779,0.0010259942,0.0011427071,0.000048204143,0.00075052824,0.00008821113,0.0005593739,0.0004879304,0.0013301654,0.53696907,0.4573112],"study_design_scores_gemma":[0.00006881823,0.00007147418,0.004282923,0.006640407,0.00010928849,0.0038109636,0.00012681859,0.0004569666,0.00026669627,0.0017726421,0.9823438,0.000049185215],"about_ca_topic_score_codex":0.009959154,"about_ca_topic_score_gemma":0.015773475,"teacher_disagreement_score":0.009959154,"about_ca_system_score_codex":0.0018664374,"about_ca_system_score_gemma":0.002374067,"threshold_uncertainty_score":0.02807802},"labels":[],"label_agreement":null},{"id":"W1895050506","doi":"10.1111/bjh.13586","title":"Classification of non‐Hodgkin lymphoma in South‐eastern Europe: review of 632 cases from the international non‐Hodgkin lymphoma classification project","year":2015,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hotel Dieu Hospital; University of Manitoba","funders":"","keywords":"Hodgkin lymphoma; Lymphoma; Medicine; Oncology; Internal medicine","score_opus":0.07000858373368732,"score_gpt":0.3261071172833843,"score_spread":0.256098533549697,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1895050506","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.2765052,0.7150835,0.0014947236,0.0006711961,0.0004041599,0.00023433044,0.0014578875,0.000039930936,0.0041090893],"genre_scores_gemma":[0.53559726,0.45474637,0.002698135,0.0007449179,0.00026955912,0.00025886192,0.0049195495,0.000032645396,0.00073269586],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99812967,0.000381081,0.0007424457,0.00024478848,0.00041560063,0.00008632631],"domain_scores_gemma":[0.99714345,0.00092719233,0.0009305869,0.00018711723,0.0007163039,0.00009526347],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0034704003,0.0003511186,0.00066343456,0.0062011955,0.00032639905,0.00075844344,0.0007912895,0.0003235737,0.00083822745],"category_scores_gemma":[0.0039393906,0.00026616125,0.00052602415,0.0065090903,0.0006656922,0.0007482077,0.00045495838,0.00021591812,0.00027454103],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00020931524,0.000044017186,0.4435558,0.0085632065,0.0005104046,0.004398152,0.0013890868,0.00024191532,0.0014608749,0.0003189419,0.007975577,0.5313327],"study_design_scores_gemma":[0.000038181104,0.000101310776,0.91936266,0.0064170556,0.00059605035,0.019703222,0.0017150281,0.00019194373,0.00046180972,0.00015531304,0.051225282,0.000032018153],"about_ca_topic_score_codex":0.004554743,"about_ca_topic_score_gemma":0.005485264,"teacher_disagreement_score":0.0062011955,"about_ca_system_score_codex":0.0005094983,"about_ca_system_score_gemma":0.0009292154,"threshold_uncertainty_score":0.018353462},"labels":[],"label_agreement":null},{"id":"W1909983746","doi":"10.1111/j.1365-2141.2005.05866.x","title":"Arsenic trioxide (AT) is a novel human neutrophil pro‐apoptotic agent: effects of catalase on AT‐induced apoptosis, degradation of cytoskeletal proteins and <i>de novo</i> protein synthesis","year":2005,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Retinoids in leukemia and cellular processes","field":"Biochemistry, Genetics and Molecular Biology","cited_by":54,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institut National de la Recherche Scientifique","funders":"Natural Sciences and Engineering Research Council of Canada; Canadian Institutes of Health Research","keywords":"Apoptosis; Arsenic trioxide; Gelsolin; Cell biology; Catalase; Biology; Nicotinamide adenine dinucleotide phosphate; Reactive oxygen species; Chemistry; Biochemistry; Oxidative stress; Actin; Enzyme; Oxidase test","score_opus":0.008687274048559564,"score_gpt":0.23310725470933086,"score_spread":0.2244199806607713,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1909983746","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98557615,0.0085946005,0.0035402456,0.00027463379,0.000079207224,0.00005897464,0.0002459903,0.00010015338,0.0015300557],"genre_scores_gemma":[0.9938876,0.0026945747,0.0016479625,0.00006194708,0.000016805841,0.00002401529,0.00032357624,0.0000055679634,0.0013380283],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9999422,0.000009708176,0.0000073901065,0.0000118806365,0.000019227817,0.00000959435],"domain_scores_gemma":[0.99996614,0.000004520956,0.000010295877,0.000003048088,0.000006819978,0.000009248539],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000072236224,0.0003089793,0.00017363335,0.000109350396,0.000095051124,0.00012909905,0.00013063097,0.00025286135,0.00047320433],"category_scores_gemma":[0.000046092042,0.00007919051,0.00017940666,0.00009999494,0.00011289595,0.000123595,0.00008961779,0.00025926426,0.00011356386],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009111265,0.000023549588,0.00009043017,0.00005314128,0.0000051471898,0.000079314574,0.0000054111183,0.000021666468,0.99818355,0.00003236106,0.000035122634,0.0013790881],"study_design_scores_gemma":[0.000019717474,0.00051110913,0.0014144068,0.000003326648,0.000018128438,0.00051196455,0.00000797571,0.00017376324,0.9952232,0.000019860829,0.002093868,0.0000026259443],"about_ca_topic_score_codex":0.00023602167,"about_ca_topic_score_gemma":0.00039510426,"teacher_disagreement_score":0.00047320433,"about_ca_system_score_codex":0.00019640576,"about_ca_system_score_gemma":0.00013890791,"threshold_uncertainty_score":0.0015830398},"labels":[],"label_agreement":null},{"id":"W1919069136","doi":"10.1111/bjh.13801","title":"Factors influencing long‐term efficacy and tolerability of bosutinib in chronic phase chronic myeloid leukaemia resistant or intolerant to imatinib","year":2015,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":42,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"National Cancer Institute; Teva Pharmaceutical Industries; Pfizer","keywords":"Bosutinib; Medicine; Internal medicine; Imatinib; Tolerability; Cumulative incidence; Adverse effect; Discontinuation; Oncology; Gastroenterology; Myeloid leukemia; Nilotinib; Cohort","score_opus":0.055125360430511784,"score_gpt":0.34971217641064417,"score_spread":0.29458681598013237,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1919069136","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99916875,0.00042254798,0.00006615409,0.000028519513,0.0000028726188,0.000008229089,0.00010047221,0.0000015175306,0.00020097959],"genre_scores_gemma":[0.99967074,0.00006000698,0.00003283245,0.000022404181,0.0000075630305,0.000005366358,0.00014127868,0.0000010960663,0.000058755384],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9994105,0.00027485422,0.00006908546,0.0000720979,0.0000938877,0.00007951005],"domain_scores_gemma":[0.99732924,0.0010074849,0.0012477811,0.000070350834,0.00010401395,0.00024117567],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015886902,0.00014131173,0.0002903684,0.0001412961,0.00015316579,0.00037354094,0.00009886561,0.00022402043,0.0010842538],"category_scores_gemma":[0.0022614368,0.00009148745,0.0005561506,0.0002831376,0.00016345223,0.0002597346,0.00012597459,0.00038689442,0.00013546678],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009882232,0.000252336,0.9705236,0.000061415085,0.0003853547,0.00016676752,0.00008362956,0.00037516092,0.0049310825,0.000028853905,0.00018687178,0.013122712],"study_design_scores_gemma":[0.00009513528,0.00259629,0.9959953,0.000006296149,0.00011695145,0.00022035101,0.000040105908,0.00025342105,0.00039075734,0.000019762263,0.00026060487,0.0000050260405],"about_ca_topic_score_codex":0.0003696617,"about_ca_topic_score_gemma":0.0009216193,"teacher_disagreement_score":0.0015886902,"about_ca_system_score_codex":0.00018393429,"about_ca_system_score_gemma":0.00020714232,"threshold_uncertainty_score":0.008401871},"labels":[],"label_agreement":null},{"id":"W1921751791","doi":"10.1111/bjh.13596","title":"Therapeutic targeting of N‐cadherin is an effective treatment for multiple myeloma","year":2015,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":32,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"Royal Adelaide Hospital; Cancer Australia; Leukaemia Foundation; Multiple Myeloma Research Foundation","keywords":"Cadherin; Stromal cell; Bone marrow; Medicine; Multiple myeloma; Extravasation; Small hairpin RNA; Homing (biology); Cancer research; Pathogenesis; Pathology; Internal medicine; Cell culture; Cell; Chemistry; Biology; Gene knockdown","score_opus":0.0663614294524306,"score_gpt":0.3575109046384235,"score_spread":0.2911494751859929,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1921751791","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8492949,0.12943788,0.00955843,0.0021580895,0.0004574042,0.00025244895,0.00074300624,0.00056767877,0.007530135],"genre_scores_gemma":[0.95613724,0.03531198,0.0031226827,0.00051590963,0.000087787615,0.000102778686,0.0006964113,0.0000153268,0.004009809],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99992526,0.000008656193,0.0000044135218,0.000012441248,0.000033843728,0.000015368383],"domain_scores_gemma":[0.99997663,0.0000028028855,0.000008084363,0.0000023002824,0.000003887222,0.000006272603],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009399026,0.00024002808,0.0003633425,0.00023010706,0.00013781237,0.00018870352,0.00021202966,0.00028536934,0.0011297221],"category_scores_gemma":[0.000060922226,0.00006853061,0.00021616243,0.00022011955,0.00014804471,0.00013697169,0.000186375,0.0006672057,0.0002176245],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00039705602,0.00039325215,0.001296439,0.00072943675,0.00006926117,0.0002596832,0.000034648278,0.00042460862,0.8995759,0.00051620835,0.0020966649,0.09420681],"study_design_scores_gemma":[0.0006261799,0.008731654,0.047727957,0.00017808171,0.00043455407,0.0031446528,0.00010560082,0.0036365916,0.7856237,0.0009341258,0.1488142,0.000042671756],"about_ca_topic_score_codex":0.00044101998,"about_ca_topic_score_gemma":0.0016238103,"teacher_disagreement_score":0.0011297221,"about_ca_system_score_codex":0.000277285,"about_ca_system_score_gemma":0.00017982368,"threshold_uncertainty_score":0.003779292},"labels":[],"label_agreement":null},{"id":"W1921878015","doi":"10.1111/bjh.13538","title":"Novel protein C gene mutation in a compound heterozygote resulting in catastrophic thrombosis in early adulthood: diagnosis and long‐term treatment with subcutaneous protein C concentrate","year":2015,"lang":"en","type":"letter","venue":"British Journal of Haematology","topic":"Blood Coagulation and Thrombosis Mechanisms","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Purpura fulminans; Thrombophilia; Protein C; Compound heterozygosity; Thrombosis; Deep vein; Protein C deficiency; Surgery; Venous thrombosis; Missense mutation; Protein S deficiency; Protein S; Internal medicine; Gastroenterology; Pediatrics; Mutation; Genetics","score_opus":0.037674407542964,"score_gpt":0.2768049761806689,"score_spread":0.2391305686377049,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1921878015","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98926216,0.0011029112,0.0033901958,0.0018240354,0.00019045496,0.00007894519,0.0002820893,0.00014907823,0.0037201059],"genre_scores_gemma":[0.9973271,0.0003623891,0.00089651713,0.00030736212,0.00014130615,0.0000089345385,0.00008332803,0.00001843065,0.00085445895],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.9997193,0.000025808678,0.000026300271,0.00008411304,0.000061030296,0.0000834342],"domain_scores_gemma":[0.9994659,0.00011977334,0.000113650945,0.000018044655,0.000046375684,0.0002363418],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002118096,0.0012571801,0.00076592487,0.0012842623,0.00087981625,0.00042848062,0.0004827947,0.002034876,0.0016840317],"category_scores_gemma":[0.0013760168,0.00040912145,0.0005846463,0.0005867243,0.0006833584,0.0004745832,0.0004846816,0.0012349137,0.00037275514],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000054171178,0.00004530939,0.011502553,0.000014797138,0.0000079317215,0.9836911,0.0001525776,0.000052479874,0.0025707015,0.00015392907,0.00034963584,0.0014047679],"study_design_scores_gemma":[0.000008588481,0.00014481595,0.01033859,0.0000065501677,0.000011124807,0.9882705,0.000047928017,0.00020495782,0.0006265384,0.00006225624,0.00027005895,0.000008082225],"about_ca_topic_score_codex":0.0017135573,"about_ca_topic_score_gemma":0.0018584207,"teacher_disagreement_score":0.002034876,"about_ca_system_score_codex":0.0003982742,"about_ca_system_score_gemma":0.000498973,"threshold_uncertainty_score":0.005633652},"labels":[],"label_agreement":null},{"id":"W1926450100","doi":"10.1111/j.1365-2141.2011.08775.x","title":"Prospective multicentre cohort study of heparin‐induced thrombocytopenia in acute ischaemic stroke patients","year":2011,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Heparin-Induced Thrombocytopenia and Thrombosis","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Medicine; Heparin-induced thrombocytopenia; Heparin; Internal medicine; Stroke (engine); Prospective cohort study; Incidence (geometry); Platelet factor 4; Anticoagulant; Cohort; Surgery","score_opus":0.026132309755626765,"score_gpt":0.2779037198846386,"score_spread":0.25177141012901183,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1926450100","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.999183,0.00016269878,0.00007967228,0.000024305557,0.000013658804,0.000029731918,0.00031144507,0.0000027651827,0.00019264106],"genre_scores_gemma":[0.9991635,0.00009173526,0.00007925234,0.000039632803,0.000017072034,0.000030783543,0.00046836655,0.0000020988298,0.00010756108],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99862003,0.00047498493,0.00013438104,0.0003567623,0.00022120387,0.00019262638],"domain_scores_gemma":[0.9980737,0.00028862094,0.00058459095,0.0002725134,0.0002730941,0.00050755043],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012762382,0.00053559546,0.0007652897,0.00080438826,0.000827553,0.0010457614,0.0005416935,0.00073558657,0.0013836016],"category_scores_gemma":[0.0027155846,0.00081377244,0.00079735345,0.001346452,0.0002922659,0.00064995897,0.00054905016,0.000915907,0.0003523029],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00033819335,0.000080613296,0.9984659,0.000008563839,0.0001711308,0.00015409861,0.00008209059,0.00001681912,0.00018022484,0.00001082677,0.00009008316,0.00040148743],"study_design_scores_gemma":[0.000058022386,0.00030649352,0.9987972,0.0000051674556,0.00006872649,0.00036165596,0.000110930094,0.00013289602,0.000026966965,0.000008930777,0.000116553354,0.0000063580073],"about_ca_topic_score_codex":0.0064095855,"about_ca_topic_score_gemma":0.006024507,"teacher_disagreement_score":0.0064095855,"about_ca_system_score_codex":0.00035339984,"about_ca_system_score_gemma":0.000489912,"threshold_uncertainty_score":0.012744546},"labels":[],"label_agreement":null},{"id":"W1926758277","doi":"10.1111/j.1365-2141.2008.07126.x","title":"Studies in haemoglobin E beta‐thalassaemia","year":2008,"lang":"en","type":"review","venue":"British Journal of Haematology","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":106,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto General Hospital; University of Toronto","funders":"","keywords":"Malaria; Medicine; Hemoglobinopathy; Cohort; Pediatrics; Natural history; Blood transfusion; Beta-thalassaemia; Thalassemia; Hemoglobin E; Immunology; Internal medicine; Hemolytic anemia","score_opus":0.0764617794259594,"score_gpt":0.3776077192738386,"score_spread":0.30114593984787924,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1926758277","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000095972915,0.99935585,0.000017614979,0.000095565294,0.00006530463,0.0000023703424,0.000009320008,0.00000121941,0.00035682908],"genre_scores_gemma":[0.00065605383,0.99896526,0.000041752493,0.00009854754,0.00006818135,0.0000032387895,0.000015560992,4.9694887e-7,0.00015095175],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99959356,0.00009334613,0.00008195125,0.00008091735,0.00012538272,0.000024817362],"domain_scores_gemma":[0.9988121,0.00065683026,0.00021406871,0.000031354048,0.00022691124,0.000058689293],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012088502,0.0007337085,0.0020841556,0.0035779797,0.000237713,0.00096377503,0.0009530875,0.0010889294,0.0051275417],"category_scores_gemma":[0.0028831954,0.00027144354,0.0006804989,0.0062572765,0.00057813997,0.0012235694,0.00064577634,0.00095124054,0.0014893323],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012216637,0.00004736148,0.0008120019,0.06352095,0.00021041188,0.00056841987,0.00016784859,0.00021696936,0.0006816408,0.001601928,0.023308214,0.90874195],"study_design_scores_gemma":[0.000064634856,0.0002024102,0.007013101,0.032818794,0.0006205706,0.008677083,0.00025085086,0.000054379754,0.00040556403,0.0014487922,0.9484099,0.000033824494],"about_ca_topic_score_codex":0.002422069,"about_ca_topic_score_gemma":0.0031244343,"teacher_disagreement_score":0.0051275417,"about_ca_system_score_codex":0.00067801046,"about_ca_system_score_gemma":0.0013494812,"threshold_uncertainty_score":0.017153382},"labels":[],"label_agreement":null},{"id":"W1929921628","doi":"10.1111/j.1365-2141.2010.08342.x","title":"The class‐I HDAC inhibitor MGCD0103 induces apoptosis in Hodgkin lymphoma cell lines and synergizes with proteasome inhibitors by an HDAC6‐independent mechanism","year":2010,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Histone Deacetylase Inhibitors Research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":57,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Pyrogenesis (Canada)","funders":"National Cancer Institute","keywords":"Proteasome; Cancer research; Proteasome inhibitor; Histone deacetylase; Carfilzomib; HDAC6; Apoptosis; In vivo; Bortezomib; Lymphoma; Biology; Cell culture; Chemistry; Multiple myeloma; Cell biology; Immunology; Histone; Biochemistry; Gene","score_opus":0.004500906008880796,"score_gpt":0.2286580455090533,"score_spread":0.22415713950017252,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1929921628","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99329454,0.0033750965,0.0009004197,0.00009022451,0.000044237444,0.00005156658,0.00027308808,0.00012042015,0.0018502728],"genre_scores_gemma":[0.99580705,0.001601654,0.0007274072,0.000074464435,0.00001644907,0.00003769196,0.0004899449,0.000011231057,0.0012340393],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.999879,0.000023483331,0.000013211756,0.000013761892,0.00003500124,0.000035419667],"domain_scores_gemma":[0.99994206,0.000011795163,0.000014133018,0.000009359278,0.0000061175865,0.00001648876],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015905182,0.00031287104,0.0004325284,0.00024224394,0.00013618157,0.0002522358,0.00017654218,0.00018085401,0.00091292855],"category_scores_gemma":[0.00008665577,0.00013816419,0.00028856297,0.00025102828,0.00015991268,0.0001163762,0.00015440799,0.0004318243,0.00027403765],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00089402066,0.00029594635,0.0010768066,0.000107026746,0.0000375557,0.00007081562,0.000028933966,0.00022934482,0.98527086,0.00010212008,0.0003501476,0.0115364175],"study_design_scores_gemma":[0.00029169075,0.003650975,0.014804079,0.000009455532,0.00006630973,0.00050308864,0.000040697396,0.00106962,0.9745368,0.0000679735,0.004952051,0.0000072479825],"about_ca_topic_score_codex":0.00087424397,"about_ca_topic_score_gemma":0.0029488367,"teacher_disagreement_score":0.00091292855,"about_ca_system_score_codex":0.0003440567,"about_ca_system_score_gemma":0.00027937445,"threshold_uncertainty_score":0.0030540824},"labels":[],"label_agreement":null},{"id":"W1939515160","doi":"10.1111/j.1365-2141.2010.08216.x","title":"Stable long‐term risk of leukaemia in patients with severe congenital neutropenia maintained on G‐CSF therapy","year":2010,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Blood disorders and treatments","field":"Biochemistry, Genetics and Molecular Biology","cited_by":261,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; University of Toronto","funders":"National Institute of Allergy and Infectious Diseases; National Cancer Institute; National Heart, Lung, and Blood Institute; National Institutes of Health","keywords":"Medicine; Congenital Neutropenia; Neutropenia; Granulocyte colony-stimulating factor; Filgrastim; Sepsis; Risk factor; Dyskeratosis congenita; Fanconi anemia; Pediatrics; Internal medicine; Myelodysplastic syndromes; Chemotherapy; Bone marrow","score_opus":0.003108226000964866,"score_gpt":0.20130763152807685,"score_spread":0.198199405527112,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1939515160","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99911267,0.00048520276,0.000041710813,0.000034050325,0.000003993828,0.0000024446495,0.000075678065,0.000002098457,0.0002419851],"genre_scores_gemma":[0.99967885,0.000087108165,0.0000233163,0.00001765696,0.000007846414,0.0000018451861,0.00011793616,0.0000010823101,0.000064359025],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9995809,0.00011962776,0.000050896662,0.00007300824,0.00007407843,0.00010148204],"domain_scores_gemma":[0.99795413,0.00031635945,0.00088269124,0.00015740271,0.00012763769,0.0005616959],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004714927,0.00017908175,0.00040461047,0.00058490963,0.00048335653,0.00070575625,0.00029131837,0.00059405854,0.00083757984],"category_scores_gemma":[0.0024822862,0.00018003813,0.00037088,0.0010413012,0.00031872312,0.00041578678,0.00035043308,0.00055759563,0.00014245033],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007309924,0.000022133376,0.9958384,0.000005822924,0.000042586416,0.00047714153,0.00005964858,0.00008067205,0.00038438302,0.000029880244,0.000051997842,0.0022764527],"study_design_scores_gemma":[0.000023825385,0.00040915378,0.9968087,0.000006509989,0.000044452885,0.0020047803,0.00007932084,0.0001756825,0.0001226168,0.00008161553,0.00023520149,0.000008125598],"about_ca_topic_score_codex":0.002215639,"about_ca_topic_score_gemma":0.0019727487,"teacher_disagreement_score":0.002215639,"about_ca_system_score_codex":0.00038670673,"about_ca_system_score_gemma":0.0004292394,"threshold_uncertainty_score":0.004405439},"labels":[],"label_agreement":null},{"id":"W1946820278","doi":"10.1111/bjh.13790","title":"Myeloma impairs mature osteoblast function but causes early expansion of osteo‐progenitors: temporal changes in bone physiology and gene expression in the KMS12BM model","year":2015,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":37,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"University College London; Leukaemia and Lymphoma Research; Leukemia and Lymphoma Research; Cancer Research UK; National Institute for Health and Care Research; Organisation Canadienne des Physiciens Médicaux","keywords":"Osteoblast; Progenitor cell; Osteoclast; Bone resorption; Bone remodeling; Resorption; Cell biology; Stromal cell; Medicine; Biology; Pathology; Cancer research; Internal medicine; Stem cell; In vitro; Receptor; Genetics","score_opus":0.03064421872906813,"score_gpt":0.283161634324778,"score_spread":0.25251741559570984,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1946820278","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99401045,0.0018522545,0.0018734431,0.00012307044,0.000026278432,0.000049782648,0.00087151286,0.00014499499,0.0010481833],"genre_scores_gemma":[0.991234,0.001077595,0.0023322096,0.000059048885,0.000012377626,0.0001140877,0.0007311026,0.000039733706,0.004399822],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9996458,0.000046680292,0.000035109675,0.000051454404,0.00012229844,0.00009866633],"domain_scores_gemma":[0.99981076,0.00002358517,0.000049061855,0.000027453732,0.000017211825,0.00007195324],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00025323217,0.00034203983,0.0006911772,0.00054919464,0.00023706547,0.00035215516,0.00027779117,0.00054498436,0.0014866663],"category_scores_gemma":[0.00012663931,0.00025458835,0.00033906623,0.00045710194,0.00032316186,0.00022666268,0.00025248024,0.0010510464,0.00044564047],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00054630847,0.00012895555,0.0003227311,0.000028389166,0.0000039067263,0.0000838401,0.000024283698,0.000055330536,0.997681,0.000055268254,0.000042740594,0.0010272011],"study_design_scores_gemma":[0.00006147032,0.0023359999,0.015197527,0.000010992028,0.000029262446,0.0006408849,0.000091299145,0.000957796,0.97820973,0.000120402394,0.0023334962,0.000011132083],"about_ca_topic_score_codex":0.0014341186,"about_ca_topic_score_gemma":0.0020540946,"teacher_disagreement_score":0.0014866663,"about_ca_system_score_codex":0.00031898665,"about_ca_system_score_gemma":0.00026394677,"threshold_uncertainty_score":0.004973352},"labels":[],"label_agreement":null},{"id":"W1963879883","doi":"10.1111/j.1365-2141.2008.07353.x","title":"Phase II multicenter study of oblimersen sodium, a Bcl‐2 antisense oligonucleotide, in combination with rituximab in patients with recurrent B‐cell non‐Hodgkin lymphoma","year":2008,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":105,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"National Cancer Institute","keywords":"Rituximab; Lymphoma; Medicine; Cancer research; Oligonucleotide; Hodgkin lymphoma; Monoclonal; Internal medicine; Oncology; Monoclonal antibody; Immunology; Chemistry; Antibody; Biochemistry; Gene","score_opus":0.010358930872147341,"score_gpt":0.24942293107160227,"score_spread":0.23906400019945492,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1963879883","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9955285,0.0018612172,0.00035975824,0.00025562732,0.000099450066,0.0010700539,0.00018275066,0.000059851187,0.00058280246],"genre_scores_gemma":[0.9934056,0.0017019395,0.0011049107,0.00038235725,0.00021296319,0.001297944,0.0005542366,0.000024465096,0.0013156392],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9992173,0.00050965755,0.000035812613,0.00010116031,0.00005375197,0.00008232836],"domain_scores_gemma":[0.99932504,0.00012624844,0.00013346427,0.000050471288,0.000043661596,0.00032108574],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002021982,0.0014417012,0.0027636795,0.0004367112,0.00033955422,0.00076909835,0.0008309049,0.0010691034,0.0017278815],"category_scores_gemma":[0.0010919294,0.00058991346,0.00088388054,0.0003924275,0.0009990333,0.00071985496,0.00037438443,0.0018681651,0.00058226],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.82096153,0.048218198,0.005744512,0.0006967259,0.0018007937,0.0002609281,0.00040786777,0.0015625169,0.03587919,0.00018322938,0.0015553242,0.08272904],"study_design_scores_gemma":[0.6019359,0.38852397,0.0049645053,0.00001762323,0.00050845696,0.00014668143,0.00005069257,0.00053785404,0.0018953851,0.000050737115,0.0013527711,0.000015479318],"about_ca_topic_score_codex":0.00091045856,"about_ca_topic_score_gemma":0.0017339942,"teacher_disagreement_score":0.0027636795,"about_ca_system_score_codex":0.00069614174,"about_ca_system_score_gemma":0.0010380865,"threshold_uncertainty_score":0.010693371},"labels":[],"label_agreement":null},{"id":"W1963910097","doi":"10.1111/bjh.12414","title":"Central nervous system involvement with multiple myeloma: long term survival can be achieved with radiation, intrathecal chemotherapy, and immunomodulatory agents","year":2013,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":117,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto General Hospital; Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Etoposide; Multiple myeloma; Chemotherapy; Cyclophosphamide; Dexamethasone; Bortezomib; Radiation therapy; Internal medicine; Oncology; Surgery; Gastroenterology","score_opus":0.013725923017352431,"score_gpt":0.24364246069732953,"score_spread":0.2299165376799771,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1963910097","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98868877,0.009160877,0.00043286354,0.00012548736,0.000010363911,0.0000051584143,0.00006194861,0.00001495532,0.001499513],"genre_scores_gemma":[0.99860966,0.001072251,0.00008978477,0.000040013176,0.000019077126,0.0000035578494,0.00006952681,0.0000016352385,0.00009452733],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99979645,0.000055433055,0.00002792383,0.000026312939,0.000045875615,0.000048075537],"domain_scores_gemma":[0.9990251,0.00026106357,0.00046265006,0.000056612836,0.00006312981,0.00013140152],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00049240247,0.00015049019,0.00032704414,0.00019921636,0.00023503877,0.00031396377,0.00014631014,0.00019135284,0.0008798409],"category_scores_gemma":[0.0016307521,0.00007103573,0.00031526794,0.00035306174,0.00024510364,0.0002875046,0.0004315891,0.0003063529,0.00014748295],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013846705,0.00011698889,0.89830095,0.00014620907,0.00034109523,0.0013565632,0.00015641637,0.000496007,0.0049137203,0.00006987798,0.00038297626,0.09233455],"study_design_scores_gemma":[0.000030140794,0.0015063959,0.98597604,0.000076326156,0.00036450246,0.008287098,0.00012235332,0.00035048692,0.0012835773,0.00012173248,0.0018728261,0.000008548039],"about_ca_topic_score_codex":0.000290657,"about_ca_topic_score_gemma":0.0007743565,"teacher_disagreement_score":0.0008798409,"about_ca_system_score_codex":0.00018450622,"about_ca_system_score_gemma":0.0001551064,"threshold_uncertainty_score":0.0029433966},"labels":[],"label_agreement":null},{"id":"W1964138393","doi":"10.1046/j.1365-2141.2001.03160.x","title":"Matrix metalloproteinase and tissue inhibitors of metalloproteinase secretion by haematopoietic and stromal precursors and their production in normal and leukaemic long‐term marrow cultures","year":2001,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Protease and Inhibitor Mechanisms","field":"Biochemistry, Genetics and Molecular Biology","cited_by":50,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta; Canadian Blood Services","funders":"National Heart, Lung, and Blood Institute","keywords":"Haematopoiesis; Matrix metalloproteinase; Stromal cell; Bone marrow; Biology; Fibroblast; Extracellular matrix; Cell culture; Immunology; Molecular biology; Cell biology; Chemistry; Stem cell; Cancer research; Biochemistry","score_opus":0.004555753348917518,"score_gpt":0.23046732550712123,"score_spread":0.2259115721582037,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1964138393","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98744696,0.007861948,0.0027771941,0.00003510389,0.00002728294,0.00006454975,0.00069890165,0.00003430327,0.0010537438],"genre_scores_gemma":[0.9852846,0.0034055603,0.004890915,0.00004259616,0.000042692547,0.00022229872,0.0029809277,0.0000130496055,0.0031173904],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9997694,0.000042223182,0.000045028413,0.000036528887,0.00007323709,0.000033602086],"domain_scores_gemma":[0.99975795,0.00005457097,0.00004193209,0.000037513553,0.000053770542,0.000054275286],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00031720262,0.00022982707,0.00025872176,0.00030075223,0.00011615612,0.00032225857,0.000224672,0.00017100334,0.0012507847],"category_scores_gemma":[0.00029183546,0.00011966633,0.0001424529,0.00026158456,0.00016650998,0.0001904144,0.00028528992,0.0003918811,0.00048395197],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00039088645,0.000050532006,0.0010523206,0.000054960732,0.000004660581,0.00016188988,0.00010525429,0.000031199153,0.9962921,0.000067730885,0.00003510272,0.0017535004],"study_design_scores_gemma":[0.00007746756,0.001903989,0.05694774,0.00004560776,0.00005974981,0.002079025,0.00031048997,0.0010496585,0.926872,0.00019438732,0.01044021,0.000019614514],"about_ca_topic_score_codex":0.0004055187,"about_ca_topic_score_gemma":0.0005670686,"teacher_disagreement_score":0.0012507847,"about_ca_system_score_codex":0.00013895548,"about_ca_system_score_gemma":0.00016423008,"threshold_uncertainty_score":0.004184246},"labels":[],"label_agreement":null},{"id":"W1964249329","doi":"10.1046/j.1365-2141.2003.03971.x","title":"The effects of chemotherapeutic agents on the regulation of thrombin on cell surfaces","year":2003,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Blood Coagulation and Thrombosis Mechanisms","field":"Medicine","cited_by":26,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Hospital for Sick Children","funders":"Heart and Stroke Foundation of Canada","keywords":"Thrombin; Vincristine; Tissue factor; Thrombomodulin; Downregulation and upregulation; Pharmacology; Cancer research; Coagulation; Chemistry; Medicine; Immunology; Internal medicine; Chemotherapy; Platelet; Cyclophosphamide; Biochemistry","score_opus":0.018761409451240846,"score_gpt":0.26089836508366904,"score_spread":0.24213695563242818,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1964249329","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.986035,0.010195475,0.0009406849,0.00011925721,0.000043381246,0.000033801145,0.00026766368,0.000028161225,0.0023365354],"genre_scores_gemma":[0.9940891,0.004107134,0.00053615344,0.000048495913,0.000014263525,0.000026969861,0.00020186292,0.0000065718896,0.0009694735],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998447,0.000048021946,0.00001417962,0.000023249728,0.000040961826,0.000028858281],"domain_scores_gemma":[0.9999006,0.000030008658,0.0000278643,0.000018079898,0.000013783296,0.000009657271],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00006853388,0.00020064686,0.00021012219,0.00017261667,0.00014215031,0.000257257,0.00007811148,0.00019309254,0.0014526027],"category_scores_gemma":[0.00015559688,0.00008437013,0.00019362888,0.00015857557,0.0001185422,0.0001387082,0.00010643323,0.0002454893,0.00028966775],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017307304,0.00004806702,0.00074091495,0.000060845734,0.00001530662,0.00010269105,0.000016119408,0.00007826648,0.99393576,0.000051449508,0.00006269582,0.0047148294],"study_design_scores_gemma":[0.000017605562,0.001069869,0.03147132,0.00001018175,0.000043722834,0.00037831833,0.0000429116,0.00050566276,0.9628924,0.000041614916,0.0035213712,0.000005079224],"about_ca_topic_score_codex":0.00047914806,"about_ca_topic_score_gemma":0.000663232,"teacher_disagreement_score":0.0014526027,"about_ca_system_score_codex":0.0002378293,"about_ca_system_score_gemma":0.00008501672,"threshold_uncertainty_score":0.004859388},"labels":[],"label_agreement":null},{"id":"W1964282764","doi":"10.1046/j.1365-2141.2001.02840.x","title":"Identification of both myeloid CD11c<sup>+</sup> and lymphoid CD11c<sup>−</sup> dendritic cell subsets in cord blood","year":2001,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Immunotherapy and Immune Responses","field":"Immunology and Microbiology","cited_by":91,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Network for Business Sustainability","funders":"","keywords":"CD11c; Myeloid; Immunology; Dendritic cell; Cord blood; CD33; Biology; Lymphatic system; CD80; T cell; Interleukin-3 receptor; Follicular dendritic cells; Antigen-presenting cell; Phenotype; Antigen; Stem cell; Immune system; Cytotoxic T cell; CD40; Cell biology; CD34; In vitro; Gene","score_opus":0.008034873086710024,"score_gpt":0.22709489989909828,"score_spread":0.21906002681238826,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1964282764","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99469537,0.0017171227,0.0019243164,0.0000643095,0.000009483138,0.00004644925,0.00039588378,0.00003418854,0.0011130155],"genre_scores_gemma":[0.9935214,0.0013389635,0.0026050573,0.00013014917,0.000029306262,0.00007405252,0.0009581975,0.000021256341,0.0013216066],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99979573,0.000028285398,0.000028883438,0.000045496483,0.000053123254,0.00004851776],"domain_scores_gemma":[0.99981636,0.000018724459,0.000049534578,0.000020448122,0.000029603198,0.000065352666],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002330523,0.00017389265,0.00024136738,0.00056124676,0.00015393065,0.000476923,0.00020832081,0.0002738258,0.0011703215],"category_scores_gemma":[0.00023316119,0.00013780475,0.00012002998,0.0003483159,0.00021823581,0.00013698605,0.00028903905,0.00037501365,0.0005798949],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00034629263,0.000023027516,0.00929388,0.000057802907,0.0000039074175,0.00021692314,0.000060761493,0.000029680927,0.9827527,0.00013023465,0.00006954192,0.0070152883],"study_design_scores_gemma":[0.00008737249,0.0010024669,0.3590163,0.000096718075,0.00006610649,0.0072109913,0.00034100225,0.0013769456,0.61694187,0.00042294015,0.01341064,0.000026579793],"about_ca_topic_score_codex":0.0006396058,"about_ca_topic_score_gemma":0.00056850165,"teacher_disagreement_score":0.0011703215,"about_ca_system_score_codex":0.00022952553,"about_ca_system_score_gemma":0.00024506086,"threshold_uncertainty_score":0.0039150715},"labels":[],"label_agreement":null},{"id":"W1964495651","doi":"10.1046/j.1365-2141.2003.04086.x","title":"Follicular lymphoma lacking the t(14;18)(q32;q21): identification of two disease subtypes","year":2003,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":140,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"National Cancer Institute; BC Cancer Agency; National Institutes of Health; Deutsche Krebshilfe","keywords":"BCL6; Biology; Follicular lymphoma; Fluorescence in situ hybridization; Karyotype; Lymphoma; Cytogenetics; Gene rearrangement; Immunohistochemistry; Pathology; Follicular phase; Molecular biology; Cancer research; Chromosome; Genetics; Immunology; B cell; Germinal center; Antibody; Gene; Medicine","score_opus":0.01638694824535327,"score_gpt":0.2833452304685933,"score_spread":0.26695828222324003,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1964495651","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9993734,0.0002334015,0.00015845387,0.000008427086,8.509643e-7,0.000015161495,0.000026821685,0.0000037732425,0.00017977004],"genre_scores_gemma":[0.999401,0.00007816599,0.00024700424,0.000010266345,0.000007707646,0.000019049776,0.0001605896,0.0000023229516,0.00007383386],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9995208,0.00007875372,0.000070415044,0.00012179946,0.000081626735,0.0001266927],"domain_scores_gemma":[0.9992545,0.00017325938,0.00024353182,0.000078003526,0.00007569675,0.00017502939],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00062661653,0.0004017628,0.00054152956,0.0015460515,0.00037586974,0.0006424546,0.00040318375,0.000629484,0.00078563864],"category_scores_gemma":[0.0016806985,0.00021719436,0.00019677689,0.000711748,0.00063588604,0.0004057039,0.0007576726,0.00025515235,0.00032085238],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00094016135,0.00012423901,0.9559692,0.00003684081,0.000034151853,0.0034311786,0.0004927103,0.00007737908,0.026314076,0.00012739027,0.0001032068,0.01234934],"study_design_scores_gemma":[0.00019377675,0.00076467276,0.9336537,0.000020662996,0.00006460319,0.059133347,0.0008184576,0.00073471933,0.0032490254,0.0004652614,0.00087708805,0.000024656776],"about_ca_topic_score_codex":0.0011660851,"about_ca_topic_score_gemma":0.0007837307,"teacher_disagreement_score":0.0015460515,"about_ca_system_score_codex":0.000360628,"about_ca_system_score_gemma":0.00025778907,"threshold_uncertainty_score":0.0033139586},"labels":[],"label_agreement":null},{"id":"W1964751152","doi":"10.1046/j.1365-2141.2002.03365.x","title":"Immunomodulatory gene therapy for haematological malignancies","year":2002,"lang":"en","type":"review","venue":"British Journal of Haematology","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":16,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Multiple myeloma; Clinical trial; Medicine; Genetic enhancement; Transplantation; Disease; Oncology; Internal medicine; Immunology; Gene; Biology; Genetics","score_opus":0.06095631754002151,"score_gpt":0.3451899757516989,"score_spread":0.2842336582116774,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1964751152","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.080703326,0.8605072,0.009885997,0.005525413,0.0014271722,0.00037201846,0.00039731557,0.00027162625,0.04090987],"genre_scores_gemma":[0.38537338,0.5699214,0.01528843,0.0044603194,0.0022559639,0.00061383494,0.0014604079,0.00006785801,0.020558376],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99978405,0.000058786594,0.000014183574,0.000028242506,0.00008492665,0.000029744017],"domain_scores_gemma":[0.999845,0.000052188436,0.00003756834,0.000016067743,0.000021106556,0.000028108423],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00055917876,0.0001859293,0.0003370966,0.00055650243,0.00013803753,0.00049653806,0.00023182959,0.00034505693,0.004302302],"category_scores_gemma":[0.00041898634,0.000047850554,0.00023935025,0.0004172539,0.00026652133,0.00038439812,0.00031316918,0.00056592154,0.001215326],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00059850625,0.0003829775,0.0012733301,0.001435199,0.000042413438,0.00025972264,0.000056054923,0.0002649844,0.06162115,0.004792214,0.015629586,0.91364384],"study_design_scores_gemma":[0.0006599318,0.004574635,0.009809291,0.0008226392,0.00017264378,0.0051751286,0.00007313216,0.000789795,0.061619062,0.0047959965,0.9114832,0.000024606932],"about_ca_topic_score_codex":0.000099857534,"about_ca_topic_score_gemma":0.00021245523,"teacher_disagreement_score":0.004302302,"about_ca_system_score_codex":0.00036291065,"about_ca_system_score_gemma":0.00036779427,"threshold_uncertainty_score":0.014392614},"labels":[],"label_agreement":null},{"id":"W1965169783","doi":"10.1111/bjh.12187","title":"<i><scp>BCR</scp>‐<scp>ABL</scp>1</i> transcript at 3 months predicts long‐term outcomes following second generation tyrosine kinase inhibitor therapy in the patients with chronic myeloid leukaemia in chronic phase who failed Imatinib","year":2012,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":27,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto General Hospital; Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"","keywords":"Imatinib; Medicine; Tyrosine kinase; Internal medicine; Tyrosine-kinase inhibitor; Myeloid leukemia; ABL; Gastroenterology; Oncology; Immunology; Receptor; Cancer","score_opus":0.017634749593782983,"score_gpt":0.26789628347300787,"score_spread":0.2502615338792249,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1965169783","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99963355,0.0001312881,0.00002874612,0.000013230587,0.0000012934896,0.000002010819,0.000058903777,0.0000011777087,0.00012959937],"genre_scores_gemma":[0.9996455,0.000055422675,0.00003846764,0.000008704849,0.0000044913754,0.0000033908727,0.00015887112,6.288404e-7,0.000084526495],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99987817,0.000028877861,0.000013542903,0.000023037273,0.000026459284,0.000029840496],"domain_scores_gemma":[0.99929106,0.00019822617,0.00032499095,0.00001991652,0.000051671595,0.000114063834],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002915679,0.00013950618,0.0002188232,0.00033240076,0.00013230325,0.00033454673,0.00013585498,0.00030246977,0.00078785396],"category_scores_gemma":[0.000895311,0.00011046383,0.00024722982,0.00026331012,0.00021464222,0.00023672417,0.00018194265,0.0002892411,0.00018485489],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005902707,0.00001754862,0.99502337,0.000008104643,0.000022029359,0.00008725878,0.000024359571,0.00009659328,0.0013763297,0.000005754456,0.00005901477,0.0026893644],"study_design_scores_gemma":[0.00001028285,0.00031026316,0.9984163,0.0000027014057,0.000023134473,0.0005027243,0.000037615973,0.00024006255,0.0002841799,0.000011321745,0.0001589593,0.0000024148067],"about_ca_topic_score_codex":0.00078197947,"about_ca_topic_score_gemma":0.0012787149,"teacher_disagreement_score":0.00078785396,"about_ca_system_score_codex":0.00017275331,"about_ca_system_score_gemma":0.00013828097,"threshold_uncertainty_score":0.0026356578},"labels":[],"label_agreement":null},{"id":"W1965512384","doi":"10.1111/j.1365-2141.2009.07721.x","title":"Highly increased familial risks for specific lymphoma subtypes","year":2009,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":100,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Cancer Institute; Socialstyrelsen; National Institutes of Health; McMaster University; World Health Organization","keywords":"Lymphoma; Follicular lymphoma; Etiology; Medicine; Internal medicine; Diffuse large B-cell lymphoma; Oncology; Population; First-degree relatives; Family history","score_opus":0.027035196651240004,"score_gpt":0.28873266542329595,"score_spread":0.26169746877205596,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1965512384","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99763584,0.00082416093,0.00029405984,0.00009164585,0.0000072404177,0.0000032640567,0.00014409023,0.0000116128585,0.0009880658],"genre_scores_gemma":[0.9993205,0.00021220473,0.00013817279,0.000010694075,0.000012274168,0.000001799183,0.00011565706,0.0000023064479,0.00018634115],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9992249,0.00031738856,0.000047369947,0.00017957832,0.000120156285,0.00011052205],"domain_scores_gemma":[0.9983242,0.00045656785,0.0006479911,0.00025538018,0.00012946456,0.00018631485],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00050478947,0.00024482407,0.0003235321,0.0007973979,0.00047848444,0.0004235295,0.000162455,0.00032642114,0.0022944368],"category_scores_gemma":[0.0029254532,0.00018575351,0.00033902403,0.0008284473,0.00026110292,0.00022189085,0.0003851839,0.00038687044,0.00018261996],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015461602,0.000012966364,0.99329257,0.000009978645,0.000101795864,0.0006734731,0.0001774752,0.00012169282,0.0009609529,0.00010746075,0.000158754,0.004228185],"study_design_scores_gemma":[0.0000061835117,0.000055540266,0.9944352,0.00001057565,0.00008028717,0.0039677056,0.00017886366,0.00016791154,0.00026028208,0.00022359536,0.0006077746,0.000006060125],"about_ca_topic_score_codex":0.003312621,"about_ca_topic_score_gemma":0.0034654469,"teacher_disagreement_score":0.003312621,"about_ca_system_score_codex":0.0002149449,"about_ca_system_score_gemma":0.00015360618,"threshold_uncertainty_score":0.0076757073},"labels":[],"label_agreement":null},{"id":"W1965612700","doi":"10.1046/j.1365-2141.2001.02700.x","title":"Clinical spectrum of hepatitis C‐related liver disease and response to treatment with interferon and ribavirin in haemophilia or von Willebrand disease","year":2001,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Hepatitis C virus research","field":"Medicine","cited_by":26,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre for Movement Disorders","funders":"","keywords":"Medicine; Ribavirin; Haemophilia; Gastroenterology; Internal medicine; Hepatitis C; Liver disease; Cirrhosis; Liver biopsy; Hepatitis C virus; Regimen; Pegylated interferon; Alpha interferon; Haemophilia A; Biopsy; Immunology; Interferon; Surgery; Virus","score_opus":0.029891757076658677,"score_gpt":0.3382607030226073,"score_spread":0.3083689459459486,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1965612700","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99882346,0.0005158537,0.000053937434,0.00004297168,0.0000028810023,0.000012042565,0.00003699123,0.0000030872582,0.0005088398],"genre_scores_gemma":[0.9997559,0.0000661991,0.0000371971,0.000028215572,0.000010444802,0.0000068244644,0.00005432354,9.1392303e-7,0.000039869494],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9991578,0.00046298673,0.00010527494,0.0000735138,0.00009508748,0.0001053967],"domain_scores_gemma":[0.99790585,0.0008575413,0.00055436214,0.00005254728,0.00012079635,0.0005090161],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008042289,0.00029457998,0.0004897871,0.0004992109,0.00036380213,0.00027802857,0.00013192078,0.00038099813,0.00091580045],"category_scores_gemma":[0.0032789565,0.00016314066,0.00024196832,0.00029185714,0.0003244114,0.00026279848,0.00023806344,0.00027717557,0.00016938732],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004144474,0.0002181037,0.9788215,0.000055662575,0.00010510738,0.002690528,0.00019865045,0.00029998441,0.0035347866,0.0000519687,0.00018274917,0.009696572],"study_design_scores_gemma":[0.00016173591,0.0016223723,0.99207604,0.000011983603,0.000032780896,0.0051813577,0.00011639452,0.00027096827,0.0002760564,0.00005605004,0.00018419547,0.000010175533],"about_ca_topic_score_codex":0.0004948657,"about_ca_topic_score_gemma":0.00055443606,"teacher_disagreement_score":0.00091580045,"about_ca_system_score_codex":0.00022383493,"about_ca_system_score_gemma":0.00014701104,"threshold_uncertainty_score":0.0042532086},"labels":[],"label_agreement":null},{"id":"W1965641972","doi":"10.1111/j.1365-2141.2008.07309.x","title":"High efficacy with five days schedule of oral fludarabine phosphate and cyclophosphamide in patients with previously untreated chronic lymphocytic leukaemia","year":2008,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hotel Dieu Hospital","funders":"","keywords":"Fludarabine; Medicine; Cyclophosphamide; Neutropenia; Internal medicine; Minimal residual disease; Chronic lymphocytic leukemia; Gastroenterology; Toxicity; Chemotherapy; Surgery; Oncology; Leukemia","score_opus":0.00704996961039125,"score_gpt":0.22922121467544762,"score_spread":0.22217124506505637,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1965641972","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9974674,0.0017806051,0.00011540218,0.000058259644,0.000022140279,0.00013495627,0.000058330308,0.000014440766,0.0003485642],"genre_scores_gemma":[0.9986929,0.00050222,0.00019889827,0.00008386514,0.00004489812,0.000108246844,0.00013951906,0.0000031182415,0.00022628605],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.99947554,0.0002507015,0.00003289294,0.00007933957,0.00007023354,0.00009138262],"domain_scores_gemma":[0.99951065,0.000111815876,0.00011457892,0.000041462805,0.000021387172,0.00020012821],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011226587,0.00066740735,0.0017093347,0.00039390722,0.00034152725,0.00053086714,0.00039014744,0.0006381153,0.0008050389],"category_scores_gemma":[0.0010338643,0.00034829715,0.00072480197,0.0004765693,0.0006081449,0.0004101539,0.00019760644,0.0007513293,0.00018184829],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.58130956,0.022375913,0.069841325,0.0011048844,0.0021001785,0.00085172005,0.0005428206,0.0035358898,0.06430678,0.00016724708,0.001417205,0.25244647],"study_design_scores_gemma":[0.1580456,0.684063,0.148967,0.000061818086,0.0007573695,0.00081613456,0.000082757564,0.0010698473,0.0031478733,0.00010539495,0.0028332036,0.00005001147],"about_ca_topic_score_codex":0.0014316215,"about_ca_topic_score_gemma":0.0028171143,"teacher_disagreement_score":0.0017093347,"about_ca_system_score_codex":0.000680259,"about_ca_system_score_gemma":0.00062319764,"threshold_uncertainty_score":0.0059372187},"labels":[],"label_agreement":null},{"id":"W1968020263","doi":"10.1111/bjh.12561","title":"Treatment of elderly patients with acute lymphoblastic leukaemia using a paediatric‐based protocol","year":2013,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":34,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Medicine; Regimen; Induction chemotherapy; Chemotherapy; Acute lymphocytic leukemia; Internal medicine; Maintenance therapy; Surgery; Pediatrics; Lymphoblastic Leukemia; Leukemia","score_opus":0.01307761137033936,"score_gpt":0.28243568657079643,"score_spread":0.26935807520045707,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1968020263","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9935056,0.001406552,0.0010558104,0.00011800621,0.00002140364,0.0009304836,0.00040685013,0.000010795384,0.0025444643],"genre_scores_gemma":[0.98821986,0.0020004704,0.0048718015,0.00021681272,0.00005795775,0.0018266712,0.002162187,0.0000073544393,0.0006368963],"study_design_codex":"observational","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9996251,0.00022637697,0.00005370145,0.000028947332,0.000040154413,0.000025687528],"domain_scores_gemma":[0.9994784,0.0001051255,0.00021204648,0.000052806205,0.00004927034,0.0001023065],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00064407743,0.00014784833,0.00023267817,0.00023114738,0.00017350244,0.00019958292,0.00024246574,0.00011638875,0.0014306736],"category_scores_gemma":[0.0013164394,0.0000709823,0.00019143951,0.000576612,0.00014539821,0.00014246989,0.00037747395,0.00023449617,0.00017124483],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.036940392,0.002990888,0.6194213,0.0021391544,0.00046222017,0.0036659841,0.0010053609,0.006378063,0.02647537,0.0009798438,0.0051140008,0.29442742],"study_design_scores_gemma":[0.003926461,0.026044609,0.9125015,0.0002322183,0.00044596943,0.007789853,0.00044869937,0.0016719846,0.0039666197,0.00032220708,0.04261773,0.000032147273],"about_ca_topic_score_codex":0.00057503773,"about_ca_topic_score_gemma":0.0012720446,"teacher_disagreement_score":0.0014306736,"about_ca_system_score_codex":0.0004868481,"about_ca_system_score_gemma":0.0009031237,"threshold_uncertainty_score":0.0047860146},"labels":[],"label_agreement":null},{"id":"W1968022162","doi":"10.1046/j.1365-2141.2001.02975.x","title":"Persistent polyclonal B‐cell lymphocytosis: further evidence for a genetic disorder associated with B‐cell abnormalities","year":2001,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":34,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval; Hôpital du Saint-Sacrement","funders":"","keywords":"Lymphocytosis; Haplotype; Immunology; Biology; Genetics; Human leukocyte antigen; Population; Allele; First-degree relatives; Polyclonal antibodies; Gene; Medicine; Antigen; Internal medicine; Family history","score_opus":0.03328294935528762,"score_gpt":0.29187458145625084,"score_spread":0.2585916321009632,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1968022162","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9977265,0.00046695245,0.00022669251,0.0001297741,0.000005539016,0.000019387791,0.00007103862,0.00001765053,0.0013364282],"genre_scores_gemma":[0.99927646,0.00015838744,0.00015473935,0.000057930938,0.000029487099,0.000008305202,0.00008542789,0.0000055272626,0.00022373303],"study_design_codex":"case_report","study_design_gemma":"observational","domain_scores_codex":[0.9997454,0.000056934437,0.000023983752,0.000059629347,0.000045633507,0.0000684327],"domain_scores_gemma":[0.9991054,0.0003939305,0.00013371583,0.000074006835,0.00005375754,0.00023922986],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00027457063,0.0006679272,0.0004222009,0.0012338578,0.00078761415,0.00032647996,0.00029912,0.0011487106,0.0047679446],"category_scores_gemma":[0.0015943379,0.00035007982,0.00029953293,0.00073765736,0.0008140951,0.00039558948,0.0005699234,0.0005708223,0.00052386307],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00067523966,0.00029939326,0.39543486,0.00023904338,0.00008503113,0.51851064,0.0014676764,0.000250559,0.069833554,0.00050670095,0.0005597049,0.012137659],"study_design_scores_gemma":[0.00010110569,0.00062472373,0.28685173,0.000033927587,0.00009527012,0.70520455,0.0003783297,0.0004456842,0.004085885,0.00033516347,0.0018241832,0.000019435985],"about_ca_topic_score_codex":0.0013119457,"about_ca_topic_score_gemma":0.0009337328,"teacher_disagreement_score":0.0047679446,"about_ca_system_score_codex":0.00022979573,"about_ca_system_score_gemma":0.00032591895,"threshold_uncertainty_score":0.015950382},"labels":[],"label_agreement":null},{"id":"W1968144270","doi":"10.1111/j.1365-2141.2007.06640.x","title":"Molecular analysis of the human thrombin‐activatable fibrinolysis inhibitor gene promoter","year":2007,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Blood Coagulation and Thrombosis Mechanisms","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Molecular biology; Transcription factor; Promoter; Binding site; Enhancer; Hepatocyte nuclear factors; Gene; Thrombin; Hepatocyte nuclear factor 4; Biology; Gene expression; Reporter gene; Response element; CAAT box; Transcription (linguistics); Chemistry; Biochemistry; Nuclear receptor","score_opus":0.016788022871631537,"score_gpt":0.28246663036943825,"score_spread":0.2656786074978067,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1968144270","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8973694,0.004839555,0.082927585,0.0006430267,0.0001554539,0.00047550577,0.005651846,0.000456722,0.007480952],"genre_scores_gemma":[0.92760044,0.002390823,0.047981795,0.00021082537,0.00004967881,0.00027626342,0.012092657,0.00013484809,0.0092627695],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99982375,0.000027793767,0.000010525589,0.000052316085,0.000049889804,0.000035724715],"domain_scores_gemma":[0.9998752,0.000039379724,0.000024647996,0.000012582963,0.000017840846,0.000030224019],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018595997,0.00030382903,0.00018996595,0.00033805353,0.00026710972,0.00034195406,0.00036740073,0.00026483685,0.0017962945],"category_scores_gemma":[0.00021888704,0.00027932916,0.0004373238,0.00024674635,0.00025031273,0.00015343344,0.00020335773,0.000791162,0.0011350899],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016919417,0.000035918307,0.00019416252,0.000041793075,0.000004254563,0.00006902022,0.000022355014,0.000109442786,0.9972258,0.00027007592,0.000053253272,0.0018047189],"study_design_scores_gemma":[0.0000907634,0.00030413317,0.0072171064,0.00003276991,0.000020899864,0.000558431,0.00006267374,0.0031114644,0.9751359,0.0003103491,0.013141359,0.000014068219],"about_ca_topic_score_codex":0.002198166,"about_ca_topic_score_gemma":0.0017200575,"teacher_disagreement_score":0.002198166,"about_ca_system_score_codex":0.00056030607,"about_ca_system_score_gemma":0.00043918623,"threshold_uncertainty_score":0.006009221},"labels":[],"label_agreement":null},{"id":"W1968232397","doi":"10.1111/bjh.12618","title":"Imatinib 800 mg daily induces deeper molecular responses than imatinib 400 mg daily: results of <scp>SWOG</scp> S0325, an intergroup randomized <scp>PHASE II</scp> trial in newly diagnosed chronic phase chronic myeloid leukaemia","year":2013,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":64,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; Princess Margaret Cancer Centre; Ontario Institute for Cancer Research","funders":"National Cancer Institute","keywords":"Imatinib; Medicine; Internal medicine; Toxicity; Imatinib mesylate; Gastroenterology; Hematology; Phases of clinical research; Chemotherapy; Oncology; Surgery; Myeloid leukemia","score_opus":0.01681967084386809,"score_gpt":0.30572050564883335,"score_spread":0.28890083480496526,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1968232397","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9978777,0.0010916324,0.00009941256,0.00011800435,0.000027956969,0.000065094646,0.00009785198,0.000026155312,0.0005961725],"genre_scores_gemma":[0.9973757,0.0007861683,0.0003062649,0.00019910515,0.00006706287,0.00005635849,0.00032314842,0.000009645654,0.0008765345],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9997999,0.000097676224,0.000015570846,0.000027915567,0.000022838429,0.000036059337],"domain_scores_gemma":[0.99969006,0.00009678207,0.000067162226,0.000027370637,0.000011251038,0.000107458596],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00075142126,0.00040991334,0.0007756922,0.00022774107,0.000100685764,0.0003926578,0.00020759016,0.0003759821,0.0028123],"category_scores_gemma":[0.00059495267,0.0001835667,0.0004190431,0.00021169856,0.00022018503,0.0004474438,0.00013309345,0.0008942001,0.00033507723],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.43151107,0.017360548,0.010445391,0.00074026786,0.0012057436,0.00020867454,0.00025062135,0.0028239898,0.16562727,0.0003868641,0.0036202301,0.36581925],"study_design_scores_gemma":[0.16853715,0.7113271,0.0865547,0.00009522211,0.0009722112,0.0006288934,0.00013921675,0.0042085066,0.021519396,0.0006402385,0.005305747,0.00007168417],"about_ca_topic_score_codex":0.0002474555,"about_ca_topic_score_gemma":0.00081524096,"teacher_disagreement_score":0.0028123,"about_ca_system_score_codex":0.00024247082,"about_ca_system_score_gemma":0.00023935434,"threshold_uncertainty_score":0.009408057},"labels":[],"label_agreement":null},{"id":"W1969261714","doi":"10.1111/j.1365-2141.2009.07674.x","title":"Prior rituximab correlates with less acute graft‐versus‐host disease and better survival in B‐cell lymphoma patients who received allogeneic peripheral blood stem cell transplantation","year":2009,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":71,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"National Cancer Institute","keywords":"Medicine; Rituximab; Internal medicine; Transplantation; Cohort; Gastroenterology; Relative risk; Immunology; Graft-versus-host disease; Lymphoma; Hematopoietic stem cell transplantation; Confidence interval","score_opus":0.0077869163399606,"score_gpt":0.21783098194565167,"score_spread":0.21004406560569108,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1969261714","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.999482,0.00025939944,0.000029212702,0.00002309875,0.0000031174332,0.0000015861017,0.000025809344,0.0000020128948,0.00017385981],"genre_scores_gemma":[0.999765,0.00005868308,0.000018327135,0.000017946519,0.000013778772,0.0000016324066,0.000071572045,8.8662216e-7,0.000052212978],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9996605,0.00012040417,0.00003894718,0.00006566193,0.000056849032,0.00005757513],"domain_scores_gemma":[0.9980732,0.00038812554,0.0010422887,0.00011822799,0.00008872593,0.0002893953],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00053850096,0.00017802518,0.0003240473,0.0004850888,0.00025418063,0.0006215989,0.00019791698,0.00043567937,0.0010847203],"category_scores_gemma":[0.0022202812,0.00020308628,0.00034158427,0.0005246041,0.00025653787,0.00031596664,0.00024055022,0.00059626513,0.0001957163],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000436988,0.000050321305,0.9967194,0.0000064177957,0.00007177825,0.00010794642,0.00003075628,0.000066995744,0.0006655031,0.000009996316,0.000054146156,0.0017796322],"study_design_scores_gemma":[0.000022378508,0.00018752634,0.99890244,0.000003106938,0.000059040714,0.00044334747,0.000032929365,0.00013130784,0.00010346336,0.000014781265,0.000097211894,0.0000023451862],"about_ca_topic_score_codex":0.001444881,"about_ca_topic_score_gemma":0.0016935904,"teacher_disagreement_score":0.001444881,"about_ca_system_score_codex":0.00022807112,"about_ca_system_score_gemma":0.00019979101,"threshold_uncertainty_score":0.0036287308},"labels":[],"label_agreement":null},{"id":"W1969292046","doi":"10.1111/j.1365-2141.2007.06840.x","title":"Outcome of haematopoietic stem cell transplantation for paediatric acute lymphoblastic leukaemia in third complete remission: a vital role for graft‐versus‐host‐disease/ graft‐versus‐leukaemia effect in survival","year":2007,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; SickKids Foundation; Hospital for Sick Children","funders":"","keywords":"Medicine; Transplantation; Hematopoietic stem cell transplantation; Haematopoiesis; Disease; Graft-versus-host disease; Internal medicine; Stem cell; Hematology; Confidence interval; Surgery; Pediatrics","score_opus":0.02138057368382721,"score_gpt":0.2935339296157734,"score_spread":0.2721533559319462,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1969292046","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9982211,0.0011415887,0.00009022063,0.000079703444,0.000007336497,0.000002761691,0.00008756766,0.000004413889,0.0003653289],"genre_scores_gemma":[0.999572,0.00016669344,0.000019617408,0.000015566391,0.000010616783,0.0000014027225,0.00017267,0.0000020879904,0.000039357867],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9992415,0.00030830415,0.00007512625,0.00006306765,0.0001637858,0.000148175],"domain_scores_gemma":[0.99569726,0.0011809472,0.0020325822,0.00024009174,0.00016089756,0.0006881654],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001568932,0.00024764266,0.00044558843,0.00030395362,0.00025661322,0.00057526544,0.00028300672,0.0003891799,0.00064198667],"category_scores_gemma":[0.0047439253,0.00009303541,0.00069986883,0.00052420894,0.0004915445,0.0004492204,0.00048059883,0.0005807063,0.00016804469],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0022346918,0.0000572877,0.98172975,0.00003848771,0.00022347011,0.00064250233,0.00017386484,0.0005882123,0.00042063883,0.000111410794,0.00026833787,0.013511264],"study_design_scores_gemma":[0.000052991913,0.0009851085,0.99502856,0.000021493379,0.00015154555,0.0024601438,0.00006192441,0.00051477324,0.00026729808,0.00016452484,0.0002831492,0.00000846162],"about_ca_topic_score_codex":0.001384312,"about_ca_topic_score_gemma":0.0015368104,"teacher_disagreement_score":0.001568932,"about_ca_system_score_codex":0.00058790937,"about_ca_system_score_gemma":0.0003950058,"threshold_uncertainty_score":0.008297384},"labels":[],"label_agreement":null},{"id":"W1969542486","doi":"10.1046/j.1365-2141.2003.04354.x","title":"Growth regulation by p27<sup>Kip1</sup> is abrogated by multiple mechanisms in aggressive malignant lymphomas","year":2003,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Cancer-related Molecular Pathways","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Women's College Hospital; University of Toronto; Sunnybrook Health Science Centre","funders":"","keywords":"Jurkat cells; Biology; Cyclin; Cyclin-dependent kinase; Cyclin E; Cyclin D3; Kinase; Cancer research; Cell growth; Lymphoma; Cell biology; Molecular biology; Cell cycle; Cyclin-dependent kinase 2; Cell; Protein kinase A; T cell; Immunology; Biochemistry; Immune system","score_opus":0.006221406325623724,"score_gpt":0.2198142490226897,"score_spread":0.21359284269706597,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1969542486","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9962929,0.002037068,0.00070662214,0.000042097836,0.000008593417,0.000012239046,0.00011866185,0.000052402793,0.00072946976],"genre_scores_gemma":[0.99623317,0.0012860469,0.00050750346,0.000033016193,0.000010978997,0.000028842975,0.00033108567,0.000014700996,0.0015547166],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99985015,0.000027991613,0.000011556765,0.000016149985,0.000043899538,0.000050226106],"domain_scores_gemma":[0.9998921,0.000019097017,0.000029662811,0.000017156992,0.000010757727,0.000031167812],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011070203,0.00032485244,0.00030100925,0.00024002626,0.00012010703,0.00040815846,0.00016631308,0.00016963495,0.00086437183],"category_scores_gemma":[0.00008979999,0.00014995561,0.00017480332,0.00015403389,0.00019545465,0.00013768299,0.00021581171,0.0004963195,0.0004160715],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009762427,0.00002422457,0.00029109002,0.000017612376,0.0000027621077,0.00008525634,0.0000099298795,0.000024004714,0.9986222,0.000041884894,0.000019464804,0.00076397235],"study_design_scores_gemma":[0.000026153843,0.00052128267,0.019713044,0.0000066267103,0.000021798798,0.00079239294,0.000054625754,0.0005728368,0.97507715,0.00006184457,0.0031479097,0.0000043116597],"about_ca_topic_score_codex":0.00056071265,"about_ca_topic_score_gemma":0.00066071947,"teacher_disagreement_score":0.00086437183,"about_ca_system_score_codex":0.00024525067,"about_ca_system_score_gemma":0.000202727,"threshold_uncertainty_score":0.0028916597},"labels":[],"label_agreement":null},{"id":"W1969593178","doi":"10.1111/j.1365-2141.2007.06690.x","title":"Distinguishing between non‐identical twins: platelet type and type 2B von Willebrand disease","year":2007,"lang":"en","type":"letter","venue":"British Journal of Haematology","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Queen's University","funders":"","keywords":"Von Willebrand disease; Medicine; Von Willebrand factor; Platelet; Genetic testing; Pediatrics; Immunology; Internal medicine","score_opus":0.019874695440283953,"score_gpt":0.28832925657126623,"score_spread":0.26845456113098226,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1969593178","genre_codex":"empirical","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.987563,0.0022219678,0.00224824,0.0023493145,0.0005007401,0.00007229217,0.0001221865,0.000019899486,0.004902379],"genre_scores_gemma":[0.9949812,0.00110595,0.0021202296,0.00080349616,0.00028559787,0.000008279052,0.000060006834,0.000016548482,0.00061867567],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.99882025,0.00020469687,0.0002192093,0.00017727444,0.00036266178,0.00021588219],"domain_scores_gemma":[0.99787235,0.0007860018,0.00048886554,0.00018590083,0.00022825188,0.0004385984],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010061819,0.0003401549,0.000446579,0.0014948501,0.0008024945,0.0008933316,0.0005691146,0.0010737629,0.0016094176],"category_scores_gemma":[0.010557913,0.00033085444,0.00026789194,0.00073437655,0.001216136,0.00094048807,0.0009775977,0.0014300423,0.00037719193],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00024848146,0.00011302682,0.3568274,0.00013464512,0.00006144951,0.6018838,0.0029619625,0.00012620458,0.0055199913,0.0018286778,0.0028494385,0.027444856],"study_design_scores_gemma":[0.0000134251195,0.00011444668,0.07175607,0.00008010578,0.000042579824,0.919649,0.0016924031,0.0002696762,0.0016818146,0.0015476649,0.0031226997,0.000030045427],"about_ca_topic_score_codex":0.0028626416,"about_ca_topic_score_gemma":0.0041057765,"teacher_disagreement_score":0.0028626416,"about_ca_system_score_codex":0.00035318866,"about_ca_system_score_gemma":0.0005315208,"threshold_uncertainty_score":0.0056919456},"labels":[],"label_agreement":null},{"id":"W1969954034","doi":"10.1111/bjh.12871","title":"Evaluation of allelic strength of human <i><scp>TET</scp>2</i> mutations and cooperation between <i>Tet2</i> knockdown and oncogenic <i>Nras</i> mutation","year":2014,"lang":"en","type":"letter","venue":"British Journal of Haematology","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"National Heart, Lung, and Blood Institute; University of Wisconsin Carbone Cancer Center; National Cancer Institute; National Institutes of Health; Greater Milwaukee Foundation; Leukemia and Lymphoma Society","keywords":"Missense mutation; Genetics; Frameshift mutation; Biology; Mutation; Nonsense mutation; Molecular biology; Allele; Gene; Cancer research","score_opus":0.03862735782896338,"score_gpt":0.3271464282958629,"score_spread":0.2885190704668995,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1969954034","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9886437,0.0007600994,0.005197568,0.00010514705,0.000046060846,0.00009018096,0.0022884218,0.00020805125,0.0026608587],"genre_scores_gemma":[0.99223495,0.00058353145,0.0026451733,0.00008847255,0.0000060466127,0.0000988883,0.0017810687,0.00007870706,0.0024830815],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99955887,0.000060548522,0.000054665776,0.000113735034,0.00016141069,0.00005064657],"domain_scores_gemma":[0.99967873,0.000088469096,0.00007302598,0.000038357703,0.0000436843,0.00007764046],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00040451443,0.00027963825,0.0002465272,0.0004568149,0.00019327711,0.000265989,0.00024068508,0.00040607632,0.0023830987],"category_scores_gemma":[0.00033613914,0.0002037597,0.00028056384,0.00034286286,0.00031653862,0.00013769191,0.00023867458,0.000704461,0.00044175374],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009950799,0.000036673333,0.0009836998,0.000039924067,0.000017742103,0.00021444199,0.000028580514,0.00013811457,0.99692094,0.00011688823,0.000121756486,0.0012818858],"study_design_scores_gemma":[0.00004802493,0.0007419157,0.030122245,0.000011206119,0.00011540419,0.002045725,0.00012594784,0.0030943935,0.95734423,0.00010436643,0.006221874,0.000024740597],"about_ca_topic_score_codex":0.0020123464,"about_ca_topic_score_gemma":0.00342146,"teacher_disagreement_score":0.0023830987,"about_ca_system_score_codex":0.00026793894,"about_ca_system_score_gemma":0.0002357419,"threshold_uncertainty_score":0.0079723},"labels":[],"label_agreement":null},{"id":"W1970405391","doi":"10.1111/j.1365-2141.2009.07601.x","title":"Post‐thrombotic syndrome: prevalence, prognostication and need for progress","year":2009,"lang":"en","type":"review","venue":"British Journal of Haematology","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":279,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Jewish General Hospital","funders":"Canadian Institutes of Health Research; Heart and Stroke Foundation of Canada","keywords":"Medicine; Post-thrombotic syndrome; Deep vein; Thrombosis; Compression stockings; Complication; Intensive care medicine; Venous thrombosis; Surgery","score_opus":0.02576258481807837,"score_gpt":0.33339186993195485,"score_spread":0.3076292851138765,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1970405391","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0014187287,0.9973636,0.00007209016,0.0003969887,0.00009065539,0.000003925273,0.00003215305,0.0000044481935,0.00061743095],"genre_scores_gemma":[0.013740217,0.98556954,0.00015477111,0.00010120686,0.00012863676,0.0000068725753,0.00005933071,0.0000010748507,0.0002383151],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9996815,0.00007910393,0.00007080545,0.00004317318,0.00010504743,0.00002052335],"domain_scores_gemma":[0.99947304,0.00024483853,0.00013578693,0.000010001808,0.000105077925,0.000031263833],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00053415546,0.00035652204,0.0012387348,0.0015122154,0.0001299287,0.000616432,0.0005013967,0.0005584672,0.001783724],"category_scores_gemma":[0.0021558253,0.00013792767,0.00028935418,0.0023089822,0.00031949743,0.0006886606,0.00024370433,0.0006469323,0.00049868156],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021059763,0.00005946895,0.014102967,0.013161568,0.00021902844,0.0008777885,0.00012435242,0.0002269552,0.00030923064,0.0008360088,0.016447796,0.95342416],"study_design_scores_gemma":[0.0002602889,0.00062933326,0.24227332,0.055224374,0.0021055422,0.06921404,0.0015182062,0.0011179928,0.0009141091,0.005184934,0.62140644,0.00015140571],"about_ca_topic_score_codex":0.0011344414,"about_ca_topic_score_gemma":0.0013816529,"teacher_disagreement_score":0.001783724,"about_ca_system_score_codex":0.00033763098,"about_ca_system_score_gemma":0.0006036116,"threshold_uncertainty_score":0.00596714},"labels":[],"label_agreement":null},{"id":"W1970909276","doi":"10.1111/j.1365-2141.2005.05770.x","title":"Florid bone marrow haematogones in a child following treatment for acute lymphoblastic leukaemia","year":2005,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; University of Toronto","funders":"","keywords":"Bone marrow; Terminal deoxynucleotidyl transferase; Pathology; Medicine; Population; CD20; Acute lymphocytic leukemia; Immunology; Leukemia; Lymphoblastic Leukemia; Lymphoma; TUNEL assay","score_opus":0.015941426168312473,"score_gpt":0.3077857726505146,"score_spread":0.29184434648220214,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1970909276","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99047345,0.0023532289,0.00045594978,0.0017877647,0.00012616237,0.00009555549,0.00023714581,0.00008755161,0.0043831686],"genre_scores_gemma":[0.99722856,0.001122552,0.00031766045,0.00046349803,0.00015807837,0.000013207746,0.00012937603,0.000015046538,0.00055203564],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.99961436,0.00004754449,0.000026432885,0.000069216025,0.000074167365,0.0001682767],"domain_scores_gemma":[0.9991479,0.00020712339,0.0001711948,0.000025599324,0.000051709936,0.0003964748],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003501639,0.0011920269,0.0007865278,0.0018712529,0.002082741,0.00095207157,0.0007862703,0.0022281785,0.0020403108],"category_scores_gemma":[0.0021168806,0.00069016416,0.00050231494,0.0011113527,0.0010863349,0.000740306,0.00092589064,0.0022428723,0.0004819694],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006798166,0.000039568204,0.014682414,0.000031554526,0.0000067962565,0.98233837,0.00034489727,0.00003974444,0.0009543343,0.00011386739,0.00021431658,0.0011661411],"study_design_scores_gemma":[0.000028151533,0.00028363118,0.035389658,0.000029470493,0.000025754163,0.9619341,0.000328627,0.00018722292,0.00039947213,0.00014127475,0.001241291,0.000011402203],"about_ca_topic_score_codex":0.004649133,"about_ca_topic_score_gemma":0.008037471,"teacher_disagreement_score":0.004649133,"about_ca_system_score_codex":0.0011901684,"about_ca_system_score_gemma":0.0006917287,"threshold_uncertainty_score":0.009244144},"labels":[],"label_agreement":null},{"id":"W1971050485","doi":"10.1046/j.1365-2141.2001.02554.x","title":"Calcein assay for multidrug resistance reliably predicts therapy response and survival rate in acute myeloid leukaemia","year":2001,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Drug Transport and Resistance Mechanisms","field":"Medicine","cited_by":79,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre","funders":"Hungarian Science Foundation; Hungarian Scientific Research Fund; National Science Foundation","keywords":"Calcein; Medicine; Multiple drug resistance; Internal medicine; Oncology; Chemotherapy; Myeloid leukaemia; Immunology; Drug resistance; Biology","score_opus":0.013900299291501045,"score_gpt":0.2700488293259492,"score_spread":0.25614853003444815,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1971050485","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9976913,0.0009909093,0.00066193374,0.00003682168,0.00000776129,0.000015624859,0.00009936479,0.000022760698,0.00047359418],"genre_scores_gemma":[0.998939,0.00014572253,0.0005301665,0.000010818231,0.00001122129,0.0000068720547,0.00014871913,0.000003150195,0.00020435391],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9993807,0.00023542841,0.00005250929,0.00007008717,0.00020295236,0.00005819847],"domain_scores_gemma":[0.99850535,0.00066573103,0.0004519478,0.00007902254,0.00019777588,0.0001001133],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00078104076,0.00022624899,0.00041679078,0.00083755393,0.0001190035,0.0003848664,0.00016787252,0.0002796353,0.0007816025],"category_scores_gemma":[0.00336849,0.00010302527,0.000103742655,0.0005331801,0.00021277412,0.00016588972,0.00021016205,0.00025806474,0.00026711737],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00093622354,0.00007944834,0.9628575,0.000047496636,0.000046317025,0.00023425352,0.00020693375,0.00039230718,0.017317075,0.000043849104,0.00020371174,0.017634876],"study_design_scores_gemma":[0.000034073048,0.00056699256,0.99027026,0.0000075686003,0.000041098487,0.0011097719,0.00011010626,0.0012017653,0.005596371,0.00007095699,0.0009825047,0.000008512739],"about_ca_topic_score_codex":0.0010690714,"about_ca_topic_score_gemma":0.00088822463,"teacher_disagreement_score":0.0010690714,"about_ca_system_score_codex":0.00018725476,"about_ca_system_score_gemma":0.0001678871,"threshold_uncertainty_score":0.004130602},"labels":[],"label_agreement":null},{"id":"W1971402906","doi":"10.1111/bjh.12642","title":"Single whole‐leg compression ultrasound for exclusion of deep vein thrombosis in symptomatic ambulatory patients: a prospective observational cohort study","year":2013,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital","funders":"College of Emergency Medicine; National Institute for Health and Care Research","keywords":"Medicine; Prospective cohort study; Ambulatory; Deep vein; Thrombosis; Confidence interval; Cohort study; Cohort; Adverse effect; Observational study; Surgery; Internal medicine; Emergency medicine","score_opus":0.01952019382695455,"score_gpt":0.2767704098926843,"score_spread":0.25725021606572973,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1971402906","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.999539,0.0001501416,0.000055430675,0.00002139594,0.000006969894,0.000016069689,0.00012094005,0.0000018695494,0.00008834537],"genre_scores_gemma":[0.99942064,0.000102874095,0.00009363622,0.00003364683,0.000021004164,0.00002044196,0.00025524234,0.000002081166,0.00005047356],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983088,0.0005664775,0.00019598495,0.00043782295,0.0002938457,0.00019709399],"domain_scores_gemma":[0.9949974,0.0012766595,0.0019034729,0.000641747,0.00033693673,0.00084373757],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002118279,0.0005428717,0.00090668193,0.0007284127,0.0006816147,0.0011683366,0.0007725754,0.0012302826,0.0020525712],"category_scores_gemma":[0.005813,0.00082622183,0.0011073343,0.0012821894,0.000513728,0.00096954824,0.00070576434,0.0014152519,0.00034673142],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00083036633,0.00021644912,0.99755317,0.000017387274,0.00017067119,0.00021077754,0.000085680585,0.000024031444,0.00021351546,0.000010865984,0.000079921294,0.00058718136],"study_design_scores_gemma":[0.00013659295,0.00088608585,0.99761766,0.0000129179425,0.00013407036,0.00059065747,0.00016841371,0.0002966809,0.000035513352,0.000020477717,0.000090193695,0.000010761082],"about_ca_topic_score_codex":0.0038413939,"about_ca_topic_score_gemma":0.0037345472,"teacher_disagreement_score":0.0038413939,"about_ca_system_score_codex":0.0003540274,"about_ca_system_score_gemma":0.0005281714,"threshold_uncertainty_score":0.011202633},"labels":[],"label_agreement":null},{"id":"W1973637908","doi":"10.1046/j.1365-2141.2002.03371.x","title":"Abnormal telomere shortening in leucocytes of children with Shwachman–Diamond syndrome","year":2002,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Blood disorders and treatments","field":"Biochemistry, Genetics and Molecular Biology","cited_by":51,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children; University of Toronto","funders":"Canadian Institutes of Health Research; Hospital for Sick Children; Sick Kids Foundation","keywords":"Telomere; Cytopenia; Stem cell; Aplasia; Basophilia; Immunology; Biology; Medicine; Internal medicine; Pathology; Bone marrow; Genetics; Gene","score_opus":0.005793199851881662,"score_gpt":0.19681144405915468,"score_spread":0.191018244207273,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1973637908","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9996364,0.00011283448,0.00007478324,0.00001224221,0.0000015153536,0.0000024351245,0.000040627427,0.0000044102608,0.00011476132],"genre_scores_gemma":[0.99967,0.00009248662,0.000090996844,0.000011026396,0.0000032848225,0.0000033275705,0.000055584478,0.0000021610688,0.000070977716],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99978226,0.000043599546,0.000027613332,0.00005206779,0.00005879871,0.000035730114],"domain_scores_gemma":[0.9996749,0.00007490667,0.0001346091,0.000014754036,0.000028280201,0.0000725367],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018661362,0.00034430687,0.00029976002,0.0010162131,0.0002954122,0.00028155372,0.00012646854,0.0003124564,0.00071652187],"category_scores_gemma":[0.0010689823,0.00023414342,0.00014804796,0.00041543457,0.00043434286,0.00019475611,0.0002562565,0.000296201,0.0001274799],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011754298,0.00009613127,0.8869028,0.00011075536,0.00009472523,0.014990117,0.0017195173,0.0002282217,0.08410701,0.00017774876,0.0002604779,0.010137062],"study_design_scores_gemma":[0.00003378481,0.00048241453,0.95517784,0.000012671189,0.000049745922,0.037330646,0.00049090816,0.00018052166,0.0054502087,0.00009420008,0.0006835008,0.0000134390275],"about_ca_topic_score_codex":0.001557103,"about_ca_topic_score_gemma":0.0014342839,"teacher_disagreement_score":0.001557103,"about_ca_system_score_codex":0.00026207586,"about_ca_system_score_gemma":0.00011442717,"threshold_uncertainty_score":0.0030961037},"labels":[],"label_agreement":null},{"id":"W1973684446","doi":"10.1046/j.1365-2141.2003.04334.x","title":"Heparin‐induced thrombocytopenia: pathogenesis and management","year":2003,"lang":"en","type":"review","venue":"British Journal of Haematology","topic":"Heparin-Induced Thrombocytopenia and Thrombosis","field":"Medicine","cited_by":542,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hamilton Health Sciences","funders":"","keywords":"Heparin-induced thrombocytopenia; Pathogenesis; Heparin; Medicine; Platelet; Immunology; Intensive care medicine; Internal medicine","score_opus":0.0734778125630492,"score_gpt":0.35235741130732806,"score_spread":0.27887959874427887,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1973684446","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0017313919,0.98746115,0.0010350624,0.0047754725,0.0007908201,0.000025675996,0.000034324967,0.00003443573,0.004111652],"genre_scores_gemma":[0.011654503,0.97842705,0.0017992704,0.0030619288,0.0032500124,0.00004092799,0.00012587414,0.000007043282,0.0016333535],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9997681,0.00005820188,0.000050328283,0.000022608387,0.000077604316,0.000023223194],"domain_scores_gemma":[0.99980015,0.00004968081,0.000060109487,0.000007316321,0.000052221138,0.000030583975],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00046784978,0.000648023,0.0006964845,0.0008803785,0.00021680127,0.00092189026,0.00071716396,0.0015259854,0.0015787828],"category_scores_gemma":[0.0007910949,0.00013608459,0.00032013585,0.0007304964,0.0003529359,0.0010034976,0.00067373895,0.0014556894,0.0012820563],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015763186,0.00015245937,0.0032857046,0.00846504,0.000113171176,0.009893868,0.00029090125,0.00068024854,0.002649152,0.0069499025,0.0883962,0.8789658],"study_design_scores_gemma":[0.000111486865,0.0004698251,0.012469993,0.011658298,0.00021176315,0.1331574,0.0005962633,0.0009026804,0.0011653906,0.01630729,0.82287014,0.00007942617],"about_ca_topic_score_codex":0.0005541072,"about_ca_topic_score_gemma":0.00068509724,"teacher_disagreement_score":0.0015787828,"about_ca_system_score_codex":0.00056820456,"about_ca_system_score_gemma":0.00072227966,"threshold_uncertainty_score":0.0052815676},"labels":[],"label_agreement":null},{"id":"W1973770267","doi":"10.1111/j.1365-2141.2007.06886.x","title":"Investigation of the interleukin (IL)‐4/IL‐4 receptor system in promyelocytic leukaemia PLB‐985 cells during differentiation toward neutrophil‐like phenotype: mechanism involved in IL‐4‐induced SOCS3 protein expression","year":2007,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Cytokine Signaling Pathways and Interactions","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institut National de la Recherche Scientifique","funders":"Canadian Institutes of Health Research","keywords":"Interleukin 3; Biology; Granulocyte colony-stimulating factor receptor; Molecular biology; Cell biology; Chemistry; Stem cell; IL-2 receptor; Cytotoxic T cell; Biochemistry; Haematopoiesis","score_opus":0.021836028249515027,"score_gpt":0.23664470797483525,"score_spread":0.21480867972532022,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1973770267","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9952455,0.001076182,0.002324308,0.000073768744,0.00001700478,0.000037237864,0.0004777902,0.000045831977,0.00070237543],"genre_scores_gemma":[0.99451447,0.000620235,0.0019881476,0.000053362328,0.000006935261,0.00007385191,0.0010373786,0.000011362796,0.0016943907],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998073,0.00004645568,0.000026826016,0.000035175875,0.000046769826,0.00003754508],"domain_scores_gemma":[0.99991775,0.000014151826,0.00002356049,0.000014723488,0.000011779161,0.000018017347],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017079573,0.0003136966,0.00026287066,0.00020820682,0.00016413818,0.00034867387,0.00014213622,0.00028057588,0.0009587087],"category_scores_gemma":[0.000074579126,0.00013104867,0.00025768782,0.00021949205,0.00019091235,0.00024700575,0.00021050939,0.0005088596,0.00062041695],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00005711342,0.00001137751,0.00015959288,0.000017506725,0.0000017711592,0.00004294606,0.0000154324,0.00001668809,0.9993167,0.000050605864,0.000007529541,0.00030279256],"study_design_scores_gemma":[0.000034222427,0.00068307976,0.007883776,0.0000063088155,0.0000233998,0.00044738743,0.0000815348,0.0007158646,0.9874713,0.000048255693,0.0026009576,0.0000038112921],"about_ca_topic_score_codex":0.00022322153,"about_ca_topic_score_gemma":0.0002938633,"teacher_disagreement_score":0.0009587087,"about_ca_system_score_codex":0.00020064361,"about_ca_system_score_gemma":0.00010702923,"threshold_uncertainty_score":0.0032072067},"labels":[],"label_agreement":null},{"id":"W1975798779","doi":"10.1046/j.1365-2141.2001.02927.x","title":"Detection and clinical significance of human acute myeloid leukaemia progenitors capable of long‐term proliferation <i>in vitro</i>","year":2001,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; Terry Fox Research Institute; BC Cancer Agency","funders":"National Cancer Institute; Terry Fox Foundation","keywords":"Progenitor cell; Nod; Myeloid; Immunology; Cancer research; Biology; In vitro; Cell culture; Stem cell; Medicine; Cell biology; In vivo; Genetics","score_opus":0.02277607601601483,"score_gpt":0.33292596399756547,"score_spread":0.31014988798155063,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1975798779","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.992407,0.003856519,0.0008969266,0.00008395238,0.000008114536,0.000032329477,0.00018692129,0.0000274792,0.0025006179],"genre_scores_gemma":[0.9970693,0.00076662225,0.00087705185,0.00004393508,0.000014692106,0.000026562846,0.0005411335,0.000006191199,0.00065442914],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9997482,0.00007733673,0.00002687113,0.00003892705,0.0000680268,0.000040739287],"domain_scores_gemma":[0.9995732,0.000209032,0.000052687057,0.00003360722,0.000057654877,0.000073817144],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00042609125,0.00012136157,0.0001710671,0.0003634809,0.00018561275,0.0004834466,0.00013587209,0.00036927126,0.0013349933],"category_scores_gemma":[0.0011736864,0.00009135712,0.000053850006,0.00021830449,0.00022541375,0.00017547666,0.0001254139,0.00034778318,0.00042885944],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0029198765,0.000400202,0.25011918,0.00021167536,0.000030103889,0.0023155557,0.0004551883,0.00037699746,0.6778249,0.00038720734,0.00071308797,0.06424594],"study_design_scores_gemma":[0.00013219382,0.0055235066,0.63734114,0.00006509598,0.00009704842,0.03049559,0.0005786623,0.0013751352,0.30652654,0.00040160058,0.017432319,0.000031124677],"about_ca_topic_score_codex":0.00034289737,"about_ca_topic_score_gemma":0.00030590693,"teacher_disagreement_score":0.0013349933,"about_ca_system_score_codex":0.0002038557,"about_ca_system_score_gemma":0.00015017482,"threshold_uncertainty_score":0.004465997},"labels":[],"label_agreement":null},{"id":"W1975995970","doi":"10.1111/j.1365-2141.2004.05292.x","title":"Management of thrombosis in cancer: primary prevention and secondary prophylaxis","year":2005,"lang":"en","type":"review","venue":"British Journal of Haematology","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":121,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"Canadian Institutes of Health Research","keywords":"Medicine; Intensive care medicine; Cancer; Clinical trial; Venous thromboembolism; Thrombosis; Population; Anticoagulant; Natural history; Surgery; Internal medicine","score_opus":0.03615422361737279,"score_gpt":0.3532053516392111,"score_spread":0.31705112802183827,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1975995970","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000082709375,0.99897003,0.00006509534,0.00020580209,0.00011336924,0.0000059111894,0.000005166793,0.000002832627,0.00054904947],"genre_scores_gemma":[0.00057725626,0.99868506,0.00015769701,0.00012904717,0.00015096656,0.000006300305,0.000009222792,5.548296e-7,0.00028381377],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9996598,0.000079133824,0.000057152756,0.00003867009,0.00014320774,0.000021982067],"domain_scores_gemma":[0.9996681,0.00015775384,0.000066969005,0.000009620054,0.00007330465,0.000024241943],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00069049705,0.00073077006,0.0019254356,0.001932467,0.00025098497,0.00082127587,0.00080994994,0.0011181969,0.0027707906],"category_scores_gemma":[0.0010103649,0.00022759865,0.00051911507,0.0022771952,0.00044337608,0.00082898786,0.00039581602,0.0012497779,0.0014714152],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006542299,0.000069682734,0.00018215476,0.022058628,0.00009029448,0.0002358767,0.00005618775,0.00023978754,0.0005187187,0.0012526822,0.019805564,0.95542514],"study_design_scores_gemma":[0.00012942975,0.0003500758,0.0036776115,0.02400684,0.0003617496,0.0073735537,0.00018014584,0.00021578406,0.00051287067,0.003660782,0.9595006,0.000030591644],"about_ca_topic_score_codex":0.0013712602,"about_ca_topic_score_gemma":0.0024318357,"teacher_disagreement_score":0.0027707906,"about_ca_system_score_codex":0.00066243287,"about_ca_system_score_gemma":0.0009587389,"threshold_uncertainty_score":0.009269178},"labels":[],"label_agreement":null},{"id":"W1976105963","doi":"10.1111/j.1365-2141.2012.09208.x","title":"Combined modality therapy <i>versus</i> chemotherapy alone as an induction regimen for primary central nervous system lymphoma: a decision analysis","year":2012,"lang":"en","type":"review","venue":"British Journal of Haematology","topic":"CNS Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":24,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Health Sciences Centre; Sunnybrook Hospital; University of Toronto; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Life expectancy; Quality of life (healthcare); Chemotherapy; Primary central nervous system lymphoma; Regimen; Oncology; Internal medicine; Quality-adjusted life year; Lymphoma; Chemotherapy regimen; Pediatrics; Cost effectiveness; Population","score_opus":0.0422187700926106,"score_gpt":0.3316830743338724,"score_spread":0.2894643042412618,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1976105963","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.012891093,0.98297346,0.0016810228,0.00045318087,0.00008087893,0.0003241222,0.00014693083,0.000010530753,0.0014387865],"genre_scores_gemma":[0.17620076,0.81668,0.0051501705,0.00047079442,0.00011344122,0.0005043354,0.00024951086,0.000011362968,0.00061957043],"study_design_codex":"design_other","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99689746,0.002434166,0.00021975258,0.000093105904,0.0002786968,0.00007681314],"domain_scores_gemma":[0.99381787,0.005563292,0.00040782985,0.000029372992,0.000113759124,0.00006788723],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003576032,0.0009272113,0.0031506799,0.0010559995,0.00013612107,0.0009252632,0.0011504687,0.00093293685,0.003011321],"category_scores_gemma":[0.009620686,0.0004396851,0.0047663134,0.0015142679,0.00019144389,0.0006868371,0.00038482368,0.0010157368,0.00020975785],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009599322,0.00047011167,0.0020147348,0.22825159,0.029381547,0.00027056114,0.00012370462,0.0520377,0.00058076065,0.0044108187,0.0046755527,0.66818357],"study_design_scores_gemma":[0.02510429,0.02241641,0.025957387,0.27235803,0.29117805,0.004144094,0.000848739,0.14797363,0.0035356425,0.041942883,0.1641254,0.00041534888],"about_ca_topic_score_codex":0.0037014822,"about_ca_topic_score_gemma":0.0056439796,"teacher_disagreement_score":0.0037014822,"about_ca_system_score_codex":0.0022268826,"about_ca_system_score_gemma":0.00215558,"threshold_uncertainty_score":0.018912077},"labels":[],"label_agreement":null},{"id":"W1976379188","doi":"10.1111/j.1365-2141.2007.06750.x","title":"Chromosome 1p21 deletion is a novel prognostic marker in patients with multiple myeloma","year":2007,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":51,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University Health Network","funders":"Leukemia and Lymphoma Research; Leukemia and Lymphoma Society of Canada; Cancer Research Society","keywords":"Multiple myeloma; Fluorescence in situ hybridization; Chromosome; Biology; Internal medicine; Overall survival; Multivariate analysis; Medicine; Pathology; Gene; Genetics","score_opus":0.011883053470565716,"score_gpt":0.2629970046912819,"score_spread":0.25111395122071617,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1976379188","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9987722,0.00079236197,0.0001051697,0.000081172024,0.0000056414337,0.0000025323175,0.00005362161,0.000007097523,0.00018011995],"genre_scores_gemma":[0.9995442,0.00017553254,0.00010078054,0.000012172235,0.000025069852,0.000003179796,0.00008091691,0.0000013107082,0.000056871213],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99975425,0.000052611336,0.000019166248,0.000052591375,0.0000780922,0.000043303164],"domain_scores_gemma":[0.99898607,0.00041841556,0.0003802106,0.000038640785,0.000071988296,0.00010467984],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000356055,0.00034787104,0.0004947395,0.0009350378,0.00034709374,0.0004139249,0.00035782962,0.0005814947,0.0006715693],"category_scores_gemma":[0.002282018,0.00027157555,0.00012477253,0.0009696102,0.00038974502,0.00042734493,0.0003006069,0.00049597875,0.00021341657],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00060873444,0.000032909848,0.9857523,0.00002104395,0.000030735497,0.0017076337,0.00009055246,0.00019479603,0.004075561,0.000023283981,0.00022266804,0.0072397706],"study_design_scores_gemma":[0.000036936308,0.0002631609,0.9875832,0.0000067360374,0.000063968524,0.009453067,0.00009149447,0.0008055046,0.0010730857,0.000100013196,0.00051413197,0.000008711911],"about_ca_topic_score_codex":0.00077408354,"about_ca_topic_score_gemma":0.0007874052,"teacher_disagreement_score":0.0009350378,"about_ca_system_score_codex":0.0002371577,"about_ca_system_score_gemma":0.0001959755,"threshold_uncertainty_score":0.0022466183},"labels":[],"label_agreement":null},{"id":"W1976995655","doi":"10.1111/j.1365-2141.2005.05406.x","title":"A third course of anti‐thymocyte globulin in aplastic anaemia is only beneficial in previous responders","year":2005,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":42,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Anti-thymocyte globulin; Medicine; Refractory (planetary science); Internal medicine; Gastroenterology; Incidence (geometry); Retrospective cohort study; Aplastic anemia; Globulin; Toxicity; Limiting; Surgery; Bone marrow","score_opus":0.012581946145246487,"score_gpt":0.2823659465268515,"score_spread":0.269784000381605,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1976995655","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9980823,0.0010829131,0.00012279839,0.000047090787,0.000011664683,0.000010751647,0.000022407909,0.000008142003,0.00061205274],"genre_scores_gemma":[0.9993962,0.00020748787,0.0000625699,0.0000699497,0.000026915981,0.000009916333,0.00008746023,0.0000039462884,0.00013554312],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9997328,0.00008712832,0.000030463614,0.00003334567,0.000036842805,0.000079343416],"domain_scores_gemma":[0.9989073,0.0002931486,0.00037007942,0.00007668841,0.00005996567,0.00029269492],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00044130426,0.00014222719,0.0004205528,0.00019272356,0.00038159246,0.0003988886,0.00014401316,0.00037740092,0.00088975317],"category_scores_gemma":[0.0012970355,0.00009565551,0.00048251366,0.00019151857,0.00027594366,0.00017450657,0.00019357477,0.0004073814,0.00030645134],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005007304,0.00046133847,0.92275715,0.00014424212,0.00022273645,0.01268604,0.00059986074,0.00063273654,0.009274767,0.00012593421,0.00064895867,0.047438912],"study_design_scores_gemma":[0.000506639,0.01543348,0.9069434,0.00010399027,0.00044796476,0.064761676,0.00053508196,0.0008722358,0.0046907286,0.00020046218,0.0054646535,0.000039799328],"about_ca_topic_score_codex":0.0003994453,"about_ca_topic_score_gemma":0.00049547147,"teacher_disagreement_score":0.00088975317,"about_ca_system_score_codex":0.00020568476,"about_ca_system_score_gemma":0.00019785491,"threshold_uncertainty_score":0.0029764771},"labels":[],"label_agreement":null},{"id":"W1977273659","doi":"10.1111/bjh.12222","title":"The efficacy and tolerability of adriamycin, bleomycin, vinblastine, dacarbazine and <scp>S</scp>tanford <scp>V</scp> in older <scp>H</scp>odgkin lymphoma patients: a comprehensive analysis from the <scp>N</scp>orth <scp>A</scp>merican intergroup trial <scp>E</scp>2496","year":2013,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":141,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network; University of British Columbia; BC Cancer Agency","funders":"National Cancer Institute","keywords":"Dacarbazine; Vinblastine; Medicine; Internal medicine; ABVD; Bleomycin; Vincristine; Tolerability; Gastroenterology; Hodgkin's lymphoma; Chemotherapy; Etoposide; Oncology; Surgery; Adverse effect; Cyclophosphamide","score_opus":0.009635228307854288,"score_gpt":0.23920548102576533,"score_spread":0.22957025271791104,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1977273659","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9959008,0.003383673,0.00005006681,0.00004883817,0.000011884495,0.00003849225,0.00017872406,0.0000039345455,0.00038357565],"genre_scores_gemma":[0.9985624,0.0007264702,0.000044030297,0.00009597558,0.000028908174,0.000019134417,0.00034834223,0.0000017198294,0.00017312118],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9996743,0.00015702324,0.00004065792,0.00003970483,0.000045427187,0.000042896823],"domain_scores_gemma":[0.99942064,0.00013665775,0.00020141326,0.000041575036,0.000024160685,0.00017550414],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010170775,0.0002484247,0.00046366794,0.00021398485,0.00012304784,0.00035004143,0.00017452403,0.00028485098,0.000770531],"category_scores_gemma":[0.0007347812,0.00014007108,0.00069115707,0.00026588986,0.00024997647,0.00040480128,0.0001494855,0.00047161605,0.00012006318],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.4178559,0.0079368185,0.28580275,0.0009536844,0.0037667826,0.0003773107,0.00030704393,0.0024147895,0.031891853,0.00019013653,0.002122056,0.24638094],"study_design_scores_gemma":[0.044337872,0.21229404,0.73078144,0.0001290033,0.0021725898,0.00085999817,0.0001810938,0.0012062486,0.0032655443,0.00023989017,0.004480459,0.00005176404],"about_ca_topic_score_codex":0.0004667475,"about_ca_topic_score_gemma":0.0018601231,"teacher_disagreement_score":0.0010170775,"about_ca_system_score_codex":0.00033846567,"about_ca_system_score_gemma":0.00021403996,"threshold_uncertainty_score":0.005378902},"labels":[],"label_agreement":null},{"id":"W1977321797","doi":"10.1111/j.1365-2141.2008.07111.x","title":"Myeloblastic transformation of chronic neutrophilic leukaemia","year":2008,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Eosinophilic Disorders and Syndromes","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Mount Sinai Hospital","funders":"","keywords":"Neutrophilia; Medicine; Monocytosis; Pathology; Bone marrow; Lymphocytosis; Trisomy 8; Cytopenia; Imatinib mesylate; Bone marrow examination; Absolute neutrophil count; White blood cell; Immunology; Gastroenterology; Internal medicine; Neutropenia; Chemotherapy; Myeloid leukemia; Imatinib; Biology; Cytogenetics","score_opus":0.013749263385858631,"score_gpt":0.2408666348970103,"score_spread":0.22711737151115166,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1977321797","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9556353,0.0056980434,0.0010670681,0.0017815398,0.00014971368,0.00023658061,0.0004554289,0.0001036707,0.03487258],"genre_scores_gemma":[0.99554294,0.0013094883,0.00030766288,0.00044920712,0.000100097015,0.00002897526,0.00021271488,0.000008263266,0.0020406407],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.99989974,0.000018072382,0.0000071612517,0.000016554442,0.000017700702,0.000040779094],"domain_scores_gemma":[0.99985576,0.000030350895,0.000028979372,0.000012855411,0.000016635106,0.000055420427],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000114833245,0.00040228214,0.0002462136,0.00042393367,0.00044387064,0.00028568076,0.00015318843,0.00064036396,0.002949051],"category_scores_gemma":[0.0007824107,0.00014794408,0.00013874444,0.00037078865,0.0002500792,0.00025527523,0.00025298627,0.00058082474,0.00090868754],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006333357,0.0001208219,0.09246197,0.00009687383,0.000013418013,0.8711113,0.00027263103,0.00013117008,0.014911335,0.0008253907,0.0022094268,0.017212335],"study_design_scores_gemma":[0.000079125115,0.00043572058,0.08076897,0.00004997898,0.000025909127,0.89985096,0.00020316002,0.00039587507,0.0013342347,0.00062703714,0.016219202,0.000009878521],"about_ca_topic_score_codex":0.00090380927,"about_ca_topic_score_gemma":0.0011677147,"teacher_disagreement_score":0.002949051,"about_ca_system_score_codex":0.00036169883,"about_ca_system_score_gemma":0.00024007476,"threshold_uncertainty_score":0.009865582},"labels":[],"label_agreement":null},{"id":"W1977477282","doi":"10.1111/j.1365-2141.2012.09109.x","title":"Human bone marrow stromal cells simultaneously support <scp>B</scp> and <scp>T</scp>/<scp>NK</scp> lineage development from human haematopoietic progenitors: a principal role for flt3 ligand in lymphopoiesis","year":2012,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Immune Cell Function and Interaction","field":"Immunology and Microbiology","cited_by":18,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Japan Society for the Promotion of Science; University of Toronto","keywords":"Lymphopoiesis; Stromal cell; Haematopoiesis; Bone marrow; Biology; Stem cell; Immunology; Progenitor cell; Stem cell factor; Cell biology; Cancer research","score_opus":0.011268792670791741,"score_gpt":0.23676514745199692,"score_spread":0.22549635478120517,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1977477282","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9846299,0.0017104768,0.007505932,0.00006164735,0.000023738448,0.00008413772,0.0010866907,0.00019979762,0.0046976497],"genre_scores_gemma":[0.98727685,0.000781028,0.0052222526,0.00004968734,0.000015124964,0.00007061577,0.0024554646,0.000033980028,0.0040949434],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9999256,0.000013081664,0.0000082522965,0.000014005027,0.000025332394,0.00001364019],"domain_scores_gemma":[0.9999168,0.00002202331,0.000016416796,0.000013025752,0.000009743666,0.000021920385],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00008458852,0.00023730562,0.00014660158,0.00012688806,0.00009460667,0.00021812743,0.000093884206,0.00009976417,0.0019933651],"category_scores_gemma":[0.000073101735,0.00006238066,0.00010968479,0.00012939853,0.000088884066,0.00007642341,0.00023117934,0.00022556684,0.0006344746],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006528331,0.000010635044,0.00021199857,0.000021656522,0.0000028285663,0.00004229322,0.000018226345,0.00003783093,0.9976901,0.00007114288,0.000048307647,0.0017796656],"study_design_scores_gemma":[0.00001714857,0.00016214918,0.0036667408,0.000005867949,0.000012129753,0.00031851805,0.000015910187,0.0006143004,0.9893784,0.000027407175,0.0057795346,0.0000018612668],"about_ca_topic_score_codex":0.0005803923,"about_ca_topic_score_gemma":0.0013531098,"teacher_disagreement_score":0.0019933651,"about_ca_system_score_codex":0.000112878835,"about_ca_system_score_gemma":0.00016908138,"threshold_uncertainty_score":0.0066684484},"labels":[],"label_agreement":null},{"id":"W1977655193","doi":"10.1111/j.1365-2141.2004.04932.x","title":"Pharmacogenetic determinants of outcome in acute lymphoblastic leukaemia","year":2004,"lang":"en","type":"review","venue":"British Journal of Haematology","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":42,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Pharmacogenetics; Oncology; Acute lymphocytic leukemia; Lymphoblastic Leukemia; Internal medicine; Leukemia; Genotype; Biology; Genetics; Gene","score_opus":0.04590820009750595,"score_gpt":0.3899198462341808,"score_spread":0.34401164613667484,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1977655193","genre_codex":"empirical","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9810245,0.011781345,0.0013894956,0.0015120673,0.00004639828,0.00003326797,0.0008892182,0.000018084756,0.0033056645],"genre_scores_gemma":[0.995933,0.0029529305,0.00034125,0.000094869036,0.0000449808,0.00001576937,0.00036476916,0.000010419042,0.00024193886],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.99892116,0.00061480876,0.000082543644,0.0001303102,0.00013965518,0.00011157476],"domain_scores_gemma":[0.9972892,0.0012439433,0.00100834,0.00014646901,0.00012159499,0.00019045333],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012886635,0.00018273789,0.00037925277,0.0005909134,0.00018947988,0.00075288344,0.00027574276,0.0004306156,0.0016172011],"category_scores_gemma":[0.004960503,0.00011167939,0.0004106428,0.0017779167,0.00040193732,0.0002733907,0.00039295774,0.0007538419,0.00030021567],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00042148374,0.000046137822,0.9809395,0.000057904297,0.00022866347,0.00032642862,0.000114047994,0.0002741236,0.00083039526,0.000527336,0.00036526087,0.015868736],"study_design_scores_gemma":[0.000014668023,0.00013167587,0.99562293,0.00002556522,0.0001557222,0.0007615319,0.000105873776,0.00043282684,0.00021260844,0.00122619,0.0013041054,0.000006249732],"about_ca_topic_score_codex":0.0014082729,"about_ca_topic_score_gemma":0.0010507145,"teacher_disagreement_score":0.0016172011,"about_ca_system_score_codex":0.0003424694,"about_ca_system_score_gemma":0.00032841298,"threshold_uncertainty_score":0.006815195},"labels":[],"label_agreement":null},{"id":"W1977886211","doi":"10.1111/j.1365-2141.2004.05194.x","title":"Long‐term disease‐free survival of patients with advanced follicular lymphoma after allogeneic bone marrow transplantation","year":2004,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":53,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency; Vancouver Hospital and Health Sciences Centre","funders":"","keywords":"Medicine; Cumulative incidence; Follicular lymphoma; Lymphoma; Total body irradiation; Internal medicine; Surgery; Transplantation; Incidence (geometry); Bone marrow; Gastroenterology; Oncology; Chemotherapy; Cyclophosphamide","score_opus":0.005038763484335681,"score_gpt":0.21835521181074105,"score_spread":0.21331644832640537,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1977886211","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9986811,0.0007979449,0.00009476662,0.00005640282,0.00001047251,0.0000056950757,0.000057397952,0.0000054522616,0.00029068414],"genre_scores_gemma":[0.9993868,0.0001877728,0.000031382082,0.00006929497,0.000025922596,0.0000060933676,0.0001886376,0.0000013991269,0.00010255383],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9997744,0.000053521202,0.000022183995,0.00003083052,0.000039053906,0.00008005939],"domain_scores_gemma":[0.9990476,0.00020464898,0.00022944094,0.00005120066,0.00006460455,0.00040253508],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005691246,0.00020751613,0.000493315,0.0003137935,0.0003909147,0.00058207527,0.0001963271,0.00050418,0.0007052254],"category_scores_gemma":[0.001605874,0.000111042566,0.00041197863,0.00032156435,0.00033143943,0.00045799627,0.00031940086,0.00048826978,0.00029006737],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0046788827,0.0004932976,0.94331354,0.000057068908,0.0002460598,0.0029214236,0.00067268044,0.0009604391,0.00714182,0.00008769618,0.0007134305,0.038713727],"study_design_scores_gemma":[0.00040956322,0.0065035974,0.9830325,0.000046681234,0.00021917406,0.005946073,0.0002195573,0.0010621104,0.00074686087,0.00022111247,0.0015651032,0.000027446456],"about_ca_topic_score_codex":0.00086841406,"about_ca_topic_score_gemma":0.0008339043,"teacher_disagreement_score":0.00086841406,"about_ca_system_score_codex":0.00027536496,"about_ca_system_score_gemma":0.00021119617,"threshold_uncertainty_score":0.0030098557},"labels":[],"label_agreement":null},{"id":"W1977996697","doi":"10.1046/j.1365-2141.2003.04685.x","title":"Transcobalamin deficiency due to activation of an intra exonic cryptic splice site","year":2003,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Folate and B Vitamins Research","field":"Medicine","cited_by":28,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"","keywords":"Exon; Splice site mutation; Intron; RNA splicing; Biology; Point mutation; Genetics; splice; Mutation; Vitamin B12; Gene; Genetic disorder; Frameshift mutation; Alternative splicing; Endocrinology; RNA","score_opus":0.0169455679132093,"score_gpt":0.2959083558901258,"score_spread":0.27896278797691654,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1977996697","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99427235,0.000693683,0.0021427844,0.00013526241,0.000072295945,0.00003653623,0.00011496256,0.00006912443,0.0024631096],"genre_scores_gemma":[0.9971601,0.00031983422,0.00072505604,0.000091028516,0.000039551032,0.000010036145,0.00008960076,0.000024505953,0.0015403056],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.99977,0.000022345737,0.0000353638,0.00007403996,0.00005678487,0.000041543746],"domain_scores_gemma":[0.99951947,0.00013501343,0.00013009374,0.000040761133,0.000047186935,0.00012747111],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001556641,0.0010223726,0.00045727493,0.0006147622,0.0006643295,0.00030436306,0.00031476817,0.00084050157,0.0022711083],"category_scores_gemma":[0.0009342707,0.00032246477,0.00032992085,0.00035816236,0.0007469335,0.00027523766,0.0005628703,0.0006510628,0.00055382046],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00076380436,0.00021160956,0.047795523,0.00027065765,0.000106469735,0.71932304,0.0018038433,0.0001958155,0.20609193,0.0015417439,0.00090825156,0.020987287],"study_design_scores_gemma":[0.00007465125,0.00049096707,0.017552769,0.000016213466,0.000086323555,0.9524379,0.0001528999,0.0003284544,0.025787322,0.00027144898,0.002783934,0.00001722008],"about_ca_topic_score_codex":0.0013146482,"about_ca_topic_score_gemma":0.0008934567,"teacher_disagreement_score":0.0022711083,"about_ca_system_score_codex":0.0003562725,"about_ca_system_score_gemma":0.00038122086,"threshold_uncertainty_score":0.0075976253},"labels":[],"label_agreement":null},{"id":"W1979916062","doi":"10.1111/j.1365-2141.2009.07889.x","title":"A Phase I/II study of the safety and efficacy of the addition of sirolimus to tacrolimus/methotrexate graft <i>versus</i> host disease prophylaxis after allogeneic haematopoietic cell transplantation in paediatric acute lymphoblastic leukaemia (ALL)","year":2009,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":27,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba; CancerCare Manitoba","funders":"National Cancer Institute; University of Utah","keywords":"Cumulative incidence; Medicine; Sirolimus; Transplantation; Internal medicine; Immunosuppression; Tacrolimus; Hematopoietic stem cell transplantation; Hazard ratio; Graft-versus-host disease; Population; Cohort; Total body irradiation; Gastroenterology; Surgery; Chemotherapy; Cyclophosphamide; Confidence interval","score_opus":0.008794542205020473,"score_gpt":0.27337090894777377,"score_spread":0.2645763667427533,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1979916062","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99543023,0.00062534376,0.00056543556,0.0001751383,0.00006253861,0.0020864194,0.00037369196,0.000041835832,0.0006393223],"genre_scores_gemma":[0.989312,0.0011083835,0.003125667,0.0006153398,0.00024315689,0.0032367706,0.0013262635,0.00003184655,0.0010005704],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9987804,0.00073942245,0.00006255616,0.0001710868,0.000104779334,0.0001417502],"domain_scores_gemma":[0.9981679,0.0003770514,0.00042594314,0.00020053178,0.00007823105,0.00075034046],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0027902233,0.001845157,0.002109273,0.0005234964,0.0004190341,0.00081153953,0.001026328,0.0011248009,0.002158459],"category_scores_gemma":[0.0016301661,0.00062685815,0.0012351702,0.00050500606,0.0017192765,0.0007639163,0.00038928905,0.003488443,0.00048695697],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.7553444,0.116124466,0.009128437,0.00044492076,0.00078112737,0.00039923674,0.00035113207,0.0016367964,0.050175708,0.00032177163,0.0014431088,0.063848816],"study_design_scores_gemma":[0.30247882,0.68485147,0.007008328,0.000014448826,0.00024699044,0.00021940691,0.000028490429,0.00056991214,0.00359308,0.00011886329,0.0008529882,0.000017265542],"about_ca_topic_score_codex":0.00082200207,"about_ca_topic_score_gemma":0.0012144459,"teacher_disagreement_score":0.0027902233,"about_ca_system_score_codex":0.0008503319,"about_ca_system_score_gemma":0.002151589,"threshold_uncertainty_score":0.014756322},"labels":[],"label_agreement":null},{"id":"W1980168719","doi":"10.1111/bjh.13004","title":"Long‐term survival with cyclophosphamide, bortezomib and dexamethasone induction therapy in patients with newly diagnosed multiple myeloma","year":2014,"lang":"en","type":"letter","venue":"British Journal of Haematology","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":42,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Princess Margaret Cancer Centre","funders":"Mayo Clinic","keywords":"Bortezomib; Multiple myeloma; Medicine; Dexamethasone; Cyclophosphamide; Induction therapy; Oncology; Internal medicine; Chemotherapy","score_opus":0.018039258852553048,"score_gpt":0.26081894217098844,"score_spread":0.24277968331843539,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1980168719","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99685967,0.0023024904,0.00007250758,0.00010152361,0.000020661348,0.000019549405,0.0001221061,0.0000052986115,0.0004960779],"genre_scores_gemma":[0.9979867,0.0009453906,0.00010161338,0.00013398226,0.000048850605,0.000022264436,0.00045045925,0.0000016811488,0.00030911656],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9997179,0.000054705197,0.000032505955,0.000052570656,0.00006601168,0.0000762698],"domain_scores_gemma":[0.9991303,0.00015658558,0.00026272383,0.00004773887,0.000041157284,0.0003613797],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007416267,0.00023699178,0.0007923613,0.0003647117,0.000667819,0.00068236014,0.00034970656,0.0005179575,0.0006999779],"category_scores_gemma":[0.0010411851,0.00019055516,0.00061062264,0.0005531431,0.00031921972,0.00052210636,0.00036922548,0.00074490544,0.00022959556],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006575015,0.0006320941,0.96070576,0.000056654117,0.0001742861,0.0014129533,0.0002501459,0.00030722356,0.0031155327,0.000020026804,0.00038141792,0.026368907],"study_design_scores_gemma":[0.0003541867,0.007249441,0.9876825,0.000023582928,0.00018394618,0.0023819755,0.000105831044,0.00028289223,0.000493578,0.00003422505,0.0011937179,0.0000139888225],"about_ca_topic_score_codex":0.0016335804,"about_ca_topic_score_gemma":0.0038454086,"teacher_disagreement_score":0.0016335804,"about_ca_system_score_codex":0.0006089688,"about_ca_system_score_gemma":0.0005971037,"threshold_uncertainty_score":0.004418373},"labels":[],"label_agreement":null},{"id":"W1980318916","doi":"10.1046/j.1365-2141.2003.04583.x","title":"The use of stimulated granulocyte transfusions to prevent recurrence of past severe infections after allogeneic stem cell transplantation","year":2003,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Antifungal resistance and susceptibility","field":"Medicine","cited_by":63,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Hospital for Sick Children","keywords":"Medicine; Neutropenia; Granulocyte; Transplantation; Surgery; Aspergillosis; Incidence (geometry); Granulocyte colony-stimulating factor; Internal medicine; Autologous stem-cell transplantation; Stem cell; Hematopoietic stem cell transplantation; Chemotherapy; Toxicity; Gastroenterology; Immunology","score_opus":0.02211683054496075,"score_gpt":0.2634044771101646,"score_spread":0.24128764656520388,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1980318916","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9977325,0.0014245072,0.0003409847,0.000082400686,0.00002243865,0.000015131464,0.0000063993766,0.000014608615,0.0003608292],"genre_scores_gemma":[0.9995403,0.00021384186,0.00015177809,0.000024611089,0.000023576247,0.0000049590303,0.000012520474,8.588459e-7,0.000027566583],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9998115,0.000090452566,0.000027205213,0.000014209959,0.000031264728,0.000025486204],"domain_scores_gemma":[0.99943143,0.0002021199,0.00019437497,0.00005999273,0.000021290809,0.00009072629],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003342907,0.00016551258,0.00030066966,0.00017169837,0.00021349045,0.00021535231,0.00017437049,0.00018750667,0.00024454342],"category_scores_gemma":[0.0021075145,0.00006602336,0.00017285482,0.000122029174,0.0003011637,0.0001370715,0.00014997534,0.00034458764,0.000056366032],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.017989047,0.0030458276,0.34321856,0.0007227937,0.00039754054,0.017152073,0.0010342642,0.0038037351,0.04884432,0.0011197197,0.001981871,0.5606903],"study_design_scores_gemma":[0.0034161198,0.13980961,0.68553287,0.0002794667,0.00063651416,0.10204436,0.00054447545,0.0063497988,0.048906714,0.001650825,0.010744748,0.00008451558],"about_ca_topic_score_codex":0.00022319684,"about_ca_topic_score_gemma":0.00024607303,"teacher_disagreement_score":0.0003342907,"about_ca_system_score_codex":0.00017790197,"about_ca_system_score_gemma":0.00019667222,"threshold_uncertainty_score":0.0017679334},"labels":[],"label_agreement":null},{"id":"W1980917241","doi":"10.1111/j.1365-2141.2007.06503.x","title":"Higher thrombin concentrations are required to induce platelet apoptosis than to induce platelet activation","year":2007,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Blood Coagulation and Thrombosis Mechanisms","field":"Medicine","cited_by":57,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; St. Michael's Hospital","funders":"Heart and Stroke Foundation of Canada","keywords":"Platelet; Thrombin; Apoptosis; Coagulation; Inducer; Platelet activation; Chemistry; Immunology; Pharmacology; Cell biology; Endocrinology; Medicine; Internal medicine; Biochemistry; Biology","score_opus":0.04151526672540003,"score_gpt":0.3051665391745776,"score_spread":0.2636512724491776,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1980917241","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9790668,0.011629765,0.0048863566,0.00061386655,0.00022016691,0.000093849056,0.0005101942,0.0001706806,0.0028085338],"genre_scores_gemma":[0.9940281,0.0017174353,0.00199338,0.00018902213,0.000056976816,0.00007778262,0.0006239275,0.000018549354,0.0012947819],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99909747,0.0002578484,0.00014834436,0.00007086424,0.0002583801,0.00016712274],"domain_scores_gemma":[0.99856806,0.0007557246,0.00021301318,0.000118841446,0.00018729434,0.00015713692],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00039785847,0.00029768673,0.0007705652,0.00038305562,0.00021045239,0.00076269574,0.0002198863,0.00070989056,0.0043118657],"category_scores_gemma":[0.0014530704,0.00020562475,0.00037295223,0.00028806104,0.00022084461,0.00042033213,0.00024092385,0.0009744805,0.0007816953],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004791193,0.00007219525,0.00037311946,0.000111134825,0.000017810882,0.00023062638,0.00004080853,0.000094355964,0.99564123,0.00017059168,0.00015872471,0.0026102706],"study_design_scores_gemma":[0.000074680385,0.0010636708,0.009458023,0.000019133835,0.00003544824,0.0011548246,0.00007912865,0.0007735991,0.9835877,0.00022052051,0.003518842,0.000014477288],"about_ca_topic_score_codex":0.00050144497,"about_ca_topic_score_gemma":0.00060333236,"teacher_disagreement_score":0.0043118657,"about_ca_system_score_codex":0.00037785002,"about_ca_system_score_gemma":0.0002441718,"threshold_uncertainty_score":0.014424622},"labels":[],"label_agreement":null},{"id":"W1981102741","doi":"10.1111/j.1365-2141.2004.04814.x","title":"Preclinical studies of fibroblast growth factor receptor 3 as a therapeutic target in multiple myeloma","year":2004,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":88,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"National Cancer Institute; Multiple Myeloma Research Foundation","keywords":"Fibroblast growth factor receptor 3; Molecular biology; Cancer research; Multiple myeloma; Biology; Cell culture; Chromosomal translocation; Tyrosine kinase; Fibroblast growth factor receptor; Fibroblast growth factor; Signal transduction; Receptor; Cell biology; Immunology; Biochemistry","score_opus":0.06970726264567276,"score_gpt":0.369823338292175,"score_spread":0.3001160756465022,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1981102741","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9517082,0.028916392,0.006110346,0.0012515116,0.0003636508,0.001476012,0.0017819043,0.00043111603,0.007960993],"genre_scores_gemma":[0.97326976,0.016597642,0.003093819,0.0003732858,0.00009061805,0.0006428696,0.0017729552,0.000044324217,0.004114768],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99977857,0.000057226036,0.000011838307,0.00002900525,0.00005966557,0.00006369558],"domain_scores_gemma":[0.999819,0.000026490437,0.000045985762,0.0000147078035,0.00002924904,0.000064581785],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007809076,0.0006775787,0.00083802093,0.00043175663,0.0003009246,0.0005648892,0.00077555876,0.0007444233,0.0023276727],"category_scores_gemma":[0.00033286822,0.0002469989,0.0006456723,0.00042127582,0.00028673487,0.00035079793,0.0003007531,0.0016713287,0.00048780435],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008881853,0.009410497,0.001111505,0.00096625055,0.00032768783,0.00042785407,0.00016822043,0.0037842595,0.9016068,0.0012092874,0.0027978003,0.06930802],"study_design_scores_gemma":[0.0059722573,0.23787975,0.01066639,0.00016792088,0.0006297544,0.0014989293,0.00015388755,0.0035540718,0.68969506,0.00078735326,0.048945155,0.000049417307],"about_ca_topic_score_codex":0.0017063585,"about_ca_topic_score_gemma":0.003020016,"teacher_disagreement_score":0.0023276727,"about_ca_system_score_codex":0.00079126004,"about_ca_system_score_gemma":0.0006742994,"threshold_uncertainty_score":0.00778687},"labels":[],"label_agreement":null},{"id":"W1982060371","doi":"10.1111/j.1365-2141.2005.05387.x","title":"Incidence and spectrum of non‐Hodgkin lymphoma in Chinese migrants to British Columbia","year":2005,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":43,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"","keywords":"Incidence (geometry); Medicine; Lymphoma; Demography; Standardized rate; Follicular lymphoma; Non-Hodgkin's lymphoma; Population; Internal medicine; Pediatrics; Epidemiology; Environmental health","score_opus":0.005149361932843713,"score_gpt":0.25333741115138453,"score_spread":0.24818804921854082,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1982060371","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.999305,0.00018686785,0.000014984091,0.000019182278,9.62372e-7,0.0000034797395,0.00018933241,0.000003189591,0.00027697248],"genre_scores_gemma":[0.9991177,0.00023200024,0.000030438454,0.000011787011,0.0000015455371,0.000004452002,0.0004056808,0.0000013985087,0.00019497829],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9998047,0.000027850683,0.000021659767,0.00003228262,0.00005644485,0.00005703139],"domain_scores_gemma":[0.99956113,0.00003659352,0.00013896904,0.000026207234,0.00012948486,0.000107541],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021100011,0.00013269074,0.00017958721,0.0010771973,0.00048651756,0.0003832702,0.00028499388,0.00016731147,0.0007497643],"category_scores_gemma":[0.0008040687,0.00015677547,0.00011953541,0.0012209429,0.0002560333,0.00012373462,0.00031236824,0.00016491505,0.000102326776],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000059773625,0.000008386497,0.99552685,0.000011403971,0.000015571422,0.00024167904,0.00023121912,0.0000405975,0.00039549026,0.000016988593,0.00019190594,0.0032602367],"study_design_scores_gemma":[0.000002948877,0.000010564909,0.999164,0.0000056126714,0.0000054322945,0.0003133082,0.00024752333,0.000055408815,0.00003507913,0.000007089488,0.00015105725,0.0000020897633],"about_ca_topic_score_codex":0.5179675,"about_ca_topic_score_gemma":0.6560482,"teacher_disagreement_score":0.48203248,"about_ca_system_score_codex":0.0017643564,"about_ca_system_score_gemma":0.0011654095,"threshold_uncertainty_score":0.96974254},"labels":[],"label_agreement":null},{"id":"W1982278453","doi":"10.1111/j.1365-2141.2007.06575.x","title":"Chronic and severe haemolytic anaemia caused by co‐inheritance of <i>β</i>‐thalassaemia and triplicated <i>α</i>‐globin genes","year":2007,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Mount Sinai Hospital","funders":"","keywords":"Microcytosis; Anisocytosis; Ineffective erythropoiesis; Medicine; Bilirubin; Internal medicine; Molecular biology; Biology; Gastroenterology; Anemia; Erythropoiesis; Iron deficiency","score_opus":0.00703357624607732,"score_gpt":0.2495829985776503,"score_spread":0.24254942233157298,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1982278453","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.962785,0.015713388,0.0026368836,0.0016950855,0.00059771125,0.000075926706,0.0010964033,0.00012357227,0.015275892],"genre_scores_gemma":[0.98548144,0.0036481002,0.0011412691,0.0009868925,0.0010058841,0.00002764255,0.00073332485,0.000036970985,0.006938496],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.99975663,0.00004889162,0.000038635902,0.00005633587,0.000045415112,0.000054151336],"domain_scores_gemma":[0.9992404,0.00022695899,0.00026397165,0.00004629877,0.00003891481,0.00018340285],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023925921,0.0007047169,0.00071647094,0.0005204741,0.00034325387,0.00041525363,0.00032132748,0.001068966,0.0029088156],"category_scores_gemma":[0.0007630065,0.0003473559,0.00025468352,0.00077502534,0.0008168591,0.00027924153,0.00035718665,0.0007510247,0.0008935257],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0034340015,0.0003302555,0.12725288,0.0012806508,0.0003465434,0.70447534,0.0006522489,0.00027658523,0.107064985,0.0016127359,0.015750417,0.03752332],"study_design_scores_gemma":[0.00016397813,0.00065795175,0.11119637,0.00007804437,0.00016398453,0.87318176,0.00011583849,0.00014781153,0.0039832895,0.00047409724,0.00981436,0.000022471271],"about_ca_topic_score_codex":0.0011350926,"about_ca_topic_score_gemma":0.0012873203,"teacher_disagreement_score":0.0029088156,"about_ca_system_score_codex":0.0003206903,"about_ca_system_score_gemma":0.000334083,"threshold_uncertainty_score":0.009730995},"labels":[],"label_agreement":null},{"id":"W1982308436","doi":"10.1111/j.1365-2141.2012.09177.x","title":"Impact of rituximab on treatment outcomes of patients with diffuse large b‐cell lymphoma: a population‐based analysis","year":2012,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":42,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Toronto; Toronto General Hospital; Institute for Clinical Evaluative Sciences; Cancer Care Ontario; St. Michael's Hospital; Princess Margaret Cancer Centre; Niagara Health System","funders":"Institute for Clinical Evaluative Sciences; Cancer Care Ontario","keywords":"Rituximab; Medicine; CHOP; Diffuse large B-cell lymphoma; Vincristine; Internal medicine; Population; Hazard ratio; Prednisone; Lymphoma; Cyclophosphamide; Oncology; Chemotherapy; Surgery; Gastroenterology; Confidence interval","score_opus":0.009586511896449226,"score_gpt":0.2774775081604935,"score_spread":0.2678909962640443,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1982308436","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.998973,0.00053429767,0.00008396077,0.000035939807,0.0000028827226,0.000009176987,0.00022472731,0.0000024619615,0.00013362814],"genre_scores_gemma":[0.9993855,0.00012096842,0.000044425764,0.00003095514,0.000008425765,0.0000106716025,0.00036473776,0.0000015186562,0.00003280349],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99774903,0.0010859995,0.00020816617,0.00041998384,0.00034935257,0.0001874896],"domain_scores_gemma":[0.9967855,0.0010765641,0.0013920778,0.00032154782,0.00017757794,0.00024680462],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0020563477,0.0002795612,0.0007265979,0.0005504925,0.00027177733,0.00080206327,0.00040695406,0.0007116853,0.000684747],"category_scores_gemma":[0.0053844065,0.00034450865,0.0017303629,0.0011799115,0.00034519148,0.00038552645,0.00041889708,0.0005628298,0.000094514246],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003096953,0.0001221077,0.9901862,0.00003202106,0.0024458272,0.00016538116,0.000055924334,0.00043338235,0.0004372982,0.00002383069,0.00012756007,0.002873365],"study_design_scores_gemma":[0.00035065282,0.0009872476,0.99597067,0.000006652533,0.0010195586,0.00031442358,0.00006331667,0.00076486846,0.0001024188,0.000045498768,0.000362054,0.00001275652],"about_ca_topic_score_codex":0.006436587,"about_ca_topic_score_gemma":0.007723703,"teacher_disagreement_score":0.006436587,"about_ca_system_score_codex":0.0008189607,"about_ca_system_score_gemma":0.0004939846,"threshold_uncertainty_score":0.01279825},"labels":[],"label_agreement":null},{"id":"W1982852792","doi":"10.1046/j.1365-2141.2000.01941.x","title":"Management Of Thrombotic Thrombocytopenic Purpura","year":2000,"lang":"en","type":"review","venue":"British Journal of Haematology","topic":"Complement system in diseases","field":"Immunology and Microbiology","cited_by":159,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Ottawa Hospital","funders":"","keywords":"Thrombotic thrombocytopenic purpura; Medicine; Fulminant; Microangiopathic hemolytic anemia; Thrombotic microangiopathy; Schistocyte; Disease; Autopsy; Pediatrics; Microangiopathy; Hyaline; Dermatology; Pathology; Internal medicine; Platelet; Diabetes mellitus","score_opus":0.041494225971076944,"score_gpt":0.3255488402267257,"score_spread":0.28405461425564876,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1982852792","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.25252658,0.5194002,0.037010845,0.048529442,0.0042980397,0.0009933366,0.00032175804,0.0010225258,0.13589728],"genre_scores_gemma":[0.7459541,0.20446984,0.012782523,0.01460514,0.009721835,0.0006785239,0.0009483985,0.000105711675,0.010733893],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99952805,0.00013648864,0.000054844717,0.000038174934,0.00016455009,0.00007796099],"domain_scores_gemma":[0.9995951,0.00008246363,0.00008564335,0.000014007023,0.00006654306,0.00015622991],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00045400832,0.0005617852,0.0008182981,0.0011829485,0.0009563139,0.0008097547,0.00072055025,0.0014614146,0.0026894226],"category_scores_gemma":[0.0017724178,0.00013899046,0.0004953053,0.00055431953,0.0003128591,0.0008123055,0.0008442128,0.0019833304,0.001184891],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005111216,0.0010712368,0.02508246,0.0023574415,0.00022076472,0.097908124,0.0011498098,0.0011726746,0.0043050507,0.0024704325,0.055664893,0.808086],"study_design_scores_gemma":[0.00070257,0.0031481448,0.063599266,0.0075332797,0.0002891305,0.5989693,0.0022467943,0.0040297927,0.0032926975,0.013824725,0.30223376,0.00013055617],"about_ca_topic_score_codex":0.0003128967,"about_ca_topic_score_gemma":0.0005008481,"teacher_disagreement_score":0.0026894226,"about_ca_system_score_codex":0.0004502939,"about_ca_system_score_gemma":0.0005738165,"threshold_uncertainty_score":0.008997023},"labels":[],"label_agreement":null},{"id":"W1983430343","doi":"10.1111/bjh.12042","title":"The immunophenotype of <scp>T</scp> ‐lymphoblastic lymphoma in children and adolescents: a <scp>C</scp> hildren's <scp>O</scp> ncology <scp>G</scp> roup report","year":2012,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":117,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Calgary Laboratory Services; University of Calgary","funders":"National Cancer Institute","keywords":"Immunophenotyping; Lymphoma; Lymphoblastic lymphoma; Flow cytometry; Medicine; T cell; Myeloid; Immunology; Immune system","score_opus":0.007669832411063022,"score_gpt":0.25108691984258413,"score_spread":0.2434170874315211,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1983430343","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99961925,0.00009384903,0.000051987656,0.000009055707,7.938647e-7,0.000005303519,0.000060460494,0.0000016109594,0.00015755488],"genre_scores_gemma":[0.999619,0.000109389606,0.000096351214,0.00001072971,0.0000024993556,0.000006341611,0.000120206765,0.0000012650689,0.000034228],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9998041,0.000042039457,0.000024719331,0.00004271101,0.000046851597,0.00003965666],"domain_scores_gemma":[0.9995023,0.00018513836,0.00015362332,0.000030308123,0.000046908666,0.00008171371],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00035407668,0.00015806773,0.00016019457,0.0011924272,0.00021646582,0.0003691076,0.00015239515,0.00021124247,0.00056787534],"category_scores_gemma":[0.0010048681,0.00014521879,0.00009657267,0.0005679311,0.00047289004,0.00031208099,0.00018432352,0.00022336376,0.0001260693],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00004754044,0.000010673747,0.9957539,0.000008141086,0.000005231142,0.00041011255,0.0000887225,0.000030092207,0.0019029628,0.000021035032,0.00005585432,0.0016657783],"study_design_scores_gemma":[0.000008758625,0.00012635541,0.99126935,0.000007270045,0.000016135236,0.0065027094,0.00030874307,0.00021262057,0.0010994341,0.000031393465,0.00041378028,0.0000033737476],"about_ca_topic_score_codex":0.0029050468,"about_ca_topic_score_gemma":0.0035400467,"teacher_disagreement_score":0.0029050468,"about_ca_system_score_codex":0.00031067655,"about_ca_system_score_gemma":0.00022266695,"threshold_uncertainty_score":0.0057763457},"labels":[],"label_agreement":null},{"id":"W1983883292","doi":"10.1111/bjh.12315","title":"Renal function is independently associated with red cell distribution width in kidney transplant recipients: a potential new auxiliary parameter for the clinical evaluation of patients with chronic kidney disease","year":2013,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Inflammatory Biomarkers in Disease Prognosis","field":"Medicine","cited_by":64,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre; University of Toronto; University Health Network","funders":"","keywords":"Medicine; Renal function; Kidney disease; Internal medicine; Red blood cell distribution width; Comorbidity; Wasting; Gastroenterology","score_opus":0.017447721097760566,"score_gpt":0.2693170002689205,"score_spread":0.25186927917116,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1983883292","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.996442,0.0023123017,0.00051753985,0.000103158236,0.000012732105,0.0000056336476,0.00022690452,0.000008420047,0.00037131636],"genre_scores_gemma":[0.99903995,0.00033861215,0.00026322826,0.000021869355,0.000028864357,0.000005662504,0.0002047138,0.000002968051,0.00009417763],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9993186,0.0003155422,0.000082948856,0.000097752934,0.00011571608,0.000069537295],"domain_scores_gemma":[0.99622595,0.0011775802,0.0017553668,0.00028075394,0.00022436188,0.00033605567],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016135413,0.00040345598,0.0007252117,0.00094129314,0.00023305851,0.00076856936,0.00043555582,0.0005386837,0.0009769729],"category_scores_gemma":[0.004361092,0.00018870944,0.00044404165,0.0016893365,0.0003273464,0.00046165756,0.00050038856,0.0008786642,0.00021980853],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00028887746,0.000020676598,0.9967539,0.000016517648,0.00007097614,0.000033483935,0.000018137975,0.000068800306,0.00033631647,0.00001533369,0.000037804446,0.0023391603],"study_design_scores_gemma":[0.00000820289,0.00010834679,0.99869174,0.000008293617,0.000062131694,0.00015832661,0.000026262493,0.00058115576,0.00015616004,0.000057067908,0.0001367435,0.0000056029185],"about_ca_topic_score_codex":0.0015092072,"about_ca_topic_score_gemma":0.0011556976,"teacher_disagreement_score":0.0016135413,"about_ca_system_score_codex":0.00022829065,"about_ca_system_score_gemma":0.000290759,"threshold_uncertainty_score":0.008533359},"labels":[],"label_agreement":null},{"id":"W1984035634","doi":"10.1046/j.1365-2141.2000.02000.x","title":"A single nucleotide polymorphism at nucleotide −1793 in the von Willebrand factor (VWF) regulatory region is associated with plasma VWF:Ag levels","year":2000,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":75,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Single-nucleotide polymorphism; Von Willebrand factor; Linkage disequilibrium; SNP; Biology; Platelet; Molecular biology; Glycoprotein; Nucleotide; Genetics; Genotype; Immunology; Gene","score_opus":0.020486983990414598,"score_gpt":0.23225101807058698,"score_spread":0.2117640340801724,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1984035634","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99626404,0.0005288603,0.0011038416,0.00022828292,0.000084351595,0.000028174896,0.0005973574,0.000029125202,0.0011360315],"genre_scores_gemma":[0.9972018,0.00016082702,0.00084538356,0.00009918372,0.000087631386,0.0000160952,0.0004791167,0.000013975193,0.0010960883],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9997081,0.00006930006,0.00004000279,0.00009426022,0.00006124393,0.000026942309],"domain_scores_gemma":[0.9994973,0.00017215629,0.0001557202,0.000027763237,0.000038983846,0.0001080883],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00025180567,0.00050124235,0.00033752556,0.00061839033,0.00045957966,0.00021092346,0.00025102423,0.00072310644,0.003219822],"category_scores_gemma":[0.0007773678,0.00011476231,0.0003731311,0.0006576982,0.00026835772,0.000102181104,0.00016865325,0.00059856294,0.0005906941],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005366054,0.0010972534,0.60100716,0.00024711958,0.00074431533,0.02006584,0.0008663019,0.00057769543,0.33378366,0.0014744065,0.002534278,0.032235995],"study_design_scores_gemma":[0.0001878692,0.0012939303,0.9515875,0.000060440205,0.00033226743,0.026531225,0.00016112132,0.0011745208,0.011720563,0.0011876927,0.0057114847,0.00005148745],"about_ca_topic_score_codex":0.0018280126,"about_ca_topic_score_gemma":0.0016239523,"teacher_disagreement_score":0.003219822,"about_ca_system_score_codex":0.00013500912,"about_ca_system_score_gemma":0.00017066712,"threshold_uncertainty_score":0.010771334},"labels":[],"label_agreement":null},{"id":"W1985256998","doi":"10.1046/j.1365-2141.2003.04033.x","title":"Fcγ receptor IIa and IIIa polymorphisms in childhood immune thrombocytopenic purpura","year":2002,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":87,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Canadian Blood Services; University of Toronto; Hospital for Sick Children","funders":"Medical Research Council; University of Toronto; Canadian Blood Services","keywords":"Thrombocytopenic purpura; Immunology; Receptor; Autoantibody; Genotype; Immune system; Platelet; Allele; Antibody; Allele frequency; Immunoglobulin G; Medicine; Internal medicine; Biology; Genetics; Gene","score_opus":0.010917906366171399,"score_gpt":0.2284805917841781,"score_spread":0.2175626854180067,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1985256998","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9972555,0.001705239,0.00017112642,0.000051845287,0.000005920768,0.000003919533,0.00014313238,0.0000047901954,0.00065862393],"genre_scores_gemma":[0.9988569,0.0006143252,0.00017549518,0.000015136876,0.000008911785,0.0000047827384,0.00011854932,0.0000034734358,0.00020248225],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99962616,0.00012131784,0.000036967227,0.00007861883,0.0000878808,0.000049120208],"domain_scores_gemma":[0.99938977,0.0002632373,0.00022535858,0.000025596097,0.00003473922,0.0000612085],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00029268724,0.00028760606,0.000244888,0.00074681814,0.00025263653,0.0003012237,0.00020085319,0.0003692561,0.0016769775],"category_scores_gemma":[0.0012082182,0.00020769091,0.00018844585,0.0011876865,0.00032243895,0.00013787624,0.00017731044,0.00033723496,0.00021378887],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00048708165,0.000045517558,0.98372436,0.000040737596,0.00009608372,0.0016672424,0.00020029962,0.00022173303,0.003983006,0.00010618483,0.00026979798,0.009157913],"study_design_scores_gemma":[0.0000143089055,0.00008555698,0.995195,0.000018049914,0.000068592024,0.0032443034,0.000089115994,0.00019700854,0.00047083123,0.000052669828,0.0005613327,0.0000032661844],"about_ca_topic_score_codex":0.006537636,"about_ca_topic_score_gemma":0.0036422384,"teacher_disagreement_score":0.006537636,"about_ca_system_score_codex":0.0002373803,"about_ca_system_score_gemma":0.00018993768,"threshold_uncertainty_score":0.012999177},"labels":[],"label_agreement":null},{"id":"W1985605429","doi":"10.1111/bjh.13146","title":"A retrospective observational study of leucoreductive strategies to manage patients with acute myeloid leukaemia presenting with hyperleucocytosis","year":2014,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":45,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"London Health Sciences Centre; University of Alberta; Sunnybrook Health Science Centre; Canadian Blood Services; Health Sciences Centre; ErinoakKids Centre for Treatment and Development; Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Medicine; Leukapheresis; Internal medicine; Hydroxycarbamide; Hazard ratio; Retrospective cohort study; Myeloid leukaemia; White blood cell; Cohort; Myeloid; Gastroenterology; Chemotherapy; Confidence interval; Stem cell","score_opus":0.024058456871464837,"score_gpt":0.2904321657146944,"score_spread":0.26637370884322953,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1985605429","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9989261,0.00035249366,0.000092742535,0.00003265787,0.000009756122,0.00006578438,0.00032747802,0.0000028500936,0.00019007095],"genre_scores_gemma":[0.9988896,0.00014587495,0.00015611517,0.000105142644,0.000021110289,0.00005857274,0.00052982767,0.0000022157587,0.000091429094],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987301,0.00039168776,0.00014737654,0.00037043708,0.00021883925,0.00014151561],"domain_scores_gemma":[0.9970565,0.00041898887,0.0015294532,0.00019337825,0.00019196708,0.0006097176],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011806098,0.00035252227,0.0008029156,0.00039801517,0.0005007376,0.0006788154,0.0005022326,0.00059360603,0.0007724532],"category_scores_gemma":[0.0029389327,0.0004190944,0.00055379304,0.0009409774,0.00036028182,0.0005119943,0.0004342944,0.0010248413,0.00020239501],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000807193,0.00023315332,0.9971527,0.000035831614,0.00013400479,0.00016439355,0.00011668493,0.00003625941,0.00028012224,0.000023750834,0.0001530904,0.00086276565],"study_design_scores_gemma":[0.00021635265,0.0027289875,0.99459285,0.000022240372,0.00012227493,0.00093466486,0.00034662196,0.00025050243,0.00009517125,0.000034817658,0.000642614,0.000012885446],"about_ca_topic_score_codex":0.0035541353,"about_ca_topic_score_gemma":0.0046997615,"teacher_disagreement_score":0.0035541353,"about_ca_system_score_codex":0.00066397444,"about_ca_system_score_gemma":0.0008142615,"threshold_uncertainty_score":0.0070669055},"labels":[],"label_agreement":null},{"id":"W1986060736","doi":"10.1111/bjh.12880","title":"Lymphoma diagnosis at an academic centre: rate of revision and impact on patient care","year":2014,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":37,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba","funders":"","keywords":"Medical diagnosis; Medicine; Referral; Lymphoma; Follicular lymphoma; Biopsy; Pediatrics; Internal medicine; Radiology; Family medicine","score_opus":0.009490982908465806,"score_gpt":0.278075712845727,"score_spread":0.26858472993726124,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1986060736","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98975825,0.005912244,0.0005781045,0.000926715,0.00007298186,0.000043296975,0.00023610068,0.00004981232,0.002422455],"genre_scores_gemma":[0.9980769,0.00086525857,0.00044845548,0.00019449288,0.000077131495,0.000010847796,0.00017131817,0.000017060023,0.0001385502],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9597998,0.018651096,0.004786945,0.0034702416,0.011188571,0.002103226],"domain_scores_gemma":[0.826987,0.07421778,0.0701466,0.008095411,0.0146501055,0.0059031053],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.01194314,0.0003330958,0.0007181978,0.0029601988,0.0006557782,0.002353169,0.0013432237,0.0011777421,0.002061924],"category_scores_gemma":[0.12082575,0.0004214389,0.00082678726,0.002545104,0.00088516745,0.0016178049,0.0022245285,0.0011898238,0.0005007784],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00030017085,0.000051680683,0.9675946,0.00012614684,0.00010267017,0.00077592884,0.00081124855,0.00017430425,0.00028292643,0.0000522355,0.00053221075,0.02919596],"study_design_scores_gemma":[0.000013899094,0.00034268873,0.9871678,0.00020197668,0.000086790504,0.008034224,0.0015332056,0.0008065918,0.0005404783,0.000071599134,0.0011666194,0.000034105513],"about_ca_topic_score_codex":0.005535036,"about_ca_topic_score_gemma":0.0061622537,"teacher_disagreement_score":0.01194314,"about_ca_system_score_codex":0.0023941179,"about_ca_system_score_gemma":0.0013152694,"threshold_uncertainty_score":0.06316215},"labels":[],"label_agreement":null},{"id":"W1986114335","doi":"10.1111/j.1365-2141.2006.05960.x","title":"Risk of recurrent venous thromboembolism or bleeding in relation to thrombophilic risk factors in patients receiving ximelagatran or placebo for long‐term secondary prevention of venous thromboembolism","year":2006,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hamilton Health Sciences; Hamilton General Hospital","funders":"","keywords":"Medicine; Ximelagatran; Factor V Leiden; Internal medicine; Population; Placebo; Risk factor; Thrombophilia; Warfarin; Venous thrombosis; Thrombosis; Atrial fibrillation; Dabigatran; Pathology","score_opus":0.01624886341386555,"score_gpt":0.28003570661110105,"score_spread":0.2637868431972355,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1986114335","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9905669,0.008538955,0.00017474132,0.00009311194,0.000036524518,0.000031761087,0.00010947459,0.000008843428,0.0004398018],"genre_scores_gemma":[0.9980101,0.0013425804,0.00012771206,0.00006106061,0.00004773858,0.00003715389,0.00013929821,0.0000027040358,0.00023181598],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.998917,0.0006322905,0.00011256214,0.00011581572,0.00013083813,0.00009149318],"domain_scores_gemma":[0.99801195,0.0011183855,0.00053974136,0.0000954651,0.000048850907,0.00018545472],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017470116,0.00028347038,0.001643587,0.00028785132,0.0001422493,0.0005292166,0.000255811,0.00088604254,0.0015398272],"category_scores_gemma":[0.0031055193,0.00026387634,0.0015817733,0.00041272474,0.0002776114,0.00026569853,0.00019302407,0.0007121833,0.0001369047],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.6295016,0.0016117889,0.2648324,0.0014551067,0.010784223,0.0007835374,0.00030536638,0.0011970124,0.010281461,0.00031726627,0.00086827006,0.07806203],"study_design_scores_gemma":[0.044782206,0.10363046,0.83045924,0.00021513739,0.009509712,0.0016165732,0.00013972141,0.004715697,0.0021253175,0.00072618434,0.0020107771,0.000069095055],"about_ca_topic_score_codex":0.00041087813,"about_ca_topic_score_gemma":0.0004738491,"teacher_disagreement_score":0.0017470116,"about_ca_system_score_codex":0.00024428125,"about_ca_system_score_gemma":0.00026449797,"threshold_uncertainty_score":0.009239197},"labels":[],"label_agreement":null},{"id":"W1986890987","doi":"10.1046/j.1365-2141.2003.04141.x","title":"Molecular pathology of haemophilia B in Turkish patients: identification of a large deletion and 33 independent point mutations","year":2003,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Hemophilia Treatment and Research","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Mount Sinai Hospital","funders":"","keywords":"Haemophilia B; Point mutation; Haplotype; Haemophilia; Haemophilia A; Mutation; Molecular pathology; Genetics; Turkish; Medicine; Mutation testing; Gene; Biology; Genotype","score_opus":0.009451106273514859,"score_gpt":0.2859079934200352,"score_spread":0.27645688714652034,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1986890987","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99931395,0.00024185043,0.00015087302,0.00002652242,0.000003613017,0.0000054127177,0.000051358697,0.0000066496086,0.00019978166],"genre_scores_gemma":[0.9991861,0.00018331612,0.0003855919,0.000023218068,0.0000072288685,0.000004522559,0.000106754036,0.0000031414688,0.00010017486],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99986124,0.000019126555,0.000017624947,0.000037911017,0.000034621364,0.000029464203],"domain_scores_gemma":[0.99982566,0.000037384627,0.000057678022,0.000012889679,0.000021438438,0.00004496268],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018105244,0.0005646056,0.00030942264,0.0011763962,0.00035946205,0.00028159076,0.00020802367,0.00047595636,0.0013384573],"category_scores_gemma":[0.00051406014,0.00022817249,0.00026297543,0.00048245705,0.0002929765,0.00016265326,0.00025470124,0.00028062752,0.0002589076],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0025245168,0.00032495105,0.48528564,0.00022741806,0.00026509428,0.08168781,0.0015472594,0.0007873526,0.36653498,0.00052860455,0.0015328784,0.05875345],"study_design_scores_gemma":[0.00016287739,0.00087160576,0.7518139,0.000031041316,0.00019488165,0.21738486,0.0004064408,0.0006453159,0.02505459,0.00017063234,0.0032227493,0.000041000298],"about_ca_topic_score_codex":0.0008842718,"about_ca_topic_score_gemma":0.00071268674,"teacher_disagreement_score":0.0013384573,"about_ca_system_score_codex":0.0002240025,"about_ca_system_score_gemma":0.00017335462,"threshold_uncertainty_score":0.0044775605},"labels":[],"label_agreement":null},{"id":"W1987057326","doi":"10.1046/j.1365-2141.2002.03718.x","title":"Gender‐specific phenotypic expression and screening strategies in C282Y‐linked haemochromatosis: a study of 9396 French people","year":2002,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Iron Metabolism and Disorders","field":"Medicine","cited_by":87,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Transferrin saturation; Penetrance; Medicine; Hemochromatosis; Population; Ferritin; Genotype; Internal medicine; Hereditary hemochromatosis; Family history; Logistic regression; Phlebotomy; Pediatrics; Genetics; Phenotype; Biology; Serum ferritin; Gene","score_opus":0.03018450554651474,"score_gpt":0.26423804935686257,"score_spread":0.23405354381034782,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1987057326","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9994573,0.0001466734,0.00008278682,0.000024357716,0.0000021403569,0.000006519268,0.00011895193,0.0000022599945,0.00015902793],"genre_scores_gemma":[0.9994954,0.00008261992,0.000057447163,0.000024939645,0.0000033535534,0.0000076212505,0.00011390528,0.0000013373206,0.00021333933],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9994228,0.00019438755,0.000039174396,0.00014820938,0.00007978531,0.000115674295],"domain_scores_gemma":[0.99940574,0.00016436151,0.0001574089,0.0000672204,0.00009334711,0.00011189972],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00083551527,0.00044186204,0.00038490785,0.0006843109,0.00071407435,0.0005056163,0.00027323957,0.00048880925,0.001504811],"category_scores_gemma":[0.0018826508,0.00031944865,0.00046793604,0.0006916878,0.00039456133,0.00023162832,0.0002613054,0.00029949212,0.00033804047],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015368809,0.00004350797,0.9944431,0.00001691339,0.000056439134,0.00029800602,0.00092845457,0.000058985584,0.00042933456,0.00003295222,0.0001509478,0.0033877662],"study_design_scores_gemma":[0.0000086900845,0.0001377687,0.9986117,0.0000052282744,0.000020594112,0.00043183175,0.000391271,0.00010022379,0.00004216279,0.000015507996,0.00023060718,0.0000044292474],"about_ca_topic_score_codex":0.05469267,"about_ca_topic_score_gemma":0.038860954,"teacher_disagreement_score":0.05469267,"about_ca_system_score_codex":0.0006650422,"about_ca_system_score_gemma":0.0003237101,"threshold_uncertainty_score":0.108748674},"labels":[],"label_agreement":null},{"id":"W1987137332","doi":"10.1111/bjh.13460","title":"Effect of anticoagulant therapy on cell-derived microparticles and pregnancy outcome in women with pregnancy loss","year":2015,"lang":"en","type":"letter","venue":"British Journal of Haematology","topic":"Pregnancy and preeclampsia studies","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Department of Science and Technology, Government of Kerala; Council of Scientific and Industrial Research, India; Department of Science and Technology, Ministry of Science and Technology, India; Leukemia and Lymphoma Society of Canada","keywords":"Pregnancy; Medicine; Obstetrics; Anticoagulant therapy; Outcome (game theory); Gynecology; Internal medicine; Biology","score_opus":0.022192344151698542,"score_gpt":0.27809886463494854,"score_spread":0.25590652048325,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1987137332","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98048615,0.01640641,0.00012437794,0.00045849677,0.00010778775,0.00005417712,0.00014249778,0.0000108230515,0.0022093223],"genre_scores_gemma":[0.99526644,0.0033697307,0.00014290874,0.00019351841,0.00007521862,0.000041534,0.00012892458,0.0000026586156,0.0007791117],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99960726,0.00017927584,0.000047558395,0.000037955786,0.00007313728,0.00005478074],"domain_scores_gemma":[0.99911815,0.0004054136,0.00022137543,0.000041709813,0.000055212327,0.0001580449],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006992869,0.00023200607,0.0005225851,0.00033208716,0.00022214085,0.00034990048,0.0001326514,0.0004663455,0.0012264813],"category_scores_gemma":[0.0035780647,0.000118940305,0.0005251259,0.00028389745,0.0001923663,0.00026146637,0.00022445939,0.00093848124,0.00019899274],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.070639774,0.0043606292,0.6744588,0.0007070049,0.0016453086,0.0038187061,0.0008686446,0.00039800824,0.0049238824,0.00022356516,0.0014072438,0.23654851],"study_design_scores_gemma":[0.0014022244,0.058029864,0.92263466,0.00031019025,0.0019193781,0.0041512023,0.00076163496,0.001178235,0.0018338746,0.000645909,0.0070764357,0.000056385747],"about_ca_topic_score_codex":0.0007417734,"about_ca_topic_score_gemma":0.0007020456,"teacher_disagreement_score":0.0012264813,"about_ca_system_score_codex":0.0002462521,"about_ca_system_score_gemma":0.0002916869,"threshold_uncertainty_score":0.004103005},"labels":[],"label_agreement":null},{"id":"W1987248979","doi":"10.1046/j.1365-2141.2001.03167.x","title":"Acute event‐related anaemia","year":2001,"lang":"en","type":"review","venue":"British Journal of Haematology","topic":"Blood transfusion and management","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Iron deficiency; Medicine; Soluble transferrin receptor; Erythropoiesis; Sepsis; Rheumatoid arthritis; Ferritin; Hepcidin; Anemia; Inflammation; Immunology; Transferrin; Serum iron; Physiology; Internal medicine; Iron status","score_opus":0.025031195972559733,"score_gpt":0.3388105507021678,"score_spread":0.31377935472960805,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1987248979","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.031515863,0.7784776,0.010121121,0.007853729,0.0042282203,0.0019848004,0.0062214285,0.00091424363,0.15868288],"genre_scores_gemma":[0.30941424,0.53952616,0.010773145,0.020396076,0.0070915306,0.001261405,0.016070718,0.00023461078,0.0952321],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99858725,0.00028744072,0.00028655396,0.000117118885,0.00048766716,0.00023401149],"domain_scores_gemma":[0.99795616,0.0003790598,0.0006819908,0.000081216,0.0006659188,0.00023555422],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007926399,0.0005990087,0.00133096,0.0012846452,0.0006590073,0.0015183613,0.000612749,0.00082378276,0.016068181],"category_scores_gemma":[0.0032543454,0.00015948768,0.00090906327,0.001677895,0.00038727542,0.00062906,0.001163311,0.0014974425,0.005048857],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016203613,0.00052744057,0.039668202,0.014964596,0.0006960881,0.01026332,0.0006279699,0.00034446965,0.0048562908,0.013626156,0.26661548,0.6461897],"study_design_scores_gemma":[0.00023167231,0.0005244225,0.047365002,0.0047625694,0.00042588718,0.032562505,0.00029009263,0.00024558566,0.0012442514,0.005393372,0.90688735,0.00006730184],"about_ca_topic_score_codex":0.0019982185,"about_ca_topic_score_gemma":0.0017616409,"teacher_disagreement_score":0.016068181,"about_ca_system_score_codex":0.0008751458,"about_ca_system_score_gemma":0.0011792454,"threshold_uncertainty_score":0.053753436},"labels":[],"label_agreement":null},{"id":"W1987647282","doi":"10.1111/j.1365-2141.2004.04856.x","title":"Improved survival in steroid‐refractory acute graft <i>versus</i> host disease after non‐myeloablative allogeneic transplantation using a daclizumab‐based strategy with comprehensive infection prophylaxis","year":2004,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":75,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Pediatric Oncology Group","funders":"National Heart, Lung, and Blood Institute","keywords":"Medicine; Daclizumab; Regimen; Internal medicine; Fludarabine; Transplantation; Gastroenterology; Cyclophosphamide; Surgery; Graft-versus-host disease; Busulfan; Hematopoietic stem cell transplantation; Chemotherapy; Tacrolimus","score_opus":0.02025438556785252,"score_gpt":0.2780161506530109,"score_spread":0.25776176508515836,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1987647282","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9997745,0.0001082903,0.000028368626,0.000004777254,0.0000020075804,0.000002394026,0.00000661515,0.00000121097,0.0000717474],"genre_scores_gemma":[0.9998282,0.000050591032,0.000034477787,0.00001036329,0.000007456991,0.000002180853,0.000040163606,5.7970607e-7,0.000025846395],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9998282,0.00006479244,0.000015478337,0.000028307366,0.00002006778,0.000043089673],"domain_scores_gemma":[0.99962723,0.000077762736,0.00011756299,0.000025464138,0.000014342577,0.00013765664],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003865099,0.00023784337,0.00029766175,0.00024418716,0.00018726387,0.00034758763,0.00013453542,0.00022523031,0.00045080716],"category_scores_gemma":[0.00062658585,0.000084531515,0.00023208481,0.00016381391,0.00020105092,0.00015672765,0.00019836171,0.00023869459,0.000096435004],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00803465,0.0010859063,0.933582,0.000051413226,0.00016153693,0.0022257236,0.00024100677,0.00055483304,0.021901391,0.000045817007,0.00018793912,0.031927653],"study_design_scores_gemma":[0.000286645,0.01178529,0.9789059,0.000016256277,0.000087757246,0.0053023184,0.0001052603,0.00087761134,0.0021733078,0.000040815266,0.00040850881,0.000010252364],"about_ca_topic_score_codex":0.00028054215,"about_ca_topic_score_gemma":0.0004190281,"teacher_disagreement_score":0.00045080716,"about_ca_system_score_codex":0.0001438368,"about_ca_system_score_gemma":0.00015486375,"threshold_uncertainty_score":0.0020440817},"labels":[],"label_agreement":null},{"id":"W1987866391","doi":"10.1111/bjh.13081","title":"Mechanisms of plasma non‐transferrin bound iron generation: insights from comparing transfused diamond blackfan anaemia with sickle cell and thalassaemia patients","year":2014,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":66,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Victoria","funders":"National Center for Advancing Translational Sciences; National Center for Research Resources; National Institutes of Health; Georgia Clinical and Translational Science Alliance; University College London; National Institute of Diabetes and Digestive and Kidney Diseases; National Institute for Health and Care Research","keywords":"Hepcidin; Erythropoiesis; Transferrin; Ineffective erythropoiesis; Diamond–Blackfan anemia; Transferrin receptor; Medicine; Immunology; Erythropoietin; Ferroportin; Anemia; Internal medicine; Endocrinology; Biology; Biochemistry; Gene; RNA","score_opus":0.006267389681336669,"score_gpt":0.1922002352447814,"score_spread":0.18593284556344472,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1987866391","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99954957,0.00024224243,0.000032760912,0.000012088984,0.0000014519119,0.0000023066948,0.000015420314,6.561196e-7,0.000143607],"genre_scores_gemma":[0.99973994,0.000106329935,0.00004845383,0.000014859379,0.000004559095,0.0000029223097,0.000036629674,5.8795655e-7,0.00004581859],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9997793,0.00009004025,0.000021886124,0.000041766278,0.00003190376,0.000035071324],"domain_scores_gemma":[0.99974924,0.00007164344,0.0000798921,0.000014557607,0.000024968185,0.000059634807],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00038653164,0.00017513783,0.0003303643,0.0007071253,0.00019780644,0.00051106693,0.0001988391,0.0003248348,0.0007943999],"category_scores_gemma":[0.0010792906,0.00010623521,0.00016645918,0.00043383572,0.00024653637,0.00022988142,0.00033341415,0.00022796894,0.00014042774],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0034473746,0.00018632838,0.957548,0.00009502845,0.00011223132,0.0019723827,0.0022496262,0.00013642636,0.017306983,0.00020612676,0.00011032245,0.01662917],"study_design_scores_gemma":[0.00003585459,0.0011415862,0.9924595,0.000014128085,0.00006270989,0.0035166482,0.0010232,0.00028889443,0.0009940156,0.00012458561,0.00033041838,0.00000851959],"about_ca_topic_score_codex":0.0015791376,"about_ca_topic_score_gemma":0.0008711909,"teacher_disagreement_score":0.0015791376,"about_ca_system_score_codex":0.00025049274,"about_ca_system_score_gemma":0.00013895759,"threshold_uncertainty_score":0.0031399727},"labels":[],"label_agreement":null},{"id":"W1988286071","doi":"10.1111/bjh.12262","title":"Gene methylation and silencing of <i><scp>SOCS</scp>3</i> in mantle cell lymphoma","year":2013,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Cytokine Signaling Pathways and Interactions","field":"Medicine","cited_by":31,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"Canadian Institutes of Health Research","keywords":"Mantle cell lymphoma; Cyclin D1; Gene silencing; Methylation; Biology; Cancer research; Cell culture; Cell growth; Molecular biology; Cell; Cell cycle; Lymphoma; Gene; Immunology; Genetics","score_opus":0.011381695726558061,"score_gpt":0.23899844757114042,"score_spread":0.22761675184458235,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1988286071","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99889886,0.00031669764,0.000293112,0.000019654199,0.0000028942734,0.000005052764,0.00012714266,0.000022236192,0.0003143143],"genre_scores_gemma":[0.9994216,0.00010191759,0.00010860293,0.0000118036705,0.0000013935665,0.0000054834713,0.00013223576,0.000004118713,0.00021290065],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99995005,0.000007801566,0.0000039353854,0.000011003388,0.000009909053,0.000017302176],"domain_scores_gemma":[0.99995136,0.0000067925375,0.00001857011,0.000004368965,0.000005182869,0.000013709531],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00007823649,0.00010083701,0.00012565295,0.00018860243,0.000078922356,0.00014016395,0.000067858266,0.000117711024,0.0007146165],"category_scores_gemma":[0.00010922492,0.00007850778,0.00015423332,0.00014028374,0.00015246695,0.00006967615,0.00009914734,0.00016862783,0.00013878492],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00053006795,0.000019700583,0.009712942,0.00002600311,0.0000124421,0.00019292631,0.00005277633,0.00011751125,0.98428476,0.00003860046,0.000075195574,0.0049369433],"study_design_scores_gemma":[0.00008110034,0.002382059,0.38559577,0.0000109747525,0.00011048416,0.0041995193,0.0002161856,0.0023004962,0.60097516,0.00015244605,0.0039615384,0.000014306107],"about_ca_topic_score_codex":0.0013601559,"about_ca_topic_score_gemma":0.0014611454,"teacher_disagreement_score":0.0013601559,"about_ca_system_score_codex":0.00021134542,"about_ca_system_score_gemma":0.00011331106,"threshold_uncertainty_score":0.0027045012},"labels":[],"label_agreement":null},{"id":"W1988489929","doi":"10.1111/bjh.12545","title":"Multiple infusions of mesenchymal stromal cells induce sustained remission in children with steroid‐refractory, grade <scp>III</scp>–<scp>IV</scp> acute graft‐versus‐host disease","year":2013,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Mesenchymal stem cell research","field":"Medicine","cited_by":233,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children; University of Toronto","funders":"Associazione Italiana per la Ricerca sul Cancro; Ministero dell’Istruzione, dell’Università e della Ricerca","keywords":"Medicine; Refractory (planetary science); Steroid; Graft-versus-host disease; Mesenchymal stem cell; Gastroenterology; Transplantation; Internal medicine; Incidence (geometry); Cumulative incidence; Surgery; Pathology; Biology","score_opus":0.015354533651776813,"score_gpt":0.27013575938298545,"score_spread":0.25478122573120865,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1988489929","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9991992,0.00051193684,0.00012656453,0.000011190428,0.0000026047112,0.000009601869,0.000050960607,0.0000050696635,0.00008291033],"genre_scores_gemma":[0.9993303,0.00028399308,0.00016510645,0.000015288231,0.000008019438,0.000012895401,0.00013698124,0.000002989603,0.000044440345],"study_design_codex":"observational","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.99973434,0.00006316583,0.0000362307,0.00004885315,0.000052665808,0.00006474584],"domain_scores_gemma":[0.9991737,0.0001898414,0.00044577496,0.000037088746,0.000027159092,0.00012633676],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003188225,0.0001958455,0.0005436593,0.0002753303,0.000163905,0.0003053131,0.00014445602,0.00019790925,0.0003340801],"category_scores_gemma":[0.00091958256,0.00012686847,0.00039268946,0.0003511914,0.00027291177,0.0001788432,0.0002647972,0.00028926096,0.00010100369],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0035937184,0.0002484914,0.93734217,0.00016625173,0.00021571544,0.0041017877,0.00045732572,0.0005833817,0.014753099,0.00007249354,0.00035571266,0.038109787],"study_design_scores_gemma":[0.00025222934,0.0076697636,0.97268313,0.000043204345,0.00021235667,0.011842294,0.00027337277,0.0006589846,0.004535887,0.00004277016,0.0017740687,0.000011911099],"about_ca_topic_score_codex":0.0007926369,"about_ca_topic_score_gemma":0.0011164433,"teacher_disagreement_score":0.0007926369,"about_ca_system_score_codex":0.00037505475,"about_ca_system_score_gemma":0.0003999786,"threshold_uncertainty_score":0.0027211905},"labels":[],"label_agreement":null},{"id":"W1988589898","doi":"10.1046/j.1365-2141.2002.34771.x","title":"Prolonged complete remission in two cases of acute promyelocytic leukaemia treated with atra alone","year":2002,"lang":"en","type":"letter","venue":"British Journal of Haematology","topic":"Retinoids in leukemia and cellular processes","field":"Biochemistry, Genetics and Molecular Biology","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Pancytopenia; Acute promyelocytic leukemia; Medicine; Chemotherapy; Gastroenterology; Internal medicine; Dexamethasone; Methotrexate; Bone marrow; Bone marrow suppression; Retinoic acid; Immunology; Biology; Cell culture","score_opus":0.013459920454041294,"score_gpt":0.24868979302633576,"score_spread":0.23522987257229447,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1988589898","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98841363,0.004598663,0.0021270483,0.00072327664,0.00010794657,0.0001311302,0.00012009499,0.000121805795,0.00365641],"genre_scores_gemma":[0.99731416,0.0006847735,0.00044755198,0.00030806154,0.00015996203,0.000042140102,0.00015091959,0.000017639297,0.00087475765],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.999443,0.0000819525,0.000077895274,0.00010802256,0.000082825434,0.00020630442],"domain_scores_gemma":[0.99829537,0.0003127977,0.0005881519,0.0002548959,0.00009460325,0.00045422016],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00037159756,0.00088498776,0.00066047045,0.0012184926,0.0010592146,0.0007780145,0.00079714344,0.0021294127,0.0016612468],"category_scores_gemma":[0.0033123437,0.0007187017,0.0008802426,0.0008330747,0.00096885196,0.00080440583,0.0012785833,0.0017995584,0.0005999294],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00071765285,0.00013838986,0.048994794,0.0001829274,0.000067145666,0.92658037,0.0011738787,0.00024538694,0.0077797435,0.00047027855,0.00053423573,0.01311524],"study_design_scores_gemma":[0.0001130991,0.00045893944,0.025798703,0.00001680249,0.0000439227,0.9694837,0.00013275187,0.00020502329,0.0013846208,0.00016593731,0.0021820923,0.0000143616],"about_ca_topic_score_codex":0.00082366506,"about_ca_topic_score_gemma":0.00080889673,"teacher_disagreement_score":0.0021294127,"about_ca_system_score_codex":0.00067623326,"about_ca_system_score_gemma":0.00035554147,"threshold_uncertainty_score":0.005557418},"labels":[],"label_agreement":null},{"id":"W1988781800","doi":"10.1111/bjh.12640","title":"Subcutaneous protein C concentrate in the management of severe protein C deficiency – experience from 12 centres","year":2014,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Blood Coagulation and Thrombosis Mechanisms","field":"Medicine","cited_by":33,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier Universitaire Sainte-Justine","funders":"","keywords":"Medicine; Subcutaneous injection; Protein C deficiency; Incidence (geometry); Protein C; Pediatrics; Surgery; Internal medicine; Thrombosis; Venous thrombosis","score_opus":0.015540227276811447,"score_gpt":0.2512115927190119,"score_spread":0.23567136544220044,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1988781800","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9835783,0.012006553,0.0010181494,0.0005312107,0.00006523736,0.00013234392,0.000058493337,0.000023905324,0.0025859063],"genre_scores_gemma":[0.9883482,0.0080472715,0.0017645811,0.00047958601,0.00018202042,0.00007519407,0.00015138814,0.000028417686,0.00092330895],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9984724,0.00078748766,0.00015045513,0.00015410314,0.0001928701,0.00024274783],"domain_scores_gemma":[0.998429,0.00037755992,0.00027392077,0.00012083006,0.00015740871,0.00064124365],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015211508,0.00068718975,0.0005567574,0.00040581624,0.0006666388,0.0007367219,0.00062832725,0.0010445442,0.001424734],"category_scores_gemma":[0.004038772,0.00036480895,0.00044754532,0.0011108838,0.00055725535,0.0005191465,0.0008591441,0.0008594135,0.00037348914],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0060279253,0.007440932,0.21858549,0.0021748836,0.00051157875,0.053010367,0.024434574,0.00345355,0.01421356,0.0010380727,0.01119972,0.65790933],"study_design_scores_gemma":[0.0036002283,0.065854736,0.6669997,0.0016521692,0.00048047127,0.15646504,0.01649566,0.0031001389,0.009674298,0.00081204355,0.07442831,0.00043723488],"about_ca_topic_score_codex":0.002492947,"about_ca_topic_score_gemma":0.0022363693,"teacher_disagreement_score":0.002492947,"about_ca_system_score_codex":0.00064883375,"about_ca_system_score_gemma":0.000978578,"threshold_uncertainty_score":0.00804472},"labels":[],"label_agreement":null},{"id":"W1989191461","doi":"10.1046/j.1365-2141.2000.02126.x","title":"Porcine von Willebrand factor and thrombin induce the activation of c‐Jun amino‐terminal kinase (JNK/SAPK) whereas only thrombin induces activation of extracellular signal‐related kinase 2 (ERK2) in human platelets","year":2000,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Blood Services; St. Michael's Hospital","funders":"Bayer Canada; Canadian Hemophilia Society","keywords":"Platelet activation; Kinase; Thrombin; MAPK/ERK pathway; Chemistry; Cell biology; Glycoprotein Ib; p38 mitogen-activated protein kinases; Platelet; Platelet membrane glycoprotein; Thrombin receptor; Mitogen-activated protein kinase; Molecular biology; Biochemistry; Biology; Receptor; Immunology","score_opus":0.01493880839794132,"score_gpt":0.2588660599708924,"score_spread":0.2439272515729511,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1989191461","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98469526,0.0075311502,0.0038077068,0.00018572311,0.00010921515,0.00014725755,0.0005110448,0.00004928786,0.0029635523],"genre_scores_gemma":[0.9869441,0.0027518012,0.00344328,0.00011908642,0.00004754636,0.00018057882,0.0021431048,0.000010982516,0.004359512],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9997212,0.00004994824,0.00003084288,0.000040692958,0.00009158518,0.000065749206],"domain_scores_gemma":[0.9999294,0.000015079061,0.00001700185,0.000008795496,0.00000909222,0.000020531492],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023836482,0.00044606146,0.000217644,0.00025027647,0.00014455977,0.00023982151,0.000112327245,0.0003144044,0.0018951218],"category_scores_gemma":[0.00020875705,0.00018031747,0.00045663072,0.00025167485,0.00017538799,0.00018694488,0.00019069786,0.00047623666,0.00045277484],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00038865305,0.000078588615,0.00013252898,0.000084647145,0.000010704336,0.000114862945,0.000026339208,0.000030496582,0.9975262,0.00007132329,0.000060754297,0.0014748729],"study_design_scores_gemma":[0.00011212415,0.001892884,0.019444598,0.000013255833,0.000043944096,0.003253767,0.000052518415,0.00087858195,0.96787417,0.00017375738,0.006249169,0.000011160402],"about_ca_topic_score_codex":0.0003983173,"about_ca_topic_score_gemma":0.0005193952,"teacher_disagreement_score":0.0018951218,"about_ca_system_score_codex":0.00015878407,"about_ca_system_score_gemma":0.00022851104,"threshold_uncertainty_score":0.006339848},"labels":[],"label_agreement":null},{"id":"W1989261711","doi":"10.1111/j.1365-2141.2009.07617.x","title":"Virchow’s triad","year":2009,"lang":"en","type":"letter","venue":"British Journal of Haematology","topic":"Cardiovascular and Diving-Related Complications","field":"Medicine","cited_by":25,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Triad (sociology); Eponym; Medicine; Presentation (obstetrics); Subject (documents); Wish; Classics; Philosophy; Psychoanalysis; History; Psychology; Surgery; Computer science; Literature; Library science","score_opus":0.016014880700962162,"score_gpt":0.2598574068674097,"score_spread":0.24384252616644755,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1989261711","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0022600414,0.07143461,0.000782897,0.85907996,0.057089575,0.00001892367,0.00003997516,0.000038818816,0.009255253],"genre_scores_gemma":[0.070269145,0.04523778,0.001252574,0.70543736,0.16871236,0.00008713663,0.000051648607,0.000041121428,0.008910935],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99721575,0.0010913521,0.00033928372,0.00043706756,0.0005835977,0.0003329366],"domain_scores_gemma":[0.9955461,0.0028472904,0.0004370692,0.00021149318,0.0005716887,0.0003863583],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0028312195,0.0007765364,0.0012615636,0.0018529898,0.0023072306,0.002605208,0.001545548,0.016430758,0.0025315266],"category_scores_gemma":[0.020359185,0.0004497268,0.0005944343,0.0015070051,0.0067266747,0.0071335426,0.0020562832,0.021426875,0.0017181614],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008226361,0.000042435342,0.001763785,0.00041371622,0.000034649784,0.063179776,0.002415115,0.00011976877,0.00025112933,0.059219185,0.83333397,0.03914425],"study_design_scores_gemma":[0.000035034773,0.00003692904,0.0007350308,0.00090886414,0.000019283107,0.21698101,0.0013749772,0.00023574177,0.00013516637,0.03954199,0.7399342,0.00006180624],"about_ca_topic_score_codex":0.0017059775,"about_ca_topic_score_gemma":0.001956813,"teacher_disagreement_score":0.016430758,"about_ca_system_score_codex":0.003122666,"about_ca_system_score_gemma":0.0017121662,"threshold_uncertainty_score":0.02265668},"labels":[],"label_agreement":null},{"id":"W1989740966","doi":"10.1111/j.1365-2141.2008.07573.x","title":"Reversibility of symptomatic peripheral neuropathy with bortezomib in the phase III APEX trial in relapsed multiple myeloma: impact of a dose‐modification guideline","year":2009,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":308,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"Takeda Oncology","keywords":"Medicine; Bortezomib; Peripheral neuropathy; Multiple myeloma; Internal medicine; Guideline; Surgery; Gastroenterology; Oncology; Diabetes mellitus; Pathology; Endocrinology","score_opus":0.030424365386935357,"score_gpt":0.361632983993509,"score_spread":0.33120861860657363,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1989740966","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98644143,0.009042564,0.0003115914,0.00071176403,0.000103159124,0.00065813476,0.00027758005,0.00003825404,0.002415599],"genre_scores_gemma":[0.9952863,0.0019814658,0.00079157186,0.0007051866,0.00011467292,0.00042523205,0.00032577084,0.0000125406905,0.00035727335],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.99693334,0.002216564,0.00025381605,0.0001365728,0.00031951914,0.00014013752],"domain_scores_gemma":[0.9972441,0.0010789001,0.0009509159,0.00019980565,0.00013663062,0.00038964095],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.006722196,0.00033650128,0.001869348,0.00015152259,0.00023628672,0.0009830212,0.0006032199,0.0007227062,0.0007475943],"category_scores_gemma":[0.00360863,0.00018782589,0.0013285796,0.00033184508,0.0003753704,0.00045612588,0.0002684777,0.002027888,0.0001190942],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.72523755,0.007624903,0.024777615,0.0013364146,0.0033441049,0.00013029733,0.00026190095,0.0043434496,0.012041637,0.00043790438,0.0034130416,0.21705122],"study_design_scores_gemma":[0.49994564,0.331193,0.14704469,0.0005429143,0.0032079145,0.0004135968,0.0001357366,0.0050874148,0.0055747167,0.0007989214,0.005965577,0.00008990013],"about_ca_topic_score_codex":0.0004095241,"about_ca_topic_score_gemma":0.0018058076,"teacher_disagreement_score":0.006722196,"about_ca_system_score_codex":0.000562475,"about_ca_system_score_gemma":0.0009511712,"threshold_uncertainty_score":0.035550773},"labels":[],"label_agreement":null},{"id":"W1990067788","doi":"10.1046/j.1365-2141.2001.03154.x","title":"Comparison of five platforms for enumeration of residual leucocytes in leucoreduced blood components","year":2001,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Blood groups and transfusion","field":"Medicine","cited_by":37,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"London Health Sciences Centre","funders":"Stichting Sanquin Bloedvoorziening","keywords":"Hemocytometer; Enumeration; Coefficient of variation; Fluorometer; Staining; Chromatography; Cell counting; Mathematics; Nuclear medicine; Pathology; Chemistry; Medicine; Fluorescence; Physics; Biochemistry; Cell","score_opus":0.03968919738181159,"score_gpt":0.33025570047647534,"score_spread":0.29056650309466375,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1990067788","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8669868,0.0046729096,0.12124644,0.0003640666,0.00032649786,0.001159261,0.0013653443,0.0010445969,0.002834102],"genre_scores_gemma":[0.701698,0.0037229843,0.283764,0.000446182,0.0001334085,0.0019649158,0.0038593495,0.00017728789,0.004233893],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9873281,0.0029128883,0.0011642489,0.0022312675,0.005716876,0.0006466314],"domain_scores_gemma":[0.99399453,0.0027971321,0.00077928527,0.0005713223,0.0015358778,0.00032176622],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0071915165,0.0014857698,0.0010848695,0.0033221059,0.0004531237,0.0019594764,0.0022662836,0.0024186163,0.00074603717],"category_scores_gemma":[0.00982208,0.0007673655,0.0010410417,0.0011915518,0.001063755,0.00094281905,0.0021261233,0.0010937643,0.00054426695],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0040038326,0.0006797673,0.029568568,0.0010092009,0.00042551087,0.00008429981,0.00077425287,0.0021310796,0.9037896,0.00085336354,0.000494679,0.056185868],"study_design_scores_gemma":[0.00018680563,0.0053441045,0.04894972,0.00016386132,0.00083194696,0.0005561472,0.00027888373,0.017803216,0.92165774,0.0004944985,0.0035791083,0.00015407123],"about_ca_topic_score_codex":0.0014004323,"about_ca_topic_score_gemma":0.0018700806,"teacher_disagreement_score":0.0071915165,"about_ca_system_score_codex":0.00087020366,"about_ca_system_score_gemma":0.00088002335,"threshold_uncertainty_score":0.03803289},"labels":[],"label_agreement":null},{"id":"W1990147363","doi":"10.1111/bjh.12882","title":"Outcome for children and young people with <scp>E</scp>arly <scp>T</scp>‐cell precursor acute lymphoblastic leukaemia treated on a contemporary protocol, <scp>UKALL</scp> 2003","year":2014,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":230,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Medical Research Council; Hospital for Sick Children; Leukaemia and Lymphoma Research","keywords":"Medicine; Pediatrics; Acute lymphocytic leukemia; Internal medicine; Lymphoblastic Leukemia; Leukemia","score_opus":0.012569722151836707,"score_gpt":0.26992127646455827,"score_spread":0.25735155431272155,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1990147363","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99923337,0.00026759284,0.000024754063,0.0000257816,0.000004033793,0.000014703297,0.00016944023,0.0000010105258,0.00025934973],"genre_scores_gemma":[0.9988361,0.0002682454,0.00005232066,0.00004653185,0.000010137213,0.00002864596,0.0006094819,0.0000013465578,0.0001471892],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99969363,0.000081904436,0.00002847697,0.000039503568,0.000046784673,0.00010967825],"domain_scores_gemma":[0.9992385,0.00016064866,0.00029201314,0.00003390147,0.000058716927,0.00021629519],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005149694,0.00019479809,0.00049128546,0.00036844387,0.00042882998,0.00043198385,0.00014791814,0.0003354539,0.00074425194],"category_scores_gemma":[0.00163429,0.00012304772,0.0005187347,0.0005185115,0.00042839278,0.0003563632,0.0007196626,0.00043537194,0.00015582508],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0036825798,0.00019663654,0.98266506,0.000087503104,0.00016440367,0.0010039501,0.0006550068,0.0002935509,0.0004775861,0.0000754675,0.00036239397,0.010335796],"study_design_scores_gemma":[0.000290358,0.0045060804,0.9903121,0.000039139682,0.00015733765,0.002544012,0.000786079,0.00014993075,0.00023193553,0.000116525014,0.0008493426,0.000016996648],"about_ca_topic_score_codex":0.0071958182,"about_ca_topic_score_gemma":0.00754155,"teacher_disagreement_score":0.0071958182,"about_ca_system_score_codex":0.0009123433,"about_ca_system_score_gemma":0.00065633,"threshold_uncertainty_score":0.014307916},"labels":[],"label_agreement":null},{"id":"W1990236086","doi":"10.1111/bjh.13408","title":"A phase‐II sequential case‐series study of all patients presenting to four plasma exchange centres with presumed relapsed/refractory thrombotic thrombocytopenic purpura treated with rituximab","year":2015,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Complement system in diseases","field":"Immunology and Microbiology","cited_by":34,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McMaster University; University of Toronto; University of Ottawa; Vancouver General Hospital; Western University","funders":"","keywords":"Medicine; Rituximab; Refractory (planetary science); Thrombotic thrombocytopenic purpura; Thrombotic microangiopathy; ADAMTS13; Internal medicine; Surgery; Gastroenterology; Platelet; Lymphoma","score_opus":0.0456436938502634,"score_gpt":0.28647971145365597,"score_spread":0.24083601760339257,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1990236086","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9992976,0.000094673764,0.000064502885,0.000013615215,0.0000029510888,0.0003320183,0.00004682733,0.0000033065257,0.00014440555],"genre_scores_gemma":[0.99824834,0.00014811543,0.00048224456,0.0001013798,0.00004315917,0.00037256477,0.00039964024,0.0000032606204,0.00020125243],"study_design_codex":"observational","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9990376,0.00044189728,0.00007225366,0.00018090472,0.000111795576,0.00015549385],"domain_scores_gemma":[0.99855155,0.00038031695,0.0003400766,0.00013531598,0.0001413084,0.00045142227],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013742849,0.000814376,0.0009800213,0.00050961267,0.0010030546,0.0006070041,0.000551627,0.00068584486,0.0013188582],"category_scores_gemma":[0.0020058383,0.0005241018,0.0006221454,0.00047481197,0.00079813116,0.0004899855,0.00038156862,0.00068140874,0.00027159654],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.06534569,0.04307577,0.8247856,0.00032027054,0.0005736413,0.004635553,0.0023573048,0.00059169705,0.018645069,0.00017105817,0.00094044046,0.03855794],"study_design_scores_gemma":[0.043085974,0.22183049,0.71679384,0.00003542986,0.00054057664,0.008586923,0.0014569395,0.0014746534,0.0032364812,0.000116706484,0.0027766684,0.00006533543],"about_ca_topic_score_codex":0.0033488318,"about_ca_topic_score_gemma":0.0036918353,"teacher_disagreement_score":0.0033488318,"about_ca_system_score_codex":0.0010447163,"about_ca_system_score_gemma":0.0013502841,"threshold_uncertainty_score":0.007580042},"labels":[],"label_agreement":null},{"id":"W1990637676","doi":"10.1046/j.1365-2141.2003.04509.x","title":"The IgG subclasses of platelet‐associated autoantibodies directed against platelet glycoproteins IIb/IIIa in patients with idiopathic thrombocytopenic purpura","year":2003,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":79,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"Canadian Institutes of Health Research","keywords":"Subclass; Autoantibody; Thrombocytopenic purpura; Medicine; Antibody; Immunology; Platelet; Polyclonal antibodies","score_opus":0.007045957135056416,"score_gpt":0.22511186464404132,"score_spread":0.2180659075089849,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1990637676","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99896514,0.00047397192,0.00007758978,0.00002103377,0.000006106524,0.000005245425,0.000028897395,0.0000052966834,0.0004168229],"genre_scores_gemma":[0.9997248,0.00008837166,0.000054472814,0.000030092271,0.0000096396925,0.0000028525087,0.0000419377,0.0000013692518,0.000046531477],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99936444,0.00015341518,0.00010969444,0.00015751501,0.00012881355,0.000086128566],"domain_scores_gemma":[0.9987619,0.0005276055,0.0003437147,0.000107445376,0.00012966988,0.00012974162],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005669,0.0005370567,0.00040466757,0.0010813983,0.0004167107,0.00048398747,0.00026096107,0.0006084777,0.0008072001],"category_scores_gemma":[0.0025072633,0.00040859546,0.0002955922,0.0006489859,0.0004967251,0.0004334141,0.0002575898,0.00044247461,0.00026128747],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003829261,0.0000358041,0.99081814,0.000020883012,0.000049319784,0.0008859314,0.00019313178,0.00005640161,0.00362032,0.000019419105,0.00008202474,0.0038358218],"study_design_scores_gemma":[0.000030136876,0.00028225532,0.9927712,0.000011720945,0.000052520863,0.005646113,0.00012687652,0.00021194552,0.00066497846,0.000038007234,0.00015896876,0.000005337494],"about_ca_topic_score_codex":0.0016356348,"about_ca_topic_score_gemma":0.0009585539,"teacher_disagreement_score":0.0016356348,"about_ca_system_score_codex":0.0002727328,"about_ca_system_score_gemma":0.00010600509,"threshold_uncertainty_score":0.0032522082},"labels":[],"label_agreement":null},{"id":"W1990750943","doi":"10.1111/j.1365-2141.2006.06209.x","title":"Comparison of the anticoagulant effect of a direct thrombin inhibitor and a low molecular weight heparin in an acquired antithrombin deficiency in children with acute lymphoblastic leukaemia treated with <scp>l</scp>‐asparaginase: an <i>in vitro</i> study","year":2006,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Blood Coagulation and Thrombosis Mechanisms","field":"Medicine","cited_by":29,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba; BC Children's Hospital; Children's Hospital of Western Ontario; Alberta Children's Hospital; Children's Hospital of Eastern Ontario; Hospital for Sick Children; Stollery Children's Hospital","funders":"AstraZeneca","keywords":"Antithrombin; Heparin; Anticoagulant; Thrombin; Low molecular weight heparin; Medicine; Direct thrombin inhibitor; Pharmacology; Immunology; Cancer research; Internal medicine; Platelet; Warfarin","score_opus":0.006391049969286977,"score_gpt":0.2547941345499197,"score_spread":0.24840308458063276,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1990750943","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99862134,0.0010608428,0.000084912455,0.000019837473,0.000004881354,0.000011539997,0.000038090544,0.000002027494,0.00015654534],"genre_scores_gemma":[0.99890804,0.00053780765,0.00020912751,0.000042381413,0.000019780573,0.000013984427,0.0001411347,0.0000027115218,0.00012503115],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9992706,0.00034045786,0.000067783105,0.000077624456,0.00017216944,0.00007139537],"domain_scores_gemma":[0.9989195,0.00056637527,0.0002096849,0.00005516619,0.00007276106,0.00017650555],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007249263,0.00032348026,0.00083207793,0.0002868683,0.00013161446,0.0004742002,0.00025071425,0.00035373558,0.00070485455],"category_scores_gemma":[0.0016459847,0.00018809705,0.0005755743,0.0004150106,0.00042419301,0.00017523738,0.00015499804,0.0006260399,0.00014960798],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.08634174,0.0047303718,0.60369766,0.0011050112,0.0022719905,0.005493849,0.0020184477,0.0015688579,0.22714004,0.000361729,0.00056301046,0.06470732],"study_design_scores_gemma":[0.0019943079,0.14249171,0.77866536,0.000049848066,0.0017177701,0.010150015,0.00067527423,0.0014191851,0.05787717,0.00008749059,0.00483743,0.000034376557],"about_ca_topic_score_codex":0.0012622379,"about_ca_topic_score_gemma":0.0008171012,"teacher_disagreement_score":0.0012622379,"about_ca_system_score_codex":0.00047680168,"about_ca_system_score_gemma":0.00030691328,"threshold_uncertainty_score":0.0038338304},"labels":[],"label_agreement":null},{"id":"W1991218989","doi":"10.1111/j.1365-2141.2006.06398.x","title":"Transmission of a follicular lymphoma by allogeneic bone marrow transplantation – evidence to support the existence of lymphoma progenitor cells","year":2006,"lang":"en","type":"letter","venue":"British Journal of Haematology","topic":"Viral-associated cancers and disorders","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Calgary Laboratory Services; University of Calgary; University of Alberta","funders":"","keywords":"Medicine; Follicular lymphoma; Lymphoma; Bone marrow; Transplantation; Cyclophosphamide; Lymph node biopsy; Chemotherapy; Pathology; Internal medicine","score_opus":0.013590459816493303,"score_gpt":0.25336617452760457,"score_spread":0.23977571471111125,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1991218989","genre_codex":"empirical","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9938114,0.0013572859,0.0016895201,0.00015715208,0.000022168117,0.000032326698,0.000031423348,0.000045394758,0.0028534455],"genre_scores_gemma":[0.99888116,0.0004242767,0.00035779184,0.000050740062,0.00007288565,0.0000049353616,0.000025128309,0.0000034683399,0.0001795222],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.99956435,0.0001324705,0.00004968928,0.00006021544,0.00008323515,0.000109953944],"domain_scores_gemma":[0.999067,0.00030963594,0.0002856404,0.0001718832,0.000054360917,0.00011156498],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005453775,0.00051946676,0.00034562024,0.0009891451,0.00064612017,0.00076275057,0.00046727905,0.0014940582,0.0025431896],"category_scores_gemma":[0.00183019,0.0003182513,0.00047203412,0.00040334716,0.0009889497,0.0007402537,0.0006445094,0.0010422986,0.00067939825],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00067563175,0.00028636545,0.15691678,0.0002586233,0.000114498835,0.77076584,0.0013505549,0.00028006147,0.046666443,0.002036699,0.00052387826,0.02012462],"study_design_scores_gemma":[0.000064552674,0.00050467625,0.021117467,0.00004140696,0.00007555837,0.96804196,0.00035049536,0.0006180065,0.0071373275,0.00030800854,0.0017265086,0.000014014493],"about_ca_topic_score_codex":0.00078663905,"about_ca_topic_score_gemma":0.00032201348,"teacher_disagreement_score":0.0025431896,"about_ca_system_score_codex":0.0003759092,"about_ca_system_score_gemma":0.0001928186,"threshold_uncertainty_score":0.008507788},"labels":[],"label_agreement":null},{"id":"W1991637447","doi":"10.1111/bjh.12066","title":"Activation of caspases‐9, ‐3 and ‐8 in human platelets triggered by <scp>BH</scp>3‐only mimetic <scp>ABT</scp>‐737 and calcium ionophore A23187: caspase‐8 is activated via bypass of the death receptors","year":2012,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Cell death mechanisms and regulation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":38,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Toronto Metropolitan University; Pediatric Oncology Group; St. Michael's Hospital","funders":"","keywords":"Apoptosis; Caspase; Cell biology; Platelet activation; Chemistry; Platelet; Intrinsic apoptosis; Mitochondrion; Caspase-9; Calcium; Programmed cell death; Biochemistry; Biology; Immunology","score_opus":0.010195320994965191,"score_gpt":0.23836542512728065,"score_spread":0.22817010413231545,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1991637447","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99584454,0.0014778399,0.001254769,0.00006316681,0.0000136282615,0.000030463028,0.000303312,0.000023069424,0.0009891837],"genre_scores_gemma":[0.9964799,0.00075920427,0.000885161,0.00002487631,0.000006420869,0.000046213503,0.000629703,0.0000040484792,0.0011644602],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998908,0.000026540692,0.000011240329,0.000016744529,0.000030804276,0.000023938788],"domain_scores_gemma":[0.99995923,0.000012043835,0.000008656313,0.0000059085332,0.000006292595,0.0000078143485],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009466398,0.00013726142,0.00013030626,0.00015891099,0.00010674619,0.0002040097,0.00008212127,0.00020817705,0.0010718458],"category_scores_gemma":[0.00011489382,0.000080185666,0.00014678105,0.00019894264,0.00015986725,0.00011224619,0.00008643591,0.0003289306,0.00028465333],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004462051,0.00003137076,0.00034209495,0.00003893832,0.000007305048,0.00024948738,0.000041905318,0.000045482237,0.99694663,0.00017333892,0.000051774543,0.0016254338],"study_design_scores_gemma":[0.000075678814,0.0005595455,0.012512182,0.0000048330553,0.000024507042,0.0012716299,0.00004727989,0.0005995269,0.9828356,0.00017193262,0.0018917413,0.000005522834],"about_ca_topic_score_codex":0.0006873643,"about_ca_topic_score_gemma":0.00051863486,"teacher_disagreement_score":0.0010718458,"about_ca_system_score_codex":0.00023697417,"about_ca_system_score_gemma":0.00018787067,"threshold_uncertainty_score":0.0035856366},"labels":[],"label_agreement":null},{"id":"W1992672718","doi":"10.1111/bjh.13347","title":"Haematopoietic stem cell transplantation for refractory Langerhans cell histiocytosis: outcome by intensity of conditioning","year":2015,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Histiocytic Disorders and Treatments","field":"Medicine","cited_by":77,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; BC Children's Hospital","funders":"National Cancer Institute","keywords":"Medicine; Transplantation; Internal medicine; Chemotherapy; Langerhans cell histiocytosis; Refractory (planetary science); Total body irradiation; Hematopoietic stem cell transplantation; Surgery; Cytarabine; Oncology; Alemtuzumab; Stem cell; Gastroenterology; Cyclophosphamide; Disease; Biology","score_opus":0.029074524984725993,"score_gpt":0.2787062183879791,"score_spread":0.2496316934032531,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1992672718","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9948441,0.0036427847,0.00029622734,0.00010812984,0.000013278368,0.000030872954,0.000060734354,0.000006976672,0.0009968897],"genre_scores_gemma":[0.9984054,0.0009463634,0.00016047906,0.00008020201,0.00004536589,0.000011334379,0.00019610749,0.0000037012808,0.00015102737],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9997657,0.0001093119,0.00001985159,0.000016997721,0.00003875279,0.00004941077],"domain_scores_gemma":[0.9995828,0.000085416934,0.000115624214,0.000030486739,0.000022495018,0.00016311507],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00064442924,0.00027545396,0.00043363377,0.00040197928,0.00017748636,0.0003871962,0.00019228562,0.00030439207,0.0008175938],"category_scores_gemma":[0.0008194177,0.000055351673,0.0003368462,0.00042214635,0.0003557873,0.00021325343,0.000313801,0.00029855617,0.00028673923],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.02595508,0.0017851639,0.7251453,0.0003534092,0.0008925705,0.0048556062,0.00051089644,0.0039049636,0.014195744,0.0004667669,0.0020885642,0.21984601],"study_design_scores_gemma":[0.0011091765,0.012509341,0.9673554,0.00015112187,0.0005301491,0.010053187,0.00019704048,0.0026591045,0.0023955964,0.0010116326,0.001996513,0.000031707874],"about_ca_topic_score_codex":0.00046389102,"about_ca_topic_score_gemma":0.0007021697,"teacher_disagreement_score":0.0008175938,"about_ca_system_score_codex":0.0003198741,"about_ca_system_score_gemma":0.00021072288,"threshold_uncertainty_score":0.003408134},"labels":[],"label_agreement":null},{"id":"W1992778934","doi":"10.1111/j.1365-2141.2008.07224.x","title":"Functional interaction between mutations in the granulocyte colony‐stimulating factor receptor in severe congenital neutropenia","year":2008,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Blood disorders and treatments","field":"Biochemistry, Genetics and Molecular Biology","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children; University of Toronto","funders":"National Institutes of Health; National Cancer Institute; KWF Kankerbestrijding; Deakin University","keywords":"Congenital Neutropenia; Neutrophil extracellular traps; Granulocyte colony-stimulating factor; Neutropenia; Mutation; Granulocyte; Granulocyte colony-stimulating factor receptor; Neutrophil elastase; Elastase; Extracellular; Immunology; Cancer research; Biology; Medicine; Internal medicine; Genetics; Gene; Chemotherapy; Biochemistry; Inflammation; Enzyme","score_opus":0.023320976975964452,"score_gpt":0.2620051258489669,"score_spread":0.23868414887300246,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1992778934","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9982134,0.00039800408,0.00026242743,0.000051519335,0.000005090112,0.000004542957,0.000066344706,0.000009811169,0.0009888387],"genre_scores_gemma":[0.99955696,0.00007669826,0.00017125983,0.000018727565,0.0000047646135,0.0000016725589,0.0000472186,0.000002564787,0.00012007408],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99975675,0.000066554654,0.00003107142,0.00004438974,0.00006080699,0.000040405066],"domain_scores_gemma":[0.9996948,0.00017012208,0.000045236124,0.00002551713,0.000012304095,0.000052057523],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021532828,0.000313915,0.00018924857,0.00034103208,0.00012734541,0.00022797198,0.0001745074,0.00046059932,0.0011992217],"category_scores_gemma":[0.0005684526,0.000099688754,0.0001968925,0.0001443193,0.00036598145,0.000112897455,0.00030433782,0.0002305043,0.00016535245],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00084966974,0.000067527144,0.0993515,0.000099110635,0.00007565185,0.05912694,0.0002627875,0.00058316864,0.8219069,0.000979916,0.0005187329,0.01617814],"study_design_scores_gemma":[0.00008282292,0.0006064096,0.32379633,0.000037951835,0.00016807877,0.36516976,0.00024537748,0.0031762156,0.3010095,0.0008213785,0.004845966,0.00004022364],"about_ca_topic_score_codex":0.0004147763,"about_ca_topic_score_gemma":0.00047314275,"teacher_disagreement_score":0.0011992217,"about_ca_system_score_codex":0.0001999189,"about_ca_system_score_gemma":0.00014246446,"threshold_uncertainty_score":0.00401175},"labels":[],"label_agreement":null},{"id":"W1992881313","doi":"10.1111/j.1365-2141.2008.07467.x","title":"CP‐4055 and CP‐4126 are active in ara‐C and gemcitabine‐resistant lymphoma cell lines","year":2008,"lang":"en","type":"letter","venue":"British Journal of Haematology","topic":"HIV/AIDS drug development and treatment","field":"Medicine","cited_by":38,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Gemcitabine; Chemistry; Nucleoside; Cell culture; Nucleoside analogue; Pharmacology; Biochemistry; Cancer research; Cancer; Biology; Medicine; Internal medicine","score_opus":0.01039855139209381,"score_gpt":0.22326354454984726,"score_spread":0.21286499315775345,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1992881313","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9711514,0.009544069,0.0045666033,0.0003775852,0.000117381394,0.0004101423,0.004402113,0.00041667023,0.009013937],"genre_scores_gemma":[0.9621784,0.004184926,0.0042882767,0.00019868863,0.000029798593,0.0005349009,0.011224822,0.00005312761,0.017306933],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9994925,0.00007581348,0.000058188667,0.00007180327,0.0002328226,0.0000689099],"domain_scores_gemma":[0.9998211,0.000025383093,0.0000354033,0.000034331697,0.000032274536,0.00005153759],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002901412,0.00047905536,0.0005509216,0.0007241954,0.00030682902,0.000615176,0.00045164998,0.000632977,0.003646108],"category_scores_gemma":[0.00028102082,0.00025511367,0.00037441423,0.0008165206,0.00026562405,0.00035394472,0.00023748579,0.00094456057,0.0016982856],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00042721635,0.00034423522,0.00042751548,0.00017381988,0.000022318858,0.00032727057,0.000060148042,0.00030228752,0.9883485,0.00046368942,0.0010807152,0.008022313],"study_design_scores_gemma":[0.00014562995,0.0018894542,0.006585099,0.000024003395,0.000053708092,0.0015133222,0.00006804481,0.0015660885,0.958417,0.00011068783,0.029607516,0.000019358658],"about_ca_topic_score_codex":0.0019579504,"about_ca_topic_score_gemma":0.0018700474,"teacher_disagreement_score":0.003646108,"about_ca_system_score_codex":0.00054068194,"about_ca_system_score_gemma":0.0005368748,"threshold_uncertainty_score":0.012197435},"labels":[],"label_agreement":null},{"id":"W1992979998","doi":"10.1111/bjh.12325","title":"D(T)<scp>PACE</scp> as salvage therapy for aggressive or refractory multiple myeloma","year":2013,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":53,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Princess Margaret Cancer Centre; University of British Columbia","funders":"","keywords":"Medicine; Salvage therapy; Internal medicine; Regimen; Etoposide; Multiple myeloma; Surgery; Refractory (planetary science); Hematopoietic stem cell transplantation; Dexamethasone; Cohort; Autologous stem-cell transplantation; Transplantation; Oncology; Chemotherapy","score_opus":0.02862974617409571,"score_gpt":0.31976015781796086,"score_spread":0.29113041164386516,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1992979998","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99721223,0.0014679926,0.00016758103,0.000077964316,0.000007041927,0.000046731613,0.000096223324,0.000016605878,0.00090779876],"genre_scores_gemma":[0.998566,0.0006500813,0.00020735031,0.00009825764,0.000024203762,0.000013115507,0.00019221187,0.0000019204258,0.00024687272],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9998776,0.000023852626,0.00001248382,0.000027036558,0.000030085506,0.000029029628],"domain_scores_gemma":[0.99978644,0.000029731154,0.00007374028,0.000013387929,0.000009387148,0.00008731642],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015891677,0.00015206797,0.00025063107,0.0002465272,0.0002746578,0.00034521898,0.00020114356,0.00017950794,0.0006749591],"category_scores_gemma":[0.00031807143,0.000072077346,0.00017483051,0.00044033377,0.0002910891,0.000109195455,0.00021623539,0.00020012334,0.00028766695],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0039099334,0.0008549699,0.7474608,0.00026970718,0.00015092698,0.008698122,0.0004783777,0.0010561945,0.027812574,0.00018055811,0.003085573,0.20604226],"study_design_scores_gemma":[0.0007593082,0.010386142,0.95788413,0.000060871367,0.0001473085,0.015246147,0.00023071808,0.0016150032,0.0058845733,0.0001387374,0.0076273894,0.000019770294],"about_ca_topic_score_codex":0.0030951325,"about_ca_topic_score_gemma":0.008468723,"teacher_disagreement_score":0.0030951325,"about_ca_system_score_codex":0.0004964534,"about_ca_system_score_gemma":0.00054851297,"threshold_uncertainty_score":0.0061541796},"labels":[],"label_agreement":null},{"id":"W1993428041","doi":"10.1111/j.1365-2141.2005.05646.x","title":"Rapid and specific detection of clinically significant haemoglobinopathies using electrospray mass spectrometry–mass spectrometry","year":2005,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":87,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Thomas Hospital","funders":"","keywords":"Mass spectrometry; False positive paradox; Population; Sickle cell trait; Medicine; Newborn screening; Disease; Biology; Genetics; Chemistry; Internal medicine; Chromatography; Computer science","score_opus":0.01470429998857489,"score_gpt":0.2591213296336968,"score_spread":0.24441702964512188,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1993428041","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.82104623,0.0072019086,0.16324063,0.0007038395,0.00016432334,0.0004940695,0.0013456644,0.0017144992,0.00408876],"genre_scores_gemma":[0.8150233,0.003284213,0.17640945,0.0005635302,0.000117921365,0.00024501194,0.001471588,0.00007237526,0.0028124922],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9992576,0.00018813983,0.00006718762,0.00015436148,0.000290437,0.000042303836],"domain_scores_gemma":[0.99898344,0.00049026683,0.00021134403,0.000054978438,0.0001756475,0.00008425224],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010751704,0.000534228,0.00045181595,0.0009867775,0.0002246039,0.00033765432,0.00038784844,0.0005669719,0.0010305685],"category_scores_gemma":[0.0016400745,0.0002791524,0.0001905239,0.0004553176,0.00041092667,0.0003670774,0.00036671312,0.000489389,0.0004895535],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014332635,0.00004899522,0.0023647167,0.000084694664,0.000027630762,0.00013554307,0.000042191146,0.0001337543,0.9846132,0.00013359828,0.00032429743,0.011948152],"study_design_scores_gemma":[0.00011171386,0.0010371094,0.035319977,0.000032876404,0.000081062855,0.0049579106,0.00009932749,0.006545082,0.9468158,0.00041975218,0.004521381,0.00005797789],"about_ca_topic_score_codex":0.00036299526,"about_ca_topic_score_gemma":0.0007389238,"teacher_disagreement_score":0.0010751704,"about_ca_system_score_codex":0.00016346689,"about_ca_system_score_gemma":0.00024969157,"threshold_uncertainty_score":0.0056861043},"labels":[],"label_agreement":null},{"id":"W1993803161","doi":"10.1046/j.1365-2141.2003.04236.x","title":"The impact of Asian descent on the incidence of acquired severe aplastic anaemia in children","year":2003,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":27,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"BC Cancer Agency; BC Children's Hospital","funders":"","keywords":"Incidence (geometry); Descent (aeronautics); Medicine; African descent; Demography; Population; Ethnic group; Pediatrics; Geography; Environmental health; History; Genealogy","score_opus":0.011143643491276363,"score_gpt":0.269209780094355,"score_spread":0.2580661366030786,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1993803161","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9984555,0.00030609046,0.000031834945,0.000062728854,0.0000033448193,0.0000013499658,0.0001319455,0.0000026653393,0.0010045893],"genre_scores_gemma":[0.99955136,0.00020048558,0.000047404363,0.000012357478,0.0000057458788,0.0000013682989,0.00006793055,0.0000022420622,0.000111045934],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9993474,0.00020487778,0.000060059698,0.00006957684,0.00017687274,0.00014121307],"domain_scores_gemma":[0.99806446,0.00033248795,0.0008032918,0.000094883486,0.00031608136,0.00038872188],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00048425555,0.00015458534,0.00018053286,0.00062392117,0.0002210696,0.00050107687,0.00024161814,0.00020121374,0.0015571172],"category_scores_gemma":[0.0022103293,0.00012702741,0.00025222087,0.0008964498,0.00038727873,0.00021839546,0.00031824128,0.00038111128,0.00017353571],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007408932,0.00000776127,0.99716836,0.000007666087,0.000020373069,0.00015716963,0.000101072044,0.000037500944,0.0003025828,0.000026162706,0.000048212863,0.0020490987],"study_design_scores_gemma":[0.0000013508977,0.000035636265,0.99922097,0.0000036086826,0.000012785732,0.00039974888,0.00010971489,0.000027445887,0.00007431996,0.000007192365,0.00010562967,0.0000015062881],"about_ca_topic_score_codex":0.033704933,"about_ca_topic_score_gemma":0.048168764,"teacher_disagreement_score":0.033704933,"about_ca_system_score_codex":0.0006183217,"about_ca_system_score_gemma":0.00074493565,"threshold_uncertainty_score":0.067017496},"labels":[],"label_agreement":null},{"id":"W1994137642","doi":"10.1111/j.1365-2141.2007.06608.x","title":"Leukaemia‐related gene expression in bone marrow cells from patients with the preleukaemic disorder Shwachman–Diamond syndrome","year":2007,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Blood disorders and treatments","field":"Biochemistry, Genetics and Molecular Biology","cited_by":28,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children; Population Health Research Institute; University of Toronto","funders":"Canadian Institutes of Health Research","keywords":"Bone marrow; Haematopoiesis; Cytopenia; Bone marrow failure; Cancer research; Myelodysplastic syndromes; Peripheral blood mononuclear cell; Leukemia; Biology; Myeloid; Carcinogenesis; Telomerase; Gene; Immunology; Pathology; Medicine; Stem cell; Genetics","score_opus":0.0023769683668472654,"score_gpt":0.18630519264697545,"score_spread":0.1839282242801282,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1994137642","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9991935,0.0003084646,0.00016008368,0.000014666955,0.000003461136,0.000005235952,0.00016066348,0.0000043898012,0.00014950696],"genre_scores_gemma":[0.99865496,0.00023832131,0.0003283472,0.000033726545,0.000005233604,0.000016332688,0.00035493082,0.0000031943143,0.00036496366],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99991393,0.000013539228,0.000008806532,0.000026823196,0.00002149319,0.00001546308],"domain_scores_gemma":[0.9999335,0.000018570665,0.000016236145,0.0000044605013,0.000011768038,0.000015432594],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00006313135,0.00018982997,0.00021835405,0.0005722326,0.0001890217,0.0002341883,0.00006227083,0.00020727409,0.0012957711],"category_scores_gemma":[0.00023956051,0.00012307565,0.00009785928,0.0002768475,0.00016363095,0.00006412779,0.00012660827,0.00016902787,0.00024863443],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013365217,0.00007559144,0.08205045,0.00009462798,0.0000447914,0.0016986799,0.00049591996,0.00007117227,0.90638834,0.00005714714,0.00011090271,0.0075758225],"study_design_scores_gemma":[0.00010978084,0.001121636,0.8931737,0.000016450793,0.000116578914,0.009182628,0.0008949701,0.0004229503,0.092741154,0.00018554824,0.0020192142,0.000015399773],"about_ca_topic_score_codex":0.0004543475,"about_ca_topic_score_gemma":0.00052487396,"teacher_disagreement_score":0.0012957711,"about_ca_system_score_codex":0.000108422355,"about_ca_system_score_gemma":0.000051210645,"threshold_uncertainty_score":0.0043348074},"labels":[],"label_agreement":null},{"id":"W1994681393","doi":"10.1111/j.1365-2141.2007.06777.x","title":"Picogram doses of lipopolysaccharide exacerbate antibody‐mediated thrombocytopenia and reduce the therapeutic efficacy of intravenous immunoglobulin in mice","year":2007,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval; Héma-Québec","funders":"Université Laval","keywords":"Antibody; In vivo; Immunology; Lipopolysaccharide; Medicine; Exacerbation; Platelet; Immune thrombocytopenia; Immune system; Thrombocytopenic purpura; Biology","score_opus":0.014394297593551885,"score_gpt":0.3026471258258413,"score_spread":0.2882528282322894,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1994681393","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99495995,0.0013148426,0.001463468,0.000321499,0.00007321039,0.00007826058,0.00023473012,0.00015103475,0.0014029777],"genre_scores_gemma":[0.99355537,0.0011932114,0.002060009,0.000258126,0.00006176365,0.00013938127,0.0004395111,0.00003501711,0.0022576882],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99943846,0.00016514638,0.0000482104,0.000060426042,0.0001207062,0.00016697233],"domain_scores_gemma":[0.999405,0.000102362035,0.00019322358,0.00005827142,0.00002897468,0.00021209197],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00044525176,0.00084726664,0.0005792108,0.0009351773,0.00019710176,0.00051243446,0.00038782164,0.0009425244,0.0012570615],"category_scores_gemma":[0.0003206906,0.0004355747,0.00043303045,0.0002872427,0.0004497013,0.00047211986,0.00039175374,0.0020718833,0.0004365907],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001894887,0.001497638,0.00048790305,0.00008327088,0.000034432185,0.00018718661,0.000051644045,0.00033212308,0.99060035,0.0002703388,0.00021065696,0.0043495265],"study_design_scores_gemma":[0.000980466,0.02944526,0.00984134,0.000052734045,0.00011510598,0.0011718823,0.0000996621,0.004164398,0.9507976,0.00039333553,0.0029108112,0.000027297287],"about_ca_topic_score_codex":0.0003371967,"about_ca_topic_score_gemma":0.00043015956,"teacher_disagreement_score":0.0012570615,"about_ca_system_score_codex":0.0003466073,"about_ca_system_score_gemma":0.0002630341,"threshold_uncertainty_score":0.0042052865},"labels":[],"label_agreement":null},{"id":"W1994818750","doi":"10.1046/j.1365-2141.2000.02162.x","title":"Lymphocyte function antigen 1 (LFA‐1) mediates early tumour necrosis factor α‐induced leucocyte adhesion in venules","year":2000,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Cell Adhesion Molecules Research","field":"Medicine","cited_by":28,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Intravital microscopy; Cell adhesion molecule; CD18; Tumor necrosis factor alpha; CD11a; Lymphocyte function-associated antigen 1; Cremaster muscle; Lymphocyte; High endothelial venules; Microcirculation; Biology; Necrosis; Adhesion; Immunology; Pathology; Chemistry; Intercellular Adhesion Molecule-1; Medicine; Flow cytometry; Integrin alpha M; Internal medicine","score_opus":0.022703635694187815,"score_gpt":0.2806299941961842,"score_spread":0.25792635850199636,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1994818750","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99483585,0.0021060412,0.0024563435,0.000041743202,0.000009744403,0.00001273664,0.000043804277,0.000030802115,0.0004628357],"genre_scores_gemma":[0.9959753,0.0011063667,0.0013935207,0.000022619373,0.00001273356,0.000020889,0.000090072426,0.000007812501,0.0013706359],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998958,0.00002546323,0.0000038441567,0.00002042587,0.000013686066,0.000040804764],"domain_scores_gemma":[0.9998896,0.000014522389,0.00004555885,0.000006402707,0.000007990945,0.00003597014],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012220605,0.00031385815,0.00019180457,0.00023234876,0.00014043176,0.0002826513,0.000115026676,0.00026088196,0.0007512391],"category_scores_gemma":[0.00009262097,0.000116875206,0.00016418014,0.000059910544,0.000129219,0.00023975864,0.00020389554,0.00040557628,0.0002746036],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000045208053,0.000008850365,0.00018560064,0.000016265047,0.0000014253244,0.0000320317,0.000009787114,0.000016909215,0.9989868,0.000039754224,0.000008952053,0.00064835255],"study_design_scores_gemma":[0.00003378945,0.0009223441,0.037256397,0.00002486934,0.000030442783,0.0007283012,0.000097573204,0.0018332929,0.95635355,0.00015242513,0.0025598872,0.0000072314847],"about_ca_topic_score_codex":0.00018505364,"about_ca_topic_score_gemma":0.00028656787,"teacher_disagreement_score":0.0007512391,"about_ca_system_score_codex":0.0001799084,"about_ca_system_score_gemma":0.000082383485,"threshold_uncertainty_score":0.0025131106},"labels":[],"label_agreement":null},{"id":"W1994943036","doi":"10.1111/j.1365-2141.2006.06097.x","title":"Long‐term results of an ultra low‐dose cytarabine‐based regimen for the treatment of acute megakaryoblastic leukaemia in children with Down syndrome","year":2006,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":55,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children; University of Toronto","funders":"Children's Hospital of Michigan; BC Children's Hospital; McMaster University","keywords":"Cytarabine; Medicine; Acute megakaryoblastic leukemia; Chemotherapy; Vincristine; Regimen; Internal medicine; Oncology; Cyclophosphamide; Leukemia","score_opus":0.009147530093686669,"score_gpt":0.26980514214674023,"score_spread":0.26065761205305354,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1994943036","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9950113,0.004252819,0.00014824166,0.00007105045,0.00002572202,0.00005261719,0.000069327696,0.000008321748,0.00036059142],"genre_scores_gemma":[0.9967608,0.0017978277,0.00041585532,0.0001006381,0.00005760583,0.000083554056,0.00047006356,0.0000045063607,0.00030922066],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9996455,0.00019297448,0.00003780994,0.000028948474,0.00004315672,0.00005166385],"domain_scores_gemma":[0.999332,0.00020737683,0.00012598424,0.000058845646,0.00003882252,0.00023683855],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006160555,0.00025348726,0.00076564786,0.00021825415,0.00026760527,0.0003084351,0.00038348825,0.0003478369,0.0006711109],"category_scores_gemma":[0.001158361,0.000098503035,0.0004475899,0.0002561827,0.00029080446,0.00025483724,0.00025877086,0.0006503332,0.00014266142],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.21067356,0.018562334,0.14852789,0.0015627053,0.002254437,0.002174042,0.0008658924,0.003198092,0.0501502,0.00047333824,0.0019963444,0.55956125],"study_design_scores_gemma":[0.02404609,0.34793225,0.5964624,0.00030716354,0.0024179276,0.00453875,0.00029373495,0.0016680694,0.012300189,0.00024119156,0.009730505,0.00006171198],"about_ca_topic_score_codex":0.0007298632,"about_ca_topic_score_gemma":0.0014607586,"teacher_disagreement_score":0.00076564786,"about_ca_system_score_codex":0.0003871802,"about_ca_system_score_gemma":0.00043294195,"threshold_uncertainty_score":0.0032580495},"labels":[],"label_agreement":null},{"id":"W1995739599","doi":"10.1111/j.1365-2141.2005.05761.x","title":"Haemolytic uraemic syndrome is an immune‐mediated disease: role of anti‐CD36 antibodies","year":2005,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Complement system in diseases","field":"Immunology and Microbiology","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa; Western University; Children's Hospital of Eastern Ontario; Ottawa Hospital","funders":"","keywords":"Antibody; CD36; Platelet; Pathogenesis; Monoclonal antibody; Western blot; Immune system; Antigen; Biology; Immune complex; Immunology; Chemistry; Molecular biology; Receptor; Biochemistry","score_opus":0.010795721815098937,"score_gpt":0.2481235718067625,"score_spread":0.23732784999166356,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1995739599","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9958263,0.0017464797,0.000885007,0.00009891616,0.000010604229,0.000011847621,0.000018677321,0.000013302929,0.0013889302],"genre_scores_gemma":[0.9989517,0.00044772396,0.0003670573,0.00003507793,0.00001923935,0.0000029626872,0.000019596935,0.0000016128956,0.00015497227],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9998336,0.0000428028,0.000027120897,0.000025612495,0.000038560614,0.00003219108],"domain_scores_gemma":[0.99968016,0.00011099893,0.000119036,0.000017789935,0.000033923054,0.000038072973],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022161957,0.0002549092,0.00024928624,0.00036609644,0.00030115075,0.00019127458,0.000084468345,0.00035999977,0.0013057478],"category_scores_gemma":[0.0008534892,0.000109060486,0.00010350068,0.00020102276,0.00033261155,0.00018494409,0.00022366382,0.00018482932,0.00013737913],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010164849,0.00017378932,0.60112023,0.0006963506,0.00014366135,0.07114691,0.002423012,0.00041054978,0.23349012,0.0017499484,0.0010736942,0.08655536],"study_design_scores_gemma":[0.00008603556,0.0012144395,0.61196166,0.00007640618,0.00012521035,0.35332558,0.0005524419,0.00071158604,0.021695092,0.0005508618,0.009680833,0.000019879424],"about_ca_topic_score_codex":0.00033544798,"about_ca_topic_score_gemma":0.0002415686,"teacher_disagreement_score":0.0013057478,"about_ca_system_score_codex":0.00013949022,"about_ca_system_score_gemma":0.00009439202,"threshold_uncertainty_score":0.004368186},"labels":[],"label_agreement":null},{"id":"W1996289772","doi":"10.1111/bjh.13372","title":"Current approaches in the management of low risk Hodgkin lymphoma in children and adolescents","year":2015,"lang":"en","type":"review","venue":"British Journal of Haematology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":24,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Hodgkin lymphoma; Radiation therapy; Clinical trial; Lymphoma; Intensive care medicine; Oncology; Pediatrics; Internal medicine","score_opus":0.045654852384713486,"score_gpt":0.3155238752040581,"score_spread":0.2698690228193446,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1996289772","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000057715355,0.99932945,0.00003872997,0.0001878731,0.00005322568,0.0000067571614,0.000011727956,0.0000030006063,0.00031159024],"genre_scores_gemma":[0.0003795223,0.9992095,0.0001357853,0.00011845315,0.00004096334,0.000007792139,0.000015839956,6.614076e-7,0.000091499634],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99953735,0.00011000205,0.00013168599,0.0000516229,0.00014335415,0.000026013779],"domain_scores_gemma":[0.99897206,0.00065743533,0.00017653791,0.00001832918,0.00013608865,0.00003960538],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010721193,0.00066573307,0.0016511683,0.0026860086,0.00028072787,0.00096490193,0.0009815076,0.0008954676,0.0034677482],"category_scores_gemma":[0.0021325538,0.000289173,0.001039989,0.002237393,0.0004631664,0.0010596507,0.0006150494,0.0015230966,0.0009872692],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000088488596,0.000045464487,0.00019713065,0.06845052,0.0001982838,0.00011216527,0.00010142269,0.00027074825,0.00033904068,0.0014095744,0.014547457,0.9142397],"study_design_scores_gemma":[0.000078767865,0.00017855027,0.0022084622,0.07518334,0.0008853479,0.0019525945,0.0002205054,0.000093206836,0.00028136178,0.002532279,0.9163571,0.000028459135],"about_ca_topic_score_codex":0.0020649356,"about_ca_topic_score_gemma":0.0040192413,"teacher_disagreement_score":0.0034677482,"about_ca_system_score_codex":0.00072719855,"about_ca_system_score_gemma":0.0015482444,"threshold_uncertainty_score":0.011600733},"labels":[],"label_agreement":null},{"id":"W1996399705","doi":"10.1046/j.1365-2141.2003.04271.x","title":"Platelets may inhibit leucotriene biosynthesis by human neutrophils at the integrin level","year":2003,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Immune Response and Inflammation","field":"Immunology and Microbiology","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval","funders":"Institut National de la Santé et de la Recherche Médicale","keywords":"Platelet; Chemistry; Biochemistry; Lipoxygenase; Arachidonate 5-lipoxygenase; Leukotriene B4; Arachidonic acid; Integrin; Platelet activation; Chemotaxis; Metabolite; Inflammation; Immunology; Biology; Enzyme; Receptor","score_opus":0.017597820731875328,"score_gpt":0.23742325087976054,"score_spread":0.21982543014788522,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1996399705","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9763091,0.01627363,0.002945004,0.00026647223,0.00007696431,0.00009278986,0.00018572553,0.000053057716,0.0037973246],"genre_scores_gemma":[0.9918893,0.0036587147,0.001055094,0.00014197292,0.000045306875,0.000053558382,0.000408844,0.0000088699735,0.0027383594],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998018,0.00008442547,0.000014952574,0.00001610746,0.000040155923,0.000042587755],"domain_scores_gemma":[0.99993336,0.00002279619,0.000015468675,0.000008604091,0.000009846414,0.000009789272],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021299963,0.00029562548,0.00017590719,0.00010992216,0.00009714153,0.0002707018,0.00013735713,0.00022173244,0.001544327],"category_scores_gemma":[0.0003300706,0.00009733532,0.00019414761,0.000079557154,0.00008316071,0.00012798244,0.00018777272,0.00030104112,0.0004926069],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011921996,0.00010160167,0.00075401017,0.00013142891,0.000035804245,0.00032336893,0.00005334318,0.0000624302,0.98583984,0.00024560269,0.00017325734,0.011086954],"study_design_scores_gemma":[0.00016668957,0.002868064,0.015887516,0.000039549224,0.00012528127,0.0010151131,0.000051801977,0.0009735774,0.968991,0.000209217,0.00966464,0.0000075136704],"about_ca_topic_score_codex":0.00037629766,"about_ca_topic_score_gemma":0.00038988065,"teacher_disagreement_score":0.001544327,"about_ca_system_score_codex":0.00008951931,"about_ca_system_score_gemma":0.00015773979,"threshold_uncertainty_score":0.005166292},"labels":[],"label_agreement":null},{"id":"W1996671618","doi":"10.1111/j.1365-2141.2009.07942.x","title":"Lymphoma cell VEGFR2 expression detected by immunohistochemistry predicts poor overall survival in diffuse large B cell lymphoma treated with immunochemotherapy (R‐CHOP)","year":2009,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":46,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"National Cancer Institute; National Institutes of Health; Fidelity Foundation","keywords":"International Prognostic Index; Vincristine; Lymphoma; CHOP; Medicine; Internal medicine; Univariate analysis; Diffuse large B-cell lymphoma; Autocrine signalling; Cyclophosphamide; Chemotherapy; Oncology; Rituximab; Vascular endothelial growth factor; Cancer research; Pathology; VEGF receptors; Receptor; Multivariate analysis","score_opus":0.004486132184889379,"score_gpt":0.22257870626120538,"score_spread":0.218092574076316,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1996671618","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99937963,0.00034240974,0.00006437107,0.000015009668,0.0000017859701,0.0000024258243,0.000020640517,0.0000030675997,0.00017055812],"genre_scores_gemma":[0.99974674,0.000076640215,0.000035916368,0.0000102705835,0.0000042336674,0.0000027042704,0.00005258315,6.8253354e-7,0.000070102],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9999132,0.000024685512,0.000010297815,0.000016338641,0.000016305923,0.000019135941],"domain_scores_gemma":[0.99973685,0.00006742587,0.00010750955,0.000015256575,0.000018930035,0.00005399103],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00025785985,0.0001231839,0.00018225136,0.00028732076,0.000079313315,0.00025428945,0.0001006755,0.00021558342,0.0005730325],"category_scores_gemma":[0.00057150197,0.00011811174,0.00015871853,0.00019322387,0.0001701686,0.00013866113,0.00013286406,0.00023130368,0.000106053216],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009351506,0.00005396828,0.98588145,0.000012074139,0.000041025436,0.00017331161,0.0000360494,0.00017481021,0.008056049,0.000012105418,0.00006701253,0.004556941],"study_design_scores_gemma":[0.000025483283,0.00032520268,0.9976255,0.0000027213632,0.000036970905,0.0006843885,0.00003834896,0.00044007617,0.00063383597,0.000017100856,0.00016868186,0.0000017840941],"about_ca_topic_score_codex":0.000503781,"about_ca_topic_score_gemma":0.00069274136,"teacher_disagreement_score":0.0005730325,"about_ca_system_score_codex":0.00013854903,"about_ca_system_score_gemma":0.000064704036,"threshold_uncertainty_score":0.0019170046},"labels":[],"label_agreement":null},{"id":"W1996885889","doi":"10.1111/j.1365-2141.2005.05418.x","title":"Does cryosupernatant plasma improve outcome in thrombotic thrombocytopenic purpura? No answer yet","year":2005,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Complement system in diseases","field":"Immunology and Microbiology","cited_by":75,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval; McMaster University; London Health Sciences Centre; Canadian Blood Services; Health Sciences Centre; Ottawa Hospital; University Health Network; Dalhousie University; University of Ottawa","funders":"Canadian Institutes of Health Research; Bayer Canada","keywords":"Thrombotic thrombocytopenic purpura; Medicine; Von Willebrand factor; Platelet; Internal medicine; Fresh frozen plasma; Gastroenterology; Protease; Prospective cohort study; Immunology; Surgery; Enzyme; Chemistry","score_opus":0.014143581743104523,"score_gpt":0.26736600149495676,"score_spread":0.2532224197518522,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1996885889","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7737666,0.18175867,0.0011346837,0.032873284,0.004638914,0.0013736865,0.00094242074,0.00009627694,0.0034154993],"genre_scores_gemma":[0.91813505,0.049841058,0.0027594343,0.02044655,0.004330494,0.0014498202,0.00080025796,0.000017599314,0.0022197857],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.99927443,0.00049906666,0.000071398834,0.00006239073,0.00004203362,0.000050676987],"domain_scores_gemma":[0.9972747,0.0019401324,0.00039003041,0.00007153518,0.00007775615,0.00024587323],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002496235,0.00036639147,0.0021584663,0.00018415012,0.0002474517,0.0006601618,0.0006418463,0.0032815589,0.005034515],"category_scores_gemma":[0.0038470072,0.00018983522,0.0010592656,0.0003180541,0.0011406232,0.0006682761,0.00022165824,0.0013349163,0.0005201914],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.80331206,0.004028004,0.0051560835,0.0074183797,0.0052544274,0.00016258853,0.00009143574,0.0006685347,0.0027031035,0.0016039951,0.0058536455,0.1637478],"study_design_scores_gemma":[0.8196817,0.14502233,0.010527546,0.0020047748,0.005058458,0.00030120296,0.00019304898,0.0007067866,0.001035172,0.0030548982,0.012361441,0.00005259713],"about_ca_topic_score_codex":0.00035919173,"about_ca_topic_score_gemma":0.0008493504,"teacher_disagreement_score":0.005034515,"about_ca_system_score_codex":0.00031711976,"about_ca_system_score_gemma":0.0004783296,"threshold_uncertainty_score":0.016842127},"labels":[],"label_agreement":null},{"id":"W1998101000","doi":"10.1046/j.1365-2141.2002.03778.x","title":"Pure red cell aplasia due to parvovirus following treatment with CHOP and rituximab for B‐cell lymphoma*","year":2002,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Parvovirus B19 Infection Studies","field":"Medicine","cited_by":69,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Princess Margaret Cancer Centre","funders":"","keywords":"Pure red cell aplasia; Rituximab; Medicine; Parvovirus; CHOP; Prednisone; Lymphoma; Cyclophosphamide; Vincristine; Non-Hodgkin's lymphoma; Immunology; Gastroenterology; Chemotherapy; Bone marrow; Internal medicine; Virus","score_opus":0.020000952522845467,"score_gpt":0.257714748392153,"score_spread":0.23771379586930755,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1998101000","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9898476,0.002604853,0.00042915653,0.0009678097,0.00010100926,0.0001332261,0.00006301202,0.0000471662,0.005806105],"genre_scores_gemma":[0.9977411,0.0005667693,0.00013393383,0.00053114386,0.00015585421,0.000016432898,0.000054774813,0.000006695574,0.0007932968],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.99954116,0.00016182706,0.0000459679,0.00006042205,0.000072473274,0.00011812352],"domain_scores_gemma":[0.9981225,0.00097075844,0.00025416096,0.00010605601,0.00012496141,0.00042154777],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006635465,0.000625465,0.00073947565,0.0008800208,0.0008111742,0.0005070577,0.000636167,0.0020283484,0.0014601432],"category_scores_gemma":[0.003912119,0.00052734546,0.00050884235,0.00050272833,0.00055588194,0.00059330114,0.00040478932,0.0013667861,0.00040836495],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001963155,0.0006132602,0.040198352,0.00013890836,0.000095642456,0.941139,0.00086345547,0.000121195,0.00519658,0.00014765834,0.0006900612,0.008832749],"study_design_scores_gemma":[0.00070904865,0.008103643,0.13938127,0.000058635054,0.0002652779,0.8427843,0.00044655637,0.00073925866,0.0026956866,0.00024434883,0.0045344783,0.00003754505],"about_ca_topic_score_codex":0.0021210236,"about_ca_topic_score_gemma":0.00216703,"teacher_disagreement_score":0.0021210236,"about_ca_system_score_codex":0.00058596814,"about_ca_system_score_gemma":0.00032152914,"threshold_uncertainty_score":0.0048846602},"labels":[],"label_agreement":null},{"id":"W1998104145","doi":"10.1111/j.1365-2141.2008.07317.x","title":"Treating TTP/HUS with plasma exchange: a single centre’s 25‐year experience","year":2008,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Complement system in diseases","field":"Immunology and Microbiology","cited_by":27,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Western University; London Health Sciences Centre","funders":"","keywords":"Medicine; Thrombotic thrombocytopenic purpura; Thrombotic microangiopathy; Internal medicine; Pediatrics; Retrospective cohort study; Mortality rate; Cohort; Disease; Platelet","score_opus":0.02106473146596851,"score_gpt":0.2333997671468564,"score_spread":0.21233503568088788,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1998104145","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99191684,0.0042815856,0.00065287243,0.000653803,0.00008466466,0.00012863438,0.0000953654,0.000034350738,0.0021518252],"genre_scores_gemma":[0.9922587,0.004723314,0.0010618627,0.00062566606,0.00019551787,0.00007942816,0.00029840932,0.000018869872,0.00073814346],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99871755,0.00051454594,0.00012509746,0.00017117494,0.00020357285,0.0002680328],"domain_scores_gemma":[0.9984212,0.00023827508,0.00028270754,0.00013566835,0.000112543625,0.00080964516],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015722197,0.00067518005,0.0006784698,0.0003955842,0.0012837584,0.0013106819,0.00089521805,0.00091392384,0.0016105691],"category_scores_gemma":[0.002851376,0.0003045529,0.0009330293,0.00088600704,0.00050556666,0.0005714407,0.00087771367,0.0007495489,0.000454309],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0059684385,0.018804455,0.37393597,0.0008156647,0.0013363046,0.03667179,0.011565898,0.00354363,0.010451934,0.0007226472,0.01283307,0.5233502],"study_design_scores_gemma":[0.004677972,0.05051941,0.8000889,0.0007573499,0.0007730783,0.08870645,0.005633444,0.003849707,0.0045840563,0.000570216,0.039352626,0.0004868806],"about_ca_topic_score_codex":0.0057546073,"about_ca_topic_score_gemma":0.009078711,"teacher_disagreement_score":0.0057546073,"about_ca_system_score_codex":0.0013924649,"about_ca_system_score_gemma":0.0017300006,"threshold_uncertainty_score":0.011442244},"labels":[],"label_agreement":null},{"id":"W1998297722","doi":"10.1111/j.1365-2141.2008.07409.x","title":"High response rate to bortezomib with or without dexamethasone in patients with relapsed or refractory multiple myeloma: results of a global phase 3b expanded access program","year":2008,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":109,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Bortezomib; Dexamethasone; Multiple myeloma; Neutropenia; Refractory (planetary science); Discontinuation; Internal medicine; Adverse effect; Gastroenterology; Progressive disease; Peripheral neuropathy; Surgery; Toxicity; Chemotherapy; Endocrinology","score_opus":0.03682708077172939,"score_gpt":0.3573689208051373,"score_spread":0.3205418400334079,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1998297722","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9928866,0.0053215954,0.0003234758,0.00033668082,0.000027986851,0.00012117094,0.00019230302,0.00007043272,0.0007197218],"genre_scores_gemma":[0.99674666,0.00095778453,0.0007273458,0.00053309806,0.00010756965,0.00009965069,0.0005691853,0.000020215517,0.00023846213],"study_design_codex":"observational","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.99902415,0.0005557493,0.00007123556,0.00014128766,0.00013040619,0.00007714133],"domain_scores_gemma":[0.9985422,0.00061186723,0.00035516123,0.00009992831,0.00006284957,0.00032798652],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002377799,0.00033919295,0.0016773167,0.0003202644,0.00021227461,0.00054179574,0.0003914071,0.0006791024,0.00086050294],"category_scores_gemma":[0.0021544718,0.00018062067,0.00053753663,0.0004514944,0.00035873576,0.00035264916,0.00027027653,0.0007246013,0.00030142363],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.14043596,0.0055044456,0.45396158,0.0007505303,0.0009003301,0.0015775117,0.0004472204,0.001916092,0.04355179,0.00011643157,0.0053550242,0.34548315],"study_design_scores_gemma":[0.026609056,0.06209533,0.89156,0.00009186048,0.00055582327,0.0044319294,0.000113893664,0.0028276204,0.006518283,0.0001813873,0.004950067,0.00006463863],"about_ca_topic_score_codex":0.0002995258,"about_ca_topic_score_gemma":0.00045320063,"teacher_disagreement_score":0.002377799,"about_ca_system_score_codex":0.00038756884,"about_ca_system_score_gemma":0.00033500118,"threshold_uncertainty_score":0.01257515},"labels":[],"label_agreement":null},{"id":"W1999820147","doi":"10.1111/j.1365-2141.2005.05528.x","title":"Thromboembolism in children with acute lymphoblastic leukaemia treated on Dana‐Farber Cancer Institute protocols: effect of age and risk stratification of disease","year":2005,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":85,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Hamilton Health Sciences; McMaster Children's Hospital","funders":"Dana-Farber Cancer Institute; Heart and Stroke Foundation of Canada","keywords":"Medicine; Internal medicine; Population; Incidence (geometry); Pediatrics; Concomitant; Dosing; Disease","score_opus":0.009706532239913534,"score_gpt":0.3029912028632998,"score_spread":0.29328467062338626,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1999820147","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9995048,0.0002381618,0.000021047019,0.000028208296,0.000002285202,0.000014201117,0.000047206275,0.0000018091924,0.00014222866],"genre_scores_gemma":[0.9992906,0.00026706053,0.00012107292,0.000035073375,0.000009128188,0.000030898376,0.00018573855,0.0000017548548,0.00005855832],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99843746,0.0008052406,0.00013227145,0.00018841957,0.00022880168,0.00020786686],"domain_scores_gemma":[0.99563867,0.0015400447,0.0018021971,0.00025315234,0.00016458442,0.00060138153],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017956046,0.00032659018,0.0004844513,0.00048368835,0.00031918625,0.0005938567,0.0003725956,0.00038983382,0.0005432363],"category_scores_gemma":[0.006752428,0.00023900683,0.00037969247,0.0006980919,0.00037116156,0.00047119276,0.0005465918,0.00066340866,0.0000847222],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015820329,0.00017271712,0.99357694,0.000013614656,0.0000450949,0.000107294065,0.00013921545,0.00010732322,0.00024103114,0.000025040086,0.00014010182,0.003849535],"study_design_scores_gemma":[0.00015017633,0.0027304583,0.99523276,0.00001762785,0.00006492514,0.0006175843,0.00021122085,0.00028739023,0.00025888823,0.000026959591,0.00039595488,0.000006191836],"about_ca_topic_score_codex":0.004893345,"about_ca_topic_score_gemma":0.0047871526,"teacher_disagreement_score":0.004893345,"about_ca_system_score_codex":0.00088957045,"about_ca_system_score_gemma":0.00079988,"threshold_uncertainty_score":0.009729683},"labels":[],"label_agreement":null},{"id":"W1999911646","doi":"10.1046/j.0007-1048.2001.03306.x","title":"The pharmacodynamics of tinzaparin in healthy volunteers","year":2002,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"ASTER","funders":"","keywords":"Partial thromboplastin time; Pharmacodynamics; Medicine; Heparin; Antithrombotic; Pharmacology; Pharmacokinetics; Low molecular weight heparin; Antithrombin; Anticoagulant; Pulmonary embolism; Anesthesia; Internal medicine; Coagulation","score_opus":0.01690104651463139,"score_gpt":0.2762180930453465,"score_spread":0.25931704653071513,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1999911646","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9976689,0.0009236387,0.00044216705,0.000041487136,0.000020813704,0.0000373926,0.00012901954,0.000025970354,0.0007105231],"genre_scores_gemma":[0.99878174,0.00021560272,0.00025559566,0.00010822209,0.00003484566,0.000031825155,0.00019126387,0.0000051581687,0.00037578496],"study_design_codex":"observational","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9997558,0.00008641542,0.000014151045,0.000061301675,0.00005218228,0.000030088842],"domain_scores_gemma":[0.9996519,0.000096669624,0.00007881326,0.000023341701,0.00004072655,0.00010851986],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00024919878,0.00037264888,0.0005027427,0.00017601474,0.00026448639,0.00027353122,0.00009845834,0.00046150884,0.0006332286],"category_scores_gemma":[0.0011428583,0.00016305156,0.00017313275,0.00010658782,0.00023732304,0.0001771646,0.00012152775,0.00032533903,0.00023577135],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.07575291,0.0043099425,0.45545152,0.00047240258,0.0006814278,0.005551337,0.001071648,0.0014160256,0.29637393,0.0002611872,0.0023878838,0.1562698],"study_design_scores_gemma":[0.001481448,0.07822589,0.8860024,0.000018170962,0.0004728336,0.006693138,0.00017317264,0.002195616,0.020055205,0.00026186468,0.004381493,0.000038694834],"about_ca_topic_score_codex":0.00049869536,"about_ca_topic_score_gemma":0.0004013398,"teacher_disagreement_score":0.0006332286,"about_ca_system_score_codex":0.00013553022,"about_ca_system_score_gemma":0.00011013461,"threshold_uncertainty_score":0.0021184087},"labels":[],"label_agreement":null},{"id":"W2000087371","doi":"10.1046/j.1365-2141.2002.03240.x","title":"T‐cell analysis in identical twins reveals an impaired anti‐follicular lymphoma immune response in the patient but not in the healthy twin","year":2002,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Immune Cell Function and Interaction","field":"Immunology and Microbiology","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre","funders":"College of Science and Health; Medical Research Council; Cancer Care Ontario","keywords":"Immune system; Immunology; Biology; Lymphoma; T cell; Cell; Follicular lymphoma; Cytokine; Cancer research; Genetics","score_opus":0.015201620299912524,"score_gpt":0.24909748779367663,"score_spread":0.23389586749376412,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2000087371","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9994407,0.00006374709,0.0001647593,0.000020783129,0.0000065518752,0.000009516935,0.000038733542,0.0000032490357,0.0002518975],"genre_scores_gemma":[0.99942756,0.00005483711,0.00015660317,0.000024679572,0.000006696959,0.0000057683083,0.000048372633,0.0000050871117,0.0002704072],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9994498,0.00010184993,0.00009036105,0.00015887576,0.00010915216,0.000090077985],"domain_scores_gemma":[0.9993625,0.00015208113,0.0001456563,0.00007916154,0.00007216242,0.00018828597],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00038607148,0.000607686,0.0006172992,0.0013212734,0.0007151343,0.0006064646,0.00031427402,0.00083609036,0.0027674825],"category_scores_gemma":[0.0019047526,0.00043779323,0.00046038642,0.0004978779,0.0005828153,0.00027633648,0.0005132503,0.00075122295,0.00036080566],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0071228743,0.0009708389,0.26267257,0.00028387405,0.00031156195,0.10230483,0.0050645443,0.00051339157,0.60023946,0.0014373359,0.00055861345,0.018520191],"study_design_scores_gemma":[0.00022997255,0.0053975536,0.5029292,0.00004157858,0.00045272816,0.40561014,0.0020127902,0.0022841801,0.07758703,0.0006818574,0.002695721,0.000077212455],"about_ca_topic_score_codex":0.0015887755,"about_ca_topic_score_gemma":0.00078685686,"teacher_disagreement_score":0.0027674825,"about_ca_system_score_codex":0.00038837403,"about_ca_system_score_gemma":0.00014301187,"threshold_uncertainty_score":0.009258091},"labels":[],"label_agreement":null},{"id":"W2001771356","doi":"10.1111/j.1365-2141.2006.06322.x","title":"High dose calcitriol may reduce thrombosis in cancer patients","year":2006,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Pharmacological Effects and Toxicity Studies","field":"Medicine","cited_by":86,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"Sanofi","keywords":"Calcitriol; Medicine; Antithrombotic; Docetaxel; Thrombosis; Placebo; Internal medicine; Calcitriol receptor; Vitamin D and neurology; Gastroenterology; Vitamin K antagonist; Cancer; Oncology; Atrial fibrillation; Pathology; Warfarin","score_opus":0.025992419118825712,"score_gpt":0.33889614562035203,"score_spread":0.3129037265015263,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2001771356","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9850138,0.012511661,0.00018086599,0.0005734429,0.00021286847,0.00026957024,0.00012145953,0.00002653063,0.0010898366],"genre_scores_gemma":[0.99680895,0.0019941288,0.0002276953,0.0003267176,0.00013500976,0.00008196413,0.00009411351,0.0000019572726,0.00032956],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.9992411,0.00049705745,0.00006808787,0.0000677994,0.00007708351,0.000048832775],"domain_scores_gemma":[0.9988243,0.0005186716,0.00030945858,0.000053673473,0.00004751127,0.00024640447],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011525293,0.0003464367,0.0012042348,0.0002865884,0.0002096469,0.00056498294,0.00032326477,0.0008383029,0.0017124605],"category_scores_gemma":[0.0022049723,0.00026686865,0.0007512766,0.00032954646,0.00044413027,0.0002569942,0.0001654706,0.0009908524,0.00014924636],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.8864435,0.006071448,0.007820609,0.0014173547,0.0028987904,0.00017483468,0.00009868508,0.0007072959,0.010639517,0.0002510369,0.001067232,0.082409725],"study_design_scores_gemma":[0.63516045,0.31038132,0.04335745,0.00013912514,0.0025833878,0.0004025525,0.00009260002,0.0010517994,0.0026139393,0.00055059284,0.003627649,0.000039137434],"about_ca_topic_score_codex":0.0007204191,"about_ca_topic_score_gemma":0.0020381138,"teacher_disagreement_score":0.0017124605,"about_ca_system_score_codex":0.00042824048,"about_ca_system_score_gemma":0.00042164605,"threshold_uncertainty_score":0.0060952306},"labels":[],"label_agreement":null},{"id":"W2002155898","doi":"10.1111/bjh.12673","title":"Autologous stem cell transplant is an effective therapy for carefully selected patients with <scp>AL</scp> amyloidosis: experience of a single institution","year":2013,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Amyloidosis: Diagnosis, Treatment, Outcomes","field":"Biochemistry, Genetics and Molecular Biology","cited_by":23,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Internal medicine; Autologous stem-cell transplantation; Troponin; Amyloidosis; Transplantation; Stem cell; AL amyloidosis; Gastroenterology; Troponin T; Surgery; Immunology; Biology","score_opus":0.00715454681679543,"score_gpt":0.22397015222085948,"score_spread":0.21681560540406405,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2002155898","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9843018,0.010430186,0.0013512436,0.00082494336,0.000079154386,0.00007257576,0.000090701986,0.00003613978,0.0028132326],"genre_scores_gemma":[0.99494016,0.003411622,0.00084679166,0.00018708484,0.00017123346,0.000018844079,0.000120058,0.0000096727945,0.00029453947],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99973756,0.00013168836,0.000023434663,0.000031586074,0.000050323048,0.000025410132],"domain_scores_gemma":[0.999012,0.0002939722,0.00020513684,0.000066689696,0.00007280612,0.00034938706],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00071822375,0.00022368728,0.00033166638,0.00015334891,0.00027959267,0.00039880554,0.0001497547,0.00023798786,0.0010845724],"category_scores_gemma":[0.001570852,0.00005729054,0.0003083066,0.00029370838,0.00023093657,0.00023092027,0.00020471879,0.00048247454,0.0002772234],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0065136603,0.0018365536,0.26458836,0.00037179925,0.0005189959,0.0063336873,0.0012909365,0.002140057,0.019371519,0.00039447218,0.0057366444,0.6909033],"study_design_scores_gemma":[0.0018586859,0.025851533,0.9103933,0.000354846,0.00053566357,0.026947858,0.00059643947,0.0019139504,0.007567897,0.0006942355,0.023215258,0.00007021943],"about_ca_topic_score_codex":0.00030786428,"about_ca_topic_score_gemma":0.0004618154,"teacher_disagreement_score":0.0010845724,"about_ca_system_score_codex":0.00019152972,"about_ca_system_score_gemma":0.00024364716,"threshold_uncertainty_score":0.0037983656},"labels":[],"label_agreement":null},{"id":"W2003006151","doi":"10.1111/j.1365-2141.2009.07793.x","title":"Differences in the prevalence of growth, endocrine and vitamin D abnormalities among the various thalassaemia syndromes in North America","year":2009,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":175,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; Toronto General Hospital; University Health Network","funders":"National Heart, Lung, and Blood Institute; Canadian Institutes of Health Research; National Center for Research Resources; University Health Network","keywords":"Medicine; Thalassemia; Subclinical infection; Hypoparathyroidism; Hypercalciuria; Vitamin D and neurology; Short stature; Endocrine system; Internal medicine; Pediatrics; Beta thalassemia; Hemoglobinopathy; vitamin D deficiency; Endocrinology; Physiology; Urine; Hemolytic anemia; Hormone","score_opus":0.007408288090983668,"score_gpt":0.22158673319938782,"score_spread":0.21417844510840414,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2003006151","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99908864,0.0002806899,0.000029279901,0.000025267684,0.0000019354575,0.0000035534406,0.000113362265,0.0000022771276,0.00045491004],"genre_scores_gemma":[0.9993753,0.00022792259,0.000043517626,0.000034625762,0.000005533611,0.0000047188205,0.00019407232,0.0000010819359,0.00011342399],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9997012,0.00008838195,0.000033056112,0.00006930924,0.00004974103,0.00005832995],"domain_scores_gemma":[0.9994282,0.000101796846,0.0002366622,0.000021696838,0.000086451146,0.0001252026],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00024528225,0.00016277349,0.00021712792,0.0010497186,0.0003319055,0.00040130864,0.00017531963,0.0002122374,0.0009511667],"category_scores_gemma":[0.00076653453,0.00014982397,0.0001711074,0.0010310776,0.00027310857,0.00023459771,0.00027318043,0.00017465571,0.00009564256],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000028124554,0.000011378529,0.99737996,0.000006441917,0.000025304822,0.00006430565,0.00029211334,0.000012864626,0.00029069022,0.000016181191,0.00007625372,0.0017964115],"study_design_scores_gemma":[0.0000012630917,0.000014517584,0.99941385,0.000003047439,0.000006656708,0.00014161748,0.00028620043,0.000017928396,0.000013783486,0.000005654741,0.000094629526,9.084399e-7],"about_ca_topic_score_codex":0.021624384,"about_ca_topic_score_gemma":0.03217038,"teacher_disagreement_score":0.021624384,"about_ca_system_score_codex":0.00032424444,"about_ca_system_score_gemma":0.00019955801,"threshold_uncertainty_score":0.042997062},"labels":[],"label_agreement":null},{"id":"W2004796866","doi":"10.1111/j.1365-2141.2008.07367.x","title":"Fluorosis detected by trephine biopsy","year":2008,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Fluoride Effects and Removal","field":"Environmental Science","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; University of Toronto; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Osteosclerosis; Trephine; Skeletal fluorosis; Biopsy; Pathology; Radiology; Surgery; Fluoride; Dental fluorosis","score_opus":0.005609643464388619,"score_gpt":0.1946915112849645,"score_spread":0.1890818678205759,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2004796866","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.928356,0.009046426,0.009769721,0.0013626583,0.0004556981,0.00036690163,0.0011529097,0.00040195012,0.049087644],"genre_scores_gemma":[0.9907522,0.00192645,0.0029102068,0.000523398,0.00020242551,0.000025680694,0.00041268914,0.000024900319,0.0032219307],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.9996488,0.00002580713,0.000025851912,0.00009327974,0.00010669209,0.00009954077],"domain_scores_gemma":[0.9996213,0.0000971527,0.00003838111,0.000050098566,0.00008229178,0.00011073189],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00024131539,0.0006368843,0.00037838295,0.0015682053,0.00055607536,0.0006180492,0.00043328854,0.0013359637,0.0035967662],"category_scores_gemma":[0.0010468614,0.000384813,0.00042319373,0.00040459735,0.0003633441,0.00061958644,0.00040850102,0.00081257796,0.001274543],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00048038163,0.00013789584,0.02726585,0.00016927285,0.000040228457,0.8771952,0.00039097024,0.00015946635,0.07346937,0.00047105917,0.0013962653,0.018824017],"study_design_scores_gemma":[0.00004352164,0.00030312315,0.06082073,0.0001315485,0.00006452842,0.9155907,0.0004162299,0.0011547612,0.012851025,0.000436541,0.008160169,0.000027148688],"about_ca_topic_score_codex":0.0020525195,"about_ca_topic_score_gemma":0.0027883386,"teacher_disagreement_score":0.0035967662,"about_ca_system_score_codex":0.0004006867,"about_ca_system_score_gemma":0.0002508319,"threshold_uncertainty_score":0.01203233},"labels":[],"label_agreement":null},{"id":"W2005515451","doi":"10.1111/bjh.13094","title":"Phase <scp>II</scp> study of targeted therapy with temozolomide in acute myeloid leukaemia and high‐risk myelodysplastic syndrome patients pre‐screened for low O<sup>6</sup>‐methylguanine DNA methyltransferase expression","year":2014,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"London Health Sciences Centre; BC Cancer Agency; Juravinski Cancer Centre; Hôpital Maisonneuve-Rosemont; Princess Margaret Cancer Centre","funders":"Merck Canada; Merck","keywords":"Temozolomide; O-6-methylguanine-DNA methyltransferase; Myelodysplastic syndromes; Myeloid leukaemia; Medicine; Methyltransferase; Oncology; Decitabine; Cancer research; DNA methyltransferase; Internal medicine; DNA; DNA methylation; Glioblastoma; Methylation; Gene expression; Gene; Biology; Genetics; Bone marrow","score_opus":0.008527743002371874,"score_gpt":0.26581174349831876,"score_spread":0.2572840004959469,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2005515451","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9925015,0.0010056386,0.00053159636,0.00029533287,0.00006265396,0.0035564012,0.00064102124,0.000058731344,0.0013469836],"genre_scores_gemma":[0.9863024,0.0010667567,0.0018870676,0.0008733092,0.00014036696,0.003959717,0.003092998,0.00002193812,0.0026554964],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.99959916,0.00022037291,0.000016795644,0.000045587945,0.000030988376,0.000087122564],"domain_scores_gemma":[0.99935085,0.0000768943,0.00010145307,0.0000531443,0.000055572502,0.00036206044],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012535679,0.0012971454,0.001746244,0.00043815566,0.00033658952,0.00065509515,0.00069187017,0.0009518185,0.0021544318],"category_scores_gemma":[0.0006010368,0.00039560386,0.0008679107,0.00037647167,0.0006680176,0.00041075674,0.00037637266,0.0018588196,0.0005311334],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.70264554,0.08582389,0.0155048445,0.0005698105,0.0008771872,0.00044932993,0.00029999026,0.0027817648,0.0936067,0.0003956116,0.0044421735,0.092603214],"study_design_scores_gemma":[0.33801824,0.6224031,0.027315997,0.000026904867,0.0002388888,0.0003841466,0.00004813898,0.001183686,0.0070353947,0.00016414172,0.003161233,0.000020165153],"about_ca_topic_score_codex":0.0013563707,"about_ca_topic_score_gemma":0.002058674,"teacher_disagreement_score":0.0021544318,"about_ca_system_score_codex":0.0007353938,"about_ca_system_score_gemma":0.0016083507,"threshold_uncertainty_score":0.007207334},"labels":[],"label_agreement":null},{"id":"W2005643874","doi":"10.1111/j.1365-2141.2005.05624.x","title":"Confirmation of paternity suggests a new mutation in the factor VII gene: ‘Pater certus quouque est’ ‐ Response to Girolami <i>et al</i>","year":2005,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Muscle Physiology and Disorders","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Genetics; Allele; Biology; Proband; Mutation; Population; Amelogenin; Microsatellite; Polymerase chain reaction; X chromosome; Gene; Demography","score_opus":0.009976333942595441,"score_gpt":0.2705955202722904,"score_spread":0.26061918632969494,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2005643874","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.025073336,0.004064278,0.0010634484,0.9217202,0.041662656,0.0000457587,0.00016772271,0.00018809292,0.0060144407],"genre_scores_gemma":[0.2120905,0.0049419263,0.0025056303,0.7053269,0.04876971,0.000069062524,0.00022716628,0.00019921835,0.025869908],"study_design_codex":"not_applicable","study_design_gemma":"case_report","domain_scores_codex":[0.9990392,0.00024294262,0.00011908907,0.00026032337,0.00019477379,0.0001437697],"domain_scores_gemma":[0.9960163,0.0018151867,0.00042662586,0.00015894994,0.0012238894,0.00035903612],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012764406,0.0005764543,0.000746232,0.0005644953,0.0010393818,0.0008155933,0.0011409824,0.0064176316,0.0045793685],"category_scores_gemma":[0.0095291985,0.00022485972,0.00063764077,0.00028910712,0.0010309028,0.0009936587,0.00045085652,0.009124331,0.0016649227],"study_design_candidate":"case_report","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000367225,0.00009133755,0.015405918,0.0002402496,0.00010188012,0.1177507,0.0010170863,0.00018409407,0.0025846218,0.0020789145,0.83051974,0.029658284],"study_design_scores_gemma":[0.00013843036,0.0003712196,0.028435223,0.00074926653,0.00016017458,0.32393536,0.0036607184,0.0017293124,0.004705034,0.00487106,0.6310165,0.00022776863],"about_ca_topic_score_codex":0.0037768143,"about_ca_topic_score_gemma":0.004381569,"teacher_disagreement_score":0.0064176316,"about_ca_system_score_codex":0.0009463013,"about_ca_system_score_gemma":0.000386397,"threshold_uncertainty_score":0.015319526},"labels":[],"label_agreement":null},{"id":"W2005795414","doi":"10.1046/j.1365-2141.2001.02748.x","title":"Origins of the discipline ‘neonatal haematology’, 1925–75","year":2001,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Blood disorders and treatments","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"National Center for Research Resources; National Heart, Lung, and Blood Institute","keywords":"Neonatology; Hematology; Medicine; Intensive care medicine; Neonatal intensive care unit; Pediatrics; Intensive care; Pregnancy; Internal medicine; Biology","score_opus":0.005752737416438261,"score_gpt":0.2352856866267437,"score_spread":0.22953294921030545,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2005795414","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0039753704,0.41819346,0.0072024046,0.15551981,0.109673396,0.00014096641,0.0002465565,0.00016670348,0.30488127],"genre_scores_gemma":[0.11567273,0.35698095,0.010433158,0.12666453,0.13723022,0.0005091721,0.0003548535,0.0007199143,0.25143445],"study_design_codex":"not_applicable","study_design_gemma":"qualitative","domain_scores_codex":[0.9959168,0.001787652,0.00035518187,0.0005575079,0.0009996296,0.00038320626],"domain_scores_gemma":[0.9954592,0.0017892281,0.00031921835,0.0002158362,0.0013953234,0.0008213054],"candidate_categories":["sts"],"consensus_categories":[],"category_scores_codex":[0.006025469,0.0009463117,0.00055206596,0.0026872123,0.002744278,0.0039028467,0.0011323343,0.004939644,0.00830573],"category_scores_gemma":[0.011576414,0.00044218582,0.000528025,0.001616349,0.013115783,0.0042257668,0.0038543288,0.009618878,0.0046313447],"study_design_candidate":"qualitative","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013038368,0.00005632828,0.0018719584,0.0007902746,0.000016592589,0.00091392023,0.0071575856,0.00025951315,0.00043636738,0.3764091,0.40350872,0.20844932],"study_design_scores_gemma":[0.0000055609034,0.000018855293,0.00071477384,0.00043975018,0.000002154031,0.0005715352,0.00020569048,0.000026949114,0.00006952022,0.010142222,0.9877906,0.000012359072],"about_ca_topic_score_codex":0.012560712,"about_ca_topic_score_gemma":0.013138386,"teacher_disagreement_score":0.99725574,"about_ca_system_score_codex":0.009269957,"about_ca_system_score_gemma":0.009939079,"threshold_uncertainty_score":0.06725854},"labels":[],"label_agreement":null},{"id":"W2005969591","doi":"10.1046/j.1365-2141.2000.01866.x","title":"Safety profile of the oral iron chelator deferiprone: a multicentre study","year":2000,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":193,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Apotex (Canada)","funders":"","keywords":"Deferiprone; Neutropenia; Medicine; Discontinuation; Internal medicine; Gastroenterology; Deferasirox; Incidence (geometry); Adverse effect; Vomiting; Surgery; Thalassemia; Chemotherapy","score_opus":0.006442121639605527,"score_gpt":0.24005370813732532,"score_spread":0.2336115864977198,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2005969591","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99599046,0.0018956725,0.0005587537,0.000091710564,0.000018916848,0.0006621625,0.0003301078,0.000021930475,0.00043043974],"genre_scores_gemma":[0.9972838,0.00082544767,0.0004896461,0.0002385795,0.000088923676,0.00033903614,0.0004738597,0.000006330043,0.0002544422],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.99771595,0.0014305944,0.000198991,0.00022159412,0.0003148971,0.0001179563],"domain_scores_gemma":[0.99653757,0.0008695237,0.0012491979,0.0004115073,0.00036828674,0.00056405267],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004414929,0.00077327364,0.0013178831,0.00036594013,0.0003478583,0.0006188496,0.0004895838,0.00091356464,0.0010846902],"category_scores_gemma":[0.0038791185,0.00026660544,0.0010782033,0.0004802075,0.0005813069,0.00038798142,0.0003340951,0.00078763743,0.00026361205],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.62808937,0.022196073,0.14667739,0.0018486741,0.00552577,0.0010554051,0.00075065694,0.00226332,0.04957971,0.00018271492,0.0017249492,0.14010598],"study_design_scores_gemma":[0.15289761,0.5902037,0.24156314,0.00010326005,0.002806127,0.0014781978,0.0001315068,0.0014531696,0.005830764,0.000101700745,0.0033385803,0.00009226558],"about_ca_topic_score_codex":0.00049731706,"about_ca_topic_score_gemma":0.00055972236,"teacher_disagreement_score":0.004414929,"about_ca_system_score_codex":0.0005247419,"about_ca_system_score_gemma":0.0008174595,"threshold_uncertainty_score":0.02334869},"labels":[],"label_agreement":null},{"id":"W2006019871","doi":"10.1111/j.1365-2141.2007.06692.x","title":"<i>Viscum album</i> agglutinin‐I induces degradation of cytoskeletal proteins in leukaemia PLB‐985 cells differentiated toward neutrophils: cleavage of non‐muscle myosin heavy chain‐IIA by caspases","year":2007,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Toxin Mechanisms and Immunotoxins","field":"Immunology and Microbiology","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institut National de la Recherche Scientifique","funders":"Canadian Institutes of Health Research","keywords":"Cytoskeleton; Myosin; Cell biology; Actin; Apoptosis; Vimentin; Gelsolin; Molecular biology; Biology; Chemistry; Cell; Immunology; Biochemistry","score_opus":0.010004128645493639,"score_gpt":0.2275923674933682,"score_spread":0.21758823884787457,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2006019871","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9966928,0.0010768619,0.0008834456,0.000073120005,0.000020278141,0.000019203939,0.0002911742,0.000040141724,0.00090293516],"genre_scores_gemma":[0.99641114,0.00046267532,0.0008599808,0.000051596486,0.000006978977,0.000027804183,0.0006703969,0.000009031174,0.001500288],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998896,0.000020666734,0.000019299076,0.000019811003,0.000020343103,0.0000301767],"domain_scores_gemma":[0.99994934,0.0000080253785,0.000016582204,0.00000858536,0.0000057075968,0.000011788613],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0000875302,0.000238246,0.00021414999,0.000112660324,0.000099356505,0.00022623519,0.00012751832,0.00023277181,0.0008313428],"category_scores_gemma":[0.000053894964,0.0000828833,0.00022121571,0.000121038545,0.00012910175,0.00013489678,0.00012466608,0.00045822203,0.00032124508],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000087968765,0.000019983903,0.00011653178,0.000014433577,0.0000023044222,0.000033333115,0.0000061874425,0.000013939416,0.9993498,0.000025302646,0.000014299268,0.00031607432],"study_design_scores_gemma":[0.000012918721,0.00038904307,0.006128398,0.000003225854,0.000008066046,0.00018683705,0.000027610498,0.00043738473,0.9916892,0.00001585896,0.0010993151,0.0000021677154],"about_ca_topic_score_codex":0.00043400386,"about_ca_topic_score_gemma":0.0003984715,"teacher_disagreement_score":0.0008313428,"about_ca_system_score_codex":0.00020010446,"about_ca_system_score_gemma":0.00008874111,"threshold_uncertainty_score":0.0027810931},"labels":[],"label_agreement":null},{"id":"W2006220544","doi":"10.1046/j.1365-2141.2001.02782-4.x","title":"Reply to Quintini <i>et al</i>","year":2001,"lang":"he","type":"article","venue":"British Journal of Haematology","topic":"Complement system in diseases","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital","funders":"","keywords":"Medicine; Splenectomy; Transplantation; Intensive care medicine; Refractory (planetary science); Cyclophosphamide; Surgery; Internal medicine; Chemotherapy","score_opus":0.01806266742701431,"score_gpt":0.2893227986604924,"score_spread":0.2712601312334781,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2006220544","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00017228132,0.0027630401,0.000088505905,0.93761325,0.05867588,0.000008521848,0.000056784073,0.0000447127,0.0005770204],"genre_scores_gemma":[0.0014067886,0.0011618183,0.0001264752,0.9520576,0.04346791,0.000019720737,0.000023755198,0.000020564801,0.001715323],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99678457,0.00075218093,0.00047486875,0.00058026065,0.00092043856,0.00048774897],"domain_scores_gemma":[0.9891144,0.0043498394,0.0011295376,0.0003810265,0.0034030422,0.0016220367],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004703055,0.0011958133,0.0017342104,0.0011766393,0.002648879,0.0035780934,0.0032377907,0.045530725,0.00568539],"category_scores_gemma":[0.0278159,0.0008884993,0.0014781948,0.0010180643,0.003395157,0.0055185985,0.0021791812,0.041466933,0.0058511505],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00002494595,0.0000102001595,0.00023672078,0.000065546374,0.000008683818,0.0006603035,0.00008409838,0.000021394435,0.000055361903,0.00043819335,0.9958846,0.0025099048],"study_design_scores_gemma":[0.000057311925,0.00004328987,0.0010874809,0.000348354,0.000025703275,0.003980181,0.00063854456,0.00019214391,0.00022494534,0.003171037,0.9901246,0.00010641769],"about_ca_topic_score_codex":0.0041568736,"about_ca_topic_score_gemma":0.0039640265,"teacher_disagreement_score":0.045530725,"about_ca_system_score_codex":0.0036662212,"about_ca_system_score_gemma":0.003467756,"threshold_uncertainty_score":0.02660042},"labels":[],"label_agreement":null},{"id":"W2006456576","doi":"10.1111/j.1365-2141.2008.07054.x","title":"Rituximab in the treatment of autoimmune haematological disorders","year":2008,"lang":"en","type":"review","venue":"British Journal of Haematology","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":205,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Michael's Hospital","funders":"","keywords":"Rituximab; Medicine; Thrombocytopenic purpura; Thrombotic thrombocytopenic purpura; Immunology; Adverse effect; Hematology; Haemophilia; Autoimmune hemolytic anemia; CD20; Monoclonal; Internal medicine; Monoclonal antibody; Antibody; Pediatrics; Platelet","score_opus":0.03901149715766658,"score_gpt":0.33250239081183297,"score_spread":0.29349089365416636,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2006456576","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00008104286,0.99912864,0.000046677054,0.00007661511,0.00009475413,0.0000031122474,0.0000034544614,0.0000046937275,0.0005610081],"genre_scores_gemma":[0.00090146996,0.9980835,0.00014467367,0.00015573368,0.00016209732,0.000006268458,0.000014368993,0.0000014869566,0.0005304135],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99963987,0.00009223896,0.000049119106,0.000046923175,0.0001441627,0.000027652879],"domain_scores_gemma":[0.99972266,0.00014789165,0.00004166994,0.000009282494,0.00005057744,0.000027958646],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006394553,0.00091250765,0.0016995992,0.0025465363,0.0003169529,0.0007103907,0.00090935174,0.0011845896,0.002686646],"category_scores_gemma":[0.00077203487,0.00023806706,0.000456713,0.002540682,0.0005728345,0.0009180383,0.00053914083,0.0017842046,0.0021189887],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000084724095,0.00006467944,0.00013034456,0.009013064,0.000090911206,0.0003712312,0.000060398994,0.00030977282,0.0008747136,0.0010476862,0.024890082,0.96306235],"study_design_scores_gemma":[0.000070692775,0.00015068472,0.0013414716,0.0046041836,0.00016787123,0.004915871,0.000068862486,0.000087716355,0.0004090383,0.0015511217,0.9866149,0.000017735072],"about_ca_topic_score_codex":0.0013367994,"about_ca_topic_score_gemma":0.002012239,"teacher_disagreement_score":0.002686646,"about_ca_system_score_codex":0.00062045694,"about_ca_system_score_gemma":0.000692379,"threshold_uncertainty_score":0.008987725},"labels":[],"label_agreement":null},{"id":"W2006857073","doi":"10.1111/j.1365-2141.2008.07094.x","title":"Routine bone marrow examination in the initial evaluation of paediatric Hodgkin lymphoma: the Canadian perspective","year":2008,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Cancer Care Nova Scotia; Izaak Walton Killam Health Centre; Dalhousie University","funders":"IWK Health Centre","keywords":"Medicine; Stage (stratigraphy); Hodgkin lymphoma; Bone marrow; Lymphoma; Pediatrics; Internal medicine","score_opus":0.04361698736652288,"score_gpt":0.3087089068437661,"score_spread":0.26509191947724325,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2006857073","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.79965436,0.10211413,0.000418437,0.06351335,0.00056810037,0.000081528604,0.0020028884,0.00003424522,0.031612903],"genre_scores_gemma":[0.9626566,0.032207787,0.0006185902,0.0028977105,0.0003781918,0.000008637162,0.00032385174,0.000008231552,0.0009003731],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987073,0.0001985655,0.00010858691,0.00011468243,0.0004825314,0.00038834545],"domain_scores_gemma":[0.99577016,0.0004922434,0.00060108706,0.00003488654,0.0015845328,0.0015170544],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009797888,0.0002822428,0.00030090395,0.001398294,0.0013723556,0.0014002735,0.00060557475,0.0009287768,0.0033673695],"category_scores_gemma":[0.005692354,0.00024959614,0.00021935544,0.002333507,0.0013259477,0.0006661828,0.00048320217,0.0014667755,0.00023617815],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003417941,0.000096675554,0.8777021,0.0010224154,0.000071979994,0.0046517616,0.0019919323,0.00044779747,0.0011842125,0.0008692681,0.015549703,0.09607024],"study_design_scores_gemma":[0.000032703032,0.00016694386,0.9707117,0.00093651185,0.00010067576,0.0052611567,0.004374069,0.00035019827,0.00024066503,0.00018031511,0.01758689,0.000058291174],"about_ca_topic_score_codex":0.93153566,"about_ca_topic_score_gemma":0.9593674,"teacher_disagreement_score":0.06846434,"about_ca_system_score_codex":0.014324153,"about_ca_system_score_gemma":0.019583818,"threshold_uncertainty_score":0.13773501},"labels":[],"label_agreement":null},{"id":"W2007047214","doi":"10.1111/j.1365-2141.2005.05849.x","title":"Lack of CD27 in myeloma delineates different presentation and outcome","year":2005,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":65,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hotel Dieu Hospital","funders":"","keywords":"Multiple myeloma; Medicine; Internal medicine; Presentation (obstetrics); Plasma cell; Overall survival; Gastroenterology; Pathology; Surgery","score_opus":0.061643159301632916,"score_gpt":0.37949167654108673,"score_spread":0.31784851723945384,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2007047214","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99942124,0.00023190521,0.00004226939,0.000013655067,9.619654e-7,0.000001544022,0.000035431793,0.0000024442106,0.0002505583],"genre_scores_gemma":[0.99975413,0.000050735413,0.00002875219,0.0000071438935,0.0000038148646,0.0000017903371,0.00009446002,0.0000010924488,0.000058047022],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9997633,0.000060061775,0.000022955504,0.00004691747,0.00004140701,0.00006532023],"domain_scores_gemma":[0.999371,0.00017617254,0.00020991758,0.00004220068,0.000059623617,0.00014122718],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00034805632,0.00018263825,0.00032666302,0.00074818876,0.00028417123,0.00042873636,0.00015429906,0.00030679247,0.00092683994],"category_scores_gemma":[0.0013783881,0.00013733447,0.00015875878,0.00042467265,0.00033093485,0.0002876483,0.0005412447,0.00026236186,0.00023021965],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0020034362,0.00003226731,0.9736873,0.000029518911,0.000048482045,0.0008532384,0.00028604883,0.00022079238,0.012760455,0.0000830415,0.00015477014,0.009840745],"study_design_scores_gemma":[0.000023049899,0.00037062936,0.99318707,0.000009867428,0.000038800987,0.0037873478,0.00017984222,0.00031464922,0.0015093747,0.00017286057,0.0003993617,0.000007162309],"about_ca_topic_score_codex":0.0006953828,"about_ca_topic_score_gemma":0.0005360799,"teacher_disagreement_score":0.00092683994,"about_ca_system_score_codex":0.00029509325,"about_ca_system_score_gemma":0.00013965591,"threshold_uncertainty_score":0.0031006336},"labels":[],"label_agreement":null},{"id":"W2007050465","doi":"10.1111/bjh.12763","title":"<scp>MYC</scp> and <scp>BCL</scp>2 protein expression predicts survival in patients with diffuse large <scp>B</scp>‐cell lymphoma treated with rituximab","year":2014,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":165,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency; University of Manitoba","funders":"","keywords":"Diffuse large B-cell lymphoma; Vincristine; Rituximab; Lymphoma; Medicine; Internal medicine; CHOP; Oncology; Cyclophosphamide; Prednisone; Survival analysis; Cancer research; Immunology; Chemotherapy","score_opus":0.00490902539138982,"score_gpt":0.19707676294554458,"score_spread":0.19216773755415475,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2007050465","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9996611,0.00016274418,0.00003639631,0.000016526676,0.0000023207172,0.0000014460321,0.000024339019,0.0000014065971,0.00009373631],"genre_scores_gemma":[0.99977237,0.00004836344,0.000027559126,0.000010999188,0.0000062572167,0.0000017223913,0.00008617925,5.4854667e-7,0.00004601538],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9998431,0.000052316205,0.00001699972,0.000027119659,0.000030957533,0.000029439092],"domain_scores_gemma":[0.99939156,0.00019978841,0.00019264781,0.000033808567,0.000054256634,0.00012793289],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00038632832,0.0001986926,0.0002554688,0.00035410083,0.00016565656,0.0003914269,0.00015382312,0.0003000308,0.00039432067],"category_scores_gemma":[0.0011781501,0.00017006218,0.00022511244,0.00028637587,0.00024216471,0.00023731399,0.00021344403,0.0003733469,0.0001323989],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00048738573,0.000029329361,0.9962218,0.0000043715895,0.00003494966,0.000117631585,0.000031230265,0.0001188153,0.0010326756,0.000005857638,0.000058966165,0.0018568707],"study_design_scores_gemma":[0.000028902496,0.00035791035,0.9974183,0.0000037939599,0.0000457063,0.0008116588,0.00006050154,0.00075113,0.00030433186,0.000021470913,0.0001930183,0.0000033036486],"about_ca_topic_score_codex":0.00081411947,"about_ca_topic_score_gemma":0.0010221502,"teacher_disagreement_score":0.00081411947,"about_ca_system_score_codex":0.00017283372,"about_ca_system_score_gemma":0.00012958201,"threshold_uncertainty_score":0.002043128},"labels":[],"label_agreement":null},{"id":"W2007306250","doi":"10.1111/j.1365-2141.2008.07517.x","title":"The prevention of hospital‐acquired venous thromboembolism in the United Kingdom","year":2008,"lang":"en","type":"review","venue":"British Journal of Haematology","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":37,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Thomas Hospital","funders":"","keywords":"Nice; Medicine; Excellence; Venous thromboembolism; Expert opinion; Dabigatran; Intensive care medicine; Family medicine; Medical emergency; Surgery; Warfarin; Internal medicine","score_opus":0.05148540768400097,"score_gpt":0.3418618845109028,"score_spread":0.2903764768269019,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2007306250","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000089175366,0.99948394,0.000009918319,0.000087782115,0.00006833369,0.0000038973603,0.000013773059,0.0000018961857,0.00024113334],"genre_scores_gemma":[0.0013277783,0.9982487,0.000063700754,0.00010479598,0.000021946265,0.000006037958,0.000021698033,5.3874834e-7,0.00020478314],"study_design_codex":"design_other","study_design_gemma":"systematic_review","domain_scores_codex":[0.9993218,0.000164776,0.00021893861,0.000067893256,0.00019039902,0.00003624415],"domain_scores_gemma":[0.9989059,0.00042149596,0.0003602213,0.000019598765,0.00023901518,0.000053840173],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010906699,0.0007170779,0.0018903391,0.0036748655,0.00021950483,0.00087618036,0.0005305831,0.00094557356,0.0045740074],"category_scores_gemma":[0.0025881098,0.00035988347,0.00073541055,0.0036242276,0.0002844176,0.00096912385,0.0006027722,0.0006174931,0.0007668027],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00028036573,0.00004204682,0.0005178231,0.14291266,0.00043616016,0.00028791733,0.000098524404,0.00023734024,0.00061620114,0.00073983637,0.03034524,0.82348585],"study_design_scores_gemma":[0.00027504948,0.00042353838,0.01261835,0.13680837,0.0022136106,0.0029978855,0.00022524949,0.0001541686,0.00057494384,0.00063656596,0.84302723,0.000045041394],"about_ca_topic_score_codex":0.010131166,"about_ca_topic_score_gemma":0.017114425,"teacher_disagreement_score":0.010131166,"about_ca_system_score_codex":0.0016258762,"about_ca_system_score_gemma":0.002186917,"threshold_uncertainty_score":0.020144403},"labels":[],"label_agreement":null},{"id":"W2007340594","doi":"10.1046/j.1365-2141.2000.02330.x","title":"Irreversible loss of donor blood leucocyte activation may explain a paucity of transfusion-associated graft-versus-host disease from stored blood","year":2000,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University Health Network","funders":"","keywords":"Immunology; Antigen; Blood transfusion; Medicine; Lymphocyte; Graft-versus-host disease; CD28; Downregulation and upregulation; CD3; Disease; Biology; Internal medicine; CD8; Biochemistry","score_opus":0.0149125471112702,"score_gpt":0.24740456202676006,"score_spread":0.23249201491548988,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2007340594","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99066013,0.0059298906,0.0024994512,0.00009014196,0.00002644072,0.000022291219,0.00012877757,0.000043283017,0.0005995851],"genre_scores_gemma":[0.9977168,0.0009450669,0.00059205526,0.000044871776,0.000009926196,0.000012449407,0.00016786471,0.00000656094,0.00050453487],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99987185,0.00002570497,0.000024529703,0.000024626319,0.00002684054,0.000026424417],"domain_scores_gemma":[0.99984694,0.000027238579,0.00007512762,0.000020287467,0.000013126572,0.000017323671],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003141701,0.0004086426,0.00032937273,0.00024815675,0.00012663024,0.0004733137,0.00034698422,0.0003787119,0.0010792973],"category_scores_gemma":[0.00022045917,0.0001328125,0.00024248843,0.00018304202,0.00025763965,0.00035117872,0.0002758232,0.00042350372,0.00030642678],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009246355,0.00006740403,0.0069694617,0.00018125978,0.000030297933,0.0006181188,0.00006969803,0.00016254885,0.98334354,0.00026038827,0.000055235207,0.0073173787],"study_design_scores_gemma":[0.00003459256,0.0016695405,0.08355101,0.000049352104,0.0001573217,0.0043036668,0.00012812957,0.0013678035,0.9049705,0.00042159526,0.003331382,0.000015130741],"about_ca_topic_score_codex":0.00016876761,"about_ca_topic_score_gemma":0.00016105072,"teacher_disagreement_score":0.0010792973,"about_ca_system_score_codex":0.00029431668,"about_ca_system_score_gemma":0.0001310338,"threshold_uncertainty_score":0.003610611},"labels":[],"label_agreement":null},{"id":"W2007356942","doi":"10.1046/j.1365-2141.2000.02173.x","title":"Hereditary cyclic neutropenia in the male members of a Chinese family with inverted Y chromosome","year":2000,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Blood disorders and treatments","field":"Biochemistry, Genetics and Molecular Biology","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"National Defence Medical Centre","funders":"","keywords":"Cyclic neutropenia; Neutropenia; Chromosomal inversion; Medicine; Monocytosis; Immunology; Internal medicine; Gastroenterology; Chromosome; Biology; Karyotype; Genetics; Chemotherapy; Bone marrow","score_opus":0.004606163107937626,"score_gpt":0.21488953232984356,"score_spread":0.21028336922190594,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2007356942","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9984804,0.00026214734,0.0003779767,0.00009214867,0.000010848043,0.000015965372,0.000032560907,0.000011930172,0.0007160412],"genre_scores_gemma":[0.998835,0.00017418392,0.0002817307,0.000060999228,0.000020369924,0.000008014538,0.00003190636,0.000004019627,0.0005838096],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.9997646,0.00004331435,0.000019875777,0.00006973333,0.000042720974,0.000059730322],"domain_scores_gemma":[0.99971014,0.00006595616,0.00008167327,0.000022826947,0.000026856169,0.00009262874],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018761415,0.0008071793,0.00042003114,0.00072231103,0.0014594774,0.0002551538,0.0002944174,0.0003556006,0.0015064965],"category_scores_gemma":[0.0008632212,0.00029790137,0.0002870248,0.00043342385,0.00070423883,0.00019044364,0.00051074015,0.00028280524,0.00014654694],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00036093808,0.00021263768,0.37206012,0.00010811621,0.00013208605,0.5693827,0.0048860563,0.00038554822,0.0236925,0.000768336,0.0010626203,0.026948316],"study_design_scores_gemma":[0.00006106433,0.0007669676,0.32656074,0.000024728899,0.0001477845,0.66234297,0.0011728434,0.0007828372,0.004619546,0.00033119178,0.0031313878,0.00005794007],"about_ca_topic_score_codex":0.007954262,"about_ca_topic_score_gemma":0.00827357,"teacher_disagreement_score":0.007954262,"about_ca_system_score_codex":0.0004622014,"about_ca_system_score_gemma":0.00045234044,"threshold_uncertainty_score":0.015815914},"labels":[],"label_agreement":null},{"id":"W2007570437","doi":"10.1111/j.1365-2141.2012.09179.x","title":"Guideline for the diagnosis and management of myelofibrosis","year":2012,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":109,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency; Queen's University","funders":"Wellcome Trust","keywords":"Guideline; Medicine; Myelofibrosis; MEDLINE; Family medicine; Intensive care medicine; Internal medicine; Pathology; Political science","score_opus":0.03466921393699031,"score_gpt":0.32107679877100503,"score_spread":0.28640758483401474,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2007570437","genre_codex":"review","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0041580126,0.5227178,0.0530228,0.21043792,0.029476276,0.015013243,0.017124582,0.0015966637,0.14645278],"genre_scores_gemma":[0.027791547,0.35098886,0.42048362,0.07199683,0.0071959617,0.017490592,0.0433296,0.00037017447,0.06035273],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9903239,0.0031124586,0.0030216996,0.00033119044,0.0028178585,0.0003927856],"domain_scores_gemma":[0.98533773,0.0038539616,0.0016027084,0.00031339325,0.008330409,0.0005618143],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.006793255,0.0013204821,0.002619295,0.005915402,0.0009702972,0.00241998,0.0050595016,0.005818528,0.0063773366],"category_scores_gemma":[0.0210093,0.0010070758,0.0031883402,0.003959174,0.0009762383,0.0017981961,0.0017531477,0.007050781,0.006449807],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009056668,0.00013270383,0.0005866681,0.007987465,0.00012833474,0.00076157704,0.0003324838,0.00078970584,0.0006592151,0.005499765,0.7377592,0.24527226],"study_design_scores_gemma":[0.00024285173,0.00012889321,0.003670279,0.029257858,0.00025559418,0.002371313,0.00012804675,0.000522165,0.00028210974,0.005476223,0.95760125,0.000063370266],"about_ca_topic_score_codex":0.014182449,"about_ca_topic_score_gemma":0.024814209,"teacher_disagreement_score":0.014182449,"about_ca_system_score_codex":0.0038271914,"about_ca_system_score_gemma":0.011911417,"threshold_uncertainty_score":0.03592664},"labels":[],"label_agreement":null},{"id":"W2007713019","doi":"10.1111/bjh.12303","title":"Ticlopidine‐associated <scp>ADAMTS</scp>13 activity deficient thrombotic thrombocytopenic purpura in 22 persons in Japan: a report from the Southern Network on Adverse Reactions (<scp>SONAR</scp>)","year":2013,"lang":"en","type":"letter","venue":"British Journal of Haematology","topic":"Complement system in diseases","field":"Immunology and Microbiology","cited_by":26,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Apheresis Group; London Health Sciences Centre","funders":"Centers for Disease Control and Prevention; National Cancer Institute; National Heart, Lung, and Blood Institute; Takeda Science Foundation","keywords":"ADAMTS13; Thrombotic thrombocytopenic purpura; Ticlopidine; Von Willebrand factor; Medicine; ADAMTS; Microangiopathic hemolytic anemia; Internal medicine; Platelet; Thrombospondin; Immunology; Metalloproteinase; Clopidogrel; Myocardial infarction","score_opus":0.022371537804919666,"score_gpt":0.24378552643378523,"score_spread":0.22141398862886558,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2007713019","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9982316,0.0006820519,0.0001342203,0.00009233734,0.000014650211,0.000024841973,0.00005939733,0.000005408088,0.0007555208],"genre_scores_gemma":[0.9987583,0.00056526164,0.00006190303,0.00014817879,0.000036894366,0.00000945327,0.00011221578,0.0000031095217,0.00030473666],"study_design_codex":"observational","study_design_gemma":"case_report","domain_scores_codex":[0.99961865,0.000050933446,0.00005227284,0.000089994704,0.00008523299,0.00010293442],"domain_scores_gemma":[0.99950695,0.000039177397,0.000114186994,0.00002833162,0.000078117635,0.00023327403],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00029403757,0.0006656776,0.0004467985,0.0008672584,0.0014783794,0.0007358379,0.00032687676,0.0006195112,0.0009717544],"category_scores_gemma":[0.0005478162,0.00069056085,0.00052923727,0.0008565016,0.00052554405,0.00038897965,0.00058051624,0.00051021465,0.00023735406],"study_design_candidate":"case_report","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014577896,0.00015431255,0.94540673,0.000055331668,0.000098479,0.044258274,0.0025165668,0.000037393886,0.0016315646,0.000036554353,0.0005269108,0.005132095],"study_design_scores_gemma":[0.000030809137,0.000277907,0.94577646,0.000022418464,0.00013071978,0.050159037,0.0017802857,0.00010222282,0.000283795,0.000015895175,0.0014006624,0.000019809051],"about_ca_topic_score_codex":0.021706607,"about_ca_topic_score_gemma":0.017622003,"teacher_disagreement_score":0.021706607,"about_ca_system_score_codex":0.000759553,"about_ca_system_score_gemma":0.0006683405,"threshold_uncertainty_score":0.043160558},"labels":[],"label_agreement":null},{"id":"W2007719100","doi":"10.1111/j.1365-2141.2007.06495.x","title":"Absence of cytokine modulation following therapeutic infusion of intravenous immunoglobulin or anti‐red blood cell antibodies in a mouse model of immune thrombocytopenic purpura","year":2007,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval; Héma-Québec","funders":"Canadian Blood Services","keywords":"Immunology; Cytokine; Antibody; Thrombocytopenic purpura; Medicine; Immune system; Proinflammatory cytokine; Immunoglobulin G; Mononuclear phagocyte system; Inflammation","score_opus":0.017259447643849696,"score_gpt":0.27159370250798914,"score_spread":0.25433425486413946,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2007719100","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9910591,0.0022646028,0.003319958,0.00019098897,0.00012781213,0.00014321065,0.00085763476,0.000220304,0.0018163923],"genre_scores_gemma":[0.9920717,0.0013407446,0.0026805722,0.00015417098,0.000045152057,0.00026869593,0.0007567437,0.000029335171,0.002652761],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9994716,0.0001078594,0.00006354051,0.00011129066,0.00012043009,0.00012530491],"domain_scores_gemma":[0.9996086,0.000050343533,0.00014490706,0.00006004332,0.000031402462,0.00010466718],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00035535614,0.0008042676,0.0005740692,0.0006667449,0.0001499955,0.0006063016,0.00034531593,0.00091888715,0.00092487806],"category_scores_gemma":[0.00019080951,0.00025371648,0.0004553582,0.00031186477,0.00045961028,0.00039957365,0.00016720143,0.002130266,0.00043775173],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009993756,0.0005574612,0.00026211038,0.00009793891,0.000015339725,0.00014588945,0.000029325825,0.0001450554,0.99563724,0.00014502827,0.00007667113,0.0018886747],"study_design_scores_gemma":[0.00022142772,0.0068882313,0.0042556655,0.000026880323,0.00007088191,0.0005065078,0.000048600275,0.0016143306,0.98432803,0.000101142534,0.0019275971,0.000010698038],"about_ca_topic_score_codex":0.0002333291,"about_ca_topic_score_gemma":0.0002996209,"teacher_disagreement_score":0.00092487806,"about_ca_system_score_codex":0.00027298517,"about_ca_system_score_gemma":0.00025250166,"threshold_uncertainty_score":0.003094077},"labels":[],"label_agreement":null},{"id":"W2007761452","doi":"10.1046/j.1365-2141.2002.03394.x","title":"Impaired gut function as risk factor for invasive candidiasis in neutropenic patients","year":2002,"lang":"en","type":"review","venue":"British Journal of Haematology","topic":"Oral health in cancer treatment","field":"Medicine","cited_by":42,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Risk factor; Medicine; Function (biology); Neutropenia; Internal medicine; Invasive candidiasis; Intensive care medicine; Oncology; Biology; Dermatology; Antifungal; Chemotherapy; Fluconazole; Genetics","score_opus":0.06718444693364929,"score_gpt":0.3655161815047349,"score_spread":0.29833173457108564,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2007761452","genre_codex":"empirical","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98992795,0.0068039563,0.00010096593,0.0003059813,0.000032035216,0.00001729557,0.00016748204,0.000008514164,0.002635874],"genre_scores_gemma":[0.99868566,0.0008687059,0.000091358655,0.000063989115,0.000027294313,0.000006146602,0.00008726471,0.0000011008098,0.00016859191],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.9997925,0.000051974355,0.00002234168,0.000027857383,0.000050719707,0.000054653894],"domain_scores_gemma":[0.99928266,0.00014394306,0.0003067504,0.000023323426,0.00005477825,0.00018857584],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000271895,0.0002509101,0.0003314508,0.0006079838,0.0004073919,0.0005147043,0.00019032657,0.00045484438,0.0022721933],"category_scores_gemma":[0.0016341326,0.0001282621,0.00029957492,0.0006959759,0.00018206933,0.00035318595,0.00031796226,0.0008531827,0.00017002683],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00022628233,0.000049453436,0.9944435,0.00003656957,0.000029909843,0.0011029651,0.000049393668,0.000027987542,0.0002399983,0.00003717792,0.00021709228,0.0035396696],"study_design_scores_gemma":[0.000011449224,0.0002945144,0.9930583,0.000049436854,0.00007002926,0.005366909,0.00021045086,0.00016612491,0.00007297589,0.00007743199,0.0006156258,0.000006735673],"about_ca_topic_score_codex":0.0008185016,"about_ca_topic_score_gemma":0.0008044427,"teacher_disagreement_score":0.0022721933,"about_ca_system_score_codex":0.00015927659,"about_ca_system_score_gemma":0.0002268988,"threshold_uncertainty_score":0.0076012015},"labels":[],"label_agreement":null},{"id":"W2007794249","doi":"10.1046/j.1365-2141.2000.02098.x","title":"Autologous stem cell transplantation for anaplastic large‐cell lymphomas: results of a prospective trial","year":2000,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":58,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hotel Dieu Hospital","funders":"","keywords":"Medicine; Anaplastic large-cell lymphoma; Internal medicine; Etoposide; Autologous stem-cell transplantation; Transplantation; Melphalan; Large cell; Oncology; Lymphoma; Chemotherapy; Gastroenterology; Chemotherapy regimen; Surgery; Cancer; Adenocarcinoma","score_opus":0.010019238523221258,"score_gpt":0.2515401976893634,"score_spread":0.24152095916614216,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2007794249","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98835015,0.007922802,0.00030309195,0.00070828723,0.00035974974,0.00084490783,0.0004952934,0.000024864028,0.0009909677],"genre_scores_gemma":[0.98999757,0.0043145246,0.0005582039,0.0011765433,0.0004703653,0.0012040945,0.0013586532,0.000013697585,0.00090628373],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.99860674,0.00097103306,0.00008509987,0.0001431617,0.0000935937,0.00010041416],"domain_scores_gemma":[0.9981178,0.00069505256,0.0003390197,0.00020951242,0.000109448265,0.0005292025],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0036078414,0.0008687616,0.0017713635,0.000261029,0.00034898848,0.0012604569,0.00061681605,0.0015425708,0.0026632687],"category_scores_gemma":[0.002156848,0.00028728816,0.0021611422,0.00044046956,0.0011490696,0.00074875186,0.00030846833,0.0022484248,0.0005350298],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9727436,0.0037110602,0.0029672643,0.00033015714,0.0011078286,0.00005325108,0.000051684532,0.0003618729,0.0013051737,0.00013504984,0.00049530494,0.016737742],"study_design_scores_gemma":[0.87393916,0.1139369,0.007642496,0.00010437589,0.0014710098,0.00009228179,0.00003871765,0.0007285239,0.00058592914,0.00031055004,0.0011320321,0.000018001963],"about_ca_topic_score_codex":0.00027539907,"about_ca_topic_score_gemma":0.00040352656,"teacher_disagreement_score":0.0036078414,"about_ca_system_score_codex":0.00051475246,"about_ca_system_score_gemma":0.0006867645,"threshold_uncertainty_score":0.019080281},"labels":[],"label_agreement":null},{"id":"W2007880821","doi":"10.1111/bjh.12199","title":"How I manage priapism due to sickle cell disease","year":2013,"lang":"en","type":"review","venue":"British Journal of Haematology","topic":"Sexual function and dysfunction studies","field":"Medicine","cited_by":43,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"CancerCare Manitoba","funders":"","keywords":"Priapism; Medicine; Intensive care medicine; Erectile dysfunction; Disease; Clinical trial; Internal medicine; Surgery","score_opus":0.05314092594757469,"score_gpt":0.3171925218703542,"score_spread":0.2640515959227795,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2007880821","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000097521,0.99837,0.00005884969,0.000666573,0.00019729772,0.000015068846,0.000013887963,0.0000044277954,0.000576371],"genre_scores_gemma":[0.0010203918,0.99732995,0.000235419,0.0008210409,0.0002024909,0.000020392954,0.000021665228,0.000001622082,0.00034707482],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9995974,0.00014044273,0.000096332406,0.000038958504,0.000100906305,0.000026024176],"domain_scores_gemma":[0.9994972,0.0002861176,0.00011060279,0.000011854767,0.00006562054,0.000028658442],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00076912146,0.00062791776,0.0017149419,0.0019007834,0.0002576399,0.0013622683,0.0009991603,0.0014515948,0.0042910003],"category_scores_gemma":[0.0022046901,0.0002586389,0.0009348366,0.0013475388,0.00041547636,0.0017663486,0.0005781683,0.0015531116,0.0014837902],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014470998,0.00007747185,0.00027329242,0.10342447,0.0004743016,0.00027479022,0.00020045765,0.00015807935,0.00061532453,0.0014441061,0.040366452,0.85254663],"study_design_scores_gemma":[0.00021745678,0.00019928481,0.0028396337,0.11677216,0.0009710037,0.004773314,0.00045865437,0.00011942484,0.00039343073,0.0039978684,0.8692206,0.000037147372],"about_ca_topic_score_codex":0.0015136539,"about_ca_topic_score_gemma":0.0024989815,"teacher_disagreement_score":0.0042910003,"about_ca_system_score_codex":0.00041867496,"about_ca_system_score_gemma":0.0010718033,"threshold_uncertainty_score":0.014354825},"labels":[],"label_agreement":null},{"id":"W2008081777","doi":"10.1111/j.1365-2141.2008.07362.x","title":"MOZ/TIF2‐induced acute myeloid leukaemia in transgenic fish","year":2008,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Epigenetics and DNA Methylation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":76,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Hospital","funders":"Fondation de France; Ligue Contre le Cancer","keywords":"Fusion gene; Biology; Transgene; Cancer research; Myeloid; Zebrafish; Gene; Molecular biology; Genetics","score_opus":0.01630303349721894,"score_gpt":0.2551407057771832,"score_spread":0.23883767227996422,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2008081777","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9636284,0.0005755736,0.023295188,0.00036112237,0.0001335214,0.000514631,0.00338852,0.0010701815,0.007032847],"genre_scores_gemma":[0.9470607,0.00079325674,0.017019954,0.00014756164,0.000028278411,0.0006295573,0.0021304078,0.00035172285,0.031838577],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99972636,0.000020909665,0.00002560838,0.00008054612,0.00008918313,0.000057446905],"domain_scores_gemma":[0.99979347,0.000028455166,0.00007501314,0.000026066793,0.000018936507,0.00005814571],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00025378834,0.00054351834,0.00034241812,0.00091616006,0.00039606701,0.0003117283,0.0005428417,0.0007961596,0.004084325],"category_scores_gemma":[0.00021033284,0.00048181275,0.0005426027,0.00029494448,0.0005842614,0.00031266527,0.00057341246,0.001079864,0.0014244486],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006148011,0.0000106982925,0.0001085722,0.000021336626,0.000004360118,0.0001446086,0.000029356335,0.00007551114,0.998533,0.00034086517,0.00006667604,0.0006034743],"study_design_scores_gemma":[0.00012609079,0.00030294465,0.005201082,0.000017275106,0.00004506251,0.0015881719,0.00005906956,0.0020168216,0.97944766,0.00023373519,0.010936462,0.000025572816],"about_ca_topic_score_codex":0.0034045,"about_ca_topic_score_gemma":0.0057705343,"teacher_disagreement_score":0.004084325,"about_ca_system_score_codex":0.0009279131,"about_ca_system_score_gemma":0.00037991404,"threshold_uncertainty_score":0.013663411},"labels":[],"label_agreement":null},{"id":"W2008411546","doi":"10.1111/j.1365-2141.2012.09176.x","title":"<scp><i>MYD88</i></scp> somatic mutations in <scp>MALT</scp> lymphomas","year":2012,"lang":"en","type":"letter","venue":"British Journal of Haematology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":46,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"Associazione Italiana per la Ricerca sul Cancro; Oncosuisse","keywords":"MALT lymphoma; Mucosa-associated lymphoid tissue; Macroglobulinemia; Cancer research; Lymphoma; Waldenstrom macroglobulinemia; Germline mutation; B cell; Biology; Marginal zone; Chromosomal translocation; Mutation; Immunology; Gene; Genetics; Antibody; Multiple myeloma","score_opus":0.01721686155693252,"score_gpt":0.257928519284201,"score_spread":0.2407116577272685,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2008411546","genre_codex":"empirical","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"editorial","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99053395,0.0016918486,0.0014859871,0.00019123963,0.00003521679,0.00006294127,0.0008768783,0.00011230835,0.005009613],"genre_scores_gemma":[0.9974898,0.0004991243,0.0007972413,0.00009224866,0.00001786556,0.000016457627,0.0004662808,0.000024478171,0.00059642066],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9998185,0.00001990834,0.000021341551,0.000038034294,0.00006960606,0.000032662552],"domain_scores_gemma":[0.9998388,0.000019613142,0.00007750367,0.000012471653,0.00001936561,0.000032274245],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014147043,0.000260647,0.0001925311,0.0005094492,0.000161773,0.0003099006,0.00019658392,0.0004461246,0.0022417137],"category_scores_gemma":[0.00040845954,0.000103498896,0.0002821263,0.00038565605,0.0003499697,0.00014384367,0.00030556094,0.00034754755,0.0008089226],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011130752,0.00008213965,0.11075319,0.00046173713,0.00017110723,0.08371317,0.00038233784,0.0008185458,0.7407486,0.0011143206,0.0044408957,0.056200936],"study_design_scores_gemma":[0.0002139027,0.00040113722,0.46028462,0.0002257708,0.00021143364,0.36776406,0.00041282957,0.002850167,0.12756966,0.0009840013,0.03903612,0.000046221645],"about_ca_topic_score_codex":0.00042423117,"about_ca_topic_score_gemma":0.0004387552,"teacher_disagreement_score":0.0022417137,"about_ca_system_score_codex":0.0002516192,"about_ca_system_score_gemma":0.00009136278,"threshold_uncertainty_score":0.007499218},"labels":[],"label_agreement":null},{"id":"W2008552288","doi":"10.1046/j.1365-2141.2000.02062.x","title":"Leucocyte Depletion Of The Blood Supply – How Will Patients Benefit?","year":2000,"lang":"en","type":"review","venue":"British Journal of Haematology","topic":"Prion Diseases and Protein Misfolding","field":"Biochemistry, Genetics and Molecular Biology","cited_by":46,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Buffy coat; Residual risk; Immunology; Medicine; Hematology; Transmission (telecommunications); Transfusion medicine; Infectivity; Cytomegalovirus; Apheresis; Virology; Disease; Blood transfusion; Platelet; Human immunodeficiency virus (HIV); Internal medicine; Virus; Viral disease; Herpesviridae","score_opus":0.00933888290141784,"score_gpt":0.24342304423973551,"score_spread":0.23408416133831766,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2008552288","genre_codex":"commentary","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.027158141,0.27431703,0.0014536538,0.6708027,0.003989796,0.00011889177,0.00043775578,0.00012444063,0.021597572],"genre_scores_gemma":[0.3551842,0.26599786,0.0056935134,0.33136743,0.023896916,0.00053553976,0.00094234187,0.0001237023,0.016258433],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99891174,0.00061394373,0.00008981107,0.00008283005,0.00017213453,0.00012956967],"domain_scores_gemma":[0.9977514,0.0009445055,0.00035062345,0.00006770697,0.00028644956,0.0005992763],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002645627,0.00024644658,0.0011985662,0.00037338553,0.00053138606,0.0025068317,0.0005481037,0.0027973133,0.00856844],"category_scores_gemma":[0.009488474,0.00012545924,0.00044981771,0.00045962102,0.0008530725,0.0024774782,0.0006901977,0.0023405657,0.0039212494],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0033646922,0.0005291009,0.012363806,0.001965002,0.00031887784,0.0011491734,0.00045634797,0.00028509865,0.0011443701,0.009751346,0.26563922,0.703033],"study_design_scores_gemma":[0.002610808,0.0035766042,0.0286651,0.0101652695,0.00062508683,0.006071625,0.0028239244,0.0005518671,0.0015269355,0.04534562,0.8978674,0.00016976178],"about_ca_topic_score_codex":0.00067231024,"about_ca_topic_score_gemma":0.00096993166,"teacher_disagreement_score":0.00856844,"about_ca_system_score_codex":0.000837088,"about_ca_system_score_gemma":0.00084868015,"threshold_uncertainty_score":0.02866429},"labels":[],"label_agreement":null},{"id":"W2008959642","doi":"10.1046/j.1365-2141.2000.02093.x","title":"A combination of anti‐interleukin 6 murine monoclonal antibody with dexamethasone and high‐dose melphalan induces high complete response rates in advanced multiple myeloma","year":2000,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":88,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hotel Dieu Hospital","funders":"","keywords":"Melphalan; Multiple myeloma; Dexamethasone; Medicine; Monoclonal antibody; Autologous stem-cell transplantation; Regimen; Monoclonal; Combination therapy; Transplantation; Internal medicine; Pharmacology; Immunology; Oncology; Antibody","score_opus":0.018043425714160972,"score_gpt":0.3049105630567748,"score_spread":0.2868671373426138,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2008959642","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99628335,0.002320755,0.00070709275,0.00004589714,0.000023509558,0.00007149468,0.00003816298,0.000029068244,0.00048070608],"genre_scores_gemma":[0.9976445,0.0008777474,0.0009408776,0.000041089457,0.000050113063,0.00004643301,0.00017885234,0.000009141231,0.00021129014],"study_design_codex":"bench_or_experimental","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.99955183,0.00014464147,0.000031553955,0.00007024733,0.000116472234,0.00008532268],"domain_scores_gemma":[0.9996195,0.000101823905,0.00007820023,0.00007222958,0.000021661663,0.00010663617],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005618235,0.00041632858,0.00083991635,0.00037748567,0.00022464908,0.00033331817,0.00039129707,0.00027494732,0.0004403917],"category_scores_gemma":[0.0005257622,0.00020164167,0.00032002875,0.00040423268,0.00041001904,0.00020933189,0.00026820705,0.0009467135,0.00025937628],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.02230642,0.008696413,0.029765733,0.00038691677,0.00052731694,0.0015643013,0.0003602542,0.0030988413,0.76320577,0.00033666875,0.0012053427,0.16854607],"study_design_scores_gemma":[0.01792188,0.26675946,0.16124074,0.000072790834,0.0011573782,0.015409442,0.00017638519,0.0050784317,0.51352626,0.00039426377,0.018171435,0.000091569076],"about_ca_topic_score_codex":0.000340813,"about_ca_topic_score_gemma":0.00093859836,"teacher_disagreement_score":0.00083991635,"about_ca_system_score_codex":0.00024786944,"about_ca_system_score_gemma":0.0002253712,"threshold_uncertainty_score":0.002971232},"labels":[],"label_agreement":null},{"id":"W2010371929","doi":"10.1046/j.1365-2141.2001.03176.x","title":"The −1185 A/G and −1051 G/A dimorphisms in the von Willebrand factor gene promoter and risk of myocardial infarction","year":2001,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":24,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Haplotype; Von Willebrand factor; Medicine; Myocardial infarction; Odds ratio; Internal medicine; Case-control study; Risk factor; Von Willebrand disease; Gastroenterology; Coronary artery disease; Cardiology; Platelet; Endocrinology; Genotype; Gene; Genetics; Biology","score_opus":0.008497404060586028,"score_gpt":0.23667828044883332,"score_spread":0.2281808763882473,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2010371929","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99921167,0.00026523083,0.00012332461,0.00004033973,0.0000062423924,0.0000045601505,0.00005147828,0.0000031391592,0.00029392412],"genre_scores_gemma":[0.9995091,0.00009671178,0.00015041827,0.00003376363,0.000019589947,0.0000039094975,0.00008017443,0.0000018596847,0.00010460518],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9996112,0.00016970518,0.000042175896,0.00008005731,0.000053853426,0.00004301939],"domain_scores_gemma":[0.9990231,0.00032697147,0.0004059195,0.0000649099,0.000042528176,0.00013661821],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003900615,0.00024452872,0.00024843868,0.000595194,0.0001972027,0.00028381436,0.00021562187,0.00039434907,0.0017276313],"category_scores_gemma":[0.0021023343,0.00014757045,0.00020011856,0.0004130361,0.0002945036,0.00011104722,0.00015080505,0.00029195903,0.00022096443],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014018774,0.0001536117,0.9818211,0.000025572888,0.00015728464,0.0005875219,0.00015912273,0.00011106555,0.0084263515,0.0002321304,0.00016939512,0.0067550004],"study_design_scores_gemma":[0.00005803734,0.0003159837,0.9955707,0.000012604835,0.00009804731,0.0021397474,0.00006159411,0.00031820848,0.00064641994,0.00031399657,0.0004581813,0.000006398123],"about_ca_topic_score_codex":0.0009683799,"about_ca_topic_score_gemma":0.00077347737,"teacher_disagreement_score":0.0017276313,"about_ca_system_score_codex":0.000094761424,"about_ca_system_score_gemma":0.000081771504,"threshold_uncertainty_score":0.005779505},"labels":[],"label_agreement":null},{"id":"W2011435372","doi":"10.1111/bjh.13088","title":"Safety and efficacy of thrombopoietin‐receptor agonists in myelodysplastic syndromes: a systematic review and meta‐analysis of randomized controlled trials","year":2014,"lang":"en","type":"review","venue":"British Journal of Haematology","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":56,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Michael's Hospital; Princess Margaret Cancer Centre; University of Toronto; Sunnybrook Health Science Centre; Mount Sinai Hospital","funders":"","keywords":"Romiplostim; Eltrombopag; Medicine; Placebo; Randomized controlled trial; Relative risk; Thrombopoietin receptor; Meta-analysis; Internal medicine; Myelodysplastic syndromes; Thrombopoietin; Confidence interval; Platelet; Bone marrow; Pathology; Haematopoiesis","score_opus":0.053660986097755686,"score_gpt":0.38175215643695076,"score_spread":0.3280911703391951,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2011435372","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.003231987,0.9950524,0.00036775842,0.00017363753,0.00015567825,0.0004124758,0.0003750608,0.000018576899,0.00021249492],"genre_scores_gemma":[0.09523048,0.89954376,0.001826814,0.0009169545,0.00022845164,0.0013138148,0.0006112502,0.00002494381,0.00030351055],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.98999083,0.0047744247,0.0031656264,0.0008108897,0.0010404962,0.00021761618],"domain_scores_gemma":[0.9832306,0.011560662,0.0032821374,0.00041446582,0.0012865212,0.00022564201],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.014668919,0.0027266445,0.02145656,0.006061057,0.00055613846,0.00319435,0.0018520524,0.002209771,0.0033505699],"category_scores_gemma":[0.02731917,0.0014138502,0.02797244,0.0065511432,0.00080562365,0.001595407,0.0012211355,0.0017325224,0.00031700067],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002280125,0.000026450629,0.0011238448,0.5806005,0.40315172,0.00009033756,0.00006426452,0.00037908801,0.00024744277,0.00011190287,0.00051675184,0.011407644],"study_design_scores_gemma":[0.0010991787,0.0002931638,0.0017920821,0.042588584,0.95180905,0.00008469988,0.000039446542,0.0001359219,0.00014396412,0.00017786726,0.0018131096,0.000022993327],"about_ca_topic_score_codex":0.004065104,"about_ca_topic_score_gemma":0.009520152,"teacher_disagreement_score":0.02145656,"about_ca_system_score_codex":0.0025260577,"about_ca_system_score_gemma":0.0035100153,"threshold_uncertainty_score":0.07757765},"labels":[],"label_agreement":null},{"id":"W2012354044","doi":"10.1111/j.1365-2141.2007.06506.x","title":"Pregnancy after bone marrow transplantation in Fanconi anaemia","year":2007,"lang":"en","type":"letter","venue":"British Journal of Haematology","topic":"Prenatal Screening and Diagnostics","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier Universitaire Sainte-Justine","funders":"","keywords":"Medicine; Pregnancy; Fanconi anemia; Savior sibling; Transplantation; Bone marrow failure; Fertility; Haematopoiesis; Bone marrow transplantation; Stem cell; Fertility preservation; Pediatrics; Obstetrics; Gynecology; Hematopoietic stem cell transplantation; Surgery; Population; Biology","score_opus":0.012234155559459482,"score_gpt":0.26020414453170887,"score_spread":0.2479699889722494,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2012354044","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.5568705,0.036466356,0.00839745,0.3099407,0.014516991,0.00023100642,0.00024343474,0.0006440418,0.07268943],"genre_scores_gemma":[0.91668004,0.008915255,0.0013466729,0.053120192,0.012367965,0.00004052343,0.000063445106,0.000043691307,0.007422233],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.9993236,0.0002745071,0.00006595953,0.00007391225,0.00013022203,0.00013173331],"domain_scores_gemma":[0.99769634,0.0014467179,0.00034635802,0.00009844208,0.000111619505,0.00030059137],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008878786,0.0005285688,0.0006186999,0.000653747,0.0012654599,0.00084781775,0.0006098014,0.0072229644,0.0013115729],"category_scores_gemma":[0.0060788533,0.00028744212,0.0005741546,0.0004957318,0.001425182,0.0006507923,0.0005134866,0.0038776041,0.00064605643],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017318221,0.00004372802,0.0044105193,0.00008464046,0.000014905531,0.9750787,0.00031746,0.00017143904,0.0012264126,0.0019144557,0.007966268,0.0085982215],"study_design_scores_gemma":[0.00006253432,0.00018375038,0.0045997505,0.00007870032,0.000024000321,0.98055375,0.0002067179,0.00060418475,0.00089546887,0.0018041178,0.010974607,0.000012376641],"about_ca_topic_score_codex":0.0013008714,"about_ca_topic_score_gemma":0.0018895756,"teacher_disagreement_score":0.0072229644,"about_ca_system_score_codex":0.0015340844,"about_ca_system_score_gemma":0.00043145072,"threshold_uncertainty_score":0.011130631},"labels":[],"label_agreement":null},{"id":"W2012785890","doi":"10.1111/bjh.12451","title":"Autologous haematopoietic cell transplantation for non‐<scp>H</scp>odgkin lymphoma with secondary <scp>CNS</scp> involvement","year":2013,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"CNS Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":31,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Children's Hospital","funders":"National Center for Advancing Translational Sciences; National Cancer Institute; National Heart, Lung, and Blood Institute","keywords":"Medicine; Lymphoma; Internal medicine; Transplantation; Oncology; Autologous stem-cell transplantation; Hematology; Hematopoietic stem cell transplantation; Non-Hodgkin's lymphoma; Haematopoiesis; Immunology; Stem cell; Biology","score_opus":0.008601899706633009,"score_gpt":0.2250511375397899,"score_spread":0.2164492378331569,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2012785890","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99929667,0.00027289937,0.000038514445,0.0000189105,0.000004691939,0.00000450351,0.000030430525,0.0000012423677,0.00033211612],"genre_scores_gemma":[0.9997017,0.000081396705,0.000026647913,0.000018117704,0.000008471819,0.0000025087732,0.00009306421,4.604061e-7,0.00006762287],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.999694,0.00012003981,0.00003075357,0.000037612026,0.00006693959,0.00005068183],"domain_scores_gemma":[0.9991781,0.00021922427,0.00035454586,0.000043846652,0.00003927522,0.00016493119],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004747045,0.00007215161,0.00013129193,0.00021421922,0.00012364841,0.00029693416,0.00013504388,0.00016672717,0.001213659],"category_scores_gemma":[0.0015116984,0.000058422487,0.00014152589,0.00031781892,0.0002293409,0.00017616166,0.00034897437,0.00022755568,0.00027741163],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016673212,0.00011607126,0.9708317,0.00003202922,0.00007140809,0.00053573446,0.00008280538,0.00014900547,0.0009800438,0.000035083343,0.0003247547,0.0251741],"study_design_scores_gemma":[0.00007167454,0.0009330368,0.9954425,0.000015971642,0.000043827476,0.002218619,0.00010053079,0.00026211058,0.00038107744,0.000052249474,0.00047554183,0.0000028880902],"about_ca_topic_score_codex":0.0012830794,"about_ca_topic_score_gemma":0.0021826634,"teacher_disagreement_score":0.0012830794,"about_ca_system_score_codex":0.00030150727,"about_ca_system_score_gemma":0.00021069213,"threshold_uncertainty_score":0.004060149},"labels":[],"label_agreement":null},{"id":"W2013079949","doi":"10.1046/j.1365-2141.2003.04333.x","title":"Six Characters in Search of An Author: The History of the Nomenclature of Coagulation Factors","year":2003,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Coagulation, Bradykinin, Polyphosphates, and Angioedema","field":"Medicine","cited_by":57,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"U.S. Public Health Service; Ryerson University","keywords":"Nomenclature; Coagulation; Medicine; Internal medicine; Biology; Taxonomy (biology); Zoology","score_opus":0.029392037531131513,"score_gpt":0.2740248050317564,"score_spread":0.2446327675006249,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2013079949","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0010651175,0.55875623,0.0035075913,0.24459383,0.1592561,0.000016866481,0.00009793316,0.00015240771,0.03255399],"genre_scores_gemma":[0.048806585,0.35439804,0.010003629,0.20197228,0.28342023,0.00014845967,0.0003566995,0.00076877023,0.10012528],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9947625,0.0027965952,0.00046017393,0.00064658263,0.0010831289,0.0002510122],"domain_scores_gemma":[0.98903394,0.0065150107,0.00056818104,0.00043089152,0.0022454471,0.0012065006],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0049311696,0.0012701863,0.001125253,0.0037463456,0.004302189,0.007165207,0.0014808655,0.0033401134,0.004780292],"category_scores_gemma":[0.016095638,0.0005629325,0.0005425572,0.003338644,0.010128944,0.011698885,0.0033173442,0.011862205,0.0053738425],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010125873,0.000019895357,0.0004503357,0.00031567627,0.0000121132425,0.00032079744,0.0052080774,0.000048598693,0.00022965606,0.056925897,0.8647799,0.07158785],"study_design_scores_gemma":[0.0000039264564,0.000012195554,0.00015955279,0.00039863746,0.0000040483915,0.00047669132,0.0006029125,0.000032857948,0.000048812977,0.0066479477,0.991601,0.0000114960085],"about_ca_topic_score_codex":0.0024691373,"about_ca_topic_score_gemma":0.0037403211,"teacher_disagreement_score":0.007165207,"about_ca_system_score_codex":0.0025593427,"about_ca_system_score_gemma":0.003113642,"threshold_uncertainty_score":0.02607882},"labels":[],"label_agreement":null},{"id":"W2013230705","doi":"10.1111/bjh.12248","title":"Multiple osteochondromas following irradiation‐containing conditioning in severe combined immunodeficiency","year":2013,"lang":"en","type":"letter","venue":"British Journal of Haematology","topic":"Bone Tumor Diagnosis and Treatments","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"SickKids Foundation; Hospital for Sick Children; University of Toronto","funders":"","keywords":"Medicine; Immune dysregulation; Total body irradiation; Severe combined immunodeficiency; Immunodeficiency; Wiskott–Aldrich syndrome; Population; Failure to thrive; Bone marrow; Pathology; Immunology; Internal medicine; Immune system; Chemotherapy; Cyclophosphamide","score_opus":0.013160400645741107,"score_gpt":0.24647362767544992,"score_spread":0.2333132270297088,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2013230705","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9918283,0.0038812652,0.0005101962,0.00016501558,0.00002214499,0.00006679986,0.00010836052,0.00003841536,0.003379543],"genre_scores_gemma":[0.99864227,0.0005951696,0.0001601051,0.00006761817,0.000016269038,0.0000072466228,0.000087348,0.0000033419053,0.00042062727],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.9997868,0.00002660148,0.000021492791,0.000042975604,0.000067802604,0.000054325323],"domain_scores_gemma":[0.9995517,0.00007016243,0.00019563644,0.000026492651,0.000039849227,0.00011616007],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002945671,0.00039359977,0.00036877135,0.0008742977,0.00045297624,0.00028741884,0.0002602723,0.0005707045,0.0012182659],"category_scores_gemma":[0.000667022,0.00018804579,0.00042056316,0.0005155121,0.00063161354,0.00019757403,0.00039881695,0.0005727641,0.00017893974],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002230068,0.0002775477,0.27432975,0.0003013565,0.000206015,0.59165955,0.0005582054,0.0005187736,0.09641688,0.00046217843,0.00066124497,0.032378443],"study_design_scores_gemma":[0.00009874245,0.001033014,0.36456004,0.00008793197,0.00022004312,0.62294745,0.00017692584,0.00060733897,0.0073825726,0.0002919076,0.0025716082,0.000022461314],"about_ca_topic_score_codex":0.002807239,"about_ca_topic_score_gemma":0.003783694,"teacher_disagreement_score":0.002807239,"about_ca_system_score_codex":0.0005586756,"about_ca_system_score_gemma":0.00033631723,"threshold_uncertainty_score":0.005581856},"labels":[],"label_agreement":null},{"id":"W2014089652","doi":"10.1111/j.1365-2141.2004.04996.x","title":"Correlation of <i>TACC3, FGFR3, MMSET</i> and <i>p21</i> expression with the t(4;14)(p16·3;q32) in multiple myeloma","year":2004,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":40,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Queen's University; Queen's University Belfast","keywords":"Chromosomal translocation; Multiple myeloma; Breakpoint; Gene; Polymerase chain reaction; Gene expression; Fusion gene; Medicine; Biology; Cancer research; Internal medicine; Genetics","score_opus":0.013295273796492525,"score_gpt":0.25969547780080554,"score_spread":0.246400204004313,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2014089652","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99947554,0.00016935478,0.00010615127,0.0000137562065,0.0000026391872,0.0000025869097,0.000060971557,0.0000061497044,0.00016287203],"genre_scores_gemma":[0.9996111,0.000056517296,0.000100219,0.000007797152,0.000007763154,0.000005212835,0.00009827994,0.0000018488553,0.00011134568],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99973446,0.00004847062,0.000030183934,0.00007938851,0.00005801013,0.00004943496],"domain_scores_gemma":[0.9994554,0.00016189685,0.00018146532,0.000043826665,0.000078167635,0.00007926514],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00028905392,0.00017495306,0.00021523245,0.0007746267,0.00030206487,0.0004280762,0.00017366548,0.00033014422,0.00089256844],"category_scores_gemma":[0.0012157393,0.00019814282,0.00013412234,0.00049186556,0.0003607487,0.00013965738,0.00017877994,0.0003038661,0.00023222869],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00056524656,0.00002374941,0.97237015,0.000014624305,0.000035086767,0.0006579921,0.00009625145,0.00012666479,0.021441365,0.000019958425,0.00014076798,0.0045082155],"study_design_scores_gemma":[0.000010610069,0.0002157623,0.99036753,0.0000025439235,0.000040405906,0.0038028401,0.00009461865,0.0004346377,0.0045448565,0.000038965667,0.00044044017,0.000006776877],"about_ca_topic_score_codex":0.0017535791,"about_ca_topic_score_gemma":0.0012700423,"teacher_disagreement_score":0.0017535791,"about_ca_system_score_codex":0.00023829598,"about_ca_system_score_gemma":0.00014532545,"threshold_uncertainty_score":0.0034867525},"labels":[],"label_agreement":null},{"id":"W2014717400","doi":"10.1046/j.1365-2141.2001.02962.x","title":"Henry Bence Jones – physician, chemist, scientist and biographer: A man for all seasons","year":2001,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"National Cancer Institute; National Institutes of Health","keywords":"Chemist; Bence Jones protein; Medicine; Chemistry; Immunology; Organic chemistry","score_opus":0.022731071670530404,"score_gpt":0.3205165059369347,"score_spread":0.2977854342664043,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2014717400","genre_codex":"commentary","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00045616413,0.11716393,0.00035144703,0.46404004,0.39037538,0.000052695967,0.00014521765,0.00030541833,0.027109709],"genre_scores_gemma":[0.007149897,0.06897008,0.00063386303,0.35597706,0.22665633,0.00010917377,0.00020349733,0.0003162635,0.33998388],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9975237,0.00033728668,0.0001180085,0.00039303734,0.0013012326,0.000326734],"domain_scores_gemma":[0.987536,0.0010223615,0.00051172375,0.0003647249,0.00480306,0.005762078],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0019773995,0.0014518582,0.0016318696,0.0019514647,0.0029748303,0.005006601,0.0014254438,0.0049766274,0.046363432],"category_scores_gemma":[0.015825223,0.00055360753,0.0005087165,0.001057004,0.0016582824,0.0041167736,0.0030584098,0.009897036,0.042468138],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000028708373,0.000004316358,0.00005332353,0.000025457932,0.0000012465896,0.00006450437,0.000033823333,0.000003928523,0.000019806417,0.00014230366,0.99379706,0.0058512804],"study_design_scores_gemma":[0.0000034595678,0.0000079564325,0.00028893864,0.0001563167,0.0000019404806,0.00068877224,0.00015293581,0.00001232615,0.000015148373,0.00013857006,0.99852645,0.0000071481836],"about_ca_topic_score_codex":0.010716528,"about_ca_topic_score_gemma":0.017024038,"teacher_disagreement_score":0.046363432,"about_ca_system_score_codex":0.0040466436,"about_ca_system_score_gemma":0.0054710256,"threshold_uncertainty_score":0.15510118},"labels":[],"label_agreement":null},{"id":"W2015701553","doi":"10.1111/j.1365-2141.2007.06649.x","title":"Aberrant nuclear p53 protein expression detected by immunohistochemistry is associated with hemizygous <i>P53</i> deletion and poor survival for multiple myeloma","year":2007,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":45,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University Health Network","funders":"Leukemia and Lymphoma Research; Cancer Research Society","keywords":"Immunohistochemistry; Fluorescence in situ hybridization; Multiple myeloma; Biology; Nuclear protein; Cancer research; Pathology; Internal medicine; Gene; Medicine; Transcription factor; Immunology; Genetics","score_opus":0.010967042469762468,"score_gpt":0.2638467855076395,"score_spread":0.252879743037877,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2015701553","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99938476,0.00029784313,0.00016072993,0.000014125519,0.0000011993848,0.0000012416019,0.0000119374945,0.00000372625,0.00012444684],"genre_scores_gemma":[0.9997136,0.00010940016,0.00010793172,0.00000591696,0.0000034413079,0.0000010344728,0.000021490747,0.0000010085741,0.000036110385],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99984276,0.000044105003,0.0000177091,0.0000314239,0.00003445715,0.000029422661],"domain_scores_gemma":[0.99901783,0.00031395414,0.0004792601,0.00004693554,0.00005252773,0.00008956126],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00030820374,0.0001952293,0.0001862524,0.00048952387,0.00014235596,0.00021281022,0.0001263562,0.000218697,0.0006872735],"category_scores_gemma":[0.001056858,0.0001659413,0.00009673286,0.00030664715,0.00042181325,0.00015600794,0.00015967515,0.000255385,0.00012926842],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00052210165,0.000035810754,0.9442359,0.000019881945,0.000043516833,0.0011035166,0.000069033085,0.00012036624,0.048620496,0.000024390763,0.00007297769,0.0051320344],"study_design_scores_gemma":[0.000011646597,0.00022727431,0.98663855,0.0000038947164,0.000044162243,0.007569304,0.000070726026,0.00042997173,0.0047361804,0.00005436449,0.00020935194,0.000004663108],"about_ca_topic_score_codex":0.00068100396,"about_ca_topic_score_gemma":0.0008572192,"teacher_disagreement_score":0.0006872735,"about_ca_system_score_codex":0.0001409543,"about_ca_system_score_gemma":0.00007241361,"threshold_uncertainty_score":0.00229913},"labels":[],"label_agreement":null},{"id":"W2016466547","doi":"10.1046/j.1365-2141.2000.01950.x","title":"Low prevalence of chronic hepatitis C virus infection in B‐cell non‐Hodgkin's lymphoma patients from a population with a high prevalence of healthy Hepatitis c virus carriers","year":2000,"lang":"en","type":"letter","venue":"British Journal of Haematology","topic":"Viral-associated cancers and disorders","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Hepatitis C virus; Population; Immunology; Lymphoma; Hepatitis C; Asymptomatic; Lymphoproliferative disorders; Virology; Virus; Internal medicine","score_opus":0.004974546936898927,"score_gpt":0.2252995049284209,"score_spread":0.220324957991522,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2016466547","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.999185,0.00023555814,0.00002980508,0.000025486344,0.000004142228,0.0000077298655,0.00009582107,0.0000040296304,0.00041239182],"genre_scores_gemma":[0.9995431,0.000092933544,0.00003310028,0.000043725635,0.000018024995,0.000008248636,0.00014827387,0.0000020844484,0.00011059363],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99949133,0.000109980094,0.00007094121,0.0001318332,0.000100040656,0.00009579918],"domain_scores_gemma":[0.99890256,0.00017029408,0.0003598196,0.00007743205,0.00015462423,0.00033517246],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00042628363,0.0002972222,0.00054328196,0.0019314232,0.0007459032,0.0013378826,0.0003692056,0.00063190015,0.0020900907],"category_scores_gemma":[0.0019512976,0.00025987034,0.00020498422,0.0008740616,0.0005178536,0.00059028744,0.0005872645,0.00037688622,0.0005341491],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011867835,0.00006209645,0.99661297,0.000016064048,0.000029472658,0.00022157154,0.0003725679,0.00000932746,0.0010117285,0.0000105132,0.000070668604,0.0014642772],"study_design_scores_gemma":[0.000007408927,0.000093171155,0.99892235,0.000004709015,0.000010955576,0.0005094782,0.00024280095,0.000028431754,0.00003863456,0.000008530543,0.00013055827,0.0000030520873],"about_ca_topic_score_codex":0.005552902,"about_ca_topic_score_gemma":0.004401387,"teacher_disagreement_score":0.005552902,"about_ca_system_score_codex":0.0003659757,"about_ca_system_score_gemma":0.00035840913,"threshold_uncertainty_score":0.011041105},"labels":[],"label_agreement":null},{"id":"W2016490813","doi":"10.1111/j.1365-2141.2007.06643.x","title":"The linear effects of <i>α</i>‐thalassaemia, the <i>UGT1A1</i> and <i>HMOX1</i> polymorphisms on cholelithiasis in sickle cell disease","year":2007,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Neonatal Health and Biochemistry","field":"Medicine","cited_by":82,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Thomas Hospital","funders":"Medical Research Council","keywords":"Gallstones; Bilirubin; Internal medicine; HMOX1; Genotype; Glucuronosyltransferase; Endocrinology; Biology; Unconjugated hyperbilirubinemia; Gastroenterology; Medicine; Heme; Gene; Heme oxygenase; Genetics; Enzyme; Biochemistry","score_opus":0.0038476320325057656,"score_gpt":0.24390715270320387,"score_spread":0.2400595206706981,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2016490813","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9993869,0.00021178597,0.00013273326,0.000028176175,0.0000039085835,0.0000016006488,0.000052876003,0.0000034489872,0.00017844561],"genre_scores_gemma":[0.99961805,0.000048184083,0.00012352783,0.000010221561,0.0000071867335,0.0000018145175,0.00005393305,0.0000024696812,0.00013462467],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99932384,0.00042050672,0.000032894037,0.000117533695,0.00005199366,0.000053271644],"domain_scores_gemma":[0.99667954,0.0019064628,0.00061570667,0.00027735063,0.0001647161,0.0003563379],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007790438,0.0003198415,0.00020800167,0.00034226963,0.00017274063,0.00031496963,0.00019999497,0.00024015327,0.0018823901],"category_scores_gemma":[0.0029028503,0.00019858635,0.00064662565,0.00027236462,0.0003840897,0.00013231751,0.00020284552,0.0003995573,0.00019330936],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0021420047,0.000044996443,0.9880625,0.000009928943,0.00034141884,0.00013576429,0.00006891803,0.0003002157,0.0055962782,0.00003675996,0.00007000627,0.003191319],"study_design_scores_gemma":[0.000023739649,0.00039071104,0.9972849,0.0000045951233,0.00021518947,0.00027860445,0.000028294688,0.0009284225,0.00066767505,0.00006118236,0.000112626076,0.000004135156],"about_ca_topic_score_codex":0.0036947043,"about_ca_topic_score_gemma":0.0031083787,"teacher_disagreement_score":0.0036947043,"about_ca_system_score_codex":0.00019975008,"about_ca_system_score_gemma":0.00023478948,"threshold_uncertainty_score":0.0073463917},"labels":[],"label_agreement":null},{"id":"W2016812202","doi":"10.1111/bjh.12620","title":"Activated prothrombin complex concentrate for dabigatran‐associated bleeding","year":2013,"lang":"en","type":"letter","venue":"British Journal of Haematology","topic":"Atrial Fibrillation Management and Outcomes","field":"Medicine","cited_by":55,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Alberta; McMaster University","funders":"","keywords":"Dabigatran; Prothrombin complex concentrate; Medicine; Internal medicine; PROTHROMBIN COMPLEX; Gastroenterology; Warfarin; Coagulation; Atrial fibrillation","score_opus":0.10344261414363952,"score_gpt":0.33750554170602143,"score_spread":0.2340629275623819,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2016812202","genre_codex":"empirical","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8470465,0.11202928,0.012293702,0.005138377,0.0005933073,0.0006187943,0.00019280882,0.00029884977,0.021788342],"genre_scores_gemma":[0.9798331,0.011715468,0.0033257545,0.0011452392,0.00020445441,0.000042113163,0.00022022538,0.000020550757,0.0034931456],"study_design_codex":"design_other","study_design_gemma":"case_report","domain_scores_codex":[0.9999175,0.000014473323,0.0000078155945,0.000009655676,0.000032914268,0.000017545204],"domain_scores_gemma":[0.9999125,0.000016576914,0.0000142772515,0.000007866036,0.000012811515,0.000035960198],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011269653,0.00023615902,0.00025628044,0.00036480353,0.0003122816,0.00023914083,0.00027128495,0.00029101333,0.0018609131],"category_scores_gemma":[0.0003944912,0.000084741194,0.00020562435,0.000246058,0.00022581345,0.00013063631,0.00014506862,0.0005499607,0.0006827146],"study_design_candidate":"case_report","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0038089016,0.0014018902,0.07244806,0.0014324537,0.0003420737,0.15304962,0.00075845915,0.0005127923,0.14201601,0.0026330692,0.020386528,0.6012101],"study_design_scores_gemma":[0.002811182,0.013962403,0.2759814,0.00047651376,0.00057387224,0.4481369,0.0004117273,0.0022208237,0.05658485,0.0016691918,0.19710332,0.00006779032],"about_ca_topic_score_codex":0.0036377644,"about_ca_topic_score_gemma":0.008173049,"teacher_disagreement_score":0.0036377644,"about_ca_system_score_codex":0.0006242055,"about_ca_system_score_gemma":0.0006320239,"threshold_uncertainty_score":0.0072332025},"labels":[],"label_agreement":null},{"id":"W2016969352","doi":"10.1111/j.1365-2141.2005.05576.x","title":"Factors predicting development of chronic disease in Nordic children with acute onset of idiopathic thrombocytopenic purpura","year":2005,"lang":"en","type":"letter","venue":"British Journal of Haematology","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Prospective cohort study; Disease; Thrombocytopenic purpura; Cohort; Autoantibody; Platelet; Pediatrics; Immunology; Internal medicine; Antibody","score_opus":0.01525597533152777,"score_gpt":0.2585459557642339,"score_spread":0.2432899804327061,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2016969352","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9988613,0.0005978071,0.000050419778,0.000029054518,0.0000067977303,0.000007710982,0.00015616436,0.0000011540332,0.00028956003],"genre_scores_gemma":[0.9990828,0.00029514002,0.0001363801,0.000020962609,0.0000074432,0.00000887589,0.00031387215,0.0000017383014,0.00013292047],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99960285,0.0001018531,0.000058040674,0.0000705057,0.00006910673,0.00009761387],"domain_scores_gemma":[0.9980919,0.00033099807,0.0008766817,0.000078015146,0.0002048803,0.00041753746],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00063947414,0.00042937975,0.0005414021,0.0008469696,0.0005274392,0.00076647353,0.00030117863,0.00072433794,0.0009514055],"category_scores_gemma":[0.0018683625,0.00033557846,0.00055500073,0.0009851289,0.00040254433,0.0004316046,0.0004049402,0.0007888509,0.00013174467],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000078696605,0.000019631438,0.9990113,0.00000843392,0.000020112802,0.00021590474,0.00007416059,0.000019632447,0.00019674725,0.000008968303,0.000032086144,0.0003142753],"study_design_scores_gemma":[0.0000089086825,0.00013017835,0.9986702,0.000012112492,0.000023053326,0.0007098508,0.00018520576,0.000054734086,0.00004434239,0.000008452737,0.00015007218,0.000002734166],"about_ca_topic_score_codex":0.016891664,"about_ca_topic_score_gemma":0.017602807,"teacher_disagreement_score":0.016891664,"about_ca_system_score_codex":0.00041968952,"about_ca_system_score_gemma":0.00061250763,"threshold_uncertainty_score":0.03358668},"labels":[],"label_agreement":null},{"id":"W2017608397","doi":"10.1111/j.1365-2141.2008.07042.x","title":"Cytogenetic abnormalities and clinical correlations in peripheral T‐cell lymphoma","year":2008,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":101,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"","keywords":"Peripheral T-cell lymphoma; Lymphoma; Anaplastic large-cell lymphoma; Anaplastic lymphoma kinase; T-cell lymphoma; Medicine; Internal medicine; Pathology; Angioimmunoblastic T-cell lymphoma; Not Otherwise Specified; Karyotype; Cytogenetics; Oncology; T cell; Biology; Immunology; Chromosome; Genetics","score_opus":0.02616071682398868,"score_gpt":0.2891621206018354,"score_spread":0.2630014037778467,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2017608397","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99830234,0.0007912448,0.00018409893,0.000021899443,0.0000036116044,0.0000051185766,0.000075535245,0.000010778559,0.00060534966],"genre_scores_gemma":[0.99951506,0.00019824528,0.00011253195,0.000008522988,0.000008665308,0.000003830472,0.00008366836,0.0000019059225,0.000067519584],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9996871,0.00007723353,0.00004736619,0.000071626004,0.0000786414,0.000038079448],"domain_scores_gemma":[0.9983265,0.00065022014,0.00053206837,0.000104373554,0.00022312846,0.0001637429],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004167471,0.00017869199,0.00019512768,0.0014982461,0.00015466394,0.0002895664,0.00018538725,0.00026775993,0.0011879972],"category_scores_gemma":[0.0028569715,0.00012869663,0.00010158672,0.0009130877,0.0004404822,0.0002491211,0.0002602497,0.00021143856,0.00022596528],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00045702906,0.0000152434195,0.9745892,0.000036832607,0.000029348828,0.0029297806,0.0001257099,0.00019114785,0.007502195,0.000049478018,0.00012017089,0.013953928],"study_design_scores_gemma":[0.000022685059,0.0002769664,0.9743749,0.00001198351,0.000053708874,0.022376925,0.00016685546,0.000455737,0.0015447261,0.000100184196,0.00060579076,0.000009595736],"about_ca_topic_score_codex":0.0008340048,"about_ca_topic_score_gemma":0.0008739271,"teacher_disagreement_score":0.0014982461,"about_ca_system_score_codex":0.00019366393,"about_ca_system_score_gemma":0.00015609514,"threshold_uncertainty_score":0.0039743185},"labels":[],"label_agreement":null},{"id":"W2018244566","doi":"10.1111/j.1365-2141.2008.07381.x","title":"Striking bone marrow plasmacytosis in a patient with sickle cell anaemia","year":2008,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St Mary's Hospital Centre","funders":"","keywords":"Medicine; Bone marrow; Pathology; Pancytopenia; Gastroenterology; Internal medicine","score_opus":0.0071577117922863994,"score_gpt":0.20473003272391382,"score_spread":0.19757232093162744,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2018244566","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98539793,0.004395827,0.0010092473,0.0015443797,0.00020955983,0.000109892375,0.00030206732,0.000124117,0.006906887],"genre_scores_gemma":[0.99793494,0.0007471745,0.00025184825,0.00039456438,0.00021477723,0.000008753668,0.00008100542,0.0000097685615,0.0003572365],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.9996668,0.000046109708,0.00003536345,0.00007803742,0.00006550924,0.00010811364],"domain_scores_gemma":[0.9993837,0.00017938399,0.000093837385,0.00002856169,0.000052704305,0.0002617777],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00031045152,0.0012152108,0.00093352946,0.0019016855,0.0014155807,0.000846233,0.0005474331,0.0022833834,0.0025086936],"category_scores_gemma":[0.0018828803,0.00065682374,0.00048206333,0.0008491085,0.00059235276,0.00071343116,0.000711995,0.0012893025,0.00067964755],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011990972,0.000026762185,0.020293007,0.000048290975,0.0000141758055,0.97573733,0.00024465035,0.00006020987,0.0017284867,0.000084456704,0.00032280482,0.001319969],"study_design_scores_gemma":[0.00003958545,0.00024463073,0.02789494,0.000035782978,0.000032912303,0.9695114,0.00016826311,0.00031473304,0.00047990622,0.0001710965,0.0010934339,0.000013322194],"about_ca_topic_score_codex":0.0013651015,"about_ca_topic_score_gemma":0.0017907328,"teacher_disagreement_score":0.0025086936,"about_ca_system_score_codex":0.00060806755,"about_ca_system_score_gemma":0.00038065488,"threshold_uncertainty_score":0.008392453},"labels":[],"label_agreement":null},{"id":"W2019016630","doi":"10.1111/j.1365-2141.2005.05633.x","title":"<i>Viscum album</i> agglutinin‐I induces apoptosis and degradation of cytoskeletal proteins via caspases in human leukaemia eosinophil AML14.3D10 cells: differences with purified human eosinophils","year":2005,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Toxin Mechanisms and Immunotoxins","field":"Immunology and Microbiology","cited_by":23,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institut National de la Recherche Scientifique","funders":"Natural Sciences and Engineering Research Council of Canada; Canadian Institutes of Health Research","keywords":"Apoptosis; Biology; Caspase; Gelsolin; Cell biology; Eosinophil; Inhibitor of apoptosis domain; Programmed cell death; Molecular biology; Immunology; Biochemistry; Actin","score_opus":0.011763441451814408,"score_gpt":0.22529496941808788,"score_spread":0.21353152796627348,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2019016630","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9945058,0.0016652548,0.0014638954,0.00015775113,0.00003730207,0.000037190144,0.0007583216,0.00003776525,0.0013367402],"genre_scores_gemma":[0.99219185,0.0011916086,0.0018380518,0.000104547566,0.000014686502,0.000067798006,0.0023813485,0.0000139724025,0.0021962398],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99984,0.000027895394,0.000027932263,0.000029062941,0.00004032205,0.000034873003],"domain_scores_gemma":[0.9999523,0.000008645084,0.000011565079,0.0000075645617,0.000008110878,0.000011750552],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000113022186,0.0002575532,0.00021104982,0.00014251703,0.00012700463,0.0002962377,0.00013408615,0.00028146594,0.0011685782],"category_scores_gemma":[0.00008531062,0.000102527985,0.00034794785,0.0001697984,0.00013207094,0.00021437427,0.00010006877,0.0005773093,0.00044865097],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00022388154,0.000045648598,0.0002718877,0.000034034856,0.000007742973,0.000070749076,0.00001661432,0.00003189735,0.9984408,0.000056501325,0.00004155639,0.0007586574],"study_design_scores_gemma":[0.00007085659,0.0005764208,0.011330511,0.000005630621,0.000024248857,0.0006153983,0.000042149917,0.00083331176,0.9834183,0.00004220868,0.0030361328,0.0000048309466],"about_ca_topic_score_codex":0.00062382425,"about_ca_topic_score_gemma":0.0007993798,"teacher_disagreement_score":0.0011685782,"about_ca_system_score_codex":0.00022924843,"about_ca_system_score_gemma":0.00013247911,"threshold_uncertainty_score":0.00390929},"labels":[],"label_agreement":null},{"id":"W2019239152","doi":"10.1111/j.1365-2141.2009.07790.x","title":"Common genetic variants in candidate genes and risk of familial lymphoid malignancies","year":2009,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":45,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Institutes of Health; McMaster University","keywords":"Chronic lymphocytic leukemia; Genetics; Biology; Germline; Allele; Lymphoma; Gene; Single-nucleotide polymorphism; Immunology; Family aggregation; Leukemia; Medicine; Genotype; Disease; Internal medicine","score_opus":0.010635021783382229,"score_gpt":0.27334576001617544,"score_spread":0.26271073823279323,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2019239152","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99876547,0.0005749477,0.00024115865,0.000045864555,0.000005439509,0.0000036373635,0.00009365546,0.0000071311138,0.00026267726],"genre_scores_gemma":[0.99947363,0.00012488557,0.00019585318,0.000014148792,0.000011372713,0.0000036363344,0.00008039063,0.0000022420204,0.00009383499],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9993494,0.00020399131,0.000070654874,0.00019492405,0.000100799436,0.00008022571],"domain_scores_gemma":[0.99856406,0.0006692833,0.00045790346,0.00010252649,0.00006312884,0.00014313456],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00070590054,0.0003403839,0.0003542139,0.0013280724,0.00038559738,0.00037683686,0.00027389658,0.00058943516,0.0025916744],"category_scores_gemma":[0.0028666637,0.0001766476,0.00041378423,0.0014270528,0.00044679746,0.00016911783,0.00028928608,0.0002806069,0.0001508475],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006248045,0.000053899563,0.9795928,0.00004383717,0.00039792067,0.0033746024,0.0002569066,0.00034648456,0.008308792,0.00025723022,0.00020215663,0.0065405588],"study_design_scores_gemma":[0.00004742083,0.0001678198,0.9912273,0.000024955367,0.00020149421,0.005678757,0.00015757456,0.0006583582,0.00085777463,0.0004964535,0.00047249132,0.000009461634],"about_ca_topic_score_codex":0.002261327,"about_ca_topic_score_gemma":0.0027881002,"teacher_disagreement_score":0.0025916744,"about_ca_system_score_codex":0.00019170073,"about_ca_system_score_gemma":0.00019649752,"threshold_uncertainty_score":0.008669972},"labels":[],"label_agreement":null},{"id":"W2019760292","doi":"10.1046/j.1365-2141.2002.03524.x","title":"Two new molecular bases for the Dombrock null phenotype","year":2002,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Blood groups and transfusion","field":"Medicine","cited_by":24,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Blood Services","funders":"National Heart, Lung, and Blood Institute; National Institutes of Health","keywords":"Proband; Exon; Genetics; Phenotype; Nonsense mutation; Mutation; Biology; Null allele; Molecular biology; Nonsense; Gene; Missense mutation","score_opus":0.01984605660688836,"score_gpt":0.26159780919677533,"score_spread":0.24175175258988696,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2019760292","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9890977,0.00094603875,0.00400469,0.00063004624,0.00015198557,0.000045753266,0.00044695547,0.00012887867,0.0045478595],"genre_scores_gemma":[0.9935284,0.0004056727,0.00359425,0.00024940903,0.00006086443,0.000032922133,0.0003926311,0.00003334278,0.0017024713],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9997876,0.000030532443,0.00002571705,0.000059045822,0.000050149116,0.000046912795],"domain_scores_gemma":[0.9993988,0.00016882544,0.00015964344,0.00005776677,0.000048437898,0.00016638821],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016178736,0.000599593,0.0003887398,0.0009592259,0.00038789652,0.00044386092,0.0006175843,0.0014330804,0.0031966844],"category_scores_gemma":[0.0008614817,0.0002096247,0.00026991576,0.00024644236,0.0007526905,0.00033203748,0.00053573947,0.0007400577,0.0005371786],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00085634284,0.00022978033,0.015988816,0.00015110607,0.00003615895,0.032729756,0.00038023165,0.00030541327,0.92647207,0.011109142,0.00071342266,0.011027684],"study_design_scores_gemma":[0.0007330991,0.0014406511,0.19199614,0.00024053709,0.00028850362,0.23653562,0.0009824659,0.0045812363,0.48800883,0.021081489,0.053880215,0.00023133021],"about_ca_topic_score_codex":0.00036205276,"about_ca_topic_score_gemma":0.0003503973,"teacher_disagreement_score":0.0031966844,"about_ca_system_score_codex":0.00020848018,"about_ca_system_score_gemma":0.00025101105,"threshold_uncertainty_score":0.010693967},"labels":[],"label_agreement":null},{"id":"W2020198050","doi":"10.1046/j.1365-2141.2002.3242_2.x","title":"THE USE OF ORAL VITAMIN K FOR REVERSAL OF OVER‐WARFARINIZATION","year":2002,"lang":"en","type":"letter","venue":"British Journal of Haematology","topic":"Atrial Fibrillation Management and Outcomes","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Warfarin; Medicine; Oral anticoagulant; Vitamin k; Vitamin; Dosing; Route of administration; Oral administration; Internal medicine; Surgery; Atrial fibrillation","score_opus":0.12578546430776633,"score_gpt":0.3273402323763966,"score_spread":0.20155476806863026,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2020198050","genre_codex":"empirical","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.5610435,0.4205323,0.0028617114,0.0021595482,0.0007690001,0.00012105565,0.00014868872,0.00012045302,0.012243758],"genre_scores_gemma":[0.9339168,0.061134044,0.0017261443,0.0007103674,0.00020503583,0.000027880815,0.00012606643,0.000018681005,0.0021348828],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9993824,0.00018901889,0.000100950914,0.00010010782,0.00017054006,0.00005705424],"domain_scores_gemma":[0.99906665,0.00038333208,0.0002849489,0.00011512681,0.000080167,0.00006974927],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00063548615,0.00023519457,0.00057670707,0.000526648,0.0002611836,0.0006476809,0.00037850256,0.0004140492,0.0019057392],"category_scores_gemma":[0.0027568555,0.00009805535,0.00047473458,0.00029743055,0.00043292277,0.0003728509,0.00035217596,0.00089301413,0.00041776893],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009397035,0.00084467605,0.010262477,0.002997963,0.0005186429,0.0015950785,0.00022672507,0.000109489745,0.029731978,0.0014459554,0.0024638744,0.94040614],"study_design_scores_gemma":[0.0069826865,0.07332415,0.16625093,0.0039959545,0.0035995657,0.08736399,0.000836271,0.0011833543,0.24251038,0.003141981,0.41058537,0.00022531983],"about_ca_topic_score_codex":0.00068435393,"about_ca_topic_score_gemma":0.00089173915,"teacher_disagreement_score":0.0019057392,"about_ca_system_score_codex":0.0003641123,"about_ca_system_score_gemma":0.00040608968,"threshold_uncertainty_score":0.006375313},"labels":[],"label_agreement":null},{"id":"W2020428172","doi":"10.1111/bjh.13100","title":"Phase I‐<scp>II</scp> trial of oral cyclophosphamide, prednisone and lenalidomide for the treatment of patients with relapsed and refractory multiple myeloma","year":2014,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Southlake Regional Health Center; Ontario Institute for Cancer Research; Princess Margaret Cancer Centre; University Health Network","funders":"Celgene","keywords":"Medicine; Lenalidomide; Prednisone; Refractory (planetary science); Cyclophosphamide; Internal medicine; Regimen; Multiple myeloma; Surgery; Gastroenterology; Chemotherapy","score_opus":0.018161703457920467,"score_gpt":0.28916118427606546,"score_spread":0.270999480818145,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2020428172","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98196906,0.004135937,0.0008640242,0.001193259,0.00023881889,0.0060915286,0.0014897498,0.0002243973,0.0037932703],"genre_scores_gemma":[0.97461784,0.0029078412,0.0044714883,0.0022365586,0.0004117403,0.0059399246,0.004856095,0.000060635663,0.0044978964],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.99937516,0.00037216724,0.00002605621,0.00008442768,0.0000643426,0.00007789422],"domain_scores_gemma":[0.9992478,0.0001182447,0.00019957876,0.00004754873,0.000042720887,0.00034411318],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0018969886,0.0017651216,0.0020163457,0.0005116216,0.00040045395,0.0009814211,0.0010855132,0.0012800369,0.0027245278],"category_scores_gemma":[0.0008699441,0.00048988353,0.0012983617,0.00048028622,0.0008070478,0.00057724136,0.0005170464,0.004064019,0.0007211263],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.75026447,0.04727594,0.0056785084,0.0009520891,0.001944189,0.000284032,0.00023905373,0.0034256452,0.03409509,0.00038999296,0.0086263865,0.14682457],"study_design_scores_gemma":[0.77616346,0.20909539,0.0067834724,0.000053583546,0.00038532386,0.000296505,0.000026164238,0.0014368948,0.0025505882,0.00018461366,0.0029964442,0.00002764641],"about_ca_topic_score_codex":0.0010156662,"about_ca_topic_score_gemma":0.0030980795,"teacher_disagreement_score":0.0027245278,"about_ca_system_score_codex":0.0012029301,"about_ca_system_score_gemma":0.0018761122,"threshold_uncertainty_score":0.010032356},"labels":[],"label_agreement":null},{"id":"W2020964516","doi":"10.1111/j.1365-2141.2006.05981.x","title":"Intravenous immunoglobulin inhibits anti‐glycoprotein IIb‐induced platelet apoptosis in a murine model of immune thrombocytopenia","year":2006,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":88,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Blood Services; University of Toronto; St. Michael's Hospital","funders":"Canadian Institutes of Health Research; Canadian Blood Services","keywords":"Platelet; Apoptosis; Phosphatidylserine; Antibody; Immunology; Immune system; Medicine; Platelet membrane glycoprotein; Membrane glycoproteins; Pharmacology; Glycoprotein; Chemistry; Molecular biology; Biology; Biochemistry","score_opus":0.012844846432987621,"score_gpt":0.2429940948551032,"score_spread":0.2301492484221156,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2020964516","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9949635,0.001333925,0.0017347852,0.0001675051,0.000046109482,0.00008528076,0.000117010146,0.0001514462,0.0014003541],"genre_scores_gemma":[0.9958525,0.0008929027,0.0013533972,0.000081666345,0.00003636316,0.00008347051,0.00022420465,0.000017202672,0.0014584245],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9996736,0.00012529857,0.000023328677,0.000031591648,0.000064789216,0.00008131861],"domain_scores_gemma":[0.99973303,0.00005871518,0.000093365736,0.000041864718,0.000014429476,0.000058587426],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00036979897,0.00062768976,0.0005065939,0.0006727961,0.00018769951,0.0003527203,0.0004268855,0.00071088853,0.0008632117],"category_scores_gemma":[0.00028380164,0.00021567903,0.0002709094,0.00023065646,0.0003914476,0.00026521916,0.00018083797,0.0013008479,0.0002486401],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017845549,0.0014189358,0.00048317158,0.00010343578,0.00002951495,0.0004795764,0.000058336143,0.00038997817,0.9863788,0.00041989126,0.00022914224,0.008224598],"study_design_scores_gemma":[0.0009511313,0.026998157,0.005503377,0.000040454106,0.00008381845,0.0017806598,0.00004192864,0.0042873304,0.9566894,0.0002683017,0.0033410531,0.000014300016],"about_ca_topic_score_codex":0.00030706724,"about_ca_topic_score_gemma":0.000437235,"teacher_disagreement_score":0.0008632117,"about_ca_system_score_codex":0.00039869302,"about_ca_system_score_gemma":0.00020039639,"threshold_uncertainty_score":0.0028927326},"labels":[],"label_agreement":null},{"id":"W2021186137","doi":"10.1111/j.1365-2141.2008.07375.x","title":"The presence of α‐thalassaemia trait blunts the response to hydroxycarbamide in patients with sickle cell disease","year":2008,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Thomas Hospital","funders":"Medical Research Council","keywords":"Hydroxycarbamide; Medicine; Mean corpuscular volume; Fetal hemoglobin; Hemoglobinopathy; Disease; Internal medicine; BETA (programming language); Clinical trial; Gastroenterology; Immunology; Fetus; Hemoglobin; Biology; Genetics; Pregnancy","score_opus":0.004404148868553122,"score_gpt":0.20414189710301134,"score_spread":0.19973774823445822,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2021186137","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99925476,0.0003437343,0.000014706781,0.00003325521,0.0000047628278,0.0000030136969,0.000017445125,0.0000017327327,0.00032647487],"genre_scores_gemma":[0.999721,0.000101426784,0.000020923735,0.00003107689,0.000011053933,0.0000018818828,0.000024641866,5.162662e-7,0.000087423185],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9997557,0.00007012925,0.000035787445,0.000036412777,0.00006239316,0.000039535345],"domain_scores_gemma":[0.998733,0.0004587175,0.00045265435,0.000039819774,0.00006351384,0.00025240137],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00027937468,0.00019595792,0.00043843742,0.000290152,0.00025338214,0.00041561518,0.00013125039,0.00036524498,0.0008801088],"category_scores_gemma":[0.0025396987,0.00015199215,0.00016972944,0.00030789332,0.0002684529,0.00019463396,0.00016715536,0.00040356058,0.00016351911],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0036501172,0.00030328296,0.9689978,0.000052669217,0.00008002075,0.0025480103,0.0004930164,0.00021723246,0.008400247,0.000053408818,0.00024640677,0.01495781],"study_design_scores_gemma":[0.00007938987,0.0026734394,0.9920557,0.000010956811,0.000051992807,0.0035607826,0.00017587865,0.00020307764,0.0007708697,0.000046217963,0.0003629522,0.000008796885],"about_ca_topic_score_codex":0.0008228963,"about_ca_topic_score_gemma":0.0010875101,"teacher_disagreement_score":0.0008801088,"about_ca_system_score_codex":0.00029043708,"about_ca_system_score_gemma":0.00014141566,"threshold_uncertainty_score":0.0029442906},"labels":[],"label_agreement":null},{"id":"W2021294789","doi":"10.1111/j.1365-2141.2007.06941.x","title":"Arsenic trioxide induces <i>de novo</i> protein synthesis of annexin‐1 in neutrophils: association with a heat shock‐like response and not apoptosis","year":2007,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"S100 Proteins and Annexins","field":"Biochemistry, Genetics and Molecular Biology","cited_by":18,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institut National de la Recherche Scientifique","funders":"National Research Council Canada; Natural Sciences and Engineering Research Council of Canada; Canadian Institutes of Health Research","keywords":"Annexin A1; Annexin; Arsenic trioxide; Apoptosis; Heat shock protein; Cell biology; Chemistry; Molecular biology; Biology; Biochemistry; Gene","score_opus":0.006654030443037917,"score_gpt":0.2267698239768873,"score_spread":0.22011579353384939,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2021294789","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99346304,0.0027258785,0.0022351656,0.00016915286,0.000027287964,0.000030604588,0.00025137045,0.00007303509,0.0010245633],"genre_scores_gemma":[0.99454486,0.0013332393,0.0015039915,0.00008062206,0.000014841377,0.000025591906,0.0004136107,0.000013734962,0.0020696013],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99990654,0.000019918563,0.000006912222,0.000016156811,0.000028891927,0.000021626967],"domain_scores_gemma":[0.99989414,0.0000215184,0.000033011544,0.000012821241,0.000020109757,0.000018379667],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010337334,0.00021567698,0.0001699787,0.00023057882,0.000103987106,0.00020379468,0.00007214755,0.00019497258,0.0010974543],"category_scores_gemma":[0.00013231093,0.00011815522,0.00017215543,0.00014143657,0.00015167263,0.00013640875,0.00012182374,0.00029911372,0.00026809867],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000076524826,0.000007833549,0.0001649634,0.000021500053,0.0000028215384,0.000049772865,0.000008371064,0.000012532752,0.9989635,0.000032255615,0.000019936593,0.0006399007],"study_design_scores_gemma":[0.000024201436,0.000290049,0.010805036,0.000005285906,0.000011989655,0.00049340806,0.000030745134,0.00027687068,0.98612624,0.00011859373,0.0018138422,0.0000036864776],"about_ca_topic_score_codex":0.00031193614,"about_ca_topic_score_gemma":0.0004209342,"teacher_disagreement_score":0.0010974543,"about_ca_system_score_codex":0.00030880878,"about_ca_system_score_gemma":0.000093276954,"threshold_uncertainty_score":0.0036712885},"labels":[],"label_agreement":null},{"id":"W2021580696","doi":"10.1046/j.1365-2141.2000.01961.x","title":"Relapse after bone marrow transplantation: evidence for distinct immunological mechanisms between adult and paediatric populations","year":2000,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Hôpital Maisonneuve-Rosemont","funders":"Cancer Research Society","keywords":"Medicine; Immunology; Transplantation; Donor lymphocyte infusion; Hematopoietic stem cell transplantation; Bone marrow; Haematopoiesis; Lymphocyte; Natural killer cell; Immune system; Progenitor cell; Stem cell; Internal medicine; Gastroenterology; Cytotoxic T cell; Biology","score_opus":0.03475342023049308,"score_gpt":0.294834983272305,"score_spread":0.2600815630418119,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2021580696","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99819154,0.00121271,0.00015015325,0.00001958981,0.0000021150317,0.000005221292,0.00002711054,0.000006117387,0.00038541312],"genre_scores_gemma":[0.9990403,0.0004723848,0.00014437635,0.00003336891,0.000012742657,0.000008202404,0.00015454117,0.000005020086,0.0001289945],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9996586,0.00010562414,0.000038699152,0.000048813123,0.00008782517,0.00006042569],"domain_scores_gemma":[0.9990007,0.00022301824,0.000518641,0.00007183107,0.00004979742,0.00013597423],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00039509035,0.00015080118,0.00031640462,0.00034424552,0.00016577696,0.00037438067,0.00023244954,0.00030173073,0.0009376416],"category_scores_gemma":[0.0013693894,0.00009792967,0.0001350717,0.00033637558,0.00031044648,0.00021120057,0.00032845177,0.0003049902,0.00021465511],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0023277602,0.00011023516,0.94124556,0.00009716248,0.000047868514,0.0035937338,0.0009018914,0.00013542252,0.020938462,0.00024973328,0.00026709356,0.03008512],"study_design_scores_gemma":[0.00007654076,0.0013488677,0.96860474,0.000035923884,0.000059658403,0.023179699,0.00031897612,0.00025117723,0.004299202,0.00010670259,0.0017088737,0.000009658285],"about_ca_topic_score_codex":0.00048525826,"about_ca_topic_score_gemma":0.00049053464,"teacher_disagreement_score":0.0009376416,"about_ca_system_score_codex":0.00024173681,"about_ca_system_score_gemma":0.00019042712,"threshold_uncertainty_score":0.0031366944},"labels":[],"label_agreement":null},{"id":"W2022816298","doi":"10.1111/j.1365-2141.2008.07266.x","title":"ADAMTS13 cleavage efficiency is altered by mutagenic and, to a lesser extent, polymorphic sequence changes in the A1 and A2 domains of von Willebrand factor","year":2008,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Complement system in diseases","field":"Immunology and Microbiology","cited_by":20,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"Canada Research Chairs; Heart and Stroke Foundation of Canada","keywords":"Von Willebrand factor; ADAMTS13; Cleavage (geology); Sequence (biology); Genetics; Biology; Molecular biology; Chemistry; Immunology; Platelet","score_opus":0.026153280497387178,"score_gpt":0.2615444333792809,"score_spread":0.23539115288189372,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2022816298","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99900335,0.000098049946,0.0005563937,0.000013613049,0.0000062255754,0.000005504309,0.00010171904,0.0000142941335,0.00020086602],"genre_scores_gemma":[0.99797946,0.00012609891,0.0008868731,0.000015140246,0.0000024966703,0.0000072099488,0.00031868037,0.000019234049,0.0006449611],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99962926,0.00011084043,0.00007368159,0.00007160888,0.00006942398,0.000045203145],"domain_scores_gemma":[0.9995479,0.00011635853,0.00019430253,0.00005346633,0.000030735384,0.000057156878],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003955667,0.00030454565,0.00017728999,0.0002576163,0.00008901529,0.00024291537,0.0002000766,0.00028630954,0.0013230023],"category_scores_gemma":[0.0004307086,0.00017665989,0.00030376413,0.00018172088,0.000191514,0.00010421611,0.00018669193,0.000381289,0.00032992868],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011891193,0.00003918701,0.00042176014,0.000013873319,0.0000139502035,0.000042215852,0.000014599833,0.000041020463,0.99880207,0.000032182965,0.000013306071,0.00044684074],"study_design_scores_gemma":[0.000023058403,0.0005488176,0.010488197,0.0000073357314,0.000040699975,0.0005347353,0.000022396296,0.00081649533,0.98668134,0.00002601266,0.0008042186,0.0000066077987],"about_ca_topic_score_codex":0.00043004742,"about_ca_topic_score_gemma":0.00039457277,"teacher_disagreement_score":0.0013230023,"about_ca_system_score_codex":0.00012831444,"about_ca_system_score_gemma":0.00011666063,"threshold_uncertainty_score":0.004425943},"labels":[],"label_agreement":null},{"id":"W2023110459","doi":"10.1111/j.1365-2141.2009.07692.x","title":"Bone marrow cells from patients with Shwachman‐Diamond syndrome abnormally express genes involved in ribosome biogenesis and RNA processing","year":2009,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Blood disorders and treatments","field":"Biochemistry, Genetics and Molecular Biology","cited_by":45,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute for Clinical Evaluative Sciences; SickKids Foundation; Hospital for Sick Children; Toronto Rehabilitation Institute; University of Toronto","funders":"","keywords":"Ribosome biogenesis; Gene; Biology; RNA; Gene expression; Ribosome; Downregulation and upregulation; Ribosomal protein; Messenger RNA; Transcription (linguistics); Molecular biology; Genetics","score_opus":0.004222464171878309,"score_gpt":0.19123282394750035,"score_spread":0.18701035977562205,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2023110459","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9975914,0.00091853214,0.00066281273,0.00003570384,0.000011720853,0.00001868632,0.0003612202,0.00001906078,0.00038086748],"genre_scores_gemma":[0.9970566,0.00048881676,0.00085626135,0.00006374543,0.000011243574,0.00003238265,0.00085528486,0.000009256697,0.0006263607],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998957,0.000013800327,0.000014096074,0.000024585559,0.00003531647,0.00001655777],"domain_scores_gemma":[0.99989307,0.000036564496,0.000023028677,0.000011060761,0.000014861287,0.000021332256],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00008571287,0.00036201603,0.00031307334,0.0005098427,0.00020570829,0.00019274966,0.00010567093,0.00025615073,0.0020802498],"category_scores_gemma":[0.0002760255,0.000148964,0.00012087488,0.00032216302,0.00021306604,0.0000931438,0.00016485451,0.0002657211,0.0004301241],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009254764,0.000078888006,0.039273832,0.00012342968,0.000046263092,0.0026645167,0.00025719017,0.00007476849,0.9479048,0.00009563045,0.0002044904,0.00835073],"study_design_scores_gemma":[0.00027151144,0.0021427358,0.65302354,0.00003787246,0.00023059847,0.034447953,0.001029738,0.0006754587,0.299086,0.0006223315,0.008401564,0.000030664527],"about_ca_topic_score_codex":0.00045045014,"about_ca_topic_score_gemma":0.0005695272,"teacher_disagreement_score":0.0020802498,"about_ca_system_score_codex":0.00009580193,"about_ca_system_score_gemma":0.00006996531,"threshold_uncertainty_score":0.0069591403},"labels":[],"label_agreement":null},{"id":"W2023591243","doi":"10.1111/j.1365-2141.2008.07345.x","title":"A family with hereditary hyperferritinaemia cataract syndrome: evidence of incomplete penetrance and clinical heterogeneity","year":2008,"lang":"en","type":"letter","venue":"British Journal of Haematology","topic":"RNA modifications and cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Ferritin; Untranslated region; Penetrance; Gene; Genetics; Medicine; Biology; Mutation; Molecular biology; Messenger RNA; Pathology; Phenotype","score_opus":0.03893172973317715,"score_gpt":0.2984226482130131,"score_spread":0.25949091847983596,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2023591243","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99673045,0.00039145525,0.0010049986,0.00008627067,0.000013045634,0.000049974224,0.00037193924,0.000026167008,0.0013258051],"genre_scores_gemma":[0.9979792,0.00026571815,0.0005002176,0.000043388674,0.00003438309,0.000018218418,0.0002674059,0.000012385221,0.00087920495],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.99945456,0.000056808436,0.00004571134,0.00021241342,0.00013204882,0.00009851047],"domain_scores_gemma":[0.9991505,0.0002966922,0.0001491128,0.000063452826,0.000090484806,0.0002496317],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00033272416,0.0013654012,0.0009976398,0.0024605994,0.0015249997,0.00046677643,0.00054323016,0.0005799361,0.005222147],"category_scores_gemma":[0.0019857811,0.000439784,0.00054267666,0.0017195761,0.00091288675,0.0003623409,0.0008038113,0.00048533623,0.00042171098],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016464634,0.00051029504,0.37696218,0.00023417528,0.00021723163,0.5398683,0.0054064724,0.00027852066,0.05298653,0.0011437526,0.0009375023,0.019808548],"study_design_scores_gemma":[0.00007924895,0.00057207287,0.37580606,0.000040265302,0.00014362644,0.61561966,0.0007615387,0.00043445782,0.0028847056,0.00046582238,0.0031360686,0.000056531982],"about_ca_topic_score_codex":0.005240335,"about_ca_topic_score_gemma":0.004138843,"teacher_disagreement_score":0.005240335,"about_ca_system_score_codex":0.00050906965,"about_ca_system_score_gemma":0.0006877119,"threshold_uncertainty_score":0.017469823},"labels":[],"label_agreement":null},{"id":"W2023816137","doi":"10.1111/bjh.12468","title":"Disseminated histoplasmosis diagnosed by peripheral blood film in a patient with chronic lymphocytic leukaemia","year":2013,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Fungal Infections and Studies","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital","funders":"","keywords":"Medicine; Lymphocytosis; Pancytopenia; Neutropenia; Schistocyte; Chronic lymphocytic leukemia; Gastroenterology; Internal medicine; Pathology; Hemophagocytosis; Surgery; Leukemia; Bone marrow; Chemotherapy","score_opus":0.0036001682148560712,"score_gpt":0.2058655726754294,"score_spread":0.20226540446057334,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2023816137","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9862831,0.0033934112,0.0005360847,0.0011601825,0.00013659037,0.00010197096,0.00017091587,0.00006382446,0.008153835],"genre_scores_gemma":[0.99829704,0.00063893216,0.00015699244,0.0003163233,0.0001748185,0.000009165452,0.00007041299,0.0000050453878,0.00033133553],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.9995809,0.00006394559,0.000049191112,0.00008727549,0.00006410006,0.00015459325],"domain_scores_gemma":[0.99906105,0.00027075649,0.00015844984,0.000041193187,0.00009762658,0.0003709313],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00040634003,0.0011753477,0.0007046051,0.0018104013,0.0013212633,0.00094374106,0.00046452755,0.001672263,0.0024478587],"category_scores_gemma":[0.0026287807,0.00060767966,0.00036188093,0.00089864805,0.00080285285,0.0011207926,0.00064236735,0.0013032673,0.0006835379],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003422223,0.00010077263,0.15025055,0.00008053096,0.000016232128,0.8421621,0.0005613695,0.000062334104,0.0026951518,0.000097026576,0.0005643845,0.0030673319],"study_design_scores_gemma":[0.0001062063,0.000506115,0.09298059,0.0000881354,0.00004544556,0.90299696,0.00053366134,0.00036281024,0.0006498923,0.00015335054,0.0015564489,0.0000204358],"about_ca_topic_score_codex":0.0025607662,"about_ca_topic_score_gemma":0.0021041578,"teacher_disagreement_score":0.0025607662,"about_ca_system_score_codex":0.00065357325,"about_ca_system_score_gemma":0.00048084164,"threshold_uncertainty_score":0.008188963},"labels":[],"label_agreement":null},{"id":"W2024903169","doi":"10.1111/bjh.13263","title":"Paediatric acute lymphoblastic leukaemia mimicking Langerhans cell histiocytosis of bone","year":2014,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Histiocytic Disorders and Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Medicine; Pelvis; Bone marrow; Pathology; Bone pain; Langerhans cell histiocytosis; Histiocytosis; Immunophenotyping; White blood cell; Radiology; Internal medicine","score_opus":0.006083556415049535,"score_gpt":0.2231461231124344,"score_spread":0.21706256669738486,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2024903169","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9692886,0.0065041906,0.0030888673,0.0021668337,0.00037544378,0.0003795609,0.0008914341,0.00034976556,0.016955476],"genre_scores_gemma":[0.9930153,0.0033242845,0.0010236719,0.00050033204,0.0003408797,0.000043701268,0.00033036075,0.000034194392,0.0013872853],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.9993148,0.00009008979,0.00008478307,0.00015790033,0.000120871184,0.00023144462],"domain_scores_gemma":[0.999003,0.00028708036,0.00025493695,0.000030927393,0.00008747143,0.00033661598],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00027506216,0.0015932886,0.0012678812,0.0016508121,0.0012146733,0.0010861332,0.00076326577,0.0021164797,0.0031138018],"category_scores_gemma":[0.0026964764,0.0010253271,0.0005472528,0.0017351195,0.0010062217,0.0015830684,0.00094141864,0.0018092962,0.0010183578],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007521568,0.000029605833,0.015095635,0.00009218879,0.000008675102,0.9809864,0.00020457698,0.00010186955,0.0014786643,0.000178242,0.00032865425,0.0014203701],"study_design_scores_gemma":[0.00003548695,0.00015542976,0.022024583,0.000038865335,0.000022229797,0.9754723,0.00019236919,0.00016198092,0.00044607287,0.00022134381,0.0012199555,0.00000934892],"about_ca_topic_score_codex":0.002051247,"about_ca_topic_score_gemma":0.0025296118,"teacher_disagreement_score":0.0031138018,"about_ca_system_score_codex":0.00081447256,"about_ca_system_score_gemma":0.000652383,"threshold_uncertainty_score":0.010416746},"labels":[],"label_agreement":null},{"id":"W2025366996","doi":"10.1111/j.1365-2141.2007.06906.x","title":"Considerations in the approach to invasive fungal infection in patients with haematological malignancies","year":2007,"lang":"en","type":"review","venue":"British Journal of Haematology","topic":"Antifungal resistance and susceptibility","field":"Medicine","cited_by":36,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba","funders":"","keywords":"Intensive care medicine; Medicine; Empiric treatment; Invasive candidiasis; Antifungal; Biology; Dermatology; Antibiotics; Fluconazole","score_opus":0.06451927805154582,"score_gpt":0.3313548320321513,"score_spread":0.2668355539806055,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2025366996","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00020550759,0.9950407,0.00026540385,0.0025177551,0.00038355388,0.0000042979373,0.0000066099124,0.000012109237,0.0015640934],"genre_scores_gemma":[0.002517493,0.99427843,0.00065191154,0.0010193164,0.00087659765,0.000008790853,0.000022248061,0.0000023449866,0.00062282145],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99944955,0.00017704084,0.00010397932,0.000055089396,0.00018584888,0.000028476372],"domain_scores_gemma":[0.9987896,0.0006932629,0.00014578164,0.000026239553,0.00025601557,0.00008920788],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010831873,0.0006802379,0.0017999894,0.0020848827,0.00037609576,0.001161312,0.0011377209,0.0017123903,0.0021003026],"category_scores_gemma":[0.0030282869,0.00022050648,0.0005004279,0.001853293,0.00074026186,0.0018067945,0.00059288484,0.0031758302,0.0018790684],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006464044,0.00007625576,0.0013744939,0.008186767,0.00007784302,0.0050498256,0.00028992002,0.0004988414,0.0005363316,0.00298134,0.056130435,0.9247334],"study_design_scores_gemma":[0.00005143972,0.00017270037,0.0077914563,0.015860138,0.00019512915,0.072190225,0.00090218417,0.00028075295,0.0003952157,0.0073652496,0.8947257,0.000069739996],"about_ca_topic_score_codex":0.0013310798,"about_ca_topic_score_gemma":0.0023877863,"teacher_disagreement_score":0.0021003026,"about_ca_system_score_codex":0.0005947656,"about_ca_system_score_gemma":0.001063018,"threshold_uncertainty_score":0.0070261955},"labels":[],"label_agreement":null},{"id":"W2025391163","doi":"10.1111/j.1365-2141.2009.07697.x","title":"Mutations of polycomb‐associated gene <i>ASXL1</i> in myelodysplastic syndromes and chronic myelomonocytic leukaemia","year":2009,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":556,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Institute of Cancer Research; Institut National Du Cancer","keywords":"Myelodysplastic syndromes; Haematopoiesis; Myeloid; Chronic myelomonocytic leukemia; Biology; Epigenetics; Cancer research; Gene; Comparative genomic hybridization; Mutation; Genetics; Genome; Immunology; Stem cell; Bone marrow","score_opus":0.014716156334597125,"score_gpt":0.2851794044656786,"score_spread":0.27046324813108147,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2025391163","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9989158,0.0005201986,0.00017574368,0.000030417594,0.0000034302882,0.0000070699116,0.000055010587,0.000003379033,0.0002889135],"genre_scores_gemma":[0.9992719,0.0002278814,0.00022473668,0.000018590265,0.000007366857,0.000004020852,0.00009078797,0.0000013038392,0.00015326308],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.999828,0.00003906803,0.000024273742,0.000039082264,0.00004301477,0.000026451244],"domain_scores_gemma":[0.99975365,0.0000860895,0.000092785995,0.000012348786,0.000018307623,0.000036720205],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002253755,0.0002087499,0.00013356104,0.0007794173,0.0002105369,0.0001921782,0.00013939502,0.0002817766,0.0009794888],"category_scores_gemma":[0.0007418603,0.000096452015,0.0000949828,0.00039897664,0.0004415624,0.000109754474,0.0001848547,0.00016335782,0.00015790007],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001126018,0.00009705924,0.6384982,0.00026629242,0.00013883736,0.014665369,0.0007906351,0.00043856367,0.30413857,0.0005390892,0.00080426,0.038497202],"study_design_scores_gemma":[0.000094232884,0.0003529818,0.86157376,0.000043587494,0.0001234724,0.080466494,0.0002719287,0.00086622935,0.05117895,0.00046438468,0.004541542,0.000022414313],"about_ca_topic_score_codex":0.0009543352,"about_ca_topic_score_gemma":0.0012027622,"teacher_disagreement_score":0.0009794888,"about_ca_system_score_codex":0.00015317748,"about_ca_system_score_gemma":0.00012298813,"threshold_uncertainty_score":0.0032767057},"labels":[],"label_agreement":null},{"id":"W2025701448","doi":"10.1111/bjh.12339","title":"Chronic myeloid leukaemia presenting with isolated thrombocythaemia, a case revealing its stem cell biology","year":2013,"lang":"en","type":"letter","venue":"British Journal of Haematology","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"Medical Research Council; Kræftens Bekæmpelse; Aarhus Universitetshospital","keywords":"Thrombocytosis; Stem cell; Myeloid; Vincristine; Anagrelide; Medicine; Progenitor cell; Haematopoiesis; Bone marrow; Immunology; Hematology; Internal medicine; Cyclophosphamide; Biology; Cancer research; Pathology; Essential thrombocythemia; Platelet; Chemotherapy","score_opus":0.019931176247564228,"score_gpt":0.2603717279615163,"score_spread":0.24044055171395207,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2025701448","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9760867,0.008883301,0.0022030827,0.0022502246,0.00026710727,0.00024454988,0.00024724717,0.00009573569,0.009722111],"genre_scores_gemma":[0.9949816,0.0025057488,0.00078087795,0.0004098328,0.00050150417,0.000022404263,0.00007954668,0.000007581553,0.0007109716],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.99966085,0.00004076865,0.000042538,0.00007956077,0.000060564864,0.000115688505],"domain_scores_gemma":[0.9994906,0.000098315904,0.000096628864,0.000049255766,0.000038147668,0.00022701062],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000261752,0.0011866032,0.0006112919,0.0026934762,0.0020181753,0.00096766656,0.000661212,0.0030769827,0.0015886826],"category_scores_gemma":[0.0015420875,0.0010092042,0.0005690541,0.0014383962,0.0012924549,0.0016415524,0.0010940859,0.0019683226,0.0006402953],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000377089,0.00003172408,0.008799388,0.000050732568,0.0000061499645,0.98568326,0.0003357826,0.000047778838,0.0023061007,0.00027565344,0.00034545438,0.0020802435],"study_design_scores_gemma":[0.00000602992,0.000032202675,0.0036819566,0.000008598347,0.0000059347926,0.9953076,0.0000773613,0.00006735062,0.00021251294,0.000108589345,0.00048707714,0.000004679462],"about_ca_topic_score_codex":0.0022926454,"about_ca_topic_score_gemma":0.0026710378,"teacher_disagreement_score":0.0030769827,"about_ca_system_score_codex":0.000707755,"about_ca_system_score_gemma":0.0005732734,"threshold_uncertainty_score":0.005314648},"labels":[],"label_agreement":null},{"id":"W2026187531","doi":"10.1046/j.1365-2141.2002.03509.x","title":"Natural history of juvenile haemochromatosis","year":2002,"lang":"en","type":"review","venue":"British Journal of Haematology","topic":"Iron Metabolism and Disorders","field":"Medicine","cited_by":176,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Hemochromatosis; Internal medicine; Medicine; Disease; Juvenile; Natural history; Cirrhosis; Gastroenterology; Genetics; Biology","score_opus":0.03336989373666223,"score_gpt":0.2922507126913472,"score_spread":0.258880818954685,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2026187531","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.005235193,0.9912383,0.00018550493,0.000624184,0.000097900425,0.000004329211,0.00002888345,0.000013868294,0.0025717148],"genre_scores_gemma":[0.057663843,0.9392809,0.00027696023,0.00047340867,0.00036585398,0.000011591165,0.000099755234,0.0000041225258,0.0018234351],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9998913,0.000029160105,0.000014335261,0.000025087478,0.000031394993,0.000008775513],"domain_scores_gemma":[0.9997758,0.00008706919,0.00006440887,0.000007127444,0.000036669506,0.000028911028],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020822727,0.00030652963,0.0006109663,0.00060362596,0.00012711223,0.00028297407,0.00025025095,0.00041805298,0.0010469381],"category_scores_gemma":[0.00080364465,0.00009114958,0.00010508891,0.00055960316,0.00023458898,0.0003132414,0.0001454351,0.00042827232,0.0004958175],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001922514,0.00004962898,0.0113890795,0.0038206985,0.00006251789,0.00865204,0.00020648257,0.00029333573,0.0015441906,0.0010075938,0.018781332,0.9540009],"study_design_scores_gemma":[0.000079155514,0.0003581564,0.1123727,0.0062106443,0.00030934173,0.26491857,0.0004939427,0.00035468827,0.0013637473,0.0037107368,0.6097643,0.000064088206],"about_ca_topic_score_codex":0.0009953347,"about_ca_topic_score_gemma":0.0016434541,"teacher_disagreement_score":0.0010469381,"about_ca_system_score_codex":0.00033205046,"about_ca_system_score_gemma":0.00041817693,"threshold_uncertainty_score":0.0035023093},"labels":[],"label_agreement":null},{"id":"W2027327114","doi":"10.1111/bjh.12033","title":"Phage display generation of a novel human anti‐<scp>CD</scp>1<scp>A</scp> monoclonal antibody with potent cytolytic activity","year":2012,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Histiocytic Disorders and Treatments","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"National Institute of Allergy and Infectious Diseases; Cancer Research Institute; Foundation for the National Institutes of Health","keywords":"Antibody-dependent cell-mediated cytotoxicity; Monoclonal antibody; Antibody; Phage display; Avidity; Antigen; Biology; Cytotoxicity; Cytolysis; Molecular biology; Cell culture; Immunology; In vitro; Biochemistry","score_opus":0.029270119024475735,"score_gpt":0.2986538871679408,"score_spread":0.26938376814346504,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2027327114","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97273827,0.001200029,0.020156814,0.00019937145,0.000059180777,0.0001732113,0.0008451589,0.00021967199,0.004408314],"genre_scores_gemma":[0.9822089,0.0006308846,0.009963342,0.000129423,0.00001308976,0.00007631422,0.0016279856,0.000048169994,0.005301869],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99989617,0.000013892239,0.000005975479,0.00002336509,0.00003222455,0.000028366449],"domain_scores_gemma":[0.99995553,0.0000076208626,0.000007418175,0.000005051259,0.000009860559,0.000014472342],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011631052,0.00028019975,0.00022462808,0.00016504609,0.00015575823,0.0003544144,0.00024804793,0.00033462135,0.0009440333],"category_scores_gemma":[0.00013561475,0.00014417144,0.00020898468,0.00020001021,0.000116015326,0.00007713639,0.00022947848,0.00050874025,0.00049915974],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000039521947,0.000024567154,0.00007584853,0.000022150867,0.000003937892,0.000047693487,0.000011446262,0.00018295688,0.9974649,0.00011888292,0.00016722336,0.0018410332],"study_design_scores_gemma":[0.000037157886,0.00033879443,0.0020575295,0.000005498882,0.000022665365,0.00043809693,0.000010544063,0.0033490467,0.9837213,0.00005081521,0.00996012,0.000008430031],"about_ca_topic_score_codex":0.0010326855,"about_ca_topic_score_gemma":0.0010613883,"teacher_disagreement_score":0.0010326855,"about_ca_system_score_codex":0.00043906877,"about_ca_system_score_gemma":0.00016512054,"threshold_uncertainty_score":0.0031856298},"labels":[],"label_agreement":null},{"id":"W2027774332","doi":"10.1111/j.1365-2141.2009.07728.x","title":"Expanded safety experience with lenalidomide plus dexamethasone in relapsed or refractory multiple myeloma","year":2009,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":74,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary; University Health Network; Princess Margaret Cancer Centre","funders":"Celgene","keywords":"Lenalidomide; Medicine; Discontinuation; Dexamethasone; Internal medicine; Multiple myeloma; Adverse effect; Thalidomide; Refractory (planetary science); Gastroenterology; Surgery","score_opus":0.03021112419302469,"score_gpt":0.31823097306370635,"score_spread":0.28801984887068166,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2027774332","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8719789,0.10682042,0.0028462713,0.003282235,0.00027528938,0.0005985391,0.00051702536,0.00014978391,0.013531565],"genre_scores_gemma":[0.9679745,0.02533806,0.0018499386,0.0018655106,0.00064424105,0.00013753412,0.0006499766,0.000031683656,0.0015085093],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99825317,0.0009820256,0.00014605335,0.00014097145,0.00037711704,0.00010068829],"domain_scores_gemma":[0.99766207,0.0010496933,0.00043153425,0.00014026872,0.0002761229,0.0004403133],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0043483297,0.00027875902,0.0008980848,0.00021338015,0.00030906737,0.0008471612,0.0006799083,0.00044043348,0.0018248057],"category_scores_gemma":[0.004460443,0.00011911305,0.00056006474,0.0005646742,0.00036984656,0.0005646456,0.00058319175,0.0014323702,0.00034471235],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.026135668,0.004620755,0.035432838,0.0013903263,0.00094748376,0.0027972532,0.0014731264,0.003364882,0.02395837,0.00090537965,0.006398493,0.8925754],"study_design_scores_gemma":[0.03315818,0.34851804,0.1861099,0.002023028,0.0017358152,0.03167643,0.0012860607,0.006210768,0.038897008,0.003073517,0.34715894,0.00015229247],"about_ca_topic_score_codex":0.00042587586,"about_ca_topic_score_gemma":0.00078899827,"teacher_disagreement_score":0.0043483297,"about_ca_system_score_codex":0.0006187732,"about_ca_system_score_gemma":0.0006590205,"threshold_uncertainty_score":0.022996426},"labels":[],"label_agreement":null},{"id":"W2028313456","doi":"10.1111/j.1365-2141.2006.06080.x","title":"Haematopoietic stem cell transplantation as primary therapy of sporadic adult Burkitt lymphoma*","year":2006,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":30,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency; Vancouver Hospital and Health Sciences Centre","funders":"","keywords":"Medicine; Transplantation; Lymphoma; Stem cell; Haematopoiesis; Internal medicine; Chemoradiotherapy; Oncology; Hematology; Chemotherapy; Hematopoietic stem cell transplantation; Disease; Gastroenterology; Biology","score_opus":0.006630559670720683,"score_gpt":0.2195492214605781,"score_spread":0.2129186617898574,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2028313456","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9916726,0.004715543,0.00032094415,0.00015586696,0.000042647553,0.000094127776,0.000051208313,0.000048384853,0.0028987231],"genre_scores_gemma":[0.99755484,0.0013372845,0.00026980918,0.00011116147,0.0000618127,0.000032732507,0.000121689096,0.0000038468306,0.00050686125],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9998728,0.000035598892,0.0000095823,0.000016352884,0.000028689372,0.00003694092],"domain_scores_gemma":[0.99977857,0.000034102275,0.000032334403,0.000013881917,0.000020905034,0.00012032678],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020958093,0.00020133446,0.00041902793,0.00030080212,0.00052189914,0.00024094501,0.00016506182,0.00023136743,0.0013099164],"category_scores_gemma":[0.00057336927,0.00009416241,0.00015618416,0.0002756941,0.00028066014,0.000100929545,0.0002358125,0.00023943014,0.00031214886],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.010135214,0.0024561791,0.34242857,0.00072830106,0.00019416276,0.029094128,0.0011857732,0.0011358751,0.037954077,0.0003180821,0.005836146,0.5685335],"study_design_scores_gemma":[0.00223935,0.032830667,0.84941185,0.00028973058,0.00034570612,0.0745676,0.00055605173,0.0024107047,0.012445125,0.0003958375,0.024481425,0.000025943815],"about_ca_topic_score_codex":0.0040238462,"about_ca_topic_score_gemma":0.012865716,"teacher_disagreement_score":0.0040238462,"about_ca_system_score_codex":0.0005087044,"about_ca_system_score_gemma":0.00046907464,"threshold_uncertainty_score":0.008000851},"labels":[],"label_agreement":null},{"id":"W2029045196","doi":"10.1111/bjh.13176","title":"Thalidomide‐prednisone maintenance following autologous stem cell transplant for <scp>M</scp>ultiple <scp>M</scp>yeloma: effect on thrombin generation and procoagulant markers in <scp>NCIC CTG MY</scp>.10","year":2014,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Princess Margaret Cancer Centre; Juravinski Cancer Centre; Hôpital Maisonneuve-Rosemont; Queen's University; London Health Sciences Centre","funders":"Canadian Cancer Society Research Institute; Celgene; Amgen; National Cancer Institute; National Institutes of Health; Cancer Research Institute","keywords":"Medicine; Thalidomide; Prednisone; Internal medicine; Autologous stem-cell transplantation; Gastroenterology; Multiple myeloma; Incidence (geometry); Oncology; Surgery","score_opus":0.01678841548025037,"score_gpt":0.2652000940276421,"score_spread":0.24841167854739174,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2029045196","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9977864,0.0015666669,0.000072540315,0.00007141596,0.000034512046,0.00005803585,0.00010358933,0.000015502008,0.00029129192],"genre_scores_gemma":[0.9985372,0.0006730936,0.00010960708,0.00009251539,0.000030757146,0.000036710866,0.00023025618,0.000001945345,0.00028800336],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.9999131,0.000025081186,0.0000077280365,0.000014457078,0.000011944387,0.000027747783],"domain_scores_gemma":[0.9997844,0.000041150266,0.00004935772,0.000020989017,0.000009253129,0.000094833405],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002566235,0.00027610868,0.0007480733,0.00016238594,0.00016374895,0.0003336908,0.00027908507,0.00021549343,0.0015310629],"category_scores_gemma":[0.00046945913,0.00009421864,0.00049362826,0.00022270008,0.00016656429,0.00017499477,0.0001040118,0.0008875288,0.00020000698],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.5038499,0.02152252,0.02002939,0.000978446,0.001448216,0.0009494916,0.00024782305,0.0012279679,0.05906468,0.00017446525,0.003213397,0.38729367],"study_design_scores_gemma":[0.11199314,0.63155967,0.22424866,0.00019788583,0.0016162212,0.0018577531,0.00015938605,0.0026365637,0.021146968,0.00017251632,0.0043608393,0.000050417373],"about_ca_topic_score_codex":0.001582268,"about_ca_topic_score_gemma":0.004291171,"teacher_disagreement_score":0.001582268,"about_ca_system_score_codex":0.00041801375,"about_ca_system_score_gemma":0.00043646607,"threshold_uncertainty_score":0.0051219463},"labels":[],"label_agreement":null},{"id":"W2029092443","doi":"10.1046/j.1365-2141.2003.04603.x","title":"Louis Diamond and His Contribution To Haematology","year":2003,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Blood disorders and treatments","field":"Biochemistry, Genetics and Molecular Biology","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"University of California, San Francisco","keywords":"Medicine; Pediatrics; Classics; Family medicine; Gerontology; History","score_opus":0.004418746664078501,"score_gpt":0.2243062754297625,"score_spread":0.21988752876568401,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2029092443","genre_codex":"commentary","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0005902692,0.40144396,0.0016927294,0.4149724,0.15371256,0.000017848008,0.00010334675,0.000162563,0.027304301],"genre_scores_gemma":[0.025202263,0.3430117,0.0037261269,0.31833324,0.19051972,0.000058787202,0.0001450936,0.00029042322,0.11871259],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.993115,0.0021195512,0.00039443767,0.001127351,0.0028810888,0.00036250218],"domain_scores_gemma":[0.98550946,0.0053648087,0.0007510502,0.0006587607,0.004067747,0.0036482073],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0058397697,0.00078531186,0.00081260933,0.0017317695,0.0015494337,0.005472349,0.0010028377,0.0045206933,0.011971364],"category_scores_gemma":[0.021973962,0.00043850916,0.00046058046,0.0007783504,0.0035996465,0.0028774915,0.0031298837,0.013970488,0.0075934553],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000023246177,0.000014765012,0.00040289765,0.00020263759,0.00001480507,0.00021324438,0.0003201005,0.0000622567,0.00012310933,0.013947228,0.9144698,0.07020599],"study_design_scores_gemma":[0.0000038549238,0.0000073382853,0.000087475724,0.00023423632,0.000002711088,0.00064297486,0.00006157974,0.000014011194,0.00003868327,0.0035264324,0.9953726,0.000008182569],"about_ca_topic_score_codex":0.004735989,"about_ca_topic_score_gemma":0.0065865233,"teacher_disagreement_score":0.011971364,"about_ca_system_score_codex":0.005706716,"about_ca_system_score_gemma":0.007843266,"threshold_uncertainty_score":0.04140532},"labels":[],"label_agreement":null},{"id":"W2029230582","doi":"10.1111/j.1365-2141.2007.06764.x","title":"IgG‐mediated immunosuppression is not dependent on erythrocyte clearance or immunological evasion: implications for the mechanism of action of anti‐D in the prevention of haemolytic disease of the newborn?","year":2007,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Blood groups and transfusion","field":"Medicine","cited_by":28,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Canadian Blood Services; St. Michael's Hospital","funders":"","keywords":"Opsonin; Immune system; Phagocytosis; Antibody; Immunology; Humoral immunity; Antigen; Immunosuppression; Antibody opsonization; Biology","score_opus":0.04960957571744798,"score_gpt":0.3315587411966382,"score_spread":0.28194916547919024,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2029230582","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9726403,0.017302044,0.0038461746,0.0012582979,0.00019800081,0.000043620872,0.000057953228,0.00009923544,0.004554394],"genre_scores_gemma":[0.99534035,0.002386719,0.0006656384,0.00026484553,0.00010907357,0.000010696394,0.000026053152,0.0000071198733,0.0011896421],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9997775,0.000045902798,0.00001695767,0.000034113393,0.000037216243,0.000088338566],"domain_scores_gemma":[0.99968755,0.00007193532,0.00009701729,0.000053951157,0.000033482454,0.000056123492],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00068868056,0.00033418203,0.00045558487,0.00021513886,0.00007712676,0.00046302358,0.0005019976,0.0009113103,0.0014811836],"category_scores_gemma":[0.00042764633,0.000121909376,0.00025383843,0.00009251672,0.00070666685,0.0005098255,0.00018395131,0.00044939274,0.0003503848],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013036745,0.0003921485,0.007463551,0.00049746496,0.00006457022,0.0017619248,0.00008164955,0.0001792574,0.9485445,0.0036889517,0.00028980512,0.035732593],"study_design_scores_gemma":[0.00045449781,0.005366817,0.10854517,0.00023421308,0.00028932653,0.009622192,0.00020565238,0.0035633466,0.85424596,0.0025112384,0.014938454,0.00002317584],"about_ca_topic_score_codex":0.0002624762,"about_ca_topic_score_gemma":0.00021304289,"teacher_disagreement_score":0.0014811836,"about_ca_system_score_codex":0.00031771348,"about_ca_system_score_gemma":0.00024030973,"threshold_uncertainty_score":0.0049550533},"labels":[],"label_agreement":null},{"id":"W2029490929","doi":"10.1111/j.1365-2141.2008.07388.x","title":"Paraneoplastic pemphigus associated with follicular lymphoma","year":2008,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Autoimmune Bullous Skin Diseases","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hotel Dieu Hospital","funders":"","keywords":"Paraneoplastic pemphigus; Medicine; Skin biopsy; Pemphigus; Pathology; Lymphoma; Acantholysis; Biopsy; Rituximab; Dermatology; Prednisolone; Vincristine; Leukemia cutis; Cyclophosphamide; Antibody; Chemotherapy; Gastroenterology; Autoantibody; Internal medicine; Immunology","score_opus":0.011386215643355065,"score_gpt":0.22030430871596593,"score_spread":0.20891809307261086,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2029490929","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.93750215,0.004171566,0.0013754659,0.0013318503,0.0002188201,0.00013952813,0.00025392143,0.0001876758,0.05481912],"genre_scores_gemma":[0.9965096,0.0006872158,0.00030229872,0.00024871278,0.00035692635,0.000023446599,0.00006916674,0.000012191447,0.0017903085],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.9994373,0.00012460456,0.000067932066,0.00007627282,0.000089802554,0.00020409505],"domain_scores_gemma":[0.99785906,0.0011280881,0.0002944984,0.0002884582,0.00013698998,0.0002928756],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00056264043,0.0015450852,0.00087772455,0.0012766613,0.0013053791,0.00090510835,0.0008177134,0.0023854373,0.008234085],"category_scores_gemma":[0.004779961,0.0007253782,0.00058610976,0.0009437038,0.0014548947,0.0016530213,0.0011252285,0.0017647537,0.0015215208],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00060808426,0.00008490978,0.02154882,0.00022350083,0.00003797791,0.9685745,0.00024364311,0.00012952344,0.0029922465,0.00071704487,0.00060828147,0.0042314306],"study_design_scores_gemma":[0.00014788649,0.0002539345,0.039207045,0.000034616616,0.00005669466,0.95687366,0.00019535451,0.0003837314,0.00072955294,0.0005442669,0.0015532996,0.00001987903],"about_ca_topic_score_codex":0.001757577,"about_ca_topic_score_gemma":0.0012975377,"teacher_disagreement_score":0.008234085,"about_ca_system_score_codex":0.0006781843,"about_ca_system_score_gemma":0.00043071987,"threshold_uncertainty_score":0.02754575},"labels":[],"label_agreement":null},{"id":"W2030675928","doi":"10.1046/j.1365-2141.2003.04636.x","title":"Heparin‐induced thrombocytopenia: pathogenesis and management – Response to Rasheed Saad","year":2003,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Heparin-Induced Thrombocytopenia and Thrombosis","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Hamilton Regional Laboratory Medicine Program; Hamilton General Hospital","funders":"","keywords":"Lepirudin; Partial thromboplastin time; Medicine; Heparin-induced thrombocytopenia; Anesthesia; Dosing; Heparin; Anticoagulant; Thrombosis; Thromboelastography; Surgery; Intensive care medicine; Platelet; Discovery and development of direct thrombin inhibitors; Internal medicine; Thrombin","score_opus":0.024551106283788635,"score_gpt":0.28960149812861324,"score_spread":0.2650503918448246,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2030675928","genre_codex":"review","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.3756712,0.41168472,0.0091894185,0.12434941,0.003994555,0.0006902509,0.00035285545,0.00065179175,0.07341581],"genre_scores_gemma":[0.8746448,0.07688602,0.00415414,0.027497243,0.007195633,0.00015064859,0.00038691697,0.000035618486,0.009048982],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9997305,0.000062928695,0.00004928,0.000028477696,0.0000938507,0.000034936485],"domain_scores_gemma":[0.9997433,0.00005876082,0.000055213426,0.00001340759,0.000073576804,0.000055808297],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003512706,0.0003944393,0.00046237741,0.0008629662,0.0002682408,0.00052560616,0.00043671325,0.0012082055,0.0015603565],"category_scores_gemma":[0.0018290256,0.000117182084,0.00040133102,0.00039249088,0.00021298479,0.00060575147,0.00030863512,0.0014261514,0.00090197206],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010123671,0.0017576447,0.15013885,0.0013901455,0.00025721054,0.07175206,0.0005446495,0.001046633,0.0068807486,0.0031009023,0.04761723,0.7145015],"study_design_scores_gemma":[0.000869466,0.0039827074,0.2905922,0.001814267,0.00036653396,0.5178871,0.0011292825,0.004499603,0.0030467825,0.011785848,0.16384685,0.00017929952],"about_ca_topic_score_codex":0.00034715395,"about_ca_topic_score_gemma":0.0004278608,"teacher_disagreement_score":0.0015603565,"about_ca_system_score_codex":0.00035746273,"about_ca_system_score_gemma":0.00023380121,"threshold_uncertainty_score":0.0052199364},"labels":[],"label_agreement":null},{"id":"W2030904107","doi":"10.1046/j.1365-2141.2003.04615.x","title":"William Osler's Legacy and his Contribution to Haematology","year":2003,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"History of Medical Practice","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; History of medicine; Classics; Humanism; Pediatrics; Family medicine; History; Philosophy; Theology","score_opus":0.012112095616201591,"score_gpt":0.2790182631522199,"score_spread":0.2669061675360183,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2030904107","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0020307924,0.54526323,0.002742634,0.26382768,0.09204593,0.000033737673,0.00011579859,0.00008006812,0.09386002],"genre_scores_gemma":[0.0525781,0.5751162,0.005422036,0.10044315,0.13617405,0.00007225469,0.00010032317,0.00018257709,0.12991136],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9970855,0.0008821475,0.00022223647,0.00042838833,0.001154841,0.00022683504],"domain_scores_gemma":[0.993968,0.002639079,0.00035904086,0.0002544249,0.001399536,0.0013800095],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0033122038,0.0007028376,0.000612226,0.0024312898,0.0026677002,0.0050001442,0.0008288852,0.0028706274,0.0059826914],"category_scores_gemma":[0.013577762,0.00039232985,0.00032904666,0.0012406814,0.006645981,0.0036799577,0.0030891486,0.009141552,0.002541887],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000033144275,0.000028950666,0.00063990435,0.0002749655,0.000015892214,0.00040206264,0.0028917016,0.000084781306,0.00013189207,0.095039226,0.74594694,0.15451054],"study_design_scores_gemma":[0.0000023043885,0.0000082999495,0.00016352972,0.0003389704,0.0000025076145,0.0006284819,0.0001651038,0.000010776536,0.00003362618,0.0100538405,0.9885831,0.000009405872],"about_ca_topic_score_codex":0.006669064,"about_ca_topic_score_gemma":0.009901527,"teacher_disagreement_score":0.006669064,"about_ca_system_score_codex":0.0040372415,"about_ca_system_score_gemma":0.0069754515,"threshold_uncertainty_score":0.029292405},"labels":[],"label_agreement":null},{"id":"W2030973337","doi":"10.1046/j.1365-2141.2001.03227.x","title":"Towards molecular medicine; reminiscences of the haemoglobin field, 1960–2000","year":2001,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":26,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"Medical Research Council","keywords":"Miller; Classics; Medicine; Disease; History; Psychoanalysis; Psychology; Family medicine; Pathology","score_opus":0.009398847257013827,"score_gpt":0.2601621112331468,"score_spread":0.25076326397613297,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2030973337","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0038369151,0.61654794,0.0010004644,0.27955446,0.07023566,0.000012931471,0.00009849072,0.000032780976,0.028680371],"genre_scores_gemma":[0.07565478,0.5362065,0.0015223435,0.19058928,0.13764437,0.00006400405,0.00010568438,0.00013845894,0.058074746],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99793136,0.0009519071,0.000087953464,0.0003307366,0.0005292308,0.00016886092],"domain_scores_gemma":[0.99739045,0.0015216459,0.0002011025,0.00009470165,0.00027468376,0.0005175095],"candidate_categories":["sts"],"consensus_categories":[],"category_scores_codex":[0.005184381,0.0012263737,0.0006700922,0.0026564382,0.005284243,0.007625568,0.0011467432,0.005219695,0.0021543712],"category_scores_gemma":[0.009058637,0.0005126071,0.0005319744,0.002322989,0.017872285,0.0094891,0.0035154084,0.016695948,0.0016425936],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002538819,0.000095368705,0.0005153725,0.0011313752,0.000038214497,0.001437401,0.06547133,0.00019754298,0.0014299816,0.24151157,0.63292813,0.05498978],"study_design_scores_gemma":[0.00000903082,0.000016561311,0.00019086993,0.00037993336,0.000004777497,0.00037384246,0.0026741659,0.000022405788,0.0001146349,0.010773945,0.9854291,0.000010738426],"about_ca_topic_score_codex":0.005320405,"about_ca_topic_score_gemma":0.0063299085,"teacher_disagreement_score":0.99471575,"about_ca_system_score_codex":0.010671035,"about_ca_system_score_gemma":0.0034028825,"threshold_uncertainty_score":0.07742411},"labels":[],"label_agreement":null},{"id":"W2032765229","doi":"10.1111/bjh.12785","title":"Long‐term follow‐up of a phase 2 trial of single agent lenalidomide in previously untreated patients with chronic lymphocytic leukaemia","year":2014,"lang":"en","type":"letter","venue":"British Journal of Haematology","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Princess Margaret Cancer Centre","funders":"Celgene","keywords":"Lenalidomide; Medicine; Neutropenia; Cytopenia; Internal medicine; Rituximab; Febrile neutropenia; Gastroenterology; Phases of clinical research; Multiple myeloma; Oncology; Toxicity; Lymphoma; Bone marrow","score_opus":0.0249349140721326,"score_gpt":0.2948622606583417,"score_spread":0.2699273465862091,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2032765229","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9866564,0.006426559,0.00082855753,0.0008056206,0.00024750375,0.0013114267,0.0013670013,0.000071333576,0.0022855508],"genre_scores_gemma":[0.9884892,0.0013521285,0.0006515152,0.0015216095,0.0003133318,0.0016878523,0.0041737854,0.000018951732,0.0017915679],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.997903,0.00077233167,0.00022470743,0.00035473966,0.0002990853,0.00044618823],"domain_scores_gemma":[0.9956958,0.000718061,0.00088540214,0.0005458288,0.00038088553,0.0017740557],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.006883784,0.0010124004,0.0027589642,0.0005615526,0.0015219534,0.0015698388,0.0005729992,0.0017073553,0.001993517],"category_scores_gemma":[0.0045351777,0.00067664555,0.0019375825,0.0006188493,0.0007975488,0.0018783289,0.00069862144,0.004541694,0.0007130838],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.6399729,0.039158136,0.083939165,0.00080791744,0.0061301226,0.0010567687,0.00082258653,0.0026689842,0.022506418,0.0002655309,0.006923427,0.19574794],"study_design_scores_gemma":[0.16580953,0.541442,0.26893443,0.00014436826,0.003967268,0.0009110095,0.00014639829,0.0014836937,0.0044727526,0.0005451608,0.01197474,0.0001688058],"about_ca_topic_score_codex":0.00088584033,"about_ca_topic_score_gemma":0.001596397,"teacher_disagreement_score":0.006883784,"about_ca_system_score_codex":0.0010198501,"about_ca_system_score_gemma":0.0012920259,"threshold_uncertainty_score":0.036405385},"labels":[],"label_agreement":null},{"id":"W2032888836","doi":"10.1111/j.1365-2141.2004.05296.x","title":"Severe FVII deficiency caused by a new point mutation combined with a previously undetected gene deletion","year":2005,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Hemophilia Treatment and Research","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"B.C. Women's Hospital & Health Centre; University of British Columbia","funders":"","keywords":"Proband; Point mutation; Genetics; Mutation; Gene; Allele; Biology; Compound heterozygosity; Gene mutation; Molecular biology","score_opus":0.013243894189483548,"score_gpt":0.2657986263926563,"score_spread":0.2525547322031727,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2032888836","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99456245,0.0016370193,0.0011262136,0.00062960136,0.00012266338,0.000040844126,0.00019285866,0.000083896026,0.0016043402],"genre_scores_gemma":[0.99620616,0.0008947562,0.0009269226,0.00016210783,0.00014654036,0.000012868346,0.000140226,0.000021700936,0.0014887352],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.999746,0.0000294487,0.000030768137,0.00007570279,0.000056051354,0.00006209079],"domain_scores_gemma":[0.9995148,0.00015657443,0.0000919977,0.000025843368,0.00002711701,0.00018357117],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019157812,0.0012042514,0.0007041677,0.00091126043,0.00046696758,0.00043750246,0.0006532967,0.0019242349,0.0012477261],"category_scores_gemma":[0.00092010497,0.00047285468,0.0005939999,0.00046444254,0.00072109705,0.00031596934,0.0003838754,0.0011229343,0.0003968823],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001285399,0.00008097606,0.0045339367,0.00003343861,0.000018931467,0.96995574,0.0001562314,0.000055848686,0.02224285,0.00012361113,0.00022316625,0.0024467283],"study_design_scores_gemma":[0.00003590978,0.0003836096,0.0200486,0.0000115893035,0.00003485328,0.9737388,0.00004719446,0.00024343755,0.0042466447,0.00008067404,0.0011124215,0.000016254548],"about_ca_topic_score_codex":0.0013373997,"about_ca_topic_score_gemma":0.0012656335,"teacher_disagreement_score":0.0019242349,"about_ca_system_score_codex":0.00043219846,"about_ca_system_score_gemma":0.00028062725,"threshold_uncertainty_score":0.0041741133},"labels":[],"label_agreement":null},{"id":"W2033740080","doi":"10.1046/j.1365-2141.2000.02179.x","title":"Monoclonal antibody‐mediated inhibition of the human HLA alloimmune response to platelet transfusion is antigen specific and independent of Fcγ receptor‐mediated immune suppression","year":2000,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Blood groups and transfusion","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Blood Services; St. Michael's Hospital","funders":"Canadian Blood Services","keywords":"Immunology; Monoclonal antibody; Human leukocyte antigen; Antigen; Immune system; Platelet; Antibody; Isoantibodies; Receptor; Medicine; Internal medicine","score_opus":0.009127417119653662,"score_gpt":0.24934381693030203,"score_spread":0.24021639981064835,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2033740080","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9924077,0.002044676,0.0030025486,0.000066079345,0.000040085266,0.000056134104,0.00005336733,0.000065650944,0.0022637034],"genre_scores_gemma":[0.99645436,0.00086271827,0.00091227115,0.000061994746,0.00002301701,0.000036555874,0.0001223464,0.000007824194,0.0015188947],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99983597,0.0000346483,0.000016202423,0.000021999618,0.000048413127,0.000042782533],"domain_scores_gemma":[0.99990726,0.000026873995,0.00002618148,0.000015578978,0.000012837058,0.000011167313],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015478299,0.00034493802,0.00020973747,0.00013146494,0.00008350878,0.00019557733,0.00019830857,0.00021507262,0.0013802778],"category_scores_gemma":[0.00015921812,0.00010312916,0.0002266804,0.0000653619,0.00012058834,0.00008453829,0.00014790657,0.0005349159,0.00021457161],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011798436,0.000050324103,0.00014255197,0.00003194173,0.000008814664,0.000062039944,0.000018294271,0.00004008699,0.9966085,0.00010137913,0.000037658745,0.0027805117],"study_design_scores_gemma":[0.00003338345,0.0012474977,0.006656609,0.000009356616,0.000029159743,0.0008179823,0.000013166373,0.0006389801,0.98775697,0.00003444565,0.0027592217,0.000003075197],"about_ca_topic_score_codex":0.00030173158,"about_ca_topic_score_gemma":0.00042703506,"teacher_disagreement_score":0.0013802778,"about_ca_system_score_codex":0.00014172087,"about_ca_system_score_gemma":0.00011755904,"threshold_uncertainty_score":0.0046174526},"labels":[],"label_agreement":null},{"id":"W2033788627","doi":"10.1111/bjh.13104","title":"Genetic polymorphisms influencing total and γ′ fibrinogen levels and fibrin clot properties in <scp>A</scp>fricans","year":2014,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Blood properties and coagulation","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Medical Research Council; McMaster University; South African Medical Research Council; Hamilton Health Sciences","keywords":"Fibrinogen; Turbidimetry; Fibrin; Single-nucleotide polymorphism; Factor XIII; SNP; Genetics; Biology; Genotype; Gene; Immunology; Molecular biology; Biochemistry","score_opus":0.017443288764823078,"score_gpt":0.2166131003874923,"score_spread":0.19916981162266922,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2033788627","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9993511,0.00015232847,0.000043180356,0.00004302321,0.000003547236,0.0000039164247,0.000131514,0.0000016961717,0.00026976143],"genre_scores_gemma":[0.99871516,0.00013619347,0.00018556857,0.00004726665,0.00000790385,0.00001495334,0.00021276984,0.000004040971,0.0006762275],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9997676,0.00004763484,0.000028424865,0.000071468145,0.00003410691,0.000050727147],"domain_scores_gemma":[0.9996768,0.00011952029,0.000104768005,0.000021292912,0.00003222759,0.000045461755],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004163131,0.00043319582,0.0003704348,0.00070750207,0.0006850152,0.0004788716,0.00025107735,0.00049701304,0.003344631],"category_scores_gemma":[0.00073731993,0.00023661,0.00041574598,0.00062658044,0.00042423847,0.0001667375,0.00027852974,0.0002799514,0.000399679],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002044916,0.00015183329,0.95462817,0.00018307187,0.00047641905,0.00347078,0.0023664522,0.00029956497,0.025396924,0.00035438675,0.0006248745,0.010002608],"study_design_scores_gemma":[0.000011652202,0.00011054363,0.99716836,0.000036628462,0.000092728136,0.0008194726,0.0005657338,0.00016574461,0.00049277616,0.00009503192,0.00043113154,0.000010103374],"about_ca_topic_score_codex":0.020621086,"about_ca_topic_score_gemma":0.02582006,"teacher_disagreement_score":0.020621086,"about_ca_system_score_codex":0.00044524454,"about_ca_system_score_gemma":0.00036842274,"threshold_uncertainty_score":0.041002154},"labels":[],"label_agreement":null},{"id":"W2034676735","doi":"10.1111/j.1365-2141.2006.06354.x","title":"Globin gene expression in Hb Lepore‐BAC transgenic mice","year":2006,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network","funders":"","keywords":"Transgene; Biology; Gene; Genetically modified mouse; Context (archaeology); Genetics; Fusion gene; Gene expression; Molecular biology; Gene cluster; Globin","score_opus":0.006557056724864285,"score_gpt":0.2328605151002298,"score_spread":0.2263034583753655,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2034676735","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99184966,0.00056782103,0.0048505752,0.000102154874,0.000029547838,0.00008602016,0.0006110144,0.00016728946,0.001735805],"genre_scores_gemma":[0.9832901,0.0007736217,0.007335472,0.0001147221,0.000023330094,0.00014325966,0.0013123228,0.00009028029,0.0069169234],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99977034,0.000038379734,0.000029454555,0.000059740523,0.00005410366,0.000047973335],"domain_scores_gemma":[0.9997589,0.00005010561,0.00006594969,0.000023774357,0.000021891567,0.000079426645],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003156547,0.00028549344,0.00022851976,0.00062419445,0.0002566044,0.00026710005,0.00025454463,0.00038383462,0.002370784],"category_scores_gemma":[0.00017509109,0.00023716086,0.00019562825,0.00015193086,0.0002923841,0.00017051585,0.0002310317,0.0007397058,0.00046330126],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018776458,0.00004732646,0.00030529272,0.000016545857,0.0000048946367,0.00008970062,0.00004240949,0.000029791148,0.99730456,0.00015883968,0.000045711287,0.0017672062],"study_design_scores_gemma":[0.00024397323,0.0015191648,0.010109684,0.000031091487,0.00007230132,0.0015355214,0.000060624134,0.0008976429,0.97851324,0.00015009685,0.006852537,0.000013965801],"about_ca_topic_score_codex":0.0005446663,"about_ca_topic_score_gemma":0.00088813406,"teacher_disagreement_score":0.002370784,"about_ca_system_score_codex":0.00020667377,"about_ca_system_score_gemma":0.0001541163,"threshold_uncertainty_score":0.007931054},"labels":[],"label_agreement":null},{"id":"W2035772349","doi":"10.1046/j.1365-2141.2000.01954.x","title":"Mutation analysis in the HFE gene in patients with hereditary haemochromatosis in Saguenay–Lac‐Saint‐Jean (Quebec, Canada)","year":2000,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Iron Metabolism and Disorders","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Cégep de Chicoutimi; Université du Québec à Chicoutimi","funders":"Institut National de la Santé et de la Recherche Médicale","keywords":"Genetics; Mutation; Founder effect; Gene; Biology; Proband; Gene mutation; Genotype; Haplotype","score_opus":0.003951972211433462,"score_gpt":0.2029711715499368,"score_spread":0.19901919933850334,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2035772349","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9972715,0.0004929662,0.00015517071,0.00015090664,0.000010687139,0.000032883225,0.00052916765,0.000011032783,0.001345815],"genre_scores_gemma":[0.99764556,0.00023269287,0.00029913313,0.00010121863,0.0000055651985,0.000013064787,0.00029632272,0.000006365459,0.0014000626],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99975616,0.000023505201,0.000022484675,0.000055601722,0.00006957982,0.00007259056],"domain_scores_gemma":[0.99961686,0.000050668063,0.000044082426,0.0000112310145,0.00015311508,0.00012399211],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020137268,0.00056001486,0.00040179997,0.0014800908,0.0022347132,0.0005367111,0.00045758084,0.0007364355,0.0026960494],"category_scores_gemma":[0.00078841613,0.00027031597,0.00032435235,0.0014678689,0.00055967487,0.00014666884,0.00033196277,0.00040299047,0.00020630441],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005741625,0.0001977645,0.91845995,0.000108296364,0.00016613831,0.022631945,0.0032146012,0.00039464846,0.028618623,0.00027604305,0.002563335,0.02279451],"study_design_scores_gemma":[0.00006167882,0.0001448671,0.9855516,0.00003620741,0.000063291605,0.00890473,0.0009240968,0.0004348838,0.0009581154,0.00003855722,0.002858227,0.000023741823],"about_ca_topic_score_codex":0.8569555,"about_ca_topic_score_gemma":0.9034976,"teacher_disagreement_score":0.14304447,"about_ca_system_score_codex":0.0037168725,"about_ca_system_score_gemma":0.00263742,"threshold_uncertainty_score":0.28777373},"labels":[],"label_agreement":null},{"id":"W2036291732","doi":"10.1111/j.1365-2141.2005.05493.x","title":"The absence of CD56 on malignant plasma cells in the cerebrospinal fluid is the hallmark of multiple myeloma involving central nervous system","year":2005,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":54,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Cerebrospinal fluid; Multiple myeloma; Central nervous system; Medicine; Pathology; Cancer research; Immunology; Internal medicine","score_opus":0.01725287106537729,"score_gpt":0.2623310306521224,"score_spread":0.2450781595867451,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2036291732","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9963552,0.0015438274,0.00050269853,0.00005879969,0.000008625163,0.0000069294297,0.00005395593,0.000019432287,0.0014504195],"genre_scores_gemma":[0.99914324,0.00029126467,0.0003386057,0.000018185112,0.000009684069,0.0000029774528,0.000031710864,0.0000028983075,0.00016156037],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99983513,0.000023458239,0.000025644234,0.00003703926,0.000046269543,0.00003248057],"domain_scores_gemma":[0.9996972,0.000083486084,0.00010707962,0.000037465907,0.000037511883,0.00003722181],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014723088,0.0002341193,0.0002858494,0.00058919366,0.0003538934,0.00039855525,0.00017171049,0.00028466174,0.0014621232],"category_scores_gemma":[0.0010054475,0.00018117609,0.00008244824,0.00043968426,0.0005119184,0.00026168037,0.00027876356,0.00026249074,0.0003526584],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008286346,0.000061259634,0.4083958,0.00026896066,0.00007131423,0.01567248,0.00059534743,0.00012683212,0.52759886,0.00027275193,0.00061805075,0.045489665],"study_design_scores_gemma":[0.00005101628,0.00046925957,0.7264055,0.00005920724,0.00012840361,0.15760542,0.00075426523,0.0004883005,0.10750942,0.0005430971,0.005966564,0.00001948207],"about_ca_topic_score_codex":0.0006524828,"about_ca_topic_score_gemma":0.00057260063,"teacher_disagreement_score":0.0014621232,"about_ca_system_score_codex":0.00014430925,"about_ca_system_score_gemma":0.00009740402,"threshold_uncertainty_score":0.004891336},"labels":[],"label_agreement":null},{"id":"W2036346083","doi":"10.1046/j.1365-2141.2003.04242.x","title":"William Bosworth Castle: Pioneer of Haematological Clinical Investigation","year":2003,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"American Society of Hematology","keywords":"Medicine; Gerontology","score_opus":0.028859312657685144,"score_gpt":0.302369718254535,"score_spread":0.27351040559684986,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2036346083","genre_codex":"review","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0016627441,0.46242568,0.015283804,0.41145712,0.06085162,0.00020622468,0.00040333305,0.00060257944,0.047106847],"genre_scores_gemma":[0.040709835,0.40479606,0.035687197,0.2490307,0.11692659,0.00043720155,0.00043163227,0.0010052097,0.15097561],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9938985,0.0016471478,0.0004375898,0.0011343901,0.0024692083,0.0004132678],"domain_scores_gemma":[0.96976626,0.0119158095,0.0010606516,0.0015069251,0.009700561,0.00604974],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.01029122,0.0009474538,0.0013420294,0.0066133314,0.003126679,0.006376464,0.0019028408,0.006099374,0.011146673],"category_scores_gemma":[0.037704833,0.0011708479,0.00062168634,0.0023744826,0.008492407,0.0056935363,0.004345746,0.019385925,0.006960552],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000083449195,0.000038313243,0.0013543159,0.0003843652,0.000018963265,0.00069645897,0.0010122316,0.00010069879,0.00041010548,0.023966486,0.8426766,0.12925802],"study_design_scores_gemma":[0.000017227983,0.000026636591,0.00090049993,0.0011991104,0.00000764006,0.0018713181,0.0002006857,0.000085859094,0.00020224444,0.01099519,0.98445094,0.00004266432],"about_ca_topic_score_codex":0.0175174,"about_ca_topic_score_gemma":0.023703257,"teacher_disagreement_score":0.0175174,"about_ca_system_score_codex":0.0068028164,"about_ca_system_score_gemma":0.013250893,"threshold_uncertainty_score":0.054425836},"labels":[],"label_agreement":null},{"id":"W2036730592","doi":"10.1111/j.1365-2141.2004.05006.x","title":"Clonal haemopoiesis may occur after conventional chemotherapy and is associated with accelerated telomere shortening and defects in the NQO1 pathway; possible mechanisms leading to an increased risk of t‐AML/MDS","year":2004,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Telomeres, Telomerase, and Senescence","field":"Medicine","cited_by":38,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"BC Cancer Agency","keywords":"Telomere; Haematopoiesis; Biology; Chemotherapy; Myeloid; Immunology; Stem cell; Myeloid leukemia; Internal medicine; Oncology; Cancer research; Medicine; Genetics; Gene","score_opus":0.015975350026451687,"score_gpt":0.26162338482845204,"score_spread":0.24564803480200037,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2036730592","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9992887,0.0003754506,0.0001176113,0.000009642612,0.00000116455,0.000004036942,0.00003108659,0.000002971373,0.00016928323],"genre_scores_gemma":[0.99970883,0.00011369896,0.00006794249,0.00000606386,0.0000049486307,0.0000018258269,0.00003820377,7.9878123e-7,0.000057572754],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99990034,0.000026054617,0.000011924793,0.000024835943,0.000020877393,0.000015999787],"domain_scores_gemma":[0.999204,0.0001971107,0.00045200484,0.00004559183,0.0000398223,0.0000615223],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017942103,0.00011142728,0.00019107151,0.00031623396,0.00017985386,0.00013761251,0.000101510705,0.00017850212,0.0013115522],"category_scores_gemma":[0.00085017184,0.00007822754,0.00008940439,0.00033592386,0.00023564124,0.00013679573,0.0001641274,0.00015581868,0.00013794792],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00057674764,0.000045463465,0.9744201,0.000043200296,0.000040814793,0.0013482815,0.00012785368,0.00007425866,0.013778594,0.000074371346,0.000107274136,0.009362905],"study_design_scores_gemma":[0.000018444955,0.0005342341,0.98927677,0.000009369637,0.000031744203,0.0074775782,0.000070166665,0.00021626135,0.0018484852,0.00006790586,0.00044433953,0.0000046210384],"about_ca_topic_score_codex":0.00045343873,"about_ca_topic_score_gemma":0.0006844753,"teacher_disagreement_score":0.0013115522,"about_ca_system_score_codex":0.00010632774,"about_ca_system_score_gemma":0.00007920252,"threshold_uncertainty_score":0.0043875575},"labels":[],"label_agreement":null},{"id":"W2036925454","doi":"10.1111/j.1365-2141.2005.05805.x","title":"Annexin A2 may not play a role as a plasminogen receptor","year":2005,"lang":"en","type":"letter","venue":"British Journal of Haematology","topic":"S100 Proteins and Annexins","field":"Biochemistry, Genetics and Molecular Biology","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Calgary","funders":"","keywords":"Annexin A2; Plasmin; Annexin; Angiostatin; Cell biology; Receptor; Chemistry; Tissue plasminogen activator; Plasminogen activator; Cell; Molecular biology; Biology; Biochemistry; Cancer research; Angiogenesis; Enzyme; Genetics","score_opus":0.00858794577405199,"score_gpt":0.23777451485373644,"score_spread":0.22918656907968443,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2036925454","genre_codex":"review","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.029893031,0.9106652,0.013276584,0.016781481,0.004117694,0.000033140408,0.00011251015,0.000103376755,0.025017003],"genre_scores_gemma":[0.431089,0.48908454,0.007727286,0.012911889,0.0052909125,0.00007072997,0.00030745828,0.00004961548,0.053468578],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.999706,0.000054668402,0.00003421391,0.00007738363,0.00007606158,0.000051736497],"domain_scores_gemma":[0.9996165,0.00017918416,0.000043355954,0.00003496263,0.00008863942,0.000037321417],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000606332,0.0002567554,0.0005427566,0.00034521174,0.00034549358,0.001199185,0.00066359836,0.0021171898,0.004158443],"category_scores_gemma":[0.0008231308,0.00012020248,0.0003807342,0.00024804226,0.0007219019,0.0029825794,0.00046617017,0.0014436686,0.001343337],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010818971,0.0002019689,0.008618113,0.008640776,0.0007394905,0.010553215,0.00063280814,0.00094462116,0.1656549,0.22063147,0.042501528,0.53979915],"study_design_scores_gemma":[0.00007371334,0.0003934187,0.0041613597,0.00073168054,0.00020571952,0.016278584,0.00038100407,0.0007547079,0.02531575,0.029725948,0.9219329,0.00004518614],"about_ca_topic_score_codex":0.0008277904,"about_ca_topic_score_gemma":0.00067606027,"teacher_disagreement_score":0.004158443,"about_ca_system_score_codex":0.00054578565,"about_ca_system_score_gemma":0.00048650274,"threshold_uncertainty_score":0.013911366},"labels":[],"label_agreement":null},{"id":"W2037703099","doi":"10.1046/j.1365-2141.2000.02109.x","title":"Dyskeratosis congenita in all its forms","year":2000,"lang":"en","type":"review","venue":"British Journal of Haematology","topic":"Telomeres, Telomerase, and Senescence","field":"Medicine","cited_by":572,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"Imperial College London; Wellcome Trust","keywords":"Dyskeratosis congenita; Medicine; Dyskeratosis; Dermatology; Hyperkeratosis; Genetics; Biology; Telomere","score_opus":0.07197924257499881,"score_gpt":0.3577913086233197,"score_spread":0.2858120660483209,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2037703099","genre_codex":"other","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.24485084,0.26666898,0.01746733,0.008483299,0.0025467488,0.00061533955,0.011897601,0.003175884,0.44429398],"genre_scores_gemma":[0.7213254,0.06908521,0.011397584,0.0039558792,0.0015311353,0.00030728342,0.0082442695,0.00029799266,0.18385525],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9996113,0.000044784487,0.00005740426,0.00010048911,0.00010753624,0.00007851471],"domain_scores_gemma":[0.9996387,0.000060452843,0.0000885993,0.000060346625,0.000072619485,0.000079458165],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00025014358,0.0009151105,0.00079131697,0.0012901748,0.0007052167,0.0010185863,0.00035648976,0.00060952397,0.010991944],"category_scores_gemma":[0.00064115325,0.00015696783,0.00042871962,0.0016855081,0.00040265545,0.00047262077,0.0007726136,0.00088728144,0.0045726206],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010983163,0.00042405736,0.049569696,0.0030030364,0.00034739438,0.047237284,0.0009719687,0.0005318541,0.02259457,0.019911144,0.12647602,0.72783464],"study_design_scores_gemma":[0.0001229406,0.00024679027,0.06339685,0.000828793,0.00039071857,0.19514044,0.00033443974,0.00031912007,0.0042855833,0.007920277,0.7269578,0.000056333305],"about_ca_topic_score_codex":0.0018224283,"about_ca_topic_score_gemma":0.0022143007,"teacher_disagreement_score":0.010991944,"about_ca_system_score_codex":0.0003199244,"about_ca_system_score_gemma":0.00048386084,"threshold_uncertainty_score":0.036771655},"labels":[],"label_agreement":null},{"id":"W2037713259","doi":"10.1111/j.1365-2141.2009.08027.x","title":"Alemtuzumab is safe and effective as immunosuppressive treatment for aplastic anaemia and single‐lineage marrow failure: a pilot study and a survey from the EBMT WPSAA","year":2009,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":75,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"Università degli Studi di Napoli Federico II","keywords":"Alemtuzumab; Medicine; Regimen; Aplastic anemia; Bone marrow failure; Internal medicine; Pure red cell aplasia; Gastroenterology; Adverse effect; Aplasia; Immunology; Bone marrow; Toxicity; Immunosuppression; Oncology; Transplantation; Stem cell; Haematopoiesis; Biology","score_opus":0.023065172866176084,"score_gpt":0.2834789399436454,"score_spread":0.2604137670774693,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2037713259","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9975101,0.0018084685,0.00014896058,0.00005079151,0.0000034819798,0.000020091104,0.000022215041,0.0000036716585,0.00043222157],"genre_scores_gemma":[0.9985252,0.0010563976,0.000102799364,0.000060938102,0.000018245184,0.000014707807,0.00006197187,0.0000013438224,0.00015847468],"study_design_codex":"observational","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.99971753,0.00012440946,0.000029450921,0.00002671256,0.0000681306,0.0000336846],"domain_scores_gemma":[0.99963796,0.00017016577,0.000078941026,0.000019985968,0.000033523098,0.00005945509],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006909618,0.0002358966,0.00036038435,0.00023674133,0.00022100868,0.00032406708,0.00010700178,0.0001955518,0.0005687675],"category_scores_gemma":[0.0010325271,0.00009321373,0.0002449025,0.0002937255,0.00025899077,0.00017627928,0.00010753132,0.00019795191,0.00013795712],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.014971053,0.006178256,0.515821,0.0005147972,0.00054005726,0.006614652,0.0016073996,0.0009967188,0.07643787,0.000356635,0.0010236207,0.3749379],"study_design_scores_gemma":[0.0030378634,0.10766704,0.84455156,0.0000754206,0.0006399169,0.017970365,0.0004994128,0.0011205312,0.0130861085,0.00023139239,0.011089193,0.000031207484],"about_ca_topic_score_codex":0.0003404204,"about_ca_topic_score_gemma":0.00037885382,"teacher_disagreement_score":0.0006909618,"about_ca_system_score_codex":0.00013148463,"about_ca_system_score_gemma":0.00021976302,"threshold_uncertainty_score":0.0036542416},"labels":[],"label_agreement":null},{"id":"W2038519972","doi":"10.1111/j.1365-2141.2007.06541.x","title":"Significance of persistent Auer rods and cytogenetic abnormality after first cycle of therapy for acute promyelocytic leukaemia","year":2007,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Retinoids in leukemia and cellular processes","field":"Biochemistry, Genetics and Molecular Biology","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver General Hospital","funders":"","keywords":"Bone marrow; Promyelocyte; Daunorubicin; Myeloid; Pathology; Chromosomal translocation; Medicine; Acute promyelocytic leukemia; Cancer research; Biology; Retinoic acid; Leukemia; Immunology; Cell culture; Genetics","score_opus":0.007216984125317701,"score_gpt":0.25628441028898274,"score_spread":0.24906742616366503,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2038519972","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9805767,0.009724387,0.00025792874,0.002333224,0.00024591346,0.000051785722,0.00038229983,0.00006886596,0.0063588917],"genre_scores_gemma":[0.99774843,0.0009459743,0.00011947543,0.00019150728,0.00019355748,0.0000048186816,0.00011538836,0.0000069384314,0.0006739154],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9996362,0.000068717214,0.000048151607,0.000058094276,0.000091997994,0.00009684481],"domain_scores_gemma":[0.9980592,0.00073697226,0.0005922317,0.00010201704,0.00022669525,0.0002828291],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00030921327,0.00023906605,0.0006017224,0.0010537193,0.000536237,0.0008494767,0.00049802364,0.0015347835,0.0025887585],"category_scores_gemma":[0.0033443817,0.00018595163,0.0003159829,0.00071103417,0.00043450706,0.0004778933,0.00020886256,0.00086375844,0.00053252286],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008163676,0.0002988037,0.6236832,0.0003125272,0.00012084833,0.2743602,0.00058184715,0.00040223467,0.020248735,0.00056971447,0.0052430606,0.066015095],"study_design_scores_gemma":[0.00014001946,0.0015397767,0.7411373,0.00008349566,0.00017072713,0.24485208,0.00056910975,0.0006985788,0.0031032062,0.00076678663,0.0068829586,0.000055877317],"about_ca_topic_score_codex":0.003090444,"about_ca_topic_score_gemma":0.0018161122,"teacher_disagreement_score":0.003090444,"about_ca_system_score_codex":0.0007094398,"about_ca_system_score_gemma":0.0005235226,"threshold_uncertainty_score":0.008660257},"labels":[],"label_agreement":null},{"id":"W2038613090","doi":"10.1111/j.1365-2141.2009.07712.x","title":"Treatment of adults with BCR‐ABL negative acute lymphoblastic leukaemia with a modified paediatric regimen","year":2009,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":148,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Medicine; Regimen; Internal medicine; Acute lymphocytic leukemia; Dosing; Adverse effect; Transplantation; Asparaginase; White blood cell; Pediatrics; Gastroenterology; Surgery; Lymphoblastic Leukemia; Leukemia","score_opus":0.009140938515400598,"score_gpt":0.25592856217296367,"score_spread":0.24678762365756307,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2038613090","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9845265,0.010976128,0.0009186768,0.00020998961,0.00003774678,0.00022689337,0.00024312291,0.000034941437,0.0028258606],"genre_scores_gemma":[0.9876508,0.0072934157,0.0027824563,0.00034220848,0.000080008016,0.00020662094,0.0007661153,0.000010976606,0.00086742226],"study_design_codex":"design_other","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.99982613,0.00007301988,0.000024585257,0.000020013422,0.00003145288,0.000024872805],"domain_scores_gemma":[0.9997018,0.000053392927,0.00012622598,0.000025839627,0.000022073682,0.000070719296],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023056564,0.00022652873,0.00046920122,0.00014481998,0.00014918958,0.00017764077,0.0001765868,0.0001535848,0.00092406856],"category_scores_gemma":[0.0008473328,0.000103490616,0.00020337326,0.0003550742,0.0001458502,0.00014578011,0.00029786388,0.000442987,0.000243321],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.019236736,0.002846496,0.268065,0.0015904795,0.00048349812,0.005618273,0.0012902496,0.0037285755,0.052774686,0.00059273053,0.005798172,0.63797516],"study_design_scores_gemma":[0.0059647537,0.06748035,0.7543904,0.00028814317,0.00063383003,0.03557613,0.00030952867,0.001305437,0.015823279,0.00034520277,0.117838085,0.00004485606],"about_ca_topic_score_codex":0.00070151594,"about_ca_topic_score_gemma":0.0012022605,"teacher_disagreement_score":0.00092406856,"about_ca_system_score_codex":0.00035300927,"about_ca_system_score_gemma":0.00031464337,"threshold_uncertainty_score":0.0030913353},"labels":[],"label_agreement":null},{"id":"W2038650283","doi":"10.1111/j.1365-2141.2012.09182.x","title":"Treatment of Philadelphia chromosome‐positive acute lymphoblastic leukaemia with imatinib combined with a paediatric‐based protocol","year":2012,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":26,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Imatinib; Medicine; Philadelphia chromosome; Lymphoblastic Leukemia; Oncology; Acute lymphocytic leukemia; Internal medicine; Protocol (science); Cancer research; Pediatrics; Genetics; Leukemia; Chromosomal translocation; Biology; Pathology; Gene","score_opus":0.013685615612186989,"score_gpt":0.2904975436426154,"score_spread":0.27681192803042837,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2038650283","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9769992,0.004171418,0.005309059,0.00039725282,0.000093560964,0.004205254,0.00050273014,0.00009565063,0.008225831],"genre_scores_gemma":[0.97448593,0.004450116,0.011434636,0.00033243594,0.00008650162,0.0053628036,0.0016472214,0.000024982963,0.0021752657],"study_design_codex":"design_other","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.99965334,0.00019915278,0.00004355623,0.000024156427,0.000049853385,0.000029878345],"domain_scores_gemma":[0.9997069,0.00005615917,0.00008762494,0.000050801526,0.000027439104,0.00007112127],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00069869764,0.00026625567,0.00053356495,0.0004427373,0.00022785681,0.00021634532,0.00057073793,0.0002227521,0.0018998402],"category_scores_gemma":[0.0008909497,0.00009787767,0.0003083369,0.00047868837,0.0002487857,0.00016311921,0.00073977065,0.0007309737,0.00035583836],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.05216432,0.014153304,0.03921908,0.0032880884,0.0006438191,0.0024229356,0.000836961,0.014674092,0.117599115,0.0034763596,0.00837549,0.74314636],"study_design_scores_gemma":[0.044547785,0.2987714,0.3301851,0.0011691867,0.0012879256,0.014559359,0.00049413793,0.009816658,0.09109876,0.003352042,0.20456444,0.000153242],"about_ca_topic_score_codex":0.00031586149,"about_ca_topic_score_gemma":0.00089335244,"teacher_disagreement_score":0.0018998402,"about_ca_system_score_codex":0.00042063734,"about_ca_system_score_gemma":0.00073522766,"threshold_uncertainty_score":0.0063555837},"labels":[],"label_agreement":null},{"id":"W2038880599","doi":"10.1111/j.1365-2141.2005.05755.x","title":"Allogeneic haematopoietic stem‐cell transplantation for relapsed and refractory aggressive histology non‐Hodgkin lymphoma*","year":2005,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":87,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency; Vancouver Hospital and Health Sciences Centre","funders":"","keywords":"Lymphoma; Medicine; Stem cell; Refractory (planetary science); Transplantation; Hematopoietic stem cell transplantation; Histology; Haematopoiesis; Non-Hodgkin's lymphoma; Aggressive lymphoma; Oncology; Hematology; Hodgkin lymphoma; Internal medicine; Pathology; Cancer research; Biology; Rituximab","score_opus":0.010519418045095994,"score_gpt":0.2520527148463884,"score_spread":0.24153329680129243,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2038880599","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99905163,0.00055319065,0.00011631385,0.000016238126,0.000008854333,0.000031862182,0.00002825168,0.000006112098,0.00018753181],"genre_scores_gemma":[0.99905044,0.00035673007,0.00015017614,0.00006473703,0.000035411347,0.000029969535,0.0001384538,0.0000018697513,0.00017217091],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99987686,0.00003298778,0.000015612015,0.00001362824,0.000021651871,0.000039150393],"domain_scores_gemma":[0.9997428,0.0000623361,0.000066581975,0.000014049525,0.00001117808,0.00010296498],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00033832132,0.0002898498,0.0003253031,0.00024634393,0.00029511435,0.00029032413,0.00016650363,0.00023396958,0.00084948033],"category_scores_gemma":[0.0006320643,0.0001363605,0.00023358194,0.00025048797,0.0002454289,0.00012506054,0.000255566,0.00023171204,0.00022101331],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006023948,0.0012647965,0.85505337,0.00027014728,0.00026599708,0.0131313,0.0006682053,0.0011300343,0.018880393,0.00013537612,0.0012097288,0.1019666],"study_design_scores_gemma":[0.0017337865,0.0191329,0.9449338,0.00007399588,0.00025290917,0.023887627,0.0004788935,0.0016486355,0.0038290715,0.00020550763,0.003803359,0.000019603067],"about_ca_topic_score_codex":0.0005222983,"about_ca_topic_score_gemma":0.0010771259,"teacher_disagreement_score":0.00084948033,"about_ca_system_score_codex":0.00022750883,"about_ca_system_score_gemma":0.00031375102,"threshold_uncertainty_score":0.0028418303},"labels":[],"label_agreement":null},{"id":"W2039715247","doi":"10.1046/j.1365-2141.2002.03554.x","title":"The safety and effectiveness of deferiprone in a large‐scale, 3‐year study in Italian patients","year":2002,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":216,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Apotex (Canada)","funders":"Ministero della Salute; Chiesi Farmaceutici","keywords":"Deferiprone; Medicine; Discontinuation; Neutropenia; Incidence (geometry); Adverse effect; Internal medicine; Christian ministry; Pediatrics; Surgery; Thalassemia; Chemotherapy","score_opus":0.005380835945948151,"score_gpt":0.22928291459355865,"score_spread":0.2239020786476105,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2039715247","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9978587,0.0013563319,0.00006199207,0.0001068078,0.000012461419,0.000059967995,0.000107662956,0.000005745768,0.0004303856],"genre_scores_gemma":[0.99816614,0.00069538126,0.00010011499,0.00031829224,0.00009444967,0.00007501442,0.00038012813,0.0000024200613,0.0001680079],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99912053,0.00039216763,0.00006527008,0.000119864715,0.0001616544,0.00014048463],"domain_scores_gemma":[0.99790287,0.0004888618,0.0007326141,0.00021784187,0.00015623309,0.00050162413],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0027266587,0.00049261015,0.0008582743,0.00033374268,0.0007174166,0.0008164148,0.0002758069,0.00079081,0.00054747664],"category_scores_gemma":[0.0034228668,0.0002658858,0.0009900045,0.00048084327,0.0006597115,0.00035963499,0.00026627418,0.0009233957,0.00024610845],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.09722039,0.009794733,0.8251148,0.00040700493,0.0013512612,0.0023608513,0.0019796002,0.00055870187,0.006694401,0.00014502842,0.0017345061,0.05263872],"study_design_scores_gemma":[0.007275231,0.06911965,0.91860396,0.000039014416,0.0004340603,0.0014825676,0.00019540128,0.00037367697,0.0004697498,0.000069612826,0.0018959328,0.00004120728],"about_ca_topic_score_codex":0.0020014255,"about_ca_topic_score_gemma":0.0014579945,"teacher_disagreement_score":0.0027266587,"about_ca_system_score_codex":0.00081748515,"about_ca_system_score_gemma":0.00065930793,"threshold_uncertainty_score":0.014420152},"labels":[],"label_agreement":null},{"id":"W2040316233","doi":"10.1046/j.1365-2141.2002.03282.x","title":"Single‐centre experience with allogeneic bone marrow transplantation for acute lymphoblastic leukaemia in childhood: similar survival after matched‐related and matched‐unrelated donor transplants","year":2002,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":41,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Princess Margaret Cancer Centre; Hospital for Sick Children","funders":"Hospital for Sick Children","keywords":"Medicine; Bone marrow; Etoposide; Total body irradiation; Internal medicine; Transplantation; Incidence (geometry); Cumulative incidence; Graft-versus-host disease; Surgery; Acute lymphocytic leukemia; Gastroenterology; Chemotherapy; Leukemia; Cyclophosphamide; Lymphoblastic Leukemia","score_opus":0.010798388676998434,"score_gpt":0.23163032715861318,"score_spread":0.22083193848161475,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2040316233","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99746513,0.0014642453,0.00020422548,0.00007292948,0.000029526429,0.000023748942,0.000061692954,0.000013443348,0.00066514086],"genre_scores_gemma":[0.99852604,0.00077733723,0.00016089015,0.00006838379,0.000050531933,0.00001695047,0.00020945905,0.0000068568565,0.00018352167],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99923086,0.00029846968,0.00008256285,0.00009340468,0.00013948961,0.00015525674],"domain_scores_gemma":[0.99858236,0.00029416205,0.00036789582,0.00013238023,0.00010295969,0.0005202368],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011607021,0.00034669242,0.00047385046,0.00047320029,0.00049633696,0.00060429604,0.00038668717,0.0005578038,0.0012207777],"category_scores_gemma":[0.0034123783,0.00016990189,0.0006591138,0.0005807132,0.0003504401,0.00032864502,0.0005322965,0.00037524142,0.00043136705],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004000515,0.0016451417,0.88661456,0.0002727867,0.0005303224,0.014932268,0.0026824423,0.0019576706,0.005735678,0.00027530742,0.0017294748,0.07962373],"study_design_scores_gemma":[0.0010010601,0.013813727,0.9183587,0.00010874641,0.00025307963,0.05709926,0.0011549299,0.0011290602,0.002707812,0.00023544575,0.0040824325,0.000055671626],"about_ca_topic_score_codex":0.0013596424,"about_ca_topic_score_gemma":0.002161642,"teacher_disagreement_score":0.0013596424,"about_ca_system_score_codex":0.00070259644,"about_ca_system_score_gemma":0.00037502308,"threshold_uncertainty_score":0.006138444},"labels":[],"label_agreement":null},{"id":"W2040339484","doi":"10.1046/j.1365-2141.2001.02543.x","title":"Progressive reduction in treatment‐related deaths in Medical Research Council childhood lymphoblastic leukaemia trials from 1980 to 1997 (UKALL VIII, X and XI)","year":2001,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":78,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Royal Ottawa Mental Health Centre","funders":"","keywords":"Medicine; Measles; Pediatrics; Incidence (geometry); Mortality rate; Internal medicine; Vaccination; Immunology","score_opus":0.06803960230585933,"score_gpt":0.3645700482302487,"score_spread":0.2965304459243894,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2040339484","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.89050716,0.09299105,0.00042002098,0.005093767,0.00044325565,0.001405224,0.004104957,0.00012273405,0.0049119242],"genre_scores_gemma":[0.95207626,0.029806904,0.001898238,0.004096289,0.00034042762,0.0029976638,0.005980762,0.000054620596,0.0027489057],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.9903334,0.0073683173,0.00089864427,0.000403215,0.0005248714,0.00047157114],"domain_scores_gemma":[0.98883444,0.0038902462,0.0045089656,0.00072313036,0.00075868226,0.001284549],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0134621635,0.00053920824,0.0022790225,0.00070257706,0.00033310056,0.0013504268,0.0009399636,0.0010688131,0.0020475646],"category_scores_gemma":[0.015524104,0.0003815652,0.0016066235,0.0018388062,0.00055574207,0.0010677207,0.00094144116,0.0019546684,0.00027633912],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.5451218,0.0027317526,0.032215904,0.014204546,0.007450554,0.00037602207,0.0011157227,0.003929976,0.004852146,0.0013587242,0.026016645,0.36062625],"study_design_scores_gemma":[0.46306813,0.16627593,0.29108024,0.00396021,0.0071210763,0.0013335698,0.00042952714,0.0010399539,0.00305751,0.00079702656,0.061698947,0.00013781508],"about_ca_topic_score_codex":0.005050475,"about_ca_topic_score_gemma":0.015581117,"teacher_disagreement_score":0.0134621635,"about_ca_system_score_codex":0.0022788665,"about_ca_system_score_gemma":0.0019769282,"threshold_uncertainty_score":0.0711956},"labels":[],"label_agreement":null},{"id":"W2040671376","doi":"10.1046/j.1365-2141.2002.03402.x","title":"Regulation of plasminogen activator inhibitor‐1 secretion by urokinase and tissue plasminogen activator in rat epithelioid‐type smooth muscle cells","year":2002,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Protease and Inhibitor Mechanisms","field":"Biochemistry, Genetics and Molecular Biology","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; St. Michael's Hospital","funders":"","keywords":"MAPK/ERK pathway; Protein kinase C; Plasminogen activator; Signal transduction; Cell biology; Activator (genetics); Kinase; Protein kinase A; Tyrosine kinase; Secretion; Proto-oncogene tyrosine-protein kinase Src; Proteases; Mitogen-activated protein kinase; Biology; Chemistry; Receptor; Biochemistry; Endocrinology; Enzyme","score_opus":0.008473699515964111,"score_gpt":0.21506683101008406,"score_spread":0.20659313149411995,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2040671376","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98978335,0.006794313,0.0014555802,0.000114011484,0.00006259641,0.000030911466,0.0003139219,0.00006521567,0.0013800062],"genre_scores_gemma":[0.9893483,0.004162589,0.002948994,0.000080158214,0.00003518581,0.000076279895,0.0006407507,0.000011992657,0.0026958736],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99959344,0.00008543404,0.00003797452,0.000040034036,0.00009250988,0.00015066082],"domain_scores_gemma":[0.99977976,0.00005065945,0.00004311027,0.00003741615,0.000032675653,0.000056332236],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002931788,0.00031896055,0.00044423004,0.00041400996,0.00014974741,0.0003318109,0.0001698397,0.00025262422,0.0008968992],"category_scores_gemma":[0.00019258047,0.00024685037,0.0005112452,0.00033369366,0.00027156755,0.00022244923,0.00020590078,0.0005582737,0.0005353974],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00022736265,0.00004141004,0.00018153207,0.000036664944,0.0000037546224,0.00006397792,0.000020740148,0.000026874732,0.9984072,0.000042771255,0.000024429382,0.00092323066],"study_design_scores_gemma":[0.00006156567,0.001326288,0.019942623,0.000008966174,0.000033087024,0.00031881678,0.000081637365,0.0009149768,0.9749772,0.000055171793,0.0022660464,0.000013569127],"about_ca_topic_score_codex":0.0015113545,"about_ca_topic_score_gemma":0.0013996869,"teacher_disagreement_score":0.0015113545,"about_ca_system_score_codex":0.00037584125,"about_ca_system_score_gemma":0.0002845448,"threshold_uncertainty_score":0.0030050874},"labels":[],"label_agreement":null},{"id":"W2040852160","doi":"10.1111/bjh.13016","title":"A phase 1 clinical trial of vorinostat in combination with decitabine in patients with acute myeloid leukaemia or myelodysplastic syndrome","year":2014,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Histone Deacetylase Inhibitors Research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":131,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital","funders":"Merck","keywords":"Decitabine; Vorinostat; Medicine; Tolerability; Myelodysplastic syndromes; Internal medicine; Oncology; Refractory (planetary science); Myeloid leukemia; Pharmacology; Adverse effect; Histone deacetylase; Bone marrow; Biology","score_opus":0.012352795511653919,"score_gpt":0.3094381602760078,"score_spread":0.2970853647643539,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2040852160","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9951336,0.0012733206,0.00034543753,0.00026680873,0.000052716376,0.0016037559,0.00034445623,0.00003993646,0.0009400566],"genre_scores_gemma":[0.9908915,0.0013398284,0.0017945658,0.0004391876,0.000101399986,0.0023256675,0.0012916223,0.000012962905,0.0018032612],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9996958,0.00017939946,0.000012373215,0.000044509714,0.000021909356,0.000045993518],"domain_scores_gemma":[0.99959487,0.00009390054,0.00010868331,0.000028639412,0.000020694835,0.00015319379],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00094613223,0.0014475839,0.0013395337,0.0003703767,0.00030822787,0.00052242243,0.00050080824,0.00078462367,0.0024948022],"category_scores_gemma":[0.0008100669,0.00041654214,0.00074682175,0.00025517933,0.00062689494,0.00037951896,0.0002806358,0.0017530825,0.00035654058],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.74427384,0.0632696,0.008319191,0.0005950968,0.0008321162,0.0005261313,0.00030366002,0.0041421875,0.05843854,0.00041314168,0.0033107551,0.11557564],"study_design_scores_gemma":[0.44689238,0.5312029,0.010913606,0.000027476271,0.0002453719,0.00033944577,0.000041251922,0.0018617032,0.0057827667,0.00022144114,0.002447793,0.00002382797],"about_ca_topic_score_codex":0.00046481568,"about_ca_topic_score_gemma":0.0014080013,"teacher_disagreement_score":0.0024948022,"about_ca_system_score_codex":0.00066870585,"about_ca_system_score_gemma":0.0010464325,"threshold_uncertainty_score":0.008345962},"labels":[],"label_agreement":null},{"id":"W2040910538","doi":"10.1046/j.1365-2141.2000.01882.x","title":"New genotypes in Fy(a− b−) individuals: nonsense mutations (Trp to stop) in the coding sequence of either <i>FY A</i> or <i>FY B</i>","year":2000,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Blood groups and transfusion","field":"Medicine","cited_by":64,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Blood Services","funders":"National Heart, Lung, and Blood Institute; National Institutes of Health","keywords":"Nonsense mutation; Coding region; Genetics; Stop codon; Nonsense; Biology; Genotype; Phenotype; Genotype-phenotype distinction; Gene; Mutation; Nonsense-mediated decay; Molecular biology; Nucleotide; Point mutation; RNA splicing; Missense mutation; RNA","score_opus":0.028225948320547332,"score_gpt":0.30216181671561354,"score_spread":0.27393586839506623,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2040910538","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99798775,0.00015312438,0.00049691333,0.00007389163,0.000029938854,0.000027253449,0.00017156625,0.000022615981,0.0010368826],"genre_scores_gemma":[0.9980292,0.00011338643,0.00058530935,0.00014676765,0.00005933077,0.000023062468,0.00016030006,0.000020567972,0.0008620504],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.99965656,0.000037615464,0.00004402082,0.00011956563,0.000068405025,0.00007386612],"domain_scores_gemma":[0.99938786,0.00012807743,0.00014414999,0.000028633864,0.000047294474,0.00026398973],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00028192572,0.001211839,0.00040804528,0.0012374481,0.0012438489,0.0004915452,0.00033775426,0.0013185813,0.0029363935],"category_scores_gemma":[0.0010365507,0.00038194587,0.0004191835,0.0005337394,0.000829607,0.0003039229,0.00056639285,0.0007368157,0.0004985596],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0038132416,0.0013951864,0.50088334,0.00016740877,0.00028325163,0.22557537,0.0058118,0.0004164828,0.2244284,0.0026703915,0.0028965136,0.03165853],"study_design_scores_gemma":[0.00044356784,0.0030618855,0.53161466,0.00009319303,0.00021355934,0.44358566,0.0010582268,0.0008473811,0.011091429,0.0010699476,0.006806912,0.00011355092],"about_ca_topic_score_codex":0.0032038277,"about_ca_topic_score_gemma":0.002935369,"teacher_disagreement_score":0.0032038277,"about_ca_system_score_codex":0.00021039383,"about_ca_system_score_gemma":0.00025464612,"threshold_uncertainty_score":0.009823203},"labels":[],"label_agreement":null},{"id":"W2041006251","doi":"10.1111/j.1365-2141.2006.06069.x","title":"Shwachman–Diamond syndrome: an inherited model of aplastic anaemia with accelerated angiogenesis","year":2006,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Blood disorders and treatments","field":"Biochemistry, Genetics and Molecular Biology","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children; Institute of Infection and Immunity; Population Health Research Institute; University of Toronto","funders":"","keywords":"Angiogenesis; Bone marrow; Medicine; Stromal cell; Bone marrow failure; Vascular endothelial growth factor; Myeloid; Neovascularization; Cancer research; Immunology; Pathology; Stem cell; Haematopoiesis; Biology; VEGF receptors","score_opus":0.009851187868672031,"score_gpt":0.21971111407312666,"score_spread":0.20985992620445462,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2041006251","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9914085,0.0015815782,0.0035272336,0.00044479553,0.00004801806,0.00011002729,0.00045716713,0.00010107037,0.0023215879],"genre_scores_gemma":[0.99319094,0.0011270732,0.002604479,0.00009953384,0.000027822425,0.00010190947,0.0003283704,0.000009208329,0.0025106743],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.999783,0.000075555494,0.000015454834,0.000039744573,0.00006009441,0.000026174182],"domain_scores_gemma":[0.99983597,0.000046598427,0.00003970974,0.000025236977,0.000006949077,0.000045621713],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022739453,0.00055810425,0.00041579074,0.0008948487,0.00028600017,0.00019333794,0.00042618188,0.000624673,0.002190905],"category_scores_gemma":[0.00023198857,0.00021567164,0.00018681497,0.000450611,0.00059210864,0.00021874621,0.00048801178,0.0004348483,0.00029927347],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0047938717,0.0011362367,0.012824142,0.0005420814,0.0001237893,0.02607038,0.00041371715,0.0018316146,0.9063965,0.018155908,0.0031118847,0.024599815],"study_design_scores_gemma":[0.006561955,0.021872789,0.15284936,0.00027976173,0.00060148584,0.33601442,0.0011721987,0.02912093,0.3223685,0.021252984,0.10765946,0.00024611846],"about_ca_topic_score_codex":0.0011498771,"about_ca_topic_score_gemma":0.0013433882,"teacher_disagreement_score":0.002190905,"about_ca_system_score_codex":0.00031412215,"about_ca_system_score_gemma":0.00031831986,"threshold_uncertainty_score":0.0073293447},"labels":[],"label_agreement":null},{"id":"W2041060786","doi":"10.1046/j.1365-2141.2000.01797.x","title":"CAN WE PREVENT CYTOTOXIC DISASTERS?","year":2000,"lang":"en","type":"review","venue":"British Journal of Haematology","topic":"Patient Safety and Medication Errors","field":"Health Professions","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Izaak Walton Killam Health Centre","funders":"IWK Health Centre","keywords":"Harm; Medicine; Human error; Intensive care medicine; Accidental; Risk analysis (engineering); Computer science; Psychology","score_opus":0.09885099792456978,"score_gpt":0.4400634920469776,"score_spread":0.34121249412240784,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2041060786","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0006849803,0.8797836,0.0015253406,0.093523644,0.013712711,0.00007826268,0.00017876382,0.00009510477,0.01041769],"genre_scores_gemma":[0.007377648,0.9424192,0.0017724779,0.03695427,0.0052827694,0.00013853786,0.00015935788,0.00003071157,0.005865024],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9986374,0.000532248,0.00015008183,0.00017266755,0.0003529129,0.00015467018],"domain_scores_gemma":[0.9959758,0.002405752,0.00036474102,0.00012810233,0.0008056504,0.0003199324],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00247898,0.0008247964,0.001155089,0.0013603767,0.0009736579,0.003465562,0.0018086435,0.004746035,0.016932026],"category_scores_gemma":[0.012750564,0.0002919969,0.0010962455,0.0010023548,0.0017380575,0.007082767,0.0018031431,0.005636855,0.0051165805],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014777179,0.00019158979,0.0006052729,0.023681602,0.00017603647,0.00064799184,0.0008179987,0.0007414572,0.00040437546,0.04514255,0.25579464,0.67164874],"study_design_scores_gemma":[0.000028861874,0.00010723815,0.0004252185,0.011226576,0.00008012335,0.00050590007,0.00087180175,0.00008895485,0.00016793875,0.017329814,0.9691423,0.000025273386],"about_ca_topic_score_codex":0.0024628607,"about_ca_topic_score_gemma":0.0045816717,"teacher_disagreement_score":0.016932026,"about_ca_system_score_codex":0.0011872244,"about_ca_system_score_gemma":0.0062919916,"threshold_uncertainty_score":0.056643307},"labels":[],"label_agreement":null},{"id":"W2041284044","doi":"10.1046/j.1365-2141.2002.03291.x","title":"ETV6 (TEL)‐AML1 pre‐B acute lymphoblastic leukaemia cells are associated with a distinct antigen‐presenting phenotype","year":2002,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":28,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Children's & Women's Health Centre of British Columbia; BC Children's Hospital; University of British Columbia","funders":"","keywords":"Immunophenotyping; ETV6; Biology; Antigen; Chromosomal translocation; Molecular biology; Immunology; Phenotype; Genetics; Gene","score_opus":0.01604182755766061,"score_gpt":0.2549685026487497,"score_spread":0.23892667509108909,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2041284044","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9990729,0.000269973,0.00020686071,0.000007928571,0.0000013685964,0.000007688665,0.00010709208,0.00000940597,0.00031682287],"genre_scores_gemma":[0.99862707,0.00022498696,0.0003284683,0.000012152511,0.0000040756463,0.000011539545,0.00040785066,0.000004458337,0.0003794939],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.999835,0.000025888581,0.000019211808,0.00003316209,0.000051865598,0.00003485773],"domain_scores_gemma":[0.9997212,0.00006736402,0.00012715113,0.000024913352,0.000020475914,0.0000388449],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009196898,0.00019274728,0.0002082537,0.000360834,0.0001620041,0.00041465595,0.00011782534,0.00029767764,0.0026971293],"category_scores_gemma":[0.00039754758,0.00015771529,0.00008764045,0.000408326,0.00028263865,0.00016272833,0.00026986044,0.00023532961,0.00059087516],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001392318,0.0001377098,0.15947206,0.00016056941,0.00004789438,0.0032769567,0.00049866055,0.00025284349,0.8193393,0.0004169118,0.00021351992,0.014791262],"study_design_scores_gemma":[0.00011967576,0.0010327313,0.8178586,0.000015953345,0.000052379688,0.059749383,0.00038055246,0.00069892156,0.11298785,0.000472739,0.0066129286,0.000018354762],"about_ca_topic_score_codex":0.00023883302,"about_ca_topic_score_gemma":0.00039200587,"teacher_disagreement_score":0.0026971293,"about_ca_system_score_codex":0.00015434659,"about_ca_system_score_gemma":0.00005807698,"threshold_uncertainty_score":0.009022832},"labels":[],"label_agreement":null},{"id":"W2041513065","doi":"10.1046/j.1365-2141.2003.04160.x","title":"Long‐term follow‐up of granulocyte colony‐stimulating factor receptor mutations in patients with severe congenital neutropenia: implications for leukaemogenesis and therapy","year":2003,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Blood disorders and treatments","field":"Biochemistry, Genetics and Molecular Biology","cited_by":45,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Hospital for Sick Children; Amgen","keywords":"Congenital Neutropenia; Neutropenia; Granulocyte colony-stimulating factor; Mutation; Granulocyte colony-stimulating factor receptor; Medicine; Myeloid; Immunology; Internal medicine; Granulocyte; Myeloid leukemia; Cancer research; Chemotherapy; Biology; Genetics; Gene","score_opus":0.01145178917496193,"score_gpt":0.2460621192961925,"score_spread":0.2346103301212306,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2041513065","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9971577,0.0015353089,0.00015584288,0.00021806317,0.000017449154,0.000011799462,0.00014049253,0.000007995024,0.00075528945],"genre_scores_gemma":[0.9991554,0.00021120247,0.00008845054,0.000078991456,0.000020826157,0.00000775085,0.00024510574,0.0000021964177,0.00019007018],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9993412,0.00016572444,0.000087382134,0.000093672454,0.00015968677,0.00015247622],"domain_scores_gemma":[0.99732697,0.00065192283,0.00065634825,0.00016257755,0.0004383616,0.00076379545],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011604887,0.00024016817,0.00056555,0.00086105947,0.00089260534,0.00054311234,0.0003183411,0.0009925517,0.0005566587],"category_scores_gemma":[0.00403379,0.00016192642,0.00043725004,0.00065497716,0.00034918284,0.00065220427,0.00035035526,0.0008826925,0.0002587647],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00081754115,0.0001452336,0.97994196,0.0000204501,0.000050740528,0.0036537834,0.00029100495,0.00014125757,0.0015904311,0.000037159825,0.00024381992,0.013066726],"study_design_scores_gemma":[0.00004273172,0.0013261994,0.9849517,0.00002876049,0.00019570491,0.010639516,0.00023786153,0.0003596215,0.0009003069,0.00013672754,0.0011517281,0.000029203038],"about_ca_topic_score_codex":0.0026412911,"about_ca_topic_score_gemma":0.0024608418,"teacher_disagreement_score":0.0026412911,"about_ca_system_score_codex":0.00047769444,"about_ca_system_score_gemma":0.0003356634,"threshold_uncertainty_score":0.0061373115},"labels":[],"label_agreement":null},{"id":"W2042224959","doi":"10.1046/j.1365-2141.2003.04235.x","title":"Clinical manifestations associated with the aberrant expression of the soluble granulocyte–macrophage colony‐stimulating factor receptor in patients presenting with haematological malignancies","year":2003,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Blood disorders and treatments","field":"Biochemistry, Genetics and Molecular Biology","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary; Mount Sinai Hospital; Princess Margaret Cancer Centre; Ontario Institute for Cancer Research","funders":"","keywords":"Myeloid; Immunology; Haematopoiesis; Population; Medicine; Internal medicine; Granulocyte macrophage colony-stimulating factor; CD64; Biology; Cytokine; Stem cell; Flow cytometry","score_opus":0.0138217327615872,"score_gpt":0.25475931577350863,"score_spread":0.24093758301192142,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2042224959","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9983334,0.0006134356,0.00009105943,0.000054473778,0.0000066013326,0.000013904868,0.00006319509,0.000008065192,0.0008159947],"genre_scores_gemma":[0.999616,0.00015285845,0.000059903294,0.000022865475,0.000013398367,0.0000044733792,0.00006048867,0.0000012241488,0.00006886481],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.999705,0.000072137045,0.000037383823,0.000058465845,0.000057581372,0.00006941481],"domain_scores_gemma":[0.9990784,0.00021998983,0.00034855612,0.000036044654,0.00005367694,0.00026321146],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020627235,0.000339289,0.00046264988,0.0009563317,0.00047115795,0.00044683064,0.00023395751,0.000586426,0.0016494014],"category_scores_gemma":[0.0017350172,0.00025412466,0.00018663409,0.000906891,0.0004976248,0.00042023376,0.00038575384,0.00047518458,0.00026411493],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00053871475,0.00005765247,0.9780212,0.000040812574,0.000023228173,0.013189291,0.00024980237,0.00006163068,0.0046005123,0.000041524014,0.00017744872,0.0029981532],"study_design_scores_gemma":[0.00001784039,0.00026692418,0.9624102,0.000010810944,0.000026001244,0.036451347,0.00018961364,0.00009148484,0.00024800637,0.0000481522,0.0002301377,0.000009421851],"about_ca_topic_score_codex":0.0013525061,"about_ca_topic_score_gemma":0.0011127568,"teacher_disagreement_score":0.0016494014,"about_ca_system_score_codex":0.00023783043,"about_ca_system_score_gemma":0.00024967347,"threshold_uncertainty_score":0.0055178404},"labels":[],"label_agreement":null},{"id":"W2043234509","doi":"10.1111/bjh.12447","title":"How I manage heavy menstrual bleeding","year":2013,"lang":"en","type":"review","venue":"British Journal of Haematology","topic":"Uterine Myomas and Treatments","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Hamilton Regional Laboratory Medicine Program","funders":"","keywords":"Medicine; Menstrual bleeding; Etiology; Intensive care medicine; Clinical research; Population; Menstruation; Pediatrics; Gynecology; Internal medicine; Environmental health","score_opus":0.04806445549984252,"score_gpt":0.32276994094456163,"score_spread":0.2747054854447191,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2043234509","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00033999322,0.9834331,0.0005295409,0.0073768063,0.0019244117,0.000034170742,0.000048199086,0.00004238778,0.006271472],"genre_scores_gemma":[0.0026469359,0.9853821,0.0009898974,0.0055339923,0.0020893277,0.00003652341,0.00007622978,0.000008676725,0.0032362626],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99976724,0.000059602793,0.00003415478,0.000029815566,0.00008682913,0.000022202503],"domain_scores_gemma":[0.9997608,0.00010024539,0.00004676141,0.000008008453,0.000052278927,0.000031881213],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00039622642,0.0005156934,0.00083132024,0.0013204507,0.00031211195,0.0011013147,0.00073007675,0.0016177393,0.006047519],"category_scores_gemma":[0.0015657867,0.00017247944,0.00048092598,0.0006801112,0.00043872464,0.001599213,0.0005849788,0.0022353034,0.0054975115],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000066832916,0.000078722594,0.00030416256,0.012129991,0.00007541759,0.00053526566,0.00017251508,0.00010314204,0.0008470752,0.0020939256,0.10436387,0.879229],"study_design_scores_gemma":[0.000041547988,0.000093993425,0.0016110542,0.014966744,0.00007614745,0.008891217,0.0002660942,0.00007125319,0.00030912008,0.0033983388,0.97025126,0.000023179364],"about_ca_topic_score_codex":0.0009608878,"about_ca_topic_score_gemma":0.0013743993,"teacher_disagreement_score":0.006047519,"about_ca_system_score_codex":0.00032478865,"about_ca_system_score_gemma":0.00061934115,"threshold_uncertainty_score":0.020230949},"labels":[],"label_agreement":null},{"id":"W2043688074","doi":"10.1111/j.1365-2141.2008.07418.x","title":"Dasatinib sensitizes primary chronic lymphocytic leukaemia lymphocytes to chlorambucil and fludarabine <i>in vitro</i>","year":2008,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":57,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; CancerCare Manitoba; Jewish General Hospital","funders":"Leukemia and Lymphoma Society; Canadian Institutes of Health Research; Bristol-Myers Squibb","keywords":"Chlorambucil; Fludarabine; Dasatinib; Chronic lymphocytic leukemia; Cancer research; Medicine; Immunology; Internal medicine; Leukemia; Chemotherapy; Imatinib; Myeloid leukemia","score_opus":0.015242801933903328,"score_gpt":0.25840118592357314,"score_spread":0.24315838398966982,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2043688074","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9907069,0.0025641078,0.002496664,0.00009853528,0.000075161406,0.00009546305,0.00062931876,0.000103479695,0.0032303068],"genre_scores_gemma":[0.99225026,0.0012247245,0.0017433998,0.00010105311,0.000025486102,0.00009930775,0.0013738321,0.000017643459,0.003164345],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9997851,0.0000378034,0.000026384154,0.000042781463,0.000037729744,0.00007015098],"domain_scores_gemma":[0.99991846,0.000023553901,0.000011668459,0.000014184372,0.000013460754,0.000018656568],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013033695,0.0004073257,0.00044355873,0.00014592851,0.00020251544,0.00036811453,0.00017147146,0.00020330655,0.0025220455],"category_scores_gemma":[0.000103093174,0.00015308987,0.00037747738,0.000153181,0.00015374055,0.00010904322,0.00019698244,0.00043032423,0.00081834017],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018680234,0.000054792665,0.00020123877,0.00007002042,0.000009661386,0.000047146157,0.000026912123,0.00008032476,0.9975591,0.000028828334,0.0000609033,0.0016742405],"study_design_scores_gemma":[0.00004553918,0.0010402055,0.004490068,0.000006150234,0.000019786175,0.00033409402,0.000027849968,0.0003653013,0.99072146,0.000022584758,0.0029215605,0.000005306219],"about_ca_topic_score_codex":0.00092242885,"about_ca_topic_score_gemma":0.0017218769,"teacher_disagreement_score":0.0025220455,"about_ca_system_score_codex":0.00035515934,"about_ca_system_score_gemma":0.00026215333,"threshold_uncertainty_score":0.008437097},"labels":[],"label_agreement":null},{"id":"W2043758540","doi":"10.1111/j.1365-2141.1991.tb08631.x","title":"DETECTION OF ABNORMAL HAEMOGLOBINS BY THE SYSMEX NE-8000 AUTOMATED CELL COUNTER","year":2008,"lang":"en","type":"letter","venue":"British Journal of Haematology","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Credit Valley Hospital; Kingston General Hospital","funders":"","keywords":"Freedman; General hospital; Citation; Medicine; Library science; Pediatrics; Family medicine; Law; Political science; Computer science","score_opus":0.006511642704602737,"score_gpt":0.2197549949642122,"score_spread":0.21324335225960944,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2043758540","genre_codex":"commentary","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"editorial","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.16491742,0.009760198,0.017861674,0.6607458,0.028442021,0.00039899343,0.00055344007,0.0011476598,0.11617278],"genre_scores_gemma":[0.52170235,0.007082225,0.019345108,0.31531316,0.022934966,0.00034669143,0.0007664662,0.00021981081,0.112289146],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9989255,0.00038907523,0.00017174073,0.000075678465,0.00033254066,0.00010539661],"domain_scores_gemma":[0.99833786,0.0009442976,0.00013492111,0.00009285389,0.00033178166,0.00015817529],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00071042485,0.00055651995,0.00087153714,0.00065327645,0.0005049892,0.0006077219,0.00075359875,0.007456411,0.0048264912],"category_scores_gemma":[0.006050501,0.00038666266,0.00040986997,0.00042032712,0.00072376354,0.0009998254,0.00036123293,0.005687088,0.0038687314],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0020722141,0.0005462942,0.056897108,0.00039833813,0.000090535104,0.14248155,0.0008942877,0.0004572336,0.022049656,0.0040863627,0.6547709,0.11525553],"study_design_scores_gemma":[0.00061084935,0.0022376098,0.05631759,0.00056451466,0.000121707504,0.34864804,0.00076442375,0.011044366,0.019144267,0.007291299,0.5530665,0.00018886525],"about_ca_topic_score_codex":0.0015755722,"about_ca_topic_score_gemma":0.0021058435,"teacher_disagreement_score":0.007456411,"about_ca_system_score_codex":0.0006981738,"about_ca_system_score_gemma":0.00041607386,"threshold_uncertainty_score":0.016146183},"labels":[],"label_agreement":null},{"id":"W2043759160","doi":"10.1111/j.1365-2141.2006.06405.x","title":"A randomised comparison of melphalan with prednisone or dexamethasone as induction therapy and dexamethasone or observation as maintenance therapy in multiple myeloma: NCIC CTG MY.7","year":2006,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":82,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Island Health; Windsor Regional Hospital; BC Cancer Agency; St. John’s Health Sciences Centre; Royal Victoria Hospital; Moncton Hospital; Humber River Regional Hospital; London Health Sciences Centre; Queen Elizabeth II Health Sciences Centre","funders":"","keywords":"Dexamethasone; Medicine; Prednisone; Melphalan; Induction therapy; Multiple myeloma; Internal medicine; Oncology; Maintenance therapy; Chemotherapy","score_opus":0.06670175160755294,"score_gpt":0.33168352285355823,"score_spread":0.2649817712460053,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2043759160","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9795431,0.009355969,0.0008745862,0.000884658,0.0017180115,0.0046883975,0.0008210549,0.00008008715,0.0020341885],"genre_scores_gemma":[0.9860102,0.003254817,0.0016241416,0.0010761208,0.00088664854,0.0040197624,0.0006544108,0.00002091411,0.0024530005],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99734396,0.0018767935,0.0001843076,0.00025689238,0.00013324773,0.00020482265],"domain_scores_gemma":[0.9973908,0.0012818113,0.0004337149,0.00021824939,0.00010801995,0.0005673963],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0026253262,0.0016422434,0.0038760924,0.0007212386,0.00043881123,0.0011392799,0.0013714763,0.0035146398,0.008136514],"category_scores_gemma":[0.0049647554,0.0007933215,0.003806358,0.00063198747,0.0013277758,0.0010860013,0.00077090744,0.002746782,0.0009741845],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.99286884,0.001119667,0.00011965048,0.00027405747,0.00044082952,0.000014126258,0.000021387496,0.00007953842,0.0005464565,0.000055767963,0.0001416632,0.0043179174],"study_design_scores_gemma":[0.9443617,0.053379916,0.0008454968,0.00004934545,0.0005561925,0.000015509431,0.000017788061,0.0001916375,0.00012476383,0.0001441587,0.0003014381,0.000012070604],"about_ca_topic_score_codex":0.002082173,"about_ca_topic_score_gemma":0.0040256907,"teacher_disagreement_score":0.008136514,"about_ca_system_score_codex":0.0015437007,"about_ca_system_score_gemma":0.0014615072,"threshold_uncertainty_score":0.027219355},"labels":[],"label_agreement":null},{"id":"W2043995760","doi":"10.1111/bjh.12714","title":"Clinical features, management and prognosis of multifocal primary bone lymphoma: a retrospective study of the international extranodal lymphoma study group (the <scp>IELSG</scp> 14 study)","year":2014,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":62,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Ontario Institute for Cancer Research","funders":"","keywords":"Medicine; Lymphoma; Diffuse large B-cell lymphoma; Internal medicine; Radiation therapy; Stage (stratigraphy); Oncology; Pathology","score_opus":0.012666216875482599,"score_gpt":0.27175735920211574,"score_spread":0.25909114232663316,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2043995760","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99904877,0.0005209448,0.000040440926,0.00001379432,0.0000024438984,0.0000075345247,0.00018100684,0.0000019473887,0.00018307849],"genre_scores_gemma":[0.999423,0.0001406929,0.000022489661,0.000011855424,0.000007426105,0.0000076009132,0.00033311648,0.0000011917675,0.000052685824],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9994593,0.0001518883,0.00006605675,0.00014310938,0.00009505941,0.00008455452],"domain_scores_gemma":[0.9990369,0.00016617465,0.00040598356,0.00008658096,0.00009893713,0.00020539781],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006373057,0.0002793723,0.00040962957,0.0008661588,0.00032968156,0.00057611294,0.0003065992,0.0004338064,0.00090260705],"category_scores_gemma":[0.001420706,0.00034662665,0.0003621422,0.0010132273,0.00030849036,0.00048429088,0.00044175313,0.0003183672,0.00025176775],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011618568,0.000012555008,0.9989153,0.000005557369,0.000027014663,0.0001500396,0.00004630653,0.000014291743,0.000106206666,0.0000048083057,0.000045652352,0.0005561884],"study_design_scores_gemma":[0.0000106766665,0.000087538516,0.9987104,0.0000036201927,0.000020170106,0.0008385053,0.0001117336,0.000037042217,0.000026548827,0.0000069830567,0.00014444173,0.0000024476906],"about_ca_topic_score_codex":0.0031235237,"about_ca_topic_score_gemma":0.0026998739,"teacher_disagreement_score":0.0031235237,"about_ca_system_score_codex":0.00034254382,"about_ca_system_score_gemma":0.00022549565,"threshold_uncertainty_score":0.006210685},"labels":[],"label_agreement":null},{"id":"W2044479160","doi":"10.1111/bjh.12878","title":"Guidelines for the first line management of classical Hodgkin lymphoma","year":2014,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":80,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"National Institute for Health and Care Research; Cancer Research UK","keywords":"Hematology; Medicine; Hodgkin lymphoma; Internal medicine; Lymphoma; Oncology; Medical physics","score_opus":0.04588011173821988,"score_gpt":0.3272710597969642,"score_spread":0.2813909480587443,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2044479160","genre_codex":"review","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.006595836,0.47595575,0.05602533,0.20528701,0.021201178,0.02531631,0.019256022,0.0019190272,0.18844342],"genre_scores_gemma":[0.034805626,0.37754562,0.36321524,0.08405786,0.0063064597,0.026400324,0.04655792,0.0004804263,0.060630437],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9906872,0.0035918173,0.0030312522,0.0002964199,0.0019995049,0.00039383816],"domain_scores_gemma":[0.9821546,0.0048023676,0.0021037252,0.0003829524,0.009894465,0.0006618636],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.007675235,0.0011638064,0.0020415005,0.005415867,0.0008347776,0.002443825,0.0039742887,0.0050063017,0.009829642],"category_scores_gemma":[0.024816219,0.00081413,0.0032254215,0.004161566,0.0007283471,0.0023048841,0.0016612888,0.004436618,0.008588444],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010231862,0.00015677,0.00072105887,0.016182177,0.000102401886,0.0005568575,0.00065188843,0.00076264597,0.0006900446,0.0049626557,0.6890883,0.28602287],"study_design_scores_gemma":[0.00023656644,0.00016557988,0.0030159545,0.05335196,0.00022827699,0.0014161787,0.0003011877,0.0005022202,0.00022868816,0.004800855,0.93569523,0.00005733109],"about_ca_topic_score_codex":0.008678057,"about_ca_topic_score_gemma":0.017531408,"teacher_disagreement_score":0.009829642,"about_ca_system_score_codex":0.0035181523,"about_ca_system_score_gemma":0.008604343,"threshold_uncertainty_score":0.040591},"labels":[],"label_agreement":null},{"id":"W2044894710","doi":"10.1046/j.1365-2141.2002.03694.x","title":"Treatment of life‐threatening post‐haemorrhagic anaemia with cell‐free haemoglobin solution in an adolescent Jehovah's Witness","year":2002,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Blood donation and transfusion practices","field":"Business, Management and Accounting","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; University of Toronto; Hospital for Sick Children","funders":"","keywords":"Medicine; Blood transfusion; Intensive care medicine; Pediatrics; Witness; Surgery","score_opus":0.024128540577014513,"score_gpt":0.22619717560941469,"score_spread":0.20206863503240016,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2044894710","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99278283,0.0016394621,0.000643252,0.0019536647,0.00012119189,0.000057028054,0.000013069952,0.00001954286,0.0027699308],"genre_scores_gemma":[0.9966588,0.001138203,0.0007631126,0.00035098242,0.00006968304,0.0000150904925,0.000012711759,0.0000055018227,0.00098591],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.99979895,0.00004838124,0.000019714824,0.000019637775,0.000034413868,0.00007895223],"domain_scores_gemma":[0.9995384,0.00009546378,0.00011252459,0.000021204049,0.000022180833,0.00021027996],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00024539218,0.00032152113,0.00037552236,0.0005395154,0.0014501861,0.0004536041,0.0005192106,0.002084816,0.0008313056],"category_scores_gemma":[0.0018173844,0.00021055277,0.00045349813,0.00022737634,0.0006471006,0.00052593614,0.00067432295,0.0016514302,0.0002014658],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001600431,0.0005069501,0.034330647,0.00013215895,0.000028113323,0.9374471,0.003241102,0.00025987276,0.004355097,0.0011338199,0.0007500247,0.017655166],"study_design_scores_gemma":[0.00007379984,0.0021457186,0.033654854,0.00013311351,0.000039625327,0.949697,0.0023396173,0.00064757984,0.0045759897,0.00042280075,0.006246067,0.00002374269],"about_ca_topic_score_codex":0.00118899,"about_ca_topic_score_gemma":0.0026079835,"teacher_disagreement_score":0.002084816,"about_ca_system_score_codex":0.0004923264,"about_ca_system_score_gemma":0.0006035586,"threshold_uncertainty_score":0.0035720468},"labels":[],"label_agreement":null},{"id":"W2046494527","doi":"10.1046/j.1365-2141.2001.03004.x","title":"Novel treatment modalities: new platelet preparations and subsititutes","year":2001,"lang":"en","type":"review","venue":"British Journal of Haematology","topic":"Blood transfusion and management","field":"Medicine","cited_by":40,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Queen's University","funders":"","keywords":"Medicine; Modalities; Platelet; Internal medicine","score_opus":0.0723685864242695,"score_gpt":0.348856371472046,"score_spread":0.2764877850477765,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2046494527","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0014759208,0.9898386,0.001513691,0.0015009943,0.00078400323,0.00003189342,0.00004122256,0.000024378973,0.0047893017],"genre_scores_gemma":[0.007862312,0.98221844,0.00298854,0.0015546939,0.0018909187,0.00007362553,0.00013056915,0.0000113234055,0.0032694743],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9996593,0.0000671667,0.000047248435,0.00007228966,0.00012451997,0.000029490519],"domain_scores_gemma":[0.99977237,0.00009832401,0.00003464372,0.0000145113145,0.000058610913,0.000021507185],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007471026,0.000579208,0.0008111758,0.0012820637,0.0002553704,0.0011457971,0.0006090721,0.0009937136,0.0041890074],"category_scores_gemma":[0.0005643734,0.00021320667,0.0005339612,0.0007301317,0.0005283361,0.0018823112,0.0006191387,0.0015808714,0.0014388943],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019524411,0.00013784475,0.0003447123,0.012501172,0.00010443401,0.0007469176,0.00018206929,0.00027332723,0.0145976655,0.012604561,0.019832944,0.938479],"study_design_scores_gemma":[0.0000462763,0.00048732272,0.0010199444,0.0026009476,0.00014382334,0.0045945942,0.0000972025,0.0002908397,0.0058169663,0.004613538,0.9802601,0.000028426623],"about_ca_topic_score_codex":0.00033438538,"about_ca_topic_score_gemma":0.0007447422,"teacher_disagreement_score":0.0041890074,"about_ca_system_score_codex":0.00044921093,"about_ca_system_score_gemma":0.0005318208,"threshold_uncertainty_score":0.014013648},"labels":[],"label_agreement":null},{"id":"W2047370882","doi":"10.1111/j.1365-2141.2006.06245.x","title":"Reversal of immune thrombocytopenia in mice by cross‐linking human immunoglobulin G with a high‐affinity monoclonal antibody","year":2006,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":45,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval; Héma-Québec","funders":"Canadian Blood Services","keywords":"Monoclonal antibody; Antibody; Immunology; Immune system; Thrombocytopenic purpura; In vivo; Monoclonal; Immunoglobulin G; Ex vivo; Medicine; Biology","score_opus":0.007130359630702071,"score_gpt":0.276273425371694,"score_spread":0.26914306574099195,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2047370882","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9755106,0.0057075345,0.00789716,0.0011977439,0.00033370123,0.00031949382,0.00085208187,0.0012479307,0.006933798],"genre_scores_gemma":[0.9765262,0.0038845267,0.0058658123,0.00061263103,0.0001738427,0.00032180597,0.0011342434,0.00016585717,0.0113151865],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9993098,0.00018048692,0.00007907843,0.00011845995,0.00014436242,0.00016782673],"domain_scores_gemma":[0.99926907,0.00013439966,0.00027252463,0.00010444161,0.000047836515,0.00017161395],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007515659,0.0011557483,0.00059830456,0.0015903384,0.00037064462,0.00062179123,0.00068075705,0.0014173742,0.0021498043],"category_scores_gemma":[0.00043144496,0.0006553359,0.00065216294,0.00035040954,0.00062040635,0.0005369733,0.00040358235,0.002368099,0.0008362644],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014156753,0.0012392484,0.00030802327,0.00015545533,0.000054437147,0.00038910692,0.000079109566,0.0002461598,0.98602676,0.001349962,0.0005440158,0.008192014],"study_design_scores_gemma":[0.0011097856,0.010682313,0.0037254724,0.00009240346,0.00012078181,0.0021008537,0.00005046862,0.0028308267,0.9669516,0.00068260444,0.011627666,0.000025196065],"about_ca_topic_score_codex":0.00054989127,"about_ca_topic_score_gemma":0.00065456715,"teacher_disagreement_score":0.0021498043,"about_ca_system_score_codex":0.00048673764,"about_ca_system_score_gemma":0.0004450421,"threshold_uncertainty_score":0.007191777},"labels":[],"label_agreement":null},{"id":"W2047634988","doi":"10.1111/j.1365-2141.2009.07836.x","title":"Phase I trial of fludarabine, bortezomib and rituximab for relapsed and refractory indolent and mantle cell non‐Hodgkin lymphoma","year":2009,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"National Center for Research Resources; National Cancer Institute; Case Comprehensive Cancer Center, Case Western Reserve University","keywords":"Bortezomib; Mantle cell lymphoma; Fludarabine; Medicine; Rituximab; Internal medicine; Chronic lymphocytic leukemia; Follicular lymphoma; Lymphoma; Regimen; Oncology; Aggressive lymphoma; Gastroenterology; Multiple myeloma; Chemotherapy; Leukemia; Cyclophosphamide","score_opus":0.014462302663390188,"score_gpt":0.315413557958335,"score_spread":0.30095125529494476,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2047634988","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9905595,0.003827126,0.00042395564,0.00060442375,0.00016080006,0.0021958838,0.0003504454,0.00008329128,0.0017945045],"genre_scores_gemma":[0.9875586,0.002347568,0.0015560333,0.0012522583,0.00021753102,0.0032149432,0.0013271048,0.00002092132,0.002505113],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9994549,0.00032765046,0.000028516692,0.000053467527,0.000033965647,0.000101564314],"domain_scores_gemma":[0.99919456,0.0001512816,0.00011288059,0.000040407078,0.000033393513,0.0004675363],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017762758,0.0012981516,0.0020712693,0.0003413852,0.0003827246,0.0008985342,0.0010296312,0.0015150164,0.0026787962],"category_scores_gemma":[0.001040041,0.0004924064,0.00090502907,0.000370539,0.0008861767,0.0005864548,0.00042011804,0.0024832368,0.0006297793],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.81797713,0.035327416,0.006299581,0.0008173286,0.0011250429,0.00071565056,0.00035455512,0.0023718083,0.026883269,0.00037764534,0.004248441,0.1035022],"study_design_scores_gemma":[0.71577483,0.272788,0.0058269096,0.000040744813,0.00027578458,0.000381409,0.000052771273,0.0007922001,0.0014998154,0.00016199588,0.0023871677,0.000018437568],"about_ca_topic_score_codex":0.0010369641,"about_ca_topic_score_gemma":0.002222986,"teacher_disagreement_score":0.0026787962,"about_ca_system_score_codex":0.0010233228,"about_ca_system_score_gemma":0.0014463464,"threshold_uncertainty_score":0.00939399},"labels":[],"label_agreement":null},{"id":"W2047649402","doi":"10.1046/j.1365-2141.2002.03492.x","title":"Antithrombotic effect of PMC, a potent α‐tocopherol analogue on platelet plug formation <i>in vivo</i>","year":2002,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"National Defence Medical Centre","funders":"National Science Council","keywords":"Medicine; Bleeding time; Aspirin; Platelet; Saline; Pharmacology; Thrombosis; In vivo; Anesthesia; Antithrombotic; Surgery; Internal medicine; Platelet aggregation","score_opus":0.00995421963956499,"score_gpt":0.23301067206485912,"score_spread":0.22305645242529412,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2047649402","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99261945,0.0031618623,0.0016384616,0.00007477878,0.00002801085,0.000027596865,0.00017434855,0.000105555395,0.0021699157],"genre_scores_gemma":[0.99630344,0.0013516967,0.001132994,0.00004286571,0.000023734885,0.000016400849,0.00025633138,0.0000138361465,0.00085867016],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9999379,0.000020717462,0.0000038637945,0.000009116347,0.000008883639,0.000019531755],"domain_scores_gemma":[0.9998946,0.000027765906,0.000037516606,0.000012847147,0.000008141525,0.000019105026],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010671921,0.00027577823,0.00018036355,0.0001731851,0.00008970602,0.00018766425,0.00013534658,0.00022184473,0.0007832159],"category_scores_gemma":[0.00012114985,0.000104496736,0.00015992337,0.00015022667,0.00022707217,0.00013671085,0.00006103341,0.00034493784,0.00023177192],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011016126,0.00005907953,0.00015895773,0.000039887967,0.000010710227,0.000089342044,0.000015780097,0.000050959912,0.9943263,0.000086410706,0.0000803428,0.003980566],"study_design_scores_gemma":[0.00009868225,0.006129456,0.0034039498,0.0000070294395,0.000043180742,0.00047343588,0.000009225012,0.00031391045,0.9878104,0.00004015755,0.0016667971,0.0000037332181],"about_ca_topic_score_codex":0.0004556311,"about_ca_topic_score_gemma":0.00036111657,"teacher_disagreement_score":0.0007832159,"about_ca_system_score_codex":0.00016417763,"about_ca_system_score_gemma":0.00013737821,"threshold_uncertainty_score":0.002620101},"labels":[],"label_agreement":null},{"id":"W2047750426","doi":"10.1046/j.1365-2141.2003.04502.x","title":"Multicolour fluorescence <i>in situ</i> hybridization analysis of t(14;18)‐positive follicular lymphoma and correlation with gene expression data and clinical outcome","year":2003,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":45,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"National Cancer Institute","keywords":"Chromosomal translocation; Comparative genomic hybridization; Fluorescence in situ hybridization; Biology; Gene duplication; Karyotype; Breakpoint; Follicular lymphoma; Chromosome; Cytogenetics; Genetics; Molecular biology; Gene; Chromosomal rearrangement; Gene dosage; Lymphoma; Gene expression; Immunology","score_opus":0.028809754963868794,"score_gpt":0.3193472609882517,"score_spread":0.29053750602438294,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2047750426","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99955195,0.00014439534,0.00013191592,0.000007345389,8.120201e-7,0.000003271561,0.00001645985,0.0000030981253,0.00014077064],"genre_scores_gemma":[0.9996562,0.00007058852,0.00014101321,0.000004990559,0.0000036756967,0.000005365026,0.000046901616,0.0000013349462,0.000069917536],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9998116,0.000038751023,0.000012363183,0.000040688716,0.00003857286,0.000057966325],"domain_scores_gemma":[0.9996953,0.000095400304,0.000099161276,0.000019908224,0.00003774611,0.000052523617],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00039876503,0.0002269754,0.00023100396,0.0012444669,0.00018930397,0.00020626036,0.00016767033,0.00028054538,0.0006828571],"category_scores_gemma":[0.00071858877,0.00014422864,0.00011843667,0.00034926523,0.0003648545,0.00017045603,0.00014749447,0.00015577041,0.00013391327],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013398172,0.000118601936,0.8498691,0.000058894024,0.00006069165,0.006252226,0.0004340902,0.00028435962,0.12194648,0.000058790716,0.00014214327,0.019434799],"study_design_scores_gemma":[0.000038781858,0.00060845463,0.9680329,0.000009924923,0.000059440594,0.018518995,0.00025788712,0.0012673497,0.010342382,0.00009581326,0.00075692247,0.000011147339],"about_ca_topic_score_codex":0.00086158834,"about_ca_topic_score_gemma":0.00072711194,"teacher_disagreement_score":0.0012444669,"about_ca_system_score_codex":0.00021493588,"about_ca_system_score_gemma":0.00007674145,"threshold_uncertainty_score":0.0022844076},"labels":[],"label_agreement":null},{"id":"W2048115478","doi":"10.1111/j.1365-2141.2004.05105.x","title":"Tetramolecular immune complexes are more efficient than IVIg to prevent antibody‐dependent <i>in vitro</i> and <i>in vivo</i> phagocytosis of blood cells","year":2004,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":42,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval; Héma-Québec","funders":"Canadian Institutes of Health Research; Bayer Canada","keywords":"Phagocytosis; In vivo; Opsonin; In vitro; Antibody; Immune system; Thrombocytopenic purpura; Immunology; Monoclonal antibody; Platelet; Immunoglobulin G; Pharmacology; Medicine; Chemistry; Biology; Biochemistry","score_opus":0.005985135252188746,"score_gpt":0.2504104959760597,"score_spread":0.24442536072387094,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2048115478","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9786064,0.013166968,0.004813082,0.00018588401,0.00015772763,0.00012345803,0.00024423836,0.00014472645,0.0025576218],"genre_scores_gemma":[0.987956,0.0025765363,0.0036049904,0.00021064494,0.0000936172,0.00007464654,0.0010268702,0.000050269828,0.0044063265],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99955493,0.00012184893,0.000056525387,0.00006510644,0.00010729549,0.00009433821],"domain_scores_gemma":[0.99952185,0.0001024619,0.00014867526,0.00006160951,0.00006307885,0.0001023738],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00039425283,0.00051700557,0.00063344324,0.00041304767,0.00011103664,0.00053269544,0.0003076753,0.00077267113,0.0019771934],"category_scores_gemma":[0.00041995087,0.00019101579,0.00041709584,0.00025460462,0.0001993471,0.00031944958,0.00013811848,0.0009379229,0.0005114553],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00055764196,0.0002554478,0.00021832823,0.00010789813,0.000038052054,0.00003481402,0.000020703128,0.00012911129,0.99311465,0.00012164899,0.00018759335,0.005214119],"study_design_scores_gemma":[0.00011941351,0.0041253297,0.0030281972,0.000011571454,0.00006591748,0.00025353333,0.000010201366,0.00044860406,0.9879518,0.000030037607,0.0039491598,0.0000061910364],"about_ca_topic_score_codex":0.0005429348,"about_ca_topic_score_gemma":0.00045328488,"teacher_disagreement_score":0.0019771934,"about_ca_system_score_codex":0.00036036168,"about_ca_system_score_gemma":0.00021051441,"threshold_uncertainty_score":0.006614387},"labels":[],"label_agreement":null},{"id":"W2048905154","doi":"10.1046/j.1365-2141.2001.03127.x","title":"Multilineage glycosylphosphatidylinositol anchor‐deficient haematopoiesis in untreated aplastic anaemia","year":2001,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Complement system in diseases","field":"Immunology and Microbiology","cited_by":103,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Victoria","funders":"National Cancer Institute","keywords":"Aerolysin; Aplastic anemia; CD59; Haematopoiesis; Paroxysmal nocturnal hemoglobinuria; Flow cytometry; Immunology; Biology; Stem cell; Medicine; Cell biology; Antibody; Genetics; Bone marrow; Gene","score_opus":0.011159427765263179,"score_gpt":0.24713699721212826,"score_spread":0.23597756944686507,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2048905154","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9983285,0.0006363666,0.00018883254,0.000015870623,0.0000048524585,0.000013100751,0.00004575879,0.00001198014,0.0007548145],"genre_scores_gemma":[0.999099,0.00015116531,0.00018089601,0.000026948912,0.000006126394,0.0000061784026,0.00010673109,0.0000026715372,0.00042032392],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9998616,0.000031943386,0.000013074391,0.00003269117,0.000040014842,0.000020632991],"domain_scores_gemma":[0.99988866,0.0000300296,0.00002516239,0.000009817535,0.000011424601,0.00003484833],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013635764,0.0001884976,0.00021563155,0.00038245614,0.0001761383,0.00018068631,0.00012810697,0.0002242164,0.00091241417],"category_scores_gemma":[0.00030986074,0.00014440465,0.00009917249,0.00014625741,0.00022512852,0.00008143402,0.00015257036,0.00021553616,0.00015090575],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003058685,0.0003672997,0.08025046,0.00016244258,0.00006827414,0.006585155,0.00046256653,0.00037435335,0.8815939,0.00028391505,0.00046289244,0.026330115],"study_design_scores_gemma":[0.00035535716,0.005285569,0.86178225,0.000042528107,0.00015300362,0.027619848,0.00023234323,0.00217703,0.09631327,0.00025791858,0.0057563693,0.000024438217],"about_ca_topic_score_codex":0.0017222384,"about_ca_topic_score_gemma":0.0020256755,"teacher_disagreement_score":0.0017222384,"about_ca_system_score_codex":0.00024144104,"about_ca_system_score_gemma":0.00013093237,"threshold_uncertainty_score":0.003424406},"labels":[],"label_agreement":null},{"id":"W2049005290","doi":"10.1111/j.1365-2141.2005.05954.x","title":"Immunohistochemical analysis of the antiapoptotic Mcl‐1 and Bcl‐2 proteins in follicular lymphoma","year":2006,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"Vedecká Grantová Agentúra MŠVVaŠ SR a SAV; Cancer Research UK","keywords":"Immunohistochemistry; Follicular lymphoma; Lymphoma; Medicine; Pathology; High-power field; Internal medicine","score_opus":0.004807008348192153,"score_gpt":0.22816037746805634,"score_spread":0.2233533691198642,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2049005290","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99789006,0.0013767912,0.00023063929,0.00002057566,0.0000021480587,0.0000051342554,0.000028222736,0.000007306398,0.0004391978],"genre_scores_gemma":[0.9993936,0.00017275859,0.00023457398,0.000016557682,0.0000037909022,0.000005051498,0.000054528195,0.000001122713,0.00011797876],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9998228,0.000041468124,0.000014616245,0.000028579934,0.00003802952,0.000054493532],"domain_scores_gemma":[0.9997751,0.00006232765,0.0000560447,0.000016931936,0.00004606508,0.000043454405],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003672829,0.00013573263,0.0001552517,0.0009368767,0.00025673068,0.000277992,0.00018135237,0.00024946907,0.0010981932],"category_scores_gemma":[0.0005946513,0.00012634283,0.00009795022,0.00035712944,0.0003531609,0.00024438865,0.00019256266,0.00013416122,0.00019378141],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007697531,0.00006930586,0.86756283,0.00010357592,0.00008414738,0.0023622066,0.00061391375,0.00019693213,0.101135254,0.00012997676,0.0002568854,0.026715193],"study_design_scores_gemma":[0.000097989294,0.0008093069,0.9661763,0.000021767122,0.00012580982,0.016371869,0.0009593693,0.0006101938,0.011678954,0.00015638258,0.002979384,0.000012634167],"about_ca_topic_score_codex":0.0010878236,"about_ca_topic_score_gemma":0.0014718986,"teacher_disagreement_score":0.0010981932,"about_ca_system_score_codex":0.00024847777,"about_ca_system_score_gemma":0.00010565935,"threshold_uncertainty_score":0.003673792},"labels":[],"label_agreement":null},{"id":"W2049601701","doi":"10.1111/j.1365-2141.2012.09196.x","title":"Duration of anticoagulant therapy for venous thromboembolism: balancing benefits and harms on the long term","year":2012,"lang":"en","type":"review","venue":"British Journal of Haematology","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":27,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Population Health Research Institute","funders":"","keywords":"Medicine; Anticoagulant therapy; Venous thromboembolism; Anticoagulant; Intensive care medicine; Risk factor; Surgery; Internal medicine; Thrombosis","score_opus":0.07509890017562146,"score_gpt":0.33232762533072274,"score_spread":0.2572287251551013,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2049601701","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000074569725,0.99933714,0.00002884608,0.00023214945,0.000058330123,0.0000023191046,0.0000060791467,0.0000015874864,0.00025897307],"genre_scores_gemma":[0.00082508643,0.99866486,0.00010987114,0.00014974756,0.0000866403,0.0000055823825,0.000010156085,9.0195414e-7,0.00014725451],"study_design_codex":"design_other","study_design_gemma":"systematic_review","domain_scores_codex":[0.999376,0.00016373319,0.00013894608,0.00005988171,0.00023373,0.000027796481],"domain_scores_gemma":[0.99846447,0.0011004017,0.00021784144,0.000025028325,0.00015185436,0.000040427487],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012169002,0.00090231077,0.0026545601,0.0023439953,0.00028008997,0.0011825986,0.0011640543,0.0014954666,0.0033401928],"category_scores_gemma":[0.002699422,0.00029732083,0.00095842604,0.0026880533,0.000601784,0.001613944,0.00052526756,0.001651257,0.000991898],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013535627,0.000049508883,0.00024132326,0.04329318,0.000376539,0.000115955576,0.00006717032,0.00021431397,0.00036770143,0.0019539124,0.016428865,0.93675625],"study_design_scores_gemma":[0.00016333298,0.00027363122,0.004959428,0.07144538,0.0017011461,0.0038206112,0.00030334466,0.0002309204,0.0004319801,0.0055695907,0.9110458,0.000054804375],"about_ca_topic_score_codex":0.0012786746,"about_ca_topic_score_gemma":0.0027599065,"teacher_disagreement_score":0.0033401928,"about_ca_system_score_codex":0.0009766249,"about_ca_system_score_gemma":0.0011777764,"threshold_uncertainty_score":0.011174023},"labels":[],"label_agreement":null},{"id":"W2049797387","doi":"10.1046/j.1365-2141.2000.02342.x","title":"Primitive haematopoietic progenitors in the blood of patients with sickle cell disease appear to be endogenously mobilized","year":2000,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"National Heart, Lung, and Blood Institute","keywords":"Progenitor cell; Haematopoiesis; Immunology; White blood cell; Biology; Blood cell; Internal medicine; Stem cell; Andrology; Medicine; Cell biology","score_opus":0.005327753068103107,"score_gpt":0.2057229196985517,"score_spread":0.2003951666304486,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2049797387","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9988902,0.0005969212,0.00021145675,0.000011315318,0.000002186344,0.000004761771,0.000072645016,0.000010956425,0.00019958842],"genre_scores_gemma":[0.99889237,0.00025800284,0.00032360156,0.000026548956,0.0000067691212,0.000009397941,0.00025316107,0.000003953533,0.00022607279],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9998573,0.000031076266,0.000029197317,0.000029410103,0.00003668229,0.000016238859],"domain_scores_gemma":[0.9998259,0.000045766843,0.00005471335,0.000016055887,0.000018695784,0.000038938506],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011312311,0.00017826383,0.00024988496,0.0004632286,0.00015355741,0.000357912,0.0000990111,0.00020830511,0.00093698467],"category_scores_gemma":[0.00059965043,0.000102447455,0.00008553911,0.00033483293,0.00018271488,0.00017053666,0.00018704151,0.00022953867,0.00024375637],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0021922172,0.00015128736,0.34336138,0.00020925056,0.000064316446,0.0033491622,0.0017403025,0.0003592131,0.6102487,0.00035555448,0.00026013755,0.03770845],"study_design_scores_gemma":[0.000065644825,0.002852863,0.89276457,0.000039330833,0.00012432713,0.012979888,0.00067896757,0.0010227265,0.08455787,0.0002825012,0.0046085333,0.00002267346],"about_ca_topic_score_codex":0.00027486397,"about_ca_topic_score_gemma":0.00023679144,"teacher_disagreement_score":0.00093698467,"about_ca_system_score_codex":0.00010017016,"about_ca_system_score_gemma":0.0000931812,"threshold_uncertainty_score":0.0031345487},"labels":[],"label_agreement":null},{"id":"W2050235018","doi":"10.1046/j.1365-2141.2003.04188.x","title":"Maxwell Wintrobe, in his own words","year":2003,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Primary Care and Health Outcomes","field":"Health Professions","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"Johns Hopkins University; University of Utah","keywords":"Medicine; Physics; Psychology","score_opus":0.02983480536067098,"score_gpt":0.3797622386518316,"score_spread":0.34992743329116066,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2050235018","genre_codex":"commentary","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0052108173,0.050082784,0.0034353174,0.68210536,0.07719163,0.000043317646,0.0002880524,0.00032516275,0.18131766],"genre_scores_gemma":[0.05511994,0.018251086,0.0020441052,0.27523187,0.011273775,0.000093170216,0.00016309117,0.0003924373,0.63743055],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9986394,0.00036016334,0.000046352274,0.00024539325,0.00048256898,0.00022614622],"domain_scores_gemma":[0.99846566,0.00039395186,0.00012471036,0.000093455885,0.00038514228,0.0005370749],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012073703,0.0007392485,0.0005111285,0.0006504674,0.0065190056,0.0072169043,0.0009182929,0.0022683362,0.02391624],"category_scores_gemma":[0.0081387,0.00038928443,0.0001887296,0.000696016,0.0038275858,0.0070846053,0.0034807308,0.007169377,0.0117701925],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000013403789,0.000007999923,0.00020472918,0.000033482305,0.0000023478517,0.00011414896,0.0035402935,0.000016857875,0.00007356634,0.021105442,0.9610448,0.013842897],"study_design_scores_gemma":[8.527871e-7,0.0000020335376,0.00008634636,0.0000407188,6.83366e-7,0.00012912953,0.0016157881,0.000007699651,0.000027185117,0.0014420238,0.9966434,0.000004022417],"about_ca_topic_score_codex":0.013238161,"about_ca_topic_score_gemma":0.02151955,"teacher_disagreement_score":0.02391624,"about_ca_system_score_codex":0.003016264,"about_ca_system_score_gemma":0.0033454164,"threshold_uncertainty_score":0.08000779},"labels":[],"label_agreement":null},{"id":"W2050746746","doi":"10.1046/j.1365-2141.2003.04551.x","title":"Role of DNA mismatch repair genetic polymorphisms in the risk of childhood acute lymphoblastic leukaemia","year":2003,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Genetic factors in colorectal cancer","field":"Medicine","cited_by":52,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Université de Montréal; Centre Hospitalier Universitaire Sainte-Justine","funders":"","keywords":"MLH1; Biology; Genetics; Genotype; Odds ratio; DNA repair; Gene; Cancer research; DNA mismatch repair; Medicine; Internal medicine","score_opus":0.005387028440765084,"score_gpt":0.22429209580105292,"score_spread":0.21890506736028784,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2050746746","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99563485,0.0028346658,0.00018852572,0.0002688106,0.000007997352,0.000005474972,0.00020710615,0.0000139530985,0.00083864515],"genre_scores_gemma":[0.9990376,0.0005137945,0.00016615164,0.000017363216,0.000010115181,0.000001647959,0.00007732703,0.00000267655,0.00017340422],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9991978,0.00031345597,0.000045585723,0.000119696,0.00020919117,0.00011424217],"domain_scores_gemma":[0.9980883,0.0007238474,0.00062698167,0.00009515761,0.00014612173,0.00031957953],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006574575,0.00035138935,0.00038967776,0.0011382283,0.00038774533,0.0006255866,0.00031571128,0.000567936,0.0018632492],"category_scores_gemma":[0.0033587744,0.0002073148,0.0002810519,0.0012893154,0.0005134421,0.00018662021,0.00023966492,0.00039715992,0.00015389809],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00056676,0.000038356196,0.98839206,0.000039827766,0.00019516592,0.0004676589,0.00014476954,0.00020996858,0.0024616679,0.00013397424,0.00011415554,0.007235627],"study_design_scores_gemma":[0.000017094837,0.00011441049,0.99731064,0.000013526379,0.00015273444,0.0010168768,0.00007895351,0.00028613355,0.00038153492,0.000108146094,0.00051433215,0.000005624917],"about_ca_topic_score_codex":0.032015353,"about_ca_topic_score_gemma":0.029466663,"teacher_disagreement_score":0.032015353,"about_ca_system_score_codex":0.0007018042,"about_ca_system_score_gemma":0.0008409899,"threshold_uncertainty_score":0.063658},"labels":[],"label_agreement":null},{"id":"W2050880574","doi":"10.1111/bjh.13271","title":"Lack of bone lesions at diagnosis is associated with inferior outcome in multisystem langerhans cell histiocytosis of childhood","year":2014,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Histiocytic Disorders and Treatments","field":"Medicine","cited_by":31,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; University of Toronto","funders":"","keywords":"Langerhans cell histiocytosis; Medicine; Histiocytosis; Bone marrow; Gastroenterology; Spleen; Internal medicine; Pathology; White blood cell; Disease","score_opus":0.025507890528389605,"score_gpt":0.2769840257622621,"score_spread":0.2514761352338725,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2050880574","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99964166,0.00019090385,0.00001982667,0.000010337205,0.0000016492133,0.0000010480248,0.000052402567,0.000001272873,0.00008089254],"genre_scores_gemma":[0.9997515,0.000079978265,0.000022524919,0.000004962737,0.0000038102553,0.0000011947895,0.000107496664,7.968325e-7,0.000027773398],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9995734,0.00010518573,0.000045318193,0.00008188772,0.00008691975,0.00010742054],"domain_scores_gemma":[0.9975478,0.00058880186,0.0012665594,0.00008535952,0.0000820098,0.00042941957],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004727059,0.00028262357,0.0003352405,0.0005827417,0.0003151997,0.00044358068,0.00028022673,0.00044082323,0.0010857519],"category_scores_gemma":[0.002310924,0.00021548828,0.00026204862,0.0005770962,0.00055111747,0.00033318475,0.00045851475,0.00042825358,0.00018097908],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000106802545,0.0000062379795,0.99867874,0.000004575701,0.000010925133,0.00013533398,0.000026633748,0.000040363346,0.00018876714,0.0000072200532,0.000023504874,0.0007708929],"study_design_scores_gemma":[0.0000049000028,0.00011203749,0.99840087,0.0000044839144,0.000014652736,0.001135547,0.00007281496,0.0001084285,0.00007166815,0.00002374922,0.000048513783,0.0000022884783],"about_ca_topic_score_codex":0.002546975,"about_ca_topic_score_gemma":0.0038303395,"teacher_disagreement_score":0.002546975,"about_ca_system_score_codex":0.00024415692,"about_ca_system_score_gemma":0.00025195672,"threshold_uncertainty_score":0.0050643086},"labels":[],"label_agreement":null},{"id":"W2050970566","doi":"10.1111/j.1365-2141.2008.07384.x","title":"Thrombin activatable fibrinolysis inhibitor gene polymorphisms are associated with antigenic levels in the Asian‐Indian population but may not be a risk for stroke","year":2008,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Blood properties and coagulation","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre for Addiction and Mental Health","funders":"University Grants Commission; Council of Scientific and Industrial Research, India; Indian Council of Medical Research","keywords":"Fibrinolysis; Haplotype; Population; Immunology; Antigen; Medicine; Plasmin; Fibrin; Carboxypeptidase; Biology; Internal medicine; Allele; Gene; Genetics; Biochemistry","score_opus":0.03733150681311397,"score_gpt":0.24932326097333418,"score_spread":0.2119917541602202,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2050970566","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9990707,0.00008149302,0.000082066326,0.000042538275,0.000009609905,0.000004526748,0.00004425078,0.000006208752,0.00065847475],"genre_scores_gemma":[0.9995571,0.00006403805,0.000061899926,0.000020867163,0.000016444777,0.000003875754,0.000051428742,0.000004052949,0.00022037017],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99959856,0.00011076835,0.000050812785,0.00007612408,0.000072567906,0.00009127523],"domain_scores_gemma":[0.9989441,0.00021543077,0.00038014314,0.000114602466,0.000111344,0.00023438329],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00037695866,0.00048793596,0.00044533066,0.00081796705,0.0007050077,0.0008069655,0.0003331765,0.00045756795,0.0031898303],"category_scores_gemma":[0.0015589158,0.0004312922,0.00043368092,0.0009971296,0.0006183933,0.00023094582,0.00029342793,0.00060171547,0.00041797766],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009723211,0.00019704794,0.982569,0.000027866647,0.0003113771,0.0019714672,0.000659753,0.00009546197,0.00904218,0.00014743087,0.00022609418,0.003780026],"study_design_scores_gemma":[0.000023048246,0.00016276512,0.99628615,0.000007239751,0.00013581534,0.0023227632,0.00023273441,0.0002173096,0.0003024074,0.00011077125,0.00018954133,0.000009408294],"about_ca_topic_score_codex":0.004871156,"about_ca_topic_score_gemma":0.0030275541,"teacher_disagreement_score":0.004871156,"about_ca_system_score_codex":0.00012946,"about_ca_system_score_gemma":0.00024715863,"threshold_uncertainty_score":0.010671079},"labels":[],"label_agreement":null},{"id":"W2051548025","doi":"10.1111/j.1365-2141.2009.07739.x","title":"The significance of <i>TP53</i> in lymphoid malignancies: mutation prevalence, regulation, prognostic impact and potential as a therapeutic target","year":2009,"lang":"en","type":"review","venue":"British Journal of Haematology","topic":"Cancer-related Molecular Pathways","field":"Medicine","cited_by":62,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Cancer; Mutation; Suppressor; Genome instability; Biology; Clinical significance; Cancer research; Lymphatic system; Immunology; Medicine; Oncology; Internal medicine; Genetics; Gene; DNA damage","score_opus":0.012685747631319109,"score_gpt":0.2977313816382422,"score_spread":0.28504563400692307,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2051548025","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00035893143,0.9986212,0.00010199751,0.00021742396,0.000083779334,0.0000015705015,0.00000828372,0.000004173312,0.0006026494],"genre_scores_gemma":[0.002300601,0.99675673,0.00020958061,0.00014637684,0.00015279978,0.000003634912,0.000019133178,0.0000012224832,0.000409868],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99988174,0.000023744285,0.0000210653,0.000021783331,0.00003878628,0.000012921923],"domain_scores_gemma":[0.9997776,0.00011274736,0.000039053022,0.000006470762,0.000048167974,0.000015961707],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00041858634,0.00037085245,0.0010026672,0.0012385371,0.00013331103,0.00051618885,0.00049766654,0.0007706055,0.0014381127],"category_scores_gemma":[0.0005720145,0.0001453806,0.00026588276,0.0013741847,0.000347793,0.0006694911,0.00027885102,0.00081042974,0.0010947541],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014747362,0.00004577277,0.00058944244,0.008804739,0.00006254039,0.0005755725,0.000045611672,0.00029295424,0.0057907086,0.0014906644,0.010254293,0.9719001],"study_design_scores_gemma":[0.000054215732,0.00040400118,0.0070772683,0.003660236,0.00028700367,0.013159739,0.00012979112,0.00025941632,0.004385197,0.0024973233,0.9680499,0.000035866822],"about_ca_topic_score_codex":0.00072947866,"about_ca_topic_score_gemma":0.001012151,"teacher_disagreement_score":0.0014381127,"about_ca_system_score_codex":0.00049384974,"about_ca_system_score_gemma":0.00052538497,"threshold_uncertainty_score":0.004810989},"labels":[],"label_agreement":null},{"id":"W2051996643","doi":"10.1111/j.1365-2141.2008.07001.x","title":"Detection of WT1‐specific T cells in paediatric acute lymphoblastic leukaemia patients in first remission","year":2008,"lang":"en","type":"letter","venue":"British Journal of Haematology","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Children's Hospital; University of British Columbia","funders":"","keywords":"Medicine; ELISPOT; Immunology; Immune system; Peripheral blood mononuclear cell; Bone marrow; Antigen; Transplantation; T cell; Internal medicine; Biology","score_opus":0.010293047939670993,"score_gpt":0.23554803089381587,"score_spread":0.22525498295414487,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2051996643","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9274986,0.0063818176,0.0006589637,0.04002135,0.002200182,0.00008360157,0.00058420125,0.00012770008,0.022443537],"genre_scores_gemma":[0.97900736,0.0032306532,0.00052036473,0.010414413,0.0021599466,0.00003694775,0.00030381393,0.00003789821,0.0042886757],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99915886,0.00019882244,0.00012142765,0.00012290447,0.00022986183,0.00016820611],"domain_scores_gemma":[0.9979121,0.0011327408,0.00030472656,0.000121258556,0.0002569966,0.00027217015],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00044302313,0.00035251756,0.0008048648,0.00068410975,0.0005868725,0.00078628986,0.00050663133,0.0038141026,0.0021065902],"category_scores_gemma":[0.0054051257,0.00040704568,0.0003157769,0.0007126429,0.0005985721,0.00065012404,0.00030543134,0.0018037468,0.00089465827],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0021977169,0.00020859599,0.42398605,0.00052883435,0.00006929336,0.42213807,0.0025754448,0.00064384524,0.016879113,0.0010260725,0.055431,0.074315995],"study_design_scores_gemma":[0.00024949215,0.0011360247,0.33358747,0.00025056908,0.00008627926,0.6181711,0.0013397896,0.0010493584,0.0050070942,0.0010641633,0.03800883,0.00004984278],"about_ca_topic_score_codex":0.0021874572,"about_ca_topic_score_gemma":0.0021835049,"teacher_disagreement_score":0.0038141026,"about_ca_system_score_codex":0.0010014591,"about_ca_system_score_gemma":0.00033855878,"threshold_uncertainty_score":0.007266164},"labels":[],"label_agreement":null},{"id":"W2052229400","doi":"10.1111/j.1365-2141.2006.06237.x","title":"Significant increase of <i>CKS1B</i> amplification from monoclonal gammopathy of undetermined significance to multiple myeloma and plasma cell leukaemia as demonstrated by interphase fluorescence <i>in situ</i> hybridisation","year":2006,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":35,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University Health Network","funders":"Cancer Research Society","keywords":"Monoclonal gammopathy of undetermined significance; Plasma cell dyscrasia; Multiple myeloma; Fluorescence in situ hybridization; Plasma cell neoplasm; Plasma cell; Plasma cell leukemia; Pathology; Molecular biology; Monoclonal; Medicine; Cancer research; Plasmacytoma; Biology; Monoclonal antibody; Internal medicine; Immunology; Antibody; Immunoglobulin light chain; Genetics","score_opus":0.008814553048158688,"score_gpt":0.2486277847795551,"score_spread":0.2398132317313964,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2052229400","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9982316,0.000547892,0.0001710838,0.000042737065,0.0000043365285,0.000003676442,0.00006494575,0.000014746229,0.0009191531],"genre_scores_gemma":[0.999463,0.0000982635,0.00006758435,0.000015867821,0.0000052876267,0.0000029828573,0.00009029179,0.0000023261243,0.00025444216],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99975556,0.00004233372,0.000019183313,0.000063801905,0.000064198575,0.000054825607],"domain_scores_gemma":[0.9994562,0.00018871223,0.0001808418,0.000022927628,0.00005176537,0.00009951609],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001617007,0.0001727805,0.00017088502,0.00076028507,0.00016619338,0.00036815892,0.00013863706,0.00034874718,0.0027482756],"category_scores_gemma":[0.0010006631,0.00018214574,0.0001299069,0.00033606467,0.0002743707,0.00019750094,0.0002331563,0.00036940523,0.0003522614],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017432537,0.000054183776,0.692251,0.00009144886,0.00009194084,0.004788659,0.0005398708,0.0001698416,0.27759463,0.000104457205,0.00042187766,0.02214888],"study_design_scores_gemma":[0.00001316753,0.00022849093,0.97989744,0.000004336678,0.000032201297,0.008680325,0.00011172585,0.00014828623,0.009991541,0.000051665775,0.000836065,0.0000048093652],"about_ca_topic_score_codex":0.00092304737,"about_ca_topic_score_gemma":0.0008712698,"teacher_disagreement_score":0.0027482756,"about_ca_system_score_codex":0.0001950092,"about_ca_system_score_gemma":0.00009801188,"threshold_uncertainty_score":0.009193897},"labels":[],"label_agreement":null},{"id":"W2052845801","doi":"10.1046/j.1365-2141.2001.02806.x","title":"Lack of CD40‐dependent B‐cell proliferation in B lymphocytes isolated from patients with persistent polyclonal B‐cell lymphocytosis","year":2001,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"T-cell and B-cell Immunology","field":"Immunology and Microbiology","cited_by":21,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval","funders":"","keywords":"Lymphocytosis; Polyclonal antibodies; B cell; Immunology; Medicine; Polyclonal B cell response; Antibody; B-cell receptor","score_opus":0.010351784704576584,"score_gpt":0.2045439477257558,"score_spread":0.1941921630211792,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2052845801","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9972383,0.0013478894,0.00032770913,0.000028094075,0.0000136011195,0.000017218696,0.00014040289,0.000024991607,0.0008617316],"genre_scores_gemma":[0.99898857,0.0002847691,0.00014638275,0.000033075703,0.000019301517,0.000013324558,0.00026274798,0.000008172519,0.00024364282],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9996674,0.00005196434,0.000046086432,0.000089213085,0.000090734386,0.000054623713],"domain_scores_gemma":[0.9996232,0.00014111713,0.000049668983,0.000042852476,0.00004507639,0.00009806999],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002105377,0.00029382153,0.00036167452,0.0011959131,0.00029440675,0.00047569242,0.00022473562,0.0005010348,0.0019343109],"category_scores_gemma":[0.0008162386,0.00027479007,0.00018407305,0.00046536495,0.00031595185,0.00019970248,0.00030353866,0.00046770554,0.0006036671],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002754939,0.00038486614,0.14259017,0.00026197213,0.000105366606,0.011894648,0.0014067465,0.00015003477,0.81791556,0.00019598815,0.00032430296,0.022015419],"study_design_scores_gemma":[0.00033906096,0.0045469785,0.7468796,0.000062896666,0.00027325525,0.109345965,0.0010176748,0.00085910346,0.128679,0.00035068035,0.007610371,0.000035407833],"about_ca_topic_score_codex":0.000554955,"about_ca_topic_score_gemma":0.00021079903,"teacher_disagreement_score":0.0019343109,"about_ca_system_score_codex":0.00013857613,"about_ca_system_score_gemma":0.00010721842,"threshold_uncertainty_score":0.0064709187},"labels":[],"label_agreement":null},{"id":"W2052918149","doi":"10.1111/bjh.12249","title":"The molecular characterization of von <scp>W</scp>illebrand disease: good in parts","year":2013,"lang":"en","type":"review","venue":"British Journal of Haematology","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":35,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"National Heart, Lung, and Blood Institute; Canadian Institutes of Health Research; National Institutes of Health; Canadian Hemophilia Society; Heart and Stroke Foundation of Canada","keywords":"Von Willebrand disease; Von Willebrand factor; Disease; Molecular pathology; Molecular genetics; Biology; Locus (genetics); Genetics; Immunology; Gene; Medicine; Pathology; Platelet","score_opus":0.015149623365299061,"score_gpt":0.2799725958858673,"score_spread":0.26482297252056824,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2052918149","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00012486552,0.9986072,0.00014877385,0.0003645088,0.000181951,0.0000027007475,0.000009219391,0.000002981679,0.0005578187],"genre_scores_gemma":[0.0011126263,0.99754983,0.00025319235,0.00027292527,0.0002772462,0.0000045632814,0.00002894581,0.000001980384,0.00049874105],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99973303,0.00004407607,0.000050969596,0.00004462171,0.00010416794,0.000023084443],"domain_scores_gemma":[0.99933064,0.00028646496,0.00009477346,0.000035331945,0.00019158538,0.00006125645],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009927673,0.00075165014,0.0016579404,0.002868075,0.00024004682,0.0011001319,0.0008296279,0.001426853,0.0020070912],"category_scores_gemma":[0.0013046856,0.00029629475,0.0005464085,0.0018919538,0.0009801376,0.0018901468,0.00076384057,0.0023082527,0.0018972469],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009766165,0.000050731807,0.00042437378,0.00917806,0.00007347035,0.00078132626,0.000078955796,0.0001903667,0.0035907351,0.0052281665,0.022547012,0.95775914],"study_design_scores_gemma":[0.000018830297,0.000064903244,0.0016579933,0.0034936096,0.00010453183,0.008564974,0.000068749214,0.000080346384,0.0015085486,0.0029880202,0.9814232,0.000026172964],"about_ca_topic_score_codex":0.0010129788,"about_ca_topic_score_gemma":0.0009190614,"teacher_disagreement_score":0.002868075,"about_ca_system_score_codex":0.000637416,"about_ca_system_score_gemma":0.0008514869,"threshold_uncertainty_score":0.0067144036},"labels":[],"label_agreement":null},{"id":"W2053445686","doi":"10.1111/j.1365-2141.2006.06474.x","title":"Biomolecular characterisation of leucocytes by infrared spectroscopy","year":2007,"lang":"en","type":"review","venue":"British Journal of Haematology","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":43,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"National Research Council Institute for Biodiagnostics","funders":"","keywords":"Hematology; Infrared spectroscopy; Spectroscopy; Personalized medicine; Chemotherapy; Medicine; Immunology; Chemistry; Biology; Bioinformatics; Internal medicine","score_opus":0.042035958297221496,"score_gpt":0.38413949484269605,"score_spread":0.34210353654547454,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2053445686","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.001270055,0.9928706,0.0018024176,0.00022322802,0.00023555823,0.000021370346,0.00004383263,0.000022842793,0.0035100186],"genre_scores_gemma":[0.0093894275,0.9836251,0.002834776,0.00027255923,0.00020016539,0.000048461883,0.00012492615,0.000007196542,0.0034974082],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9996439,0.000056176526,0.000031937372,0.00007077741,0.00016928981,0.000027858398],"domain_scores_gemma":[0.9997383,0.000100394864,0.000043236654,0.0000141890405,0.0000882743,0.00001558853],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00066440966,0.00089020515,0.0016873376,0.0025025464,0.00025288787,0.00092574075,0.00091273244,0.001065795,0.001675712],"category_scores_gemma":[0.0007205963,0.0002880473,0.00040489231,0.0018003774,0.000730925,0.0011970139,0.0004740332,0.0012332122,0.0026460222],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012988367,0.00009537193,0.00065516453,0.012143841,0.00006155513,0.0005363249,0.00013666009,0.0005068299,0.07289818,0.00426845,0.008863805,0.8997039],"study_design_scores_gemma":[0.00003017323,0.00023927029,0.004610912,0.0017486301,0.000095731986,0.0056166057,0.00022800278,0.00040699381,0.059646223,0.0031669503,0.9241406,0.0000698631],"about_ca_topic_score_codex":0.00078225665,"about_ca_topic_score_gemma":0.0007761939,"teacher_disagreement_score":0.0025025464,"about_ca_system_score_codex":0.0005017546,"about_ca_system_score_gemma":0.00040843873,"threshold_uncertainty_score":0.0056058764},"labels":[],"label_agreement":null},{"id":"W2053633180","doi":"10.1111/j.1365-2141.2004.04867.x","title":"The t(4;14) is associated with poor prognosis in myeloma patients undergoing autologous stem cell transplant","year":2004,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":195,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"","keywords":"Multiple myeloma; Medicine; Stem cell; Autologous stem-cell transplantation; Oncology; Internal medicine; Hematology; Biology","score_opus":0.013867100637654962,"score_gpt":0.2478277717385602,"score_spread":0.23396067110090524,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2053633180","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9997167,0.0001311097,0.000035939134,0.000016636028,0.0000020831967,0.0000015433977,0.000012873889,0.0000016849079,0.0000814338],"genre_scores_gemma":[0.9998517,0.000037377653,0.000030265042,0.000007910558,0.000006576409,0.000001692701,0.000030262445,6.149305e-7,0.000033596712],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9997348,0.000069638874,0.00003269048,0.00004916858,0.000057767793,0.000055905628],"domain_scores_gemma":[0.9985663,0.00027499447,0.0007819297,0.000057899208,0.00008711077,0.00023174973],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00034535935,0.00021124753,0.0003151135,0.0006146122,0.00040877255,0.00043154266,0.0002388298,0.0004605291,0.000981299],"category_scores_gemma":[0.0017214647,0.0002085599,0.0002144221,0.00057131326,0.0005289216,0.00028800176,0.00038044882,0.00043982093,0.00018361783],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002944889,0.000014426614,0.9967257,0.0000050786593,0.000021512964,0.0002335512,0.000041165385,0.000060663868,0.0010765108,0.00000777437,0.000036042245,0.0014830976],"study_design_scores_gemma":[0.000014698094,0.0002555376,0.9961428,0.0000049274813,0.00004388647,0.0026460872,0.00010199716,0.00028018837,0.0003140778,0.0000545507,0.00013571499,0.000005544392],"about_ca_topic_score_codex":0.001026991,"about_ca_topic_score_gemma":0.0010991519,"teacher_disagreement_score":0.001026991,"about_ca_system_score_codex":0.00024756594,"about_ca_system_score_gemma":0.00023398719,"threshold_uncertainty_score":0.0032827854},"labels":[],"label_agreement":null},{"id":"W2053876119","doi":"10.1046/j.1365-2141.2003.03849.x","title":"The role of hydroxyurea in sickle cell disease","year":2003,"lang":"en","type":"review","venue":"British Journal of Haematology","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":144,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"Imperial College London","keywords":"Medicine; Hydroxycarbamide; Disease; Acute chest syndrome; Clinical trial; Intensive care medicine; Sickle cell anemia; Pediatrics; Internal medicine","score_opus":0.008760281200906848,"score_gpt":0.2659662079715537,"score_spread":0.25720592677064685,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2053876119","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00016200857,0.9992642,0.00005297595,0.0001285644,0.00008991965,0.0000017871303,0.000004298369,0.0000019648555,0.00029431967],"genre_scores_gemma":[0.0018204396,0.9975012,0.00011616823,0.00014638394,0.00021665549,0.0000037222292,0.000010184837,7.438596e-7,0.00018461425],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99970347,0.00007409084,0.0000657046,0.00004007825,0.000095163276,0.000021464804],"domain_scores_gemma":[0.9995752,0.00023628923,0.000085794185,0.000008727528,0.00007099941,0.000022927317],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00067127554,0.0004890127,0.0012776429,0.0012594566,0.00024783492,0.0008223425,0.0006301704,0.00094275066,0.0016216972],"category_scores_gemma":[0.000755555,0.00018084297,0.00038714844,0.0009872194,0.0004949716,0.0009986084,0.00052496226,0.0011423619,0.0006266566],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00023474946,0.00008962796,0.00062175107,0.020751573,0.00013624546,0.0010234126,0.00025922369,0.000422229,0.0044923676,0.0047483756,0.0126141,0.95460635],"study_design_scores_gemma":[0.000052216245,0.0005081526,0.003502388,0.009189178,0.00030841934,0.005642663,0.00017062058,0.00017945595,0.002699978,0.004785488,0.9729145,0.000046955887],"about_ca_topic_score_codex":0.001139586,"about_ca_topic_score_gemma":0.0014428508,"teacher_disagreement_score":0.0016216972,"about_ca_system_score_codex":0.0005440214,"about_ca_system_score_gemma":0.0009294119,"threshold_uncertainty_score":0.0054250956},"labels":[],"label_agreement":null},{"id":"W2054001622","doi":"10.1111/j.1365-2141.2009.07734.x","title":"Does acetyl salicylic acid (ASA) have a role in the prevention of venous thromboembolism?","year":2009,"lang":"en","type":"review","venue":"British Journal of Haematology","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":47,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Hamilton General Hospital","funders":"","keywords":"Medicine; Aspirin; Warfarin; Venous thromboembolism; Heparin; Randomized controlled trial; Intensive care medicine; Placebo; Salicylic acid; Anticoagulant; Low molecular weight heparin; Clinical trial; Internal medicine; Alternative medicine; Thrombosis; Atrial fibrillation","score_opus":0.02887187761625183,"score_gpt":0.33777563567307356,"score_spread":0.30890375805682174,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2054001622","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00007109998,0.99895585,0.000014528849,0.00066593906,0.00010577651,0.0000015278183,0.000004506484,6.805071e-7,0.00017999887],"genre_scores_gemma":[0.000707009,0.9987657,0.000046060413,0.00028691092,0.00011003061,0.0000020392658,0.000005351809,3.1457296e-7,0.00007669992],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99950516,0.0001409501,0.0001222894,0.000047844806,0.000159158,0.000024591009],"domain_scores_gemma":[0.9989453,0.0006015385,0.00021066466,0.000022874248,0.00017589206,0.000043776607],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014853764,0.00048149296,0.002393871,0.0012593607,0.00022337526,0.0010284637,0.0009326831,0.0016728457,0.0035851505],"category_scores_gemma":[0.0028506918,0.00029107076,0.0009068586,0.002110211,0.0007733812,0.0013708221,0.00037492483,0.0013970701,0.0012262184],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00033364352,0.000056274643,0.00043134083,0.063818716,0.0005636787,0.00018569261,0.00009091006,0.00011194005,0.00062289793,0.0023268105,0.019274358,0.9121839],"study_design_scores_gemma":[0.0004185984,0.0005656519,0.006380867,0.06940913,0.0025750725,0.0030330415,0.0005244605,0.00016935387,0.00062769226,0.0060168477,0.9102233,0.000056041936],"about_ca_topic_score_codex":0.0022560037,"about_ca_topic_score_gemma":0.004335386,"teacher_disagreement_score":0.0035851505,"about_ca_system_score_codex":0.0005647339,"about_ca_system_score_gemma":0.0014602023,"threshold_uncertainty_score":0.011993527},"labels":[],"label_agreement":null},{"id":"W2054346225","doi":"10.1111/bjh.12233","title":"Anthracyclines during induction therapy in acute myeloid leukaemia: a systematic review and meta‐analysis","year":2013,"lang":"en","type":"review","venue":"British Journal of Haematology","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":63,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute for Clinical Evaluative Sciences; University of Toronto; SickKids Foundation; Public Health Ontario; Hospital for Sick Children; McMaster University","funders":"Canadian Institutes of Health Research","keywords":"Medicine; Idarubicin; Daunorubicin; Internal medicine; Anthracycline; Confidence interval; Relative risk; Meta-analysis; Gastroenterology; Randomized controlled trial; Myeloid leukemia; Chemotherapy; Cytarabine; Cancer; Breast cancer","score_opus":0.06713767490013349,"score_gpt":0.3773710469999473,"score_spread":0.3102333720998138,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2054346225","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0045070024,0.99409384,0.00032182506,0.00013115794,0.000114599665,0.00017455292,0.00042600647,0.00001766446,0.00021337795],"genre_scores_gemma":[0.13966042,0.85621685,0.0014341086,0.00072988466,0.00018860828,0.0006665994,0.00075594627,0.000022420792,0.00032509307],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9943749,0.0028518017,0.0014404138,0.00054625113,0.0005862076,0.0002005836],"domain_scores_gemma":[0.99043614,0.006827995,0.0015972316,0.00026741694,0.00072686607,0.00014437926],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.008154317,0.0022953814,0.01599049,0.00447372,0.0004700439,0.0025272076,0.0014502937,0.0017145567,0.0029852192],"category_scores_gemma":[0.018650135,0.0012233123,0.030291954,0.006297378,0.0005263406,0.0013354168,0.0010916808,0.0016940952,0.0002818255],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0019178941,0.00002153891,0.0023251812,0.41078717,0.57200086,0.0001082953,0.00006396861,0.0006321688,0.00026397136,0.00012803859,0.00070522184,0.011045652],"study_design_scores_gemma":[0.00054582214,0.00017179643,0.002718186,0.021815138,0.9726961,0.00007834271,0.000029684057,0.000154027,0.00009376708,0.000122029,0.0015574582,0.000017642978],"about_ca_topic_score_codex":0.007772722,"about_ca_topic_score_gemma":0.017487455,"teacher_disagreement_score":0.01599049,"about_ca_system_score_codex":0.0023320375,"about_ca_system_score_gemma":0.0026384436,"threshold_uncertainty_score":0.043124676},"labels":[],"label_agreement":null},{"id":"W2054603081","doi":"10.1111/bjh.12903","title":"Variance of pain prevalence and associated severity during the transfusion cycle of adult thalassaemia patients","year":2014,"lang":"en","type":"letter","venue":"British Journal of Haematology","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"National Center for Advancing Translational Sciences; National Heart, Lung, and Blood Institute; National Institutes of Health; Translational Cancer Research Network; National Center for Research Resources; Harvard Catalyst","keywords":"Medicine; Blood transfusion; Observational study; Incidence (geometry); Thalassemia; Ineffective erythropoiesis; Anemia; Internal medicine; Pediatrics; Physical therapy; Erythropoiesis","score_opus":0.0038851346201163118,"score_gpt":0.2027078690148284,"score_spread":0.1988227343947121,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2054603081","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9985846,0.00034213735,0.00005361323,0.000046439905,0.000006989106,0.000017559085,0.0005908101,0.0000034648974,0.00035442584],"genre_scores_gemma":[0.9992642,0.000120860794,0.00005456665,0.00002278024,0.000008148909,0.00001781463,0.0003730919,0.0000012312837,0.00013733801],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99932003,0.0001770927,0.00011250966,0.00016036358,0.00011688905,0.000113162416],"domain_scores_gemma":[0.9981912,0.00030717402,0.00095551787,0.0001007095,0.00018904077,0.00025636607],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00071585877,0.00017434092,0.0004279177,0.0006451461,0.00041242386,0.00057111995,0.00034490446,0.0004443863,0.0022672715],"category_scores_gemma":[0.0030320364,0.00021910566,0.00054208783,0.0008186716,0.00018117591,0.0003839931,0.00051806914,0.00069725356,0.0002749077],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003618569,0.00005342754,0.99663997,0.00002620586,0.00008063033,0.000037267535,0.00029816487,0.00002807508,0.0001328272,0.000014319941,0.00022473936,0.0021024325],"study_design_scores_gemma":[0.0000050851468,0.0001087745,0.9995609,0.000007305675,0.000013010876,0.000058756545,0.00013214261,0.0000465956,0.00000774049,0.0000069627386,0.000049960425,0.0000027845763],"about_ca_topic_score_codex":0.0056023276,"about_ca_topic_score_gemma":0.009059865,"teacher_disagreement_score":0.0056023276,"about_ca_system_score_codex":0.000381162,"about_ca_system_score_gemma":0.00019100649,"threshold_uncertainty_score":0.011139452},"labels":[],"label_agreement":null},{"id":"W2054709506","doi":"10.1111/j.1365-2141.2012.09170.x","title":"Allogeneic haematopoietic stem cell transplantation for chronic lymphocytic leukaemia: outcome in a 20‐year cohort","year":2012,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":25,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver General Hospital; University of British Columbia; BC Cancer Agency","funders":"","keywords":"Stem cell; Haematopoiesis; Transplantation; Medicine; Cohort; Hematology; Oncology; Immunology; Hematopoietic stem cell transplantation; Internal medicine; Biology; Genetics","score_opus":0.024302804094947922,"score_gpt":0.30568320253903714,"score_spread":0.28138039844408924,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2054709506","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9996246,0.000083622006,0.000018158113,0.000017609686,0.000002995633,0.0000036918213,0.00012402075,0.0000012643053,0.00012406238],"genre_scores_gemma":[0.99906915,0.0001382051,0.000015869042,0.00002398529,0.000011872018,0.00000685006,0.0005229645,0.0000015300621,0.00020962134],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99979395,0.000023262965,0.00001786231,0.000050343886,0.00004005677,0.000074586445],"domain_scores_gemma":[0.999521,0.000040333252,0.00013129911,0.000042037456,0.00006601214,0.00019929589],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00046884976,0.00029352194,0.00029638858,0.0007091228,0.00063486176,0.00075664726,0.00031530162,0.00050374406,0.0010125397],"category_scores_gemma":[0.0007420541,0.0002390948,0.0004945681,0.0006130832,0.00031947577,0.0005499985,0.00052609056,0.00058875413,0.0004630898],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00023894913,0.00006293901,0.9974335,0.0000028325999,0.000032044052,0.00047852806,0.00012647155,0.000039120514,0.00033421448,0.000010193018,0.0001225269,0.0011187498],"study_design_scores_gemma":[0.000018432109,0.00035420747,0.99753547,0.000004145419,0.000031691012,0.001278028,0.00022653739,0.00013304118,0.00006763128,0.000016342314,0.00032757586,0.0000068827962],"about_ca_topic_score_codex":0.009229397,"about_ca_topic_score_gemma":0.0061072595,"teacher_disagreement_score":0.009229397,"about_ca_system_score_codex":0.0005174384,"about_ca_system_score_gemma":0.0004989088,"threshold_uncertainty_score":0.018351316},"labels":[],"label_agreement":null},{"id":"W2055566240","doi":"10.1111/j.1365-2141.2005.05638.x","title":"Transfusion related acute lung injury (TRALI)","year":2005,"lang":"en","type":"letter","venue":"British Journal of Haematology","topic":"Blood transfusion and management","field":"Medicine","cited_by":34,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Transfusion-related acute lung injury; Medicine; Seriousness; Intensive care medicine; Consensus conference; Acute respiratory distress; Chest radiograph; Blood transfusion; Lung; Internal medicine; Pulmonary edema","score_opus":0.007921628867928887,"score_gpt":0.26014014864279816,"score_spread":0.25221851977486925,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2055566240","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.012909298,0.0144570945,0.0008915242,0.9176248,0.016456405,0.00008320081,0.00015902681,0.00012993012,0.0372888],"genre_scores_gemma":[0.16052692,0.019007696,0.0022550593,0.7376948,0.05399288,0.00010765019,0.00019257178,0.00006189948,0.026160564],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9986236,0.0004906281,0.00022110618,0.00015021797,0.00033958617,0.00017481133],"domain_scores_gemma":[0.99730897,0.0012006282,0.00048932957,0.00012409956,0.0004867803,0.00039022134],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009254634,0.00062522426,0.0008484926,0.00057664333,0.0019506002,0.001287861,0.00092725153,0.014404435,0.00422286],"category_scores_gemma":[0.009348398,0.000384295,0.0006000761,0.00087710796,0.0017977854,0.0019286383,0.00080647354,0.009949007,0.0037402182],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016886341,0.000097608616,0.015040422,0.00045842907,0.00003507793,0.22002907,0.00078222924,0.00018863294,0.0010075446,0.006047836,0.7187963,0.037348066],"study_design_scores_gemma":[0.00015141141,0.0002911992,0.0144031495,0.0016043589,0.000060199618,0.5404191,0.0012333238,0.0011476191,0.0007726818,0.013919693,0.42591482,0.000082460654],"about_ca_topic_score_codex":0.0032229316,"about_ca_topic_score_gemma":0.0043808245,"teacher_disagreement_score":0.014404435,"about_ca_system_score_codex":0.0022042338,"about_ca_system_score_gemma":0.0011767425,"threshold_uncertainty_score":0.01599294},"labels":[],"label_agreement":null},{"id":"W2056075603","doi":"10.1046/j.1365-2141.2002.03657.x","title":"Glycophorin A‐mediated haemolysis of normal human erythrocytes: evidence for antigen aggregation in the pathogenesis of immune haemolysis","year":2002,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Erythrocyte Function and Pathophysiology","field":"Medicine","cited_by":30,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"McMaster University; University of Calgary","keywords":"Haemolysis; Glycophorin; Concanavalin A; Red blood cell; Biochemistry; Biology; Hemolysis; Autoantibody; Antigen; Lectin; Immunology; Chemistry; Antibody; In vitro","score_opus":0.06167586477753055,"score_gpt":0.3061833449068399,"score_spread":0.24450748012930934,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2056075603","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99603575,0.0020464822,0.00072667934,0.000060316124,0.000010177036,0.000013371123,0.000047364214,0.000017559454,0.001042293],"genre_scores_gemma":[0.99876815,0.00055280986,0.00035063716,0.000036951915,0.000007019892,0.000005517717,0.000060943163,0.0000020308073,0.00021583862],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9998703,0.000041778047,0.000020043644,0.000018937853,0.00003266767,0.000016246007],"domain_scores_gemma":[0.9998598,0.000034995228,0.00003918196,0.000021865606,0.000019879491,0.00002419208],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00026533805,0.00017331229,0.0001264108,0.00030247957,0.00009834245,0.00015892903,0.00019099993,0.00045271593,0.0008305174],"category_scores_gemma":[0.00031112233,0.00006886616,0.00011686384,0.00017661156,0.00031238314,0.00017336007,0.0002139359,0.00027695578,0.00023370405],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00045938944,0.000068467074,0.0072307438,0.00011482787,0.000021925087,0.0017573289,0.00008782698,0.00005563988,0.986101,0.0002312565,0.00008021088,0.0037914023],"study_design_scores_gemma":[0.00015036737,0.0018384021,0.2336559,0.000042750078,0.000111580404,0.02939312,0.00016695405,0.0027607095,0.7273304,0.0010420408,0.003489569,0.000018324663],"about_ca_topic_score_codex":0.00026770963,"about_ca_topic_score_gemma":0.00010187143,"teacher_disagreement_score":0.0008305174,"about_ca_system_score_codex":0.00012821733,"about_ca_system_score_gemma":0.00007723974,"threshold_uncertainty_score":0.002778411},"labels":[],"label_agreement":null},{"id":"W2056118078","doi":"10.1046/j.1365-2141.2001.03080.x","title":"Hb H hydrops foetalis syndrome: a case report and review of literature","year":2001,"lang":"en","type":"review","venue":"British Journal of Haematology","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":95,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Hospital for Sick Children","funders":"","keywords":"Medicine; Pediatrics","score_opus":0.016308857000320923,"score_gpt":0.31110944823553205,"score_spread":0.29480059123521113,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2056118078","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0089981,0.98406583,0.00079548283,0.00082300644,0.00088503055,0.000040853454,0.0001012476,0.000064042375,0.004226376],"genre_scores_gemma":[0.03436631,0.9587684,0.0013281786,0.0010242566,0.0015315404,0.00004621212,0.00024015596,0.000010606085,0.0026843764],"study_design_codex":"design_other","study_design_gemma":"case_report","domain_scores_codex":[0.9996922,0.000040696472,0.000078773235,0.00006672709,0.00007982014,0.00004177646],"domain_scores_gemma":[0.99956566,0.00016237088,0.00011435609,0.00001800791,0.00006572199,0.00007380899],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00025906166,0.0011208481,0.0016980957,0.0047133467,0.00051155797,0.0009010165,0.0013042054,0.0017323872,0.0038880243],"category_scores_gemma":[0.0008471919,0.00034177938,0.00041609685,0.004260524,0.0006287082,0.0018688287,0.000542724,0.0007250378,0.0023714008],"study_design_candidate":"case_report","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014310787,0.000228122,0.0049284175,0.014197319,0.00021861003,0.29093963,0.00059189537,0.000545077,0.0033549434,0.0007787061,0.040811695,0.6432625],"study_design_scores_gemma":[0.000040086383,0.00016676399,0.0096099535,0.002819413,0.00026926192,0.78840184,0.00063046784,0.00019534133,0.00047891476,0.0008296469,0.19650131,0.00005695675],"about_ca_topic_score_codex":0.0011930004,"about_ca_topic_score_gemma":0.0021631997,"teacher_disagreement_score":0.0047133467,"about_ca_system_score_codex":0.000473552,"about_ca_system_score_gemma":0.00091767096,"threshold_uncertainty_score":0.013006687},"labels":[],"label_agreement":null},{"id":"W2056575733","doi":"10.1111/j.1365-2141.2008.06979.x","title":"Valproate‐induced pure red cell aplasia and megakaryocyte dysplasia","year":2008,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Parvovirus B19 Infection Studies","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children","funders":"","keywords":"Pallor; Valproic Acid; Medicine; Pure red cell aplasia; Gastroenterology; Pancytopenia; Bone marrow; Pathology; Internal medicine; Epilepsy","score_opus":0.02688016103082492,"score_gpt":0.2635860535105062,"score_spread":0.23670589247968127,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2056575733","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9703821,0.005830724,0.0021597187,0.0018872735,0.00012515542,0.00023031441,0.0008241822,0.0002681731,0.018292248],"genre_scores_gemma":[0.9950859,0.001747942,0.00064779475,0.00040602882,0.00009505738,0.000020163347,0.00019817385,0.000026870477,0.0017719512],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.9997241,0.000046996458,0.000034682074,0.000073266325,0.000057449513,0.00006344858],"domain_scores_gemma":[0.99948776,0.00015404537,0.00010548078,0.000026588832,0.00003679291,0.00018932893],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017837128,0.0012797834,0.00073420757,0.0015500202,0.000733019,0.00041262363,0.0006064096,0.0014058636,0.0023702043],"category_scores_gemma":[0.0009325542,0.00080797926,0.000399475,0.0009456691,0.00057341054,0.000665032,0.00064911274,0.0013276107,0.0008274107],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008692218,0.000051835832,0.012623816,0.00006731401,0.000017905784,0.9812794,0.000119990575,0.000080091886,0.002658041,0.00021561053,0.0003756433,0.0024235435],"study_design_scores_gemma":[0.000022574457,0.00015410711,0.021468662,0.000016995431,0.0000128436495,0.97674555,0.00003938129,0.00014604379,0.00052935793,0.0001000574,0.00075848354,0.000005966964],"about_ca_topic_score_codex":0.0015949544,"about_ca_topic_score_gemma":0.0022036375,"teacher_disagreement_score":0.0023702043,"about_ca_system_score_codex":0.0005212312,"about_ca_system_score_gemma":0.00037748658,"threshold_uncertainty_score":0.007929146},"labels":[],"label_agreement":null},{"id":"W2056793347","doi":"10.1111/j.1365-2141.2004.04804.x","title":"Intravenous (IV) anti‐D and IV immunoglobulin achieve acute platelet increases by different mechanisms: modulation of cytokine and platelet responses to IV anti‐D by Fc<i>γ</i>RIIa and Fc<i>γ</i>RIIIa polymorphisms","year":2004,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":95,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Cytokine; Platelet; Immunology; Monocyte; Antibody; CD16; Internal medicine; Receptor; Medicine; Tumor necrosis factor alpha; Endocrinology; Immune system","score_opus":0.006039635380252142,"score_gpt":0.23073422710106847,"score_spread":0.22469459172081632,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2056793347","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9991235,0.00044608494,0.00016608133,0.000019537936,0.000006110393,0.000010601844,0.000009547836,0.0000051810975,0.00021328355],"genre_scores_gemma":[0.9996556,0.000073365554,0.0000963484,0.000041693103,0.000010213125,0.0000070632145,0.000020711848,0.0000011736813,0.000093804025],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998062,0.00008262867,0.000013886115,0.000027196977,0.000024983068,0.00004496999],"domain_scores_gemma":[0.9997631,0.00009370109,0.000071758695,0.000013821625,0.00001016359,0.00004754458],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023733074,0.0002201246,0.0002542371,0.000088595516,0.000062320614,0.00026030553,0.00010143078,0.00023102202,0.00045630592],"category_scores_gemma":[0.00062388164,0.00008967909,0.00020026193,0.000079563986,0.00014897948,0.0001273329,0.00010879187,0.00035381937,0.00011246916],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.04496165,0.003217123,0.28362903,0.00023721723,0.0005034666,0.0020923011,0.00048728578,0.0008684505,0.49053824,0.00028145322,0.0007325553,0.17245118],"study_design_scores_gemma":[0.004361389,0.114951424,0.7690118,0.000057922516,0.00055775064,0.0056561483,0.00041074504,0.0020164973,0.09985666,0.00022247166,0.0028745322,0.000022654853],"about_ca_topic_score_codex":0.00018811948,"about_ca_topic_score_gemma":0.00023262072,"teacher_disagreement_score":0.00045630592,"about_ca_system_score_codex":0.00014513794,"about_ca_system_score_gemma":0.00008866744,"threshold_uncertainty_score":0.001526475},"labels":[],"label_agreement":null},{"id":"W2057626036","doi":"10.1111/bjh.12348","title":"Outcomes of treatment for relapsed acute lymphoblastic leukaemia in children with <scp>D</scp>own syndrome","year":2013,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":38,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children; University of Toronto","funders":"Deutsche Kinderkrebsstiftung; Deutsche Krebshilfe","keywords":"Medicine; Internal medicine; Chemotherapy; Cohort; Clinical trial; Adverse effect; Population; Down syndrome; Pediatrics","score_opus":0.010784235844708775,"score_gpt":0.26481597854033706,"score_spread":0.2540317426956283,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2057626036","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99888355,0.000746566,0.00003369626,0.000047621823,0.0000025117024,0.0000050527397,0.00013485664,0.0000019920276,0.00014407988],"genre_scores_gemma":[0.9993375,0.00024286596,0.000038790495,0.000015319532,0.000005239829,0.000007710679,0.0003175121,0.0000011058206,0.000033942746],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99935204,0.0002999604,0.000074077514,0.00006598563,0.00011441115,0.000093572664],"domain_scores_gemma":[0.99799466,0.0004901169,0.0011025179,0.00009718127,0.00008145246,0.00023404643],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00091763126,0.00014573759,0.00036857522,0.0003628641,0.00019150469,0.00032822046,0.00020723062,0.00019892311,0.000385588],"category_scores_gemma":[0.0032513768,0.000097791555,0.00044658003,0.00059628417,0.00024037524,0.00026210136,0.0003256208,0.0003407885,0.00007727547],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015158962,0.00005895344,0.988598,0.00003482581,0.000114369606,0.00021188971,0.0001086017,0.00036303973,0.00032249046,0.000036233672,0.0001844747,0.008451241],"study_design_scores_gemma":[0.00006815177,0.001062284,0.99728906,0.000012547317,0.000083495004,0.0006780274,0.00008659771,0.00023343886,0.0001847284,0.000040015515,0.00025714005,0.000004570101],"about_ca_topic_score_codex":0.0026967623,"about_ca_topic_score_gemma":0.0029885408,"teacher_disagreement_score":0.0026967623,"about_ca_system_score_codex":0.0006777695,"about_ca_system_score_gemma":0.00045669952,"threshold_uncertainty_score":0.0053620934},"labels":[],"label_agreement":null},{"id":"W2057629675","doi":"10.1046/j.1365-2141.2003.04541.x","title":"A selective history of the therapy of Hodgkin's disease","year":2003,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":27,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"ABVD; Procarbazine; Medicine; Dacarbazine; Vinblastine; Disease; Oncology; Bleomycin; Radiation therapy; Chemotherapy; Combination chemotherapy; Internal medicine; Intensive care medicine; Vincristine; Cyclophosphamide","score_opus":0.015480755791139101,"score_gpt":0.23823477701964668,"score_spread":0.22275402122850757,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2057629675","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0024150377,0.877736,0.0029394946,0.04743846,0.029571138,0.000032146487,0.00013011717,0.000083776256,0.039653838],"genre_scores_gemma":[0.028819615,0.83320487,0.0028230655,0.04600335,0.038589004,0.00006594279,0.00022021297,0.00013161989,0.050142355],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9990728,0.00039259304,0.00007396392,0.00013201198,0.0002450558,0.000083522384],"domain_scores_gemma":[0.998993,0.00046854126,0.00007192806,0.000086038766,0.00019495563,0.00018558744],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012759677,0.00047265567,0.0005270098,0.0010384243,0.0008788405,0.0017425838,0.0005454222,0.0016037968,0.006777248],"category_scores_gemma":[0.0021593713,0.00019325776,0.00037633805,0.0009210325,0.0025227808,0.0024315314,0.0016164568,0.005667422,0.0034104476],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00035353072,0.00022680439,0.00095899426,0.0030526896,0.000054089654,0.00056878873,0.0015294921,0.0003442385,0.0037480963,0.08061178,0.34219533,0.56635606],"study_design_scores_gemma":[0.0000061899173,0.00007375281,0.00031217997,0.00040388975,0.00000882302,0.0005814374,0.000063044856,0.000016007752,0.00027447115,0.003814256,0.9944377,0.000008330667],"about_ca_topic_score_codex":0.0011654928,"about_ca_topic_score_gemma":0.0021414582,"teacher_disagreement_score":0.006777248,"about_ca_system_score_codex":0.0016847566,"about_ca_system_score_gemma":0.0012027646,"threshold_uncertainty_score":0.022672176},"labels":[],"label_agreement":null},{"id":"W2058886769","doi":"10.1111/j.1365-2141.2008.07419.x","title":"Improved prospective identification of megakaryocyte–erythrocyte progenitor cells","year":2008,"lang":"en","type":"letter","venue":"British Journal of Haematology","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Megakaryocyte; Progenitor cell; Identification (biology); Immunology; Medicine; Biology; Cell biology; Stem cell","score_opus":0.012403684601254529,"score_gpt":0.24943634696682762,"score_spread":0.2370326623655731,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2058886769","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.87256056,0.0034226624,0.118613474,0.00014326695,0.00003690396,0.00030488303,0.001595162,0.00047167134,0.0028512815],"genre_scores_gemma":[0.8620464,0.002097421,0.12632704,0.00016283459,0.00003134398,0.00029857326,0.005071852,0.00018114789,0.0037833794],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99967074,0.000049620547,0.000041013056,0.000079850404,0.00010299635,0.000055841727],"domain_scores_gemma":[0.9998148,0.000043922486,0.000024087372,0.000027572338,0.000055045028,0.000034535868],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00045307796,0.0003777976,0.0004486401,0.0006110846,0.00013050759,0.0004988446,0.00030397362,0.00036560185,0.0012117825],"category_scores_gemma":[0.00039561928,0.0001830689,0.00019271052,0.00037192594,0.000109269095,0.00029791726,0.0006597391,0.00062136236,0.0011545318],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000031965512,0.000009066921,0.00041735108,0.000022859063,0.0000026161008,0.000017996883,0.000015719137,0.000024351175,0.99612623,0.000078096506,0.000035468074,0.003218326],"study_design_scores_gemma":[0.00000720877,0.000115265546,0.008681736,0.000009390405,0.000022669787,0.00031303184,0.000017150334,0.0019302418,0.9848643,0.000062785446,0.003970812,0.000005573593],"about_ca_topic_score_codex":0.00015308331,"about_ca_topic_score_gemma":0.0002677387,"teacher_disagreement_score":0.0012117825,"about_ca_system_score_codex":0.00010719817,"about_ca_system_score_gemma":0.00013787243,"threshold_uncertainty_score":0.004053831},"labels":[],"label_agreement":null},{"id":"W2059028235","doi":"10.1046/j.1365-2141.2003.04082.x","title":"Complete remission of tumour with interleukin 2 therapy in a patient with non‐Hodgkin's lymphoma post allogeneic bone marrow transplant associated with polyclonal T‐cell bone marrow lymphocytosis","year":2003,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Sunnybrook Health Science Centre; Princess Margaret Cancer Centre; Health Sciences Centre; University Health Network","funders":"","keywords":"Medicine; Bone marrow; Lymphoma; Lymphocytosis; Pathology","score_opus":0.009166110864208193,"score_gpt":0.2111154780458491,"score_spread":0.20194936718164092,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2059028235","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9946556,0.001753888,0.00037697944,0.0005650796,0.000043891003,0.000038127633,0.00007176981,0.000028975399,0.002465716],"genre_scores_gemma":[0.9983028,0.0004997548,0.00015916328,0.00032546316,0.00007386013,0.0000105337795,0.00009057511,0.0000066414555,0.00053098815],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.9998405,0.000032423242,0.000018646291,0.000027171698,0.00002065886,0.000060678376],"domain_scores_gemma":[0.9994116,0.00022157289,0.00009873854,0.000043928016,0.000025157842,0.00019904558],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002162449,0.00040826725,0.0006812104,0.00035918612,0.0007034607,0.00047986614,0.0003650507,0.0014669844,0.0006541085],"category_scores_gemma":[0.0013284448,0.00026858755,0.00039284184,0.00032137037,0.000513893,0.00031992383,0.00028200907,0.0011338951,0.00023732416],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0027910352,0.00078197464,0.07925428,0.00023886391,0.00012371443,0.86145824,0.0016656077,0.0009938587,0.02109162,0.0005300794,0.0011410054,0.02992984],"study_design_scores_gemma":[0.0008777329,0.0067622014,0.14072065,0.00006169321,0.00021335461,0.8398963,0.00028261618,0.0014058768,0.0049480917,0.00048189823,0.004298376,0.000051169027],"about_ca_topic_score_codex":0.0011314276,"about_ca_topic_score_gemma":0.00200124,"teacher_disagreement_score":0.0014669844,"about_ca_system_score_codex":0.00043035313,"about_ca_system_score_gemma":0.0003929147,"threshold_uncertainty_score":0.0031225085},"labels":[],"label_agreement":null},{"id":"W2060670573","doi":"10.1111/j.1365-2141.2007.06924.x","title":"Genomic profiling reveals different genetic aberrations in systemic ALK‐positive and ALK‐negative anaplastic large cell lymphomas","year":2008,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":152,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"Generalitat de Catalunya","keywords":"Anaplastic lymphoma kinase; Anaplastic large-cell lymphoma; Comparative genomic hybridization; Biology; Chromosomal translocation; Cancer research; Fluorescence in situ hybridization; Lymphoma; Molecular biology; Gene; Chromosome; Genetics; Pathology; Medicine; Immunology","score_opus":0.010674375375968518,"score_gpt":0.2332291182757592,"score_spread":0.2225547428997907,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2060670573","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99931264,0.00016204917,0.00022110707,0.000007809333,6.895627e-7,0.0000028665818,0.000059813196,0.000006732496,0.00022637572],"genre_scores_gemma":[0.99944395,0.00007834391,0.00018012029,0.000010838637,0.000002067809,0.0000046768864,0.00013363326,0.0000026896314,0.00014374623],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99985003,0.000025754392,0.000012046828,0.000038851605,0.00004834312,0.000024932844],"domain_scores_gemma":[0.999814,0.00005343167,0.00006677915,0.000012095642,0.000019944795,0.0000338286],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010980985,0.00011909295,0.00016720829,0.00079724443,0.00009658372,0.00024949404,0.00005668547,0.00014300342,0.00094101107],"category_scores_gemma":[0.00045486103,0.00009087993,0.00007772021,0.00032301247,0.00018854075,0.00008487399,0.0001620934,0.0001145667,0.00019737783],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010218985,0.00006460578,0.51246095,0.00005511804,0.00007897041,0.0026911274,0.00028781,0.00018845794,0.46415222,0.00012598536,0.00015009295,0.018722776],"study_design_scores_gemma":[0.000022892818,0.00029420666,0.97372705,0.0000040133514,0.00005648509,0.007057049,0.00018216907,0.00033829475,0.01763474,0.000086427666,0.0005922029,0.000004464281],"about_ca_topic_score_codex":0.00032863126,"about_ca_topic_score_gemma":0.00050167734,"teacher_disagreement_score":0.00094101107,"about_ca_system_score_codex":0.00011647312,"about_ca_system_score_gemma":0.00006645606,"threshold_uncertainty_score":0.0031479597},"labels":[],"label_agreement":null},{"id":"W2061022771","doi":"10.1111/bjh.13209","title":"LMWH to prevent placenta‐mediated pregnancy complications: an update","year":2014,"lang":"en","type":"review","venue":"British Journal of Haematology","topic":"Blood Coagulation and Thrombosis Mechanisms","field":"Medicine","cited_by":54,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; University of Ottawa","funders":"","keywords":"Pregnancy; Medicine; Placenta; Placental abruption; Preeclampsia; Obstetrics; Intrauterine growth restriction; Low molecular weight heparin; Placental insufficiency; Heparin; Gestation; Fetus; Surgery","score_opus":0.05485541388276022,"score_gpt":0.3644749037831243,"score_spread":0.3096194899003641,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2061022771","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00007668541,0.9992274,0.000036314384,0.00019243477,0.00012509675,0.0000033251968,0.0000127063295,0.0000025999575,0.00032340616],"genre_scores_gemma":[0.00035089973,0.9991954,0.000082600316,0.00010731613,0.00011173606,0.000003990542,0.000016537339,6.626914e-7,0.00013079536],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9997843,0.00004521145,0.00006059632,0.000031204927,0.00006464788,0.000014153473],"domain_scores_gemma":[0.9993193,0.00043428256,0.00008486985,0.00001366089,0.00011840924,0.000029493089],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006630597,0.0006937562,0.0013592655,0.0020675824,0.00020908554,0.0008616651,0.000979459,0.001119003,0.005244366],"category_scores_gemma":[0.0014099409,0.00027651148,0.00063121365,0.0019361741,0.00033831858,0.0010733395,0.00048874685,0.0013803357,0.0014246365],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009676568,0.00007267216,0.00016777974,0.0293651,0.00014494822,0.00020806899,0.00005781356,0.00020004132,0.00046286243,0.001323729,0.024090266,0.9438099],"study_design_scores_gemma":[0.00006152236,0.00021709157,0.0015859928,0.020260332,0.000582269,0.0031292925,0.00009731787,0.00014282281,0.00032700575,0.0012447579,0.9723245,0.00002705429],"about_ca_topic_score_codex":0.0013630567,"about_ca_topic_score_gemma":0.0020099452,"teacher_disagreement_score":0.005244366,"about_ca_system_score_codex":0.00048470654,"about_ca_system_score_gemma":0.0010803996,"threshold_uncertainty_score":0.01754415},"labels":[],"label_agreement":null},{"id":"W2061175590","doi":"10.1111/j.1365-2141.2005.05857.x","title":"Thrombotic thrombocytopenic purpura/haemolytic uraemic syndrome: a new index predicting response to plasma exchange","year":2005,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Complement system in diseases","field":"Immunology and Microbiology","cited_by":66,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Ottawa Hospital; University of Ottawa; Western University","funders":"Canadian Institutes of Health Research","keywords":"Thrombotic thrombocytopenic purpura; Medicine; Logistic regression; Internal medicine; Creatinine; Population; Gastroenterology; Retrospective cohort study; Platelet; Pediatrics","score_opus":0.01700635865591939,"score_gpt":0.26432345110619965,"score_spread":0.24731709245028025,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2061175590","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99708694,0.0002533161,0.0012093221,0.00014189906,0.000012336936,0.0000253787,0.00027491042,0.000023096467,0.0009728149],"genre_scores_gemma":[0.9980392,0.0001078697,0.0011834884,0.00001529263,0.000014535423,0.000009148513,0.00040230158,0.000003757339,0.0002243783],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9997229,0.00006908037,0.000027237329,0.000025323467,0.00010880914,0.000046584493],"domain_scores_gemma":[0.99856657,0.00047351565,0.00033798112,0.000041897103,0.00032434706,0.0002556644],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007249107,0.0004543709,0.00038342172,0.00093204214,0.00021399524,0.00055609946,0.0003158236,0.0003566922,0.0007661073],"category_scores_gemma":[0.0046716346,0.000113808645,0.00030479167,0.00056100986,0.00028715204,0.00029028507,0.0003096422,0.00061792287,0.0002363951],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013206333,0.000042357166,0.99238,0.0000075556527,0.00002933886,0.000061024803,0.000033973258,0.00075772573,0.00016928685,0.000030961895,0.000251745,0.0061040586],"study_design_scores_gemma":[0.000029586006,0.0002492593,0.9738598,0.00001771542,0.00007254654,0.00072992436,0.00010983964,0.023757627,0.00032522625,0.00014280202,0.00069174345,0.000013953972],"about_ca_topic_score_codex":0.04237266,"about_ca_topic_score_gemma":0.029363075,"teacher_disagreement_score":0.04237266,"about_ca_system_score_codex":0.00084224984,"about_ca_system_score_gemma":0.0014691602,"threshold_uncertainty_score":0.084252},"labels":[],"label_agreement":null},{"id":"W2061303590","doi":"10.1046/j.1365-2141.2001.02556.x","title":"Engagement of the CrkL adaptor in interferon α signalling in BCR–ABL‐expressing cells","year":2001,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":36,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University Health Network","funders":"National Cancer Institute; Medical Research Council; National Institutes of Health; U.S. Department of Veterans Affairs","keywords":"breakpoint cluster region; STAT5; Signal transducing adaptor protein; Cancer research; Chemistry; Chronic myelogenous leukemia; K562 cells; Interferon; ABL; Phosphorylation; Biology; Cell biology; Signal transduction; Leukemia; Virology; Cell; Immunology; Receptor; Tyrosine kinase; Biochemistry","score_opus":0.02612113893396738,"score_gpt":0.2746797086129177,"score_spread":0.2485585696789503,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2061303590","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.995191,0.0014056145,0.0014676518,0.00010699763,0.000022705326,0.000016924188,0.00023751438,0.00003096417,0.0015206386],"genre_scores_gemma":[0.9963864,0.0005941242,0.0008834454,0.00005364909,0.000006131498,0.000017969096,0.0004275425,0.000005629091,0.0016250728],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99983144,0.000028210034,0.000016406442,0.000029971832,0.000060229006,0.000033743934],"domain_scores_gemma":[0.999948,0.000008259489,0.000015707723,0.000009900541,0.0000071148706,0.000010970548],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011429217,0.00021239286,0.00019576408,0.000118921016,0.00021686038,0.00037421103,0.00015062153,0.00029057777,0.0010057171],"category_scores_gemma":[0.0000787369,0.0001288656,0.0002010726,0.00018453016,0.00014885297,0.00020504072,0.00018185783,0.00055279076,0.0006555973],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000764108,0.000009548149,0.00014166134,0.00001445151,0.0000015527578,0.0000468174,0.000011113311,0.000021663584,0.99916005,0.0000453891,0.000012954793,0.00045839965],"study_design_scores_gemma":[0.000029185605,0.00020653491,0.012310201,0.000008673876,0.000011268762,0.0007464738,0.000046569665,0.0009600983,0.98221624,0.00004744281,0.0034125256,0.000004959114],"about_ca_topic_score_codex":0.0005135936,"about_ca_topic_score_gemma":0.0007377298,"teacher_disagreement_score":0.0010057171,"about_ca_system_score_codex":0.00037567955,"about_ca_system_score_gemma":0.00016959647,"threshold_uncertainty_score":0.0033644438},"labels":[],"label_agreement":null},{"id":"W2061322150","doi":"10.1111/j.1365-2141.2006.06377.x","title":"Identification of transcripts modulated by ETV6 expression","year":2006,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Centre Hospitalier Universitaire Sainte-Justine","funders":"","keywords":"ETV6; Gene; Biology; Transcription factor; Gene expression; Real-time polymerase chain reaction; Genetics; Reverse transcription polymerase chain reaction; Polymerase chain reaction; Regulation of gene expression; Cancer research; Molecular biology; Chromosomal translocation","score_opus":0.007440739157703324,"score_gpt":0.25954879732504743,"score_spread":0.2521080581673441,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2061322150","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99141055,0.0026308736,0.0020183076,0.000052283827,0.000022496002,0.000036091824,0.0024620786,0.000048902468,0.0013184919],"genre_scores_gemma":[0.9856959,0.00207563,0.003946242,0.00007306133,0.000023351917,0.0001084498,0.0044289078,0.000029566558,0.0036189258],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9998485,0.000015159128,0.000009645493,0.000049514212,0.000033638,0.000043587544],"domain_scores_gemma":[0.99985206,0.000039502596,0.000044911623,0.000012684224,0.000023685321,0.000027124375],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0000997853,0.00018641514,0.00020564886,0.00049292087,0.00014271258,0.0003315431,0.00008847689,0.00023871781,0.0018291814],"category_scores_gemma":[0.00016223875,0.00010808069,0.00020767191,0.0005083532,0.00020747438,0.0001477997,0.00017470367,0.00033480962,0.0004433076],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002283668,0.0000100029065,0.0037078043,0.000050787276,0.0000070262545,0.000101809965,0.000056497694,0.00003552892,0.99335736,0.000048940354,0.00003557242,0.0023603146],"study_design_scores_gemma":[0.00003565393,0.00070774055,0.2997252,0.000036217953,0.00008485484,0.0021424138,0.0003877274,0.0007505239,0.6882065,0.00020748742,0.007700739,0.000015005017],"about_ca_topic_score_codex":0.0003447759,"about_ca_topic_score_gemma":0.00049899874,"teacher_disagreement_score":0.0018291814,"about_ca_system_score_codex":0.00019522948,"about_ca_system_score_gemma":0.000118137774,"threshold_uncertainty_score":0.0061191916},"labels":[],"label_agreement":null},{"id":"W2062191416","doi":"10.1111/j.1365-2141.2005.05893.x","title":"Differential immune effects mediated by Toll‐like receptors stimulation in precursor B‐cell acute lymphoblastic leukaemia","year":2005,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Immune Response and Inflammation","field":"Immunology and Microbiology","cited_by":29,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Children's Hospital; University of British Columbia","funders":"","keywords":"TLR9; TLR2; Immune system; Immunology; Receptor; T cell; Immunogenicity; Toll-like receptor; Biology; Immune tolerance; Cancer research; Innate immune system; Medicine; Internal medicine; Gene expression","score_opus":0.002975571795830646,"score_gpt":0.20532692617898107,"score_spread":0.20235135438315044,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2062191416","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9973279,0.001504463,0.00028416424,0.000019231888,0.000010884624,0.000015305372,0.00008601209,0.000011072123,0.0007407698],"genre_scores_gemma":[0.9973126,0.0014405763,0.0005092484,0.000037090125,0.000013305706,0.00003617173,0.00021530097,0.000005467107,0.00043021468],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99967194,0.00016245783,0.000026646716,0.000025088819,0.000047706024,0.00006618792],"domain_scores_gemma":[0.9998379,0.00007113114,0.000023396795,0.000018882705,0.000017179706,0.00003158581],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00025547855,0.00022756393,0.00027938135,0.0003672216,0.00012890481,0.00039168447,0.000111279056,0.00024565225,0.0011971074],"category_scores_gemma":[0.00029269033,0.0001878927,0.00020243612,0.00026319717,0.00018751169,0.00024910734,0.00030498614,0.00051116385,0.0003859569],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00071578595,0.000056911642,0.0013220982,0.0001283079,0.0000051912843,0.00022267978,0.000058515845,0.00005481706,0.9941341,0.00008451149,0.000030719744,0.0031863598],"study_design_scores_gemma":[0.00016689318,0.004380342,0.09339876,0.00004425258,0.000097992124,0.0036674093,0.00040381376,0.0006046001,0.8896151,0.0003107496,0.007293312,0.000016693417],"about_ca_topic_score_codex":0.00012657882,"about_ca_topic_score_gemma":0.0001656343,"teacher_disagreement_score":0.0011971074,"about_ca_system_score_codex":0.00018027588,"about_ca_system_score_gemma":0.0000933654,"threshold_uncertainty_score":0.004004717},"labels":[],"label_agreement":null},{"id":"W2062277180","doi":"10.1111/j.1365-2141.2010.08281.x","title":"Microangiopathic haemolytic anaemia and hyposplenism in angiosarcoma","year":2010,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Vascular Tumors and Angiosarcomas","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver General Hospital","funders":"","keywords":"Pathology; Medicine; Angiosarcoma; Bone marrow; Microangiopathic hemolytic anemia; CD34; Lymph node; Biology; Internal medicine; Thrombotic thrombocytopenic purpura; Platelet; Stem cell","score_opus":0.005165440566828386,"score_gpt":0.23161382019209106,"score_spread":0.22644837962526268,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2062277180","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9929684,0.0020054348,0.00031056293,0.0004055746,0.000054202537,0.000042678854,0.00007395908,0.000037116402,0.0041021784],"genre_scores_gemma":[0.99851435,0.00060683466,0.00013792828,0.00010764507,0.0001261571,0.0000055864516,0.000034640107,0.0000029663931,0.00046388723],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.9998671,0.000028205553,0.000016946517,0.000020289868,0.000024015073,0.000043559477],"domain_scores_gemma":[0.99957055,0.00015062261,0.00008754517,0.000021793629,0.000022817538,0.00014671225],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000264121,0.00052384933,0.00031886538,0.0010078197,0.00047667715,0.00041184004,0.00026289446,0.0010115684,0.002503032],"category_scores_gemma":[0.0014514626,0.00043940355,0.00019931137,0.00052292016,0.00040573796,0.00043296898,0.00032408405,0.00064467714,0.0007058013],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00029520385,0.00010852448,0.07467946,0.00007099374,0.000018497916,0.9169933,0.00023082683,0.00009047433,0.0028974463,0.00017059055,0.0004929103,0.003951841],"study_design_scores_gemma":[0.000050597442,0.00027085174,0.11250474,0.00002732111,0.00002513036,0.88516784,0.00017170995,0.00027983967,0.00045372473,0.00017269135,0.0008651044,0.000010417134],"about_ca_topic_score_codex":0.0009667717,"about_ca_topic_score_gemma":0.0012545295,"teacher_disagreement_score":0.002503032,"about_ca_system_score_codex":0.00029877087,"about_ca_system_score_gemma":0.00020775212,"threshold_uncertainty_score":0.008373499},"labels":[],"label_agreement":null},{"id":"W2063319055","doi":"10.1111/j.1365-2141.2004.04955.x","title":"Validation and extension of the EBMT Risk Score for patients with chronic myeloid leukaemia (CML) receiving allogeneic haematopoietic stem cell transplants","year":2004,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":97,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University Medical Centre","funders":"National Institute of Allergy and Infectious Diseases; National Cancer Institute","keywords":"Medicine; Internal medicine; Framingham Risk Score; Transplantation; Oncology; Population; Hematopoietic stem cell transplantation; Chronic myeloid leukaemia; Disease","score_opus":0.009854361523955739,"score_gpt":0.21968413883645418,"score_spread":0.20982977731249844,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2063319055","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9951911,0.00021003032,0.0030690646,0.00008675641,0.000033918324,0.00012460724,0.00046076466,0.000019130875,0.00080466334],"genre_scores_gemma":[0.99571425,0.00008112208,0.0027004164,0.000023077891,0.0000285924,0.00007420889,0.0011237097,0.0000119432525,0.00024260885],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99659157,0.0017488864,0.00038604252,0.00033950672,0.00075496646,0.00017902566],"domain_scores_gemma":[0.9861881,0.0069964686,0.0017473857,0.001793682,0.0026643928,0.0006099772],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.010663748,0.00058595615,0.00050914026,0.0014125468,0.00028910738,0.00070494926,0.000643658,0.00049978937,0.0008178685],"category_scores_gemma":[0.04098705,0.00015488856,0.0006430807,0.0011117286,0.00039724642,0.00056880165,0.0010534609,0.00060717744,0.00047603805],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014008848,0.0001264282,0.96026355,0.00002987189,0.00012213625,0.00008396311,0.00021358609,0.0016309374,0.0006196607,0.00019823006,0.00055225985,0.034758534],"study_design_scores_gemma":[0.00027894194,0.001665922,0.9761874,0.000041197727,0.00019813098,0.00052252156,0.00016406848,0.016587019,0.0012533806,0.0006815194,0.0023962136,0.000023696026],"about_ca_topic_score_codex":0.002215624,"about_ca_topic_score_gemma":0.0018127657,"teacher_disagreement_score":0.010663748,"about_ca_system_score_codex":0.0004061561,"about_ca_system_score_gemma":0.00080371666,"threshold_uncertainty_score":0.056395948},"labels":[],"label_agreement":null},{"id":"W2064827504","doi":"10.1046/j.1365-2141.2002.03233.x","title":"Mechanisms responsible for the failure of protamine 
to inactivate low‐molecular‐weight heparin","year":2002,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Atrial Fibrillation Management and Outcomes","field":"Medicine","cited_by":186,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; McMaster University","funders":"Medical Research Council; Canadian Institutes of Health Research","keywords":"Protamine; Protamine sulfate; Low molecular weight heparin; Heparin; Molecular mass; Chemistry; Anticoagulant; Fractionation; Pharmacology; Chromatography; Biochemistry; Internal medicine; Medicine; Enzyme","score_opus":0.03502419630825718,"score_gpt":0.2988683484815472,"score_spread":0.26384415217329005,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2064827504","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96106714,0.021086056,0.013247606,0.000979607,0.000134276,0.00020482924,0.00014389069,0.00014306643,0.002993586],"genre_scores_gemma":[0.9909671,0.004457149,0.0022964317,0.00023139718,0.00007943257,0.000055000764,0.000116268624,0.000014320439,0.0017829088],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9995215,0.000099750636,0.00007737075,0.00006390059,0.0001177406,0.000119856566],"domain_scores_gemma":[0.999102,0.00024454325,0.00040049266,0.00010259033,0.00009475187,0.00005559354],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007797925,0.00062230224,0.0006388543,0.00046129114,0.00021047205,0.0011177805,0.00074116787,0.001199032,0.0015814262],"category_scores_gemma":[0.001125349,0.00033621574,0.00054400915,0.00014564785,0.0008574978,0.00095777377,0.00045313063,0.00085034117,0.00077075063],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00072056905,0.00013508873,0.005057069,0.0004736806,0.00011858153,0.0017471164,0.00022152721,0.00031114486,0.97447133,0.0019414163,0.00027614032,0.014526309],"study_design_scores_gemma":[0.000214607,0.0021777193,0.04819007,0.000084344414,0.00020587737,0.016289813,0.00024144705,0.003083114,0.91849035,0.0022548316,0.008730222,0.000037654376],"about_ca_topic_score_codex":0.0003168342,"about_ca_topic_score_gemma":0.00014469244,"teacher_disagreement_score":0.0015814262,"about_ca_system_score_codex":0.00031250826,"about_ca_system_score_gemma":0.00024986517,"threshold_uncertainty_score":0.005290389},"labels":[],"label_agreement":null},{"id":"W2064866439","doi":"10.1046/j.1365-2141.2001.02953.x","title":"Transcript profiling of human dendritic cells maturation‐induced under defined culture conditions: comparison of the effects of tumour necrosis factor alpha, soluble CD40 ligand trimer and interferon gamma","year":2001,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Immunotherapy and Immune Responses","field":"Immunology and Microbiology","cited_by":34,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Columbia College","funders":"National Center for Research Resources","keywords":"Biology; Chemokine; CD40; Tumor necrosis factor alpha; Interferon gamma; Cell biology; Gene expression; Dendritic cell; Interferon; Phenotype; Gene expression profiling; Immunology; Molecular biology; Cytokine; Gene; Inflammation; In vitro; Immune system; Genetics; Cytotoxic T cell","score_opus":0.01872965282265199,"score_gpt":0.27515903059516444,"score_spread":0.25642937777251246,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2064866439","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97757727,0.0039609983,0.009941547,0.00013236093,0.00006311567,0.00014874831,0.006315123,0.000064919885,0.0017957757],"genre_scores_gemma":[0.9546923,0.0066176625,0.019170059,0.00029717066,0.00010827729,0.0006212712,0.014743206,0.000072915565,0.0036772245],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9996425,0.000057019643,0.00002997134,0.00009771759,0.00010710592,0.00006562651],"domain_scores_gemma":[0.9998061,0.00007185471,0.000027157655,0.000023377808,0.000054654898,0.00001680962],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00025176437,0.00018956425,0.00046162697,0.00031731575,0.00019989032,0.00045872747,0.00009543093,0.00021985002,0.00069726486],"category_scores_gemma":[0.0003351788,0.00014132104,0.00023422134,0.00058564876,0.00018043064,0.00013580616,0.00015081296,0.00037924913,0.0005459493],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014098,0.000017087765,0.0006811531,0.000041661642,0.000005968617,0.000024806139,0.000037935748,0.0000648984,0.99690187,0.000023669549,0.000046507117,0.0020136095],"study_design_scores_gemma":[0.00003837419,0.0005473177,0.030299565,0.000021165619,0.00007880941,0.0003452867,0.00013688894,0.0013196766,0.96106875,0.00012181308,0.0060036867,0.000018586123],"about_ca_topic_score_codex":0.00039122693,"about_ca_topic_score_gemma":0.0006409703,"teacher_disagreement_score":0.00069726486,"about_ca_system_score_codex":0.00020791878,"about_ca_system_score_gemma":0.00027553356,"threshold_uncertainty_score":0.0023325682},"labels":[],"label_agreement":null},{"id":"W2064929711","doi":"10.1111/bjh.13112","title":"Long‐acting recombinant factor IX Fc fusion protein (<scp>rFIXF</scp>c) for perioperative management of subjects with haemophilia B in the phase 3 <scp>B‐LONG</scp> study","year":2014,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Hemophilia Treatment and Research","field":"Medicine","cited_by":49,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Paul's Hospital","funders":"Novo Nordisk; Swedish Orphan Biovitrum; CSL Behring; Amgen; Pfizer; GlaxoSmithKline; Biogen; Biogen Idec; Bristol-Myers Squibb","keywords":"Medicine; Haemophilia B; Haemophilia; Perioperative; Dosing; Factor IX; Pharmacokinetics; Population; Surgery; Haemophilia A; Anesthesia; Internal medicine","score_opus":0.031366387462393626,"score_gpt":0.32556108692500857,"score_spread":0.29419469946261495,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2064929711","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98689485,0.008143462,0.001470921,0.00036419654,0.00006324383,0.0009050094,0.0006474321,0.00007478513,0.0014360739],"genre_scores_gemma":[0.99258137,0.002809153,0.0017727237,0.0004565468,0.000060156774,0.0005973832,0.0005986978,0.000009431431,0.0011144563],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.99981326,0.00010509234,0.0000095908335,0.000023656456,0.000024307925,0.000024179904],"domain_scores_gemma":[0.9997143,0.000073030176,0.00008380995,0.00001365571,0.000020714568,0.000094419695],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014144885,0.00044011828,0.00050818437,0.000118204254,0.00017673319,0.00045344303,0.00016774453,0.00041468954,0.0015356928],"category_scores_gemma":[0.00055167644,0.00015843047,0.00065170194,0.00013923002,0.00018109733,0.00016284242,0.00011683197,0.0007710841,0.00024080239],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.47958264,0.017320627,0.04711459,0.0016254345,0.0034877448,0.0003910241,0.00032398244,0.0022136583,0.057389144,0.0006872622,0.0067455163,0.38311845],"study_design_scores_gemma":[0.17704439,0.62843037,0.1612762,0.00026427917,0.0028577233,0.00094619085,0.00012058319,0.0031439122,0.010070713,0.0006080253,0.015169722,0.00006790209],"about_ca_topic_score_codex":0.0006573416,"about_ca_topic_score_gemma":0.0015098059,"teacher_disagreement_score":0.0015356928,"about_ca_system_score_codex":0.000258894,"about_ca_system_score_gemma":0.0007156971,"threshold_uncertainty_score":0.0074806213},"labels":[],"label_agreement":null},{"id":"W2065665685","doi":"10.1046/j.1365-2141.2001.03060.x","title":"A comparison of three rapid D‐dimer methods for the diagnosis of venous thromboembolism","year":2001,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":67,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hamilton Health Sciences; Ottawa Hospital; Queen Elizabeth II Health Sciences Centre; London Health Sciences Centre","funders":"London Health Sciences Centre","keywords":"D-dimer; Pulmonary embolism; Medicine; Deep vein; Thrombosis; Venous thromboembolism; Venous thrombosis; Pre- and post-test probability; Vein; Radiology; Internal medicine","score_opus":0.07319588517560331,"score_gpt":0.40756343188394045,"score_spread":0.3343675467083371,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2065665685","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98607165,0.008901073,0.0031567349,0.00025625236,0.00012430032,0.00013316023,0.00012173351,0.000053241052,0.0011818991],"genre_scores_gemma":[0.99100846,0.0015801727,0.006719664,0.0001373714,0.000070505404,0.000088195404,0.0002098831,0.000010757062,0.00017501954],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9884213,0.006602653,0.00081042293,0.00076000526,0.0030545488,0.0003509672],"domain_scores_gemma":[0.9545467,0.037152067,0.0028554543,0.0009802687,0.003123726,0.0013417909],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.011614827,0.00096646283,0.00095670536,0.0019402492,0.0002633907,0.0012191852,0.0009713012,0.00094941875,0.0004937841],"category_scores_gemma":[0.034982882,0.00064398104,0.00079556846,0.00064034626,0.00058355764,0.00073237007,0.0008341705,0.00078296673,0.0002549736],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.058668554,0.001173076,0.7292182,0.0010917975,0.0022968263,0.0003597256,0.00067060516,0.00477839,0.0058751553,0.0005362264,0.0010956881,0.19423585],"study_design_scores_gemma":[0.009583609,0.06709354,0.84677005,0.0005272275,0.0024677836,0.0046012076,0.0006337633,0.050549537,0.012535931,0.0016088603,0.0033076007,0.00032093344],"about_ca_topic_score_codex":0.0011922693,"about_ca_topic_score_gemma":0.0017712488,"teacher_disagreement_score":0.011614827,"about_ca_system_score_codex":0.0009160436,"about_ca_system_score_gemma":0.00058319396,"threshold_uncertainty_score":0.061425805},"labels":[],"label_agreement":null},{"id":"W2066107675","doi":"10.1111/j.1365-2141.2006.06105.x","title":"Clinical relevance of cytogenetic abnormalities at diagnosis of acquired aplastic anaemia in adults","year":2006,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":73,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Karyotype; Monosomy; Trisomy 8; Trisomy; Abnormality; Cytogenetics; Clinical significance; Aneuploidy; Chromosome 7 (human); Aplastic anemia; Medicine; Internal medicine; Chromosomal Abnormality; Pediatrics; Pathology; Gastroenterology; Immunology; Chromosome; Biology; Bone marrow; Genetics","score_opus":0.016547343313685896,"score_gpt":0.2875936727352343,"score_spread":0.2710463294215484,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2066107675","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9980945,0.0007500235,0.000044852604,0.0000881848,0.000007688787,0.0000044503363,0.00006376106,0.000003230561,0.00094332715],"genre_scores_gemma":[0.9997292,0.00010523012,0.000022574568,0.000022679396,0.00001711108,0.000001979569,0.00005591203,8.424634e-7,0.000044319317],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99943537,0.00015715258,0.000088787565,0.000072277595,0.00014607732,0.00010032913],"domain_scores_gemma":[0.9965982,0.0012486508,0.0011872962,0.000079721685,0.00040172934,0.00048449397],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00045088577,0.00018759035,0.00028105592,0.00056133076,0.0002976646,0.00047528444,0.00017593571,0.0004791675,0.0010796732],"category_scores_gemma":[0.0057390933,0.00012380756,0.00010684272,0.0003823311,0.0005108942,0.00032699583,0.00024297903,0.00036885063,0.00020296586],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00040208062,0.000019229641,0.99205595,0.000014188111,0.000010656249,0.0018937066,0.00009545885,0.00008008439,0.0005767105,0.00002890656,0.00014105334,0.0046818512],"study_design_scores_gemma":[0.000022005408,0.0005211254,0.9869556,0.00001685621,0.000028017628,0.011101591,0.00023568416,0.0001550355,0.00041575998,0.000056257766,0.00048416102,0.00000799685],"about_ca_topic_score_codex":0.0009798743,"about_ca_topic_score_gemma":0.0008741819,"teacher_disagreement_score":0.0010796732,"about_ca_system_score_codex":0.00028704613,"about_ca_system_score_gemma":0.00020125731,"threshold_uncertainty_score":0.0036118627},"labels":[],"label_agreement":null},{"id":"W2066131474","doi":"10.1046/j.1365-2141.2003.04346.x","title":"The molecular basis for the thalassaemias in Sri Lanka","year":2003,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":74,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Toronto General Hospital; Hospital for Sick Children","funders":"Medical Research Council; Hospital for Sick Children; Leverhulme Trust; Ministry Of Health, Nutrition and Indigenous Medicine; Wellcome Trust","keywords":"Genetics; Gene; Biology; Allele; Phenotype; Mutation; Globin; Thalassemia; Hemoglobinopathy; Molecular biology; Hemolytic anemia; Immunology","score_opus":0.008703283845785625,"score_gpt":0.2535034113074311,"score_spread":0.24480012746164548,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2066131474","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9978962,0.0010451893,0.000080865815,0.000092705945,0.000003819505,0.000006286581,0.00008593611,0.0000071070795,0.0007819138],"genre_scores_gemma":[0.99890983,0.0006323227,0.00014324093,0.000033428598,0.000007210087,0.0000039971856,0.0001417614,0.0000027333097,0.00012552168],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9997434,0.00004820814,0.00005380988,0.000039362065,0.00005362775,0.000061473256],"domain_scores_gemma":[0.99973184,0.000045871642,0.00011399798,0.000019370298,0.00003195319,0.000056934965],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019314374,0.0004617086,0.00034153933,0.0010700516,0.00039486913,0.0006993835,0.00032787645,0.00025847694,0.001709111],"category_scores_gemma":[0.00059536734,0.00025960934,0.00042664888,0.00083966594,0.0005068265,0.00016065822,0.0003640028,0.000293914,0.00031566885],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00043828634,0.000039306906,0.906756,0.00021623273,0.0003087738,0.009491797,0.0016340715,0.0003754968,0.0487749,0.0006201429,0.00047015387,0.0308748],"study_design_scores_gemma":[0.000034749413,0.0002316094,0.9726069,0.00005337517,0.0001914087,0.021643238,0.0010095389,0.00017831301,0.0016147377,0.00018003971,0.0022362638,0.000019933053],"about_ca_topic_score_codex":0.0040985607,"about_ca_topic_score_gemma":0.0035772386,"teacher_disagreement_score":0.0040985607,"about_ca_system_score_codex":0.00040914034,"about_ca_system_score_gemma":0.00026398856,"threshold_uncertainty_score":0.008149445},"labels":[],"label_agreement":null},{"id":"W2066286024","doi":"10.1111/j.1365-2141.2008.07337.x","title":"A multicentre randomised clinical endpoint study of <scp>parma</scp> 5 computer‐assisted oral anticoagulant dosage","year":2008,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Atrial Fibrillation Management and Outcomes","field":"Medicine","cited_by":30,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hamilton General Hospital","funders":"","keywords":"Medicine; Deep vein; Oral anticoagulant; Thrombosis; Clinical trial; Pulmonary embolism; Clinical endpoint; Emergency medicine; Surgery; Internal medicine; Warfarin","score_opus":0.11317277180393226,"score_gpt":0.37187592069718417,"score_spread":0.2587031488932519,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2066286024","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98914135,0.0017824284,0.0008030855,0.0002917627,0.00037160437,0.0053314944,0.0006967632,0.000056710014,0.0015248178],"genre_scores_gemma":[0.9881413,0.00079168985,0.0016988514,0.00054340146,0.00047878237,0.0059168492,0.0008578195,0.000013838207,0.0015575016],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9931676,0.005032515,0.00040336678,0.0005131198,0.00053693267,0.00034655543],"domain_scores_gemma":[0.9926513,0.002937541,0.0022058662,0.00070632296,0.00044444494,0.0010545831],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.007307571,0.0015627034,0.0029958668,0.0005648766,0.00042684318,0.0012864475,0.0010590723,0.0022542558,0.0043947166],"category_scores_gemma":[0.008527615,0.0007654086,0.0026773915,0.0006544674,0.0011029699,0.0011606506,0.000886431,0.0029721374,0.0007020841],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.99258983,0.0028254117,0.00060772616,0.00018409535,0.0006078392,0.000017008777,0.000028254586,0.00014282008,0.00053281157,0.000050626222,0.00014988428,0.0022636007],"study_design_scores_gemma":[0.8882232,0.105160855,0.005067102,0.000019364888,0.00053044944,0.000031371404,0.00001416225,0.00036639167,0.00016455619,0.00007339208,0.00033216653,0.000016996906],"about_ca_topic_score_codex":0.00088866055,"about_ca_topic_score_gemma":0.001178695,"teacher_disagreement_score":0.007307571,"about_ca_system_score_codex":0.00088294665,"about_ca_system_score_gemma":0.001179356,"threshold_uncertainty_score":0.03864658},"labels":[],"label_agreement":null},{"id":"W2067792512","doi":"10.1046/j.1365-2141.2001.03046.x","title":"Glycoconjugate abnormalities in patients with congenital dyserythropoietic anaemia type I, II and III","year":2001,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Erythrocyte Function and Pathophysiology","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Glycoconjugate; Glycophorin; Internal medicine; Erythrocyte membrane; Biology; Membrane; Biochemistry; Endocrinology; Immunology; Pathology; Molecular biology; Medicine","score_opus":0.00824839023504261,"score_gpt":0.2277147774359792,"score_spread":0.21946638720093659,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2067792512","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99913114,0.00030639724,0.00004525997,0.000021058242,0.000002624661,0.000004868825,0.000028311219,0.000004671104,0.0004557171],"genre_scores_gemma":[0.9996125,0.00012736241,0.00008035903,0.000021460743,0.0000039490737,0.0000035710473,0.000045421562,0.0000014905276,0.000103902195],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99977905,0.000042551383,0.000035282595,0.00005694417,0.000034112993,0.000052105122],"domain_scores_gemma":[0.999689,0.00008230998,0.00010572481,0.000017334387,0.000026204787,0.00007943609],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016541129,0.00051971833,0.0003806538,0.0013619056,0.00050859747,0.00044645727,0.00021428989,0.0005628818,0.0010561796],"category_scores_gemma":[0.0010573348,0.00026654723,0.0001723979,0.0007619591,0.00042481822,0.0002058523,0.00028447673,0.00030928844,0.0001402439],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010678914,0.00009207743,0.9387543,0.00006442488,0.000056522378,0.022502948,0.0013388279,0.00009552394,0.026840726,0.00016322166,0.00021301175,0.00881063],"study_design_scores_gemma":[0.000042920758,0.00051700993,0.9547486,0.000021480435,0.00005584778,0.041268982,0.0004580365,0.00013411924,0.0021495048,0.000093776616,0.0005002013,0.0000095534715],"about_ca_topic_score_codex":0.0019573746,"about_ca_topic_score_gemma":0.0012338256,"teacher_disagreement_score":0.0019573746,"about_ca_system_score_codex":0.0003320432,"about_ca_system_score_gemma":0.00017122671,"threshold_uncertainty_score":0.003891945},"labels":[],"label_agreement":null},{"id":"W2067920937","doi":"10.1111/j.1365-2141.2005.05639.x","title":"Transfusion‐related acute lung injury – response to Urbaniak","year":2005,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Blood transfusion and management","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Transfusion-related acute lung injury; Medicine; Intensive care medicine; Age limit; Pediatrics; Lung; Internal medicine; Pulmonary edema","score_opus":0.005761890945050774,"score_gpt":0.2664000473537781,"score_spread":0.26063815640872734,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2067920937","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.028477289,0.010287545,0.00091031665,0.93649167,0.008378408,0.0001385669,0.00008953107,0.00016372297,0.015062924],"genre_scores_gemma":[0.4085859,0.016386906,0.002557256,0.5346284,0.025638437,0.00016775796,0.0001571922,0.00012125494,0.011756852],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.997157,0.0011248321,0.0005402982,0.00037576503,0.0004685529,0.00033354366],"domain_scores_gemma":[0.98969686,0.0045308247,0.0014733224,0.0003609122,0.0026413263,0.001296737],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0025768357,0.00036160194,0.0005544643,0.00052439887,0.0010483973,0.0013673669,0.0015207365,0.004358395,0.005726705],"category_scores_gemma":[0.023988832,0.00020735455,0.00056186016,0.0007605967,0.0010945392,0.001356646,0.0013587323,0.0048021423,0.0012068311],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00085149496,0.00033176385,0.057418417,0.0011837535,0.00011924162,0.10554097,0.0020359177,0.0014678843,0.0020760994,0.004016949,0.703413,0.12154453],"study_design_scores_gemma":[0.00032706658,0.00096196425,0.09125651,0.0018147929,0.00012641266,0.15431632,0.005592049,0.0026393149,0.0013090638,0.0062788455,0.73502076,0.00035686078],"about_ca_topic_score_codex":0.0045771915,"about_ca_topic_score_gemma":0.007808907,"teacher_disagreement_score":0.005726705,"about_ca_system_score_codex":0.0026023893,"about_ca_system_score_gemma":0.0016707447,"threshold_uncertainty_score":0.019157708},"labels":[],"label_agreement":null},{"id":"W2068331840","doi":"10.1111/bjh.12244","title":"Modern management of lymphocyte predominant <scp>H</scp>odgkin lymphoma","year":2013,"lang":"en","type":"review","venue":"British Journal of Haematology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"National Cancer Institute","keywords":"CD15; CD30; Lymphoma; CD20; Medicine; Lymphocyte; Pathological; Stage (stratigraphy); Hodgkin lymphoma; Pathology; Immunology; Biology; CD34","score_opus":0.03051863911245825,"score_gpt":0.30376686698209776,"score_spread":0.27324822786963954,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2068331840","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00016441087,0.99899405,0.000055894634,0.00016469964,0.00007614019,0.0000029258495,0.000012355348,0.000004316635,0.00052522775],"genre_scores_gemma":[0.00085039507,0.99864095,0.00012275879,0.000104745915,0.000087801054,0.0000038099884,0.000025989386,8.664359e-7,0.00016265489],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9998099,0.00003281783,0.000046456997,0.000030794414,0.00006437244,0.000015616017],"domain_scores_gemma":[0.999721,0.00013741404,0.000056440986,0.000006950226,0.00005930277,0.000018775994],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00040919223,0.0005154322,0.0011175734,0.0021030148,0.00021467618,0.0006361527,0.0008133906,0.0006726198,0.0024765877],"category_scores_gemma":[0.0008288015,0.00019011254,0.00045622938,0.0017972807,0.00030061178,0.00089231925,0.00044897143,0.0010319891,0.001070382],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000059611066,0.000042931566,0.00024087675,0.023554744,0.000078269506,0.0002909194,0.00005529909,0.00023585763,0.00068459555,0.00081924774,0.016621456,0.9573161],"study_design_scores_gemma":[0.000038851904,0.00017146843,0.0036429956,0.01863338,0.0003287099,0.007518764,0.00015525238,0.00013007164,0.0006146685,0.00168184,0.9670569,0.000027063834],"about_ca_topic_score_codex":0.0009382135,"about_ca_topic_score_gemma":0.0018378508,"teacher_disagreement_score":0.0024765877,"about_ca_system_score_codex":0.0005147618,"about_ca_system_score_gemma":0.00070290855,"threshold_uncertainty_score":0.008284986},"labels":[],"label_agreement":null},{"id":"W2071152504","doi":"10.1111/j.1365-2141.2008.07389.x","title":"Outcomes of older patients (≥60 years) with acquired aplastic anaemia treated with immunosuppressive therapy","year":2008,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":32,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Internal medicine; Confidence interval; Tolerability; Cumulative incidence; Incidence (geometry); Surgery; Toxicity; Single Center; Gastroenterology; Ciclosporin; Adverse effect; Chemotherapy; Transplantation","score_opus":0.010762798218822294,"score_gpt":0.2361154553272821,"score_spread":0.2253526571084598,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2071152504","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99917835,0.00046670123,0.000050233688,0.000039715917,0.000006739768,0.000007552668,0.000027344106,0.0000019258578,0.00022139172],"genre_scores_gemma":[0.9994567,0.00020785912,0.0000662562,0.000058685575,0.000035126308,0.000008507793,0.00009808452,9.179814e-7,0.00006792211],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99975616,0.00006517173,0.00003796325,0.00003199333,0.000041405805,0.0000673523],"domain_scores_gemma":[0.9988141,0.00018584076,0.00046603373,0.000034228568,0.000086537715,0.00041330256],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00041573527,0.00023796949,0.0004897086,0.00025376148,0.00054203405,0.000530227,0.00014543871,0.00035712705,0.00065728894],"category_scores_gemma":[0.0016681897,0.00012708035,0.00035358386,0.0002957137,0.00022662488,0.0002591936,0.00034162123,0.0003593474,0.0001380882],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00068322656,0.00024878327,0.9823047,0.000037302532,0.00008195517,0.0023792998,0.00043750234,0.00028490194,0.000864221,0.000020572026,0.00025513372,0.012402415],"study_design_scores_gemma":[0.0001643274,0.0040005413,0.98500836,0.00002956944,0.00014231757,0.008223047,0.00050836446,0.00044319237,0.00033832272,0.00006606495,0.001062356,0.000013538509],"about_ca_topic_score_codex":0.0007480572,"about_ca_topic_score_gemma":0.0012731272,"teacher_disagreement_score":0.0007480572,"about_ca_system_score_codex":0.00028708117,"about_ca_system_score_gemma":0.0002201781,"threshold_uncertainty_score":0.002198875},"labels":[],"label_agreement":null},{"id":"W2071523584","doi":"10.1111/bjh.12492","title":"Genome‐wide genotype‐based risk model for survival in acute myeloid leukaemia patients with normal karyotype","year":2013,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"Chonnam National University Hwasun Hospital","keywords":"Single-nucleotide polymorphism; SNP; Genotyping; Oncology; SNP array; Genotype; Tag SNP; Internal medicine; Genome-wide association study; SNP genotyping; Biology; Medicine; Genetics; Gene","score_opus":0.012529249896750734,"score_gpt":0.25487343524030087,"score_spread":0.24234418534355015,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2071523584","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9442152,0.0007035468,0.051423818,0.0008359045,0.00006547375,0.00007763139,0.0015682711,0.00033596318,0.00077421893],"genre_scores_gemma":[0.9916523,0.00013242956,0.0050104726,0.00006374512,0.00002763679,0.00009177197,0.0016524061,0.000028491106,0.0013407159],"study_design_codex":"simulation_or_modeling","study_design_gemma":"observational","domain_scores_codex":[0.9992317,0.00039113473,0.000030780302,0.00020175408,0.000057254547,0.000087408065],"domain_scores_gemma":[0.9982601,0.0012718786,0.00016669882,0.000091726644,0.000114886076,0.0000947939],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002285073,0.000882075,0.0010482749,0.0009869133,0.00035648007,0.0010739543,0.001102474,0.0008890964,0.0020332355],"category_scores_gemma":[0.0032630465,0.0003980952,0.0018193551,0.0004672628,0.00027661482,0.00029487727,0.0005617102,0.00096379296,0.0005380161],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0019066182,0.00044026828,0.43087253,0.00008966372,0.0020497616,0.00087736256,0.00030095543,0.525608,0.0027254934,0.0021396673,0.002286188,0.030703405],"study_design_scores_gemma":[0.00007374069,0.00019572357,0.0383165,0.000021660977,0.00039008935,0.00026508232,0.000053493564,0.9578735,0.0002302873,0.0020558725,0.0004950775,0.000028873881],"about_ca_topic_score_codex":0.008572398,"about_ca_topic_score_gemma":0.005010032,"teacher_disagreement_score":0.008572398,"about_ca_system_score_codex":0.0006135599,"about_ca_system_score_gemma":0.00085202616,"threshold_uncertainty_score":0.017045021},"labels":[],"label_agreement":null},{"id":"W2072018052","doi":"10.1111/j.1365-2141.2004.05207.x","title":"A population study to define the incidence and survival of multiple myeloma in a National Health Service Region in UK","year":2004,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":143,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Thomas Hospital","funders":"","keywords":"Medicine; Incidence (geometry); Population; Epidemiology; Multiple myeloma; Cancer registry; Demography; Clinical trial; Pediatrics; Internal medicine; Environmental health","score_opus":0.042833296858364185,"score_gpt":0.3484106212694448,"score_spread":0.3055773244110806,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2072018052","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9941303,0.00084863586,0.0004393764,0.00014790037,0.000021007583,0.00027884895,0.0031348874,0.000009282306,0.0009897685],"genre_scores_gemma":[0.99488163,0.00063751615,0.00058482325,0.00029272746,0.000029527797,0.000493809,0.0024743453,0.000005142772,0.00060046336],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99803966,0.00085473113,0.00025702137,0.00028434698,0.00030494953,0.0002593108],"domain_scores_gemma":[0.9984976,0.00024322205,0.00060204323,0.00014804649,0.00024862355,0.000260436],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00096492865,0.00037666966,0.00071108976,0.001621431,0.0006683372,0.00078144576,0.0004086946,0.000793675,0.002305126],"category_scores_gemma":[0.004301511,0.0004815554,0.0006260018,0.0029889557,0.0004957616,0.0008379143,0.0014181857,0.0006946904,0.000575084],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00035454857,0.00012630575,0.991115,0.00012322265,0.00016262956,0.0006060103,0.0014473832,0.000065991255,0.00042465865,0.00009389648,0.0013482496,0.0041320873],"study_design_scores_gemma":[0.000070934126,0.00035007836,0.9966294,0.00004125179,0.00005233308,0.00077897724,0.00085666706,0.000084036554,0.000025925488,0.000024391584,0.0010759982,0.000009873039],"about_ca_topic_score_codex":0.0712945,"about_ca_topic_score_gemma":0.07477617,"teacher_disagreement_score":0.0712945,"about_ca_system_score_codex":0.0014036521,"about_ca_system_score_gemma":0.00117345,"threshold_uncertainty_score":0.14175904},"labels":[],"label_agreement":null},{"id":"W2072135692","doi":"10.1046/j.1365-2141.2002.03407.x","title":"Fluoro‐deoxyglucose positron emission tomography imaging for the detection of occult disease in multiple myeloma","year":2002,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":63,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Thomas Hospital","funders":"","keywords":"Positron emission tomography; Medicine; Occult; Multiple myeloma; Magnetic resonance imaging; Deoxyglucose; Radiology; Nuclear medicine; Plasmacytoma; Transplantation; Pathology; Internal medicine","score_opus":0.019733550068863362,"score_gpt":0.27477393162081304,"score_spread":0.2550403815519497,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2072135692","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.37702757,0.51945597,0.046596855,0.012077322,0.0015553314,0.0005827355,0.00032039714,0.0007385361,0.041645337],"genre_scores_gemma":[0.7841231,0.1596368,0.0446784,0.001839548,0.0013509948,0.00029724694,0.00035805654,0.00010294586,0.0076129255],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99973696,0.0001070992,0.00003112431,0.000016791744,0.00005762222,0.00005041597],"domain_scores_gemma":[0.99976796,0.00010949055,0.000028707982,0.000018363753,0.00003112646,0.00004441497],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008841635,0.00052553095,0.000846671,0.001612278,0.00042445408,0.000532432,0.0006642067,0.0013728072,0.002807462],"category_scores_gemma":[0.0011982905,0.0003508491,0.00041282037,0.000945506,0.0005241982,0.00058482157,0.0004301766,0.0012616611,0.0008616134],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0030204947,0.00051157025,0.11911743,0.0019800973,0.00022664557,0.17156866,0.0005147753,0.0009902918,0.09187993,0.0027548145,0.014425086,0.5930102],"study_design_scores_gemma":[0.0005501601,0.0024925813,0.18120082,0.0006250693,0.00038220323,0.66871345,0.00036033412,0.0025090445,0.031567488,0.0021751642,0.109321676,0.00010208191],"about_ca_topic_score_codex":0.0016314455,"about_ca_topic_score_gemma":0.0025706966,"teacher_disagreement_score":0.002807462,"about_ca_system_score_codex":0.0004672975,"about_ca_system_score_gemma":0.00055530894,"threshold_uncertainty_score":0.009391904},"labels":[],"label_agreement":null},{"id":"W2073345996","doi":"10.1046/j.1365-2141.2001.02642.x","title":"Myristoylated alanine‐rich C kinase substrate phosphorylation is involved in thrombin‐induced serotonin release from platelets","year":2001,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":27,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa","funders":"Heart and Stroke Foundation of Canada","keywords":"MARCKS; Phosphorylation; Protein kinase C; Biology; Biochemistry; Thrombin; Platelet activation; Cell biology; Platelet; Chemistry","score_opus":0.020294200464926526,"score_gpt":0.2641070788124191,"score_spread":0.2438128783474926,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2073345996","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9940445,0.003715519,0.001016408,0.00013458809,0.000018632456,0.000021962253,0.00012765192,0.000020701022,0.00090002944],"genre_scores_gemma":[0.99703896,0.0013082171,0.0007575033,0.000034824585,0.000012125712,0.0000119692295,0.00020606232,0.000003841074,0.0006265411],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9999269,0.000014538466,0.000010465754,0.000011003155,0.00001686231,0.000020187317],"domain_scores_gemma":[0.9998807,0.000024968516,0.000049348022,0.000012594664,0.000009091794,0.00002331371],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00008557893,0.00019480553,0.00018013205,0.00015328238,0.0001290647,0.00020242357,0.00006773516,0.00025091824,0.0010002614],"category_scores_gemma":[0.00016595775,0.0001239947,0.00022048796,0.0000997441,0.0001487928,0.000165928,0.00011835369,0.00038056253,0.00023468451],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003699528,0.000016731557,0.00041769797,0.000049446855,0.000005936291,0.000244602,0.000010970176,0.000030281133,0.99772507,0.00006132214,0.000026639853,0.0010413887],"study_design_scores_gemma":[0.00004994763,0.00043479097,0.049043454,0.000012073468,0.00003420556,0.002933997,0.00002651214,0.00072799413,0.9454464,0.000093256545,0.0011896993,0.000007755678],"about_ca_topic_score_codex":0.00030404172,"about_ca_topic_score_gemma":0.0003635809,"teacher_disagreement_score":0.0010002614,"about_ca_system_score_codex":0.00016616279,"about_ca_system_score_gemma":0.00009857041,"threshold_uncertainty_score":0.0033462048},"labels":[],"label_agreement":null},{"id":"W2073378227","doi":"10.1046/j.1365-2141.2001.02867.x","title":"Characterization of a partial prostaglandin endoperoxide H synthase‐1 deficiency in a patient with a bleeding disorder","year":2001,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Inflammatory mediators and NSAID effects","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; University of Ottawa","funders":"Medical Research Council","keywords":"Prostaglandin H2; Thromboxane A2; Platelet; Thromboxane-A synthase; Western blot; Chemistry; Prostaglandin; Enzyme; Northern blot; Platelet activation; Blot; Internal medicine; Arachidonic acid; Endocrinology; Molecular biology; Biochemistry; Messenger RNA; Medicine; Biology; Gene","score_opus":0.006901339428721705,"score_gpt":0.22349779098483108,"score_spread":0.21659645155610938,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2073378227","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9978161,0.0005348355,0.0003959605,0.00026247135,0.000019221623,0.00002203978,0.00015964711,0.000022544393,0.0007671254],"genre_scores_gemma":[0.9989768,0.00021098094,0.0001981546,0.00009436137,0.00003736158,0.0000062000513,0.00013901794,0.0000074868817,0.00032969262],"study_design_codex":"case_report","study_design_gemma":"observational","domain_scores_codex":[0.9998267,0.000024653875,0.000020685506,0.000052627194,0.000035650864,0.000039666334],"domain_scores_gemma":[0.9996654,0.00012321376,0.00004871923,0.000015766609,0.00002645297,0.00012050757],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015083051,0.0010481777,0.0005315512,0.0013678109,0.0006660802,0.0004964534,0.000421558,0.0013436985,0.0015852208],"category_scores_gemma":[0.0011297652,0.00036916707,0.00047538622,0.00049755815,0.00053757423,0.00036497434,0.00029739426,0.00084711885,0.00036914612],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00094861246,0.00026832405,0.11654218,0.00009929297,0.00008509054,0.80860007,0.0012492336,0.00020022182,0.06297164,0.0003990284,0.0005882255,0.008048041],"study_design_scores_gemma":[0.00007769004,0.0017331721,0.18558599,0.000026190912,0.00011770785,0.80254954,0.00029995415,0.0009816621,0.0066026235,0.00027659145,0.001714956,0.00003387882],"about_ca_topic_score_codex":0.0010881936,"about_ca_topic_score_gemma":0.00049900846,"teacher_disagreement_score":0.0015852208,"about_ca_system_score_codex":0.00024383399,"about_ca_system_score_gemma":0.00017747468,"threshold_uncertainty_score":0.005303085},"labels":[],"label_agreement":null},{"id":"W2073497841","doi":"10.1046/j.1365-2141.2002.03507.x","title":"DDAVP challenge tests in boys with mild/moderate haemophilia A*","year":2002,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Hemophilia Treatment and Research","field":"Medicine","cited_by":38,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children; University of Toronto","funders":"","keywords":"Medicine; Haemophilia; Desmopressin; Haemophilia A; Internal medicine; Gastroenterology; Pediatrics","score_opus":0.04605492140485093,"score_gpt":0.2975334411994076,"score_spread":0.2514785197945567,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2073497841","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9980421,0.0011695045,0.00016677818,0.00005103521,0.00001156241,0.000037090576,0.000036380326,0.000019405543,0.00046605914],"genre_scores_gemma":[0.99914885,0.00026453566,0.00026202906,0.000053440497,0.000016732789,0.000010558292,0.000042903317,0.0000042308934,0.0001968162],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9993279,0.00027723756,0.00005158207,0.00008594916,0.00011932211,0.00013801511],"domain_scores_gemma":[0.998706,0.0005569911,0.00028884845,0.00003383955,0.00009642271,0.00031795213],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005806476,0.00042380093,0.0006026407,0.00043968493,0.00030540803,0.00024310025,0.0003677436,0.00055909296,0.0009078602],"category_scores_gemma":[0.001911098,0.00023962883,0.00029150845,0.00023850329,0.0003794189,0.00027325936,0.00032234,0.0005878914,0.00028505636],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010538185,0.0004976733,0.95907325,0.0001536953,0.000035101024,0.010614211,0.00091018796,0.00026172743,0.0057294434,0.00004761295,0.00061383157,0.021009514],"study_design_scores_gemma":[0.000083982246,0.011886433,0.93997747,0.000048742684,0.0000587346,0.03737072,0.0012534112,0.0009676688,0.005882682,0.000038164846,0.0024161688,0.000015819545],"about_ca_topic_score_codex":0.0019873013,"about_ca_topic_score_gemma":0.0023677307,"teacher_disagreement_score":0.0019873013,"about_ca_system_score_codex":0.0002710525,"about_ca_system_score_gemma":0.00017816102,"threshold_uncertainty_score":0.0039514303},"labels":[],"label_agreement":null},{"id":"W2074559183","doi":"10.1046/j.1365-2141.2001.02657.x","title":"Transient adhesion refractoriness of circulating platelets under shear stress: the role of partial activation and microaggregate formation by suboptimal ADP concentration","year":2001,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Platelet; Refractory period; Adhesion; Transient (computer programming); Chemistry; Shear stress; Biophysics; Cell biology; Immunology; Medicine; Internal medicine; Materials science; Biology; Composite material; Organic chemistry","score_opus":0.010230121453233688,"score_gpt":0.24375439460473622,"score_spread":0.23352427315150254,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2074559183","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9913291,0.0037188593,0.0036978398,0.00011479718,0.000027948916,0.000040264174,0.0002563452,0.000048754377,0.0007659837],"genre_scores_gemma":[0.99537826,0.0010186572,0.0021107541,0.00012308157,0.000029844232,0.00006773145,0.00047495574,0.000020769561,0.000775855],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99969864,0.000063501626,0.000036110985,0.000059456663,0.00009196172,0.00005030809],"domain_scores_gemma":[0.99974865,0.00006193494,0.000070444876,0.000043871645,0.00004063567,0.00003447389],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002672376,0.00037403073,0.00046153547,0.00013387944,0.00014457796,0.0004630944,0.00019674894,0.00037547402,0.0011427413],"category_scores_gemma":[0.000369839,0.00015671509,0.00027918964,0.00016823981,0.0001751487,0.00022735617,0.0002171163,0.00063543586,0.00026359042],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000115871415,0.000008358183,0.00044457804,0.00003526576,0.000011878397,0.00012887173,0.000024270901,0.000022909273,0.9982495,0.00001597648,0.000020081792,0.0009223698],"study_design_scores_gemma":[0.00002317991,0.0005902968,0.07766529,0.00001289288,0.000059888687,0.00095784705,0.000049504833,0.0012084626,0.91828674,0.0000756172,0.001058235,0.000012046791],"about_ca_topic_score_codex":0.0006049991,"about_ca_topic_score_gemma":0.0006338222,"teacher_disagreement_score":0.0011427413,"about_ca_system_score_codex":0.00019974893,"about_ca_system_score_gemma":0.0001290236,"threshold_uncertainty_score":0.003822863},"labels":[],"label_agreement":null},{"id":"W2074599609","doi":"10.1111/j.1365-2141.2009.07814.x","title":"Primary del 17 chronic lymphocytic leukaemia lymphocytes are hypersensitive to dasatinib <i>in vitro</i>","year":2009,"lang":"en","type":"letter","venue":"British Journal of Haematology","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal; McGill University; CancerCare Manitoba; Jewish General Hospital","funders":"Canadian Institutes of Health Research; Jewish General Hospital; McGill University","keywords":"Dasatinib; Chronic lymphocytic leukemia; Lymphocyte; Immunology; Tyrosine kinase; Cancer research; Cytotoxicity; Biology; Medicine; Leukemia; In vitro; Internal medicine; Receptor","score_opus":0.0155208006435872,"score_gpt":0.2702042294054852,"score_spread":0.25468342876189803,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2074599609","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97042537,0.007614503,0.0029520637,0.0003946404,0.00033034926,0.00017552768,0.004240287,0.00026426653,0.013602849],"genre_scores_gemma":[0.9799406,0.0018938603,0.0013948611,0.0003261438,0.00004999865,0.00019691893,0.0070619863,0.000046894096,0.0090887565],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9994548,0.000088619505,0.0000670631,0.00009694772,0.00014782339,0.00014472305],"domain_scores_gemma":[0.99971,0.00007020996,0.000047375004,0.000054715354,0.00006005783,0.00005758397],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019444495,0.000435095,0.0006646582,0.00028297838,0.00025900116,0.00065998815,0.00021240479,0.0003459486,0.0082991775],"category_scores_gemma":[0.00025038028,0.000266244,0.0004543952,0.0003021104,0.0001711877,0.00022346579,0.00030186825,0.00065490755,0.004166903],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00042020052,0.0001499489,0.0014791199,0.00013453708,0.000019467061,0.00035831984,0.000053147378,0.00009355862,0.9924696,0.00008127909,0.0007769882,0.0039638206],"study_design_scores_gemma":[0.00012287115,0.004024693,0.036884274,0.000024550687,0.00005281282,0.0032104482,0.00019059917,0.000819572,0.9352299,0.00012380886,0.019296598,0.000019851856],"about_ca_topic_score_codex":0.0010482057,"about_ca_topic_score_gemma":0.0013585978,"teacher_disagreement_score":0.0082991775,"about_ca_system_score_codex":0.00045110093,"about_ca_system_score_gemma":0.0001796398,"threshold_uncertainty_score":0.027763486},"labels":[],"label_agreement":null},{"id":"W2074668374","doi":"10.1111/bjh.12237","title":"Selective triggering of platelet apoptosis, platelet activation or both","year":2013,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":45,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Toronto Metropolitan University; Pediatric Oncology Group; St. Michael's Hospital","funders":"","keywords":"Platelet; Platelet activation; Apoptosis; Chemistry; Depolarization; Thrombin; Stimulation; Biophysics; Membrane potential; Cell biology; Immunology; Biochemistry; Endocrinology; Medicine; Biology","score_opus":0.01393741326774213,"score_gpt":0.2614926709717485,"score_spread":0.24755525770400638,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2074668374","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9568371,0.010919817,0.025086874,0.0003535988,0.00018240693,0.00020442852,0.00049173465,0.00015680568,0.0057673375],"genre_scores_gemma":[0.98640764,0.0034477778,0.0067575583,0.00022086293,0.00004133914,0.0002038163,0.0003384263,0.000017955388,0.002564459],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99949694,0.00012422791,0.00004054145,0.00008851369,0.0001358661,0.00011392197],"domain_scores_gemma":[0.9998503,0.000048347698,0.000035176956,0.000025843883,0.000021206639,0.000019077594],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00028328397,0.0003091546,0.0003448338,0.00015305865,0.00014553775,0.00031367387,0.00020535456,0.0003600332,0.001096788],"category_scores_gemma":[0.00025454586,0.000115429044,0.00023418339,0.00017599511,0.00019133423,0.00018981096,0.00037594806,0.0006178816,0.0003175088],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021023914,0.000026209873,0.00015031564,0.00008595666,0.000008824065,0.00013569502,0.000024176496,0.000053181724,0.9962071,0.00031072163,0.00008010536,0.0027075182],"study_design_scores_gemma":[0.00003218156,0.00055745826,0.002062097,0.000008506682,0.00001932993,0.0006405618,0.000019300036,0.00033513492,0.9922816,0.00016147581,0.0038772898,0.000005115073],"about_ca_topic_score_codex":0.00017777174,"about_ca_topic_score_gemma":0.00034904337,"teacher_disagreement_score":0.001096788,"about_ca_system_score_codex":0.00020873039,"about_ca_system_score_gemma":0.0002537397,"threshold_uncertainty_score":0.0036690831},"labels":[],"label_agreement":null},{"id":"W2074710972","doi":"10.1046/j.1365-2141.2002.03450.x","title":"Transfusion‐associated graft‐versus‐host disease","year":2002,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":132,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba; CancerCare Manitoba","funders":"","keywords":"Graft-versus-host disease; Medicine; Host (biology); Disease; Blood transfusion; Intensive care medicine; Immunology; Internal medicine; Biology","score_opus":0.026815588356179927,"score_gpt":0.26026873665430017,"score_spread":0.23345314829812025,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2074710972","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8578709,0.04385207,0.0021355874,0.004401191,0.0010130495,0.00010061177,0.00082898786,0.000112576825,0.08968499],"genre_scores_gemma":[0.9840434,0.005779003,0.00030648807,0.0008998388,0.0005456763,0.000022308808,0.000498275,0.000017346483,0.007887576],"study_design_codex":"design_other","study_design_gemma":"case_report","domain_scores_codex":[0.9997218,0.000106340885,0.000032453238,0.000019931416,0.00004344724,0.00007591235],"domain_scores_gemma":[0.9995202,0.00017413346,0.0000936051,0.00006176167,0.0000377096,0.00011260777],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00039008012,0.00017998321,0.00038954034,0.00034040614,0.00052329514,0.0005862905,0.00019470692,0.000543864,0.011546558],"category_scores_gemma":[0.0010490402,0.00009144908,0.00022854416,0.00048590466,0.00035535154,0.000214571,0.00037756286,0.00072558667,0.0011414347],"study_design_candidate":"case_report","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.012649236,0.00088180596,0.33666927,0.0020586282,0.00083222915,0.14868101,0.0009834714,0.0006907375,0.017558962,0.015682142,0.03209603,0.43121642],"study_design_scores_gemma":[0.0006567448,0.0021454904,0.40028217,0.0007263921,0.0006348802,0.45425996,0.00043560192,0.0009251276,0.004660799,0.0076309196,0.12757125,0.000070687034],"about_ca_topic_score_codex":0.00041241208,"about_ca_topic_score_gemma":0.0005049163,"teacher_disagreement_score":0.011546558,"about_ca_system_score_codex":0.0003199653,"about_ca_system_score_gemma":0.00032769676,"threshold_uncertainty_score":0.038627088},"labels":[],"label_agreement":null},{"id":"W2074887437","doi":"10.1111/bjh.12480","title":"Cellular immune dysfunction in immune thrombocytopenia (<scp>ITP</scp>)","year":2013,"lang":"en","type":"review","venue":"British Journal of Haematology","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":187,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Blood Services; University of Toronto; St. Michael's Hospital","funders":"","keywords":"Immune system; Immunology; Disease; Immune thrombocytopenia; Immune dysregulation; Autoimmune disease; Autoimmunity; Medicine; Biology; Antibody; Pathology","score_opus":0.027055765429861607,"score_gpt":0.29156114893024004,"score_spread":0.26450538350037844,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2074887437","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00013127357,0.99855405,0.00008197869,0.00017549985,0.0001688115,0.000003416202,0.000011260557,0.0000057741586,0.00086791365],"genre_scores_gemma":[0.001135739,0.9975822,0.00014293136,0.00023273489,0.00021451956,0.0000051181637,0.00003194816,0.0000013229508,0.0006534673],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99987125,0.000018021732,0.000023698203,0.000019071811,0.000053217984,0.000014735923],"domain_scores_gemma":[0.99981886,0.00008316215,0.00003259299,0.000005262299,0.000038406015,0.000021819882],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00033417373,0.00063014374,0.0010732996,0.0017815493,0.00023017311,0.00065177085,0.00045723878,0.0010537449,0.0025057243],"category_scores_gemma":[0.0004724073,0.00016422271,0.00033723158,0.0016368617,0.0003817385,0.0007280452,0.0004942851,0.0012567592,0.002019745],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000073563206,0.000044276316,0.00024716245,0.010101842,0.00006578969,0.00053981843,0.00004041274,0.00015321367,0.0014914647,0.0023704716,0.030353116,0.9545189],"study_design_scores_gemma":[0.000034704695,0.00012758948,0.0017854406,0.0034282047,0.0001270878,0.0102601135,0.00006744061,0.000076967684,0.00076393667,0.0022308966,0.9810776,0.000020025805],"about_ca_topic_score_codex":0.000876296,"about_ca_topic_score_gemma":0.001458157,"teacher_disagreement_score":0.0025057243,"about_ca_system_score_codex":0.00034331213,"about_ca_system_score_gemma":0.0005878726,"threshold_uncertainty_score":0.00838244},"labels":[],"label_agreement":null},{"id":"W2075128381","doi":"10.1111/j.1365-2141.2004.05240.x","title":"Effect of IL‐2R<i>β</i>‐binding cytokines on costimulatory properties of chronic lymphocytic leukaemia cells: implications for immunotherapy","year":2004,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Women's College Hospital; University of Toronto; Sunnybrook Health Science Centre","funders":"","keywords":"CD80; CD86; Immunology; CD38; Immunotherapy; Cancer research; Chronic lymphocytic leukemia; CD40; Biology; T cell; Immune system; Cytotoxic T cell; Cell biology; Leukemia; Stem cell; In vitro","score_opus":0.02028842482611792,"score_gpt":0.30829855182407145,"score_spread":0.28801012699795353,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2075128381","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9947767,0.0036985837,0.00034455312,0.00006256445,0.000016270407,0.000018585679,0.00006196384,0.000011181219,0.0010096238],"genre_scores_gemma":[0.99735826,0.0011863257,0.00057856,0.000066450404,0.000022169377,0.000017427315,0.00011187961,0.000005131509,0.00065377436],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998037,0.000071295835,0.000014210473,0.000016234597,0.000025654459,0.00006895634],"domain_scores_gemma":[0.99986935,0.000051142986,0.000016737336,0.000017939783,0.000015384581,0.000029522016],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00032049988,0.00035745694,0.0003105498,0.00013036889,0.00010449055,0.0004010163,0.00009525709,0.00023640749,0.0011041973],"category_scores_gemma":[0.00016098608,0.00007909459,0.00023091413,0.00010333185,0.0002799178,0.00019917097,0.00011435812,0.00041491745,0.00020525118],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00058263016,0.00008690566,0.0006722928,0.000050669438,0.0000063200946,0.000037838494,0.00002258595,0.000104124105,0.994441,0.000052444044,0.000017666633,0.0039254585],"study_design_scores_gemma":[0.00009512878,0.0029192725,0.009359217,0.000013293575,0.00003520501,0.0002374126,0.000037938913,0.00027685284,0.9847329,0.00005823042,0.0022307222,0.0000038717217],"about_ca_topic_score_codex":0.00031273568,"about_ca_topic_score_gemma":0.00039480627,"teacher_disagreement_score":0.0011041973,"about_ca_system_score_codex":0.00023911052,"about_ca_system_score_gemma":0.00015552256,"threshold_uncertainty_score":0.0036939383},"labels":[],"label_agreement":null},{"id":"W2075300818","doi":"10.1111/bjh.13404","title":"Circulating proplatelets in a patient with acute blood loss following liver transplantation","year":2015,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; Vancouver General Hospital","funders":"","keywords":"Platelet; Thrombopoiesis; Medicine; Disseminated intravascular coagulation; Coagulopathy; Liver transplantation; Thrombopoietin; Pathology; Transplantation; Immunology; Internal medicine; Megakaryocyte; Biology; Stem cell; Cell biology; Haematopoiesis","score_opus":0.012200297397103153,"score_gpt":0.24426516971646695,"score_spread":0.2320648723193638,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2075300818","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97754616,0.008617587,0.0021113118,0.0041519185,0.00040152838,0.00014197569,0.0001923912,0.000115613366,0.0067214915],"genre_scores_gemma":[0.99563545,0.0016845684,0.00042320185,0.0010042147,0.00038198387,0.000017128965,0.00012868096,0.000016979757,0.0007078192],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.9995765,0.00004715081,0.00005932887,0.00009187511,0.00008458251,0.00014047396],"domain_scores_gemma":[0.99891436,0.00026325663,0.00023078884,0.00005113489,0.000073304436,0.0004671659],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003069569,0.0010190426,0.0011208551,0.0021123898,0.0016580864,0.0010951776,0.0008792258,0.00272508,0.0018338024],"category_scores_gemma":[0.0030276622,0.0006399186,0.0006985582,0.0015336828,0.0009305527,0.0014077612,0.0011120278,0.0028240748,0.00050916837],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008157064,0.00003729967,0.012120111,0.000026360885,0.0000074847753,0.98587334,0.00023291206,0.000035826914,0.000432099,0.00006308716,0.00019077634,0.0008991715],"study_design_scores_gemma":[0.000016496435,0.00015303638,0.010637212,0.000030200938,0.000017450962,0.9879483,0.00021462135,0.0002046186,0.00017958709,0.00013455558,0.00045222827,0.000011702086],"about_ca_topic_score_codex":0.0021992747,"about_ca_topic_score_gemma":0.0021176836,"teacher_disagreement_score":0.00272508,"about_ca_system_score_codex":0.0009593099,"about_ca_system_score_gemma":0.0006307506,"threshold_uncertainty_score":0.006960273},"labels":[{"model":"gemma","categories":[],"domain":null,"study_design":"case_report","genre":"empirical","about_ca_system":false,"about_ca_topic":false,"confidence":"low"},{"model":"gpt","categories":[],"domain":null,"study_design":"case_report","genre":"empirical","about_ca_system":false,"about_ca_topic":false,"confidence":"high"}],"label_agreement":"agree"},{"id":"W2075340069","doi":"10.1046/j.1365-2141.2001.02996.x","title":"Immune function in patients with Shwachman–Diamond syndrome","year":2001,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Blood disorders and treatments","field":"Biochemistry, Genetics and Molecular Biology","cited_by":109,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto General Hospital; University of Toronto; University Health Network; SickKids Foundation; Hospital for Sick Children","funders":"","keywords":"Cytopenia; Immunology; Neutropenia; Immune system; Lymphocyte; Lymphopoiesis; Bone marrow; Medicine; Biology; Haematopoiesis; Stem cell; Internal medicine; Toxicity","score_opus":0.003034333140689503,"score_gpt":0.18720479620723968,"score_spread":0.18417046306655016,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2075340069","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9986431,0.00044552423,0.000096820404,0.00006151334,0.000008772754,0.0000112837715,0.00005366435,0.00000823271,0.00067106733],"genre_scores_gemma":[0.9995802,0.00014444032,0.000056687742,0.00004440532,0.000012893251,0.0000052447062,0.00005938802,0.0000017126968,0.0000950798],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9996735,0.00006283922,0.00004751721,0.00008142694,0.00006209481,0.0000725921],"domain_scores_gemma":[0.99936074,0.00022442744,0.0001614207,0.000032285712,0.000050431037,0.00017071114],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00026808944,0.00075931667,0.0005978941,0.0011296899,0.00068991754,0.00044987432,0.00026728856,0.0007176361,0.0015658843],"category_scores_gemma":[0.0018278091,0.00026815463,0.00023880319,0.00073386723,0.00057976367,0.00044859943,0.00037440442,0.00051856984,0.00023510444],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009937355,0.00013263225,0.9194445,0.00007255633,0.00007788449,0.057846487,0.0010553455,0.0002886916,0.008369721,0.00026010541,0.00050982466,0.010948477],"study_design_scores_gemma":[0.00014132283,0.0017239072,0.81980306,0.000056786084,0.00011276828,0.17362997,0.00075002294,0.0005415066,0.0011935106,0.0004045233,0.0016020414,0.00004040824],"about_ca_topic_score_codex":0.0013765326,"about_ca_topic_score_gemma":0.0009295625,"teacher_disagreement_score":0.0015658843,"about_ca_system_score_codex":0.0003301414,"about_ca_system_score_gemma":0.00021705174,"threshold_uncertainty_score":0.005238354},"labels":[],"label_agreement":null},{"id":"W2075365678","doi":"10.1111/j.1365-2141.2000.02416.x","title":"Rapid flow cytometric test for the diagnosis of membrane cytoskeleton‐associated haemolytic anaemia","year":2000,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Erythrocyte Function and Pathophysiology","field":"Medicine","cited_by":187,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St Mary's Hospital Centre","funders":"","keywords":"Hereditary spherocytosis; Spherocytosis; Spectrin; Molecular biology; Medicine; Band 3; Polyacrylamide gel electrophoresis; Flow cytometry; Pathology; Chemistry; Biology; Membrane protein; Immunology; Internal medicine; Biochemistry; Membrane; Cytoskeleton; Enzyme","score_opus":0.022412945853514072,"score_gpt":0.2678358312813185,"score_spread":0.2454228854278044,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2075365678","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.66584045,0.024274731,0.24591878,0.0032145595,0.0019522051,0.003688893,0.007873643,0.0062994016,0.040937446],"genre_scores_gemma":[0.7529803,0.005765096,0.2045063,0.0017624972,0.00061130367,0.0027623773,0.006296195,0.0001895387,0.025126439],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9989188,0.0003362273,0.000070241695,0.00016534756,0.00040609043,0.00010332031],"domain_scores_gemma":[0.99902487,0.0004130729,0.00014618548,0.00006745262,0.00025824705,0.00009034366],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001581037,0.000591976,0.00067210296,0.0028065238,0.0003686195,0.00040060538,0.00065706193,0.0011070489,0.009758491],"category_scores_gemma":[0.0022247338,0.00025274782,0.00027106598,0.0008224024,0.00029998107,0.000549848,0.0003490364,0.0009207473,0.003239489],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003404248,0.0011878923,0.061730362,0.0007727769,0.00015292382,0.0017246215,0.00045295185,0.0006857418,0.7625959,0.005128945,0.019683136,0.14248048],"study_design_scores_gemma":[0.0012211675,0.009057266,0.2435464,0.00070668216,0.0003940765,0.03876979,0.000498502,0.035745006,0.51271677,0.006424389,0.15059404,0.00032597483],"about_ca_topic_score_codex":0.00029825405,"about_ca_topic_score_gemma":0.00042370922,"teacher_disagreement_score":0.009758491,"about_ca_system_score_codex":0.00030903495,"about_ca_system_score_gemma":0.00029542204,"threshold_uncertainty_score":0.032645464},"labels":[],"label_agreement":null},{"id":"W2075365709","doi":"10.1111/bjh.12688","title":"Genome‐wide <scp>DNA</scp> profiling identifies clonal heterogeneity in marginal zone lymphomas","year":2013,"lang":"en","type":"letter","venue":"British Journal of Haematology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"Oncosuisse","keywords":"Biology; Genome; Somatic evolution in cancer; SNP array; Genetics; Cancer; Gene; Genotype; Single-nucleotide polymorphism","score_opus":0.01687744581327626,"score_gpt":0.25179646801281375,"score_spread":0.23491902219953747,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2075365709","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99080503,0.0014232325,0.003245256,0.000049405233,0.0000042035394,0.000019001965,0.0034527453,0.000068474335,0.00093264494],"genre_scores_gemma":[0.98816293,0.00067603926,0.00408358,0.0001043479,0.0000083983,0.0000412481,0.0060989,0.000030232515,0.0007943303],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9998492,0.000012907991,0.000007346858,0.000049237224,0.000051441806,0.000029778197],"domain_scores_gemma":[0.99986017,0.000048579317,0.000037643906,0.000016343478,0.000020546993,0.000016783151],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016780324,0.00014185256,0.00022093178,0.0010156358,0.00013242062,0.00032577387,0.00016940817,0.00021277553,0.001328269],"category_scores_gemma":[0.00026037628,0.00008804756,0.00021255451,0.0008419096,0.0001475841,0.00010477532,0.00021779929,0.0002743278,0.00027146915],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00023873783,0.00002025758,0.04583066,0.00011110517,0.00007277566,0.00020079674,0.00011127642,0.00028656627,0.9348646,0.00010978876,0.0003602141,0.017793262],"study_design_scores_gemma":[0.000016545857,0.00013894973,0.86026675,0.000012418231,0.00012839357,0.001292416,0.00012334225,0.0013599775,0.13027194,0.00027902477,0.0060970597,0.000013254357],"about_ca_topic_score_codex":0.0010605474,"about_ca_topic_score_gemma":0.002358488,"teacher_disagreement_score":0.001328269,"about_ca_system_score_codex":0.00016196564,"about_ca_system_score_gemma":0.00010400068,"threshold_uncertainty_score":0.0044434667},"labels":[],"label_agreement":null},{"id":"W2075456403","doi":"10.1111/j.1365-2141.2012.09247.x","title":"Impact of central nervous system (<scp>CNS</scp>) prophylaxis on the incidence and risk factors for <scp>CNS</scp> relapse in patients with diffuse large <scp>B</scp>‐cell lymphoma treated in the rituximab era: a single centre experience and review of the literature","year":2012,"lang":"en","type":"review","venue":"British Journal of Haematology","topic":"CNS Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":84,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Medicine; Rituximab; Vincristine; Diffuse large B-cell lymphoma; Prednisone; Internal medicine; Methotrexate; Cyclophosphamide; Lymphoma; Chemotherapy; Gastroenterology; Surgery","score_opus":0.012507581673858459,"score_gpt":0.2506385733961153,"score_spread":0.23813099172225682,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2075456403","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.033655092,0.9655984,0.000046201163,0.00017064599,0.000037769867,0.000006780992,0.00010162554,0.0000036086533,0.00037985158],"genre_scores_gemma":[0.13446428,0.86458784,0.00018804107,0.00023580776,0.00019633207,0.000009754219,0.00019501333,0.000002725585,0.000120261146],"study_design_codex":"design_other","study_design_gemma":"systematic_review","domain_scores_codex":[0.9995964,0.000098659664,0.00013312355,0.000056298115,0.00009942283,0.000016111893],"domain_scores_gemma":[0.9977012,0.0013308752,0.00066186994,0.000030168228,0.00022461958,0.000051203784],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006392276,0.0001673777,0.00074957573,0.0012977108,0.00008144419,0.00062090444,0.00031237124,0.00032125274,0.0004972895],"category_scores_gemma":[0.0018713617,0.0001227229,0.0005292653,0.002116817,0.0002906609,0.0003777452,0.0001380524,0.00022181976,0.00010249475],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010116528,0.00009337634,0.2109287,0.057087053,0.002769445,0.0034425121,0.0003810806,0.0004176343,0.0026997535,0.00018090862,0.0049932897,0.7159946],"study_design_scores_gemma":[0.00012586208,0.0013235703,0.8834071,0.022033023,0.011131971,0.028805885,0.0010071078,0.0003216653,0.0016300535,0.00022634484,0.049918126,0.00006924491],"about_ca_topic_score_codex":0.001444383,"about_ca_topic_score_gemma":0.0024933442,"teacher_disagreement_score":0.001444383,"about_ca_system_score_codex":0.00032456455,"about_ca_system_score_gemma":0.0006226508,"threshold_uncertainty_score":0.0033805966},"labels":[],"label_agreement":null},{"id":"W2075626785","doi":"10.1046/j.1365-2141.2003.04229.x","title":"Transient leukaemia – a benign form of leukaemia in newborn infants with trisomy 21","year":2003,"lang":"en","type":"review","venue":"British Journal of Haematology","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":195,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; SickKids Foundation; University of Toronto","funders":"","keywords":"Medicine; Disease; Trisomy; Down syndrome; Rash; Hematology; Preleukemia; Leukemia; Pathology; Pediatrics; Immunology; Internal medicine; Biology","score_opus":0.027749685117960436,"score_gpt":0.3250905824510643,"score_spread":0.29734089733310387,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2075626785","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.050085813,0.9353315,0.0014112439,0.0013024467,0.0007198991,0.000042856496,0.00018802269,0.00008180995,0.010836332],"genre_scores_gemma":[0.30229574,0.6897916,0.0011420153,0.0011188122,0.0010748333,0.000050641036,0.0005259644,0.000019262328,0.0039811563],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99976116,0.000049676648,0.000050401322,0.000030727315,0.00006623884,0.0000417486],"domain_scores_gemma":[0.99975866,0.00009208985,0.000087277185,0.0000061324918,0.00003638126,0.000019553188],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023847484,0.00023718821,0.00048506772,0.0008574835,0.0002146238,0.0005690261,0.0002277365,0.00059991766,0.001001606],"category_scores_gemma":[0.00096015935,0.00010944167,0.0002492848,0.0007496668,0.0003022919,0.0003559588,0.0003348585,0.0005427638,0.00039704688],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00048163402,0.00007885509,0.06049386,0.012147962,0.00025329104,0.12699135,0.0031320925,0.0005875777,0.044062257,0.01169385,0.039320476,0.7007568],"study_design_scores_gemma":[0.00002194129,0.00030282777,0.07518011,0.0032759516,0.00028433025,0.48922107,0.0011612274,0.00015098628,0.005915607,0.0034405603,0.4209933,0.00005210944],"about_ca_topic_score_codex":0.0010727205,"about_ca_topic_score_gemma":0.0013785108,"teacher_disagreement_score":0.0010727205,"about_ca_system_score_codex":0.00027364027,"about_ca_system_score_gemma":0.00034252374,"threshold_uncertainty_score":0.003350675},"labels":[],"label_agreement":null},{"id":"W2075864830","doi":"10.1111/bjh.13085","title":"<scp>CD</scp>30 expression in <i>de novo</i> diffuse large B‐cell lymphoma: a population‐based study from British Columbia","year":2014,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":97,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Diffuse large B-cell lymphoma; Vincristine; Tissue microarray; Lymphoma; CHOP; Rituximab; Medicine; International Prognostic Index; Immunohistochemistry; Population; Internal medicine; Germinal center; Cancer research; Oncology; Cyclophosphamide; Pathology; Immunology; Antibody; B cell; Chemotherapy","score_opus":0.007589520789091803,"score_gpt":0.2362843618387992,"score_spread":0.2286948410497074,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2075864830","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99893135,0.00017482901,0.00003074512,0.000020121803,0.0000018913962,0.000008786324,0.0002326972,0.0000043156433,0.00059530867],"genre_scores_gemma":[0.9989754,0.0001834623,0.000036077603,0.000037442354,0.0000027753808,0.000007785188,0.00036760952,0.0000038110172,0.00038571577],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9995827,0.000036491572,0.000031093874,0.00012578772,0.00011756727,0.00010633105],"domain_scores_gemma":[0.9993087,0.000072094146,0.00011013738,0.000048114078,0.0002565679,0.00020433929],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00026305343,0.0003766885,0.00043287672,0.0014177029,0.0013693332,0.0010820074,0.000659192,0.0004775051,0.0016386056],"category_scores_gemma":[0.0007822049,0.00042300782,0.00023129134,0.0015883469,0.00065285387,0.00023266599,0.0006576693,0.00043089048,0.00043838707],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014627143,0.00004039579,0.99236006,0.000023098035,0.000044775596,0.0006428006,0.0005851306,0.000030899097,0.002875203,0.000019831454,0.0003600333,0.0028716037],"study_design_scores_gemma":[0.000006828839,0.00002768467,0.9979984,0.000009832986,0.000025199726,0.00066058274,0.0005200312,0.000099894656,0.00013174217,0.000007702167,0.00050548697,0.0000065440295],"about_ca_topic_score_codex":0.6443433,"about_ca_topic_score_gemma":0.7086404,"teacher_disagreement_score":0.35565668,"about_ca_system_score_codex":0.002644964,"about_ca_system_score_gemma":0.0014539527,"threshold_uncertainty_score":0.7155024},"labels":[],"label_agreement":null},{"id":"W2076241720","doi":"10.1111/bjh.12656","title":"Paroxysmal nocturnal haemoglobinuria phenotype cells and leucocyte subset telomere length in childhood acquired aplastic anaemia","year":2013,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":29,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver General Hospital; Child and Family Research Institute; BC Cancer Agency; BC Children's Hospital; University of British Columbia","funders":"National Institute of General Medical Sciences; National Institutes of Health; Canadian Institutes of Health Research; Terry Fox Foundation; National Institute for Health and Care Research","keywords":"Medicine; Telomere; Paroxysmal nocturnal hemoglobinuria; Confidence interval; Lymphocyte; Odds ratio; Immunology; Aplastic anemia; Internal medicine; Bone marrow failure; Gastroenterology; Bone marrow; Biology; Haematopoiesis; Stem cell; Gene; Genetics","score_opus":0.007951439306216525,"score_gpt":0.22396972605112442,"score_spread":0.2160182867449079,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2076241720","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9984864,0.0010798047,0.00007470603,0.000036938458,0.000004015324,0.0000013779265,0.00006373756,0.000004148592,0.0002487939],"genre_scores_gemma":[0.9994382,0.00030332684,0.00007757309,0.000009511884,0.00000653253,0.0000019087045,0.0000784414,0.0000014421101,0.00008304887],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9994862,0.00020831772,0.000057982343,0.00006777465,0.00012721412,0.000052403866],"domain_scores_gemma":[0.99746954,0.0008783341,0.001188925,0.00007762419,0.00011989488,0.00026570127],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006624527,0.00019001703,0.00018657341,0.0007785043,0.00017455398,0.00033364247,0.00026784162,0.0004980901,0.0011587819],"category_scores_gemma":[0.0031489714,0.00021434831,0.0001961015,0.0006250821,0.0003911822,0.0004093487,0.00038363138,0.0005092111,0.0001475613],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00038883145,0.00002129346,0.9936138,0.000027234308,0.000034727036,0.0002546551,0.00009479427,0.000115105315,0.0005683825,0.000037763126,0.00008500692,0.004758498],"study_design_scores_gemma":[0.0000055846103,0.00015818204,0.9974753,0.000009582297,0.000020475243,0.0017776525,0.00007707993,0.00016473289,0.00015377655,0.00003896031,0.00011605072,0.0000026877278],"about_ca_topic_score_codex":0.0018622422,"about_ca_topic_score_gemma":0.001560867,"teacher_disagreement_score":0.0018622422,"about_ca_system_score_codex":0.0002047709,"about_ca_system_score_gemma":0.00015750654,"threshold_uncertainty_score":0.0038765073},"labels":[],"label_agreement":null},{"id":"W2076443949","doi":"10.1046/j.1365-2141.2000.01923.x","title":"Haemophagocytic lymphohistiocytosis in X‐linked severe combined immunodeficiency","year":2000,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Autoimmune and Inflammatory Disorders Research","field":"Medicine","cited_by":32,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children; University of Toronto","funders":"Medical Research Council; Hospital for Sick Children","keywords":"Hemophagocytic lymphohistiocytosis; Immunology; Immune system; Immunodeficiency; Biology; Flow cytometry; Medicine; Internal medicine","score_opus":0.012800641419438761,"score_gpt":0.2701111359028205,"score_spread":0.2573104944833817,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2076443949","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99267876,0.0023167569,0.00069573463,0.00017610446,0.000016577162,0.000028627283,0.000049251503,0.000036190002,0.004001983],"genre_scores_gemma":[0.99877435,0.00058565644,0.0002481608,0.000057135905,0.000031016032,0.0000060538086,0.00003460907,0.000003119305,0.00025975375],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.9998759,0.000045288263,0.000016533868,0.000015940806,0.00001974287,0.000026541386],"domain_scores_gemma":[0.99981767,0.00008018725,0.000047298345,0.0000107104215,0.000009118216,0.000035018824],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016581919,0.00054077007,0.00020223373,0.0005036451,0.00028476707,0.00023717577,0.00014972943,0.0006109002,0.00092362403],"category_scores_gemma":[0.00071997405,0.00015724363,0.00010148534,0.00033034573,0.0006254903,0.00018493138,0.00031509035,0.0003476771,0.00016198434],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009659131,0.00013967777,0.19205013,0.0003996107,0.00007730471,0.7198065,0.00070271676,0.0007321747,0.043585226,0.0010104772,0.0017258868,0.038804486],"study_design_scores_gemma":[0.00007928896,0.00037070364,0.14295179,0.000055751334,0.000064707594,0.8493188,0.00016454315,0.0005596909,0.0038109515,0.00043737068,0.0021728792,0.000013543982],"about_ca_topic_score_codex":0.0007400658,"about_ca_topic_score_gemma":0.0007936153,"teacher_disagreement_score":0.00092362403,"about_ca_system_score_codex":0.0001894871,"about_ca_system_score_gemma":0.00014997304,"threshold_uncertainty_score":0.0030898452},"labels":[],"label_agreement":null},{"id":"W2076575287","doi":"10.1111/j.1365-2141.2006.06332.x","title":"Increased prevalence of iron‐overload associated endocrinopathy in thalassaemia <i>versus</i> sickle‐cell disease","year":2006,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":182,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"National Center for Research Resources; National Institute of Diabetes and Digestive and Kidney Diseases; NIH Clinical Center; National Institutes of Health","keywords":"Medicine; Internal medicine; Hemoglobinopathy; Gastroenterology; Odds ratio; Transfusion therapy; Diabetes mellitus; Complication; Thalassemia; Sickle cell anemia; Disease; Blood transfusion; Endocrinology","score_opus":0.005310286519819731,"score_gpt":0.22123580054918715,"score_spread":0.2159255140293674,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2076575287","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9996972,0.00011960288,0.000010356529,0.0000066298403,0.0000019780016,0.0000013289822,0.000022988097,0.00000108025,0.00013883084],"genre_scores_gemma":[0.9998423,0.00004062049,0.000012244895,0.000013494393,0.0000049508494,9.766426e-7,0.000032369142,7.084108e-7,0.000052308875],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9995845,0.00010069995,0.00005399629,0.00009644901,0.000080842794,0.00008362368],"domain_scores_gemma":[0.99867463,0.00023989899,0.0006078078,0.00004133948,0.00011965068,0.0003167878],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00040976095,0.00018692955,0.00035045278,0.0009754694,0.00040432654,0.0006579505,0.00021093574,0.00039781412,0.0021508734],"category_scores_gemma":[0.001635697,0.00017397956,0.00019283919,0.00062750763,0.00036300145,0.00025617442,0.00033829777,0.00033676845,0.00023650487],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000084306004,0.0000112532,0.9980301,0.0000090213125,0.00001808677,0.0001265787,0.00020245032,0.000009590425,0.000572639,0.000008096653,0.00004037693,0.00088737626],"study_design_scores_gemma":[0.000003279688,0.000079416,0.999054,0.000004052856,0.0000091937445,0.00055925315,0.00017646972,0.00002407653,0.000033696353,0.000004758239,0.0000498436,0.0000018069921],"about_ca_topic_score_codex":0.006896548,"about_ca_topic_score_gemma":0.0089994045,"teacher_disagreement_score":0.006896548,"about_ca_system_score_codex":0.00024643226,"about_ca_system_score_gemma":0.00018847425,"threshold_uncertainty_score":0.013712823},"labels":[],"label_agreement":null},{"id":"W2077022406","doi":"10.1111/j.1365-2141.2009.07985.x","title":"Successful correction of murine sickle cell disease with reduced stem cell requirements reinforced by fractionated marrow infusions","year":2009,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Montreal Clinical Research Institute","funders":"Canadian Institutes of Health Research","keywords":"Stem cell; Medicine; Bone marrow; Haematopoiesis; Transplantation; Genetic enhancement; Hematopoietic stem cell transplantation; Immunology; Therapeutic effect; Internal medicine; Biology","score_opus":0.005915678126429018,"score_gpt":0.22930286685783216,"score_spread":0.22338718873140315,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2077022406","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9952602,0.0004328307,0.003450444,0.000031528874,0.000009346067,0.00007647628,0.00019968885,0.000070338516,0.00046920596],"genre_scores_gemma":[0.9935643,0.0004249891,0.004634647,0.000018309354,0.000008115465,0.00005973492,0.000299371,0.000021522892,0.0009688683],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9996873,0.00005994151,0.000033966353,0.000051275285,0.00009839162,0.000069094844],"domain_scores_gemma":[0.99976546,0.000040959912,0.000088177076,0.000035529007,0.000019417244,0.000050454055],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003365082,0.00046118518,0.0005042984,0.00036842507,0.00013981422,0.0002607825,0.00023356703,0.0002671907,0.00076143246],"category_scores_gemma":[0.00017944051,0.00015788274,0.00022366871,0.00013567517,0.0002908688,0.00016159064,0.00028849667,0.0005361982,0.00015759893],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012464236,0.000045766334,0.00012825122,0.000021059794,0.0000048260645,0.000025564452,0.00001769346,0.00015231923,0.997804,0.00018446418,0.000018717736,0.0014727203],"study_design_scores_gemma":[0.000054426524,0.0018952589,0.0021094712,0.000009810035,0.00003022828,0.00028515936,0.000014509607,0.001210237,0.9923409,0.000072152405,0.0019725673,0.000005183378],"about_ca_topic_score_codex":0.00030120244,"about_ca_topic_score_gemma":0.0006583557,"teacher_disagreement_score":0.00076143246,"about_ca_system_score_codex":0.00023222162,"about_ca_system_score_gemma":0.0002358206,"threshold_uncertainty_score":0.0025472045},"labels":[],"label_agreement":null},{"id":"W2077192057","doi":"10.1046/j.1365-2141.2000.01827.x","title":"THE INTRODUCTION OF CITRATE AS AN ANTICOAGULANT FOR TRANSFUSION AND OF GLUCOSE AS A RED CELL PRESERVATIVE","year":2000,"lang":"en","type":"review","venue":"British Journal of Haematology","topic":"Erythrocyte Function and Pathophysiology","field":"Medicine","cited_by":81,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Calcium oxalate; Oxalate; Preservative; Red Cell; Clotting time; Blood product; Red blood cell; Anticoagulant; Fibrin; Calcium; Surgery; Platelet; Internal medicine; Chemistry; Food science; Immunology","score_opus":0.03145102258703633,"score_gpt":0.3233955673657478,"score_spread":0.29194454477871146,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2077192057","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.041360702,0.7095323,0.08659055,0.04845516,0.043396886,0.0006050175,0.00049867557,0.00052826304,0.069032475],"genre_scores_gemma":[0.19797412,0.52357626,0.15752365,0.048383117,0.023811165,0.0008958426,0.000616872,0.00062104827,0.04659792],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9971733,0.0008682958,0.00036656656,0.0004649153,0.0009436945,0.0001830793],"domain_scores_gemma":[0.9957806,0.0014359257,0.0006276713,0.00026804965,0.0015072309,0.00038053165],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0035949226,0.0010523254,0.00068212865,0.0032952826,0.0007072314,0.0027351752,0.00091582665,0.0032895084,0.0025915732],"category_scores_gemma":[0.0053063203,0.00073057436,0.0012064547,0.0016941201,0.003129128,0.0029154117,0.0019360874,0.0069351564,0.0018087253],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0024382232,0.00061505823,0.0030074606,0.004035769,0.00016811759,0.0028409224,0.0012082934,0.0012465869,0.0721646,0.24216738,0.025787815,0.64431965],"study_design_scores_gemma":[0.00013889447,0.0019577278,0.0020325675,0.00080752885,0.000121590834,0.0047449726,0.00015942716,0.0004725626,0.049959008,0.010974231,0.9284224,0.00020914935],"about_ca_topic_score_codex":0.004268447,"about_ca_topic_score_gemma":0.0022600847,"teacher_disagreement_score":0.004268447,"about_ca_system_score_codex":0.002596002,"about_ca_system_score_gemma":0.0030923882,"threshold_uncertainty_score":0.019011974},"labels":[],"label_agreement":null},{"id":"W2077344703","doi":"10.1046/j.1365-2141.2002.03232.x","title":"THE LANGERHANS CELL HISTIOCYTOSIS X FILES REVEALED","year":2002,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Histiocytic Disorders and Treatments","field":"Medicine","cited_by":89,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary; Alberta Children's Hospital","funders":"Louisiana State University; Yale University","keywords":"Langerhans cell histiocytosis; Histiocytosis X; Histiocytosis; Medicine; Dermatology; Pathology","score_opus":0.013810031497288955,"score_gpt":0.2260560722221078,"score_spread":0.21224604072481884,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2077344703","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8043758,0.0061039045,0.0058593345,0.040036313,0.00745036,0.00037656075,0.0070380443,0.0007195481,0.12804008],"genre_scores_gemma":[0.9374705,0.0022991826,0.003344329,0.003948036,0.0017551153,0.00004044171,0.0017158034,0.00013527874,0.04929126],"study_design_codex":"case_report","study_design_gemma":"observational","domain_scores_codex":[0.99979705,0.00001808506,0.000016278642,0.0000396982,0.000052348227,0.00007659146],"domain_scores_gemma":[0.99936205,0.00019143395,0.00006805963,0.00007283093,0.00011853712,0.00018712926],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018094837,0.00040390526,0.00035060235,0.0017702112,0.0008263025,0.0009053214,0.00062126137,0.0021020933,0.017341308],"category_scores_gemma":[0.0014855377,0.00020559417,0.00039379948,0.00078773656,0.00075033255,0.0007184842,0.00068127405,0.0017607001,0.0030745615],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00066130434,0.00011153793,0.019279972,0.00019702705,0.000038188882,0.89611036,0.0014700221,0.00025342626,0.014417668,0.004085278,0.034241892,0.02913338],"study_design_scores_gemma":[0.000057233483,0.0002046194,0.054780878,0.00018059871,0.00008251854,0.8428133,0.0014612713,0.000820706,0.009470529,0.0032424314,0.08682686,0.000059006084],"about_ca_topic_score_codex":0.0031075648,"about_ca_topic_score_gemma":0.0031855588,"teacher_disagreement_score":0.017341308,"about_ca_system_score_codex":0.00053080794,"about_ca_system_score_gemma":0.0004320862,"threshold_uncertainty_score":0.058012486},"labels":[],"label_agreement":null},{"id":"W2077392272","doi":"10.1046/j.1365-2141.2000.02165-1.x","title":"Compound Heterozygosity For Triplicated α‐Globin Gene and (– –<sup>SEA</sup>) α‐Globin Gene Deletion: Implication For Thalassaemia Screening","year":2000,"lang":"en","type":"letter","venue":"British Journal of Haematology","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McMaster University","funders":"","keywords":"Hydrops fetalis; Mean corpuscular volume; Thalassemia; Prenatal diagnosis; Fetus; Medicine; In utero; Obstetrics; Genetics; Pregnancy; Hematocrit; Pediatrics; Internal medicine; Biology","score_opus":0.01802994836608749,"score_gpt":0.26315364478069503,"score_spread":0.24512369641460754,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2077392272","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95470804,0.0071141203,0.006443867,0.019034741,0.00040442863,0.00013810764,0.0004816182,0.00017389964,0.01150124],"genre_scores_gemma":[0.9906483,0.0027672169,0.003481974,0.0012197626,0.00089013734,0.000019258694,0.0001206055,0.000028114064,0.00082453026],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.99937147,0.00012297613,0.0000514957,0.00014928183,0.00015426752,0.00015051063],"domain_scores_gemma":[0.9973666,0.0014208994,0.000494491,0.000100645215,0.0002034026,0.00041392748],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010879138,0.0012000346,0.00103988,0.0013933356,0.0007719572,0.0010618935,0.0016193427,0.003927844,0.004829827],"category_scores_gemma":[0.0063597453,0.00038359262,0.00044880348,0.00073993776,0.0017600458,0.001399849,0.000593092,0.001959562,0.00067981984],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008350084,0.00024172531,0.43457305,0.00026159405,0.00010279073,0.5216544,0.00054230174,0.00062073866,0.0071542985,0.0032048745,0.0041992487,0.026609953],"study_design_scores_gemma":[0.000079645055,0.00042957545,0.16663475,0.00056288874,0.00030858896,0.8092083,0.0017070961,0.006047571,0.0022630054,0.008046747,0.0046012145,0.00011063749],"about_ca_topic_score_codex":0.002078193,"about_ca_topic_score_gemma":0.0014016798,"teacher_disagreement_score":0.004829827,"about_ca_system_score_codex":0.0003329158,"about_ca_system_score_gemma":0.0006024503,"threshold_uncertainty_score":0.016157389},"labels":[],"label_agreement":null},{"id":"W2077869291","doi":"10.1111/j.1365-2141.2005.05768.x","title":"Fetal haemoglobin augmentation in E/<i>β</i><sup>0</sup> thalassaemia: clinical and haematological outcome","year":2005,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":61,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children; University of Toronto","funders":"National Center for Research Resources; National Heart, Lung, and Blood Institute","keywords":"Medicine; Fetal hemoglobin; Erythropoietin; Hydroxycarbamide; Toxicity; Hemoglobinopathy; Gastroenterology; Fetus; Internal medicine; Anemia; Pediatrics; Disease; Pregnancy; Biology","score_opus":0.026093110987352258,"score_gpt":0.32471704026329834,"score_spread":0.29862392927594605,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2077869291","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99892586,0.0006035518,0.000050448914,0.000021815451,0.000005217624,0.000014543787,0.000019964265,0.0000034409122,0.00035506737],"genre_scores_gemma":[0.99961936,0.00016354768,0.000033245615,0.00003369209,0.00000982897,0.000007024803,0.000058611782,7.620091e-7,0.00007391171],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9998282,0.00009377953,0.0000152120865,0.00001592651,0.000016383328,0.00003047672],"domain_scores_gemma":[0.99943715,0.00012531206,0.0001709482,0.000032965163,0.00003653528,0.00019699054],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005254799,0.00016791208,0.000388752,0.00011556727,0.00011481212,0.00026339522,0.000116871975,0.0002345154,0.00046564653],"category_scores_gemma":[0.000907346,0.000072104696,0.00024533627,0.0001583533,0.0002835685,0.00016878966,0.000136286,0.00036412844,0.000105104446],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.12523854,0.0058388533,0.6131246,0.0003637279,0.0006093841,0.0027530899,0.00071748096,0.0019753443,0.039859742,0.00016767655,0.00092220784,0.20842937],"study_design_scores_gemma":[0.0042690393,0.15910777,0.8231208,0.00006636554,0.00034181916,0.0043448354,0.00027532762,0.001349002,0.0056677745,0.00016529247,0.001268082,0.0000239052],"about_ca_topic_score_codex":0.0005727529,"about_ca_topic_score_gemma":0.00038506146,"teacher_disagreement_score":0.0005727529,"about_ca_system_score_codex":0.00017262949,"about_ca_system_score_gemma":0.000118915246,"threshold_uncertainty_score":0.002779007},"labels":[],"label_agreement":null},{"id":"W2078841730","doi":"10.1111/j.1365-2141.2007.06494.x","title":"Phase II study of three dose levels of continuous erythropoietin receptor activator (C.E.R.A.) in anaemic patients with aggressive non‐Hodgkin’s lymphoma receiving combination chemotherapy","year":2007,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Erythropoietin and Anemia Treatment","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen Elizabeth II Health Sciences Centre; Dalhousie University","funders":"","keywords":"Medicine; Internal medicine; Gastroenterology; Lymphoma; Chemotherapy; Population; Anemia; Erythropoietin; Surgery","score_opus":0.012435657114650878,"score_gpt":0.2832025753712983,"score_spread":0.2707669182566474,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2078841730","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99638593,0.0007821989,0.00047146523,0.000119713586,0.000058368172,0.0013311541,0.0001556391,0.000051656625,0.0006439549],"genre_scores_gemma":[0.99428153,0.0009252766,0.0012612583,0.00033846163,0.00013192894,0.0015659921,0.0005422189,0.000014599476,0.0009386911],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.99924326,0.00042112253,0.00003823058,0.00009993364,0.0000730546,0.00012446732],"domain_scores_gemma":[0.99871135,0.00029677455,0.00023166361,0.00012225103,0.000082405255,0.0005555774],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015658374,0.0011867479,0.002397674,0.0005893152,0.00035549267,0.0009835927,0.0011455516,0.0011972734,0.0024864965],"category_scores_gemma":[0.0010203088,0.0006890331,0.0012070886,0.00055613345,0.0011991656,0.0005955149,0.00034155365,0.0030925204,0.00051683676],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.75227386,0.12426538,0.0035867007,0.00047886904,0.0010610945,0.00019617935,0.00032610516,0.001792737,0.056327928,0.0002645512,0.001077997,0.05834866],"study_design_scores_gemma":[0.36406025,0.62606233,0.005493723,0.000016780477,0.00021384441,0.00014749798,0.00004227194,0.00064944674,0.0024369054,0.00009294573,0.0007608463,0.000023262084],"about_ca_topic_score_codex":0.0009391525,"about_ca_topic_score_gemma":0.0014547658,"teacher_disagreement_score":0.0024864965,"about_ca_system_score_codex":0.0007108146,"about_ca_system_score_gemma":0.0012362642,"threshold_uncertainty_score":0.008318186},"labels":[],"label_agreement":null},{"id":"W2079462672","doi":"10.1111/bjh.13451","title":"Clinical characteristics and early treatment outcomes of follicular lymphoma in young adults","year":2015,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Follicular lymphoma; Multivariate analysis; Stage (stratigraphy); Internal medicine; International Prognostic Index; Young adult; Retrospective cohort study; Lymphoma; Surgery; B symptoms; Pediatrics; Rituximab","score_opus":0.027510097228572006,"score_gpt":0.3125271388128811,"score_spread":0.28501704158430907,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2079462672","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9980406,0.0013695776,0.000031379557,0.000036457866,0.0000031718291,0.0000040881037,0.00024577128,0.0000012701267,0.0002677413],"genre_scores_gemma":[0.9992219,0.00033811101,0.000026253665,0.000026290294,0.00000817361,0.0000051812717,0.0002955583,6.824974e-7,0.00007773668],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9995982,0.000110568624,0.000097527896,0.000058912145,0.00007732446,0.000057518584],"domain_scores_gemma":[0.9985066,0.00035697766,0.0008589602,0.000039267245,0.00009052865,0.0001475829],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004684475,0.00009702534,0.00028715725,0.0007017098,0.00019191451,0.00034782646,0.00014672718,0.0003181709,0.0010686723],"category_scores_gemma":[0.0022198153,0.00013628173,0.00020481895,0.00086437265,0.0001867327,0.0004028391,0.000267629,0.00019495473,0.00021385512],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009246992,0.000009262194,0.9975279,0.000018900966,0.0000149819425,0.0002082332,0.00006602486,0.000017263625,0.000101735546,0.00000696183,0.00007151405,0.0018648031],"study_design_scores_gemma":[0.000003837526,0.00005739644,0.9988949,0.000011929537,0.0000071612903,0.0007157194,0.000103224265,0.000021192844,0.00002168919,0.00000804457,0.00015348605,0.0000013585666],"about_ca_topic_score_codex":0.002720209,"about_ca_topic_score_gemma":0.0039651543,"teacher_disagreement_score":0.002720209,"about_ca_system_score_codex":0.00023222517,"about_ca_system_score_gemma":0.00013283176,"threshold_uncertainty_score":0.0054088235},"labels":[],"label_agreement":null},{"id":"W2079838949","doi":"10.1046/j.1365-2141.2002.03511.x","title":"Assessment of thrombocytopenic disorders using the Platelet Function Analyzer (PFA‐100<sup>®</sup>)*","year":2002,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":37,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Hospital for Sick Children","funders":"","keywords":"Platelet; Medicine; Platelet disorder; Blood Platelet Disorders; Mean platelet volume; Platelet transfusion; Nuclear medicine; Spectrum analyzer; Internal medicine; Platelet aggregation; Physics; Optics","score_opus":0.02679226782795243,"score_gpt":0.2961434745761081,"score_spread":0.2693512067481557,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2079838949","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97984374,0.0040847957,0.01090165,0.0001297077,0.000027162812,0.00015990526,0.0003628114,0.00015713382,0.0043330775],"genre_scores_gemma":[0.99196833,0.000791801,0.006450362,0.00003926201,0.000013449664,0.00006734394,0.00018858316,0.000009939354,0.00047105004],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9992706,0.0003077541,0.00012738601,0.000056338027,0.00019944481,0.000038487848],"domain_scores_gemma":[0.99830425,0.0007955649,0.000399812,0.00010180443,0.00026672214,0.00013177865],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013895405,0.00038287873,0.00039684825,0.00084970985,0.00018380892,0.0003792193,0.00023432833,0.00045119147,0.0015019802],"category_scores_gemma":[0.0033949227,0.00012052891,0.00015018485,0.000617932,0.00044646428,0.00037899506,0.00027648328,0.00040501778,0.0002482971],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0029101083,0.00048344515,0.8054724,0.0005013844,0.00014956978,0.0023062262,0.00051176304,0.00046955032,0.10100191,0.0005911685,0.0010765665,0.08452601],"study_design_scores_gemma":[0.00015756015,0.007695789,0.8906498,0.00007098603,0.00018237859,0.023955561,0.00030131364,0.0055337176,0.06868992,0.00043975734,0.0022786793,0.000044463755],"about_ca_topic_score_codex":0.0005441256,"about_ca_topic_score_gemma":0.0006359551,"teacher_disagreement_score":0.0015019802,"about_ca_system_score_codex":0.00017237735,"about_ca_system_score_gemma":0.00017578344,"threshold_uncertainty_score":0.0073486567},"labels":[],"label_agreement":null},{"id":"W2080155184","doi":"10.1111/j.1365-2141.2007.06810.x","title":"Family studies in chronic lymphocytic leukaemia and other lymphoproliferative tumours","year":2007,"lang":"en","type":"review","venue":"British Journal of Haematology","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":28,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Institutes of Health; McMaster University","keywords":"Chronic lymphocytic leukemia; Lymphocytosis; Lymphoma; Immunology; Family aggregation; Lymphoproliferative disorders; Population; Medicine; Biology; Genetics; Leukemia","score_opus":0.1723417138094271,"score_gpt":0.4585856399438753,"score_spread":0.2862439261344482,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2080155184","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00009786437,0.9992945,0.00003386075,0.000099779725,0.000059336235,0.0000018799575,0.000007283334,0.0000023059347,0.00040317635],"genre_scores_gemma":[0.00089229713,0.99867153,0.000059826834,0.00007605472,0.000075703465,0.0000030994966,0.000016642885,5.613124e-7,0.00020429841],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9996309,0.00010018831,0.000053359516,0.00007090512,0.00011625761,0.00002825526],"domain_scores_gemma":[0.9988669,0.0007076294,0.00016706665,0.000026882235,0.00014934754,0.00008223634],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011398129,0.00078222237,0.002171962,0.0037244575,0.0003089575,0.0007603387,0.00097595935,0.0011274811,0.004142831],"category_scores_gemma":[0.001888859,0.0002739441,0.00047571282,0.0042567207,0.000795465,0.00097362825,0.00058291806,0.00085026346,0.0014111573],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000098832454,0.000042870943,0.000998878,0.021133266,0.00016295338,0.0011984536,0.00010123835,0.00026842704,0.00037239445,0.0014642369,0.026328115,0.9478304],"study_design_scores_gemma":[0.00006638073,0.00015091962,0.008601446,0.014587552,0.0004473102,0.016758872,0.00024239023,0.00007420087,0.0002387837,0.0024435157,0.9563541,0.00003461736],"about_ca_topic_score_codex":0.0021520928,"about_ca_topic_score_gemma":0.0035930716,"teacher_disagreement_score":0.004142831,"about_ca_system_score_codex":0.000627772,"about_ca_system_score_gemma":0.0010020469,"threshold_uncertainty_score":0.013859093},"labels":[],"label_agreement":null},{"id":"W2081076752","doi":"10.1046/j.1365-2141.2000.01826.x","title":"Induction of remission after donor leucocyte infusion for the treatment of relapsed chronic idiopathic myelofibrosis following allogeneic transplantation: evidence for a ‘graft vs. myelofibrosis’ effect","year":2000,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":59,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Hospital","funders":"","keywords":"Myelofibrosis; Medicine; Transplantation; Haematopoiesis; Graft-versus-host disease; Stem cell; Disease; Internal medicine; Gastroenterology; Surgery; Bone marrow","score_opus":0.02444582817807832,"score_gpt":0.306062339335051,"score_spread":0.28161651115697267,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2081076752","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9867763,0.0074090906,0.00086655165,0.00096878805,0.00012510044,0.00016169451,0.0000840125,0.0000611545,0.0035472855],"genre_scores_gemma":[0.99646324,0.0020389187,0.0005224938,0.00031237848,0.00016584175,0.000037401736,0.000109937355,0.000007264846,0.0003425334],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99971396,0.00013318288,0.0000311636,0.000021412423,0.000034975976,0.000065410815],"domain_scores_gemma":[0.9991198,0.0004034647,0.00016584329,0.000080951155,0.000026324766,0.00020365135],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007490063,0.00027635176,0.00070122286,0.0004471524,0.00033356677,0.00017887866,0.0004820778,0.0008324375,0.0009297596],"category_scores_gemma":[0.001466485,0.00014483255,0.00043353334,0.0003313876,0.0003991589,0.00020288286,0.00017258883,0.0013141638,0.00026357334],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0637393,0.013381003,0.04797233,0.0019481118,0.0008470807,0.049141876,0.00093423744,0.001428097,0.110728994,0.0011633211,0.003504378,0.70521134],"study_design_scores_gemma":[0.044790316,0.34590852,0.36122292,0.00049225846,0.0012020702,0.1487328,0.00030045377,0.0035529686,0.058278807,0.0012943582,0.034089133,0.00013544707],"about_ca_topic_score_codex":0.00039681702,"about_ca_topic_score_gemma":0.0012068835,"teacher_disagreement_score":0.0009297596,"about_ca_system_score_codex":0.00029270037,"about_ca_system_score_gemma":0.000251131,"threshold_uncertainty_score":0.003961146},"labels":[],"label_agreement":null},{"id":"W2081222723","doi":"10.1046/j.1365-2141.2001.02705.x","title":"Autotransplants for histologically transformed follicular non‐Hodgkin's lymphoma","year":2001,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":87,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Medicine; Surgery; Melphalan; Follicular lymphoma; Internal medicine; Etoposide; Lymphoma; Total body irradiation; Progressive disease; Chemotherapy; B symptoms; Transplantation; Gastroenterology; Salvage therapy; Cyclophosphamide","score_opus":0.016168254243755266,"score_gpt":0.2685698339200709,"score_spread":0.2524015796763156,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2081222723","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99939036,0.00025595515,0.0001086215,0.0000069283024,0.000003296247,0.000009452065,0.000025308309,0.0000062473678,0.00019378321],"genre_scores_gemma":[0.99955887,0.00013443401,0.000064348606,0.000021627096,0.000010268907,0.0000055775417,0.00010646012,0.000002432531,0.0000959957],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.999782,0.00004360099,0.00002091097,0.000031600073,0.000047975318,0.000073848125],"domain_scores_gemma":[0.9990821,0.00028508785,0.00026863717,0.00006994352,0.00003695669,0.00025728418],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00033717472,0.0001884771,0.00029126147,0.00041743476,0.00036916125,0.00043868742,0.00018055162,0.00031528957,0.0018616855],"category_scores_gemma":[0.001085332,0.00018143297,0.00031624688,0.00037542084,0.0003812325,0.00029681894,0.0002627902,0.0004372602,0.00033499862],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001055245,0.00017978899,0.96908647,0.00003319956,0.000042376152,0.013495733,0.00025923186,0.00013376489,0.0035011226,0.00006462794,0.00016637486,0.011982097],"study_design_scores_gemma":[0.00014199366,0.003117514,0.9067304,0.000029161461,0.00008814208,0.08586933,0.00045217402,0.0004976664,0.0015621695,0.00012656621,0.0013705621,0.000014429129],"about_ca_topic_score_codex":0.00037968325,"about_ca_topic_score_gemma":0.0005404627,"teacher_disagreement_score":0.0018616855,"about_ca_system_score_codex":0.00022063854,"about_ca_system_score_gemma":0.0002509895,"threshold_uncertainty_score":0.00622797},"labels":[],"label_agreement":null},{"id":"W2082706184","doi":"10.1111/bjh.12015","title":"Algorithm for initial management of priapism in chronic myeloid leukaemia","year":2012,"lang":"en","type":"letter","venue":"British Journal of Haematology","topic":"Reproductive System and Pregnancy","field":"Immunology and Microbiology","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"CancerCare Manitoba; University of Manitoba","funders":"","keywords":"Priapism; Medicine; Intensive care medicine; Apheresis; Myeloproliferative neoplasm; Pediatrics; Immunology; Surgery; Bone marrow","score_opus":0.018972193019164155,"score_gpt":0.26949717154262,"score_spread":0.25052497852345584,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2082706184","genre_codex":"methods","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.06700183,0.13117819,0.2882319,0.17860797,0.010182075,0.021115119,0.009710275,0.0079018,0.28607082],"genre_scores_gemma":[0.22646117,0.063273735,0.5879029,0.03476297,0.005135771,0.01090685,0.015273859,0.0009012206,0.05538155],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99898726,0.00028112085,0.0002442835,0.00013466322,0.00020552574,0.00014717877],"domain_scores_gemma":[0.9989222,0.00014416956,0.00013927295,0.00004086203,0.0004825225,0.00027095285],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001197539,0.000977654,0.00093544053,0.0021059318,0.0012803174,0.0018120102,0.0016789554,0.0020263174,0.018978138],"category_scores_gemma":[0.0037996285,0.0003010678,0.001776724,0.0008399716,0.00044802422,0.0020417084,0.0020622213,0.003683101,0.008252843],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00075491366,0.00061872427,0.03052488,0.0020075855,0.0001214328,0.009321496,0.0009051101,0.0050216927,0.0027030078,0.010922737,0.22384554,0.71325296],"study_design_scores_gemma":[0.0005722942,0.001194652,0.050788235,0.010009865,0.0003977465,0.046533857,0.0017278062,0.011790079,0.00409826,0.039479766,0.8331221,0.00028533675],"about_ca_topic_score_codex":0.0028478506,"about_ca_topic_score_gemma":0.004698892,"teacher_disagreement_score":0.018978138,"about_ca_system_score_codex":0.002244717,"about_ca_system_score_gemma":0.0026086273,"threshold_uncertainty_score":0.063488245},"labels":[],"label_agreement":null},{"id":"W2082863510","doi":"10.1111/j.1365-2141.2012.09232.x","title":"An open‐label, single‐arm, phase 2 study of single‐agent carfilzomib in patients with relapsed and/or refractory multiple myeloma who have been previously treated with bortezomib","year":2012,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":176,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta; University of Calgary","funders":"Onyx Pharmaceuticals; Exelixis; National Cancer Institute; Celgene; Bristol-Myers Squibb","keywords":"Carfilzomib; Medicine; Bortezomib; Nausea; Refractory (planetary science); Proteasome inhibitor; Adverse effect; Multiple myeloma; Internal medicine; Regimen; Phases of clinical research; Oncology; Clinical trial; Surgery","score_opus":0.04593809647162775,"score_gpt":0.33000503209728976,"score_spread":0.284066935625662,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2082863510","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99385923,0.0014412961,0.00045103542,0.00036783257,0.0001546181,0.0018808383,0.0005715466,0.00009585379,0.0011777547],"genre_scores_gemma":[0.98959446,0.0014273224,0.0013646669,0.00071740005,0.000304323,0.002683616,0.0014985941,0.000023480501,0.002386212],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.99951255,0.00022664093,0.000017664326,0.000095640826,0.00003990665,0.00010760901],"domain_scores_gemma":[0.9991767,0.00016436678,0.000118173164,0.000059588037,0.0000443733,0.0004367767],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016600001,0.0020015542,0.0028910502,0.0005814714,0.00040235787,0.0008227261,0.00082948443,0.0015162736,0.00367156],"category_scores_gemma":[0.0011242914,0.0008051298,0.0015810573,0.00034222737,0.00094019243,0.0010368016,0.00034298413,0.003192744,0.0008051329],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.8158861,0.102454305,0.0027726048,0.00043241342,0.0009992564,0.00021873838,0.00022855608,0.0017790701,0.023424843,0.00014958401,0.001865996,0.049788486],"study_design_scores_gemma":[0.5374514,0.45263788,0.006070452,0.000013189614,0.00020822938,0.00010617166,0.000024639212,0.0010828947,0.0012060971,0.00009759338,0.0010801732,0.00002126483],"about_ca_topic_score_codex":0.00093217136,"about_ca_topic_score_gemma":0.0020297002,"teacher_disagreement_score":0.00367156,"about_ca_system_score_codex":0.00066138,"about_ca_system_score_gemma":0.0011980229,"threshold_uncertainty_score":0.01228261},"labels":[],"label_agreement":null},{"id":"W2083073031","doi":"10.1111/bjh.12985","title":"Use of <scp>JAK</scp> inhibitors in the management of myelofibrosis: a revision of the <scp>B</scp>ritish <scp>C</scp>ommittee for <scp>S</scp>tandards in <scp>H</scp>aematology <scp>G</scp>uidelines for <scp>I</scp>nvestigation and <scp>M</scp>anagement of <scp>M</scp>yelofibrosis 2012","year":2014,"lang":"en","type":"letter","venue":"British Journal of Haematology","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":38,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"Medical Research Council; Public Health Agency","keywords":"Ruxolitinib; Myelofibrosis; Medicine; Hazard ratio; Internal medicine; Calreticulin; Confidence interval; Hematology; Oncology; Biology; Bone marrow; Genetics","score_opus":0.02982384085572492,"score_gpt":0.2775194712061712,"score_spread":0.24769563035044628,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2083073031","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.020356314,0.24713585,0.013792725,0.6462257,0.028973382,0.00076989434,0.0017902338,0.000616496,0.040339407],"genre_scores_gemma":[0.1427043,0.32609907,0.062905684,0.3668664,0.056036443,0.0013635835,0.0071347286,0.00069715735,0.036192633],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99508274,0.0009015299,0.0018246816,0.0002858044,0.0015381473,0.00036706464],"domain_scores_gemma":[0.99071723,0.0017350422,0.0013648055,0.00031104346,0.004670177,0.0012017799],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0059884624,0.0004821621,0.0012078391,0.0014223454,0.0011062393,0.0018321195,0.0016030181,0.0028534092,0.0015260463],"category_scores_gemma":[0.008569784,0.00034057183,0.0016936121,0.0011359893,0.0014959287,0.0015306394,0.0015398434,0.007992145,0.0013788345],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00022195095,0.00016572293,0.005633113,0.0023783902,0.00011471205,0.0025648486,0.0005816577,0.00066367356,0.0035002488,0.004029365,0.5752221,0.40492424],"study_design_scores_gemma":[0.00011846909,0.00018854246,0.012723236,0.005765958,0.00014017259,0.0056353454,0.00024069384,0.00034884532,0.0009685049,0.0020539698,0.97174406,0.00007215371],"about_ca_topic_score_codex":0.010416751,"about_ca_topic_score_gemma":0.025670165,"teacher_disagreement_score":0.010416751,"about_ca_system_score_codex":0.0024480426,"about_ca_system_score_gemma":0.00684594,"threshold_uncertainty_score":0.03167039},"labels":[],"label_agreement":null},{"id":"W2083141185","doi":"10.1046/j.1365-2141.2002.03910.x","title":"Telomere maintenance in human B lymphocytes","year":2002,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Telomeres, Telomerase, and Senescence","field":"Medicine","cited_by":93,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Terry Fox Research Institute","funders":"Deutsche Forschungsgemeinschaft; European Commission","keywords":"Telomere; Biology; CD19; Haematopoiesis; Senescence; Lymphocyte; Flow cytometry; Molecular biology; Immunology; Cell biology; Stem cell; Genetics; DNA","score_opus":0.019966626141806516,"score_gpt":0.2570709779284967,"score_spread":0.23710435178669018,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2083141185","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8859886,0.09556943,0.0062239505,0.0003715606,0.000080179445,0.000071091024,0.0018009573,0.000178515,0.009715774],"genre_scores_gemma":[0.9748219,0.016156562,0.0022824062,0.00015169922,0.000078328594,0.0000666036,0.0020871856,0.000015374077,0.0043398933],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9999175,0.00001764407,0.000007799609,0.000025029158,0.00002008125,0.000011981711],"domain_scores_gemma":[0.99991214,0.00001876258,0.000024530456,0.000013583565,0.00001785972,0.000013060533],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00025864702,0.00010179287,0.000115147835,0.00046657777,0.00018648946,0.00034574102,0.000100864796,0.00022139086,0.0018802616],"category_scores_gemma":[0.000372667,0.00007625343,0.00008994664,0.00039555368,0.00008818721,0.00016083909,0.00014899425,0.00016804438,0.00084529456],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011096831,0.000037708694,0.011516215,0.00038227258,0.000035309266,0.00035366352,0.00042112006,0.00020365717,0.89099205,0.0007756113,0.0012233445,0.092949316],"study_design_scores_gemma":[0.00027099648,0.0022673893,0.28184223,0.00028510037,0.00025737178,0.009910919,0.0005436549,0.00083208166,0.46152782,0.0033469996,0.23886934,0.000046110054],"about_ca_topic_score_codex":0.00055570103,"about_ca_topic_score_gemma":0.00030538475,"teacher_disagreement_score":0.0018802616,"about_ca_system_score_codex":0.00014560536,"about_ca_system_score_gemma":0.000112510446,"threshold_uncertainty_score":0.006290078},"labels":[],"label_agreement":null},{"id":"W2083377554","doi":"10.1111/j.1365-2141.2007.06733.x","title":"Childhood acute lymphoblastic leukaemia simulating multifocal osteomyelitis","year":2007,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Orthopedic Infections and Treatments","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; SickKids Foundation","funders":"","keywords":"Medicine; Erythrocyte sedimentation rate; Immunophenotyping; White blood cell; Bone marrow; Bone pain; Absolute neutrophil count; Rib cage; Complete blood count; Leukocytosis; Osteomyelitis; Nuclear medicine; Pathology; Internal medicine; Surgery; Neutropenia; Chemotherapy; Anatomy; Immunology","score_opus":0.007311494748825923,"score_gpt":0.27155236412734934,"score_spread":0.2642408693785234,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2083377554","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9817016,0.00243564,0.00091378926,0.0010916784,0.00012343746,0.00014957144,0.00034350288,0.00015712698,0.013083455],"genre_scores_gemma":[0.99636,0.0011739803,0.00054959604,0.00023093443,0.00013557446,0.000015353306,0.00014734177,0.0000150512205,0.0013721791],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.9996076,0.00006060139,0.000032661304,0.00007123082,0.00006153929,0.00016639062],"domain_scores_gemma":[0.99924004,0.00027375555,0.00019481184,0.000035667617,0.000041573356,0.00021421396],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023711586,0.0011514813,0.0007240957,0.00097552704,0.0011051302,0.0006757086,0.00043128338,0.0012353567,0.0038503727],"category_scores_gemma":[0.0019857904,0.0006733602,0.00028316866,0.00082766695,0.0007503801,0.0008995008,0.00062213535,0.0011219217,0.00083174335],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014373624,0.0000688305,0.025869524,0.00009194796,0.000009335437,0.96743697,0.00027719128,0.00016804694,0.0022168322,0.00036853898,0.000590558,0.0027585677],"study_design_scores_gemma":[0.00005319006,0.00023010482,0.0305655,0.000032649223,0.00002117458,0.96624446,0.00018386227,0.00024183893,0.0005028303,0.00021512964,0.001701574,0.000007713844],"about_ca_topic_score_codex":0.0024002746,"about_ca_topic_score_gemma":0.0039266283,"teacher_disagreement_score":0.0038503727,"about_ca_system_score_codex":0.0007242092,"about_ca_system_score_gemma":0.0004614952,"threshold_uncertainty_score":0.012880802},"labels":[],"label_agreement":null},{"id":"W2083617340","doi":"10.1111/bjh.12931","title":"Acute promyelocytic leukaemia is characterized by stable incidence and improved survival that is restricted to patients managed in leukaemia referral centres: a pan-Canadian epidemiological study","year":2014,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Retinoids in leukemia and cellular processes","field":"Biochemistry, Genetics and Molecular Biology","cited_by":87,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Toronto; McGill University Health Centre; University of Ottawa; Memorial University of Newfoundland; Dalhousie University; Hôpital Maisonneuve-Rosemont; Queen Elizabeth II Health Sciences Centre; Université de Montréal; Princess Margaret Cancer Centre; University of Calgary; CancerCare Manitoba; Ottawa Hospital; University of Manitoba","funders":"","keywords":"Medicine; Referral; Incidence (geometry); Epidemiology; Pediatrics; Cohort; Cancer registry; Acute promyelocytic leukemia; Cohort study; Malignancy; Internal medicine; Family medicine","score_opus":0.011995909131393642,"score_gpt":0.250683099887268,"score_spread":0.23868719075587436,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2083617340","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97300375,0.008342328,0.00038117307,0.0015268602,0.000037939215,0.00012190262,0.011803997,0.000037985883,0.004744056],"genre_scores_gemma":[0.9916611,0.003960004,0.0004167784,0.00022140656,0.000028315424,0.000026628637,0.0032207721,0.000011923052,0.00045304422],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99793637,0.00016812742,0.00020916293,0.00037039444,0.00084276183,0.00047331947],"domain_scores_gemma":[0.99567443,0.00019250781,0.0011128008,0.00022174891,0.0020717445,0.00072672893],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016071888,0.0006010268,0.00060234836,0.0034798805,0.0030778225,0.0023612643,0.001298789,0.0008615247,0.0025825936],"category_scores_gemma":[0.003415589,0.00066633866,0.0009492687,0.013322327,0.0008483726,0.00090103794,0.001396615,0.001047189,0.00028755426],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006799071,0.000026548083,0.9932712,0.000109192,0.0001247434,0.000115243645,0.000488406,0.0000759007,0.00013555704,0.00015856826,0.0011851622,0.004241534],"study_design_scores_gemma":[0.000005304349,0.000017478354,0.99799806,0.00004310985,0.000047329613,0.00016757048,0.0005269273,0.00012644746,0.000017356633,0.00002160245,0.0010180543,0.000010785245],"about_ca_topic_score_codex":0.9815518,"about_ca_topic_score_gemma":0.9836463,"teacher_disagreement_score":0.018448174,"about_ca_system_score_codex":0.016986744,"about_ca_system_score_gemma":0.025425157,"threshold_uncertainty_score":0.12324804},"labels":[],"label_agreement":null},{"id":"W2084346498","doi":"10.1111/bjh.13261","title":"c.1058C&gt;T variant in the <i>SERPINC1</i> gene is pathogenic for antithrombin deficiency","year":2014,"lang":"en","type":"letter","venue":"British Journal of Haematology","topic":"Blood Coagulation and Thrombosis Mechanisms","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McMaster Children's Hospital; Hospital for Sick Children; McMaster University; University of Toronto","funders":"","keywords":"Serpin; Antithrombin; Thrombophilia; Medicine; Venous thrombosis; Thrombosis; Internal medicine; Genetics; Immunology; Biology; Gene; Heparin","score_opus":0.029427371689610897,"score_gpt":0.27374433843586793,"score_spread":0.24431696674625702,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2084346498","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95141304,0.012195838,0.0055942787,0.0042461106,0.0019999808,0.0004487612,0.005075562,0.0006507077,0.018375613],"genre_scores_gemma":[0.9853977,0.0012959422,0.0020655706,0.0018020831,0.00056729023,0.00007549672,0.0013573783,0.00011525179,0.00732338],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.9995702,0.00006686666,0.000054966884,0.00012036447,0.00012375407,0.000063874446],"domain_scores_gemma":[0.99951863,0.0001606911,0.0001759722,0.000015265921,0.00004110376,0.00008836548],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003044844,0.0017336146,0.0007279446,0.0008965138,0.00075234234,0.00046325932,0.00052633684,0.001783921,0.0075072763],"category_scores_gemma":[0.0010606005,0.00019551262,0.0010169132,0.000986486,0.0007674968,0.00027730482,0.00040336672,0.0009244111,0.0022888638],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018246226,0.00047773894,0.09706729,0.0007985377,0.0005555463,0.65677816,0.0015917108,0.0011183438,0.1657174,0.0035398768,0.01778957,0.052741226],"study_design_scores_gemma":[0.00049866893,0.001570953,0.29960114,0.0007602481,0.00067050336,0.5934655,0.00065113226,0.0019814542,0.023253376,0.0019216363,0.07537427,0.00025102764],"about_ca_topic_score_codex":0.0041001495,"about_ca_topic_score_gemma":0.0037018184,"teacher_disagreement_score":0.0075072763,"about_ca_system_score_codex":0.00054634985,"about_ca_system_score_gemma":0.00040301296,"threshold_uncertainty_score":0.025114298},"labels":[],"label_agreement":null},{"id":"W2084978878","doi":"10.1046/j.1365-2141.2003.04389.x","title":"The trouble with consent","year":2003,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Medical Malpractice and Liability Issues","field":"Health Professions","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Law; Sign (mathematics); Power (physics); Certainty; Criminal law; Subject (documents); Liability; Political science; Psychology; Computer science; Philosophy","score_opus":0.05842515429108066,"score_gpt":0.4069596284499723,"score_spread":0.34853447415889166,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2084978878","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00096022687,0.023998003,0.012960727,0.87671673,0.010193361,0.00007127193,0.00019703148,0.0002849048,0.07461768],"genre_scores_gemma":[0.106880605,0.028574958,0.01476729,0.7401412,0.020464635,0.0005800385,0.0004085014,0.0013757435,0.08680702],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.91041386,0.052880816,0.0070880717,0.009362681,0.016681207,0.003573268],"domain_scores_gemma":[0.81723773,0.1408347,0.0043657473,0.020332213,0.012584323,0.0046451716],"candidate_categories":["research_integrity"],"consensus_categories":[],"category_scores_codex":[0.07697512,0.0010746778,0.0017723434,0.001900144,0.0063812695,0.014134714,0.0042791083,0.026002813,0.023631673],"category_scores_gemma":[0.18228063,0.0011849643,0.0016273321,0.0020624236,0.068244845,0.044134818,0.011935299,0.05562362,0.018838381],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":"theoretical_or_conceptual","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000025826892,0.00001530381,0.00014169978,0.000231478,0.000013239545,0.000100370824,0.0046655587,0.00005716438,0.00008291637,0.70680887,0.25360638,0.034251217],"study_design_scores_gemma":[0.000024203633,0.0000196634,0.00016238373,0.0010055715,0.000008462254,0.00054428243,0.0022912393,0.0000845954,0.00014363727,0.30743033,0.6882368,0.000048857815],"about_ca_topic_score_codex":0.007917443,"about_ca_topic_score_gemma":0.0055565555,"teacher_disagreement_score":0.9739972,"about_ca_system_score_codex":0.0056435354,"about_ca_system_score_gemma":0.01567229,"threshold_uncertainty_score":0.40708822},"labels":[],"label_agreement":null},{"id":"W2085164828","doi":"10.1046/j.0007-1048.2002.03354.x","title":"<i>Ex vivo</i> expansion of megakaryocyte progenitor cells from normal bone marrow and peripheral blood and from patients with haematological malignancies","year":2002,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Hospital for Sick Children","keywords":"Megakaryocyte; Bone marrow; Progenitor cell; Haematopoiesis; Thrombopoietin; CD34; Multiple myeloma; Medicine; Immunology; Myeloid; Ex vivo; Stem cell; Transplantation; Neutropenia; Cytokine; Stem cell factor; Interleukin 3; Cancer research; Biology; Internal medicine; In vivo; Chemotherapy; T cell; Immune system","score_opus":0.007064586933197078,"score_gpt":0.19004046394547114,"score_spread":0.18297587701227405,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2085164828","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98849034,0.0038847832,0.004093483,0.00011820889,0.000034839,0.00029600158,0.0006111138,0.00007860829,0.0023924077],"genre_scores_gemma":[0.9792219,0.00251795,0.01156604,0.00018830116,0.000052666746,0.00054167776,0.004200832,0.000037287915,0.0016733492],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99979454,0.000076653094,0.000025591182,0.000030722134,0.000044299228,0.000028146838],"domain_scores_gemma":[0.9999112,0.00003426838,0.000010932255,0.000013653451,0.00001115602,0.000018732004],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00035529342,0.00029618153,0.0002726148,0.00020519247,0.000104321116,0.00034197836,0.00015590727,0.00019379825,0.0016163974],"category_scores_gemma":[0.00026732017,0.00010214642,0.00018494092,0.00014673319,0.000099385215,0.00012911012,0.00027878614,0.00051788,0.00053745386],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008385921,0.00027931778,0.003092157,0.00014018912,0.00001640529,0.00019758225,0.00008968579,0.00033986018,0.979567,0.000066248824,0.00025172945,0.015121271],"study_design_scores_gemma":[0.00016469961,0.0061650868,0.029544381,0.000043715863,0.00009717731,0.0017635464,0.000051399707,0.0011639884,0.95173687,0.00005542596,0.009204179,0.000009438183],"about_ca_topic_score_codex":0.000109355184,"about_ca_topic_score_gemma":0.0001919438,"teacher_disagreement_score":0.0016163974,"about_ca_system_score_codex":0.00007499698,"about_ca_system_score_gemma":0.00010525579,"threshold_uncertainty_score":0.0054073334},"labels":[],"label_agreement":null},{"id":"W2085190236","doi":"10.1111/j.1365-2141.2004.05199.x","title":"Multiple myeloma involving central nervous system: high frequency of chromosome 17p13.1 (p53) deletions","year":2004,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":126,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Fluorescence in situ hybridization; Multiple myeloma; Biology; Chromosomal translocation; Pathology; Immunoglobulin heavy chain; Central nervous system; Immunofluorescence; Chromosome 13; Interphase; Immunoglobulin light chain; Cancer research; Molecular biology; Antibody; Chromosome; Genetics; Immunology; Gene; Medicine; Endocrinology","score_opus":0.015568707168997865,"score_gpt":0.2584159840179656,"score_spread":0.24284727684896776,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2085190236","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9985941,0.00052263506,0.00029746335,0.000026313872,0.000002969976,0.0000054692423,0.00006410497,0.000015896007,0.0004710631],"genre_scores_gemma":[0.99950004,0.00018523207,0.00013196544,0.000011309599,0.000009972893,0.000002754333,0.000055866225,0.0000037791842,0.00009912224],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99975485,0.00004075351,0.000022345272,0.00008058706,0.00006422162,0.00003731598],"domain_scores_gemma":[0.9991805,0.00022718032,0.00031021205,0.00008472238,0.00007812468,0.000119287564],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015272494,0.00028539466,0.00036697576,0.0010804238,0.00031780105,0.00032557332,0.00027355028,0.00041298824,0.0019051442],"category_scores_gemma":[0.0008910775,0.00019302829,0.00009673488,0.000840267,0.0004191084,0.00023638787,0.00035703514,0.00026913843,0.00038562185],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000525415,0.0000483494,0.8786816,0.00010991618,0.00008978543,0.04579992,0.00057212455,0.00013563182,0.051043566,0.00010977558,0.00049493194,0.022388915],"study_design_scores_gemma":[0.00003145888,0.0002575647,0.7404958,0.000022774779,0.00010422634,0.24887219,0.00033442516,0.0002428464,0.007903006,0.00016106278,0.0015612624,0.000013442387],"about_ca_topic_score_codex":0.0005443134,"about_ca_topic_score_gemma":0.0008404363,"teacher_disagreement_score":0.0019051442,"about_ca_system_score_codex":0.00011892374,"about_ca_system_score_gemma":0.000102301696,"threshold_uncertainty_score":0.006373346},"labels":[],"label_agreement":null},{"id":"W2085230960","doi":"10.1046/j.1365-2141.2002.03479.x","title":"Roles for both cyclic GMP and cyclic AMP in the inhibition of collagen‐induced platelet aggregation by nitroprusside*","year":2002,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":56,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"Heart and Stroke Foundation of Canada","keywords":"Adenylyl cyclase; Protein kinase A; Platelet; Chemistry; Soluble guanylyl cyclase; Internal medicine; Endocrinology; cGMP-dependent protein kinase; Cyclic nucleotide; Forskolin; Kinase; Biochemistry; Enzyme; Biology; Receptor; Nucleotide; Guanylate cyclase; Mitogen-activated protein kinase kinase; Medicine","score_opus":0.020051450754191,"score_gpt":0.2610448748605599,"score_spread":0.24099342410636887,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2085230960","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.78713185,0.14826949,0.024654055,0.0024750633,0.0007512224,0.0005929969,0.0016058644,0.0006072119,0.033912215],"genre_scores_gemma":[0.9755765,0.0097058695,0.009147424,0.0003735325,0.00026449657,0.00021711564,0.00048957026,0.000027437365,0.004197987],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99986625,0.000032801123,0.000013270646,0.000024712854,0.000026255815,0.000036766356],"domain_scores_gemma":[0.99978215,0.00006584854,0.000037213118,0.000031344687,0.000028658058,0.0000549077],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00028375754,0.00072337314,0.00031932624,0.00023140208,0.00019675869,0.00032358206,0.00032365703,0.00067085,0.0014223482],"category_scores_gemma":[0.00024288523,0.0002398645,0.0002932235,0.00013083828,0.0003791416,0.00026965057,0.000270588,0.0007573727,0.0006307245],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00032564087,0.000036400983,0.00009419797,0.00012404202,0.00000822011,0.0004193909,0.00003232415,0.00005969542,0.99306256,0.00049143814,0.000064644206,0.005281476],"study_design_scores_gemma":[0.00016990758,0.0019298823,0.012371076,0.0000549237,0.000073900876,0.0028307345,0.000047661502,0.0017539476,0.96487194,0.0007928705,0.015086284,0.000016922733],"about_ca_topic_score_codex":0.00051217293,"about_ca_topic_score_gemma":0.00051411154,"teacher_disagreement_score":0.0014223482,"about_ca_system_score_codex":0.0002682656,"about_ca_system_score_gemma":0.00028755123,"threshold_uncertainty_score":0.004758239},"labels":[],"label_agreement":null},{"id":"W2085276059","doi":"10.1111/bjh.12343","title":"<scp>B</scp>‐cell lymphoma, unclassifiable, with features intermediate between diffuse large <scp>B</scp>‐cell lymphoma and burkitt lymphoma: study of 39 cases","year":2013,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":83,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba","funders":"","keywords":"BCL6; Lymphoma; Medicine; International Prognostic Index; Diffuse large B-cell lymphoma; Immunohistochemistry; Fluorescence in situ hybridization; Pathology; Stage (stratigraphy); B-cell lymphoma; Internal medicine; Oncology; B cell; Gastroenterology; Immunology; Biology; Gene; Antibody; Chromosome","score_opus":0.010707840875849922,"score_gpt":0.2343592752815923,"score_spread":0.2236514344057424,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2085276059","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9988707,0.00045523798,0.000107473985,0.0000150828455,0.000002451705,0.000027515056,0.00008297132,0.0000039526103,0.000434572],"genre_scores_gemma":[0.99915576,0.00027548976,0.00016714653,0.00001495108,0.000010088851,0.000021493202,0.00024557914,0.0000024254891,0.00010704908],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9993606,0.00011455079,0.00009784136,0.00015962272,0.0001466371,0.00012076058],"domain_scores_gemma":[0.9990569,0.00023337097,0.0003593102,0.00010562068,0.00007565984,0.0001692146],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00052845344,0.00043437432,0.00036710242,0.001601225,0.00075879693,0.0006298546,0.00046255815,0.00048001503,0.001469755],"category_scores_gemma":[0.0020128626,0.00050473755,0.00024421976,0.001279934,0.0007497675,0.0004034725,0.0006703144,0.00025590978,0.00050126074],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015504242,0.00007194496,0.97717494,0.00005330153,0.00003172331,0.01612177,0.00040164543,0.000030174846,0.0021366288,0.00003625567,0.00013035153,0.0036562737],"study_design_scores_gemma":[0.000054327957,0.0002910814,0.8825156,0.000028217,0.000045785782,0.11342439,0.00068170764,0.00023310553,0.0007500501,0.00005793763,0.0019071236,0.000010669108],"about_ca_topic_score_codex":0.003263608,"about_ca_topic_score_gemma":0.0034855155,"teacher_disagreement_score":0.003263608,"about_ca_system_score_codex":0.00047862701,"about_ca_system_score_gemma":0.00049730286,"threshold_uncertainty_score":0.006489277},"labels":[],"label_agreement":null},{"id":"W2085359619","doi":"10.1111/j.1365-2141.2007.06913.x","title":"The selective Aurora B kinase inhibitor AZD1152 is a potential new treatment for multiple myeloma","year":2007,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Microtubule and mitosis dynamics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":61,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"Applied Materials","keywords":"Aurora inhibitor; Aurora B kinase; Aurora kinase; Multiple myeloma; Plasma Cell Myeloma; Aurora A kinase; Cancer research; Apoptosis; Kinase; Medicine; Cell cycle; Biology; Internal medicine; Cell; Cancer; Cytokinesis; Cell biology; Cell division; Biochemistry","score_opus":0.007704250812778182,"score_gpt":0.24970108456124435,"score_spread":0.24199683374846617,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2085359619","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.6266975,0.3389166,0.009947256,0.0037449747,0.00055802084,0.00017722056,0.0012125978,0.0011270551,0.01761879],"genre_scores_gemma":[0.8803529,0.10276493,0.004689545,0.00062370155,0.00023068399,0.000075598306,0.0017531789,0.00003367585,0.009475775],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9999484,0.0000068027084,0.0000047346934,0.000011652283,0.000018139966,0.00001032993],"domain_scores_gemma":[0.9999759,0.0000036374959,0.000006856984,0.0000022130046,0.0000031407872,0.0000082495635],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001053326,0.0003174301,0.0004711474,0.00036042146,0.00017073663,0.00032641555,0.00030331267,0.0002918591,0.0013978933],"category_scores_gemma":[0.0000639477,0.00012955903,0.00023141906,0.00030172584,0.00016141831,0.0002032583,0.00017759674,0.00058769004,0.0004766097],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012992747,0.00025260609,0.001476073,0.00080503756,0.00007909351,0.00084299734,0.000044831257,0.0009319942,0.7397364,0.0013432996,0.0047005834,0.24848782],"study_design_scores_gemma":[0.0012384955,0.007438982,0.028854402,0.00010327239,0.00033014594,0.010563486,0.00005989107,0.0030460393,0.67933995,0.00087462657,0.26808345,0.00006721646],"about_ca_topic_score_codex":0.0003842265,"about_ca_topic_score_gemma":0.0016353662,"teacher_disagreement_score":0.0013978933,"about_ca_system_score_codex":0.00037884878,"about_ca_system_score_gemma":0.00015936379,"threshold_uncertainty_score":0.004676461},"labels":[],"label_agreement":null},{"id":"W2085371417","doi":"10.1046/j.1365-2141.2003.04068.x","title":"Hemolink™, an <i>o</i>‐raffinose cross‐linked haemoglobin‐based oxygen carrier, does not affect activation and function of human platelets in whole blood <i>in vitro</i>","year":2003,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Hemoglobin structure and function","field":"Biochemistry, Genetics and Molecular Biology","cited_by":20,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Toronto; St. Michael's Hospital","funders":"","keywords":"Platelet; Whole blood; Platelet activation; Chemistry; Flow cytometry; Annexin; Andrology; Phosphatidylserine; CD63; In vitro; Blood substitute; Hemoglobin; Immunology; Endocrinology; Biochemistry; Medicine; Phospholipid; Membrane","score_opus":0.00817003747731621,"score_gpt":0.2516014473007202,"score_spread":0.243431409823404,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2085371417","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99276465,0.0027578436,0.0016900325,0.00009624947,0.000050902836,0.000063523534,0.0002728227,0.000066809385,0.0022371532],"genre_scores_gemma":[0.9893868,0.0015816595,0.0028225929,0.000095362586,0.00002516864,0.00007463142,0.0014386014,0.000029673445,0.0045455676],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998739,0.000025970228,0.000012291661,0.000021657714,0.000041695366,0.000024504454],"domain_scores_gemma":[0.999877,0.000038171078,0.000034218978,0.000012187045,0.000021074462,0.000017319897],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001320275,0.00024151977,0.00018043493,0.00008817998,0.00010175211,0.0001905112,0.00019271897,0.0002450375,0.0013414008],"category_scores_gemma":[0.00021406566,0.00007700631,0.0001451497,0.000080360805,0.00013766775,0.00014959043,0.000086837004,0.00028937683,0.00031350914],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006494292,0.00008401834,0.0002742075,0.00007989693,0.000011095018,0.00013466101,0.000044643257,0.00003173831,0.9940766,0.000063301275,0.00018089816,0.0043694484],"study_design_scores_gemma":[0.000033859702,0.0015990188,0.0038119622,0.00000940929,0.00003403089,0.0005059782,0.000021641397,0.00023945286,0.9892167,0.000013676916,0.00450878,0.0000054471648],"about_ca_topic_score_codex":0.0009745447,"about_ca_topic_score_gemma":0.0010717334,"teacher_disagreement_score":0.0013414008,"about_ca_system_score_codex":0.000116754,"about_ca_system_score_gemma":0.00015501061,"threshold_uncertainty_score":0.004487455},"labels":[],"label_agreement":null},{"id":"W2087700674","doi":"10.1111/bjh.12274","title":"The clinical benefit of ruxolitinib across patient subgroups: analysis of a placebo‐controlled, Phase <scp>III</scp> study in patients with myelofibrosis","year":2013,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":94,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"National Cancer Institute; Incyte","keywords":"Ruxolitinib; Myelofibrosis; Medicine; Placebo; Internal medicine; Randomization; International Prognostic Scoring System; Population; Polycythaemia; Gastroenterology; Clinical trial; Surgery; Myelodysplastic syndromes; Bone marrow; Pathology","score_opus":0.01525759521435154,"score_gpt":0.31945351406109845,"score_spread":0.3041959188467469,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2087700674","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99125063,0.00435701,0.00058749,0.00031466232,0.00020613696,0.0016944982,0.0008344845,0.000066437235,0.00068861886],"genre_scores_gemma":[0.9933755,0.0014906237,0.0009535729,0.00043894904,0.00029995706,0.0017703368,0.0010337667,0.000022627602,0.0006146662],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9966329,0.0023232326,0.00024670025,0.0003796313,0.0001968151,0.00022072918],"domain_scores_gemma":[0.9964413,0.0012840708,0.0009863762,0.0004657305,0.00021853417,0.00060393306],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0068209143,0.0015508293,0.0038976283,0.00043521612,0.00042308625,0.0013742094,0.00078664435,0.0016356838,0.0024573642],"category_scores_gemma":[0.0043817377,0.00064016687,0.0038758824,0.0005412411,0.0013040234,0.0009784218,0.0004514167,0.002589559,0.00040669716],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.97497493,0.003503094,0.0011771892,0.00038379082,0.00248199,0.000027718464,0.00004431963,0.00037441633,0.0058628367,0.000046129004,0.0003311443,0.0107924715],"study_design_scores_gemma":[0.8276976,0.15926565,0.00825216,0.000035995716,0.002405086,0.000052305724,0.000028502287,0.0005254118,0.0009907313,0.00011512314,0.0006005558,0.000030933898],"about_ca_topic_score_codex":0.00059069745,"about_ca_topic_score_gemma":0.0013584063,"teacher_disagreement_score":0.0068209143,"about_ca_system_score_codex":0.00086943124,"about_ca_system_score_gemma":0.0010859573,"threshold_uncertainty_score":0.03607291},"labels":[],"label_agreement":null},{"id":"W2088430322","doi":"10.1111/j.1365-2141.2006.06259.x","title":"JSI‐124 (cucurbitacin I) inhibits Janus kinase‐3/signal transducer and activator of transcription‐3 signalling, downregulates nucleophosmin‐anaplastic lymphoma kinase (ALK), and induces apoptosis in ALK‐positive anaplastic large cell lymphoma cells","year":2006,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Cytokine Signaling Pathways and Interactions","field":"Medicine","cited_by":77,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Anaplastic lymphoma kinase; Anaplastic large-cell lymphoma; Janus kinase; STAT protein; Cancer research; Lymphoma; Apoptosis; Nucleophosmin; Kinase; Anaplastic thyroid cancer; Janus kinase 2; STAT3; Medicine; Chemistry; Biology; Immunology; Internal medicine; Cell biology; Lung cancer; Cancer","score_opus":0.007720805082192493,"score_gpt":0.21861174935908956,"score_spread":0.21089094427689706,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2088430322","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99463046,0.0021581524,0.0011069052,0.0000687734,0.000033386426,0.00004140159,0.00029627982,0.00014858751,0.0015159975],"genre_scores_gemma":[0.9955291,0.0010009797,0.00089950766,0.000036372538,0.000013657091,0.000029478562,0.0007723844,0.000017919598,0.0017005913],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9999261,0.00001352085,0.00000681531,0.000010604937,0.000021190841,0.000021773163],"domain_scores_gemma":[0.99993014,0.000011156019,0.000022055912,0.000005846348,0.000007825038,0.000022979246],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00007957324,0.00053393043,0.0002484766,0.00030326008,0.000113110815,0.0001719325,0.00019372765,0.00021861505,0.00083306036],"category_scores_gemma":[0.0000824032,0.00012978307,0.00026473714,0.0002150394,0.00025409777,0.00013192922,0.00009442542,0.0004261305,0.00026031272],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001256415,0.00005342606,0.00007576722,0.000038097387,0.0000061961155,0.000026437074,0.0000073108904,0.000072674055,0.9986217,0.00002407068,0.000043971475,0.00090478885],"study_design_scores_gemma":[0.000041240233,0.0008704382,0.002376984,0.000003489047,0.00001843528,0.0001557367,0.0000110483425,0.000577468,0.9948737,0.000010717922,0.0010564106,0.00000431306],"about_ca_topic_score_codex":0.001184957,"about_ca_topic_score_gemma":0.00164443,"teacher_disagreement_score":0.001184957,"about_ca_system_score_codex":0.00031652712,"about_ca_system_score_gemma":0.00018321995,"threshold_uncertainty_score":0.0027868748},"labels":[],"label_agreement":null},{"id":"W2089213155","doi":"10.1046/j.1365-2141.2001.02833.x","title":"The storage defects in grey platelet syndrome and αδ‐storage pool deficiency affect α‐granule factor V and multimerin storage without altering their proteolytic processing","year":2001,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":25,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Hamilton Regional Laboratory Medicine Program","funders":"","keywords":"Platelet; Platelet factor 4; Immunology; Biology","score_opus":0.013293789583400353,"score_gpt":0.2573305787923217,"score_spread":0.24403678920892133,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2089213155","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9970456,0.0009391334,0.0009995692,0.000048397545,0.000009020746,0.00001652855,0.00017953406,0.00001883157,0.00074347097],"genre_scores_gemma":[0.9987839,0.00026554443,0.0005605761,0.00002479894,0.000004882744,0.000010311938,0.00011412626,0.000005143649,0.00023078863],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9999051,0.000017786439,0.000014266054,0.000027690145,0.000024573226,0.000010559182],"domain_scores_gemma":[0.9998331,0.00005906473,0.000049813152,0.000021270827,0.000006639721,0.00003003595],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000107399435,0.0004135027,0.00019233585,0.0005513889,0.0001221909,0.00012515527,0.00017042467,0.00035096135,0.0015989091],"category_scores_gemma":[0.00036983864,0.00014725656,0.00020846825,0.00029829243,0.00060321443,0.00016618388,0.00033502097,0.00032292996,0.00012873739],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012177229,0.00007945951,0.040563747,0.00023306633,0.00015046258,0.024123581,0.00042473667,0.00043108867,0.90957814,0.0013736452,0.00027520943,0.021549175],"study_design_scores_gemma":[0.00041989627,0.0032379143,0.43545276,0.00006529579,0.00035953606,0.1753802,0.00041993032,0.0016945625,0.37310603,0.0031082807,0.0067076143,0.000047917933],"about_ca_topic_score_codex":0.0007124582,"about_ca_topic_score_gemma":0.0006611736,"teacher_disagreement_score":0.0015989091,"about_ca_system_score_codex":0.00014860109,"about_ca_system_score_gemma":0.00015652424,"threshold_uncertainty_score":0.005348861},"labels":[],"label_agreement":null},{"id":"W2089259280","doi":"10.1111/bjh.13294","title":"A comparison of chronic manual and automated red blood cell exchange transfusion in sickle cell disease patients","year":2015,"lang":"en","type":"letter","venue":"British Journal of Haematology","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":48,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Toronto; University Health Network","funders":"","keywords":"Medicine; Phlebotomy; Observational study; Intensive care medicine; Disease; Blood transfusion; Internal medicine","score_opus":0.010601842450553662,"score_gpt":0.26473717627003096,"score_spread":0.2541353338194773,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2089259280","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9994753,0.00021496622,0.000017582577,0.00001477945,0.0000039805673,0.000010952309,0.00010414119,7.236021e-7,0.00015763407],"genre_scores_gemma":[0.9995215,0.000099600635,0.000036051737,0.000028412882,0.000008769257,0.000013894133,0.00022080282,6.3240856e-7,0.00007027093],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987344,0.0003794227,0.00027042415,0.00019595186,0.00023984473,0.00017995073],"domain_scores_gemma":[0.992474,0.0016176571,0.004296234,0.00026105047,0.0006365798,0.000714283],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016214433,0.0001854295,0.00056127703,0.0006780564,0.00036348336,0.0007595131,0.00032984346,0.00047412675,0.0011331906],"category_scores_gemma":[0.0055691986,0.00024002578,0.0005665373,0.0009568603,0.00034858382,0.00066119,0.0006223619,0.0005093342,0.00018039143],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00194222,0.00010408717,0.9954904,0.000055264198,0.00007809773,0.00004345898,0.0003001104,0.000022480503,0.00012536717,0.000016770533,0.00008508912,0.0017367122],"study_design_scores_gemma":[0.000055972996,0.0015157786,0.99766976,0.000017427306,0.000036608664,0.00010619732,0.0003794799,0.00005848079,0.000029330115,0.0000073292777,0.00011902624,0.0000045213146],"about_ca_topic_score_codex":0.004923452,"about_ca_topic_score_gemma":0.0068669803,"teacher_disagreement_score":0.004923452,"about_ca_system_score_codex":0.00076396944,"about_ca_system_score_gemma":0.00050980144,"threshold_uncertainty_score":0.009789586},"labels":[],"label_agreement":null},{"id":"W2089776693","doi":"10.1111/j.1365-2141.2008.07243.x","title":"Clinical features and outcome of pulmonary embolism in children","year":2008,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":206,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"Hospital for Sick Children","keywords":"Medicine; Pulmonary embolism; Thrombolysis; Deep vein; Thrombosis; Surgery; Prospective cohort study; Pediatrics; Venous thrombosis; Inferior vena cava; Coagulopathy; Inferior vena cava filter; Internal medicine","score_opus":0.023713961668551435,"score_gpt":0.3164160708316388,"score_spread":0.29270210916308737,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2089776693","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9978236,0.0012425013,0.000053154297,0.00006426049,0.000009065823,0.000007964265,0.00021151114,0.000004945653,0.0005831473],"genre_scores_gemma":[0.99918014,0.0004263812,0.00004287594,0.000017652053,0.000014349733,0.0000073529573,0.00024878993,0.0000020339442,0.000060437334],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99927884,0.00016765071,0.00010211862,0.000104192135,0.00017209188,0.00017509426],"domain_scores_gemma":[0.99648285,0.000903543,0.0016100892,0.00008051175,0.00025811468,0.0006649223],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00045057622,0.00037627347,0.0005149139,0.0011689233,0.00048211502,0.0005920691,0.00031912964,0.0006491876,0.0012752989],"category_scores_gemma":[0.0054296106,0.0002749177,0.0002890454,0.0010675504,0.00077462586,0.00063221523,0.0004447404,0.00052915106,0.0003188678],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000053755804,0.00001058875,0.99607444,0.000014835398,0.000009713643,0.0024942749,0.000076977405,0.00004521554,0.0001034397,0.000014316281,0.00012326532,0.0009792153],"study_design_scores_gemma":[0.000004787679,0.00011331398,0.9818965,0.000016493588,0.0000099429,0.017505197,0.00019218474,0.00005004348,0.000036804333,0.000020864809,0.00014894528,0.0000049605405],"about_ca_topic_score_codex":0.0037917201,"about_ca_topic_score_gemma":0.002662176,"teacher_disagreement_score":0.0037917201,"about_ca_system_score_codex":0.00058086903,"about_ca_system_score_gemma":0.00036435816,"threshold_uncertainty_score":0.0075392723},"labels":[],"label_agreement":null},{"id":"W2089902119","doi":"10.1111/j.1365-2141.2006.06325.x","title":"Multiple myeloma patients with <i>CKS1B</i> gene amplification have a shorter progression‐free survival post‐autologous stem cell transplantation","year":2006,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":87,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Toronto General Hospital; University Health Network","funders":"Cancer Research Society","keywords":"Multiple myeloma; Gastroenterology; Fluorescence in situ hybridization; Internal medicine; Transplantation; Autologous stem-cell transplantation; Medicine; Bone marrow; Beta-2 microglobulin; Pathology; Biology; Oncology; Immunology; Chromosome; Gene","score_opus":0.011202216900912006,"score_gpt":0.251527055066778,"score_spread":0.24032483816586603,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2089902119","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99961144,0.00013704773,0.000051785708,0.000015067856,0.0000021976048,0.0000011345576,0.000026818303,0.000005044616,0.00014959846],"genre_scores_gemma":[0.99968576,0.000047644753,0.000025115354,0.000013527777,0.000005766041,0.0000018650544,0.00007379991,0.0000012953817,0.00014532029],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9998919,0.00001403437,0.000010385153,0.00002334303,0.000027040043,0.00003331992],"domain_scores_gemma":[0.99950564,0.000107578104,0.00022166457,0.0000206748,0.000037690177,0.0001068867],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012250368,0.00017487867,0.00028267744,0.00027012042,0.00022604565,0.00033955323,0.000101927595,0.0002745803,0.0016754183],"category_scores_gemma":[0.00060439104,0.00012733969,0.00019150195,0.00019770708,0.00017311146,0.00018636485,0.00012963207,0.00034613296,0.0002705702],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013349049,0.000099388446,0.96296525,0.000022892917,0.00008769126,0.00078212016,0.00019632593,0.00024995406,0.021402992,0.000031671138,0.00023013497,0.012596655],"study_design_scores_gemma":[0.000025850473,0.000522175,0.9940528,0.000003244629,0.000046028727,0.003244733,0.000052477746,0.00022956426,0.0014059781,0.000027198133,0.00038607637,0.000003928672],"about_ca_topic_score_codex":0.0006525133,"about_ca_topic_score_gemma":0.0005685336,"teacher_disagreement_score":0.0016754183,"about_ca_system_score_codex":0.00014240497,"about_ca_system_score_gemma":0.00010101793,"threshold_uncertainty_score":0.005604863},"labels":[],"label_agreement":null},{"id":"W2091264926","doi":"10.1111/j.1365-2141.2010.08387.x","title":"Southwest Oncology Group Study S0530: a phase 2 trial of clofarabine and cytarabine for relapsed or refractory acute lymphocytic leukaemia","year":2010,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":63,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"National Cancer Institute","keywords":"Clofarabine; Medicine; Cytarabine; Internal medicine; Refractory (planetary science); Nucleoside analogue; Fludarabine; Oncology; Regimen; Gastroenterology; Chemotherapy; Nucleoside; Biology","score_opus":0.02900181210569678,"score_gpt":0.37947960225634775,"score_spread":0.35047779015065095,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2091264926","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9950594,0.0013304828,0.0001416347,0.00031763915,0.000039168488,0.0011494571,0.0006548303,0.000036465066,0.0012710093],"genre_scores_gemma":[0.98684406,0.0017125013,0.001746728,0.0010836122,0.00009333534,0.0015959687,0.0035848443,0.000019611542,0.0033193144],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.99939847,0.00040390412,0.00003001499,0.000043768032,0.000049284492,0.0000745089],"domain_scores_gemma":[0.9993536,0.00008082096,0.00011395399,0.000034296078,0.000024373754,0.00039282418],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001981666,0.0008480521,0.0011495218,0.00040124936,0.00029587274,0.0005368415,0.00053671846,0.0006735952,0.0033870442],"category_scores_gemma":[0.000782483,0.00037741082,0.00073071226,0.00041706619,0.00073677005,0.00039066514,0.00040191124,0.0012682346,0.0007839242],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.76894486,0.030200794,0.024318336,0.0011429453,0.0018435887,0.0010479371,0.0006358161,0.0035186713,0.042277187,0.00069478335,0.008688169,0.116687],"study_design_scores_gemma":[0.5882852,0.3536269,0.0437236,0.00009418321,0.00054395985,0.00093058834,0.00013766372,0.0015202272,0.002245879,0.00026153462,0.008592933,0.000037264093],"about_ca_topic_score_codex":0.002555154,"about_ca_topic_score_gemma":0.008314108,"teacher_disagreement_score":0.0033870442,"about_ca_system_score_codex":0.000887457,"about_ca_system_score_gemma":0.0019469407,"threshold_uncertainty_score":0.011330783},"labels":[],"label_agreement":null},{"id":"W2091563004","doi":"10.1111/j.1365-2141.2005.05782.x","title":"Inhibition and reversal of platelet aggregation by <i>α</i>IIb<i>β</i>3 antagonists depends on the anticoagulant and flow conditions: differential effects of Abciximab and Lamifiban","year":2005,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Abciximab; Platelet aggregation; Platelet; Anticoagulant; Medicine; Pharmacology; Differential effects; Differential (mechanical device); Internal medicine; Physics","score_opus":0.004715397502538273,"score_gpt":0.22600456104123742,"score_spread":0.22128916353869915,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2091563004","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9949681,0.0031221765,0.0009728307,0.000060876064,0.000017937773,0.000010233674,0.000057646084,0.000023545948,0.0007667406],"genre_scores_gemma":[0.9974553,0.0010483629,0.00076453324,0.00007756033,0.000033856337,0.000022399194,0.00013343719,0.0000058626706,0.00045861237],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99972826,0.00007513985,0.000038702325,0.00003321704,0.00006536623,0.000059300935],"domain_scores_gemma":[0.99984217,0.000047513167,0.000053264015,0.000015484784,0.00002008439,0.000021333206],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023674133,0.00028251932,0.00022112335,0.00015888509,0.00012462818,0.00033233294,0.00013476718,0.00029651774,0.0007284925],"category_scores_gemma":[0.00028616108,0.00011920691,0.00021672333,0.00013032825,0.00019489731,0.00016846278,0.00010545702,0.00043604165,0.0001861947],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00026004168,0.000028324377,0.0002918902,0.000018550034,0.0000065493787,0.0000319224,0.000017582779,0.00002448385,0.99733305,0.000040424675,0.000018186074,0.001929019],"study_design_scores_gemma":[0.000034558827,0.000812995,0.01745025,0.0000043420937,0.00003632949,0.00028410554,0.000013621883,0.0006882719,0.97984374,0.00003506805,0.00079165003,0.000005004482],"about_ca_topic_score_codex":0.00044492204,"about_ca_topic_score_gemma":0.0003240334,"teacher_disagreement_score":0.0007284925,"about_ca_system_score_codex":0.00021244228,"about_ca_system_score_gemma":0.00012906261,"threshold_uncertainty_score":0.002437055},"labels":[],"label_agreement":null},{"id":"W2092353327","doi":"10.1046/j.1365-2141.2000.01935.x","title":"Mastocytosis cells bearing a c‐<i>kit</i> activating point mutation are characterized by hypersensitivity to stem cell factor and increased apoptosis","year":2000,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Mast cells and histamine","field":"Immunology and Microbiology","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Lunenfeld-Tanenbaum Research Institute; Mount Sinai Hospital; Hospital for Sick Children; University of Toronto","funders":"","keywords":"Stem cell factor; Cutaneous Mastocytosis; Systemic mastocytosis; Proto-Oncogene Proteins c-kit; Stem cell; Bone marrow; Progenitor cell; Cancer research; Immunology; Tryptase; Biology; Mast cell; Pathology; Medicine; Cell biology","score_opus":0.007191897665352768,"score_gpt":0.18969529693887657,"score_spread":0.1825033992735238,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2092353327","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9952544,0.0017013743,0.0006927903,0.00006428982,0.000016241778,0.000032345888,0.0003490146,0.000073430245,0.001816102],"genre_scores_gemma":[0.99767834,0.00090937485,0.00038856853,0.00003802958,0.000014826772,0.000010992239,0.00022059056,0.000009954916,0.0007292396],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9999138,0.000009519315,0.000009075809,0.000021859612,0.000021519068,0.000024115043],"domain_scores_gemma":[0.9998698,0.000029219329,0.000055627297,0.0000071485642,0.000008070682,0.000029984732],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00005074406,0.00043346247,0.00030918702,0.00035461414,0.0002180501,0.00025423444,0.00011352542,0.00044643533,0.0016079657],"category_scores_gemma":[0.00026364898,0.00014143104,0.00013078788,0.0002462535,0.00031488464,0.00015436558,0.00016049056,0.00028101922,0.0006424044],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00096440216,0.00007484566,0.039238956,0.00021703375,0.000025348554,0.10125167,0.00030877176,0.00013677342,0.84221905,0.0003538378,0.0008140249,0.014395338],"study_design_scores_gemma":[0.00014786773,0.0014124683,0.20350459,0.00005838115,0.00007536235,0.5753835,0.0002841054,0.00035789658,0.20608924,0.00048809056,0.012164803,0.00003366966],"about_ca_topic_score_codex":0.00021617561,"about_ca_topic_score_gemma":0.0003182,"teacher_disagreement_score":0.0016079657,"about_ca_system_score_codex":0.00011499367,"about_ca_system_score_gemma":0.00005182045,"threshold_uncertainty_score":0.0053791404},"labels":[],"label_agreement":null},{"id":"W2093653074","doi":"10.1111/j.1365-2141.2010.08076.x","title":"The effect of rituximab on humoral and cell mediated immunity and infection in the treatment of autoimmune diseases","year":2010,"lang":"en","type":"review","venue":"British Journal of Haematology","topic":"Polyomavirus and related diseases","field":"Medicine","cited_by":157,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Canadian Blood Services","funders":"Canadian Institutes of Health Research","keywords":"Rituximab; Immunology; Autoimmunity; Medicine; CD20; Immune system; Antibody; Immunity","score_opus":0.012633628985397128,"score_gpt":0.3038136764428474,"score_spread":0.2911800474574503,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2093653074","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00010918864,0.9991985,0.000032369688,0.00008024038,0.00007510997,0.0000021220858,0.0000054931747,0.000002322654,0.00049460575],"genre_scores_gemma":[0.00061535375,0.9988055,0.00008130164,0.00009411505,0.00009357109,0.0000032633056,0.000013023243,7.382822e-7,0.00029312848],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9997694,0.00004904112,0.00004153204,0.00002952095,0.000092676026,0.000017905293],"domain_scores_gemma":[0.9996662,0.00017639308,0.00004625811,0.000008395948,0.00007658261,0.000026190299],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006162778,0.0007164235,0.0017324968,0.0022425062,0.00022998752,0.0006533366,0.000806361,0.0010116618,0.00290583],"category_scores_gemma":[0.0007166301,0.00025072906,0.0004491857,0.0022291786,0.0003926928,0.00086939894,0.00045801656,0.0013120351,0.0016918232],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012487386,0.0000680343,0.00016240463,0.017392663,0.00012487767,0.000308518,0.000050791732,0.00021885843,0.0013489677,0.0011032025,0.016190607,0.9629061],"study_design_scores_gemma":[0.00007738856,0.00018865334,0.0022071593,0.0059495657,0.00029306748,0.0041026426,0.00007434141,0.00008426637,0.0007842601,0.0010706164,0.9851458,0.000022222279],"about_ca_topic_score_codex":0.0011802095,"about_ca_topic_score_gemma":0.0021918528,"teacher_disagreement_score":0.00290583,"about_ca_system_score_codex":0.00063246564,"about_ca_system_score_gemma":0.0007637539,"threshold_uncertainty_score":0.0097209215},"labels":[],"label_agreement":null},{"id":"W2094323365","doi":"10.1111/j.1365-2141.2006.06134.x","title":"The status of new anticoagulants","year":2006,"lang":"en","type":"review","venue":"British Journal of Haematology","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":100,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University Medical Centre; McMaster University","funders":"Canadian Institutes of Health Research","keywords":"Medicine; Intensive care medicine; Internal medicine","score_opus":0.04987724414517279,"score_gpt":0.3572936881835021,"score_spread":0.3074164440383293,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2094323365","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00011042944,0.99818194,0.00006847663,0.00056096853,0.00020949871,0.0000017411718,0.00000545842,0.0000055158407,0.0008559448],"genre_scores_gemma":[0.00081589166,0.99715173,0.00026236515,0.00044210095,0.00052192225,0.000005053026,0.000018378549,0.0000015062957,0.00078091404],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9990953,0.00016669118,0.00017338844,0.00013282913,0.00037459188,0.000057195764],"domain_scores_gemma":[0.99847597,0.00077731087,0.00021324697,0.000049314476,0.00035913105,0.00012504573],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0019217071,0.00077704014,0.0018803028,0.0024063613,0.0004544534,0.0019387206,0.0011714608,0.0019144944,0.007266764],"category_scores_gemma":[0.002188963,0.00032631474,0.00055352703,0.0022940112,0.0007935794,0.0029187207,0.00068183296,0.0020310462,0.0034203331],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000749867,0.00006765122,0.00023186869,0.0077886432,0.000058150275,0.00028852397,0.00006265995,0.00017578261,0.0010741652,0.0027798438,0.018151777,0.9692459],"study_design_scores_gemma":[0.000022901328,0.00008231402,0.00063170155,0.002893898,0.000081482525,0.0019720718,0.00006624583,0.00006845679,0.00031532347,0.0020777658,0.9917734,0.000014476796],"about_ca_topic_score_codex":0.0010024915,"about_ca_topic_score_gemma":0.0013630438,"teacher_disagreement_score":0.007266764,"about_ca_system_score_codex":0.00097386376,"about_ca_system_score_gemma":0.0018202325,"threshold_uncertainty_score":0.024309754},"labels":[],"label_agreement":null},{"id":"W2094898938","doi":"10.1111/j.1365-2141.2009.07844.x","title":"International variations in infection supportive care practices for paediatric patients with acute myeloid leukaemia","year":2009,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Neutropenia and Cancer Infections","field":"Medicine","cited_by":80,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"Canadian Institutes of Health Research; Children’s Oncology Group","keywords":"Cog; Medicine; Myeloid leukaemia; Randomized controlled trial; Pediatrics; Internal medicine; Family medicine","score_opus":0.009429926794853348,"score_gpt":0.29878695222045226,"score_spread":0.28935702542559893,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2094898938","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9984458,0.0005157172,0.00008721788,0.00014199017,0.0000061199194,0.000009705951,0.000101966565,0.0000029668797,0.00068873004],"genre_scores_gemma":[0.9995709,0.00019112004,0.000090227506,0.000036717905,0.0000047198837,0.0000061599,0.00006213316,0.0000012204891,0.000036759386],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9979473,0.00093052746,0.00033610605,0.00024183543,0.0003189787,0.00022537263],"domain_scores_gemma":[0.9922787,0.0022617832,0.004087087,0.00027458687,0.0004536079,0.0006441783],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0019523965,0.000093069226,0.00020982506,0.00093020266,0.00025815086,0.000543021,0.00028422245,0.00026122344,0.001227149],"category_scores_gemma":[0.01014312,0.00011050355,0.00017625623,0.00174829,0.00057273294,0.00053093344,0.00074413285,0.00034594082,0.0001312962],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00004242538,0.000013765915,0.9916046,0.000026361442,0.000013898024,0.00005890748,0.0018560669,0.000049585728,0.00012961568,0.000053599924,0.0001229542,0.006028213],"study_design_scores_gemma":[0.0000040790187,0.00007309206,0.99705803,0.00001986487,0.00000623519,0.00024342281,0.0018856796,0.000054552467,0.000046055917,0.000020280775,0.0005838569,0.000004852582],"about_ca_topic_score_codex":0.004052105,"about_ca_topic_score_gemma":0.0059325737,"teacher_disagreement_score":0.004052105,"about_ca_system_score_codex":0.00069772784,"about_ca_system_score_gemma":0.0005137047,"threshold_uncertainty_score":0.010325372},"labels":[],"label_agreement":null},{"id":"W2095095686","doi":"10.1046/j.1365-2141.2000.02064.x","title":"Management of kostmann syndrome in the g‐csf era","year":2000,"lang":"en","type":"review","venue":"British Journal of Haematology","topic":"Blood disorders and treatments","field":"Biochemistry, Genetics and Molecular Biology","cited_by":112,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; University of Toronto","funders":"University of Washington","keywords":"Neutropenia; Medicine; Absolute neutrophil count; Internal medicine; Granulocyte colony-stimulating factor; Transplantation; Congenital Neutropenia; Hematopoietic stem cell transplantation; Gastroenterology; Immunology; Chemotherapy","score_opus":0.013670857495450436,"score_gpt":0.2834793716767484,"score_spread":0.269808514181298,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2095095686","genre_codex":"empirical","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8512246,0.09651899,0.012011563,0.009102382,0.000881815,0.00022939265,0.00016998248,0.0004450138,0.029416282],"genre_scores_gemma":[0.98450524,0.009867238,0.0022597914,0.0014262135,0.000370631,0.000053195225,0.00012519711,0.000018941997,0.00137344],"study_design_codex":"case_report","study_design_gemma":"not_applicable","domain_scores_codex":[0.99986184,0.00002255591,0.000019035271,0.00001834545,0.000028558952,0.0000496182],"domain_scores_gemma":[0.999881,0.000020719168,0.000024847262,0.000003243314,0.000009095805,0.00006115997],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016422663,0.0003676442,0.00047171838,0.00065176684,0.0005001294,0.0002665246,0.00030670734,0.0005984326,0.00056973],"category_scores_gemma":[0.00068012933,0.00008119597,0.00028751284,0.00033953023,0.00032724158,0.00038263356,0.00038190087,0.0006835642,0.00016426234],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012636404,0.00033604616,0.095868655,0.00062950974,0.00014744858,0.62126124,0.00046921178,0.0023772055,0.027077375,0.0063355397,0.013239389,0.23099473],"study_design_scores_gemma":[0.00028937607,0.0011285803,0.057617877,0.00095091516,0.00016158944,0.89055055,0.0004017989,0.004725122,0.0065940185,0.0066026836,0.030915868,0.0000615385],"about_ca_topic_score_codex":0.00088703254,"about_ca_topic_score_gemma":0.0010958873,"teacher_disagreement_score":0.00088703254,"about_ca_system_score_codex":0.00043812933,"about_ca_system_score_gemma":0.000441703,"threshold_uncertainty_score":0.003178835},"labels":[],"label_agreement":null},{"id":"W2096608457","doi":"10.1111/bjh.12529","title":"Concurrent and separate inside‐out transition of platelet apoptosis and activation markers to the platelet surface","year":2013,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":24,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Toronto Metropolitan University; Pediatric Oncology Group; St. Michael's Hospital","funders":"","keywords":"Phosphatidylserine; Platelet; Chemistry; Apoptosis; Platelet activation; Thrombin; Stimulation; Biophysics; Membrane; Immunology; Endocrinology; Biochemistry; Phospholipid; Biology","score_opus":0.012785506952164629,"score_gpt":0.2571666617906231,"score_spread":0.24438115483845846,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2096608457","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9923282,0.0017494779,0.004553941,0.0000627546,0.000015035817,0.000019937695,0.00010434448,0.000020016052,0.001146284],"genre_scores_gemma":[0.9971205,0.00054811686,0.0012252346,0.000041351857,0.000009924389,0.000029697327,0.00012326632,0.000006457437,0.0008955193],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9997602,0.000051023315,0.0000140790635,0.000051586667,0.00008063362,0.000042399373],"domain_scores_gemma":[0.99986804,0.00003129961,0.00003143408,0.000024964273,0.000030390978,0.000013801629],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012566529,0.00014829422,0.00024251753,0.000097115226,0.00014234238,0.0003786812,0.000121370256,0.00022580934,0.0007085966],"category_scores_gemma":[0.00021960174,0.0000930607,0.00017245115,0.00012036891,0.000153028,0.00033798974,0.00025313874,0.00046786448,0.00021034127],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00020161075,0.0000121478115,0.00047849116,0.000037108868,0.000005892573,0.00009266354,0.00005022831,0.000031782027,0.99675506,0.00011939131,0.000021990805,0.0021935022],"study_design_scores_gemma":[0.000012761966,0.00027067465,0.01921846,0.000008300681,0.000019494448,0.00047010978,0.00010935546,0.0006299743,0.9774016,0.00013876501,0.0017145637,0.000005983787],"about_ca_topic_score_codex":0.00018081367,"about_ca_topic_score_gemma":0.00029533135,"teacher_disagreement_score":0.0007085966,"about_ca_system_score_codex":0.0001713796,"about_ca_system_score_gemma":0.00011539087,"threshold_uncertainty_score":0.0023705363},"labels":[],"label_agreement":null},{"id":"W2097952279","doi":"10.1111/bjh.12594","title":"Moderate endurance exercise in patients with sickle cell anaemia: effects on oxidative stress and endothelial activation","year":2013,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":46,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Agence Universitaire de la Francophonie","keywords":"Oxidative stress; Nitric oxide; Endothelial dysfunction; Medicine; Malondialdehyde; Endothelial activation; Internal medicine; Endothelium; Endocrinology; Cell adhesion molecule; Immunology","score_opus":0.002943902337246819,"score_gpt":0.19241244101686236,"score_spread":0.18946853867961555,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2097952279","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9983582,0.0013232972,0.000043045155,0.00003774307,0.000005706411,0.0000065543977,0.00002219556,0.0000013353123,0.00020193367],"genre_scores_gemma":[0.99914515,0.000537657,0.000066025845,0.00004865614,0.000018429311,0.000009768038,0.000044576456,5.3647256e-7,0.00012909345],"study_design_codex":"observational","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9998833,0.00005112902,0.000014852073,0.000019776558,0.000014039163,0.000016798016],"domain_scores_gemma":[0.9997507,0.00008356534,0.0000672572,0.000009234755,0.000017530505,0.00007177669],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020045659,0.0002110635,0.00041741825,0.00018321209,0.00019727492,0.00017769531,0.00006387487,0.00028946262,0.00063723134],"category_scores_gemma":[0.0005998971,0.00006261387,0.0001798463,0.00017754576,0.000120727214,0.00011080109,0.00016186976,0.00020085205,0.0000711634],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009744948,0.001233775,0.9028059,0.00044323504,0.0004345266,0.0011948051,0.0007569177,0.0002408775,0.023503995,0.000054594726,0.0002385275,0.05934795],"study_design_scores_gemma":[0.000060972536,0.0039078286,0.99472,0.000018271974,0.00007818538,0.00040181595,0.00011962301,0.00008811552,0.0003262335,0.000037239326,0.00023736054,0.0000042484153],"about_ca_topic_score_codex":0.00047660898,"about_ca_topic_score_gemma":0.00082942005,"teacher_disagreement_score":0.00063723134,"about_ca_system_score_codex":0.00007070316,"about_ca_system_score_gemma":0.00007557664,"threshold_uncertainty_score":0.0021317601},"labels":[],"label_agreement":null},{"id":"W2101808775","doi":"10.1111/bjh.12076","title":"Increased leucocyte apoptosis in transfused β‐thalassaemia patients","year":2012,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; University of Victoria","funders":"National Center for Advancing Translational Sciences; National Center for Research Resources; National Institute of Diabetes and Digestive and Kidney Diseases; National Heart, Lung, and Blood Institute","keywords":"Deferasirox; Deferoxamine; Apoptosis; Medicine; DNA fragmentation; Deferiprone; Chelation therapy; Hematology; Immunology; Caspase 3; Gastroenterology; Blood transfusion; Internal medicine; Thalassemia; Programmed cell death; Biology; Biochemistry","score_opus":0.008318224324515469,"score_gpt":0.23547474104876845,"score_spread":0.22715651672425297,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2101808775","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99928623,0.00045191945,0.000047476246,0.000015558111,0.0000024526453,0.000004456186,0.000022401886,0.0000028980699,0.00016654981],"genre_scores_gemma":[0.9995117,0.0001645127,0.000051356714,0.000026079586,0.0000064197575,0.0000046452064,0.000055783985,7.86168e-7,0.00017869953],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99984694,0.00004554991,0.000019422103,0.000024995452,0.000039972267,0.000023164948],"domain_scores_gemma":[0.9997087,0.0000360335,0.00014220367,0.000013755677,0.000045247714,0.00005406422],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017830734,0.00014616986,0.00030558542,0.00042197015,0.00023733618,0.0004490048,0.000080051424,0.00021648129,0.00069363817],"category_scores_gemma":[0.000824003,0.00010014447,0.00014963851,0.000298876,0.000119640106,0.00017223603,0.0001668668,0.00027123166,0.00012593604],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0067302654,0.00029662365,0.87141234,0.00011300014,0.00010894417,0.0035458007,0.0015085038,0.000198315,0.07412811,0.000070572474,0.00019819096,0.041689288],"study_design_scores_gemma":[0.00008334637,0.0030757945,0.98361444,0.000018453085,0.00008490386,0.0071688155,0.00033638516,0.00023369337,0.0044430313,0.00005466822,0.0008766231,0.000009800649],"about_ca_topic_score_codex":0.00056266243,"about_ca_topic_score_gemma":0.0005408512,"teacher_disagreement_score":0.00069363817,"about_ca_system_score_codex":0.00023045641,"about_ca_system_score_gemma":0.00008436941,"threshold_uncertainty_score":0.0023204684},"labels":[],"label_agreement":null},{"id":"W2102791712","doi":"10.1111/bjh.12709","title":"Rho kinase inhibition drives megakaryocyte polyploidization and proplatelet formation through <i><scp>MYC</scp></i> and <i><scp>NFE</scp>2</i> downregulation","year":2014,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":39,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"University of Toronto; F. M. Kirby Foundation","keywords":"Megakaryocyte; Downregulation and upregulation; Cell biology; Chemistry; Kinase; Transcription factor; Biology; Haematopoiesis; Gene; Biochemistry; Stem cell","score_opus":0.007804593438874412,"score_gpt":0.22587183485504694,"score_spread":0.21806724141617254,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2102791712","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99181575,0.0018038033,0.0023560156,0.00015426811,0.000029452358,0.00005091552,0.0006571189,0.00012295574,0.0030096392],"genre_scores_gemma":[0.9929716,0.00094888394,0.0020312842,0.00006283555,0.000009000086,0.00008836843,0.00076123053,0.000031356933,0.0030955535],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99980265,0.000031387954,0.00002707889,0.00003839891,0.00005253286,0.00004801256],"domain_scores_gemma":[0.99988794,0.00003100218,0.00003294916,0.000014381455,0.000007945687,0.000025748419],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011219429,0.00027782322,0.00031208305,0.00020779255,0.00012055776,0.00032605042,0.00022322453,0.00027705534,0.0016574061],"category_scores_gemma":[0.00010924544,0.00015595232,0.000301931,0.00016845828,0.00024960874,0.00016734641,0.00021303985,0.000826523,0.000315748],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012605196,0.00003195002,0.00006485518,0.000029254052,0.000004312476,0.00003245109,0.000009298953,0.000056981684,0.99872273,0.00011416357,0.000041216368,0.0007666521],"study_design_scores_gemma":[0.00001863459,0.00018523805,0.0015159562,0.0000032265168,0.0000072294506,0.00008737901,0.000010062389,0.00063761265,0.99615604,0.000027182607,0.0013488055,0.0000026260557],"about_ca_topic_score_codex":0.0006427771,"about_ca_topic_score_gemma":0.0010175301,"teacher_disagreement_score":0.0016574061,"about_ca_system_score_codex":0.00029139698,"about_ca_system_score_gemma":0.0002214415,"threshold_uncertainty_score":0.0055445433},"labels":[],"label_agreement":null},{"id":"W2104365621","doi":"10.1111/j.1365-2141.2004.05106.x","title":"Effects of genetic fusion of factor IX to albumin on <i>in vivo</i> clearance in mice and rabbits","year":2004,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Hemophilia Treatment and Research","field":"Medicine","cited_by":32,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Canadian Blood Services","funders":"","keywords":"Factor IX; Recombinant DNA; Albumin; Fusion protein; In vivo; Coagulation; Blood proteins; Medicine; Pharmacology; Immunology; Internal medicine; Chemistry; Biochemistry; Biology; Biotechnology","score_opus":0.010107355210831967,"score_gpt":0.2762570932542004,"score_spread":0.26614973804336844,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2104365621","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99411786,0.0013663457,0.002703033,0.00024251388,0.000053518266,0.000051908402,0.00030755546,0.00020464101,0.0009525794],"genre_scores_gemma":[0.993565,0.0011001652,0.0021791635,0.00015749312,0.000034967325,0.000085836095,0.00041452798,0.00014712881,0.002315764],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9990752,0.00026854567,0.000101448684,0.00024148155,0.0001392952,0.00017399467],"domain_scores_gemma":[0.99853694,0.00034614178,0.0006091823,0.00016270945,0.00008989784,0.000255085],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010012687,0.00069779897,0.00071322726,0.0006813691,0.00023274451,0.0008984186,0.00055032305,0.0009987478,0.0006696896],"category_scores_gemma":[0.00096371904,0.0004116675,0.00082785386,0.00035486574,0.0010436743,0.0005908486,0.00031230808,0.0015333461,0.00051849964],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0026654925,0.00025290597,0.0003799901,0.000056922432,0.00003545153,0.00012903544,0.0000945705,0.00024139362,0.99411124,0.00020615065,0.00010677242,0.0017201641],"study_design_scores_gemma":[0.00013716574,0.005609986,0.0026397214,0.000009870848,0.00009141776,0.0004176178,0.000046106605,0.0015305055,0.9875639,0.00010286799,0.0018269408,0.000023732196],"about_ca_topic_score_codex":0.0017751633,"about_ca_topic_score_gemma":0.00091003,"teacher_disagreement_score":0.0017751633,"about_ca_system_score_codex":0.0009155374,"about_ca_system_score_gemma":0.00033664602,"threshold_uncertainty_score":0.006642759},"labels":[],"label_agreement":null},{"id":"W2104980846","doi":"10.1111/bjh.12177","title":"Pain in thalassaemia: the effects of age on pain frequency and severity","year":2012,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":37,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Center for Research Resources; National Heart, Lung, and Blood Institute; Harvard Catalyst; Research England; National Institutes of Health; New England Research Institutes; University Health Network","keywords":"Medicine; Observational study; Etiology; Prospective cohort study; Physical therapy; Internal medicine; Pediatrics","score_opus":0.005705330211282905,"score_gpt":0.22958228046926962,"score_spread":0.2238769502579867,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2104980846","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9968124,0.0022755568,0.00008773478,0.00010230477,0.000013444431,0.000012051166,0.000105101266,0.0000018174595,0.00058968534],"genre_scores_gemma":[0.9992378,0.0004314527,0.00006120082,0.000022896487,0.000026328173,0.0000063233124,0.00007188115,8.096665e-7,0.0001413962],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9990645,0.00048178647,0.00009350962,0.0000778752,0.00017331944,0.0001090795],"domain_scores_gemma":[0.99596655,0.0014750556,0.0017841288,0.0001231157,0.00022328628,0.000427764],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011803207,0.00019861116,0.00034660156,0.00060089794,0.0002278879,0.00054517295,0.0002115775,0.0004239215,0.0025454161],"category_scores_gemma":[0.005618707,0.00021220643,0.0003972432,0.0005921473,0.00027014798,0.00055665127,0.00044161544,0.0005418969,0.00025256522],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009791284,0.000104941966,0.9895075,0.000059791735,0.000072254225,0.00014857651,0.00016630466,0.00007062477,0.0005069334,0.000018674817,0.00009490359,0.008270301],"study_design_scores_gemma":[0.000009097886,0.00046887674,0.9990088,0.000009644095,0.000018944575,0.000277563,0.000061857536,0.000061696985,0.000020359326,0.000017250779,0.000043373828,0.000002711084],"about_ca_topic_score_codex":0.0009653332,"about_ca_topic_score_gemma":0.0016185072,"teacher_disagreement_score":0.0025454161,"about_ca_system_score_codex":0.00023213749,"about_ca_system_score_gemma":0.00013870462,"threshold_uncertainty_score":0.008515239},"labels":[],"label_agreement":null},{"id":"W2106732574","doi":"10.1111/j.1365-2141.2010.08531.x","title":"No association of HLA‐A supertype with outcome in childhood acute lymphoblastic leukaemia: results of the UKALL XI trial","year":2011,"lang":"en","type":"letter","venue":"British Journal of Haematology","topic":"Immune Cell Function and Interaction","field":"Immunology and Microbiology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre","funders":"National Institute of Diabetes and Digestive and Kidney Diseases; Cancer Research UK; Wellcome Trust","keywords":"Human leukocyte antigen; Genetics; Allele; Biology; Antigen; Gene","score_opus":0.010698586326282974,"score_gpt":0.21347533302510857,"score_spread":0.2027767466988256,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2106732574","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9907991,0.0062299003,0.00013875621,0.00031291923,0.00006219674,0.00005272964,0.0006884306,0.000009919216,0.0017060617],"genre_scores_gemma":[0.99672616,0.0011701544,0.00012098712,0.0002616002,0.000055357028,0.00008344413,0.0010542283,0.000010435138,0.0005175823],"study_design_codex":"observational","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9969187,0.0019932382,0.00023307659,0.00026089253,0.00039326368,0.0002009307],"domain_scores_gemma":[0.9959558,0.001398138,0.001334264,0.0005781433,0.00018171557,0.0005518876],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003138159,0.00034291123,0.0013090214,0.00018981077,0.00026382852,0.0007043727,0.00038581764,0.00052547787,0.0015540903],"category_scores_gemma":[0.004893621,0.00017354812,0.0008809038,0.00065588695,0.00034384767,0.0005224389,0.0005435051,0.0010104814,0.00021965096],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.365829,0.00067693304,0.5344837,0.0015470627,0.006397562,0.00060378044,0.00068906165,0.0016676121,0.00530692,0.0005305475,0.0050845593,0.07718332],"study_design_scores_gemma":[0.020345034,0.02598942,0.9406709,0.00023785503,0.004047851,0.00064836803,0.00014121234,0.00064698263,0.0010210592,0.00024431787,0.0059554167,0.000051430292],"about_ca_topic_score_codex":0.0021045662,"about_ca_topic_score_gemma":0.004131411,"teacher_disagreement_score":0.003138159,"about_ca_system_score_codex":0.0006338342,"about_ca_system_score_gemma":0.00045673084,"threshold_uncertainty_score":0.016596317},"labels":[],"label_agreement":null},{"id":"W2106736124","doi":"10.1111/bjh.12014","title":"Cytoadherence in paediatric malaria:<scp>ABO</scp>blood group,<scp>CD</scp>36, and<scp>ICAM</scp>1 expression and severe<i><scp>P</scp>lasmodium falciparum</i>infection","year":2012,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Malaria Research and Control","field":"Medicine","cited_by":33,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University Health Network","funders":"Johnson Cancer Research Center, Kansas State University; Massachusetts General Hospital; University of California, San Francisco; University of Toronto; Masimo; National Blood Foundation","keywords":"Plasmodium falciparum; Malaria; Cerebral Malaria; Immunology; CD36; ABO blood group system; Biology; Platelet; Odds ratio; Case fatality rate; Internal medicine; Endothelial activation; Medicine; Receptor; Inflammation; Epidemiology","score_opus":0.011995810952829734,"score_gpt":0.2499905163482136,"score_spread":0.23799470539538387,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2106736124","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99932575,0.00046329826,0.00003209998,0.000027903976,0.0000027666488,0.000001661173,0.000026471209,9.883256e-7,0.0001190535],"genre_scores_gemma":[0.99951375,0.0003121781,0.000053103307,0.000008757631,0.0000049966,0.0000031470397,0.000046710906,7.609795e-7,0.000056587724],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9994091,0.00027779897,0.0000350151,0.000060069076,0.00012383802,0.00009425441],"domain_scores_gemma":[0.9988759,0.0002958355,0.000613168,0.000036849688,0.000050221024,0.00012802087],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00059799897,0.00022290953,0.00022037365,0.0004527794,0.0002463608,0.00040074115,0.00024186104,0.0003282261,0.0007896488],"category_scores_gemma":[0.00297322,0.00021206606,0.0002342028,0.00069119956,0.00041713662,0.00028063232,0.000459402,0.0006580063,0.000091697075],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001677855,0.000023952734,0.99685425,0.000020624519,0.000022562625,0.00019945743,0.00014243586,0.00007082992,0.00021620383,0.000034896355,0.00006777848,0.0021792916],"study_design_scores_gemma":[0.000005732297,0.00020090445,0.9978908,0.000017705077,0.000024521338,0.0010596704,0.00020623856,0.00022966514,0.00015586361,0.00003736897,0.00016872557,0.000002806353],"about_ca_topic_score_codex":0.0039840955,"about_ca_topic_score_gemma":0.0038865344,"teacher_disagreement_score":0.0039840955,"about_ca_system_score_codex":0.00028399084,"about_ca_system_score_gemma":0.00033464973,"threshold_uncertainty_score":0.007921815},"labels":[],"label_agreement":null},{"id":"W2108233576","doi":"10.1111/bjh.13320","title":"Outcomes in splenic marginal zone lymphoma: analysis of 107 patients treated in British Columbia","year":2015,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":67,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Vancouver General Hospital; Surrey Memorial Hospital; BC Cancer Agency","funders":"BC Cancer Agency; University of British Columbia","keywords":"Medicine; Splenic marginal zone lymphoma; Splenectomy; Rituximab; Chemoimmunotherapy; Internal medicine; Gastroenterology; Hazard ratio; Chemotherapy; Lymphoma; Surgery; Confidence interval; Spleen","score_opus":0.014724133313153866,"score_gpt":0.25854078237018446,"score_spread":0.2438166490570306,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2108233576","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99754816,0.00060535537,0.000044443073,0.00008280917,0.0000038328017,0.000014538681,0.0011337864,0.0000048094143,0.0005622317],"genre_scores_gemma":[0.99718386,0.00049277034,0.00005640787,0.00012196329,0.000005325029,0.000017140983,0.0018099843,0.0000053298104,0.0003071328],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99950683,0.000061378945,0.000051455194,0.00009536922,0.00013786025,0.00014708859],"domain_scores_gemma":[0.9989729,0.00014264388,0.00029794933,0.00005523137,0.00023344885,0.00029787462],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00030496868,0.00028198352,0.0005945791,0.0009822213,0.0010274476,0.000937961,0.0007227661,0.00049145246,0.0014371023],"category_scores_gemma":[0.0011735383,0.0004387163,0.0002584964,0.002829898,0.00045000858,0.00023433057,0.00083798176,0.0006214322,0.00031830955],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018054803,0.0000301297,0.99519724,0.000034907724,0.00006443435,0.00030261,0.00021898815,0.00009075019,0.00024673305,0.000018130177,0.0006292277,0.0029862404],"study_design_scores_gemma":[0.000025476953,0.000033779077,0.99830365,0.00003679965,0.0000380125,0.00028258152,0.00044589682,0.00023827564,0.000051148774,0.000014500392,0.00052135513,0.0000084881285],"about_ca_topic_score_codex":0.6865934,"about_ca_topic_score_gemma":0.7731046,"teacher_disagreement_score":0.3134066,"about_ca_system_score_codex":0.0056722285,"about_ca_system_score_gemma":0.003966177,"threshold_uncertainty_score":0.6305046},"labels":[],"label_agreement":null},{"id":"W2109363414","doi":"10.1111/j.1365-2141.2009.07859.x","title":"Multiple isoforms of <i>PAX5</i> are expressed in both lymphomas and normal B‐cells","year":2009,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":24,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University; Atlantic Cancer Research Institute; Dr. Georges-L.-Dumont University Hospital Centre; Université de Moncton; Fisheries and Oceans Canada","funders":"Canadian Institutes of Health Research","keywords":"Gene isoform; PAX5; B cell; Biology; Alternative splicing; Gene expression; Molecular biology; RNA splicing; Transcription factor; Gene; Lymphoma; Antibody; RNA; Genetics; Immunology","score_opus":0.007966033997693042,"score_gpt":0.22840499862092944,"score_spread":0.2204389646232364,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2109363414","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99325645,0.0032755707,0.0016777929,0.000038509148,0.0000054932993,0.000008172067,0.00015127679,0.0000455455,0.0015411483],"genre_scores_gemma":[0.9961163,0.0009948773,0.0016518919,0.000016628457,0.00001105518,0.000012362903,0.00038364803,0.000013203059,0.0008000351],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99977595,0.000020133497,0.000022071132,0.000054864227,0.0000821053,0.00004493211],"domain_scores_gemma":[0.9998011,0.00003720974,0.00008797334,0.000018964176,0.000023737231,0.000031053132],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016533339,0.00018510252,0.00018700265,0.0007371289,0.00014457619,0.00040090198,0.00015131179,0.00021851837,0.0014359881],"category_scores_gemma":[0.00026378827,0.00018249046,0.00012544417,0.00035913868,0.00025926475,0.00029169608,0.0002391388,0.00021124851,0.0003961656],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019802088,0.000010940075,0.009584079,0.000046108395,0.000017562266,0.0004980087,0.00008707333,0.000028496752,0.9818118,0.0001639082,0.000036897694,0.007517054],"study_design_scores_gemma":[0.00007131934,0.0008364158,0.33638027,0.00005484653,0.00017443627,0.02912995,0.0007892619,0.0007631105,0.6143646,0.0009715065,0.016431458,0.000032800966],"about_ca_topic_score_codex":0.0004082367,"about_ca_topic_score_gemma":0.00045900172,"teacher_disagreement_score":0.0014359881,"about_ca_system_score_codex":0.00017562429,"about_ca_system_score_gemma":0.00010588194,"threshold_uncertainty_score":0.004803896},"labels":[],"label_agreement":null},{"id":"W2110168457","doi":"10.1111/j.1365-2141.2006.06200.x","title":"The post‐thrombotic syndrome: progress and pitfalls","year":2006,"lang":"en","type":"review","venue":"British Journal of Haematology","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":197,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Jewish General Hospital","funders":"","keywords":"Medicine; Post-thrombotic syndrome; Compression stockings; Thrombosis; Deep vein; Complication; Thrombolysis; Venous thrombosis; Intermittent pneumatic compression; Incidence (geometry); Intensive care medicine; Surgery; May–Thurner syndrome; Internal medicine","score_opus":0.01758684991946817,"score_gpt":0.31146394584604553,"score_spread":0.29387709592657735,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2110168457","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00009406423,0.9981129,0.00006793023,0.0010136437,0.00026686437,0.0000014696989,0.000005311459,0.00000597319,0.00043196298],"genre_scores_gemma":[0.00095201045,0.9974522,0.0001491171,0.00049056386,0.00067710463,0.0000024734281,0.00000901504,0.0000014836697,0.00026597554],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99953926,0.00009767032,0.00010484374,0.00006498557,0.0001587364,0.000034599856],"domain_scores_gemma":[0.9982034,0.000966416,0.00026953235,0.000058070513,0.00036572627,0.00013695926],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001252897,0.0010435987,0.0022639236,0.0028625708,0.00040817168,0.0016206531,0.0011960901,0.0017176609,0.0029557745],"category_scores_gemma":[0.0023279574,0.00036862426,0.0005547043,0.0030877464,0.0012614868,0.0038522114,0.0008154009,0.0024157222,0.0019477626],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000064217034,0.00004202012,0.00053821155,0.0104291225,0.000067846304,0.0012637995,0.00013029456,0.00020533976,0.0004000141,0.0029660375,0.036960293,0.94693285],"study_design_scores_gemma":[0.000042805605,0.00010566942,0.0033585501,0.013060098,0.00017293156,0.02691564,0.00056530593,0.00020996423,0.00024488964,0.009385705,0.94587874,0.000059665996],"about_ca_topic_score_codex":0.001166504,"about_ca_topic_score_gemma":0.0021552427,"teacher_disagreement_score":0.0029557745,"about_ca_system_score_codex":0.0007145226,"about_ca_system_score_gemma":0.001384088,"threshold_uncertainty_score":0.009887993},"labels":[],"label_agreement":null},{"id":"W2110310627","doi":"10.1111/bjh.13024","title":"Systemic mastocytosis emerging after azacitidine treatment of refractory anaemia with excess blasts type 2","year":2014,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Mast cells and histamine","field":"Immunology and Microbiology","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital","funders":"","keywords":"Systemic mastocytosis; Medicine; Bone marrow; Pathology; Pancytopenia; Myeloid; Granulopoiesis; Tryptase; Azacitidine; Haematopoiesis; Internal medicine; Immunology; Mast cell; Biology; Stem cell","score_opus":0.006874578529180452,"score_gpt":0.21217701214683735,"score_spread":0.2053024336176569,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2110310627","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9855273,0.0050326632,0.0008937955,0.0014531618,0.00016582031,0.00017246499,0.00023232568,0.00016324484,0.0063593225],"genre_scores_gemma":[0.9971361,0.0008146901,0.00017707277,0.00058716454,0.0001846312,0.000012397296,0.00011733904,0.0000072330718,0.00096329144],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.99985564,0.000026105234,0.000015480444,0.00002930892,0.000026314823,0.000047032056],"domain_scores_gemma":[0.999676,0.00009095452,0.000052949737,0.000019566383,0.000023244964,0.00013732046],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022583711,0.0006334598,0.0007758548,0.0005928492,0.0005432366,0.00033755388,0.00031895872,0.0014928635,0.0010908492],"category_scores_gemma":[0.00077990734,0.0002800801,0.00055916415,0.00042861988,0.00026004732,0.00031188468,0.0002161952,0.0012113515,0.00031009037],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00087358576,0.00014297028,0.029613521,0.00008657894,0.00005839716,0.9554097,0.00026917856,0.00018575472,0.0062327594,0.000113958784,0.0006944958,0.0063190614],"study_design_scores_gemma":[0.00039150813,0.0028568627,0.21385385,0.00007066479,0.00018323807,0.77424324,0.00016790401,0.0015155975,0.002706058,0.00021807011,0.0037607783,0.00003227193],"about_ca_topic_score_codex":0.0015928615,"about_ca_topic_score_gemma":0.002502455,"teacher_disagreement_score":0.0015928615,"about_ca_system_score_codex":0.00048105046,"about_ca_system_score_gemma":0.00025166862,"threshold_uncertainty_score":0.0036492944},"labels":[],"label_agreement":null},{"id":"W2111030516","doi":"10.1111/j.1365-2141.2009.07946.x","title":"<i>IRF4</i> polymorphism rs872071 and risk of Hodgkin lymphoma","year":2009,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Cancer Research","funders":"Cancer Research UK","keywords":"IRF4; Odds ratio; Genotype; Lymphoma; Chronic lymphocytic leukemia; Hematology; Oncology; Confidence interval; Internal medicine; Genetics; Biology; Medicine; Immunology; Gene; Transcription factor; Leukemia","score_opus":0.008592146408013122,"score_gpt":0.2646952606401587,"score_spread":0.25610311423214555,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2111030516","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99911076,0.00012505699,0.00015451007,0.000055200388,0.0000070355795,0.0000037867658,0.00012374086,0.000008921677,0.00041101058],"genre_scores_gemma":[0.9994678,0.000039877053,0.00017796006,0.000024406034,0.000018974692,0.000004249927,0.00009952226,0.0000048727975,0.00016238191],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99961424,0.00014531126,0.00004459913,0.00007776676,0.00006763669,0.00005041401],"domain_scores_gemma":[0.9989324,0.0004517655,0.00033067394,0.0001079956,0.00006364052,0.00011350734],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004588324,0.00027733998,0.00029243706,0.00068911357,0.00030315228,0.00035555082,0.00023782522,0.00044552324,0.003644951],"category_scores_gemma":[0.001895201,0.0001642506,0.00029280197,0.0005408373,0.0002976697,0.00011235264,0.00018457818,0.00028692084,0.00029027817],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0034462048,0.00019264806,0.95467913,0.00005838056,0.0005219406,0.002151073,0.00028276144,0.00058070663,0.025218913,0.00033295967,0.00084782933,0.011687337],"study_design_scores_gemma":[0.00012138066,0.00029359266,0.98764926,0.000023741857,0.00030606752,0.005291395,0.0001221353,0.0011946196,0.0035297251,0.0003158651,0.0011375238,0.0000146957245],"about_ca_topic_score_codex":0.0025021918,"about_ca_topic_score_gemma":0.0023050979,"teacher_disagreement_score":0.003644951,"about_ca_system_score_codex":0.00016271422,"about_ca_system_score_gemma":0.00013529895,"threshold_uncertainty_score":0.012193561},"labels":[],"label_agreement":null},{"id":"W2113950318","doi":"10.1111/bjh.13493","title":"A phase <scp>II</scp> trial of <scp>RCHOP</scp> followed by radioimmunotherapy for early stage (stages I/<scp>II</scp>) diffuse large B‐cell non‐Hodgkin lymphoma: <scp>ECOG</scp>3402","year":2015,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":23,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"Pharmacyclics; Genentech; ECOG-ACRIN Cancer Research Group; Roche; American College of Radiology Imaging Network; Spectrum Pharmaceuticals; National Cancer Institute; National Institutes of Health; U.S. Department of Health and Human Services","keywords":"Radioimmunotherapy; Medicine; Diffuse large B-cell lymphoma; Rituximab; Chemoimmunotherapy; Internal medicine; Phases of clinical research; Lymphoma; Nuclear medicine; Clinical trial; Immunology","score_opus":0.019109684220618747,"score_gpt":0.2890661712795868,"score_spread":0.269956487058968,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2113950318","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98425853,0.0026769731,0.0007433055,0.0005716273,0.00019257578,0.005354661,0.0010331528,0.00015157669,0.005017681],"genre_scores_gemma":[0.9770946,0.0026803887,0.0028487782,0.0020470174,0.00023231842,0.004453437,0.00412983,0.000042811334,0.0064709033],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9997634,0.00012525282,0.000010642144,0.000028684455,0.000023504028,0.00004853734],"domain_scores_gemma":[0.9997085,0.00003689771,0.00004763525,0.000025422407,0.000025440644,0.00015609304],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011002928,0.001077959,0.0009768174,0.00036652945,0.00034608398,0.0005498449,0.00042254897,0.00074336666,0.0034125566],"category_scores_gemma":[0.0003205579,0.00028899082,0.0010360166,0.0002964496,0.00044535424,0.0002873747,0.0002579688,0.0019341691,0.0006684803],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.6028094,0.054622483,0.008153491,0.0017851957,0.0019240915,0.0004302818,0.0002708236,0.0033097395,0.07144839,0.00089526625,0.013519587,0.2408313],"study_design_scores_gemma":[0.62490916,0.34438312,0.014217047,0.00011242968,0.00044410478,0.00041879792,0.00004738541,0.0015021822,0.005292436,0.00028154787,0.008368159,0.000023594628],"about_ca_topic_score_codex":0.0011345136,"about_ca_topic_score_gemma":0.0034330415,"teacher_disagreement_score":0.0034125566,"about_ca_system_score_codex":0.0005395771,"about_ca_system_score_gemma":0.0010743769,"threshold_uncertainty_score":0.011416078},"labels":[],"label_agreement":null},{"id":"W2114637038","doi":"10.1111/bjh.12999","title":"A transgenic zebrafish model expressing <i><scp>KIT</scp></i>‐<scp>D</scp>816<scp>V</scp> recapitulates features of aggressive systemic mastocytosis","year":2014,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Mast cells and histamine","field":"Immunology and Microbiology","cited_by":21,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Moncton; Atlantic Cancer Research Institute; University of New Brunswick; Dalhousie University; Montfort Hospital; Izaak Walton Killam Health Centre; University of Ottawa","funders":"Canadian Institutes of Health Research; Université Laval; Abramson Family Cancer Research Institute; University of Pennsylvania","keywords":"Zebrafish; Systemic mastocytosis; Biology; Transgene; Phenotype; Cancer research; Proto-Oncogene Proteins c-kit; Genetically modified mouse; Mutation; Immunology; Mast cell; Progenitor cell; Genetics; Stem cell factor; Stem cell; Gene","score_opus":0.009126055458390034,"score_gpt":0.2112625725921467,"score_spread":0.20213651713375666,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2114637038","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95197225,0.0010434474,0.027385928,0.00088291324,0.00019893283,0.00034445294,0.0041936333,0.0010473257,0.012931192],"genre_scores_gemma":[0.9527928,0.0011851077,0.018166434,0.00020320214,0.000018676643,0.0003823444,0.0017307525,0.00019847206,0.025322305],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998634,0.000009120598,0.000012014451,0.000035341207,0.00004894676,0.00003106946],"domain_scores_gemma":[0.99989295,0.000012110309,0.000036148293,0.000010304915,0.000013383291,0.00003510074],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015815985,0.0005148607,0.0002854839,0.0004543315,0.00037248374,0.00025063084,0.0004440998,0.0007983457,0.0033937194],"category_scores_gemma":[0.000094241645,0.00024398237,0.0003512192,0.00014668352,0.00048410697,0.0002993642,0.00029730183,0.0009805284,0.0008572821],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000058516267,0.000017339493,0.000103477396,0.000028041199,0.0000036487736,0.00019864201,0.000021405882,0.00011164731,0.99769163,0.0004372653,0.00016966529,0.0011586514],"study_design_scores_gemma":[0.00013833176,0.0009383917,0.0044532386,0.000037038582,0.00006243741,0.0017711429,0.000084391,0.0028351303,0.97391146,0.00029188528,0.015445988,0.000030696665],"about_ca_topic_score_codex":0.0046116333,"about_ca_topic_score_gemma":0.0073465533,"teacher_disagreement_score":0.0046116333,"about_ca_system_score_codex":0.00066331285,"about_ca_system_score_gemma":0.0005565698,"threshold_uncertainty_score":0.0113530755},"labels":[],"label_agreement":null},{"id":"W2117641266","doi":"10.1111/j.1365-2141.2007.06900.x","title":"Inferior outcomes for overweight children undergoing allogeneic stem cell transplantation","year":2007,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":34,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"Hospital for Sick Children","keywords":"Overweight; Stem cell; Medicine; Transplantation; Pediatrics; Oncology; Internal medicine; Obesity; Biology; Genetics","score_opus":0.013378450368468981,"score_gpt":0.2699723408139908,"score_spread":0.25659389044552183,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2117641266","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99965477,0.000105411316,0.00003991815,0.000013383037,0.0000035982364,0.0000023374905,0.000078447025,8.0162414e-7,0.000101468824],"genre_scores_gemma":[0.99967074,0.000071650386,0.00004158124,0.000010425044,0.0000051286634,0.0000033426238,0.0001536353,0.0000011379517,0.000042413976],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9996444,0.00007782951,0.000033794775,0.000070471055,0.00006543434,0.00010805969],"domain_scores_gemma":[0.9986099,0.00019680423,0.00081643125,0.000067170964,0.0000637046,0.00024600132],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00043599785,0.00023356391,0.00035591892,0.0005302583,0.00042282155,0.0004198974,0.00016928255,0.0003074281,0.0013640221],"category_scores_gemma":[0.0018397219,0.00017358121,0.00036151233,0.00050469156,0.00036583564,0.0003580185,0.00038797123,0.0004602932,0.000120904035],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016904103,0.0000142727495,0.9981073,0.000006153709,0.00002627635,0.00031812722,0.0000552565,0.00003111785,0.00025781975,0.000025664134,0.00003986651,0.0009491485],"study_design_scores_gemma":[0.000017458857,0.0003829794,0.99487215,0.000009562824,0.000049652,0.0038364916,0.00026633474,0.000111251335,0.00015853964,0.000058872414,0.00023006767,0.000006545317],"about_ca_topic_score_codex":0.0014400986,"about_ca_topic_score_gemma":0.0020556522,"teacher_disagreement_score":0.0014400986,"about_ca_system_score_codex":0.00021010255,"about_ca_system_score_gemma":0.00029308794,"threshold_uncertainty_score":0.004563093},"labels":[],"label_agreement":null},{"id":"W2117761540","doi":"10.1046/j.1365-2141.2001.03136.x","title":"IVIg inhibits reticuloendothelial system function and ameliorates murine passive‐immune thrombocytopenia independent of anti‐idiotype reactivity","year":2001,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":112,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Blood Services; St. Michael's Hospital","funders":"","keywords":"Mononuclear phagocyte system; Immunology; Idiotype; Immune system; Immune thrombocytopenia; Medicine; Hematology; Antibody; Monoclonal antibody","score_opus":0.01003274467971319,"score_gpt":0.23822193987193285,"score_spread":0.22818919519221967,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2117761540","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9927563,0.0028689473,0.0016689779,0.000113794435,0.00003675847,0.000061403654,0.00014699966,0.00027089464,0.0020758763],"genre_scores_gemma":[0.993962,0.0016370796,0.0011192783,0.000080590646,0.0000379629,0.000043723416,0.00036426762,0.00002997587,0.002725305],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99977237,0.00006167741,0.000017103546,0.000018284532,0.00004509396,0.00008548732],"domain_scores_gemma":[0.9997751,0.000038505957,0.000083612904,0.000029582334,0.000021762942,0.000051322746],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00025983565,0.00063783745,0.0004616393,0.0004748946,0.00010258813,0.00024582446,0.00035233397,0.00038196828,0.0007320393],"category_scores_gemma":[0.00025110296,0.00015749452,0.00020356746,0.00012494123,0.00022589807,0.00016182053,0.0001373642,0.0008315017,0.0002298641],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001036522,0.0006827234,0.0005260485,0.00012774167,0.000028694783,0.00021133454,0.000026452022,0.00032086487,0.9827033,0.00024340165,0.00022025334,0.01387269],"study_design_scores_gemma":[0.0004676382,0.013623085,0.008856889,0.00003649857,0.000097284246,0.0008683643,0.00002487667,0.0019326137,0.9696674,0.00014380133,0.0042739296,0.0000075599864],"about_ca_topic_score_codex":0.00045437698,"about_ca_topic_score_gemma":0.00053402636,"teacher_disagreement_score":0.0007320393,"about_ca_system_score_codex":0.00024484834,"about_ca_system_score_gemma":0.000196556,"threshold_uncertainty_score":0.0024489164},"labels":[],"label_agreement":null},{"id":"W2118281789","doi":"10.1111/bjh.12584","title":"How I treat children and adolescents with acute promyelocytic leukaemia","year":2013,"lang":"en","type":"review","venue":"British Journal of Haematology","topic":"Retinoids in leukemia and cellular processes","field":"Biochemistry, Genetics and Molecular Biology","cited_by":36,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children; University of Toronto","funders":"National Cancer Institute; National Institutes of Health; American Lebanese Syrian Associated Charities","keywords":"Medicine; Acute promyelocytic leukemia; Cytarabine; Arsenic trioxide; Anthracycline; Idarubicin; Internal medicine; Pediatrics; Tretinoin; Myeloid leukaemia; Leukemia; Oncology; Retinoic acid; Cancer","score_opus":0.008127734421031584,"score_gpt":0.2432180593678311,"score_spread":0.23509032494679952,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2118281789","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00019364528,0.9955922,0.00015456189,0.0011316983,0.0007624327,0.000011998914,0.00002878766,0.0000139108615,0.002110775],"genre_scores_gemma":[0.0012361287,0.9949138,0.00040291928,0.0011290547,0.00044356534,0.000015736505,0.000057250236,0.0000037855634,0.0017976824],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99984455,0.00003483975,0.000024731531,0.000024793571,0.000058324462,0.00001284234],"domain_scores_gemma":[0.9998246,0.00006949584,0.000030674517,0.000005103884,0.000045734843,0.000024474193],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00034044898,0.0005152276,0.0008486798,0.00108515,0.0002534771,0.00079690304,0.0007971533,0.0012091508,0.0038733003],"category_scores_gemma":[0.0007219741,0.00018246975,0.0004442457,0.00064227893,0.00032433536,0.0010430039,0.0005134196,0.0021702854,0.0036837643],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000061511644,0.000055358552,0.00017623525,0.0073064966,0.000060518327,0.00022242895,0.00005029165,0.000108459884,0.00077679515,0.0011221557,0.035626244,0.95443356],"study_design_scores_gemma":[0.000032178003,0.00007194507,0.0008661617,0.0046225856,0.000069578105,0.0025513626,0.00006723532,0.00004051498,0.00034788126,0.0012422692,0.9900755,0.000012657889],"about_ca_topic_score_codex":0.0012055426,"about_ca_topic_score_gemma":0.0024834613,"teacher_disagreement_score":0.0038733003,"about_ca_system_score_codex":0.0003777533,"about_ca_system_score_gemma":0.0005035657,"threshold_uncertainty_score":0.012957454},"labels":[],"label_agreement":null},{"id":"W2119853530","doi":"10.1111/bjh.12917","title":"Evaluation of the validity of Hb A<sub>2</sub> and mean corpuscular haemoglobin action values in antenatal screening for beta thalassaemia carriers in <scp>E</scp>ngland","year":2014,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Thomas Hospital","funders":"","keywords":"Medicine; False positive paradox; Mean corpuscular volume; Population; Pediatrics; Internal medicine; Hemoglobin; Statistics; Mathematics; Environmental health","score_opus":0.031433122151947906,"score_gpt":0.28139491739196143,"score_spread":0.24996179524001352,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2119853530","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99675375,0.00026216093,0.00048353095,0.00015761224,0.000029642666,0.00004526653,0.00012316741,0.0000071394147,0.002137741],"genre_scores_gemma":[0.9989237,0.000079845544,0.0005785183,0.00003023626,0.000013117528,0.000013592493,0.00011968223,0.0000023632872,0.00023895221],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.986026,0.008962303,0.0010944026,0.0007750163,0.0026728208,0.0004694211],"domain_scores_gemma":[0.9522892,0.03520891,0.0053645503,0.0021011948,0.0041632312,0.0008728913],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.022190504,0.0003661308,0.00031092425,0.0013090825,0.0004209599,0.00095686124,0.0011714435,0.0009289246,0.00076926034],"category_scores_gemma":[0.06377494,0.00039040655,0.00046449748,0.0008537784,0.001756279,0.0011395187,0.0010168067,0.00074739807,0.00041631842],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00036001083,0.00005243502,0.99284667,0.000027344633,0.00002684875,0.000105207066,0.00080631254,0.00027095003,0.00020578888,0.00008690156,0.00011014591,0.005101352],"study_design_scores_gemma":[0.000037224796,0.0009478027,0.9890659,0.00006743825,0.00007201249,0.00082317,0.0010065583,0.0059721237,0.0010156047,0.00018390015,0.0007912453,0.000016976035],"about_ca_topic_score_codex":0.007112783,"about_ca_topic_score_gemma":0.0072812666,"teacher_disagreement_score":0.022190504,"about_ca_system_score_codex":0.00075917266,"about_ca_system_score_gemma":0.00072461826,"threshold_uncertainty_score":0.11735594},"labels":[],"label_agreement":null},{"id":"W2120523756","doi":"10.1111/j.1365-2141.2008.07527.x","title":"Fluorescence‐activated cell sorting (FACS) of whole mount <i>in situ</i> hybridization (WISH) labelled haematopoietic cell populations in the zebrafish","year":2009,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Zebrafish Biomedical Research Applications","field":"Biochemistry, Genetics and Molecular Biology","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Izaak Walton Killam Health Centre; Dalhousie University","funders":"","keywords":"Zebrafish; Cell sorting; In situ hybridization; Biology; Haematopoiesis; Fluorescence in situ hybridization; Cell biology; Embryonic stem cell; Cell; Stem cell; Messenger RNA; Genetics; Gene","score_opus":0.014605188190065212,"score_gpt":0.2806999816855471,"score_spread":0.2660947934954819,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2120523756","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.6076817,0.002239291,0.3500369,0.0011093586,0.00026560493,0.0013209517,0.010368913,0.0036725579,0.023304839],"genre_scores_gemma":[0.6583041,0.00380496,0.30685863,0.00059644826,0.000085428095,0.0013440003,0.0060219695,0.0012382019,0.021746239],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99976796,0.000022830882,0.00002183555,0.000057248628,0.000081152895,0.000048996448],"domain_scores_gemma":[0.999793,0.000055460838,0.000033662443,0.00003535895,0.00005165674,0.000031023985],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00043630757,0.0003397237,0.00044898404,0.00064293825,0.00069857383,0.00058291585,0.0004776077,0.0004243918,0.0033740972],"category_scores_gemma":[0.0002609852,0.00028738705,0.00032230405,0.00052432687,0.0006634924,0.0003822438,0.00035496845,0.00096582214,0.0014844545],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000032793385,0.000005702643,0.00014392467,0.000038179067,0.0000019961046,0.000028909639,0.000034248864,0.00009713136,0.9970884,0.000415515,0.0001795959,0.0019336203],"study_design_scores_gemma":[0.00002419872,0.000090460635,0.004567194,0.000019382715,0.000013608587,0.00021124793,0.00006225616,0.0022089677,0.9814299,0.00042856316,0.010928761,0.000015487078],"about_ca_topic_score_codex":0.0042780032,"about_ca_topic_score_gemma":0.008309186,"teacher_disagreement_score":0.0042780032,"about_ca_system_score_codex":0.0005919404,"about_ca_system_score_gemma":0.00053760095,"threshold_uncertainty_score":0.01128751},"labels":[],"label_agreement":null},{"id":"W2129168589","doi":"10.1046/j.0007-1048.2001.03300.x","title":"Cytotoxicity of 2‐chlorodeoxyadenosine and arabinosylcytosine in leukaemic lymphoblasts from paediatric patients: significance of cellular nucleoside transporter content","year":2002,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"Fondation pour la Recherche Médicale; University of Alberta","keywords":"Lymphoblast; Nucleoside analogue; Nucleoside transporter; Cytotoxicity; Nucleoside; Cladribine; Transporter; Chemistry; Medicine; Biology; Biochemistry; Cell culture; In vitro; Internal medicine; Gene; Genetics","score_opus":0.01967873500142383,"score_gpt":0.22021659962444393,"score_spread":0.2005378646230201,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2129168589","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99669373,0.0017558008,0.000712121,0.000026244667,0.0000057098696,0.000015355974,0.0002954556,0.000017128916,0.0004784907],"genre_scores_gemma":[0.9976901,0.0007820338,0.0006453046,0.000019493054,0.000007531716,0.000021538606,0.0005747815,0.0000071114755,0.00025219168],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9996897,0.00009337879,0.000040893072,0.00005620696,0.00008410397,0.000035736244],"domain_scores_gemma":[0.99955887,0.00019232613,0.00008420612,0.00004748802,0.00006227413,0.000054709588],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00027621427,0.0002613657,0.00047096444,0.00036442556,0.0001764015,0.0006238656,0.0001626801,0.0003015852,0.0008969337],"category_scores_gemma":[0.0006910112,0.00016802867,0.00016606871,0.00038700746,0.00028311872,0.00023250919,0.00022745982,0.00044382008,0.000263284],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002251869,0.00004837022,0.052480564,0.00021730353,0.00006160892,0.0010189568,0.00090197334,0.00048035034,0.9334816,0.00012738364,0.0000844394,0.008845593],"study_design_scores_gemma":[0.000102140715,0.0031602364,0.28963363,0.000046531248,0.00019210008,0.011064175,0.001073174,0.0017041628,0.6872311,0.00011340339,0.0056511,0.000028104289],"about_ca_topic_score_codex":0.0010077525,"about_ca_topic_score_gemma":0.0008111421,"teacher_disagreement_score":0.0010077525,"about_ca_system_score_codex":0.00032479485,"about_ca_system_score_gemma":0.0001952574,"threshold_uncertainty_score":0.0030005574},"labels":[],"label_agreement":null},{"id":"W2129806364","doi":"10.1046/j.1365-2141.2002.03469.x","title":"Receptor tyrosine kinase mutations in myeloid neoplasms","year":2002,"lang":"en","type":"review","venue":"British Journal of Haematology","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":36,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Cancer Research","funders":"","keywords":"Receptor tyrosine kinase; Platelet-derived growth factor receptor; Tyrosine kinase; ROR1; Biology; Proto-oncogene tyrosine-protein kinase Src; Cell biology; Cancer research; Tropomyosin receptor kinase C; GRB2; Growth factor receptor; Epidermal growth factor; SH2 domain; Signal transduction; Biochemistry; Growth factor; Receptor","score_opus":0.036678624574928306,"score_gpt":0.31797710477744523,"score_spread":0.2812984802025169,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2129806364","genre_codex":"empirical","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.47362286,0.23324525,0.010020701,0.0042259376,0.0015230868,0.00033752347,0.004821827,0.00078168145,0.27142116],"genre_scores_gemma":[0.8565559,0.08529845,0.009885366,0.0010180305,0.0003461158,0.00011287013,0.0035256196,0.0000687139,0.04318891],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9999435,0.000008405167,0.000004792217,0.000011942118,0.00001960416,0.00001181256],"domain_scores_gemma":[0.9999721,0.0000044183694,0.000008567527,0.0000019957968,0.0000055354376,0.000007419472],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000064760025,0.00018232905,0.0001476577,0.00031076866,0.00012936017,0.00018577176,0.0001308263,0.00026746394,0.0053451927],"category_scores_gemma":[0.00019166215,0.000041539617,0.00012742958,0.0004147164,0.00012505172,0.00022806764,0.00020013003,0.00027184264,0.002192082],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006904334,0.00009694394,0.05543378,0.0019927062,0.0000644516,0.052336425,0.000541163,0.0013400047,0.13276526,0.021640278,0.082938716,0.65015984],"study_design_scores_gemma":[0.000053003565,0.00016143628,0.056288775,0.00043925561,0.000075319105,0.10039527,0.00021821885,0.00045059563,0.009962572,0.0037534276,0.82818174,0.000020434734],"about_ca_topic_score_codex":0.00045987827,"about_ca_topic_score_gemma":0.00044792859,"teacher_disagreement_score":0.0053451927,"about_ca_system_score_codex":0.0002076525,"about_ca_system_score_gemma":0.000109796754,"threshold_uncertainty_score":0.017881453},"labels":[],"label_agreement":null},{"id":"W2131149366","doi":"10.1046/j.0007-1048.2001.03302.x","title":"A novel immunocytochemical assay for the detection of serotonin in platelets","year":2002,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Mast cells and histamine","field":"Immunology and Microbiology","cited_by":40,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Blood Services; University of British Columbia","funders":"University of British Columbia; Canadian Blood Services; Hermansky-Pudlak Syndrome Network","keywords":"Serotonin; Platelet; Calcium; Chemistry; High-performance liquid chromatography; Chromatography; Neurotransmitter; Molecular biology; Biochemistry; Internal medicine; Medicine; Biology; Receptor","score_opus":0.016291734690072276,"score_gpt":0.22394802230371186,"score_spread":0.20765628761363958,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2131149366","genre_codex":"methods","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":"methods","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.31706098,0.022112112,0.6416908,0.00096195284,0.001863029,0.0010941733,0.0011534103,0.0022615576,0.011801996],"genre_scores_gemma":[0.4733622,0.013118498,0.49739432,0.0005586061,0.0007643269,0.0014594997,0.0021646502,0.00013487916,0.011042906],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99928975,0.0001608789,0.00007771557,0.00018204516,0.00021568501,0.00007385246],"domain_scores_gemma":[0.99943715,0.00020054853,0.000042548556,0.00010285127,0.00015322924,0.0000637107],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006246408,0.0008320387,0.0005440561,0.00093513005,0.00039607155,0.00035651063,0.0007709475,0.00094587356,0.0030407188],"category_scores_gemma":[0.0005295968,0.00040483198,0.00057238725,0.0003530791,0.00043835575,0.00054202345,0.0005898235,0.0010115891,0.0016861148],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000035482262,0.000028981714,0.00023939557,0.00010801049,0.000011951925,0.00013193209,0.000016362384,0.00002355069,0.99252605,0.00022405386,0.00022809107,0.0064261113],"study_design_scores_gemma":[0.00019270691,0.0022914628,0.018486407,0.00010420792,0.0003236708,0.0117169935,0.0000845486,0.009237287,0.9160745,0.0008645112,0.040544644,0.00007896949],"about_ca_topic_score_codex":0.0004210213,"about_ca_topic_score_gemma":0.00096885336,"teacher_disagreement_score":0.0030407188,"about_ca_system_score_codex":0.00028808112,"about_ca_system_score_gemma":0.00027141924,"threshold_uncertainty_score":0.010172248},"labels":[],"label_agreement":null},{"id":"W2132062481","doi":"10.1111/j.1365-2141.2005.05947.x","title":"Autotransplantation <i>versus</i> HLA‐matched unrelated donor transplantation for acute myeloid leukaemia: a retrospective analysis from the Center for International Blood and Marrow Transplant Research","year":2006,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":60,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Manitoba; University of Toronto; CancerCare Manitoba","funders":"National Cancer Institute","keywords":"Medicine; Transplantation; Internal medicine; Single Center; Retrospective cohort study; Surgery; Autotransplantation; Myeloid; Oncology; Gastroenterology","score_opus":0.02031420621659094,"score_gpt":0.31000582067879745,"score_spread":0.2896916144622065,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2132062481","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9991756,0.00033940695,0.00008828134,0.000013168974,0.00000413337,0.000008645703,0.0001955979,0.0000025062147,0.00017253504],"genre_scores_gemma":[0.9993556,0.00015839002,0.000050825245,0.000025406602,0.0000108474715,0.000011134434,0.00032070294,0.00000268536,0.00006437136],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9992384,0.0002019048,0.00011991475,0.0002035035,0.000131349,0.000104841565],"domain_scores_gemma":[0.9979576,0.0005355982,0.00088250573,0.00021367967,0.00012559998,0.00028498],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008687091,0.00026602932,0.00037756612,0.0006838907,0.0003974309,0.0006901546,0.00026955752,0.00036733854,0.0013353296],"category_scores_gemma":[0.0017060325,0.0004069242,0.0006042776,0.001111601,0.0003329939,0.00032464563,0.00035788844,0.00046028304,0.00034783027],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00038751497,0.000044500877,0.9971648,0.000017842798,0.000121143596,0.00034540796,0.00007987738,0.000046591933,0.00025427283,0.000018137562,0.0001258724,0.0013940273],"study_design_scores_gemma":[0.000037985163,0.0004572411,0.9958709,0.000013861658,0.00013644573,0.002334249,0.00023058103,0.00018875214,0.00018407188,0.00002869801,0.00050767226,0.000009642607],"about_ca_topic_score_codex":0.0023372653,"about_ca_topic_score_gemma":0.0020435262,"teacher_disagreement_score":0.0023372653,"about_ca_system_score_codex":0.00040925425,"about_ca_system_score_gemma":0.00039769543,"threshold_uncertainty_score":0.004647374},"labels":[],"label_agreement":null},{"id":"W2132834885","doi":"10.1046/j.1365-2141.2002.03444.x","title":"Cell‐specific abnormal prenylation of Rab proteins in platelets and melanocytes of the gunmetal mouse","year":2002,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Cellular transport and secretion","field":"Biochemistry, Genetics and Molecular Biology","cited_by":27,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"National Cancer Institute; National Heart, Lung, and Blood Institute; Medical Research Council; Canadian Institutes of Health Research; National Eye Institute; Johns Hopkins University","keywords":"Prenylation; Rab; Platelet; Geranylgeranylation; Biology; Cell biology; Organelle; Biochemistry; Immunology; Enzyme; GTPase","score_opus":0.007727659738770571,"score_gpt":0.18190158192110287,"score_spread":0.1741739221823323,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2132834885","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9955258,0.00052443956,0.0018676692,0.000060817078,0.000009136532,0.000018130593,0.00048030436,0.00011693568,0.0013967514],"genre_scores_gemma":[0.99400866,0.0004272485,0.0022209657,0.000036776,0.000005600971,0.000033287524,0.00053000817,0.00006413047,0.0026733903],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998079,0.000024637455,0.000024816838,0.000054986987,0.00006079601,0.000026869866],"domain_scores_gemma":[0.9997038,0.000053774456,0.00010772018,0.00004418926,0.000014666486,0.00007575693],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013213292,0.00035996048,0.0001779069,0.0008097258,0.00019289672,0.0003523328,0.00016105194,0.000557232,0.0013456078],"category_scores_gemma":[0.0002240371,0.00034965717,0.00024395862,0.00019031277,0.0003166877,0.00020838458,0.0002930385,0.0005710658,0.00040067293],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013790143,0.000011525342,0.00041635794,0.000013117968,0.000007440582,0.00033190392,0.000023058392,0.00005269719,0.9977823,0.00027340782,0.000033455184,0.000916785],"study_design_scores_gemma":[0.00008296432,0.00051373086,0.034450464,0.000015217988,0.00006656523,0.009084547,0.00006796789,0.0011992184,0.9500557,0.00047816464,0.003962922,0.000022487235],"about_ca_topic_score_codex":0.0005404714,"about_ca_topic_score_gemma":0.00071411376,"teacher_disagreement_score":0.0013456078,"about_ca_system_score_codex":0.00025024117,"about_ca_system_score_gemma":0.00010946202,"threshold_uncertainty_score":0.0045015216},"labels":[],"label_agreement":null},{"id":"W2135471715","doi":"10.1111/j.1365-2141.2010.08331.x","title":"Comparison of conventional prognostic indices in patients older than 60 years with diffuse large B‐cell lymphoma treated with R‐CHOP in the US Intergroup Study (ECOG 4494, CALGB 9793): consideration of age greater than 70 years in an elderly prognostic index (E‐IPI)","year":2010,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":97,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"National Cancer Institute","keywords":"International Prognostic Index; Medicine; Diffuse large B-cell lymphoma; Internal medicine; Prednisone; Vincristine; Population; CHOP; Rituximab; Oncology; Lymphoma; Cyclophosphamide; Chemotherapy","score_opus":0.011323437320668489,"score_gpt":0.26909237899233773,"score_spread":0.25776894167166925,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2135471715","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9993357,0.0002993457,0.00007325945,0.000012350771,0.0000059117233,0.000004624165,0.0000908369,0.000002242716,0.00017572519],"genre_scores_gemma":[0.99932647,0.00008070086,0.000060489834,0.000016762488,0.000021255873,0.0000070935425,0.00043960946,0.0000017934975,0.000045896002],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99960417,0.00015015795,0.000050618637,0.0000639397,0.00006457807,0.000066510926],"domain_scores_gemma":[0.9983487,0.00056371605,0.0004997731,0.00009910537,0.00014421258,0.00034453388],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017133646,0.0004194345,0.00057088595,0.00069522654,0.00015611552,0.0005617986,0.00023337424,0.00040127232,0.0003256509],"category_scores_gemma":[0.0024929827,0.00011982712,0.00047801834,0.0006345813,0.00021291172,0.0004086747,0.00041313746,0.00043274593,0.00014033685],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002963908,0.000046260808,0.9924811,0.000012457649,0.00019498289,0.0000784068,0.000058507703,0.00029897733,0.0004469017,0.000014605041,0.00007547992,0.003328314],"study_design_scores_gemma":[0.000084664855,0.00079984893,0.9975789,0.000004536983,0.00012522134,0.00013861795,0.00007103109,0.0008667309,0.000119530574,0.000038856702,0.00016634646,0.0000057074944],"about_ca_topic_score_codex":0.00081501686,"about_ca_topic_score_gemma":0.001065936,"teacher_disagreement_score":0.0017133646,"about_ca_system_score_codex":0.00027992795,"about_ca_system_score_gemma":0.00018635561,"threshold_uncertainty_score":0.009061277},"labels":[],"label_agreement":null},{"id":"W2137364453","doi":"10.1111/bjh.13341","title":"Pyoderma gangrenosum secondary to azacitidine in myelodysplastic syndrome","year":2015,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Autoimmune and Inflammatory Disorders","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Health Sciences Centre; University of Toronto; Sunnybrook Health Science Centre","funders":"","keywords":"Azacitidine; Medicine; Pyoderma gangrenosum; Cytopenia; Myelodysplastic syndromes; Trisomy 8; Dysplasia; Dermatology; Prednisone; Leukocytosis; Surgery; Internal medicine; Gastroenterology; Bone marrow; Disease","score_opus":0.016075887073292428,"score_gpt":0.2564479097958372,"score_spread":0.24037202272254476,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2137364453","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98456466,0.0060664,0.0007340351,0.0008601347,0.000094942334,0.0000963766,0.000118547505,0.00011154534,0.0073533836],"genre_scores_gemma":[0.998009,0.0009784886,0.00016003747,0.00022692372,0.00009678606,0.0000068628683,0.00004351412,0.0000039001284,0.000474511],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.9998505,0.000027391641,0.000016738153,0.000027475307,0.000027414691,0.000050482897],"domain_scores_gemma":[0.99970955,0.00007575238,0.00006522639,0.000018801546,0.000015798552,0.00011487889],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018858857,0.00067941344,0.00046550317,0.0007997334,0.0005992842,0.00037302633,0.0002452516,0.001174726,0.0016060302],"category_scores_gemma":[0.0009128081,0.0003384481,0.00039095554,0.00046870453,0.00045551299,0.00042809785,0.00049014646,0.00093327684,0.00036290946],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00023160738,0.0000500569,0.027504234,0.000067098365,0.000023585006,0.9641032,0.00017726565,0.00010504946,0.0029777216,0.00012691836,0.00028155142,0.0043516946],"study_design_scores_gemma":[0.0000709918,0.0002650164,0.052013323,0.000038366954,0.0000421436,0.9450913,0.000100501624,0.00037457765,0.00068496325,0.00015673082,0.0011525223,0.000009489498],"about_ca_topic_score_codex":0.001027915,"about_ca_topic_score_gemma":0.0011989293,"teacher_disagreement_score":0.0016060302,"about_ca_system_score_codex":0.00033070272,"about_ca_system_score_gemma":0.0002520538,"threshold_uncertainty_score":0.0053726435},"labels":[],"label_agreement":null},{"id":"W2137460829","doi":"10.1111/bjh.13310","title":"Array comparative genomic hybridization reveals similarities between nodular lymphocyte predominant Hodgkin lymphoma and T cell/histiocyte rich large B cell lymphoma","year":2015,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":76,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"Deutsche Forschungsgemeinschaft","keywords":"Histiocyte; Lymphoma; Comparative genomic hybridization; Pathology; Biology; Locus (genetics); Medicine; Gene; Genetics; Chromosome","score_opus":0.027286588475523964,"score_gpt":0.26722657711876363,"score_spread":0.23993998864323968,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2137460829","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99289906,0.0010285062,0.0037266037,0.0000440298,0.00001206146,0.000013207818,0.00038045915,0.000055032626,0.0018410011],"genre_scores_gemma":[0.9966646,0.000281818,0.0016534672,0.00007492329,0.00001013731,0.000028186303,0.00067563955,0.00000794884,0.00060334406],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99969244,0.000058886464,0.00001729871,0.00012357684,0.000061162784,0.000046727542],"domain_scores_gemma":[0.9997527,0.00010778196,0.000061678606,0.000031220403,0.00001965399,0.000026882426],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017150807,0.00014699268,0.0001543968,0.00063999573,0.0001324061,0.00027142154,0.00013043854,0.00026366833,0.0015051916],"category_scores_gemma":[0.00060473906,0.00012842473,0.00012809488,0.00036562435,0.0002573669,0.00012989761,0.00027801347,0.00019057261,0.00024420858],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00034821974,0.000028062961,0.05585895,0.00011161946,0.00008045316,0.0013566719,0.00019262568,0.00015965421,0.9252336,0.00029420742,0.000112236536,0.016223742],"study_design_scores_gemma":[0.000032975204,0.00055444264,0.9052048,0.000016151387,0.00011912428,0.013912902,0.0003883906,0.0006623651,0.072247036,0.0007560625,0.006090531,0.000015288751],"about_ca_topic_score_codex":0.0003287867,"about_ca_topic_score_gemma":0.00063485594,"teacher_disagreement_score":0.0015051916,"about_ca_system_score_codex":0.00013749301,"about_ca_system_score_gemma":0.00008997589,"threshold_uncertainty_score":0.0050354004},"labels":[],"label_agreement":null},{"id":"W2139789114","doi":"10.1111/bjh.13389","title":"Response‐adapted therapy for aggressive non‐Hodgkin's lymphomas based on early [18F] FDG‐PET scanning: ECOG‐ACRIN Cancer Research Group study (E3404)","year":2015,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":57,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"U.S. Public Health Service; ECOG-ACRIN Cancer Research Group; National Cancer Institute; U.S. Department of Health and Human Services; National Institutes of Health; American College of Radiology Imaging Network","keywords":"Medicine; Vincristine; Internal medicine; Positron emission tomography; Confidence interval; Rituximab; Lymphoma; Nuclear medicine; Prednisone; Etoposide; PET-CT; Oncology; Cyclophosphamide; Chemotherapy","score_opus":0.08657996483546601,"score_gpt":0.39282087888565004,"score_spread":0.30624091405018405,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2139789114","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99658453,0.0007453853,0.00029385503,0.000098858276,0.00003365598,0.0009867714,0.00049423036,0.00002026405,0.0007423424],"genre_scores_gemma":[0.9938008,0.00049949164,0.0009230321,0.00053088117,0.00010363746,0.0013616517,0.0018068327,0.000010958764,0.00096271717],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99857616,0.0010010975,0.00006155815,0.0001211688,0.0000976871,0.00014223249],"domain_scores_gemma":[0.9993012,0.00012989453,0.00015210574,0.000120171295,0.00004277911,0.0002537898],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0038735524,0.0010409802,0.0015289569,0.00040891912,0.0002522714,0.0006561186,0.0008063898,0.0010817606,0.0014401417],"category_scores_gemma":[0.0009723419,0.00039138363,0.0012167455,0.00047518525,0.00051070366,0.0006082281,0.00047550997,0.001421927,0.00033961458],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.802172,0.027401645,0.07268018,0.0004401859,0.002671923,0.00028036142,0.00020505166,0.0038250217,0.01729455,0.00026300896,0.0016564497,0.0711097],"study_design_scores_gemma":[0.36588418,0.43517503,0.18989883,0.00005860723,0.0012722212,0.0003232723,0.000058406258,0.0014527636,0.0015775437,0.00040696192,0.0038462426,0.00004585068],"about_ca_topic_score_codex":0.0005411931,"about_ca_topic_score_gemma":0.0011150382,"teacher_disagreement_score":0.0038735524,"about_ca_system_score_codex":0.00049481215,"about_ca_system_score_gemma":0.0005898808,"threshold_uncertainty_score":0.02048558},"labels":[],"label_agreement":null},{"id":"W2142086292","doi":"10.1111/bjh.12631","title":"Validation and reliability of a disease‐specific quality of life measure (the <scp>T</scp>ran<scp>Q</scp>ol) in adults and children with thalassaemia major","year":2013,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":59,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Laurentian University; BC Children's Hospital; St. Paul's Hospital; Hospital for Sick Children; Ottawa Hospital; Children's Hospital of Eastern Ontario","funders":"National Center for Research Resources","keywords":"Medicine; Quality of life (healthcare); Internal medicine; Limits of agreement; Gastroenterology; Nuclear medicine","score_opus":0.008488720035266033,"score_gpt":0.2236597595770129,"score_spread":0.21517103954174685,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2142086292","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9975084,0.00043992486,0.0010589685,0.00005954803,0.000036930516,0.00010085507,0.00020036164,0.0000059876747,0.0005889178],"genre_scores_gemma":[0.99769396,0.00015203179,0.0013583212,0.00004696503,0.000017659466,0.00014990817,0.00043519537,0.0000037822183,0.00014221095],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99438584,0.0027223104,0.00079165515,0.00051937276,0.0013454583,0.00023542461],"domain_scores_gemma":[0.98878956,0.005627492,0.0022260293,0.00081474095,0.0021331173,0.00040897288],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.012282042,0.00036079154,0.0003338496,0.00063540135,0.00022236122,0.0005586141,0.0003893037,0.000531062,0.00059422216],"category_scores_gemma":[0.022156276,0.0002140373,0.0006348814,0.00048691564,0.000568214,0.00063720276,0.00073704077,0.0006523078,0.00028582435],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00033608294,0.00013606252,0.97693217,0.00007763218,0.00018069865,0.000036030193,0.0010076726,0.00027992838,0.0011757606,0.00008556333,0.00030870628,0.01944366],"study_design_scores_gemma":[0.00006946495,0.0013479926,0.99489635,0.00006234885,0.00006689291,0.0003157332,0.0003910397,0.0009911682,0.0005202297,0.00006275809,0.001263578,0.00001249727],"about_ca_topic_score_codex":0.0010355682,"about_ca_topic_score_gemma":0.001391985,"teacher_disagreement_score":0.012282042,"about_ca_system_score_codex":0.0002850762,"about_ca_system_score_gemma":0.00036046995,"threshold_uncertainty_score":0.06495446},"labels":[],"label_agreement":null},{"id":"W2142098084","doi":"10.1111/bjh.13825","title":"From <scp>CLL</scp> to Multiple Myeloma ‐ Spleen Tyrosine Kinase (<scp>SYK</scp>) influences multiple myeloma cell survival and migration","year":2015,"lang":"en","type":"letter","venue":"British Journal of Haematology","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Syk; Cancer research; CD38; CXCR4; Multiple myeloma; Downregulation and upregulation; Chronic lymphocytic leukemia; Medicine; Chemistry; Immunology; Tyrosine kinase; Leukemia; Receptor; Biology; Chemokine; Stem cell; Cell biology; Immune system; Internal medicine; CD34","score_opus":0.028114109119932396,"score_gpt":0.2817599126208232,"score_spread":0.25364580350089083,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2142098084","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9927489,0.002749736,0.0004633268,0.00035358593,0.0001077786,0.00002638449,0.0005847813,0.000090023284,0.0028755933],"genre_scores_gemma":[0.99244964,0.0019491619,0.00046748132,0.00023756661,0.00002342825,0.000060542894,0.0008827407,0.000025631172,0.003903763],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998276,0.000019692052,0.000014781473,0.000030088422,0.00004361508,0.00006410946],"domain_scores_gemma":[0.99993384,0.00001310391,0.00001265894,0.0000055367464,0.000007580266,0.000027261345],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013622183,0.00019339638,0.00032010503,0.00025076946,0.00024666684,0.00051070633,0.00016565973,0.00033366663,0.004423186],"category_scores_gemma":[0.00016398347,0.00014937221,0.00038077845,0.00019773647,0.00028304046,0.0002864081,0.00030504662,0.001165612,0.0007402855],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00066175597,0.00017147954,0.00067591603,0.00016443708,0.000016421054,0.00010570696,0.000058133202,0.00015271646,0.99164915,0.0002933693,0.0007385072,0.00531231],"study_design_scores_gemma":[0.00021348358,0.0032386156,0.02752239,0.00007055555,0.000110621564,0.0007525322,0.00028020976,0.0016944818,0.93731683,0.0003578377,0.028405866,0.00003655842],"about_ca_topic_score_codex":0.0013502571,"about_ca_topic_score_gemma":0.0022636997,"teacher_disagreement_score":0.004423186,"about_ca_system_score_codex":0.00040518463,"about_ca_system_score_gemma":0.000422406,"threshold_uncertainty_score":0.014796972},"labels":[],"label_agreement":null},{"id":"W2142599682","doi":"10.1046/j.1365-2141.2003.04203.x","title":"Autologous stem cell transplant for relapsed and refractory peripheral T‐cell lymphoma: variable outcome according to pathological subtype","year":2003,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":103,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Medicine; Etoposide; Lymphoma; Univariate analysis; Internal medicine; Melphalan; Diffuse large B-cell lymphoma; Autologous stem-cell transplantation; Gastroenterology; Large-cell lymphoma; Aggressive lymphoma; Survival analysis; Chemotherapy; Surgery; Oncology; Rituximab; Multivariate analysis","score_opus":0.020477174359010752,"score_gpt":0.2595813583051911,"score_spread":0.23910418394618033,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2142599682","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99950624,0.00028704645,0.000051160456,0.000015813863,0.0000026857902,0.000004183345,0.000020070003,0.0000015821579,0.00011112185],"genre_scores_gemma":[0.9996977,0.000091369984,0.00004069002,0.000021900101,0.000014816471,0.0000032881478,0.00009278779,9.996699e-7,0.000036586545],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99977595,0.000093635754,0.000022067088,0.00002638746,0.000035137793,0.000046891088],"domain_scores_gemma":[0.9990294,0.00028795333,0.00036457757,0.000048723537,0.000050018312,0.00021942651],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00044259382,0.0001255502,0.00027730534,0.00029343241,0.00022290251,0.00034961887,0.0001441148,0.0002437385,0.0005084896],"category_scores_gemma":[0.0017761379,0.00007038557,0.00022782163,0.0002925235,0.00028281115,0.00020673664,0.00020264776,0.00021896385,0.00017214393],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001815515,0.00013406647,0.97776014,0.000026662543,0.00007023927,0.0010849055,0.00012254143,0.00026622944,0.0015881262,0.000026966029,0.00012852877,0.016976027],"study_design_scores_gemma":[0.00017253592,0.003151533,0.98538554,0.000022153954,0.000083655534,0.00873931,0.0001857314,0.0010023266,0.00080448244,0.00008371818,0.00036117842,0.000007706587],"about_ca_topic_score_codex":0.00041698292,"about_ca_topic_score_gemma":0.0010135681,"teacher_disagreement_score":0.0005084896,"about_ca_system_score_codex":0.00023589974,"about_ca_system_score_gemma":0.00016138723,"threshold_uncertainty_score":0.0023406744},"labels":[],"label_agreement":null},{"id":"W2149252069","doi":"10.1111/j.1365-2141.2006.06133.x","title":"Acquired and inherited disorders of cobalamin and folate in children","year":2006,"lang":"en","type":"review","venue":"British Journal of Haematology","topic":"Folate and B Vitamins Research","field":"Medicine","cited_by":175,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Montreal Children's Hospital","funders":"Medical Research Council; Cancer Research Society; McGill University","keywords":"Cobalamin; Methionine synthase; Megaloblastic anemia; Malabsorption; Internal medicine; Methylenetetrahydrofolate reductase; Intrinsic factor; Medicine; Endocrinology; Biology; Vitamin B12; Methionine; Allele; Genetics; Gene","score_opus":0.018494374297071604,"score_gpt":0.32437645443380336,"score_spread":0.30588208013673174,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2149252069","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00014256933,0.9985518,0.000054424676,0.00013724495,0.00013003897,0.0000031612112,0.000016148282,0.0000067085084,0.00095784507],"genre_scores_gemma":[0.00066194066,0.99828523,0.00010223154,0.000075656506,0.00011019647,0.000003837375,0.00003206227,0.0000010523246,0.0007277599],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9997501,0.00003720192,0.000053137195,0.000040472787,0.00009125443,0.000027820837],"domain_scores_gemma":[0.99968565,0.0001310775,0.000064594045,0.000013449255,0.00006796801,0.00003727587],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004386011,0.0010956263,0.0017307568,0.0027224491,0.00030640312,0.00063264533,0.0009265697,0.000916884,0.0046018204],"category_scores_gemma":[0.0008154747,0.0003150513,0.00034765538,0.004001555,0.00059422816,0.000983268,0.0006119763,0.0010920371,0.0029911208],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009368146,0.000056498582,0.00074010424,0.012550039,0.00009307945,0.0012725323,0.00008719366,0.00015281336,0.0010951507,0.0010074045,0.03959378,0.94325787],"study_design_scores_gemma":[0.0000281069,0.00006009122,0.0035706598,0.004339494,0.00013049344,0.012329272,0.00009373194,0.00003116258,0.00036154946,0.00070913055,0.9783311,0.000015164358],"about_ca_topic_score_codex":0.002687409,"about_ca_topic_score_gemma":0.0037304389,"teacher_disagreement_score":0.0046018204,"about_ca_system_score_codex":0.0007189117,"about_ca_system_score_gemma":0.0009754447,"threshold_uncertainty_score":0.015394568},"labels":[],"label_agreement":null},{"id":"W2158060003","doi":"10.1111/j.1365-2141.2007.06909.x","title":"Familial myelodysplasia and acute myeloid leukaemia – a review","year":2007,"lang":"en","type":"review","venue":"British Journal of Haematology","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":183,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver General Hospital; BC Cancer Agency","funders":"Cancer Research UK; Lady Tata Memorial Trust","keywords":"CEBPA; Medicine; Myeloid; Germline; Pedigree chart; RUNX1; Germline mutation; Myelodysplastic syndromes; Oncology; Internal medicine; Mutation; Genetics; Gene; Biology; Haematopoiesis; Bone marrow; Stem cell","score_opus":0.04561530417102781,"score_gpt":0.3816885380774147,"score_spread":0.3360732339063869,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2158060003","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00019900774,0.9981768,0.00008478874,0.00019381408,0.0002490305,0.0000064470823,0.000016074518,0.0000074176946,0.0010666888],"genre_scores_gemma":[0.0008964911,0.9980636,0.00019621357,0.00014430538,0.0002486205,0.000006096441,0.000039983137,0.0000013553224,0.0004033412],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9997454,0.00005026493,0.000056284603,0.000042627245,0.000086304906,0.000019106656],"domain_scores_gemma":[0.9993882,0.00028388307,0.00011093351,0.00001796403,0.00013767192,0.0000612518],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00049435766,0.00097063335,0.0016169323,0.0039683534,0.00032678826,0.0007907562,0.0011217924,0.0009112917,0.004716278],"category_scores_gemma":[0.0011259179,0.000290995,0.00036287762,0.0043188175,0.00043701104,0.0014376411,0.0005062792,0.0009599618,0.00235457],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00005434211,0.0000826347,0.00058931916,0.016507687,0.00010310551,0.0019122259,0.000098660756,0.00036833814,0.00076558726,0.0013769864,0.057696715,0.92044437],"study_design_scores_gemma":[0.00003052414,0.00010554713,0.0037554794,0.01084181,0.00019997204,0.021945456,0.00018444103,0.00010450198,0.00019849648,0.0015752588,0.9610297,0.000028700633],"about_ca_topic_score_codex":0.001440733,"about_ca_topic_score_gemma":0.002569368,"teacher_disagreement_score":0.004716278,"about_ca_system_score_codex":0.00042713826,"about_ca_system_score_gemma":0.0011131247,"threshold_uncertainty_score":0.015777528},"labels":[],"label_agreement":null},{"id":"W2160457008","doi":"10.1111/j.1365-2141.2009.07881.x","title":"Phase II study of the histone deacetylase inhibitor MGCD0103 in patients with previously treated chronic lymphocytic leukaemia","year":2009,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":114,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Pyrogenesis (Canada); Princess Margaret Cancer Centre; Ottawa Hospital; Queen Elizabeth II Health Sciences Centre","funders":"National Cancer Institute; D. Warren Brown Family Foundation; Leukemia and Lymphoma Society","keywords":"Fludarabine; Medicine; Chronic lymphocytic leukemia; Rituximab; Internal medicine; Concomitant; Histone deacetylase inhibitor; Histone deacetylase; Tolerability; Gastroenterology; Pharmacokinetics; Toxicity; Refractory (planetary science); Oncology; Pharmacology; Lymphoma; Leukemia; Chemotherapy; Adverse effect; Histone; Biology; Cyclophosphamide","score_opus":0.009130678814489193,"score_gpt":0.29054384125824373,"score_spread":0.2814131624437545,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2160457008","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9941024,0.0025533203,0.00048177064,0.0002819664,0.00007973435,0.001099644,0.0003500845,0.00009097972,0.00096004293],"genre_scores_gemma":[0.9919608,0.001802748,0.0012650705,0.000749999,0.00012566014,0.0013969749,0.0012520252,0.000022589064,0.0014241339],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9997538,0.00009703963,0.0000124069,0.000044497057,0.000025095656,0.00006716318],"domain_scores_gemma":[0.9995264,0.000064881315,0.000062752966,0.000036620135,0.000021969578,0.00028742693],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00091417594,0.000895262,0.0019453549,0.0002986108,0.0003798954,0.0007509592,0.00065573753,0.0008520059,0.0019015354],"category_scores_gemma":[0.0005966807,0.0004206498,0.0006576731,0.00043386323,0.0008340743,0.0003896033,0.00032307807,0.0017951569,0.00058804295],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.47088838,0.09418982,0.035932235,0.00078497967,0.0012794139,0.0010422404,0.0006826463,0.0040904265,0.13286872,0.00046109862,0.00542062,0.25235945],"study_design_scores_gemma":[0.31059596,0.63536966,0.03733207,0.00003844882,0.00038254555,0.00079822046,0.00009642832,0.0018461482,0.0072169625,0.0002066355,0.0060855304,0.000031466094],"about_ca_topic_score_codex":0.0014965293,"about_ca_topic_score_gemma":0.0028637156,"teacher_disagreement_score":0.0019453549,"about_ca_system_score_codex":0.00082761847,"about_ca_system_score_gemma":0.0013277808,"threshold_uncertainty_score":0.006361246},"labels":[],"label_agreement":null},{"id":"W2162350156","doi":"10.1111/bjh.12630","title":"Phase <scp>IA</scp>/<scp>II</scp>, multicentre, open‐label study of the <scp>CD</scp>40 antagonistic monoclonal antibody lucatumumab in adult patients with advanced non‐<scp>H</scp>odgkin or <scp>H</scp>odgkin lymphoma","year":2013,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":77,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; McGill University; Jewish General Hospital","funders":"National Cancer Institute","keywords":"Lymphoma; Medicine; Follicular lymphoma; Internal medicine; Monoclonal antibody; Radioimmunotherapy; Refractory (planetary science); Gastroenterology; MALT lymphoma; Antibody; Immunology; Biology","score_opus":0.013425289530544553,"score_gpt":0.29821879913674515,"score_spread":0.2847935096062006,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2162350156","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9930697,0.001100719,0.0005704644,0.00018976929,0.000074614756,0.0031307964,0.0006555115,0.00007219547,0.0011362141],"genre_scores_gemma":[0.98952943,0.0012390278,0.0017560178,0.00085045217,0.00015066835,0.002710501,0.0019428125,0.000024597763,0.0017965593],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.99944204,0.0002504269,0.000031991764,0.00007772326,0.00006841592,0.00012931506],"domain_scores_gemma":[0.99918514,0.00010031645,0.00016734476,0.00006819804,0.00008301985,0.00039596923],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0020055396,0.0017741431,0.0019741415,0.0004796508,0.0004477192,0.00095507066,0.0008849313,0.0011260953,0.0016341459],"category_scores_gemma":[0.0008739529,0.0008229469,0.0011486078,0.00045425445,0.0011322222,0.00079645094,0.00040536837,0.0027500063,0.0006307717],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.69745976,0.10436907,0.013215562,0.001169285,0.0012989857,0.00039786752,0.00058107363,0.0037130774,0.0908791,0.0003383485,0.004936489,0.08164136],"study_design_scores_gemma":[0.47373915,0.49852473,0.018389512,0.000030390467,0.00036897266,0.000265491,0.00007399064,0.0011062938,0.0046442645,0.00012518669,0.0026992606,0.000032862034],"about_ca_topic_score_codex":0.0016344034,"about_ca_topic_score_gemma":0.0041388986,"teacher_disagreement_score":0.0020055396,"about_ca_system_score_codex":0.0013250931,"about_ca_system_score_gemma":0.0022535298,"threshold_uncertainty_score":0.010606408},"labels":[],"label_agreement":null},{"id":"W2164957039","doi":"10.1046/j.1365-2141.2001.02763.x","title":"Technetium‐99m‐sestamethoxyisobutylisonitrile scan as a predictor of chemotherapy response in malignant lymphomas compared with P‐glycoprotein expression, multidrug resistance‐related protein expression and other prognosis factors","year":2001,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Drug Transport and Resistance Mechanisms","field":"Medicine","cited_by":24,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"National Defence Medical Centre","funders":"Taichung Veterans General Hospital","keywords":"Chemotherapy; P-glycoprotein; Medicine; Immunohistochemistry; Biopsy; Multiple drug resistance; Internal medicine; Lymphoma; Incidence (geometry); Gastroenterology; Pathology; Nuclear medicine; Oncology; Drug resistance; Biology","score_opus":0.009495923457740786,"score_gpt":0.24353561889019243,"score_spread":0.23403969543245165,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2164957039","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9994906,0.0002974316,0.00005368654,0.000013890418,0.0000017168145,0.000003225659,0.000014045753,0.0000028313264,0.00012261812],"genre_scores_gemma":[0.99971265,0.00006149366,0.000053362353,0.000011866892,0.0000069268167,0.0000052192095,0.000057929534,9.961443e-7,0.000089471716],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.999816,0.00008406088,0.000020838079,0.000022802733,0.000029337454,0.000027029326],"domain_scores_gemma":[0.99907994,0.00041835412,0.00024220852,0.000026299347,0.00007520492,0.0001580039],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00049674074,0.00021037637,0.00026356228,0.00051400304,0.00011158146,0.000278897,0.00011818723,0.00039307034,0.00058610615],"category_scores_gemma":[0.0018015072,0.00011230465,0.00015595766,0.00021354521,0.00017587667,0.00021226834,0.00014876753,0.00021749196,0.00022004294],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018540355,0.00006874474,0.98643005,0.000015071763,0.000024121731,0.00023148199,0.000060652324,0.0002379613,0.0053235777,0.000007920712,0.00005497597,0.0056912424],"study_design_scores_gemma":[0.000049654605,0.0013556934,0.99295926,0.000008366558,0.00005298757,0.0012718376,0.00014086935,0.0019141942,0.0019853802,0.000017511566,0.00023923501,0.0000050512776],"about_ca_topic_score_codex":0.00049652223,"about_ca_topic_score_gemma":0.00063048134,"teacher_disagreement_score":0.00058610615,"about_ca_system_score_codex":0.00013947001,"about_ca_system_score_gemma":0.000083627674,"threshold_uncertainty_score":0.0026270747},"labels":[],"label_agreement":null},{"id":"W2166156877","doi":"10.1111/bjh.12842","title":"Clinical presentation and molecular basis of congenital antithrombin deficiency in children: a cohort study","year":2014,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Blood Coagulation and Thrombosis Mechanisms","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; University of Toronto; McMaster Children's Hospital","funders":"","keywords":"Medicine; Cohort; Pedigree chart; Pediatrics; Family history; Antithrombin III deficiency; Internal medicine; Antithrombin; Genetics; Gene; Heparin","score_opus":0.014809815999926068,"score_gpt":0.311962380162508,"score_spread":0.2971525641625819,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2166156877","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99921334,0.00013301443,0.00013198722,0.000015904241,0.0000040015893,0.0000133049,0.00028988897,0.0000034614095,0.00019494584],"genre_scores_gemma":[0.99900824,0.0001738971,0.00017869673,0.000020354773,0.000009552007,0.000018776893,0.00046137572,0.000006517339,0.0001225885],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9993024,0.00011689623,0.000073305855,0.00024602402,0.00013276837,0.00012856159],"domain_scores_gemma":[0.9987692,0.00023997,0.0003925709,0.00017495907,0.00014481672,0.0002785055],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00046125773,0.00052297476,0.0006791283,0.0012188989,0.0008127092,0.0007294036,0.00036069937,0.00042478056,0.0015366831],"category_scores_gemma":[0.0021468806,0.0003747931,0.0005966745,0.0011765884,0.00043566548,0.00048483614,0.0007242392,0.00053942745,0.0003304172],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007064084,0.000026434316,0.9964561,0.000007528874,0.00003578948,0.001387593,0.0002474727,0.000032122072,0.00043604875,0.000022699245,0.00010998774,0.0011675587],"study_design_scores_gemma":[0.0000131390925,0.00030196866,0.9829505,0.00001159376,0.00005626207,0.01502795,0.0006104893,0.00008454028,0.00016701425,0.000031520005,0.00073236326,0.000012568235],"about_ca_topic_score_codex":0.005489855,"about_ca_topic_score_gemma":0.004983875,"teacher_disagreement_score":0.005489855,"about_ca_system_score_codex":0.00043198923,"about_ca_system_score_gemma":0.00060166646,"threshold_uncertainty_score":0.010915816},"labels":[],"label_agreement":null},{"id":"W2166273322","doi":"10.1111/bjh.13452","title":"Dysregulated arginine metabolism and cardiopulmonary dysfunction in patients with thalassaemia","year":2015,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":34,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto General Hospital","funders":"National Center for Advancing Translational Sciences; National Center for Research Resources; National Institutes of Health; Translational Cancer Research Network; National Heart, Lung, and Blood Institute; U.S. Food and Drug Administration; Georgia Clinical and Translational Science Alliance","keywords":"Medicine; Internal medicine; Cardiology; Pulmonary hypertension; Haemolysis; Immunology","score_opus":0.006200360883476113,"score_gpt":0.20430049996936722,"score_spread":0.1981001390858911,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2166273322","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9994584,0.00029929023,0.00007641233,0.000012075402,0.0000024047588,0.0000041278618,0.000022395556,0.0000020233344,0.00012294391],"genre_scores_gemma":[0.99977225,0.00008524218,0.000050995328,0.000010557617,0.000009328552,0.000003056351,0.00003605875,6.242038e-7,0.000031946438],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9996257,0.000108952125,0.000049396032,0.000095084666,0.000074659576,0.000046072997],"domain_scores_gemma":[0.9993705,0.00014966929,0.00026021755,0.000047081878,0.000046513967,0.00012607698],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00041945153,0.000393575,0.0004492726,0.00090910925,0.0004472619,0.0006423628,0.0002084903,0.00047759266,0.000999725],"category_scores_gemma":[0.0015645548,0.00022176479,0.00025547587,0.000469955,0.0003944626,0.0003399957,0.00032993688,0.00034355308,0.00014093186],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000309299,0.000049273654,0.9959869,0.000011994722,0.000037814894,0.0008992791,0.00012590906,0.000023414217,0.0010955979,0.000019387795,0.000024188492,0.0014169305],"study_design_scores_gemma":[0.000013033397,0.00045310368,0.99323565,0.0000062477275,0.000043027627,0.0056830985,0.00016127553,0.000115480245,0.0001583755,0.000039414692,0.00008603666,0.0000052033924],"about_ca_topic_score_codex":0.0005811191,"about_ca_topic_score_gemma":0.00043301788,"teacher_disagreement_score":0.000999725,"about_ca_system_score_codex":0.00015699747,"about_ca_system_score_gemma":0.00012749314,"threshold_uncertainty_score":0.0033444166},"labels":[],"label_agreement":null},{"id":"W2167591463","doi":"10.1046/j.1365-2141.2000.01920.x","title":"A new mutation (G51C) in the iron‐responsive element (IRE) of <scp>l</scp>‐ferritin associated with hyperferritinaemia–cataract syndrome decreases the binding affinity of the mutated IRE for iron‐regulatory proteins","year":2000,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"RNA and protein synthesis mechanisms","field":"Biochemistry, Genetics and Molecular Biology","cited_by":42,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of British Columbia","funders":"","keywords":"Ferritin; Point mutation; Mutation; Chemistry; Gene; Molecular biology; Cell biology; Biology; Genetics; Biochemistry","score_opus":0.009340888441430854,"score_gpt":0.22319651720773828,"score_spread":0.21385562876630743,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2167591463","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99205434,0.00056846824,0.0025199382,0.00048820607,0.00019019694,0.0001426656,0.0006183757,0.00015760347,0.0032601918],"genre_scores_gemma":[0.99529004,0.0002282582,0.002119169,0.0002649943,0.000066132874,0.000026090747,0.0003500585,0.000038064154,0.0016172822],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99966204,0.000042731015,0.000034249388,0.00009668932,0.00008877586,0.00007555111],"domain_scores_gemma":[0.9994611,0.00016946705,0.00012050902,0.000041167692,0.00006992262,0.00013790744],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001841173,0.0015369077,0.00047357095,0.00074354484,0.001160613,0.0003395406,0.0006550948,0.0019102187,0.0030617747],"category_scores_gemma":[0.0010399825,0.00022256677,0.00089854316,0.0005034073,0.0013043681,0.00019091416,0.000439586,0.0007086844,0.0006926731],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017144937,0.00050637394,0.019158939,0.00039048595,0.00035285286,0.15875493,0.001060966,0.0020302532,0.7796329,0.0017415497,0.002823803,0.031832404],"study_design_scores_gemma":[0.0008680448,0.0027206317,0.30909654,0.00025355056,0.00074179226,0.33126968,0.0011378487,0.006259616,0.31879964,0.0009068827,0.027474474,0.0004712439],"about_ca_topic_score_codex":0.061357234,"about_ca_topic_score_gemma":0.055980098,"teacher_disagreement_score":0.061357234,"about_ca_system_score_codex":0.0014424195,"about_ca_system_score_gemma":0.0017191283,"threshold_uncertainty_score":0.12200016},"labels":[],"label_agreement":null},{"id":"W2167772724","doi":"10.1111/j.1365-2141.2007.06897.x","title":"Neutrophil elastase mutations and risk of leukaemia in severe congenital neutropenia","year":2007,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Blood disorders and treatments","field":"Biochemistry, Genetics and Molecular Biology","cited_by":97,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"National Institute of Diabetes and Digestive and Kidney Diseases; National Institute of Allergy and Infectious Diseases; National Institutes of Health","keywords":"Congenital Neutropenia; Neutropenia; Medicine; Internal medicine; Neutrophil elastase; Cyclic neutropenia; Bone marrow failure; Absolute neutrophil count; Bone marrow; Granulocyte colony-stimulating factor; Immunology; Myeloid; Chemotherapy; Haematopoiesis; Biology; Genetics; Inflammation; Stem cell","score_opus":0.004255106154128514,"score_gpt":0.22641033152833667,"score_spread":0.22215522537420815,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2167772724","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9997545,0.00007609677,0.000023689518,0.000009461362,5.46091e-7,0.0000013423086,0.000020202015,8.523636e-7,0.00011330364],"genre_scores_gemma":[0.999841,0.000031537897,0.00003093212,0.0000045700826,0.0000017774572,9.635891e-7,0.000032827862,4.707265e-7,0.000055871053],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99969196,0.00010063052,0.000028857701,0.00007064998,0.00006254163,0.000045338355],"domain_scores_gemma":[0.9990584,0.00019445665,0.000377087,0.000059047,0.00005368933,0.0002572636],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003782838,0.00020352358,0.00023761851,0.0006358787,0.00032175786,0.0003242052,0.00020721402,0.00044001863,0.0010568459],"category_scores_gemma":[0.0016543036,0.0002244155,0.00016359522,0.00044773478,0.00042634603,0.00019439842,0.00042393245,0.00037961194,0.00010114382],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00025246508,0.000022838954,0.9949567,0.000006609846,0.000032023796,0.0005796651,0.00014479997,0.000116422525,0.0019767163,0.000035800196,0.000046265355,0.0018296404],"study_design_scores_gemma":[0.0000069581433,0.00012127865,0.9970282,0.0000036935958,0.000013785956,0.0022394431,0.00006341945,0.00017110862,0.0002029283,0.00003158039,0.0001133997,0.000004149187],"about_ca_topic_score_codex":0.0031374863,"about_ca_topic_score_gemma":0.0033652112,"teacher_disagreement_score":0.0031374863,"about_ca_system_score_codex":0.00022745808,"about_ca_system_score_gemma":0.00021779702,"threshold_uncertainty_score":0.0062384605},"labels":[],"label_agreement":null},{"id":"W2170261953","doi":"10.1111/j.1365-2141.2008.06999.x","title":"Toll‐like receptor 4 ligand can differentially modulate the release of cytokines by human platelets","year":2008,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Immune Response and Inflammation","field":"Immunology and Microbiology","cited_by":137,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba","funders":"","keywords":"Platelet; Angiogenin; TLR4; Platelet activation; Cytokine; Receptor; Toll-like receptor; Monoclonal antibody; Lipopolysaccharide; Growth factor; Chemistry; Platelet-derived growth factor receptor; Biology; Cell biology; Molecular biology; Immunology; Biochemistry; Antibody; Cancer research; Innate immune system; Angiogenesis","score_opus":0.009058776191474764,"score_gpt":0.2116198140966306,"score_spread":0.20256103790515584,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2170261953","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9937064,0.0038515166,0.0010503916,0.00011882245,0.000032066597,0.00003419555,0.00017263637,0.000011880653,0.001022063],"genre_scores_gemma":[0.99509037,0.0017463336,0.0011587244,0.00010869784,0.000040642557,0.00006896878,0.0005471485,0.0000036989752,0.0012352987],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99984443,0.00006411709,0.000013335287,0.00001576112,0.00002468506,0.00003768275],"domain_scores_gemma":[0.9999578,0.000016496113,0.000008927122,0.000004837497,0.0000055959467,0.000006337036],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015773815,0.0002034873,0.00013724506,0.00009603261,0.00005832674,0.0002416566,0.00008723265,0.00023788259,0.0012701077],"category_scores_gemma":[0.0002296444,0.00009641248,0.00016470824,0.00008722442,0.00007326001,0.00012867284,0.0001475153,0.00025829882,0.00035398116],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007424602,0.00003910564,0.0005900443,0.00006865472,0.000010808657,0.00019824624,0.00002868343,0.000054359527,0.9950422,0.00006218523,0.00008092643,0.003082407],"study_design_scores_gemma":[0.000155448,0.002133157,0.020711359,0.000023598635,0.000073072304,0.0013034064,0.00008862482,0.00095918536,0.9691076,0.00013346391,0.0053015347,0.000009489064],"about_ca_topic_score_codex":0.00008821935,"about_ca_topic_score_gemma":0.00009908307,"teacher_disagreement_score":0.0012701077,"about_ca_system_score_codex":0.000075081625,"about_ca_system_score_gemma":0.00007331403,"threshold_uncertainty_score":0.0042489767},"labels":[],"label_agreement":null},{"id":"W2171267773","doi":"10.1046/j.1365-2141.2002.03973.x","title":"Comparison of outcome following allogeneic bone marrow transplantation with cyclophosphamide–total body irradiation versus busulphan–cyclophosphamide conditioning regimens for acute myelogenous leukaemia in first remission","year":2002,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":101,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Children's Hospital; Princess Margaret Cancer Centre","funders":"National Cancer Institute","keywords":"Total body irradiation; Cyclophosphamide; Medicine; Internal medicine; Bone marrow; Busulfan; Transplantation; Gastroenterology; Surgery; Chemotherapy","score_opus":0.026056513904695936,"score_gpt":0.30676602770503475,"score_spread":0.2807095138003388,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2171267773","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99880314,0.0009134462,0.00007340408,0.000035082783,0.000008692729,0.00001001432,0.000019049767,0.000002208142,0.00013498693],"genre_scores_gemma":[0.99944264,0.00027664422,0.00004561703,0.000026856178,0.000028838042,0.0000066702128,0.00012890254,0.0000011879113,0.0000426683],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9993345,0.00033962578,0.00004705096,0.000062088315,0.00012830591,0.00008835325],"domain_scores_gemma":[0.99863535,0.00038131516,0.00053818483,0.00006616672,0.00006411563,0.0003147385],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013866845,0.0003248193,0.0005501096,0.0003619139,0.00018101238,0.00036721022,0.00022578416,0.00035523673,0.00046298624],"category_scores_gemma":[0.0028212212,0.00011278964,0.00067002856,0.00034275255,0.00027345197,0.00023730403,0.00028081567,0.0004712723,0.000112686],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.050063316,0.0015975147,0.8613691,0.00032306803,0.002373484,0.0010725467,0.00029684778,0.002590904,0.008379595,0.000148019,0.00043178207,0.07135383],"study_design_scores_gemma":[0.0011980827,0.029681968,0.96342003,0.000050654427,0.0006534616,0.0013850858,0.00012218124,0.0015478296,0.0013484865,0.00014317533,0.0004330887,0.000015886462],"about_ca_topic_score_codex":0.0006791377,"about_ca_topic_score_gemma":0.0012079265,"teacher_disagreement_score":0.0013866845,"about_ca_system_score_codex":0.0005353775,"about_ca_system_score_gemma":0.00032680633,"threshold_uncertainty_score":0.0073335767},"labels":[],"label_agreement":null},{"id":"W2173155709","doi":"10.1111/bjh.13810","title":"Laboratory measurement of the direct oral anticoagulants","year":2015,"lang":"en","type":"review","venue":"British Journal of Haematology","topic":"Atrial Fibrillation Management and Outcomes","field":"Medicine","cited_by":100,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Thrombosis and Atherosclerosis Research Institute; McMaster University; Population Health Research Institute","funders":"Canadian Institutes of Health Research","keywords":"Rivaroxaban; Edoxaban; Apixaban; Dabigatran; Medicine; Anticoagulant; Discovery and development of direct thrombin inhibitors; Pharmacology; Coagulation; Direct thrombin inhibitor; Drug; Warfarin; Thrombin; Internal medicine; Atrial fibrillation","score_opus":0.1989839693630975,"score_gpt":0.39664341475641934,"score_spread":0.19765944539332184,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2173155709","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0011447317,0.99142903,0.0011318167,0.00071842707,0.00036675856,0.00004375889,0.0002974912,0.000047399593,0.004820597],"genre_scores_gemma":[0.012340385,0.98194444,0.0015757519,0.0005949812,0.00049974694,0.00006480551,0.0006744332,0.00000860777,0.0022968824],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99810576,0.00042140702,0.00035805168,0.0002557632,0.0007656511,0.00009332335],"domain_scores_gemma":[0.9981201,0.0007094926,0.00044565203,0.00008052722,0.0005990667,0.000045186585],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015941202,0.0012128876,0.0022027632,0.00414458,0.0002121702,0.0012540694,0.0010170887,0.0009094255,0.004133442],"category_scores_gemma":[0.0035016695,0.00024270768,0.0011805389,0.0038520158,0.00060243567,0.00093858544,0.00064701244,0.0011197333,0.0022769591],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018218944,0.00012931676,0.0061762044,0.022546439,0.0006459829,0.0003777912,0.00014133623,0.0002775997,0.002187076,0.0023770162,0.03469872,0.93026036],"study_design_scores_gemma":[0.00008994037,0.0003656582,0.022678494,0.02193851,0.0014685009,0.010662548,0.0002997598,0.0003825301,0.0044808267,0.005617841,0.93191475,0.00010074515],"about_ca_topic_score_codex":0.0018350075,"about_ca_topic_score_gemma":0.001512903,"teacher_disagreement_score":0.00414458,"about_ca_system_score_codex":0.00051137904,"about_ca_system_score_gemma":0.0010574925,"threshold_uncertainty_score":0.013827682},"labels":[],"label_agreement":null},{"id":"W2182872902","doi":"10.1111/bjh.13855","title":"A phase <scp>II</scp> study of cyclophosphamide, etoposide, vincristine and prednisone ( <scp>CEOP</scp> ) Alternating with Pralatrexate (P) as front line therapy for patients with peripheral T‐cell lymphoma ( <scp>PTCL</scp> ): final results from the T‐ cell consortium trial","year":2015,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":93,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"National Cancer Institute; Genentech; Spectrum Pharmaceuticals","keywords":"Vincristine; Etoposide; Medicine; Cyclophosphamide; Prednisone; Lymphoma; Internal medicine; Chemotherapy","score_opus":0.02110693813914477,"score_gpt":0.2709042396403967,"score_spread":0.24979730150125196,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2182872902","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9935713,0.0013226029,0.0003882683,0.0003349237,0.00010458723,0.001875475,0.00063453335,0.000067625,0.0017007346],"genre_scores_gemma":[0.9887567,0.0015681699,0.0016780422,0.0010085278,0.00021222852,0.0019038072,0.0020385375,0.000031869316,0.00280207],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.99968386,0.00016578365,0.000013168135,0.000047687034,0.000030845724,0.000058718957],"domain_scores_gemma":[0.99948394,0.00010334978,0.00009292184,0.000045788114,0.00002734793,0.00024660435],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012474034,0.0012858546,0.0011736718,0.00046339052,0.00031196617,0.0007912031,0.00057034043,0.0010275327,0.002599684],"category_scores_gemma":[0.0005834158,0.00040771806,0.0011014794,0.00029527338,0.00070146145,0.0006266548,0.00029043708,0.0023341207,0.00045046734],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.787361,0.05425408,0.0047171963,0.00074512174,0.0013712835,0.00029949113,0.00025648272,0.0028400829,0.040058807,0.00047199638,0.0041542673,0.10347016],"study_design_scores_gemma":[0.6681331,0.3190626,0.0054934677,0.000028808094,0.00039059494,0.0002260396,0.000034958735,0.0011341537,0.002996094,0.00021830652,0.0022603283,0.000021549246],"about_ca_topic_score_codex":0.00091828546,"about_ca_topic_score_gemma":0.0023795438,"teacher_disagreement_score":0.002599684,"about_ca_system_score_codex":0.00074562954,"about_ca_system_score_gemma":0.0011029767,"threshold_uncertainty_score":0.0086967945},"labels":[],"label_agreement":null},{"id":"W2214404358","doi":"10.1111/bjh.13876","title":"Relative frequency of non‐Hodgkin lymphoma subtypes in selected centres in North Africa, the middle east and India: a review of 971 cases","year":2015,"lang":"en","type":"review","venue":"British Journal of Haematology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba","funders":"","keywords":"Hodgkin lymphoma; Lymphoma; Medicine; Epidemiology; Internal medicine; Follicular lymphoma; Gastroenterology","score_opus":0.06435771200033749,"score_gpt":0.29654128465463137,"score_spread":0.23218357265429387,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2214404358","genre_codex":"empirical","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.85663164,0.1397114,0.00027602553,0.00013674135,0.0000629442,0.00005573851,0.0008909644,0.00002832632,0.0022062466],"genre_scores_gemma":[0.9294448,0.069058165,0.000289582,0.00009602496,0.000056728746,0.00003860729,0.0008141668,0.0000073250035,0.00019454487],"study_design_codex":"observational","study_design_gemma":"systematic_review","domain_scores_codex":[0.99893564,0.00016595447,0.0003682226,0.00021857554,0.00023033291,0.00008126959],"domain_scores_gemma":[0.9979797,0.0007925517,0.00081085274,0.00010106509,0.00023630206,0.000079527024],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007169621,0.0002668071,0.0005233819,0.004571811,0.00041868453,0.0009228003,0.0007775812,0.0003301074,0.00080067205],"category_scores_gemma":[0.0016781115,0.00038225038,0.00043611962,0.0056314664,0.0005878317,0.00058386975,0.00043860593,0.00016361987,0.00021687715],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00023831676,0.000030347046,0.8968797,0.005200998,0.00042894442,0.011288249,0.0025269173,0.0001061956,0.0017825194,0.00011115933,0.0011239315,0.08028273],"study_design_scores_gemma":[0.00001415108,0.00009249928,0.95324844,0.001030597,0.0004898315,0.03513336,0.0032932558,0.00006052146,0.0005324474,0.00003265476,0.0060517075,0.000020481282],"about_ca_topic_score_codex":0.0051008007,"about_ca_topic_score_gemma":0.0064266077,"teacher_disagreement_score":0.0051008007,"about_ca_system_score_codex":0.0004902717,"about_ca_system_score_gemma":0.0005426565,"threshold_uncertainty_score":0.010142207},"labels":[],"label_agreement":null},{"id":"W2220332556","doi":"10.1111/bjh.13885","title":"Non‐Hodgkin lymphoma in Southern Africa: review of 487 cases from The International Non‐Hodgkin Lymphoma Classification Project","year":2015,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":36,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba","funders":"Coordenação de Aperfeiçoamento de Pessoal de Nível Superior; University of Nebraska Medical Center","keywords":"Lymphoma; Hodgkin lymphoma; Epidemiology; Medicine; Follicular lymphoma; Internal medicine; Demography; Human immunodeficiency virus (HIV); Oncology; Immunology","score_opus":0.0644318610691131,"score_gpt":0.3120596814207806,"score_spread":0.24762782035166753,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2220332556","genre_codex":"empirical","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.66989815,0.32001284,0.0005254082,0.00062898966,0.00021217561,0.00020507793,0.003258887,0.000042262673,0.0052161464],"genre_scores_gemma":[0.78628504,0.20700856,0.00073818606,0.0003091743,0.00016035775,0.0001747623,0.004738386,0.000018215633,0.0005672508],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9992648,0.00013773987,0.00022634352,0.00009988053,0.00018961281,0.00008159891],"domain_scores_gemma":[0.99851805,0.00043989878,0.00050788827,0.000079844096,0.00035384484,0.00010042698],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013834159,0.00039170988,0.0004609325,0.006304188,0.00045832293,0.00058140774,0.00051120576,0.00028283542,0.0011964138],"category_scores_gemma":[0.0025261082,0.00029985898,0.00030451806,0.0075702164,0.00053680927,0.0005687241,0.00042133944,0.00015404841,0.00030083943],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00032798716,0.00004111886,0.69574124,0.007170098,0.00030353357,0.010014211,0.002681119,0.0001920065,0.0024284052,0.00023176975,0.009230333,0.27163818],"study_design_scores_gemma":[0.000039392788,0.00008183989,0.9358059,0.002870052,0.00031056983,0.01739929,0.0025256816,0.000082469574,0.00039071377,0.00007682898,0.04039751,0.0000198706],"about_ca_topic_score_codex":0.011701841,"about_ca_topic_score_gemma":0.012879905,"teacher_disagreement_score":0.011701841,"about_ca_system_score_codex":0.0005661608,"about_ca_system_score_gemma":0.00090950605,"threshold_uncertainty_score":0.023267508},"labels":[],"label_agreement":null},{"id":"W2224902945","doi":"10.1111/bjh.13903","title":"Late mortality, secondary malignancy and hospitalisation in teenage and young adult survivors of Hodgkin lymphoma: report of the Childhood/Adolescent/Young Adult Cancer Survivors Research Program and the <scp>BC</scp> Cancer Agency Centre for Lymphoid Cancer","year":2016,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Childhood Cancer Survivors' Quality of Life","field":"Medicine","cited_by":49,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency; BC Children's Hospital; University of British Columbia","funders":"Canadian Cancer Society Research Institute; University of British Columbia; Canadian Cancer Society; Cancer Research Institute","keywords":"Medicine; Hazard ratio; Malignancy; Standardized mortality ratio; Cancer registry; Cancer; Pediatrics; Incidence (geometry); Confidence interval; Radiation therapy; Internal medicine; Proportional hazards model; Young adult","score_opus":0.02136133460009234,"score_gpt":0.3242810595503829,"score_spread":0.30291972495029057,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2224902945","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9988675,0.0005049123,0.000027961705,0.000029641571,0.000002449524,0.000004216701,0.00040132977,0.0000014789201,0.00016052408],"genre_scores_gemma":[0.99849427,0.0005649565,0.00003707449,0.000013832205,0.000007882427,0.000008066776,0.00071950146,0.0000011742278,0.00015333189],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9997017,0.00007526744,0.000045178964,0.000040741317,0.00007488882,0.00006227079],"domain_scores_gemma":[0.99880254,0.00018588276,0.0005240399,0.00004828451,0.00021668797,0.00022252493],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00065588224,0.00016029098,0.00021927242,0.0006905628,0.00020731876,0.00040344038,0.0002202646,0.00019669528,0.0005189209],"category_scores_gemma":[0.0017642053,0.00017432262,0.000305739,0.0007563067,0.00017172622,0.00020667238,0.00037907835,0.00028584886,0.00008856375],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000025330202,0.0000048809484,0.9985784,0.000007890064,0.00001922162,0.000039668113,0.000077107936,0.000012956824,0.000021823947,0.0000025085537,0.000069756956,0.0011403839],"study_design_scores_gemma":[0.0000016740436,0.000020945023,0.9995745,0.000005029529,0.00001454908,0.00012365068,0.000118633805,0.000028543476,0.000021382135,0.000002947819,0.00008683532,0.0000011432459],"about_ca_topic_score_codex":0.050135612,"about_ca_topic_score_gemma":0.06672738,"teacher_disagreement_score":0.9498644,"about_ca_system_score_codex":0.00045938254,"about_ca_system_score_gemma":0.0005987809,"threshold_uncertainty_score":0.09968758},"labels":[],"label_agreement":null},{"id":"W22346506","doi":"10.1155/1994/587573","title":"Hormonal replacement therapy, prothromboic mutations and the risk of venous thrombosis","year":2002,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Venous thrombosis; Thrombosis; Venous thromboembolism; Hormonal therapy; Internal medicine; Intensive care medicine; Cancer; Breast cancer","score_opus":0.020574201144031377,"score_gpt":0.25487942168497907,"score_spread":0.23430522054094768,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W22346506","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99565756,0.0031693159,0.00005690983,0.00024132774,0.000011771895,0.000002637813,0.00006428877,0.0000028204977,0.00079339667],"genre_scores_gemma":[0.9990151,0.0006469972,0.0000534675,0.000033333305,0.000018394498,0.0000015202824,0.00003702501,8.0956323e-7,0.00019338964],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9997794,0.000095446005,0.000022053218,0.00001592822,0.000054115968,0.00003303884],"domain_scores_gemma":[0.9985002,0.0006264292,0.0005150002,0.000034701217,0.000047143003,0.0002764764],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00028991117,0.00009981993,0.00017317585,0.00045168767,0.00020249227,0.00034720742,0.0001361769,0.00039686792,0.0019041237],"category_scores_gemma":[0.0038097205,0.00009767488,0.000103986014,0.0005853198,0.00019004094,0.00016739157,0.000092115035,0.00033546236,0.00011389887],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005358096,0.00006108356,0.9886065,0.000021114387,0.00006801379,0.0010838009,0.00008917118,0.00007788745,0.0005736522,0.00008232763,0.00017307959,0.008627475],"study_design_scores_gemma":[0.000027916964,0.0003128799,0.993224,0.000018851968,0.00005718473,0.005132897,0.000119346776,0.00025003028,0.00017410655,0.00013611643,0.00054211245,0.000004522492],"about_ca_topic_score_codex":0.0026178926,"about_ca_topic_score_gemma":0.0028202878,"teacher_disagreement_score":0.0026178926,"about_ca_system_score_codex":0.00017852562,"about_ca_system_score_gemma":0.00026437972,"threshold_uncertainty_score":0.0063699484},"labels":[],"label_agreement":null},{"id":"W2240689260","doi":"10.1111/bjh.13848","title":"<scp>ROR</scp>1‐based immunomagnetic protocol allows efficient separation of <scp>CLL</scp> and healthy B cells","year":2015,"lang":"en","type":"letter","venue":"British Journal of Haematology","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"Agentura Pro Zdravotnický Výzkum České Republiky","keywords":"Immunomagnetic separation; Protocol (science); Medicine; Chemistry; Chromatography; Pathology","score_opus":0.024498568174911556,"score_gpt":0.32620084715174036,"score_spread":0.3017022789768288,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2240689260","genre_codex":"empirical","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.56579924,0.014242711,0.33146924,0.0023629616,0.0011116675,0.004601742,0.0056620613,0.0066063893,0.06814393],"genre_scores_gemma":[0.7239042,0.0063597998,0.20731711,0.0024719862,0.00032857692,0.0055549876,0.014423067,0.0011181918,0.038522065],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.99894434,0.00016616307,0.00009983574,0.00024372453,0.000410569,0.0001353812],"domain_scores_gemma":[0.9997774,0.000041249383,0.0000331022,0.000054895136,0.00006226636,0.000031169762],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005334917,0.00063536415,0.0006324409,0.00089240255,0.0005414562,0.0006118267,0.00065904437,0.00070833054,0.0046567786],"category_scores_gemma":[0.0004800409,0.0002791002,0.00030331995,0.0005069038,0.00037073385,0.00024539218,0.0006531314,0.0012700611,0.004560251],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012419558,0.00008385296,0.00036221286,0.00016522991,0.000021610376,0.00016004311,0.00008105766,0.00026517073,0.9801471,0.00069230935,0.0031258038,0.014771294],"study_design_scores_gemma":[0.00008057581,0.00041767972,0.007423763,0.000077005665,0.00007826892,0.0013408839,0.000051785806,0.004794253,0.8952806,0.0006017784,0.089797504,0.00005590406],"about_ca_topic_score_codex":0.0007804831,"about_ca_topic_score_gemma":0.0020067443,"teacher_disagreement_score":0.0046567786,"about_ca_system_score_codex":0.0003080636,"about_ca_system_score_gemma":0.00047548546,"threshold_uncertainty_score":0.015578508},"labels":[],"label_agreement":null},{"id":"W2292975070","doi":"10.1111/bjh.14007","title":"Rituximab extended schedule or retreatment trial for low tumour burden non‐follicular indolent B‐cell non‐Hodgkin lymphomas: Eastern Cooperative Oncology Group Protocol E4402","year":2016,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":50,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"National Cancer Institute; National Institutes of Health; U.S. Department of Health and Human Services","keywords":"Rituximab; Medicine; Follicular lymphoma; Internal medicine; Clinical endpoint; Randomization; Lymphoma; Randomized controlled trial; Oncology; Asymptomatic; Gastroenterology; Surgery","score_opus":0.02048215489209315,"score_gpt":0.3183431877896765,"score_spread":0.29786103289758337,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2292975070","genre_codex":"empirical","genre_gemma":"protocol","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"protocol","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.656206,0.018068498,0.006216146,0.004195256,0.001585712,0.25017044,0.025875801,0.0008332341,0.03684889],"genre_scores_gemma":[0.6437936,0.008639723,0.012681389,0.0085161375,0.0007490293,0.26608676,0.019686548,0.00012718065,0.039719574],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9989768,0.00071236776,0.00004909673,0.000072126306,0.00008777072,0.00010190557],"domain_scores_gemma":[0.9993932,0.0001378175,0.00017174463,0.000055802113,0.0000679791,0.00017329135],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0026868402,0.0009635662,0.0012008842,0.00033423942,0.0003410745,0.0007392967,0.00079283974,0.0011686556,0.011599774],"category_scores_gemma":[0.0019857953,0.00041357562,0.0010199905,0.00040112488,0.0004048717,0.00058032287,0.00041539973,0.0018763309,0.0015544151],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.89908224,0.005398118,0.0021965965,0.0027968877,0.0009903876,0.00013606882,0.000132365,0.001135066,0.0057937223,0.001307333,0.01887235,0.062158823],"study_design_scores_gemma":[0.95378786,0.029745994,0.003594583,0.00013718546,0.0002788414,0.00006523313,0.00001636763,0.00069324544,0.00043030674,0.0004988554,0.010737333,0.000014186255],"about_ca_topic_score_codex":0.0008456168,"about_ca_topic_score_gemma":0.0023497574,"teacher_disagreement_score":0.011599774,"about_ca_system_score_codex":0.00073775015,"about_ca_system_score_gemma":0.0016610144,"threshold_uncertainty_score":0.038805127},"labels":[],"label_agreement":null},{"id":"W2298793090","doi":"10.1111/bjh.14033","title":"Patient‐related factors independently impact overall survival in patients with myelodysplastic syndromes: an <scp>MDS</scp>‐<scp>CAN</scp> prospective study","year":2016,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":97,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto General Hospital; Statistics Canada; Queen Elizabeth II Health Sciences Centre; Royal Victoria Hospital; Royal Victoria Regional Health Centre; McGill University Health Centre; Dalhousie University; University of Ottawa; Vancouver General Hospital; Princess Margaret Cancer Centre; Alberta Hospital Edmonton; Hamilton Health Sciences; Dr. Georges-L.-Dumont University Hospital Centre; Saskatchewan Cancer Agency; CancerCare Manitoba; Ottawa Hospital; Health Sciences Centre; University of Alberta Hospital; University Health Network; Nova Scotia Health Authority; St. Paul's Hospital; University of British Columbia; Juravinski Cancer Centre; Jewish General Hospital; Sunnybrook Health Science Centre","funders":"Canadian Institutes of Health Research; Celgene","keywords":"Medicine; Comorbidity; Hazard ratio; Proportional hazards model; Internal medicine; Myelodysplastic syndromes; International Prognostic Scoring System; Prospective cohort study; Confidence interval; Multivariate analysis; Grip strength; Physical therapy","score_opus":0.011184719016116514,"score_gpt":0.26630601102931284,"score_spread":0.25512129201319633,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2298793090","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9990439,0.00037098344,0.000059649992,0.000023982124,0.000004940946,0.000010029533,0.00035921542,0.0000019167858,0.00012542591],"genre_scores_gemma":[0.99901855,0.00013640788,0.00006415388,0.000023499802,0.000019749472,0.000012632528,0.00065635325,0.0000014260455,0.00006713312],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99959284,0.00015540513,0.000051836774,0.00008702295,0.000056938887,0.00005599501],"domain_scores_gemma":[0.9980907,0.00042049598,0.0007023629,0.0001920931,0.00015344482,0.00044082946],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013086599,0.00053972396,0.00045769557,0.0005166748,0.00048513658,0.0007565734,0.0004166303,0.0006116542,0.0014710643],"category_scores_gemma":[0.0019668618,0.00037117413,0.00073780044,0.0008573834,0.00036480476,0.00053646736,0.00055906124,0.0006729461,0.00030454187],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00053143955,0.00004939416,0.9983113,0.00001208403,0.00011007992,0.00004000389,0.00002456946,0.000053468415,0.00007122663,0.000008002167,0.00007057945,0.0007179451],"study_design_scores_gemma":[0.00006114068,0.0004842388,0.9984366,0.000013350754,0.00017214866,0.0002413371,0.00006573396,0.00022841079,0.00005384445,0.000024902158,0.00021208843,0.0000062430904],"about_ca_topic_score_codex":0.0020672982,"about_ca_topic_score_gemma":0.0025567634,"teacher_disagreement_score":0.0020672982,"about_ca_system_score_codex":0.00024770925,"about_ca_system_score_gemma":0.00043480002,"threshold_uncertainty_score":0.0069209337},"labels":[],"label_agreement":null},{"id":"W2300177903","doi":"10.1111/bjh.14038","title":"Increased microcirculation detected by dynamic contrast‐enhanced magnetic resonance imaging is of prognostic significance in asymptomatic myeloma","year":2016,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":34,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"inVentiv Health Clinical","funders":"Dietmar Hopp Stiftung; Deutsche Forschungsgemeinschaft","keywords":"Medicine; Monoclonal gammopathy of undetermined significance; Asymptomatic; Magnetic resonance imaging; Multiple myeloma; Hazard ratio; Radiology; Bone marrow; Nuclear medicine; Dynamic contrast; Clinical significance; Univariate analysis; Internal medicine; Multivariate analysis; Confidence interval; Monoclonal; Monoclonal antibody","score_opus":0.006446553114684086,"score_gpt":0.25826079424191345,"score_spread":0.2518142411272294,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2300177903","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9992095,0.00043934133,0.0001035624,0.000021005755,0.0000041533585,0.0000024935684,0.00003742842,0.0000039290444,0.00017842602],"genre_scores_gemma":[0.99975127,0.00007296736,0.000054019518,0.000008788716,0.000015319798,0.0000018677166,0.00004736065,9.636184e-7,0.000047332836],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99980634,0.00005392387,0.000015182536,0.00005311946,0.00003154977,0.00003996931],"domain_scores_gemma":[0.9991229,0.00030806212,0.00034179495,0.000049362476,0.000053779917,0.0001240517],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003338445,0.00030223254,0.00037514558,0.00050398055,0.00033340207,0.0004966763,0.0002156961,0.0004725496,0.0008677263],"category_scores_gemma":[0.0018033956,0.0002065022,0.0001681569,0.000453914,0.00034276285,0.00030424702,0.00024529462,0.00041225858,0.00014872101],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007592039,0.000029161447,0.9941467,0.000015333539,0.000029997915,0.00031545135,0.000049498547,0.000057362064,0.0017551219,0.000024615747,0.000052386287,0.002765101],"study_design_scores_gemma":[0.000016928554,0.0002861482,0.9977449,0.0000034666352,0.000036498335,0.001141031,0.000047428704,0.00025849606,0.00027442208,0.00004419467,0.00014152413,0.000005001943],"about_ca_topic_score_codex":0.0007943514,"about_ca_topic_score_gemma":0.0006328805,"teacher_disagreement_score":0.0008677263,"about_ca_system_score_codex":0.00016279895,"about_ca_system_score_gemma":0.00016625313,"threshold_uncertainty_score":0.0029028058},"labels":[],"label_agreement":null},{"id":"W2305844465","doi":"10.1111/bjh.13993","title":"Bortezomib in the treatment of refractory thrombotic thrombocytopenic purpura","year":2016,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Complement system in diseases","field":"Immunology and Microbiology","cited_by":82,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Bortezomib; Medicine; Thrombotic thrombocytopenic purpura; Rituximab; Internal medicine; Refractory (planetary science); Gastroenterology; Surgery; Multiple myeloma; Platelet; Lymphoma","score_opus":0.024693447355493295,"score_gpt":0.27605972359650444,"score_spread":0.25136627624101116,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2305844465","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96898717,0.028334273,0.0003381144,0.00039649504,0.000051713814,0.00004993134,0.00008014421,0.00003711502,0.0017250082],"genre_scores_gemma":[0.99280083,0.00586925,0.00040413233,0.0003066765,0.00012909339,0.000019418869,0.00013952002,0.000006211872,0.00032472186],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.99971145,0.0001066168,0.00005218599,0.0000369188,0.00004733691,0.000045509398],"domain_scores_gemma":[0.9993986,0.00023203403,0.00015974362,0.000022459491,0.000027057495,0.00016007759],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003631323,0.00030882144,0.00078953337,0.00034361647,0.0003637182,0.00035723636,0.00023524322,0.00039318576,0.0009892536],"category_scores_gemma":[0.0013504596,0.0001403243,0.00034503455,0.00036894117,0.00024640595,0.00013854785,0.00021209678,0.00045060477,0.00023199013],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.013689467,0.0009320315,0.44825196,0.0021622581,0.0008455223,0.09566905,0.0014092542,0.0017174117,0.053898323,0.0002602449,0.0052020103,0.37596247],"study_design_scores_gemma":[0.0021660798,0.013188554,0.771097,0.00042348454,0.00048245335,0.18735006,0.00049746246,0.001520826,0.006197164,0.00020232092,0.016840983,0.000033512097],"about_ca_topic_score_codex":0.0006761269,"about_ca_topic_score_gemma":0.0017395266,"teacher_disagreement_score":0.0009892536,"about_ca_system_score_codex":0.0003086981,"about_ca_system_score_gemma":0.0002632087,"threshold_uncertainty_score":0.003309369},"labels":[],"label_agreement":null},{"id":"W2335871284","doi":"10.1111/bjh.14074","title":"Adolescent and young adult non‐Hodgkin lymphoma","year":2016,"lang":"en","type":"review","venue":"British Journal of Haematology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":36,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Lymphoma; Medicine; Hodgkin lymphoma; Young adult; Lymphoblastic lymphoma; Incidence (geometry); Population; Anaplastic large-cell lymphoma; Oncology; Internal medicine; Pediatrics; Immunology; T cell; Environmental health","score_opus":0.01933729423817133,"score_gpt":0.3062607323202361,"score_spread":0.2869234380820648,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2335871284","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000251856,0.9981949,0.00004654089,0.00017665562,0.00009560241,0.0000053050862,0.000028763527,0.000005234916,0.0011950284],"genre_scores_gemma":[0.0021304216,0.99696016,0.00008892619,0.0001837345,0.00009896186,0.0000064460933,0.000052595857,0.0000011480619,0.00047767514],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.999811,0.000034864705,0.000041333387,0.00002915426,0.00006303804,0.000020660556],"domain_scores_gemma":[0.9997315,0.00012377017,0.00005669405,0.000006479071,0.000057516492,0.000023964916],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00029065285,0.00037732557,0.00083167996,0.001429563,0.0002251004,0.00065588666,0.00038363156,0.0005433451,0.0041187275],"category_scores_gemma":[0.0009544634,0.00014057312,0.00037926793,0.0013384472,0.00023466685,0.00063446123,0.0004073082,0.0007938618,0.0013264638],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000058101865,0.00003460591,0.0011051267,0.022572076,0.000098038065,0.00048606866,0.00010799667,0.00013563332,0.0005287393,0.0010803654,0.03277312,0.9410202],"study_design_scores_gemma":[0.000020406434,0.00006618851,0.004775783,0.015346482,0.00018938251,0.008176141,0.00014552582,0.00004124069,0.00024693497,0.0008988329,0.97007984,0.000013384525],"about_ca_topic_score_codex":0.0016467025,"about_ca_topic_score_gemma":0.0030548205,"teacher_disagreement_score":0.0041187275,"about_ca_system_score_codex":0.00036029195,"about_ca_system_score_gemma":0.0008271919,"threshold_uncertainty_score":0.013778567},"labels":[],"label_agreement":null},{"id":"W2336690489","doi":"10.1111/bjh.14093","title":"Residual disease detected by flow cytometry is an independent predictor of survival in childhood acute myeloid leukaemia; results of the <scp>NOPHO</scp>‐<scp>AML</scp> 2004 study","year":2016,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":84,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto General Hospital; University Health Network","funders":"Stiftelsen Assar Gabrielssons Fond","keywords":"Flow cytometry; Myeloid leukaemia; Minimal residual disease; Myeloid; Residual; Disease; Medicine; Immunology; Oncology; Cancer research; Internal medicine; Leukemia; Computer science","score_opus":0.012338223372052443,"score_gpt":0.26754120234998485,"score_spread":0.2552029789779324,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2336690489","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.998833,0.000653846,0.00008237153,0.0000287059,0.0000042450083,0.000009076033,0.00021367996,0.000004297145,0.0001707978],"genre_scores_gemma":[0.99885035,0.00012491057,0.00010331352,0.00001997506,0.000009721039,0.000008170594,0.00075922994,0.0000025834404,0.00012165683],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9993426,0.0002519754,0.00006558787,0.00012662182,0.00015086368,0.000062251216],"domain_scores_gemma":[0.997747,0.00066061167,0.0007800542,0.00021896164,0.00019792008,0.00039552452],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0020202738,0.00038583882,0.0004470818,0.00040494214,0.00021235317,0.0008017657,0.00033332803,0.00055910816,0.00033800455],"category_scores_gemma":[0.0022039383,0.00020581068,0.00037816644,0.00038196406,0.00033924083,0.00029904302,0.00026683303,0.0005007882,0.00014780322],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0032666402,0.00011596353,0.9883724,0.000026059577,0.00013827623,0.00006699387,0.00006829566,0.000242976,0.0026623886,0.000012511096,0.00016351357,0.0048638764],"study_design_scores_gemma":[0.00011987295,0.0010060079,0.99696475,0.0000056289646,0.000114626,0.00023038083,0.000023110359,0.00040668802,0.00064575823,0.000015100092,0.00046143663,0.0000066075654],"about_ca_topic_score_codex":0.0019396261,"about_ca_topic_score_gemma":0.0019623917,"teacher_disagreement_score":0.0020202738,"about_ca_system_score_codex":0.0004022286,"about_ca_system_score_gemma":0.0003284784,"threshold_uncertainty_score":0.010684311},"labels":[],"label_agreement":null},{"id":"W2337251176","doi":"10.1111/bjh.14084","title":"Comparison of international normalized ratio audit parameters in patients enrolled in GARFIELD‐AF and treated with vitamin K antagonists","year":2016,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Atrial Fibrillation Management and Outcomes","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Medicine; Atrial fibrillation; Internal medicine; Confidence interval; Vitamin K antagonist; Warfarin; Concordance; Cardiology; Gastroenterology","score_opus":0.023763203230809004,"score_gpt":0.31243937967231206,"score_spread":0.28867617644150306,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2337251176","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99949443,0.000065376626,0.000070371636,0.000012243367,0.000004668535,0.0000062996414,0.0001111922,0.0000027564197,0.00023272271],"genre_scores_gemma":[0.9995573,0.00002426488,0.000048198526,0.000010907187,0.0000058664987,0.0000057699262,0.00030502726,0.0000021560431,0.000040522948],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9954014,0.0019101462,0.0006688332,0.0007979991,0.0008068315,0.00041491564],"domain_scores_gemma":[0.9855892,0.0060946406,0.0053702905,0.0010196051,0.0012291879,0.00069708406],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0042247674,0.00031497623,0.00087216723,0.0013448291,0.00026939876,0.0012123758,0.00049926154,0.00077172107,0.00067368377],"category_scores_gemma":[0.019080278,0.00028436474,0.0005563895,0.001614431,0.00045487646,0.0007721135,0.00074191764,0.00066279725,0.00022367832],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006481355,0.000022747334,0.9979607,0.0000065004238,0.00007524005,0.000029819732,0.000133583,0.00006855749,0.00009102813,0.0000137962315,0.00003738781,0.00091247115],"study_design_scores_gemma":[0.000020019419,0.00020954966,0.9988971,0.000004129279,0.000034396373,0.00009488243,0.0001465934,0.00042405492,0.00006206102,0.000024059185,0.00007724348,0.0000058710325],"about_ca_topic_score_codex":0.0025608828,"about_ca_topic_score_gemma":0.0022227217,"teacher_disagreement_score":0.0042247674,"about_ca_system_score_codex":0.00048651316,"about_ca_system_score_gemma":0.0003103453,"threshold_uncertainty_score":0.02234292},"labels":[],"label_agreement":null},{"id":"W2337260374","doi":"10.1111/bjh.14076","title":"Economic impact of genomic diagnostics for intermediate‐risk acute myeloid leukaemia","year":2016,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Terry Fox Research Institute; Canadian Centre for Applied Research in Cancer Control; Vancouver General Hospital; Canada's Michael Smith Genome Sciences Centre; University of British Columbia; Simon Fraser University; BC Cancer Agency","funders":"Canadian Cancer Society; European Society for Medical Oncology; Genome British Columbia; Canadian Centre for Applied Research in Cancer Control","keywords":"Transplantation; Medicine; Quality of life (healthcare); Myeloid leukaemia; Oncology; Cost effectiveness; Cost-effectiveness analysis; Intensive care medicine; Internal medicine; Risk analysis (engineering)","score_opus":0.01220701428138869,"score_gpt":0.310135410717287,"score_spread":0.2979283964358983,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2337260374","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.93756354,0.010528042,0.015590763,0.010216144,0.00019446803,0.00048406058,0.0025783805,0.00010160086,0.022742968],"genre_scores_gemma":[0.9949244,0.0014902771,0.0023812214,0.00029028056,0.000015188101,0.00003322614,0.0003425734,0.000007837314,0.00051499746],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99731207,0.0019213683,0.00006485029,0.00010503438,0.00035532843,0.00024141083],"domain_scores_gemma":[0.9921246,0.0067077223,0.00043274823,0.00010289146,0.00031451206,0.00031751583],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0034123217,0.0006578032,0.0005288019,0.0008136542,0.00034338902,0.0018377283,0.00064204726,0.00077064446,0.0031940176],"category_scores_gemma":[0.01754775,0.00023896557,0.00096331467,0.00093666866,0.00068012736,0.0011306907,0.00093405833,0.0012124573,0.00014806165],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004663326,0.00066993316,0.048951965,0.000678814,0.00086672226,0.0005249542,0.0001223993,0.7724026,0.0011672092,0.026016666,0.0050111646,0.13892423],"study_design_scores_gemma":[0.0010660478,0.002580381,0.07008903,0.00057726156,0.002121585,0.0008256427,0.001079212,0.8655094,0.0018155682,0.042704627,0.011446775,0.00018450149],"about_ca_topic_score_codex":0.06443494,"about_ca_topic_score_gemma":0.059691705,"teacher_disagreement_score":0.06443494,"about_ca_system_score_codex":0.008588164,"about_ca_system_score_gemma":0.006269965,"threshold_uncertainty_score":0.12811977},"labels":[],"label_agreement":null},{"id":"W2339180098","doi":"10.1111/bjh.14100","title":"Outcomes of <scp>MYC</scp>‐associated lymphomas after R‐<scp>CHOP</scp> with and without consolidative autologous stem cell transplant: subset analysis of randomized trial intergroup <scp>SWOG</scp> S9704","year":2016,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":35,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Juravinski Cancer Centre; McMaster University; Queen Elizabeth II Health Sciences Centre; Dalhousie University","funders":"National Cancer Institute; National Institutes of Health; Bristol-Myers Squibb","keywords":"Vincristine; CHOP; Rituximab; Medicine; Cyclophosphamide; Autologous stem-cell transplantation; Lymphoma; Internal medicine; Prednisolone; Stem cell; Oncology; Immunology; Chemotherapy; Biology","score_opus":0.008891470140877315,"score_gpt":0.24090978472075344,"score_spread":0.23201831457987612,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2339180098","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.998317,0.00082562503,0.00008336247,0.00006596394,0.000026013731,0.00015872747,0.00025628958,0.0000069494863,0.0002599993],"genre_scores_gemma":[0.99770564,0.00035832258,0.00015535406,0.00014521499,0.00006108997,0.00019272677,0.0011887137,0.0000050756885,0.0001878245],"study_design_codex":"randomized_trial","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9976897,0.0015130339,0.00017202596,0.00022746917,0.00018195555,0.00021579626],"domain_scores_gemma":[0.9971818,0.00082811405,0.00083501794,0.0003006341,0.00012405273,0.000730372],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0035708994,0.00080242916,0.0019282483,0.0004246034,0.00027717897,0.00074059627,0.0006666026,0.0009636639,0.0014435373],"category_scores_gemma":[0.0023654813,0.00032422188,0.0029267683,0.000521307,0.000868938,0.0007151234,0.00047481537,0.0014567516,0.00031986772],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.934169,0.0037611444,0.030915337,0.00025959132,0.0035832797,0.00008473238,0.000057818183,0.00082124776,0.0028246741,0.000072903225,0.0006190177,0.022831213],"study_design_scores_gemma":[0.35358316,0.4442938,0.18833646,0.0001416378,0.006187125,0.0004076487,0.00015286585,0.002473827,0.0026280526,0.00053245557,0.001190801,0.00007218927],"about_ca_topic_score_codex":0.00071819575,"about_ca_topic_score_gemma":0.0013341632,"teacher_disagreement_score":0.0035708994,"about_ca_system_score_codex":0.0009366929,"about_ca_system_score_gemma":0.00086046767,"threshold_uncertainty_score":0.018884957},"labels":[],"label_agreement":null},{"id":"W2339455879","doi":"10.1111/bjh.14090","title":"Molecular structural analysis of a novel and de‐novo mutation in the <i><scp>SERPINC</scp>1</i> gene associated with type 1 antithrombin deficiency","year":2016,"lang":"en","type":"letter","venue":"British Journal of Haematology","topic":"Blood Coagulation and Thrombosis Mechanisms","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster Children's Hospital; SickKids Foundation; Hospital for Sick Children; McMaster University; University of Toronto","funders":"","keywords":"Thrombophilia; Medicine; Antithrombin III deficiency; Antithrombin; Internal medicine; Protein S deficiency; Protein S; Protein C deficiency; Gastroenterology; Thrombosis; Venous thrombosis; Heparin","score_opus":0.017174447786262006,"score_gpt":0.26308198930510557,"score_spread":0.24590754151884356,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2339455879","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99093425,0.002422176,0.0022249892,0.000997392,0.00030509528,0.0000682785,0.00084146817,0.00006910291,0.0021372142],"genre_scores_gemma":[0.99536234,0.00074968615,0.0018416038,0.0003746654,0.00009944475,0.00000876641,0.00063386204,0.000025958194,0.00090386433],"study_design_codex":"bench_or_experimental","study_design_gemma":"case_report","domain_scores_codex":[0.999838,0.000023466093,0.000021639471,0.000042965345,0.00005061725,0.000023203744],"domain_scores_gemma":[0.9996145,0.00011394482,0.00013284796,0.00001375404,0.000039415063,0.00008546469],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014573023,0.0004838659,0.00038332667,0.0004064427,0.00025536504,0.00036319013,0.0004950603,0.0012882941,0.0010694799],"category_scores_gemma":[0.00059701066,0.00017744253,0.00066933135,0.00027530378,0.0003751064,0.00022063265,0.00026906608,0.0008786789,0.00037670447],"study_design_candidate":"case_report","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006785972,0.0003584189,0.017890997,0.00037802538,0.00019919283,0.41702452,0.00048342874,0.001272176,0.54445344,0.0011631337,0.0025138382,0.013584192],"study_design_scores_gemma":[0.0002755691,0.0016348469,0.123943664,0.00019647978,0.0005509414,0.6594205,0.00054204173,0.007600798,0.18125716,0.00070694194,0.023704791,0.00016632586],"about_ca_topic_score_codex":0.0013789015,"about_ca_topic_score_gemma":0.0012107625,"teacher_disagreement_score":0.0013789015,"about_ca_system_score_codex":0.00033001645,"about_ca_system_score_gemma":0.00026185357,"threshold_uncertainty_score":0.0035777688},"labels":[],"label_agreement":null},{"id":"W2366481835","doi":"10.1111/bjh.14125","title":"A pharmacokinetics and safety phase 1/1b study of oral ixazomib in patients with multiple myeloma and severe renal impairment or end‐stage renal disease requiring haemodialysis","year":2016,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":52,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network","funders":"Takeda Oncology","keywords":"Ixazomib; Medicine; Multiple myeloma; Renal function; Pharmacokinetics; Urology; End stage renal disease; Adverse effect; Internal medicine; Gastroenterology; Pharmacology; Proteasome inhibitor; Hemodialysis; Carfilzomib","score_opus":0.019561755818772963,"score_gpt":0.3082482007602953,"score_spread":0.28868644494152235,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2366481835","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99552745,0.0016765993,0.0005538484,0.0001657157,0.00003291233,0.0009093349,0.0004188763,0.00003786672,0.0006775243],"genre_scores_gemma":[0.99335855,0.0012967078,0.0013942823,0.00042951936,0.000059236085,0.00082648685,0.00087222096,0.000015705404,0.0017472773],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.99970526,0.00011691036,0.000012487146,0.00006847898,0.000049130984,0.00004765986],"domain_scores_gemma":[0.9996501,0.000043603388,0.00010180741,0.00002778449,0.00002665691,0.00014998481],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00084280816,0.0007241809,0.0013684846,0.00022371118,0.00027982012,0.0005425052,0.00027473085,0.0005244786,0.0020618122],"category_scores_gemma":[0.0006259161,0.00046964825,0.000953604,0.00025220282,0.00045899008,0.00038458567,0.00019431261,0.0016063619,0.00042554492],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.58342165,0.056968927,0.04069797,0.0013502701,0.0036700594,0.00051625253,0.00056630967,0.0033928633,0.16375655,0.0003251672,0.003822317,0.14151166],"study_design_scores_gemma":[0.19142109,0.69363695,0.09713276,0.000047500555,0.0010926408,0.0007377619,0.000097169126,0.002268647,0.0070598256,0.00020197932,0.006255294,0.000048361904],"about_ca_topic_score_codex":0.0006093052,"about_ca_topic_score_gemma":0.0016688601,"teacher_disagreement_score":0.0020618122,"about_ca_system_score_codex":0.00060249824,"about_ca_system_score_gemma":0.0010187571,"threshold_uncertainty_score":0.0068974495},"labels":[],"label_agreement":null},{"id":"W2419183473","doi":"10.1111/bjh.14131","title":"Clinical utility of next‐generation sequencing in the diagnosis of hereditary haemolytic anaemias","year":2016,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Neonatal Health and Biochemistry","field":"Medicine","cited_by":97,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"DNA sequencing; Haemolytic disease; Gene; Medicine; Biology; Computational biology; Genetics; Bioinformatics; Pregnancy","score_opus":0.12277414179609776,"score_gpt":0.3655510035409665,"score_spread":0.24277686174486873,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2419183473","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9330979,0.013014155,0.04363526,0.0014220845,0.00024805198,0.0002010935,0.0010367237,0.00038654066,0.006958121],"genre_scores_gemma":[0.94631624,0.0030951994,0.04851364,0.00064700545,0.00007396716,0.00006517558,0.00054275675,0.000035516376,0.0007104755],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99898726,0.00048308203,0.00008214184,0.00014212342,0.00024299024,0.0000624319],"domain_scores_gemma":[0.99832135,0.0010848664,0.00018164323,0.000069200505,0.00023305931,0.00010987273],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0019252277,0.00040518751,0.00044804774,0.0012861051,0.00023708062,0.0007078517,0.00030550646,0.00066260307,0.0007065776],"category_scores_gemma":[0.0035774917,0.00021621211,0.00021766248,0.0005285302,0.00034501846,0.00022424011,0.00036708807,0.0004260675,0.0002941248],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0023664297,0.00025401247,0.27260745,0.00052963925,0.00026414642,0.009362113,0.00092966325,0.008896366,0.42832333,0.0014019202,0.0031241865,0.27194077],"study_design_scores_gemma":[0.00024214394,0.00259832,0.476428,0.0007594431,0.00083756284,0.050799377,0.0009788227,0.09315356,0.3171621,0.007020189,0.04982873,0.00019173531],"about_ca_topic_score_codex":0.00093778624,"about_ca_topic_score_gemma":0.0013953642,"teacher_disagreement_score":0.0019252277,"about_ca_system_score_codex":0.00030387598,"about_ca_system_score_gemma":0.00030065016,"threshold_uncertainty_score":0.010181725},"labels":[],"label_agreement":null},{"id":"W2462737759","doi":"10.1111/bjh.14199","title":"Multiple myeloma and family history of lymphohaematopoietic cancers: Results from the International Multiple Myeloma Consortium","year":2016,"lang":"en","type":"review","venue":"British Journal of Haematology","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":60,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency; University of British Columbia; Public Health Ontario; Toronto Public Health; University of Saskatchewan; Saskatchewan Health Authority","funders":"National Cancer Institute; National Institutes of Health; Fondation de France; University of Alabama; National Institute of Environmental Health Sciences; American Cancer Society; University of Southern California; Brown University","keywords":"Medicine; Odds ratio; Family history; Multiple myeloma; Relative risk; Confidence interval; Internal medicine; Etiology; First-degree relatives; Oncology; Cancer; Demography; Family aggregation; Disease","score_opus":0.051699426396183724,"score_gpt":0.3146568069504227,"score_spread":0.26295738055423895,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2462737759","genre_codex":"empirical","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.970574,0.021452773,0.0018218795,0.0004955772,0.000048902377,0.00006070691,0.003625191,0.000043226883,0.0018777252],"genre_scores_gemma":[0.99269557,0.003443999,0.0012287758,0.000092312555,0.000058815647,0.000058756832,0.0021304714,0.000013782571,0.00027755467],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9975165,0.0008511116,0.00024781708,0.00076185766,0.0004901344,0.00013252477],"domain_scores_gemma":[0.9943421,0.0019495479,0.0022569583,0.00053177396,0.0005218154,0.0003978849],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004409736,0.0006388388,0.00077021646,0.0029669476,0.0005155007,0.0010175892,0.00082015205,0.0006751881,0.0016004583],"category_scores_gemma":[0.007846377,0.00025515843,0.0012820074,0.0065112924,0.00044655136,0.0004502761,0.0009867088,0.00069220323,0.00011191531],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017278847,0.000011904293,0.993127,0.00012708962,0.0013081112,0.000119919234,0.00009802076,0.00014948007,0.00018670152,0.00004463844,0.00019469937,0.0044595827],"study_design_scores_gemma":[0.000010598205,0.000030469648,0.99823964,0.000038911963,0.0006031423,0.0003265381,0.000052598705,0.00012450962,0.0000852036,0.000060287006,0.000421254,0.0000067475335],"about_ca_topic_score_codex":0.020350672,"about_ca_topic_score_gemma":0.01727439,"teacher_disagreement_score":0.020350672,"about_ca_system_score_codex":0.00062770204,"about_ca_system_score_gemma":0.00054611743,"threshold_uncertainty_score":0.0404644},"labels":[],"label_agreement":null},{"id":"W2466421941","doi":"10.1111/bjh.14201","title":"The tumour microenvironment influences survival and time to transformation in follicular lymphoma in the rituximab era","year":2016,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":69,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"Helse Sør-Øst RHF; Norges Forskningsråd; Kreftforeningen","keywords":"Follicular lymphoma; CD68; CD163; Tumor microenvironment; Rituximab; Medicine; FOXP3; CD20; Lymphoma; CD8; Internal medicine; Oncology; Survival analysis; Pathology; Immunology; Cancer research; Immunohistochemistry; Cancer; Biology; Macrophage; Antigen; Immune system","score_opus":0.0067823435448768855,"score_gpt":0.228218332319174,"score_spread":0.2214359887742971,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2466421941","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9992107,0.0005039282,0.00003568674,0.0000136455,0.0000012289854,0.0000013617024,0.00002819376,0.0000024865521,0.00020283116],"genre_scores_gemma":[0.999782,0.000074078715,0.000016498361,0.000006634812,0.0000032620255,0.0000012593583,0.000055747954,5.325582e-7,0.00006008387],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9998839,0.000031702246,0.000009992121,0.000019351251,0.000019685534,0.0000353362],"domain_scores_gemma":[0.9996012,0.0000949802,0.00017742757,0.0000199454,0.000034784964,0.00007165989],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021194821,0.000088386405,0.00017963945,0.00027485559,0.00015082103,0.00034816368,0.00008841415,0.00021294887,0.00055032095],"category_scores_gemma":[0.0006997975,0.00008132351,0.00015480646,0.00025268566,0.00012149704,0.00022785574,0.00019324393,0.0001963245,0.00014721388],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014874899,0.0000369173,0.97866994,0.00001201978,0.000041308052,0.00032573484,0.00014207141,0.0002257679,0.0069007645,0.000023050387,0.00009213166,0.012042781],"study_design_scores_gemma":[0.000010458585,0.00034143968,0.9972676,0.0000037371196,0.000041659765,0.0008506712,0.00009061953,0.0003150108,0.0007087795,0.000034854573,0.0003319932,0.0000032061328],"about_ca_topic_score_codex":0.0009726728,"about_ca_topic_score_gemma":0.0010238118,"teacher_disagreement_score":0.0009726728,"about_ca_system_score_codex":0.00022616099,"about_ca_system_score_gemma":0.00009316939,"threshold_uncertainty_score":0.0019340515},"labels":[],"label_agreement":null},{"id":"W2488556807","doi":"10.1111/bjh.14238","title":"Increased plasminogen activator inhibitor results in a hypofibrinolytic state in adolescents with obesity: <i>in vivo</i> and <i>ex vivo</i> evidence","year":2016,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Blood properties and coagulation","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Stollery Children's Hospital; University of Alberta","funders":"Canadian Institutes of Health Research","keywords":"In vivo; Ex vivo; Plasminogen activator inhibitor-1; Medicine; Obesity; Plasminogen activator; Internal medicine; Biology; Genetics","score_opus":0.015534032394573948,"score_gpt":0.2305116104448712,"score_spread":0.21497757805029724,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2488556807","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99896276,0.00067632523,0.00011324782,0.00002375076,0.0000035152784,0.0000040214254,0.000047862683,0.000001618939,0.00016684351],"genre_scores_gemma":[0.9993451,0.00030238906,0.00014938755,0.000026894568,0.000011164196,0.0000054223983,0.00008516003,0.0000015454865,0.000072782066],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9998118,0.00007134532,0.00001993644,0.000035624027,0.000038929826,0.000022372302],"domain_scores_gemma":[0.9992974,0.00017966621,0.00036414713,0.000026736445,0.00007237811,0.000059584094],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00033343546,0.00023627387,0.00023399299,0.00039374334,0.00012425083,0.00035293755,0.00014324402,0.00026016808,0.0013452541],"category_scores_gemma":[0.0006307323,0.00018124121,0.00018557931,0.00026088223,0.00033142456,0.00015167784,0.00017322639,0.0003963418,0.00014690441],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010061533,0.00013496028,0.9781179,0.0001004613,0.00016016113,0.00065014267,0.00010533024,0.000041700354,0.013969702,0.00006746415,0.00008136869,0.00556466],"study_design_scores_gemma":[0.000033038254,0.0010335633,0.98999304,0.00002186688,0.00017835682,0.0039945734,0.0002085845,0.00016917949,0.0039085434,0.00006161719,0.00039385317,0.0000038454555],"about_ca_topic_score_codex":0.0004059099,"about_ca_topic_score_gemma":0.0002747086,"teacher_disagreement_score":0.0013452541,"about_ca_system_score_codex":0.00010178899,"about_ca_system_score_gemma":0.00008437898,"threshold_uncertainty_score":0.00450027},"labels":[],"label_agreement":null},{"id":"W2496211488","doi":"10.1111/bjh.14229","title":"Site of central nervous system (CNS) relapse in patients with diffuse large B‐cell lymphoma (DLBCL) by the CNS‐IPI risk model","year":2016,"lang":"en","type":"letter","venue":"British Journal of Haematology","topic":"CNS Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":33,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"BC Cancer Agency; University of British Columbia","keywords":"Diffuse large B-cell lymphoma; Medicine; Central nervous system; Lymphoma; Rituximab; Oncology; Internal medicine","score_opus":0.004372215322738275,"score_gpt":0.19078944596344047,"score_spread":0.1864172306407022,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2496211488","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9704926,0.0017617623,0.017957648,0.0024898862,0.00014026309,0.00019518522,0.002091225,0.00018891173,0.004682458],"genre_scores_gemma":[0.99498725,0.0002667662,0.0021570993,0.00010987097,0.00005978243,0.00007443529,0.0010275552,0.000020962303,0.0012963286],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99944514,0.00024059406,0.000025381605,0.00012624208,0.000056930254,0.000105671],"domain_scores_gemma":[0.99866533,0.00056934496,0.0002788385,0.00007476432,0.00013052156,0.0002813118],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016667593,0.0010020168,0.0007282267,0.0010273942,0.00032190056,0.0014071361,0.0012193123,0.00063076086,0.003043529],"category_scores_gemma":[0.0030367954,0.00036637834,0.0017457763,0.00063181313,0.0003522317,0.0005602556,0.001317813,0.0013282557,0.00068723195],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011955928,0.00019670349,0.93907136,0.00005885076,0.0006370155,0.000546414,0.00014601865,0.03699501,0.00032263537,0.0018424438,0.0027946527,0.016193317],"study_design_scores_gemma":[0.00026015038,0.00073622545,0.20264424,0.00010211671,0.0013185334,0.0022524484,0.00039018228,0.7815358,0.00025457446,0.007392893,0.0030180248,0.0000949478],"about_ca_topic_score_codex":0.010835036,"about_ca_topic_score_gemma":0.0065328307,"teacher_disagreement_score":0.010835036,"about_ca_system_score_codex":0.0006941341,"about_ca_system_score_gemma":0.0009953561,"threshold_uncertainty_score":0.02154392},"labels":[],"label_agreement":null},{"id":"W2521880072","doi":"10.1111/bjh.14313","title":"Management of relapsed and refractory childhood acute promyelocytic leukaemia: recommendations from an international expert panel","year":2016,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Retinoids in leukemia and cellular processes","field":"Biochemistry, Genetics and Molecular Biology","cited_by":16,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children; University of Toronto","funders":"","keywords":"Arsenic trioxide; Acute promyelocytic leukemia; Medicine; Anthracycline; Internal medicine; Oncology; Cog; Retinoic acid; Pediatrics; Cancer; Biology; Gene","score_opus":0.010244343041789608,"score_gpt":0.2641757588843881,"score_spread":0.2539314158425985,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2521880072","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0049388683,0.6718021,0.01746162,0.22726446,0.0095374705,0.0027303777,0.004150651,0.0007548984,0.06135963],"genre_scores_gemma":[0.037226707,0.6929178,0.09193483,0.13130887,0.005900986,0.004877487,0.0154358335,0.00049868436,0.01989878],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99491537,0.001735681,0.0013824917,0.00033498748,0.0011800762,0.0004513905],"domain_scores_gemma":[0.9908585,0.0020036304,0.0009829556,0.00021302108,0.004979468,0.00096247246],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.013989637,0.0012947299,0.0027879372,0.0020946455,0.0008922241,0.0024204992,0.005866067,0.0051624705,0.004449013],"category_scores_gemma":[0.01342739,0.00051648443,0.0035046507,0.0018999894,0.00076019595,0.0018376417,0.0025670987,0.005901925,0.0037784043],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00027210492,0.00016365307,0.0020588567,0.008834594,0.00028247794,0.00042762555,0.0004082929,0.0014622451,0.0014073019,0.003953338,0.35288185,0.6278477],"study_design_scores_gemma":[0.00022918655,0.00016438315,0.0049553397,0.036227863,0.0007057114,0.0008759178,0.00047523924,0.0006084158,0.0006301396,0.0042059934,0.95084894,0.00007287199],"about_ca_topic_score_codex":0.0071429918,"about_ca_topic_score_gemma":0.0077478606,"teacher_disagreement_score":0.013989637,"about_ca_system_score_codex":0.0027218058,"about_ca_system_score_gemma":0.008253062,"threshold_uncertainty_score":0.07398516},"labels":[],"label_agreement":null},{"id":"W2525561810","doi":"10.1111/bjh.14325","title":"Uterine, but not ovarian, female reproductive organ involvement at presentation by diffuse large B‐cell lymphoma is associated with poor outcomes and a high frequency of secondary <scp>CNS</scp> involvement","year":2016,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":46,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"A.P. Møller og Hustru Chastine Mc-Kinney Møllers Fond til almene Formaal","keywords":"Medicine; Diffuse large B-cell lymphoma; Hazard ratio; Concomitant; Rituximab; Oncology; Internal medicine; Uterus; Lymphoma; Confidence interval; Gynecology","score_opus":0.011641997026197897,"score_gpt":0.24066100495847698,"score_spread":0.22901900793227908,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2525561810","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9972888,0.001477855,0.00008423133,0.00006970781,0.0000052018504,0.000005123768,0.00028973428,0.0000053390654,0.00077392167],"genre_scores_gemma":[0.9991278,0.00049109326,0.000045876688,0.00001871799,0.000008149677,0.0000022321108,0.00025163693,0.0000012670582,0.00005329448],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9996588,0.00009385212,0.000040170435,0.000071089366,0.00006443727,0.000071654926],"domain_scores_gemma":[0.9986482,0.0002902516,0.000715827,0.00008966792,0.00008123466,0.00017487415],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003677911,0.00011025251,0.0003338458,0.00044883278,0.00021058609,0.00051426643,0.00017527348,0.00022057355,0.0012172497],"category_scores_gemma":[0.0018968695,0.00014529288,0.00022083406,0.00079421944,0.0003162056,0.00017768938,0.0003161655,0.00028221455,0.00014812886],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000050967705,0.0000036247363,0.99749607,0.00001293455,0.000026489424,0.00018809694,0.000012421361,0.000015496153,0.0002613251,0.000007717005,0.00006522195,0.0018597088],"study_design_scores_gemma":[0.000003444191,0.000018519064,0.99823123,0.000009477087,0.000022239392,0.0012746255,0.000060332448,0.00005240819,0.00008059649,0.000015724512,0.00022968938,0.0000017596944],"about_ca_topic_score_codex":0.0038872324,"about_ca_topic_score_gemma":0.0056601046,"teacher_disagreement_score":0.0038872324,"about_ca_system_score_codex":0.00023867933,"about_ca_system_score_gemma":0.0003196677,"threshold_uncertainty_score":0.0077292323},"labels":[],"label_agreement":null},{"id":"W2531432151","doi":"10.1111/bjh.14392","title":"Diffuse large B‐cell lymphoma with testicular involvement: outcome and risk of <scp>CNS</scp> relapse in the rituximab era","year":2016,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":103,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"Roche","keywords":"Rituximab; Medicine; Diffuse large B-cell lymphoma; International Prognostic Index; Internal medicine; Vincristine; Prednisone; Lymphoma; Cyclophosphamide; Hazard ratio; Oncology; CHOP; Chemotherapy; Confidence interval","score_opus":0.00952445031165164,"score_gpt":0.22998264182981218,"score_spread":0.22045819151816054,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2531432151","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9981883,0.0011403091,0.000021167192,0.00010606472,0.0000046878527,0.0000017605688,0.00009588035,0.0000024425226,0.00043929138],"genre_scores_gemma":[0.99946064,0.00028856043,0.000010587504,0.000027448308,0.000012920806,8.22147e-7,0.00012800946,8.8909184e-7,0.00007016708],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9997644,0.000066001776,0.000014358971,0.00003970595,0.000053572447,0.00006201878],"domain_scores_gemma":[0.99900454,0.000116787975,0.00044918148,0.000043329575,0.00007429126,0.00031181617],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004144356,0.00010342639,0.00022891033,0.00034012555,0.00019393429,0.0005755693,0.00026594184,0.00026110045,0.0009410411],"category_scores_gemma":[0.0014681785,0.000103658116,0.00024000082,0.00074347504,0.00021931948,0.00027210428,0.00027690746,0.00048255315,0.00013497823],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00020283078,0.000026152715,0.9953987,0.000009383487,0.000055076285,0.00026395026,0.00003730634,0.00008362007,0.000103168415,0.00002203666,0.00018664417,0.0036111868],"study_design_scores_gemma":[0.000009408898,0.000089399575,0.9986161,0.000010475025,0.000036940863,0.00071364356,0.00007222524,0.00020785509,0.00003087717,0.000034091387,0.00017522846,0.0000036844442],"about_ca_topic_score_codex":0.012492151,"about_ca_topic_score_gemma":0.015670877,"teacher_disagreement_score":0.012492151,"about_ca_system_score_codex":0.00050815725,"about_ca_system_score_gemma":0.00049271394,"threshold_uncertainty_score":0.024838865},"labels":[],"label_agreement":null},{"id":"W2539269622","doi":"10.1111/bjh.14404","title":"Outcome of primary cutaneous anaplastic large cell lymphoma: a 20‐year British Columbia Cancer Agency experience","year":2016,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Cutaneous lymphoproliferative disorders research","field":"Medicine","cited_by":28,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Medicine; Lymphoma; Internal medicine; Chemotherapy; Stage (stratigraphy); Cancer; Oncology; Radiation therapy; Lymphoproliferative disorders; Surgery","score_opus":0.017728846321293696,"score_gpt":0.29263374925412733,"score_spread":0.27490490293283365,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2539269622","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9884964,0.003639965,0.000088826855,0.00050846004,0.000022048802,0.000029794413,0.0004172144,0.00001535375,0.0067819376],"genre_scores_gemma":[0.9952859,0.0025094906,0.000072844305,0.00020493851,0.000019757324,0.000015384085,0.0005284763,0.00000894649,0.0013542444],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99946946,0.000090260604,0.000050813393,0.00006427238,0.00016836466,0.00015691562],"domain_scores_gemma":[0.99867886,0.00014695103,0.00032992923,0.00006863098,0.00038984575,0.00038573294],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00056997687,0.00026081133,0.00023433795,0.0007036096,0.0010985144,0.0010597389,0.000421107,0.00046346162,0.0013818416],"category_scores_gemma":[0.0018369595,0.00019469782,0.0001414367,0.0017717058,0.0004938309,0.00028568594,0.0007127241,0.00045234666,0.00033600474],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00037307144,0.00028972904,0.91671574,0.00019926405,0.00008634525,0.014297833,0.0036144706,0.0003650336,0.0017270911,0.00019531528,0.0069560404,0.055180084],"study_design_scores_gemma":[0.000028689625,0.00021213767,0.97435725,0.00014578967,0.000049846083,0.013933268,0.0018826226,0.00031042023,0.00022734127,0.00004781784,0.008773029,0.00003185358],"about_ca_topic_score_codex":0.41132432,"about_ca_topic_score_gemma":0.48609987,"teacher_disagreement_score":0.5886757,"about_ca_system_score_codex":0.0045013744,"about_ca_system_score_gemma":0.0031196717,"threshold_uncertainty_score":0.8178603},"labels":[],"label_agreement":null},{"id":"W2550146082","doi":"10.1111/bjh.14450","title":"Spleen hypofunction in eosinophilic gastrointestinal disease","year":2016,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Eosinophilic Esophagitis","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Hospital Foundation","funders":"","keywords":"Medicine; Pathology; Spleen; Gastroenterology; Eosinophilia; Eosinophil; Eosinophilic gastroenteritis; Eosinophilic; Internal medicine; Asthma","score_opus":0.011734813129516058,"score_gpt":0.24498675998251715,"score_spread":0.2332519468530011,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2550146082","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.987512,0.007798816,0.0005054823,0.00040931578,0.00008030558,0.000022873079,0.00008340796,0.00006248493,0.0035254196],"genre_scores_gemma":[0.998713,0.00076276634,0.00009840725,0.0000945593,0.00008452379,0.0000026188031,0.000050919632,0.0000036814297,0.00018949131],"study_design_codex":"case_report","study_design_gemma":"observational","domain_scores_codex":[0.9998995,0.000021061214,0.000009350298,0.000019051842,0.0000135273785,0.000037615777],"domain_scores_gemma":[0.99965084,0.00010623633,0.00007021719,0.000020991858,0.000027247524,0.0001244121],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00025631758,0.0006230242,0.00045406847,0.000627519,0.00031335434,0.00036949327,0.00026571043,0.00078494305,0.002206092],"category_scores_gemma":[0.0009882466,0.00021061278,0.00023924735,0.00029179873,0.00045375066,0.00044180616,0.0003306195,0.0006635044,0.00045261002],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00096661906,0.00013311657,0.25642854,0.000251875,0.000059953898,0.7159193,0.00032243272,0.00018025345,0.012223324,0.00033540907,0.0010835788,0.012095575],"study_design_scores_gemma":[0.00005411813,0.0005368641,0.170109,0.00006687804,0.000068430454,0.8248868,0.00021693233,0.00046572264,0.0014456648,0.00021727232,0.0019185264,0.000013703682],"about_ca_topic_score_codex":0.0002850183,"about_ca_topic_score_gemma":0.00029851688,"teacher_disagreement_score":0.002206092,"about_ca_system_score_codex":0.00017553389,"about_ca_system_score_gemma":0.0001280265,"threshold_uncertainty_score":0.0073800683},"labels":[],"label_agreement":null},{"id":"W2558083009","doi":"10.1111/bjh.14437","title":"The evolutionary and clinical implications of the uneven distribution of the frequency of the inherited haemoglobin variants over short geographical distances","year":2016,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":34,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"National Institute for Health and Care Research; Wellcome Trust; Medical Research Council; Wellcome; University of Oxford; World Health Organization","keywords":"Ethnic group; Malaria; Consanguinity; Distribution (mathematics); Variation (astronomy); Geography; Altitude (triangle); Demography; Heterozygote advantage; Evolutionary biology; Biology; Genetics; Allele; Immunology; Gene","score_opus":0.010724204692361674,"score_gpt":0.27337346438821475,"score_spread":0.26264925969585307,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2558083009","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99628735,0.0010703126,0.00046225442,0.00049387186,0.000010300573,0.00000472104,0.00007609816,0.000004062431,0.0015909885],"genre_scores_gemma":[0.9992023,0.00034361222,0.00018683725,0.00004446534,0.000021077203,0.0000019043017,0.000036849357,0.000003483898,0.00015944759],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99916744,0.00039017707,0.00004776068,0.00018617939,0.00009492133,0.000113476024],"domain_scores_gemma":[0.9985318,0.00058553065,0.00048313173,0.0001412505,0.000105008105,0.00015325256],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009870238,0.00017447428,0.0002475029,0.001111898,0.00062921474,0.00083870563,0.00050742517,0.00050627143,0.002343111],"category_scores_gemma":[0.0042512994,0.00019622213,0.00010634376,0.0011373082,0.0019343513,0.000949195,0.0006617356,0.0007050087,0.00027893714],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006018403,0.0000470981,0.94905907,0.00005786727,0.00009833346,0.005838028,0.0027197425,0.0006150303,0.0065173367,0.0020242524,0.00033393287,0.03208739],"study_design_scores_gemma":[0.0000065696413,0.00010322095,0.9894142,0.000013725385,0.00001771656,0.006698172,0.001675638,0.00025944423,0.00024169165,0.000947971,0.000607689,0.000013870895],"about_ca_topic_score_codex":0.002918141,"about_ca_topic_score_gemma":0.003283303,"teacher_disagreement_score":0.002918141,"about_ca_system_score_codex":0.00036509425,"about_ca_system_score_gemma":0.00020224742,"threshold_uncertainty_score":0.007838488},"labels":[],"label_agreement":null},{"id":"W2558735096","doi":"10.1111/bjh.14424","title":"The severity of anaemia depletes cerebrovascular dilatory reserve in children with sickle cell disease: a quantitative magnetic resonance imaging study","year":2016,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":66,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Michael's Hospital; Hospital for Sick Children; University of Toronto","funders":"","keywords":"Medicine; Magnetic resonance imaging; Cerebral blood flow; Cardiology; Pathophysiology; Stroke (engine); Internal medicine; Disease; Anemia; Gastroenterology; Radiology","score_opus":0.0051466232312964485,"score_gpt":0.22645350098786787,"score_spread":0.22130687775657143,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2558735096","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99963737,0.00011004779,0.000060488634,0.0000097422535,0.0000011802813,0.00000395624,0.00005259716,0.0000024729484,0.00012219728],"genre_scores_gemma":[0.9996437,0.00007235432,0.00014505234,0.000010494738,0.0000065591835,0.000006378792,0.00006764145,0.0000019460524,0.00004591031],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99981624,0.00004471104,0.000022823711,0.000036627545,0.000045255474,0.000034346464],"domain_scores_gemma":[0.9991634,0.00022005365,0.00036255654,0.00004249141,0.00009205039,0.00011944182],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00040898967,0.00032243345,0.00021651019,0.0006793578,0.00019298578,0.00026602045,0.00016310427,0.00034198991,0.00075300504],"category_scores_gemma":[0.001413684,0.00020414338,0.00020571101,0.00034397913,0.00039998544,0.00023147665,0.0001962109,0.00025580075,0.00014411124],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00057251647,0.00009958925,0.9844648,0.00005200326,0.00006116336,0.001632221,0.0004168589,0.00014555744,0.009173494,0.00005739238,0.0001493353,0.0031751266],"study_design_scores_gemma":[0.000011905808,0.00030492168,0.99561477,0.0000051797147,0.00002648565,0.0029704927,0.00013598034,0.0001631266,0.0005892951,0.000016242177,0.00015655105,0.000004939149],"about_ca_topic_score_codex":0.0019700376,"about_ca_topic_score_gemma":0.0015328557,"teacher_disagreement_score":0.0019700376,"about_ca_system_score_codex":0.0002816654,"about_ca_system_score_gemma":0.00015420729,"threshold_uncertainty_score":0.0039171576},"labels":[],"label_agreement":null},{"id":"W2559321616","doi":"10.1111/bjh.14454","title":"C‐reactive protein prior to myeloablative allogeneic haematopoietic cell transplantation identifies patients at risk of early‐ and long‐term mortality","year":2016,"lang":"en","type":"letter","venue":"British Journal of Haematology","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Institute of Cancer Research; Imperial College Healthcare NHS Trust; National Institute for Health and Care Research; Royal Marsden NHS Foundation Trust","keywords":"Medicine; Transplantation; Internal medicine; Hematology; Cohort; Hematopoietic stem cell transplantation; Comorbidity; C-reactive protein; Oncology","score_opus":0.013685764641273707,"score_gpt":0.25854568144354284,"score_spread":0.24485991680226912,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2559321616","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.998923,0.0004924515,0.00010620212,0.00002521896,0.00000744345,0.000009288843,0.000117744086,0.0000024535339,0.00031600383],"genre_scores_gemma":[0.99925894,0.00020160973,0.00012227363,0.000020221754,0.000017638939,0.000007352163,0.00025742076,0.0000011115253,0.00011354606],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9996475,0.00008850626,0.000044801913,0.00008029956,0.000073992705,0.00006488305],"domain_scores_gemma":[0.99898154,0.00018811923,0.00046711398,0.00006140837,0.00007409963,0.0002277535],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006045955,0.0002894908,0.00053799996,0.0006025976,0.00028202494,0.0006397722,0.00023986632,0.00039729374,0.00088356604],"category_scores_gemma":[0.0013999562,0.00016001321,0.00038856882,0.0006440894,0.00020155497,0.00038064166,0.00046789367,0.00073617976,0.00023446063],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000741641,0.000076205106,0.99574643,0.000017570954,0.000035683894,0.00012177528,0.000034803033,0.000055450597,0.00057665876,0.000018973888,0.00005260873,0.0025222069],"study_design_scores_gemma":[0.000011861124,0.00071053026,0.9978974,0.000015240142,0.000048954702,0.0005640889,0.00008155683,0.00023397364,0.00020207062,0.000042540778,0.0001862256,0.0000055850874],"about_ca_topic_score_codex":0.00076284504,"about_ca_topic_score_gemma":0.0016546051,"teacher_disagreement_score":0.00088356604,"about_ca_system_score_codex":0.00019605867,"about_ca_system_score_gemma":0.00034853196,"threshold_uncertainty_score":0.0031974912},"labels":[],"label_agreement":null},{"id":"W2561128146","doi":"10.1111/bjh.14449","title":"Brentuximab vedotin and bendamustine produce high complete response rates in patients with chemotherapy refractory Hodgkin lymphoma","year":2016,"lang":"en","type":"letter","venue":"British Journal of Haematology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; BC Cancer Agency","funders":"","keywords":"Medicine; Etoposide; Ifosfamide; Salvage therapy; Internal medicine; Cytarabine; Oncology; Melphalan; Autologous stem-cell transplantation; Chemotherapy; Carboplatin; Surgery; Refractory (planetary science); Cisplatin","score_opus":0.008487921881119955,"score_gpt":0.23021511396207464,"score_spread":0.22172719208095468,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2561128146","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99304235,0.005086112,0.00021916741,0.00023312747,0.000023194976,0.000036388028,0.00011375278,0.000034981444,0.0012108764],"genre_scores_gemma":[0.9988325,0.0004940773,0.00011962406,0.00013669355,0.000023243056,0.000013726357,0.00015739664,0.0000041155236,0.00021858259],"study_design_codex":"observational","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.99968505,0.00011119781,0.00002821984,0.000034565852,0.00010337255,0.000037659825],"domain_scores_gemma":[0.999022,0.0003977002,0.00030534228,0.0000647817,0.00006196386,0.0001481963],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007181352,0.00011428966,0.00047126014,0.00018723332,0.000112454465,0.00026597935,0.0001287299,0.00021096792,0.00065852137],"category_scores_gemma":[0.0020301822,0.00011007676,0.00018872619,0.0002268921,0.00010285526,0.00022454865,0.00017155748,0.0004089072,0.0001921029],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.016984247,0.0012458131,0.5132733,0.00038138076,0.00040968994,0.0020711755,0.00044559495,0.0017108333,0.06385682,0.00020222766,0.0040873154,0.39533156],"study_design_scores_gemma":[0.000834839,0.011680517,0.97106105,0.000032127933,0.00016248164,0.0044722506,0.00008896198,0.00077723735,0.0042947116,0.00016532674,0.006416729,0.000013597248],"about_ca_topic_score_codex":0.00027517337,"about_ca_topic_score_gemma":0.0005961259,"teacher_disagreement_score":0.0007181352,"about_ca_system_score_codex":0.00021964533,"about_ca_system_score_gemma":0.00012623529,"threshold_uncertainty_score":0.0037978888},"labels":[],"label_agreement":null},{"id":"W2562513582","doi":"10.1111/bjh.14482","title":"How do we approach thrombocytopenia in critically ill patients?","year":2016,"lang":"en","type":"review","venue":"British Journal of Haematology","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":121,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Hamilton Regional Laboratory Medicine Program; Hamilton Health Sciences; Hamilton General Hospital","funders":"","keywords":"Medicine; Platelet; Von Willebrand factor; Etiology; Platelet transfusion; Heparin-induced thrombocytopenia; Incidence (geometry); Internal medicine; Immunology; Intensive care medicine; Gastroenterology","score_opus":0.03016398038053072,"score_gpt":0.3095621459360054,"score_spread":0.2793981655554747,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2562513582","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00019039934,0.992065,0.0002507511,0.005335143,0.0008021771,0.000008111547,0.000016554199,0.000011610248,0.0013201917],"genre_scores_gemma":[0.0019260475,0.9933222,0.0006590462,0.002381464,0.0010341965,0.000015142445,0.00002554631,0.0000030119586,0.0006333545],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99978596,0.00006700622,0.000040798102,0.000024733125,0.000065159315,0.000016320586],"domain_scores_gemma":[0.999458,0.0002469835,0.00008218885,0.000013615907,0.00013617019,0.00006305533],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006542653,0.00048293374,0.0008941444,0.0009830658,0.00027539697,0.0011816206,0.00062065147,0.001647794,0.0026561348],"category_scores_gemma":[0.0022265203,0.00015311294,0.00043767472,0.00077107386,0.00044505528,0.0016922791,0.0006037246,0.0025714685,0.0019342675],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000049294267,0.000039932205,0.00045122879,0.009301975,0.00006426457,0.00053713314,0.00013784175,0.000114339025,0.00027515643,0.0025696969,0.056135423,0.9303237],"study_design_scores_gemma":[0.00006050119,0.0001538543,0.0032254688,0.024157813,0.00013904789,0.0084768515,0.00049495953,0.00011513345,0.00019220455,0.0075524263,0.95539707,0.00003461334],"about_ca_topic_score_codex":0.0011335842,"about_ca_topic_score_gemma":0.0021106538,"teacher_disagreement_score":0.0026561348,"about_ca_system_score_codex":0.00035922328,"about_ca_system_score_gemma":0.000994044,"threshold_uncertainty_score":0.008885622},"labels":[],"label_agreement":null},{"id":"W2587140037","doi":"10.1111/bjh.14542","title":"Intravenous immunoglobulin treatment of spleen cells from patients with immune thrombocytopenia significantly increases the percentage of myeloid‐derived suppressor cells","year":2017,"lang":"en","type":"letter","venue":"British Journal of Haematology","topic":"Immune cells in cancer","field":"Immunology and Microbiology","cited_by":16,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Hospital for Sick Children; Canadian Blood Services; University of Toronto","funders":"National Center for Advancing Translational Sciences; National Center for Research Resources; National Cancer Institute; Health Canada","keywords":"Spleen; Antibody; Immune system; Immunology; Immune thrombocytopenia; Medicine; Myeloid; Immunoglobulin G; Immunoglobulin M; Platelet","score_opus":0.009655386263604453,"score_gpt":0.21536055519606812,"score_spread":0.20570516893246366,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2587140037","genre_codex":"empirical","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9986582,0.00048245225,0.00021021844,0.000032010903,0.000010576552,0.000010649111,0.000058502956,0.00001756403,0.00051984005],"genre_scores_gemma":[0.9989297,0.00021956264,0.0002094618,0.000051029867,0.00001786199,0.000012045718,0.0002467456,0.00000377024,0.00030987372],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.99990904,0.000023744527,0.000010100464,0.000020319765,0.000017796418,0.000019003903],"domain_scores_gemma":[0.99988294,0.000036852416,0.000023828177,0.00001236113,0.000009442926,0.000034553537],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012281223,0.00023604464,0.0003071387,0.00033489263,0.000115716466,0.00016372005,0.00009527599,0.00014944928,0.0016963305],"category_scores_gemma":[0.0002986094,0.00008605455,0.0001618244,0.00015704418,0.00012950518,0.000072756164,0.00015767754,0.00033111032,0.00023783701],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0027809904,0.0004133609,0.05403573,0.00013642815,0.00006013499,0.0018624191,0.0002938687,0.00016086668,0.904569,0.000062779305,0.0006419824,0.034982428],"study_design_scores_gemma":[0.0006387259,0.025486851,0.65328455,0.00006212443,0.0002257048,0.021779925,0.00056075444,0.001354628,0.28843784,0.00014154275,0.008005563,0.000021821517],"about_ca_topic_score_codex":0.00013197878,"about_ca_topic_score_gemma":0.00015305047,"teacher_disagreement_score":0.0016963305,"about_ca_system_score_codex":0.000081937214,"about_ca_system_score_gemma":0.000067808905,"threshold_uncertainty_score":0.0056747794},"labels":[],"label_agreement":null},{"id":"W2590943925","doi":"10.1111/bjh.14508","title":"The <scp>JAK</scp>2 blocker <scp>TG</scp>101209 is a potent inhibitor of clonogenic progenitor cell growth in patients with chronic myeloid leukaemia","year":2017,"lang":"en","type":"letter","venue":"British Journal of Haematology","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"Austrian Science Fund","keywords":"CFU-GM; Progenitor cell; Clonogenic assay; Progenitor; Myeloid; Cancer research; Medicine; Cell; Stem cell; Biology; Cell biology","score_opus":0.0073944042852346435,"score_gpt":0.22014401739104578,"score_spread":0.21274961310581114,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2590943925","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98572046,0.0093778465,0.00046926536,0.0003667872,0.00005620526,0.00014642855,0.00069989485,0.00009058988,0.0030725542],"genre_scores_gemma":[0.9939122,0.002979644,0.0004950924,0.00015392806,0.00002448715,0.00007760847,0.0010555682,0.0000089348405,0.0012923649],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9999274,0.000016608856,0.0000059539243,0.000011164279,0.000019068008,0.00001978641],"domain_scores_gemma":[0.9999387,0.0000141054625,0.000009882723,0.0000042205065,0.0000048792986,0.000028208704],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017058561,0.0003309645,0.0006832416,0.00017126997,0.00016313103,0.00019084683,0.00017815812,0.00023443223,0.0016411665],"category_scores_gemma":[0.00014180456,0.0001249989,0.0002358062,0.00021958562,0.0001158273,0.00009618933,0.00013009868,0.0009700504,0.00040852555],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.035641674,0.003805939,0.019632407,0.00071405777,0.0002390027,0.0019940564,0.0002988926,0.0013814619,0.7047452,0.00036552924,0.0076876655,0.22349407],"study_design_scores_gemma":[0.017386595,0.12595424,0.39101306,0.00013885119,0.0006838955,0.01273004,0.0002037814,0.003627446,0.38577244,0.00046743554,0.06192931,0.00009288413],"about_ca_topic_score_codex":0.00070622383,"about_ca_topic_score_gemma":0.002445845,"teacher_disagreement_score":0.0016411665,"about_ca_system_score_codex":0.0002451548,"about_ca_system_score_gemma":0.00035429548,"threshold_uncertainty_score":0.005490184},"labels":[],"label_agreement":null},{"id":"W2592575030","doi":"10.1111/bjh.14610","title":"Large scale studies assessing anti‐factor <scp>VIII</scp> antibody development in previously untreated haemophilia A: what has been learned, what to believe and how to learn more","year":2017,"lang":"en","type":"review","venue":"British Journal of Haematology","topic":"Hemophilia Treatment and Research","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Haemophilia; Medicine; Clinical trial; Population; Immunogenicity; Intensive care medicine; Randomized controlled trial; Scale (ratio); Immunology; Pediatrics; Internal medicine; Antibody; Environmental health","score_opus":0.15076785362023828,"score_gpt":0.43635405741611977,"score_spread":0.2855862037958815,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2592575030","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.009047992,0.98458165,0.00087538635,0.0031688267,0.0008490201,0.00036349214,0.00022929326,0.000014609021,0.00086965156],"genre_scores_gemma":[0.09097826,0.8943814,0.004369071,0.006481052,0.0021562823,0.00064980524,0.0005224009,0.000028917313,0.00043285204],"study_design_codex":"design_other","study_design_gemma":"systematic_review","domain_scores_codex":[0.98362297,0.00915676,0.0043492513,0.0010310367,0.0016098185,0.00023008238],"domain_scores_gemma":[0.6999205,0.2529653,0.027157642,0.0055818753,0.013102085,0.0012725017],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.045203067,0.0007404033,0.0058210883,0.0009830667,0.00033879513,0.0027828761,0.0011626175,0.0019730933,0.003488904],"category_scores_gemma":[0.09472262,0.0005073686,0.003906263,0.0020534142,0.0011987111,0.002955426,0.00086475286,0.0019686786,0.0005069746],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00971346,0.0004994183,0.016542595,0.42931187,0.045740675,0.00026775312,0.00077580445,0.00045139928,0.002974015,0.0018118008,0.006591801,0.48531947],"study_design_scores_gemma":[0.006179568,0.02508646,0.12518083,0.46899974,0.17877272,0.0018786546,0.0021718994,0.0005096522,0.003199128,0.008350751,0.1793778,0.0002928261],"about_ca_topic_score_codex":0.0013222257,"about_ca_topic_score_gemma":0.00307507,"teacher_disagreement_score":0.045203067,"about_ca_system_score_codex":0.00083310483,"about_ca_system_score_gemma":0.0032837444,"threshold_uncertainty_score":0.23905957},"labels":[],"label_agreement":null},{"id":"W2594701169","doi":"10.1111/bjh.14460","title":"Incidence and outcomes of paediatric myelodysplastic syndrome in the United States","year":2017,"lang":"en","type":"letter","venue":"British Journal of Haematology","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Incidence (geometry); Medicine; Myelodysplastic syndromes; Pediatrics; Intensive care medicine; Internal medicine; Bone marrow","score_opus":0.018600780384170408,"score_gpt":0.29613254222005475,"score_spread":0.27753176183588435,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2594701169","genre_codex":"empirical","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"editorial","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9774573,0.0057290094,0.00026725183,0.0005531008,0.0000435966,0.000029757017,0.011781814,0.00003912501,0.0040990068],"genre_scores_gemma":[0.98880905,0.0026211399,0.00027128772,0.00013747116,0.000031720723,0.000034484507,0.007840823,0.000008499157,0.00024567725],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.999416,0.00011484614,0.0001213238,0.0001091491,0.00017457003,0.00006424375],"domain_scores_gemma":[0.9982191,0.00013261431,0.0011405254,0.000041102303,0.00026325107,0.00020352054],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00050247007,0.0001689125,0.00026401298,0.0012270263,0.00021713536,0.00038059303,0.00024232453,0.00020099936,0.0012361177],"category_scores_gemma":[0.0024399105,0.00016440822,0.00024989448,0.0018415275,0.00022966892,0.00039244207,0.00046009864,0.0003949156,0.00016741137],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000020257788,0.000012657636,0.9948041,0.000024053532,0.00003157929,0.00010474767,0.000054922522,0.00013992387,0.000039327566,0.000089379,0.0012684511,0.0034106153],"study_design_scores_gemma":[0.000002845042,0.000026786314,0.998164,0.000037284288,0.000016811357,0.000530208,0.00011246313,0.00017529583,0.000027355165,0.000056087363,0.0008468742,0.000004030864],"about_ca_topic_score_codex":0.02295472,"about_ca_topic_score_gemma":0.027209938,"teacher_disagreement_score":0.02295472,"about_ca_system_score_codex":0.0007874573,"about_ca_system_score_gemma":0.0006555473,"threshold_uncertainty_score":0.045642257},"labels":[],"label_agreement":null},{"id":"W2603924317","doi":"10.1111/bjh.14569","title":"A phase 1 trial of temsirolimus and intensive re-induction chemotherapy for 2nd or greater relapse of acute lymphoblastic leukaemia: a Children's Oncology Group study (ADVL1114)","year":2017,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"PI3K/AKT/mTOR signaling in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":40,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"National Institutes of Health; Leukemia and Lymphoma Society; National Cancer Institute; Rally Foundation","keywords":"Temsirolimus; Medicine; Mucositis; Internal medicine; Toxicity; Regimen; Induction chemotherapy; Sirolimus; Clinical endpoint; Chemotherapy; Gastroenterology; Oncology; Clinical trial; PI3K/AKT/mTOR pathway; Discovery and development of mTOR inhibitors; Biology","score_opus":0.023863981803932538,"score_gpt":0.336079125056828,"score_spread":0.31221514325289546,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2603924317","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99636745,0.00093462097,0.00018152544,0.00020393927,0.00004746098,0.00091103616,0.00040156397,0.000050112245,0.00090217876],"genre_scores_gemma":[0.9884671,0.0016942654,0.0015998037,0.000590258,0.00012151893,0.0020588702,0.0023627575,0.000027050564,0.003078393],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99969935,0.00016622142,0.000011462563,0.000048495545,0.000024921148,0.000049595474],"domain_scores_gemma":[0.9994898,0.000095740856,0.00011650555,0.0000558313,0.000014376291,0.0002277314],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011364239,0.0011693359,0.0017063478,0.00036191478,0.00020528917,0.0005371338,0.0007413557,0.00090301177,0.0029261198],"category_scores_gemma":[0.0005910238,0.0004962691,0.0007331291,0.000339421,0.00078088115,0.00039144946,0.00034022285,0.0027018122,0.0005748659],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.7386949,0.064694464,0.009798363,0.0009911547,0.0012866324,0.00048333502,0.00042734988,0.0036733844,0.052750506,0.0005995134,0.0049352245,0.12166521],"study_design_scores_gemma":[0.5731153,0.401119,0.015456155,0.00003395893,0.00033287547,0.0006007966,0.00004549128,0.00087259174,0.0042764153,0.00020215524,0.00391751,0.000027895625],"about_ca_topic_score_codex":0.000764551,"about_ca_topic_score_gemma":0.0020451,"teacher_disagreement_score":0.0029261198,"about_ca_system_score_codex":0.0007785585,"about_ca_system_score_gemma":0.0010906897,"threshold_uncertainty_score":0.009788811},"labels":[],"label_agreement":null},{"id":"W2604750786","doi":"10.1111/bjh.14603","title":"The unique immunological features of heparin‐induced thrombocytopenia","year":2017,"lang":"en","type":"review","venue":"British Journal of Haematology","topic":"Heparin-Induced Thrombocytopenia and Thrombosis","field":"Medicine","cited_by":29,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University Medical Centre; Canadian Blood Services; McMaster University","funders":"","keywords":"Platelet factor 4; Immune system; Immunology; Heparin-induced thrombocytopenia; Heparin; Antibody; Monocyte; Chemokine; Platelet; Platelet activation; Antigen; Tissue factor; Medicine; Internal medicine; Coagulation","score_opus":0.1509917286448088,"score_gpt":0.4198737521707472,"score_spread":0.2688820235259384,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2604750786","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00038840342,0.9968637,0.0001533432,0.00029905062,0.00024405336,0.000004371229,0.000013721921,0.000007066391,0.0020263146],"genre_scores_gemma":[0.003206559,0.99501836,0.00016084428,0.00030673892,0.000451952,0.0000053444046,0.000032265056,0.0000015033082,0.0008163658],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.999848,0.000023879255,0.000027408554,0.000022694987,0.000060889895,0.000017111874],"domain_scores_gemma":[0.999846,0.00006545028,0.00002491539,0.000005496394,0.00004357393,0.0000145675995],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002107082,0.00062261283,0.0008944588,0.0015371836,0.00021753302,0.00075367413,0.00042367144,0.00083354913,0.0017051664],"category_scores_gemma":[0.00048219867,0.00013961903,0.0003141632,0.0012657944,0.00046065726,0.00077680434,0.00042608968,0.001253381,0.0008551115],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006792412,0.00005629588,0.0009023341,0.012984587,0.00009249395,0.0021049217,0.00017120622,0.000220356,0.0038871008,0.005020199,0.036797136,0.9376955],"study_design_scores_gemma":[0.00001756357,0.0000909648,0.003964058,0.0033178658,0.0001303084,0.03366446,0.00014224424,0.00009205813,0.00086532714,0.0027751683,0.9549137,0.000026293801],"about_ca_topic_score_codex":0.0007892073,"about_ca_topic_score_gemma":0.0009862595,"teacher_disagreement_score":0.0017051664,"about_ca_system_score_codex":0.00033644532,"about_ca_system_score_gemma":0.00057718606,"threshold_uncertainty_score":0.0057043433},"labels":[],"label_agreement":null},{"id":"W2606563895","doi":"10.1111/bjh.14667","title":"Long‐term outcomes, secondary malignancies and stem cell collection following bendamustine in patients with previously treated non‐Hodgkin lymphoma","year":2017,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":33,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Royal Victoria Regional Health Centre; Health Sciences North; Centre Hospitalier de l’Université de Montréal; Ottawa Hospital; Dalhousie University","funders":"National Center for Advancing Translational Sciences; Teva Pharmaceutical Industries","keywords":"Bendamustine; Medicine; Mantle cell lymphoma; Internal medicine; Lymphoma; Rituximab; Follicular lymphoma; Oncology; Surgery","score_opus":0.009923570703720143,"score_gpt":0.24021416140833168,"score_spread":0.23029059070461155,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2606563895","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99628675,0.0031234953,0.00008374641,0.000046809775,0.0000071375393,0.000016750528,0.00008203174,0.0000030712993,0.00035026437],"genre_scores_gemma":[0.9989507,0.0004946715,0.000045343248,0.00007609622,0.000019366094,0.00001603605,0.00031248314,0.0000013685725,0.00008386542],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9992316,0.0003051973,0.00013287929,0.00008861543,0.00013977774,0.000101924845],"domain_scores_gemma":[0.99670875,0.0011680614,0.0013049127,0.00017094112,0.00020714237,0.00044018717],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00184063,0.00014584101,0.0005382936,0.00040176013,0.0004424816,0.0008099739,0.0002006375,0.00036653102,0.00038739524],"category_scores_gemma":[0.0040562986,0.00014159067,0.00062566827,0.0006057205,0.0003530774,0.0005797004,0.00037025494,0.00050623744,0.000094535695],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004892755,0.00026966902,0.97130597,0.00011402378,0.0004592381,0.0010081963,0.00027703695,0.00028936588,0.0014946428,0.00004056518,0.00014582639,0.019702788],"study_design_scores_gemma":[0.00037138947,0.009336565,0.9830525,0.00006110329,0.0005649738,0.0036912535,0.0001975814,0.00040734495,0.0010474267,0.00012393652,0.0011253748,0.00002058272],"about_ca_topic_score_codex":0.00071944896,"about_ca_topic_score_gemma":0.001519561,"teacher_disagreement_score":0.00184063,"about_ca_system_score_codex":0.0005843156,"about_ca_system_score_gemma":0.0003676626,"threshold_uncertainty_score":0.009734333},"labels":[],"label_agreement":null},{"id":"W2606741855","doi":"10.1111/bjh.14646","title":"Acquired blue sclerae in <scp>POEMS</scp> syndrome","year":2017,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Peripheral Neuropathies and Disorders","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency; Vancouver General Hospital","funders":"","keywords":"POEMS syndrome; Medicine; Organomegaly; Blurred vision; Polyneuropathy; Pathology; Skin hyperpigmentation; Dermatology; Hyperpigmentation; Surgery","score_opus":0.02254611917426599,"score_gpt":0.2754709675557134,"score_spread":0.2529248483814474,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2606741855","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9852083,0.0018572094,0.0008840816,0.0010567699,0.000078284545,0.000060159982,0.00024497506,0.000104016144,0.010506271],"genre_scores_gemma":[0.99804187,0.00042132198,0.00019625384,0.00015496377,0.0000722667,0.00000665793,0.00006223687,0.0000074699656,0.0010370389],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.99985874,0.000021728303,0.000011306195,0.000028897219,0.000025009102,0.000054246808],"domain_scores_gemma":[0.9997061,0.00008350928,0.000069535934,0.000012517346,0.000019514253,0.00010883356],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000105348474,0.0008522397,0.00043491193,0.00061423186,0.0005214347,0.00044145572,0.0002199622,0.0010510224,0.0026428567],"category_scores_gemma":[0.0007667617,0.00025603597,0.00025542153,0.00053275714,0.0005630825,0.00051869,0.00038230792,0.00076377986,0.00060967467],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014846862,0.000034715544,0.021419501,0.000051740564,0.000014124216,0.9695439,0.00015302878,0.00009511528,0.004284231,0.00016923808,0.0005054966,0.003580449],"study_design_scores_gemma":[0.000026705691,0.00014969033,0.03250584,0.000014899607,0.000014091833,0.9651086,0.00006477133,0.00016892768,0.00067912176,0.00016726258,0.0010912576,0.000008932038],"about_ca_topic_score_codex":0.001397595,"about_ca_topic_score_gemma":0.0015081342,"teacher_disagreement_score":0.0026428567,"about_ca_system_score_codex":0.00030045447,"about_ca_system_score_gemma":0.00025377164,"threshold_uncertainty_score":0.008841276},"labels":[],"label_agreement":null},{"id":"W2606884609","doi":"10.1111/bjh.14609","title":"Prevalence and risk factors for red blood cell alloimmunization in 175 children with sickle cell disease in a French university hospital reference centre","year":2017,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Blood groups and transfusion","field":"Medicine","cited_by":52,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Hospital for Sick Children; Agence Nationale de la Recherche","keywords":"Medicine; Confidence interval; Autoantibody; Red Cell; Fetal hemoglobin; Internal medicine; Pediatrics; Antibody; Blood transfusion; Red blood cell; Immunology; Pregnancy; Fetus","score_opus":0.005022565778677179,"score_gpt":0.19242971326490899,"score_spread":0.1874071474862318,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2606884609","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99945635,0.00024398763,0.000026951944,0.00002756929,0.0000026509267,0.0000034313787,0.00012627637,0.0000030582362,0.00010975109],"genre_scores_gemma":[0.9995926,0.00011616526,0.00004789533,0.000020658958,0.0000063725197,0.0000033895553,0.00016617625,8.182129e-7,0.0000459782],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9993861,0.00014319473,0.00006991397,0.00011685743,0.00014001042,0.00014399475],"domain_scores_gemma":[0.99898857,0.00019480535,0.00051402405,0.000033011955,0.00010658554,0.00016301451],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006507666,0.0002846289,0.00032543647,0.0016566947,0.0005993519,0.00056179595,0.00047926663,0.00045089007,0.0016859503],"category_scores_gemma":[0.0012706189,0.0002998261,0.00036471436,0.0010743636,0.00040803806,0.00023309475,0.00032396824,0.00030929878,0.00015273118],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000015794149,0.000014312585,0.99879444,0.0000074736313,0.00001149006,0.00021912066,0.00013891293,0.000018611476,0.00009385989,0.000011886922,0.00008887222,0.00058531895],"study_design_scores_gemma":[0.0000028497684,0.00005960937,0.99848455,0.000008605966,0.0000090523845,0.00079003454,0.00033022795,0.00008344383,0.000043455217,0.000004228112,0.00018069045,0.0000033380143],"about_ca_topic_score_codex":0.036392733,"about_ca_topic_score_gemma":0.021821242,"teacher_disagreement_score":0.036392733,"about_ca_system_score_codex":0.001337894,"about_ca_system_score_gemma":0.00064619037,"threshold_uncertainty_score":0.07236183},"labels":[],"label_agreement":null},{"id":"W2607531045","doi":"10.1111/bjh.14720","title":"Outcome after intensive reinduction therapy and allogeneic stem cell transplant in paediatric relapsed acute myeloid leukaemia","year":2017,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":48,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto General Hospital; University Health Network","funders":"Barncancerfonden; International Business Machines Corporation","keywords":"Medicine; Myeloid leukaemia; Hematology; Stem cell; Myeloid; Oncology; Internal medicine; Intensive care medicine","score_opus":0.029290773422042834,"score_gpt":0.29209955568642304,"score_spread":0.2628087822643802,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2607531045","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9976788,0.0015180124,0.000076574885,0.00006631259,0.000010763281,0.00001027991,0.00012647106,0.0000066445364,0.0005061206],"genre_scores_gemma":[0.99889886,0.0003897171,0.00006130938,0.00003369494,0.000016714635,0.000011006118,0.00048774516,0.0000032038456,0.00009773797],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9995363,0.00016285242,0.00003948357,0.000055424338,0.00010111418,0.00010486493],"domain_scores_gemma":[0.99830616,0.00043747976,0.00079341163,0.00010149751,0.00006487848,0.00029655115],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007146349,0.00017347085,0.00048190367,0.0002707679,0.00023190853,0.00033393555,0.00023940367,0.00029894867,0.00068587816],"category_scores_gemma":[0.0021060049,0.00007044594,0.00045688977,0.00036603483,0.0003721948,0.00025822644,0.0005609211,0.0006525954,0.00013873095],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006922892,0.0005363887,0.9062951,0.00020509103,0.00038019972,0.0104799215,0.00075425,0.002407222,0.0027433236,0.00028539178,0.0013601109,0.067630105],"study_design_scores_gemma":[0.00018644452,0.0040902602,0.9811895,0.00006418505,0.00014506916,0.011455781,0.00015493234,0.00044235095,0.0005799566,0.00018776263,0.0014874885,0.000016161293],"about_ca_topic_score_codex":0.0013523715,"about_ca_topic_score_gemma":0.0012452484,"teacher_disagreement_score":0.0013523715,"about_ca_system_score_codex":0.0007007128,"about_ca_system_score_gemma":0.00040660216,"threshold_uncertainty_score":0.005084038},"labels":[],"label_agreement":null},{"id":"W2608927536","doi":"10.1111/bjh.14664","title":"The effect of rituximab on anti‐platelet autoantibody levels in patients with immune thrombocytopenia","year":2017,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":40,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Canadian Blood Services","funders":"Canadian Institutes of Health Research; Canadian Blood Services; McMaster University","keywords":"Rituximab; Autoantibody; Medicine; Platelet; Immunology; Internal medicine; Immune thrombocytopenia; Adjuvant; Placebo; Gastroenterology; Antibody; Pathology","score_opus":0.007389295413148649,"score_gpt":0.2695791835000823,"score_spread":0.26218988808693366,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2608927536","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98273635,0.01603973,0.00011119081,0.00027924724,0.000083790874,0.00004437716,0.000029653867,0.000010291509,0.00066536263],"genre_scores_gemma":[0.99844176,0.0010780675,0.0000984481,0.00016550583,0.000088151915,0.000016388829,0.000036331574,0.0000014610615,0.0000738869],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.9968741,0.0020967457,0.00025481472,0.00020767088,0.0003822075,0.00018446514],"domain_scores_gemma":[0.99580765,0.0026942256,0.0007889398,0.00019690812,0.00013183552,0.00038035042],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0030167587,0.0005076332,0.0017345424,0.00031952208,0.00023216894,0.0006936841,0.00045973802,0.0011315343,0.00069728476],"category_scores_gemma":[0.007789888,0.00036938392,0.0012149678,0.00034850324,0.00059951755,0.00053968583,0.00026180487,0.0010374978,0.00013565525],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.54524213,0.010295976,0.22070114,0.001361657,0.010283146,0.0020678502,0.00043256,0.0015303661,0.018854005,0.00029378964,0.001485884,0.18745156],"study_design_scores_gemma":[0.053448506,0.22149497,0.7061967,0.00026789136,0.0064249705,0.002137157,0.00018377221,0.0022409954,0.0040427423,0.00032863638,0.0031550298,0.0000786726],"about_ca_topic_score_codex":0.00050218013,"about_ca_topic_score_gemma":0.0007991913,"teacher_disagreement_score":0.0030167587,"about_ca_system_score_codex":0.0004946035,"about_ca_system_score_gemma":0.000376427,"threshold_uncertainty_score":0.015954316},"labels":[],"label_agreement":null},{"id":"W2609884290","doi":"10.1111/bjh.14698","title":"A phase 2 study of mocetinostat, a histone deacetylase inhibitor, in relapsed or refractory lymphoma","year":2017,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Histone Deacetylase Inhibitors Research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":109,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital Charles-Le Moyne; McGill University; University of Ottawa; Princess Margaret Cancer Centre","funders":"National Cancer Institute; Mirati Therapeutics","keywords":"Medicine; Internal medicine; Histone deacetylase inhibitor; Follicular lymphoma; Oncology; Adverse effect; Diffuse large B-cell lymphoma; Refractory (planetary science); Lymphoma; Aggressive lymphoma; Gastroenterology; Histone deacetylase; Rituximab; Biology; Histone","score_opus":0.022412711113689827,"score_gpt":0.3520875203780766,"score_spread":0.3296748092643868,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2609884290","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9946631,0.0014898104,0.0004180728,0.00023830387,0.00005937376,0.0016665676,0.00038936202,0.000056848756,0.0010184478],"genre_scores_gemma":[0.99048424,0.0019926608,0.0014257156,0.0007873823,0.000104082064,0.0018696941,0.0012299243,0.000020378287,0.0020860452],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.99976605,0.00012018422,0.000009382858,0.000037057365,0.000017679258,0.000049709026],"domain_scores_gemma":[0.99974793,0.000045298017,0.000042876054,0.00002121096,0.00001972209,0.00012295184],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009262754,0.0008404944,0.0012185344,0.00038516038,0.00021266642,0.0004933131,0.00040235862,0.000655691,0.0022097742],"category_scores_gemma":[0.0005663551,0.0003835513,0.00073383923,0.00022133513,0.00034870845,0.00039483863,0.00021595127,0.0014515616,0.0004014701],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.49073493,0.106075004,0.013554703,0.0010506257,0.0014608083,0.0010800143,0.00058560696,0.0036564714,0.10301752,0.00047833493,0.0054902574,0.27281573],"study_design_scores_gemma":[0.47461355,0.4947238,0.017377263,0.000044752738,0.0003909873,0.0006905368,0.00008559602,0.001930019,0.0051929834,0.00023433579,0.004677794,0.000038384653],"about_ca_topic_score_codex":0.0006748562,"about_ca_topic_score_gemma":0.0016901658,"teacher_disagreement_score":0.0022097742,"about_ca_system_score_codex":0.00044518636,"about_ca_system_score_gemma":0.00075134216,"threshold_uncertainty_score":0.007392466},"labels":[],"label_agreement":null},{"id":"W2610591083","doi":"10.1111/bjh.14605","title":"“On‐demand” treatment with Thrombopoietin mimetics as “bridge to recovery” from chemotherapy in chronic immune thrombocytopenia patients with cancer. A single centre experience in nine patients","year":2017,"lang":"en","type":"letter","venue":"British Journal of Haematology","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Splenectomy; Thrombopoietin; Chemotherapy; Cancer; Platelet; Internal medicine; Surgery; Spleen","score_opus":0.015444520703470169,"score_gpt":0.2739747162665569,"score_spread":0.2585301955630867,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2610591083","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9934522,0.0036109218,0.0005017504,0.00018519814,0.00004925792,0.000099492914,0.00005394674,0.0000117360005,0.0020355317],"genre_scores_gemma":[0.995615,0.0023140039,0.0006117191,0.0003834489,0.0000779621,0.00006922548,0.00022772902,0.0000093961835,0.0006914094],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9998228,0.00006431412,0.000019642028,0.000027606367,0.00002147531,0.000044138207],"domain_scores_gemma":[0.99961615,0.00007042654,0.000055748915,0.000028400345,0.000020790863,0.00020846943],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00031755754,0.00031933142,0.0003721664,0.00013949368,0.0006071045,0.00054420804,0.0003081133,0.00036346584,0.0011970989],"category_scores_gemma":[0.0009438323,0.0001800263,0.00063982344,0.00025070587,0.0002830156,0.000317137,0.00044263978,0.0007244677,0.00034113973],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.016849913,0.015749602,0.26959965,0.0010523407,0.0008540625,0.040663145,0.007265373,0.0020570415,0.02255395,0.0008990587,0.009069362,0.61338645],"study_design_scores_gemma":[0.00820623,0.19101167,0.55652523,0.0005644808,0.0015224486,0.15561983,0.0031331154,0.0034128886,0.012914595,0.00081592245,0.06607989,0.00019374645],"about_ca_topic_score_codex":0.0006780574,"about_ca_topic_score_gemma":0.0010113323,"teacher_disagreement_score":0.0011970989,"about_ca_system_score_codex":0.00031286388,"about_ca_system_score_gemma":0.0003753314,"threshold_uncertainty_score":0.004004717},"labels":[],"label_agreement":null},{"id":"W2610626477","doi":"10.1111/bjh.14623","title":"Glanzmann thrombasthenia platelets compete with transfused platelets, reducing the haemostatic impact of platelet transfusions","year":2017,"lang":"en","type":"letter","venue":"British Journal of Haematology","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Institute for Clinical Evaluative Sciences; Centre Hospitalier Universitaire Sainte-Justine; SickKids Foundation; Hospital for Sick Children; University of Toronto","funders":"","keywords":"Thrombasthenia; Platelet; Glanzmann's thrombasthenia; Medicine; Platelet transfusion; Blood Platelet Disorders; Immunology; Platelet aggregation","score_opus":0.01912580188991389,"score_gpt":0.28541380140699174,"score_spread":0.2662879995170778,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2610626477","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.586531,0.3305533,0.01757036,0.011334206,0.0026216728,0.0006164011,0.0011613322,0.0010169151,0.048594933],"genre_scores_gemma":[0.93189174,0.042417586,0.008663621,0.00300959,0.00073889515,0.00027114587,0.000929009,0.0001553614,0.011923105],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9991804,0.00021688263,0.00008046559,0.0000793819,0.00032373102,0.00011912998],"domain_scores_gemma":[0.9995159,0.00013534904,0.00014149047,0.000034756067,0.00007636697,0.000096141826],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006305715,0.0005963328,0.0009515161,0.0005035894,0.00024437674,0.0009978708,0.00038966924,0.0005536843,0.005462346],"category_scores_gemma":[0.0022628866,0.00016947846,0.00044567257,0.0003456252,0.00027825954,0.0004462579,0.0006553958,0.0013377419,0.0018877975],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0053979047,0.0020086071,0.013675638,0.004246012,0.0010250014,0.0048735086,0.00059729157,0.0015563796,0.32771558,0.0083977,0.053883824,0.57662255],"study_design_scores_gemma":[0.003559635,0.023687646,0.1257107,0.0022491324,0.0014996295,0.05611149,0.000823704,0.005709793,0.26051563,0.0128458245,0.5070657,0.00022115698],"about_ca_topic_score_codex":0.0011805631,"about_ca_topic_score_gemma":0.0008380014,"teacher_disagreement_score":0.005462346,"about_ca_system_score_codex":0.0004196149,"about_ca_system_score_gemma":0.0003789255,"threshold_uncertainty_score":0.018273354},"labels":[],"label_agreement":null},{"id":"W2611251974","doi":"10.1111/bjh.14702","title":"Physical activity, obesity and survival in diffuse large B‐cell and follicular lymphoma cases","year":2017,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":25,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; Royal Jubilee Hospital; Public Health Ontario; University of Toronto; BC Cancer Agency","funders":"National Cancer Institute; BC Cancer Agency; National Health and Medical Research Council; Canadian Institutes of Health Research; Killam Trusts; Michael Smith Health Research BC","keywords":"Follicular lymphoma; Medicine; Lymphoma; Hazard ratio; Internal medicine; Diffuse large B-cell lymphoma; Body mass index; Confidence interval; International Prognostic Index; Non-Hodgkin's lymphoma; Oncology; Obesity; Proportional hazards model; Gastroenterology","score_opus":0.01669004799159555,"score_gpt":0.28590569905521374,"score_spread":0.26921565106361817,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2611251974","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9993268,0.00032867934,0.000016092976,0.000015229477,0.0000018415677,0.0000016462524,0.00008205324,0.0000010992017,0.00022663946],"genre_scores_gemma":[0.99958485,0.00010478745,0.000013978015,0.0000062370336,0.000004997251,0.000002445161,0.00019101756,5.973388e-7,0.00009112039],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99973387,0.000077267134,0.000033346598,0.000045169607,0.000042054067,0.000068292524],"domain_scores_gemma":[0.99936014,0.00016953803,0.00023861609,0.00005152188,0.000037244157,0.00014294681],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00044332136,0.0001370472,0.00023398497,0.0011076988,0.00023375462,0.0004026675,0.00020289194,0.00027637125,0.0013024271],"category_scores_gemma":[0.0014962088,0.0002062808,0.00028122586,0.0009518843,0.0003012958,0.00036891375,0.0005172549,0.00031533107,0.00021754981],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018081565,0.000020370084,0.9982515,0.000005387995,0.00002534706,0.000106233805,0.000050671,0.000027463093,0.00010728933,0.0000082023225,0.000030662606,0.0011859306],"study_design_scores_gemma":[0.0000048250045,0.000048112724,0.99940264,0.0000028389825,0.000011327871,0.00026573197,0.000098876175,0.000049758197,0.00001608295,0.000015533415,0.00008283543,0.0000014036007],"about_ca_topic_score_codex":0.0033095179,"about_ca_topic_score_gemma":0.0037824933,"teacher_disagreement_score":0.0033095179,"about_ca_system_score_codex":0.00024549957,"about_ca_system_score_gemma":0.00010591304,"threshold_uncertainty_score":0.0065805316},"labels":[],"label_agreement":null},{"id":"W2613509107","doi":"10.1111/bjh.14592","title":"Turf wars: exploring splenomegaly in sickle cell disease in malaria‐endemic regions","year":2017,"lang":"en","type":"review","venue":"British Journal of Haematology","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":28,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Heart, Lung, and Blood Institute; National Institutes of Health; AGE-WELL; Wellcome Trust; Wellcome","keywords":"Malaria; Disease; Medicine; Severe Malaria; Immunology; Pediatrics; Internal medicine; Plasmodium falciparum","score_opus":0.10019103310777724,"score_gpt":0.3359890896213423,"score_spread":0.23579805651356503,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2613509107","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00011695622,0.9989011,0.000028821509,0.00028109018,0.00015620247,0.000002732587,0.000013022081,0.000002818861,0.0004972571],"genre_scores_gemma":[0.0008492593,0.998434,0.00007895099,0.00020465598,0.00013474481,0.0000033866793,0.00002471285,0.0000010618243,0.0002693507],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9998202,0.000046309815,0.000039511433,0.000023173543,0.000053507116,0.000017238039],"domain_scores_gemma":[0.9995541,0.00024498824,0.000064424996,0.00000809829,0.00009497672,0.000033381388],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000511955,0.0005034788,0.0008760889,0.0029241478,0.00026706822,0.0008475,0.00055866333,0.00095867494,0.0038936648],"category_scores_gemma":[0.0012222112,0.00020686422,0.00054225576,0.002262006,0.00036830304,0.0011008704,0.00065109535,0.0011135436,0.0010187305],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010030909,0.00003964421,0.000556831,0.03154966,0.00013793868,0.00035254224,0.00022787944,0.00020865398,0.00054186414,0.0023081678,0.037815005,0.9261615],"study_design_scores_gemma":[0.000025696614,0.00011707401,0.0035227505,0.02410301,0.00028980547,0.004841999,0.00030323857,0.000085488246,0.0002843389,0.0013381587,0.9650639,0.000024457666],"about_ca_topic_score_codex":0.0022248016,"about_ca_topic_score_gemma":0.003668462,"teacher_disagreement_score":0.0038936648,"about_ca_system_score_codex":0.00046774742,"about_ca_system_score_gemma":0.0011263996,"threshold_uncertainty_score":0.013025641},"labels":[],"label_agreement":null},{"id":"W2614011808","doi":"10.1111/bjh.14733","title":"Management of adverse events associated with ixazomib plus lenalidomide/dexamethasone in relapsed/refractory multiple myeloma","year":2017,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":60,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Royal Victoria Hospital","funders":"Takeda Pharmaceutical Company","keywords":"Medicine; Lenalidomide; Ixazomib; Nausea; Adverse effect; Multiple myeloma; Rash; Placebo; Internal medicine; Mucositis; Dexamethasone; Vomiting; Thalidomide; Gastroenterology; Surgery; Chemotherapy; Carfilzomib","score_opus":0.029417235466169988,"score_gpt":0.30637939824332555,"score_spread":0.2769621627771556,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2614011808","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.521077,0.46073014,0.0038590743,0.0038324036,0.00041208114,0.00071804784,0.00025224005,0.00033522383,0.008783807],"genre_scores_gemma":[0.91256505,0.07806071,0.005384983,0.0015250889,0.00039740693,0.00016804208,0.0002865217,0.000029828154,0.0015825556],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99927825,0.00043544103,0.000094930045,0.000028428243,0.00013188912,0.00003111655],"domain_scores_gemma":[0.99922216,0.0003066526,0.00030439734,0.000017849014,0.00006135567,0.00008760401],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016063459,0.00022428118,0.0008341864,0.0003255069,0.00024426566,0.0003565181,0.00029188526,0.00032804528,0.00064033526],"category_scores_gemma":[0.0018091403,0.000101068814,0.00054680393,0.0003478261,0.0001752531,0.00018161473,0.0002081312,0.000830123,0.00021654674],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.014160859,0.0007558961,0.016352303,0.0056195906,0.0009407494,0.0044721724,0.0003268565,0.0016841128,0.028402135,0.00032074764,0.007949971,0.9190146],"study_design_scores_gemma":[0.02349787,0.1319763,0.41984126,0.0077230744,0.005146536,0.09760701,0.0016087912,0.015041035,0.055602737,0.0030677596,0.23863958,0.0002480201],"about_ca_topic_score_codex":0.00046313502,"about_ca_topic_score_gemma":0.0019250244,"teacher_disagreement_score":0.0016063459,"about_ca_system_score_codex":0.00047826464,"about_ca_system_score_gemma":0.0003424235,"threshold_uncertainty_score":0.008495271},"labels":[],"label_agreement":null},{"id":"W2616337382","doi":"10.1111/bjh.14756","title":"Incidental finding of recent parvovirus infection","year":2017,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Parvovirus B19 Infection Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Children's Hospital of Eastern Ontario","funders":"","keywords":"Parvovirus; Medicine; Bone marrow; Asymptomatic; Pathology; Erythropoiesis; Bone marrow examination; Platelet; Serology; Ineffective erythropoiesis; Immunology; Anemia; Gastroenterology; Internal medicine; Virus","score_opus":0.0710185415896461,"score_gpt":0.3736143194802201,"score_spread":0.302595777890574,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2616337382","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96712565,0.008397725,0.0022320533,0.0026614624,0.00038963524,0.00014965254,0.00075592747,0.00037724967,0.017910646],"genre_scores_gemma":[0.9939958,0.0020797849,0.00072818005,0.00066584285,0.00028440088,0.000013082701,0.00030098966,0.000032397358,0.001899535],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.9996538,0.000033383574,0.000026849253,0.000112467955,0.00005629689,0.00011730617],"domain_scores_gemma":[0.9990933,0.0002012377,0.00011095768,0.00006290351,0.000088791545,0.00044269275],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002106172,0.0012728216,0.0010679124,0.002337402,0.0011685397,0.00066326326,0.0010160727,0.0018944959,0.003982985],"category_scores_gemma":[0.0016471682,0.0007183175,0.0006031213,0.0008832638,0.0006652701,0.0011459695,0.0008452072,0.0020297146,0.0010294974],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000106355015,0.00006998713,0.026214072,0.000049692768,0.000013778182,0.9669368,0.00022595892,0.00007164833,0.0028967366,0.00015021236,0.0007444995,0.002520264],"study_design_scores_gemma":[0.000013079167,0.00015078462,0.01492686,0.00003675262,0.00001770847,0.98262215,0.000099089746,0.00021753255,0.0005500646,0.0000897725,0.0012654623,0.0000107183305],"about_ca_topic_score_codex":0.0030088825,"about_ca_topic_score_gemma":0.0026965057,"teacher_disagreement_score":0.003982985,"about_ca_system_score_codex":0.00055060425,"about_ca_system_score_gemma":0.00048069705,"threshold_uncertainty_score":0.0133244395},"labels":[],"label_agreement":null},{"id":"W2616381323","doi":"10.1111/j.1365-2141.2000.02342.x","title":"Primitive haematopoietic progenitors in the blood of patients with sickle cell disease appear to be endogenously mobilized","year":2000,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"National Institutes of Health; Associazione Italiana per la Ricerca sul Cancro","keywords":"Progenitor cell; Haematopoiesis; Immunology; Biology; White blood cell; Blood cell; Stem cell; Internal medicine; Andrology; Medicine; Cell biology","score_opus":0.005327753068103107,"score_gpt":0.2057229196985517,"score_spread":0.2003951666304486,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2616381323","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9989901,0.00050494616,0.00019234358,0.000010932251,0.0000023432099,0.0000045817924,0.00007544728,0.000009852626,0.00020939736],"genre_scores_gemma":[0.9989525,0.00022827245,0.00028018473,0.000025658055,0.000006405497,0.000008462533,0.00025602634,0.0000039858714,0.00023840254],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99986887,0.00002720252,0.00002690109,0.000027501083,0.000033665703,0.000015838894],"domain_scores_gemma":[0.99982387,0.000046503523,0.000053775322,0.000015836533,0.000019809475,0.00004022323],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000109638255,0.00017177648,0.0002431051,0.00045357706,0.00015729477,0.0003520365,0.00009486965,0.00020196608,0.0010153261],"category_scores_gemma":[0.00059123256,0.000104073704,0.00008587109,0.00033653431,0.00017665466,0.00017231374,0.00018845285,0.0002389011,0.00024806685],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002353685,0.00015620615,0.39562446,0.00019804227,0.00006774143,0.0035649869,0.001954717,0.00037936875,0.55720466,0.0003672419,0.00029112966,0.037837785],"study_design_scores_gemma":[0.000062578416,0.0026554365,0.9110249,0.000036230045,0.00010778318,0.011822075,0.0006557214,0.0009371589,0.068102054,0.0002510974,0.0043227314,0.000022222595],"about_ca_topic_score_codex":0.00031899975,"about_ca_topic_score_gemma":0.000254059,"teacher_disagreement_score":0.0010153261,"about_ca_system_score_codex":0.00009908703,"about_ca_system_score_gemma":0.00009316032,"threshold_uncertainty_score":0.0033966303},"labels":[],"label_agreement":null},{"id":"W2620016413","doi":"10.1111/bjh.14780","title":"Recent progress in relapsed multiple myeloma therapy: implications for treatment decisions","year":2017,"lang":"en","type":"review","venue":"British Journal of Haematology","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":44,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hotel Dieu Hospital","funders":"Amgen","keywords":"Multiple myeloma; Medicine; Intensive care medicine; Oncology; Internal medicine","score_opus":0.2364325585495828,"score_gpt":0.4665470139031241,"score_spread":0.23011445535354128,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2620016413","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000044033946,0.99666995,0.000073819254,0.002497883,0.0002793814,0.0000020309249,0.000008797772,0.0000024277153,0.00042167498],"genre_scores_gemma":[0.00068690773,0.9975078,0.00019894303,0.0010472605,0.00038796375,0.000004894976,0.000014864881,0.0000013127805,0.00015000104],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99861515,0.0005174404,0.00026034273,0.00013315266,0.00040567172,0.00006814575],"domain_scores_gemma":[0.99592173,0.002864823,0.0004246411,0.00006527265,0.0005830107,0.00014045092],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0039348914,0.00066498166,0.0019072146,0.0023935873,0.0004284181,0.0022957777,0.0013855076,0.0021538967,0.0037871678],"category_scores_gemma":[0.006294398,0.00035817004,0.00081272004,0.0029307157,0.0013123844,0.0036546094,0.001066285,0.004227238,0.0012182472],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008913978,0.00005129491,0.0002153751,0.030733261,0.00017842422,0.00024452162,0.00033692678,0.0007206715,0.00035190937,0.019173669,0.05890773,0.88899714],"study_design_scores_gemma":[0.000024230038,0.000056729932,0.0005647049,0.025356913,0.00015028488,0.00096134644,0.00037323593,0.00011202519,0.000112767266,0.012263598,0.9599943,0.00003003013],"about_ca_topic_score_codex":0.0017787233,"about_ca_topic_score_gemma":0.0030443524,"teacher_disagreement_score":0.0039348914,"about_ca_system_score_codex":0.0021262555,"about_ca_system_score_gemma":0.0032400738,"threshold_uncertainty_score":0.020809948},"labels":[],"label_agreement":null},{"id":"W2621898599","doi":"10.1111/bjh.14641","title":"Impact of red blood cell transfusion strategies in haemato‐oncological patients: a systematic review and meta‐analysis","year":2017,"lang":"en","type":"review","venue":"British Journal of Haematology","topic":"Blood transfusion and management","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"Leids Universitair Medisch Centrum; McMaster University","keywords":"Medicine; Observational study; Meta-analysis; CINAHL; Relative risk; Randomized controlled trial; MEDLINE; Confidence interval; Blood transfusion; Red Blood Cell Transfusion; Intensive care medicine; Pediatrics; Internal medicine; Psychological intervention","score_opus":0.0673367142916423,"score_gpt":0.37788481544982205,"score_spread":0.31054810115817977,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2621898599","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0032438184,0.9955318,0.00032640266,0.00013503987,0.00009424506,0.00022868758,0.0002666219,0.000013807799,0.00015952639],"genre_scores_gemma":[0.10292449,0.8919676,0.0019787399,0.00074170344,0.00022145652,0.0012371152,0.00059744756,0.000023136148,0.00030828497],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9919803,0.0036169456,0.0025073627,0.0007392105,0.00089771306,0.00025854638],"domain_scores_gemma":[0.982888,0.013076282,0.002331814,0.00041423092,0.0010818125,0.00020792896],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.012104029,0.0028196645,0.018300544,0.00604725,0.0006603902,0.0034058774,0.0021899827,0.0024823532,0.0034584438],"category_scores_gemma":[0.02690952,0.0014380217,0.035415486,0.007016196,0.00068003824,0.0018618895,0.001419783,0.0019113455,0.00029546008],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0019810833,0.00003854033,0.0020655994,0.51927465,0.4642003,0.000107866705,0.00009357635,0.00032791114,0.00017445974,0.000115263785,0.00043708997,0.011183708],"study_design_scores_gemma":[0.00047912935,0.00021878457,0.0023053624,0.03205227,0.96289706,0.000083885134,0.000049985978,0.00013094659,0.00011187667,0.00014319824,0.0015054293,0.000022057257],"about_ca_topic_score_codex":0.0051030396,"about_ca_topic_score_gemma":0.012507874,"teacher_disagreement_score":0.018300544,"about_ca_system_score_codex":0.0025838765,"about_ca_system_score_gemma":0.0035408696,"threshold_uncertainty_score":0.064013004},"labels":[],"label_agreement":null},{"id":"W2725925241","doi":"10.1111/bjh.14820","title":"Randomized, phase 3 trial of inotuzumab ozogamicin plus rituximab <i>versus</i> chemotherapy plus rituximab for relapsed/refractory aggressive B‐cell non‐Hodgkin lymphoma","year":2017,"lang":"en","type":"letter","venue":"British Journal of Haematology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":62,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"National Cancer Institute; Pfizer","keywords":"Rituximab; Medicine; Calicheamicin; Internal medicine; Oncology; Hazard ratio; Interim analysis; Refractory (planetary science); CD22; Clinical endpoint; Aggressive lymphoma; Lymphoma; CD20; Clinical trial; Confidence interval","score_opus":0.02536001530919176,"score_gpt":0.31448059661853234,"score_spread":0.2891205813093406,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2725925241","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9759889,0.0025214567,0.0012490886,0.0011056553,0.0011294325,0.011098627,0.0022804611,0.00028523264,0.0043412354],"genre_scores_gemma":[0.9735675,0.0018278576,0.0035875707,0.00268899,0.0006425912,0.010425676,0.0024309098,0.00007681621,0.004752147],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99909866,0.00052683195,0.000040105377,0.00014540223,0.000059238955,0.00012982622],"domain_scores_gemma":[0.99887806,0.00026928095,0.00026055385,0.00011509147,0.00006840138,0.0004086675],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0028926532,0.001942108,0.0028238182,0.000416761,0.0005338541,0.0015635042,0.0011321973,0.0014757526,0.005655257],"category_scores_gemma":[0.0017098188,0.0009154833,0.0020803637,0.00037639416,0.0014635782,0.0013087876,0.0005409363,0.0046492545,0.001215095],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.98203707,0.006801816,0.00029127137,0.00021075041,0.0005578116,0.000027459382,0.000043766166,0.00032628968,0.0025181966,0.00012885164,0.0009174399,0.0061391797],"study_design_scores_gemma":[0.9364002,0.060744587,0.00088774384,0.0000143451025,0.0002769906,0.000023825209,0.000015766256,0.000476849,0.00030612238,0.00022382961,0.0006169484,0.000012864092],"about_ca_topic_score_codex":0.00141417,"about_ca_topic_score_gemma":0.004492153,"teacher_disagreement_score":0.005655257,"about_ca_system_score_codex":0.0013364956,"about_ca_system_score_gemma":0.0017035203,"threshold_uncertainty_score":0.018918753},"labels":[],"label_agreement":null},{"id":"W2726575446","doi":"10.1111/bjh.14767","title":"British Committee for Standards in Haematology guidelines for aplastic anaemia: single centre retrospective review finds no compelling evidence for the recommended higher platelet count threshold of 20 × 10<sup>9</sup>/l","year":2017,"lang":"en","type":"letter","venue":"British Journal of Haematology","topic":"Blood transfusion and management","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre; University of Toronto","funders":"","keywords":"Medicine; Platelet; Platelet transfusion; Aplastic anemia; Retrospective cohort study; Internal medicine; Pharmacy; Hematology; Absolute neutrophil count; Pediatrics; Neutropenia; Chemotherapy; Family medicine; Bone marrow","score_opus":0.10077469349514713,"score_gpt":0.3586829078346189,"score_spread":0.2579082143394718,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2726575446","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.009628447,0.24182239,0.008695496,0.6302524,0.03861719,0.0021207032,0.018523008,0.0007179297,0.04962245],"genre_scores_gemma":[0.21629886,0.23460151,0.061940957,0.3971894,0.021079967,0.011310092,0.035800718,0.0013134527,0.020464996],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.93241274,0.02299585,0.025548372,0.0013438482,0.016428696,0.0012704572],"domain_scores_gemma":[0.74050605,0.11803668,0.043535482,0.0114264,0.08258329,0.003912109],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.040901385,0.00048189357,0.0018708925,0.0046914225,0.0017427913,0.0031786705,0.002013774,0.0053041033,0.0070216567],"category_scores_gemma":[0.2107915,0.0006973257,0.0013940943,0.0067378664,0.002325708,0.002079098,0.0016099764,0.0073086256,0.003952187],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00032342513,0.000051580475,0.013254779,0.008461897,0.00029360637,0.00051095244,0.0005167178,0.00016185884,0.00021929534,0.0050491444,0.88209695,0.08905976],"study_design_scores_gemma":[0.0005070078,0.00019221213,0.038564373,0.04925545,0.00096306537,0.004064913,0.0011390973,0.00048068297,0.0008010817,0.010773115,0.89307034,0.00018858071],"about_ca_topic_score_codex":0.016616374,"about_ca_topic_score_gemma":0.02366836,"teacher_disagreement_score":0.040901385,"about_ca_system_score_codex":0.0063533513,"about_ca_system_score_gemma":0.020063972,"threshold_uncertainty_score":0.21630973},"labels":[],"label_agreement":null},{"id":"W2727740953","doi":"10.1111/bjh.14825","title":"Overall survival in lower <scp>IPSS</scp> risk <scp>MDS</scp> by receipt of iron chelation therapy, adjusting for patient‐related factors and measuring from time of first red blood cell transfusion dependence: an <scp>MDS</scp>‐<scp>CAN</scp> analysis","year":2017,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":64,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McGill University; McGill University Health Centre; Foothills Medical Centre; Université Laval; Centre hospitalier universitaire de Québec; Queen Elizabeth II Health Sciences Centre; Princess Margaret Cancer Centre; University of Saskatchewan; Leukemia & Lymphoma Society of Canada; CancerCare Manitoba; Ottawa Hospital; Health Sciences Centre; University Health Network; University of Alberta Hospital; University of Alberta; Jewish General Hospital; Sunnybrook Health Science Centre; Université de Moncton; University of Toronto; McMaster University; St. Paul's Hospital; University of British Columbia","funders":"Canadian Institutes of Health Research; Celgene","keywords":"Medicine; Comorbidity; Hazard ratio; Internal medicine; Multivariate analysis; Proportional hazards model; International Prognostic Scoring System; Prospective cohort study; Myelodysplastic syndromes; Physical therapy; Confidence interval","score_opus":0.016676949285730536,"score_gpt":0.2494884291091361,"score_spread":0.23281147982340555,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2727740953","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99886036,0.00013166081,0.00006405312,0.000025514291,0.000002855486,0.0000038105784,0.00052342966,0.0000032766636,0.00038501303],"genre_scores_gemma":[0.9989754,0.000033768716,0.000024991461,0.000009266191,0.000003762776,0.0000034288314,0.0006884493,9.571229e-7,0.00026000605],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9998634,0.000014326197,0.000007496271,0.000027939124,0.00002670507,0.00006011237],"domain_scores_gemma":[0.9996747,0.00005436722,0.000069788264,0.00003099131,0.000024818075,0.00014532241],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00038936254,0.0001990937,0.00025965885,0.0004564366,0.00018363024,0.00027458448,0.00024306269,0.00019012141,0.0026307232],"category_scores_gemma":[0.00057609426,0.00007869111,0.0005840784,0.0002775558,0.00017628194,0.00015702996,0.00029271655,0.00032107453,0.00012270815],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0027431208,0.00005052743,0.984639,0.000019221483,0.00026009107,0.0001574523,0.0000621396,0.0008313546,0.0014028038,0.00010748686,0.0007208988,0.009005909],"study_design_scores_gemma":[0.000037384387,0.00029518158,0.9978084,0.0000055394285,0.00014030239,0.00015448034,0.000032984964,0.0009092662,0.00018941863,0.00006068264,0.0003622704,0.000004174654],"about_ca_topic_score_codex":0.036802445,"about_ca_topic_score_gemma":0.054106712,"teacher_disagreement_score":0.036802445,"about_ca_system_score_codex":0.00069187704,"about_ca_system_score_gemma":0.000886507,"threshold_uncertainty_score":0.07317644},"labels":[],"label_agreement":null},{"id":"W2731162750","doi":"10.1111/bjh.14741","title":"Acute myeloid leukemia with mutated <i><scp>NPM</scp>1</i> demonstrating multilineage dysplasia and marked thrombocytosis","year":2017,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University Health Network","funders":"","keywords":"Thrombocytosis; NPM1; Dysplasia; Myeloid; Pathology; Trisomy 8; Polycythemia vera; Medicine; Bone marrow; Internal medicine; Karyotype; Immunology; Biology; Platelet; Genetics; Chromosome","score_opus":0.01509676414474175,"score_gpt":0.2863323800750135,"score_spread":0.27123561593027173,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2731162750","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97186345,0.001702185,0.00089452823,0.0013716628,0.00013415639,0.0001675724,0.00076524774,0.00013522072,0.022966081],"genre_scores_gemma":[0.9970962,0.00045979975,0.00031619813,0.0002439704,0.00013423357,0.000011165043,0.00032264742,0.000008094139,0.0014076845],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.9998894,0.0000107033065,0.000008671812,0.000024833987,0.000023972178,0.000042409658],"domain_scores_gemma":[0.9997936,0.000045929857,0.000034306926,0.0000098693945,0.000020464628,0.000095758085],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000104330364,0.00067265215,0.00039727995,0.0006879062,0.00051858166,0.0003219048,0.0003120221,0.00086353667,0.0028796347],"category_scores_gemma":[0.0005299473,0.00022781055,0.00019999174,0.000502506,0.00031245314,0.00027517442,0.0002463202,0.0007190966,0.00081478345],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006339002,0.00012635022,0.05030166,0.00012444603,0.000025190664,0.9177819,0.0002835715,0.00028224115,0.01902372,0.00054344465,0.0031502855,0.0077233436],"study_design_scores_gemma":[0.00009155902,0.0006913782,0.14187166,0.000053196472,0.000044690187,0.84608364,0.00017382241,0.0010022315,0.0030246782,0.00051207293,0.0064331074,0.000017901502],"about_ca_topic_score_codex":0.0016462784,"about_ca_topic_score_gemma":0.0016945492,"teacher_disagreement_score":0.0028796347,"about_ca_system_score_codex":0.00034671772,"about_ca_system_score_gemma":0.00025426524,"threshold_uncertainty_score":0.009633362},"labels":[],"label_agreement":null},{"id":"W2732548543","doi":"10.1111/bjh.14787","title":"Elotuzumab plus lenalidomide/dexamethasone for relapsed or refractory multiple myeloma: <scp>ELOQUENT</scp>‐2 follow‐up and <i>post‐hoc</i> analyses on progression‐free survival and tumour growth","year":2017,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":133,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta; Queen Elizabeth II Health Sciences Centre; Princess Margaret Cancer Centre; Dalhousie University","funders":"AbbVie Biotherapeutics; Bristol-Myers Squibb","keywords":"Lenalidomide; Medicine; Dexamethasone; Hazard ratio; Internal medicine; Multiple myeloma; Progression-free survival; Post-hoc analysis; Oncology; Interim analysis; Refractory (planetary science); Gastroenterology; Surgery; Chemotherapy; Randomized controlled trial; Confidence interval; Biology","score_opus":0.07180174197422885,"score_gpt":0.37094425773124934,"score_spread":0.2991425157570205,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2732548543","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9945945,0.0018767208,0.00036220948,0.00020676429,0.00004726019,0.00041504911,0.0016329719,0.00003119903,0.00083327043],"genre_scores_gemma":[0.99353784,0.00048891647,0.0005644549,0.0003388622,0.000079036356,0.00042698588,0.0034021577,0.000013672462,0.0011480192],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.99914527,0.00038995195,0.000044195076,0.00015522922,0.00011922877,0.00014609956],"domain_scores_gemma":[0.99902046,0.0002216343,0.00033620413,0.00010992179,0.0000632015,0.00024850975],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002877062,0.00069970585,0.0014993344,0.0002892312,0.0002445392,0.00070973026,0.0005426808,0.0005455815,0.0022660107],"category_scores_gemma":[0.0013041873,0.0003033428,0.0017277771,0.00040887838,0.00042583424,0.0006389776,0.00039656422,0.0013643712,0.00036248623],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.8817261,0.0063664974,0.02831502,0.00050757435,0.003471163,0.0001692882,0.00010622031,0.002178026,0.008112895,0.00009692531,0.0017925141,0.06715777],"study_design_scores_gemma":[0.31058365,0.38086253,0.27953628,0.00015826845,0.0057456302,0.00051968935,0.0001265766,0.004139192,0.008856222,0.0005855249,0.008798279,0.000088212735],"about_ca_topic_score_codex":0.00088373275,"about_ca_topic_score_gemma":0.0025479393,"teacher_disagreement_score":0.002877062,"about_ca_system_score_codex":0.0010845559,"about_ca_system_score_gemma":0.0010275596,"threshold_uncertainty_score":0.015215516},"labels":[],"label_agreement":null},{"id":"W2735244554","doi":"10.1111/bjh.14844","title":"Intracranial haemorrhage in children and adolescents with severe haemophilia A or B – the impact of prophylactic treatment","year":2017,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Hemophilia Treatment and Research","field":"Medicine","cited_by":78,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"Vetenskapsrådet","keywords":"Medicine; Pediatrics; Haemophilia; Prophylactic treatment; Intracranial haemorrhage; Haemophilia A; Coagulopathy; Intensive care medicine; Surgery; Complication","score_opus":0.018531424079559787,"score_gpt":0.31708270752871165,"score_spread":0.2985512834491519,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2735244554","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99418867,0.004884119,0.000034005945,0.0001452416,0.000013649854,0.000006271305,0.00019385494,0.0000014468902,0.00053271436],"genre_scores_gemma":[0.9971584,0.0024119935,0.000058158617,0.00004097867,0.000032175816,0.000007126487,0.00022136851,0.0000015904602,0.00006809918],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9991178,0.00034235918,0.00010173738,0.00013364125,0.00018611386,0.00011838029],"domain_scores_gemma":[0.9979018,0.00043098454,0.001265223,0.00007140446,0.00013670001,0.00019382239],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006091468,0.00019720814,0.00039888197,0.0010914806,0.00028253466,0.0006341865,0.00025530587,0.00046172424,0.0011362138],"category_scores_gemma":[0.003330633,0.00026360853,0.0005118755,0.001589092,0.00052949414,0.0005652692,0.00040698724,0.000745938,0.00014950486],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015779382,0.000028581233,0.9954326,0.000048603433,0.00008274395,0.00044794095,0.00013945032,0.000036827172,0.00005470763,0.000052022082,0.00018326483,0.0033355183],"study_design_scores_gemma":[0.0000073391116,0.00014397781,0.9974623,0.00005019143,0.00004291934,0.0016212703,0.0003027303,0.00004217861,0.000026424064,0.00003152663,0.00026521174,0.000004019147],"about_ca_topic_score_codex":0.0074736443,"about_ca_topic_score_gemma":0.0067237252,"teacher_disagreement_score":0.0074736443,"about_ca_system_score_codex":0.00046945305,"about_ca_system_score_gemma":0.0004933103,"threshold_uncertainty_score":0.014860272},"labels":[],"label_agreement":null},{"id":"W2735470706","doi":"10.1111/bjh.14833","title":"Expansion of <i><scp>BCR</scp>/<scp>ABL</scp>1</i><sup>+</sup> cells requires <scp>PAK</scp>2 but not <scp>PAK</scp>1","year":2017,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Extracellular vesicles in disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":17,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"Austrian Science Fund","keywords":"Haematopoiesis; Cell biology; Microvesicles; Gene isoform; Cell growth; Cell culture; Exosome; Motility; Biology; Chemistry; Cancer research; Stem cell; Biochemistry; microRNA","score_opus":0.012674225525350899,"score_gpt":0.2513405071914531,"score_spread":0.2386662816661022,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2735470706","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9905585,0.0007349024,0.0030335838,0.0001530883,0.00003584418,0.00006845084,0.0009665994,0.00015474211,0.004294256],"genre_scores_gemma":[0.9908789,0.00029746056,0.002616707,0.00007806626,0.000012208135,0.000070436785,0.001944961,0.00006201759,0.0040394743],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9997892,0.00003755643,0.000025832522,0.00003267761,0.000067193236,0.000047500504],"domain_scores_gemma":[0.9997522,0.00006455032,0.00005218369,0.000047088768,0.000020247295,0.00006365863],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016183041,0.0003680703,0.00019168282,0.00022530397,0.00013876098,0.00034372017,0.00021780614,0.00027396186,0.0038776798],"category_scores_gemma":[0.00012663472,0.00014946255,0.0003112383,0.00012739871,0.00018161195,0.00023350136,0.00033663283,0.0008046048,0.0013055998],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000033999033,0.000027157934,0.00010966809,0.000014228255,0.0000021670567,0.00003583706,0.000008851416,0.000030506197,0.9991597,0.000072202485,0.0000778697,0.00042783006],"study_design_scores_gemma":[0.0000133902,0.00021040696,0.0039617997,0.0000054538623,0.0000115323255,0.0004217217,0.000022071048,0.00073609286,0.99106044,0.00004083097,0.0035128933,0.0000033629447],"about_ca_topic_score_codex":0.00032999474,"about_ca_topic_score_gemma":0.00045162134,"teacher_disagreement_score":0.0038776798,"about_ca_system_score_codex":0.00025291077,"about_ca_system_score_gemma":0.00012879043,"threshold_uncertainty_score":0.0129721165},"labels":[],"label_agreement":null},{"id":"W2735850899","doi":"10.1111/bjh.14829","title":"Nilotinib dose‐optimization in newly diagnosed chronic myeloid leukaemia in chronic phase: final results from <scp>ENEST</scp>xtnd","year":2017,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"Novartis Pharmaceuticals Corporation","keywords":"Nilotinib; Medicine; Adverse effect; Rash; Internal medicine; Clinical endpoint; Nausea; Clinical trial; Oncology; Myeloid leukemia; Imatinib","score_opus":0.02974140965789916,"score_gpt":0.31044792188506387,"score_spread":0.2807065122271647,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2735850899","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9939469,0.002204384,0.0005715447,0.00025333077,0.000024459903,0.0005233989,0.0009896606,0.000038690578,0.0014476452],"genre_scores_gemma":[0.9897001,0.0015195253,0.0024062302,0.00045345546,0.00005404794,0.0004794078,0.004036656,0.000019215213,0.0013313976],"study_design_codex":"design_other","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9991743,0.0004136697,0.000052190044,0.00009107306,0.00015978684,0.00010897627],"domain_scores_gemma":[0.998912,0.00025309648,0.00032229678,0.00012263482,0.00011164675,0.000278197],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0029523799,0.000504441,0.001045114,0.00018063617,0.00018217404,0.0006153264,0.00044751354,0.0003563333,0.00068578345],"category_scores_gemma":[0.0017099248,0.00018309211,0.00096909486,0.00024522355,0.00028855941,0.00028527496,0.00038825985,0.0010925105,0.00018572605],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.2761624,0.03546276,0.07656839,0.00092458376,0.0030151587,0.0007423425,0.0005743303,0.024941573,0.0905487,0.0007114319,0.011958486,0.47838983],"study_design_scores_gemma":[0.17200784,0.4565203,0.29438275,0.00016572293,0.0018476519,0.001948951,0.00015926283,0.0115079535,0.028234143,0.00061106606,0.032469247,0.00014516027],"about_ca_topic_score_codex":0.0014335766,"about_ca_topic_score_gemma":0.004238682,"teacher_disagreement_score":0.0029523799,"about_ca_system_score_codex":0.0010903551,"about_ca_system_score_gemma":0.00124382,"threshold_uncertainty_score":0.015613854},"labels":[],"label_agreement":null},{"id":"W2736240933","doi":"10.1111/bjh.14852","title":"A proposed treatment algorithm for adults with Haemoglobin <scp>SC</scp> disease","year":2017,"lang":"en","type":"letter","venue":"British Journal of Haematology","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Toronto; McGill University Health Centre","funders":"","keywords":"Disease; Algorithm; Medicine; Computer science; Computational biology; Internal medicine; Biology","score_opus":0.011003561486876026,"score_gpt":0.2485203128074188,"score_spread":0.23751675132054276,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2736240933","genre_codex":"methods","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.21863705,0.03798005,0.5282574,0.12839155,0.004660788,0.01594858,0.0067233797,0.0038031319,0.0555979],"genre_scores_gemma":[0.2604547,0.010089761,0.69729924,0.0077901734,0.0017546917,0.0060293656,0.007915855,0.0001901236,0.008476145],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99845004,0.0005118441,0.0004124484,0.00024346758,0.0002166619,0.00016553498],"domain_scores_gemma":[0.99825114,0.00032619364,0.00028879094,0.000053190717,0.00075093284,0.00032969422],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0022526348,0.0010390313,0.0008856673,0.0036532,0.0011804287,0.0019336464,0.0020194396,0.0015210349,0.0045318445],"category_scores_gemma":[0.00470322,0.00037088283,0.0016439244,0.0012087045,0.00041457787,0.001726127,0.0016697295,0.0023568203,0.0019424518],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00096213765,0.0018226926,0.21993235,0.00126053,0.00046363974,0.0052780528,0.001107919,0.013478798,0.002690349,0.012276058,0.123029314,0.6176982],"study_design_scores_gemma":[0.0026872007,0.005588118,0.35315013,0.008983321,0.0020240722,0.045798223,0.008406268,0.19225703,0.0068680765,0.10703184,0.26642805,0.0007777382],"about_ca_topic_score_codex":0.0034780556,"about_ca_topic_score_gemma":0.006979998,"teacher_disagreement_score":0.0045318445,"about_ca_system_score_codex":0.001434527,"about_ca_system_score_gemma":0.003967454,"threshold_uncertainty_score":0.015160501},"labels":[],"label_agreement":null},{"id":"W2747789314","doi":"10.1111/bjh.14903","title":"Role of mitochondrial membrane permeabilization and depolarization in platelet apoptosis","year":2017,"lang":"en","type":"letter","venue":"British Journal of Haematology","topic":"Cell death mechanisms and regulation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Toronto Metropolitan University; St. Michael's Hospital","funders":"","keywords":"Depolarization; Apoptosis; Mitochondrion; Membrane potential; Cell biology; Mitochondrial apoptosis-induced channel; Platelet; Inner mitochondrial membrane; Chemistry; Biophysics; Medicine; Biology; Internal medicine; Biochemistry","score_opus":0.005555728466858051,"score_gpt":0.21560429992831207,"score_spread":0.210048571461454,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2747789314","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.51221263,0.4268012,0.031125698,0.0042556063,0.001104421,0.00027426658,0.0012361375,0.00045096956,0.022539074],"genre_scores_gemma":[0.9488503,0.044982847,0.0021242634,0.00041083543,0.00025311406,0.00009662827,0.00050428143,0.000015390895,0.0027623884],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99931586,0.0001837427,0.00008183524,0.00010204822,0.00018568302,0.00013081176],"domain_scores_gemma":[0.99952567,0.0000901332,0.00016842745,0.000036141904,0.00010984833,0.000069737805],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005055447,0.00039698958,0.0004366814,0.00071430637,0.00037821417,0.0007823272,0.0002765713,0.0010663907,0.0017186211],"category_scores_gemma":[0.0008240741,0.00016122803,0.00042994003,0.00042110877,0.00040900346,0.0009168054,0.0009222061,0.0011620153,0.00061851],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0035846538,0.0003271827,0.012947334,0.0053362795,0.00023888076,0.012531542,0.0009679701,0.0010682569,0.82599735,0.017497672,0.004833287,0.11466955],"study_design_scores_gemma":[0.0002741509,0.002618963,0.09071591,0.0008821884,0.00029981692,0.03571712,0.00090290786,0.0043313894,0.74933517,0.018091917,0.09670491,0.00012558074],"about_ca_topic_score_codex":0.00018222495,"about_ca_topic_score_gemma":0.00012810831,"teacher_disagreement_score":0.0017186211,"about_ca_system_score_codex":0.00051179226,"about_ca_system_score_gemma":0.0003081265,"threshold_uncertainty_score":0.005749345},"labels":[],"label_agreement":null},{"id":"W2762525341","doi":"10.1111/bjh.14954","title":"Haematopoietic cell transplantation for blastic plasmacytoid dendritic cell neoplasm: a North American multicentre collaborative study","year":2017,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Cutaneous lymphoproliferative disorders research","field":"Medicine","cited_by":83,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Medicine; Transplantation; Internal medicine; Hematology; Hematopoietic cell; Population; Retrospective cohort study; Regimen; Clinical endpoint; Confidence interval; Gastroenterology; Haematopoiesis; Oncology; Clinical trial; Stem cell","score_opus":0.013372610641705326,"score_gpt":0.3078861006597773,"score_spread":0.294513490018072,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2762525341","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9981318,0.00086020946,0.00017295993,0.00007986134,0.000008338297,0.0001807612,0.00025092502,0.000004216884,0.00031098988],"genre_scores_gemma":[0.9972652,0.00084071973,0.0004153619,0.00019363392,0.000031987573,0.00018315887,0.00089834264,0.000005003163,0.00016670431],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9975593,0.0013565852,0.00015934868,0.0003236416,0.0004576469,0.0001435514],"domain_scores_gemma":[0.9958229,0.0007885269,0.0011055224,0.0006192894,0.00065414765,0.0010096423],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0048784865,0.00040606706,0.00078688946,0.00052160025,0.0006791811,0.00080086733,0.00055081345,0.0006212164,0.0006027159],"category_scores_gemma":[0.003274481,0.00033339826,0.000612674,0.0016491588,0.00056446134,0.0004116836,0.0007620495,0.0004240836,0.00018194958],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.011295181,0.0019367178,0.95934,0.00029100777,0.0014654917,0.00045763853,0.0014332047,0.00027589028,0.002442775,0.0001492474,0.0014752126,0.0194377],"study_design_scores_gemma":[0.002369874,0.002696946,0.9911549,0.000058946054,0.00071186473,0.0005283117,0.00046323668,0.00025096373,0.00015844907,0.000035516063,0.0015532046,0.000017800414],"about_ca_topic_score_codex":0.014147325,"about_ca_topic_score_gemma":0.021267945,"teacher_disagreement_score":0.014147325,"about_ca_system_score_codex":0.0010217597,"about_ca_system_score_gemma":0.0022014554,"threshold_uncertainty_score":0.028129935},"labels":[],"label_agreement":null},{"id":"W2765257980","doi":"10.1111/bjh.14993","title":"Approach to transfusion in pregnant women with sickle cell disease: a survey of physicians","year":2017,"lang":"en","type":"letter","venue":"British Journal of Haematology","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University Health Network; Lunenfeld-Tanenbaum Research Institute; University of Toronto; Mount Sinai Hospital","funders":"University of Toronto; Canadian Blood Services","keywords":"Medicine; Specialty; Transfusion medicine; Pregnancy; Disease; Randomized controlled trial; Maternal-fetal medicine; Family medicine; Pediatrics; Blood transfusion; MEDLINE; Obstetrics; Intensive care medicine; Obstetrics and gynaecology; Internal medicine","score_opus":0.011877538619092676,"score_gpt":0.23153924607189982,"score_spread":0.21966170745280714,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2765257980","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9932232,0.0033910158,0.00011339339,0.0015253758,0.00001936025,0.000035672005,0.00042824124,0.0000037712425,0.0012599225],"genre_scores_gemma":[0.9954372,0.0032207915,0.00027731838,0.0005717314,0.00001872459,0.000035743473,0.00017994274,0.0000018150838,0.00025674334],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986203,0.00045546453,0.00031152446,0.00016674623,0.00033448322,0.000111453424],"domain_scores_gemma":[0.99627316,0.0011498986,0.0016716191,0.00007807928,0.0003777679,0.00044944335],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0018199328,0.00008544813,0.00028111998,0.0006970928,0.00059010775,0.0004971592,0.00027071653,0.0005118613,0.0015082419],"category_scores_gemma":[0.007403698,0.00031545706,0.00037728457,0.0011051686,0.00024445273,0.00065030874,0.00067013176,0.000634001,0.00021878355],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007786871,0.000045847646,0.98406386,0.00021379096,0.00004597528,0.0002827075,0.005755253,0.000042668617,0.00020956811,0.00005892448,0.0009028657,0.008300837],"study_design_scores_gemma":[0.000009685129,0.0001643238,0.9862379,0.0003892437,0.000043477696,0.0011843806,0.009184758,0.00016166623,0.000074031734,0.0000496413,0.0024863058,0.000014598539],"about_ca_topic_score_codex":0.014774256,"about_ca_topic_score_gemma":0.018609365,"teacher_disagreement_score":0.014774256,"about_ca_system_score_codex":0.0007355767,"about_ca_system_score_gemma":0.00097382814,"threshold_uncertainty_score":0.029376507},"labels":[],"label_agreement":null},{"id":"W2765461391","doi":"10.1111/bjh.14985","title":"A highly purified form of staphylococcal protein A alleviates murine immune thrombocytopenia (<scp>ITP</scp>)","year":2017,"lang":"en","type":"letter","venue":"British Journal of Haematology","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Canadian Blood Services; University of Toronto; Innovative Research Group (Canada); St. Michael's Hospital","funders":"Health Canada; Canadian Blood Services","keywords":"Platelet; Immunology; Immune system; Antibody; Medicine; Autoimmune thrombocytopenia; Phagocytosis","score_opus":0.01638865244362331,"score_gpt":0.26062624106426396,"score_spread":0.24423758862064066,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2765461391","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9798054,0.0061802054,0.004388321,0.0008130652,0.0005861728,0.00023320704,0.0028080968,0.00063758873,0.0045478586],"genre_scores_gemma":[0.9806698,0.003095083,0.0038593356,0.00053731754,0.00008695762,0.0002544445,0.0035822566,0.000065437416,0.007849368],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99969065,0.0000397215,0.00003679504,0.000056923174,0.00010397793,0.00007199539],"domain_scores_gemma":[0.9997875,0.000019419986,0.000059281665,0.000017041657,0.000023214414,0.00009356141],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022226817,0.0005877578,0.0005858871,0.0006816653,0.00019813281,0.00036641644,0.0002888396,0.0007805709,0.0025185524],"category_scores_gemma":[0.0001834213,0.00017182317,0.0005167279,0.00031516637,0.00031936585,0.0003320204,0.0002447965,0.0020862562,0.00068538263],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011982744,0.00080872927,0.0002815604,0.00021251936,0.00003818585,0.0002041087,0.000030001991,0.0001753025,0.989484,0.0002008889,0.0008682804,0.006498102],"study_design_scores_gemma":[0.0006708746,0.015684191,0.009991443,0.00010824848,0.00013161852,0.001319156,0.00011889235,0.0015694726,0.94948137,0.00025303685,0.020638047,0.000033622167],"about_ca_topic_score_codex":0.0014845161,"about_ca_topic_score_gemma":0.0015527221,"teacher_disagreement_score":0.0025185524,"about_ca_system_score_codex":0.0003366632,"about_ca_system_score_gemma":0.0004422988,"threshold_uncertainty_score":0.008425415},"labels":[],"label_agreement":null},{"id":"W2765486607","doi":"10.1111/bjh.14951","title":"Outcomes of adults and children with primary mediastinal B‐cell lymphoma treated with dose‐adjusted <scp>EPOCH</scp>‐R","year":2017,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":128,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"Hyundai Hope On Wheels; Lymphoma Foundation; National Cancer Institute; St. Baldrick's Foundation","keywords":"Medicine; Epoch (astronomy); Vincristine; Etoposide; Confidence interval; Rituximab; Prednisone; Lymphoma; Internal medicine; Chemotherapy; Pediatrics; Cyclophosphamide; Surgery","score_opus":0.008756289721170108,"score_gpt":0.225588035526222,"score_spread":0.2168317458050519,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2765486607","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99941885,0.00026912472,0.000022625893,0.000021388227,0.0000019609156,0.000004660749,0.00012843515,0.0000012758813,0.00013171975],"genre_scores_gemma":[0.99947494,0.00015530249,0.00002712679,0.00001774706,0.000007857018,0.0000065777563,0.0002785567,9.362023e-7,0.000030963703],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9995227,0.00012938803,0.00006883895,0.00009720595,0.000080172846,0.00010169837],"domain_scores_gemma":[0.9981001,0.0002475585,0.0012472972,0.000052928062,0.00007966597,0.0002724741],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00058318034,0.00020604041,0.00040119197,0.0005442268,0.00027101891,0.0005593211,0.00024450658,0.00034357194,0.00058612064],"category_scores_gemma":[0.001956045,0.00020787636,0.00033762338,0.0008207134,0.00047292947,0.0004945752,0.00057967525,0.00042702814,0.00013057592],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001861167,0.000018781495,0.9974688,0.000010649948,0.000035202745,0.0002184441,0.000110388864,0.00008448308,0.000118056036,0.000013434644,0.00007231226,0.0016633795],"study_design_scores_gemma":[0.000022484128,0.00036538925,0.99742436,0.000011884879,0.000028437214,0.0014606075,0.00029618107,0.000118442076,0.0000625563,0.000019759162,0.00018555067,0.000004410703],"about_ca_topic_score_codex":0.0025899052,"about_ca_topic_score_gemma":0.0028937457,"teacher_disagreement_score":0.0025899052,"about_ca_system_score_codex":0.0006861694,"about_ca_system_score_gemma":0.0003113345,"threshold_uncertainty_score":0.005149603},"labels":[],"label_agreement":null},{"id":"W2766892765","doi":"10.1111/bjh.14977","title":"Autoantibodies in immune thrombocytopenia affect the physiological interaction between megakaryocytes and bone marrow extracellular matrix proteins","year":2017,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Hospital Foundation","funders":"Consejo Nacional de Investigaciones Científicas y Técnicas; Fondazione Cariplo","keywords":"Thrombopoiesis; Platelet; Autoantibody; Platelet membrane glycoprotein; Platelet Glycoprotein GPIb-IX Complex; Immunology; Von Willebrand factor; Bone marrow; Platelet disorder; Receptor; Immune system; Chemistry; Megakaryocyte; Biology; Cell biology; Antibody; Medicine; Internal medicine; Haematopoiesis; Stem cell","score_opus":0.028583414062916063,"score_gpt":0.32188685528518873,"score_spread":0.2933034412222727,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2766892765","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9495136,0.036050532,0.0017617918,0.0005774465,0.00012326358,0.000051609182,0.00026263602,0.00013112223,0.011528071],"genre_scores_gemma":[0.9952852,0.0029153086,0.00032974387,0.00019182333,0.000065734646,0.000010233402,0.0001425393,0.00000936578,0.0010500263],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9997807,0.000066267494,0.00003262113,0.00003555958,0.00004975542,0.000035126668],"domain_scores_gemma":[0.9998312,0.00005170362,0.00005824609,0.000011410889,0.00002154076,0.00002584036],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00028997805,0.000547935,0.00038328627,0.0010612044,0.00021978567,0.00035909846,0.00019720758,0.00074739306,0.002866961],"category_scores_gemma":[0.0006766375,0.00026487422,0.00032683933,0.00051319966,0.00019207875,0.0002720161,0.00035189974,0.0004340475,0.00054336095],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004933134,0.000434622,0.39047298,0.0017676107,0.000787912,0.15231228,0.0012090019,0.0005403488,0.28881034,0.0020121937,0.0074424515,0.14927714],"study_design_scores_gemma":[0.00020333027,0.001044813,0.73555726,0.00037358055,0.0007871724,0.21553911,0.00035056227,0.0011617555,0.023433924,0.0018752619,0.019645311,0.000027942036],"about_ca_topic_score_codex":0.0006825976,"about_ca_topic_score_gemma":0.00035375226,"teacher_disagreement_score":0.002866961,"about_ca_system_score_codex":0.00020218051,"about_ca_system_score_gemma":0.00007902048,"threshold_uncertainty_score":0.009590924},"labels":[],"label_agreement":null},{"id":"W2768619340","doi":"10.1111/bjh.15016","title":"Castleman disease: delineating the spectrum","year":2017,"lang":"en","type":"letter","venue":"British Journal of Haematology","topic":"Viral-associated cancers and disorders","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Paul's Hospital; University of British Columbia","funders":"","keywords":"Medicine; Disease; Proinflammatory cytokine; Immunology; Etiology; Context (archaeology); Pathology; Inflammation; Biology","score_opus":0.01937286626686992,"score_gpt":0.28459061686732234,"score_spread":0.26521775060045244,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2768619340","genre_codex":"empirical","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.47147384,0.45007208,0.017993536,0.008937785,0.001041377,0.00037004685,0.00058729015,0.0002554143,0.049268715],"genre_scores_gemma":[0.8912682,0.08822486,0.013153032,0.0019358391,0.00213339,0.00007399717,0.00054102676,0.000056387726,0.0026134055],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9994198,0.00011557868,0.000065671295,0.00007762894,0.00018039322,0.00014094585],"domain_scores_gemma":[0.9992894,0.00013924047,0.00014223963,0.000024710589,0.00013633989,0.0002680436],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00083871477,0.0007603427,0.0008907032,0.002618412,0.00071404374,0.0013357156,0.00097207754,0.0007877894,0.0014004896],"category_scores_gemma":[0.0015729212,0.00019669754,0.00034993366,0.0012729773,0.00092045916,0.0012776471,0.0014979815,0.0013746304,0.00047770242],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011215552,0.00036883485,0.19107746,0.004008572,0.00017401784,0.09827527,0.0029713,0.0024158915,0.029578635,0.03894745,0.018863447,0.6121975],"study_design_scores_gemma":[0.00012440646,0.00045819886,0.17100085,0.0043248693,0.00019764989,0.6336205,0.003511942,0.004020454,0.0032343497,0.03667014,0.14267512,0.00016153435],"about_ca_topic_score_codex":0.0018744887,"about_ca_topic_score_gemma":0.0018456489,"teacher_disagreement_score":0.002618412,"about_ca_system_score_codex":0.00069318915,"about_ca_system_score_gemma":0.000797491,"threshold_uncertainty_score":0.00502944},"labels":[],"label_agreement":null},{"id":"W2777932111","doi":"10.1111/bjh.15063","title":"Frequent somatic mutations of <i><scp>KMT</scp>2D</i> (<i><scp>MLL</scp>2</i>) and <i><scp>CARD</scp>11</i> genes in primary cold agglutinin disease","year":2017,"lang":"en","type":"letter","venue":"British Journal of Haematology","topic":"Blood groups and transfusion","field":"Medicine","cited_by":76,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University Health Network","funders":"Helse Sør-Øst RHF; Kreftforeningen","keywords":"Lymphoplasmacytic Lymphoma; Bone marrow; Lymphoproliferative disorders; Immunophenotyping; Immunology; Lymphoma; Medicine; Pathology; Biology; Waldenstrom macroglobulinemia; Antigen","score_opus":0.012194398042926761,"score_gpt":0.23674013307369834,"score_spread":0.22454573503077158,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2777932111","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98111063,0.0044651744,0.002151671,0.00025920602,0.00007734533,0.000080433405,0.0026441952,0.00014285941,0.009068533],"genre_scores_gemma":[0.99565923,0.00078094704,0.00071929186,0.00018622553,0.00003063091,0.000011506437,0.0010669233,0.000025569077,0.0015197473],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9997739,0.000017749335,0.000020653742,0.00007754802,0.00007299887,0.00003723638],"domain_scores_gemma":[0.9997147,0.00005168122,0.00012436061,0.000018319937,0.000027068478,0.000063802094],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013223363,0.00040218548,0.00023015293,0.00069942314,0.00024326672,0.0003464788,0.00027581083,0.0006684446,0.004604429],"category_scores_gemma":[0.00054643373,0.00014178726,0.00040091117,0.0006929127,0.0003799068,0.00016850488,0.00031243556,0.000427158,0.0011354581],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012925132,0.00016285476,0.3643729,0.0008524622,0.0004823502,0.2026991,0.001039553,0.0008248231,0.33581692,0.0014342165,0.011870589,0.079151675],"study_design_scores_gemma":[0.000077005854,0.00021020243,0.53680843,0.00023486614,0.00029457748,0.4113311,0.0003485945,0.0006744341,0.029795483,0.00083851913,0.019315343,0.000071505914],"about_ca_topic_score_codex":0.0010329128,"about_ca_topic_score_gemma":0.00148917,"teacher_disagreement_score":0.004604429,"about_ca_system_score_codex":0.0002522507,"about_ca_system_score_gemma":0.00012854235,"threshold_uncertainty_score":0.01540333},"labels":[],"label_agreement":null},{"id":"W2782718700","doi":"10.1111/bjh.15082","title":"Comparing transfusion reaction risks for various plasma products – an analysis of 7 years of ISTARE haemovigilance data","year":2018,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Blood transfusion and management","field":"Medicine","cited_by":27,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Héma-Québec","funders":"","keywords":"Transfusion-related acute lung injury; Medicine; Apheresis; Confidence interval; Interquartile range; Transfusion reaction; Blood transfusion; Odds ratio; Intensive care medicine; Allergic reaction; Emergency medicine; Internal medicine; Immunology; Platelet; Allergy; Lung","score_opus":0.09132004440978062,"score_gpt":0.34373763768618787,"score_spread":0.2524175932764072,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2782718700","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9920075,0.0018825305,0.0004830784,0.0001104549,0.000016995004,0.000034901394,0.004986635,0.0000170771,0.00046073814],"genre_scores_gemma":[0.9923005,0.0003419558,0.00037198313,0.00007121097,0.000026978136,0.000058754067,0.006710595,0.000012027778,0.000105958025],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9832282,0.0072285635,0.0034510863,0.0022475051,0.0030000792,0.00084447104],"domain_scores_gemma":[0.94355404,0.02016128,0.029335694,0.003200865,0.0027982036,0.0009498878],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.012573985,0.00037363582,0.0009557693,0.0035157006,0.0002685074,0.0010500991,0.001052722,0.0009779619,0.0012812244],"category_scores_gemma":[0.023281094,0.00043983918,0.0027030318,0.004612921,0.00032342353,0.001208057,0.0012882684,0.0012486385,0.00023029273],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006571626,0.000043372835,0.99377865,0.00008203354,0.0014729124,0.00006962162,0.000096631105,0.00067948387,0.00006672835,0.000050297538,0.00048391847,0.0025191244],"study_design_scores_gemma":[0.000026573936,0.0002735145,0.9966564,0.000045697616,0.0003638059,0.0002662857,0.000120553894,0.0014073313,0.00007562582,0.000049602917,0.0006984994,0.00001604697],"about_ca_topic_score_codex":0.0047083525,"about_ca_topic_score_gemma":0.0025846027,"teacher_disagreement_score":0.012573985,"about_ca_system_score_codex":0.0007036149,"about_ca_system_score_gemma":0.00055048516,"threshold_uncertainty_score":0.0664984},"labels":[],"label_agreement":null},{"id":"W2789240070","doi":"10.1111/bjh.15142","title":"Cord gas parameters in infants born to women with sickle cell disease: a retrospective matched cohort study","year":2018,"lang":"en","type":"letter","venue":"British Journal of Haematology","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University Health Network; Lunenfeld-Tanenbaum Research Institute; University of Toronto; Mount Sinai Hospital","funders":"University of Toronto","keywords":"Retrospective cohort study; Medicine; Disease; Pediatrics; Cohort; Cohort study; Internal medicine","score_opus":0.006370689200937249,"score_gpt":0.23693625296035564,"score_spread":0.2305655637594184,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2789240070","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99887866,0.00033711587,0.00006240934,0.000014265047,0.0000060218536,0.000043396274,0.00041847833,0.0000021585365,0.00023742681],"genre_scores_gemma":[0.9986927,0.00034998194,0.00013162616,0.000033292974,0.000010698197,0.000048364363,0.00058589433,0.0000017330914,0.00014569159],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.999443,0.00007138555,0.0000800669,0.00022073556,0.000105580926,0.00007920521],"domain_scores_gemma":[0.9993492,0.000074918906,0.00024850213,0.00010473407,0.00010593166,0.00011673571],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00057257846,0.00030944005,0.00051175884,0.000927059,0.0006654676,0.00051213853,0.00043237171,0.00044589545,0.001083322],"category_scores_gemma":[0.0015167003,0.00048993906,0.0004562289,0.0011793369,0.00027032962,0.000387898,0.0004659216,0.0004883075,0.00021954293],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013532543,0.000037747333,0.99842715,0.000019968422,0.000057813842,0.00026621722,0.00012454299,0.0000090853155,0.00020485902,0.000017182268,0.000069405,0.0006307518],"study_design_scores_gemma":[0.000012018513,0.00025145896,0.99819463,0.00001651013,0.000069843685,0.00076368573,0.00030277288,0.000067981935,0.000046016605,0.000013954249,0.00025668475,0.0000044441836],"about_ca_topic_score_codex":0.018480282,"about_ca_topic_score_gemma":0.018988675,"teacher_disagreement_score":0.018480282,"about_ca_system_score_codex":0.000603464,"about_ca_system_score_gemma":0.0005175363,"threshold_uncertainty_score":0.03674543},"labels":[],"label_agreement":null},{"id":"W2789551032","doi":"10.1111/bjh.15165","title":"Autoantibodies to thrombopoietin and the thrombopoietin receptor in patients with immune thrombocytopenia","year":2018,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Blood Services; McMaster University","funders":"Canadian Institutes of Health Research","keywords":"Autoantibody; Thrombopoietin; Medicine; Immune thrombocytopenia; Thrombopoietin receptor; Immunology; Eltrombopag; Romiplostim; Internal medicine; Thrombocytopenic purpura; Immune system; Antibody; Biology; Haematopoiesis","score_opus":0.005093820726147307,"score_gpt":0.2361385386775163,"score_spread":0.231044717951369,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2789551032","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9986065,0.00062017265,0.00011247287,0.00004447317,0.000009613211,0.000008277596,0.000035030782,0.000010374731,0.00055307604],"genre_scores_gemma":[0.999681,0.000114590795,0.000050272858,0.00003103957,0.000015229573,0.000004174045,0.00004095711,0.0000014313279,0.000061286795],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99926573,0.00021716153,0.000113978414,0.00015211513,0.00013905775,0.00011200927],"domain_scores_gemma":[0.99864966,0.0005264007,0.0003442406,0.00009938097,0.00013672719,0.00024352277],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000743032,0.0007244677,0.0006895179,0.0022718452,0.0005757948,0.0006483871,0.00042204757,0.0010097466,0.001525211],"category_scores_gemma":[0.0030402564,0.0005285935,0.00041096332,0.0010681739,0.00054860633,0.000738695,0.00044106116,0.00068978965,0.00032798367],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000417594,0.00007166218,0.99141145,0.000022383438,0.000056918063,0.0029570875,0.00015511246,0.00006290607,0.0018823533,0.00003201516,0.000111462476,0.002819104],"study_design_scores_gemma":[0.000050118248,0.00043160093,0.9772614,0.000020513402,0.00011072469,0.02063992,0.00018510155,0.0004524034,0.00049205974,0.00006537462,0.00027962646,0.000011170773],"about_ca_topic_score_codex":0.000993174,"about_ca_topic_score_gemma":0.0006206763,"teacher_disagreement_score":0.0022718452,"about_ca_system_score_codex":0.00019089233,"about_ca_system_score_gemma":0.00018541659,"threshold_uncertainty_score":0.005102396},"labels":[],"label_agreement":null},{"id":"W2791254844","doi":"10.1111/bjh.15118","title":"Autologous stem cell transplant and combination immunotherapy of rituximab and interferon‐α induces prolonged clinical and molecular remissions in patients with follicular lymphoma","year":2018,"lang":"en","type":"letter","venue":"British Journal of Haematology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; University of Toronto; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Internal medicine; Oncology; Vincristine; Rituximab; Autologous stem-cell transplantation; Cyclophosphamide; Follicular lymphoma; Etoposide; Anthracycline; Progression-free survival; Salvage therapy; Transplantation; Chemotherapy; Gastroenterology; Surgery; Lymphoma; Cancer","score_opus":0.009935397769000119,"score_gpt":0.24685820627028415,"score_spread":0.23692280850128403,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2791254844","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9955505,0.0031225656,0.0002438346,0.000077363955,0.000047140744,0.00019746723,0.000060619335,0.000030971543,0.0006696221],"genre_scores_gemma":[0.99852633,0.0005661723,0.0001870782,0.00010988324,0.000038858976,0.000120673234,0.00015619329,0.0000026643363,0.00029213552],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99978906,0.000081866034,0.000017824208,0.000037026213,0.000024938552,0.00004928965],"domain_scores_gemma":[0.999826,0.00002928165,0.00003329288,0.000026443624,0.000008192829,0.00007679957],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00064027734,0.00035826105,0.0014666364,0.00032385148,0.00020456719,0.0003372083,0.00024675857,0.00035211266,0.0012301913],"category_scores_gemma":[0.00039192164,0.00023784497,0.0006330992,0.00026585234,0.00037180097,0.00033077147,0.00021189365,0.0007499322,0.00035079775],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.31434837,0.046792686,0.03658577,0.00093371404,0.0011848821,0.001132647,0.0004587621,0.0019666478,0.1008337,0.00033181362,0.0037696976,0.49166134],"study_design_scores_gemma":[0.0837067,0.7878508,0.1024687,0.000104043116,0.0009565737,0.001735804,0.00014874323,0.0021016086,0.014102651,0.00044680585,0.0063373353,0.00004032022],"about_ca_topic_score_codex":0.00025669517,"about_ca_topic_score_gemma":0.0007038121,"teacher_disagreement_score":0.0014666364,"about_ca_system_score_codex":0.00035122293,"about_ca_system_score_gemma":0.00045207576,"threshold_uncertainty_score":0.004115343},"labels":[],"label_agreement":null},{"id":"W2792936122","doi":"10.1111/bjh.15124","title":"A phase 1 dose‐finding study of intravenous L‐citrulline in sickle cell disease: a potential novel therapy for sickle cell pain crisis","year":2018,"lang":"en","type":"letter","venue":"British Journal of Haematology","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Citrulline; Arginase; Medicine; Arginine; Argininosuccinate synthase; Nitric oxide; Enos; Sickle cell anemia; Endothelial dysfunction; Endothelium; Nitric oxide synthase; Pharmacology; Disease; Internal medicine; Chemistry; Biochemistry; Amino acid","score_opus":0.015996054661994757,"score_gpt":0.27746972086424265,"score_spread":0.2614736662022479,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2792936122","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96708494,0.013341131,0.0030193657,0.0017879514,0.0013671131,0.0080141965,0.001998551,0.00020555,0.0031812594],"genre_scores_gemma":[0.95111704,0.014132629,0.006746571,0.0032243617,0.0005629603,0.010021119,0.0025461814,0.000060594728,0.011588533],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9997813,0.00006262463,0.000011559265,0.00005959408,0.000026554722,0.00005837213],"domain_scores_gemma":[0.999757,0.000037898608,0.000031168092,0.000026927599,0.000032918248,0.00011405729],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007306022,0.0012459209,0.0023854068,0.00043174284,0.00043295205,0.0009637902,0.0007803233,0.0019033552,0.0049939705],"category_scores_gemma":[0.00056272006,0.0005193947,0.0015149963,0.00031177825,0.00065788184,0.00080204115,0.00031816695,0.0032864504,0.00094789756],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.51085126,0.22826785,0.0014658237,0.0038916732,0.002675218,0.0006143238,0.0003877072,0.0022642224,0.104756616,0.0012519065,0.0088172695,0.13475609],"study_design_scores_gemma":[0.35151094,0.62891555,0.0025967355,0.00011435868,0.0007325082,0.00030849027,0.00007703046,0.00093367323,0.0050052768,0.00052053743,0.009233973,0.000050915096],"about_ca_topic_score_codex":0.0008066549,"about_ca_topic_score_gemma":0.0016093678,"teacher_disagreement_score":0.0049939705,"about_ca_system_score_codex":0.0004492561,"about_ca_system_score_gemma":0.001015834,"threshold_uncertainty_score":0.016706526},"labels":[],"label_agreement":null},{"id":"W2793922029","doi":"10.1111/bjh.15100","title":"Diagnostic approach to pulmonary embolism in pregnancy: are the winds of change upon us or is it <i>déjà vu</i> all over again?","year":2018,"lang":"en","type":"editorial","venue":"British Journal of Haematology","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Lunenfeld-Tanenbaum Research Institute; University of Toronto; Mount Sinai Hospital","funders":"","keywords":"Déjà vu; Pulmonary embolism; Pregnancy; Medicine; Intensive care medicine; Internal medicine; Psychiatry","score_opus":0.04307367623126506,"score_gpt":0.30824436508397146,"score_spread":0.2651706888527064,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2793922029","genre_codex":"commentary","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"editorial","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0023124379,0.22839971,0.004389169,0.73952585,0.018233713,0.00002785199,0.000071473194,0.00014903427,0.006890775],"genre_scores_gemma":[0.09247883,0.4620279,0.02084697,0.34764475,0.07186534,0.000111034664,0.0002622148,0.0003071454,0.0044559026],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9897878,0.0042044297,0.0013556632,0.0012742166,0.0026878712,0.0006901438],"domain_scores_gemma":[0.9549789,0.018385012,0.003032927,0.0016784831,0.017278904,0.004645875],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.01758755,0.0009083443,0.0015595854,0.0052571953,0.0040577166,0.0071036927,0.0029375793,0.009209957,0.0045538004],"category_scores_gemma":[0.067717,0.00076446676,0.00104874,0.0023726714,0.014556769,0.015179508,0.0053638406,0.024069067,0.0028444456],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00022777288,0.00014349874,0.013603487,0.0025862579,0.00011656778,0.0037767512,0.008896162,0.0003083178,0.0009142341,0.035506748,0.3600639,0.5738563],"study_design_scores_gemma":[0.00006362253,0.0003435096,0.014704559,0.021296678,0.00016520113,0.027773127,0.033028524,0.0009354097,0.0004838857,0.14124608,0.759517,0.00044230354],"about_ca_topic_score_codex":0.01581215,"about_ca_topic_score_gemma":0.018801624,"teacher_disagreement_score":0.01758755,"about_ca_system_score_codex":0.006732262,"about_ca_system_score_gemma":0.008518634,"threshold_uncertainty_score":0.09301299},"labels":[],"label_agreement":null},{"id":"W2799318639","doi":"10.1111/bjh.15255","title":"Early‐stage Hodgkin lymphoma in the modern era: simulation modelling to delineate long‐term patient outcomes","year":2018,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; McMaster University; Juravinski Hospital","funders":"Leukemia and Lymphoma Society","keywords":"Medicine; Stage (stratigraphy); Positron emission tomography; Quality of life (healthcare); Lymphoma; Internal medicine; Hodgkin lymphoma; Oncology; Nuclear medicine; Pediatrics","score_opus":0.029527695126070064,"score_gpt":0.30520773175521354,"score_spread":0.2756800366291435,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2799318639","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.83811855,0.0010688537,0.14427105,0.0025091632,0.000099006924,0.00021003626,0.0019383753,0.0002151605,0.011569796],"genre_scores_gemma":[0.9862039,0.00033714334,0.010864284,0.00014927745,0.00002164977,0.00018328636,0.0005392959,0.000021767526,0.0016794524],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99954885,0.00030146042,0.000015569194,0.000040096744,0.000035488127,0.000058422043],"domain_scores_gemma":[0.99654657,0.0027427266,0.0002610019,0.00009113803,0.00021401093,0.00014465714],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001664978,0.0006024735,0.00088963186,0.00047907815,0.00033361575,0.0009615101,0.0010138892,0.0012558695,0.0024174363],"category_scores_gemma":[0.0046555568,0.0004699391,0.0012214285,0.0006432554,0.0005007328,0.00063982373,0.00084511895,0.0012833196,0.00018726368],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000040611307,0.0000137712195,0.0012055091,0.0000070129,0.000017717892,0.000020861295,0.00000910848,0.99741566,0.000042581563,0.0007088053,0.00007677183,0.0004414376],"study_design_scores_gemma":[0.000023261231,0.00002009478,0.00020776509,0.000004170342,0.000009178721,0.000007970521,0.000009095956,0.9987388,0.000036220103,0.0007760942,0.0001637279,0.0000037093698],"about_ca_topic_score_codex":0.0309791,"about_ca_topic_score_gemma":0.015535398,"teacher_disagreement_score":0.0309791,"about_ca_system_score_codex":0.0021195456,"about_ca_system_score_gemma":0.0017247326,"threshold_uncertainty_score":0.061597586},"labels":[],"label_agreement":null},{"id":"W2799800445","doi":"10.1111/bjh.15250","title":"Novel findings from the multinational <scp>DOVE</scp> study on geographic and age‐related differences in pain perception and analgesic usage in children with sickle cell anaemia","year":2018,"lang":"en","type":"letter","venue":"British Journal of Haematology","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Centre Hospitalier Universitaire Sainte-Justine","funders":"Daiichi-Sankyo; Eli Lilly and Company","keywords":"Medicine; Analgesic; Placebo; Clinical endpoint; Clinical trial; Chronic pain; Young adult; Pediatrics; Physical therapy; Internal medicine; Anesthesia; Alternative medicine","score_opus":0.008639105925011607,"score_gpt":0.21354663254713646,"score_spread":0.20490752662212486,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2799800445","genre_codex":"empirical","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.805891,0.072584756,0.0030977845,0.0486239,0.0049570296,0.00068183476,0.03811864,0.00010703416,0.025938066],"genre_scores_gemma":[0.9341734,0.020003995,0.004776166,0.018731318,0.008096169,0.00040905323,0.01089918,0.00008293682,0.002827807],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99772376,0.0007820426,0.00034061103,0.0003600816,0.0005867208,0.00020678341],"domain_scores_gemma":[0.99039596,0.00442198,0.0021987346,0.00059027073,0.0016257908,0.0007674019],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0040099258,0.0003769238,0.0006922547,0.0004396541,0.00033850828,0.0011538557,0.000500344,0.000624751,0.005473587],"category_scores_gemma":[0.013486922,0.00016610751,0.0014042129,0.0007095379,0.00037349106,0.0006744305,0.0007690357,0.0014057677,0.00042461697],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.02568913,0.0014656592,0.57475334,0.010923894,0.0067177108,0.006157153,0.0039251847,0.0006484618,0.009627063,0.003991247,0.112241484,0.24385954],"study_design_scores_gemma":[0.00212787,0.0030446819,0.9028101,0.0015226305,0.004033,0.004848617,0.0015043898,0.00031053615,0.0011948801,0.0023498011,0.07614095,0.00011263588],"about_ca_topic_score_codex":0.003231257,"about_ca_topic_score_gemma":0.006687794,"teacher_disagreement_score":0.005473587,"about_ca_system_score_codex":0.00037623724,"about_ca_system_score_gemma":0.0012993575,"threshold_uncertainty_score":0.021206796},"labels":[],"label_agreement":null},{"id":"W2800507359","doi":"10.1111/bjh.15262","title":"Excellent real‐world outcomes of adults with Burkitt lymphoma treated with <scp>CODOX</scp>‐M/<scp>IVAC</scp> plus or minus rituximab","year":2018,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":24,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Paul's Hospital; Spinal Cord Injury BC; University of British Columbia","funders":"","keywords":"Medicine; Rituximab; Internal medicine; Vincristine; Regimen; Hazard ratio; Oncology; Cytarabine; Methotrexate; Population; Progression-free survival; Cyclophosphamide; Folinic acid; Chemotherapy; Lymphoma; Gastroenterology; Confidence interval; Fluorouracil","score_opus":0.014055335191638763,"score_gpt":0.25617953853306774,"score_spread":0.24212420334142898,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2800507359","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.999648,0.000082026236,0.00001866962,0.000021877888,7.4194264e-7,0.000002880868,0.000071489994,0.0000012027858,0.00015311765],"genre_scores_gemma":[0.9998062,0.00003162755,0.000011503455,0.000011711382,0.0000015826554,0.000001542197,0.00010521294,3.421838e-7,0.00003036908],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9996289,0.000119683136,0.000038938113,0.000055968307,0.00006478792,0.00009164067],"domain_scores_gemma":[0.9991259,0.00009679906,0.0004727561,0.000036604382,0.00011342737,0.00015455308],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00051149965,0.00015564941,0.00021571976,0.0002579688,0.00027761617,0.0006407187,0.0001513444,0.0002627173,0.00035795412],"category_scores_gemma":[0.0013062696,0.00012415656,0.00020697627,0.00037492215,0.00035894872,0.00040043617,0.00034727925,0.0003239432,0.00009516321],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00023951451,0.000036917885,0.9968136,0.0000056877616,0.000045907647,0.00006377817,0.00010751441,0.00013157848,0.00019547841,0.000007857319,0.00007223913,0.0022799047],"study_design_scores_gemma":[0.000012693501,0.00026191922,0.9989785,0.000003741318,0.000027659975,0.00018039648,0.00018518431,0.00016149646,0.000059543956,0.00001125789,0.00011419499,0.0000033970684],"about_ca_topic_score_codex":0.022041108,"about_ca_topic_score_gemma":0.039916597,"teacher_disagreement_score":0.022041108,"about_ca_system_score_codex":0.00076785556,"about_ca_system_score_gemma":0.00037295613,"threshold_uncertainty_score":0.043825626},"labels":[],"label_agreement":null},{"id":"W2800635168","doi":"10.1111/bjh.15215","title":"Unifying the diagnosis of isolated central nervous system relapse in acute lymphoblastic leukaemia based on minimal residual disease testing","year":2018,"lang":"en","type":"letter","venue":"British Journal of Haematology","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Cog; Minimal residual disease; Lymphoblast; Cerebrospinal fluid; White blood cell; Internal medicine; Immunophenotyping; Acute lymphocytic leukemia; Central nervous system; Pediatrics; Bone marrow; Gastroenterology; Lymphoblastic Leukemia; Leukemia; Immunology; Antigen","score_opus":0.022616446444059947,"score_gpt":0.2689461117619998,"score_spread":0.24632966531793984,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2800635168","genre_codex":"empirical","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8053062,0.051155366,0.047561456,0.013982777,0.0021131902,0.0026060285,0.006351096,0.0008463824,0.070077576],"genre_scores_gemma":[0.9537717,0.005976359,0.027905358,0.0019996637,0.00058777054,0.0005456763,0.007287993,0.0000921663,0.0018333077],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.99605477,0.001078136,0.0009366124,0.0004839528,0.0009948009,0.0004517144],"domain_scores_gemma":[0.99533087,0.0012904635,0.0010074327,0.00048640266,0.0012387835,0.0006460433],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.008194255,0.00063181977,0.0015534526,0.0032099825,0.00064647954,0.0018274811,0.0025361364,0.0010670089,0.001563234],"category_scores_gemma":[0.008556878,0.00033246636,0.0010176105,0.0017112055,0.0012220162,0.0016498867,0.0024891899,0.0022617767,0.0007322374],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0041169296,0.00016305482,0.7252531,0.0009524338,0.00024372703,0.0036004703,0.00093706866,0.0015575406,0.007857317,0.008850245,0.02019417,0.22627394],"study_design_scores_gemma":[0.0004941822,0.001868723,0.85384977,0.0020520769,0.0008097523,0.023899663,0.0019449103,0.012873554,0.007121089,0.017036822,0.07783394,0.00021544468],"about_ca_topic_score_codex":0.0067648855,"about_ca_topic_score_gemma":0.010844857,"teacher_disagreement_score":0.008194255,"about_ca_system_score_codex":0.0015613337,"about_ca_system_score_gemma":0.001440884,"threshold_uncertainty_score":0.043335855},"labels":[],"label_agreement":null},{"id":"W2801066337","doi":"10.1111/bjh.15182","title":"Risk factors for red blood cell alloimmunization in the Recipient Epidemiology and Donor Evaluation Study (<scp>REDS</scp>‐<scp>III</scp>) database","year":2018,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Blood groups and transfusion","field":"Medicine","cited_by":129,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"National Heart, Lung, and Blood Institute; National Institutes of Health","keywords":"Epidemiology; Medicine; Immunology; Internal medicine","score_opus":0.03952452172693926,"score_gpt":0.31286146532190967,"score_spread":0.2733369435949704,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2801066337","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97827315,0.0003642762,0.00026416068,0.00013580809,0.000012604899,0.00006448254,0.019547733,0.000014999297,0.0013228146],"genre_scores_gemma":[0.98600554,0.00031692916,0.00034884023,0.000092674076,0.000021772468,0.00011070468,0.012643565,0.0000066446814,0.0004533194],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99946266,0.00014732142,0.00010937844,0.00009548414,0.000111586494,0.0000735389],"domain_scores_gemma":[0.99861515,0.00022064235,0.00074379926,0.000091354814,0.00013197391,0.00019704358],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00076141505,0.00013220185,0.00030598888,0.00077373727,0.00024632842,0.00033271272,0.00025001864,0.00018046128,0.0013600463],"category_scores_gemma":[0.0013920466,0.00016372208,0.0001923698,0.0017049676,0.00006981782,0.00026423406,0.00030900165,0.0003510676,0.0001974776],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007313216,0.000025477102,0.9971866,0.000015611253,0.000021844298,0.000039381546,0.00003881417,0.00003444633,0.00008330708,0.000038482744,0.0014389355,0.0010038374],"study_design_scores_gemma":[0.000015078989,0.00003077014,0.9988667,0.000012068162,0.000017880531,0.0001249641,0.000076407014,0.00019617677,0.000061905914,0.000022734766,0.0005723633,0.0000029300725],"about_ca_topic_score_codex":0.00650316,"about_ca_topic_score_gemma":0.007938681,"teacher_disagreement_score":0.00650316,"about_ca_system_score_codex":0.00026566687,"about_ca_system_score_gemma":0.0004181355,"threshold_uncertainty_score":0.012930632},"labels":[],"label_agreement":null},{"id":"W2801087080","doi":"10.1111/bjh.15173","title":"Frequency of bowel perforation and impact of bowel rest in aggressive non‐Hodgkin lymphoma with gastrointestinal involvement","year":2018,"lang":"en","type":"letter","venue":"British Journal of Haematology","topic":"Neutropenia and Cancer Infections","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Medicine; Perforation; Chemoimmunotherapy; Gastrointestinal perforation; Surgery; Chemotherapy; Parenteral nutrition; Internal medicine; General surgery; Peritonitis; Cyclophosphamide","score_opus":0.012665597507818975,"score_gpt":0.27455599387412577,"score_spread":0.2618903963663068,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2801087080","genre_codex":"empirical","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9994273,0.0002903387,0.000016683129,0.000016566752,0.0000015585682,0.000004443366,0.000053514665,0.0000010239506,0.00018860368],"genre_scores_gemma":[0.99967444,0.00015187332,0.000040105035,0.00000886813,0.000005023953,0.0000029471103,0.000067350906,4.934565e-7,0.000048817248],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9994361,0.00015203025,0.000102932405,0.00007065574,0.00012157538,0.000116803996],"domain_scores_gemma":[0.9961307,0.000684928,0.0022751978,0.00012349102,0.0002930036,0.0004927017],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00081732083,0.00014597402,0.00027494496,0.0014659014,0.00037583683,0.00064458407,0.0003701748,0.00032844144,0.00084364176],"category_scores_gemma":[0.003894656,0.00025344812,0.00028780245,0.0011920717,0.00054261147,0.0005727256,0.00070622656,0.00049244775,0.00015838456],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007133828,0.000008842488,0.9989384,0.000009119924,0.000006038121,0.00018991058,0.000064322216,0.000011728142,0.000066881905,0.0000034061222,0.000013890757,0.00061611476],"study_design_scores_gemma":[0.0000019552024,0.00008744565,0.99858665,0.000005090754,0.000009541613,0.00092933915,0.00025273068,0.000037941634,0.000027974005,0.0000056237463,0.00005393575,0.0000017948107],"about_ca_topic_score_codex":0.006669263,"about_ca_topic_score_gemma":0.010546299,"teacher_disagreement_score":0.006669263,"about_ca_system_score_codex":0.0005768784,"about_ca_system_score_gemma":0.0003988842,"threshold_uncertainty_score":0.013260841},"labels":[],"label_agreement":null},{"id":"W2801354368","doi":"10.1111/bjh.15232","title":"A tale of two antibodies: obinutuzumab <i>versus</i> rituximab","year":2018,"lang":"en","type":"review","venue":"British Journal of Haematology","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":195,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Spinal Cord Injury BC; University of British Columbia; BC Cancer Agency","funders":"Centers for Disease Control and Prevention","keywords":"Obinutuzumab; Rituximab; Medicine; CD20; Clinical trial; Immunology; Oncology; Context (archaeology); Dosing; Lymphoma; Internal medicine; Biology","score_opus":0.06548623625567729,"score_gpt":0.39946261266057015,"score_spread":0.33397637640489286,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2801354368","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0001346377,0.997943,0.00007165627,0.00094442244,0.0002642217,0.000004794467,0.000011848213,0.0000053228455,0.00062018185],"genre_scores_gemma":[0.0012603044,0.99640083,0.00019716338,0.0010520817,0.00027451303,0.000010068531,0.00002748744,0.0000030795497,0.0007744188],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99967444,0.00007762924,0.00006016111,0.000052208048,0.000102495134,0.000033097178],"domain_scores_gemma":[0.9996111,0.00022534937,0.000048806196,0.000011311482,0.00007038475,0.00003302679],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011284095,0.00058300665,0.0016279062,0.0021696452,0.00034619763,0.0013582238,0.000906983,0.0015960825,0.0038651072],"category_scores_gemma":[0.001088877,0.0002882748,0.0006871177,0.0016172357,0.0006115574,0.002325987,0.0007739615,0.0025423914,0.0013443636],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00022202401,0.000056480683,0.00012874002,0.027562633,0.0001781631,0.00018978138,0.000112954076,0.00022695126,0.0019928152,0.008026838,0.042687517,0.9186152],"study_design_scores_gemma":[0.00003995879,0.00013171903,0.00045121927,0.009089277,0.0001547808,0.0009443622,0.000092547765,0.000050101775,0.0004253474,0.003610689,0.98499507,0.000014924904],"about_ca_topic_score_codex":0.00088042207,"about_ca_topic_score_gemma":0.0019858235,"teacher_disagreement_score":0.0038651072,"about_ca_system_score_codex":0.00092695426,"about_ca_system_score_gemma":0.0013074926,"threshold_uncertainty_score":0.012930036},"labels":[],"label_agreement":null},{"id":"W2802234447","doi":"10.1111/bjh.15226","title":"Abstracts","year":2018,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":23,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Tyrosine-kinase inhibitor; Tyrosine kinase; Imatinib; Molecular biomarkers","score_opus":0.015911102005050557,"score_gpt":0.2857256306784795,"score_spread":0.2698145286734289,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2802234447","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.003145085,0.020982035,0.0040948777,0.061474003,0.118974544,0.0015014702,0.041717313,0.0022615937,0.7458491],"genre_scores_gemma":[0.013161824,0.010720958,0.0018769627,0.015608054,0.019458007,0.0006695808,0.01868724,0.00095349987,0.9188638],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9981172,0.00030759652,0.00022481226,0.00025484845,0.0009124107,0.00018322203],"domain_scores_gemma":[0.99252135,0.00079230324,0.0004095351,0.0004942769,0.0039828974,0.0017996359],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0018606836,0.0010212084,0.00081468065,0.0017924068,0.0014824069,0.004078977,0.0017001154,0.0022263625,0.7517387],"category_scores_gemma":[0.011765018,0.00029633177,0.0009507309,0.0016591944,0.00042727182,0.002106875,0.0022517454,0.0018286722,0.5827655],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017873943,0.000032352116,0.00022645066,0.000580945,0.00000948995,0.00018054547,0.000050326562,0.00003584398,0.00035502433,0.001744394,0.92624515,0.07036069],"study_design_scores_gemma":[0.000024325305,0.000027715907,0.00040970035,0.000283396,0.0000058399437,0.00026326583,0.000061193954,0.000019823974,0.00014927227,0.0011265122,0.9976221,0.0000067531155],"about_ca_topic_score_codex":0.0016312025,"about_ca_topic_score_gemma":0.0018369954,"teacher_disagreement_score":0.24826127,"about_ca_system_score_codex":0.0019610687,"about_ca_system_score_gemma":0.0031302941,"threshold_uncertainty_score":0},"labels":[],"label_agreement":null},{"id":"W2803157865","doi":"10.1111/bjh.15274","title":"How i treat primary haemophagocytic lymphohistiocytosis","year":2018,"lang":"en","type":"review","venue":"British Journal of Haematology","topic":"Autoimmune and Inflammatory Disorders Research","field":"Medicine","cited_by":61,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Centre Hospitalier Universitaire Sainte-Justine","funders":"","keywords":"Medicine; Intensive care medicine; Disease; Hemophagocytic lymphohistiocytosis; Transplantation; Hematopoietic stem cell transplantation; Pediatrics; Immunology; Pathology; Internal medicine","score_opus":0.04900986726128549,"score_gpt":0.33305637764447515,"score_spread":0.2840465103831897,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2803157865","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00018109848,0.9910131,0.00020511111,0.0031987634,0.0025173747,0.000012379636,0.000023290047,0.00002418615,0.002824721],"genre_scores_gemma":[0.0016013533,0.9896576,0.00039823903,0.0035259319,0.002170765,0.000017277725,0.000052361385,0.0000056979366,0.002570891],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99976176,0.00005751165,0.00003688687,0.00003728753,0.00008113924,0.0000253601],"domain_scores_gemma":[0.9997534,0.00010439283,0.00004886028,0.000009517734,0.00005284915,0.000031005988],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004203231,0.00058967766,0.00076178805,0.0012925596,0.00029700776,0.0012078276,0.00054931897,0.0014903651,0.0050276173],"category_scores_gemma":[0.0010049236,0.0001459601,0.0004689425,0.00066316524,0.0005006321,0.0015891539,0.0006924364,0.0025969911,0.0041434094],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007731887,0.00008869633,0.00020956922,0.011228886,0.00007519474,0.0004276892,0.00010372579,0.000117517106,0.0013708535,0.0040197535,0.119397976,0.8628828],"study_design_scores_gemma":[0.00001911632,0.00007919597,0.0004856646,0.004249034,0.000062326,0.0029806027,0.00007349024,0.000032651955,0.00025258475,0.0022657018,0.98948926,0.000010354197],"about_ca_topic_score_codex":0.00054591213,"about_ca_topic_score_gemma":0.0008359202,"teacher_disagreement_score":0.0050276173,"about_ca_system_score_codex":0.00035974092,"about_ca_system_score_gemma":0.0007173127,"threshold_uncertainty_score":0.01681906},"labels":[],"label_agreement":null},{"id":"W2804149848","doi":"10.1111/bjh.15230","title":"Machine learning algorithms for accurate differential diagnosis of lymphocytosis based on cell population data","year":2018,"lang":"en","type":"letter","venue":"British Journal of Haematology","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Lymphocytosis; Algorithm; Population; Differential diagnosis; Medicine; Computer science; Artificial intelligence; Pathology","score_opus":0.06015985908385949,"score_gpt":0.3357553190887895,"score_spread":0.27559546000492996,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2804149848","genre_codex":"methods","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.03429757,0.0014745353,0.9596844,0.00035487817,0.000081930804,0.00022066578,0.00034575083,0.0022952934,0.0012449659],"genre_scores_gemma":[0.31759834,0.0007935411,0.6782442,0.0002682209,0.00013062678,0.00058231986,0.0010201384,0.00011094273,0.0012516986],"study_design_codex":"design_other","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9985884,0.00047796706,0.00021720667,0.00037119412,0.00026898854,0.00007609149],"domain_scores_gemma":[0.9956995,0.0029685877,0.00035818297,0.00024873487,0.00064726116,0.0000777209],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0039203702,0.0012668286,0.0016064789,0.0023280226,0.00052823714,0.0013368477,0.0016183271,0.0012778589,0.0017004829],"category_scores_gemma":[0.011046658,0.00053410657,0.0010786585,0.0014602635,0.00042645863,0.001060106,0.0010528287,0.002252428,0.0016205959],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00029564233,0.0002665224,0.010910159,0.00027225434,0.00022189326,0.00015952587,0.00013656465,0.1949848,0.0073803314,0.0033200057,0.0032582309,0.778794],"study_design_scores_gemma":[0.000014578797,0.000054413722,0.0014283068,0.000022050497,0.000017080938,0.00004498434,0.00002107475,0.992663,0.001586102,0.003343418,0.00079320074,0.000011815911],"about_ca_topic_score_codex":0.0021316123,"about_ca_topic_score_gemma":0.0016807208,"teacher_disagreement_score":0.0039203702,"about_ca_system_score_codex":0.00074213895,"about_ca_system_score_gemma":0.000917615,"threshold_uncertainty_score":0.020733178},"labels":[],"label_agreement":null},{"id":"W2804724049","doi":"10.1111/bjh.15273","title":"Azacitidine in the ‘real‐world’: an evaluation of 1101 higher‐risk myelodysplastic syndrome/low blast count acute myeloid leukaemia patients in Ontario, Canada","year":2018,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":56,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Health Sciences Centre; University of Toronto; Cancer Care Ontario; Sunnybrook Health Science Centre","funders":"Sunnybrook Foundation; Cancer Care Ontario; Celgene","keywords":"Medicine; Azacitidine; Myelodysplastic syndromes; Internal medicine; Dosing; Myeloid leukaemia; Confidence interval; International Prognostic Scoring System; Cohort; Surgery; Pediatrics; Bone marrow","score_opus":0.017853528374629706,"score_gpt":0.2824927445244323,"score_spread":0.26463921614980257,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2804724049","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9978059,0.00071901985,0.00003237983,0.00013534368,0.000004159185,0.00009730736,0.00048839964,0.00000333649,0.0007141671],"genre_scores_gemma":[0.9977233,0.0006822564,0.0001711827,0.00018721998,0.000016463508,0.000035684185,0.000864524,0.0000025872573,0.00031687983],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9992642,0.00022180594,0.000044221204,0.00008978443,0.0002448838,0.00013514316],"domain_scores_gemma":[0.9985446,0.00016212488,0.00034052535,0.000058943286,0.00046410927,0.00042964864],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00096541725,0.00035196752,0.00049544737,0.00045994998,0.0011315121,0.00066108414,0.00064467837,0.0004784874,0.00081020745],"category_scores_gemma":[0.0014931074,0.00023470643,0.000367016,0.0011284971,0.00070943305,0.00024216033,0.00041849157,0.0003672577,0.000119434364],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.013603716,0.0015985229,0.9342746,0.00059100863,0.000562441,0.0010660276,0.002267621,0.0026431605,0.0056044897,0.00020889596,0.002234823,0.03534475],"study_design_scores_gemma":[0.0006092815,0.002964138,0.99170095,0.000024063787,0.00011730701,0.00031703294,0.0005120096,0.0007622907,0.00025925098,0.000019735238,0.0026843844,0.000029531859],"about_ca_topic_score_codex":0.7957241,"about_ca_topic_score_gemma":0.8950794,"teacher_disagreement_score":0.7957241,"about_ca_system_score_codex":0.0154946465,"about_ca_system_score_gemma":0.009024185,"threshold_uncertainty_score":0.4109578},"labels":[],"label_agreement":null},{"id":"W2807264331","doi":"10.1111/bjh.15275","title":"Spectral domain optical coherence tomography interpretation","year":2018,"lang":"en","type":"letter","venue":"British Journal of Haematology","topic":"CNS Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University","funders":"","keywords":"Optical coherence tomography; Choroid; Retinal pigment epithelium; Retina; Ophthalmology; Medicine; Physics; Computer science; Optics","score_opus":0.010479355440735543,"score_gpt":0.2602983928789914,"score_spread":0.24981903743825587,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2807264331","genre_codex":"methods","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.11356536,0.17045821,0.2927864,0.25803804,0.037256964,0.0009755306,0.005798896,0.004328676,0.116791934],"genre_scores_gemma":[0.6782923,0.03890644,0.106854126,0.10444906,0.022994192,0.00040744964,0.0023926224,0.001229809,0.04447406],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99922,0.00015577323,0.000112916525,0.00014133853,0.00030392245,0.000066021785],"domain_scores_gemma":[0.9983006,0.00039855982,0.000121869074,0.00019679056,0.0008825271,0.00009966861],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008063736,0.0005241008,0.00043121635,0.0018209369,0.00045837494,0.0010857561,0.0005932766,0.0021511335,0.0056539513],"category_scores_gemma":[0.0047218413,0.00017633542,0.0004267315,0.00069154287,0.00054098066,0.0011791504,0.0007605039,0.0026040955,0.0021839535],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006521251,0.00013801729,0.020092165,0.0015930829,0.00022592898,0.07130838,0.0008770132,0.0018289649,0.08400021,0.011756816,0.28945026,0.5180771],"study_design_scores_gemma":[0.00008969637,0.0002461634,0.021346595,0.0015407341,0.0001583737,0.19039224,0.0006812065,0.007782328,0.02156977,0.015001351,0.74098986,0.00020160868],"about_ca_topic_score_codex":0.001519593,"about_ca_topic_score_gemma":0.0012978227,"teacher_disagreement_score":0.0056539513,"about_ca_system_score_codex":0.0005925515,"about_ca_system_score_gemma":0.0004871315,"threshold_uncertainty_score":0.018914342},"labels":[],"label_agreement":null},{"id":"W2807483925","doi":"10.1111/bjh.15414","title":"Viral lymphomagenesis: beyond the usual suspects","year":2018,"lang":"en","type":"editorial","venue":"British Journal of Haematology","topic":"Viral-associated cancers and disorders","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Lymphoma; Follicular lymphoma; Medicine; Mantle cell lymphoma; Immunology; Diffuse large B-cell lymphoma; Virology","score_opus":0.006608023363758983,"score_gpt":0.2643054942354318,"score_spread":0.25769747087167283,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2807483925","genre_codex":"commentary","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"editorial","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.011029823,0.33970928,0.0031114619,0.38110548,0.25816813,0.00005456439,0.0002872906,0.00021657869,0.0063173654],"genre_scores_gemma":[0.042624872,0.1310084,0.0015790513,0.088442676,0.7330191,0.000028104647,0.00028843313,0.00013576561,0.0028735402],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.998483,0.00038832932,0.0003122895,0.0002716939,0.00038421626,0.00016040936],"domain_scores_gemma":[0.981766,0.012072075,0.0017772634,0.00058101746,0.0026146676,0.0011889449],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0027759138,0.0007051868,0.0016110635,0.0025689553,0.0011396072,0.0041351872,0.0015612727,0.005279553,0.003736437],"category_scores_gemma":[0.017279962,0.000566536,0.0007110012,0.0011993736,0.001754146,0.0044708834,0.001307424,0.0058733234,0.0012788037],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00043520576,0.00011014424,0.025502477,0.0019948552,0.00021716826,0.0058620027,0.0005031394,0.00019706058,0.0007854613,0.006574236,0.7120868,0.24573149],"study_design_scores_gemma":[0.00009793887,0.00019674707,0.01664014,0.0042036325,0.00031277136,0.019944072,0.0010613339,0.0007656942,0.00040195353,0.016473291,0.9398018,0.00010056287],"about_ca_topic_score_codex":0.0006696028,"about_ca_topic_score_gemma":0.0016162567,"teacher_disagreement_score":0.005279553,"about_ca_system_score_codex":0.00092487107,"about_ca_system_score_gemma":0.0012302066,"threshold_uncertainty_score":0.014680564},"labels":[],"label_agreement":null},{"id":"W2883619056","doi":"10.1111/bjh.15509","title":"Incidence of intracranial bleeding in anticoagulated patients with minor head injury: a systematic review and meta‐analysis of prospective studies","year":2018,"lang":"en","type":"review","venue":"British Journal of Haematology","topic":"Traumatic Brain Injury and Neurovascular Disturbances","field":"Medicine","cited_by":37,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University; University of Ottawa; McMaster University","funders":"Physicians' Services Incorporated Foundation; Hamilton Health Sciences","keywords":"Medicine; Apixaban; Head injury; Dabigatran; Rivaroxaban; Glasgow Coma Scale; Warfarin; Prospective cohort study; Incidence (geometry); Edoxaban; Stroke (engine); Anesthesia; Surgery; Internal medicine; Atrial fibrillation","score_opus":0.05319414739067776,"score_gpt":0.3596773635940956,"score_spread":0.30648321620341784,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2883619056","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0033192958,0.9955871,0.00024615598,0.000113240014,0.00007891364,0.00012730813,0.00036193337,0.0000121547255,0.00015384376],"genre_scores_gemma":[0.09186356,0.9050747,0.0011132252,0.000492415,0.00014902205,0.00045436088,0.0006385007,0.00001706557,0.00019716962],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99403316,0.002315485,0.0021383325,0.00064757175,0.0006543625,0.00021115787],"domain_scores_gemma":[0.98444355,0.011173885,0.0025615164,0.00045208127,0.001203095,0.00016578875],"candidate_categories":["metaepi_broad"],"consensus_categories":[],"category_scores_codex":[0.00796618,0.0021468836,0.012830662,0.0057295947,0.00051908364,0.00259374,0.0015041233,0.001683074,0.0026816167],"category_scores_gemma":[0.023675745,0.0014064835,0.026182853,0.007021364,0.000517576,0.0013137795,0.0012322676,0.0013069535,0.0002693484],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011616123,0.000023222077,0.006234936,0.5319949,0.44239777,0.0001862198,0.00009207039,0.00037791324,0.00021846112,0.00013187517,0.0008605561,0.016320491],"study_design_scores_gemma":[0.00030735778,0.00014222106,0.0053709997,0.037867855,0.95341593,0.00018172145,0.000047282694,0.00011933734,0.00013403186,0.00016287975,0.002226157,0.000024253868],"about_ca_topic_score_codex":0.005784183,"about_ca_topic_score_gemma":0.013372974,"teacher_disagreement_score":0.9871693,"about_ca_system_score_codex":0.0019048868,"about_ca_system_score_gemma":0.0030867087,"threshold_uncertainty_score":0.042129695},"labels":[],"label_agreement":null},{"id":"W2885321887","doi":"10.1111/bjh.15518","title":"The <scp>MCL</scp>35 gene expression proliferation assay predicts high‐risk <scp>MCL</scp> patients in a Norwegian cohort of younger patients given intensive first line therapy","year":2018,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":26,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"National Cancer Institute","keywords":"Medicine; Mantle cell lymphoma; Internal medicine; Cytarabine; International Prognostic Index; Oncology; Proliferation index; Cohort; Alemtuzumab; Rituximab; Chemotherapy; Immunohistochemistry; Lymphoma; Transplantation","score_opus":0.008423637202699478,"score_gpt":0.2330102971033561,"score_spread":0.22458665990065663,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2885321887","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99952626,0.00012328642,0.0001231258,0.000008765887,0.000001642572,0.0000035556345,0.000053229007,0.0000028267461,0.00015722383],"genre_scores_gemma":[0.9994547,0.00007430503,0.00018529307,0.000010005278,0.0000032659154,0.000005765115,0.00014255298,8.870844e-7,0.00012335238],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99989223,0.000021904843,0.000011953356,0.000025268937,0.000028301918,0.000020357773],"domain_scores_gemma":[0.9998267,0.000047591795,0.00006486962,0.000008370191,0.000019044754,0.000033420598],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00026857373,0.00014659026,0.00013126628,0.00026605013,0.00013128355,0.0002507678,0.000092589704,0.0001373558,0.000604091],"category_scores_gemma":[0.00047466173,0.00007711875,0.00010945743,0.00011641238,0.0002216067,0.00009222551,0.00017813282,0.00015309616,0.00010662625],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007804978,0.000030128756,0.9351012,0.00002914609,0.000019000556,0.0002986291,0.0002331971,0.0004310511,0.055229884,0.00002659594,0.00012593676,0.0076947776],"study_design_scores_gemma":[0.0000119459955,0.0004228929,0.99147743,0.000006771072,0.000021533677,0.00078469224,0.00019917077,0.0006935751,0.005875541,0.000016914522,0.00048487986,0.0000047117896],"about_ca_topic_score_codex":0.0038394693,"about_ca_topic_score_gemma":0.0052783387,"teacher_disagreement_score":0.0038394693,"about_ca_system_score_codex":0.0002675662,"about_ca_system_score_gemma":0.00016908073,"threshold_uncertainty_score":0.0076342225},"labels":[],"label_agreement":null},{"id":"W2886638978","doi":"10.1111/bjh.15519","title":"Validation of the <scp>MCL</scp>35 gene expression proliferation assay in randomized trials of the European Mantle Cell Lymphoma Network","year":2018,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":25,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"National Cancer Institute","keywords":"Mantle cell lymphoma; Medicine; International Prognostic Index; Oncology; Lymphoma; Clinical trial; Internal medicine; Proliferation index; Cancer research; Immunohistochemistry; Diffuse large B-cell lymphoma","score_opus":0.021410796049099793,"score_gpt":0.2683324955108397,"score_spread":0.24692169946173992,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2886638978","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9622604,0.014664786,0.010504961,0.0017217998,0.00039719517,0.004662066,0.0018538662,0.00009980249,0.0038350974],"genre_scores_gemma":[0.98805076,0.00076142227,0.0052950126,0.0007883773,0.00015202884,0.003593048,0.0009956879,0.000020022168,0.00034371318],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9472136,0.04684836,0.0022067765,0.0016225339,0.0016449548,0.00046377623],"domain_scores_gemma":[0.971696,0.017795995,0.0065852776,0.0022530926,0.0010119192,0.00065775163],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.040888034,0.0005571385,0.0011272959,0.00035372513,0.0003078443,0.0010156832,0.00047672918,0.0009873512,0.0014525723],"category_scores_gemma":[0.033161364,0.00021894695,0.0015104846,0.00059789757,0.0008553418,0.0008097597,0.0006809533,0.0012620144,0.00028585186],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.790131,0.0016459584,0.09043201,0.002538047,0.010650443,0.00009561021,0.00022401869,0.0043088594,0.011723494,0.0019619185,0.0018200811,0.08446862],"study_design_scores_gemma":[0.29487982,0.26852697,0.35799295,0.00084928086,0.015785994,0.0005968221,0.00020828983,0.014663737,0.018181412,0.005781234,0.022324108,0.000209389],"about_ca_topic_score_codex":0.00019448556,"about_ca_topic_score_gemma":0.00043437225,"teacher_disagreement_score":0.040888034,"about_ca_system_score_codex":0.0005535368,"about_ca_system_score_gemma":0.00084627577,"threshold_uncertainty_score":0.21623915},"labels":[],"label_agreement":null},{"id":"W2887374999","doi":"10.1111/bjh.15499","title":"Differences in infection prophylaxis measures between paediatric acute myeloid leukaemia study groups within the international Berlin–Frankfürt–Münster (I‐<scp>BFM</scp>) study group","year":2018,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Neutropenia and Cancer Infections","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Pediatric Oncology Group","funders":"","keywords":"Medicine; Antibiotic prophylaxis; Internal medicine; Myeloid leukaemia; Pediatrics; Family medicine; Antibiotics","score_opus":0.02458430059342628,"score_gpt":0.2832823376880826,"score_spread":0.25869803709465633,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2887374999","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9939891,0.0024969298,0.00013770655,0.0001555736,0.000023778279,0.00011770771,0.0015995116,0.000006002534,0.0014736439],"genre_scores_gemma":[0.9968252,0.00053158705,0.00019920924,0.0001258156,0.000016528269,0.00033004442,0.0017664891,0.0000060196385,0.00019912225],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99323213,0.002571043,0.0017075636,0.0008654998,0.0011321887,0.0004916109],"domain_scores_gemma":[0.9894029,0.0031040767,0.005273374,0.0004950279,0.0007861148,0.0009384734],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0043287063,0.00026537018,0.0009084018,0.0017967126,0.0002675866,0.0011137356,0.00046336398,0.0006286099,0.0014656549],"category_scores_gemma":[0.012590383,0.00029242144,0.0008454339,0.0022640938,0.00048473355,0.00076739327,0.00096705084,0.0005890044,0.00024005279],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00042544957,0.00007337384,0.99533635,0.00012776165,0.00028735134,0.000034569726,0.0005919293,0.000058561585,0.00012753582,0.00007518015,0.00037033914,0.0024916327],"study_design_scores_gemma":[0.000038121016,0.00024322724,0.99864846,0.000035168734,0.000044401764,0.000059338097,0.00042008868,0.000043290263,0.000038129125,0.000015988278,0.0004080829,0.000005703434],"about_ca_topic_score_codex":0.0045398106,"about_ca_topic_score_gemma":0.0055628615,"teacher_disagreement_score":0.0045398106,"about_ca_system_score_codex":0.0007456651,"about_ca_system_score_gemma":0.0006260987,"threshold_uncertainty_score":0.022892714},"labels":[],"label_agreement":null},{"id":"W2888250172","doi":"10.1111/bjh.15533","title":"Predictive value of venous thromboembolism (<scp>VTE</scp>)‐<scp>BLEED</scp> to predict major bleeding and other adverse events in a practice‐based cohort of patients with <scp>VTE</scp>: results of the <scp>XALIA</scp> study","year":2018,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":40,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"Bundesministerium für Bildung und Forschung","keywords":"Medicine; Bleed; Interquartile range; Hazard ratio; Internal medicine; Prospective cohort study; Confidence interval; Rivaroxaban; Incidence (geometry); Cohort; Anticoagulant; Adverse effect; Warfarin; Surgery; Atrial fibrillation","score_opus":0.009358130126132092,"score_gpt":0.26053678341756376,"score_spread":0.2511786532914317,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2888250172","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99881953,0.00035388736,0.0001224316,0.000068923684,0.000009966133,0.000014972783,0.00036501407,0.00000419596,0.0002409434],"genre_scores_gemma":[0.99915886,0.00006637493,0.00012782372,0.00002596297,0.000018316337,0.0000078312705,0.000543865,0.000001596159,0.000049430815],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99878436,0.00050176523,0.00014472034,0.00026419945,0.00021046447,0.000094561],"domain_scores_gemma":[0.9950493,0.0016313357,0.0016874674,0.00052256713,0.0003686745,0.00074061693],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0024496955,0.0004404742,0.0005563712,0.000725891,0.00024205183,0.0011410172,0.0005825773,0.00092713186,0.0008744127],"category_scores_gemma":[0.0075733657,0.00040237437,0.00081500283,0.0009757469,0.00040263127,0.00057130505,0.0005614921,0.0013420876,0.00024066857],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00047150656,0.000042616797,0.9981316,0.0000076148076,0.00017953142,0.00002655658,0.00002262679,0.00014496919,0.00007528781,0.000020986035,0.00010428234,0.00077260035],"study_design_scores_gemma":[0.0002286953,0.00047121377,0.99509454,0.00001077107,0.00020644885,0.0002705411,0.00005869405,0.0032117611,0.000098625125,0.00010785908,0.00023029561,0.000010583348],"about_ca_topic_score_codex":0.002682932,"about_ca_topic_score_gemma":0.0025651776,"teacher_disagreement_score":0.002682932,"about_ca_system_score_codex":0.00041120767,"about_ca_system_score_gemma":0.0004154243,"threshold_uncertainty_score":0.012955368},"labels":[],"label_agreement":null},{"id":"W2888530710","doi":"10.1111/bjh.15530","title":"Idiopathic pulmonary arterial hypertension – a unrecognized cause of high‐shear high‐flow haemostatic defects (otherwise referred to as acquired von Willebrand syndrome) in children","year":2018,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University; Institute for Clinical Evaluative Sciences; SickKids Foundation; Hospital for Sick Children; University of Toronto","funders":"","keywords":"Medicine; Von Willebrand factor; Internal medicine; Pulmonary hypertension; Cardiology; Thrombosis; Bleeding diathesis; Platelet; Von Willebrand disease; Gastroenterology","score_opus":0.012181626432528406,"score_gpt":0.24752354220710415,"score_spread":0.23534191577457575,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2888530710","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99902284,0.00027034568,0.00016813334,0.00003727852,0.0000059365916,0.0000089377545,0.00006467983,0.0000100207835,0.00041181262],"genre_scores_gemma":[0.9995159,0.0001623465,0.00017671067,0.000018471961,0.000015962263,0.000005718359,0.00006192944,0.000002046471,0.00004091401],"study_design_codex":"observational","study_design_gemma":"case_report","domain_scores_codex":[0.99950635,0.00011271861,0.00005903687,0.00012204559,0.000106664884,0.00009330808],"domain_scores_gemma":[0.9991844,0.00020745558,0.00037492267,0.00004752604,0.000057674242,0.00012801925],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00026288867,0.0004825879,0.00031235514,0.00091705343,0.0004218404,0.00031984545,0.00026579382,0.0005051382,0.0011758187],"category_scores_gemma":[0.0014342634,0.00024665767,0.00021628056,0.0005997582,0.0007464418,0.00047238948,0.00034820716,0.00044597025,0.00016641237],"study_design_candidate":"case_report","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000058237747,0.000049495495,0.97604054,0.000033794742,0.000018099305,0.01810585,0.00018859119,0.00005292649,0.0026483168,0.00008621908,0.00014028398,0.0025775628],"study_design_scores_gemma":[0.000010943822,0.0002751832,0.85522866,0.000017215556,0.000026575275,0.1427301,0.00028427932,0.00014229369,0.00089070504,0.00006207672,0.0003247913,0.0000070742585],"about_ca_topic_score_codex":0.0012760236,"about_ca_topic_score_gemma":0.0011793284,"teacher_disagreement_score":0.0012760236,"about_ca_system_score_codex":0.00019034962,"about_ca_system_score_gemma":0.0003429065,"threshold_uncertainty_score":0.0039334893},"labels":[],"label_agreement":null},{"id":"W2891438885","doi":"10.1111/bjh.15579","title":"Extreme hyperferritinaemia, soluble interleukin‐2 receptor, and haemophagocytic lymphohistiocytosis","year":2018,"lang":"en","type":"letter","venue":"British Journal of Haematology","topic":"Autoimmune and Inflammatory Disorders Research","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Ferritin; Hemophagocytic lymphohistiocytosis; Medicine; Malignancy; Pathognomonic; Histiocyte; Internal medicine; Immunology; Gastroenterology; Disease; Pediatrics","score_opus":0.034040019876605224,"score_gpt":0.2753757449316984,"score_spread":0.2413357250550932,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2891438885","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0026275378,0.076372504,0.0007730209,0.74114007,0.17755644,0.000026596208,0.00027609948,0.00009596617,0.0011317089],"genre_scores_gemma":[0.042156935,0.03438347,0.0011953572,0.37940374,0.5389784,0.000050391132,0.00021788503,0.00009813133,0.0035156677],"study_design_codex":"not_applicable","study_design_gemma":"case_report","domain_scores_codex":[0.9959688,0.001080025,0.0010154734,0.000675903,0.0008964325,0.00036336397],"domain_scores_gemma":[0.98126423,0.009445697,0.0020807157,0.0005807413,0.0050614555,0.0015671308],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0052126953,0.0009394519,0.0023492174,0.0012588468,0.0009298428,0.0027092295,0.0024520198,0.010100499,0.0036670242],"category_scores_gemma":[0.040532764,0.0006444228,0.0013970315,0.0005950193,0.0024299035,0.005254109,0.0014579251,0.016311947,0.0020904487],"study_design_candidate":"case_report","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002153601,0.00004227157,0.0069666663,0.0010171101,0.0002261384,0.0120373545,0.00050978066,0.00011690917,0.00032797776,0.0016633265,0.9490882,0.027788853],"study_design_scores_gemma":[0.00017847327,0.0002394476,0.01562662,0.004120824,0.00041654956,0.106299244,0.0018050561,0.0011033514,0.00093799306,0.012825865,0.8561365,0.0003100524],"about_ca_topic_score_codex":0.002481979,"about_ca_topic_score_gemma":0.0045977267,"teacher_disagreement_score":0.010100499,"about_ca_system_score_codex":0.0014994721,"about_ca_system_score_gemma":0.0014974232,"threshold_uncertainty_score":0.027567685},"labels":[],"label_agreement":null},{"id":"W2891826418","doi":"10.1111/bjh.15571","title":"Safety and efficacy of vismodegib in relapsed/refractory acute myeloid leukaemia: results of a phase Ib trial","year":2018,"lang":"en","type":"letter","venue":"British Journal of Haematology","topic":"Hedgehog Signaling Pathway Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":22,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Jewish General Hospital; Princess Margaret Cancer Centre","funders":"National Cancer Institute; F. Hoffmann-La Roche","keywords":"Medicine; Refractory (planetary science); Internal medicine; Oncology; Myeloid leukaemia; Vismodegib; Clinical trial","score_opus":0.017307318351377894,"score_gpt":0.28590158929735987,"score_spread":0.268594270945982,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2891826418","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98018026,0.009120835,0.00073666504,0.0011577283,0.00020966919,0.002262846,0.0022211268,0.00022804197,0.0038828976],"genre_scores_gemma":[0.9800795,0.0061787516,0.0018628665,0.0020640828,0.00018717533,0.0023591805,0.0034927113,0.00006127661,0.0037145428],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9996061,0.00017873345,0.000021256974,0.00006980017,0.00004762533,0.00007657099],"domain_scores_gemma":[0.99946064,0.000094677656,0.00010474235,0.000047927886,0.000042993306,0.00024903237],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015572957,0.0013734428,0.0018896905,0.00035381402,0.00033131684,0.0011287739,0.0006784474,0.0013965473,0.00396975],"category_scores_gemma":[0.0011096717,0.00031904236,0.0015123427,0.00029710974,0.00074189116,0.00088540494,0.0003172852,0.0030988026,0.0010727282],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.7298749,0.024177143,0.00363908,0.0021074952,0.0027131522,0.0002850202,0.0002814797,0.0032192331,0.043724414,0.0006290753,0.0081103,0.18123867],"study_design_scores_gemma":[0.63579035,0.32925683,0.015619984,0.00022628489,0.0011397238,0.0007226188,0.00010430155,0.0024474664,0.0048078042,0.001160893,0.008655896,0.00006790321],"about_ca_topic_score_codex":0.0005649563,"about_ca_topic_score_gemma":0.001701909,"teacher_disagreement_score":0.00396975,"about_ca_system_score_codex":0.0010051534,"about_ca_system_score_gemma":0.00077245024,"threshold_uncertainty_score":0.013280153},"labels":[],"label_agreement":null},{"id":"W2891925028","doi":"10.1111/bjh.15592","title":"Plasma metabolomics analysis in sickle cell disease patients with albuminuria – an exploratory study","year":2018,"lang":"en","type":"letter","venue":"British Journal of Haematology","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"National Institute of Diabetes and Digestive and Kidney Diseases; National Heart, Lung, and Blood Institute; U.S. Food and Drug Administration; Common Fund; National Institutes of Health","keywords":"Albuminuria; Renal function; Medicine; Kidney disease; Creatinine; Internal medicine; Urology","score_opus":0.007541269113817907,"score_gpt":0.22518261481236326,"score_spread":0.21764134569854535,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2891925028","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99887973,0.00032652574,0.00023355334,0.000040010716,0.0000071040167,0.00006999034,0.00020620605,0.0000046161294,0.00023223736],"genre_scores_gemma":[0.9980153,0.00024176105,0.00065059087,0.0001480574,0.000037223028,0.00008788255,0.00053716433,0.000003272999,0.00027875186],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9997899,0.000050820378,0.000021237192,0.000068022106,0.000036590234,0.00003343961],"domain_scores_gemma":[0.99964833,0.00004502481,0.000062434556,0.000033568936,0.000084335414,0.00012630965],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005058226,0.0005277754,0.0007228519,0.0005120924,0.0007018509,0.0006381612,0.00018985459,0.00052270415,0.00071830215],"category_scores_gemma":[0.000696076,0.00019805632,0.0007343086,0.0004926085,0.00026054017,0.0002622083,0.0007025091,0.00058685406,0.00020878215],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.010043627,0.003125686,0.94191265,0.00027954907,0.000756971,0.004143953,0.001980379,0.0003186856,0.01758246,0.00025800365,0.0010370888,0.01856103],"study_design_scores_gemma":[0.00026673742,0.007450982,0.98168415,0.00004304788,0.0004920906,0.0034770626,0.0012844121,0.0009181748,0.0016300217,0.00027092473,0.0024389264,0.000043456155],"about_ca_topic_score_codex":0.0006619447,"about_ca_topic_score_gemma":0.0007243124,"teacher_disagreement_score":0.0007228519,"about_ca_system_score_codex":0.00023656194,"about_ca_system_score_gemma":0.0003617209,"threshold_uncertainty_score":0.0026750565},"labels":[],"label_agreement":null},{"id":"W2892009646","doi":"10.1111/bjh.15552","title":"An open‐label phase 2 trial of entospletinib in indolent non‐Hodgkin lymphoma and mantle cell lymphoma","year":2018,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":47,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; McGill University Health Centre","funders":"Gilead Sciences","keywords":"Medicine; Mantle cell lymphoma; Internal medicine; Gastroenterology; Neutropenia; Follicular lymphoma; Lymphoma; Marginal zone B-cell lymphoma; Nausea; Non-Hodgkin's lymphoma; Adverse effect; Chemotherapy; Immunology; Marginal zone; B cell","score_opus":0.02868457587111895,"score_gpt":0.3463085454962921,"score_spread":0.31762396962517314,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2892009646","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9912425,0.0026254365,0.00038951903,0.00039413953,0.00016906782,0.002091583,0.0010833624,0.00009687032,0.001907419],"genre_scores_gemma":[0.987148,0.0019136907,0.0009141138,0.00089287874,0.00019155403,0.0027018639,0.0023935626,0.000019133066,0.0038252429],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.999703,0.00014660483,0.0000135029,0.000048379177,0.000024305893,0.00006421798],"domain_scores_gemma":[0.99960023,0.00007693271,0.00007283593,0.000029188086,0.00003069461,0.0001900975],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012076729,0.0012996761,0.0016466876,0.0003296476,0.00027423442,0.0007393869,0.0007128542,0.0010839201,0.005373172],"category_scores_gemma":[0.00076873304,0.00044563285,0.0009353332,0.00024706862,0.0006447982,0.0009965365,0.00035371297,0.0022605623,0.0009264563],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.899034,0.025773343,0.0018447619,0.0009485815,0.00096101325,0.00022038296,0.00018431642,0.0010509482,0.011642788,0.00028397515,0.0030193492,0.055036563],"study_design_scores_gemma":[0.81239116,0.17728403,0.0056290985,0.000038143524,0.00024743317,0.00019246181,0.000057325124,0.0008329025,0.0008679101,0.0002016792,0.002237586,0.00002023563],"about_ca_topic_score_codex":0.00062943547,"about_ca_topic_score_gemma":0.0024676754,"teacher_disagreement_score":0.005373172,"about_ca_system_score_codex":0.00064588716,"about_ca_system_score_gemma":0.0006486684,"threshold_uncertainty_score":0.017975092},"labels":[],"label_agreement":null},{"id":"W2897944648","doi":"10.1111/bjh.15572","title":"Primary cutaneous acral <scp>CD</scp>8<sup>+</sup> T‐cell lymphomas relapse more frequently in younger patients","year":2018,"lang":"en","type":"review","venue":"British Journal of Haematology","topic":"Cutaneous lymphoproliferative disorders research","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Hôpital Maisonneuve-Rosemont","funders":"","keywords":"Medicine; Immunology; Cancer research; Dermatology","score_opus":0.02208848779556157,"score_gpt":0.3066862042369397,"score_spread":0.28459771644137816,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2897944648","genre_codex":"empirical","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99670595,0.00142999,0.00013372689,0.000053820928,0.000012570383,0.000008331072,0.00015502151,0.000026579819,0.001473987],"genre_scores_gemma":[0.99877757,0.00044997927,0.00006926237,0.00005932002,0.000046950932,0.0000041149365,0.00020532354,0.000008582548,0.0003789668],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99984777,0.000018271197,0.000017559043,0.000041501436,0.00003874359,0.000036150486],"domain_scores_gemma":[0.99940133,0.00010418385,0.00025948882,0.000044770382,0.00005556503,0.0001346828],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015213511,0.00020411749,0.00033542752,0.00045797948,0.00020965848,0.0004338159,0.0001355854,0.000269924,0.0029683458],"category_scores_gemma":[0.0008313135,0.00010195083,0.00023440162,0.00048088405,0.00015305865,0.00033364497,0.00016300492,0.00036572595,0.0008453831],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00042916267,0.00007675561,0.92033523,0.00013088135,0.00007924067,0.03111247,0.0005456834,0.00009009776,0.014252029,0.0000715688,0.0011655642,0.031711336],"study_design_scores_gemma":[0.000016204694,0.00021541369,0.89408314,0.000027860588,0.000054118053,0.10106012,0.0003511016,0.00012376008,0.0009320259,0.00008447588,0.0030411433,0.000010745896],"about_ca_topic_score_codex":0.00041406302,"about_ca_topic_score_gemma":0.0004946113,"teacher_disagreement_score":0.0029683458,"about_ca_system_score_codex":0.00012240828,"about_ca_system_score_gemma":0.00009555086,"threshold_uncertainty_score":0.009930074},"labels":[],"label_agreement":null},{"id":"W2898342993","doi":"10.1111/bjh.15605","title":"Angiogenin‐mediated <scp>tRNA</scp> cleavage as a novel feature of stored red blood cells","year":2018,"lang":"en","type":"letter","venue":"British Journal of Haematology","topic":"MicroRNA in disease regulation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Institute of Diabetes and Digestive and Kidney Diseases; National Heart, Lung, and Blood Institute; World Anti-Doping Agency; Duke University; National Science Foundation","keywords":"Cleavage (geology); Angiogenin; Transfer RNA; Chemistry; Molecular biology; Biochemistry; Biology; Genetics; RNA; Gene; Angiogenesis","score_opus":0.006408275870990761,"score_gpt":0.2148371617211662,"score_spread":0.20842888585017544,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2898342993","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98255986,0.0024210257,0.009460064,0.00017093332,0.000093840405,0.000048415768,0.001389374,0.0002292359,0.003627288],"genre_scores_gemma":[0.98787665,0.00055373035,0.0061982577,0.00020709001,0.000031304167,0.000050477065,0.0015722091,0.000084113635,0.003426241],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99985945,0.000014446752,0.0000073491055,0.00005388088,0.00004354191,0.000021247668],"domain_scores_gemma":[0.9998578,0.000029590366,0.000043529795,0.000016913968,0.000024289404,0.000027825134],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016910025,0.0001696005,0.00017405987,0.00020969826,0.00021525766,0.00035446556,0.00011884609,0.00021622366,0.0015549295],"category_scores_gemma":[0.0002519666,0.00011297726,0.00021116577,0.00018451431,0.00023300208,0.00022153696,0.0001742603,0.0004569168,0.0005227505],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008582435,0.0000054033712,0.0009183423,0.000027540338,0.0000044779545,0.00014865225,0.000029533145,0.000021707618,0.9968285,0.0001104479,0.00013159263,0.0016879338],"study_design_scores_gemma":[0.000014134657,0.00021408654,0.08762416,0.000015561847,0.000031594907,0.0015721114,0.00008026783,0.001218011,0.9007801,0.00032519328,0.008104117,0.000020701505],"about_ca_topic_score_codex":0.00035230877,"about_ca_topic_score_gemma":0.0005348537,"teacher_disagreement_score":0.0015549295,"about_ca_system_score_codex":0.00021138592,"about_ca_system_score_gemma":0.00015300435,"threshold_uncertainty_score":0.005201757},"labels":[],"label_agreement":null},{"id":"W2899858024","doi":"10.1111/bjh.15657","title":"The incidence of symptomatic osteonecrosis after allogeneic haematopoietic stem cell transplantation in children with acute lymphoblastic leukaemia – controversy on dexamethasone as a risk factor","year":2018,"lang":"en","type":"letter","venue":"British Journal of Haematology","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Medicine; Prednisone; Cumulative incidence; Incidence (geometry); Dexamethasone; Hematopoietic stem cell transplantation; Transplantation; Population; Internal medicine; Hematology; Risk factor; Disease; Pediatrics; Immunology","score_opus":0.0060447181095238415,"score_gpt":0.2398717343043126,"score_spread":0.23382701619478877,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2899858024","genre_codex":"review","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.36724633,0.59330094,0.0012078366,0.028914057,0.0015151226,0.000019936739,0.000913772,0.000028175084,0.0068539083],"genre_scores_gemma":[0.89565367,0.09596752,0.0006850518,0.003971583,0.002918901,0.000016801825,0.0004383453,0.0000233414,0.00032478725],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.996228,0.00084882946,0.00077346823,0.0008660728,0.0010433187,0.00024039893],"domain_scores_gemma":[0.9850133,0.00767895,0.0047247997,0.00039388821,0.0015142403,0.0006746948],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0031013978,0.00019396721,0.0006850029,0.0013291365,0.00032209393,0.0011300871,0.00065050425,0.0011081442,0.0012419074],"category_scores_gemma":[0.013001642,0.00021169512,0.000635388,0.0016942958,0.0011093033,0.0009750521,0.0006290223,0.0020183194,0.00022755635],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005501743,0.0000484318,0.87284994,0.0015264092,0.00041465976,0.0008374249,0.0011499816,0.00015767751,0.00064470887,0.0013670762,0.004801326,0.115652144],"study_design_scores_gemma":[0.000032498378,0.00025239342,0.96361923,0.002100728,0.0005273592,0.0077573387,0.0026328962,0.00014179108,0.00055709656,0.0011048847,0.021208188,0.0000656253],"about_ca_topic_score_codex":0.0054400694,"about_ca_topic_score_gemma":0.0032300332,"teacher_disagreement_score":0.0054400694,"about_ca_system_score_codex":0.0006873813,"about_ca_system_score_gemma":0.00068370136,"threshold_uncertainty_score":0.016401947},"labels":[],"label_agreement":null},{"id":"W2901969852","doi":"10.1111/bjh.15654","title":"Aplastic anaemia in pregnancy – a single centre, North American series","year":2018,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network; Lunenfeld-Tanenbaum Research Institute; Mount Sinai Hospital; University of Toronto","funders":"","keywords":"Medicine; Pregnancy; Obstetrics; Tertiary care; Postpartum period; Pediatrics; Gynecology; Surgery","score_opus":0.007528069294928242,"score_gpt":0.2294438928388538,"score_spread":0.22191582354392556,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2901969852","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9930748,0.0035211146,0.00037510603,0.0002518225,0.00006243592,0.000029808749,0.00008954491,0.000025842875,0.00256961],"genre_scores_gemma":[0.9977354,0.0015550322,0.00011003132,0.00013628478,0.000092544215,0.000010923498,0.0000619535,0.0000074497607,0.00029044488],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9995135,0.00010823241,0.00010058377,0.00011338527,0.00009631513,0.00006808383],"domain_scores_gemma":[0.99851435,0.00036960514,0.0005633715,0.00014736607,0.00010389838,0.00030138541],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003151297,0.00039034814,0.0003823883,0.00093248714,0.0010878247,0.0005895565,0.0003496064,0.00071527297,0.0016666189],"category_scores_gemma":[0.0021690156,0.00046409958,0.00025025642,0.0010589391,0.0005796236,0.00044837222,0.00046734812,0.0005534577,0.00044702814],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00024240815,0.00021005503,0.8714162,0.00019280953,0.00015121979,0.09401879,0.001950628,0.00019799291,0.0023912757,0.00021838247,0.0017488693,0.027261285],"study_design_scores_gemma":[0.000060639206,0.00054252305,0.59043545,0.00013623032,0.00012000439,0.40215918,0.0018401217,0.0003207768,0.0005635365,0.00015182915,0.0036241196,0.000045557175],"about_ca_topic_score_codex":0.0042253714,"about_ca_topic_score_gemma":0.0046405,"teacher_disagreement_score":0.0042253714,"about_ca_system_score_codex":0.0004101848,"about_ca_system_score_gemma":0.00052473886,"threshold_uncertainty_score":0.008401573},"labels":[],"label_agreement":null},{"id":"W2902815908","doi":"10.1111/bjh.15690","title":"Incidence of and risk factors for major haemorrhage in patients treated with ibrutinib: An integrated analysis","year":2018,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":90,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Juravinski Cancer Centre","funders":"National Cancer Institute","keywords":"Ibrutinib; Medicine; Discontinuation; Internal medicine; Population; Confidence interval; Oncology; Gastroenterology; Leukemia; Chronic lymphocytic leukemia","score_opus":0.014358552172936766,"score_gpt":0.2956627147591522,"score_spread":0.28130416258621543,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2902815908","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.89415574,0.09262514,0.0018753435,0.00037185985,0.00009884835,0.0002738327,0.008914574,0.000065200315,0.0016194215],"genre_scores_gemma":[0.98644966,0.0073684733,0.0010384917,0.00017443953,0.00011938976,0.00020436064,0.0043711923,0.000027785052,0.00024619704],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99110234,0.0025573685,0.002722776,0.0017629921,0.0014658042,0.00038885794],"domain_scores_gemma":[0.98356414,0.0069185677,0.006870818,0.00084104534,0.0011909144,0.0006145159],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.007480935,0.00068571937,0.0037564826,0.003418715,0.00024003793,0.0017246971,0.0010208251,0.00092222716,0.001997167],"category_scores_gemma":[0.014683566,0.0006787129,0.014052794,0.005311104,0.00032749935,0.00086778385,0.0016195008,0.0014629129,0.00018635916],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.012182421,0.000104089624,0.857506,0.005340817,0.104025014,0.0001899358,0.00019579164,0.0008928413,0.00059580855,0.00015696185,0.0008692773,0.017941086],"study_design_scores_gemma":[0.0011751782,0.0011204372,0.9235256,0.00064120226,0.06825973,0.00068531296,0.000174672,0.0020190906,0.00023789714,0.00024885536,0.0018511862,0.000060764254],"about_ca_topic_score_codex":0.0029819286,"about_ca_topic_score_gemma":0.0030783054,"teacher_disagreement_score":0.007480935,"about_ca_system_score_codex":0.0009065459,"about_ca_system_score_gemma":0.0006832936,"threshold_uncertainty_score":0.039563417},"labels":[],"label_agreement":null},{"id":"W2906950405","doi":"10.1111/bjh.15732","title":"Health‐related quality of life in children with chronic immune thrombocytopenia treated with eltrombopag in the PETIT study","year":2018,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"Novartis; Wellcome Trust; GlaxoSmithKline","keywords":"Eltrombopag; Immune thrombocytopenia; Medicine; Quality of life (healthcare); Health related quality of life; Pediatrics; Platelet; Interquartile range; Internal medicine; Disease","score_opus":0.01754459785667855,"score_gpt":0.2984179456191908,"score_spread":0.28087334776251227,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2906950405","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99192315,0.0050335447,0.000065814,0.00021809708,0.00002549029,0.000046029912,0.0017999712,0.000004504945,0.00088326586],"genre_scores_gemma":[0.9954365,0.0014290992,0.00017628376,0.0001130731,0.000028495668,0.000114850896,0.0024875742,0.000004118801,0.00020988466],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9991147,0.00040929092,0.000105933264,0.00007589374,0.00016136342,0.00013281219],"domain_scores_gemma":[0.9985934,0.00033293295,0.0007099448,0.00008363091,0.00008691687,0.00019317698],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015712461,0.00032173085,0.00086514757,0.00051543367,0.00025894606,0.0006761872,0.0003464058,0.00050253666,0.00096922956],"category_scores_gemma":[0.0023766095,0.00022103798,0.0013841137,0.00096433493,0.00030169822,0.00044675058,0.0006711384,0.0010462452,0.0001189682],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0052584833,0.00034733175,0.9775073,0.00050202647,0.0016361704,0.0003275199,0.00036711598,0.0003955445,0.00039469797,0.00015543913,0.001343866,0.011764395],"study_design_scores_gemma":[0.00039537365,0.0009147189,0.99650973,0.000101336715,0.00035977832,0.00038721296,0.0001045848,0.0000976314,0.000089433765,0.000031865395,0.0009992889,0.000009007638],"about_ca_topic_score_codex":0.002882421,"about_ca_topic_score_gemma":0.003015577,"teacher_disagreement_score":0.002882421,"about_ca_system_score_codex":0.0005331224,"about_ca_system_score_gemma":0.00023895303,"threshold_uncertainty_score":0.008309662},"labels":[],"label_agreement":null},{"id":"W2910201624","doi":"10.1111/bjh.15734","title":"Mature B‐<scp>NHL</scp> in children, adolescents and young adults: current therapeutic approach and emerging treatment strategies","year":2019,"lang":"en","type":"review","venue":"British Journal of Haematology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":41,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children; University of Toronto","funders":"","keywords":"Medicine; Rituximab; Lymphoma; Clinical trial; Oncology; Chemotherapy; Immunotherapy; Internal medicine; Disease; Intensive care medicine; Cancer","score_opus":0.02410139797830113,"score_gpt":0.30930287162341014,"score_spread":0.285201473645109,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2910201624","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00007712897,0.9993967,0.000022267055,0.00013147447,0.00005245242,0.0000025451552,0.000012324239,0.0000027632432,0.00030237902],"genre_scores_gemma":[0.00041158748,0.99924064,0.000067996276,0.00009922229,0.000039178125,0.0000031653144,0.000017429962,5.7277725e-7,0.00012011016],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99981874,0.000034067107,0.000044104952,0.000028263721,0.00005930744,0.00001554295],"domain_scores_gemma":[0.99964356,0.00019591712,0.00006134374,0.0000073324554,0.000070857146,0.000020932212],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005095408,0.00051688973,0.0012622759,0.0018014868,0.00017150644,0.0007871648,0.00059887767,0.0006967298,0.0035466028],"category_scores_gemma":[0.0007691182,0.00018510074,0.0005708236,0.0017336707,0.0003000766,0.0008500119,0.00041884478,0.0011431305,0.0010682396],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008706304,0.000028511977,0.00018701225,0.03990043,0.00012550452,0.000104021114,0.00004801333,0.00017793241,0.00058627524,0.0011092453,0.015398613,0.9422474],"study_design_scores_gemma":[0.00004366181,0.00015151044,0.0022515035,0.023747768,0.000524033,0.0019671263,0.00012199427,0.000085108564,0.00029187085,0.0012623445,0.9695357,0.000017372771],"about_ca_topic_score_codex":0.0015777805,"about_ca_topic_score_gemma":0.003140436,"teacher_disagreement_score":0.0035466028,"about_ca_system_score_codex":0.0005426588,"about_ca_system_score_gemma":0.0011471459,"threshold_uncertainty_score":0.011864543},"labels":[],"label_agreement":null},{"id":"W2913619907","doi":"10.1111/bjh.15748","title":"Decision‐analysis modelling of the effects of thromboprophylaxis for people with lower limb immobilisation for injury","year":2019,"lang":"en","type":"letter","venue":"British Journal of Haematology","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hamilton General Hospital","funders":"Engineering and Physical Sciences Research Council; National Institute for Health and Care Research; National Institute on Handicapped Research","keywords":"Lower limb; Medicine; Physical medicine and rehabilitation; Intensive care medicine; Physical therapy; Surgery","score_opus":0.010277512491547531,"score_gpt":0.24476669273344612,"score_spread":0.23448918024189858,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2913619907","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.5326161,0.0035699813,0.39771867,0.009334473,0.00044544338,0.001762104,0.014630366,0.00042879893,0.039494045],"genre_scores_gemma":[0.92262614,0.001377194,0.05820901,0.00067836174,0.00009453362,0.0020040493,0.0031146186,0.000052147858,0.01184407],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9982162,0.0010439962,0.00008189423,0.00026445012,0.00014230507,0.0002511339],"domain_scores_gemma":[0.9880783,0.010171828,0.00061830523,0.00012349903,0.00063547434,0.00037258043],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0036713213,0.0014774173,0.0017391964,0.0011033829,0.00064365,0.0023009365,0.0019742176,0.0030562761,0.013121969],"category_scores_gemma":[0.015036652,0.0010228826,0.0028754168,0.0011765055,0.000751755,0.0009835922,0.0012831375,0.002441146,0.0006938636],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015840693,0.00006498069,0.0017739914,0.00009512091,0.00008567117,0.00009385791,0.0000653274,0.9874499,0.00012955962,0.0067984937,0.0005853242,0.0026993337],"study_design_scores_gemma":[0.0000959879,0.000068118214,0.00050077017,0.00003582645,0.00007115862,0.000026505346,0.00003271148,0.9929933,0.000053038428,0.0053219264,0.00078516424,0.000015450363],"about_ca_topic_score_codex":0.040660605,"about_ca_topic_score_gemma":0.019142931,"teacher_disagreement_score":0.040660605,"about_ca_system_score_codex":0.0030313923,"about_ca_system_score_gemma":0.0040847515,"threshold_uncertainty_score":0.08084792},"labels":[],"label_agreement":null},{"id":"W2919311410","doi":"10.1111/bjh.15813","title":"Fetal and neonatal alloimmune thrombocytopenia: recommendations for evidence‐based practice, an international approach","year":2019,"lang":"en","type":"review","venue":"British Journal of Haematology","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":114,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Mount Sinai Hospital; Canadian Blood Services; Canadian Red Cross Society; Université de Montréal; McMaster University; Centre Hospitalier Universitaire Sainte-Justine; University Health Network; University of Toronto; SickKids Foundation; Hospital for Sick Children; St. Michael's Hospital","funders":"Canadian Blood Services","keywords":"Neonatal alloimmune thrombocytopenia; Medicine; Obstetrics; Pregnancy; Fetus; Platelet transfusion; Gestation; Pediatrics; Platelet; Immunology; Biology","score_opus":0.12097169493317016,"score_gpt":0.41695698924584124,"score_spread":0.29598529431267107,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2919311410","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00012688761,0.9697983,0.0011932289,0.02152133,0.0029998138,0.0007226212,0.0005225294,0.000071712486,0.003043488],"genre_scores_gemma":[0.0014656974,0.977974,0.009761279,0.006989874,0.0006499287,0.0009956177,0.0007663795,0.000025104304,0.001372146],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9902248,0.0027663438,0.0037913928,0.0005246947,0.0023441366,0.0003487203],"domain_scores_gemma":[0.9647642,0.016637942,0.0053106598,0.0008606568,0.011273491,0.0011530977],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.019404672,0.0020720777,0.0059804777,0.016650684,0.0010387835,0.0048251767,0.007225731,0.005935172,0.011256808],"category_scores_gemma":[0.04411202,0.0013189123,0.006552112,0.011627293,0.001438406,0.0053861714,0.0036974368,0.0057439823,0.004177189],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001924147,0.00010864103,0.00041926833,0.21366847,0.0008939854,0.00031915252,0.0003697767,0.0005819438,0.00037620118,0.005206682,0.1518161,0.6260473],"study_design_scores_gemma":[0.00014487634,0.00007823785,0.0010573951,0.4906716,0.001846392,0.00042125105,0.0002403015,0.00021179045,0.000108204586,0.005285345,0.49988255,0.000051980198],"about_ca_topic_score_codex":0.010545761,"about_ca_topic_score_gemma":0.015131376,"teacher_disagreement_score":0.019404672,"about_ca_system_score_codex":0.0061802226,"about_ca_system_score_gemma":0.022405526,"threshold_uncertainty_score":0.102622926},"labels":[],"label_agreement":null},{"id":"W2920983629","doi":"10.1111/bjh.15860","title":"Identification of high‐risk <i> <scp>DUSP</scp> 22 </i> ‐rearranged <scp>ALK</scp> ‐negative anaplastic large cell lymphoma","year":2019,"lang":"en","type":"letter","venue":"British Journal of Haematology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":75,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; St. Francis Xavier University; University Health Network; Spinal Cord Injury BC","funders":"National Cancer Institute; Michael Smith Health Research BC; Terry Fox Research Institute; Mayo Clinic","keywords":"Anaplastic lymphoma kinase; Identification (biology); Lymphoma; Anaplastic large-cell lymphoma; Cancer research; Biology; Medicine; Immunology; Internal medicine; Lung cancer","score_opus":0.007333538314844853,"score_gpt":0.22504839674683372,"score_spread":0.21771485843198887,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2920983629","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99756926,0.0004740231,0.00034713905,0.00003128918,0.0000078988705,0.000021123522,0.000085689,0.000010973128,0.0014525823],"genre_scores_gemma":[0.9992021,0.00017509783,0.0002125038,0.000025395891,0.000005597672,0.000004569122,0.00016886741,0.0000037842885,0.00020217858],"study_design_codex":"observational","study_design_gemma":"case_report","domain_scores_codex":[0.99971026,0.000028930093,0.00003331631,0.000073298856,0.000080315935,0.000073844734],"domain_scores_gemma":[0.9995493,0.00007862074,0.00008520107,0.000049519604,0.00010503645,0.00013224232],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00025137054,0.00021190335,0.00016440699,0.0011618187,0.00034928657,0.0007527794,0.00030664715,0.00048143783,0.0016710025],"category_scores_gemma":[0.0011770009,0.00019289288,0.0002060239,0.00056629843,0.00035775985,0.0002948295,0.00041745484,0.00023005749,0.000522973],"study_design_candidate":"case_report","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018180488,0.000036266192,0.9435226,0.00005104378,0.000017107457,0.015465565,0.00040467796,0.00005631118,0.02752749,0.000102730824,0.00041367847,0.012220782],"study_design_scores_gemma":[0.000027317308,0.00035175122,0.82171184,0.00006008126,0.000088333014,0.15804209,0.0016948078,0.00082055543,0.011097431,0.00018645912,0.0058981027,0.000021179614],"about_ca_topic_score_codex":0.0026452208,"about_ca_topic_score_gemma":0.0032501533,"teacher_disagreement_score":0.0026452208,"about_ca_system_score_codex":0.000316669,"about_ca_system_score_gemma":0.0003341712,"threshold_uncertainty_score":0.005590081},"labels":[],"label_agreement":null},{"id":"W2921063124","doi":"10.1111/bjh.15865","title":"Expression and function of phosphoinositide 3‐kinase delta in mesenchymal stromal cells from normal and leukaemic bone marrow","year":2019,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; Health Sciences Centre; University of Manitoba; Research Institute in Oncology and Hematology; CancerCare Manitoba","funders":"Leukemia and Lymphoma Society of Canada; CancerCare Manitoba Foundation; Research Manitoba","keywords":"Idelalisib; Mesenchymal stem cell; Bone marrow; Stromal cell; PI3K/AKT/mTOR pathway; Haematopoiesis; Cancer research; Chronic lymphocytic leukemia; Phosphoinositide 3-kinase; Medicine; Biology; Immunology; Pathology; Leukemia; Stem cell; Cell biology; Signal transduction; Ibrutinib","score_opus":0.007748141663317778,"score_gpt":0.23961043869336562,"score_spread":0.23186229703004785,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2921063124","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9944167,0.0023263516,0.0008164447,0.000050112918,0.000010032653,0.000024847042,0.0006560289,0.000016446435,0.001683076],"genre_scores_gemma":[0.9943416,0.0012633534,0.0008852281,0.000045047607,0.000009345815,0.00004522896,0.0014968701,0.000007383326,0.0019059129],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99984777,0.00002178288,0.000021725062,0.000020883046,0.000048513855,0.000039382438],"domain_scores_gemma":[0.9999095,0.000020676389,0.0000140822,0.000007774305,0.000015727848,0.000032212385],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012257812,0.0001191068,0.00014240156,0.00040071554,0.00016921476,0.00034842567,0.00011713528,0.00016428615,0.0015288171],"category_scores_gemma":[0.00012382703,0.0000931605,0.00013810967,0.0003175006,0.00016662244,0.00011111185,0.00017876289,0.0003159787,0.0004322712],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021521177,0.000020297708,0.0010677624,0.000033166732,0.000004710952,0.00009059263,0.00007207233,0.000028235994,0.99649733,0.00020124651,0.000027465234,0.0017419233],"study_design_scores_gemma":[0.00008451204,0.00076772395,0.1032339,0.000032416596,0.00007129819,0.0018425471,0.0005688265,0.001467076,0.8802357,0.00027341975,0.011406868,0.000015851772],"about_ca_topic_score_codex":0.001081874,"about_ca_topic_score_gemma":0.0009122704,"teacher_disagreement_score":0.0015288171,"about_ca_system_score_codex":0.00021103049,"about_ca_system_score_gemma":0.00014057446,"threshold_uncertainty_score":0.005114436},"labels":[],"label_agreement":null},{"id":"W2921129431","doi":"10.1111/bjh.15839","title":"<scp>UK</scp> results from the myeloproliferative neoplasms (<scp>MPN</scp>) landmark survey on the symptom, emotional and economic burden of <scp>MPN</scp>","year":2019,"lang":"en","type":"letter","venue":"British Journal of Haematology","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"Medical Research Council; Cancer Research UK","keywords":"Presenteeism; Medicine; Absenteeism; Disease burden; Quality of life (healthcare); Productivity; Burden of disease; Disease; Demography; Gerontology; Physical therapy; Family medicine; Internal medicine; Psychology","score_opus":0.02177184820432684,"score_gpt":0.2481609981325034,"score_spread":0.22638914992817655,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2921129431","genre_codex":"dataset","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.3442748,0.004075814,0.0006842862,0.0056575253,0.0005534483,0.0014404019,0.60674983,0.00019355,0.03637032],"genre_scores_gemma":[0.564457,0.005876682,0.0024749083,0.0062742713,0.00049160904,0.0022467002,0.39577946,0.00012408705,0.02227529],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.998865,0.00022295436,0.00029365998,0.00008503976,0.00038583836,0.00014756437],"domain_scores_gemma":[0.9940686,0.0006473917,0.0018959015,0.00023568372,0.0022053446,0.0009471163],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00077997043,0.00031417666,0.00047463886,0.001292711,0.00037339618,0.0006805809,0.0003042618,0.0004416843,0.007705183],"category_scores_gemma":[0.0050551104,0.00021177165,0.000318495,0.0031513628,0.00022225524,0.00040990984,0.0011806013,0.0005926018,0.0017395781],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006533113,0.00008248537,0.37951055,0.0019929954,0.00023557154,0.00052965444,0.0010675455,0.0002951783,0.0009583343,0.0004134208,0.57883275,0.03542829],"study_design_scores_gemma":[0.000052167416,0.000057945686,0.9481762,0.00026152332,0.000023232242,0.0001878542,0.00027204546,0.000045839868,0.00012234776,0.000018119741,0.050767314,0.000015428497],"about_ca_topic_score_codex":0.18500458,"about_ca_topic_score_gemma":0.29142207,"teacher_disagreement_score":0.18500458,"about_ca_system_score_codex":0.0018037972,"about_ca_system_score_gemma":0.0016170833,"threshold_uncertainty_score":0.3678555},"labels":[],"label_agreement":null},{"id":"W2921300961","doi":"10.1111/bjh.15825","title":"Headache: an important symptom possibly linked to white matter lesions in thalassaemia","year":2019,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"Medical Research Council","keywords":"Headaches; Medicine; Magnetic resonance imaging; Internal medicine; White matter; Hyperintensity; Thalassemia; Pediatrics; Surgery; Radiology","score_opus":0.008028939191389672,"score_gpt":0.26102565662082805,"score_spread":0.25299671742943836,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2921300961","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9924731,0.005278877,0.0001268862,0.00017119537,0.000025304113,0.000008737665,0.00007725364,0.000011500744,0.0018272442],"genre_scores_gemma":[0.9980453,0.0014720472,0.00005620802,0.000059428057,0.00007341318,0.0000018355178,0.00005313975,0.0000014251616,0.00023706113],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99987173,0.000031337302,0.000017938133,0.000018895953,0.000028391683,0.000031753236],"domain_scores_gemma":[0.9995671,0.000103321916,0.00019962141,0.000022900298,0.000035899262,0.000071280665],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017652214,0.00019996407,0.0002611256,0.00053384213,0.00029859715,0.000373495,0.00013185538,0.00031239566,0.0018348057],"category_scores_gemma":[0.0010531252,0.00012456662,0.000086762266,0.00055614504,0.00036950104,0.00022045748,0.00020436422,0.0002573009,0.00028650588],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011343881,0.0001464309,0.8997428,0.00047175612,0.00011554611,0.023428218,0.0013375605,0.000073346455,0.016062515,0.00012033274,0.0015582783,0.05580882],"study_design_scores_gemma":[0.000012113977,0.0001705204,0.9792203,0.000025112693,0.000023904791,0.019566232,0.0001820888,0.000027808619,0.00020927575,0.00006182959,0.0004959933,0.0000048868496],"about_ca_topic_score_codex":0.0021441877,"about_ca_topic_score_gemma":0.0019927023,"teacher_disagreement_score":0.0021441877,"about_ca_system_score_codex":0.00016559592,"about_ca_system_score_gemma":0.00012607855,"threshold_uncertainty_score":0.0061380267},"labels":[],"label_agreement":null},{"id":"W2921370113","doi":"10.1111/bjh.15846","title":"Risk of invasive pneumococcal disease in children with sickle cell disease in the era of conjugate vaccines: a systematic review of the literature","year":2019,"lang":"en","type":"review","venue":"British Journal of Haematology","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":43,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Infection and Immunity","funders":"","keywords":"Medicine; Case fatality rate; Serotype; Pediatrics; Pneumococcal conjugate vaccine; Meningitis; Pneumococcal disease; Streptococcus pneumoniae; Conjugate vaccine; Disease; Respiratory tract infections; Confidence interval; Internal medicine; Immunology; Immunization; Antibiotics; Epidemiology; Respiratory system; Antibody","score_opus":0.006269978456085123,"score_gpt":0.2448178869222165,"score_spread":0.2385479084661314,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2921370113","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0018174354,0.9971855,0.000051223065,0.00013273196,0.000049485578,0.000065724125,0.000556058,0.0000032730077,0.00013851772],"genre_scores_gemma":[0.015643641,0.9832802,0.00025859446,0.0002617867,0.00006138427,0.00014025802,0.00030134886,0.0000029622056,0.00004980493],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.99451524,0.0013356945,0.002738351,0.00050089,0.00073934527,0.0001704797],"domain_scores_gemma":[0.9751403,0.017213281,0.0048649227,0.00027137826,0.0022614307,0.00024877195],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004575658,0.0011755342,0.0060745417,0.011526591,0.00048821443,0.0020272194,0.0010585054,0.0013970116,0.0027117957],"category_scores_gemma":[0.023174053,0.0009612935,0.0069471044,0.01282736,0.000665702,0.0015383214,0.0011534254,0.0008032672,0.00022631565],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00022847134,0.000012201946,0.004012213,0.954581,0.0116020795,0.0002078988,0.00022940624,0.0000882933,0.00018298811,0.00012625511,0.0012688666,0.02746023],"study_design_scores_gemma":[0.00021484982,0.00023616765,0.0221466,0.8536314,0.10264074,0.0013648464,0.00050786807,0.00009124492,0.00022520406,0.00022296743,0.01866065,0.000057463985],"about_ca_topic_score_codex":0.010292526,"about_ca_topic_score_gemma":0.024188867,"teacher_disagreement_score":0.011526591,"about_ca_system_score_codex":0.0024197532,"about_ca_system_score_gemma":0.00811292,"threshold_uncertainty_score":0.024198651},"labels":[],"label_agreement":null},{"id":"W2921403167","doi":"10.1111/bjh.15827","title":"Genomic data in prognostic models—what is lost in translation? The case of deletion 17p and mutant<i>TP53</i>in chronic lymphocytic leukaemia","year":2019,"lang":"en","type":"review","venue":"British Journal of Haematology","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University; University of Toronto","funders":"","keywords":"Copy-number variation; Chronic lymphocytic leukemia; Genomics; Mutation; Cytogenetics; Clinical significance; Bioinformatics; Medicine; Biology; Oncology; Chromosome; Computational biology; Internal medicine; Genetics; Leukemia; Gene; Genome","score_opus":0.09968734266479744,"score_gpt":0.3740238798445964,"score_spread":0.27433653717979894,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2921403167","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000048555507,0.99442166,0.00029960848,0.0043285536,0.00057174545,0.0000024237963,0.00001084556,0.0000072057774,0.00030941813],"genre_scores_gemma":[0.0010352574,0.9954081,0.00054695975,0.0018599399,0.00096196553,0.0000065191693,0.000013662634,0.000005619602,0.00016183218],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99725264,0.0015449085,0.00036304936,0.00020365982,0.0005600867,0.00007566523],"domain_scores_gemma":[0.9866573,0.010786078,0.0005563823,0.0004115304,0.0013728255,0.00021590109],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0073060486,0.0010871135,0.0033122196,0.003148316,0.000458229,0.0031559393,0.002454892,0.0036902102,0.0017939705],"category_scores_gemma":[0.017138466,0.0007350452,0.0010200536,0.0035264585,0.004369442,0.007049709,0.001622444,0.0070621464,0.001651997],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010515471,0.000028513023,0.0003071521,0.02033721,0.00032400838,0.00049539603,0.00052820856,0.0009894796,0.00025820595,0.03457258,0.05454114,0.88751304],"study_design_scores_gemma":[0.000034742392,0.000083209634,0.00083909865,0.024814202,0.00024989393,0.002177269,0.00049673923,0.000429592,0.0001704229,0.041142933,0.92949325,0.000068557834],"about_ca_topic_score_codex":0.004149131,"about_ca_topic_score_gemma":0.003206614,"teacher_disagreement_score":0.0073060486,"about_ca_system_score_codex":0.002483043,"about_ca_system_score_gemma":0.003028962,"threshold_uncertainty_score":0.03863859},"labels":[],"label_agreement":null},{"id":"W2921964142","doi":"10.1111/bjh.15859","title":"Comparison of the NCCN‐IPI, the IPI and PIT scores as prognostic tools in peripheral T‐cell lymphomas","year":2019,"lang":"en","type":"letter","venue":"British Journal of Haematology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":24,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre intégré de santé et de services sociaux de Chaudière-Appalaches; Hôpital Charles-Le Moyne; Spinal Cord Injury BC; University of British Columbia","funders":"National Cancer Institute; National Institutes of Health","keywords":"Hematology; Internal medicine; Medicine; Oncology; Hematology analyzer; Medical physics","score_opus":0.025382776882994854,"score_gpt":0.29401247669001146,"score_spread":0.2686296998070166,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2921964142","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9627616,0.017123612,0.0050338255,0.0009105819,0.00067811046,0.0003761,0.0046399855,0.00009617638,0.008380002],"genre_scores_gemma":[0.9844379,0.0030313032,0.003389811,0.00018372574,0.00037943953,0.00034222702,0.0073720715,0.000044146473,0.0008194745],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99715805,0.0011314348,0.00026304022,0.00034361074,0.00090714754,0.00019669622],"domain_scores_gemma":[0.9943626,0.0020618304,0.00083183375,0.00035398002,0.0016783372,0.0007114657],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0064475797,0.00080855266,0.0012402353,0.0020695205,0.0003105439,0.0015511231,0.0007303649,0.00063826947,0.0011715919],"category_scores_gemma":[0.017291132,0.00019434764,0.0011061123,0.0019286675,0.00034469526,0.0015289446,0.0015265456,0.0011853701,0.0003890462],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.013377226,0.0002904366,0.784259,0.00060908205,0.0019666753,0.0001212545,0.0004345429,0.004056651,0.0007542363,0.001131046,0.009122315,0.1838775],"study_design_scores_gemma":[0.0007399688,0.0034534985,0.9515322,0.0003944758,0.0019695763,0.00067796133,0.0006777532,0.024172356,0.00066832633,0.0022418667,0.013351914,0.000120141834],"about_ca_topic_score_codex":0.0041120946,"about_ca_topic_score_gemma":0.0063596577,"teacher_disagreement_score":0.0064475797,"about_ca_system_score_codex":0.0011969922,"about_ca_system_score_gemma":0.0012022628,"threshold_uncertainty_score":0.034098506},"labels":[],"label_agreement":null},{"id":"W2922836953","doi":"10.1111/bjh.15866","title":"Late mortality in blood or marrow transplant survivors with venous thromboembolism: report from the Blood or Marrow Transplant Survivor Study","year":2019,"lang":"en","type":"letter","venue":"British Journal of Haematology","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"National Cancer Institute; Leukemia and Lymphoma Society","keywords":"Medicine; Incidence (geometry); Cumulative incidence; Transplantation; Thrombosis; Bone marrow transplant; Venous thrombosis; Surgery; Internal medicine; Pediatrics; Intensive care medicine; Bone marrow transplantation","score_opus":0.025093660341219015,"score_gpt":0.26659780407166417,"score_spread":0.24150414373044515,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2922836953","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99449205,0.0009014679,0.00008725685,0.00017030706,0.000027001644,0.000024193501,0.003727126,0.0000054395805,0.0005651301],"genre_scores_gemma":[0.996167,0.0005911847,0.00006443634,0.000090648486,0.000037655132,0.00003722258,0.0027838373,0.0000027245544,0.00022528447],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99954754,0.0001211141,0.00009065734,0.00008369007,0.000094710274,0.000062202904],"domain_scores_gemma":[0.99833506,0.00015836729,0.0007514968,0.000081820675,0.0002887497,0.0003845407],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010522797,0.00025448375,0.00039772558,0.0008459041,0.00039645706,0.00058179407,0.00036623867,0.00033908934,0.00077938987],"category_scores_gemma":[0.0021744736,0.00018592965,0.0004981993,0.001258965,0.00013940831,0.00046982063,0.00064657873,0.00052235153,0.00017416943],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000050738807,0.000015920834,0.99883074,0.000017588272,0.0000498519,0.000027346483,0.000073765834,0.0000091290885,0.00003063876,0.000006862842,0.00030941458,0.00057790434],"study_design_scores_gemma":[0.000008707367,0.000044783937,0.99935216,0.0000152105285,0.00004464982,0.00006454806,0.00016960845,0.000041126044,0.000017497765,0.000006913913,0.00023150649,0.0000032683627],"about_ca_topic_score_codex":0.011591362,"about_ca_topic_score_gemma":0.015576676,"teacher_disagreement_score":0.011591362,"about_ca_system_score_codex":0.00027548627,"about_ca_system_score_gemma":0.0003795944,"threshold_uncertainty_score":0.023047805},"labels":[],"label_agreement":null},{"id":"W2936779111","doi":"10.1111/bjh.15919","title":"Bortezomib reinduction chemotherapy in high‐risk <scp>ALL</scp> in first relapse: a report from the Children's Oncology Group","year":2019,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":101,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"Hyundai Hope On Wheels; Hospital for Sick Children; NIH Clinical Center; National Cancer Institute; National Institutes of Health; St. Baldrick's Foundation; Children's Hospital of Philadelphia; New York University","keywords":"Bortezomib; Medicine; Internal medicine; Chemotherapy; Oncology; Minimal residual disease; Proteasome inhibitor; Induction chemotherapy; Multiple myeloma; Bone marrow","score_opus":0.008315574203433823,"score_gpt":0.26377815723717574,"score_spread":0.2554625830337419,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2936779111","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96391046,0.033442404,0.00048412115,0.0005296618,0.000080438775,0.00012281611,0.00018002925,0.000044472825,0.0012055764],"genre_scores_gemma":[0.98019236,0.017375374,0.00077124336,0.00059305475,0.00011892515,0.00007648602,0.0004376172,0.00002162395,0.00041317445],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99954873,0.00016278193,0.00007715784,0.00006126362,0.000096369804,0.000053601005],"domain_scores_gemma":[0.9992866,0.00035428707,0.0001581011,0.000052646843,0.000076946504,0.000071426206],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010698457,0.00027570146,0.0005172658,0.00024391308,0.00017976436,0.00033170875,0.00027159136,0.00032035843,0.00024176999],"category_scores_gemma":[0.0018619248,0.00015985125,0.00051487883,0.0004352062,0.00024303768,0.00014850477,0.00013773919,0.0006472203,0.00007671635],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0114841275,0.0016609984,0.1907034,0.0017872077,0.0009340185,0.004078322,0.0012284352,0.002350318,0.03859244,0.00014440702,0.006379316,0.740657],"study_design_scores_gemma":[0.004366306,0.043126516,0.82185304,0.0004938784,0.0027475343,0.019743243,0.0003813213,0.0016684913,0.054786585,0.00013436732,0.05061808,0.00008064327],"about_ca_topic_score_codex":0.0020577034,"about_ca_topic_score_gemma":0.0030153394,"teacher_disagreement_score":0.0020577034,"about_ca_system_score_codex":0.00048067328,"about_ca_system_score_gemma":0.00047759767,"threshold_uncertainty_score":0.005657971},"labels":[],"label_agreement":null},{"id":"W2946051233","doi":"10.1111/bjh.15954","title":"Next generation sequencing redefines a triple negative essential thrombocythaemia as double‐positive with rare mutations on <i><scp>JAK</scp>2 </i>V617 and <i><scp>MPL</scp></i> W515 hotspots","year":2019,"lang":"en","type":"letter","venue":"British Journal of Haematology","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"Institut National Du Cancer","keywords":"Medicine; Genetics; Biology","score_opus":0.03528295247028962,"score_gpt":0.2704517237881554,"score_spread":0.2351687713178658,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2946051233","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97648484,0.0029373753,0.007657228,0.0014762059,0.00016589666,0.00007822664,0.00056502095,0.0002481227,0.010387153],"genre_scores_gemma":[0.99287945,0.0008950173,0.004085056,0.00055111136,0.0000758312,0.000010444371,0.00027913015,0.0000386731,0.0011852097],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.9997949,0.000017265209,0.000028272403,0.00005303361,0.00006409661,0.000042396918],"domain_scores_gemma":[0.9995092,0.00017911025,0.00007688786,0.00003960706,0.00008168264,0.00011352502],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020509723,0.00052109984,0.0003041513,0.0011797716,0.0003908294,0.0004397534,0.00035780677,0.0012700593,0.0015564531],"category_scores_gemma":[0.00095368846,0.00020188848,0.00035495593,0.00032956025,0.00041121902,0.00042666742,0.00036005245,0.0007198015,0.0005056768],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018227322,0.000050113806,0.036891215,0.00013350867,0.00003119755,0.8213192,0.0006617982,0.0003357832,0.11794876,0.00047451124,0.0018209269,0.020150745],"study_design_scores_gemma":[0.000008384074,0.000111630085,0.03265154,0.00007643639,0.000073186944,0.9292587,0.00029624492,0.0020473383,0.02889858,0.000630113,0.0059282705,0.000019530342],"about_ca_topic_score_codex":0.0013945657,"about_ca_topic_score_gemma":0.0018889253,"teacher_disagreement_score":0.0015564531,"about_ca_system_score_codex":0.00025476218,"about_ca_system_score_gemma":0.00016408857,"threshold_uncertainty_score":0.005206883},"labels":[],"label_agreement":null},{"id":"W2946281117","doi":"10.1111/bjh.15990","title":"Longitudinal sequencing of <i><scp>RUNX</scp>1</i> familial platelet disorder: new insights into genetic mechanisms of transformation to myeloid malignancies","year":2019,"lang":"en","type":"review","venue":"British Journal of Haematology","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"Coordenação de Aperfeiçoamento de Pessoal de Nível Superior; Ontario Institute for Cancer Research; Fundação de Amparo à Pesquisa do Estado de São Paulo; Southeastern Ontario Academic Medical Organization; European Hematology Association","keywords":"Transformation (genetics); Myeloid; Cancer research; Genetics; Immunology; Medicine; Gene; Biology","score_opus":0.03612463633027961,"score_gpt":0.3049050492315919,"score_spread":0.26878041290131227,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2946281117","genre_codex":"empirical","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98341954,0.0069835535,0.003916061,0.00036394203,0.000022906248,0.00005157348,0.0033929488,0.000072124916,0.0017774195],"genre_scores_gemma":[0.9869097,0.0031916446,0.0045039393,0.00044815283,0.000048804897,0.000045298257,0.0043810783,0.000043643413,0.00042766816],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.9994555,0.00010629572,0.00008924914,0.00016328509,0.00014519678,0.000040383995],"domain_scores_gemma":[0.9977817,0.00086712907,0.0007375054,0.00015399212,0.00032143606,0.00013829459],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006069567,0.00021856649,0.00025342492,0.0010634571,0.00023935345,0.00049899914,0.00025515017,0.00048551388,0.0008262049],"category_scores_gemma":[0.0023468337,0.00013120408,0.00039972202,0.0011055034,0.00023143385,0.00020373365,0.00026622368,0.00032140958,0.00025978315],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00068994286,0.000080423946,0.5873465,0.0011694309,0.00071101804,0.01320189,0.001716954,0.0009882184,0.27087188,0.00067430234,0.0030722553,0.119477086],"study_design_scores_gemma":[0.00008333814,0.0006700771,0.8385861,0.00046526283,0.0013857699,0.047004007,0.0006973613,0.001845961,0.06559302,0.0009340192,0.04267066,0.00006451509],"about_ca_topic_score_codex":0.0015740816,"about_ca_topic_score_gemma":0.0038387582,"teacher_disagreement_score":0.0015740816,"about_ca_system_score_codex":0.00033484283,"about_ca_system_score_gemma":0.00041487144,"threshold_uncertainty_score":0.003209889},"labels":[],"label_agreement":null},{"id":"W2947003039","doi":"10.1111/bjh.15994","title":"Large deletions of the 5′ region of <i><scp>IKZF</scp>1</i> lead to haploinsufficiency in B‐cell precursor acute lymphoblastic leukaemia","year":2019,"lang":"en","type":"letter","venue":"British Journal of Haematology","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Institut National Du Cancer; Ligue Contre le Cancer; Institute of Cancer Research; Université de Strasbourg; Agence Nationale de la Recherche","keywords":"Multiplex ligation-dependent probe amplification; Exon; Haploinsufficiency; Breakpoint; Biology; Genetics; Molecular biology; Locus (genetics); Gene; Chromosomal translocation; Phenotype","score_opus":0.01334823704894283,"score_gpt":0.2596701559756887,"score_spread":0.24632191892674588,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2947003039","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98773116,0.0021036367,0.004111156,0.00016557702,0.000031712992,0.00004077912,0.0018551218,0.0003674902,0.0035935615],"genre_scores_gemma":[0.9957833,0.00079833734,0.0013067944,0.000057694964,0.000009155986,0.000019138828,0.001094546,0.000035548634,0.0008955572],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9998789,0.00001686687,0.000010688139,0.00003875356,0.000036713634,0.000017983788],"domain_scores_gemma":[0.9998771,0.000031564014,0.000052404164,0.000011085485,0.0000055481764,0.000022213966],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013459046,0.0003077818,0.00021525664,0.00059759844,0.00018068045,0.00021208444,0.00017618836,0.0002750425,0.002956885],"category_scores_gemma":[0.00029372884,0.00019268754,0.0002044106,0.00041885677,0.0002498647,0.000106332394,0.00020879628,0.00036804035,0.00091350026],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003936867,0.000028813862,0.013453887,0.00011667322,0.00003454453,0.00272058,0.00005944492,0.0006797809,0.9631856,0.00023240999,0.0008369681,0.018257566],"study_design_scores_gemma":[0.00012437424,0.0004979669,0.52187264,0.00008034655,0.00023847765,0.038935386,0.00016899385,0.0018968977,0.4128871,0.0010843641,0.022174668,0.000038843715],"about_ca_topic_score_codex":0.0012009231,"about_ca_topic_score_gemma":0.0015656785,"teacher_disagreement_score":0.002956885,"about_ca_system_score_codex":0.00022306154,"about_ca_system_score_gemma":0.00014751079,"threshold_uncertainty_score":0.009891808},"labels":[],"label_agreement":null},{"id":"W2947079603","doi":"10.1111/bjh.15970","title":"Allodepleted T‐cell immunotherapy after haploidentical haematopoietic stem cell transplantation without severe acute graft‐versus‐host disease (<scp>GVHD</scp>) in the absence of <scp>GVHD</scp> prophylaxis","year":2019,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Hôpital Maisonneuve-Rosemont","funders":"Fonds de Recherche du Québec - Santé; Kiadis Pharma; George Washington University","keywords":"Immunosuppression; Medicine; Graft-versus-host disease; Immunology; Stem cell; Transplantation; Hematopoietic stem cell transplantation; Haematopoiesis; Donor lymphocyte infusion; Immunotherapy; Internal medicine; Immune system; Biology","score_opus":0.00918680580712249,"score_gpt":0.24160085263505504,"score_spread":0.23241404682793254,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2947079603","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9985454,0.00038665644,0.00034104352,0.000029883964,0.00001335561,0.000054621967,0.000036085876,0.00002155999,0.0005714393],"genre_scores_gemma":[0.99888283,0.00018304616,0.00032904348,0.000065441825,0.000018881336,0.000049284394,0.00017311268,0.0000028535112,0.00029547294],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9999018,0.000037129437,0.00000895862,0.000018747609,0.000010248536,0.000023146718],"domain_scores_gemma":[0.9998903,0.000033993667,0.000020498957,0.000017516406,0.000005381386,0.000032267908],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00027492267,0.00028685958,0.00047375812,0.00014612665,0.00018724956,0.00023775699,0.00014421558,0.00022858709,0.00057387416],"category_scores_gemma":[0.00023990063,0.00009464727,0.00022322986,0.00009843628,0.00024814915,0.00017734982,0.00013499598,0.00056007353,0.00016887595],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.03122963,0.019169614,0.032014817,0.00056742865,0.0003588016,0.004650504,0.0005552116,0.006105028,0.6752565,0.00073304155,0.0020570406,0.2273024],"study_design_scores_gemma":[0.014004003,0.6023127,0.15621115,0.000082819555,0.00052348763,0.013948646,0.00016109407,0.0072752647,0.19406326,0.0004999129,0.010863791,0.00005395224],"about_ca_topic_score_codex":0.00018176579,"about_ca_topic_score_gemma":0.00030129263,"teacher_disagreement_score":0.00057387416,"about_ca_system_score_codex":0.00014818594,"about_ca_system_score_gemma":0.00022257185,"threshold_uncertainty_score":0.001919806},"labels":[],"label_agreement":null},{"id":"W2947314253","doi":"10.1111/bjh.15996","title":"The effects of hydroxycarbamide on the plasma proteome of children with sickle cell anaemia","year":2019,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Thomas Hospital","funders":"King's College London; Stroke Association","keywords":"Haptoglobin; Blood proteins; Protein S; Medicine; Internal medicine; Endocrinology; Immunology; Protein C","score_opus":0.0021332309815199285,"score_gpt":0.18401204221340262,"score_spread":0.18187881123188268,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2947314253","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99909294,0.00066141953,0.0000395589,0.000017660665,0.0000020342786,0.0000023815608,0.00007987271,0.0000020765904,0.000102010476],"genre_scores_gemma":[0.9991714,0.00038000345,0.00016140477,0.000030016987,0.00000413459,0.0000033776805,0.00016013204,0.0000021622825,0.00008739337],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99978894,0.00005234416,0.000016486205,0.00005360151,0.000058093792,0.000030698295],"domain_scores_gemma":[0.99963236,0.000063480154,0.00018966447,0.00001441504,0.000047309157,0.000052670282],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022873926,0.00020841598,0.00021884301,0.0003623639,0.00020012679,0.0003414267,0.000113548485,0.0002066996,0.00039535578],"category_scores_gemma":[0.00064692367,0.00013624612,0.00022541956,0.00039302986,0.00021565333,0.00020361676,0.0002499524,0.000250135,0.00008679711],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0028868213,0.00008243112,0.72699314,0.00022634893,0.00026416703,0.0015378168,0.0009196321,0.0001910078,0.24769458,0.000047368678,0.00023584244,0.018920934],"study_design_scores_gemma":[0.000005980368,0.00031865895,0.99361813,0.0000058053665,0.000033670753,0.0008579048,0.00015964957,0.00008509976,0.0045268373,0.000010147301,0.00037480192,0.000003278709],"about_ca_topic_score_codex":0.0016903816,"about_ca_topic_score_gemma":0.0017033386,"teacher_disagreement_score":0.0016903816,"about_ca_system_score_codex":0.00022313878,"about_ca_system_score_gemma":0.00013222669,"threshold_uncertainty_score":0.003361106},"labels":[],"label_agreement":null},{"id":"W2947829757","doi":"10.1111/bjh.15963","title":"Amustaline‐glutathione pathogen‐reduced red blood cell concentrates for transfusion‐dependent thalassaemia","year":2019,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":32,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Ontario Institute for Regenerative Medicine; Ege Üniversitesi","keywords":"Glutathione; Medicine; Confidence interval; Red blood cell; Gastroenterology; Adverse effect; Crossover study; Internal medicine; Immunology; Pharmacology; Surgery; Biology; Pathology; Biochemistry; Placebo; Enzyme","score_opus":0.006364015243809111,"score_gpt":0.22784146049325704,"score_spread":0.22147744524944793,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2947829757","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9958735,0.002133642,0.0011356273,0.00008540704,0.000049621845,0.0003267891,0.00004845664,0.0000208236,0.00032617387],"genre_scores_gemma":[0.99820745,0.0005841714,0.00075896416,0.00005081151,0.000037139096,0.00013452808,0.000051100556,0.0000025739107,0.00017321123],"study_design_codex":"randomized_trial","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99933976,0.00040320153,0.000057862715,0.00007117506,0.000093314244,0.0000346469],"domain_scores_gemma":[0.9994899,0.00020123197,0.00014606245,0.000062528816,0.000023502394,0.00007674148],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010605615,0.00029034071,0.0006224123,0.00018424778,0.000109894274,0.00025350854,0.00033851116,0.00038139094,0.0011929639],"category_scores_gemma":[0.0009876799,0.000140775,0.00038297387,0.00015434423,0.00042587932,0.00019576482,0.00016389969,0.0006084777,0.0001432458],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.47586137,0.015324853,0.0068042884,0.00201238,0.0014366752,0.00034618276,0.00030945975,0.0023115692,0.17560616,0.0014392444,0.0010408809,0.31750694],"study_design_scores_gemma":[0.1440832,0.789904,0.022363443,0.00010237529,0.0011047963,0.00074348296,0.000056649267,0.002608217,0.035003867,0.00043997134,0.0035495353,0.000040543673],"about_ca_topic_score_codex":0.00018879276,"about_ca_topic_score_gemma":0.00033124452,"teacher_disagreement_score":0.0011929639,"about_ca_system_score_codex":0.00024303512,"about_ca_system_score_gemma":0.00028408994,"threshold_uncertainty_score":0.0056088567},"labels":[],"label_agreement":null},{"id":"W2947924227","doi":"10.1111/bjh.15965","title":"Real world data as a key element in precision medicine for lymphoid malignancies: potentials and pitfalls","year":2019,"lang":"en","type":"review","venue":"British Journal of Haematology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Spinal Cord Injury BC; BC Cancer Agency","funders":"","keywords":"Key (lock); Element (criminal law); Precision medicine; Medicine; Data science; Computer science; Computational biology; Intensive care medicine; Biology; Pathology; Political science; Computer security; Law","score_opus":0.10610159408223732,"score_gpt":0.4056930360424656,"score_spread":0.29959144196022824,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2947924227","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0004307238,0.9512737,0.0143370535,0.029184032,0.0015836032,0.00010569156,0.0006597997,0.000076638426,0.002348772],"genre_scores_gemma":[0.017498279,0.92178684,0.036022466,0.019180382,0.0035975133,0.00051075825,0.0007813163,0.00008853591,0.0005339847],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.94576323,0.03708919,0.005694194,0.002756115,0.008270952,0.00042619856],"domain_scores_gemma":[0.5427805,0.42327318,0.009030527,0.012251804,0.011658466,0.0010054696],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.09002086,0.0014604235,0.0074912594,0.0065116566,0.00097013084,0.010187327,0.004457152,0.0058213314,0.004847866],"category_scores_gemma":[0.15386082,0.0012712629,0.0037058387,0.007223864,0.007892197,0.015814954,0.00574944,0.013051786,0.0012055552],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00031099998,0.00005098435,0.0015405795,0.0862892,0.0026513243,0.00032227862,0.0011741563,0.0026208165,0.00060119695,0.13328874,0.028161416,0.74298835],"study_design_scores_gemma":[0.000121082456,0.00017186423,0.0020308702,0.08882209,0.0015313192,0.0009469415,0.0008798306,0.0014330273,0.00087890856,0.24799868,0.65497375,0.00021158962],"about_ca_topic_score_codex":0.00310611,"about_ca_topic_score_gemma":0.0042350627,"teacher_disagreement_score":0.09002086,"about_ca_system_score_codex":0.004044772,"about_ca_system_score_gemma":0.009995128,"threshold_uncertainty_score":0.4760815},"labels":[],"label_agreement":null},{"id":"W2949084717","doi":"10.1111/bjh.16014","title":"Response‐adapted therapy for the treatment of children with newly diagnosed high risk Hodgkin lymphoma (AHOD0831): a report from the Children’s Oncology Group","year":2019,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":79,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"National Institutes of Health; National Cancer Institute; St. Baldrick's Foundation","keywords":"Medicine; Lymphoma; Hodgkin lymphoma; Oncology; Internal medicine; Pediatric oncology; Pediatrics; Cancer","score_opus":0.010637086228555123,"score_gpt":0.25825139555063376,"score_spread":0.24761430932207862,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2949084717","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9887651,0.007597307,0.0003721254,0.00045478262,0.000063269246,0.00042417154,0.0012471816,0.000029819654,0.0010461914],"genre_scores_gemma":[0.9833626,0.0070876344,0.002311896,0.001231508,0.00010100614,0.00067902694,0.0045467597,0.000020932242,0.0006585674],"study_design_codex":"design_other","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9986493,0.00079383794,0.000108769644,0.000098006225,0.0002481489,0.00010196313],"domain_scores_gemma":[0.9983339,0.00070607313,0.0004337184,0.000119071294,0.000097594595,0.00030976333],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0033052722,0.0004158637,0.0008425842,0.00033799393,0.00016010844,0.00035850413,0.00040048754,0.00043207116,0.00039200103],"category_scores_gemma":[0.0017550621,0.00019431244,0.0008726943,0.00049156277,0.0002455567,0.00025264686,0.0003229192,0.0009314376,0.00010070181],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.07998034,0.00614248,0.351135,0.0023408174,0.0050516445,0.0007695499,0.00066245534,0.0039014388,0.015040163,0.00037221808,0.011124228,0.5234797],"study_design_scores_gemma":[0.044978175,0.112598404,0.80839753,0.00030619593,0.0017393689,0.002836938,0.0001480623,0.0012355782,0.004477655,0.00013353181,0.023086675,0.00006190241],"about_ca_topic_score_codex":0.0022505578,"about_ca_topic_score_gemma":0.005441107,"teacher_disagreement_score":0.0033052722,"about_ca_system_score_codex":0.0006934564,"about_ca_system_score_gemma":0.0008403899,"threshold_uncertainty_score":0.017480135},"labels":[],"label_agreement":null},{"id":"W2949223966","doi":"10.1111/bjh.16063","title":"Hydroxycarbamide treatment in children with Sickle Cell Anaemia is associated with more intact white matter integrity: a quantitative MRI study","year":2019,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; University of Toronto","funders":"","keywords":"Hydroxycarbamide; Medicine; White matter; Internal medicine; White blood cell; Cerebral blood flow; Gastroenterology; Cardiology; Magnetic resonance imaging; Radiology","score_opus":0.006736400016567123,"score_gpt":0.2464130421419799,"score_spread":0.2396766421254128,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2949223966","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9995524,0.00016209688,0.0000615299,0.000014028804,0.0000011936692,0.0000031041423,0.000044168963,0.000003800722,0.00015766398],"genre_scores_gemma":[0.9996594,0.00009434285,0.00010055108,0.000012748668,0.0000049507744,0.000003249985,0.0000539731,0.0000029118014,0.0000678089],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9998497,0.000036544086,0.000018566187,0.000038048358,0.00003474702,0.000022326729],"domain_scores_gemma":[0.99923015,0.00017295533,0.0004353576,0.00003542137,0.000044055454,0.000082063605],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00024049287,0.00024031202,0.00022715596,0.00048033387,0.00016321862,0.00023088724,0.00014499146,0.0003580369,0.00079516025],"category_scores_gemma":[0.0010221505,0.00016441308,0.00020240618,0.0003756122,0.0003094501,0.00021929461,0.00014138116,0.00024644236,0.000115598894],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012593928,0.00016218222,0.955893,0.000102773105,0.0001261817,0.0057446305,0.00075714546,0.00016842214,0.02854806,0.000073957795,0.00015030819,0.0070140334],"study_design_scores_gemma":[0.000009429605,0.00028069073,0.9940402,0.0000056337954,0.000028718398,0.004577883,0.000099378594,0.00013672054,0.00065828377,0.000015099697,0.00014356968,0.0000042589677],"about_ca_topic_score_codex":0.001608033,"about_ca_topic_score_gemma":0.0011614796,"teacher_disagreement_score":0.001608033,"about_ca_system_score_codex":0.00019630577,"about_ca_system_score_gemma":0.00013289815,"threshold_uncertainty_score":0.0031973124},"labels":[],"label_agreement":null},{"id":"W2949605560","doi":"10.1111/bjh.16065","title":"EBV‐associated hydroa vacciniforme‐like T‐cell lymphoma","year":2019,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Viral-associated cancers and disorders","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Ottawa; Université de Montréal","funders":"","keywords":"Medicine; Vincristine; CHOP; CD30; Rituximab; Internal medicine; Pathology; Lymphoma; Cyclophosphamide; Chemotherapy","score_opus":0.0059180207982115615,"score_gpt":0.22864097923278534,"score_spread":0.2227229584345738,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2949605560","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9882328,0.00170061,0.0007143607,0.00056018756,0.00010953143,0.00007128162,0.00024626343,0.00007821993,0.008286741],"genre_scores_gemma":[0.9974848,0.0005689201,0.00017066293,0.00015912813,0.000057954654,0.0000073778883,0.000085733154,0.000009284337,0.0014562084],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.99989796,0.0000069984444,0.0000072728462,0.00002780283,0.000014131141,0.00004577136],"domain_scores_gemma":[0.9998337,0.000039098442,0.00002464455,0.000010130707,0.000018687464,0.00007368796],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00008311354,0.00050217606,0.0004075568,0.00042097855,0.0007732707,0.00038738322,0.0002333805,0.00073878997,0.0023664571],"category_scores_gemma":[0.0005015726,0.0002946339,0.0002921283,0.00028305798,0.0003264087,0.0005038636,0.00032988435,0.0006807853,0.0004863648],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001782933,0.000087902146,0.033921916,0.00007634369,0.000018805402,0.95126873,0.000247242,0.0000918184,0.008766907,0.00019405285,0.0006092829,0.004538679],"study_design_scores_gemma":[0.00006788559,0.0003294594,0.061685797,0.00003826778,0.000035325615,0.9304808,0.0003523452,0.00067300507,0.0019029898,0.00018735448,0.00423278,0.000014007059],"about_ca_topic_score_codex":0.0029143833,"about_ca_topic_score_gemma":0.0029720003,"teacher_disagreement_score":0.0029143833,"about_ca_system_score_codex":0.00054466707,"about_ca_system_score_gemma":0.00029881703,"threshold_uncertainty_score":0.00791657},"labels":[],"label_agreement":null},{"id":"W2956596030","doi":"10.1111/bjh.16099","title":"Langerhans cell histiocytosis: progress and controversies","year":2019,"lang":"en","type":"editorial","venue":"British Journal of Haematology","topic":"Histiocytic Disorders and Treatments","field":"Medicine","cited_by":33,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children; University of Toronto","funders":"","keywords":"Langerhans cell histiocytosis; Histiocytosis; Medicine; Pathology; Disease","score_opus":0.0038619294494136886,"score_gpt":0.24047414007037163,"score_spread":0.23661221062095794,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2956596030","genre_codex":"review","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"editorial","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0003088911,0.94443065,0.00022132261,0.050082162,0.004263246,0.0000044938547,0.00004762437,0.0000189895,0.000622515],"genre_scores_gemma":[0.005903212,0.9317699,0.0007071391,0.037988126,0.023079038,0.000022361746,0.00012259358,0.00002050302,0.000387143],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99658006,0.0010400795,0.00064115826,0.000665621,0.0008211668,0.00025187936],"domain_scores_gemma":[0.95885676,0.031205062,0.001732369,0.000860764,0.005705579,0.0016394374],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0125595955,0.00090342446,0.0028778103,0.0030471815,0.0013801503,0.004623475,0.0027093338,0.0060970215,0.0048100585],"category_scores_gemma":[0.023992784,0.00049645104,0.001365301,0.0031030464,0.0054523507,0.009997851,0.002705336,0.01170942,0.0020000956],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00041560704,0.00014035469,0.0016773229,0.012098615,0.00027074205,0.0005115277,0.0008871129,0.00031995692,0.0006031513,0.029571883,0.19182977,0.7616739],"study_design_scores_gemma":[0.000057985428,0.00014979868,0.0020233875,0.020022491,0.0002576055,0.0016373778,0.0022216528,0.0002074523,0.00024879133,0.05602852,0.91705227,0.00009261699],"about_ca_topic_score_codex":0.0024376393,"about_ca_topic_score_gemma":0.0031106744,"teacher_disagreement_score":0.0125595955,"about_ca_system_score_codex":0.002420999,"about_ca_system_score_gemma":0.0047986475,"threshold_uncertainty_score":0.06642228},"labels":[],"label_agreement":null},{"id":"W2966178814","doi":"10.1111/bjh.16116","title":"Longitudinal minimal residual disease (MRD) evaluation in acute myeloid leukaemia with <i>NPM1</i> mutation: from definition of molecular relapse to MRD‐driven salvage approach","year":2019,"lang":"en","type":"letter","venue":"British Journal of Haematology","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Minimal residual disease; NPM1; Medicine; Myeloid leukaemia; Oncology; Mutation; Salvage therapy; Residual; Internal medicine; Disease; Leukemia; Genetics; Chemotherapy; Biology; Karyotype; Gene","score_opus":0.0277667867759721,"score_gpt":0.2855302546066979,"score_spread":0.2577634678307258,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2966178814","genre_codex":"empirical","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9977314,0.0009237679,0.0006997244,0.00005940551,0.000009212016,0.000023299612,0.00014971735,0.0000119829565,0.0003915551],"genre_scores_gemma":[0.9981298,0.00032147704,0.0007265704,0.00007149554,0.000037837206,0.000026271831,0.00046344774,0.000008305979,0.00021486444],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.9997086,0.000080347214,0.000036686837,0.0000863405,0.00004525919,0.00004275314],"domain_scores_gemma":[0.9991999,0.000164521,0.00031140374,0.00008398841,0.000079201964,0.00016103298],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006379967,0.00018933341,0.00037027418,0.00041560744,0.00020976584,0.00063367747,0.00028970005,0.00026101482,0.00076822925],"category_scores_gemma":[0.0017522074,0.00012278659,0.00024042754,0.00028430508,0.00025977177,0.00031183235,0.00079150556,0.00048519654,0.00030973135],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0020023189,0.00016943683,0.9545368,0.00007043925,0.000054679305,0.00067856436,0.00044167874,0.00040716195,0.0106013715,0.00012663053,0.0004230317,0.030487714],"study_design_scores_gemma":[0.00005472686,0.001746542,0.98314947,0.00004088098,0.00014471728,0.0048153396,0.00036780094,0.0018597039,0.0033479044,0.00034034371,0.004107877,0.000024791923],"about_ca_topic_score_codex":0.0005046865,"about_ca_topic_score_gemma":0.0007010588,"teacher_disagreement_score":0.00076822925,"about_ca_system_score_codex":0.00031551844,"about_ca_system_score_gemma":0.0003142276,"threshold_uncertainty_score":0.0033740997},"labels":[],"label_agreement":null},{"id":"W2978510275","doi":"10.1111/bjh.16213","title":"Pomalidomide plus low‐dose dexamethasone in relapsed refractory multiple myeloma after lenalidomide treatment failure","year":2019,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":45,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary; McGill University Health Centre; Vancouver General Hospital","funders":"Celgene","keywords":"Lenalidomide; Pomalidomide; Medicine; Bortezomib; Multiple myeloma; Dexamethasone; Internal medicine; Clinical endpoint; Thalidomide; Oncology; Adverse effect; Refractory (planetary science); Population; Surgery; Clinical trial","score_opus":0.015517708207336058,"score_gpt":0.2802767169421137,"score_spread":0.26475900873477765,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2978510275","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9944865,0.004084549,0.00013979104,0.00019295928,0.000055950793,0.00020562988,0.00012824204,0.000020953232,0.00068529893],"genre_scores_gemma":[0.997905,0.0010296019,0.00020674881,0.00022598657,0.0000603708,0.000093626004,0.00020891933,0.0000033382094,0.00026642458],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9995772,0.00022715873,0.000033762037,0.000059562597,0.0000429317,0.00005943],"domain_scores_gemma":[0.99945205,0.00014526137,0.0001322437,0.00003276368,0.000017272923,0.00022037537],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011093699,0.00041414038,0.0013520843,0.0003178662,0.0002893931,0.00052076095,0.00046500465,0.0004234336,0.0008151621],"category_scores_gemma":[0.0011100702,0.00020307775,0.00066478585,0.00039119044,0.00030698616,0.00039047783,0.00032400622,0.0011737769,0.00019999781],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.46153104,0.013581097,0.09583387,0.001043888,0.0019506271,0.0018273401,0.00047637476,0.0045048203,0.025408164,0.0003632665,0.003072469,0.3904071],"study_design_scores_gemma":[0.18110897,0.5819942,0.21111076,0.00031735943,0.001252343,0.002586428,0.00030145363,0.0049963444,0.0058589038,0.0009617727,0.009416708,0.00009483868],"about_ca_topic_score_codex":0.0009094805,"about_ca_topic_score_gemma":0.0020514678,"teacher_disagreement_score":0.0013520843,"about_ca_system_score_codex":0.00067640055,"about_ca_system_score_gemma":0.000840331,"threshold_uncertainty_score":0.0058670044},"labels":[],"label_agreement":null},{"id":"W2979071352","doi":"10.1111/bjh.16201","title":"Brentuximab vedotin for the treatment of patients with relapsed or refractory Hodgkin lymphoma after autologous stem cell transplantation","year":2019,"lang":"en","type":"review","venue":"British Journal of Haematology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Spinal Cord Injury BC; University of British Columbia","funders":"Takeda Pharmaceutical Company","keywords":"Brentuximab vedotin; Medicine; Autologous stem-cell transplantation; Oncology; Transplantation; Lymphoma; Refractory (planetary science); Stem cell; Internal medicine; Hematopoietic stem cell transplantation; Chemotherapy; Surgery; Hodgkin lymphoma; Biology","score_opus":0.027315288273761344,"score_gpt":0.2859260486957481,"score_spread":0.2586107604219868,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2979071352","genre_codex":"empirical","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9580325,0.0374424,0.001167055,0.00073732424,0.000060448387,0.00022677759,0.000292433,0.000012796673,0.0020283875],"genre_scores_gemma":[0.9958762,0.003073718,0.0005940279,0.00013501443,0.00003245784,0.00004399359,0.0001353303,0.0000010590687,0.00010814339],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9981675,0.001284508,0.00012477912,0.00007739235,0.0002882855,0.000057461024],"domain_scores_gemma":[0.99785405,0.0012414525,0.00062291004,0.000052905325,0.00009799844,0.0001305945],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0042024474,0.000085452775,0.00040723154,0.0006361879,0.000112249945,0.00039734188,0.00016449933,0.00012689739,0.0007341446],"category_scores_gemma":[0.0038757997,0.000048654965,0.00046523588,0.00046795947,0.00027465806,0.00026751522,0.00025099528,0.00039786551,0.00007187733],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.051435824,0.0010595979,0.2380401,0.002450303,0.0030841236,0.00090376043,0.00041966804,0.0019220648,0.008604114,0.0015305312,0.0013471849,0.6892028],"study_design_scores_gemma":[0.013177311,0.15183447,0.76811874,0.001657214,0.0057964604,0.0056712916,0.0010852024,0.005907562,0.010428257,0.0028652446,0.03336498,0.000093291885],"about_ca_topic_score_codex":0.00034986844,"about_ca_topic_score_gemma":0.0013334455,"teacher_disagreement_score":0.0042024474,"about_ca_system_score_codex":0.00047193447,"about_ca_system_score_gemma":0.00067078765,"threshold_uncertainty_score":0.022224903},"labels":[],"label_agreement":null},{"id":"W2979227727","doi":"10.1111/bjh.16214","title":"Pomalidomide in lenalidomide‐refractory multiple myeloma: Far from futile","year":2019,"lang":"en","type":"letter","venue":"British Journal of Haematology","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Pomalidomide; Lenalidomide; Multiple myeloma; Medicine; Oncology; Refractory (planetary science); Internal medicine; Biology","score_opus":0.024522558363938365,"score_gpt":0.2838409606787506,"score_spread":0.25931840231481224,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2979227727","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.003109027,0.342078,0.0010125291,0.39892235,0.24278839,0.000044640547,0.0005482925,0.00026008385,0.011236691],"genre_scores_gemma":[0.018655304,0.20477347,0.001982287,0.20757931,0.5498931,0.000057757585,0.0005713199,0.00021595796,0.016271519],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99851245,0.0004251189,0.00020527688,0.00013449579,0.0005847855,0.00013776551],"domain_scores_gemma":[0.9947449,0.0024961275,0.00044624967,0.00023272811,0.0013775049,0.0007025281],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004584395,0.00043982215,0.001406296,0.0011588257,0.0007044801,0.0035174785,0.0014110807,0.0024552133,0.0031968625],"category_scores_gemma":[0.0075433953,0.00032479886,0.00065367785,0.0010619785,0.0013488341,0.0028168822,0.0010893558,0.005449195,0.0021690694],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00031781005,0.000049758346,0.000735882,0.00059782574,0.00007066882,0.00014274119,0.00008999758,0.00009181728,0.00042786374,0.002481672,0.8335826,0.16141143],"study_design_scores_gemma":[0.00017354879,0.0002608856,0.002315899,0.0013980416,0.0000831027,0.000364085,0.0001649753,0.0002339052,0.000354182,0.0042490573,0.9903661,0.00003622067],"about_ca_topic_score_codex":0.0024012923,"about_ca_topic_score_gemma":0.010062248,"teacher_disagreement_score":0.004584395,"about_ca_system_score_codex":0.002230299,"about_ca_system_score_gemma":0.0026210283,"threshold_uncertainty_score":0.024244905},"labels":[],"label_agreement":null},{"id":"W2981250529","doi":"10.1111/bjh.16236","title":"Cystic lung disease with kappa light chain deposition in newly diagnosed multiple myeloma","year":2019,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Amyloidosis: Diagnosis, Treatment, Outcomes","field":"Biochemistry, Genetics and Molecular Biology","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre; Health Sciences Centre; Queen's University","funders":"","keywords":"Immunoglobulin light chain; Medicine; Multiple myeloma; Immunofixation; Pathology; Kappa; Bence Jones protein; Plasma cell dyscrasia; Gastroenterology; Internal medicine; Antibody; Monoclonal; Immunology","score_opus":0.003587835730124114,"score_gpt":0.21839081380507439,"score_spread":0.21480297807495027,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2981250529","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98033696,0.009902061,0.0014432565,0.0012787203,0.0004941118,0.00014518328,0.0002013409,0.00012365842,0.0060746917],"genre_scores_gemma":[0.9958055,0.0023839506,0.00033395994,0.00031817667,0.0004880717,0.000013279923,0.00008205837,0.000010328222,0.0005646422],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.9994517,0.000051957184,0.00007471346,0.00014258287,0.00011424091,0.00016476707],"domain_scores_gemma":[0.9983487,0.000465156,0.00036865118,0.00012816627,0.000115356524,0.0005739081],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004373705,0.0016558613,0.00094346324,0.0024363317,0.0019392716,0.0012426866,0.0012954491,0.0030667242,0.0018565906],"category_scores_gemma":[0.0029181493,0.0012200914,0.0007995341,0.0019293003,0.001417553,0.0014037859,0.0013909135,0.0017584354,0.00097398955],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000039333634,0.0000362365,0.019343065,0.000050567123,0.0000125919905,0.9780899,0.0001585271,0.000049150167,0.00065869396,0.000037765654,0.00021401863,0.0013101044],"study_design_scores_gemma":[0.00001615,0.000059603248,0.017026963,0.000021800515,0.000018534723,0.9819412,0.0001246476,0.00011425443,0.00020088069,0.000048396778,0.00041860962,0.000008857685],"about_ca_topic_score_codex":0.0026594377,"about_ca_topic_score_gemma":0.004103254,"teacher_disagreement_score":0.0030667242,"about_ca_system_score_codex":0.00090062607,"about_ca_system_score_gemma":0.00077486987,"threshold_uncertainty_score":0.006534517},"labels":[],"label_agreement":null},{"id":"W2985152406","doi":"10.1111/bjh.16332","title":"Pegylated interferon alpha 2a is an effective and well‐tolerated treatment option for lymphocyte‐variant hypereosinophilic syndrome","year":2019,"lang":"en","type":"letter","venue":"British Journal of Haematology","topic":"Eosinophilic Disorders and Syndromes","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Medicine; Alpha interferon; Internal medicine; Gastroenterology; Discontinuation; Immunology; Methotrexate; Hypereosinophilic syndrome; Population; Interferon; Eosinophilia","score_opus":0.0165750259208535,"score_gpt":0.2646448905418397,"score_spread":0.2480698646209862,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2985152406","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.6311091,0.3035814,0.010985281,0.008123362,0.0012356578,0.00031985398,0.000734898,0.00048429272,0.04342619],"genre_scores_gemma":[0.95773345,0.027780164,0.0037983775,0.0021553542,0.00041448383,0.00013621121,0.0006376494,0.000038041828,0.0073063234],"study_design_codex":"design_other","study_design_gemma":"case_report","domain_scores_codex":[0.99992347,0.000019652192,0.0000097590855,0.000010560442,0.000024178098,0.000012353181],"domain_scores_gemma":[0.99995124,0.0000131392635,0.000014501832,0.0000030973035,0.000006307475,0.000011667039],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014634154,0.00014469493,0.00036444917,0.0002200117,0.00013744281,0.000113146845,0.0001243345,0.0002870913,0.0024432705],"category_scores_gemma":[0.00025687856,0.000042656742,0.00023420904,0.0001282067,0.00008160916,0.00019212929,0.00013037288,0.0006057015,0.00062558276],"study_design_candidate":"case_report","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003978494,0.0006754899,0.0047809733,0.0007866473,0.00025710248,0.0038997482,0.000108458866,0.0005181119,0.026535066,0.0007262841,0.010607285,0.9471263],"study_design_scores_gemma":[0.008723857,0.021555701,0.1894866,0.0029872425,0.0012171235,0.06035568,0.0005797845,0.0053759804,0.04606507,0.0077536954,0.6557514,0.00014783743],"about_ca_topic_score_codex":0.00021077752,"about_ca_topic_score_gemma":0.0004500536,"teacher_disagreement_score":0.0024432705,"about_ca_system_score_codex":0.00017513767,"about_ca_system_score_gemma":0.00009060847,"threshold_uncertainty_score":0.008173585},"labels":[],"label_agreement":null},{"id":"W2990892067","doi":"10.1111/bjh.16307","title":"Prognostic relevance of CD123 expression in adult AML with normal karyotype","year":2019,"lang":"en","type":"letter","venue":"British Journal of Haematology","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Genome Canada; University Health Network","funders":"University Health Network","keywords":"Karyotype; Medicine; Internal medicine; Oncology; Biology; Cancer research; Genetics; Chromosome; Gene","score_opus":0.011060819117868426,"score_gpt":0.26246253753529375,"score_spread":0.2514017184174253,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2990892067","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99898046,0.00045308354,0.00006670719,0.000019864961,0.0000037205073,0.0000057673005,0.0000628744,0.000002755231,0.0004047437],"genre_scores_gemma":[0.9995937,0.0001144886,0.00007983991,0.000009252785,0.0000111342315,0.000004212256,0.00013310606,0.0000010755259,0.00005331348],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99976,0.000044929806,0.00004484911,0.000047996087,0.000044332854,0.000057986275],"domain_scores_gemma":[0.9993131,0.00015459118,0.00023763656,0.000041263585,0.00006969878,0.00018370399],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00026605013,0.00016708254,0.00027269588,0.0006613851,0.00021706436,0.00038609232,0.00020580912,0.00033679607,0.0010008161],"category_scores_gemma":[0.0013491856,0.00012630645,0.00014429179,0.00058588857,0.00029968348,0.00035982238,0.00036918395,0.00027000895,0.0002182943],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00036367847,0.000014052425,0.9935774,0.000009271484,0.000007997543,0.00064750644,0.000027824679,0.000045189634,0.0020796433,0.00002255528,0.00007224823,0.0031326076],"study_design_scores_gemma":[0.000018560368,0.0002260635,0.99160004,0.0000074100535,0.00004127647,0.005652267,0.00015256421,0.00043417542,0.0009849829,0.00005489918,0.0008211934,0.0000064847977],"about_ca_topic_score_codex":0.00048466655,"about_ca_topic_score_gemma":0.0006483136,"teacher_disagreement_score":0.0010008161,"about_ca_system_score_codex":0.00020911086,"about_ca_system_score_gemma":0.0001843374,"threshold_uncertainty_score":0.0033480525},"labels":[],"label_agreement":null},{"id":"W2992515443","doi":"10.1111/bjh.16319","title":"Poor outcomes for double‐hit lymphoma patients treated with curative‐intent second‐line immunochemotherapy following failure of intensive front‐line immunochemotherapy","year":2019,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Jewish General Hospital","funders":"","keywords":"Medicine; Front line; Second line; Oncology; Internal medicine; Refractory (planetary science); Lymphoma; Progression-free survival; Overall survival; Salvage therapy; First line; Chemotherapy","score_opus":0.010816700181680735,"score_gpt":0.2613074448371707,"score_spread":0.25049074465549,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2992515443","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9993149,0.00013308784,0.00005046418,0.000026232632,0.000002888341,0.000006573204,0.000061657476,0.0000029435341,0.00040139694],"genre_scores_gemma":[0.9997844,0.000030603213,0.000018209279,0.000016691443,0.0000049828755,0.0000035697578,0.00008847863,7.389903e-7,0.00005236439],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9998294,0.000035294335,0.000018785984,0.000028287512,0.000020080017,0.000068167545],"domain_scores_gemma":[0.9989993,0.00021639689,0.00040218027,0.000052600495,0.000042337735,0.00028717294],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00026414366,0.00014371876,0.0003652899,0.0003659539,0.000328268,0.00069954415,0.00013223135,0.00023781616,0.0012641276],"category_scores_gemma":[0.0011686232,0.00007786955,0.00020216317,0.00032428929,0.00028697634,0.0003279796,0.0004386197,0.0003661872,0.0002537869],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00084206247,0.000071891256,0.99029493,0.000015525779,0.000030813742,0.001212574,0.00017616744,0.00020426232,0.0009526946,0.000048118753,0.00019308006,0.005957892],"study_design_scores_gemma":[0.000046599736,0.0010894445,0.9917114,0.00001729645,0.00006221602,0.0049152575,0.0003936273,0.00045117908,0.00047792023,0.000119170014,0.0007034405,0.000012487594],"about_ca_topic_score_codex":0.00084104884,"about_ca_topic_score_gemma":0.0012029696,"teacher_disagreement_score":0.0012641276,"about_ca_system_score_codex":0.00029038225,"about_ca_system_score_gemma":0.0002297149,"threshold_uncertainty_score":0.0042289495},"labels":[],"label_agreement":null},{"id":"W2993178565","doi":"10.1111/bjh.16306","title":"Day 15 bone marrow minimal residual disease predicts response to blinatumomab in relapsed/refractory paediatric B‐ALL","year":2019,"lang":"en","type":"letter","venue":"British Journal of Haematology","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"Amgen","keywords":"Blinatumomab; Medicine; Minimal residual disease; Refractory (planetary science); Bone marrow; Bone marrow failure; Immunology; Internal medicine; Oncology; Antibody; Stem cell; CD19; Haematopoiesis; Biology","score_opus":0.014262885081018549,"score_gpt":0.2729198481157316,"score_spread":0.2586569630347131,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2993178565","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9920408,0.0054040477,0.00014491995,0.00021353863,0.000036570877,0.0000337622,0.00034699767,0.000033873923,0.0017453964],"genre_scores_gemma":[0.99741334,0.0010441636,0.0001837472,0.00012498605,0.000027304917,0.000018781524,0.00080992316,0.0000075699463,0.00037015477],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99967253,0.00009307118,0.000040556577,0.00005442038,0.00008305964,0.000056426627],"domain_scores_gemma":[0.9990792,0.00022846062,0.0003162284,0.000033889213,0.00008104364,0.00026122443],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007487851,0.00032998784,0.0007035925,0.00040202736,0.00019440269,0.0008115689,0.00045247734,0.00064809155,0.002113866],"category_scores_gemma":[0.0020676167,0.0002172186,0.00043615644,0.00034079351,0.00030859862,0.00049207447,0.0005122103,0.0011855492,0.0006515641],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00478086,0.00017100446,0.9458168,0.00016839648,0.00009629299,0.00080450205,0.00022710954,0.0008764772,0.0042393673,0.00011561706,0.001744075,0.040959537],"study_design_scores_gemma":[0.00013991026,0.0018314618,0.9856215,0.00014230747,0.00013794992,0.0046341573,0.00022274382,0.001299042,0.0015019246,0.00021902299,0.0042278687,0.000022090644],"about_ca_topic_score_codex":0.0011038571,"about_ca_topic_score_gemma":0.0016893583,"teacher_disagreement_score":0.002113866,"about_ca_system_score_codex":0.00052371604,"about_ca_system_score_gemma":0.0002749646,"threshold_uncertainty_score":0.0070716143},"labels":[],"label_agreement":null},{"id":"W2995451675","doi":"10.1111/bjh.16334","title":"Increased cytotoxic potential of CD8<sup>+ </sup>T cells in immune thrombocytopenia","year":2019,"lang":"en","type":"letter","venue":"British Journal of Haematology","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McMaster University","funders":"Canadian Institutes of Health Research; Health Canada; Canadian Blood Services","keywords":"Cytotoxic T cell; Degranulation; CD8; Immunology; Autoantibody; MHC class I; Major histocompatibility complex; Immune system; Immunosurveillance; Platelet; T cell; Biology; Chemistry; Antibody; In vitro; Biochemistry","score_opus":0.009302029730761411,"score_gpt":0.23881200488243873,"score_spread":0.22950997515167731,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2995451675","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99020785,0.004898428,0.00059403514,0.00012094236,0.000054638273,0.000031731775,0.00020379432,0.00007608298,0.0038124735],"genre_scores_gemma":[0.99718374,0.0006246887,0.00042551546,0.00014256831,0.00011906349,0.00004515095,0.00026884672,0.000017240856,0.0011731399],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.999816,0.000038751157,0.000026516595,0.00003972883,0.000034406778,0.000044669177],"domain_scores_gemma":[0.99974424,0.000067308276,0.00007144555,0.000022090308,0.000035965637,0.00005895852],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00025668024,0.00040782962,0.00040102642,0.00097100093,0.00017541174,0.00061347045,0.0002118809,0.00069347525,0.0042055175],"category_scores_gemma":[0.000500179,0.00019430983,0.00016343946,0.0003296762,0.00023798083,0.0004331415,0.0002795604,0.000623637,0.0010550764],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009830324,0.00052794686,0.18951449,0.00096211483,0.00008299519,0.016612118,0.00061525655,0.00043481597,0.6705541,0.000549345,0.0028015194,0.107515],"study_design_scores_gemma":[0.0006948343,0.00605689,0.73862916,0.00037737604,0.0003875628,0.08865385,0.0013581639,0.005179214,0.12764995,0.0029520052,0.028000776,0.000060081675],"about_ca_topic_score_codex":0.000108974615,"about_ca_topic_score_gemma":0.00008652497,"teacher_disagreement_score":0.0042055175,"about_ca_system_score_codex":0.00016605477,"about_ca_system_score_gemma":0.000063440166,"threshold_uncertainty_score":0.014068902},"labels":[],"label_agreement":null},{"id":"W2995608308","doi":"10.1111/bjh.16325","title":"Mixed phenotype acute leukaemia with predominant myeloid blasts and a small subset of B/myeloid blasts shares the same mutation profile","year":2019,"lang":"en","type":"letter","venue":"British Journal of Haematology","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Toronto; University Health Network; University of Ottawa","funders":"Leukemia and Lymphoma Society of Canada; Cancer Research Society","keywords":"Myeloid leukaemia; Myeloid; Phenotype; Mutation; Medicine; Cancer research; Immunology; Biology; Gene; Genetics","score_opus":0.018643480693947053,"score_gpt":0.25187470689634,"score_spread":0.23323122620239295,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2995608308","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98730475,0.0025289655,0.0051479056,0.0004191147,0.000026774971,0.00007506011,0.00026706612,0.00024657897,0.0039838743],"genre_scores_gemma":[0.99671197,0.0004101949,0.001858061,0.00012360704,0.000069598886,0.000019348507,0.00012491604,0.000021692333,0.00066061516],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.9996259,0.00006960918,0.000044417386,0.000095424715,0.000074569085,0.0000899305],"domain_scores_gemma":[0.9993948,0.00013823682,0.0001888351,0.000069602844,0.000044691344,0.00016389608],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00025276543,0.0009952395,0.00062270305,0.0013912434,0.0005094553,0.00088323985,0.00045155312,0.0011237672,0.0024519584],"category_scores_gemma":[0.0011680385,0.00042980685,0.0003153488,0.0008656007,0.00056638964,0.00057262793,0.00077348517,0.0005883732,0.0011631846],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006111529,0.00012379317,0.114924364,0.00031263617,0.00007845828,0.7628802,0.00042261506,0.00035096178,0.09430328,0.0013145412,0.0011147624,0.023563147],"study_design_scores_gemma":[0.000022764754,0.00015974331,0.021614563,0.00001694827,0.000033603785,0.96984273,0.00011644793,0.000557568,0.0049233767,0.00038459696,0.0023170288,0.000010670033],"about_ca_topic_score_codex":0.00031740044,"about_ca_topic_score_gemma":0.00043193798,"teacher_disagreement_score":0.0024519584,"about_ca_system_score_codex":0.00026320794,"about_ca_system_score_gemma":0.00013642371,"threshold_uncertainty_score":0.008202612},"labels":[],"label_agreement":null},{"id":"W2996675598","doi":"10.1111/bjh.16293","title":"Validation of a simplified international prognostic score (IPS‐3) in patients with advanced‐stage classic Hodgkin lymphoma","year":2019,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Francis Xavier University; Spinal Cord Injury BC","funders":"","keywords":"ABVD; Dacarbazine; Vinblastine; Stage (stratigraphy); Medicine; Bleomycin; Internal medicine; Oncology; Brentuximab vedotin; Lymphoma; Neoplasm staging; Hodgkin lymphoma; Chemotherapy; Vincristine; Cancer; Cyclophosphamide","score_opus":0.00815239974218571,"score_gpt":0.23888078609825175,"score_spread":0.23072838635606605,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2996675598","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9898941,0.00030713933,0.0049635842,0.00014806383,0.00003767321,0.000107880645,0.0033187887,0.00006488887,0.001157837],"genre_scores_gemma":[0.9915705,0.00007626327,0.0013907836,0.000045406443,0.00002075881,0.00006401338,0.0066547426,0.000011090047,0.0001663722],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9990086,0.00045395055,0.00006888259,0.00017496411,0.00020029437,0.000093400646],"domain_scores_gemma":[0.9974619,0.0010630519,0.00028522636,0.00044534117,0.00048382833,0.00026060885],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0038298154,0.00053930486,0.0005792497,0.0006790277,0.00023122474,0.0008400513,0.0005653969,0.00040729227,0.001216833],"category_scores_gemma":[0.0099351145,0.0001521444,0.0005169055,0.00060685404,0.00036904815,0.00032555874,0.0009235994,0.0006304029,0.00042843996],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0042447876,0.00021545852,0.8794936,0.00014702416,0.00049817853,0.00030443317,0.0002469382,0.043355495,0.002340762,0.00042975502,0.005211751,0.06351177],"study_design_scores_gemma":[0.00064930605,0.0014876008,0.7957268,0.00009445883,0.00035660018,0.0010978351,0.00022757123,0.18963009,0.001710825,0.0016292098,0.007330602,0.000059129427],"about_ca_topic_score_codex":0.00719541,"about_ca_topic_score_gemma":0.0051820106,"teacher_disagreement_score":0.00719541,"about_ca_system_score_codex":0.0006163882,"about_ca_system_score_gemma":0.00093586225,"threshold_uncertainty_score":0.020254254},"labels":[],"label_agreement":null},{"id":"W2999009584","doi":"10.1111/j.1365-2141.2000.02330.x","title":"Irreversible loss of donor blood leucocyte activation may explain a paucity of transfusion‐associated graft‐versus‐host disease from stored blood","year":2000,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Canadian Blood Services; University of Toronto; University Health Network","funders":"","keywords":"Antigen; Immunology; Blood transfusion; Graft-versus-host disease; Medicine; Lymphocyte; CD28; CD3; Downregulation and upregulation; Disease; Biology; Internal medicine; CD8; Biochemistry","score_opus":0.015869114739918148,"score_gpt":0.24838151109196852,"score_spread":0.23251239635205037,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2999009584","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99397826,0.0031485653,0.0020489288,0.00006674309,0.000022502016,0.000017720191,0.0001360243,0.000029463954,0.0005517286],"genre_scores_gemma":[0.9982759,0.00052595796,0.00044589717,0.00003263425,0.000006045463,0.000012532477,0.0001834085,0.0000052399914,0.00051240536],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99988306,0.000024103427,0.000021139105,0.00002147646,0.0000223443,0.000027937676],"domain_scores_gemma":[0.9998665,0.000025191002,0.00005780847,0.000020760599,0.000012030964,0.000017719249],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00028022673,0.00036497312,0.0002679627,0.00021706684,0.0001299022,0.00044380888,0.00030641304,0.00033744,0.0012367936],"category_scores_gemma":[0.00019965449,0.00013683017,0.00024815506,0.00014991814,0.00021668078,0.00034276073,0.00027377022,0.00046067088,0.00031777011],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00089918886,0.000065494,0.0062660333,0.00013616304,0.000028694925,0.00040708855,0.00006401498,0.00012038289,0.98691016,0.00024437348,0.000048757,0.004809685],"study_design_scores_gemma":[0.00003219489,0.0015458455,0.088146456,0.000048280686,0.00015070564,0.002954544,0.00012367814,0.0012761111,0.90215355,0.00031459102,0.0032397895,0.000014402318],"about_ca_topic_score_codex":0.00019522091,"about_ca_topic_score_gemma":0.0001766092,"teacher_disagreement_score":0.0012367936,"about_ca_system_score_codex":0.00027360112,"about_ca_system_score_gemma":0.00013721063,"threshold_uncertainty_score":0.004137516},"labels":[],"label_agreement":null},{"id":"W3001673888","doi":"10.1111/bjh.16338","title":"Experience with ponatinib in paediatric patients with leukaemia","year":2020,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":35,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; BC Children's Hospital","funders":"","keywords":"Ponatinib; Medicine; Chronic myeloid leukaemia; Pediatrics; Cohort; Lymphoblastic Leukemia; Internal medicine; Disease; Leukemia; Myeloid leukemia; Dasatinib","score_opus":0.010286206791769429,"score_gpt":0.23234594625693816,"score_spread":0.22205973946516874,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3001673888","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.80129224,0.15086874,0.004610676,0.0066937185,0.00035837913,0.00022619733,0.00093431154,0.00010558713,0.034910098],"genre_scores_gemma":[0.9175234,0.07379745,0.002327897,0.0019457209,0.0003740634,0.0000823903,0.0012092816,0.00006244928,0.0026773685],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99950814,0.00019996021,0.00006596435,0.0000599828,0.00010154386,0.000064402244],"domain_scores_gemma":[0.99904734,0.0002978863,0.00020737668,0.00006868296,0.00010389279,0.0002748815],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008196673,0.00023938858,0.0006730587,0.0001156355,0.0003266045,0.00047903688,0.0002586172,0.00030089507,0.002477014],"category_scores_gemma":[0.0033892614,0.00009032422,0.0003691104,0.0005829414,0.0003654914,0.000552331,0.0005087194,0.00087743613,0.00071002933],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003917041,0.00071155245,0.20602359,0.002752153,0.0005755119,0.022588829,0.006422326,0.002428308,0.010875649,0.002536338,0.025927054,0.71524173],"study_design_scores_gemma":[0.0016894774,0.0121995,0.23279363,0.0010498485,0.00068125786,0.21489972,0.0018221586,0.00097592757,0.0058902907,0.0017442098,0.52614653,0.000107451124],"about_ca_topic_score_codex":0.0009156766,"about_ca_topic_score_gemma":0.0014620946,"teacher_disagreement_score":0.002477014,"about_ca_system_score_codex":0.00046398255,"about_ca_system_score_gemma":0.0005376342,"threshold_uncertainty_score":0.008286476},"labels":[],"label_agreement":null},{"id":"W3002741063","doi":"10.1111/bjh.16347","title":"Red cell transfusion in outpatients with myelodysplastic syndromes: a feasibility and exploratory randomised trial","year":2020,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":75,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; University of Toronto; Sunnybrook Health Science Centre","funders":"Medical Research Council; National Institute for Health and Care Research; Cancer Research UK; Australian and New Zealand Society of Blood Transfusion","keywords":"Medicine; Confidence interval; Myelodysplastic syndromes; Population; Quality of life (healthcare); Randomized controlled trial; Blood transfusion; Red Cell; Pediatrics; Internal medicine","score_opus":0.039661416918017875,"score_gpt":0.2762267365054811,"score_spread":0.23656531958746319,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3002741063","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9834696,0.0023403775,0.0006537641,0.0008778019,0.0003536685,0.010979951,0.0002270076,0.000036767447,0.0010610495],"genre_scores_gemma":[0.9800009,0.0014574303,0.002444664,0.0008750617,0.00034906415,0.013542415,0.00020642529,0.0000071583427,0.0011168807],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9962702,0.00299098,0.00017788436,0.00019750993,0.00015525502,0.00020823283],"domain_scores_gemma":[0.9961991,0.0017399228,0.0008379461,0.00028534135,0.00015715513,0.00078063755],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0045602093,0.0010601499,0.0021930188,0.00036576152,0.0004694036,0.00097293407,0.0007602275,0.002263511,0.004258148],"category_scores_gemma":[0.0064213057,0.00050183106,0.0014179413,0.0005381325,0.001423643,0.0008967197,0.0007963967,0.0021182287,0.00048752682],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9674144,0.010510339,0.0011618962,0.0008315588,0.00035807624,0.00010904037,0.00018474564,0.0003489009,0.0012321774,0.00016672241,0.00028787358,0.017394304],"study_design_scores_gemma":[0.8739152,0.12285131,0.001998051,0.00008311342,0.00017982724,0.000039410803,0.00005648902,0.00020661624,0.000095190546,0.00018756924,0.0003752251,0.00001200605],"about_ca_topic_score_codex":0.00080271176,"about_ca_topic_score_gemma":0.0014701415,"teacher_disagreement_score":0.0045602093,"about_ca_system_score_codex":0.0007563002,"about_ca_system_score_gemma":0.001965085,"threshold_uncertainty_score":0.024116933},"labels":[],"label_agreement":null},{"id":"W3004714210","doi":"10.1111/bjh.16462","title":"Primary analysis of JUMP, a phase 3b, expanded‐access study evaluating the safety and efficacy of ruxolitinib in patients with myelofibrosis, including those with low platelet counts","year":2020,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":113,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; St. Paul's Hospital; University of British Columbia","funders":"AOP Orphan; Incyte; Baxalta; Pfizer; Novartis Pharmaceuticals Corporation; Celgene; Alexion Pharmaceuticals; Amgen; Ariad Pharmaceuticals; Teva Pharmaceutical Industries; Gilead Sciences; Sanofi; Bristol-Myers Squibb","keywords":"Ruxolitinib; Medicine; Myelofibrosis; Discontinuation; Internal medicine; Cohort; Adverse effect; Bone marrow","score_opus":0.04091387740162374,"score_gpt":0.35841570427673825,"score_spread":0.3175018268751145,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3004714210","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9763668,0.0040632915,0.0009559669,0.00035725077,0.000109795954,0.0022407013,0.01223255,0.00011068875,0.003562964],"genre_scores_gemma":[0.97405905,0.0007505064,0.00115272,0.00067640113,0.0003239412,0.0029848341,0.017473485,0.00004368421,0.0025353604],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9980737,0.0007753248,0.00016062736,0.0004069517,0.00040946153,0.00017394281],"domain_scores_gemma":[0.9960129,0.0013505688,0.0011144176,0.00038428782,0.0006060656,0.0005317362],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00533472,0.0010805004,0.002211657,0.00056230166,0.000613068,0.0009998208,0.00053637504,0.000731394,0.0052958154],"category_scores_gemma":[0.0032010041,0.00039299388,0.0027894727,0.0005336468,0.0004336065,0.0006809692,0.00070779474,0.0013067811,0.0007844162],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.701011,0.0050122025,0.18332945,0.0055115777,0.017768152,0.0006725816,0.00029886028,0.0020243153,0.022691585,0.0006371948,0.019690817,0.04135227],"study_design_scores_gemma":[0.14300579,0.10847553,0.69391495,0.0003331223,0.023772573,0.0013003987,0.00019067967,0.004152238,0.005563556,0.0011035089,0.018026395,0.00016126879],"about_ca_topic_score_codex":0.00070499897,"about_ca_topic_score_gemma":0.0026589204,"teacher_disagreement_score":0.00533472,"about_ca_system_score_codex":0.00053441135,"about_ca_system_score_gemma":0.0012206278,"threshold_uncertainty_score":0.028213024},"labels":[],"label_agreement":null},{"id":"W3007287792","doi":"10.1111/bjh.16377","title":"Advances in knowledge of inhibitor formation in severe haemophilia A","year":2020,"lang":"en","type":"review","venue":"British Journal of Haematology","topic":"Hemophilia Treatment and Research","field":"Medicine","cited_by":41,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Haemophilia; Haemophilia A; Medicine; Antibody; Immunology; Alloimmunity; Bioinformatics; Biology; Pediatrics","score_opus":0.04295337339649063,"score_gpt":0.37313078340151085,"score_spread":0.3301774100050202,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3007287792","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00006574117,0.99898726,0.0000488362,0.00021526407,0.000113734946,0.0000018577443,0.000013078539,0.0000037710902,0.0005504391],"genre_scores_gemma":[0.00046319395,0.9989832,0.000084683845,0.000115102266,0.000106686864,0.000002313784,0.000019885525,8.0909433e-7,0.00022420984],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9997379,0.000048368784,0.0000492923,0.0000426919,0.00009978898,0.000021898559],"domain_scores_gemma":[0.99925476,0.00044674473,0.00009554705,0.000018599289,0.0001462745,0.000038107548],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00076239556,0.00061789074,0.0014307759,0.0023988774,0.0002292812,0.0011625931,0.00065646606,0.00093577756,0.005715866],"category_scores_gemma":[0.0013329973,0.00027378954,0.00058188004,0.0024336458,0.00044462888,0.0011755147,0.00064514275,0.0016548856,0.0021550837],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007814634,0.00003824122,0.00016773539,0.037235595,0.00010835224,0.00020491052,0.00008886705,0.0002577965,0.0010012161,0.0036376033,0.024303615,0.932878],"study_design_scores_gemma":[0.000013225816,0.00006278938,0.0008636703,0.006538862,0.00015678426,0.0010809612,0.000058734026,0.000052451487,0.00024224403,0.0017018797,0.98921293,0.00001540119],"about_ca_topic_score_codex":0.0016993952,"about_ca_topic_score_gemma":0.0021609755,"teacher_disagreement_score":0.005715866,"about_ca_system_score_codex":0.00073071325,"about_ca_system_score_gemma":0.0012644237,"threshold_uncertainty_score":0.019121528},"labels":[],"label_agreement":null},{"id":"W3007882742","doi":"10.1111/bjh.16533","title":"Anti‐myeloma potential of ruxolitinib in co‐existing <i>JAK2V617F</i>‐positive smouldering myeloma and polycythaemia vera","year":2020,"lang":"en","type":"letter","venue":"British Journal of Haematology","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Foothills Medical Centre; University of Calgary","funders":"","keywords":"Polycythaemia; Polycythemia vera; Multiple myeloma; Ruxolitinib; Medicine; Internal medicine; Oncology; Cancer research; Dermatology; Myelofibrosis; Bone marrow","score_opus":0.020054852191899845,"score_gpt":0.2821120807715569,"score_spread":0.2620572285796571,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3007882742","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9874888,0.010007524,0.00025666005,0.00023969317,0.00007614698,0.000028854212,0.00008244153,0.00005642704,0.001763452],"genre_scores_gemma":[0.9977574,0.0014043197,0.00014218826,0.00012941968,0.000034448367,0.000008665899,0.00014927317,0.000004004995,0.00037044176],"study_design_codex":"bench_or_experimental","study_design_gemma":"case_report","domain_scores_codex":[0.9998784,0.00002618372,0.000010565044,0.00002258474,0.000027272396,0.00003494172],"domain_scores_gemma":[0.9999273,0.000015611804,0.000019358791,0.000007731861,0.0000079870015,0.000022128135],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023739274,0.00021057825,0.0005765609,0.0002214567,0.00018115,0.00054715975,0.00021061701,0.00029109488,0.0009890245],"category_scores_gemma":[0.00028602444,0.00011933132,0.00029939963,0.00012224335,0.00013392886,0.00024356773,0.00022176966,0.0006022889,0.00028962054],"study_design_candidate":"case_report","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.022046808,0.0033526793,0.03382352,0.0008769648,0.0005370224,0.0057428107,0.00019151375,0.00098861,0.6121849,0.0005719017,0.00462473,0.31505847],"study_design_scores_gemma":[0.0092732115,0.06741355,0.2978545,0.0003010165,0.003537926,0.04973075,0.00043877264,0.014920274,0.46904296,0.00087223575,0.08645283,0.00016199419],"about_ca_topic_score_codex":0.0004292674,"about_ca_topic_score_gemma":0.0009968532,"teacher_disagreement_score":0.0009890245,"about_ca_system_score_codex":0.00020217436,"about_ca_system_score_gemma":0.00019641736,"threshold_uncertainty_score":0.0033085942},"labels":[],"label_agreement":null},{"id":"W3008934723","doi":"10.1111/bjh.16304","title":"Failure of rituximab is associated with a poor outcome in diffuse large B cell lymphoma‐type post‐transplant lymphoproliferative disorder","year":2020,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Viral-associated cancers and disorders","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre; CancerCare Manitoba; University of Alberta; Princess Margaret Cancer Centre; Toronto General Hospital; University Health Network; University of Toronto; Spinal Cord Injury BC","funders":"Alberta Innovates - Health Solutions; European Hematology Association","keywords":"Rituximab; Medicine; Internal medicine; Diffuse large B-cell lymphoma; Post-transplant lymphoproliferative disorder; CHOP; Lymphoma; Gastroenterology; Induction chemotherapy; Oncology; Chemotherapy","score_opus":0.009618416916319015,"score_gpt":0.23823553398621125,"score_spread":0.22861711706989224,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3008934723","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9992505,0.00044544507,0.000047849768,0.000030887037,0.000004694515,0.0000021626497,0.000034716297,0.0000029481425,0.0001808632],"genre_scores_gemma":[0.9997992,0.000070109236,0.000011737286,0.000018396424,0.0000111925665,0.000001478691,0.000049142956,9.8075e-7,0.00003777585],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.999613,0.00011471267,0.00005152121,0.00008444632,0.00006442031,0.00007188223],"domain_scores_gemma":[0.99742967,0.0004398652,0.0015076537,0.00015567396,0.00011730487,0.00034976343],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006512931,0.00021720743,0.000421217,0.00043547445,0.00032285452,0.00058950874,0.00023794292,0.00039223448,0.0009855251],"category_scores_gemma":[0.0023738197,0.00017824836,0.0003470747,0.00045666163,0.00033989717,0.00030136303,0.0003384268,0.000591445,0.00023896717],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00092951435,0.000042098818,0.99396545,0.000013911543,0.00009085639,0.00041548852,0.00003916971,0.00007637585,0.00093319337,0.000014643828,0.000097447344,0.0033818674],"study_design_scores_gemma":[0.000032312993,0.000475413,0.9964958,0.000009380562,0.00008755623,0.0021409055,0.0000582231,0.00018639515,0.00022734911,0.000035566332,0.0002451656,0.000005943402],"about_ca_topic_score_codex":0.0006477096,"about_ca_topic_score_gemma":0.00062905945,"teacher_disagreement_score":0.0009855251,"about_ca_system_score_codex":0.00021784996,"about_ca_system_score_gemma":0.00017114394,"threshold_uncertainty_score":0.0034444332},"labels":[],"label_agreement":null},{"id":"W3009416494","doi":"10.1111/bjh.16553","title":"Platelet factor 4 inhibits ADAMTS13 activity and regulates the multimeric distribution of von Willebrand factor","year":2020,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Complement system in diseases","field":"Immunology and Microbiology","cited_by":28,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Blood Services; McMaster University","funders":"Canadian Institutes of Health Research","keywords":"ADAMTS13; Von Willebrand factor; Thrombotic thrombocytopenic purpura; Platelet; Platelet factor 4; Thrombus; Chemistry; Internal medicine; Immunology; Molecular biology; Medicine; Biology","score_opus":0.017537134773179575,"score_gpt":0.23606936631349137,"score_spread":0.2185322315403118,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3009416494","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99286544,0.0037879108,0.001526253,0.0001099615,0.000027258602,0.000012585902,0.000056690358,0.00003410186,0.0015798165],"genre_scores_gemma":[0.9964695,0.0009187907,0.0006061864,0.000039009272,0.000018478802,0.000010288337,0.00009179415,0.000009916378,0.0018359836],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998363,0.000054913715,0.000006534472,0.000012729007,0.000026901165,0.00006252699],"domain_scores_gemma":[0.9999006,0.00003202702,0.000019755751,0.00000970307,0.000015331878,0.000022522521],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013183037,0.00025604694,0.00020698753,0.00029902192,0.00018601422,0.00023187623,0.00017864958,0.00020843148,0.0014777066],"category_scores_gemma":[0.00031830135,0.000091227754,0.00025879184,0.00012293068,0.00022481728,0.00012162803,0.00014252112,0.0002515005,0.00021933035],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006954336,0.00007580169,0.0013463575,0.00005762829,0.000025751295,0.00015413073,0.000025300082,0.00013573235,0.99009365,0.00022587276,0.00016351053,0.0070008296],"study_design_scores_gemma":[0.000081789985,0.0015941621,0.028817868,0.000009412789,0.000053497824,0.00064502173,0.00004197827,0.0014523494,0.9616753,0.00037738492,0.00524372,0.0000076186384],"about_ca_topic_score_codex":0.0014591938,"about_ca_topic_score_gemma":0.00082060596,"teacher_disagreement_score":0.0014777066,"about_ca_system_score_codex":0.0002852725,"about_ca_system_score_gemma":0.00026450126,"threshold_uncertainty_score":0.00494349},"labels":[],"label_agreement":null},{"id":"W3010413675","doi":"10.1111/bjh.16445","title":"Androgen therapy in inherited bone marrow failure syndromes: analysis from the Canadian Inherited Marrow Failure Registry","year":2020,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Blood disorders and treatments","field":"Biochemistry, Genetics and Molecular Biology","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Alberta; Centre hospitalier universitaire de Québec; Janeway Children's Health and Rehabilitation Centre; Princess Margaret Cancer Centre; Kingston General Hospital; Centre Hospitalier Universitaire de Sherbrooke; McMaster University; London Health Sciences Centre; Centre Hospitalier Universitaire Sainte-Justine; Children's Hospital of Eastern Ontario; CancerCare Manitoba; Capital District Health Authority; Izaak Walton Killam Health Centre; Alberta Children's Hospital; University of Toronto; Royal University Hospital; Montreal Children's Hospital; University of Manitoba; BC Children's Hospital; SickKids Foundation; Hospital for Sick Children","funders":"","keywords":"Cytopenia; Medicine; Danazol; Bone marrow failure; Bone marrow; Bone Marrow Aplasia; Internal medicine; Endometriosis; Biology; Genetics","score_opus":0.012986223251701196,"score_gpt":0.22505769687738678,"score_spread":0.21207147362568557,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3010413675","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9214157,0.0035934097,0.00023427783,0.00059118035,0.000020608793,0.00020138544,0.064873226,0.00004447379,0.009025701],"genre_scores_gemma":[0.9563509,0.0034235714,0.0006198905,0.00020749163,0.00002302819,0.00012819788,0.037827753,0.000025066929,0.0013940695],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99741983,0.00014120116,0.00019132467,0.00019760948,0.0017146218,0.00033542933],"domain_scores_gemma":[0.99395424,0.00041846547,0.0016096268,0.00021236752,0.0030915593,0.00071362825],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010895219,0.00030002938,0.00047609067,0.0048465203,0.0011644945,0.00068740454,0.0008952649,0.00035110943,0.0029866444],"category_scores_gemma":[0.00431092,0.00022288828,0.000484813,0.010696421,0.00030824842,0.00020352514,0.0006999796,0.00039284836,0.0004231689],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015140792,0.000019419525,0.9869183,0.00008378837,0.00006661246,0.00026831895,0.00015395468,0.00012715581,0.00024504456,0.00009471405,0.0039396086,0.00793163],"study_design_scores_gemma":[0.000010616503,0.0000188695,0.99659294,0.00003187009,0.000029295443,0.0002496092,0.00010652399,0.00009254551,0.00005939372,0.000009864104,0.0027894697,0.000008891408],"about_ca_topic_score_codex":0.92772293,"about_ca_topic_score_gemma":0.9336105,"teacher_disagreement_score":0.07227707,"about_ca_system_score_codex":0.0070044356,"about_ca_system_score_gemma":0.014353961,"threshold_uncertainty_score":0.14540541},"labels":[],"label_agreement":null},{"id":"W3016576844","doi":"10.1111/bjh.16635","title":"Statin and cyclooxygenase‐2 inhibitors improve survival in newly diagnosed diffuse large B‐cell lymphoma: a large population‐based study of 4913 subjects","year":2020,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Cancer, Lipids, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":34,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Toronto; Health Sciences Centre; Sunnybrook Health Science Centre","funders":"Institute of Chemical and Engineering Sciences; Ontario Ministry of Health and Long-Term Care","keywords":"Diffuse large B-cell lymphoma; Cyclooxygenase; Statin; Medicine; Lymphoma; Internal medicine; Population; Oncology; Chemistry; Enzyme","score_opus":0.007064698358016912,"score_gpt":0.23354987644474418,"score_spread":0.22648517808672727,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3016576844","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9984407,0.00038485913,0.000053592976,0.000024460976,0.0000034060065,0.000014802301,0.00090492633,0.0000029760236,0.0001703337],"genre_scores_gemma":[0.99887687,0.00017921114,0.000052693704,0.0000423592,0.000008221022,0.000013010791,0.00069430936,0.0000017907394,0.00013156998],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99944824,0.000101959886,0.000051796414,0.00018623847,0.000105911146,0.00010583603],"domain_scores_gemma":[0.9991283,0.00010888286,0.00035748398,0.00009853449,0.0001307271,0.00017607215],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00051826914,0.00036089285,0.00048124383,0.0004468948,0.0007729344,0.0006885664,0.0004917048,0.00047488257,0.00097382383],"category_scores_gemma":[0.0011732649,0.00046584697,0.0006500497,0.0014953151,0.00034602097,0.00033347646,0.00042072436,0.0005522567,0.00022835813],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00022043897,0.00003493447,0.9986247,0.000011711473,0.000118030635,0.00003292156,0.000054734046,0.000017139577,0.00013571451,0.0000051595416,0.00010513011,0.0006394312],"study_design_scores_gemma":[0.000030042127,0.00006971488,0.99940383,0.0000046711402,0.00008924819,0.0000609773,0.00006507338,0.00006268087,0.00002753221,0.000005787467,0.00017771972,0.0000027782291],"about_ca_topic_score_codex":0.13789615,"about_ca_topic_score_gemma":0.18200836,"teacher_disagreement_score":0.13789615,"about_ca_system_score_codex":0.0013946726,"about_ca_system_score_gemma":0.0011073521,"threshold_uncertainty_score":0.27418703},"labels":[],"label_agreement":null},{"id":"W3018389620","doi":"10.1111/bjh.16694","title":"Thrombotic microangiopathy in pregnancy: when you hear hoofbeats, consider the zebras?","year":2020,"lang":"en","type":"letter","venue":"British Journal of Haematology","topic":"Complement system in diseases","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Lunenfeld-Tanenbaum Research Institute; Mount Sinai Hospital","funders":"","keywords":"Thrombotic microangiopathy; ADAMTS13; HELLP syndrome; Medicine; Thrombotic thrombocytopenic purpura; Preeclampsia; Pregnancy; Eclampsia; Acute kidney injury; Antiphospholipid syndrome; Gastroenterology; Alternative complement pathway; Nephropathy; Internal medicine; Immunology; Complement system; Platelet; Endocrinology; Disease; Biology; Thrombosis; Immune system","score_opus":0.026115423843351925,"score_gpt":0.24706009837492884,"score_spread":0.22094467453157693,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3018389620","genre_codex":"commentary","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"editorial","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.05200539,0.33715945,0.0027740598,0.541942,0.026579024,0.00018247723,0.0003566224,0.00036353356,0.038637403],"genre_scores_gemma":[0.37275052,0.32663167,0.0045092464,0.19593175,0.07269357,0.00017807078,0.00044562187,0.00016234253,0.026697276],"study_design_codex":"not_applicable","study_design_gemma":"case_report","domain_scores_codex":[0.999542,0.00015624888,0.00004803012,0.00005957436,0.000106878855,0.00008731096],"domain_scores_gemma":[0.9991357,0.00036824963,0.00012422554,0.000025566927,0.00015128392,0.00019508356],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00048364938,0.00047093956,0.00056268816,0.0008013452,0.0011213687,0.0019655854,0.00057305733,0.00391559,0.0054803845],"category_scores_gemma":[0.0077873943,0.0002198607,0.00025702163,0.00054571364,0.001025911,0.00265258,0.0007084568,0.0036415362,0.0014526726],"study_design_candidate":"case_report","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00040963854,0.00020370375,0.037428696,0.0016429127,0.00007089387,0.14417864,0.0064282557,0.00015720948,0.0012054399,0.0054123034,0.44764176,0.35522056],"study_design_scores_gemma":[0.00009181803,0.000300259,0.030393591,0.0076688384,0.00014357982,0.53871006,0.015329444,0.00040384298,0.00037452162,0.017717639,0.3887033,0.00016306977],"about_ca_topic_score_codex":0.0046798717,"about_ca_topic_score_gemma":0.00570703,"teacher_disagreement_score":0.0054803845,"about_ca_system_score_codex":0.00076104724,"about_ca_system_score_gemma":0.0010034168,"threshold_uncertainty_score":0.018333673},"labels":[],"label_agreement":null},{"id":"W3022891390","doi":"10.1111/bjh.16768","title":"Concomitant haemorrhagic syndrome and recurrent extensive arterial thrombosis in a patient with COVID‐19 and acute promyelocytic leukaemia","year":2020,"lang":"en","type":"letter","venue":"British Journal of Haematology","topic":"COVID-19 Clinical Research Studies","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Acute promyelocytic leukemia; Concomitant; Ecchymosis; Gastroenterology; Internal medicine; Coagulopathy; Pallor; Atypical pneumonia; Pathology; Pneumonia","score_opus":0.039895434079188434,"score_gpt":0.34992987390033903,"score_spread":0.3100344398211506,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3022891390","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98717064,0.0032378014,0.00096650486,0.0018845501,0.00016802219,0.00011445689,0.00015748512,0.000064339714,0.0062362305],"genre_scores_gemma":[0.9977629,0.00056789303,0.00036840324,0.00042815725,0.0003403182,0.000011796989,0.0000612684,0.0000049532864,0.00045441822],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.9993729,0.00011044464,0.000087758555,0.00014914172,0.000094728406,0.00018499243],"domain_scores_gemma":[0.9989183,0.00028549874,0.00024890437,0.00007696459,0.00005627167,0.00041405385],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00043642594,0.0012227847,0.0009928354,0.0017893618,0.0015618125,0.0011865529,0.00061303994,0.0028842925,0.002476564],"category_scores_gemma":[0.0031395033,0.0008669763,0.0006601983,0.0009825531,0.0012236399,0.0012648158,0.0010335196,0.0022565918,0.0005989824],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002203372,0.00005241569,0.042932976,0.000036799993,0.000019540492,0.95336044,0.00036130458,0.000051049894,0.0010424409,0.00015779276,0.00022953085,0.0015352875],"study_design_scores_gemma":[0.000024760926,0.00023918149,0.023090098,0.00001763014,0.000022181923,0.97532743,0.00020080169,0.0001871433,0.00021679995,0.00014066817,0.00051984005,0.000013435027],"about_ca_topic_score_codex":0.001531396,"about_ca_topic_score_gemma":0.0016834001,"teacher_disagreement_score":0.0028842925,"about_ca_system_score_codex":0.000745803,"about_ca_system_score_gemma":0.00057802314,"threshold_uncertainty_score":0.008284986},"labels":[],"label_agreement":null},{"id":"W3024646314","doi":"10.1111/bjh.16731","title":"Thromboprophylaxis in patients with multiple myeloma","year":2020,"lang":"en","type":"letter","venue":"British Journal of Haematology","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; University of Ottawa","funders":"","keywords":"Medicine; Rivaroxaban; Apixaban; Aspirin; Internal medicine; Malignancy; Cancer; Population; Ambulatory; Low molecular weight heparin; Randomized controlled trial; Intensive care medicine; Heparin; Surgery; Warfarin","score_opus":0.008775893951695805,"score_gpt":0.21603038267171465,"score_spread":0.20725448872001884,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3024646314","genre_codex":"empirical","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9043507,0.068327695,0.00029371656,0.008489103,0.00034791365,0.000112276364,0.002047409,0.000044492535,0.015986662],"genre_scores_gemma":[0.9868645,0.0091327885,0.00021871043,0.00188445,0.00055382657,0.000057092235,0.00062950136,0.0000039877427,0.0006550874],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.99950016,0.00011523532,0.0000800772,0.0000676211,0.00014905818,0.0000878151],"domain_scores_gemma":[0.9990921,0.00014294362,0.00049932546,0.0000211983,0.0000764801,0.00016808392],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00032427072,0.00018894962,0.00052612665,0.00065165595,0.00074786687,0.00064232846,0.00021295658,0.0005042309,0.0039336616],"category_scores_gemma":[0.0028236546,0.00015106758,0.00038130954,0.0017402305,0.00017743357,0.00048147023,0.0003605438,0.0012196015,0.00033845406],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00041293856,0.00015829712,0.96804976,0.00025993932,0.00015291934,0.0010502153,0.000184533,0.000058823625,0.00019593089,0.00014153845,0.003845797,0.025489287],"study_design_scores_gemma":[0.00009806736,0.00027330342,0.9867595,0.00031653358,0.00017779107,0.0062286677,0.0003764515,0.00022411862,0.00007060637,0.00034985255,0.005110662,0.000014562558],"about_ca_topic_score_codex":0.0045600687,"about_ca_topic_score_gemma":0.0035517833,"teacher_disagreement_score":0.0045600687,"about_ca_system_score_codex":0.0005606653,"about_ca_system_score_gemma":0.000695587,"threshold_uncertainty_score":0.013159454},"labels":[],"label_agreement":null},{"id":"W3024682048","doi":"10.1111/bjh.16695","title":"Anticoagulation prophylaxis reduces venous thromboembolism rate in adult acute lymphoblastic leukaemia treated with asparaginase‐based therapy","year":2020,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":26,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta; Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"","keywords":"Medicine; Pulmonary embolism; Deep vein; Thrombosis; Asparaginase; Odds ratio; Low molecular weight heparin; Internal medicine; Cohort; Venous thrombosis; Confidence interval; Incidence (geometry); Chemotherapy; Surgery; Retrospective cohort study; Complication; Lymphoblastic Leukemia; Leukemia","score_opus":0.01907587033070731,"score_gpt":0.2739000290572717,"score_spread":0.2548241587265644,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3024682048","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9965779,0.0028770717,0.00007606614,0.000094777766,0.000010507018,0.000011691439,0.000043356024,0.0000060098514,0.00030271927],"genre_scores_gemma":[0.9988732,0.00081362296,0.000096537864,0.00006284961,0.000017183716,0.000007688082,0.000079388905,0.0000013475817,0.000048202484],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99937254,0.00029837995,0.000094729636,0.000060049068,0.0001329963,0.00004144482],"domain_scores_gemma":[0.9988066,0.00032390043,0.00062048447,0.00005248768,0.00005788233,0.00013871417],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006389076,0.00013217199,0.0005864098,0.0003188824,0.00009957636,0.0004055823,0.00014058825,0.0002300735,0.00051397976],"category_scores_gemma":[0.0045191078,0.00010083701,0.00041653024,0.00054397597,0.00008914211,0.0001942189,0.00014515968,0.0004007039,0.00009055708],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005883084,0.00062048633,0.9234338,0.00013463508,0.00054731435,0.00026496596,0.00012163543,0.00030465215,0.0024603806,0.00006421154,0.00061713986,0.06554775],"study_design_scores_gemma":[0.0004951041,0.00365759,0.99196786,0.000041828745,0.0004394609,0.00082894013,0.000046857323,0.00069819635,0.000547487,0.00006818364,0.0012033738,0.0000052023042],"about_ca_topic_score_codex":0.00070204027,"about_ca_topic_score_gemma":0.0006254528,"teacher_disagreement_score":0.00070204027,"about_ca_system_score_codex":0.0002488327,"about_ca_system_score_gemma":0.0002840748,"threshold_uncertainty_score":0.003378868},"labels":[],"label_agreement":null},{"id":"W3025928387","doi":"10.1111/bjh.16815","title":"COVID‐19 and myeloma: what are the implications for now and in the future?","year":2020,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"COVID-19 and healthcare impacts","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Spinal Cord Injury BC; University of British Columbia; BC Cancer Agency","funders":"","keywords":"Pandemic; Coronavirus disease 2019 (COVID-19); 2019-20 coronavirus outbreak; Multiple myeloma; Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2); Medicine; Intensive care medicine; Health care; Disease; Virology; Immunology; Internal medicine; Economic growth; Economics; Infectious disease (medical specialty)","score_opus":0.06370502020138194,"score_gpt":0.3764738029191794,"score_spread":0.3127687827177975,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3025928387","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0047583375,0.30327052,0.0002182308,0.6782504,0.003962943,0.000012140437,0.00034764616,0.00002238465,0.009157435],"genre_scores_gemma":[0.13142176,0.701911,0.0014529076,0.14283744,0.0156324,0.000069498084,0.00064583245,0.000051725063,0.0059774383],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99741566,0.0011039315,0.00016669606,0.00019309144,0.00052854535,0.0005920812],"domain_scores_gemma":[0.99261487,0.0028375818,0.0008334277,0.0001549714,0.0012134191,0.0023457038],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003973134,0.00035297056,0.0007932497,0.00084469473,0.0018663183,0.0057290047,0.0009288148,0.0048303017,0.020694913],"category_scores_gemma":[0.014269285,0.0002548888,0.00092313974,0.0014579903,0.0022403565,0.0062408927,0.0029816634,0.006688402,0.0027079312],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000855215,0.00033101471,0.025448164,0.003826442,0.00029892812,0.0014197148,0.0023158898,0.00067353086,0.0004563718,0.051572762,0.41494584,0.4978562],"study_design_scores_gemma":[0.000087225904,0.00036928683,0.03921604,0.016519126,0.0002563817,0.0022320976,0.013634704,0.00032001777,0.00026089317,0.07339555,0.8535002,0.00020850604],"about_ca_topic_score_codex":0.01662659,"about_ca_topic_score_gemma":0.02600922,"teacher_disagreement_score":0.020694913,"about_ca_system_score_codex":0.0033559212,"about_ca_system_score_gemma":0.007844169,"threshold_uncertainty_score":0.06923139},"labels":[],"label_agreement":null},{"id":"W3026628563","doi":"10.1111/bjh.16736","title":"Triage tool for the rationing of blood for massively bleeding patients during a severe national blood shortage: guidance from the National Blood Transfusion Committee","year":2020,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Blood donation and transfusion practices","field":"Business, Management and Accounting","cited_by":47,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Health Sciences Centre; University of Toronto; Sunnybrook Health Science Centre","funders":"","keywords":"Economic shortage; Triage; Rationing; Medicine; Blood transfusion; Pandemic; Intensive care medicine; Medical emergency; Transfusion medicine; Blood supply; Business; Health care; Coronavirus disease 2019 (COVID-19); Emergency medicine; Surgery; Economics","score_opus":0.026887631576474176,"score_gpt":0.24674203496198513,"score_spread":0.21985440338551096,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3026628563","genre_codex":"commentary","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0052225604,0.013028831,0.050361197,0.78860426,0.010540167,0.006132633,0.0012745335,0.0022454027,0.12259048],"genre_scores_gemma":[0.07217434,0.032676034,0.5604723,0.16746391,0.006381135,0.01193312,0.003790063,0.00094938144,0.14415972],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9681465,0.016415535,0.0042911237,0.00059099,0.008372529,0.0021832613],"domain_scores_gemma":[0.93743354,0.020856155,0.0051435274,0.0016998531,0.026737807,0.008129082],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.03149449,0.0012616917,0.0014075736,0.0038022103,0.002975502,0.0057484037,0.0040413197,0.011573637,0.008168166],"category_scores_gemma":[0.073942274,0.0010780642,0.0017185083,0.0017801558,0.0030357318,0.0038934723,0.004749465,0.010157022,0.008799311],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00005298378,0.00019924868,0.0015453446,0.00032036484,0.000014671058,0.00048839883,0.0018918209,0.0013183312,0.00036806596,0.008530151,0.9179362,0.0673343],"study_design_scores_gemma":[0.00013150065,0.00015766286,0.0038212696,0.0031223933,0.000033406282,0.00059919106,0.002241104,0.0021202457,0.00046057935,0.009365983,0.97778577,0.0001609334],"about_ca_topic_score_codex":0.04521015,"about_ca_topic_score_gemma":0.06294564,"teacher_disagreement_score":0.04521015,"about_ca_system_score_codex":0.0074572186,"about_ca_system_score_gemma":0.06284063,"threshold_uncertainty_score":0.16656071},"labels":[],"label_agreement":null},{"id":"W3026834368","doi":"10.1111/bjh.16711","title":"Pharmacokinetic and pharmacodynamic effects of ravulizumab and eculizumab on complement component 5 in adults with paroxysmal nocturnal haemoglobinuria: results of two phase 3 randomised, multicentre studies","year":2020,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Complement system in diseases","field":"Immunology and Microbiology","cited_by":65,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; University of Toronto; Sunnybrook Health Science Centre","funders":"Alexion Pharmaceuticals","keywords":"Eculizumab; Pharmacodynamics; Pharmacokinetics; Medicine; Complement component 5; Pharmacology; Internal medicine; Antibody; Immunology; Complement system","score_opus":0.015201525832797956,"score_gpt":0.29815317506785755,"score_spread":0.2829516492350596,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3026834368","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99600476,0.002957863,0.00028670422,0.00009705542,0.00002060496,0.00021410642,0.000120950404,0.000022144444,0.00027578362],"genre_scores_gemma":[0.9977502,0.0007774269,0.000562356,0.00019770603,0.000060438735,0.0002192505,0.00022977409,0.000007891291,0.00019494815],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9982711,0.001033656,0.00015038234,0.00022072163,0.00020364627,0.000120519464],"domain_scores_gemma":[0.99801505,0.0008025197,0.00055564736,0.00013730205,0.0001122853,0.0003771551],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0038597554,0.0007788334,0.0018880625,0.00023082891,0.00019030007,0.00065788307,0.0004986899,0.0010941129,0.00088472856],"category_scores_gemma":[0.0036497544,0.00054718246,0.0013582504,0.00025522072,0.00051262864,0.00078848377,0.00029336585,0.001381445,0.00024363834],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.82528776,0.00945698,0.014186979,0.00093433587,0.0028825128,0.00022010693,0.0005809637,0.0015516415,0.043515597,0.00013114612,0.00078907254,0.10046282],"study_design_scores_gemma":[0.3551724,0.46912467,0.15956837,0.00006174094,0.0027763506,0.0006936873,0.00012041252,0.0030140968,0.0066410974,0.00023238828,0.0024965801,0.00009827577],"about_ca_topic_score_codex":0.00050232525,"about_ca_topic_score_gemma":0.00074792287,"teacher_disagreement_score":0.0038597554,"about_ca_system_score_codex":0.0007514445,"about_ca_system_score_gemma":0.00053540483,"threshold_uncertainty_score":0.020412624},"labels":[],"label_agreement":null},{"id":"W3027036348","doi":"10.1111/bjh.16756","title":"Checkpoint blockade treatment sensitises relapsed/refractory non‐Hodgkin lymphoma to subsequent therapy","year":2020,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":24,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"Pharmacyclics; Genentech; Incyte; Astex Pharmaceuticals; Adaptive Biotechnologies; Gilead Sciences; Celgene; AstraZeneca; Bristol-Myers Squibb; TG Therapeutics; Pfizer; Regeneron Pharmaceuticals; American Cancer Society","keywords":"Medicine; Internal medicine; Refractory (planetary science); Regimen; Salvage therapy; Chemotherapy; Oncology; Lymphoma; Surgery","score_opus":0.03151984129911549,"score_gpt":0.275926385001685,"score_spread":0.24440654370256948,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3027036348","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9986994,0.0007846337,0.000047272217,0.000010899883,0.000002302716,0.00001607364,0.000031809028,0.000004405211,0.00040319306],"genre_scores_gemma":[0.9994455,0.00028327567,0.000052544256,0.000033051187,0.00000997254,0.000006134916,0.00008382226,0.0000017535357,0.00008384265],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99938655,0.00027673473,0.00007134504,0.00007465965,0.0001097718,0.00008099022],"domain_scores_gemma":[0.9981669,0.0007281318,0.0007799063,0.00013150607,0.00006852211,0.00012503969],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008304897,0.000090254216,0.00037718783,0.00044345515,0.00015276746,0.0004598307,0.00014937208,0.0001696322,0.0012071191],"category_scores_gemma":[0.0021165563,0.00009966975,0.00026765984,0.00045592006,0.0002220845,0.00018743641,0.0002186205,0.0002360273,0.00017558612],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001257176,0.00009317679,0.96356225,0.0000897796,0.00009650031,0.0005759382,0.00015856708,0.00009778561,0.0031402544,0.000025146373,0.000115872725,0.030787691],"study_design_scores_gemma":[0.00004288494,0.0010616808,0.9959798,0.000018581342,0.0000651972,0.0014036298,0.00008728095,0.00010261753,0.0005494623,0.000021030373,0.00066438486,0.0000034819673],"about_ca_topic_score_codex":0.00070843485,"about_ca_topic_score_gemma":0.0015645936,"teacher_disagreement_score":0.0012071191,"about_ca_system_score_codex":0.00026361807,"about_ca_system_score_gemma":0.00021507795,"threshold_uncertainty_score":0.0043920875},"labels":[],"label_agreement":null},{"id":"W3028582164","doi":"10.1111/bjh.16750","title":"Genotype–phenotype correlation in children with hereditary spherocytosis","year":2020,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Erythrocyte Function and Pathophysiology","field":"Medicine","cited_by":84,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute for Clinical Evaluative Sciences; Hospital for Sick Children; SickKids Foundation; University of Toronto; London Health Sciences Centre; St. Michael's Hospital; Western University","funders":"Hospital for Sick Children","keywords":"Splenectomy; Hereditary spherocytosis; Spherocytosis; Medicine; Phenotype; Genotype; Gastroenterology; Hemolytic anemia; Internal medicine; Immunology; Pediatrics; Genetics; Spleen; Biology; Gene","score_opus":0.012775078847471243,"score_gpt":0.22471166352952437,"score_spread":0.21193658468205312,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3028582164","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99925274,0.00020541064,0.00008796551,0.00002410887,0.0000053092554,0.000004396434,0.00012645536,0.000008275988,0.00028525814],"genre_scores_gemma":[0.99950874,0.00008987744,0.0001114318,0.00001458217,0.00000641028,0.0000049484097,0.00019912643,0.000004673306,0.000060320945],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99943405,0.00014193877,0.000067191155,0.0001427149,0.00013185962,0.00008219393],"domain_scores_gemma":[0.99874544,0.0005021483,0.00043543862,0.00007500257,0.000092281836,0.00014976822],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00039616937,0.00040622073,0.0004544264,0.00092221843,0.00033961228,0.00043369952,0.00019298466,0.0005454978,0.002080536],"category_scores_gemma":[0.0034234263,0.00032126805,0.0002574371,0.00084367633,0.00042173587,0.00029655674,0.00038157575,0.00046430845,0.00041782449],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008802944,0.000011285125,0.99614125,0.000007744305,0.000016374082,0.0015460702,0.00012003912,0.000070744296,0.00060832634,0.000023656565,0.000097026146,0.0012694078],"study_design_scores_gemma":[0.000009793933,0.00019448485,0.9830791,0.000009356395,0.000024771454,0.01557806,0.00018437054,0.00023286647,0.00029509093,0.000056807537,0.00032755017,0.00000771758],"about_ca_topic_score_codex":0.001056013,"about_ca_topic_score_gemma":0.0007468794,"teacher_disagreement_score":0.002080536,"about_ca_system_score_codex":0.00017253176,"about_ca_system_score_gemma":0.00016386108,"threshold_uncertainty_score":0.006960094},"labels":[],"label_agreement":null},{"id":"W3029104222","doi":"10.1111/bjh.16724","title":"The pyruvate kinase (PK) to hexokinase enzyme activity ratio and erythrocyte PK protein level in the diagnosis and phenotype of PK deficiency","year":2020,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Erythrocyte Function and Pathophysiology","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University Health Network","funders":"Agios Pharmaceuticals; American Society of Hematology; National Hemophilia Foundation","keywords":"Pyruvate kinase; Hexokinase; Pyruvate kinase deficiency; Enzyme; Phenotype; Biochemistry; Chemistry; Endocrinology; Internal medicine; Glycolysis; Medicine; Gene","score_opus":0.04615363799648283,"score_gpt":0.2771513698068661,"score_spread":0.23099773181038327,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3029104222","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99890804,0.0004301868,0.00025166053,0.000021074953,0.000005359804,0.000015399411,0.00007222541,0.0000054225548,0.00029070582],"genre_scores_gemma":[0.9995617,0.00006505976,0.00020777195,0.000016608958,0.000004757235,0.000006335233,0.00006417052,0.0000017251729,0.00007182118],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99864644,0.000559575,0.00019431974,0.00028465554,0.00022453324,0.00009056861],"domain_scores_gemma":[0.99731135,0.0011468433,0.00083923055,0.00019526218,0.00025210553,0.00025514883],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0019247707,0.0005263348,0.00056521856,0.0007015814,0.00023918485,0.00096712745,0.0003858,0.00058486644,0.00085478934],"category_scores_gemma":[0.0050458927,0.00045622393,0.00025421867,0.00060776476,0.00046821003,0.00060515624,0.0007192954,0.0006843647,0.000390559],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004597391,0.0000319815,0.9966851,0.000009218043,0.00002719419,0.00007720757,0.00006873253,0.00008426388,0.00069535244,0.000010003468,0.00003112324,0.0018200851],"study_design_scores_gemma":[0.000026412847,0.00045625775,0.99734026,0.000007942767,0.000031275795,0.000785616,0.00010357471,0.00066575693,0.00043021818,0.00002752241,0.000119686745,0.000005379638],"about_ca_topic_score_codex":0.00082712737,"about_ca_topic_score_gemma":0.0007051545,"teacher_disagreement_score":0.0019247707,"about_ca_system_score_codex":0.00021352731,"about_ca_system_score_gemma":0.00018084368,"threshold_uncertainty_score":0.010179281},"labels":[],"label_agreement":null},{"id":"W3030042359","doi":"10.1111/bjh.16888","title":"Haemoglobin oxygen affinity in patients with severe COVID‐19 infection","year":2020,"lang":"en","type":"letter","venue":"British Journal of Haematology","topic":"COVID-19 Clinical Research Studies","field":"Medicine","cited_by":47,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"British Heart Foundation; Heart and Stroke Foundation of British Columbia and Yukon","keywords":"ARDS; Hydroxychloroquine; Lung; Coronavirus; Hypoxia (environmental); Medicine; Pandemic; Docking (animal); Immunology; Receptor; Coronavirus disease 2019 (COVID-19); Biology; Virology; Disease; Pathology; Internal medicine; Chemistry; Infectious disease (medical specialty); Oxygen","score_opus":0.03523524728419551,"score_gpt":0.34575688320529274,"score_spread":0.3105216359210972,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3030042359","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9978816,0.00049136137,0.00019406373,0.00014521983,0.000008528119,0.000011567046,0.0001218809,0.000009690563,0.0011359857],"genre_scores_gemma":[0.9995721,0.000108224405,0.000085485684,0.000036973124,0.000007139637,0.000003975599,0.000099354256,0.0000012260928,0.00008554759],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9999225,0.00001908995,0.000009346323,0.000015252207,0.000018275648,0.000015619475],"domain_scores_gemma":[0.99975437,0.00007856677,0.000069991656,0.000009235705,0.000021838188,0.000066117216],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015284147,0.00022034423,0.00039644967,0.00034879887,0.00029174337,0.00036526466,0.00013428293,0.00046649642,0.0017024308],"category_scores_gemma":[0.001190703,0.00011660336,0.000314518,0.00038314197,0.00017244654,0.00022065199,0.00026042073,0.00051858317,0.00016004662],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00074030826,0.000073427786,0.9892491,0.00004575386,0.000049778482,0.0018663363,0.00019482152,0.0009206166,0.0015228947,0.00011065863,0.00035971866,0.0048666145],"study_design_scores_gemma":[0.000041536114,0.0011187261,0.98482335,0.00002939683,0.00007254694,0.006258046,0.00045348005,0.005428331,0.0006168249,0.00037466877,0.00076831057,0.0000147984965],"about_ca_topic_score_codex":0.002020942,"about_ca_topic_score_gemma":0.0011409253,"teacher_disagreement_score":0.002020942,"about_ca_system_score_codex":0.00026724703,"about_ca_system_score_gemma":0.00013419782,"threshold_uncertainty_score":0.005695164},"labels":[],"label_agreement":null},{"id":"W3032347427","doi":"10.1111/bjh.16784","title":"<i>Clostridium perfringens</i> sepsis with spherocytosis and green neutrophil inclusions","year":2020,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Sepsis Diagnosis and Treatment","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver General Hospital; University of British Columbia","funders":"","keywords":"Clostridium perfringens; Hereditary spherocytosis; Sepsis; Medicine; Microbiology; Immunology; Biology; Internal medicine; Bacteria; Genetics","score_opus":0.04286148041934137,"score_gpt":0.2746661956047065,"score_spread":0.23180471518536513,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3032347427","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.94692147,0.004807182,0.0025793843,0.0065388964,0.0008325925,0.0003043737,0.0010084833,0.00047737022,0.03653031],"genre_scores_gemma":[0.992443,0.0009559424,0.00082502613,0.0015593118,0.00043708814,0.000022578697,0.00051563,0.000032181455,0.0032092223],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.9998896,0.000010632065,0.000012792116,0.000024773746,0.000017104428,0.00004512308],"domain_scores_gemma":[0.9998292,0.000027436388,0.000048275684,0.000008112532,0.00002539596,0.00006156226],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011042476,0.0008833568,0.0003232725,0.00070622924,0.0005578051,0.000484077,0.00031855152,0.0011871611,0.0025862653],"category_scores_gemma":[0.00048989657,0.0002432892,0.00028775417,0.00039079695,0.0004362737,0.00034653975,0.0003046647,0.00077543384,0.0008979385],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00023063768,0.000050022,0.017027497,0.00009288882,0.000014923923,0.96465844,0.0001566839,0.00009145298,0.007262409,0.00027538693,0.0067668795,0.0033727007],"study_design_scores_gemma":[0.00002771773,0.0002140395,0.044933125,0.00009427816,0.000030380917,0.9419981,0.00026833382,0.00060868927,0.0037371488,0.00027791908,0.0077919704,0.000018305089],"about_ca_topic_score_codex":0.0030537783,"about_ca_topic_score_gemma":0.0030288384,"teacher_disagreement_score":0.0030537783,"about_ca_system_score_codex":0.00057675573,"about_ca_system_score_gemma":0.00021631974,"threshold_uncertainty_score":0.008651972},"labels":[],"label_agreement":null},{"id":"W3033465546","doi":"10.1111/bjh.16777","title":"Validation of the RHL30 digital gene expression assay as a prognostic biomarker for relapsed Hodgkin lymphoma","year":2020,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Canada's Michael Smith Genome Sciences Centre; Princess Margaret Cancer Centre; Spinal Cord Injury BC; University Health Network","funders":"Princess Margaret Cancer Foundation; Genome Canada","keywords":"Medicine; Biomarker; Oncology; Lymphoma; Internal medicine; Transplantation; Cohort; Autologous stem-cell transplantation; Biology","score_opus":0.02296941156267117,"score_gpt":0.26572079870523535,"score_spread":0.24275138714256417,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3033465546","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99446774,0.00063286244,0.0035997485,0.00007225755,0.000016603379,0.000057278623,0.00044201946,0.000042440242,0.00066911965],"genre_scores_gemma":[0.99733585,0.00011163548,0.0016585209,0.000059434027,0.000017906636,0.000044771863,0.0005145895,0.000010323043,0.0002469609],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989532,0.00040007842,0.0000504298,0.00022746205,0.00027977242,0.00008913422],"domain_scores_gemma":[0.9991473,0.0003447981,0.00013535333,0.000167636,0.00012538041,0.00007957391],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0019350058,0.0003075483,0.00035760234,0.00062061305,0.0002174681,0.00070368504,0.00023240391,0.00032121936,0.0007662322],"category_scores_gemma":[0.0025547883,0.0001477701,0.00020311298,0.00032587297,0.00046387175,0.00021820357,0.00046189106,0.00045874386,0.00041792748],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0022141787,0.00029352074,0.67411184,0.00011649316,0.00024050204,0.00045859377,0.0005015082,0.0045870645,0.2774561,0.00031964073,0.00076231593,0.03893827],"study_design_scores_gemma":[0.00017224296,0.0035656285,0.84596384,0.000040350104,0.00024410768,0.0029614274,0.00033265387,0.030624025,0.10996714,0.00067358784,0.005395161,0.00005969885],"about_ca_topic_score_codex":0.00080418325,"about_ca_topic_score_gemma":0.0008677085,"teacher_disagreement_score":0.0019350058,"about_ca_system_score_codex":0.00027128676,"about_ca_system_score_gemma":0.00024301541,"threshold_uncertainty_score":0.010233402},"labels":[],"label_agreement":null},{"id":"W3033518311","doi":"10.1111/bjh.16812","title":"Severe macrothrombocytopenia with platelet CD9 deficiency responsive to romiplostim","year":2020,"lang":"en","type":"letter","venue":"British Journal of Haematology","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"Children's Hospital of Michigan; Children’s Hospital of Michigan Foundation","keywords":"Eltrombopag; Bernard–Soulier syndrome; Romiplostim; Thrombopoietin receptor; Platelet; Platelet Glycoprotein GPIb-IX Complex; Ristocetin; Medicine; Platelet disorder; Thrombopoietin; Platelet membrane glycoprotein; Megakaryocyte; Platelet transfusion; Internal medicine; Bone marrow failure; Bone marrow; Mean platelet volume; Pediatrics; Gastroenterology; Von Willebrand factor; Biology; Genetics; Haematopoiesis","score_opus":0.015400076659829294,"score_gpt":0.25664684406926347,"score_spread":0.24124676740943418,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3033518311","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9778968,0.0058566686,0.003342831,0.001201613,0.0001482164,0.00015931777,0.00047372782,0.0003011421,0.010619818],"genre_scores_gemma":[0.99751484,0.00078859273,0.00051622884,0.00034287135,0.00007000397,0.000014463671,0.00016746507,0.000017941236,0.0005675118],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.9998385,0.000032170396,0.000021670663,0.00004011693,0.000031770473,0.000035706267],"domain_scores_gemma":[0.9998387,0.000052541618,0.000040774972,0.000010628837,0.000012118375,0.00004518714],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009484939,0.00082097115,0.0004245777,0.00039291446,0.00024295542,0.0002149287,0.00022871964,0.0005981324,0.0009240523],"category_scores_gemma":[0.0004749283,0.00016417529,0.00025534947,0.00026693076,0.00029653724,0.00019953346,0.00026458473,0.0006120326,0.00033216222],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005469895,0.000108145134,0.03010636,0.00017794274,0.000055920125,0.8968165,0.00022849652,0.00034325966,0.0521924,0.00044902565,0.0020549071,0.016920052],"study_design_scores_gemma":[0.00006814295,0.0005322425,0.054589424,0.000040641815,0.000052159347,0.92971784,0.00008001684,0.0009006978,0.009350376,0.00026490042,0.004390061,0.000013587037],"about_ca_topic_score_codex":0.0005483637,"about_ca_topic_score_gemma":0.0006303702,"teacher_disagreement_score":0.0009240523,"about_ca_system_score_codex":0.00023742557,"about_ca_system_score_gemma":0.00013185953,"threshold_uncertainty_score":0.0030912757},"labels":[],"label_agreement":null},{"id":"W3033592362","doi":"10.1111/bjh.16751","title":"Fatigue in children and adolescents with immune thrombocytopenia","year":2020,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":43,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier Universitaire Sainte-Justine; McMaster University; Children's Hospital of Eastern Ontario; University of Ottawa","funders":"National Heart, Lung, and Blood Institute; Vanderbilt University","keywords":"Medicine; Immune thrombocytopenia; Quality of life (healthcare); Cohort; Platelet; Observational study; Pediatrics; Cohort study; Internal medicine","score_opus":0.011942441310740555,"score_gpt":0.24611527355799226,"score_spread":0.23417283224725172,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3033592362","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9978909,0.001314687,0.000028247829,0.00009172184,0.000011471261,0.000016028955,0.0001845114,0.0000029527605,0.0004595194],"genre_scores_gemma":[0.99896955,0.0005693267,0.000038996644,0.00006178954,0.000012915405,0.000015483063,0.00023212782,0.0000013146001,0.0000985179],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99961144,0.00009696282,0.000043430056,0.00006586442,0.00008831724,0.00009410112],"domain_scores_gemma":[0.9990559,0.00014839678,0.00053255504,0.000022515129,0.00008080529,0.0001598095],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003589624,0.00020116809,0.0005229787,0.0006530384,0.00033307928,0.00039911587,0.00016775925,0.00042339548,0.0014032378],"category_scores_gemma":[0.0019864663,0.0002631505,0.00034588113,0.0006863003,0.00027739868,0.0003875238,0.00031840242,0.0005696556,0.00014753878],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00005140492,0.000032400643,0.9971132,0.0000304517,0.000012667129,0.00043458774,0.000174262,0.000015084952,0.00008571462,0.000015777372,0.00018157417,0.001852772],"study_design_scores_gemma":[0.0000097685415,0.0001189572,0.997285,0.000024855508,0.000010656377,0.0020080672,0.00023317046,0.0000252614,0.000016353442,0.00001116175,0.00025483855,0.0000019301883],"about_ca_topic_score_codex":0.006325828,"about_ca_topic_score_gemma":0.0075324406,"teacher_disagreement_score":0.006325828,"about_ca_system_score_codex":0.0004869855,"about_ca_system_score_gemma":0.00031866203,"threshold_uncertainty_score":0.01257807},"labels":[],"label_agreement":null},{"id":"W3033832930","doi":"10.1111/bjh.16740","title":"Long‐term follow‐up of neonatal intracranial haemorrhage in children with severe haemophilia","year":2020,"lang":"en","type":"letter","venue":"British Journal of Haematology","topic":"Hemophilia Treatment and Research","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute for Clinical Evaluative Sciences; SickKids Foundation; Hospital for Sick Children","funders":"Vetenskapsrådet; Bayer HealthCare","keywords":"Intracranial haemorrhage; Medicine; Haemophilia; Pediatrics; Term (time); Haemophilia A; Intracranial bleeding; Intensive care medicine; Surgery; Complication","score_opus":0.015836447458398996,"score_gpt":0.26451536946000614,"score_spread":0.24867892200160716,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3033832930","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9961288,0.0030219287,0.00005161774,0.000043425556,0.0000113418655,0.000010407632,0.00042899625,0.0000021193625,0.00030137502],"genre_scores_gemma":[0.99790096,0.0012795685,0.000074740165,0.000026037134,0.000016991342,0.000015491523,0.00060622673,0.0000015056703,0.00007848689],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9992434,0.00016360017,0.00016595463,0.0001161989,0.00018369047,0.0001272309],"domain_scores_gemma":[0.99705136,0.0007086214,0.0012847326,0.00017803181,0.00039816945,0.00037907512],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010570644,0.0001965856,0.0006076304,0.0015911895,0.00051380147,0.00050035183,0.00046783392,0.0005117584,0.00085296156],"category_scores_gemma":[0.0047533815,0.00022991386,0.00066519657,0.0015239887,0.0004302705,0.00066876033,0.00053559244,0.0006322936,0.00015369966],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00005853126,0.000009667448,0.9966498,0.000034692544,0.000034811463,0.0013206742,0.00019538273,0.000017750814,0.000050865056,0.0000069933285,0.000060418442,0.0015603342],"study_design_scores_gemma":[0.0000021480262,0.000103329345,0.9945687,0.000044020006,0.000047960588,0.0044915974,0.00044190546,0.000024179219,0.000051667655,0.000009432253,0.00020951279,0.000005604222],"about_ca_topic_score_codex":0.008055474,"about_ca_topic_score_gemma":0.0077778823,"teacher_disagreement_score":0.008055474,"about_ca_system_score_codex":0.0007292284,"about_ca_system_score_gemma":0.00062667654,"threshold_uncertainty_score":0.016017199},"labels":[],"label_agreement":null},{"id":"W3034037943","doi":"10.1111/bjh.16793","title":"Early relapse after high‐dose melphalan autologous stem cell transplant predicts inferior survival and is associated with high disease burden and genetically high‐risk disease in multiple myeloma","year":2020,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":51,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Merck Sharp and Dohme; Myeloma UK; University of Leeds; National Institute for Health and Care Research; Institute of Cancer Research; Cancer Research UK; Royal Marsden NHS Foundation Trust; National Cancer Research Institute; Celgene; University of Birmingham; Cancer Research Institute","keywords":"Medicine; Multiple myeloma; Melphalan; Oncology; Stem cell; Internal medicine; Disease; Transplantation; Overall survival; Surgery; Biology","score_opus":0.011623310942427956,"score_gpt":0.22495124785147702,"score_spread":0.21332793690904905,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3034037943","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9997348,0.00007398732,0.000023896167,0.00001588525,0.0000018492939,0.0000016015023,0.000033680488,0.0000022382242,0.000111990914],"genre_scores_gemma":[0.99971145,0.000028343959,0.000024615538,0.000012553444,0.000007187062,0.000002119392,0.00011411182,0.0000012756209,0.000098277895],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9997248,0.00008355449,0.000024281402,0.00003816876,0.00004829555,0.00008088901],"domain_scores_gemma":[0.9985489,0.0003356648,0.00061549526,0.00009654297,0.00006716008,0.0003361304],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00062525045,0.0002832483,0.00028835726,0.0004421664,0.00030714952,0.0005481393,0.00030482246,0.00044036968,0.0011249105],"category_scores_gemma":[0.0015559922,0.00011371242,0.00028605468,0.00035337795,0.00032567076,0.0003009487,0.000499317,0.0006185713,0.00023620763],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014334563,0.00015913915,0.9918791,0.000012597896,0.00004148409,0.00032568516,0.00008401638,0.00020016872,0.0019597022,0.000025795864,0.00010978764,0.0037688934],"study_design_scores_gemma":[0.00001543911,0.00051978027,0.99730945,0.0000050319145,0.0000280674,0.0008619986,0.000075684395,0.00039261914,0.00056421,0.00006934125,0.00015225462,0.000005970431],"about_ca_topic_score_codex":0.0009845063,"about_ca_topic_score_gemma":0.001222713,"teacher_disagreement_score":0.0011249105,"about_ca_system_score_codex":0.00035566353,"about_ca_system_score_gemma":0.00027819033,"threshold_uncertainty_score":0.0037631989},"labels":[],"label_agreement":null},{"id":"W3037719485","doi":"10.1111/bjh.16961","title":"Amelioration of COVID‐19‐related cytokine storm syndrome: parallels to chimeric antigen receptor‐T cell cytokine release syndrome","year":2020,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":40,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"International Collaboration On Repair Discoveries; University of British Columbia, Okanagan Campus; University of British Columbia","funders":"Vancouver Coastal Health Research Institute","keywords":"Cytokine release syndrome; Cytokine storm; Chimeric antigen receptor; Cytokine; Coronavirus disease 2019 (COVID-19); Immunology; Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2); Cytokine receptor; Medicine; Receptor; 2019-20 coronavirus outbreak; Virology; Immunotherapy; Immune system; Internal medicine; Infectious disease (medical specialty); Disease","score_opus":0.025521533568235832,"score_gpt":0.2938366043423085,"score_spread":0.2683150707740727,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3037719485","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99052787,0.0034864529,0.002400797,0.00023086755,0.000094856696,0.00076428836,0.0002420528,0.00012359793,0.0021292309],"genre_scores_gemma":[0.9957438,0.0010255073,0.0017599855,0.00023319588,0.000106695945,0.00020488698,0.00032134692,0.000013624778,0.00059092906],"study_design_codex":"bench_or_experimental","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.9996731,0.000095896045,0.000039362563,0.00003013138,0.00006718313,0.0000943285],"domain_scores_gemma":[0.99954104,0.0000911058,0.00010001063,0.000051124436,0.000046222507,0.00017053721],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007101944,0.0006716803,0.0008459412,0.0003515904,0.00016326469,0.00025189837,0.0003631391,0.0005933515,0.0015658292],"category_scores_gemma":[0.0005346197,0.00011604387,0.0005070828,0.00017023578,0.00046344966,0.00039370204,0.00025196993,0.0012490097,0.00026040708],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.022883492,0.008594643,0.007108795,0.00092167896,0.00012509509,0.0026983304,0.00013641166,0.0010012117,0.8822197,0.000541552,0.00046071858,0.073308475],"study_design_scores_gemma":[0.0057151318,0.505106,0.12635036,0.000100569334,0.00040200693,0.011810995,0.00015237945,0.003625233,0.33765507,0.00052254036,0.008507448,0.00005234663],"about_ca_topic_score_codex":0.00024492468,"about_ca_topic_score_gemma":0.00044928095,"teacher_disagreement_score":0.0015658292,"about_ca_system_score_codex":0.0002282336,"about_ca_system_score_gemma":0.0003826505,"threshold_uncertainty_score":0.0052382946},"labels":[],"label_agreement":null},{"id":"W3037948978","doi":"10.1111/bjh.16891","title":"Clinical value of next‐generation sequencing compared to cytogenetics in patients with suspected myelodysplastic syndrome","year":2020,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University; London Health Sciences Centre","funders":"","keywords":"Medicine; Cytogenetics; Myelodysplastic syndromes; Internal medicine; Oncology; Predictive value; DNA sequencing; Pathology; Bone marrow; Biology; Chromosome; Gene; Genetics","score_opus":0.07179874823036245,"score_gpt":0.3178360345580713,"score_spread":0.24603728632770885,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3037948978","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9949885,0.0024774827,0.00034400242,0.00045302976,0.000047585694,0.000012921798,0.00009963195,0.000022341113,0.0015544788],"genre_scores_gemma":[0.9987721,0.00030998414,0.00056905433,0.00010021867,0.000037442944,0.0000054940156,0.00010434827,0.0000040507975,0.00009742128],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982681,0.0009947681,0.00016571772,0.00020829971,0.00026788586,0.00009517112],"domain_scores_gemma":[0.9926657,0.0051682824,0.00079531514,0.00018656444,0.00057724054,0.0006068584],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0028652835,0.00038680554,0.00054386555,0.0013667353,0.00030859775,0.00076368265,0.00033022228,0.0007006109,0.0011974216],"category_scores_gemma":[0.014590529,0.00023099426,0.00022011912,0.00065664906,0.0004809801,0.0006529665,0.00046612014,0.00051420176,0.00034379947],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0026308186,0.00005101935,0.9638373,0.000064875305,0.00005085831,0.0009125405,0.00019460688,0.00117269,0.0030454649,0.00009649288,0.0005314789,0.02741172],"study_design_scores_gemma":[0.00013492999,0.0016738013,0.9663267,0.0001453306,0.00018179115,0.0066407654,0.0004123935,0.016975505,0.0049861134,0.00047542804,0.001993845,0.0000534928],"about_ca_topic_score_codex":0.0016836148,"about_ca_topic_score_gemma":0.0018790505,"teacher_disagreement_score":0.0028652835,"about_ca_system_score_codex":0.00050511945,"about_ca_system_score_gemma":0.00039847946,"threshold_uncertainty_score":0.015153229},"labels":[],"label_agreement":null},{"id":"W3043437003","doi":"10.1111/bjh.16945","title":"Optimising the value of immunomodulatory drugs during induction and maintenance in transplant ineligible patients with newly diagnosed multiple myeloma: results from Myeloma XI, a multicentre, open‐label, randomised, Phase III trial","year":2020,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"University of Leeds; National Institute for Health and Care Research; Institute of Cancer Research; Cancer Research UK; Royal Marsden NHS Foundation Trust; National Cancer Research Institute; Celgene; University of Birmingham; Cancer Research Institute; Merck; Myeloma UK","keywords":"Medicine; Lenalidomide; Thalidomide; Multiple myeloma; Tolerability; Internal medicine; Discontinuation; Maintenance therapy; Cyclophosphamide; Dexamethasone; Oncology; Dosing; Surgery; Chemotherapy; Adverse effect","score_opus":0.02275721751476278,"score_gpt":0.28080097173672386,"score_spread":0.2580437542219611,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3043437003","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98441505,0.011843803,0.00039176087,0.00078424544,0.00025016826,0.0008465502,0.00042364764,0.000031784984,0.0010130627],"genre_scores_gemma":[0.99217695,0.003243271,0.0010053937,0.0010878982,0.00022223737,0.00072902674,0.0008103539,0.000012965048,0.00071190804],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9989421,0.00059478363,0.00010197815,0.00012184485,0.00008539971,0.00015397168],"domain_scores_gemma":[0.9983329,0.00054269686,0.000498677,0.00011033498,0.000078413716,0.00043702926],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0036174806,0.00070991565,0.0018240798,0.00022014977,0.00024066925,0.0013436736,0.00057371665,0.0010419005,0.0019853823],"category_scores_gemma":[0.002518466,0.00027050133,0.0027543316,0.0002895217,0.0005201026,0.00094201305,0.000487184,0.0027073002,0.00032519022],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.8917726,0.005920278,0.0051491703,0.001052579,0.0026077097,0.00006128536,0.00016726571,0.0012011738,0.0067978217,0.00016645955,0.0010494103,0.08405426],"study_design_scores_gemma":[0.728472,0.24087858,0.022890491,0.0002661135,0.0023665237,0.00010845352,0.000056412482,0.00095399836,0.001140294,0.0002826261,0.0025427851,0.000041711275],"about_ca_topic_score_codex":0.000520931,"about_ca_topic_score_gemma":0.0013353989,"teacher_disagreement_score":0.0036174806,"about_ca_system_score_codex":0.00078871334,"about_ca_system_score_gemma":0.0007676767,"threshold_uncertainty_score":0.019131303},"labels":[],"label_agreement":null},{"id":"W3044441835","doi":"10.1111/bjh.16959","title":"Fostamatinib is an effective second‐line therapy in patients with immune thrombocytopenia","year":2020,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":69,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Michael's Hospital","funders":"","keywords":"Medicine; Immune thrombocytopenia; Second-line therapy; Second line; Second line treatment; Post-hoc analysis; Syk; Post hoc; Internal medicine; Line (geometry); Platelet; Oncology; First line; Chemotherapy; Receptor; Mathematics","score_opus":0.013784286313514221,"score_gpt":0.25728712456209923,"score_spread":0.243502838248585,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3044441835","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97065353,0.02392014,0.0006359793,0.0007231615,0.00015993755,0.00035242198,0.0006773846,0.000045405704,0.0028321801],"genre_scores_gemma":[0.99456996,0.0033870107,0.0004999854,0.00025218888,0.00008978011,0.00015300218,0.00065187324,0.000005719834,0.00039056205],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.99911195,0.00045637635,0.00010084643,0.00010257218,0.00012742459,0.00010079452],"domain_scores_gemma":[0.9993248,0.00030894767,0.00017073187,0.000033493172,0.00003209,0.00013006879],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001507554,0.0003098365,0.0017274242,0.00037136028,0.0001892724,0.00053606374,0.00027965076,0.0005424951,0.0016972648],"category_scores_gemma":[0.0012270322,0.000110807116,0.0009914653,0.00045431373,0.00030315487,0.00048743899,0.00018377039,0.0008938603,0.00016178426],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.5520026,0.0030893094,0.02293985,0.0025263554,0.005042835,0.00073484395,0.00019628298,0.0025040153,0.027121874,0.0005448791,0.0035504096,0.3797467],"study_design_scores_gemma":[0.33230627,0.44578654,0.1626872,0.00036226475,0.0038149273,0.004655044,0.00022915946,0.0035167085,0.015943151,0.0008850675,0.029690055,0.00012359454],"about_ca_topic_score_codex":0.00035214238,"about_ca_topic_score_gemma":0.0016898377,"teacher_disagreement_score":0.0017274242,"about_ca_system_score_codex":0.0005421325,"about_ca_system_score_gemma":0.00040723485,"threshold_uncertainty_score":0.007972777},"labels":[],"label_agreement":null},{"id":"W3045194329","doi":"10.1111/bjh.16940","title":"Building Canadian capacity for CAR‐T cells in relapsed/refractory acute lymphoblastic leukaemia: a retrospective cohort study","year":2020,"lang":"en","type":"letter","venue":"British Journal of Haematology","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of British Columbia; Ottawa Hospital; University of Manitoba; Ottawa Public Health; Canada's Michael Smith Genome Sciences Centre; University of Ottawa","funders":"","keywords":"Medicine; Chimeric antigen receptor; Malignancy; Progenitor cell; Hematopoietic stem cell transplantation; Stem cell; Internal medicine; Immunology; Haematopoiesis; Oncology; Transplantation; Immunotherapy; Cancer; Biology","score_opus":0.02159558664857928,"score_gpt":0.2844037094014702,"score_spread":0.2628081227528909,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3045194329","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9440832,0.03310212,0.0007798868,0.0006058989,0.00013243624,0.0002314353,0.017191742,0.000034591543,0.0038386201],"genre_scores_gemma":[0.9908382,0.0028696386,0.00033108762,0.00035989296,0.00006437196,0.00012204136,0.0049165105,0.000021754804,0.00047652776],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99609995,0.00089832046,0.0005353936,0.0012179116,0.0008164559,0.0004319245],"domain_scores_gemma":[0.99440163,0.0010467164,0.0020524373,0.0011553495,0.000924247,0.00041957735],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0044618705,0.00051846384,0.0013414213,0.0011329898,0.0007656592,0.0014977205,0.0014849544,0.0010753768,0.0044198995],"category_scores_gemma":[0.008256256,0.00059478346,0.003807443,0.0036391683,0.00031146896,0.0011779178,0.00094213017,0.0018328303,0.00062852155],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0021787132,0.00007424956,0.98003834,0.0005891247,0.00892329,0.00015682202,0.0001812488,0.00017508364,0.00017197269,0.00023492187,0.002147154,0.0051291473],"study_design_scores_gemma":[0.0003958367,0.00045659044,0.98138255,0.00032965717,0.010371135,0.00054801354,0.0004846573,0.00062579894,0.000086175045,0.00022019784,0.005043896,0.00005542109],"about_ca_topic_score_codex":0.040320273,"about_ca_topic_score_gemma":0.052304726,"teacher_disagreement_score":0.9596797,"about_ca_system_score_codex":0.001713231,"about_ca_system_score_gemma":0.0014912524,"threshold_uncertainty_score":0.08017117},"labels":[],"label_agreement":null},{"id":"W3081654405","doi":"10.1111/bjh.17039","title":"Measurement of long‐term iron absorption and loss during iron supplementation using a stable isotope of iron (<sup>57</sup>Fe)","year":2020,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Iron Metabolism and Disorders","field":"Medicine","cited_by":25,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Columbia College","funders":"Bill and Melinda Gates Foundation","keywords":"Iron deficiency; Micronutrient; Population; Iron status; Interquartile range; Chemistry; Animal science; Absorption (acoustics); Radiochemistry; Anemia; Medicine; Internal medicine; Materials science; Biology","score_opus":0.024900412390044226,"score_gpt":0.2700254076746449,"score_spread":0.24512499528460066,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3081654405","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99754673,0.0009815211,0.0010525667,0.000017808008,0.0000041008325,0.0000086507935,0.00010722953,0.000014885151,0.00026645116],"genre_scores_gemma":[0.9978079,0.00030145785,0.0011382484,0.000021660588,0.0000045451234,0.000018926099,0.00015631062,0.00001009777,0.00054099446],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99975985,0.00006901766,0.0000115489565,0.000038610462,0.00008067528,0.000040300976],"domain_scores_gemma":[0.9995783,0.00007914594,0.00015761695,0.000036013684,0.00010015161,0.000048751932],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00043977358,0.00027176517,0.0003407979,0.00026326042,0.00022126992,0.00035474636,0.00024210422,0.00035083454,0.0007270271],"category_scores_gemma":[0.0007142237,0.00020866713,0.00016354313,0.00026248145,0.00028687844,0.00024244077,0.00020242183,0.0005191485,0.00018580699],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0054034353,0.00014896075,0.22311376,0.00019340316,0.00013398791,0.00023196496,0.00055349537,0.00023595811,0.74352396,0.000058845122,0.00022722379,0.026174964],"study_design_scores_gemma":[0.00004247922,0.0034657838,0.77796376,0.000044137545,0.00018188731,0.0009741787,0.00046164548,0.0014396467,0.21313567,0.00006598418,0.0022031835,0.000021633865],"about_ca_topic_score_codex":0.0020969152,"about_ca_topic_score_gemma":0.0019968124,"teacher_disagreement_score":0.0020969152,"about_ca_system_score_codex":0.0002587003,"about_ca_system_score_gemma":0.00018811892,"threshold_uncertainty_score":0.004169345},"labels":[],"label_agreement":null},{"id":"W3086825036","doi":"10.1111/bjh.17073","title":"Results of a UK National Cancer Research Institute Phase II study of brentuximab vedotin using a response‐adapted design in the first‐line treatment of patients with classical Hodgkin lymphoma unsuitable for chemotherapy due to age, frailty or comorbidity (BREVITY)","year":2020,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":32,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Discovery Centre","funders":"Medical Research Council; Takeda Oncology; Blood Cancer UK; National Institute for Health and Care Research; Department of Health and Social Care; Cancer Research UK; Bloodwise; King’s College London; Health Research","keywords":"Medicine; Brentuximab vedotin; Internal medicine; Adverse effect; Confidence interval; Classical Hodgkin lymphoma; Oncology; Surgery; Gastroenterology; Lymphoma; Hodgkin lymphoma","score_opus":0.2288983498756854,"score_gpt":0.4219077485188068,"score_spread":0.19300939864312142,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3086825036","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9884334,0.00449039,0.0013224081,0.00063735177,0.0001417408,0.0020778624,0.0014113821,0.0000854304,0.0014000748],"genre_scores_gemma":[0.9852792,0.002546575,0.0026448567,0.0011669259,0.000110497655,0.0021529126,0.004442623,0.000046258523,0.001610235],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9965677,0.0024960896,0.0001745175,0.00025861102,0.00024648468,0.00025658062],"domain_scores_gemma":[0.9970188,0.0009292185,0.00064078026,0.0004010795,0.00022469147,0.0007855295],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.006982358,0.0009270731,0.002008076,0.00035673965,0.00032244663,0.00080840016,0.00065944524,0.0012167814,0.0013701838],"category_scores_gemma":[0.0036594607,0.00053245586,0.0013152123,0.0005455545,0.0011002955,0.0005930722,0.0004103262,0.0024297405,0.0004323435],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.6233521,0.05024474,0.025971923,0.0012805084,0.0049809883,0.00054429466,0.0008118108,0.0059903176,0.08537162,0.00031608096,0.006992335,0.19414331],"study_design_scores_gemma":[0.24819449,0.662284,0.076869465,0.00006400004,0.0014987664,0.0005233167,0.00007854052,0.0011065459,0.0035307526,0.00015073418,0.005627569,0.00007189243],"about_ca_topic_score_codex":0.0019638287,"about_ca_topic_score_gemma":0.0036461754,"teacher_disagreement_score":0.006982358,"about_ca_system_score_codex":0.0012970682,"about_ca_system_score_gemma":0.0011691354,"threshold_uncertainty_score":0.036926687},"labels":[],"label_agreement":null},{"id":"W3087694498","doi":"10.1111/bjh.17095","title":"Microcytosis in patients with haemoglobin C trait: is α‐thalassaemia trait to blame?","year":2020,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McMaster University; University Health Network; Hamilton Health Sciences; Hamilton Regional Laboratory Medicine Program; Thrombosis and Atherosclerosis Research Institute; Centre Hospitalier de l’Université de Montréal","funders":"","keywords":"Microcytosis; Sickle cell trait; Medicine; Mean corpuscular volume; Population; Red Cell; Asymptomatic; Immunology; Iron deficiency; Genetics; Internal medicine; Hematocrit; Biology; Disease; Anemia","score_opus":0.00793975500152309,"score_gpt":0.21870849919555127,"score_spread":0.2107687441940282,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3087694498","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9937734,0.0032832182,0.00019615573,0.00021065543,0.000027295371,0.00004703959,0.00044225506,0.000016312883,0.002003706],"genre_scores_gemma":[0.9985051,0.000652979,0.00013608731,0.0001038889,0.000083872954,0.000010254287,0.00032914124,0.0000028923573,0.00017583535],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99972504,0.000032033735,0.00004761846,0.00006051864,0.00007294361,0.00006181086],"domain_scores_gemma":[0.99902534,0.0002487929,0.00043518472,0.00004954833,0.000082747094,0.00015839175],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00025272733,0.00023374414,0.00037138828,0.0012258196,0.00038245157,0.00041149688,0.0003038994,0.0004484357,0.0022464916],"category_scores_gemma":[0.0018977816,0.00015379685,0.00016222885,0.0014074577,0.00041948512,0.00036793368,0.0002140281,0.0002877163,0.0003002918],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013066585,0.000015251736,0.9810682,0.000044188666,0.000010926712,0.013631085,0.00012657011,0.00002394698,0.00048320746,0.000038539976,0.00038852828,0.0040389206],"study_design_scores_gemma":[0.000013586219,0.00016116606,0.90338576,0.00006067184,0.00003995391,0.09429845,0.00030381666,0.00019698289,0.0002632576,0.00009000764,0.0011756278,0.000010649717],"about_ca_topic_score_codex":0.0031948406,"about_ca_topic_score_gemma":0.0044033728,"teacher_disagreement_score":0.0031948406,"about_ca_system_score_codex":0.00032285147,"about_ca_system_score_gemma":0.00029841645,"threshold_uncertainty_score":0.0075153112},"labels":[],"label_agreement":null},{"id":"W3091505034","doi":"10.1111/bjh.17125","title":"Use of an anti‐CD200‐blocking antibody improves immune responses to AML <i>in vitro</i> and <i>in vivo</i>","year":2020,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Neuroinflammation and Neurodegeneration Mechanisms","field":"Neuroscience","cited_by":27,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Trillium Therapeutics (Canada)","funders":"European Regional Development Fund; Medical Research Council; Blood Cancer UK; Cardiff University; Cancer Research UK; Cancer Research Wales; National Cancer Research Institute","keywords":"In vivo; Immune system; In vitro; Antibody; Immunology; Medicine; Effector; Cancer research; Blocking antibody; Myeloid; Biology","score_opus":0.0376269655903632,"score_gpt":0.28235328763955914,"score_spread":0.24472632204919592,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3091505034","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99200386,0.0027635924,0.001271882,0.00017606464,0.00008107933,0.000045434135,0.0001698816,0.00014493072,0.0033432187],"genre_scores_gemma":[0.99441916,0.0017866516,0.0012788536,0.00017431154,0.00004225168,0.000026008494,0.00045219055,0.000019761514,0.0018007915],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99993587,0.000011505144,0.0000047977683,0.000009441733,0.000011278043,0.000027140388],"domain_scores_gemma":[0.9999418,0.000011363227,0.000012243078,0.000006009573,0.0000054355073,0.000023039926],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000120827055,0.000282033,0.00029911715,0.00018786728,0.00009056416,0.00021427192,0.00022781968,0.00025838107,0.0015419032],"category_scores_gemma":[0.00009505792,0.00007807745,0.00017761892,0.00008721011,0.00012585777,0.00016765259,0.00009422187,0.00066761667,0.00039445938],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00068131415,0.00047537524,0.00012975342,0.00006207875,0.000019864448,0.00003600494,0.000013126156,0.00014206552,0.987502,0.00008463645,0.00028663725,0.010567013],"study_design_scores_gemma":[0.00023793183,0.011609598,0.00627319,0.000016882006,0.000081684535,0.00051480834,0.000027002674,0.0008591992,0.97482634,0.00009161382,0.0054537435,0.00000807086],"about_ca_topic_score_codex":0.0005070666,"about_ca_topic_score_gemma":0.0008299798,"teacher_disagreement_score":0.0015419032,"about_ca_system_score_codex":0.000144201,"about_ca_system_score_gemma":0.00017812228,"threshold_uncertainty_score":0.005158186},"labels":[],"label_agreement":null},{"id":"W3093987483","doi":"10.1111/bjh.16922","title":"Treatment patterns and outcomes among mantle cell lymphoma patients treated with ibrutinib in the United States: a retrospective electronic medical record database and chart review study","year":2020,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":24,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"AstraZeneca Canada","keywords":"Ibrutinib; Medicine; Discontinuation; Hazard ratio; Mantle cell lymphoma; Internal medicine; Retrospective cohort study; Proportional hazards model; Database; Oncology; Medical record; Population; Confidence interval; Survival analysis; Lymphoma","score_opus":0.012567597786852335,"score_gpt":0.2618785143198141,"score_spread":0.24931091653296178,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3093987483","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.995178,0.00067991525,0.00015379066,0.00008071501,0.0000045541506,0.00005111385,0.0033699533,0.000008608994,0.0004733694],"genre_scores_gemma":[0.99652004,0.00045680188,0.00023946361,0.000060894195,0.000008966096,0.000054299646,0.002571684,0.0000035689093,0.000084306266],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983109,0.00045013143,0.0004260448,0.00035390284,0.00032419476,0.000134767],"domain_scores_gemma":[0.9926317,0.0013605712,0.0046687755,0.00030941988,0.0007096044,0.00032002348],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012630335,0.00014643394,0.00037755744,0.0022871646,0.00040348023,0.0008522447,0.00039018312,0.00031099602,0.0009086815],"category_scores_gemma":[0.004333485,0.00027386422,0.00033981085,0.004495624,0.00030035252,0.00067562616,0.0004919551,0.00039988116,0.00014640378],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00003351087,0.000018679255,0.99847513,0.000024756899,0.00003397282,0.00006131494,0.00010795181,0.000023222445,0.0000442163,0.00001266137,0.00017385287,0.0009906864],"study_design_scores_gemma":[0.00000833226,0.000042303087,0.9983512,0.00003303109,0.000029113302,0.0003333945,0.00045352423,0.00023094048,0.000057418074,0.000011321341,0.0004439583,0.000005489114],"about_ca_topic_score_codex":0.0112314,"about_ca_topic_score_gemma":0.014348112,"teacher_disagreement_score":0.0112314,"about_ca_system_score_codex":0.0008848357,"about_ca_system_score_gemma":0.0008973911,"threshold_uncertainty_score":0.022332013},"labels":[],"label_agreement":null},{"id":"W3094397867","doi":"10.1111/bjh.17094","title":"The evolution of clinical research in thalassaemia: where has all the funding gone?","year":2020,"lang":"en","type":"letter","venue":"British Journal of Haematology","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Population; Pediatrics; Blood transfusion; Thalassemia; Hematology; Hemoglobinopathy; Internal medicine; Demography; Hemolytic anemia","score_opus":0.12268476347597426,"score_gpt":0.39009002098155554,"score_spread":0.2674052575055813,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3094397867","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":"incentives","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":"incentives","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00028506358,0.19824131,0.0003249185,0.57590395,0.22311907,0.00002237418,0.000112566966,0.000065290325,0.0019254835],"genre_scores_gemma":[0.004074386,0.32010752,0.0012190967,0.17769036,0.49297774,0.00005457546,0.00027485783,0.00024151278,0.0033599646],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.952739,0.016150795,0.011071612,0.0027521995,0.014565022,0.0027212445],"domain_scores_gemma":[0.6545737,0.19705752,0.020802105,0.00777827,0.081184246,0.03860414],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.06210815,0.0013546539,0.004111612,0.0092445435,0.0045753494,0.025531,0.005879711,0.020505711,0.015905242],"category_scores_gemma":[0.16714786,0.0018525788,0.0022250663,0.011832686,0.010895933,0.027351387,0.0055469573,0.022866858,0.0061760354],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002519345,0.00006189968,0.0010529647,0.0040655187,0.000118083604,0.00026580723,0.00047093624,0.00008387232,0.00017631207,0.0051429574,0.81506187,0.17324778],"study_design_scores_gemma":[0.00006187938,0.00010415267,0.001810087,0.0072052316,0.000069827765,0.00036179286,0.00086821173,0.00007574616,0.00005770829,0.004634359,0.9846808,0.0000702745],"about_ca_topic_score_codex":0.005578867,"about_ca_topic_score_gemma":0.012360216,"teacher_disagreement_score":0.93789184,"about_ca_system_score_codex":0.012231028,"about_ca_system_score_gemma":0.023146149,"threshold_uncertainty_score":0.3284632},"labels":[],"label_agreement":null},{"id":"W3102807271","doi":"10.1111/bjh.17226","title":"The need for locally generated data in haematology: a real‐world experience of aplastic anaemia in Nepal","year":2020,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Medicine; Internal medicine; Cyclophosphamide; Regimen; Transplantation; Gastroenterology; Population; Bone marrow; Pancytopenia; Incidence (geometry); Hematology; Survival rate; Surgery; Chemotherapy","score_opus":0.04732333201275769,"score_gpt":0.3179674115005981,"score_spread":0.2706440794878404,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3102807271","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.83726954,0.011625577,0.015129539,0.0819275,0.0008827406,0.0016597811,0.0026418085,0.0006243959,0.04823916],"genre_scores_gemma":[0.9629307,0.0070751607,0.011599297,0.01188382,0.0005194724,0.00047238998,0.0014555737,0.00041103078,0.0036526332],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9920032,0.0049384213,0.00081345445,0.00067451247,0.0010375971,0.0005328434],"domain_scores_gemma":[0.9600899,0.018579531,0.0033535825,0.0051734727,0.0048138285,0.007989673],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.011222862,0.00038416407,0.00038816064,0.0011532635,0.0014198973,0.0042106425,0.0026377975,0.0016301234,0.010785697],"category_scores_gemma":[0.033319995,0.0004302873,0.00036193733,0.0019236333,0.0025834402,0.0039253174,0.0059407656,0.0034076627,0.0024029],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00094093307,0.0022159438,0.28605074,0.0040611555,0.00016664252,0.0699546,0.066754945,0.0024623582,0.0029554383,0.008239812,0.044442005,0.51175535],"study_design_scores_gemma":[0.00038446148,0.003458306,0.21888414,0.010402317,0.00020417232,0.16128077,0.12691447,0.0058333236,0.0036675339,0.013354337,0.4551198,0.0004963032],"about_ca_topic_score_codex":0.0027268585,"about_ca_topic_score_gemma":0.0030945688,"teacher_disagreement_score":0.011222862,"about_ca_system_score_codex":0.0023069375,"about_ca_system_score_gemma":0.005342617,"threshold_uncertainty_score":0.059352815},"labels":[],"label_agreement":null},{"id":"W3103119508","doi":"10.1111/bjh.17119","title":"Comparison of two vitamin D supplementation strategies in children with sickle cell disease: a randomized controlled trial","year":2020,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier Universitaire de Sherbrooke; Québec International; Université de Montréal; Centre Hospitalier Universitaire Sainte-Justine","funders":"","keywords":"Medicine; Vitamin D and neurology; Placebo; Internal medicine; Hypercalciuria; vitamin D deficiency; Gastroenterology; Bolus (digestion); Vitamin; Randomized controlled trial; Endocrinology; Urinary system","score_opus":0.009141292289453234,"score_gpt":0.28979639465249035,"score_spread":0.28065510236303715,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3103119508","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9341956,0.052202936,0.0009266563,0.0018565296,0.0021912856,0.005254819,0.0013939271,0.00016255982,0.0018156794],"genre_scores_gemma":[0.96537745,0.018565007,0.0022829373,0.0016102102,0.0010246428,0.008357321,0.0008032273,0.000022818072,0.0019562459],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99801195,0.0011133732,0.00025978603,0.00026373594,0.000163323,0.00018778867],"domain_scores_gemma":[0.99803764,0.00093220925,0.00043479737,0.00008804996,0.00011170328,0.00039560426],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0023893178,0.001374944,0.005569436,0.00076705153,0.0005487951,0.0014804736,0.0010624825,0.0033101519,0.00676299],"category_scores_gemma":[0.004030737,0.0007369484,0.0033027127,0.0007961015,0.0011554224,0.0010389482,0.0005726358,0.002860266,0.0005614919],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.983441,0.0020398481,0.00038390406,0.002369236,0.0021814466,0.000042171072,0.00003447076,0.00010265574,0.0004957992,0.000098496785,0.00032401053,0.008487145],"study_design_scores_gemma":[0.9800829,0.017497258,0.00077345263,0.00015203287,0.0009766812,0.0000193384,0.000019159364,0.000108188746,0.00007728502,0.00006437312,0.00022050894,0.000008990643],"about_ca_topic_score_codex":0.0024843202,"about_ca_topic_score_gemma":0.0036889813,"teacher_disagreement_score":0.00676299,"about_ca_system_score_codex":0.0011687975,"about_ca_system_score_gemma":0.0014859996,"threshold_uncertainty_score":0.022624433},"labels":[],"label_agreement":null},{"id":"W3107023394","doi":"10.1111/bjh.17238","title":"Shotgun sequencing of the faecal microbiome to predict response to steroids in patients with lower gastrointestinal acute graft‐<i>versus</i>‐host disease: An exploratory analysis","year":2020,"lang":"en","type":"letter","venue":"British Journal of Haematology","topic":"Gut microbiota and health","field":"Biochemistry, Genetics and Molecular Biology","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Center for Advancing Translational Sciences; National Institute of Allergy and Infectious Diseases; National Cancer Institute; NIH Clinical Center; Minnesota Obesity Center, University of Minnesota; Danone Institute of Canada","keywords":"Microbiome; Shotgun sequencing; Medicine; Disease; Gastrointestinal disease; Gut microbiome; Host (biology); Biology; Immunology; Gastroenterology; Internal medicine; Bioinformatics; DNA sequencing; Genetics","score_opus":0.009531421034147669,"score_gpt":0.23473800465536365,"score_spread":0.22520658362121598,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3107023394","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99777406,0.00029848938,0.0006840365,0.000058159683,0.000010077179,0.00008560202,0.0008753626,0.000008300802,0.00020584073],"genre_scores_gemma":[0.9941586,0.00021213242,0.0025671588,0.00014437357,0.000023617657,0.000084339816,0.0025708461,0.000012200115,0.0002267413],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99908864,0.0002069287,0.00009772727,0.00025122013,0.00019366597,0.00016175072],"domain_scores_gemma":[0.9992305,0.00019003588,0.00017473282,0.00006150574,0.00017099454,0.00017217091],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00092395756,0.00046855755,0.00081098755,0.0012709984,0.00051292166,0.0011022793,0.00030710324,0.0005247101,0.00089909986],"category_scores_gemma":[0.001555927,0.00026117289,0.00088825123,0.0010271628,0.0003549087,0.00030576024,0.0010808418,0.0005466,0.00023977236],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0030529725,0.0005419358,0.9375219,0.00023448362,0.000460984,0.0010927481,0.0005696941,0.0007165515,0.03486607,0.000106058884,0.0005082654,0.02032833],"study_design_scores_gemma":[0.00007406945,0.0026402296,0.9826592,0.00010356493,0.00039485685,0.0015659934,0.0012766775,0.0040671355,0.0051287385,0.00013867894,0.0019156784,0.00003514856],"about_ca_topic_score_codex":0.0016064232,"about_ca_topic_score_gemma":0.002123058,"teacher_disagreement_score":0.0016064232,"about_ca_system_score_codex":0.0004201583,"about_ca_system_score_gemma":0.0005429695,"threshold_uncertainty_score":0.0048864484},"labels":[],"label_agreement":null},{"id":"W3107310190","doi":"10.1111/bjh.17168","title":"COVID‐19 and myeloma clinical research – experience from the CARDAMON clinical trial","year":2020,"lang":"en","type":"letter","venue":"British Journal of Haematology","topic":"COVID-19 and healthcare impacts","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Medical Research Council; Centre For Medical Engineering, King’s College London; University College London; King's College London; Engineering and Physical Sciences Research Council; National Institute for Health and Care Research; Department of Health and Social Care; Cancer Research UK; Wellcome Trust; Canada Economic Development for Quebec Regions; University College London Hospitals NHS Foundation Trust; Amgen","keywords":"Medicine; Clinical trial; Pandemic; Intensive care medicine; Coronavirus disease 2019 (COVID-19); Health care; Isolation (microbiology); Transplantation; Medical emergency; Internal medicine; Disease","score_opus":0.4888445932700773,"score_gpt":0.5790517989394028,"score_spread":0.09020720566932555,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3107310190","genre_codex":"review","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.24599648,0.4665287,0.0024284571,0.1535881,0.0077535147,0.011561565,0.010650103,0.0003669061,0.10112614],"genre_scores_gemma":[0.71282285,0.15533252,0.018957134,0.06973935,0.008473508,0.012170347,0.0113512175,0.00032063795,0.010832409],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9467476,0.0398967,0.004058136,0.0016694551,0.005697991,0.0019300103],"domain_scores_gemma":[0.94239503,0.025850825,0.0072010616,0.0035780773,0.00547398,0.015501012],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0957645,0.0006450207,0.0021526385,0.0006434225,0.0019171248,0.006186698,0.0019563837,0.0030366902,0.007244414],"category_scores_gemma":[0.09846376,0.0004984482,0.0018173428,0.0029097272,0.0022863941,0.00280741,0.003829135,0.0053590094,0.0012444395],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.14814211,0.006063877,0.017107874,0.009308484,0.0018813699,0.00072231237,0.0026506556,0.001267746,0.0011288343,0.012910441,0.15392686,0.6448894],"study_design_scores_gemma":[0.17789185,0.063347235,0.10038534,0.016870368,0.0019316056,0.0018144113,0.0014531362,0.0014915562,0.0012655016,0.0061891424,0.627028,0.00033181318],"about_ca_topic_score_codex":0.004892219,"about_ca_topic_score_gemma":0.0062666773,"teacher_disagreement_score":0.0957645,"about_ca_system_score_codex":0.006047665,"about_ca_system_score_gemma":0.014307035,"threshold_uncertainty_score":0.50645715},"labels":[],"label_agreement":null},{"id":"W3111110582","doi":"10.1111/bjh.17141","title":"Clinical and biological features of B‐cell neoplasms with <i>CDK6</i> translocations: an association with a subgroup of splenic marginal zone lymphomas displaying frequent CD5 expression, prolymphocytic cells, and <i>TP53</i> abnormalities","year":2020,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval","funders":"","keywords":"Splenic marginal zone lymphoma; Biology; CD5; IGHV@; Chronic lymphocytic leukemia; Gene rearrangement; Mantle cell lymphoma; Prolymphocytic leukemia; Molecular biology; Cancer research; B cell; Pathology; Lymphoma; Antibody; Immunology; Leukemia; Genetics; Medicine; Gene","score_opus":0.01806354584269679,"score_gpt":0.26378142896968043,"score_spread":0.24571788312698364,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3111110582","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9994056,0.00014867897,0.00007084352,0.000011448698,0.0000016701699,0.000004398877,0.000024108513,0.0000045767742,0.0003287153],"genre_scores_gemma":[0.99979,0.000044629098,0.00005354348,0.00000824969,0.000008775955,0.0000033392655,0.000040956696,0.0000012121756,0.00004916585],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9997974,0.000028589895,0.000025836973,0.000060117116,0.000033874334,0.00005414332],"domain_scores_gemma":[0.9992168,0.00018627473,0.00026016912,0.000050355247,0.00005332378,0.00023303511],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001814861,0.00032784487,0.00029991986,0.00087372604,0.00039597985,0.00040823416,0.0002609041,0.00036926175,0.0010731703],"category_scores_gemma":[0.0012123106,0.00025287727,0.00015022924,0.00044879236,0.0006577662,0.00028206364,0.00033608513,0.00022744616,0.0003088541],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00037249175,0.000061688945,0.9585806,0.00002671566,0.0000269941,0.02091112,0.0002532694,0.00009606358,0.01614272,0.00007330623,0.00013084385,0.0033242789],"study_design_scores_gemma":[0.000040655315,0.00034015483,0.8335012,0.000007990282,0.000032453576,0.16334668,0.00036850446,0.00033024352,0.0014398785,0.00009620593,0.00048344643,0.000012538988],"about_ca_topic_score_codex":0.00074627605,"about_ca_topic_score_gemma":0.00060779345,"teacher_disagreement_score":0.0010731703,"about_ca_system_score_codex":0.00017718824,"about_ca_system_score_gemma":0.00017063686,"threshold_uncertainty_score":0.0035901666},"labels":[],"label_agreement":null},{"id":"W3112370628","doi":"10.1111/bjh.17273","title":"Von Willebrand factor propeptide in severe coronavirus disease 2019 (COVID‐19): evidence of acute and sustained endothelial cell activation","year":2020,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"COVID-19 Clinical Research Studies","field":"Medicine","cited_by":119,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"3M Foundation; Health Service Executive; Royal College of Surgeons in Ireland; Wellcome Trust; Canadian Institute for Theoretical Astrophysics","keywords":"Von Willebrand factor; Coagulopathy; Endothelial activation; Medicine; Internal medicine; Pathogenesis; Sepsis; Endothelial dysfunction; Coronavirus disease 2019 (COVID-19); Immunology; Endocrinology; Gastroenterology; Endothelium; Platelet; Disease","score_opus":0.0719022932819618,"score_gpt":0.4038994174974825,"score_spread":0.3319971242155207,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3112370628","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.997463,0.0014296405,0.00025199723,0.000054517925,0.0000197597,0.000029541121,0.00017186128,0.000005874889,0.00057376595],"genre_scores_gemma":[0.9990507,0.0002920142,0.00018063109,0.000026790533,0.00002464696,0.000009556558,0.0003230287,0.0000010729814,0.00009154112],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99941933,0.00013202087,0.00010329512,0.00012317086,0.00013800627,0.00008424208],"domain_scores_gemma":[0.9990877,0.0001543579,0.00031096075,0.000047923208,0.0001041875,0.00029484383],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00066168077,0.000360594,0.00039341295,0.00054564734,0.00028782358,0.00043322163,0.00021655335,0.00065647135,0.00078249606],"category_scores_gemma":[0.0011207317,0.00020403849,0.00028797594,0.0005977796,0.00034813216,0.00035029664,0.00048193536,0.0006609018,0.00016766826],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0048165424,0.00035698543,0.89183587,0.00021930905,0.0002531295,0.009027672,0.00035571493,0.0001665714,0.08014145,0.00020447017,0.0004518132,0.0121704],"study_design_scores_gemma":[0.00003335043,0.0014521714,0.98490715,0.000012157564,0.00004529753,0.009349279,0.00013965415,0.00043507782,0.0027493306,0.00007471891,0.00079177355,0.000010119736],"about_ca_topic_score_codex":0.00057882944,"about_ca_topic_score_gemma":0.00041422868,"teacher_disagreement_score":0.00078249606,"about_ca_system_score_codex":0.00020142703,"about_ca_system_score_gemma":0.00019731047,"threshold_uncertainty_score":0.0034993887},"labels":[],"label_agreement":null},{"id":"W3112534080","doi":"10.1111/bjh.17247","title":"Inherited predisposition to haematopoietic malignancies: overcoming barriers and exploring opportunities","year":2020,"lang":"en","type":"review","venue":"British Journal of Haematology","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":28,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Queen Elizabeth II Health Sciences Centre; Dalhousie University","funders":"","keywords":"Genetic predisposition; Malignancy; Germline; Haematopoiesis; Myeloid; Medicine; Genetic testing; Genetics; Biology; Immunology; Bioinformatics; Disease; Stem cell; Pathology; Gene","score_opus":0.13372246372914656,"score_gpt":0.34408265996454523,"score_spread":0.21036019623539867,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3112534080","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00005961982,0.9981377,0.000071880255,0.00092453504,0.00022358594,0.0000015365049,0.0000072760267,0.0000044840326,0.0005692808],"genre_scores_gemma":[0.00039737037,0.99871194,0.00013082812,0.00033261353,0.00020631931,0.0000023573912,0.000012198062,0.0000013253828,0.00020499778],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99958247,0.00012396918,0.0000719065,0.000045397246,0.00014182278,0.000034490917],"domain_scores_gemma":[0.99857867,0.00096691214,0.00012916725,0.000030718733,0.00022431192,0.00007032768],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001278503,0.0005594325,0.0014247978,0.0024660574,0.0002761987,0.001196154,0.0009091868,0.0013287524,0.0036116433],"category_scores_gemma":[0.0024638285,0.00023058057,0.00046953856,0.0020426803,0.00070021517,0.0017906073,0.000745922,0.0020174792,0.0015397334],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00005928788,0.00003455884,0.00030923425,0.024738431,0.000116164636,0.0006872973,0.00020124848,0.0002699348,0.00068634073,0.0071954066,0.049604166,0.9160978],"study_design_scores_gemma":[0.000013052503,0.00004450708,0.0007746384,0.012437972,0.000106533196,0.0034930378,0.00018760549,0.00004738843,0.00013797167,0.0034298205,0.97930866,0.00001888762],"about_ca_topic_score_codex":0.0012582553,"about_ca_topic_score_gemma":0.0022559187,"teacher_disagreement_score":0.0036116433,"about_ca_system_score_codex":0.00069517945,"about_ca_system_score_gemma":0.0015651851,"threshold_uncertainty_score":0.0120821595},"labels":[],"label_agreement":null},{"id":"W3127209017","doi":"10.1111/bjh.17281","title":"Outcome of relapsed and refractory nodular lymphocyte‐predominant Hodgkin lymphoma: a North American analysis","year":2021,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Spinal Cord Injury BC; BC Cancer Agency","funders":"NIH Clinical Center; Lymphoma Research Foundation","keywords":"Medicine; Internal medicine; Lenalidomide; Oncology; Refractory (planetary science); Rituximab; Chemotherapy; Chlorambucil; Brentuximab vedotin; Progression-free survival; Lymphoma; Salvage therapy; Surgery; Hodgkin lymphoma; Multiple myeloma; Cyclophosphamide","score_opus":0.011420359829982848,"score_gpt":0.2678203961424771,"score_spread":0.25640003631249425,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3127209017","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.999233,0.0002456466,0.000024566196,0.000015735399,0.0000019911442,0.0000037734428,0.00018708728,0.0000015372905,0.00028657416],"genre_scores_gemma":[0.99930656,0.000128359,0.000015728396,0.00001659302,0.0000088518045,0.000005812097,0.00045574296,0.0000018353343,0.000060481998],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9995597,0.00016772613,0.000048500562,0.00009147576,0.00006938195,0.000063213425],"domain_scores_gemma":[0.9989693,0.00023152067,0.00037572204,0.00009514583,0.00011786638,0.0002104071],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006909032,0.00021682998,0.00034004837,0.0006487299,0.00024595036,0.00038910072,0.00027657344,0.00034900432,0.00072086207],"category_scores_gemma":[0.0010121115,0.00015432393,0.00043906397,0.0008178712,0.00027596313,0.0003176202,0.0003685654,0.0002816227,0.00019564018],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00061183126,0.00006391898,0.9949432,0.000022829216,0.00021937971,0.0003739313,0.00012316737,0.00017150349,0.0003377373,0.000021782169,0.00016200454,0.0029486483],"study_design_scores_gemma":[0.000029236271,0.00016936228,0.99858224,0.0000059579083,0.000072676725,0.000529498,0.00011076184,0.00017872415,0.000042339198,0.00001627613,0.00025747274,0.000005425105],"about_ca_topic_score_codex":0.0039020719,"about_ca_topic_score_gemma":0.0033739659,"teacher_disagreement_score":0.0039020719,"about_ca_system_score_codex":0.000396322,"about_ca_system_score_gemma":0.0002347973,"threshold_uncertainty_score":0.0077587366},"labels":[],"label_agreement":null},{"id":"W3127479238","doi":"10.1111/bjh.17350","title":"Real‐world outcomes with bortezomib‐containing regimens and lenalidomide plus dexamethasone for the treatment of transplant‐ineligible multiple myeloma: a multi‐institutional report from the Canadian Myeloma Research Group database","year":2021,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Saint John Regional Hospital; Hôpital Maisonneuve-Rosemont; University of Calgary; Princess Margaret Cancer Centre; Vancouver General Hospital; CancerCare Manitoba; Ottawa Regional Cancer Foundation; Ottawa Hospital; Saskatchewan Cancer Agency; Alberta Cancer Foundation; Canadian Institutes of Health Research; Université de Montréal; University of Saskatchewan; University of Alberta; McGill University","funders":"","keywords":"Bortezomib; Lenalidomide; Multiple myeloma; Dexamethasone; Medicine; Regimen; Melphalan; Prednisone; Internal medicine; Oncology; Thalidomide; Cyclophosphamide; Chemotherapy","score_opus":0.09525598580510063,"score_gpt":0.36691124114013407,"score_spread":0.27165525533503343,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3127479238","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.84006613,0.0077963644,0.00017586208,0.0011743633,0.000022462931,0.00016278583,0.14713839,0.00003093514,0.003432708],"genre_scores_gemma":[0.92574185,0.0026120858,0.0004399911,0.0003936547,0.000017514885,0.00011020085,0.07036797,0.000010180366,0.00030652975],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99694866,0.00039007288,0.00045551546,0.00031698975,0.0015132213,0.00037548307],"domain_scores_gemma":[0.99089736,0.0010366559,0.0042936094,0.00035316215,0.0024648274,0.00095449726],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0019290486,0.00024095028,0.00054082595,0.0013922607,0.000639996,0.001393858,0.0010788143,0.00040355654,0.0011641895],"category_scores_gemma":[0.0079959,0.00017478033,0.00067367154,0.006868337,0.00037722033,0.00050756667,0.00063794927,0.00054073706,0.00015958899],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010021303,0.00005494419,0.97906977,0.0003352247,0.00047236992,0.0000611581,0.00017767963,0.00030461897,0.00009613971,0.00012665606,0.007236608,0.011062764],"study_design_scores_gemma":[0.000120993165,0.000058375044,0.9942392,0.00009492851,0.00019855531,0.000113442184,0.00027005194,0.00033664968,0.00009508254,0.00003002767,0.0044214074,0.000021422184],"about_ca_topic_score_codex":0.77688843,"about_ca_topic_score_gemma":0.86416304,"teacher_disagreement_score":0.22311157,"about_ca_system_score_codex":0.011683239,"about_ca_system_score_gemma":0.010114802,"threshold_uncertainty_score":0.448851},"labels":[],"label_agreement":null},{"id":"W3129079371","doi":"10.1111/bjh.17322","title":"Patients with haemophilia A with inhibitors in China: a national real‐world analysis and follow‐up","year":2021,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Hemophilia Treatment and Research","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Foothills Medical Centre; University of Calgary; Alberta Health Services","funders":"","keywords":"Medicine; Haemophilia; Haemophilia A; Interquartile range; Internal medicine; Odds ratio; Population; Gastroenterology; Confidence interval; Surgery; Complication; Pediatrics","score_opus":0.010520812217706822,"score_gpt":0.27333180635112164,"score_spread":0.2628109941334148,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3129079371","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99923587,0.00017716648,0.000032950888,0.000035556473,0.0000028255502,0.0000091358825,0.00028805842,0.0000018892611,0.00021655964],"genre_scores_gemma":[0.9991191,0.00015667881,0.000039878956,0.000036853213,0.0000077156865,0.000011236465,0.0005235243,8.9935406e-7,0.00010407687],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99949837,0.00007621582,0.00007233966,0.00013223721,0.000097485616,0.00012335119],"domain_scores_gemma":[0.9992466,0.00006226679,0.0002710972,0.00007215211,0.00012683684,0.000221068],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00048999116,0.0003253313,0.00037016525,0.0010286748,0.0009148856,0.0004985539,0.00038261074,0.00047101427,0.0010880496],"category_scores_gemma":[0.0007684441,0.00043663188,0.0005026104,0.0019813,0.0003949036,0.0007536723,0.0006597042,0.00044961472,0.00018016314],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000026420257,0.000015638667,0.99911684,0.0000060811226,0.000019231615,0.00010358688,0.00007246828,0.000019700057,0.00006972917,0.0000062111358,0.000047413905,0.00049675436],"study_design_scores_gemma":[0.000004008793,0.000025234784,0.99937916,0.0000028016648,0.000013859059,0.0002135101,0.0001596298,0.00008488943,0.00001689894,0.000006730716,0.00008999511,0.0000033179276],"about_ca_topic_score_codex":0.03836651,"about_ca_topic_score_gemma":0.025393888,"teacher_disagreement_score":0.03836651,"about_ca_system_score_codex":0.0011091237,"about_ca_system_score_gemma":0.0011002016,"threshold_uncertainty_score":0.076286376},"labels":[],"label_agreement":null},{"id":"W3130331670","doi":"10.1111/bjh.17326","title":"Safety and efficacy of obinutuzumab alone or with chemotherapy in previously untreated or relapsed/refractory chronic lymphocytic leukaemia patients: Final analysis of the Phase IIIb GREEN study","year":2021,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen Elizabeth II Health Sciences Centre","funders":"F. Hoffmann-La Roche","keywords":"Bendamustine; Medicine; Internal medicine; Chlorambucil; Fludarabine; Neutropenia; Obinutuzumab; Gastroenterology; Cyclophosphamide; Chemotherapy; Adverse effect; Oncology; Chronic lymphocytic leukemia; Surgery; Leukemia","score_opus":0.018755368573689667,"score_gpt":0.3081063094491247,"score_spread":0.28935094087543506,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3130331670","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9932319,0.0037522817,0.00019759404,0.00022805136,0.000033753742,0.00040947043,0.001137176,0.000024785058,0.0009849785],"genre_scores_gemma":[0.9931263,0.0012433822,0.0005037511,0.00053173595,0.000059983737,0.00047349875,0.003271441,0.000021353926,0.00076841516],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.999114,0.0004987947,0.00004140175,0.000116755444,0.000096166514,0.00013284197],"domain_scores_gemma":[0.99898714,0.00021498585,0.00037604853,0.00008501642,0.00006534955,0.00027143862],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0033484402,0.00072905957,0.0018797257,0.0004070852,0.00027498743,0.0012443886,0.00054059224,0.0007960329,0.0013393429],"category_scores_gemma":[0.0014797921,0.0002907324,0.0018248352,0.000627676,0.0006136184,0.00065368006,0.00042268977,0.0013366045,0.00030250582],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.82400554,0.007933918,0.048079357,0.0007979146,0.0044743824,0.00016518649,0.00027692356,0.002701141,0.013927966,0.00035981636,0.003616483,0.09366136],"study_design_scores_gemma":[0.4398332,0.35966048,0.17367153,0.00028247785,0.0050826473,0.0005529888,0.00020102,0.0031553023,0.0045219045,0.0010903289,0.011846077,0.00010206433],"about_ca_topic_score_codex":0.00053037755,"about_ca_topic_score_gemma":0.0020641682,"teacher_disagreement_score":0.0033484402,"about_ca_system_score_codex":0.0010591843,"about_ca_system_score_gemma":0.0010626353,"threshold_uncertainty_score":0.01770848},"labels":[],"label_agreement":null},{"id":"W3135026042","doi":"10.1111/bjh.17404","title":"The diagnostic and therapeutic challenges of Grade 3B follicular lymphoma","year":2021,"lang":"en","type":"review","venue":"British Journal of Haematology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":25,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Spinal Cord Injury BC; University of British Columbia; BC Cancer Agency","funders":"","keywords":"Medicine; Follicular lymphoma; Positron emission tomography; Clinical trial; Lymphoma; Medical physics; Intensive care medicine; Oncology; Pathology; Radiology","score_opus":0.045986671335053575,"score_gpt":0.3238952963564847,"score_spread":0.2779086250214311,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3135026042","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00010122954,0.9987508,0.0000727664,0.00066169543,0.00008829449,0.0000025998652,0.000011872605,0.0000028616496,0.0003077551],"genre_scores_gemma":[0.0019228348,0.9969222,0.00025681144,0.00048897864,0.00020076918,0.0000063722764,0.000030882376,0.0000019701536,0.00016917007],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9990514,0.00032666067,0.00020837807,0.000105196195,0.0002507082,0.0000575709],"domain_scores_gemma":[0.9975242,0.001723032,0.0002512491,0.000047767648,0.00039686618,0.000056948433],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0020851942,0.00051559805,0.0024797784,0.0020319007,0.00029465609,0.0017990643,0.000774998,0.0012821382,0.0028042386],"category_scores_gemma":[0.0044382783,0.00031893165,0.0009970878,0.0015824361,0.0006697107,0.0017333382,0.0007944245,0.0020852864,0.0009628168],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001031665,0.000018537014,0.00036394625,0.036686923,0.0002502664,0.00030304803,0.00012522387,0.00023160233,0.0005732043,0.0019257936,0.019500265,0.93991804],"study_design_scores_gemma":[0.000056905334,0.00017091694,0.0028357925,0.047106914,0.0010512129,0.005383716,0.0004548495,0.00017954115,0.00050761463,0.0053349775,0.93687296,0.000044509114],"about_ca_topic_score_codex":0.0022202316,"about_ca_topic_score_gemma":0.004137401,"teacher_disagreement_score":0.0028042386,"about_ca_system_score_codex":0.0008190602,"about_ca_system_score_gemma":0.001601735,"threshold_uncertainty_score":0.011027694},"labels":[],"label_agreement":null},{"id":"W3138534794","doi":"10.1111/bjh.17338","title":"Expert review on soft‐tissue plasmacytomas in multiple myeloma: definition, disease assessment and treatment considerations","year":2021,"lang":"en","type":"review","venue":"British Journal of Haematology","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":174,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; Hotel Dieu Hospital","funders":"Instituto de Salud Carlos III","keywords":"Medicine; Bortezomib; Multiple myeloma; Lenalidomide; Thalidomide; Regimen; Autologous stem-cell transplantation; Internal medicine; Oncology; Etoposide; Melphalan; Cyclophosphamide; Population; Dexamethasone; Surgery; Chemotherapy","score_opus":0.12401649811821401,"score_gpt":0.4253183885157965,"score_spread":0.3013018903975825,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3138534794","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0000639765,0.9980708,0.00008392743,0.00055447704,0.0004130716,0.000009700899,0.000046001285,0.000005740641,0.0007522912],"genre_scores_gemma":[0.00047276926,0.99785244,0.00020754467,0.00052811834,0.0003376756,0.000011981462,0.00009283575,0.0000020489072,0.00049455767],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9996406,0.00007304602,0.00009074406,0.000053261097,0.000115831215,0.000026572694],"domain_scores_gemma":[0.9989077,0.0005591484,0.00019181575,0.00001932775,0.00027546863,0.00004658856],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008790708,0.0007127452,0.0015853075,0.0032411073,0.00021555467,0.0010606176,0.0010074304,0.0011789802,0.0070323497],"category_scores_gemma":[0.0021844234,0.00026940336,0.001029592,0.002973535,0.00030490995,0.0012357609,0.00065068906,0.0013220904,0.002128105],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008764988,0.00003595278,0.00014865308,0.07192888,0.00020155984,0.00030342178,0.00009217368,0.00033278504,0.00084612175,0.0016072525,0.09602507,0.82839054],"study_design_scores_gemma":[0.000040669674,0.00008102653,0.0009276312,0.037412517,0.0005056586,0.0022607057,0.00006878876,0.00008240359,0.0002303914,0.0012328007,0.9571337,0.000023762308],"about_ca_topic_score_codex":0.0013153107,"about_ca_topic_score_gemma":0.0025141132,"teacher_disagreement_score":0.0070323497,"about_ca_system_score_codex":0.00060823705,"about_ca_system_score_gemma":0.0016069945,"threshold_uncertainty_score":0.023525596},"labels":[],"label_agreement":null},{"id":"W3155637160","doi":"10.1111/bjh.17447","title":"Optimal duration of imatinib treatment/deep molecular response for treatment‐free remission after imatinib discontinuation from a Canadian tyrosine kinase inhibitor discontinuation trial","year":2021,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McMaster University; Toronto General Hospital; University of Alberta; London Health Sciences Centre; Hôpital de l'Enfant-Jésus; Université de Montréal; Hôpital Maisonneuve-Rosemont; Queen Elizabeth II Health Sciences Centre; McGill University Health Centre; University of Ottawa; Princess Margaret Cancer Centre; Vancouver General Hospital; University of Calgary; BC Cancer Agency; Alberta Health Services; CancerCare Manitoba; University Health Network; Ottawa Hospital; Dalhousie University; Western University; University of Toronto; University of British Columbia","funders":"","keywords":"Discontinuation; Imatinib; Medicine; Internal medicine; Tyrosine-kinase inhibitor; Imatinib mesylate; Gastroenterology; Cancer","score_opus":0.013217752408859433,"score_gpt":0.27940593252199886,"score_spread":0.26618818011313944,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3155637160","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9879292,0.006496411,0.00024931648,0.000725507,0.000065743516,0.00021179645,0.0016726253,0.000018467657,0.00263104],"genre_scores_gemma":[0.9971162,0.0005810565,0.00022834794,0.00022351205,0.00004418814,0.00006605661,0.0012605827,0.000004740191,0.00047536977],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.99905616,0.00030981188,0.000049188693,0.00011598317,0.00022706673,0.00024176938],"domain_scores_gemma":[0.99827945,0.00041214126,0.00044829032,0.00008686296,0.0001889926,0.00058428926],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002154075,0.00035750907,0.0010959739,0.00021417755,0.000489132,0.00064017356,0.00048011844,0.00062587764,0.0014639678],"category_scores_gemma":[0.002803532,0.00010937897,0.0010457385,0.00046086067,0.00031180796,0.00026245994,0.0002856775,0.00091035006,0.00008375122],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.5743121,0.0010479486,0.2691165,0.0009211685,0.0028420635,0.00032928216,0.00026132987,0.0046642413,0.0065076337,0.0008898448,0.006105584,0.13300227],"study_design_scores_gemma":[0.03445265,0.018304281,0.92816496,0.00031167938,0.0030434716,0.0002469902,0.00012778975,0.0042555905,0.0013098905,0.00059043255,0.009104356,0.00008789213],"about_ca_topic_score_codex":0.115786225,"about_ca_topic_score_gemma":0.25626326,"teacher_disagreement_score":0.8842138,"about_ca_system_score_codex":0.0026274282,"about_ca_system_score_gemma":0.004962765,"threshold_uncertainty_score":0.23022455},"labels":[],"label_agreement":null},{"id":"W3155962936","doi":"10.1111/bjh.17444","title":"How much imatinib is enough?","year":2021,"lang":"en","type":"letter","venue":"British Journal of Haematology","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Imatinib; Discontinuation; Dasatinib; Medicine; Tyrosine kinase; Hematology; Tyrosine-kinase inhibitor; Internal medicine; Oncology; Imatinib mesylate; Myeloid leukemia; Cancer","score_opus":0.023454219672114904,"score_gpt":0.26698682004997143,"score_spread":0.2435326003778565,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3155962936","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.023578048,0.14388327,0.0006219473,0.7987315,0.006799998,0.000054043787,0.00042167425,0.000054680626,0.025854895],"genre_scores_gemma":[0.29371473,0.11392068,0.0017149709,0.56101334,0.01613295,0.00015534066,0.00075608003,0.00008743007,0.012504523],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99634665,0.0018101333,0.00043460476,0.0003287578,0.0008102646,0.00026958625],"domain_scores_gemma":[0.9918283,0.004491333,0.0012391108,0.00022797313,0.0008784023,0.0013349198],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004679885,0.0002473397,0.00087312434,0.00043909054,0.00087375555,0.003073261,0.00058196404,0.0023209278,0.009752623],"category_scores_gemma":[0.021836692,0.00020094535,0.00045384542,0.0005391989,0.0018328879,0.004317319,0.0010684202,0.0037402587,0.0023237693],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017071432,0.00017493151,0.015597185,0.0017025288,0.00024719318,0.0006856753,0.0007138447,0.00010827553,0.00087034825,0.009654069,0.21937244,0.7491664],"study_design_scores_gemma":[0.00082654617,0.0013757435,0.033628076,0.006695554,0.00061308226,0.004744962,0.0039290604,0.00033023005,0.0011569228,0.051160477,0.89539325,0.00014607978],"about_ca_topic_score_codex":0.0010677237,"about_ca_topic_score_gemma":0.0033438045,"teacher_disagreement_score":0.009752623,"about_ca_system_score_codex":0.0016742048,"about_ca_system_score_gemma":0.0019096333,"threshold_uncertainty_score":0.032625794},"labels":[],"label_agreement":null},{"id":"W3157181626","doi":"10.1111/bjh.17450","title":"Comparison of immunohistochemistry and gene expression profiling subtyping for diffuse large B‐cell lymphoma in the phase III clinical trial of R‐CHOP ± ibrutinib","year":2021,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Spinal Cord Injury BC","funders":"Janssen Research and Development; National Institutes of Health","keywords":"Ibrutinib; Diffuse large B-cell lymphoma; Internal medicine; Vincristine; Rituximab; Concordance; CHOP; Oncology; Medicine; Hazard ratio; Immunohistochemistry; Lymphoma; Cyclophosphamide; Subtyping; Confidence interval; Chemotherapy; Leukemia; Chronic lymphocytic leukemia","score_opus":0.05427044841385749,"score_gpt":0.41826787618117156,"score_spread":0.3639974277673141,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3157181626","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99633056,0.0019119303,0.0005510801,0.00012298708,0.00004730094,0.000099092525,0.00015879945,0.000024091612,0.000754178],"genre_scores_gemma":[0.99889404,0.00017224904,0.00024044854,0.00010148805,0.000022717551,0.000064210144,0.00035333892,0.000007884553,0.000143591],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9957508,0.0029190958,0.0001678075,0.0004904576,0.00049453526,0.00017725053],"domain_scores_gemma":[0.9946597,0.0025443088,0.0014217213,0.0004915484,0.0005188969,0.00036381555],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.010426315,0.00055276207,0.0011853939,0.00028300428,0.00016047418,0.00086568616,0.0005358773,0.0005988012,0.00043330173],"category_scores_gemma":[0.00671978,0.0003904974,0.0006822681,0.00033575832,0.000410725,0.00047870388,0.00035195544,0.00091153575,0.00020300226],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.29764697,0.0014966264,0.57292885,0.0004211109,0.005424347,0.00016426624,0.0005414338,0.005424137,0.03389032,0.00015270074,0.0015830396,0.08032621],"study_design_scores_gemma":[0.01835133,0.04483939,0.91163856,0.000052046034,0.0023032096,0.0004483661,0.00017299097,0.012272333,0.0071322145,0.00027473675,0.0024554238,0.000059374754],"about_ca_topic_score_codex":0.00045957832,"about_ca_topic_score_gemma":0.0008565529,"teacher_disagreement_score":0.010426315,"about_ca_system_score_codex":0.00049248367,"about_ca_system_score_gemma":0.00041721654,"threshold_uncertainty_score":0.055140257},"labels":[],"label_agreement":null},{"id":"W3157661441","doi":"10.1111/bjh.17438","title":"Viral hepatitis in haemophilia: historical perspective and current management","year":2021,"lang":"en","type":"review","venue":"British Journal of Haematology","topic":"Hepatitis C virus research","field":"Medicine","cited_by":28,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Infection and Immunity","funders":"Grifols; Universitair Medisch Centrum Utrecht; Swedish Orphan Biovitrum; CSL Behring; Gilead Sciences; Sanofi; Pfizer","keywords":"Haemophilia; Clotting factor; Medicine; Blood clotting; Immunology; Viral hepatitis; Transmission (telecommunications); Virology; Hepatitis C virus; Vaccination; Viral disease; Hepatitis C; Natural history; Hepatitis; Human immunodeficiency virus (HIV); Virus; Pediatrics; Internal medicine","score_opus":0.060529879623563654,"score_gpt":0.39718481629393415,"score_spread":0.3366549366703705,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3157661441","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000043735854,0.9989666,0.00001897368,0.00031558,0.00027085998,9.148873e-7,0.000005015677,0.0000020013986,0.0003763222],"genre_scores_gemma":[0.00034684973,0.9987835,0.00004205835,0.00019463057,0.00045307502,0.0000016885092,0.000009398887,5.3419376e-7,0.0001683064],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99976724,0.00005780714,0.00004677969,0.00003705066,0.00006806125,0.000022953209],"domain_scores_gemma":[0.99936146,0.00032466315,0.00010449551,0.000015180875,0.00012978101,0.00006449605],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006618419,0.0008711851,0.0011942857,0.003147891,0.00037667484,0.001446699,0.0007667124,0.0011908545,0.0034762148],"category_scores_gemma":[0.0013763582,0.00030016902,0.00040667155,0.0037613253,0.00074168533,0.002054246,0.0006535872,0.002119124,0.0017798616],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012329209,0.000074404554,0.0004898761,0.025820013,0.00008787247,0.0006560742,0.0002724106,0.00034714284,0.00054017967,0.0062951357,0.07595375,0.8893399],"study_design_scores_gemma":[0.00001235069,0.0001054572,0.0015759937,0.015292511,0.00011470919,0.004571602,0.00024931753,0.000060836657,0.00010142861,0.0027827495,0.97510594,0.000027031421],"about_ca_topic_score_codex":0.0014118105,"about_ca_topic_score_gemma":0.0018290995,"teacher_disagreement_score":0.0034762148,"about_ca_system_score_codex":0.00073998637,"about_ca_system_score_gemma":0.0011573733,"threshold_uncertainty_score":0.011629045},"labels":[],"label_agreement":null},{"id":"W3160548032","doi":"","title":"The psychological impact of the COVID-19 pandemic on multiple myeloma patients","year":2021,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Cancer survivorship and care","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Interquartile range; Quality of life (healthcare); Family medicine; Patient satisfaction; Observational study; Internal medicine; Surgery; Nursing","score_opus":0.041681356166496396,"score_gpt":0.35497236904638124,"score_spread":0.31329101287988487,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3160548032","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9933119,0.00085323455,0.000027080243,0.0022828057,0.000045938654,0.000017011202,0.00067629537,0.0000043338882,0.0027815162],"genre_scores_gemma":[0.99834144,0.00042612,0.000032727654,0.00056727853,0.00004440886,0.000012817763,0.0002433529,0.0000013483628,0.00033044178],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9993549,0.00030909636,0.000056288965,0.00003005384,0.0001102321,0.00013954338],"domain_scores_gemma":[0.99833256,0.00030795232,0.00077332946,0.000032963475,0.00013683873,0.00041629942],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00081026956,0.000092614515,0.00020861141,0.00034438734,0.00067282305,0.0010280273,0.00016422648,0.00032280313,0.0036829785],"category_scores_gemma":[0.0040977937,0.00007685885,0.00030173562,0.0006521313,0.00037426664,0.00044640535,0.0009798439,0.0008266278,0.00029644847],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00023673863,0.00015130363,0.97286236,0.00008999092,0.00007232657,0.0002455392,0.0015830126,0.00007437968,0.00018937845,0.0000997781,0.0038182763,0.020576896],"study_design_scores_gemma":[0.000009157246,0.0001543933,0.9927806,0.000042570755,0.000016077292,0.00038190704,0.004229062,0.000085729895,0.00004365046,0.000044837012,0.0022039392,0.000008134135],"about_ca_topic_score_codex":0.004134553,"about_ca_topic_score_gemma":0.006918497,"teacher_disagreement_score":0.004134553,"about_ca_system_score_codex":0.00071631157,"about_ca_system_score_gemma":0.00063109124,"threshold_uncertainty_score":0.012320757},"labels":[],"label_agreement":null},{"id":"W3162049986","doi":"10.1111/bjh.17420","title":"A phase 3, randomized study of ofatumumab combined with bendamustine in rituximab‐refractory iNHL (COMPLEMENT A + B study)","year":2021,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University","funders":"Novartis Pharma","keywords":"Ofatumumab; Bendamustine; Medicine; Rituximab; Internal medicine; Clinical endpoint; Neutropenia; Adverse effect; Combination therapy; Chemoimmunotherapy; Oncology; Randomized controlled trial; Chemotherapy; Lymphoma","score_opus":0.021369117207070507,"score_gpt":0.31655173029278194,"score_spread":0.2951826130857114,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3162049986","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9793099,0.0053923125,0.0010862597,0.0012042872,0.000709038,0.0070191147,0.0022867222,0.00016016436,0.0028322204],"genre_scores_gemma":[0.9794883,0.0033586589,0.0026397235,0.0024380155,0.0004899585,0.006065715,0.0024020567,0.00003960631,0.0030780057],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99931943,0.00039844317,0.00003260372,0.00010435389,0.000055802197,0.000089332694],"domain_scores_gemma":[0.9990688,0.000267825,0.00024563505,0.00006079477,0.000076064876,0.00028087312],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0026897576,0.0013853341,0.0020121252,0.0004109308,0.00039588756,0.0011073722,0.000627854,0.0016293282,0.0044073714],"category_scores_gemma":[0.0018463966,0.000692413,0.002442162,0.0003720586,0.0006423665,0.00075786357,0.0004359793,0.0031920734,0.0007610143],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.96434385,0.007601611,0.0011558965,0.0005237308,0.0022481026,0.000074713105,0.00006591925,0.00040621377,0.004111273,0.00017101414,0.001795512,0.01750218],"study_design_scores_gemma":[0.94469243,0.0508501,0.0019750132,0.000028654362,0.0006807624,0.000045554945,0.000012182924,0.00030412644,0.00029298922,0.0001479512,0.00095705385,0.000013217328],"about_ca_topic_score_codex":0.0008636062,"about_ca_topic_score_gemma":0.0024665957,"teacher_disagreement_score":0.0044073714,"about_ca_system_score_codex":0.0007488268,"about_ca_system_score_gemma":0.0012698687,"threshold_uncertainty_score":0.014744163},"labels":[],"label_agreement":null},{"id":"W3164281877","doi":"10.1111/bjh.17537","title":"Patient‐reported fatigue refines prognosis in higher‐risk myelodysplastic syndromes (MDS): a MDS‐CAN study","year":2021,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Saskatoon Medical Imaging; Université Laval; Royal Victoria Hospital; Royal Victoria Regional Health Centre; Vancouver General Hospital; Princess Margaret Cancer Centre; Dr. Georges-L.-Dumont University Hospital Centre; St. Paul's Hospital; Centre hospitalier de l'Université Laval; Alberta Hospital Edmonton; University of British Columbia; Sunnybrook Health Science Centre; Jewish General Hospital; McGill University Health Centre; University of Ottawa; Queen Elizabeth II Health Sciences Centre; CancerCare Manitoba; Saskatchewan Cancer Agency; University of Alberta Hospital; Health Sciences Centre; Juravinski Cancer Centre","funders":"","keywords":"International Prognostic Scoring System; Medicine; Myelodysplastic syndromes; Quality of life (healthcare); Internal medicine; Rating scale; Risk assessment; Disease; Physical therapy; Psychology; Bone marrow","score_opus":0.052329744327299005,"score_gpt":0.31594641755058034,"score_spread":0.2636166732232813,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3164281877","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9964296,0.0004984989,0.00019304043,0.00016778328,0.000012147506,0.00006450535,0.0009852299,0.000007940634,0.0016413247],"genre_scores_gemma":[0.99821556,0.00013996667,0.00015726058,0.000045692566,0.000030270232,0.000024495188,0.00090000604,0.0000040679106,0.0004827908],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99925286,0.00024963063,0.00004362411,0.00014707644,0.00014484195,0.00016191605],"domain_scores_gemma":[0.99789447,0.0003741199,0.00059704256,0.00040066932,0.0003561478,0.00037757843],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0035725962,0.00068717136,0.00039424456,0.0006869661,0.0007426256,0.0007822593,0.0006884913,0.0005187997,0.0036646205],"category_scores_gemma":[0.005111859,0.00021402139,0.00058052177,0.0012557756,0.00061711355,0.00047513703,0.0009720521,0.0005015344,0.00047523147],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00088900496,0.00008341427,0.99405646,0.000030651037,0.00016850242,0.000060693626,0.00013888298,0.00011263048,0.00020735426,0.00006116708,0.00040687213,0.0037843636],"study_design_scores_gemma":[0.000059060156,0.00018139921,0.99812275,0.000011376387,0.00014929677,0.00010809438,0.00011633899,0.00022408551,0.00004226869,0.000053808173,0.0009237765,0.000007760849],"about_ca_topic_score_codex":0.108983964,"about_ca_topic_score_gemma":0.1884675,"teacher_disagreement_score":0.108983964,"about_ca_system_score_codex":0.0015856994,"about_ca_system_score_gemma":0.0024791923,"threshold_uncertainty_score":0.21669924},"labels":[],"label_agreement":null},{"id":"W3165141334","doi":"10.1111/bjh.17551","title":"Mass Cytometry: a robust platform for the comprehensive immunomonitoring of CAR‐T‐cell therapies","year":2021,"lang":"en","type":"letter","venue":"British Journal of Haematology","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Mass cytometry; Immune system; Medicine; Immunology; Cytometry; Flow cytometry; Immunotherapy; Cancer research; Biology","score_opus":0.06295627033005305,"score_gpt":0.3147752223489589,"score_spread":0.2518189520189058,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3165141334","genre_codex":"methods","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.071768224,0.006690813,0.9022849,0.00084037124,0.00029856706,0.0013235202,0.00381633,0.0074689696,0.005508297],"genre_scores_gemma":[0.25968605,0.0052251983,0.7145454,0.0009953197,0.0005996838,0.00371562,0.005336728,0.00085011247,0.009045892],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.997792,0.00043125884,0.0001252832,0.00055730215,0.0009482534,0.00014595984],"domain_scores_gemma":[0.9994141,0.0001576629,0.00011647973,0.000120572564,0.00011080633,0.00008042487],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0021144685,0.0014783272,0.0010380795,0.0024500045,0.00056348334,0.0014869063,0.0016223043,0.0013991845,0.0048069665],"category_scores_gemma":[0.0013603956,0.00065881235,0.0004628881,0.0007924515,0.00077700685,0.001128754,0.0015190301,0.0016729899,0.0035673787],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001428464,0.00008856754,0.0005435931,0.00015504766,0.000027482722,0.00007837944,0.000056736608,0.00062542845,0.96026474,0.0015384892,0.0028084356,0.03367017],"study_design_scores_gemma":[0.000060107915,0.0003942562,0.0019066028,0.000036905512,0.000042091982,0.0004929561,0.00002050578,0.013042227,0.9558898,0.0012051082,0.026852004,0.00005747589],"about_ca_topic_score_codex":0.00029562463,"about_ca_topic_score_gemma":0.00040472543,"teacher_disagreement_score":0.0048069665,"about_ca_system_score_codex":0.0007215349,"about_ca_system_score_gemma":0.00057139713,"threshold_uncertainty_score":0.016080916},"labels":[],"label_agreement":null},{"id":"W3165234271","doi":"10.1111/bjh.17541","title":"Carfilzomib, dexamethasone and daratumumab in relapsed or refractory multiple myeloma: results of the phase III study CANDOR by prior lines of therapy","year":2021,"lang":"en","type":"letter","venue":"British Journal of Haematology","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"Amgen","keywords":"Lenalidomide; Daratumumab; Carfilzomib; Medicine; Multiple myeloma; Bortezomib; Oncology; Internal medicine; Dexamethasone; Proteasome inhibitor; Ixazomib","score_opus":0.039036589010301034,"score_gpt":0.33193391277954026,"score_spread":0.2928973237692392,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3165234271","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.88262534,0.093855895,0.0010442995,0.004179902,0.0007849501,0.0020360386,0.0055939723,0.0001962175,0.009683406],"genre_scores_gemma":[0.92601687,0.04050409,0.0028841428,0.005678634,0.0017247546,0.0017605092,0.0140568,0.00012580777,0.0072483798],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9980603,0.0009761881,0.00010256041,0.00021401697,0.00039227805,0.0002546738],"domain_scores_gemma":[0.9977041,0.00058666454,0.00050812657,0.0001639501,0.00019269488,0.00084457133],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005792635,0.001192743,0.002749185,0.00032616017,0.00044479803,0.0015970294,0.00096308655,0.0013682415,0.0024869945],"category_scores_gemma":[0.0023000631,0.0003303281,0.0031165308,0.0005460693,0.0007069919,0.0008604385,0.00046305513,0.0035817216,0.0006629403],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.6788296,0.028896015,0.015068651,0.0014101232,0.0056202607,0.00023175805,0.0002908565,0.0020511528,0.009925625,0.0005750954,0.016260074,0.24084075],"study_design_scores_gemma":[0.51563007,0.36876193,0.07207263,0.00036732346,0.004559787,0.0006002278,0.000114853785,0.001761057,0.0046876594,0.00046133468,0.030890577,0.00009257781],"about_ca_topic_score_codex":0.002294593,"about_ca_topic_score_gemma":0.0061181923,"teacher_disagreement_score":0.005792635,"about_ca_system_score_codex":0.0013624051,"about_ca_system_score_gemma":0.001930181,"threshold_uncertainty_score":0.03063476},"labels":[],"label_agreement":null},{"id":"W3168080535","doi":"10.1111/bjh.17507","title":"Thrombosis and myeloma: it is time to get the elephant out of the room","year":2021,"lang":"en","type":"letter","venue":"British Journal of Haematology","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University; London Health Sciences Centre","funders":"","keywords":"Medicine; Internal medicine; Multiple myeloma; Cancer; Hazard ratio; Thrombosis; Pulmonary embolism; Malignancy; Deep vein; Incidence (geometry); Gastroenterology; Surgery; Oncology; Confidence interval","score_opus":0.02268384006164728,"score_gpt":0.272954111887821,"score_spread":0.2502702718261737,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3168080535","genre_codex":"review","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.004213338,0.570951,0.0004213374,0.40441594,0.011022354,0.00001511861,0.00012380618,0.00006338973,0.008773641],"genre_scores_gemma":[0.059133373,0.7356998,0.0009156449,0.13370498,0.05840865,0.000043052307,0.0002887851,0.00005666301,0.011749033],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99823415,0.00057950127,0.00017135007,0.00022745444,0.0005497963,0.0002377919],"domain_scores_gemma":[0.99721354,0.0009338183,0.00048275533,0.00009903186,0.00051406486,0.00075687555],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0021119746,0.0004407054,0.0009947574,0.0008790185,0.0017975449,0.0055243033,0.0006852131,0.0048409533,0.014035397],"category_scores_gemma":[0.007804246,0.0002759221,0.00050580886,0.0015678768,0.0022025115,0.004704269,0.0024246662,0.0067498283,0.0030667274],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00067370705,0.00019831097,0.013335531,0.002358601,0.00022200416,0.001495689,0.0016368577,0.00013484187,0.0005124626,0.020530825,0.42009372,0.53880745],"study_design_scores_gemma":[0.00009381299,0.00029921575,0.011539932,0.0072002597,0.00014463831,0.0071155424,0.0020834531,0.00010421027,0.00017703263,0.03054405,0.94063044,0.00006752671],"about_ca_topic_score_codex":0.0037439778,"about_ca_topic_score_gemma":0.0037090762,"teacher_disagreement_score":0.014035397,"about_ca_system_score_codex":0.001902158,"about_ca_system_score_gemma":0.0026467824,"threshold_uncertainty_score":0.046953082},"labels":[],"label_agreement":null},{"id":"W3168255462","doi":"10.1111/bjh.17476","title":"Thromboembolic risk in patients with lung cancer receiving systemic therapy","year":2021,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"U.S. Department of Veterans Affairs","keywords":"Medicine; Internal medicine; Thrombosis; Incidence (geometry); Chemotherapy; Retrospective cohort study; Confounding; Cancer; Lung cancer; Oncology; Cohort; Immunotherapy; Cohort study; Surgery","score_opus":0.007592728411007423,"score_gpt":0.2574933553613805,"score_spread":0.2499006269503731,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3168255462","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9988896,0.00046842152,0.00006179497,0.000039289538,0.000005785637,0.000003849547,0.00013694119,0.0000022860597,0.00039195773],"genre_scores_gemma":[0.99965906,0.000093367285,0.000034068977,0.00002050446,0.000011473629,0.0000024162819,0.00010729306,5.553204e-7,0.00007139356],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9996855,0.000118644486,0.000032751876,0.000051474854,0.000060044735,0.000051546278],"domain_scores_gemma":[0.9989801,0.00019790273,0.00051055243,0.00006137363,0.00007205044,0.00017795415],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00029928974,0.00011977753,0.0002772419,0.00030772254,0.00023095572,0.00042894974,0.00014135514,0.0002594161,0.0008993252],"category_scores_gemma":[0.001557413,0.0001357686,0.00026433612,0.00056559604,0.00014782746,0.00021838048,0.00015538455,0.00042717365,0.00011925239],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000054124364,0.0000124213875,0.99915004,0.000002824052,0.000019784195,0.000054907643,0.000014977995,0.000019380434,0.000055098102,0.000006760956,0.000033080545,0.0005765535],"study_design_scores_gemma":[0.000007688149,0.00021367248,0.9982324,0.0000051524808,0.000031381907,0.00092872954,0.00008283153,0.0001421381,0.00006780987,0.000020684649,0.00026454922,0.000003069498],"about_ca_topic_score_codex":0.0025746147,"about_ca_topic_score_gemma":0.0028967657,"teacher_disagreement_score":0.0025746147,"about_ca_system_score_codex":0.00017915007,"about_ca_system_score_gemma":0.00018269311,"threshold_uncertainty_score":0.005119264},"labels":[],"label_agreement":null},{"id":"W3168576198","doi":"10.1111/bjh.17617","title":"Association of frailty with clinical outcomes in myelofibrosis: a retrospective cohort study","year":2021,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre; Toronto General Hospital; Princess Margaret Cancer Centre","funders":"Princess Margaret Cancer Foundation","keywords":"Medicine; Hazard ratio; Internal medicine; Myelofibrosis; Retrospective cohort study; Cohort; Proportional hazards model; Incidence (geometry); Cumulative incidence; Cohort study; Confidence interval; Surgery; Bone marrow","score_opus":0.02073554156395444,"score_gpt":0.3295500093735605,"score_spread":0.30881446780960603,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3168576198","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9988695,0.00034424034,0.00014992259,0.000022979293,0.0000051783973,0.00001559459,0.0004518919,0.000002826562,0.00013784094],"genre_scores_gemma":[0.9991259,0.00014387685,0.00011042503,0.00002974888,0.000010143638,0.000017090188,0.00051588885,0.0000023352957,0.000044626173],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99903274,0.00020158353,0.00014810366,0.00034912885,0.00014151663,0.00012689366],"domain_scores_gemma":[0.9976299,0.00028770682,0.0010297825,0.00045726702,0.00024308369,0.00035226616],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0018004195,0.0003387819,0.0005325787,0.0009586694,0.0006075942,0.0007179323,0.00042459008,0.000419293,0.0007956765],"category_scores_gemma":[0.0030611253,0.00044616268,0.0007107601,0.0013345528,0.00034947024,0.0005823533,0.0007165379,0.0006525248,0.00016975502],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012821006,0.000018227407,0.99880314,0.000008300208,0.00010983899,0.000084396896,0.00005290653,0.000031336727,0.00010487419,0.000015237865,0.00007941091,0.00056414824],"study_design_scores_gemma":[0.000017079275,0.00015428315,0.998483,0.000012497692,0.00009934155,0.00054751884,0.00013903725,0.00021832593,0.000036982146,0.000036773836,0.00024644175,0.0000087626195],"about_ca_topic_score_codex":0.005068107,"about_ca_topic_score_gemma":0.00537734,"teacher_disagreement_score":0.005068107,"about_ca_system_score_codex":0.00035352167,"about_ca_system_score_gemma":0.0005058156,"threshold_uncertainty_score":0.0100771785},"labels":[],"label_agreement":null},{"id":"W3168849811","doi":"10.1111/bjh.17448","title":"Pembrolizumab combined with carfilzomib and low‐dose dexamethasone for relapsed or refractory multiple myeloma: Cohort 2 of the phase I KEYNOTE‐023 study","year":2021,"lang":"en","type":"letter","venue":"British Journal of Haematology","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hotel Dieu Hospital","funders":"Merck","keywords":"Carfilzomib; Medicine; Pembrolizumab; Dexamethasone; Daratumumab; Multiple myeloma; Cohort; Oncology; Refractory (planetary science); Lenalidomide; Internal medicine; Cancer; Immunotherapy; Materials science","score_opus":0.030762873772526903,"score_gpt":0.31395151268870836,"score_spread":0.28318863891618146,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3168849811","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9514174,0.011720876,0.0011279738,0.0019751647,0.000592873,0.009966784,0.017849306,0.00015320217,0.0051964843],"genre_scores_gemma":[0.9365411,0.008379877,0.0032349017,0.004234291,0.000980643,0.0110316705,0.029231474,0.000109668814,0.0062563433],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.99913883,0.00033177278,0.000049511636,0.00021043337,0.000105217936,0.00016423472],"domain_scores_gemma":[0.9989029,0.00011940647,0.00028552566,0.00013172168,0.000109902154,0.00045052596],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0030818104,0.0023287116,0.0028827952,0.00035186333,0.0006426883,0.002063523,0.0015294476,0.0018333348,0.006046149],"category_scores_gemma":[0.00203599,0.00082127395,0.0034830254,0.0006015985,0.0007093354,0.0011754687,0.0006729247,0.004112229,0.0017884884],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.88105655,0.030847572,0.014865708,0.0016420508,0.0067371703,0.00026181055,0.00024645164,0.0014495124,0.009049877,0.00034488307,0.011819192,0.041679285],"study_design_scores_gemma":[0.75691867,0.18664762,0.03374985,0.00026049005,0.0049261665,0.00047182877,0.00013485247,0.0009033019,0.0018333317,0.00038611697,0.013687268,0.00008041925],"about_ca_topic_score_codex":0.0027703661,"about_ca_topic_score_gemma":0.005430308,"teacher_disagreement_score":0.006046149,"about_ca_system_score_codex":0.002251499,"about_ca_system_score_gemma":0.002984395,"threshold_uncertainty_score":0.02022636},"labels":[],"label_agreement":null},{"id":"W3170560832","doi":"10.1111/bjh.17615","title":"Treatment of lymphocyte‐variant hypereosinophilic syndrome (L‐HES): what to consider after confirming the elusive diagnosis","year":2021,"lang":"en","type":"review","venue":"British Journal of Haematology","topic":"Eosinophilic Disorders and Syndromes","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Medicine; Hypereosinophilic syndrome; Alemtuzumab; Discontinuation; Internal medicine; Mepolizumab; Monoclonal; Monoclonal antibody; Immunology; Gastroenterology; Oncology; Eosinophilia; Antibody; Eosinophil","score_opus":0.04424739997915796,"score_gpt":0.3373157517829593,"score_spread":0.29306835180380136,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3170560832","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.028893718,0.8611922,0.0043871882,0.09316168,0.004667252,0.00014610945,0.0002542633,0.00013650286,0.007161075],"genre_scores_gemma":[0.28118983,0.59066236,0.015155002,0.08319747,0.023902517,0.0002988064,0.001020255,0.00010170274,0.004472031],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9987563,0.0004518575,0.0003210882,0.0001101355,0.00024559733,0.0001150149],"domain_scores_gemma":[0.9930461,0.004404491,0.0006911417,0.00015699453,0.0011246027,0.0005766775],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0021184455,0.0005339434,0.0025651068,0.0010648248,0.00090378686,0.0019930208,0.0010298686,0.003999554,0.0034187085],"category_scores_gemma":[0.010144943,0.0002539038,0.0011432606,0.0006226292,0.0011572929,0.004051593,0.00048412243,0.0032591904,0.0011787366],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017159459,0.00044053842,0.035370033,0.010169902,0.00061131676,0.033773,0.0005165581,0.0006667442,0.002667619,0.0029719067,0.108316444,0.80278003],"study_design_scores_gemma":[0.0014486065,0.002008202,0.066312686,0.07370985,0.0027659957,0.21203788,0.010691725,0.0024728917,0.0061837956,0.032200404,0.58965075,0.00051721744],"about_ca_topic_score_codex":0.0019304923,"about_ca_topic_score_gemma":0.0031931263,"teacher_disagreement_score":0.003999554,"about_ca_system_score_codex":0.0008716152,"about_ca_system_score_gemma":0.0016022047,"threshold_uncertainty_score":0.01143676},"labels":[],"label_agreement":null},{"id":"W3171915784","doi":"10.1111/bjh.17566","title":"Performance characteristics of platelet autoantibody testing for the diagnosis of immune thrombocytopenia using strict clinical criteria","year":2021,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary; McMaster University","funders":"Canadian Institutes of Health Research","keywords":"Autoantibody; Medicine; Immune thrombocytopenia; Platelet; Confidence interval; Immunology; Internal medicine; Gastroenterology; Predictive value of tests; Immunopathology; Antibody","score_opus":0.08226177243990211,"score_gpt":0.37258094884522674,"score_spread":0.2903191764053246,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3171915784","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9957273,0.0008486598,0.0008593644,0.00010857132,0.000027422244,0.000026239155,0.00031309377,0.000025558245,0.0020637782],"genre_scores_gemma":[0.9993143,0.000039225135,0.00017988923,0.00002965981,0.000012339335,0.000008223798,0.00032388093,0.00000584073,0.00008660029],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99354386,0.002503486,0.0009953423,0.0011290123,0.0013258833,0.0005023161],"domain_scores_gemma":[0.95415944,0.02773467,0.010307254,0.0021362007,0.0033512898,0.0023112532],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.008014404,0.00044195255,0.0005966981,0.0014925785,0.0002907446,0.0010454057,0.00059122185,0.0011900319,0.001387861],"category_scores_gemma":[0.034119498,0.00020156841,0.0007982574,0.0012104391,0.00060667854,0.00072560256,0.000677414,0.0006335618,0.0008485738],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00068610016,0.000034724435,0.99471587,0.00001536938,0.00009386925,0.00010409152,0.000052012394,0.00043283336,0.00033758863,0.000052975865,0.00015092888,0.0033234863],"study_design_scores_gemma":[0.00002689768,0.00072316494,0.9924682,0.000017567889,0.00006384054,0.0007863098,0.00005922427,0.005014458,0.00035210716,0.0001374409,0.00033551967,0.000015279149],"about_ca_topic_score_codex":0.0019137932,"about_ca_topic_score_gemma":0.0011204147,"teacher_disagreement_score":0.008014404,"about_ca_system_score_codex":0.00045124182,"about_ca_system_score_gemma":0.00035482988,"threshold_uncertainty_score":0.042384744},"labels":[],"label_agreement":null},{"id":"W3172175561","doi":"10.1111/bjh.17582","title":"Marginal zone lymphoma transdifferentiated to histiocytic sarcoma","year":2021,"lang":"en","type":"letter","venue":"British Journal of Haematology","topic":"Histiocytic Disorders and Treatments","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University Health Network","funders":"","keywords":"Medicine; Histiocytic sarcoma; Lymphoma; Histiocyte; Cancer research; Pathology","score_opus":0.016339959070728813,"score_gpt":0.2503002997237911,"score_spread":0.23396034065306226,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3172175561","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97698975,0.006487586,0.0028056311,0.00039984053,0.00007263202,0.00018588743,0.00016462042,0.00022619769,0.012667745],"genre_scores_gemma":[0.99693006,0.0009420859,0.00088729727,0.00019124002,0.000098090866,0.000016374566,0.000073069714,0.000012782015,0.00084899116],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.99980086,0.00002300693,0.00002258777,0.000052709915,0.00004154705,0.000059167123],"domain_scores_gemma":[0.9996045,0.00009243436,0.00010390147,0.000043622862,0.000042250656,0.00011319809],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019946936,0.0005866723,0.0003123462,0.000965376,0.0004432544,0.00053779257,0.00041615198,0.0007221141,0.003367123],"category_scores_gemma":[0.000948192,0.0002527637,0.00024667225,0.00057644607,0.0006932928,0.0007154847,0.00072785275,0.0008153419,0.0012288532],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00023424161,0.0000823371,0.039011113,0.00030429813,0.000022026386,0.90347916,0.00054364133,0.00013368328,0.04055923,0.0015456933,0.0004146996,0.013669781],"study_design_scores_gemma":[0.0000539648,0.00019417742,0.026552325,0.00003873225,0.000035956466,0.962436,0.00026300355,0.00063418224,0.0051150126,0.00067177863,0.003991214,0.000013477736],"about_ca_topic_score_codex":0.0006818251,"about_ca_topic_score_gemma":0.00080063584,"teacher_disagreement_score":0.003367123,"about_ca_system_score_codex":0.00055036345,"about_ca_system_score_gemma":0.0002063957,"threshold_uncertainty_score":0.011264145},"labels":[],"label_agreement":null},{"id":"W3172711549","doi":"10.1111/bjh.17607","title":"Distinct maternal and fetal pregnancy outcomes in women with sickle cell disease can be predicted using routine clinical and laboratory data","year":2021,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; Lunenfeld-Tanenbaum Research Institute; University of Toronto; Mount Sinai Hospital","funders":"","keywords":"Medicine; Pregnancy; Obstetrics; Gestational age; Cohort; Fetus; Acute chest syndrome; Disease; Pediatrics; Internal medicine; Sickle cell anemia","score_opus":0.019933002517142286,"score_gpt":0.285798374809486,"score_spread":0.2658653722923437,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3172711549","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99105716,0.0004904401,0.0071207127,0.00026510906,0.000012574091,0.000022499416,0.00043578236,0.0000496116,0.0005461811],"genre_scores_gemma":[0.99717015,0.00019619802,0.0018810786,0.00003560368,0.000010933418,0.000014096179,0.0005527361,0.0000065719078,0.00013261249],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9967906,0.0020663592,0.00018627716,0.00049332186,0.00027368413,0.00018967202],"domain_scores_gemma":[0.98030937,0.014925104,0.0026214765,0.0012776287,0.00052652805,0.0003398733],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.008440676,0.0011178214,0.0006205761,0.0013548526,0.00027872447,0.0012877053,0.0007236545,0.00090985623,0.000758887],"category_scores_gemma":[0.032436527,0.0006296653,0.0010432234,0.0008236906,0.0005614908,0.0010388998,0.0010534197,0.0011225353,0.00039837215],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001711238,0.00003568297,0.9857978,0.00001559263,0.00020371769,0.000086512,0.000089393216,0.0073427563,0.000121884026,0.00012044899,0.000101308055,0.0059137284],"study_design_scores_gemma":[0.000033219152,0.00044266734,0.7679331,0.00007162039,0.0002804132,0.00069009076,0.00023308696,0.22697483,0.00044156268,0.0022977856,0.00055521843,0.000046548354],"about_ca_topic_score_codex":0.005686651,"about_ca_topic_score_gemma":0.005281239,"teacher_disagreement_score":0.008440676,"about_ca_system_score_codex":0.0004111941,"about_ca_system_score_gemma":0.0005998519,"threshold_uncertainty_score":0.04463911},"labels":[],"label_agreement":null},{"id":"W3174565213","doi":"10.1111/bjh.17654","title":"Dasatinib dose optimisation based on therapeutic drug monitoring reduces pleural effusion rates in chronic myeloid leukaemia patients","year":2021,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":44,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Hôpital Maisonneuve-Rosemont","funders":"Bristol-Myers Squibb","keywords":"Dasatinib; Medicine; Cumulative incidence; Clinical endpoint; Internal medicine; Incidence (geometry); Pleural effusion; Adverse effect; Tyrosine-kinase inhibitor; Gastroenterology; Oncology; Myeloid leukemia; Randomized controlled trial; Imatinib; Cohort; Cancer","score_opus":0.019886682977544506,"score_gpt":0.29675663241679906,"score_spread":0.2768699494392546,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3174565213","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9874163,0.007842661,0.00070410647,0.0005898704,0.0000897734,0.00046646685,0.0002208016,0.00005640337,0.0026134797],"genre_scores_gemma":[0.9970893,0.0012370835,0.0006673087,0.0002723049,0.000044570304,0.00018198015,0.00016305441,0.000006157442,0.0003382833],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9993734,0.00035130396,0.00006296623,0.00008597243,0.00006869364,0.000057627087],"domain_scores_gemma":[0.99949026,0.0001763526,0.00016635886,0.000039590945,0.00002805229,0.0000994358],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00081962394,0.00019358014,0.0010695069,0.00016257341,0.00009270765,0.00035473888,0.00021316177,0.0003421742,0.0022844523],"category_scores_gemma":[0.002344002,0.00010435215,0.00057872984,0.0002664733,0.00015444774,0.00023892387,0.00026621783,0.0007032445,0.0003282921],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.22628018,0.004972622,0.016910931,0.0017367123,0.0012193094,0.0001846224,0.0002729695,0.0049060252,0.027273586,0.0006481156,0.0049229944,0.7106719],"study_design_scores_gemma":[0.31455207,0.31342405,0.29362735,0.00073116703,0.0030192041,0.0017899096,0.00024102883,0.0119192805,0.017050158,0.0038721566,0.03962149,0.00015208675],"about_ca_topic_score_codex":0.00021359367,"about_ca_topic_score_gemma":0.0004317385,"teacher_disagreement_score":0.0022844523,"about_ca_system_score_codex":0.00030690746,"about_ca_system_score_gemma":0.00029142285,"threshold_uncertainty_score":0.0076422095},"labels":[],"label_agreement":null},{"id":"W3181697634","doi":"10.1111/bjh.17694","title":"Qualitative study to support the content validity of the immune thrombocytopenia (ITP) Life Quality Index (ILQI)","year":2021,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Debriefing; Immune thrombocytopenia; Medicine; Content validity; Health related quality of life; Quality of life (healthcare); Recall; Anxiety; Qualitative research; Clinical psychology; Internal medicine; Psychology; Physical therapy; Psychometrics; Psychiatry; Disease; Platelet","score_opus":0.16145510285626585,"score_gpt":0.4023588061605687,"score_spread":0.24090370330430283,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3181697634","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9554493,0.0011728237,0.017099395,0.008684306,0.00032124552,0.0031090458,0.0009156243,0.000048377526,0.01319993],"genre_scores_gemma":[0.97815734,0.00096031063,0.008193365,0.0026673733,0.00006655907,0.0044383463,0.00025486172,0.000037892798,0.005223945],"study_design_codex":"qualitative","study_design_gemma":"qualitative","domain_scores_codex":[0.9733647,0.021494584,0.00073703495,0.0009876501,0.0019216136,0.0014943765],"domain_scores_gemma":[0.92430687,0.06112122,0.0029093286,0.0012843834,0.008243479,0.0021347103],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.028242925,0.00050988526,0.00077935046,0.0018636475,0.0060111126,0.0030714,0.0014038634,0.001389561,0.0046566124],"category_scores_gemma":[0.047554858,0.00040638767,0.00041279636,0.0017525853,0.006949164,0.0029554623,0.0040885997,0.0027706851,0.0006128095],"study_design_candidate":"qualitative","study_design_consensus":"qualitative","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000063808955,0.000065375236,0.002002916,0.00044665515,0.000004900109,0.0006311135,0.98686767,0.00007143688,0.0011145782,0.0030892477,0.00097623694,0.004665982],"study_design_scores_gemma":[0.000020834299,0.0001127592,0.0015072144,0.0006378373,0.00000510865,0.00041889053,0.97697645,0.00026177947,0.00065719354,0.0011276054,0.01825088,0.000023359267],"about_ca_topic_score_codex":0.006878834,"about_ca_topic_score_gemma":0.0068779513,"teacher_disagreement_score":0.028242925,"about_ca_system_score_codex":0.0078029796,"about_ca_system_score_gemma":0.006101904,"threshold_uncertainty_score":0.14936465},"labels":[],"label_agreement":null},{"id":"W3191805895","doi":"10.1111/bjh.17677","title":"Current status of haemophilia inhibitor management in mainland China: a haemophilia treatment centres survey on treatment preferences and real‐world clinical practices","year":2021,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Hemophilia Treatment and Research","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Foothills Medical Centre; University of Calgary; Alberta Health Services","funders":"National Key Research and Development Program of China; Tianjin Science and Technology Committee; National Natural Science Foundation of China","keywords":"Haemophilia; Medicine; Haemophilia A; Clinical Practice; Surgery; Family medicine; Internal medicine; Intensive care medicine","score_opus":0.10675397024042184,"score_gpt":0.4209203461063319,"score_spread":0.31416637586591006,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3191805895","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99889225,0.00021675682,0.000018294604,0.0002138798,0.0000024822014,0.00000791259,0.00027472823,0.0000018363589,0.00037189692],"genre_scores_gemma":[0.999295,0.0001671687,0.000039353003,0.00011656674,0.000004283279,0.000007502212,0.0002288469,7.011899e-7,0.00014061894],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99920386,0.00019090014,0.00016569314,0.00011266064,0.00018251884,0.0001444745],"domain_scores_gemma":[0.9960382,0.00040575129,0.0019338067,0.00009676071,0.00045391291,0.0010715416],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010093254,0.00017230585,0.00019756008,0.00080288114,0.00043182023,0.00053426164,0.00035123245,0.00039583733,0.00168143],"category_scores_gemma":[0.0019868985,0.00019586865,0.00018369907,0.0017570942,0.00041206132,0.0005483159,0.00047750643,0.00031335643,0.00015713212],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000019249814,0.000027815062,0.99474406,0.000046386675,0.000021847683,0.00011666636,0.001446767,0.000049631788,0.00023590932,0.000021600299,0.0003371844,0.0029329755],"study_design_scores_gemma":[0.0000028325128,0.000032386048,0.99794334,0.000012949387,0.000004905873,0.000106082785,0.0014038635,0.0001452658,0.00003118739,0.000006292637,0.00030550922,0.0000053672156],"about_ca_topic_score_codex":0.047069073,"about_ca_topic_score_gemma":0.05666565,"teacher_disagreement_score":0.047069073,"about_ca_system_score_codex":0.0012991936,"about_ca_system_score_gemma":0.0014189896,"threshold_uncertainty_score":0.0935902},"labels":[],"label_agreement":null},{"id":"W3195024161","doi":"10.1111/bjh.17811","title":"Molecular profiling in diffuse large B‐cell lymphoma: why so many types of subtypes?","year":2021,"lang":"en","type":"review","venue":"British Journal of Haematology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":107,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canada's Michael Smith Genome Sciences Centre; Genome British Columbia; Spinal Cord Injury BC; Simon Fraser University","funders":"Medical Research Council; National Institute for Health and Care Research; Michael Smith Health Research BC; Cancer Research UK; NIHR Cambridge Biomedical Research Centre; Wellcome Trust","keywords":"Subtyping; Computational biology; Lymphoma; Profiling (computer programming); Precision medicine; Diffuse large B-cell lymphoma; Clinical trial; Bioinformatics; Biology; Medicine; Computer science; Pathology","score_opus":0.018647779673183526,"score_gpt":0.3013110141533433,"score_spread":0.2826632344801598,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3195024161","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00007049652,0.9987332,0.00009222001,0.00073685934,0.00011578569,0.000002117225,0.000013326285,0.0000040690807,0.00023190741],"genre_scores_gemma":[0.00075764937,0.9979808,0.00025605818,0.0005699303,0.00018479252,0.0000051278216,0.000031835072,0.000002276703,0.00021158664],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.999496,0.00014179197,0.00008819577,0.000082877705,0.00015236072,0.000038726153],"domain_scores_gemma":[0.998818,0.0006530466,0.00011710195,0.00004232678,0.00031042556,0.00005918646],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001709849,0.0005647285,0.0022633355,0.0022980517,0.0002064329,0.0015557886,0.001182936,0.0012839297,0.001629886],"category_scores_gemma":[0.0026043048,0.0003295766,0.0007548044,0.0023850435,0.0007979076,0.0020979883,0.0006748308,0.0026154188,0.0014564416],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009152255,0.000019280624,0.0003065772,0.01207873,0.00014032057,0.00015687113,0.00008256923,0.00024676468,0.0007805344,0.003224337,0.02475184,0.95812064],"study_design_scores_gemma":[0.00003531594,0.00010835335,0.0018802352,0.010239732,0.00029865152,0.0030414935,0.00017054506,0.00014477795,0.0004919702,0.0050004683,0.9785533,0.000035239234],"about_ca_topic_score_codex":0.0016307428,"about_ca_topic_score_gemma":0.0023524414,"teacher_disagreement_score":0.0022980517,"about_ca_system_score_codex":0.0008793887,"about_ca_system_score_gemma":0.0010570055,"threshold_uncertainty_score":0.00904268},"labels":[],"label_agreement":null},{"id":"W3195636258","doi":"10.1111/bjh.17789","title":"Characterisation of immune checkpoints in Richter syndrome identifies LAG3 as a potential therapeutic target","year":2021,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Spinal Cord Injury BC","funders":"Snowdome Foundation; Peter MacCallum Cancer Centre","keywords":"Lymphoma; Immune checkpoint; Immune system; Cancer research; Follicular lymphoma; Context (archaeology); T cell; Immunohistochemistry; Immunology; Biology; Medicine; Immunotherapy","score_opus":0.00913646912819125,"score_gpt":0.25974973975312615,"score_spread":0.2506132706249349,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3195636258","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99688905,0.0011424391,0.0011946221,0.00010576817,0.0000045386605,0.000011514201,0.00021211481,0.00002974306,0.0004102521],"genre_scores_gemma":[0.9986388,0.00031837708,0.00066689047,0.000046159472,0.0000044054646,0.000008025125,0.00018086043,0.0000047762705,0.00013169214],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9999385,0.000010717376,0.000007858683,0.000015372883,0.000013137292,0.000014407702],"domain_scores_gemma":[0.9998629,0.000046939018,0.000045468787,0.000010683729,0.000010153723,0.00002391496],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013889931,0.0002141706,0.00016858264,0.0004047561,0.0000743953,0.00020894883,0.0001221075,0.00023728344,0.0007354155],"category_scores_gemma":[0.00028295978,0.00009397529,0.00023357886,0.00021233941,0.00020684529,0.00015378454,0.0001661376,0.00023980344,0.00014426414],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012469946,0.000037700258,0.1042333,0.00015174119,0.000066065506,0.006194711,0.00012393486,0.001009031,0.8600051,0.00045583004,0.00034049634,0.026135199],"study_design_scores_gemma":[0.0001905868,0.0016049468,0.61468196,0.00007513075,0.00024420678,0.048390266,0.00043936056,0.009491333,0.31531632,0.0015809719,0.007949498,0.00003552403],"about_ca_topic_score_codex":0.0003922743,"about_ca_topic_score_gemma":0.0006591439,"teacher_disagreement_score":0.0007354155,"about_ca_system_score_codex":0.0002488844,"about_ca_system_score_gemma":0.00009660675,"threshold_uncertainty_score":0.0024601817},"labels":[],"label_agreement":null},{"id":"W3196277711","doi":"10.1111/bjh.17778","title":"Statins in mature B‐cell lymphomas and leukaemias","year":2021,"lang":"en","type":"letter","venue":"British Journal of Haematology","topic":"Cancer, Lipids, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; University of Toronto; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Hydroxymethylglutaryl-CoA Reductase Inhibitors; B cell; Cancer research; Internal medicine; Oncology; Immunology; Statin; Antibody","score_opus":0.006973920958572838,"score_gpt":0.2218642614538068,"score_spread":0.21489034049523398,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3196277711","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.016179452,0.06792265,0.0005682686,0.85559845,0.036831707,0.000067637,0.00041602823,0.00013036751,0.022285506],"genre_scores_gemma":[0.21869831,0.061352104,0.001131736,0.49624518,0.17621315,0.00016885097,0.00048501056,0.00008738508,0.045618217],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9992055,0.00021891021,0.0001320051,0.000069533206,0.00023127857,0.00014274241],"domain_scores_gemma":[0.9979651,0.00096840016,0.0001957606,0.00011312307,0.00030271194,0.000454796],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010905624,0.00034689906,0.00091438583,0.00044821537,0.00085609476,0.0011280059,0.00041113436,0.007938952,0.0024557938],"category_scores_gemma":[0.0050008465,0.0001988465,0.0005516331,0.0004801171,0.00068753894,0.00070925057,0.0006273393,0.004963632,0.0021676735],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0025810995,0.00013754152,0.0060419403,0.00063184375,0.00011911311,0.032762192,0.00016615723,0.00023158008,0.003672541,0.00893983,0.81720096,0.12751509],"study_design_scores_gemma":[0.0011726074,0.00039430163,0.012871305,0.00054773595,0.00011241776,0.022791954,0.00019799653,0.0007226957,0.0014008794,0.012204963,0.9475378,0.000045453897],"about_ca_topic_score_codex":0.0022433312,"about_ca_topic_score_gemma":0.00575314,"teacher_disagreement_score":0.007938952,"about_ca_system_score_codex":0.0018042747,"about_ca_system_score_gemma":0.0010630039,"threshold_uncertainty_score":0.013091028},"labels":[],"label_agreement":null},{"id":"W3197298513","doi":"10.1111/bjh.17806","title":"Convalescent plasma and remdesivir for protracted COVID‐19 in a patient with chronic lymphocytic leukaemia: a case report of late relapse after rapid initial response","year":2021,"lang":"en","type":"letter","venue":"British Journal of Haematology","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"Canadian Institutes of Health Research","keywords":"Medicine; IGHV@; Rituximab; Fludarabine; Internal medicine; Case fatality rate; Immunology; Cyclophosphamide; Antibody; Chronic lymphocytic leukemia; Chemotherapy; Epidemiology; Leukemia","score_opus":0.025218921200069765,"score_gpt":0.302841886507987,"score_spread":0.27762296530791725,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3197298513","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9825633,0.0035689026,0.0020203104,0.003777242,0.00026459718,0.00021427244,0.00022552436,0.0001360477,0.007229737],"genre_scores_gemma":[0.99554473,0.000865227,0.0007271622,0.0011716028,0.00042339964,0.000024984403,0.00010574579,0.000020992218,0.0011161357],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.99939156,0.000093788374,0.00007316865,0.00016164027,0.00007043275,0.00020946475],"domain_scores_gemma":[0.9989735,0.00028650434,0.00021116543,0.0000635089,0.00006206435,0.00040328177],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00042837526,0.0014893812,0.0011916653,0.0015393713,0.002209875,0.0013955042,0.0012768515,0.004129675,0.0015143314],"category_scores_gemma":[0.0024533279,0.0010009897,0.0012589577,0.0008438919,0.0010619628,0.0015614756,0.0011680335,0.0029330533,0.0007866702],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007961296,0.00006446947,0.0064994576,0.000022913231,0.000008606732,0.99111336,0.00026250782,0.000042903925,0.00044210872,0.00009672165,0.00021995854,0.0011474483],"study_design_scores_gemma":[0.000021353617,0.00020775867,0.005642756,0.000019886058,0.0000124689805,0.99279565,0.00014102638,0.00029018507,0.00028935852,0.00007943772,0.00048724684,0.000012780313],"about_ca_topic_score_codex":0.002953711,"about_ca_topic_score_gemma":0.0035648034,"teacher_disagreement_score":0.004129675,"about_ca_system_score_codex":0.0014737142,"about_ca_system_score_gemma":0.0008851915,"threshold_uncertainty_score":0.010692537},"labels":[],"label_agreement":null},{"id":"W3197361064","doi":"10.1111/bjh.17807","title":"<i>BCR–ABL1</i> transcript doubling time as a predictor for treatment‐free remission failure after imatinib discontinuation in chronic myeloid leukaemia in chronic phase","year":2021,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Toronto General Hospital; University of Alberta; London Health Sciences Centre; Hôpital de l'Enfant-Jésus; Queen Elizabeth II Health Sciences Centre; Dalhousie University; Université de Montréal; Hôpital Maisonneuve-Rosemont; Princess Margaret Cancer Centre; Vancouver General Hospital; University of Calgary; BC Cancer Agency; Alberta Health Services; McGill University Health Centre; University of Ottawa; Calgary Laboratory Services; CancerCare Manitoba; Ottawa Hospital; University Health Network; Western University; University of Toronto; University of British Columbia","funders":"Bristol-Myers Squibb Canada; Princess Margaret Cancer Foundation; Novartis","keywords":"Discontinuation; Imatinib; Chronic myeloid leukaemia; Internal medicine; Medicine; Doubling time; Imatinib mesylate; Gastroenterology; breakpoint cluster region; Oncology; Immunology; Myeloid leukemia; Biology; Cell; Genetics; Receptor","score_opus":0.013792805251477757,"score_gpt":0.2961651463502976,"score_spread":0.28237234109881987,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3197361064","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99931955,0.0003990254,0.00008643251,0.000014439309,0.0000028154093,0.0000030628203,0.00006241188,0.000002846367,0.000109432156],"genre_scores_gemma":[0.99971026,0.00004716782,0.000055465236,0.000007808336,0.0000056872277,0.000003334026,0.00011883756,0.000001407505,0.000049917453],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9996654,0.00009457908,0.000042790944,0.000067374254,0.00006775972,0.00006213713],"domain_scores_gemma":[0.9977029,0.0006870323,0.0011978182,0.00007419658,0.00008342512,0.00025471547],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007351709,0.00018869882,0.00035135838,0.00040870334,0.00021681532,0.00039949192,0.00019638588,0.00038037248,0.00046972683],"category_scores_gemma":[0.0018349078,0.00013690483,0.000304442,0.00040644052,0.00022590604,0.00019243985,0.00025278566,0.00047020926,0.00014218326],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014104552,0.0000336633,0.98902905,0.00001781472,0.000041851126,0.00011169425,0.00006248229,0.00024369272,0.0025962635,0.000015738358,0.00008361063,0.006353695],"study_design_scores_gemma":[0.000018180972,0.00034503726,0.9979284,0.0000043650193,0.0000358886,0.00045424828,0.000032843964,0.00055811135,0.00039183884,0.000019934441,0.0002057338,0.0000055595824],"about_ca_topic_score_codex":0.0011733532,"about_ca_topic_score_gemma":0.0013201582,"teacher_disagreement_score":0.0011733532,"about_ca_system_score_codex":0.00030148085,"about_ca_system_score_gemma":0.00021025623,"threshold_uncertainty_score":0.0038879514},"labels":[],"label_agreement":null},{"id":"W3197660694","doi":"10.1111/bjh.17643","title":"Flow adhesion of whole blood to P‐selectin: a prognostic biomarker for vaso‐occlusive crisis in sickle cell disease","year":2021,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Pfizer Canada; Pfizer","keywords":"Medicine; Hazard ratio; Internal medicine; E-selectin; Biomarker; White blood cell; Confidence interval; Gastroenterology; Vaso-occlusive crisis; Proportional hazards model; Endothelial activation; Immunology; Cell adhesion; Sickle cell anemia; Endothelium; Cell; Disease; Chemistry; Biochemistry","score_opus":0.00919731736547448,"score_gpt":0.2549882324553377,"score_spread":0.24579091508986323,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3197660694","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99959856,0.00015341761,0.00012856095,0.000010825137,0.0000019879367,0.0000030599901,0.00004747569,0.0000027584374,0.00005339434],"genre_scores_gemma":[0.9995784,0.000049819326,0.00015503209,0.0000074043037,0.000008941932,0.000004497911,0.00009457934,7.525055e-7,0.00010056882],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99975747,0.00009452224,0.000016627064,0.000049892868,0.000049434686,0.00003201987],"domain_scores_gemma":[0.9992316,0.00019066583,0.0003113934,0.00005641357,0.000081308164,0.00012866459],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013269623,0.0004094041,0.00031960098,0.0004911309,0.00018137571,0.0005260963,0.00019239455,0.0004603129,0.0004284618],"category_scores_gemma":[0.0015443653,0.00017100252,0.00026225232,0.00034949958,0.00017703726,0.00035932552,0.00029399892,0.00044652558,0.000102175356],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013795515,0.00008742543,0.9906393,0.000012415489,0.000078090416,0.000047736445,0.00007913867,0.0001147325,0.0037666026,0.000012275268,0.00006285882,0.003719972],"study_design_scores_gemma":[0.00002241186,0.0006148679,0.9971992,0.000003047764,0.0000597126,0.00012975301,0.00003503273,0.0009806342,0.0008289574,0.00002456014,0.00009681678,0.0000051077354],"about_ca_topic_score_codex":0.0011791952,"about_ca_topic_score_gemma":0.00093741424,"teacher_disagreement_score":0.0013269623,"about_ca_system_score_codex":0.00015630871,"about_ca_system_score_gemma":0.00015480735,"threshold_uncertainty_score":0.0070177317},"labels":[],"label_agreement":null},{"id":"W3198972272","doi":"10.1111/bjh.17793","title":"9p24.1 alterations and programmed cell death 1 ligand 1 expression in early stage unfavourable classical Hodgkin lymphoma: an analysis from the German Hodgkin Study Group NIVAHL trial","year":2021,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Spinal Cord Injury BC","funders":"Deutsche Krebshilfe; European Hematology Association","keywords":"Lymphoma; Cancer research; Classical Hodgkin lymphoma; Aggressive lymphoma; Stage (stratigraphy); Pathology; Biology; Oncology; Medicine; Hodgkin lymphoma; Rituximab","score_opus":0.02258221528194429,"score_gpt":0.30006858239557443,"score_spread":0.2774863671136302,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3198972272","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9823397,0.014260551,0.0001257557,0.00020991518,0.000061295505,0.00018949468,0.0019074512,0.0000056922972,0.0009002985],"genre_scores_gemma":[0.9941189,0.0017028189,0.00019188966,0.0002389527,0.000050416253,0.0001774603,0.0031352732,0.000007465866,0.00037686765],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9988655,0.0006327827,0.00009175705,0.00018310164,0.00012028753,0.00010662811],"domain_scores_gemma":[0.99950135,0.00020154349,0.00012370049,0.000060913844,0.00003757449,0.00007500903],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0019455391,0.00048689966,0.0012494421,0.00034063647,0.00024650487,0.0009165298,0.0004938629,0.0005536183,0.001076048],"category_scores_gemma":[0.0018004116,0.00019534118,0.0010025349,0.00068851124,0.00041343155,0.0004888177,0.00055098935,0.0004890749,0.00016614553],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.44281235,0.0011775019,0.42156586,0.0056112367,0.029086323,0.00059343415,0.000493633,0.002981136,0.007913301,0.00092899305,0.004579891,0.08225629],"study_design_scores_gemma":[0.07120881,0.012852349,0.870477,0.0008426494,0.021811914,0.0007671488,0.0004455789,0.001650453,0.0011854261,0.001875249,0.016774373,0.00010907173],"about_ca_topic_score_codex":0.0018725548,"about_ca_topic_score_gemma":0.0058589666,"teacher_disagreement_score":0.0019455391,"about_ca_system_score_codex":0.0007217605,"about_ca_system_score_gemma":0.00049485813,"threshold_uncertainty_score":0.010289133},"labels":[],"label_agreement":null},{"id":"W3200216624","doi":"10.1111/bjh.17842","title":"Refusing blood transfusions from COVID‐19‐vaccinated donors: are we repeating history?","year":2021,"lang":"en","type":"letter","venue":"British Journal of Haematology","topic":"Vaccine Coverage and Hesitancy","field":"Social Sciences","cited_by":23,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Blood transfusion; Donation; Lesbian; Blood donor; Pandemic; Disease; Family medicine; Infectious disease (medical specialty); Immunology; Coronavirus disease 2019 (COVID-19); Gender studies; Political science; Internal medicine; Law; Sociology","score_opus":0.05385048798505866,"score_gpt":0.29416421446839464,"score_spread":0.240313726483336,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3200216624","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00888418,0.1192236,0.00041151964,0.85371673,0.008454225,0.000013822296,0.0002238751,0.000046568908,0.009025463],"genre_scores_gemma":[0.17521748,0.31238672,0.0012591346,0.47363248,0.030706182,0.00006681466,0.00055063097,0.000106287865,0.0060743415],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9958864,0.0020165811,0.00038967398,0.00043267637,0.000813529,0.00046117828],"domain_scores_gemma":[0.96061987,0.022088218,0.004514588,0.0012186643,0.006227529,0.005331135],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0061971587,0.00025184985,0.00081273593,0.0010164363,0.002548607,0.004234761,0.0018057507,0.0058051045,0.019339306],"category_scores_gemma":[0.07199386,0.00044775376,0.0003553868,0.0013777155,0.0046388176,0.009489647,0.001417327,0.010214568,0.0032459435],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014513517,0.00024962114,0.029261444,0.0013410373,0.0000618846,0.001130708,0.006886236,0.00006179738,0.00008842995,0.0119606685,0.55326664,0.39554635],"study_design_scores_gemma":[0.000085064974,0.00032338488,0.051710308,0.042523794,0.00030538873,0.009896328,0.04530491,0.0005559644,0.00034540883,0.08686965,0.76176906,0.00031078348],"about_ca_topic_score_codex":0.014356234,"about_ca_topic_score_gemma":0.025284396,"teacher_disagreement_score":0.019339306,"about_ca_system_score_codex":0.0028999667,"about_ca_system_score_gemma":0.0056601204,"threshold_uncertainty_score":0.06469637},"labels":[],"label_agreement":null},{"id":"W3202137838","doi":"10.1111/bjh.17884","title":"CD4<sup>+</sup> T cells from patients with glucocorticoid‐refractory immune thrombocytopenia have altered cytokine expression","year":2021,"lang":"en","type":"letter","venue":"British Journal of Haematology","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"Moorfields Eye Hospital NHS Foundation Trust; British Medical Association; Research for Patient Benefit Programme; Department of Health and Social Care; National Institute for Health and Care Research","keywords":"Glucocorticoid; Refractory (planetary science); Cytokine; Immune system; Immunology; Medicine; Immune thrombocytopenia; Internal medicine; Biology; Platelet","score_opus":0.010789824943499804,"score_gpt":0.22841076869098798,"score_spread":0.21762094374748817,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3202137838","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98984677,0.0028962945,0.000772938,0.0004364508,0.00011786891,0.0007144432,0.0015369083,0.00004710462,0.0036312276],"genre_scores_gemma":[0.99063474,0.00073572126,0.0012647585,0.0015190454,0.00029388812,0.00067457906,0.00312903,0.000021509959,0.001726583],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9995834,0.000121490484,0.00006561244,0.00008726281,0.00007842153,0.000063718806],"domain_scores_gemma":[0.9995421,0.00015145881,0.000098356504,0.00006181016,0.000055843328,0.00009051422],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00068748184,0.0003799731,0.0005024859,0.00039122903,0.00057167874,0.0007326514,0.00031910164,0.0004922046,0.004658237],"category_scores_gemma":[0.0010269118,0.0001877575,0.00022612175,0.0003890592,0.00035878315,0.0002903573,0.00033222907,0.00068902754,0.0009631136],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.031431098,0.0036236418,0.48779297,0.0020868173,0.00041708077,0.013521297,0.0017471325,0.0006941698,0.20700379,0.00051991554,0.018332122,0.23282991],"study_design_scores_gemma":[0.003546876,0.026311751,0.87746906,0.0002295775,0.00044998294,0.025031645,0.0010804066,0.00087584235,0.027572231,0.0005850975,0.03678991,0.00005752792],"about_ca_topic_score_codex":0.00050818967,"about_ca_topic_score_gemma":0.00095667073,"teacher_disagreement_score":0.004658237,"about_ca_system_score_codex":0.00022755722,"about_ca_system_score_gemma":0.0002391404,"threshold_uncertainty_score":0.015583396},"labels":[],"label_agreement":null},{"id":"W3202152517","doi":"10.1111/bjh.17845","title":"Guidelines: the same evidence but different conclusions — relaxation of indications for irradiation of cellular blood components?","year":2021,"lang":"en","type":"letter","venue":"British Journal of Haematology","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Transplantation; Stem cell; Total body irradiation; Fludarabine; Hematology; Internal medicine; Graft-versus-host disease; Surgery; Chemotherapy","score_opus":0.10102457520370553,"score_gpt":0.35122052373425006,"score_spread":0.2501959485305445,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3202152517","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0010961832,0.18114273,0.004895667,0.71018356,0.08623493,0.0013517368,0.0034366832,0.00023032732,0.011428189],"genre_scores_gemma":[0.012955694,0.10838193,0.047200084,0.7753272,0.035970807,0.0036975825,0.0057356046,0.00047115545,0.010259824],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.94060415,0.02557114,0.017565927,0.0034240887,0.011203865,0.001630707],"domain_scores_gemma":[0.844739,0.060152296,0.014778024,0.006454476,0.068934664,0.0049415487],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.049738303,0.0014283701,0.0051864204,0.005466635,0.0018068305,0.0074801026,0.00663949,0.016005032,0.008518449],"category_scores_gemma":[0.14896247,0.0013754352,0.0049964897,0.004879866,0.0038739573,0.007503021,0.0032822574,0.0149209695,0.0055242926],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00048256246,0.000114518814,0.0010247384,0.022741353,0.0009829939,0.00018699614,0.0004081906,0.0002934382,0.000477887,0.010967302,0.78945726,0.17286275],"study_design_scores_gemma":[0.0008886606,0.000115891744,0.0023069135,0.09707803,0.0017311294,0.00046881445,0.00047766406,0.00037012642,0.00033693036,0.020436011,0.87561995,0.00016985263],"about_ca_topic_score_codex":0.013170736,"about_ca_topic_score_gemma":0.012395536,"teacher_disagreement_score":0.049738303,"about_ca_system_score_codex":0.006692312,"about_ca_system_score_gemma":0.01605403,"threshold_uncertainty_score":0.26304442},"labels":[],"label_agreement":null},{"id":"W3202720100","doi":"10.1111/bjh.17862","title":"Superior outcomes with paediatric protocols in adolescents and young adults with aggressive B‐cell non‐Hodgkin lymphoma","year":2021,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"St. Michael's Hospital; University of Toronto; University Health Network; Princess Margaret Cancer Centre; Institute for Work & Health; Hospital for Sick Children; Public Health Ontario","funders":"Ontario Ministry of Health and Long-Term Care; Cancer Care Ontario; Pediatric Oncology Group of Ontario; C17 Council; Institute of Chemical and Engineering Sciences; Canadian Institutes of Health Research; Alex's Lemonade Stand Foundation for Childhood Cancer","keywords":"Medicine; Hazard ratio; Young adult; Confidence interval; Pediatrics; Internal medicine; Lymphoma; Rituximab; Oncology","score_opus":0.007072907837043763,"score_gpt":0.26216951484127204,"score_spread":0.25509660700422826,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3202720100","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9954951,0.0022726608,0.00008990631,0.00026857018,0.000011242657,0.00003856393,0.0004417208,0.000005338324,0.0013768049],"genre_scores_gemma":[0.99783653,0.0010674973,0.00017714528,0.00013537159,0.000011960869,0.000027296346,0.0005510978,0.0000025645122,0.00019055403],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99948466,0.00014497685,0.00005535629,0.000065408916,0.000113791684,0.00013577906],"domain_scores_gemma":[0.9981817,0.00020761654,0.0009858541,0.00006439399,0.0001618755,0.00039865507],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00082684634,0.00007851437,0.00021506853,0.0002856086,0.00031910592,0.0006916493,0.00025569933,0.00017847268,0.001562403],"category_scores_gemma":[0.0041559697,0.00008922834,0.00025168614,0.0009059229,0.00035618898,0.0004083737,0.0006649107,0.00026732858,0.000113968614],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00065023254,0.00006997849,0.9764374,0.00011633182,0.00006243639,0.00011554084,0.00046923972,0.00017192369,0.0002496306,0.00018360093,0.0008949591,0.020578735],"study_design_scores_gemma":[0.00007050563,0.00048788107,0.9966472,0.00008477928,0.000037545236,0.00022794904,0.0005718052,0.00009702905,0.00007561496,0.00007226668,0.0016236397,0.0000037758653],"about_ca_topic_score_codex":0.07214748,"about_ca_topic_score_gemma":0.15523572,"teacher_disagreement_score":0.07214748,"about_ca_system_score_codex":0.0027181401,"about_ca_system_score_gemma":0.0029216672,"threshold_uncertainty_score":0.14345509},"labels":[],"label_agreement":null},{"id":"W3203015600","doi":"10.1111/bjh.17847","title":"Intensified antiplatelet therapy in patients after percutaneous coronary intervention with high on‐treatment platelet reactivity: the OPTImal Management of Antithrombotic Agents (OPTIMA)‐2 Trial","year":2021,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Hamilton General Hospital","funders":"","keywords":"Medicine; Clopidogrel; Percutaneous coronary intervention; Mace; Ticagrelor; Cilostazol; Conventional PCI; Internal medicine; Aspirin; Randomized controlled trial; Antithrombotic; Clinical trial; Cardiology; Myocardial infarction","score_opus":0.015220089550454327,"score_gpt":0.2512518552541826,"score_spread":0.23603176570372825,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3203015600","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9893149,0.006413478,0.00021605054,0.0006423847,0.00017128584,0.00066809,0.0006392801,0.000025044967,0.0019095037],"genre_scores_gemma":[0.988514,0.0037161794,0.0012800753,0.0011598828,0.0007635748,0.0010820859,0.0016915511,0.000010360914,0.0017823336],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99961346,0.00022592445,0.000025771931,0.000050876577,0.000032557127,0.00005147762],"domain_scores_gemma":[0.999448,0.00014312429,0.00018184927,0.000052594714,0.000026929212,0.00014759222],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011561882,0.00066390954,0.001686375,0.00021648129,0.00013919816,0.0008149818,0.00044287468,0.0010079339,0.0027141683],"category_scores_gemma":[0.0013532612,0.0003274104,0.0013256448,0.0002301323,0.0003424865,0.00045048518,0.00039104407,0.0018341944,0.00029921127],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9388271,0.004224848,0.009291356,0.0010958505,0.0025192488,0.00012635249,0.000093148534,0.0007770066,0.004906346,0.00032074505,0.0020788184,0.035739247],"study_design_scores_gemma":[0.8389659,0.0877775,0.06308373,0.0003073636,0.004199714,0.00027041032,0.000055990236,0.0013333318,0.00067223754,0.0005382241,0.00275538,0.000040220628],"about_ca_topic_score_codex":0.00049769477,"about_ca_topic_score_gemma":0.0010208169,"teacher_disagreement_score":0.0027141683,"about_ca_system_score_codex":0.00036873127,"about_ca_system_score_gemma":0.00034606582,"threshold_uncertainty_score":0.009079754},"labels":[],"label_agreement":null},{"id":"W3204177860","doi":"10.1111/bjh.17673","title":"Earlier corticosteroid use for adverse event management in patients receiving axicabtagene ciloleucel for large B‐cell lymphoma","year":2021,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":121,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; University of British Columbia","funders":"Gilead Sciences","keywords":"Medicine; Cytokine release syndrome; Tocilizumab; Adverse effect; Internal medicine; Corticosteroid; Lymphoma; Gastroenterology; Surgery; Oncology; Chimeric antigen receptor; Cancer; Immunotherapy; Rheumatoid arthritis","score_opus":0.02358306920221175,"score_gpt":0.29881096608573343,"score_spread":0.27522789688352167,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3204177860","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9889608,0.0076368097,0.00027934115,0.0005552409,0.00006906955,0.00013496079,0.00035577617,0.000026177271,0.0019817976],"genre_scores_gemma":[0.9978759,0.00083455787,0.0002863613,0.00034191672,0.00007219662,0.000059441038,0.000268523,0.0000023097166,0.000258773],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9996829,0.00013591223,0.000037537397,0.000044080713,0.00005835303,0.00004117117],"domain_scores_gemma":[0.9990847,0.0002991421,0.00036642552,0.000028801964,0.00007458766,0.00014632761],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008133399,0.0001917499,0.0005084467,0.0001654949,0.00021710906,0.00037012732,0.00015325799,0.0001702788,0.001659801],"category_scores_gemma":[0.0010953471,0.000055289318,0.00056091684,0.00018680251,0.00010578566,0.00018740908,0.00012739957,0.000589211,0.00013293985],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.041500088,0.0022061616,0.6544932,0.00088290026,0.0013238124,0.0013369402,0.00022122357,0.0014026592,0.020812562,0.00019752655,0.0054073394,0.2702156],"study_design_scores_gemma":[0.0064103096,0.042560376,0.9167764,0.00032485652,0.0018292237,0.0029122103,0.00022852347,0.0025096694,0.0076662414,0.00027511723,0.018457325,0.000049643306],"about_ca_topic_score_codex":0.0006943141,"about_ca_topic_score_gemma":0.0024511698,"teacher_disagreement_score":0.001659801,"about_ca_system_score_codex":0.00046388904,"about_ca_system_score_gemma":0.000701983,"threshold_uncertainty_score":0.00555259},"labels":[],"label_agreement":null},{"id":"W3204995219","doi":"10.1111/bjh.17866","title":"Targeted treatment of immune thrombocytopenia in CTLA‐4 insufficiency: a case report","year":2021,"lang":"en","type":"letter","venue":"British Journal of Haematology","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Paul's Hospital; University of British Columbia","funders":"","keywords":"Medicine; Common variable immunodeficiency; Immunology; Thrombocytopenic purpura; Evans syndrome; Thrombopoietin; Splenectomy; Immune system; Rituximab; Internal medicine; Antibody; Gastroenterology; Autoimmune hemolytic anemia","score_opus":0.02228561532827067,"score_gpt":0.28378276830608007,"score_spread":0.2614971529778094,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3204995219","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8001643,0.08799148,0.036589004,0.022455133,0.002998353,0.0013197793,0.00088425644,0.0012176374,0.046380006],"genre_scores_gemma":[0.967351,0.012811132,0.0066835107,0.005274608,0.0034156633,0.00014283926,0.00034704263,0.00009974992,0.0038744328],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.998911,0.00017938964,0.0001398709,0.00024039326,0.00017861374,0.00035065252],"domain_scores_gemma":[0.99888617,0.00025235437,0.00026646027,0.00010858969,0.00008473507,0.00040158516],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005013004,0.0028051133,0.0022597064,0.003085525,0.0029784562,0.0024998102,0.0018454846,0.0076096426,0.0020991536],"category_scores_gemma":[0.002391393,0.0009282239,0.0020487958,0.0026032212,0.0014168008,0.0024308134,0.0016799339,0.0047651213,0.0011841711],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000012883211,0.00004693976,0.0008884614,0.000029092713,0.000010473696,0.9969547,0.000051714906,0.000055647695,0.00017628324,0.00013521507,0.00031693513,0.0013216693],"study_design_scores_gemma":[0.000010652486,0.000028644854,0.0004741661,0.000022339207,0.000012314441,0.99843556,0.00003518716,0.00019287126,0.0001363669,0.00011989053,0.000525173,0.000006731913],"about_ca_topic_score_codex":0.0022729177,"about_ca_topic_score_gemma":0.0025585918,"teacher_disagreement_score":0.0076096426,"about_ca_system_score_codex":0.0018636138,"about_ca_system_score_gemma":0.0013171209,"threshold_uncertainty_score":0.013521552},"labels":[],"label_agreement":null},{"id":"W3208273355","doi":"10.1111/bjh.17946","title":"The future of myeloma research in Canada and beyond: results of a James Lind Alliance priority setting partnership","year":2021,"lang":"en","type":"letter","venue":"British Journal of Haematology","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Dalhousie University; University of New Brunswick; Princess Margaret Cancer Centre; Essar Steel Algoma (Canada); Saint John Regional Hospital; Vancouver General Hospital; Université de Moncton; Horizon Health Network","funders":"","keywords":"Multiple myeloma; Medicine; General partnership; Alliance; Quality of life (healthcare); Disease; Intensive care medicine; Internal medicine; Political science; Nursing","score_opus":0.03986587115633533,"score_gpt":0.33406215830674396,"score_spread":0.29419628715040863,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3208273355","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":"methods","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.050972108,0.04600899,0.0026999502,0.8197781,0.0051254374,0.0021006488,0.002391356,0.00018174425,0.07074168],"genre_scores_gemma":[0.59765273,0.073351726,0.04474833,0.250067,0.0015245208,0.002161448,0.0034204372,0.00030236636,0.026771514],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.8829177,0.04932048,0.0042081513,0.0031947864,0.040024094,0.020334788],"domain_scores_gemma":[0.68160856,0.040559,0.0054459944,0.0045067556,0.07445523,0.19342445],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.10091966,0.00084570464,0.001318197,0.003964186,0.029154118,0.027236957,0.004830134,0.0072476496,0.009536573],"category_scores_gemma":[0.1016517,0.00096264214,0.001516982,0.007885674,0.009021426,0.0085648345,0.025887014,0.011417209,0.0008998866],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.0011980453,0.0015449941,0.08172836,0.004623762,0.0005502658,0.0017159081,0.051877633,0.0014078176,0.00077757594,0.1349342,0.39966702,0.31997433],"study_design_scores_gemma":[0.0005594555,0.0007178,0.10206012,0.014460247,0.00041252977,0.0005893331,0.094065055,0.0018468027,0.0006049623,0.033291895,0.750767,0.0006247698],"about_ca_topic_score_codex":0.921574,"about_ca_topic_score_gemma":0.9678155,"teacher_disagreement_score":0.921574,"about_ca_system_score_codex":0.23271896,"about_ca_system_score_gemma":0.75680935,"threshold_uncertainty_score":0.8899373},"labels":[],"label_agreement":null},{"id":"W3211066619","doi":"10.1111/bjh.17684","title":"The impact of surveillance imaging after curative‐intent radiotherapy for limited‐stage follicular lymphoma","year":2021,"lang":"en","type":"letter","venue":"British Journal of Haematology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Spinal Cord Injury BC; University of British Columbia; BC Cancer Agency","funders":"","keywords":"Medicine; Stage (stratigraphy); Asymptomatic; Radiology; Positron emission tomography; Biopsy; Follicular lymphoma; Radiation therapy; Cancer; Lymphoma; Surgery; Internal medicine","score_opus":0.014292579778912665,"score_gpt":0.29188823638578976,"score_spread":0.2775956566068771,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3211066619","genre_codex":"empirical","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99193,0.006420277,0.00022334134,0.00018574737,0.00003092629,0.000023566241,0.00012169034,0.000008104999,0.0010562991],"genre_scores_gemma":[0.99890625,0.0005935361,0.00014793174,0.000053762615,0.00005438499,0.0000105712315,0.00014674947,0.0000029206526,0.00008381732],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9991398,0.000405479,0.000097722586,0.00009129932,0.0001740788,0.0000916092],"domain_scores_gemma":[0.9965358,0.001351091,0.0013002426,0.0001449149,0.00029307776,0.00037493653],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0018054894,0.00016278794,0.00040280362,0.0004167725,0.00018742641,0.00064631755,0.00038499243,0.00024893426,0.0010265562],"category_scores_gemma":[0.007830331,0.000093998424,0.0005414807,0.00033996592,0.00029926264,0.0005557752,0.00037667502,0.0004007971,0.00012467512],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005642498,0.00022211781,0.9006594,0.00024377219,0.00018984001,0.0006624323,0.00015213453,0.00049521285,0.0020726891,0.00006816243,0.0004346712,0.08915717],"study_design_scores_gemma":[0.000055535565,0.0043557268,0.9903413,0.00011977506,0.0003704881,0.0016616606,0.00018221901,0.00092975795,0.0007322342,0.000083224266,0.001157001,0.000011171096],"about_ca_topic_score_codex":0.0014983003,"about_ca_topic_score_gemma":0.004485733,"teacher_disagreement_score":0.0018054894,"about_ca_system_score_codex":0.00071502523,"about_ca_system_score_gemma":0.00048195192,"threshold_uncertainty_score":0.009548426},"labels":[],"label_agreement":null},{"id":"W3216554864","doi":"10.1111/bjh.17956","title":"Outcome predictors for maternal red blood cell alloimmunisation with anti‐K and anti‐D managed with intrauterine blood transfusion","year":2021,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Blood groups and transfusion","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Mount Sinai Hospital","funders":"","keywords":"Medicine; Gestational age; Obstetrics; Fetus; Pregnancy; Blood transfusion; In utero; Blood product; Red blood cell; Adverse effect; Pediatrics; Gynecology; Internal medicine; Surgery","score_opus":0.007742638810525106,"score_gpt":0.21788436055000948,"score_spread":0.21014172173948437,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3216554864","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9992293,0.00035576732,0.00004686277,0.00004582913,0.000006361765,0.0000033746405,0.00004916565,0.0000018913562,0.00026151643],"genre_scores_gemma":[0.99973506,0.00013422863,0.000026742773,0.0000076177294,0.0000087356775,0.000002333486,0.000054400327,7.9051745e-7,0.000030174166],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9995448,0.00015586073,0.000061482046,0.00006320778,0.00009120419,0.00008346539],"domain_scores_gemma":[0.99597883,0.0016275869,0.0016102282,0.00011211232,0.0002063753,0.0004648615],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00057762495,0.00018083022,0.00034606073,0.00067348825,0.0003302012,0.00042629402,0.000302464,0.00034164632,0.0010651986],"category_scores_gemma":[0.0056624343,0.00018546273,0.00031607327,0.0007400418,0.00039271958,0.0002796841,0.00038008668,0.0006618012,0.00012555762],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000041655323,0.000007595025,0.99920326,0.000002539903,0.0000071953937,0.00020626024,0.000023249488,0.00002563404,0.00003762509,0.000007336442,0.000019860698,0.00041781805],"study_design_scores_gemma":[0.000003951591,0.00011278565,0.9973436,0.000013846338,0.000022758626,0.0018108442,0.00018263551,0.000309965,0.00008693096,0.000033374847,0.00007585869,0.0000034551797],"about_ca_topic_score_codex":0.0026538824,"about_ca_topic_score_gemma":0.0018124604,"teacher_disagreement_score":0.0026538824,"about_ca_system_score_codex":0.0003835535,"about_ca_system_score_gemma":0.00056393,"threshold_uncertainty_score":0.0052769184},"labels":[],"label_agreement":null},{"id":"W4200448701","doi":"10.1111/bjh.17999","title":"The safety and acceptability of twice‐daily deferiprone for transfusional iron overload: A multicentre, open‐label, phase 2 study","year":2021,"lang":"en","type":"letter","venue":"British Journal of Haematology","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Apotex (Canada); Altasciences (Canada); St. Paul's Hospital","funders":"","keywords":"Deferiprone; Medicine; Pharmacokinetics; Deferoxamine; Regimen; Pharmacology; Clinical trial; Thalassemia; Internal medicine","score_opus":0.023291634809372845,"score_gpt":0.31673040661311025,"score_spread":0.2934387718037374,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4200448701","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97288674,0.009023635,0.0012723998,0.009182652,0.001784078,0.001601021,0.00088027323,0.00008452842,0.003284673],"genre_scores_gemma":[0.9801902,0.0028852406,0.001464081,0.008898208,0.0015458992,0.0013850059,0.0004436095,0.000023254792,0.0031644648],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9982951,0.0011482575,0.00008402279,0.00018094464,0.00020705441,0.00008460082],"domain_scores_gemma":[0.9960885,0.0021332088,0.000625865,0.00030123154,0.0002722532,0.0005789379],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0033839762,0.000715484,0.0019340817,0.00015096749,0.00050982233,0.0010183952,0.00065602944,0.0039717527,0.003114844],"category_scores_gemma":[0.0054950067,0.00038114729,0.00095268455,0.00028133206,0.0009049743,0.0007707947,0.00021023219,0.002877713,0.0008345032],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.83652073,0.015427197,0.004926093,0.0016155603,0.0015712347,0.0014561252,0.0006655723,0.0003277116,0.016985392,0.0003319471,0.011678312,0.108494185],"study_design_scores_gemma":[0.43333292,0.517673,0.026228772,0.00023753484,0.0013798373,0.0023082057,0.00030064635,0.001778605,0.0031523264,0.00077254546,0.01270985,0.00012566532],"about_ca_topic_score_codex":0.00050282344,"about_ca_topic_score_gemma":0.0008711548,"teacher_disagreement_score":0.0039717527,"about_ca_system_score_codex":0.0008769371,"about_ca_system_score_gemma":0.00097653223,"threshold_uncertainty_score":0.017896414},"labels":[],"label_agreement":null},{"id":"W4205536854","doi":"10.1111/bjh.18016","title":"Pre‐treatment total metabolic tumour volumes in lymphoma: Does quantity matter?","year":2022,"lang":"en","type":"review","venue":"British Journal of Haematology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":24,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"Novo Nordisk Fonden; Kræftens Bekæmpelse","keywords":"Medicine; Positron emission tomography; Lymphoma; Standardized uptake value; Thresholding; Nuclear medicine; Bone marrow; Follicular lymphoma; Stage (stratigraphy); Diffuse large B-cell lymphoma; Receiver operating characteristic; Radiology; Pathology; Internal medicine; Biology","score_opus":0.02800837093846967,"score_gpt":0.31771224054511343,"score_spread":0.28970386960664374,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4205536854","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00006167776,0.99962366,0.000020140722,0.00012223185,0.000038150236,0.0000015695043,0.0000076761735,0.0000012021098,0.00012365394],"genre_scores_gemma":[0.0010436531,0.998577,0.000058319616,0.00012494739,0.00007041864,0.000004718529,0.000017028331,0.000001098137,0.000102707585],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99962926,0.00011110077,0.00007848528,0.0000588878,0.000099354445,0.000022771268],"domain_scores_gemma":[0.99893886,0.0007606025,0.00012949684,0.000018941948,0.00012667221,0.000025440464],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012057952,0.0005888765,0.0027774149,0.001706205,0.00014325822,0.0012960057,0.0010712745,0.0010823972,0.0030692678],"category_scores_gemma":[0.0022213757,0.00032121534,0.0011157055,0.0021154738,0.00060900796,0.0015775032,0.00050284044,0.0015661236,0.0010050543],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002271028,0.00003219851,0.00028780004,0.0382043,0.00031602258,0.000066689696,0.000048711765,0.00022463127,0.00024218326,0.0017684575,0.010414549,0.94816744],"study_design_scores_gemma":[0.00025799926,0.00052359095,0.008801224,0.06384478,0.0023618343,0.0029246118,0.00022999819,0.0003872174,0.0006175847,0.006810187,0.9131699,0.00007101187],"about_ca_topic_score_codex":0.00161125,"about_ca_topic_score_gemma":0.0022116136,"teacher_disagreement_score":0.0030692678,"about_ca_system_score_codex":0.0007756009,"about_ca_system_score_gemma":0.0008944836,"threshold_uncertainty_score":0.010267794},"labels":[],"label_agreement":null},{"id":"W4213039994","doi":"10.1111/bjh.18077","title":"Optimizing transfusion therapy for survivors of Haemoglobin Bart's hydrops fetalis syndrome: Defining the targets for <scp>haemoglobin‐H</scp> fraction and “functional” haemoglobin level","year":2022,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; Children's Hospital of Eastern Ontario; BC Children's Hospital","funders":"","keywords":"Hydrops fetalis; Medicine; Haemolysis; Transfusion therapy; Lactate dehydrogenase; Thalassemia; Hemoglobinopathy; Exchange transfusion; Gastroenterology; Soluble transferrin receptor; Pathophysiology; Blood transfusion; Internal medicine; Pediatrics; Anemia; Immunology; Hemolytic anemia; Chemistry; Gestation; Iron deficiency; Pregnancy; Enzyme; Biology; Biochemistry","score_opus":0.018837968156403755,"score_gpt":0.24838748924528548,"score_spread":0.22954952108888171,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4213039994","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9954726,0.0025315213,0.00091558613,0.00051654794,0.000015539543,0.000017679027,0.000030043308,0.0000147227875,0.00048577142],"genre_scores_gemma":[0.99858177,0.0006029817,0.00061778724,0.000068015244,0.000015266907,0.000012921145,0.000036704736,0.000003092855,0.00006150991],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9995704,0.00023219592,0.000058216072,0.000026790312,0.000063411186,0.000048874495],"domain_scores_gemma":[0.9989986,0.00041836256,0.00033687172,0.000034068846,0.000085191736,0.00012691606],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010381547,0.0002180085,0.00035447386,0.00035249876,0.00025965512,0.00059760985,0.00021152706,0.0003009269,0.0002356756],"category_scores_gemma":[0.0035543526,0.00007942904,0.00016797132,0.00032126653,0.00026275514,0.00033136326,0.00023022931,0.00046209036,0.000088753724],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013555726,0.00023089499,0.9345138,0.00008279182,0.00007089688,0.0004945159,0.0010138145,0.0014873691,0.004516529,0.00016733899,0.0007035962,0.055362854],"study_design_scores_gemma":[0.00007759453,0.0032178531,0.9812781,0.00018756697,0.00015721309,0.0019724255,0.0013248407,0.004991719,0.004527843,0.0004967142,0.0017407291,0.000027376422],"about_ca_topic_score_codex":0.0010669652,"about_ca_topic_score_gemma":0.0011576059,"teacher_disagreement_score":0.0010669652,"about_ca_system_score_codex":0.00029226116,"about_ca_system_score_gemma":0.00042970976,"threshold_uncertainty_score":0.005490303},"labels":[],"label_agreement":null},{"id":"W4213141299","doi":"10.1111/bjh.18085","title":"Cardiovascular disease in hereditary haemophilia: The challenges of longevity","year":2022,"lang":"en","type":"review","venue":"British Journal of Haematology","topic":"Hemophilia Treatment and Research","field":"Medicine","cited_by":27,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Medical Research Council Canada; Medical Research Council; Department of Health and Aged Care, Australian Government; National Institute for Health and Care Research; NIHR Biomedical Research Centre, Royal Marsden NHS Foundation Trust/Institute of Cancer Research","keywords":"Medicine; Haemophilia; Life expectancy; Antithrombotic; Disease; Coronary artery disease; Atrial fibrillation; Stroke (engine); Secondary prevention; Population; Longevity; Intensive care medicine; Pediatrics; Internal medicine; Gerontology","score_opus":0.09147133416868582,"score_gpt":0.3427219267745441,"score_spread":0.2512505926058583,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4213141299","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00007277529,0.99898523,0.000034158114,0.00045679003,0.000115296396,0.0000012458919,0.000006553375,0.0000028335267,0.00032510658],"genre_scores_gemma":[0.00069295237,0.99862313,0.000056432047,0.00021120594,0.0001911139,0.0000025169359,0.000011675213,7.432758e-7,0.0002103045],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99970585,0.000089710775,0.000045706085,0.000029046185,0.00010617401,0.000023465876],"domain_scores_gemma":[0.99926645,0.00045977515,0.00008629236,0.000019557547,0.00012284529,0.000045105535],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00070688577,0.00046843904,0.0012897471,0.0013684154,0.00028816788,0.0011399877,0.0004545156,0.0010250439,0.0033094725],"category_scores_gemma":[0.0014297741,0.00015414995,0.00054397597,0.0012729712,0.00043152127,0.0010275891,0.0006271893,0.0015553131,0.00095808046],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000059104,0.000032529642,0.00021774453,0.018858902,0.00015505592,0.00014906477,0.00011554194,0.00017372363,0.00044411578,0.0040790457,0.0357482,0.9399669],"study_design_scores_gemma":[0.000023845767,0.00011693803,0.0015137141,0.018217778,0.00026258087,0.0019692678,0.00014962707,0.00008102981,0.00015881806,0.0045474377,0.97293764,0.00002128152],"about_ca_topic_score_codex":0.0012962315,"about_ca_topic_score_gemma":0.0018364795,"teacher_disagreement_score":0.0033094725,"about_ca_system_score_codex":0.000443767,"about_ca_system_score_gemma":0.0011869005,"threshold_uncertainty_score":0.011071265},"labels":[],"label_agreement":null},{"id":"W4214843492","doi":"10.1111/bjh.18116","title":"<scp>KIT D816V</scp> is dimerization‐independent and activates downstream pathways frequently perturbed in mastocytosis","year":2022,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Mast cells and histamine","field":"Immunology and Microbiology","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Children's Hospital of Eastern Ontario; Sunnybrook Hospital; Sunnybrook Health Science Centre; University of Ottawa; Dalhousie University","funders":"Canadian Institutes of Health Research","keywords":"Receptor tyrosine kinase; Tyrosine kinase; Signal transduction; Stem cell factor; Proto-Oncogene Proteins c-kit; Systemic mastocytosis; Mutant; Biology; Proto-oncogene tyrosine-protein kinase Src; Cancer research; MAPK/ERK pathway; Cell biology; Chemistry; Haematopoiesis; Biochemistry; Mast cell; Immunology; Stem cell; Gene","score_opus":0.008797379183238982,"score_gpt":0.19460889825290079,"score_spread":0.1858115190696618,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4214843492","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99559456,0.0005476626,0.0012599861,0.00013069354,0.000025175472,0.000015377735,0.0006636217,0.000050197592,0.0017126742],"genre_scores_gemma":[0.9972621,0.00021075684,0.00051473797,0.00006804881,0.0000054732513,0.00001559452,0.0006210986,0.000015451986,0.0012868382],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998123,0.00002978755,0.000016352378,0.0000370553,0.00006341649,0.000041135994],"domain_scores_gemma":[0.9999331,0.000011669186,0.000022326354,0.000010194364,0.0000055779064,0.000017153754],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00007964346,0.00021064491,0.00017905272,0.00011004486,0.00016979856,0.00024680424,0.00014223275,0.0003871418,0.001971572],"category_scores_gemma":[0.00010108664,0.00008495779,0.00022582013,0.00012698708,0.00022182146,0.00012503217,0.00015711908,0.00045868047,0.0006831849],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00005500035,0.000011301962,0.00018705335,0.000014627513,0.000003242739,0.00020212041,0.000004447907,0.0000467344,0.99872416,0.00010088068,0.000075697,0.00057475694],"study_design_scores_gemma":[0.000018286599,0.0002419749,0.012396336,0.0000066856974,0.00001078788,0.0034837173,0.000044812703,0.00090762874,0.9784581,0.00018307235,0.0042409794,0.000007600492],"about_ca_topic_score_codex":0.0003765237,"about_ca_topic_score_gemma":0.00040405986,"teacher_disagreement_score":0.001971572,"about_ca_system_score_codex":0.00021240197,"about_ca_system_score_gemma":0.00011051082,"threshold_uncertainty_score":0.006595552},"labels":[],"label_agreement":null},{"id":"W4220926328","doi":"10.1111/bjh.18145","title":"Platelet degranulation and bleeding phenotype in a large cohort of Von Willebrand disease patients","year":2022,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Hemophilia Society","funders":"Fonds de dotation CSL Behring pour la recherche; Nederlandse Organisatie voor Wetenschappelijk Onderzoek; Bayer Schering; European Hematology Association; Swedish Orphan Biovitrum; CSL Behring; Baxter International; Landsteiner Foundation for Blood Transfusion Research; Novo Nordisk; Sanofi","keywords":"Von Willebrand factor; Von Willebrand disease; Platelet; Degranulation; Immunology; Medicine; Phenotype; Platelet factor 4; Coagulopathy; Cohort; Internal medicine; Biology; Genetics; Gene; Receptor","score_opus":0.006303401762602738,"score_gpt":0.2324116702544911,"score_spread":0.22610826849188836,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4220926328","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99911386,0.00028874548,0.00006911075,0.00003693299,0.0000071134245,0.000008261213,0.00017707508,0.000003515478,0.0002953607],"genre_scores_gemma":[0.99909806,0.00014995517,0.00008117234,0.000038775877,0.00002521073,0.0000124703765,0.0004016219,0.000003837183,0.00018883396],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99962485,0.000067675406,0.000033916713,0.00014430331,0.0000773176,0.0000519015],"domain_scores_gemma":[0.9994655,0.000099979035,0.0001285166,0.00006737724,0.00005759861,0.00018101622],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003616564,0.00033406098,0.0005351747,0.00094349566,0.0006051392,0.00074336596,0.00025773695,0.00056280755,0.0017682019],"category_scores_gemma":[0.0015032787,0.00029385654,0.00036348178,0.0007177052,0.00031286987,0.00044768932,0.00047039308,0.0006354071,0.00041587083],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00050695415,0.00008714044,0.99198395,0.000014674578,0.000102774895,0.0015484064,0.00023189897,0.000044543118,0.002495831,0.000049630675,0.00036314508,0.0025710552],"study_design_scores_gemma":[0.0000259842,0.00024681166,0.993749,0.0000070232823,0.00005794849,0.0048759594,0.0001801801,0.0001250288,0.00014217185,0.0000558721,0.00052429247,0.000009629994],"about_ca_topic_score_codex":0.0012667044,"about_ca_topic_score_gemma":0.00083732774,"teacher_disagreement_score":0.0017682019,"about_ca_system_score_codex":0.00019017111,"about_ca_system_score_gemma":0.00015793274,"threshold_uncertainty_score":0.0059152246},"labels":[],"label_agreement":null},{"id":"W4223450106","doi":"10.1111/bjh.18170","title":"International guidelines regarding the role of IVIG in the management of Rh‐ and ABO‐mediated haemolytic disease of the newborn","year":2022,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Neonatal Health and Biochemistry","field":"Medicine","cited_by":29,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta; University of Ottawa; Hospital for Sick Children; St. Michael's Hospital; University Health Network; University of Toronto; Mount Sinai Hospital; Canadian Blood Services; Health Sciences Centre; Sunnybrook Health Science Centre","funders":"Health Canada; National Center for Advancing Translational Sciences; Canadian Blood Services; Australian Government","keywords":"Medicine; ABO incompatibility; ABO blood group system; Haemolytic disease; Exchange transfusion; Disease; Intensive care medicine; Pediatrics; Immunology; Internal medicine; Pregnancy","score_opus":0.013885008988860513,"score_gpt":0.2885092310104996,"score_spread":0.27462422202163905,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4223450106","genre_codex":"review","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0020414926,0.83829176,0.013249636,0.0769165,0.010850468,0.0060316576,0.009342575,0.0004534243,0.042822517],"genre_scores_gemma":[0.015765605,0.79160905,0.11954509,0.03488973,0.0028616309,0.011093393,0.011692474,0.00028547616,0.012257627],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.98283225,0.0051984456,0.007996186,0.0006221371,0.002799713,0.000551164],"domain_scores_gemma":[0.963035,0.014459499,0.007931263,0.0010720376,0.012438368,0.0010637528],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.021081848,0.0015106328,0.0027227392,0.010194589,0.00131787,0.0030084436,0.0044719153,0.0051402207,0.007240883],"category_scores_gemma":[0.04472243,0.001027107,0.006736989,0.008022297,0.0015438411,0.0021781838,0.002653977,0.0040703136,0.003023968],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00041279758,0.00021056912,0.002404151,0.11544026,0.0011798961,0.00091512507,0.0013169396,0.0012365299,0.0012041471,0.01135096,0.28510332,0.57922536],"study_design_scores_gemma":[0.00032703025,0.0001539134,0.0040097195,0.22241239,0.0026179904,0.0007679317,0.0004962778,0.00031277293,0.0005634543,0.00588463,0.762357,0.0000968626],"about_ca_topic_score_codex":0.020091757,"about_ca_topic_score_gemma":0.021505337,"teacher_disagreement_score":0.021081848,"about_ca_system_score_codex":0.004257675,"about_ca_system_score_gemma":0.019266253,"threshold_uncertainty_score":0.11149281},"labels":[],"label_agreement":null},{"id":"W4223488219","doi":"10.1111/bjh.18153","title":"How to dose and monitor argatroban for treatment of <scp>HIT</scp>","year":2022,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Heparin-Induced Thrombocytopenia and Thrombosis","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Argatroban; Heparin-induced thrombocytopenia; Dosing; Medicine; Heparin; Discovery and development of direct thrombin inhibitors; Direct thrombin inhibitor; Pharmacology; Intensive care medicine; Thrombin; Internal medicine; Platelet; Warfarin","score_opus":0.032393869956374305,"score_gpt":0.29219900362419793,"score_spread":0.25980513366782365,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4223488219","genre_codex":"commentary","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0009793929,0.024387496,0.0010564761,0.94151396,0.027915195,0.000052802097,0.00031406037,0.00007314699,0.0037074117],"genre_scores_gemma":[0.019083632,0.033255074,0.004237177,0.8268693,0.11062607,0.00017582685,0.0002691317,0.00009508859,0.005388739],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9963427,0.0014508932,0.00080630626,0.00034246634,0.000858,0.00019958583],"domain_scores_gemma":[0.9739754,0.013446256,0.0024155446,0.00074135396,0.00800239,0.0014190035],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004294023,0.0007582808,0.0018331732,0.0011381155,0.0010514515,0.0019224134,0.0022115253,0.013401718,0.0053196177],"category_scores_gemma":[0.03909405,0.00046490517,0.001709901,0.000890558,0.001704049,0.0039775404,0.00068237574,0.016680902,0.00627734],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00058899604,0.00007395655,0.0019402498,0.0011026396,0.0001534435,0.0013206645,0.00019084227,0.00034638436,0.0006735315,0.0023546757,0.9009716,0.09028289],"study_design_scores_gemma":[0.0011170314,0.00046619278,0.008102336,0.007977044,0.00048632058,0.004619452,0.0009791022,0.0010633082,0.0015052806,0.019988457,0.9533276,0.00036789954],"about_ca_topic_score_codex":0.008842498,"about_ca_topic_score_gemma":0.012974405,"teacher_disagreement_score":0.013401718,"about_ca_system_score_codex":0.002163988,"about_ca_system_score_gemma":0.003659285,"threshold_uncertainty_score":0.02270925},"labels":[],"label_agreement":null},{"id":"W4223998135","doi":"10.1111/bjh.18167","title":"Functional impairment of erythropoiesis in Congenital Dyserythropoietic Anaemia type I arises at the progenitor level","year":2022,"lang":"en","type":"letter","venue":"British Journal of Haematology","topic":"Erythrocyte Function and Pathophysiology","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Medical Research Council; Medical Research Council Canada; Action Medical Research","keywords":"Biology; Progenitor cell; Erythropoiesis; Haematopoiesis; Mutation; Cell biology; Genetics; Stem cell; Gene; Anemia","score_opus":0.03746162389033963,"score_gpt":0.269505748988604,"score_spread":0.2320441250982644,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4223998135","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99103653,0.0039803726,0.0021479635,0.00006124726,0.000020768357,0.000017500273,0.00046625288,0.0000969683,0.0021723984],"genre_scores_gemma":[0.9976999,0.0006431144,0.0007219047,0.000022343214,0.0000052483074,0.000010367715,0.0002837421,0.000015121275,0.00059831876],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99987566,0.00001998565,0.000017258735,0.000028657105,0.00004160341,0.00001680715],"domain_scores_gemma":[0.99988234,0.000033088472,0.000020288802,0.000017497132,0.000012185925,0.00003460074],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018581409,0.00019309015,0.0002464407,0.00043243376,0.00015445246,0.00020658986,0.00024871007,0.00028442545,0.0021312595],"category_scores_gemma":[0.00028971635,0.00009348853,0.00014051334,0.00022527733,0.00031397815,0.00012814093,0.0002568406,0.00030638734,0.00041828057],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00044925825,0.000034265897,0.013265215,0.00019435555,0.000025985419,0.0017528262,0.00011333307,0.00016422913,0.9696353,0.00060193584,0.00024044333,0.013522779],"study_design_scores_gemma":[0.00004216605,0.0010009158,0.36235464,0.000038552997,0.00010140309,0.04597954,0.00017889008,0.0013919012,0.5756408,0.00081761176,0.012434927,0.00001859243],"about_ca_topic_score_codex":0.00041035848,"about_ca_topic_score_gemma":0.00021944311,"teacher_disagreement_score":0.0021312595,"about_ca_system_score_codex":0.00015326953,"about_ca_system_score_gemma":0.00009615943,"threshold_uncertainty_score":0.007129729},"labels":[],"label_agreement":null},{"id":"W4224085202","doi":"10.1111/bjh.18172","title":"Outcomes of daratumumab in the treatment of multiple myeloma: A retrospective cohort study from the Canadian Myeloma Research Group Database","year":2022,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Alberta; Queen Elizabeth II Health Sciences Centre; Dalhousie University; Saskatchewan Cancer Agency; CancerCare Manitoba; Ottawa Hospital; Ottawa Regional Cancer Foundation; Princess Margaret Cancer Centre; University of Calgary; Vancouver General Hospital; McGill University; Saint John Regional Hospital; BC Cancer Agency; Canadian Institutes of Health Research; Juravinski Cancer Centre; University of Saskatchewan; Université de Montréal; Hôpital Maisonneuve-Rosemont","funders":"","keywords":"Daratumumab; Lenalidomide; Medicine; Pomalidomide; Multiple myeloma; Bortezomib; Internal medicine; Retrospective cohort study; Cohort; Progression-free survival; Oncology; Overall survival","score_opus":0.055654552876401295,"score_gpt":0.35681313966272865,"score_spread":0.30115858678632734,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4224085202","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98690945,0.001256099,0.00008762806,0.00017774975,0.000010150429,0.000073666684,0.010578,0.000008692553,0.00089846045],"genre_scores_gemma":[0.992038,0.00058915245,0.00014296587,0.000113232694,0.000011332188,0.000044327597,0.00691088,0.000005744555,0.00014424018],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9980919,0.0001583905,0.00018625763,0.00042945283,0.0007449112,0.00038911903],"domain_scores_gemma":[0.99669516,0.00019380065,0.0013954998,0.00024391158,0.0010081538,0.00046352413],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010861808,0.00042302496,0.0007622002,0.0016787251,0.0013330944,0.0011798566,0.0012553326,0.00045802526,0.00090839627],"category_scores_gemma":[0.0030148749,0.00032138446,0.0007104889,0.005321538,0.00043800488,0.00046620434,0.00077360304,0.00074911903,0.00017139676],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015906754,0.000019176568,0.99707353,0.000032452233,0.00011937958,0.00009305753,0.00012735053,0.00006240216,0.00008473988,0.00004324933,0.0007387084,0.0014468402],"study_design_scores_gemma":[0.000023366216,0.00004289114,0.99747556,0.000022132523,0.000099333076,0.00027365578,0.0002963491,0.00025645117,0.0000639184,0.000017651037,0.0014142899,0.000014408954],"about_ca_topic_score_codex":0.7696879,"about_ca_topic_score_gemma":0.81410515,"teacher_disagreement_score":0.23031211,"about_ca_system_score_codex":0.009555725,"about_ca_system_score_gemma":0.011143762,"threshold_uncertainty_score":0.46333688},"labels":[],"label_agreement":null},{"id":"W4225014393","doi":"10.1111/bjh.18213","title":"Myeloproliferative neoplasms – a global view","year":2022,"lang":"en","type":"letter","venue":"British Journal of Haematology","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital Maisonneuve-Rosemont","funders":"","keywords":"Phlebotomy; Presentation (obstetrics); Medicine; Disease; Schedule; Intensive care medicine; Surgery; Pathology; Management; Economics","score_opus":0.017986190241884616,"score_gpt":0.2806940402939551,"score_spread":0.2627078500520705,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4225014393","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0030885877,0.14234513,0.0013880497,0.807999,0.028512102,0.000012518094,0.00008097205,0.00008710461,0.01648658],"genre_scores_gemma":[0.09420276,0.25307518,0.0040887753,0.56044394,0.072252646,0.000060618597,0.00018338763,0.00018523374,0.0155073805],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9973756,0.001252403,0.00020191008,0.00027351905,0.0005608204,0.0003357316],"domain_scores_gemma":[0.9945926,0.0020864885,0.000329786,0.00021805178,0.001068788,0.0017044103],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0056875544,0.0007409867,0.0007867867,0.0017311381,0.002094245,0.00824632,0.0012881199,0.0066534085,0.005543255],"category_scores_gemma":[0.0052282237,0.00038245026,0.00053153926,0.0012567071,0.0061975964,0.016722508,0.0064077633,0.015398062,0.0016624787],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00005313616,0.00008099994,0.0029801312,0.0014634103,0.00006724077,0.0016945988,0.009829506,0.0003972222,0.0010148615,0.09752945,0.7132083,0.17168115],"study_design_scores_gemma":[0.0000053642457,0.00006113109,0.0011233856,0.0016850728,0.000022919654,0.0019093769,0.0074445717,0.00008059006,0.00009438021,0.015285024,0.97226226,0.000026065487],"about_ca_topic_score_codex":0.0013308681,"about_ca_topic_score_gemma":0.0023600548,"teacher_disagreement_score":0.00824632,"about_ca_system_score_codex":0.0024875589,"about_ca_system_score_gemma":0.0028451816,"threshold_uncertainty_score":0.030079007},"labels":[],"label_agreement":null},{"id":"W4226363923","doi":"10.1111/bjh.18188","title":"The Montreal cognitive assessment as a cognitive screening tool in sickle cell disease: Associations with clinically significant cognitive domains","year":2022,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"Eunice Kennedy Shriver National Institute of Child Health and Human Development; National Institute on Aging; National Institutes of Health; American Society of Hematology; National Heart, Lung, and Blood Institute; Andrew W. Mellon Foundation","keywords":"Montreal Cognitive Assessment; Medicine; Interquartile range; Health literacy; Cognition; Cognitive test; Population; Gerontology; Generalizability theory; Clinical psychology; Physical therapy; Internal medicine; Cognitive impairment; Psychiatry; Psychology; Developmental psychology; Environmental health; Health care","score_opus":0.011125609341265216,"score_gpt":0.28689932632623594,"score_spread":0.2757737169849707,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4226363923","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99650574,0.0018375079,0.0002741777,0.00021024962,0.000011215018,0.00004033379,0.00036259933,0.000009192859,0.00074905064],"genre_scores_gemma":[0.9987318,0.00033887045,0.00048193734,0.00004629948,0.00001752674,0.000027526137,0.00024832872,0.0000013618156,0.000106357926],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9993086,0.00027688924,0.000072091934,0.0000932471,0.0001807789,0.00006832156],"domain_scores_gemma":[0.9978794,0.00053603837,0.0008616719,0.00008454785,0.00031459116,0.00032369976],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015785175,0.00049949146,0.0003207921,0.0016935179,0.0002694401,0.00057892624,0.0003972402,0.00046564118,0.0006833854],"category_scores_gemma":[0.0068041985,0.000106435466,0.0003584144,0.001148005,0.00024568738,0.0005061139,0.00048401605,0.0005132432,0.000096216856],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011085165,0.00007216088,0.99300486,0.000023255565,0.000077073455,0.000035109464,0.000038345934,0.00007675006,0.000089024754,0.000021702674,0.00015720376,0.006293589],"study_design_scores_gemma":[0.000010562358,0.00022472156,0.9988703,0.00001498686,0.000032878794,0.00009617149,0.00004046028,0.0004852278,0.000052767788,0.000038741277,0.00012832144,0.000004715627],"about_ca_topic_score_codex":0.014994655,"about_ca_topic_score_gemma":0.028437681,"teacher_disagreement_score":0.014994655,"about_ca_system_score_codex":0.00048890227,"about_ca_system_score_gemma":0.0007076548,"threshold_uncertainty_score":0.02981472},"labels":[],"label_agreement":null},{"id":"W4247323900","doi":"10.1046/j.0007-1048.2001.03282.x","title":"Single-centre experience with allogeneic bone marrow transplantation for acute lymphoblastic leukaemia in childhood: similar survival after matched-related and matched-unrelated donor transplants","year":2002,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Princess Margaret Cancer Centre; Hospital for Sick Children","funders":"","keywords":"Medicine; Bone marrow transplantation; Acute lymphocytic leukemia; Transplantation; Bone marrow; Transplantation Chimera; Hematology; Childhood leukaemia; Hematopoietic cell; Oncology; Lymphoblastic Leukemia; Leukemia; Immunology; Internal medicine; Pediatrics; Haematopoiesis; Stem cell; Biology; Genetics","score_opus":0.011556599870816127,"score_gpt":0.23077006236579145,"score_spread":0.21921346249497534,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4247323900","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99703014,0.0016861963,0.000244981,0.00009753075,0.00003612153,0.000025814059,0.000087190034,0.000012984384,0.0007789925],"genre_scores_gemma":[0.99856645,0.0007084995,0.00015420912,0.00006766645,0.00004830902,0.000013397644,0.00022870426,0.000005833087,0.00020690201],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9993304,0.00025753173,0.000068605645,0.00008682083,0.00011229451,0.0001443047],"domain_scores_gemma":[0.99867415,0.00024628427,0.0003482774,0.00013802706,0.00010032254,0.0004929273],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010923534,0.00032855326,0.0003859313,0.0004614587,0.0005172064,0.00051648787,0.00035201703,0.0004730476,0.0015026274],"category_scores_gemma":[0.0030031777,0.00014191371,0.0006003284,0.0005416973,0.00030675268,0.00033493477,0.0005223702,0.00037179104,0.00050075643],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0029053113,0.0014306166,0.9007196,0.00021831061,0.0005156289,0.012277496,0.001798869,0.0015300311,0.004088555,0.00027448143,0.0017334739,0.07250763],"study_design_scores_gemma":[0.0007322814,0.010358203,0.9288144,0.00011570199,0.00025895794,0.05109562,0.0009956377,0.0010784873,0.0019513968,0.0002971939,0.0042565055,0.000045634788],"about_ca_topic_score_codex":0.0014027995,"about_ca_topic_score_gemma":0.0024285181,"teacher_disagreement_score":0.0015026274,"about_ca_system_score_codex":0.0006859772,"about_ca_system_score_gemma":0.000342908,"threshold_uncertainty_score":0.0057770014},"labels":[],"label_agreement":null},{"id":"W4280582101","doi":"10.1111/bjh.18241","title":"Outcomes of Hodgkin variant Richter transformation in chronic lymphocytic leukaemia and small lymphocytic lymphoma in British Columbia","year":2022,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Dalhousie University; University of British Columbia","funders":"Servier; Gilead Sciences; AstraZeneca","keywords":"Medicine; ABVD; Internal medicine; Cohort; Population; Chronic lymphocytic leukemia; Gastroenterology; Oncology; Surgery; Chemotherapy; Leukemia; Vincristine; Cyclophosphamide","score_opus":0.013864597988323587,"score_gpt":0.2579462476717944,"score_spread":0.24408164968347082,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4280582101","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9988527,0.00018862364,0.000021440688,0.00003763773,0.0000021558471,0.000009456598,0.0003691348,0.0000028615789,0.00051589415],"genre_scores_gemma":[0.99891424,0.00010414717,0.000020989477,0.000039682818,0.0000018765253,0.000006518224,0.0006197801,0.0000020376892,0.00029066522],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99962544,0.00003868997,0.000030562824,0.000062105086,0.00009561387,0.00014765305],"domain_scores_gemma":[0.9989054,0.00010151602,0.00025156265,0.00005408604,0.00033667267,0.00035070005],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00031273713,0.00022690637,0.0003669649,0.00074923295,0.0012848825,0.0009814687,0.00065498374,0.000415106,0.0012083534],"category_scores_gemma":[0.0014322421,0.00023538165,0.00021414916,0.0015705834,0.0006165525,0.00026300727,0.0010898416,0.00049625064,0.00024049355],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000192448,0.00002338126,0.99506795,0.000016468588,0.00002658183,0.00048025473,0.00038552767,0.00009444321,0.00034862457,0.000020261114,0.00033936015,0.0030047083],"study_design_scores_gemma":[0.000012591678,0.00005045228,0.9981269,0.000016613154,0.000014694344,0.0005160823,0.00065103796,0.00014604046,0.000054743654,0.000021645208,0.00038103634,0.000008195014],"about_ca_topic_score_codex":0.7928661,"about_ca_topic_score_gemma":0.87801635,"teacher_disagreement_score":0.20713389,"about_ca_system_score_codex":0.006379501,"about_ca_system_score_gemma":0.0036713053,"threshold_uncertainty_score":0.41670746},"labels":[],"label_agreement":null},{"id":"W4281550684","doi":"10.1111/bjh.18276","title":"Unanswered questions in cancer‐associated thrombosis","year":2022,"lang":"en","type":"review","venue":"British Journal of Haematology","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":30,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Spinal Cord Injury BC; University of British Columbia; BC Cancer Agency","funders":"","keywords":"Medicine; Intensive care medicine; Observational study; Cancer; Venous thromboembolism; Anticoagulant; Thrombosis; Disease; Clinical trial; Randomized controlled trial; MEDLINE; Anticoagulant therapy; Internal medicine","score_opus":0.08788620242320794,"score_gpt":0.39159304090842745,"score_spread":0.3037068384852195,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4281550684","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000019448293,0.99892336,0.00001980855,0.00061988714,0.00023288271,0.0000018086763,0.000006917072,0.0000016140978,0.00017429837],"genre_scores_gemma":[0.0003389689,0.99875915,0.000047732876,0.0005207965,0.00021869663,0.000003904561,0.000008962022,7.285109e-7,0.00010110053],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99898607,0.00033075572,0.0002176499,0.000109692024,0.00029861208,0.000057234687],"domain_scores_gemma":[0.9967146,0.0023676257,0.00035013352,0.000059968057,0.0004121487,0.00009551765],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0024297694,0.00075348455,0.0025794536,0.0023896701,0.00037240222,0.002077988,0.0012011084,0.0021759535,0.005478955],"category_scores_gemma":[0.0064798407,0.00037010864,0.0014251419,0.0033900493,0.0010838102,0.002792432,0.0009914478,0.0025189896,0.0012716207],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001051532,0.000032518823,0.0001787451,0.12675388,0.0004575691,0.00020795928,0.0002281132,0.00028127525,0.0002681476,0.0068744635,0.059124578,0.8054877],"study_design_scores_gemma":[0.000042932785,0.00008345525,0.0008969722,0.08329948,0.0006222202,0.001094823,0.00027686267,0.000081549835,0.00008021405,0.008217013,0.90527993,0.000024516758],"about_ca_topic_score_codex":0.002307258,"about_ca_topic_score_gemma":0.0036969061,"teacher_disagreement_score":0.005478955,"about_ca_system_score_codex":0.001093806,"about_ca_system_score_gemma":0.0038029999,"threshold_uncertainty_score":0.018328905},"labels":[],"label_agreement":null},{"id":"W4281910137","doi":"10.1111/bjh.18286","title":"Early integration of palliative care for patients with haematological malignancies","year":2022,"lang":"en","type":"review","venue":"British Journal of Haematology","topic":"Palliative Care and End-of-Life Issues","field":"Medicine","cited_by":56,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"University of Toronto; University Health Network","keywords":"Palliative care; Medicine; Specialty; Cancer; Intensive care medicine; Quality of life (healthcare); MEDLINE; Clinical trial; Oncology; Internal medicine; Family medicine; Nursing","score_opus":0.14447986898910548,"score_gpt":0.4147919607515019,"score_spread":0.2703120917623964,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4281910137","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00008912916,0.9993081,0.000025618792,0.00013610366,0.00004813704,0.0000045888005,0.000007934356,0.0000016319547,0.0003787655],"genre_scores_gemma":[0.0008115647,0.9988632,0.00008063614,0.000107234126,0.0000322296,0.000006433722,0.000013028405,4.884769e-7,0.000085178894],"study_design_codex":"design_other","study_design_gemma":"systematic_review","domain_scores_codex":[0.99956137,0.00016850288,0.00008206483,0.000044889744,0.00011184075,0.000031229167],"domain_scores_gemma":[0.9991535,0.0005869763,0.00013048576,0.0000126476625,0.00008689607,0.0000294338],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007906318,0.00062580104,0.001154362,0.001549301,0.00030937485,0.0009410972,0.0005737287,0.0010163723,0.0035251917],"category_scores_gemma":[0.0019787797,0.00020038111,0.0008987011,0.0015492898,0.00028938786,0.000984694,0.0009000581,0.0011177548,0.0006497434],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000080560065,0.000038535505,0.0001697028,0.09937915,0.0002572975,0.00008698549,0.00013047538,0.00019781812,0.00031472006,0.0015737894,0.010527717,0.88724333],"study_design_scores_gemma":[0.000093593546,0.00022133034,0.0036402724,0.12579791,0.0011400859,0.0022005155,0.0003293756,0.00012733444,0.0003026045,0.0018229877,0.86429316,0.00003073027],"about_ca_topic_score_codex":0.0014226604,"about_ca_topic_score_gemma":0.0038631891,"teacher_disagreement_score":0.0035251917,"about_ca_system_score_codex":0.0006322824,"about_ca_system_score_gemma":0.0015754866,"threshold_uncertainty_score":0.011792958},"labels":[],"label_agreement":null},{"id":"W4283369873","doi":"10.1111/bjh.18333","title":"Sequential loss of B‐cell target antigens in multiply relapsed high‐grade B‐cell lymphoma treated with targeted therapies","year":2022,"lang":"en","type":"letter","venue":"British Journal of Haematology","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Bristol-Myers Squibb Canada","keywords":"Lymphoma; Medicine; B cell; Antigen; B-cell lymphoma; Oncology; Immunology; Cancer research; Internal medicine; Antibody","score_opus":0.016211989628227813,"score_gpt":0.25931032101338936,"score_spread":0.24309833138516154,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4283369873","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.76784027,0.01763687,0.0024347364,0.14898,0.0075661787,0.00024128958,0.00050069945,0.00028406252,0.054515917],"genre_scores_gemma":[0.94180584,0.0030761561,0.0008084953,0.036553383,0.005769196,0.000056907644,0.00028028587,0.00003976994,0.011609945],"study_design_codex":"case_report","study_design_gemma":"observational","domain_scores_codex":[0.9996549,0.00010406766,0.000035097335,0.00003908821,0.000079415506,0.0000874923],"domain_scores_gemma":[0.9989311,0.0005150674,0.00009695942,0.00006511509,0.00010445998,0.0002873037],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00045109214,0.0002817199,0.000788867,0.0003781976,0.0006738764,0.0007601503,0.00044373763,0.003919529,0.0013509787],"category_scores_gemma":[0.0024994034,0.00020236528,0.0004078944,0.00041675742,0.00043686607,0.00043850724,0.00031112027,0.0020349051,0.0007258927],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.012845788,0.0007249992,0.042194266,0.00045748637,0.00023426898,0.6447912,0.0008242439,0.0015229736,0.024697635,0.0030792768,0.115891166,0.15273668],"study_design_scores_gemma":[0.002384212,0.0058442145,0.14143454,0.0002849347,0.00035142017,0.656536,0.00069319777,0.007539902,0.010955511,0.0074908137,0.16636972,0.00011559687],"about_ca_topic_score_codex":0.0013888382,"about_ca_topic_score_gemma":0.0027243854,"teacher_disagreement_score":0.003919529,"about_ca_system_score_codex":0.0014619081,"about_ca_system_score_gemma":0.00039420792,"threshold_uncertainty_score":0.010606945},"labels":[],"label_agreement":null},{"id":"W4283516342","doi":"10.1111/bjh.18329","title":"Quality of life independently predicts overall survival in myelofibrosis: Key insights from the COntrolled MyeloFibrosis Study with ORal Janus kinase inhibitor Treatment <scp>(COMFORT)‐I</scp> study","year":2022,"lang":"en","type":"letter","venue":"British Journal of Haematology","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Myelofibrosis; Ruxolitinib; Medicine; Janus; Quality of life (healthcare); Janus kinase 2; Oncology; Internal medicine; Key (lock); Cancer research; Biology; Nanotechnology; Materials science","score_opus":0.03137900389653403,"score_gpt":0.2793989253585921,"score_spread":0.2480199214620581,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4283516342","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.55157655,0.43235147,0.0011617641,0.0026563164,0.0003445726,0.0005058985,0.009040261,0.000025502557,0.0023376376],"genre_scores_gemma":[0.9501321,0.03762651,0.0011960686,0.0013429499,0.0010371457,0.00048516304,0.007834232,0.000018538984,0.00032736952],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99695766,0.0017441902,0.00035689757,0.00046998248,0.0003388464,0.00013246645],"domain_scores_gemma":[0.9910171,0.0050738445,0.002275246,0.00049575354,0.0006875532,0.00045045448],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00859058,0.001180178,0.0028986174,0.0007197707,0.0003217916,0.0015381845,0.00076547096,0.0009732327,0.0020264555],"category_scores_gemma":[0.009758191,0.00039927778,0.0055363327,0.0015482598,0.00048844505,0.0005380087,0.0008068159,0.0014381737,0.0001776284],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.1342595,0.00094781624,0.5633999,0.022111729,0.15569127,0.0003503783,0.00041896536,0.0017032893,0.0015764551,0.00072837947,0.0060391314,0.112773225],"study_design_scores_gemma":[0.026051378,0.0076033697,0.8187536,0.0028981057,0.13245733,0.0003933858,0.00017803088,0.001538944,0.00041984007,0.0015687477,0.007978947,0.00015825275],"about_ca_topic_score_codex":0.0020980402,"about_ca_topic_score_gemma":0.0037667502,"teacher_disagreement_score":0.00859058,"about_ca_system_score_codex":0.00047108746,"about_ca_system_score_gemma":0.0007073534,"threshold_uncertainty_score":0.045431852},"labels":[],"label_agreement":null},{"id":"W4285591962","doi":"10.1111/bjh.18355","title":"Diversity in the bone marrow niche: Classic and novel strategies to uncover niche composition","year":2022,"lang":"en","type":"review","venue":"British Journal of Haematology","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":26,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"American Society of Hematology; Medical Research Council Canada; Cancer Research UK; Leukaemia UK; Medical Research Council; Barts Charity","keywords":"Niche; Biology; Haematopoiesis; Stem cell; Bone marrow; Stromal cell; Cell biology; Stem cell niche; Mesenchymal stem cell; Progenitor cell; Immunology; Cancer research; Ecology","score_opus":0.07090257376211874,"score_gpt":0.3278305803355364,"score_spread":0.2569280065734177,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4285591962","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00007331928,0.99875164,0.0001823597,0.0003318777,0.00017756596,0.000001931453,0.000007846362,0.0000047741055,0.00046862956],"genre_scores_gemma":[0.0006041057,0.9983077,0.00025932083,0.00024977798,0.00022464147,0.000005317859,0.000017224656,0.0000020673815,0.00032982137],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99974173,0.000043786284,0.00003398557,0.00005528695,0.000101583384,0.00002370951],"domain_scores_gemma":[0.99946874,0.00030445887,0.00004244226,0.00001973197,0.0001143137,0.00005037289],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010151569,0.0008001415,0.0013806473,0.0027847877,0.00028755533,0.0013617935,0.0010508432,0.0015268386,0.0027178945],"category_scores_gemma":[0.0010663413,0.00032517812,0.00047950973,0.00201753,0.001329146,0.0023643516,0.00096553564,0.0027292364,0.0015616124],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009785127,0.000042291504,0.00017795015,0.01417063,0.00007323041,0.00026609618,0.00009858666,0.00032441257,0.003392066,0.012592711,0.019782444,0.9489817],"study_design_scores_gemma":[0.000013826275,0.00008452973,0.00067226175,0.002711394,0.000063522304,0.0013405283,0.00008412473,0.00008887308,0.00087801926,0.0043773395,0.9896582,0.00002743054],"about_ca_topic_score_codex":0.00085442583,"about_ca_topic_score_gemma":0.0011369544,"teacher_disagreement_score":0.0027847877,"about_ca_system_score_codex":0.00090390316,"about_ca_system_score_gemma":0.0010380736,"threshold_uncertainty_score":0.009092212},"labels":[],"label_agreement":null},{"id":"W4286491901","doi":"10.1111/bjh.18368","title":"A phase 2, multicentre, open‐label trial (<scp>ACE‐LY</scp>‐003) of acalabrutinib in patients with relapsed or refractory marginal zone lymphoma","year":2022,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":30,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"London Health Sciences Centre","funders":"AstraZeneca","keywords":"Medicine; Internal medicine; Gastroenterology; Neutropenia; Adverse effect; Discontinuation; Refractory (planetary science); Hazard ratio; Febrile neutropenia; Phases of clinical research; Progression-free survival; Surgery; Confidence interval; Toxicity; Chemotherapy","score_opus":0.03317684450859787,"score_gpt":0.33373213869567864,"score_spread":0.30055529418708077,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4286491901","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9924388,0.0018148716,0.0006008264,0.0004373144,0.00007648578,0.0018034643,0.00087330845,0.000077178716,0.0018778369],"genre_scores_gemma":[0.9912293,0.0009878813,0.0016218055,0.00084563624,0.0001836597,0.0013966651,0.0021443744,0.000019111167,0.0015715503],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99957246,0.00026744202,0.000015765172,0.0000489146,0.000031647127,0.00006371477],"domain_scores_gemma":[0.9994425,0.00012742882,0.00011288901,0.000043016724,0.000028772629,0.0002453923],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016549834,0.0010122653,0.0009963822,0.00034063615,0.00023713463,0.0005964004,0.00045805497,0.00083982636,0.0027720002],"category_scores_gemma":[0.0008084991,0.00027697187,0.00081807235,0.00027195152,0.0005793262,0.00046534746,0.000315124,0.0020122975,0.0006159572],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.64362955,0.044691246,0.01651564,0.0012270138,0.0015682719,0.00080914714,0.00053941645,0.0020411543,0.075884424,0.0005514842,0.008590917,0.20395175],"study_design_scores_gemma":[0.7216419,0.24728705,0.021054687,0.000033535016,0.0003071589,0.00055762136,0.000043575696,0.001382519,0.0039164494,0.00022383333,0.0035190796,0.00003254953],"about_ca_topic_score_codex":0.00062345364,"about_ca_topic_score_gemma":0.0023832754,"teacher_disagreement_score":0.0027720002,"about_ca_system_score_codex":0.00056716375,"about_ca_system_score_gemma":0.0008478772,"threshold_uncertainty_score":0.009273291},"labels":[],"label_agreement":null},{"id":"W4287510456","doi":"10.1111/bjh.18331","title":"Recurrence after stopping anticoagulants in women with combined oral contraceptive‐associated venous thromboembolism: A systematic review and <scp>meta‐analysis</scp>","year":2022,"lang":"en","type":"review","venue":"British Journal of Haematology","topic":"Reproductive Health and Contraception","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Joseph’s Healthcare Hamilton; Ottawa Hospital; Princess Margaret Cancer Centre; Thrombosis and Atherosclerosis Research Institute; University of Ottawa; University of Toronto; University Health Network; University of Calgary; Impact; McGill University; McMaster University","funders":"Canadian Institutes of Health Research","keywords":"Medicine; Discontinuation; Meta-analysis; Incidence (geometry); Confidence interval; Cohort study; Venous thromboembolism; Internal medicine; Systematic review; Prospective cohort study; Hazard ratio; Relative risk; Randomized controlled trial; MEDLINE; Obstetrics; Thrombosis","score_opus":0.05127652155252074,"score_gpt":0.3320020267003685,"score_spread":0.2807255051478478,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4287510456","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0042048898,0.9945603,0.0002322371,0.00016925266,0.00014242652,0.00023735841,0.00026056767,0.000013227544,0.0001797712],"genre_scores_gemma":[0.13966167,0.85521036,0.0015677523,0.0010933576,0.00039358018,0.0010641066,0.00065017946,0.000021639562,0.00033724657],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99183005,0.003751779,0.0023978192,0.00069793925,0.0010843638,0.0002380756],"domain_scores_gemma":[0.982421,0.0123223,0.0032915277,0.00042228738,0.0013680918,0.00017481305],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.012812719,0.0021602702,0.016889662,0.005041875,0.00047648774,0.0031960935,0.0016114294,0.002104382,0.0029165626],"category_scores_gemma":[0.029977784,0.0013246483,0.03732214,0.00507709,0.0005705582,0.0013468644,0.0011400833,0.0014633309,0.0002181106],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00152609,0.0000294229,0.0039604004,0.43148655,0.5476098,0.00013157687,0.000073267925,0.00036499323,0.000189575,0.00010469495,0.00066217786,0.013861464],"study_design_scores_gemma":[0.00051884906,0.0002313066,0.004076925,0.03528863,0.9575538,0.00013766607,0.000042572145,0.00021199365,0.00010264697,0.00012793421,0.0016860098,0.000021562171],"about_ca_topic_score_codex":0.00683919,"about_ca_topic_score_gemma":0.013546026,"teacher_disagreement_score":0.016889662,"about_ca_system_score_codex":0.00220169,"about_ca_system_score_gemma":0.0034024946,"threshold_uncertainty_score":0.067760944},"labels":[],"label_agreement":null},{"id":"W4288067544","doi":"10.1111/bjh.18388","title":"The potential impact of monkeypox infection and vaccination on blood donor deferrals and the blood supply","year":2022,"lang":"en","type":"letter","venue":"British Journal of Haematology","topic":"Poxvirus research and outbreaks","field":"Immunology and Microbiology","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Monkeypox; Virology; Vaccination; Medicine; Blood supply; Blood donor; Immunology; Biology; Surgery; Vaccinia; Genetics","score_opus":0.009241911725103361,"score_gpt":0.25566603833240276,"score_spread":0.2464241266072994,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4288067544","genre_codex":"empirical","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8429821,0.070080794,0.0014415039,0.045494,0.0012716429,0.000104674546,0.00089067203,0.000056004315,0.037678633],"genre_scores_gemma":[0.9868628,0.007942606,0.00031231696,0.002725305,0.0004286989,0.000020868292,0.00019417629,0.000009048737,0.001504308],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.997563,0.0015943608,0.00008111257,0.00012190358,0.00026968302,0.00036988882],"domain_scores_gemma":[0.9949587,0.0019457745,0.0012647241,0.00014254624,0.00065720454,0.0010310574],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0030225755,0.0002127794,0.0002824307,0.00028852583,0.00036341557,0.0011257301,0.00059096725,0.0009517714,0.009694357],"category_scores_gemma":[0.017431114,0.00011040633,0.00027074802,0.0003398672,0.00040403462,0.0009086048,0.0008196837,0.0008481754,0.0006384316],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0035307412,0.0011757544,0.6261025,0.0014204136,0.00038307853,0.003891952,0.0015536883,0.0016982658,0.002722065,0.017605262,0.02770502,0.3122112],"study_design_scores_gemma":[0.00037115582,0.0065829144,0.83844006,0.0067832796,0.00062739383,0.008120942,0.004768356,0.006600674,0.0023543586,0.015858395,0.109397806,0.00009473038],"about_ca_topic_score_codex":0.009312392,"about_ca_topic_score_gemma":0.007214008,"teacher_disagreement_score":0.009694357,"about_ca_system_score_codex":0.0016074622,"about_ca_system_score_gemma":0.0018043546,"threshold_uncertainty_score":0.032430887},"labels":[],"label_agreement":null},{"id":"W4291019328","doi":"10.1111/bjh.18401","title":"Quality of <scp>end‐of‐life</scp> care in multiple myeloma: A <scp>13‐year</scp> analysis of a population‐based cohort in Ontario, Canada","year":2022,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Palliative Care and End-of-Life Issues","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Canadian Centre for Applied Research in Cancer Control; Sunnybrook Health Science Centre; McMaster University; Queen's University","funders":"Canadian Cancer Society Research Institute; Canadian Centre for Applied Research in Cancer Control","keywords":"Medicine; Palliative care; End-of-life care; Emergency department; Cohort; Intensive care unit; Population; Emergency medicine; Multiple myeloma; Internal medicine; Family medicine; Nursing; Environmental health","score_opus":0.048865337670489034,"score_gpt":0.33041631312927544,"score_spread":0.2815509754587864,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4291019328","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97752315,0.0016175797,0.000110099725,0.0008344508,0.000023792802,0.00009363845,0.018006353,0.000013473764,0.0017774975],"genre_scores_gemma":[0.99183404,0.00073359953,0.0001403108,0.00019928915,0.000015340851,0.000051210838,0.006211407,0.000008821153,0.00080593623],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99836606,0.00012815115,0.0001429864,0.00022722018,0.00055261416,0.0005830004],"domain_scores_gemma":[0.995314,0.00014538743,0.0013251728,0.00015043402,0.0018938043,0.0011711317],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010875625,0.0005037174,0.0007466403,0.0015477977,0.0024668197,0.0019422604,0.0018628582,0.00067562104,0.0019714094],"category_scores_gemma":[0.0029559094,0.00055119686,0.0016743077,0.007293019,0.0010513444,0.000622216,0.0016850019,0.001104749,0.00027618054],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000087338114,0.000021310596,0.99652195,0.00004368045,0.00011288453,0.000037127087,0.00033125523,0.000089021814,0.00005010903,0.00004869719,0.0014452548,0.0012114642],"study_design_scores_gemma":[0.000012798063,0.000013852239,0.99880445,0.00003014743,0.000031058084,0.000018510269,0.00033070822,0.00017419107,0.000012613148,0.000010073328,0.00055420183,0.0000072716716],"about_ca_topic_score_codex":0.99507207,"about_ca_topic_score_gemma":0.9951881,"teacher_disagreement_score":0.048449233,"about_ca_system_score_codex":0.048449233,"about_ca_system_score_gemma":0.040616184,"threshold_uncertainty_score":0.35152543},"labels":[],"label_agreement":null},{"id":"W4291111788","doi":"10.1111/bjh.18399","title":"Clinicopathological characteristics and long‐term outcomes of plasmablastic lymphoma in British Columbia","year":2022,"lang":"en","type":"review","venue":"British Journal of Haematology","topic":"Viral-associated cancers and disorders","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of British Columbia","funders":"","keywords":"Medicine; Plasmablastic lymphoma; Internal medicine; Vincristine; Prednisone; Cohort; Cyclophosphamide; Population; Confidence interval; Immunosuppression; Lymphoma; Chemotherapy; Surgery; Gastroenterology","score_opus":0.04128212699196619,"score_gpt":0.32728726184317536,"score_spread":0.28600513485120915,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4291111788","genre_codex":"empirical","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9986731,0.00030947462,0.000021805794,0.00006326062,0.0000026147852,0.0000058793357,0.0003021918,0.0000030214019,0.00061863766],"genre_scores_gemma":[0.99903536,0.00016194551,0.000024444846,0.000038236765,0.0000030152655,0.0000051566644,0.0004581672,0.000001665855,0.00027210073],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9997763,0.000023124554,0.000019791349,0.00003754893,0.00006568188,0.0000776336],"domain_scores_gemma":[0.99873346,0.00013612065,0.00030899254,0.000052886746,0.00041330268,0.0003553758],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002531325,0.00015236971,0.00020434766,0.00090523047,0.0012720671,0.0007943844,0.000578162,0.00037017674,0.0011390689],"category_scores_gemma":[0.0012250036,0.00019173289,0.0001170608,0.0012818902,0.00049701444,0.00020640259,0.00046262873,0.00031841485,0.00023592988],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000096874224,0.000017488646,0.99491924,0.000011426134,0.000013990289,0.00058890757,0.00022202451,0.00007447415,0.0005006101,0.000014933046,0.00037330392,0.0031667592],"study_design_scores_gemma":[0.0000070261904,0.000027200535,0.99820864,0.0000144334535,0.000010022524,0.00066670874,0.0004046509,0.00012583447,0.00005494727,0.000014294141,0.00045998077,0.000006190547],"about_ca_topic_score_codex":0.73457605,"about_ca_topic_score_gemma":0.8562649,"teacher_disagreement_score":0.26542395,"about_ca_system_score_codex":0.0046055526,"about_ca_system_score_gemma":0.0026933237,"threshold_uncertainty_score":0.5339742},"labels":[],"label_agreement":null},{"id":"W4295755071","doi":"10.1111/bjh.18449","title":"Intravenous immunoglobulin in the management of severe early onset red blood cell alloimmunisation","year":2022,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Blood groups and transfusion","field":"Medicine","cited_by":24,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Mount Sinai Hospital","funders":"","keywords":"Medicine; Pregnancy; Gestation; Fetus; Gestational age; Obstetrics; Antibody; Blood transfusion; Pediatrics; Immunology","score_opus":0.007553665406260023,"score_gpt":0.21575638122413276,"score_spread":0.20820271581787275,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4295755071","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9772903,0.02064528,0.0005351475,0.0004195429,0.00005377359,0.00003311758,0.0000149697435,0.000007867704,0.0009999975],"genre_scores_gemma":[0.9967103,0.002711006,0.0002888516,0.00012474938,0.00006741614,0.00000927473,0.000014627172,0.0000012332434,0.000072580835],"study_design_codex":"observational","study_design_gemma":"case_report","domain_scores_codex":[0.9993272,0.00043847194,0.00005272199,0.000042729578,0.000090404355,0.000048399193],"domain_scores_gemma":[0.9989845,0.0004307284,0.00038316022,0.00002888528,0.000030740946,0.00014197413],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00076939113,0.00018418788,0.00036849407,0.00025813683,0.00013142396,0.00031009657,0.00022835966,0.00036943285,0.00020491934],"category_scores_gemma":[0.0020985731,0.00006438508,0.00019229532,0.00021596425,0.0002370243,0.00010355458,0.00017203185,0.0004779069,0.000031340584],"study_design_candidate":"case_report","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00515289,0.0015717015,0.64422995,0.0007571921,0.00042137576,0.0145153515,0.0003611788,0.0009898125,0.006704072,0.0005057556,0.0009501525,0.32384062],"study_design_scores_gemma":[0.0010928703,0.044084255,0.873925,0.0009129923,0.00046877167,0.063173525,0.000645368,0.0033497592,0.0043071858,0.0006663313,0.0073302845,0.00004366485],"about_ca_topic_score_codex":0.0005070884,"about_ca_topic_score_gemma":0.0005598601,"teacher_disagreement_score":0.00076939113,"about_ca_system_score_codex":0.00024698477,"about_ca_system_score_gemma":0.0003767417,"threshold_uncertainty_score":0.0040689707},"labels":[],"label_agreement":null},{"id":"W4303986419","doi":"10.1111/bjh.18486","title":"Dasatinib plus <scp>Peg‐Interferon</scp> alpha 2b combination in newly diagnosed chronic phase chronic myeloid leukaemia: Results of a multicenter phase 2 study (<scp>DASA‐PegIFN</scp> study)","year":2022,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Bristol-Myers Squibb Canada; Merck KGaA","keywords":"Dasatinib; Medicine; Internal medicine; Neutropenia; Gastroenterology; Clinical endpoint; Adverse effect; Pegylated interferon; PEG ratio; Phases of clinical research; Immunology; Imatinib; Myeloid leukemia; Toxicity; Virus; Clinical trial","score_opus":0.02136001394846421,"score_gpt":0.3168797094254256,"score_spread":0.2955196954769614,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4303986419","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99749607,0.0014226446,0.0001785861,0.00012814699,0.000035166326,0.00022988825,0.00019885231,0.000014180689,0.00029641116],"genre_scores_gemma":[0.9960598,0.0015307056,0.00051799475,0.00021195009,0.00010817745,0.00025526495,0.0007578934,0.000011661847,0.00054663356],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.99926406,0.00041092606,0.00004956036,0.00009129151,0.00009701235,0.000087253065],"domain_scores_gemma":[0.9993074,0.00012348473,0.00018480644,0.00004958681,0.00005763526,0.00027716527],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0022263338,0.00086267927,0.0017919607,0.00023294344,0.0002649788,0.00060442707,0.00034887524,0.000559069,0.0008490927],"category_scores_gemma":[0.00084945,0.0003304607,0.0009770138,0.0002750852,0.00042028388,0.00037425576,0.00018600412,0.0013801595,0.00028535412],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.5593698,0.058439042,0.051824674,0.0012027312,0.0048941574,0.0009151834,0.00063609466,0.0034550258,0.14155278,0.00027050433,0.0043189367,0.17312111],"study_design_scores_gemma":[0.4174385,0.45602414,0.10883325,0.000056188503,0.0012858144,0.001649049,0.00009750721,0.0020691482,0.008140175,0.0001296866,0.004225498,0.000051039162],"about_ca_topic_score_codex":0.0007032128,"about_ca_topic_score_gemma":0.0015197181,"teacher_disagreement_score":0.0022263338,"about_ca_system_score_codex":0.0006553877,"about_ca_system_score_gemma":0.00080266234,"threshold_uncertainty_score":0.011774123},"labels":[],"label_agreement":null},{"id":"W4306743619","doi":"10.1111/bjh.18519","title":"<scp>Real‐world</scp> experience among patients with relapsed/refractory mantle cell lymphoma after Bruton tyrosine kinase inhibitor failure in Europe: The <scp>SCHOLAR</scp>‐2 retrospective chart review study","year":2022,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":44,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"MD Precision (Canada); Precision Nanosystems (Canada)","funders":"National Cancer Institute; Allergan; Incyte; Genentech; Sunesis; Bristol-Myers Squibb; Eli Lilly and Company; AstraZeneca; National Cancer Research Institute; Gilead Sciences; Sanofi; Amgen; Pfizer; MorphoSys; Celgene; BeiGene; Patient-Centered Outcomes Research Institute","keywords":"Mantle cell lymphoma; Medicine; Bruton's tyrosine kinase; Refractory (planetary science); Chart; Cancer research; Ibrutinib; Tyrosine kinase; Internal medicine; Lymphoma; Oncology; Leukemia; Biology; Chronic lymphocytic leukemia","score_opus":0.006174186714432873,"score_gpt":0.22688186975725133,"score_spread":0.22070768304281846,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4306743619","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9969536,0.00071351556,0.0000892665,0.000051710605,0.0000042139427,0.000030530533,0.0015287589,0.0000070672295,0.00062143046],"genre_scores_gemma":[0.99749255,0.0005430712,0.00012113639,0.00005796478,0.000011498373,0.000019231302,0.0016187055,0.0000049730656,0.00013085981],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99891543,0.000302557,0.00020518978,0.00024378023,0.00021251518,0.000120556775],"domain_scores_gemma":[0.99466985,0.0008424734,0.0032524958,0.00026064905,0.000556333,0.00041816058],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009479283,0.00015600288,0.00031266172,0.0015850819,0.00041914254,0.0010869075,0.00038310786,0.00030201103,0.00079874624],"category_scores_gemma":[0.0025817219,0.0001971352,0.00033843727,0.0022940112,0.00048507465,0.00058418815,0.0006684592,0.0002834047,0.00017835207],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007088624,0.000027246975,0.99558735,0.00005627858,0.000045063156,0.00060991466,0.000396431,0.000035799287,0.00015836579,0.000029464098,0.00039735076,0.002585929],"study_design_scores_gemma":[0.000016831871,0.00013966847,0.99431413,0.00004017487,0.000040183033,0.0024932697,0.000990231,0.00008809503,0.00022439266,0.000014938032,0.001626538,0.0000116050405],"about_ca_topic_score_codex":0.009180777,"about_ca_topic_score_gemma":0.010151736,"teacher_disagreement_score":0.009180777,"about_ca_system_score_codex":0.0009178043,"about_ca_system_score_gemma":0.0010791138,"threshold_uncertainty_score":0.018254697},"labels":[],"label_agreement":null},{"id":"W4306912135","doi":"10.1111/bjh.18510","title":"Clinical significance of mitochondrial <scp>DNA</scp> content in acute promyelocytic leukaemia","year":2022,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Retinoids in leukemia and cellular processes","field":"Biochemistry, Genetics and Molecular Biology","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"Conselho Nacional de Desenvolvimento Científico e Tecnológico; Fundação de Amparo à Pesquisa do Estado de São Paulo","keywords":"Mitochondrial DNA; Cumulative incidence; Clinical significance; Incidence (geometry); Internal medicine; Proportional hazards model; Medicine; Mitochondrion; Multivariate analysis; Oncology; Immunology; Biology; Genetics; Gene","score_opus":0.019354211405302055,"score_gpt":0.2738056603305992,"score_spread":0.25445144892529714,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4306912135","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99360484,0.004211342,0.00022865759,0.0002993087,0.000008265533,0.000010784544,0.00030069542,0.000024905512,0.0013111954],"genre_scores_gemma":[0.9993648,0.00027136388,0.00011313964,0.000020253834,0.000011559695,0.000002928795,0.00010531925,0.0000028688619,0.00010776522],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9995691,0.00018422322,0.000058637124,0.00006667371,0.00008267835,0.000038614515],"domain_scores_gemma":[0.9979365,0.00073737226,0.00077603926,0.000120173594,0.0001359713,0.00029398836],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000649329,0.0001306565,0.0003887774,0.00060433114,0.00022999366,0.0006404201,0.00018457361,0.00035267675,0.0013938228],"category_scores_gemma":[0.0023187129,0.000074172436,0.00011349274,0.0006225968,0.0004713736,0.00027191394,0.0003308134,0.0005158608,0.00024569535],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0044510625,0.000056512512,0.9480788,0.00013216316,0.00009600963,0.0011136334,0.00011255631,0.00041776692,0.01769716,0.00012980516,0.00024671247,0.027467847],"study_design_scores_gemma":[0.000037095284,0.0006866988,0.9895342,0.000032012857,0.00008608452,0.0038769583,0.00014832977,0.0006223721,0.003558961,0.0003706581,0.0010330873,0.000013546915],"about_ca_topic_score_codex":0.00040611968,"about_ca_topic_score_gemma":0.00041746776,"teacher_disagreement_score":0.0013938228,"about_ca_system_score_codex":0.00028388362,"about_ca_system_score_gemma":0.00022459448,"threshold_uncertainty_score":0.0046628118},"labels":[],"label_agreement":null},{"id":"W4307972632","doi":"10.1111/bjh.18536","title":"The second revision of the International Staging System (R2‐ISS) stratifies progression‐free and overall survival in multiple myeloma: Real world data results in an Australian and New Zealand Population","year":2022,"lang":"en","type":"letter","venue":"British Journal of Haematology","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Takeda Pharmaceutical Company; Celgene; Bristol-Myers Squibb Canada; Gilead Sciences; AbbVie; Sanofi; Janssen Research and Development; Novartis; Amgen","keywords":"Multiple myeloma; Staging system; Medicine; Progression-free survival; Overall survival; Oncology; Internal medicine; Population; Cancer; Environmental health","score_opus":0.07219630896276948,"score_gpt":0.3477075047314594,"score_spread":0.27551119576868993,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4307972632","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9966515,0.00029588182,0.0007025294,0.00014075369,0.00001657057,0.00016597625,0.001220238,0.000013064944,0.0007935762],"genre_scores_gemma":[0.99547887,0.00023767736,0.0012791192,0.00006346061,0.00003625341,0.00018870087,0.002260003,0.000017100614,0.00043888955],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99798226,0.0006594419,0.00020967385,0.00039062943,0.0005862184,0.00017185631],"domain_scores_gemma":[0.9960295,0.0004707984,0.001569399,0.00045682618,0.001013606,0.00045983863],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0043875454,0.00081737805,0.0006882436,0.0015673334,0.00055832026,0.0010755443,0.0012282354,0.00056065066,0.0009986988],"category_scores_gemma":[0.009025127,0.00038933134,0.0009050976,0.0019912727,0.0009293965,0.00096980605,0.0016789001,0.0009781679,0.0003246797],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00036841308,0.000074037656,0.9905758,0.000043675722,0.00012215713,0.00013222615,0.00058071135,0.00036705832,0.00048851484,0.000075238306,0.0006810786,0.006490984],"study_design_scores_gemma":[0.00005046861,0.00022238976,0.9971625,0.0000142874715,0.000046519013,0.00024209483,0.00017569071,0.0011815446,0.000092065406,0.0000533278,0.0007412819,0.000017862405],"about_ca_topic_score_codex":0.10435936,"about_ca_topic_score_gemma":0.08838371,"teacher_disagreement_score":0.10435936,"about_ca_system_score_codex":0.0015182854,"about_ca_system_score_gemma":0.0013184871,"threshold_uncertainty_score":0.20750386},"labels":[],"label_agreement":null},{"id":"W4308325444","doi":"10.1111/bjh.18531","title":"Thymic stromal lymphopoietin induces platelet mitophagy and promotes thrombosis in Kawasaki disease","year":2022,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Kawasaki Disease and Coronary Complications","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Blood Services; University of Toronto; St. Michael's Hospital","funders":"Basic and Applied Basic Research Foundation of Guangdong Province","keywords":"Mitophagy; Platelet activation; Thymic stromal lymphopoietin; Medicine; Platelet; Immunology; Thrombosis; Thrombopoiesis; Pharmacology; Autophagy; Internal medicine; Chemistry; Biology; Cytokine; Apoptosis; Cell biology; Biochemistry; Haematopoiesis","score_opus":0.01629557942302739,"score_gpt":0.26820816001799036,"score_spread":0.25191258059496296,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4308325444","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99665266,0.0022002968,0.00054645963,0.00007320176,0.000014974565,0.000013542785,0.00009085777,0.000021807653,0.00038621092],"genre_scores_gemma":[0.9986696,0.00059304957,0.00020710935,0.00004255024,0.000009912639,0.000014106905,0.000113601134,0.000002521046,0.00034754304],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9999113,0.000020525267,0.000010676088,0.00001769765,0.000017749844,0.000021969323],"domain_scores_gemma":[0.9999411,0.0000062437384,0.000024880743,0.000003970848,0.0000064777105,0.000017339024],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009128659,0.00019172815,0.00017623036,0.00016305545,0.00013065862,0.000151982,0.000059516497,0.00016616184,0.0007381144],"category_scores_gemma":[0.00011394873,0.00009740849,0.00017541376,0.00008502547,0.00014387576,0.00011208533,0.00024063532,0.00033630905,0.00009434523],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00072873925,0.00007574152,0.00790755,0.00015420899,0.000038296366,0.0011934385,0.000092471375,0.00007035254,0.98592746,0.00010117325,0.00023047983,0.003480132],"study_design_scores_gemma":[0.00024807005,0.002404524,0.48472312,0.000066825116,0.00020329561,0.010298818,0.00048647032,0.002708616,0.48972812,0.00040819583,0.008698691,0.000025291733],"about_ca_topic_score_codex":0.00014711145,"about_ca_topic_score_gemma":0.0002677875,"teacher_disagreement_score":0.0007381144,"about_ca_system_score_codex":0.00012759981,"about_ca_system_score_gemma":0.00006758374,"threshold_uncertainty_score":0.0024692416},"labels":[],"label_agreement":null},{"id":"W4308548721","doi":"10.1111/bjh.18545","title":"Evaluating the impact of thrombopoietin receptor agonist medications on patient outcomes and quality of life in paediatric immune thrombocytopenia through <scp>semi‐structured</scp> interviews","year":2022,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Children's Hospital of Eastern Ontario; University of Ottawa; SickKids Foundation; University of Toronto; University of Alberta","funders":"","keywords":"Medicine; Thrombopoietin; Thrombopoietin receptor; Quality of life (healthcare); Immune thrombocytopenia; Dosing; Eltrombopag; Romiplostim; Cohort; Adverse effect; Pediatrics; Agonist; Internal medicine; Platelet; Receptor","score_opus":0.055446450926084745,"score_gpt":0.37886493924155773,"score_spread":0.323418488315473,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4308548721","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99678695,0.0002342562,0.0005341517,0.0003847473,0.000010273013,0.00066128426,0.00026814354,0.0000057857715,0.0011145234],"genre_scores_gemma":[0.99196506,0.0006367466,0.0036088757,0.00024442357,0.000013082235,0.0028912541,0.0002966316,0.000004339783,0.00033963443],"study_design_codex":"qualitative","study_design_gemma":"qualitative","domain_scores_codex":[0.99302024,0.0055479673,0.0004057755,0.00016388769,0.00034554684,0.0005166022],"domain_scores_gemma":[0.98679966,0.00771167,0.0024610208,0.00032427977,0.0012875877,0.0014157705],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.011586299,0.00024221251,0.00045135967,0.00061811396,0.0010424043,0.0012637471,0.00062149146,0.00040005732,0.0020763879],"category_scores_gemma":[0.012819446,0.00033892517,0.00058069715,0.00064865756,0.00095762097,0.00084993534,0.0023420425,0.0011544856,0.00027524002],"study_design_candidate":"qualitative","study_design_consensus":"qualitative","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00071172253,0.0011712095,0.42853776,0.0020107965,0.00011540025,0.0023042543,0.48343813,0.00074272155,0.0025418245,0.0008647421,0.004401997,0.07315938],"study_design_scores_gemma":[0.00023971929,0.0030534638,0.4387396,0.0015910162,0.00010554425,0.0019244964,0.53157765,0.0019846598,0.002540253,0.0009276047,0.017189085,0.00012688438],"about_ca_topic_score_codex":0.0034285677,"about_ca_topic_score_gemma":0.0060878973,"teacher_disagreement_score":0.011586299,"about_ca_system_score_codex":0.002082833,"about_ca_system_score_gemma":0.0035638143,"threshold_uncertainty_score":0.061274886},"labels":[],"label_agreement":null},{"id":"W4310086091","doi":"10.1111/bjh.18579","title":"Treatment response in acute myeloid leukaemia—Clues in the biopsy core","year":2022,"lang":"en","type":"letter","venue":"British Journal of Haematology","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Myeloid leukaemia; Medicine; Bone marrow; Transcriptome; Myeloid; Biopsy; Core biopsy; Internal medicine; Myeloid cells; Oncology; Pathology; Cancer research; Biology; Gene; Cancer; Gene expression; Breast cancer","score_opus":0.03624912448035942,"score_gpt":0.3255512199774176,"score_spread":0.28930209549705815,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4310086091","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0005701218,0.0032040754,0.00017250577,0.9638605,0.031251606,0.000016628645,0.000087294364,0.00004238869,0.0007949308],"genre_scores_gemma":[0.005632359,0.0025584293,0.00036508773,0.9046387,0.08484672,0.000043352244,0.000067331355,0.000024429935,0.0018235918],"study_design_codex":"not_applicable","study_design_gemma":"case_report","domain_scores_codex":[0.99643743,0.0011394912,0.00067930156,0.00042223887,0.0010171476,0.000304426],"domain_scores_gemma":[0.98663783,0.008015511,0.0006448028,0.0004159989,0.003148947,0.0011369172],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004393469,0.000703196,0.0016367369,0.0008577928,0.002119378,0.0023942979,0.0019281721,0.03272357,0.003468165],"category_scores_gemma":[0.026410503,0.0006276904,0.0011696847,0.0007597418,0.0021899159,0.0031199446,0.001310129,0.029009217,0.0051544593],"study_design_candidate":"case_report","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018796939,0.000031527663,0.0010523337,0.00016277542,0.000024961424,0.0027797075,0.00013360893,0.00007083253,0.00066094904,0.0013000066,0.9725572,0.021038275],"study_design_scores_gemma":[0.00037563735,0.0002793557,0.004399749,0.0008976407,0.000104927676,0.010540111,0.000766874,0.0008105642,0.001179535,0.018611927,0.9618987,0.00013485705],"about_ca_topic_score_codex":0.003510813,"about_ca_topic_score_gemma":0.0055983863,"teacher_disagreement_score":0.03272357,"about_ca_system_score_codex":0.0031490703,"about_ca_system_score_gemma":0.00212653,"threshold_uncertainty_score":0.023235202},"labels":[],"label_agreement":null},{"id":"W4310705764","doi":"10.1111/bjh.18586","title":"Erythrocyte type 1 equilibrative nucleoside transporter expression in sickle cell disease and sickle cell trait","year":2022,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Cancer Foundation; University of Alberta","funders":"Agence Nationale de la Recherche","keywords":"Adenosine; Pathophysiology; Red blood cell; Hypoxia (environmental); Sickle cell trait; Internal medicine; Nucleoside; Immunology; Endocrinology; Medicine; Biology; Disease; Chemistry; Biochemistry","score_opus":0.007203260723477073,"score_gpt":0.2207642883257057,"score_spread":0.21356102760222861,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4310705764","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9995776,0.00022356857,0.00006492983,0.000007013866,7.750484e-7,8.623496e-7,0.000042079744,0.0000013250346,0.00008186292],"genre_scores_gemma":[0.99958235,0.00009895227,0.000084088206,0.0000069725966,0.0000017952507,0.0000015778965,0.00007854621,7.4436736e-7,0.0001449765],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99994373,0.000013030589,0.000006583434,0.00001733315,0.0000094516445,0.000009893042],"domain_scores_gemma":[0.99989736,0.000024235987,0.000043485587,0.000005120027,0.000011550203,0.00001815697],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00007661451,0.000072586656,0.00011164925,0.00024132343,0.00009096567,0.00016110954,0.00004512134,0.00017754408,0.00090946234],"category_scores_gemma":[0.00020890898,0.00005314431,0.00006396014,0.00017682386,0.0000912784,0.00007676905,0.00008489681,0.00010567496,0.00008296341],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0020471248,0.00005340743,0.34202108,0.000109405846,0.00005071277,0.001332129,0.00070168846,0.0001789274,0.6400037,0.00013007999,0.00016073001,0.013210967],"study_design_scores_gemma":[0.000009931462,0.0003720695,0.9796051,0.000007493087,0.000030686253,0.0029444436,0.0001993924,0.00036774302,0.0159155,0.000056523553,0.0004869284,0.000004287745],"about_ca_topic_score_codex":0.00041146865,"about_ca_topic_score_gemma":0.0004083377,"teacher_disagreement_score":0.00090946234,"about_ca_system_score_codex":0.00007708934,"about_ca_system_score_gemma":0.000036326,"threshold_uncertainty_score":0.0030423999},"labels":[],"label_agreement":null},{"id":"W4310786296","doi":"10.1111/bjh.18582","title":"Fostamatinib for the treatment of Japanese patients with primary immune thrombocytopenia: A phase 3, placebo‐controlled, double‐blind, parallel‐group study","year":2022,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":26,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Placebo; Syk; Immune thrombocytopenia; Adverse effect; Internal medicine; Placebo group; Gastroenterology; Double blind; Platelet; Tyrosine kinase; Receptor; Pathology","score_opus":0.02356153659679367,"score_gpt":0.2988072891600148,"score_spread":0.27524575256322115,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4310786296","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99157614,0.0050128833,0.000352839,0.00032292106,0.00015951654,0.0015138218,0.00028283653,0.00003314064,0.0007459394],"genre_scores_gemma":[0.9924638,0.0032753611,0.0008343585,0.0006468985,0.00021389082,0.0014596058,0.00039766557,0.000008028478,0.00070045434],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99941623,0.00025577756,0.000060197217,0.00009429995,0.000080311926,0.00009319927],"domain_scores_gemma":[0.99939156,0.00007812806,0.00013126293,0.000049620507,0.000078800025,0.00027069447],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017621028,0.0011146495,0.0032405867,0.0002482625,0.00047070257,0.0006412966,0.0005500648,0.0009933122,0.0020323773],"category_scores_gemma":[0.0009932776,0.0004179958,0.001861862,0.00045377403,0.00094115007,0.0005759894,0.00023188532,0.0014033534,0.00029442442],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.89699745,0.0153377745,0.0031857502,0.0024649978,0.003113597,0.0002656861,0.0003147353,0.0004849057,0.022849677,0.00012787197,0.0013454864,0.053512134],"study_design_scores_gemma":[0.7938682,0.18844263,0.012750143,0.000037565173,0.0015901143,0.00021019837,0.000062228515,0.00037691166,0.0011590509,0.00007751054,0.0013945912,0.000031032094],"about_ca_topic_score_codex":0.0014594455,"about_ca_topic_score_gemma":0.0040957145,"teacher_disagreement_score":0.0032405867,"about_ca_system_score_codex":0.00068672065,"about_ca_system_score_gemma":0.0017216654,"threshold_uncertainty_score":0.009319007},"labels":[],"label_agreement":null},{"id":"W4311027234","doi":"10.1111/bjh.18568","title":"Time‐to‐event surrogate end‐points in multiple myeloma randomised trials from 2005 to 2019: A surrogacy analysis","year":2022,"lang":"en","type":"review","venue":"British Journal of Haematology","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":24,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Cancer Care Ontario; Queen's University","funders":"","keywords":"Surrogate endpoint; Medicine; Confidence interval; Hazard ratio; Internal medicine; Progression-free survival; Clinical endpoint; Multiple myeloma; Oncology; Clinical trial; Proportional hazards model; Pearson product-moment correlation coefficient; Overall survival; Statistics; Mathematics","score_opus":0.07511153867178022,"score_gpt":0.38234383984500037,"score_spread":0.30723230117322015,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4311027234","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":"methods","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.015589914,0.9670021,0.006939845,0.002802069,0.0012849824,0.0024921428,0.0020888029,0.00007792816,0.0017221272],"genre_scores_gemma":[0.5913545,0.35573077,0.021088343,0.008964886,0.0010823864,0.01661367,0.003264997,0.00018239055,0.0017181548],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.73769593,0.19108453,0.05012073,0.0064417482,0.013261409,0.001395723],"domain_scores_gemma":[0.58440816,0.3464719,0.047832694,0.009942947,0.010538665,0.0008055338],"candidate_categories":["metaresearch","metaepi_broad"],"consensus_categories":[],"category_scores_codex":[0.1411579,0.0014862154,0.00886674,0.004091424,0.00048706814,0.004001346,0.0016819158,0.0030124907,0.003641808],"category_scores_gemma":[0.40381438,0.0010056654,0.024810016,0.006366653,0.0014589584,0.0041056476,0.0025782736,0.0034302885,0.0004523081],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.018764079,0.000063291634,0.011008755,0.5836107,0.27650142,0.00021067455,0.0006029855,0.002032824,0.00039301277,0.0046549803,0.0039014346,0.0982558],"study_design_scores_gemma":[0.02001494,0.003474392,0.022582533,0.28994945,0.61513114,0.00065450545,0.00030775508,0.002815762,0.00074487564,0.008253408,0.035887685,0.00018355998],"about_ca_topic_score_codex":0.0024879032,"about_ca_topic_score_gemma":0.0047005937,"teacher_disagreement_score":0.9911333,"about_ca_system_score_codex":0.0049774214,"about_ca_system_score_gemma":0.0052325185,"threshold_uncertainty_score":0.74652326},"labels":[],"label_agreement":null},{"id":"W4311416811","doi":"10.1111/bjh.18580","title":"Bone marrow carcinomatosis with carcinocythemia clinically mimicking thrombotic thrombocytopenic purpura","year":2022,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Medical Imaging and Pathology Studies","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Thrombotic thrombocytopenic purpura; Medicine; Purpura (gastropod); Pathology; Bone marrow; Thrombocytopenic purpura; Hematology; Platelet; Internal medicine","score_opus":0.027468090686141422,"score_gpt":0.2872243090484477,"score_spread":0.2597562183623063,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4311416811","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9052762,0.010287806,0.0032620144,0.0050106593,0.00067410234,0.00054956094,0.00083784526,0.0004010709,0.073700726],"genre_scores_gemma":[0.9936605,0.0011980552,0.0010151034,0.0010241994,0.0010597896,0.000043729036,0.00016975297,0.00003550169,0.001793348],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.99900633,0.00018873274,0.00012425956,0.00016840175,0.00021882441,0.00029363376],"domain_scores_gemma":[0.9973417,0.0010854702,0.0004932762,0.00022817729,0.00018859621,0.00066280604],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006421293,0.0022874693,0.0010549432,0.0034268734,0.0011880933,0.0014527418,0.0016340852,0.0049522184,0.008450037],"category_scores_gemma":[0.0058851126,0.0011956026,0.00080462283,0.002595306,0.0017965074,0.0014532815,0.0013216352,0.0021478555,0.0033807952],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014440877,0.000029526003,0.0057556033,0.00006372394,0.0000097579195,0.99137384,0.00004972879,0.00007317714,0.0010233828,0.00023389145,0.00030595894,0.0009369757],"study_design_scores_gemma":[0.00006877481,0.00009741713,0.013650803,0.000019139263,0.00001751754,0.9845856,0.000052364594,0.00024839875,0.0004035545,0.00026517743,0.0005820114,0.000009376286],"about_ca_topic_score_codex":0.0021999027,"about_ca_topic_score_gemma":0.0018065484,"teacher_disagreement_score":0.008450037,"about_ca_system_score_codex":0.0011181036,"about_ca_system_score_gemma":0.0007104753,"threshold_uncertainty_score":0.028268158},"labels":[],"label_agreement":null},{"id":"W4313453615","doi":"10.1111/bjh.18638","title":"Addition of plasma exchange to red cell exchange improves outcomes of fat embolism syndrome in sickle cell disease","year":2023,"lang":"en","type":"letter","venue":"British Journal of Haematology","topic":"Infectious Encephalopathies and Encephalitis","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Medicine; Cytotoxic T cell; Inflammation; Internal medicine; Immunology; Endocrinology; Biology; Biochemistry","score_opus":0.012982937393231187,"score_gpt":0.24195513876052482,"score_spread":0.22897220136729363,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4313453615","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9338877,0.058277328,0.0012259552,0.0012453246,0.00064351835,0.0001710204,0.00031264478,0.00021947185,0.0040171538],"genre_scores_gemma":[0.98688865,0.0084532555,0.0013362581,0.0005878019,0.0003990557,0.000086692184,0.00047054206,0.000022787422,0.0017549838],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9998683,0.00003789762,0.000024104542,0.000017549746,0.000027115737,0.000025081828],"domain_scores_gemma":[0.9997106,0.00006254531,0.000064690284,0.000019782197,0.000039744315,0.00010261816],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002922595,0.0003026489,0.00094388676,0.00026216634,0.00017986329,0.00039497286,0.00022267523,0.000325818,0.003745344],"category_scores_gemma":[0.0010854561,0.00004811255,0.0005631153,0.00015181299,0.00010206521,0.0003830925,0.00023754669,0.00083229755,0.0002770643],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.07488308,0.015426864,0.016736396,0.003260342,0.0014469445,0.0020535537,0.00047010952,0.0012131634,0.03017748,0.0005744852,0.008308479,0.84544915],"study_design_scores_gemma":[0.03747743,0.22440119,0.59936166,0.0061600115,0.0063519613,0.013609693,0.0010454581,0.0078045335,0.031200254,0.005202057,0.067200385,0.00018544341],"about_ca_topic_score_codex":0.00046215006,"about_ca_topic_score_gemma":0.00047972737,"teacher_disagreement_score":0.003745344,"about_ca_system_score_codex":0.00018655225,"about_ca_system_score_gemma":0.0002192944,"threshold_uncertainty_score":0.012529433},"labels":[],"label_agreement":null},{"id":"W4315436222","doi":"10.1111/bjh.18640","title":"Long‐term follow‐up demonstrates curative potential of autologous stem cell transplantation for relapsed follicular lymphoma","year":2023,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Baker Hughes (Canada); University of Alberta; University of Calgary","funders":"","keywords":"Medicine; Autologous stem-cell transplantation; Follicular lymphoma; Internal medicine; Oncology; Surgery; Transplantation; Confidence interval; Progression-free survival; Lymphoma; Overall survival","score_opus":0.01479505417405778,"score_gpt":0.2630927141485054,"score_spread":0.2482976599744476,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4315436222","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9992471,0.000416205,0.00008662924,0.000017218139,0.0000013270038,0.000003125803,0.000034889934,0.000004362454,0.00018924201],"genre_scores_gemma":[0.9997825,0.000049779956,0.000035303787,0.000009519317,0.0000022434708,0.0000014086555,0.000056123044,5.656727e-7,0.000062623585],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99986506,0.000035865574,0.000007867853,0.000016249407,0.000040431954,0.00003457425],"domain_scores_gemma":[0.99949753,0.00010822779,0.00015324696,0.000062963605,0.000068856905,0.000109165914],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005766516,0.00007718408,0.0001630545,0.00017606527,0.0001778862,0.0003535776,0.00015188321,0.00015101298,0.00042409572],"category_scores_gemma":[0.0009239735,0.00006309999,0.00013269605,0.00020839354,0.00023168862,0.00013544856,0.00014867166,0.00022535896,0.00012356449],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002310267,0.00013813374,0.9504313,0.000030352525,0.00006558778,0.0004801398,0.00024671873,0.00037137634,0.0081365965,0.000041542888,0.00022193097,0.03752601],"study_design_scores_gemma":[0.000038873543,0.0013583748,0.995589,0.0000074171785,0.000050789702,0.0009348389,0.0001083374,0.00049006,0.00091171975,0.0000362306,0.00046970355,0.00000462567],"about_ca_topic_score_codex":0.010808865,"about_ca_topic_score_gemma":0.018633764,"teacher_disagreement_score":0.010808865,"about_ca_system_score_codex":0.0006623356,"about_ca_system_score_gemma":0.0004244199,"threshold_uncertainty_score":0.021491885},"labels":[],"label_agreement":null},{"id":"W4319826332","doi":"10.1111/bjh.18685","title":"Characteristics and outcome of primary resistant disease in paediatric acute myeloid leukaemia","year":2023,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto General Hospital; University Health Network","funders":"","keywords":"Myeloid leukaemia; Medicine; Disease; Myeloid; Pediatrics; Oncology; Internal medicine; Intensive care medicine; Immunology","score_opus":0.020634197476799714,"score_gpt":0.29337911821910345,"score_spread":0.2727449207423037,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4319826332","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99847704,0.0005695509,0.00006527115,0.000027217424,0.000004726572,0.000007939576,0.00048527482,0.000003827111,0.00035908454],"genre_scores_gemma":[0.99910337,0.00014208801,0.00003216346,0.000009807757,0.00000647891,0.000007922599,0.0006435106,0.0000023808796,0.00005233436],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99940884,0.0001519909,0.00008207265,0.00010373244,0.000156065,0.00009731889],"domain_scores_gemma":[0.99653983,0.00059567735,0.002093621,0.00012054405,0.00019799174,0.0004522211],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006492426,0.00017649707,0.00045540967,0.0005865303,0.00022853806,0.0004885526,0.00026053842,0.00029318104,0.0012078781],"category_scores_gemma":[0.0035950046,0.00013349713,0.00037910222,0.0008469703,0.00034667077,0.00036570887,0.00042692068,0.00047160752,0.00027010165],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017019954,0.000013858379,0.9974896,0.0000170636,0.00003102125,0.00025250675,0.00006183867,0.00012694414,0.00021329305,0.000018051582,0.0001165645,0.0014891478],"study_design_scores_gemma":[0.000009226689,0.00021656168,0.9970331,0.0000081143235,0.000017576518,0.0020401413,0.00007558583,0.00009866179,0.00009547903,0.000030580908,0.00037109875,0.0000038608982],"about_ca_topic_score_codex":0.0013576251,"about_ca_topic_score_gemma":0.001155034,"teacher_disagreement_score":0.0013576251,"about_ca_system_score_codex":0.00038453506,"about_ca_system_score_gemma":0.00027505297,"threshold_uncertainty_score":0.0040407777},"labels":[],"label_agreement":null},{"id":"W4321004546","doi":"10.1111/bjh.18683","title":"Venous thromboembolism incidence associated with pegylated asparaginase (ASP) compared to the native L‐ASP: A retrospective analysis with an ASP‐based protocol in adult patients <scp>with acute lymphoblastic leukaemia</scp>","year":2023,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Medicine; Odds ratio; Incidence (geometry); Internal medicine; Asparaginase; PEG ratio; Retrospective cohort study; Confidence interval; Venous thromboembolism; Gastroenterology; Surgery; Thrombosis; Lymphoblastic Leukemia; Leukemia","score_opus":0.011295729715497825,"score_gpt":0.2880218732793905,"score_spread":0.2767261435638927,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4321004546","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99948895,0.00020859303,0.000047942365,0.0000068872964,0.0000017821942,0.000019046236,0.0001376678,0.0000010551721,0.00008808142],"genre_scores_gemma":[0.9994541,0.00013330887,0.00006725609,0.000016122909,0.0000059310605,0.000022042112,0.00027183496,0.0000012336629,0.00002815752],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99783665,0.00067986693,0.0004224048,0.0004980604,0.0004179302,0.00014518738],"domain_scores_gemma":[0.9952903,0.0008032001,0.002791774,0.0004130305,0.00031911302,0.00038255967],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016772721,0.0002476115,0.00043796166,0.0007264149,0.00020262437,0.0008148832,0.00032453207,0.00037215665,0.00047035856],"category_scores_gemma":[0.004371336,0.00038927418,0.00062281283,0.0014714684,0.00037151697,0.00043023177,0.00039765905,0.0003984299,0.00011148967],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00055200205,0.000034113364,0.99814653,0.000017856262,0.00008802228,0.000055995635,0.000053199346,0.00004233485,0.00013166915,0.000007915934,0.000029725104,0.00084065215],"study_design_scores_gemma":[0.000043198248,0.00073015713,0.9982114,0.0000074436475,0.00008763574,0.00040015514,0.000121006655,0.00016426547,0.00008772504,0.000007567266,0.00013443395,0.0000049160153],"about_ca_topic_score_codex":0.0026950778,"about_ca_topic_score_gemma":0.0021526488,"teacher_disagreement_score":0.0026950778,"about_ca_system_score_codex":0.00065573445,"about_ca_system_score_gemma":0.0005448732,"threshold_uncertainty_score":0.008870363},"labels":[],"label_agreement":null},{"id":"W4322757139","doi":"10.1111/bjh.18702","title":"<scp>IVI</scp>g treatment increases thrombin activation of platelets and thrombin generation in paediatric patients with immune thrombocytopenia","year":2023,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; University of Toronto","funders":"EMDO Stiftung","keywords":"Platelet; Thrombin; Medicine; Platelet activation; Coagulation; CD63; Immunology; Flow cytometry; Internal medicine; Gastroenterology; Chemistry; Biochemistry","score_opus":0.013949139080768388,"score_gpt":0.24290575909401807,"score_spread":0.22895662001324968,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4322757139","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99823284,0.0010944945,0.000084591666,0.000050189883,0.0000073238602,0.000008205158,0.000092892835,0.000010252448,0.00041922784],"genre_scores_gemma":[0.9992895,0.0002949166,0.00013317727,0.000045390258,0.000012513013,0.000007200916,0.00015271529,0.0000033178892,0.00006117102],"study_design_codex":"observational","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9996728,0.00010156408,0.00003632066,0.00004890347,0.00008069341,0.000059802976],"domain_scores_gemma":[0.99919254,0.00021262522,0.0004023187,0.000023079314,0.000054310953,0.000115042974],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000231367,0.00032840733,0.0007111026,0.00033459582,0.00023491688,0.0004033062,0.00014468306,0.00033375857,0.00078410946],"category_scores_gemma":[0.0013471737,0.00016061778,0.0003136613,0.00046667122,0.00033899272,0.00020759332,0.00015004557,0.0004913953,0.00010379145],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0021101942,0.000175076,0.95797896,0.0001768791,0.00012539126,0.008243539,0.00040440797,0.00021699247,0.012188747,0.00008039234,0.000681642,0.017617757],"study_design_scores_gemma":[0.00007870482,0.0014106666,0.9779482,0.000025889303,0.000068109715,0.017847111,0.00016506988,0.0001482345,0.001439409,0.0000269996,0.00083611556,0.0000055283713],"about_ca_topic_score_codex":0.0013993011,"about_ca_topic_score_gemma":0.0011197099,"teacher_disagreement_score":0.0013993011,"about_ca_system_score_codex":0.00034676003,"about_ca_system_score_gemma":0.00023324412,"threshold_uncertainty_score":0.0027822852},"labels":[],"label_agreement":null},{"id":"W4324318067","doi":"10.1111/bjh.18734","title":"Baseline metabolic tumour burden improves risk stratification in Hodgkin lymphoma: A Children's Oncology Group study","year":2023,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency; University of Toronto","funders":"National Cancer Institute; National Institutes of Health; Children’s Oncology Group","keywords":"Medicine; Risk stratification; Oncology; Internal medicine; Hodgkin lymphoma; Lymphoma; Baseline (sea); Biology","score_opus":0.012649448597859235,"score_gpt":0.28815157069404135,"score_spread":0.27550212209618213,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4324318067","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99820006,0.0005883415,0.000038613955,0.00013411716,0.000008524017,0.000016289898,0.0006572468,0.000003951392,0.00035287597],"genre_scores_gemma":[0.9987435,0.00019145508,0.00012103202,0.000049773582,0.000019033518,0.000016313586,0.0007518515,0.0000036814085,0.00010341504],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9993672,0.00030402897,0.00005365749,0.00009558552,0.00010509745,0.00007459351],"domain_scores_gemma":[0.9977598,0.00053107203,0.00086490536,0.00021254442,0.00021934713,0.0004123174],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016478773,0.00034319022,0.0005037313,0.0004928873,0.00028318027,0.0006261357,0.00031185764,0.00036109003,0.00082816044],"category_scores_gemma":[0.0027966443,0.0001712014,0.0005681566,0.00079456985,0.00023541981,0.00039756674,0.00036455583,0.0005305823,0.00013576783],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00082723016,0.000032015098,0.9963735,0.000015331727,0.00013140582,0.000036147147,0.00002904128,0.00011820361,0.000093364884,0.000018529978,0.00031260305,0.0020125364],"study_design_scores_gemma":[0.00010831197,0.0003079298,0.99855274,0.000011484498,0.00014305064,0.00010793519,0.000042885324,0.00015634006,0.00010750445,0.000025380938,0.00043128338,0.0000051463344],"about_ca_topic_score_codex":0.0077648037,"about_ca_topic_score_gemma":0.009233523,"teacher_disagreement_score":0.0077648037,"about_ca_system_score_codex":0.0006880715,"about_ca_system_score_gemma":0.0005633453,"threshold_uncertainty_score":0.015439212},"labels":[],"label_agreement":null},{"id":"W4327544833","doi":"10.1111/bjh.18760","title":"Use of minigene assays as a useful tool to confirm the pathogenic role of intronic variations of the <scp><i>ANK1</i></scp> gene: Report of two cases of hereditary spherocytosis","year":2023,"lang":"en","type":"letter","venue":"British Journal of Haematology","topic":"Erythrocyte Function and Pathophysiology","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Hospital for Sick Children","funders":"Agence Nationale de la Recherche","keywords":"Hereditary spherocytosis; Minigene; Intron; Genetics; Biology; RNA splicing; Gene; Context (archaeology); Frameshift mutation; Alternative splicing; Mutation; Exon","score_opus":0.029390138128050466,"score_gpt":0.26590050279959493,"score_spread":0.23651036467154446,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4327544833","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.92477363,0.0037245722,0.064607345,0.00035241502,0.0002043042,0.00046761954,0.0022430972,0.00102373,0.0026033998],"genre_scores_gemma":[0.93353224,0.0018596662,0.05862457,0.00042057023,0.00014766656,0.0004692109,0.0035646188,0.00013164547,0.0012497468],"study_design_codex":"bench_or_experimental","study_design_gemma":"case_report","domain_scores_codex":[0.99915874,0.00016334328,0.000093522896,0.00033940203,0.00017870849,0.00006634625],"domain_scores_gemma":[0.9985802,0.0008063721,0.00024508635,0.00014303371,0.00011566532,0.0001096048],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00046539912,0.0013865867,0.0005152961,0.002395739,0.00032484843,0.00046652218,0.0006164396,0.0013518467,0.0013960134],"category_scores_gemma":[0.0018970997,0.0003138022,0.0003365815,0.00065398973,0.00092289306,0.0003275181,0.0004804264,0.0008233802,0.0009704165],"study_design_candidate":"case_report","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019266436,0.00009961551,0.013620944,0.00017638362,0.000028102078,0.005856407,0.00030461335,0.00012088808,0.97010505,0.00034250392,0.00019680806,0.008955975],"study_design_scores_gemma":[0.00005767476,0.0013209599,0.10108357,0.000053408443,0.000270875,0.055595633,0.00023232978,0.003699089,0.82729775,0.0008605533,0.009454331,0.00007386133],"about_ca_topic_score_codex":0.00036694828,"about_ca_topic_score_gemma":0.00022201274,"teacher_disagreement_score":0.002395739,"about_ca_system_score_codex":0.00018497671,"about_ca_system_score_gemma":0.00014245168,"threshold_uncertainty_score":0.0046700835},"labels":[],"label_agreement":null},{"id":"W4360600617","doi":"10.1111/bjh.18730","title":"Extensive histiocytosis masking anaplastic large‐cell lymphoma (<scp>ALCL</scp>)","year":2023,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University Health Network","funders":"","keywords":"Malignancy; Lymphoma; Anaplastic large-cell lymphoma; Medicine; Pathology; Etiology; Pathological; Malignant histiocytosis; Immunology; Histiocyte","score_opus":0.013828634285665772,"score_gpt":0.2544446971270109,"score_spread":0.24061606284134512,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4360600617","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.838211,0.027132113,0.006095707,0.0017004327,0.00024448603,0.00030532962,0.0009983724,0.00054726464,0.12476518],"genre_scores_gemma":[0.99015605,0.0025582842,0.0010635294,0.0004968061,0.00014614782,0.000016703385,0.00029945176,0.000026114949,0.0052369903],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.99987817,0.000016748501,0.000011435742,0.0000186796,0.000036802787,0.00003813885],"domain_scores_gemma":[0.9997993,0.000048551814,0.000046836765,0.000020420062,0.00002198694,0.000062964],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015780839,0.00022691264,0.00029205283,0.00062379276,0.00029979006,0.00041618772,0.00014497845,0.00037632996,0.005278366],"category_scores_gemma":[0.0004162994,0.000108968896,0.00014224021,0.0004827455,0.0003931779,0.00038403735,0.00038081096,0.00038372338,0.001591404],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010640299,0.00021033995,0.12029147,0.0009973883,0.00009918624,0.4849638,0.00044557065,0.00029671655,0.13938439,0.0024475092,0.011592987,0.2382066],"study_design_scores_gemma":[0.000070184215,0.000624885,0.13721699,0.00018871253,0.00006123181,0.79620975,0.00020690628,0.0003628071,0.012221676,0.0012330301,0.051583562,0.000020235291],"about_ca_topic_score_codex":0.00070132606,"about_ca_topic_score_gemma":0.0015198643,"teacher_disagreement_score":0.005278366,"about_ca_system_score_codex":0.00020313312,"about_ca_system_score_gemma":0.0002049209,"threshold_uncertainty_score":0.017657936},"labels":[],"label_agreement":null},{"id":"W4362452432","doi":"10.1111/bjh.18773","title":"B cells and antibodies in refractory immune thrombocytopenia","year":2023,"lang":"en","type":"review","venue":"British Journal of Haematology","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":30,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Blood Services; University of Toronto; St. Michael's Hospital","funders":"Agence Nationale de la Recherche","keywords":"Rituximab; Immunology; Autoantibody; Medicine; Syk; Antibody; Splenectomy; CD20; CD38; Immune system; B cell; Monoclonal antibody; Spleen; Biology; Stem cell; Tyrosine kinase; Internal medicine; Receptor; CD34","score_opus":0.04698228506897362,"score_gpt":0.3492826305637311,"score_spread":0.3023003454947575,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4362452432","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00006528005,0.9993667,0.000024142682,0.00008683383,0.000079814934,0.0000016060966,0.0000053518434,0.0000025185843,0.00036777524],"genre_scores_gemma":[0.0006289314,0.99863786,0.000052206415,0.0001347961,0.00012255418,0.0000033796814,0.000018908162,9.545666e-7,0.0004005048],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9998436,0.000030782703,0.000026872567,0.00002093071,0.000061982355,0.000015828904],"domain_scores_gemma":[0.99976903,0.00011507751,0.000041718118,0.0000061277206,0.00004605434,0.000021998061],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00044152242,0.00073775405,0.0015392555,0.002322252,0.00021539441,0.000819545,0.00080125703,0.0011030051,0.0039852653],"category_scores_gemma":[0.0006051392,0.00025416416,0.00046859714,0.0018742648,0.00038300434,0.00071544515,0.0005854337,0.0015913888,0.0022444082],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010879343,0.00005801248,0.00014198286,0.017126959,0.00011064303,0.00029989282,0.000042025164,0.00022968267,0.00065779244,0.0014898157,0.02706796,0.9526664],"study_design_scores_gemma":[0.000060763003,0.00012255667,0.001260359,0.008046993,0.0002275439,0.004017841,0.000053485877,0.00009710317,0.0003065248,0.0016218325,0.98416704,0.000017942933],"about_ca_topic_score_codex":0.0010288528,"about_ca_topic_score_gemma":0.0018411883,"teacher_disagreement_score":0.0039852653,"about_ca_system_score_codex":0.00044752634,"about_ca_system_score_gemma":0.00056718267,"threshold_uncertainty_score":0.013332009},"labels":[],"label_agreement":null},{"id":"W4362454530","doi":"10.1111/bjh.18781","title":"British Society for Haematology guideline for anticoagulant management of pregnant individuals with mechanical heart valves","year":2023,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Cardiovascular Issues in Pregnancy","field":"Medicine","cited_by":26,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Thomas Hospital","funders":"","keywords":"Guideline; Hematology; Medicine; Anticoagulant; Internal medicine; Intensive care medicine; Cardiology; Pathology","score_opus":0.024418300005441707,"score_gpt":0.3155447000805487,"score_spread":0.291126400075107,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4362454530","genre_codex":"commentary","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00516337,0.30620423,0.022604596,0.3631337,0.029418793,0.0017756654,0.011882546,0.0021532446,0.25766382],"genre_scores_gemma":[0.07837929,0.42348886,0.13793129,0.14341877,0.020617029,0.0044728736,0.041531198,0.0013729447,0.14878777],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9943949,0.0014632395,0.0016275266,0.00017910358,0.0020143907,0.0003207996],"domain_scores_gemma":[0.9896909,0.003367979,0.0013946318,0.0002491121,0.004545326,0.00075208955],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0038381272,0.0006622596,0.001423319,0.0023222088,0.00076183025,0.002046058,0.0020392286,0.00393824,0.008740289],"category_scores_gemma":[0.016828006,0.00048264448,0.0015693144,0.0021886795,0.0008174228,0.0009807537,0.0010756857,0.005891658,0.007315621],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007023857,0.000058359798,0.00086324953,0.0012755203,0.000039046034,0.0004793528,0.00013218628,0.00034670433,0.00040455812,0.0030023966,0.87663776,0.116690636],"study_design_scores_gemma":[0.00018219843,0.00008653099,0.0064168265,0.0062820166,0.00010392101,0.0031335389,0.0001347931,0.00038366384,0.0003750918,0.004888878,0.9779679,0.00004458884],"about_ca_topic_score_codex":0.013865193,"about_ca_topic_score_gemma":0.022965753,"teacher_disagreement_score":0.013865193,"about_ca_system_score_codex":0.0022632321,"about_ca_system_score_gemma":0.0067386543,"threshold_uncertainty_score":0.029239118},"labels":[],"label_agreement":null},{"id":"W4362458479","doi":"10.1111/bjh.18792","title":"A pilot feasibility trial of daily versus every other day oral iron supplementation in patients with iron deficiency anaemia","year":2023,"lang":"en","type":"letter","venue":"British Journal of Haematology","topic":"Iron Metabolism and Disorders","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Kingston Health Sciences Centre; Queen's University; St. Michael's Hospital; Health Sciences Centre; Canadian Blood Services; University of Toronto; Sunnybrook Health Science Centre","funders":"Canadian Blood Services","keywords":"Iron supplementation; Iron deficiency; Medicine; Pediatrics; Internal medicine; Anemia","score_opus":0.03142566660395843,"score_gpt":0.2976678909840674,"score_spread":0.2662422243801089,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4362458479","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98162234,0.003816831,0.0004728207,0.0050449315,0.0020877193,0.0019436128,0.0005549777,0.00008078162,0.0043760617],"genre_scores_gemma":[0.9868994,0.0015782948,0.0014408441,0.003016726,0.0015778119,0.0026786602,0.00041942752,0.000019625588,0.002369266],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99908185,0.0005829218,0.000060398317,0.00012595786,0.000043855183,0.00010501697],"domain_scores_gemma":[0.99646324,0.0017715954,0.0002341848,0.0002591994,0.00016119464,0.001110661],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015732783,0.0010238839,0.0031189497,0.0002669081,0.00069156295,0.0009578673,0.0008942138,0.0029667486,0.008794284],"category_scores_gemma":[0.0038588077,0.0005414916,0.0012258798,0.00046597086,0.0013680656,0.0010858492,0.00055319077,0.0038828459,0.0015481027],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9732925,0.009610748,0.00038424387,0.000211468,0.00023227275,0.0001373006,0.000059386137,0.00011541632,0.0014745033,0.000085633794,0.0010244113,0.013372054],"study_design_scores_gemma":[0.7429564,0.25210157,0.0027491415,0.000040017876,0.0001801154,0.00012909173,0.00005958127,0.0002937488,0.00016498193,0.00028206687,0.0010240796,0.00001915406],"about_ca_topic_score_codex":0.0010322487,"about_ca_topic_score_gemma":0.0014129115,"teacher_disagreement_score":0.008794284,"about_ca_system_score_codex":0.00081477064,"about_ca_system_score_gemma":0.0010991968,"threshold_uncertainty_score":0.02941978},"labels":[],"label_agreement":null},{"id":"W4362527258","doi":"10.1111/bjh.18757","title":"Treatment patterns and outcomes in adolescents and young adults with nodular lymphocyte‐predominant Hodgkin lymphoma: an <scp>IMPACT</scp> cohort study","year":2023,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Institute for Clinical Evaluative Sciences; Princess Margaret Cancer Centre; Institute for Work & Health; St. Michael's Hospital; Pediatric Oncology Group; University of Toronto; SickKids Foundation; Hospital for Sick Children; Public Health Ontario","funders":"Canadian Institutes of Health Research; C17 Children's Cancer and Blood Disorders; Pediatric Oncology Group of Ontario","keywords":"Medicine; Cohort; Lymphoma; Hodgkin lymphoma; Lymphocyte; Young adult; Cohort study; Immunology; Oncology; Internal medicine","score_opus":0.009237723298726562,"score_gpt":0.269366761292752,"score_spread":0.2601290379940254,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4362527258","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9990729,0.000050968254,0.0000236529,0.000017598255,0.0000015057001,0.000013539843,0.0006552266,0.0000010024808,0.00016347635],"genre_scores_gemma":[0.9986765,0.00009893484,0.00006815923,0.000030865107,0.0000037854447,0.000016960705,0.00093922636,0.0000016246005,0.00016396472],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99967146,0.000039114548,0.00003516325,0.000075354365,0.000073899486,0.00010499039],"domain_scores_gemma":[0.9991279,0.000052390576,0.00030435383,0.00006881767,0.0001848575,0.00026175514],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005003294,0.00023946528,0.0002980323,0.00087729277,0.000782467,0.00097173254,0.00038658068,0.0002916577,0.0009787211],"category_scores_gemma":[0.00108732,0.00032717793,0.00046553422,0.0016138287,0.00029557222,0.00049157144,0.00073178194,0.00043573874,0.00021230863],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000019564344,0.000012660249,0.9993374,0.0000024461785,0.000013943616,0.000038385653,0.00013700819,0.000006018136,0.0000414587,0.000005249216,0.000057161524,0.00032868786],"study_design_scores_gemma":[0.000005168288,0.000038781025,0.9990439,0.0000055016826,0.000013616795,0.0001231239,0.00048808428,0.000050402596,0.000014168899,0.0000066467787,0.00020841924,0.0000021365352],"about_ca_topic_score_codex":0.25118387,"about_ca_topic_score_gemma":0.36128476,"teacher_disagreement_score":0.25118387,"about_ca_system_score_codex":0.001915128,"about_ca_system_score_gemma":0.0017279931,"threshold_uncertainty_score":0.49944365},"labels":[],"label_agreement":null},{"id":"W4365479509","doi":"10.1111/bjh.18815","title":"Transcriptional and genomic characterization of measurable residual disease in acute myeloid leukaemia","year":2023,"lang":"en","type":"letter","venue":"British Journal of Haematology","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"Associazione Italiana per la Ricerca sul Cancro","keywords":"Medicine; Minimal residual disease; Oncology; Internal medicine; Chemotherapy; Disease; Myeloid; Clinical trial; Myeloid leukemia; Acute promyelocytic leukemia; Leukemia; Gene; Biology; Retinoic acid; Genetics","score_opus":0.023147937565040133,"score_gpt":0.2680327022710182,"score_spread":0.2448847647059781,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4365479509","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99854773,0.0005364861,0.00019328,0.000012929554,0.0000021027035,0.000011230286,0.00048038963,0.000004846683,0.00021095549],"genre_scores_gemma":[0.99873143,0.00015203626,0.00014869405,0.00002486157,0.0000062900494,0.00001267407,0.00078668335,0.00000190229,0.00013548291],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99978966,0.000036705704,0.000019984178,0.000060030314,0.000054081385,0.000039442762],"domain_scores_gemma":[0.9997335,0.00006547113,0.00009949064,0.000022702994,0.000033104658,0.000045711276],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020628278,0.00010440759,0.00024113023,0.0005091944,0.00011402568,0.00031180886,0.00012477931,0.00018302124,0.00084855605],"category_scores_gemma":[0.00061359024,0.00007842832,0.00012260079,0.0004897117,0.00027256957,0.00012633982,0.00023262293,0.00019892481,0.00020077259],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002594905,0.0001786441,0.7859462,0.00013499279,0.000067482586,0.0004698488,0.00043088745,0.00048493166,0.18446802,0.00015549612,0.00024275889,0.024825756],"study_design_scores_gemma":[0.000023821078,0.00083288254,0.9914374,0.0000036551892,0.000026334308,0.0007557487,0.00014147366,0.00021764876,0.00568274,0.00005994933,0.00081339374,0.00000501166],"about_ca_topic_score_codex":0.00044637662,"about_ca_topic_score_gemma":0.00048647998,"teacher_disagreement_score":0.00084855605,"about_ca_system_score_codex":0.00013576499,"about_ca_system_score_gemma":0.00008792389,"threshold_uncertainty_score":0.0028387308},"labels":[],"label_agreement":null},{"id":"W4366602268","doi":"10.1111/bjh.18718","title":"<scp>BSH</scp> 2023 Oral abstracts book","year":2023,"lang":"ceb","type":"article","venue":"British Journal of Haematology","topic":"Complement system in diseases","field":"Immunology and Microbiology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"University of Texas MD Anderson Cancer Center; Centre Hospitalier Universitaire de Toulouse; Universitätsklinikum Hamburg-Eppendorf; Syddansk Universitet; Université de Toulouse; Memorial Sloan-Kettering Cancer Center; Karolinska Institutet; St Vincent's Hospital Melbourne; Université de Lille; Massachusetts General Hospital; University of Alberta; Cancer Research Institute","keywords":"Medicine; Pharmacology","score_opus":0.02179639717170954,"score_gpt":0.274689843042991,"score_spread":0.25289344587128143,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4366602268","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00067719404,0.0014304807,0.0006720628,0.0054293475,0.008628819,0.00079441903,0.0191186,0.0032482815,0.9600008],"genre_scores_gemma":[0.0021845484,0.00083921704,0.00043523766,0.0056344843,0.0050388547,0.00023748897,0.0070407647,0.00091554434,0.9776739],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99966514,0.000042950298,0.00002455866,0.000048584574,0.00017102178,0.000047765472],"domain_scores_gemma":[0.99794513,0.0004353691,0.000105229126,0.00013187516,0.0008000663,0.000582311],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00040873027,0.0009391131,0.0010522733,0.0008916406,0.0007941861,0.0033698073,0.0010522277,0.0026614454,0.8773185],"category_scores_gemma":[0.0022180765,0.0004121747,0.00067341066,0.00078545936,0.00038131862,0.0010157184,0.00084475346,0.0022374622,0.6738185],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000083577,0.000036950616,0.00004518998,0.00009520075,0.0000028708735,0.00004446867,0.0000032643388,0.00002800619,0.00017875114,0.000276227,0.977009,0.022196526],"study_design_scores_gemma":[0.0001135233,0.000056108354,0.0005079909,0.00012869421,0.0000029585879,0.00007165037,0.000007819322,0.000079153615,0.00016107317,0.0004340918,0.99842995,0.000006923909],"about_ca_topic_score_codex":0.00398515,"about_ca_topic_score_gemma":0.008947311,"teacher_disagreement_score":0.1226815,"about_ca_system_score_codex":0.0011563943,"about_ca_system_score_gemma":0.001145065,"threshold_uncertainty_score":0.17499018},"labels":[],"label_agreement":null},{"id":"W4366775420","doi":"10.1111/bjh.18720","title":"BSH 2023 Poster Abstract Book","year":2023,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Cancer Center, University of Kansas; Robert H. Lurie Comprehensive Cancer Center; Feinberg School of Medicine; University of North Carolina at Chapel Hill; Sierra Oncology; Śląski Uniwersytet Medyczny w Katowicach; Università degli Studi dell'Insubria; Oxford University Hospitals NHS Foundation Trust; Università degli Studi di Firenze; Leonard M. Miller School of Medicine; University of Toronto; Catholic University of Korea; Northwell Health; University Hospitals Plymouth NHS Trust; Eli Lilly and Company; Seoul St. Mary's Hospital, Catholic University of Korea; Uniwersytet Śląski w Katowicach; Northwestern University; University of Miami; Heart of England NHS Foundation Trust; Memorial Sloan-Kettering Cancer Center; Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico; Moffitt Cancer Center; University of Oxford; University of Texas MD Anderson Cancer Center; Cleveland Clinic; Université de Paris; Sylvester Comprehensive Cancer Center, University of Miami Health Systems","keywords":"Medicine","score_opus":0.025355088687982207,"score_gpt":0.3179291228743691,"score_spread":0.2925740341863869,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4366775420","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0027809846,0.0031525898,0.002219533,0.005673606,0.026570706,0.00039915644,0.0050775493,0.001244085,0.95288175],"genre_scores_gemma":[0.0030716385,0.00060637546,0.00045758288,0.00051690894,0.001884197,0.000034118915,0.00093800947,0.00021708502,0.9922741],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99976903,0.00002244169,0.000012600755,0.00006875578,0.00008551713,0.000041561856],"domain_scores_gemma":[0.9993668,0.00007446662,0.00001805197,0.000039020975,0.00022180885,0.00027979698],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00037520798,0.00078040466,0.00061038864,0.001036929,0.00088307995,0.0022367097,0.00079283444,0.0015058495,0.8906492],"category_scores_gemma":[0.00087931374,0.00029949666,0.00070268725,0.00055838865,0.00025506745,0.0009827085,0.0011943807,0.00140171,0.67775893],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019188189,0.000076523145,0.00022290423,0.00018594779,0.000008567861,0.00037682487,0.000031613883,0.00013572276,0.0015650904,0.0017659818,0.85493636,0.14050266],"study_design_scores_gemma":[0.000024697016,0.00007256801,0.0005677183,0.00007793151,0.0000040195987,0.00037260578,0.00003288396,0.00011300838,0.0004717083,0.000730344,0.9975259,0.0000066262187],"about_ca_topic_score_codex":0.0009100552,"about_ca_topic_score_gemma":0.0018510048,"teacher_disagreement_score":0.8906492,"about_ca_system_score_codex":0.00065272907,"about_ca_system_score_gemma":0.0006904316,"threshold_uncertainty_score":0.15597558},"labels":[],"label_agreement":null},{"id":"W4376642978","doi":"10.1111/bjh.18870","title":"Long non‐coding <scp>RNAs</scp> associated with transcriptomic signatures and treatment outcome in diffuse large B‐cell lymphoma","year":2023,"lang":"en","type":"letter","venue":"British Journal of Haematology","topic":"Cancer-related molecular mechanisms research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Simon Fraser University; Spinal Cord Injury BC; University of British Columbia","funders":"Canadian Institutes of Health Research","keywords":"Transcriptome; Diffuse large B-cell lymphoma; Lymphoma; Cancer research; Medicine; Computational biology; Biology; Internal medicine; Gene; Gene expression; Genetics","score_opus":0.012350178188672739,"score_gpt":0.2511725602757425,"score_spread":0.23882238208706974,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4376642978","genre_codex":"empirical","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9971585,0.001200956,0.0002946702,0.00009555663,0.000009406785,0.000007727404,0.0008613924,0.000013953704,0.00035787906],"genre_scores_gemma":[0.9979297,0.00022783676,0.00022217828,0.00010619531,0.000016765707,0.00001716945,0.0012941674,0.000008910528,0.00017717754],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99982053,0.00003587246,0.000022142069,0.000053417603,0.0000344767,0.0000335392],"domain_scores_gemma":[0.9995988,0.00012117565,0.00016881786,0.000024699693,0.000038970375,0.000047576774],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00028377512,0.0001118705,0.00025304584,0.00034950254,0.00014267313,0.0003967565,0.00010407708,0.00021000019,0.0010775088],"category_scores_gemma":[0.00067038496,0.000053237898,0.00019831728,0.0005982008,0.0002146287,0.00017436552,0.00019532054,0.00029811446,0.00021576707],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002359606,0.00008164338,0.93406653,0.000118082564,0.0002385611,0.00025253103,0.0001343444,0.0004943871,0.038654245,0.000053335818,0.0007898864,0.022756787],"study_design_scores_gemma":[0.00001622545,0.00014348225,0.9964142,0.0000095122605,0.00006811874,0.00029979995,0.00007431433,0.0005424944,0.0014975459,0.00008400527,0.0008433925,0.0000068918976],"about_ca_topic_score_codex":0.00078090123,"about_ca_topic_score_gemma":0.0011403533,"teacher_disagreement_score":0.0010775088,"about_ca_system_score_codex":0.00025568396,"about_ca_system_score_gemma":0.00014721866,"threshold_uncertainty_score":0.003604591},"labels":[],"label_agreement":null},{"id":"W4377195778","doi":"10.1111/bjh.18863","title":"Granulocyte transfusion during cord blood transplant for relapsed, refractory <scp>AML</scp> is associated with massive <scp>CD8</scp><sup>+</sup> T‐cell expansion, significant cytokine release syndrome and induction of disease remission","year":2023,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Infection and Immunity","funders":"Children's Cancer and Leukaemia Group","keywords":"Medicine; Cytokine release syndrome; Internal medicine; Immunology; Hematopoietic stem cell transplantation; Gastroenterology; Transplantation; T cell; Immune system","score_opus":0.015426651381661008,"score_gpt":0.24959361001121064,"score_spread":0.23416695862954962,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4377195778","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9989581,0.00043704858,0.00023523325,0.000050511877,0.000013890037,0.00003282366,0.000025694439,0.000021417974,0.00022518735],"genre_scores_gemma":[0.9994161,0.00013821328,0.00020274441,0.000051875522,0.00001746016,0.000015981932,0.00007323894,0.000003442729,0.00008091896],"study_design_codex":"design_other","study_design_gemma":"case_report","domain_scores_codex":[0.9997428,0.0001315747,0.000027549562,0.000022538581,0.000043651118,0.000031924785],"domain_scores_gemma":[0.99951386,0.0001281323,0.00019606926,0.000044811477,0.000014996572,0.00010204109],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00051510043,0.00017715749,0.00042653852,0.000084807325,0.00013025035,0.0002821683,0.00021142463,0.00020812567,0.0006333083],"category_scores_gemma":[0.00091537036,0.00007014763,0.00018767624,0.00013262812,0.00027947567,0.00016268846,0.0001424915,0.00063722464,0.00012333435],"study_design_candidate":"case_report","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.14779048,0.0073184324,0.102058955,0.0012076225,0.0008269257,0.0074922876,0.0007714321,0.004403159,0.25394243,0.0009821939,0.006861992,0.46634415],"study_design_scores_gemma":[0.021237608,0.34301263,0.40771952,0.0002836262,0.0010789847,0.031998385,0.0003270728,0.018859046,0.1650255,0.0008489616,0.009545285,0.00006346675],"about_ca_topic_score_codex":0.00038636476,"about_ca_topic_score_gemma":0.000712664,"teacher_disagreement_score":0.0006333083,"about_ca_system_score_codex":0.00032560155,"about_ca_system_score_gemma":0.00028943448,"threshold_uncertainty_score":0.0027241707},"labels":[],"label_agreement":null},{"id":"W4378348239","doi":"10.1111/bjh.18879","title":"Real‐world management of small lymphocytic lymphoma as chronic lymphocytic leukaemia versus an indolent <scp>non‐Hodgkin</scp> lymphoma","year":2023,"lang":"en","type":"letter","venue":"British Journal of Haematology","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta; University of Calgary","funders":"","keywords":"Lymphoma; Classical Hodgkin lymphoma; Chronic lymphocytic leukemia; Hodgkin lymphoma; Medicine; Internal medicine; Oncology; Leukemia","score_opus":0.03610100405571235,"score_gpt":0.3133634652034648,"score_spread":0.27726246114775244,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4378348239","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.122117,0.018097997,0.0011548518,0.7802425,0.025152963,0.00010752444,0.0003057041,0.000093340044,0.05272804],"genre_scores_gemma":[0.68141925,0.008993559,0.0017491231,0.21027742,0.08138597,0.00006684687,0.00031439585,0.00009510665,0.01569834],"study_design_codex":"case_report","study_design_gemma":"not_applicable","domain_scores_codex":[0.99899775,0.00037042328,0.00015727352,0.00011113419,0.00016928594,0.00019419541],"domain_scores_gemma":[0.99598396,0.0018982281,0.00045974876,0.00012912326,0.0003962322,0.0011327949],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010899547,0.000337135,0.00059416017,0.0005691273,0.0014743998,0.0021174871,0.00069037767,0.0072615985,0.004222459],"category_scores_gemma":[0.011336199,0.00025508204,0.00037083495,0.0007398021,0.0012426103,0.0017919289,0.00066616153,0.004537417,0.0017141944],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011991055,0.00020255362,0.026650919,0.00032309443,0.00005710863,0.60874504,0.00068035774,0.00068107893,0.0016817375,0.005147547,0.307637,0.046994552],"study_design_scores_gemma":[0.00042823981,0.0005357936,0.019442283,0.00059245777,0.00008455113,0.79146713,0.0022007104,0.0023447485,0.0006859277,0.011532075,0.17058876,0.000097372715],"about_ca_topic_score_codex":0.0018350694,"about_ca_topic_score_gemma":0.0042344555,"teacher_disagreement_score":0.0072615985,"about_ca_system_score_codex":0.003008359,"about_ca_system_score_gemma":0.0008338578,"threshold_uncertainty_score":0.02182734},"labels":[],"label_agreement":null},{"id":"W4378640330","doi":"10.1111/bjh.18883","title":"Treatment‐free remission after dasatinib in patients with chronic myeloid leukaemia in chronic phase with deep molecular response: Final 5‐year analysis of <scp>DASFREE</scp>","year":2023,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":23,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"National Cancer Institute; National Institutes of Health; Bristol-Myers Squibb","keywords":"Dasatinib; Discontinuation; Medicine; Internal medicine; Adverse effect; Drug holiday; Chronic myeloid leukaemia; Surgery; Gastroenterology; Imatinib; Immunology; Myeloid leukemia; Human immunodeficiency virus (HIV)","score_opus":0.01022971088303479,"score_gpt":0.27219947009552864,"score_spread":0.2619697592124938,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4378640330","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9967411,0.001790849,0.0001759781,0.000065941145,0.000008098999,0.00005227873,0.0007656178,0.000007774298,0.0003924038],"genre_scores_gemma":[0.9971865,0.0002875773,0.00012755423,0.00009007908,0.000016416858,0.000028896053,0.0020766216,0.0000021944575,0.00018428903],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99868876,0.0004258006,0.00014055427,0.00020852365,0.0002794989,0.0002567315],"domain_scores_gemma":[0.99825305,0.00034796423,0.0007710734,0.00014295384,0.00014014129,0.00034474375],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0025734126,0.00034810713,0.001082494,0.00046221062,0.00032852477,0.0010766196,0.00039642304,0.00062323385,0.00064590713],"category_scores_gemma":[0.0017498471,0.00022406958,0.0018008687,0.00074746396,0.00031017905,0.0008131031,0.00049285556,0.0011186912,0.00017336536],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.08134892,0.0014809222,0.82946783,0.00051891,0.004534462,0.00045282106,0.00033813584,0.0021344007,0.0070956554,0.00017938916,0.0014213875,0.07102714],"study_design_scores_gemma":[0.0037098061,0.018027527,0.9713787,0.000039123657,0.0013759227,0.00053783465,0.00011982141,0.0015030885,0.000745865,0.00011824375,0.0024103604,0.00003379225],"about_ca_topic_score_codex":0.0016401409,"about_ca_topic_score_gemma":0.0040703774,"teacher_disagreement_score":0.0025734126,"about_ca_system_score_codex":0.00062980456,"about_ca_system_score_gemma":0.0007130254,"threshold_uncertainty_score":0.013609707},"labels":[],"label_agreement":null},{"id":"W4378952773","doi":"10.1111/bjh.18900","title":"Genome‐wide <scp>CRISPR</scp> screening uncovers potential targets and mechanisms of vincristine resistance in <scp>DLBCL</scp>","year":2023,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Vincristine; CRISPR; Drug resistance; Cancer research; Biology; Medicine; Cell cycle checkpoint; Computational biology; Apoptosis; Bioinformatics; Cell cycle; Internal medicine; Genetics; Chemotherapy; Gene","score_opus":0.015495743719001967,"score_gpt":0.27458812039269387,"score_spread":0.2590923766736919,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4378952773","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0018654554,0.012327432,0.0013759296,0.74995977,0.23002245,0.00005925849,0.00065259956,0.00038917764,0.0033479633],"genre_scores_gemma":[0.015821392,0.022125784,0.0019058187,0.6107071,0.32330796,0.00011571125,0.00054768566,0.0001915769,0.025277013],"study_design_codex":"not_applicable","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9986929,0.00020766522,0.00013186567,0.00019665548,0.00057507673,0.00019584657],"domain_scores_gemma":[0.99397814,0.0032240888,0.00032869462,0.00018360975,0.0015733585,0.0007121089],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002852408,0.00090056506,0.0011285272,0.0005964632,0.001424669,0.0024292471,0.0023693047,0.01378228,0.005403219],"category_scores_gemma":[0.0075460444,0.0004942295,0.0010103051,0.00038370615,0.0016583202,0.0015148701,0.0010161864,0.0147820255,0.0027476405],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001225004,0.000024947658,0.00025134566,0.00012253756,0.000020646785,0.000384776,0.000042962252,0.00008273905,0.0012086552,0.0009604519,0.98129404,0.015484352],"study_design_scores_gemma":[0.00015652,0.00014513236,0.0017012007,0.00019145565,0.00008090213,0.0007877421,0.00016947056,0.00055144005,0.002114136,0.0050453222,0.9890036,0.000053144122],"about_ca_topic_score_codex":0.0023535844,"about_ca_topic_score_gemma":0.006959194,"teacher_disagreement_score":0.01378228,"about_ca_system_score_codex":0.0016166598,"about_ca_system_score_gemma":0.0020002592,"threshold_uncertainty_score":0.018075585},"labels":[],"label_agreement":null},{"id":"W4384923042","doi":"10.1111/bjh.18972","title":"Outcomes of patients with indolent lymphoma treated with bendamustine plus rituximab compared to rituximab plus <scp>CVP</scp> or <scp>CHOP</scp> chemoimmunotherapy in Ontario","year":2023,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Princess Margaret Cancer Centre; Health Sciences Centre; Sunnybrook Health Science Centre; Institute for Clinical Evaluative Sciences; University of Toronto","funders":"American Society of Hematology","keywords":"Rituximab; Chemoimmunotherapy; Medicine; Bendamustine; CHOP; Internal medicine; Oncology; Lymphoma","score_opus":0.01750002979747422,"score_gpt":0.25031042060235265,"score_spread":0.23281039080487842,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4384923042","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99879056,0.0003966754,0.000015018454,0.00009498748,0.000003746005,0.000013126217,0.00032996832,0.0000016146529,0.00035443675],"genre_scores_gemma":[0.99932814,0.00016824632,0.000017659382,0.000058419897,0.0000059871163,0.000007747505,0.0003021902,8.7394903e-7,0.000110739005],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99961436,0.00004927164,0.000033102104,0.00006416282,0.00008708336,0.0001519123],"domain_scores_gemma":[0.9988949,0.00006193672,0.00058035285,0.000026425123,0.00012006666,0.000316335],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00029318215,0.00017045929,0.00040590853,0.0002964728,0.0007397344,0.00053737854,0.00043316174,0.00028307416,0.00075782643],"category_scores_gemma":[0.0011304935,0.00021615336,0.0006499884,0.001012876,0.00047811994,0.00022613598,0.00042520126,0.00035157567,0.00006914379],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015659687,0.00008013126,0.9929623,0.000037732538,0.00013524712,0.00014826053,0.0002344155,0.00020262916,0.0005526398,0.00003289145,0.0004232848,0.0036244714],"study_design_scores_gemma":[0.00012301146,0.00026215528,0.99866295,0.000016390019,0.0000790109,0.000109660214,0.00019512704,0.00017103126,0.00006880591,0.000017637887,0.00028745373,0.000006754619],"about_ca_topic_score_codex":0.658213,"about_ca_topic_score_gemma":0.79834855,"teacher_disagreement_score":0.34178698,"about_ca_system_score_codex":0.010767264,"about_ca_system_score_gemma":0.0066901664,"threshold_uncertainty_score":0.68759966},"labels":[],"label_agreement":null},{"id":"W4385264639","doi":"10.1111/bjh.19004","title":"Human leucocyte antigen‐matched related haematopoietic stem cell transplantation using low‐dose cyclophosphamide, fludarabine and thymoglobulin in children with severe aplastic anaemia","year":2023,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Windsor Regional Hospital; Western University","funders":"","keywords":"Thymoglobulin; Fludarabine; Medicine; Cyclophosphamide; Bone marrow failure; Transplantation; Fanconi anemia; Internal medicine; Immunology; Hematopoietic stem cell transplantation; Regimen; Gastroenterology; Stem cell; Oncology; Haematopoiesis; Chemotherapy; Tacrolimus; Biology","score_opus":0.01142940841902273,"score_gpt":0.24666444567627835,"score_spread":0.2352350372572556,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4385264639","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9988513,0.0009049356,0.00008270033,0.000010275662,0.0000022504585,0.00001409156,0.00002129721,0.0000031700793,0.00010997332],"genre_scores_gemma":[0.9984962,0.0009335599,0.00037407104,0.000021035868,0.0000046835244,0.00001589692,0.0001029621,0.0000012135001,0.000050331793],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99968004,0.00014544437,0.00004410241,0.000041242656,0.00005279309,0.000036373265],"domain_scores_gemma":[0.99969804,0.000072968134,0.00011919238,0.000019051311,0.000025493911,0.000065270935],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00050360913,0.0003520021,0.00034483793,0.00036087408,0.00018855171,0.00017437682,0.00022961023,0.0002228594,0.00031260628],"category_scores_gemma":[0.000713574,0.00012368744,0.00023622319,0.00039693507,0.00042690526,0.00020752306,0.00024822677,0.00027497878,0.00007823239],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0036285694,0.00063251,0.88506395,0.0007907031,0.00019047568,0.005074938,0.0005166693,0.0007711147,0.030314866,0.00011831687,0.0003675342,0.072530404],"study_design_scores_gemma":[0.0003427318,0.0137621015,0.9514825,0.00011374705,0.00026939425,0.01932954,0.0005157725,0.0005521389,0.011376973,0.00005658854,0.0021824443,0.000016227383],"about_ca_topic_score_codex":0.0020865065,"about_ca_topic_score_gemma":0.0053205895,"teacher_disagreement_score":0.0020865065,"about_ca_system_score_codex":0.0004868184,"about_ca_system_score_gemma":0.0007905335,"threshold_uncertainty_score":0.0041487217},"labels":[],"label_agreement":null},{"id":"W4385850624","doi":"10.1111/bjh.19018","title":"<scp>ETS1</scp> phosphorylation at threonine 38 is associated with the cell of origin of diffuse large B cell lymphoma and sustains the growth of tumour cells","year":2023,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Spinal Cord Injury BC; University of British Columbia; BC Cancer Agency","funders":"Swiss Cancer Research Foundation; Rotary Foundation","keywords":"Diffuse large B-cell lymphoma; ETS1; Cancer research; Phosphorylation; Lymphoma; Cell growth; Threonine; Biology; Immunology; Cell biology; Transcription factor; Genetics; Gene","score_opus":0.008459143445706712,"score_gpt":0.22323029198025593,"score_spread":0.2147711485345492,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4385850624","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99478626,0.0019402781,0.00063974183,0.00010784119,0.00001581075,0.000012074249,0.00058570236,0.000050266688,0.0018619564],"genre_scores_gemma":[0.99498415,0.0006412907,0.0004879413,0.000032934793,0.0000072765806,0.000013555139,0.0009875626,0.00001393696,0.0028313252],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9999106,0.000012275969,0.0000059130825,0.000019007628,0.000025819698,0.000026273863],"domain_scores_gemma":[0.999956,0.0000060357465,0.0000145136755,0.0000043882274,0.000004875782,0.000014099236],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000079776706,0.00019806331,0.00016287752,0.00015119382,0.00013334141,0.00020853127,0.000100259706,0.000115615105,0.0030036846],"category_scores_gemma":[0.00007249555,0.00007464309,0.0001469547,0.00013631475,0.00014926998,0.00012806398,0.00014889994,0.0003436394,0.00062999694],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00020060563,0.000015063139,0.00048782144,0.00003258091,0.000005933412,0.00008347292,0.0000062292797,0.000046247973,0.9971794,0.00006116003,0.00008666362,0.0017948446],"study_design_scores_gemma":[0.00001769859,0.00025973958,0.035343144,0.000008168233,0.000014289192,0.0010630094,0.000039945375,0.00048539022,0.9564258,0.00011074255,0.006227202,0.0000049237146],"about_ca_topic_score_codex":0.00057586917,"about_ca_topic_score_gemma":0.0009971315,"teacher_disagreement_score":0.0030036846,"about_ca_system_score_codex":0.00022939143,"about_ca_system_score_gemma":0.00011432279,"threshold_uncertainty_score":0.01004833},"labels":[],"label_agreement":null},{"id":"W4386251475","doi":"10.1111/bjh.19075","title":"Refractory immune thrombocytopenia in adults: Towards a new definition","year":2023,"lang":"en","type":"review","venue":"British Journal of Haematology","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Immune thrombocytopenia; Refractory (planetary science); Medicine; Immune system; Immunology; Platelet; Intensive care medicine; Biology","score_opus":0.0744130106936674,"score_gpt":0.35112243319075204,"score_spread":0.27670942249708463,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386251475","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00019980242,0.99703693,0.00022698565,0.0016082275,0.0005257107,0.000011998919,0.000017051432,0.000005186955,0.00036810501],"genre_scores_gemma":[0.0025438007,0.9927891,0.0010761059,0.0021612812,0.0010679371,0.00004942133,0.0000824638,0.0000037132868,0.00022621978],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99813443,0.000568263,0.0006385948,0.00016949938,0.00040858024,0.00008060183],"domain_scores_gemma":[0.9965733,0.0019195469,0.0006486591,0.000067407986,0.0006689926,0.00012214205],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004160258,0.0011249605,0.0030704702,0.004508153,0.0003798172,0.0024738573,0.0015880065,0.002129813,0.0011185484],"category_scores_gemma":[0.0047562383,0.0004125676,0.0010687206,0.004622301,0.0015732843,0.0052570286,0.0015453935,0.0042062225,0.00053332647],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021035178,0.00012240153,0.0014494141,0.06632451,0.00021799943,0.000555783,0.00077672413,0.00034757267,0.0006489507,0.01650008,0.053954087,0.858892],"study_design_scores_gemma":[0.00011386859,0.0002430353,0.0051792474,0.07054597,0.00063631934,0.0065558925,0.001057337,0.0003646769,0.00021769988,0.010963689,0.9040556,0.0000666296],"about_ca_topic_score_codex":0.0017417065,"about_ca_topic_score_gemma":0.0018324719,"teacher_disagreement_score":0.004508153,"about_ca_system_score_codex":0.0015144518,"about_ca_system_score_gemma":0.003123371,"threshold_uncertainty_score":0.022001803},"labels":[],"label_agreement":null},{"id":"W4386593535","doi":"10.1111/bjh.19099","title":"Provider prescription of hydroxyurea in youth and adults with sickle cell disease: A review of prescription barriers and facilitators","year":2023,"lang":"en","type":"review","venue":"British Journal of Haematology","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Concordia University","funders":"National Heart, Lung, and Blood Institute; American Lebanese Syrian Associated Charities; American Society of Hematology","keywords":"Medical prescription; Medicine; Demographics; Family medicine; Disease; Inclusion (mineral); MEDLINE; Internal medicine; Pharmacology; Psychology","score_opus":0.013779167626060853,"score_gpt":0.26216336592165074,"score_spread":0.2483841982955899,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386593535","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00045071164,0.9990545,0.00003709575,0.00013665068,0.000038404698,0.00004494604,0.000057909783,0.00000226986,0.00017763505],"genre_scores_gemma":[0.0027372153,0.99678123,0.00016817208,0.000121379926,0.000016396623,0.00006407977,0.000044050288,0.0000011810939,0.000066367254],"study_design_codex":"systematic_review","study_design_gemma":"not_applicable","domain_scores_codex":[0.9973205,0.000834601,0.00097167084,0.00017241092,0.0005750561,0.00012571411],"domain_scores_gemma":[0.9842868,0.012095865,0.0021500273,0.00011637616,0.001188981,0.00016196416],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004810524,0.00097380206,0.004084422,0.0063107517,0.0005210263,0.0017120701,0.0011561937,0.0014298216,0.0036460666],"category_scores_gemma":[0.018088691,0.0007233377,0.004000861,0.0076013003,0.00043371852,0.0015510558,0.0011398672,0.0009644667,0.00029240138],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000120797486,0.000028498487,0.0005104664,0.8749621,0.0018820749,0.00009694889,0.00041800656,0.000091991,0.00014971767,0.00028058843,0.0020348637,0.11942399],"study_design_scores_gemma":[0.00007738123,0.00018391447,0.0041358843,0.92603517,0.01677691,0.0004239968,0.0005927972,0.00006485397,0.00017465292,0.00019368893,0.051316686,0.000024192663],"about_ca_topic_score_codex":0.012894725,"about_ca_topic_score_gemma":0.032294113,"teacher_disagreement_score":0.012894725,"about_ca_system_score_codex":0.0024051494,"about_ca_system_score_gemma":0.008983183,"threshold_uncertainty_score":0.025639355},"labels":[],"label_agreement":null},{"id":"W4386623512","doi":"10.1111/bjh.19058","title":"Final report of <scp>TKI</scp> discontinuation trial with dasatinib for the second attempt of treatment‐free remission after failing the first attempt with imatinib: Treatment‐free Remission Accomplished by Dasatinib (<scp>TRAD</scp>) study","year":2023,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Toronto General Hospital; University of Alberta; London Health Sciences Centre; Hôpital de l'Enfant-Jésus; Université de Montréal; Hôpital Maisonneuve-Rosemont; Queen Elizabeth II Health Sciences Centre; Princess Margaret Cancer Centre; Vancouver General Hospital; University of Calgary; BC Cancer Agency; Alberta Health Services; McGill University Health Centre; University of Ottawa; CancerCare Manitoba; University Health Network; Ottawa Hospital; Dalhousie University; Western University; University of Toronto; University of British Columbia","funders":"Bristol-Myers Squibb Canada; Princess Margaret Cancer Foundation","keywords":"Dasatinib; Discontinuation; Medicine; Imatinib; Internal medicine; Tyrosine-kinase inhibitor; Drug holiday; Oncology; Immunology; Myeloid leukemia; Human immunodeficiency virus (HIV); Cancer","score_opus":0.03349169713017222,"score_gpt":0.2989456162039855,"score_spread":0.2654539190738133,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386623512","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.91612065,0.010330982,0.003115267,0.009144673,0.002578257,0.0062656063,0.022925816,0.00033588204,0.029182913],"genre_scores_gemma":[0.9567799,0.0035373655,0.0018854237,0.0071855825,0.0011782135,0.0027888084,0.014580198,0.000103555605,0.011960905],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9987471,0.0006262364,0.000102395374,0.0001474423,0.00022286746,0.00015394427],"domain_scores_gemma":[0.9973425,0.00082455686,0.00040409205,0.00021808113,0.0002978531,0.0009128718],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0040044123,0.00068480906,0.0021888283,0.00023138837,0.0006138585,0.0016017914,0.0007114866,0.0016004728,0.003100497],"category_scores_gemma":[0.0025945136,0.00024969107,0.0021486771,0.00026257656,0.0003443177,0.00056195393,0.0003147061,0.0025881391,0.0009094177],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.6215351,0.0149890585,0.052477468,0.0021428873,0.009734082,0.0027167827,0.00067900785,0.0029129232,0.021031588,0.0018293897,0.08389801,0.18605363],"study_design_scores_gemma":[0.52952653,0.28912723,0.10235061,0.00030280164,0.0038789061,0.0013689748,0.0001842286,0.0026143172,0.004909557,0.0012266859,0.06436745,0.00014261698],"about_ca_topic_score_codex":0.0011221456,"about_ca_topic_score_gemma":0.002812371,"teacher_disagreement_score":0.0040044123,"about_ca_system_score_codex":0.00055526686,"about_ca_system_score_gemma":0.0012522134,"threshold_uncertainty_score":0.02117765},"labels":[],"label_agreement":null},{"id":"W4386850841","doi":"10.1111/bjh.19107","title":"Ratio of stemness to interferon signalling as a biomarker and therapeutic target of myeloproliferative neoplasm progression to acute myeloid leukaemia","year":2023,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Princess Margaret Cancer Centre; University Health Network","funders":"Instituto Nacional de Ciência e Tecnologia da Criosfera; Conselho Nacional de Desenvolvimento Científico e Tecnológico; Canadian Network for Research and Innovation in Machining Technology, Natural Sciences and Engineering Research Council of Canada; Fundação de Amparo à Pesquisa do Estado de São Paulo; Institute of Cancer Research; Ontario Institute for Cancer Research; World Health Organization","keywords":"Myeloproliferative neoplasm; Interferon; Cancer research; Biology; Myeloid; Biomarker; Immunology; Stem cell; Myelofibrosis; Bone marrow; Cell biology","score_opus":0.02302117307169929,"score_gpt":0.32677305605342655,"score_spread":0.3037518829817273,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386850841","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9578898,0.032275684,0.003862168,0.00052602,0.0000640733,0.00013834356,0.00042095408,0.00017496505,0.004647973],"genre_scores_gemma":[0.992649,0.003658927,0.002221725,0.00012864183,0.000045183417,0.00007573686,0.00029151206,0.000012530981,0.00091657817],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9997242,0.00008720613,0.000022796943,0.000034030894,0.00010658125,0.000025278234],"domain_scores_gemma":[0.9997943,0.000053852098,0.0000757354,0.0000128558095,0.000031297455,0.00003193328],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004319925,0.0002246887,0.0003960442,0.0006453955,0.000103532366,0.0005472975,0.0001524059,0.0002984503,0.0010392471],"category_scores_gemma":[0.00041294767,0.00009755871,0.00008267388,0.00033956164,0.0001801336,0.00023307429,0.00017630433,0.0006812094,0.00029267804],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017410768,0.00023428656,0.021969324,0.00035084586,0.000043188847,0.0002218407,0.00009669595,0.00037614375,0.8809913,0.00041744235,0.00048805797,0.09306981],"study_design_scores_gemma":[0.00017966994,0.009966858,0.27677804,0.00015282603,0.00028209755,0.0046352963,0.00027892803,0.004779509,0.67092067,0.0013674651,0.030620005,0.00003864386],"about_ca_topic_score_codex":0.00010296064,"about_ca_topic_score_gemma":0.00016820742,"teacher_disagreement_score":0.0010392471,"about_ca_system_score_codex":0.00032243805,"about_ca_system_score_gemma":0.00015420993,"threshold_uncertainty_score":0.0034766197},"labels":[],"label_agreement":null},{"id":"W4386944495","doi":"10.1111/bjh.19085","title":"In Memoriam Robert <scp>McMillan</scp>","year":2023,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Toronto","funders":"","keywords":"Citation; Library science; Tribute; Medicine; Classics; Law; History; Computer science; Political science","score_opus":0.011508388526205966,"score_gpt":0.2715650234754753,"score_spread":0.26005663494926934,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386944495","genre_codex":"editorial","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00012015499,0.006746471,0.0002562287,0.21504903,0.758613,0.00006943256,0.00041823782,0.00022760242,0.01849986],"genre_scores_gemma":[0.0034227578,0.0136471195,0.00056132843,0.15877242,0.5486212,0.00022753562,0.00086960394,0.00053266785,0.27334538],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9967679,0.0004543912,0.00032109843,0.00048415316,0.0016452275,0.00032727793],"domain_scores_gemma":[0.98390055,0.0021385928,0.00070416415,0.00066219334,0.010000415,0.0025941401],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0038662404,0.0012931044,0.0015628857,0.0018347332,0.0020400544,0.0061525195,0.0026204337,0.005663774,0.118768856],"category_scores_gemma":[0.03022887,0.0005274133,0.0013875511,0.00085830095,0.0015899999,0.002793654,0.0020566462,0.011386116,0.09721781],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000071642044,0.0000016595396,0.000010212303,0.000015604399,0.0000013786358,0.000019581337,0.0000036127508,0.000002783795,0.000008322266,0.000093163675,0.99743146,0.0024051003],"study_design_scores_gemma":[0.000011468838,0.000011517581,0.00014871811,0.00015088975,0.0000061678575,0.00023631967,0.000029621813,0.000021579202,0.00006656866,0.00040269148,0.9989064,0.000008109197],"about_ca_topic_score_codex":0.004623495,"about_ca_topic_score_gemma":0.0061412957,"teacher_disagreement_score":0.118768856,"about_ca_system_score_codex":0.0034142875,"about_ca_system_score_gemma":0.00391025,"threshold_uncertainty_score":0.3973214},"labels":[],"label_agreement":null},{"id":"W4386945076","doi":"10.1111/bjh.19071","title":"A tribute to Paul Imbach","year":2023,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Tribute; Medicine; Art; Art history","score_opus":0.016300594271200817,"score_gpt":0.294703260735729,"score_spread":0.27840266646452816,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386945076","genre_codex":"commentary","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00014553165,0.014060246,0.00037252938,0.8058113,0.17085469,0.000010838013,0.00005689782,0.00012100558,0.008566925],"genre_scores_gemma":[0.005596125,0.013679937,0.0008566709,0.82056004,0.08182242,0.000057130466,0.00009240225,0.00037802113,0.076957256],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9917977,0.0020739632,0.000429349,0.0017438765,0.0030788076,0.00087634946],"domain_scores_gemma":[0.9773861,0.0065510604,0.000792794,0.0011560486,0.007269074,0.006844996],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0072825,0.0015353017,0.0024432717,0.0013623681,0.0055168974,0.009563107,0.0026823096,0.010965512,0.025986308],"category_scores_gemma":[0.043514315,0.0007009028,0.0010650555,0.00085191656,0.0060508535,0.008885445,0.0041663116,0.044629507,0.021838272],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000012501869,0.00001025112,0.00004139448,0.000023895247,0.00000443586,0.000053065818,0.00006579066,0.00001178445,0.000022724891,0.0033683851,0.9920963,0.0042895153],"study_design_scores_gemma":[0.0000075771254,0.000014570957,0.00006682745,0.00014027253,0.0000026102969,0.00020076946,0.00017193271,0.00003332311,0.000045677487,0.003048509,0.9962535,0.000014383219],"about_ca_topic_score_codex":0.0038335724,"about_ca_topic_score_gemma":0.0057441816,"teacher_disagreement_score":0.025986308,"about_ca_system_score_codex":0.0032129989,"about_ca_system_score_gemma":0.0071186777,"threshold_uncertainty_score":0.0869329},"labels":[],"label_agreement":null},{"id":"W4386945459","doi":"10.1111/bjh.19079","title":"The role of T cells and myeloid‐derived suppressor cells in refractory immune thrombocytopenia","year":2023,"lang":"en","type":"review","venue":"British Journal of Haematology","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"National Institutes of Health; National Heart, Lung, and Blood Institute; Vetenskapsrådet","keywords":"Immune system; Immunology; Immune thrombocytopenia; T cell; Medicine; Refractory (planetary science); Pathogenesis; Myeloid; Platelet; Myeloid-derived Suppressor Cell; Immune tolerance; Suppressor; Biology; Internal medicine; Cancer","score_opus":0.02207948068169229,"score_gpt":0.2982389809109268,"score_spread":0.2761595002292345,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386945459","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000119891556,0.99907553,0.000036384223,0.00015092423,0.000093018345,0.0000020380455,0.0000073879064,0.0000023522925,0.0005124904],"genre_scores_gemma":[0.0006708357,0.99876213,0.000058767742,0.000104928105,0.00009037797,0.0000032667756,0.000012871892,6.2735546e-7,0.00029623453],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.999884,0.000023118731,0.000022324852,0.00001498614,0.000044367756,0.000011227344],"domain_scores_gemma":[0.9998153,0.000103414706,0.000028459366,0.0000041014546,0.000034542078,0.000014188185],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00032930335,0.00043220792,0.0009620388,0.001448438,0.00017321631,0.00064303965,0.0004914576,0.0007577004,0.0026988252],"category_scores_gemma":[0.00055016467,0.00015896237,0.00033436847,0.001415837,0.00026813007,0.0006150658,0.00042984253,0.001132923,0.0013851455],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010697736,0.000044476084,0.0001349409,0.016090838,0.0000764677,0.0002652565,0.000056629215,0.00020369134,0.0011394188,0.0019400576,0.01667691,0.96326435],"study_design_scores_gemma":[0.00004595118,0.00018927036,0.0014723357,0.0071380693,0.00016937777,0.0034390255,0.00007614139,0.00008245687,0.00051489024,0.0020130007,0.98484325,0.000016149712],"about_ca_topic_score_codex":0.00065101875,"about_ca_topic_score_gemma":0.0011522066,"teacher_disagreement_score":0.0026988252,"about_ca_system_score_codex":0.0003084239,"about_ca_system_score_gemma":0.0005693131,"threshold_uncertainty_score":0.009028494},"labels":[],"label_agreement":null},{"id":"W4386945474","doi":"10.1111/bjh.19073","title":"Paediatric‐onset Evans syndrome: Breaking away from refractory immune thrombocytopenia","year":2023,"lang":"en","type":"review","venue":"British Journal of Haematology","topic":"Blood disorders and treatments","field":"Biochemistry, Genetics and Molecular Biology","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Centre Hospitalier Universitaire Sainte-Justine","funders":"Fondation pour la Recherche Médicale; Institut National de la Santé et de la Recherche Médicale; Agence Nationale de la Recherche","keywords":"Evans syndrome; Splenectomy; Medicine; Immune system; Immunology; Immune thrombocytopenia; Neutropenia; Spleen; Internal medicine; Autoimmune hemolytic anemia; Antibody; Chemotherapy","score_opus":0.025913705102565996,"score_gpt":0.3083330017252585,"score_spread":0.2824192966226925,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386945474","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00015515923,0.9982539,0.000119979195,0.00037838164,0.00023245404,0.0000025959735,0.000010580299,0.000007927717,0.00083898247],"genre_scores_gemma":[0.0013588667,0.9971745,0.00016752435,0.00034455064,0.00029088822,0.0000044730114,0.000037328475,0.0000025879413,0.0006192154],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9998629,0.000022801845,0.000024373854,0.000023338169,0.000049290848,0.000017249038],"domain_scores_gemma":[0.9998115,0.00009493634,0.000028845932,0.000005620595,0.00003419452,0.000024940184],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00037573543,0.0007572832,0.001300706,0.0018620791,0.0002069019,0.00070558407,0.0008534754,0.0010049825,0.0023637007],"category_scores_gemma":[0.0006143946,0.00018872619,0.0003682758,0.0012741655,0.0004225393,0.00089162024,0.00051944546,0.0022182665,0.0016825005],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000092394,0.000050131763,0.00022838639,0.0071945027,0.000074877906,0.0012295656,0.00003612512,0.00027940408,0.0006820121,0.0023683088,0.03239651,0.9553679],"study_design_scores_gemma":[0.000050716077,0.00010633442,0.0014264156,0.0044931015,0.00011576213,0.016285332,0.00006241207,0.00011770774,0.0004396524,0.0024874746,0.974394,0.00002112228],"about_ca_topic_score_codex":0.00081451604,"about_ca_topic_score_gemma":0.0012270567,"teacher_disagreement_score":0.0023637007,"about_ca_system_score_codex":0.00041795796,"about_ca_system_score_gemma":0.00050929165,"threshold_uncertainty_score":0.007907391},"labels":[],"label_agreement":null},{"id":"W4386994638","doi":"10.1111/bjh.19067","title":"Treatment outcomes of childhood <i>PICALM::MLLT10</i> acute leukaemias","year":2023,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Medicine; Oncology; Internal medicine","score_opus":0.020307007821183592,"score_gpt":0.31756159382189847,"score_spread":0.29725458600071486,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386994638","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9977514,0.0008843317,0.00007601314,0.00009059357,0.0000068038544,0.000006010459,0.0004292005,0.000005246217,0.0007504277],"genre_scores_gemma":[0.9991436,0.00012425863,0.00002297795,0.000022843884,0.0000050426784,0.0000044216777,0.00059491955,0.0000020952402,0.000079786456],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9995371,0.0001109093,0.000050891133,0.000061890656,0.000077003904,0.00016223249],"domain_scores_gemma":[0.99847203,0.00029607254,0.00081417896,0.00005114394,0.000100193625,0.00026632263],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004996179,0.00013378181,0.00035560387,0.000355652,0.00019033908,0.0004587135,0.00018811355,0.00026687502,0.0006287052],"category_scores_gemma":[0.0017762174,0.000055158718,0.0003618604,0.0005402943,0.00024926412,0.00030400982,0.00036149716,0.00037225866,0.00011402558],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0025165284,0.00010836241,0.970362,0.00005997836,0.0001660905,0.00043956685,0.00022185383,0.0010706696,0.0010103291,0.00013338671,0.0005937348,0.023317413],"study_design_scores_gemma":[0.000058549325,0.0014638875,0.9955894,0.00002343688,0.000107262305,0.000804261,0.000158802,0.00036717308,0.0004599064,0.00009094105,0.0008659023,0.0000104962655],"about_ca_topic_score_codex":0.0030485464,"about_ca_topic_score_gemma":0.003495613,"teacher_disagreement_score":0.0030485464,"about_ca_system_score_codex":0.0008481168,"about_ca_system_score_gemma":0.00027919657,"threshold_uncertainty_score":0.006153524},"labels":[],"label_agreement":null},{"id":"W4387296226","doi":"10.1111/bjh.19121","title":"Acute myeloid leukaemia relapse after allogeneic haematopoietic stem cell transplantation: Mechanistic diversity and therapeutic directions","year":2023,"lang":"en","type":"review","venue":"British Journal of Haematology","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Transplantation; Mechanism (biology); Stem cell; Haematopoiesis; Immunology; Oncology; Donor lymphocyte infusion; Hematopoietic stem cell transplantation; Bioinformatics; Internal medicine; Biology","score_opus":0.0449286521236952,"score_gpt":0.3134743992064491,"score_spread":0.2685457470827539,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4387296226","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00010059191,0.9993523,0.00003455734,0.00017081294,0.000070842034,0.0000021045444,0.000008033722,0.0000019931524,0.0002587138],"genre_scores_gemma":[0.00073226966,0.99891114,0.00006335474,0.00010087724,0.00005621881,0.0000033089275,0.000014539717,5.222653e-7,0.00011772787],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99980277,0.000047746584,0.000041842493,0.00003487832,0.000053198455,0.000019603047],"domain_scores_gemma":[0.9996132,0.00023963147,0.00005679151,0.000009093706,0.000064968684,0.000016300968],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00071237335,0.00044974225,0.0013205487,0.0011728191,0.00015968976,0.0009413371,0.00069017865,0.00084846385,0.0021916118],"category_scores_gemma":[0.0011462807,0.00016415304,0.00056775165,0.0012265192,0.00035996648,0.00088697125,0.00048435433,0.0011135696,0.0006704077],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016286205,0.00004765608,0.00017809706,0.037035424,0.00016946801,0.00015714177,0.00006630415,0.00037028492,0.0010548043,0.0029971236,0.013077115,0.9446838],"study_design_scores_gemma":[0.000059833306,0.00031637846,0.0020047717,0.023845213,0.0006375522,0.0022316237,0.00018005756,0.00017426681,0.0006861293,0.003745621,0.9660896,0.000028931014],"about_ca_topic_score_codex":0.0007667705,"about_ca_topic_score_gemma":0.001429354,"teacher_disagreement_score":0.0021916118,"about_ca_system_score_codex":0.00054667756,"about_ca_system_score_gemma":0.0011553867,"threshold_uncertainty_score":0.0073316693},"labels":[],"label_agreement":null},{"id":"W4387420858","doi":"10.1111/bjh.19133","title":"Natural history of blood pressure in sickle cell disease pregnancy","year":2023,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Lunenfeld-Tanenbaum Research Institute; Sinai Health System; University of Toronto; University Health Network","funders":"National Heart, Lung, and Blood Institute; National Institutes of Health; Andrew W. Mellon Foundation; Pfizer; Johns Hopkins University; Teva Pharmaceutical Industries; National Institute of Mental Health; Novo Nordisk","keywords":"Medicine; Blood pressure; Pregnancy; Cohort; Obstetrics; Disease; Cohort study; Internal medicine; Pediatrics","score_opus":0.007500559336759999,"score_gpt":0.22144134458821657,"score_spread":0.21394078525145657,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4387420858","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9981553,0.00039869492,0.00011493692,0.0000580376,0.000007826286,0.000005745054,0.0009394375,0.000004989662,0.00031496544],"genre_scores_gemma":[0.99905616,0.00013282873,0.00006314851,0.000022247817,0.0000062276977,0.000008976817,0.0005985054,0.000001815858,0.00011006597],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99934405,0.00017449405,0.000065732485,0.0001972,0.00011185217,0.00010660221],"domain_scores_gemma":[0.998793,0.00017068152,0.00053966476,0.00012982934,0.00009611656,0.00027061853],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006689289,0.00016236829,0.00030191286,0.0005497993,0.00049803837,0.000611393,0.00038105354,0.00040978615,0.0008512898],"category_scores_gemma":[0.0023837844,0.00035573082,0.00036711222,0.00082614465,0.00025546708,0.0004231536,0.0005206272,0.0007701034,0.00016837558],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000054913995,0.000009833705,0.99925333,0.000003842298,0.000022053095,0.0000736732,0.00005206789,0.000017786579,0.000089209476,0.000013323413,0.00004924633,0.0003607468],"study_design_scores_gemma":[0.0000024023805,0.00003794248,0.999435,0.000004421647,0.000008629312,0.00025731762,0.00006856672,0.00007601414,0.000022662367,0.000016602895,0.000067978704,0.000002276045],"about_ca_topic_score_codex":0.010931331,"about_ca_topic_score_gemma":0.010286675,"teacher_disagreement_score":0.010931331,"about_ca_system_score_codex":0.00033792175,"about_ca_system_score_gemma":0.00035047886,"threshold_uncertainty_score":0.02173543},"labels":[],"label_agreement":null},{"id":"W4387950790","doi":"10.1111/bjh.19153","title":"Evaluation of clinical parameters and biomarkers in older, untreated mantle cell lymphoma patients receiving <scp>bendamustine–rituximab</scp>","year":2023,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Spinal Cord Injury BC; BC Cancer Agency","funders":"National Cancer Institute; National Institutes of Health","keywords":"Bendamustine; Mantle cell lymphoma; Rituximab; Medicine; Internal medicine; Oncology; Lymphoma","score_opus":0.043650211586456954,"score_gpt":0.33396383853634376,"score_spread":0.2903136269498868,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4387950790","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9991677,0.00036844655,0.00007238134,0.000012821167,0.0000029967375,0.0000051602697,0.000112112626,0.0000024844396,0.00025600893],"genre_scores_gemma":[0.9993343,0.00010642747,0.00007161445,0.000025541714,0.000014435955,0.000006095651,0.0003339049,0.0000011793217,0.000106521904],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9997563,0.000059017624,0.00003210116,0.00006410128,0.000046387922,0.000042196298],"domain_scores_gemma":[0.99918574,0.00014915275,0.00038407327,0.00004671482,0.0000702925,0.00016409451],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005119735,0.00023072923,0.0003966179,0.0005441043,0.00020736284,0.00044319648,0.00013332424,0.00029001315,0.00051582395],"category_scores_gemma":[0.0012011736,0.00009687058,0.00025505797,0.00049898395,0.00016464213,0.00035150678,0.00031900645,0.0003022533,0.00017524793],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00090933754,0.00004826842,0.9926904,0.000012399382,0.000052573865,0.00012650965,0.000065482665,0.00010389532,0.0018550643,0.000013868742,0.000055892364,0.004066334],"study_design_scores_gemma":[0.000014938084,0.0005932006,0.9982425,0.0000035252413,0.000041355062,0.00033398,0.000085192725,0.00015975158,0.00022105256,0.000025781492,0.0002751167,0.0000035884955],"about_ca_topic_score_codex":0.0006917604,"about_ca_topic_score_gemma":0.0010346397,"teacher_disagreement_score":0.0006917604,"about_ca_system_score_codex":0.00021468826,"about_ca_system_score_gemma":0.00015716584,"threshold_uncertainty_score":0.0027076006},"labels":[],"label_agreement":null},{"id":"W4387966857","doi":"10.1111/bjh.19166","title":"Indolent lymphoma care delivery and outcomes during the COVID‐19 pandemic in Ontario, Canada","year":2023,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"COVID-19 and healthcare impacts","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Sunnybrook Health Science Centre; Institute for Clinical Evaluative Sciences; Princess Margaret Cancer Centre; University of Toronto","funders":"Institute for Clinical Evaluative Sciences; Princess Margaret Cancer Foundation","keywords":"Medicine; Rituximab; Hazard ratio; Internal medicine; Regimen; Proportional hazards model; Retrospective cohort study; Pandemic; Population; Emergency department; Cohort; Neutropenia; Bendamustine; Lymphoma; Disease; Coronavirus disease 2019 (COVID-19); Chemotherapy; Confidence interval; Infectious disease (medical specialty)","score_opus":0.040712605719758654,"score_gpt":0.32196209625978983,"score_spread":0.2812494905400312,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4387966857","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98921144,0.0010334516,0.00008915973,0.0006580186,0.000013941941,0.0000628513,0.0067868754,0.000011448965,0.002132878],"genre_scores_gemma":[0.99727327,0.00046190197,0.00007412263,0.00016018828,0.000008363684,0.000020089592,0.0015882258,0.0000035408464,0.0004102838],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9990864,0.000061431696,0.000073386254,0.0001508473,0.0002337532,0.00039416426],"domain_scores_gemma":[0.99738246,0.00010326938,0.0010079134,0.00006713756,0.0007685311,0.00067069754],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004885582,0.00026503237,0.00040359347,0.00081643387,0.0019905157,0.0011111214,0.0008538301,0.00037574454,0.0014167407],"category_scores_gemma":[0.0016436959,0.00035133108,0.00050900993,0.0034438432,0.0006489902,0.00039146608,0.00071290816,0.00063434336,0.00012941728],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000071839684,0.000022295382,0.99596393,0.00003559634,0.00004021433,0.00008040561,0.00046102575,0.00012355433,0.0001265577,0.00005566513,0.0010156548,0.0020032215],"study_design_scores_gemma":[0.000012205238,0.00002540856,0.99828583,0.000032309414,0.000017366607,0.000059122776,0.0006279306,0.0001860694,0.000031647498,0.000014185434,0.00069945684,0.000008421408],"about_ca_topic_score_codex":0.9927199,"about_ca_topic_score_gemma":0.9948906,"teacher_disagreement_score":0.041585594,"about_ca_system_score_codex":0.041585594,"about_ca_system_score_gemma":0.035081606,"threshold_uncertainty_score":0.30172604},"labels":[],"label_agreement":null},{"id":"W4388459786","doi":"10.1111/bjh.19164","title":"Diagnosis and evaluation of prognosis of myelofibrosis: A British Society for Haematology Guideline","year":2023,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Queen's University; Queen's University Belfast; Wellcome Trust; Academy of Medical Sciences; European Hematology Association; National Institute for Health and Care Research; Cancer Research UK","keywords":"Medicine; Guideline; Myelofibrosis; MEDLINE; Grading (engineering); Family medicine; Polycythaemia; Clinical trial; Internal medicine; Pathology","score_opus":0.04995317493433869,"score_gpt":0.34855145415029,"score_spread":0.2985982792159513,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388459786","genre_codex":"review","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0027930844,0.6328888,0.019354116,0.22450472,0.01731698,0.004422626,0.013589267,0.0010167557,0.08411364],"genre_scores_gemma":[0.028265322,0.64931166,0.13812782,0.073579855,0.009728455,0.0075216834,0.038124062,0.00048107473,0.054860145],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9869016,0.0034139056,0.004843509,0.0004859809,0.0038553358,0.0004996965],"domain_scores_gemma":[0.9778755,0.0049326047,0.0020186428,0.0004303027,0.013846715,0.00089620065],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.011271068,0.0013364078,0.002931266,0.007208105,0.001057566,0.0034684173,0.0036877582,0.0049575428,0.007651708],"category_scores_gemma":[0.02994185,0.00085588475,0.0036566188,0.0045998944,0.0011738021,0.0025644274,0.00261825,0.005208234,0.008185362],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000104589264,0.00007491721,0.0011986754,0.011644271,0.0001560444,0.00042998898,0.00027044644,0.0005249971,0.00054951524,0.003411107,0.6611548,0.3204806],"study_design_scores_gemma":[0.00015127908,0.00007990762,0.0041239187,0.04111243,0.0003136597,0.0012071152,0.00015471525,0.00037162338,0.00022974593,0.004491188,0.9477076,0.000056903104],"about_ca_topic_score_codex":0.023933472,"about_ca_topic_score_gemma":0.03492396,"teacher_disagreement_score":0.023933472,"about_ca_system_score_codex":0.005123306,"about_ca_system_score_gemma":0.012211785,"threshold_uncertainty_score":0.059607863},"labels":[],"label_agreement":null},{"id":"W4389083699","doi":"10.1111/bjh.19214","title":"Early liver complications after allogeneic haematopoietic stem cell transplantation in patients with myelofibrosis: A study on behalf of the Chronic Malignancies Working Party of the <scp>EBMT</scp>","year":2023,"lang":"en","type":"letter","venue":"British Journal of Haematology","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Myelofibrosis; Haematopoiesis; Stem cell; Medicine; Transplantation; Hematopoietic stem cell transplantation; Internal medicine; Oncology; Biology; Bone marrow","score_opus":0.015941105747327575,"score_gpt":0.21995706357661698,"score_spread":0.2040159578292894,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389083699","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9987031,0.00059770903,0.000048253696,0.000022890501,0.000006105283,0.000029647888,0.0003218378,0.0000010696662,0.00026930077],"genre_scores_gemma":[0.99848074,0.0004351929,0.000067051624,0.000047428115,0.000046493653,0.000036887843,0.00073072524,0.0000018467451,0.00015371577],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99952173,0.00012530378,0.000086951484,0.00008727898,0.00011222479,0.00006652822],"domain_scores_gemma":[0.99838126,0.00024686047,0.00095742126,0.00008221486,0.00010980369,0.00022242534],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010109864,0.00024502535,0.0003512274,0.00054441974,0.00039148345,0.00058985554,0.0002624324,0.0002971352,0.001161322],"category_scores_gemma":[0.0016384451,0.0002691415,0.00043675676,0.0011392409,0.00027422764,0.00048628598,0.0005200665,0.0004964361,0.00020497132],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00040016606,0.00003735898,0.99767715,0.00003029522,0.00003450619,0.00013015585,0.000086204425,0.000016277341,0.00010436925,0.000015278816,0.00010569373,0.0013625661],"study_design_scores_gemma":[0.00005989043,0.00034714106,0.9981659,0.000035967394,0.000043633834,0.0006052114,0.00017312013,0.00006647804,0.000040734554,0.000016871796,0.00044110324,0.000003968065],"about_ca_topic_score_codex":0.0014295153,"about_ca_topic_score_gemma":0.0021954766,"teacher_disagreement_score":0.0014295153,"about_ca_system_score_codex":0.00029606294,"about_ca_system_score_gemma":0.0004950466,"threshold_uncertainty_score":0.005346656},"labels":[],"label_agreement":null},{"id":"W4389224369","doi":"10.1111/bjh.19186","title":"The management of myelofibrosis: A British Society for Haematology Guideline","year":2023,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Queen's University; Queen's University Belfast; Wellcome Trust; Academy of Medical Sciences; European Hematology Association; National Institute for Health and Care Research; Cancer Research UK","keywords":"Myelofibrosis; Guideline; Hematology; Medicine; Internal medicine; Intensive care medicine; Family medicine; Pathology","score_opus":0.018734447172604585,"score_gpt":0.3053347433035227,"score_spread":0.28660029613091814,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389224369","genre_codex":"review","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0021755863,0.58691454,0.012309605,0.26175952,0.018148301,0.0035300052,0.008408148,0.0008395884,0.105914734],"genre_scores_gemma":[0.020190757,0.69288385,0.09024881,0.094552524,0.009294837,0.0052109184,0.025805144,0.00043581802,0.061377347],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.98922825,0.002757005,0.0033717765,0.00038760123,0.0037753107,0.00048001762],"domain_scores_gemma":[0.9853168,0.0033033164,0.0014491043,0.00031038694,0.008648106,0.00097218977],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.009385149,0.0010891494,0.002108043,0.0060801785,0.0010784905,0.0035198946,0.0029746564,0.0053315856,0.009430257],"category_scores_gemma":[0.02366175,0.0007087279,0.0024556315,0.0050001987,0.001140602,0.0023095962,0.0022791668,0.006198169,0.008177871],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000057496618,0.000072354866,0.0004616669,0.006090122,0.00006183258,0.00035279308,0.00024572972,0.00037039383,0.00040220938,0.0034731808,0.7400873,0.24832502],"study_design_scores_gemma":[0.00008154102,0.000041180527,0.001406006,0.017752845,0.00008437294,0.00076132227,0.000093620096,0.00014363056,0.00011124947,0.0025675977,0.9769288,0.000027816825],"about_ca_topic_score_codex":0.022379143,"about_ca_topic_score_gemma":0.033511184,"teacher_disagreement_score":0.022379143,"about_ca_system_score_codex":0.005302313,"about_ca_system_score_gemma":0.015545953,"threshold_uncertainty_score":0.04963404},"labels":[],"label_agreement":null},{"id":"W4389608524","doi":"10.1111/bjh.19257","title":"Evidence creation for myelofibrosis: Challenges and opportunities","year":2023,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Myelofibrosis; Medicine; Hematology; Guideline; Intensive care medicine; Internal medicine; Pathology; Bone marrow","score_opus":0.17640818437281713,"score_gpt":0.34452391725671927,"score_spread":0.16811573288390214,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389608524","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000058379683,0.048612975,0.0013687902,0.9332296,0.015895689,0.000047841306,0.00007685429,0.00002971806,0.00068012346],"genre_scores_gemma":[0.0074383495,0.10605229,0.022033306,0.76735175,0.09476809,0.00065479416,0.00030162744,0.00014741239,0.0012523505],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.7362545,0.17855194,0.035927556,0.009929359,0.034044318,0.0052923057],"domain_scores_gemma":[0.120597,0.7662877,0.014775115,0.013410049,0.07069039,0.014239689],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.27119622,0.002328902,0.008399317,0.0100764455,0.005803093,0.022000702,0.013162433,0.054795753,0.019974705],"category_scores_gemma":[0.6367827,0.002517041,0.009740523,0.0062791905,0.0238434,0.04569794,0.020685125,0.063955314,0.006113978],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00030593798,0.000089721696,0.00039627278,0.021386582,0.0006688449,0.0006095925,0.0020383915,0.0008188773,0.00015874072,0.08828148,0.6876795,0.1975661],"study_design_scores_gemma":[0.0003592934,0.00013531192,0.00043760397,0.12181965,0.00037227586,0.0007741319,0.0016172484,0.0008926967,0.00013055158,0.24770835,0.6255123,0.00024047768],"about_ca_topic_score_codex":0.011564362,"about_ca_topic_score_gemma":0.017016284,"teacher_disagreement_score":0.27119622,"about_ca_system_score_codex":0.021873062,"about_ca_system_score_gemma":0.08384957,"threshold_uncertainty_score":0.8987448},"labels":[],"label_agreement":null},{"id":"W4389628406","doi":"10.1111/bjh.19246","title":"Cognitive decline in thrombotic thrombocytopenic purpura survivors: The role of white matter health as assessed by <scp>MRI</scp>","year":2023,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Complement system in diseases","field":"Immunology and Microbiology","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Lawson Health Research Institute; St. Michael's Hospital; University Health Network; Western University","funders":"Physicians' Services Incorporated Foundation","keywords":"Neurocognitive; Neuropsychology; Hyperintensity; Depression (economics); Medicine; Internal medicine; Cardiology; White matter; Cognitive decline; Anterior cingulate cortex; Magnetic resonance imaging; Cognition; Psychology; Psychiatry; Radiology; Disease","score_opus":0.013546551378534152,"score_gpt":0.2885804475056531,"score_spread":0.2750338961271189,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389628406","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9993845,0.00028500694,0.000021817603,0.000029879286,0.0000024829749,0.0000031293712,0.00002391232,0.0000016478176,0.0002476122],"genre_scores_gemma":[0.9997156,0.00010833413,0.000023729703,0.000015678153,0.000009201632,0.000002248637,0.0000427709,6.195587e-7,0.00008179454],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9999263,0.00002304256,0.0000075740163,0.000012007669,0.0000139276535,0.000017041],"domain_scores_gemma":[0.9995449,0.00008678979,0.00019037108,0.000023782102,0.00004218891,0.00011187241],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002873868,0.00023100969,0.00025913873,0.00044016927,0.0002419095,0.00035436335,0.00017478349,0.00031664543,0.0007095521],"category_scores_gemma":[0.0012902035,0.00007897739,0.00010218851,0.00027730165,0.00027705426,0.0002562218,0.00021196032,0.00027407892,0.00013526181],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016930338,0.00024181265,0.97392684,0.00004608535,0.00011545167,0.00106687,0.0004174609,0.000098692966,0.002281914,0.00001920158,0.00017361424,0.019919135],"study_design_scores_gemma":[0.000009354106,0.00046979607,0.99852437,0.000005445706,0.000020728086,0.00061415933,0.000099192584,0.000075327865,0.00008117062,0.00002314757,0.00007512125,0.00000226562],"about_ca_topic_score_codex":0.0018991331,"about_ca_topic_score_gemma":0.002006392,"teacher_disagreement_score":0.0018991331,"about_ca_system_score_codex":0.0001441364,"about_ca_system_score_gemma":0.000097012664,"threshold_uncertainty_score":0.003776133},"labels":[],"label_agreement":null},{"id":"W4389742255","doi":"10.1111/bjh.19248","title":"Blood pressure thresholds for the diagnosis of hypertensive disorders of pregnancy in sickle cell disease","year":2023,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Lunenfeld-Tanenbaum Research Institute; Sinai Health System; University of Toronto; University Health Network","funders":"National Institute of Mental Health; National Institutes of Health; American Society of Hematology; National Heart, Lung, and Blood Institute; NHLBI Division of Intramural Research; Doris Duke Charitable Foundation","keywords":"Medicine; Blood pressure; Pregnancy; Proteinuria; Receiver operating characteristic; Internal medicine; Preeclampsia; Population; Cohort; Disease; Cardiology; Diastole; Eclampsia; Obstetrics; Pediatrics","score_opus":0.011915885176225341,"score_gpt":0.24638468028871924,"score_spread":0.2344687951124939,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389742255","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9961515,0.0009969374,0.0006480962,0.00010775114,0.000028678707,0.000027766046,0.0011994904,0.000020380088,0.0008192289],"genre_scores_gemma":[0.9988527,0.00010230283,0.00039871465,0.0000336929,0.000014599391,0.0000329249,0.00048234605,0.0000043718837,0.00007830967],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99756986,0.0009944342,0.0003496773,0.00035054225,0.0005465303,0.00018891554],"domain_scores_gemma":[0.9947937,0.0015774769,0.0025236246,0.0003046545,0.000363863,0.000436778],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0023904433,0.00033737082,0.0005421868,0.0012105602,0.00035829522,0.00075087656,0.00053791946,0.000777881,0.0008646099],"category_scores_gemma":[0.007668233,0.0004093058,0.0006365017,0.0012550098,0.00028620719,0.0004993489,0.00048915047,0.0010276791,0.00026860318],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000082345134,0.000008224024,0.9990644,0.0000065452373,0.00002298597,0.000054423435,0.00003150589,0.00003211133,0.00009973069,0.000010896964,0.000070294955,0.00051647093],"study_design_scores_gemma":[0.0000070673277,0.00006779489,0.99896216,0.000008585017,0.00002297783,0.0003430062,0.00003689486,0.00029604053,0.00009274464,0.000030075224,0.00012861738,0.000004069377],"about_ca_topic_score_codex":0.0038183737,"about_ca_topic_score_gemma":0.0034129932,"teacher_disagreement_score":0.0038183737,"about_ca_system_score_codex":0.00044093694,"about_ca_system_score_gemma":0.00039060533,"threshold_uncertainty_score":0.012642026},"labels":[],"label_agreement":null},{"id":"W4390561560","doi":"10.1111/bjh.19243","title":"Mental health, pain and likelihood of opioid misuse among adults with sickle cell disease","year":2024,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute for Work & Health; Institute for Clinical Evaluative Sciences; SickKids Foundation; Hospital for Sick Children; University of Toronto","funders":"H2020 European Research Council; National Institute of Mental Health; National Institute of Nursing Research; University of Pittsburgh; Patient-Centered Outcomes Research Institute","keywords":"Medicine; Pain catastrophizing; Mood; Quality of life (healthcare); Depression (economics); Anxiety; Chronic pain; Patient Health Questionnaire; Brief Pain Inventory; Opioid; Physical therapy; Cohort; Psychiatry; Internal medicine; Depressive symptoms","score_opus":0.003023397402571859,"score_gpt":0.21802772436894566,"score_spread":0.2150043269663738,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4390561560","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9993492,0.0002487378,0.000015731528,0.000044489105,0.0000031699237,0.000005704927,0.00014961328,6.0021665e-7,0.0001827098],"genre_scores_gemma":[0.9995103,0.00011103957,0.000026588696,0.00004572666,0.000007451031,0.0000059690274,0.00018655507,3.2941327e-7,0.0001058847],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.999683,0.00011284825,0.000048252972,0.00003755409,0.000070870214,0.00004748115],"domain_scores_gemma":[0.99924254,0.00013092147,0.00038917366,0.000036488684,0.00007078935,0.00013012259],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005327452,0.00011171017,0.0002552426,0.00031196675,0.00025465025,0.00048401605,0.00012506626,0.00037006135,0.0010963095],"category_scores_gemma":[0.0020306865,0.000179216,0.0003262824,0.00036089148,0.00015035507,0.00029749153,0.00034282068,0.0004748948,0.00014137386],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010937949,0.00004648522,0.9986272,0.000008279939,0.000037033515,0.000020252342,0.000049431565,0.000013212075,0.00007829296,0.000005286536,0.000059497645,0.00094566453],"study_design_scores_gemma":[0.000007233195,0.00010264137,0.9996363,0.000004766319,0.0000116255615,0.000068799316,0.000069459034,0.000039481005,0.000009681837,0.000006412816,0.00004225752,0.000001219723],"about_ca_topic_score_codex":0.0032969085,"about_ca_topic_score_gemma":0.0057496005,"teacher_disagreement_score":0.0032969085,"about_ca_system_score_codex":0.00014959999,"about_ca_system_score_gemma":0.00012455962,"threshold_uncertainty_score":0.006555438},"labels":[],"label_agreement":null},{"id":"W4391104484","doi":"10.1111/bjh.19295","title":"New standards of care for treatment of diffuse large B‐cell lymphoma","year":2024,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"National Health and Medical Research Council; Victorian Cancer Agency","keywords":"Guideline; Medicine; Rituximab; Diffuse large B-cell lymphoma; Lymphoma; Hematology; Internal medicine; Clinical trial; CHOP; Oncology; Intensive care medicine; Pediatrics; Pathology","score_opus":0.009537349733890525,"score_gpt":0.2938472672033778,"score_spread":0.28430991746948725,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4391104484","genre_codex":"commentary","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"editorial","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00016995595,0.039863262,0.0015682698,0.86052823,0.088542275,0.00011994227,0.00067233597,0.00014700665,0.008388734],"genre_scores_gemma":[0.0026650466,0.035449147,0.005326793,0.89045936,0.057125535,0.000520649,0.0011535236,0.000102192564,0.0071976683],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9643118,0.013127883,0.0061846385,0.0016346275,0.012512929,0.0022280565],"domain_scores_gemma":[0.90944284,0.0321885,0.006538724,0.0024584383,0.044633854,0.0047375825],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.019558245,0.001548514,0.0028207237,0.0027143194,0.0022246821,0.00433317,0.0071291737,0.033941887,0.0098827155],"category_scores_gemma":[0.09183764,0.0010451783,0.0057773753,0.0027525641,0.00418227,0.006778506,0.0037855906,0.04496539,0.009905094],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007533618,0.000035936337,0.00010383314,0.0014144428,0.00006252478,0.00011648439,0.00010252943,0.00017744886,0.00019000427,0.0072116666,0.9603025,0.030207293],"study_design_scores_gemma":[0.00024776722,0.00008119725,0.0010190218,0.009139716,0.00012970013,0.000302588,0.00013320953,0.00019495678,0.0001429758,0.013299939,0.9752337,0.00007518462],"about_ca_topic_score_codex":0.01853783,"about_ca_topic_score_gemma":0.033573728,"teacher_disagreement_score":0.033941887,"about_ca_system_score_codex":0.008543624,"about_ca_system_score_gemma":0.019023553,"threshold_uncertainty_score":0.10343516},"labels":[],"label_agreement":null},{"id":"W4391213043","doi":"10.1111/bjh.19298","title":"Past meets present: Reviving 80‐year‐old Canadian dried serum from World War <scp>II</scp> and its significance in advancing modern freeze‐dried plasma for prehospital management of haemorrhage","year":2024,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Trauma, Hemostasis, Coagulopathy, Resuscitation","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McMaster University; Thrombosis and Atherosclerosis Research Institute; Defence Research and Development Canada; University of Toronto; Canadian Armed Forces; St. Michael's Hospital","funders":"University of Toronto; Canadian Blood Services; Defence Research and Development Canada","keywords":"Resuscitation; Fresh frozen plasma; Medicine; Albumin; Saline; Blood clotting; Intensive care medicine; Surgery; Internal medicine; Platelet","score_opus":0.013647383193896856,"score_gpt":0.2558194531407312,"score_spread":0.24217206994683432,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4391213043","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.6521888,0.16467755,0.011349181,0.08555847,0.009186219,0.00029388795,0.0022925984,0.00061461894,0.07383868],"genre_scores_gemma":[0.88505554,0.039581545,0.022993034,0.013693065,0.0008470431,0.000044513097,0.001782454,0.0002985706,0.035704266],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99907434,0.00009100127,0.000032785738,0.00008785156,0.0005614979,0.00015246561],"domain_scores_gemma":[0.9982886,0.00009361547,0.00011044776,0.00007771016,0.0010977178,0.00033198617],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0028847503,0.00032425157,0.00021069877,0.00080660766,0.002802342,0.002697564,0.0010537816,0.00076503307,0.0028653243],"category_scores_gemma":[0.0031983168,0.00010380491,0.00027754816,0.0008517234,0.001728198,0.0010211247,0.00081166445,0.00079884595,0.0005969452],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0024142703,0.00031696906,0.04306172,0.0014595147,0.00013366873,0.0029434618,0.009313502,0.0011089419,0.19709837,0.016647642,0.12569676,0.59980524],"study_design_scores_gemma":[0.00004743847,0.0004556719,0.050789636,0.00050912664,0.0001176696,0.0028055215,0.0035066241,0.0007218391,0.077948034,0.0017470105,0.86122936,0.00012216628],"about_ca_topic_score_codex":0.6128558,"about_ca_topic_score_gemma":0.69224983,"teacher_disagreement_score":0.3871442,"about_ca_system_score_codex":0.011870162,"about_ca_system_score_gemma":0.014268272,"threshold_uncertainty_score":0.77884835},"labels":[],"label_agreement":null},{"id":"W4391282252","doi":"10.1111/bjh.19308","title":"Variant <scp>ALK</scp>‐fusion positive anaplastic large cell lymphoma (<scp>ALCL</scp>): A population‐based paediatric study of the <scp>NHL‐BFM</scp> study group","year":2024,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; McMaster Children's Hospital","funders":"Deutsche Kinderkrebsstiftung","keywords":"Anaplastic large-cell lymphoma; Anaplastic lymphoma kinase; NPM1; Lymphoma; Fusion gene; Population; Medicine; Cancer research; Oncology; Biology; Internal medicine; Gene; Genetics","score_opus":0.008075213031464162,"score_gpt":0.24370080411177006,"score_spread":0.2356255910803059,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4391282252","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9994368,0.000091867085,0.000059554855,0.000011768409,0.0000017674133,0.00000868716,0.00022617079,0.0000024090496,0.00016101125],"genre_scores_gemma":[0.99909663,0.00012345043,0.000072416384,0.0000173464,0.0000068629997,0.000018306186,0.00055678777,0.0000031313593,0.000105008],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9992436,0.0002193863,0.00008004925,0.00020303059,0.00017016663,0.00008369048],"domain_scores_gemma":[0.99929714,0.00015375139,0.00025912301,0.00007284691,0.00006574037,0.00015136047],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00057045405,0.00029160126,0.0003902209,0.00087060966,0.00047215927,0.0007526213,0.00035059682,0.00045394685,0.0014655482],"category_scores_gemma":[0.0016483881,0.00044940412,0.0003186806,0.0010206744,0.0005459904,0.00059491355,0.0007819061,0.00046628056,0.0004303616],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012168731,0.00003080439,0.99717015,0.000013681548,0.000032450953,0.00045654204,0.00015607804,0.000032376083,0.0005910837,0.000022682325,0.00013671367,0.0012357838],"study_design_scores_gemma":[0.000033699052,0.00028722125,0.99233115,0.000010918113,0.000035076442,0.006003669,0.0003528131,0.00012171543,0.00026503502,0.000034573823,0.00051890546,0.000005238383],"about_ca_topic_score_codex":0.0024006811,"about_ca_topic_score_gemma":0.0023005118,"teacher_disagreement_score":0.0024006811,"about_ca_system_score_codex":0.0003563124,"about_ca_system_score_gemma":0.00027927774,"threshold_uncertainty_score":0.00490278},"labels":[],"label_agreement":null},{"id":"W4392168815","doi":"10.1111/bjh.19299","title":"Correlation of T‐cell receptor constant beta‐chain 1 by flow cytometry with molecular T‐cell receptor clonality for the investigation of T‐cell lymphoproliferation","year":2024,"lang":"en","type":"letter","venue":"British Journal of Haematology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Institute of Cancer Research","keywords":"Foundation (evidence); Medicine; Editorial board; Library science; Family medicine; Law; Political science; Computer science","score_opus":0.010241620617665053,"score_gpt":0.23256297959925865,"score_spread":0.22232135898159358,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4392168815","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.25485843,0.008191569,0.0108712595,0.6221954,0.023418827,0.0005931022,0.0006631935,0.0004990246,0.07870917],"genre_scores_gemma":[0.81711835,0.0038822053,0.007107897,0.115856946,0.027914902,0.0005344718,0.00030398215,0.00019055525,0.027090663],"study_design_codex":"case_report","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9983479,0.0005951786,0.00023909954,0.00015383463,0.00043481204,0.0002291775],"domain_scores_gemma":[0.9931942,0.005391497,0.00017125685,0.00027775025,0.00063191523,0.00033346657],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016664966,0.000552077,0.0007146431,0.0009401803,0.0009738801,0.0011451637,0.0010622587,0.008790607,0.0047386694],"category_scores_gemma":[0.009078729,0.00050772366,0.0004574358,0.00037701777,0.0016424655,0.0014239908,0.00038554374,0.008813092,0.0028315913],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0043871314,0.000993919,0.057142347,0.0008096379,0.00015138178,0.35386848,0.0016958152,0.0014056542,0.07636833,0.01390262,0.34169835,0.1475764],"study_design_scores_gemma":[0.00086993206,0.0022788928,0.06808377,0.00048580574,0.00016823663,0.51982176,0.0012798617,0.02348615,0.03576461,0.02780073,0.319742,0.00021820598],"about_ca_topic_score_codex":0.00092824816,"about_ca_topic_score_gemma":0.0012089119,"teacher_disagreement_score":0.008790607,"about_ca_system_score_codex":0.0014424517,"about_ca_system_score_gemma":0.0004771147,"threshold_uncertainty_score":0.015852392},"labels":[],"label_agreement":null},{"id":"W4392297809","doi":"10.1111/bjh.19346","title":"Impact of elranatamab on quality of life: Patient‐reported outcomes from <scp>MagnetisMM</scp>‐3","year":2024,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Cancer Foundation; University of Calgary","funders":"Pfizer","keywords":"Medicine; Multiple myeloma; Quality of life (healthcare); Disease; Internal medicine; Physical therapy","score_opus":0.046974038907692715,"score_gpt":0.36968905573581284,"score_spread":0.32271501682812015,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4392297809","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99833614,0.00059302687,0.000046980917,0.000051897066,0.0000048728534,0.000026161115,0.00044839748,0.0000045527713,0.00048809397],"genre_scores_gemma":[0.9989956,0.00012805976,0.000042904143,0.000047198202,0.000009339982,0.000025242858,0.0006365963,9.090302e-7,0.000114239534],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9995322,0.00022462828,0.000036449244,0.00004138836,0.00010075799,0.00006455532],"domain_scores_gemma":[0.99921346,0.00020848881,0.00034548077,0.000034398963,0.000058643323,0.00013961321],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001320186,0.0002173027,0.0004303181,0.000235502,0.00015399438,0.00044960075,0.00019254944,0.00025789771,0.00090632343],"category_scores_gemma":[0.0010361592,0.00006679814,0.0007657818,0.00035483867,0.00015340098,0.000273429,0.00030408375,0.0005153197,0.00012685709],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.067546755,0.0035509148,0.7881221,0.0004034078,0.0023383151,0.0002532025,0.00032746364,0.0023728968,0.007099883,0.000081968916,0.0019577025,0.1259454],"study_design_scores_gemma":[0.0018590912,0.016775096,0.97670865,0.0000280135,0.00056085776,0.00029473516,0.00009491497,0.0013210014,0.0013288917,0.000049357273,0.00095983484,0.000019516925],"about_ca_topic_score_codex":0.00075170485,"about_ca_topic_score_gemma":0.0012106553,"teacher_disagreement_score":0.001320186,"about_ca_system_score_codex":0.0002962394,"about_ca_system_score_gemma":0.00021787718,"threshold_uncertainty_score":0.0069819093},"labels":[],"label_agreement":null},{"id":"W4392788581","doi":"10.1111/bjh.19314","title":"Venetoclax resistance in acute myeloid leukaemia—Clinical and biological insights","year":2024,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Venetoclax; Medicine; Myeloid leukemia; Clinical trial; Oncology; Immunology; Internal medicine; Leukemia; Chronic lymphocytic leukemia","score_opus":0.03499079100878444,"score_gpt":0.3486252767249856,"score_spread":0.3136344857162012,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4392788581","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0058113984,0.9908501,0.00028518616,0.00089443976,0.000102965874,0.000010239308,0.00003310188,0.000011314506,0.0020013016],"genre_scores_gemma":[0.058494143,0.9377538,0.000718178,0.0006487337,0.0006392232,0.000021386204,0.00013153581,0.000004134427,0.0015889863],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9999143,0.00002413719,0.000010672058,0.000013233899,0.000024342258,0.000013310146],"domain_scores_gemma":[0.9998807,0.00004942682,0.000026387708,0.0000053723193,0.000024514906,0.000013617093],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004542438,0.0001866444,0.00035018945,0.00056255335,0.000095672665,0.00055484707,0.00026219257,0.00039274408,0.0013569212],"category_scores_gemma":[0.00031961346,0.00007974583,0.00018584103,0.00051169767,0.00019484675,0.00047849014,0.00021459884,0.0007456938,0.0003639884],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005950533,0.00022675317,0.0026324594,0.005720978,0.00007264746,0.0011700088,0.00013938983,0.0005605784,0.021666711,0.0056040897,0.009015078,0.9525963],"study_design_scores_gemma":[0.0003531388,0.0037302366,0.019826999,0.002838204,0.00043081693,0.023717524,0.00022267556,0.0013708214,0.015113885,0.010150225,0.9221918,0.000053593616],"about_ca_topic_score_codex":0.00022184345,"about_ca_topic_score_gemma":0.00050370104,"teacher_disagreement_score":0.0013569212,"about_ca_system_score_codex":0.000255672,"about_ca_system_score_gemma":0.00027380727,"threshold_uncertainty_score":0.0045393705},"labels":[],"label_agreement":null},{"id":"W4394921808","doi":"10.1111/bjh.19470","title":"Primary gastric diffuse large B‐cell lymphoma: A multicentre retrospective study","year":2024,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Spinal Cord Injury BC; University of British Columbia","funders":"BeiGene; Regeneron Pharmaceuticals; CSL Behring; AstraZeneca; Celgene; Gilead Sciences; Bristol-Myers Squibb; TG Therapeutics; Amgen","keywords":"Medicine; Vincristine; Rituximab; Internal medicine; CHOP; Diffuse large B-cell lymphoma; Oncology; Prednisolone; Radiation therapy; Chemoimmunotherapy; Gastroenterology; Retrospective cohort study; Cyclophosphamide; Lymphoma; Surgery; Chemotherapy","score_opus":0.007356814304960758,"score_gpt":0.2515189810320495,"score_spread":0.24416216672708874,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4394921808","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9989195,0.0005615241,0.00006712448,0.000018904911,0.0000033731342,0.00003421139,0.00014808023,0.0000019508095,0.00024544736],"genre_scores_gemma":[0.99924064,0.0002682773,0.00006362441,0.000049232225,0.000010849316,0.000024970983,0.00024386495,0.0000023616756,0.00009625304],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9990281,0.00022868281,0.0001448316,0.00030253798,0.00014507685,0.00015076916],"domain_scores_gemma":[0.9987116,0.0002318533,0.00042400102,0.00017519208,0.00017099801,0.0002864112],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008281451,0.00044315954,0.0007284988,0.0009410931,0.000700083,0.0009687302,0.00042641774,0.00054230384,0.001790991],"category_scores_gemma":[0.0016304386,0.00070108153,0.0005247031,0.001617643,0.00055677886,0.0006250541,0.00085053523,0.00040729172,0.0005765411],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002910861,0.0000811544,0.9959818,0.00006218682,0.00009090769,0.0014947634,0.00034213255,0.000025920874,0.00035991363,0.000019103723,0.000100874495,0.0011500289],"study_design_scores_gemma":[0.00007795611,0.000659035,0.9904683,0.000032912507,0.00015063192,0.006546704,0.0010399512,0.00010939044,0.00007187716,0.000028099521,0.0008022341,0.000012845639],"about_ca_topic_score_codex":0.0042285826,"about_ca_topic_score_gemma":0.0049027293,"teacher_disagreement_score":0.0042285826,"about_ca_system_score_codex":0.0006867736,"about_ca_system_score_gemma":0.0006377131,"threshold_uncertainty_score":0.00840795},"labels":[],"label_agreement":null},{"id":"W4395045220","doi":"10.1111/bjh.19484","title":"Diagnostic delay of <scp><i>MYH9</i></scp>‐related disorder in Japan","year":2024,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Immunodeficiency and Autoimmune Disorders","field":"Immunology and Microbiology","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hatch (Canada)","funders":"","keywords":"Medicine; Internal medicine; Chemistry","score_opus":0.004446911528493551,"score_gpt":0.2155602980445826,"score_spread":0.21111338651608905,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4395045220","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99908316,0.0003296878,0.000067753914,0.000064494816,0.000009418076,0.0000028727345,0.00008493173,0.0000037774673,0.0003538621],"genre_scores_gemma":[0.99957556,0.00015144495,0.00007242423,0.000026231068,0.0000115462435,0.0000024835795,0.0001126573,0.0000016231563,0.000046054083],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99948704,0.00009785877,0.00010149903,0.00012683532,0.00005872106,0.0001279628],"domain_scores_gemma":[0.9980367,0.00032009615,0.0009223391,0.00009249239,0.00024635042,0.0003820897],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005196906,0.00020785457,0.0003098687,0.0008291008,0.0004891479,0.00054930453,0.0002900527,0.00029939704,0.0009833163],"category_scores_gemma":[0.002822814,0.00022455293,0.00018823304,0.0007361125,0.00031882766,0.00052651897,0.0004939752,0.00047046327,0.00019775817],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000036986134,0.000006933151,0.9968569,0.000007105205,0.000005749752,0.0009720703,0.0002298959,0.000014292657,0.00029890405,0.000016047123,0.00010825381,0.0014467916],"study_design_scores_gemma":[0.0000041538965,0.00004485657,0.99339736,0.000014534713,0.000019322915,0.005119221,0.00070173736,0.00010583496,0.00015917403,0.000026679154,0.00040090183,0.000006275249],"about_ca_topic_score_codex":0.012051815,"about_ca_topic_score_gemma":0.009325753,"teacher_disagreement_score":0.012051815,"about_ca_system_score_codex":0.00042237743,"about_ca_system_score_gemma":0.00047726207,"threshold_uncertainty_score":0.023963332},"labels":[],"label_agreement":null},{"id":"W4395670257","doi":"10.1111/bjh.19397","title":"Oral Abstracts","year":2024,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Pharmaceutical studies and practices","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Perelman School of Medicine, University of Pennsylvania; Barts Health NHS Trust; Irving Medical Center, Columbia University; Assistance publique-Hôpitaux de Paris; University College London Hospitals NHS Foundation Trust; Hospital for Sick Children; Università Cattolica del Sacro Cuore; Universität Regensburg; National and Kapodistrian University of Athens; Eberhard Karls Universität Tübingen; Imperial College London; Imperial College Healthcare NHS Trust; Ospedale Pediatrico Bambino Gesù; Medizinische Fakultät, Heinrich-Heine-Universität Düsseldorf; University of Pennsylvania; Università degli Studi di Milano; University College London; University of Toronto; University of Illinois at Urbana-Champaign; BC Children's Hospital; Vertex Pharmaceuticals; University of California, San Francisco; Children's Hospital of Philadelphia","keywords":"Medicine","score_opus":0.05628692762392688,"score_gpt":0.39107500764995873,"score_spread":0.33478808002603183,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4395670257","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00096123054,0.007380861,0.0021466855,0.015908768,0.060318254,0.0007575214,0.009642651,0.0015157056,0.9013684],"genre_scores_gemma":[0.0049324417,0.005949278,0.0015171337,0.0059243995,0.010903193,0.00040936968,0.006572053,0.0008468205,0.9629452],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9981694,0.0002762354,0.0001628911,0.00025526312,0.0009384971,0.00019771104],"domain_scores_gemma":[0.99595296,0.0005679887,0.00020012364,0.00048122887,0.0020367333,0.0007608992],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0016377659,0.0011950686,0.0010827024,0.00245528,0.002046353,0.0076728133,0.0023240303,0.003255009,0.81674564],"category_scores_gemma":[0.008793736,0.0005144287,0.0012228453,0.0018441508,0.0006981502,0.0035246524,0.0035063063,0.002689498,0.6085244],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000048788766,0.000033453038,0.00008238937,0.000402659,0.0000054136426,0.00012188256,0.000060112878,0.000041123774,0.00014103045,0.0022304854,0.9359261,0.06090661],"study_design_scores_gemma":[0.000010438289,0.000014772561,0.00016480888,0.00024356338,0.0000032423945,0.00012241694,0.00008938014,0.000017209366,0.000067424706,0.0009027841,0.998359,0.000005006444],"about_ca_topic_score_codex":0.002392425,"about_ca_topic_score_gemma":0.0029844558,"teacher_disagreement_score":0.18325436,"about_ca_system_score_codex":0.0021789602,"about_ca_system_score_gemma":0.0034573511,"threshold_uncertainty_score":0.26139003},"labels":[],"label_agreement":null},{"id":"W4396642541","doi":"10.1111/bjh.19501","title":"Diagnosis of systemic mastocytosis with cryptic deletion of <scp>TET2</scp> and <scp>DNMT3A</scp> resulting from unbalanced translocation","year":2024,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Mast cells and histamine","field":"Immunology and Microbiology","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Michael's Hospital; Health Sciences Centre; University of Toronto; Western University; Sunnybrook Health Science Centre","funders":"","keywords":"Chromosomal translocation; Gain of function; Systemic mastocytosis; Mutation; Function (biology); Biology; Neoplasm; Immunologic function; Genetics; Cancer research; Immunology; Gene; Immune system","score_opus":0.00760221591256105,"score_gpt":0.20598042527168486,"score_spread":0.1983782093591238,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4396642541","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9754262,0.0034658867,0.0046780924,0.0031374537,0.000283456,0.0003655046,0.00048360365,0.00017945639,0.011980285],"genre_scores_gemma":[0.997095,0.00067922205,0.00088736106,0.00046569234,0.00022872121,0.000014633055,0.000100659454,0.000008711861,0.0005200572],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.99970835,0.000035519526,0.000025062804,0.00006768958,0.00006996127,0.000093451985],"domain_scores_gemma":[0.99958855,0.00010090484,0.00005689956,0.000016158574,0.000031722542,0.000205723],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002624822,0.00082282926,0.00070730894,0.0011875808,0.0005354724,0.00044644385,0.00062426645,0.002237124,0.0019725142],"category_scores_gemma":[0.0011065729,0.0003955096,0.00032605382,0.0005216512,0.00058337214,0.00086913136,0.0007814688,0.0013335453,0.0004901626],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016299497,0.000036508132,0.025965108,0.000069436755,0.0000075065186,0.9605798,0.00012535826,0.00009901695,0.007439644,0.0002558589,0.00070061325,0.004558132],"study_design_scores_gemma":[0.000029535007,0.00024095924,0.032709874,0.00002791051,0.000014638022,0.96330917,0.00012156851,0.0005997337,0.0015057677,0.00031127207,0.0011167873,0.000012818116],"about_ca_topic_score_codex":0.00084062456,"about_ca_topic_score_gemma":0.000926779,"teacher_disagreement_score":0.002237124,"about_ca_system_score_codex":0.0004119643,"about_ca_system_score_gemma":0.00041402216,"threshold_uncertainty_score":0.0065987706},"labels":[],"label_agreement":null},{"id":"W4396847734","doi":"10.1111/bjh.19497","title":"Atrial arrhythmias following <scp>CAR‐chimeric</scp> antigen receptor T‐cell therapy: Incidence, risk factors and biomarker profile","year":2024,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba","funders":"National Cancer Institute; Swim Across America; National Institutes of Health; Memorial Sloan-Kettering Cancer Center","keywords":"Medicine; Chimeric antigen receptor; Atrial fibrillation; Internal medicine; Cardiotoxicity; Cardiology; Cancer; Immunotherapy; Chemotherapy","score_opus":0.02320608738721138,"score_gpt":0.30156380719973097,"score_spread":0.2783577198125196,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4396847734","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.998782,0.0005266251,0.00018251385,0.000026285012,0.000002481345,0.0000061587434,0.00010339634,0.0000063779266,0.00036420565],"genre_scores_gemma":[0.999506,0.00015365393,0.00008907355,0.000022007545,0.000011689235,0.0000039090974,0.00015688901,0.0000020510365,0.000054864482],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9994548,0.00013920043,0.00008202979,0.000114978495,0.00013950252,0.00006948936],"domain_scores_gemma":[0.99677557,0.0006871004,0.0019455446,0.00015079636,0.00016349973,0.00027754268],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00058583415,0.00011937389,0.0003082499,0.00036664167,0.00014632926,0.0005662609,0.00016352317,0.00031911902,0.00084709184],"category_scores_gemma":[0.001961418,0.000083446605,0.00028837236,0.00058796,0.0002075838,0.00026320017,0.00021262262,0.00034961954,0.00020062199],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00031866846,0.00003177797,0.9925236,0.000014299692,0.000038229256,0.000348691,0.000029851986,0.000096701806,0.0013389677,0.000023234365,0.00005325566,0.0051827533],"study_design_scores_gemma":[0.000012302913,0.00048161994,0.9945856,0.000006753119,0.000042642252,0.0035821556,0.0000658293,0.00035843306,0.00056617125,0.000047286907,0.00024617775,0.0000050770914],"about_ca_topic_score_codex":0.00035549505,"about_ca_topic_score_gemma":0.0003359668,"teacher_disagreement_score":0.00084709184,"about_ca_system_score_codex":0.00017575965,"about_ca_system_score_gemma":0.0001996088,"threshold_uncertainty_score":0.0030982494},"labels":[],"label_agreement":null},{"id":"W4399032715","doi":"10.1111/bjh.19569","title":"Outcomes of patients with secondary central nervous system lymphoma treated with chimeric antigen receptor T‐cell therapy: A <scp>CIBMTR</scp> analysis","year":2024,"lang":"en","type":"letter","venue":"British Journal of Haematology","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Cancer Moonshot; Moonshot Research and Development Program; National Institute of Environmental Health Sciences; National Institute of Allergy and Infectious Diseases; Office of Naval Research; Legend Biotech; Alexion Pharmaceuticals; bluebird bio; Pharmacyclics; Takeda Oncology; AstraZeneca; Genentech; Adaptive Biotechnologies; Health Resources and Services Administration; National Institutes of Health; MorphoSys; Seagen; Pediatric Blood and Marrow Transplant Consortium; Pediatric Transplantation and Cellular Therapy Consortium; CareDx; BeiGene; Juno Therapeutics; Swedish Orphan Biovitrum; Astellas Pharma; GlaxoSmithKline; Kiadis Pharma; Jazz Pharmaceuticals; Medical College of Wisconsin; Gateway for Cancer Research; Celgene; Omeros Corporation; Vertex Pharmaceuticals; Atara Biotherapeutics; Actinium Pharmaceuticals; National Cancer Institute; Gilead Sciences; CSL Behring; Bristol-Myers Squibb; Eli Lilly and Company; National Marrow Donor Program; Mallinckrodt Pharmaceuticals; Astellas Pharma US; National Heart, Lung, and Blood Institute; Novartis Pharmaceuticals Corporation; Incyte; Pfizer; Amgen; Sanofi; HistoGenetics","keywords":"Chimeric antigen receptor; Medicine; Central nervous system; Lymphoma; Antigen; Receptor; Immunology; Oncology; Immunotherapy; Cancer research; Internal medicine; Immune system","score_opus":0.008835141096105326,"score_gpt":0.23265787953333253,"score_spread":0.2238227384372272,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399032715","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9759405,0.0013590899,0.00036000175,0.0012988653,0.00012755966,0.00010487979,0.014549181,0.000019582123,0.0062402603],"genre_scores_gemma":[0.9887143,0.00038590629,0.00011536067,0.00043532142,0.00012900676,0.00012605629,0.008573802,0.000009569734,0.0015106897],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99930465,0.0002029762,0.00007815458,0.00010505611,0.00016036478,0.00014884368],"domain_scores_gemma":[0.9983859,0.0004793634,0.0005311937,0.00009897285,0.00022320516,0.0002814652],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00073603605,0.00019888084,0.00050770334,0.0006505058,0.00028500092,0.0004207344,0.0003165914,0.0004450489,0.0057012835],"category_scores_gemma":[0.0021709441,0.00012418035,0.00085315463,0.001171799,0.00016127585,0.0004620212,0.0003682855,0.00061656657,0.0005801462],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0119152,0.00020935314,0.93017197,0.00028211417,0.0011785299,0.0020104551,0.00018275663,0.0015251419,0.0007804426,0.00039227965,0.021651126,0.029700689],"study_design_scores_gemma":[0.0008857578,0.001569205,0.9873954,0.00009386562,0.000611274,0.002300614,0.00027661462,0.0013189737,0.00021843235,0.0005655539,0.0047298297,0.00003452294],"about_ca_topic_score_codex":0.004031113,"about_ca_topic_score_gemma":0.004815021,"teacher_disagreement_score":0.0057012835,"about_ca_system_score_codex":0.0010202577,"about_ca_system_score_gemma":0.00047742928,"threshold_uncertainty_score":0.019072652},"labels":[],"label_agreement":null},{"id":"W4399045402","doi":"10.1111/bjh.19555","title":"Canadian cancer trials group <scp>LY</scp>.17: A randomized phase <scp>II</scp> study evaluating novel salvage therapy pre‐autologous stem cell transplant in relapsed/refractory diffuse large B‐cell lymphoma—outcome of rituximab‐dose‐intensive cyclophosphamide, etoposide, cisplatin (R‐<scp>DICEP</scp>) versus R‐<scp>GDP</scp>","year":2024,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McMaster University; University of Manitoba; Hôpital de l'Enfant-Jésus; Juravinski Cancer Centre; Hôpital Maisonneuve-Rosemont; Centre hospitalier universitaire de Québec; University of Calgary; Princess Margaret Cancer Centre; Queen's University; Moncton Hospital; University Health Network; Queen Elizabeth II Health Sciences Centre; University of Alberta","funders":"Canadian Cancer Society; Roche Canada","keywords":"Medicine; Rituximab; Gemcitabine; Autologous stem-cell transplantation; Internal medicine; Etoposide; Salvage therapy; Oncology; Diffuse large B-cell lymphoma; Interim analysis; Cyclophosphamide; Melphalan; Surgery; Lymphoma; Chemotherapy; Urology; Clinical trial","score_opus":0.04200162874759488,"score_gpt":0.33967622265958025,"score_spread":0.29767459391198536,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399045402","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.92629457,0.009713547,0.0010720422,0.0042504747,0.0007850236,0.03285711,0.013733681,0.00021246933,0.01108106],"genre_scores_gemma":[0.91656166,0.00759079,0.008501448,0.0078987675,0.000699697,0.027125955,0.014275682,0.00011273372,0.017233267],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99919254,0.00041889658,0.000027917557,0.00009319059,0.00013187024,0.00013569329],"domain_scores_gemma":[0.99906665,0.00012975695,0.00017581985,0.00006001706,0.0001202419,0.00044757375],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002192613,0.0016688346,0.0020823255,0.00038837033,0.00080859003,0.00095983053,0.00090287405,0.0014968836,0.005303253],"category_scores_gemma":[0.0014379135,0.0005334241,0.0021312828,0.0006607084,0.0010911422,0.0003589034,0.0003540674,0.0025863857,0.0006616451],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9298992,0.008149896,0.0023357237,0.0010772722,0.0022483652,0.00009641133,0.000121417565,0.0012606377,0.0050999336,0.00052655744,0.011037666,0.038147036],"study_design_scores_gemma":[0.94824773,0.040557835,0.003962059,0.000054349148,0.0008049626,0.000043469656,0.00002450659,0.00046323743,0.0005977583,0.00015555136,0.0050667315,0.000021884907],"about_ca_topic_score_codex":0.09561674,"about_ca_topic_score_gemma":0.23823276,"teacher_disagreement_score":0.09561674,"about_ca_system_score_codex":0.0049580513,"about_ca_system_score_gemma":0.016040944,"threshold_uncertainty_score":0.1901204},"labels":[],"label_agreement":null},{"id":"W4399514809","doi":"10.1111/bjh.19566","title":"A sinister case of pseudothrombocytosis","year":2024,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Children's Hospital; University of British Columbia","funders":"","keywords":"Medicine","score_opus":0.018063261334557216,"score_gpt":0.31474170711812055,"score_spread":0.29667844578356334,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399514809","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.972031,0.0057488857,0.0043427176,0.0035901405,0.00084610353,0.00019695614,0.0003907494,0.00036217071,0.012491174],"genre_scores_gemma":[0.99461716,0.0015669668,0.0010154806,0.0008582622,0.00055600016,0.00003892228,0.00010670499,0.000029642495,0.0012107737],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.9993734,0.00007148522,0.000060707203,0.00019184004,0.00009972481,0.0002028307],"domain_scores_gemma":[0.9985354,0.00042475158,0.00029428233,0.00019080265,0.0000865191,0.00046829446],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00031093642,0.0016308283,0.0010526848,0.0018067162,0.001525973,0.0012744943,0.00088193,0.004150434,0.0021511118],"category_scores_gemma":[0.003862013,0.0009589521,0.0007812849,0.0013314703,0.0014340018,0.0012492156,0.0014983367,0.0029409803,0.0009170163],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000016055908,0.0000089480645,0.0033571909,0.000015295267,0.0000025655713,0.99540234,0.00006949172,0.000016562242,0.00036629607,0.00009376102,0.00012923591,0.0005221982],"study_design_scores_gemma":[0.000005283291,0.000027413678,0.0020706928,0.00000839592,0.0000045803945,0.99715984,0.000043182714,0.000076022276,0.00018841137,0.00007807644,0.00033401762,0.0000040843947],"about_ca_topic_score_codex":0.0009061141,"about_ca_topic_score_gemma":0.0010039241,"teacher_disagreement_score":0.004150434,"about_ca_system_score_codex":0.00090257265,"about_ca_system_score_gemma":0.00056742306,"threshold_uncertainty_score":0.0071961284},"labels":[],"label_agreement":null},{"id":"W4399922214","doi":"10.1111/bjh.19601","title":"Comorbidities and complications in adult and paediatric patients with pyruvate kinase deficiency: Analysis from the Peak Registry","year":2024,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Erythrocyte Function and Pathophysiology","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"Agios Pharmaceuticals","keywords":"Medicine; Pyruvate kinase deficiency; Splenectomy; Pediatrics; Osteoporosis; Internal medicine; Jaundice; Disease; Pyruvate kinase; Surgery","score_opus":0.009090418354144507,"score_gpt":0.2330358204627708,"score_spread":0.2239454021086263,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399922214","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98787326,0.00091310276,0.00014674079,0.00008900728,0.000010714729,0.000042567706,0.010171531,0.000010206394,0.0007429036],"genre_scores_gemma":[0.9777729,0.0011957121,0.00037829802,0.00010519734,0.000039128758,0.0001636999,0.020121923,0.000015058055,0.00020795809],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99839693,0.00039395242,0.0003804438,0.00027944893,0.00037622024,0.00017290641],"domain_scores_gemma":[0.9965025,0.0005761623,0.0019082004,0.00026804398,0.00036232438,0.00038280833],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011232632,0.00021104336,0.0006476939,0.001498784,0.0003452588,0.00066315394,0.00045245106,0.00043121903,0.0015931285],"category_scores_gemma":[0.0041794884,0.00034563144,0.0005433112,0.0032415604,0.00018776162,0.0005954235,0.0009862145,0.0007135525,0.0003701037],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019069233,0.000016611451,0.9973073,0.00004323901,0.00007151733,0.00016135025,0.00005960585,0.00004459089,0.000057263755,0.000021399494,0.0006083912,0.0014181933],"study_design_scores_gemma":[0.000018319619,0.000056057233,0.9984977,0.000026081965,0.000030171184,0.0006577555,0.0001067614,0.000083417406,0.00002242902,0.00001722041,0.00047753527,0.0000065267186],"about_ca_topic_score_codex":0.004892305,"about_ca_topic_score_gemma":0.0048981276,"teacher_disagreement_score":0.004892305,"about_ca_system_score_codex":0.00035695295,"about_ca_system_score_gemma":0.0005014729,"threshold_uncertainty_score":0.009727657},"labels":[],"label_agreement":null},{"id":"W4401045198","doi":"10.1111/bjh.19649","title":"Increased risk of haematological malignancy in adults over age 60 with thrombocytopenia compared with matched controls: Time for an upfront bone marrow evaluation?","year":2024,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Hematological disorders and diagnostics","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Institute for Clinical Evaluative Sciences; Ontario Medical Association; Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Malignancy; Incidence (geometry); Internal medicine; Bone marrow; Cohort; Population; Retrospective cohort study; Hematology; Surgery; Gastroenterology; Pediatrics","score_opus":0.021002577794189813,"score_gpt":0.29791286772585185,"score_spread":0.27691028993166206,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4401045198","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99878424,0.00058209157,0.00006144487,0.00007452343,0.000015686719,0.0000032852502,0.00022058189,0.0000029852013,0.00025518736],"genre_scores_gemma":[0.99940777,0.00019812233,0.000038074,0.000040828858,0.000028870661,0.0000039752795,0.00018929824,0.0000012732963,0.00009180337],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99952006,0.00013281274,0.000049133643,0.0001548286,0.000051938645,0.00009130741],"domain_scores_gemma":[0.99865794,0.0002571737,0.0006344051,0.00011293171,0.00007210053,0.00026542938],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007259449,0.00029581098,0.00041100936,0.00063807186,0.0003009533,0.0009201242,0.0004017699,0.00076297374,0.0017899121],"category_scores_gemma":[0.0021755684,0.0004084619,0.0010157045,0.0009823247,0.00032746283,0.00057308923,0.00040612256,0.00075122225,0.00020015884],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00028358714,0.000026130741,0.9987674,0.0000069322296,0.00008976375,0.000077227785,0.000023289509,0.000018573135,0.00008088101,0.000012919382,0.00006140874,0.0005518453],"study_design_scores_gemma":[0.000021797297,0.00015868332,0.998904,0.0000074394834,0.0001216383,0.0003072773,0.0000887693,0.00020884087,0.000030474084,0.00003011543,0.000117243224,0.0000037776867],"about_ca_topic_score_codex":0.005319754,"about_ca_topic_score_gemma":0.004690734,"teacher_disagreement_score":0.005319754,"about_ca_system_score_codex":0.00018869253,"about_ca_system_score_gemma":0.00022133281,"threshold_uncertainty_score":0.0105775595},"labels":[],"label_agreement":null},{"id":"W4401045493","doi":"10.1111/bjh.19655","title":"Rolling the <scp>DICEP</scp> on lymphoma salvage treatments? Choose wisely","year":2024,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Rituximab; Etoposide; Medicine; Salvage therapy; Lymphoma; Internal medicine; Cyclophosphamide; Oncology; Surgery; Transplantation; Autologous stem-cell transplantation; Chemotherapy","score_opus":0.013722826710478291,"score_gpt":0.2684085778397481,"score_spread":0.2546857511292698,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4401045493","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00034038626,0.01951035,0.0003652848,0.92647475,0.050289113,0.00004881675,0.00012495801,0.00009258103,0.0027537888],"genre_scores_gemma":[0.0017001112,0.009076768,0.00054877857,0.9217576,0.063421234,0.00006481107,0.00004832296,0.000044722983,0.003337749],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99323773,0.002706849,0.0010189548,0.0006943829,0.0018563315,0.0004857116],"domain_scores_gemma":[0.96482897,0.021473294,0.0014951037,0.0011343838,0.007172074,0.003896146],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.012591232,0.001413931,0.0036578837,0.0014330025,0.00269627,0.0046659927,0.004985706,0.031252224,0.014889476],"category_scores_gemma":[0.035989128,0.0010501082,0.0032944006,0.0010338386,0.0070239273,0.011583252,0.0025644398,0.049613092,0.013354614],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004479182,0.00007191947,0.00018208205,0.00047358254,0.00007551515,0.00034824637,0.00008616924,0.000120229015,0.00033488675,0.003062342,0.9585083,0.036288764],"study_design_scores_gemma":[0.00084298366,0.0003329113,0.000805685,0.00255521,0.00018170621,0.00070532056,0.0007215168,0.00031352544,0.0004207338,0.022208253,0.97070575,0.00020634437],"about_ca_topic_score_codex":0.010375087,"about_ca_topic_score_gemma":0.02615369,"teacher_disagreement_score":0.031252224,"about_ca_system_score_codex":0.004408901,"about_ca_system_score_gemma":0.007610427,"threshold_uncertainty_score":0.066589594},"labels":[],"label_agreement":null},{"id":"W4401045711","doi":"10.1111/bjh.19662","title":"Quality of life in childhood immune thrombocytopenia: Revision of the Kids' <scp>ITP</scp> Tools (<scp>KIT</scp>)","year":2024,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Children's Hospital of Eastern Ontario","funders":"","keywords":"Immune thrombocytopenia; Quality of life (healthcare); Proxy (statistics); Health related quality of life; Medicine; Pediatrics; Family medicine; Psychology; Immunology; Computer science; Disease; Internal medicine; Nursing; Antibody","score_opus":0.022442898658234196,"score_gpt":0.29594959649046026,"score_spread":0.2735066978322261,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4401045711","genre_codex":"empirical","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.89631027,0.031795166,0.011310288,0.005677941,0.001321034,0.0058651483,0.024214774,0.00041924822,0.023086159],"genre_scores_gemma":[0.9059065,0.010951249,0.043895595,0.00086528336,0.0002649837,0.008439994,0.025260543,0.0001440286,0.004271851],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.99693334,0.001003862,0.00079126714,0.00014200796,0.00091047236,0.00021905574],"domain_scores_gemma":[0.9938599,0.0017773329,0.0017613007,0.00034153817,0.0018680448,0.0003919423],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005170154,0.00073319965,0.0009649065,0.0022817792,0.00037081994,0.0010826354,0.0009860384,0.0004903998,0.0011656655],"category_scores_gemma":[0.006939364,0.00026988826,0.0019465347,0.0016955757,0.00057907164,0.00069751375,0.0015120964,0.0014409656,0.00035357542],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005846908,0.00038768124,0.51574856,0.002313419,0.00060650636,0.0006868938,0.0024839928,0.0032506995,0.001358555,0.0016165876,0.037479464,0.43348294],"study_design_scores_gemma":[0.0001119594,0.00050191034,0.9498992,0.0015017986,0.00017016749,0.0018584955,0.0012704685,0.0018173186,0.0005580487,0.00077648624,0.041451346,0.00008269363],"about_ca_topic_score_codex":0.006558493,"about_ca_topic_score_gemma":0.01073049,"teacher_disagreement_score":0.006558493,"about_ca_system_score_codex":0.0015498084,"about_ca_system_score_gemma":0.00146523,"threshold_uncertainty_score":0.027342677},"labels":[],"label_agreement":null},{"id":"W4401189126","doi":"10.1111/bjh.19667","title":"Exploring the role of viscosity–vaso‐occlusion and haemolysis–endothelial dysfunction in pain sensitization among Jamaicans with sickle cell disease","year":2024,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Medicine; Haemolysis; Internal medicine; Sensitization; Endothelial dysfunction; Chronic pain; Threshold of pain; Crossover study; Disease; Sickle cell anemia; Quantitative sensory testing; Gastroenterology; Anesthesia; Physical therapy; Immunology; Pathology; Sensory system; Psychology","score_opus":0.007431630629600678,"score_gpt":0.19596107691257533,"score_spread":0.18852944628297466,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4401189126","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9998073,0.000030878025,0.000020286177,0.000010254527,4.2869848e-7,0.0000022182558,0.000035275043,3.1256337e-7,0.000093132825],"genre_scores_gemma":[0.999861,0.000023984989,0.000022184224,0.0000061807564,0.0000011208464,0.0000016503053,0.0000400136,1.8812429e-7,0.00004357126],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9998097,0.000059487316,0.000019213683,0.000037733476,0.00003038196,0.000043479908],"domain_scores_gemma":[0.9995964,0.000114859424,0.00013462163,0.000026353675,0.00005809158,0.000069587484],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00036279976,0.00014375043,0.00014750475,0.0004351157,0.00042749348,0.00043824565,0.00019286253,0.00021554725,0.0008220898],"category_scores_gemma":[0.0011570101,0.00014571175,0.00020861777,0.00047351298,0.0002865277,0.00020168051,0.0003044237,0.00025006584,0.00008783514],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000056352794,0.00002331769,0.99865496,0.000003760744,0.00001207965,0.000032554617,0.0001665842,0.000018083121,0.00024303824,0.000007837196,0.000018608203,0.0007629093],"study_design_scores_gemma":[0.0000018427102,0.000040863157,0.99923754,0.0000025224988,0.000009576722,0.000057411093,0.00044730466,0.00012264437,0.00004000658,0.000008833621,0.000030456538,9.4315095e-7],"about_ca_topic_score_codex":0.022696488,"about_ca_topic_score_gemma":0.028300263,"teacher_disagreement_score":0.022696488,"about_ca_system_score_codex":0.00026147361,"about_ca_system_score_gemma":0.0002855599,"threshold_uncertainty_score":0.045128763},"labels":[],"label_agreement":null},{"id":"W4401191697","doi":"10.1111/bjh.19674","title":"Automated red blood cell exchange with a post‐procedure haematocrit targeted at 34% in the chronic management of sickle cell disease","year":2024,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal","funders":"","keywords":"Medicine; Red blood cell; Hematocrit; Red Cell; Gastroenterology; Cell; Internal medicine; Immunology; Biology; Biochemistry","score_opus":0.004572566225777708,"score_gpt":0.22142041773291732,"score_spread":0.21684785150713962,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4401191697","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9990458,0.000692086,0.00006608901,0.000037557507,0.0000037896264,0.0000038327216,0.000011656951,0.0000011446851,0.00013805248],"genre_scores_gemma":[0.9995437,0.00026469395,0.0000744181,0.000027385377,0.000013410782,0.000004973682,0.000036132293,7.240873e-7,0.00003448754],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9995962,0.00018335428,0.000038436116,0.000043462544,0.000080635924,0.00005788888],"domain_scores_gemma":[0.9983406,0.0005616032,0.0006720363,0.00007112086,0.00005168343,0.00030289835],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008834536,0.00014058732,0.00036259784,0.0002648644,0.00022583154,0.0005649845,0.00017456946,0.00038265708,0.00043796207],"category_scores_gemma":[0.0020210883,0.00009408039,0.00021637048,0.00039869035,0.0004043136,0.00027499607,0.00039027224,0.00044240293,0.0000838595],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.018746303,0.0008982649,0.9177488,0.00016985218,0.00021220672,0.0013348077,0.00049832783,0.0009395371,0.003178346,0.00016490057,0.00049183547,0.0556167],"study_design_scores_gemma":[0.0006447696,0.012547262,0.98138547,0.000060042217,0.00016870616,0.0018904018,0.00026325043,0.0013290272,0.0007347177,0.00016343113,0.00079430715,0.000018498582],"about_ca_topic_score_codex":0.00086931605,"about_ca_topic_score_gemma":0.0009672915,"teacher_disagreement_score":0.0008834536,"about_ca_system_score_codex":0.0004605146,"about_ca_system_score_gemma":0.00032545696,"threshold_uncertainty_score":0.0046722293},"labels":[],"label_agreement":null},{"id":"W4401437309","doi":"10.1111/bjh.19698","title":"Single gene mutations and prognosis in limited‐stage follicular lymphoma treated with radiation therapy","year":2024,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Jewish General Hospital; Princess Margaret Cancer Centre; Queen's University; University Health Network","funders":"Leukemia and Lymphoma Society of Canada; Leukemia and Lymphoma Society","keywords":"Follicular lymphoma; Radiation therapy; Oncology; Medicine; Stage (stratigraphy); Internal medicine; Lymphoma; Cohort; Gene; Bioinformatics; Biology; Genetics","score_opus":0.015915330690542677,"score_gpt":0.25425456712591393,"score_spread":0.23833923643537125,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4401437309","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9996419,0.00017028349,0.000035019282,0.000011066053,0.000001091722,0.0000015160298,0.000029446335,0.0000016341525,0.00010803314],"genre_scores_gemma":[0.9998354,0.000039583047,0.000023969946,0.000006027127,0.0000019800643,0.00000123395,0.00005304881,0.0000010208898,0.000037703692],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9998518,0.000047292746,0.000013701043,0.000026350232,0.00003275017,0.000028042961],"domain_scores_gemma":[0.99953926,0.00018086062,0.0001295003,0.000035300112,0.000034421275,0.000080593585],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00027203734,0.000087355096,0.0002504125,0.0003753613,0.00013332196,0.00023938333,0.00019081663,0.00026813342,0.001125275],"category_scores_gemma":[0.0012786381,0.00009354739,0.00015527866,0.0003076545,0.00025775563,0.0001421712,0.00017127242,0.00020865837,0.00019056606],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015417105,0.000062981526,0.98184615,0.000013901732,0.00006362289,0.0005790679,0.00008805257,0.00037603793,0.00478726,0.000019309666,0.00010410492,0.010517895],"study_design_scores_gemma":[0.000051718656,0.00067428884,0.9946214,0.000009471161,0.00007186898,0.0020898718,0.00009186197,0.00059109164,0.0014804973,0.000069542046,0.0002434619,0.000004923044],"about_ca_topic_score_codex":0.0010989017,"about_ca_topic_score_gemma":0.0011488561,"teacher_disagreement_score":0.001125275,"about_ca_system_score_codex":0.00027901135,"about_ca_system_score_gemma":0.00010704188,"threshold_uncertainty_score":0.0037644506},"labels":[],"label_agreement":null},{"id":"W4401624983","doi":"10.1111/bjh.19696","title":"Genome‐wide study identifies novel genes associated with bone toxicities in children with acute lymphoblastic leukaemia","year":2024,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre hospitalier universitaire de Québec; Université de Montréal; Centre Hospitalier Universitaire Sainte-Justine; McMaster University","funders":"Common Fund; National Institute of Neurological Disorders and Stroke; NIH Office of the Director; National Institute on Drug Abuse; National Institutes of Health; National Cancer Institute; University of Rochester; National Institute of Mental Health; National Heart, Lung, and Blood Institute; Dana-Farber Cancer Institute; Bundesinstitut für Bau- Stadt- und Raumforschung; McMaster University; Roswell Park Alliance Foundation, Roswell Park Cancer Institute; Irving Medical Center, Columbia University; Medical Center, University of Rochester; National Human Genome Research Institute; Seagen; Rally Foundation","keywords":"Medicine; Genome-wide association study; Internal medicine; Oncology; Meta-analysis; Gene; Bioinformatics; Single-nucleotide polymorphism; Genetics; Genotype; Biology","score_opus":0.01103540603332483,"score_gpt":0.2621516035166131,"score_spread":0.2511161974832883,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4401624983","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9681178,0.024812438,0.0009513135,0.0009301421,0.00008411007,0.000025455409,0.0041552195,0.000040652492,0.00088284357],"genre_scores_gemma":[0.992542,0.0038002688,0.0006955386,0.000428609,0.00007004107,0.000033176904,0.002133754,0.000020002979,0.00027660362],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9992465,0.00022971937,0.00008140621,0.0002181539,0.0001484149,0.00007591627],"domain_scores_gemma":[0.9983931,0.00076112925,0.00051853544,0.00011155694,0.00011317558,0.00010237734],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00090460404,0.00040622771,0.0006935542,0.0006706617,0.00027758308,0.0008834768,0.00041811098,0.00061933027,0.0021103283],"category_scores_gemma":[0.0021672205,0.00026094317,0.0014837204,0.0022892482,0.00035173877,0.00022774063,0.00045927262,0.0009696203,0.00021881277],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0023859427,0.00007146655,0.9568155,0.000780194,0.007009172,0.0009530009,0.00014495439,0.00097178284,0.0074542756,0.0002985838,0.0028843724,0.02023081],"study_design_scores_gemma":[0.00028668277,0.00025068113,0.98522884,0.0000923293,0.004740551,0.0011329153,0.0001346635,0.0006166112,0.0010077264,0.0005979513,0.005895152,0.00001576083],"about_ca_topic_score_codex":0.0035748086,"about_ca_topic_score_gemma":0.0051066433,"teacher_disagreement_score":0.0035748086,"about_ca_system_score_codex":0.00035042258,"about_ca_system_score_gemma":0.00042754546,"threshold_uncertainty_score":0.0071080327},"labels":[],"label_agreement":null},{"id":"W4401715291","doi":"10.1111/bjh.19706","title":"<scp>PembroWM</scp> : A phase <scp>II</scp> trial to investigate the safety and efficacy of rituximab and pembrolizumab in relapsed/refractory Waldenström's Macroglobulinaemia","year":2024,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Thomas Hospital","funders":"Merck Sharp and Dohme","keywords":"Medicine; Rituximab; Internal medicine; Chemoimmunotherapy; Tolerability; Refractory (planetary science); Oncology; Pembrolizumab; Gastroenterology; Phases of clinical research; Clinical trial; Adverse effect; Immunotherapy; Lymphoma","score_opus":0.01723235397203564,"score_gpt":0.3111091422852666,"score_spread":0.29387678831323094,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4401715291","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9828631,0.0033230376,0.0005547594,0.0011477005,0.00011230097,0.0046739513,0.002680929,0.00012233606,0.004521909],"genre_scores_gemma":[0.97984195,0.001839122,0.0022743538,0.0014897628,0.00016098401,0.004447716,0.0054948973,0.000039161667,0.004412109],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.99966156,0.0001939669,0.000014203941,0.00003934522,0.00003712179,0.000053722208],"domain_scores_gemma":[0.99954647,0.00006082395,0.000080043574,0.00002396165,0.000027286127,0.00026134634],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013978686,0.00079619413,0.0009146429,0.0003191385,0.0003208178,0.0006647485,0.00047326612,0.0008619205,0.0048141987],"category_scores_gemma":[0.0005800953,0.00024973156,0.00068214786,0.00028493788,0.00046679622,0.0004540722,0.0004884227,0.0016693098,0.0008031945],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.7507625,0.019779963,0.008904937,0.0019013046,0.0016712106,0.0005779089,0.00029259626,0.0024364472,0.063707724,0.0008861362,0.015216756,0.13386253],"study_design_scores_gemma":[0.80809337,0.15742399,0.018823184,0.00012317697,0.0004931229,0.0005200673,0.000056318317,0.0011528552,0.004203416,0.00037579055,0.008707205,0.00002752371],"about_ca_topic_score_codex":0.0011379502,"about_ca_topic_score_gemma":0.0033855122,"teacher_disagreement_score":0.0048141987,"about_ca_system_score_codex":0.00064017845,"about_ca_system_score_gemma":0.0014520835,"threshold_uncertainty_score":0.016105115},"labels":[],"label_agreement":null},{"id":"W4402528918","doi":"10.1111/bjh.19764","title":"A randomized trial of ibrutinib and R‐<scp>GDP</scp> prior to stem cell transplant in relapsed diffuse large B‐cell lymphoma","year":2024,"lang":"en","type":"letter","venue":"British Journal of Haematology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University; Spinal Cord Injury BC; Jewish General Hospital; University of Manitoba; Juravinski Cancer Centre; Hôpital Maisonneuve-Rosemont; Alberta Health Services; Hôpital Notre-Dame; Moncton Hospital; University of British Columbia; Université Laval; Université de Montréal; University of Saskatchewan; University of Calgary; Princess Margaret Cancer Centre; Kingston General Hospital; Simon Fraser University","funders":"Janssen Research and Development; Canadian Cancer Society; Roche Canada","keywords":"Ibrutinib; Lymphoma; Medicine; Stem cell; Oncology; Internal medicine; Cancer research; Leukemia; Biology; Chronic lymphocytic leukemia","score_opus":0.011479990470827229,"score_gpt":0.24372286820860742,"score_spread":0.23224287773778018,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402528918","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7281621,0.031423174,0.0010941138,0.18639041,0.018078377,0.0017776005,0.0032617964,0.00028009393,0.029532334],"genre_scores_gemma":[0.8926623,0.0054675746,0.0016682206,0.07570865,0.007642462,0.0016279345,0.0016631881,0.000045636614,0.0135141015],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99928826,0.0004805094,0.00004030848,0.000068735295,0.000044869263,0.00007731405],"domain_scores_gemma":[0.99859685,0.00077845325,0.00012339799,0.00004128241,0.00006686821,0.00039306522],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012223654,0.000596141,0.001485501,0.00021655129,0.00040845157,0.0006871609,0.00065808906,0.003460775,0.0054605566],"category_scores_gemma":[0.0021095732,0.00025035808,0.00049037917,0.00033825068,0.0005250301,0.0006021733,0.00022743226,0.0036153998,0.0014165484],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.7386686,0.0050334255,0.004901316,0.00092620094,0.00084607303,0.0045424015,0.0001386719,0.0012169413,0.0064371983,0.001188481,0.12505561,0.111045174],"study_design_scores_gemma":[0.86402947,0.05137213,0.011115665,0.00027484391,0.00068252475,0.0031251167,0.00013272077,0.0034614874,0.0020435282,0.0025539757,0.061138492,0.000070122194],"about_ca_topic_score_codex":0.00094007276,"about_ca_topic_score_gemma":0.0021699404,"teacher_disagreement_score":0.0054605566,"about_ca_system_score_codex":0.0011567781,"about_ca_system_score_gemma":0.0006734709,"threshold_uncertainty_score":0.018267393},"labels":[],"label_agreement":null},{"id":"W4402816183","doi":"10.1111/bjh.19741","title":"Oral decitabine/cedazuridine versus intravenous decitabine for acute myeloid leukaemia: A randomised, crossover, registration, pharmacokinetics study","year":2024,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen Elizabeth II Health Sciences Centre","funders":"Astex Pharmaceuticals","keywords":"Decitabine; Medicine; Pharmacokinetics; Myeloid leukaemia; Crossover study; Internal medicine; Oncology; Pharmacology; Pathology","score_opus":0.029821483431669165,"score_gpt":0.36354717657950447,"score_spread":0.3337256931478353,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402816183","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9945438,0.0013012752,0.0005259821,0.00026472643,0.00029639446,0.001945232,0.00035479796,0.00005268825,0.0007151255],"genre_scores_gemma":[0.99185926,0.0013868992,0.0013791353,0.00037674076,0.0004174644,0.0019848763,0.0004489276,0.000025024132,0.002121574],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9982796,0.0010037925,0.000103007034,0.00025333816,0.00012137391,0.00023887078],"domain_scores_gemma":[0.9975725,0.0007672579,0.00048204817,0.00031479594,0.0001258877,0.0007374134],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002924299,0.0017741498,0.004386906,0.0005913864,0.00039740757,0.0012661532,0.0010388868,0.0016706056,0.004743869],"category_scores_gemma":[0.0029984415,0.00094972143,0.0016458506,0.0007403508,0.0019051526,0.0014065572,0.00051882566,0.0033842013,0.0011771095],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9738911,0.013092819,0.00024581715,0.00017023084,0.000271845,0.000022195076,0.000053304797,0.00020103902,0.004276881,0.00006739252,0.00017284973,0.0075344825],"study_design_scores_gemma":[0.76574415,0.2310711,0.0012352951,0.00001343107,0.00026736487,0.000028972538,0.000025277384,0.00038210905,0.00067961216,0.00011137069,0.00042414456,0.000017101152],"about_ca_topic_score_codex":0.0007711584,"about_ca_topic_score_gemma":0.0012402299,"teacher_disagreement_score":0.004743869,"about_ca_system_score_codex":0.0009240501,"about_ca_system_score_gemma":0.0011669869,"threshold_uncertainty_score":0.015869856},"labels":[],"label_agreement":null},{"id":"W4403104246","doi":"10.1111/bjh.19816","title":"Warfarin reversal in patients with antiphospholipid syndrome: Caution required, but clear guidance not available","year":2024,"lang":"en","type":"letter","venue":"British Journal of Haematology","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Warfarin; Medicine; Antiphospholipid syndrome; Intensive care medicine; Internal medicine; Thrombosis; Atrial fibrillation","score_opus":0.009687052408266093,"score_gpt":0.215298940964952,"score_spread":0.2056118885566859,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4403104246","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.1990345,0.15294454,0.029936181,0.50388354,0.008817652,0.0004430334,0.00048702292,0.0016156972,0.10283788],"genre_scores_gemma":[0.78058624,0.048458166,0.034867316,0.11021021,0.014540537,0.00021465188,0.00040552558,0.00027951755,0.010437858],"study_design_codex":"case_report","study_design_gemma":"not_applicable","domain_scores_codex":[0.99810034,0.00076975935,0.00048249806,0.00014058994,0.0003526246,0.00015421756],"domain_scores_gemma":[0.9958236,0.0017429367,0.0007004699,0.00027168804,0.00088646886,0.00057488447],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0020950295,0.00046992945,0.0008033227,0.001322824,0.0012990017,0.0019898375,0.00087538303,0.0050286762,0.0015255081],"category_scores_gemma":[0.0153058665,0.00034185546,0.00066877116,0.0006472638,0.0009923815,0.002026446,0.0007044798,0.0047791353,0.0014435394],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000593753,0.000277466,0.121873416,0.0014001017,0.00026652298,0.34655732,0.0041584433,0.00068766164,0.0036985218,0.0039177765,0.19019432,0.32637468],"study_design_scores_gemma":[0.00025860805,0.00048505433,0.048932694,0.005520761,0.00023821932,0.6359836,0.004878692,0.0020689396,0.003719358,0.016459974,0.28126377,0.00019040251],"about_ca_topic_score_codex":0.001898385,"about_ca_topic_score_gemma":0.0033112566,"teacher_disagreement_score":0.0050286762,"about_ca_system_score_codex":0.00062465365,"about_ca_system_score_gemma":0.0016351389,"threshold_uncertainty_score":0.011079729},"labels":[],"label_agreement":null},{"id":"W4403137636","doi":"10.1111/bjh.19814","title":"Impaired apoptosis underlying lymphoproliferative disease in a patient with haploinsufficient <scp>NFKB1</scp> deficiency","year":2024,"lang":"en","type":"letter","venue":"British Journal of Haematology","topic":"NF-κB Signaling Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; McGill University Health Centre","funders":"","keywords":"Haploinsufficiency; Apoptosis; NFKB1; Disease; Medicine; Lymphoproliferative disease; Lymphoproliferative disorders; Immunology; Cancer research; Internal medicine; Biology; Genetics; Lymphoma; Phenotype; Gene; Transcription factor","score_opus":0.015082338120603294,"score_gpt":0.23616973204717215,"score_spread":0.22108739392656884,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4403137636","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8948065,0.003987056,0.0021546064,0.056404438,0.0040302556,0.0001820148,0.0010898281,0.00036918983,0.036976],"genre_scores_gemma":[0.97896314,0.0014059426,0.0011464567,0.0067959297,0.0023592818,0.000027584832,0.00016889091,0.00004255003,0.009090269],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.9997087,0.000043383403,0.00003606547,0.00007751583,0.000062859544,0.0000714974],"domain_scores_gemma":[0.9989644,0.0006440535,0.00008786233,0.000060336355,0.000069395945,0.00017386343],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003618737,0.0006867144,0.00081663113,0.00072907313,0.0010091902,0.0006612435,0.0006155182,0.0036595804,0.0036510848],"category_scores_gemma":[0.002187066,0.00032650115,0.0004261187,0.00049458485,0.0009997026,0.00053516193,0.00039115816,0.002276972,0.0008475832],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00033883002,0.000040510204,0.005535615,0.00007683872,0.000016916727,0.9788753,0.00021256538,0.0001107341,0.0037406944,0.0006264083,0.0058302907,0.00459537],"study_design_scores_gemma":[0.00009429941,0.00026010541,0.015957866,0.00005544903,0.000052105042,0.9687552,0.00014676152,0.00079823995,0.0029081032,0.0015105641,0.009434551,0.00002679116],"about_ca_topic_score_codex":0.0016185597,"about_ca_topic_score_gemma":0.0015482162,"teacher_disagreement_score":0.0036595804,"about_ca_system_score_codex":0.00087026256,"about_ca_system_score_gemma":0.00034952356,"threshold_uncertainty_score":0.012214065},"labels":[],"label_agreement":null},{"id":"W4403369008","doi":"10.1111/bjh.19823","title":"The value of semiquantitative <scp>PET</scp> features and end‐of‐therapy <scp>PET</scp> in grade <scp>3B</scp> follicular lymphoma","year":2024,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Spinal Cord Injury BC; University of British Columbia","funders":"University of Melbourne","keywords":"Medicine; Lymphoma; Follicular lymphoma; Positron emission tomography; Standardized uptake value; Diffuse large B-cell lymphoma; CHOP; Nuclear medicine; Aggressive lymphoma; Chemotherapy; Internal medicine; Oncology; Rituximab","score_opus":0.012043750600632674,"score_gpt":0.2742954154243849,"score_spread":0.26225166482375223,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4403369008","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99756205,0.00035478218,0.0010852189,0.000028682009,0.0000025363265,0.0000073973424,0.00020161818,0.000026247799,0.0007315014],"genre_scores_gemma":[0.9995598,0.000023442164,0.00023455908,0.0000063017296,0.0000023866057,0.000004104749,0.00012606297,0.000004452053,0.00003893245],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9996873,0.00014878158,0.0000370121,0.000043086886,0.000054508808,0.000029352484],"domain_scores_gemma":[0.99907863,0.0003461227,0.0002926008,0.000091258036,0.00011770539,0.00007366785],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010725718,0.00019030532,0.00016285795,0.0007223079,0.00010630888,0.0008890523,0.00021556206,0.0002911851,0.00067092635],"category_scores_gemma":[0.0015620028,0.000089347035,0.00018401709,0.0003928435,0.00030525317,0.00029644847,0.00020198034,0.0001734892,0.00019428074],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001152776,0.000027081747,0.96993476,0.000033984255,0.00008149951,0.00028531026,0.00008176444,0.0010777091,0.008115542,0.000063811945,0.00024243057,0.018903358],"study_design_scores_gemma":[0.000018465085,0.00028803162,0.9838102,0.0000126991,0.000091418086,0.0017177108,0.00014866027,0.0074574007,0.0053682406,0.0003022509,0.0007728382,0.000011979716],"about_ca_topic_score_codex":0.00074397295,"about_ca_topic_score_gemma":0.00077437237,"teacher_disagreement_score":0.0010725718,"about_ca_system_score_codex":0.00034761662,"about_ca_system_score_gemma":0.00009123785,"threshold_uncertainty_score":0.0056723356},"labels":[],"label_agreement":null},{"id":"W4403796224","doi":"10.1111/bjh.19864","title":"Goodbye etoposide? Taking the leap to ruxolitinib in haemophagocytic lymphohistiocytosis","year":2024,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Autoimmune and Inflammatory Disorders Research","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University; University of British Columbia","funders":"","keywords":"Hemophagocytic lymphohistiocytosis; Ruxolitinib; Medicine; Etoposide; Regimen; Malignancy; Oncology; Internal medicine; Immunology; Chemotherapy; Disease; Pediatrics; Myelofibrosis; Bone marrow","score_opus":0.025978103313114637,"score_gpt":0.33176759991438465,"score_spread":0.30578949660127,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4403796224","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0027287954,0.027754195,0.00026271227,0.9158781,0.048796445,0.000029261297,0.00023953487,0.000047117624,0.0042638285],"genre_scores_gemma":[0.029431777,0.022841537,0.00041439247,0.8037907,0.13588528,0.00006173605,0.000114704555,0.000034273384,0.007425551],"study_design_codex":"not_applicable","study_design_gemma":"case_report","domain_scores_codex":[0.9990151,0.00037490093,0.00017132131,0.000121579804,0.00022161957,0.000095365765],"domain_scores_gemma":[0.99572057,0.0027454547,0.00030648356,0.00008068851,0.00086016906,0.00028657072],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014533943,0.00038601135,0.0007336448,0.00045592134,0.00066748966,0.0010292218,0.0013661413,0.008491829,0.0024385056],"category_scores_gemma":[0.009907961,0.0002212752,0.00065256644,0.00042536645,0.0008302744,0.0013943074,0.0004475063,0.008336247,0.0017244738],"study_design_candidate":"case_report","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021048747,0.00001689326,0.0011795488,0.00039222586,0.00005940147,0.0046851514,0.00014692306,0.000090861584,0.0003122088,0.0011712739,0.96634823,0.025386842],"study_design_scores_gemma":[0.00029860588,0.00019438384,0.004202363,0.0021113574,0.00015723213,0.01241647,0.0005107015,0.000361711,0.00071530935,0.0037360764,0.9752178,0.00007795545],"about_ca_topic_score_codex":0.004533204,"about_ca_topic_score_gemma":0.009244408,"teacher_disagreement_score":0.008491829,"about_ca_system_score_codex":0.0013976276,"about_ca_system_score_gemma":0.0014322698,"threshold_uncertainty_score":0.010140538},"labels":[],"label_agreement":null},{"id":"W4404196418","doi":"10.1111/bjh.19859","title":"Long‐term follow‐up of bulky classic Hodgkin lymphoma managed with ABVD and PET‐guided RT demonstrates excellent outcomes in PET‐negative cases","year":2024,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency; Spinal Cord Injury BC; University of British Columbia","funders":"Loxo Oncology; Seagen; Veracyte; BeiGene; Regeneron Pharmaceuticals; AstraZeneca","keywords":"ABVD; Hodgkin lymphoma; Medicine; Lymphoma; Term (time); Nuclear medicine; Oncology; Internal medicine; Chemotherapy; Vincristine; Physics; Cyclophosphamide","score_opus":0.019706015738161328,"score_gpt":0.2827852178886166,"score_spread":0.26307920215045527,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4404196418","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99931896,0.00031302765,0.0000751877,0.000014737577,0.0000022538625,0.0000025355525,0.00003006781,0.0000026664106,0.00024050816],"genre_scores_gemma":[0.9997508,0.00005276446,0.00002253092,0.000008445324,0.000006495715,0.0000016995774,0.00010131843,7.483366e-7,0.000055206627],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9998165,0.000040630595,0.000019810801,0.000040936542,0.000028787183,0.000053330245],"domain_scores_gemma":[0.99946326,0.0001639711,0.00014491279,0.000053841555,0.000042593234,0.00013151996],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002931282,0.00014493271,0.00028256967,0.0002683449,0.00032833408,0.00039458822,0.00013905464,0.0002964092,0.0005015563],"category_scores_gemma":[0.00092082366,0.00011251496,0.0002882201,0.00023632884,0.00027906775,0.00027284492,0.00036348196,0.00024305204,0.0001944963],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0020947661,0.00015128119,0.96965045,0.000021967484,0.000088408735,0.0045300317,0.0003501348,0.0005236164,0.003661698,0.000021652291,0.00013457306,0.01877141],"study_design_scores_gemma":[0.000053299937,0.0013683167,0.98815596,0.000011489429,0.00009911325,0.008191224,0.00021437657,0.000504157,0.00089872483,0.000045291486,0.00044651589,0.000011547693],"about_ca_topic_score_codex":0.0018776691,"about_ca_topic_score_gemma":0.0021487295,"teacher_disagreement_score":0.0018776691,"about_ca_system_score_codex":0.00032760616,"about_ca_system_score_gemma":0.00013187261,"threshold_uncertainty_score":0.0037334561},"labels":[],"label_agreement":null},{"id":"W4404220871","doi":"10.1111/bjh.19885","title":"Genetic predisposition to vaccine‐induced immune thrombotic thrombocytopenia","year":2024,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Heparin-Induced Thrombocytopenia and Thrombosis","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Genetic predisposition; Immune system; Immunology; Medicine; Immune thrombocytopenia; Platelet; Internal medicine; Disease","score_opus":0.018412784940449185,"score_gpt":0.296513983286822,"score_spread":0.2781011983463728,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4404220871","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.009329299,0.020403937,0.00066167157,0.905776,0.057192307,0.000033019278,0.0006193297,0.00008031589,0.0059040124],"genre_scores_gemma":[0.08595398,0.03178307,0.00062768254,0.6079113,0.2612079,0.00007862657,0.0005911002,0.000058243873,0.011788049],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.9991567,0.0003023941,0.0000790471,0.00017256239,0.0001952429,0.00009408109],"domain_scores_gemma":[0.99722147,0.0018905103,0.00016456017,0.00006229849,0.00047388973,0.00018737331],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010038142,0.00078956416,0.0010373277,0.0004311588,0.0006460192,0.0006834799,0.00119278,0.011061738,0.005495737],"category_scores_gemma":[0.0053888876,0.00023704376,0.0005923409,0.00040879028,0.0007505589,0.000987455,0.00044907926,0.006472299,0.0016367121],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00041460956,0.000044156153,0.008198164,0.00060029206,0.0001675981,0.00932985,0.00032312222,0.00021966996,0.0017548953,0.0033062415,0.9446466,0.030994892],"study_design_scores_gemma":[0.00087609456,0.00074108905,0.054980915,0.004135819,0.00079256896,0.06299688,0.0013894294,0.0018858667,0.0018341676,0.030280218,0.8397469,0.00034000727],"about_ca_topic_score_codex":0.00351794,"about_ca_topic_score_gemma":0.0037966713,"teacher_disagreement_score":0.011061738,"about_ca_system_score_codex":0.00064246537,"about_ca_system_score_gemma":0.0005985156,"threshold_uncertainty_score":0.018385053},"labels":[],"label_agreement":null},{"id":"W4404329246","doi":"10.1111/bjh.19837","title":"Red cell specifications for blood group matching in patients with haemoglobinopathies: An updated systematic review and clinical practice guideline from the International Collaboration for Transfusion Medicine Guidelines","year":2024,"lang":"en","type":"review","venue":"British Journal of Haematology","topic":"Blood groups and transfusion","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University Health Network; Université Laval; Université de Montréal; Centre Hospitalier Universitaire Sainte-Justine; Canadian Blood Services","funders":"Health Canada; Government of Canada; Canadian Blood Services","keywords":"Medicine; ABO blood group system; Guideline; Transfusion medicine; Observational study; Grading (engineering); Matching (statistics); Internal medicine; Intensive care medicine; Blood transfusion; Pathology","score_opus":0.054667365454976545,"score_gpt":0.38531843517732944,"score_spread":0.3306510697223529,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4404329246","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0010120588,0.970433,0.0033743917,0.0091438005,0.0016855026,0.0049998546,0.007510902,0.0001694545,0.0016709247],"genre_scores_gemma":[0.010055145,0.93767095,0.025585264,0.0069713513,0.00052807125,0.010812216,0.0069393497,0.00007178799,0.0013659167],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9695388,0.008454031,0.015633011,0.0015283977,0.004297758,0.0005479767],"domain_scores_gemma":[0.9375144,0.030738221,0.016426982,0.0014712188,0.013155329,0.0006938747],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.030021714,0.0019379662,0.008299201,0.017508335,0.0009071537,0.003385242,0.0045048394,0.0034674464,0.006333668],"category_scores_gemma":[0.10150796,0.0014597727,0.0114408275,0.015100132,0.0010177022,0.0036640374,0.0026671535,0.002361583,0.0013525184],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018630175,0.000026963331,0.00094331463,0.81482035,0.0053196405,0.00012100121,0.0004259901,0.00034651594,0.00036704188,0.0010496113,0.040272757,0.13612063],"study_design_scores_gemma":[0.00047078734,0.000095001174,0.0029377989,0.89191085,0.020822702,0.00031582915,0.00019968089,0.00023236689,0.00022560898,0.0016001619,0.08110357,0.00008574821],"about_ca_topic_score_codex":0.02319262,"about_ca_topic_score_gemma":0.04383982,"teacher_disagreement_score":0.030021714,"about_ca_system_score_codex":0.0060717235,"about_ca_system_score_gemma":0.028490067,"threshold_uncertainty_score":0.15877187},"labels":[],"label_agreement":null},{"id":"W4404455557","doi":"10.1111/bjh.19895","title":"Somatic co‐alteration signatures are prognostic in high‐grade <scp><i>TP53</i></scp>‐mutated myeloid neoplasms","year":2024,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Hazard ratio; Proportional hazards model; Myeloid; Somatic cell; Internal medicine; Cohort; Medicine; Oncology; Subgroup analysis; Gene signature; Survival analysis; Gastroenterology; Gene; Biology; Genetics; Confidence interval; Gene expression","score_opus":0.013073356458643819,"score_gpt":0.28831015895985046,"score_spread":0.27523680250120663,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4404455557","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9991998,0.0001738394,0.00022549868,0.0000071782893,0.000001828765,0.000008272772,0.00015336578,0.000006143231,0.00022404404],"genre_scores_gemma":[0.99954104,0.00003103043,0.00010373903,0.000005899105,0.000003737974,0.0000033327624,0.00025076792,0.000003101361,0.000057427384],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9991535,0.00020189822,0.00011641537,0.00023668968,0.0001766018,0.000114883784],"domain_scores_gemma":[0.99831784,0.00041558343,0.0006163501,0.0002664456,0.00018212863,0.00020171955],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015190699,0.00028224953,0.00054937677,0.001098141,0.00021920387,0.0007791058,0.00025687023,0.00031746854,0.0014100758],"category_scores_gemma":[0.002688052,0.00021813616,0.00053908746,0.0009974906,0.00024859034,0.000258704,0.0007192567,0.00023216537,0.00029857637],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00069372,0.000018240833,0.9880238,0.00001928226,0.00022751205,0.00009331174,0.00006232528,0.00034662077,0.005966062,0.0000141611345,0.00006269112,0.004472277],"study_design_scores_gemma":[0.000012075247,0.00020375405,0.99762183,0.000003461583,0.00014046223,0.0004943182,0.000047755882,0.00042275226,0.00084001233,0.000031901352,0.00017807797,0.0000036321906],"about_ca_topic_score_codex":0.0009458961,"about_ca_topic_score_gemma":0.0014311218,"teacher_disagreement_score":0.0015190699,"about_ca_system_score_codex":0.0001930964,"about_ca_system_score_gemma":0.00020922573,"threshold_uncertainty_score":0.008033693},"labels":[],"label_agreement":null},{"id":"W4404865836","doi":"10.1111/bjh.19937","title":"Impact of body mass index on outcomes of multiple myeloma patients undergoing upfront autologous stem cell transplant","year":2024,"lang":"en","type":"letter","venue":"British Journal of Haematology","topic":"Cancer Risks and Factors","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University","funders":"National Cancer Institute; Paula and Rodger Riney Foundation; University of Texas MD Anderson Cancer Center; Dr. Miriam and Sheldon G. Adelson Medical Research Foundation","keywords":"Multiple myeloma; Medicine; Autologous stem-cell transplantation; Body mass index; Stem cell; Oncology; Internal medicine; Surgery; Biology","score_opus":0.013289545083618588,"score_gpt":0.2676295951782495,"score_spread":0.25434005009463095,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4404865836","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9977822,0.0007764056,0.00007145408,0.00014522017,0.000021064494,0.0000073911815,0.000532193,0.000004116567,0.00065997813],"genre_scores_gemma":[0.9985966,0.00024588287,0.00003783516,0.000054636806,0.00003992483,0.0000073783394,0.00087900413,0.0000032005678,0.00013559413],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9995378,0.00009385472,0.00005864871,0.00007752505,0.00011708803,0.00011503478],"domain_scores_gemma":[0.99812156,0.0003299351,0.00095609296,0.000072151815,0.00014233186,0.00037794613],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000760029,0.00022034506,0.0004298138,0.0005685448,0.00035115329,0.000872592,0.00027849656,0.00027945195,0.0016242224],"category_scores_gemma":[0.0026529485,0.00011667878,0.000586802,0.0009904782,0.00023364766,0.0005346307,0.00077798404,0.000953638,0.0002636427],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005394515,0.000046534653,0.9945333,0.000014802051,0.0000855727,0.00013340155,0.000042802734,0.00018725696,0.00014795017,0.000024390798,0.00022342047,0.0040211617],"study_design_scores_gemma":[0.000010342668,0.00024100723,0.99864787,0.000015734617,0.000050027924,0.00025752746,0.000080380385,0.00033525605,0.000054574877,0.00004535303,0.00025625867,0.0000055964133],"about_ca_topic_score_codex":0.0022493235,"about_ca_topic_score_gemma":0.00319204,"teacher_disagreement_score":0.0022493235,"about_ca_system_score_codex":0.0005046418,"about_ca_system_score_gemma":0.0004358316,"threshold_uncertainty_score":0.0054335594},"labels":[],"label_agreement":null},{"id":"W4404910207","doi":"10.1111/bjh.19924","title":"Clinical perspectives on post‐induction maintenance therapy in patients with acute myeloid leukaemia in remission who are ineligible for allogeneic haematopoietic stem cell transplantation","year":2024,"lang":"en","type":"review","venue":"British Journal of Haematology","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Bristol-Myers Squibb Canada","keywords":"Medicine; Maintenance therapy; Transplantation; Internal medicine; Clinical trial; Oncology; Stem cell; Midostaurin; Sorafenib; Myeloid leukemia; Intensive care medicine; Chemotherapy","score_opus":0.03584553251121494,"score_gpt":0.3575606456003801,"score_spread":0.32171511308916517,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4404910207","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00005969792,0.9989241,0.000030843923,0.00034855498,0.00013423811,0.0000036835143,0.000009035458,0.0000024277126,0.00048747842],"genre_scores_gemma":[0.0005803954,0.9984301,0.00012950397,0.00042858944,0.00012722278,0.0000077242685,0.000021987024,9.848582e-7,0.0002735016],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9996538,0.000118748714,0.00006979905,0.000042717547,0.0000983585,0.000016584927],"domain_scores_gemma":[0.99896777,0.0006457005,0.00014797642,0.000018472365,0.00017954069,0.00004049932],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011507275,0.000496651,0.0013684774,0.0012820686,0.00018441932,0.0008627397,0.0009013343,0.0011284767,0.004353868],"category_scores_gemma":[0.0018777266,0.00016517911,0.0007184555,0.0013194097,0.00036521172,0.001166033,0.0003606999,0.0018369718,0.001504046],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018444705,0.00005684526,0.0001409496,0.034663238,0.00013175968,0.0001285681,0.00007976362,0.00018584673,0.000678361,0.0021288067,0.029243957,0.9323775],"study_design_scores_gemma":[0.000121696925,0.0002478837,0.0015302476,0.030755255,0.00042588313,0.0013429903,0.00013309205,0.00007679129,0.00025246968,0.0017778366,0.9633129,0.000022857128],"about_ca_topic_score_codex":0.00081722153,"about_ca_topic_score_gemma":0.0021328188,"teacher_disagreement_score":0.004353868,"about_ca_system_score_codex":0.00042494695,"about_ca_system_score_gemma":0.00096133875,"threshold_uncertainty_score":0.01456517},"labels":[],"label_agreement":null},{"id":"W4405309932","doi":"10.1111/bjh.19951","title":"Acalabrutinib in combination with rituximab and lenalidomide in patients with relapsed or refractory follicular lymphoma: Results of the phase 1b open‐label study ( <scp>ACE</scp> ‐ <scp>LY</scp> ‐003)","year":2024,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"AstraZeneca","keywords":"Lenalidomide; Rituximab; Follicular lymphoma; Medicine; Open label; Refractory (planetary science); Oncology; Internal medicine; Lymphoma; Phases of clinical research; Pharmacology; Multiple myeloma; Chemotherapy; Clinical trial; Biology","score_opus":0.022463868599533244,"score_gpt":0.31535590560799254,"score_spread":0.2928920370084593,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405309932","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9896578,0.007621173,0.0002167151,0.00035567008,0.00007361528,0.00042331187,0.00040486225,0.000046424942,0.00120028],"genre_scores_gemma":[0.99402666,0.0029590449,0.0005496196,0.0005428492,0.00017232398,0.00028528116,0.0007833484,0.000013145992,0.00066770444],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9994017,0.00034003652,0.000045538924,0.00006609069,0.000072682975,0.0000740062],"domain_scores_gemma":[0.9994247,0.00012192534,0.00013857623,0.000035373436,0.00004786003,0.00023157673],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017930306,0.00081265735,0.0015610541,0.00038811864,0.00024334234,0.00082050293,0.00060066057,0.00069993496,0.0010190842],"category_scores_gemma":[0.0010144555,0.0003866964,0.0013292751,0.00038282838,0.0004673882,0.0005955671,0.00021638184,0.0017625819,0.00031048557],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.48576316,0.047416482,0.041370153,0.0018137703,0.0074999086,0.0008085384,0.0007203353,0.0046288935,0.074944906,0.0003150479,0.008596166,0.3261227],"study_design_scores_gemma":[0.4154598,0.46313906,0.09685159,0.0001538523,0.0034027721,0.0010972305,0.00024752374,0.0041843434,0.0057896986,0.0003487475,0.009243014,0.00008221827],"about_ca_topic_score_codex":0.0015426684,"about_ca_topic_score_gemma":0.0041673463,"teacher_disagreement_score":0.0017930306,"about_ca_system_score_codex":0.00087964686,"about_ca_system_score_gemma":0.000986424,"threshold_uncertainty_score":0.009482563},"labels":[],"label_agreement":null},{"id":"W4405585460","doi":"10.1111/bjh.19944","title":"Olutasidenib demonstrates significant clinical activity in mutated <i>IDH1</i> acute myeloid leukaemia arising from a prior myeloproliferative neoplasm","year":2024,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Medicine; Internal medicine; Myeloproliferative neoplasm; Gastroenterology; IDH1; Myeloid; Refractory (planetary science); Confidence interval; Adverse effect; Azacitidine; Myeloid leukaemia; Surgery; Oncology; Myelofibrosis; Bone marrow; Biology","score_opus":0.023683305550631133,"score_gpt":0.3325004295931669,"score_spread":0.30881712404253575,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405585460","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9962656,0.0023517495,0.00025621286,0.000038995822,0.000008946922,0.000024740304,0.00008035836,0.000031230775,0.00094232487],"genre_scores_gemma":[0.9988588,0.00051966665,0.00021551368,0.000034959194,0.000013253305,0.000008278393,0.0001739492,0.00000385677,0.0001716569],"study_design_codex":"bench_or_experimental","study_design_gemma":"case_report","domain_scores_codex":[0.99990165,0.00003777007,0.000011029371,0.0000144047535,0.000016007212,0.000019148152],"domain_scores_gemma":[0.9998455,0.000048091788,0.000035374498,0.0000115970315,0.000010774156,0.00004871235],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002504543,0.00021239223,0.00040631622,0.00014526393,0.00008248796,0.00022564299,0.00011045602,0.00015730901,0.0008575774],"category_scores_gemma":[0.00026276865,0.00007386624,0.00016000557,0.00014116682,0.00016048155,0.00010132618,0.00010935613,0.00042962824,0.0001734492],"study_design_candidate":"case_report","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.034397062,0.0028137802,0.047578838,0.0005179903,0.0002929938,0.0012380036,0.00014189498,0.0011530514,0.66797245,0.00015382326,0.00092035066,0.24281965],"study_design_scores_gemma":[0.012597249,0.2128131,0.37188375,0.000099886835,0.0007070731,0.013482888,0.0001440233,0.0038189173,0.3659037,0.00026401668,0.018244509,0.0000408326],"about_ca_topic_score_codex":0.00027955027,"about_ca_topic_score_gemma":0.0006514952,"teacher_disagreement_score":0.0008575774,"about_ca_system_score_codex":0.00017210898,"about_ca_system_score_gemma":0.00016911943,"threshold_uncertainty_score":0.0028689504},"labels":[],"label_agreement":null},{"id":"W4405880619","doi":"10.1111/bjh.19969","title":"Successful autologous haematopoietic stem cell transplantation in a refractory anti‐myelin‐associated glycoprotein antibody neuropathy","year":2024,"lang":"en","type":"letter","venue":"British Journal of Haematology","topic":"Peripheral Neuropathies and Disorders","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Stem cell; Transplantation; Immunology; Haematopoiesis; Medicine; Antibody; Biology; Internal medicine; Cell biology","score_opus":0.009893368139931233,"score_gpt":0.25211610471802715,"score_spread":0.2422227365780959,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405880619","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.73044723,0.012014267,0.0052870763,0.14343107,0.02106863,0.00062490755,0.0009978522,0.00058501033,0.08554392],"genre_scores_gemma":[0.90694517,0.004178732,0.0016733588,0.03762963,0.012165444,0.00012718527,0.00044300032,0.00009360594,0.03674386],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.99953854,0.00010307362,0.00005798444,0.000064936576,0.00010284562,0.00013260561],"domain_scores_gemma":[0.99877197,0.0007284804,0.000058033424,0.000080918646,0.00005154305,0.00030907991],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006925506,0.0008819128,0.0009719802,0.000771845,0.0018740543,0.0009522679,0.001063216,0.006981264,0.0018349637],"category_scores_gemma":[0.0029469794,0.0003927877,0.0010642066,0.00070419785,0.0013653297,0.00075065624,0.0006033165,0.00442314,0.0013652712],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007485984,0.00019703775,0.0011837045,0.00010187917,0.000035553032,0.97331613,0.00016431342,0.0005784255,0.0017640946,0.00078672945,0.011983797,0.009139648],"study_design_scores_gemma":[0.0013678358,0.0029216823,0.020943552,0.00026635156,0.00014527263,0.917792,0.00039584548,0.005537855,0.0054075,0.006748306,0.038381174,0.000092524424],"about_ca_topic_score_codex":0.0025219135,"about_ca_topic_score_gemma":0.0032041473,"teacher_disagreement_score":0.006981264,"about_ca_system_score_codex":0.0016412962,"about_ca_system_score_gemma":0.00066256477,"threshold_uncertainty_score":0.011908531},"labels":[],"label_agreement":null},{"id":"W4406044641","doi":"10.1111/bjh.19972","title":"Systemic lupus erythematosus‐associated autoantibodies in sickle cell disease: Spontaneous emergence in a patient and in transgenic sickle mice","year":2025,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Systemic Lupus Erythematosus Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"National Heart, Lung, and Blood Institute; Canadian Institutes of Health Research; National Institutes of Health","keywords":"Autoantibody; Medicine; Immunology; Autoimmunity; Antiphospholipid syndrome; Disease; Autoimmune disease; Immunopathology; Systemic lupus erythematosus; Antibody; Sickle cell anemia; Internal medicine","score_opus":0.008476728864202225,"score_gpt":0.26095123016762906,"score_spread":0.25247450130342686,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4406044641","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9979055,0.00029526523,0.00052343775,0.00014850154,0.000013831907,0.000012864802,0.00008594166,0.00004620637,0.0009684338],"genre_scores_gemma":[0.9990609,0.00017319144,0.00021105526,0.00008538576,0.000023954099,0.0000041307203,0.00007123927,0.000010495864,0.0003596644],"study_design_codex":"case_report","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99976784,0.00003880546,0.00003138417,0.000065766006,0.00005111863,0.000045147972],"domain_scores_gemma":[0.9993656,0.00015635516,0.00012877134,0.000049492653,0.000036932754,0.00026283207],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00026239065,0.0007457038,0.0004497461,0.00075779506,0.000791991,0.00062928855,0.00034156113,0.0013423024,0.00093235786],"category_scores_gemma":[0.0008072197,0.00028702203,0.00046887278,0.00041144408,0.0006387974,0.00037381914,0.0004847218,0.0008669982,0.00039313667],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007745422,0.0005234476,0.13444623,0.00009055837,0.000083818486,0.7146959,0.001757465,0.00049418287,0.13471496,0.0011559018,0.0007582638,0.010504766],"study_design_scores_gemma":[0.00008881161,0.00126829,0.085355416,0.00002233455,0.000094831135,0.8961666,0.00023579945,0.0013528252,0.01298025,0.0004483876,0.0019359421,0.00005052174],"about_ca_topic_score_codex":0.0006237211,"about_ca_topic_score_gemma":0.00045413038,"teacher_disagreement_score":0.0013423024,"about_ca_system_score_codex":0.0002453442,"about_ca_system_score_gemma":0.00019696535,"threshold_uncertainty_score":0.0031190515},"labels":[],"label_agreement":null},{"id":"W4406114877","doi":"10.1111/bjh.19984","title":"An approach to Hemequity: Identifying the barriers and facilitators of iron deficiency reduction strategies in low‐ to middle‐income countries","year":2025,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Child Nutrition and Water Access","field":"Nursing","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Michael's Hospital; University of Toronto; McMaster University","funders":"","keywords":"Iron deficiency; Low and middle income countries; Low income; Reduction (mathematics); Medicine; Environmental health; Business; Economic growth; Internal medicine; Socioeconomics; Developing country; Economics; Anemia","score_opus":0.014712830878825264,"score_gpt":0.2915485019699765,"score_spread":0.27683567109115126,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4406114877","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.06911085,0.5641364,0.031851906,0.2853808,0.0051636654,0.0071680374,0.0008175015,0.00014784692,0.036222924],"genre_scores_gemma":[0.4284209,0.3485141,0.14156538,0.056251347,0.000749782,0.014486352,0.00052219623,0.000103516264,0.009386369],"study_design_codex":"design_other","study_design_gemma":"qualitative","domain_scores_codex":[0.9579761,0.033577073,0.0029542847,0.001271384,0.002919698,0.0013014557],"domain_scores_gemma":[0.9383669,0.050164826,0.0024591705,0.001119462,0.0069552613,0.00093441154],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.06378928,0.0016526735,0.002752864,0.014329283,0.006367714,0.013403584,0.0033334452,0.004635129,0.0035368928],"category_scores_gemma":[0.06486674,0.0009800213,0.0023747582,0.010853986,0.0081960885,0.013791291,0.014062873,0.0057514706,0.00035762787],"study_design_candidate":"qualitative","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019675722,0.00031071034,0.010663083,0.12252233,0.0012415957,0.0014703214,0.27721655,0.0009001353,0.0013437915,0.11890696,0.02624696,0.43898082],"study_design_scores_gemma":[0.00015391133,0.000549453,0.008573632,0.214491,0.0020218887,0.0012070935,0.42041123,0.00088624173,0.0015470525,0.054965254,0.29506642,0.0001268277],"about_ca_topic_score_codex":0.010926104,"about_ca_topic_score_gemma":0.027422447,"teacher_disagreement_score":0.06378928,"about_ca_system_score_codex":0.014502012,"about_ca_system_score_gemma":0.05870229,"threshold_uncertainty_score":0.337354},"labels":[],"label_agreement":null},{"id":"W4407499244","doi":"10.1111/bjh.19995","title":"Fibrosis and treatment‐free remission in chronic myeloid leukaemia","year":2025,"lang":"en","type":"letter","venue":"British Journal of Haematology","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Jewish General Hospital; Centre intégré universitaire de santé et de services sociaux de la Mauricie-et-du-Centre-du-Québec; Hôpital du Sacré-Cœur de Montréal; Hôpital Maisonneuve-Rosemont; MPB Technologies & Communications (Canada); Hôpital Charles-Le Moyne; McGill University","funders":"","keywords":"Chronic myeloid leukaemia; Medicine; Fibrosis; Hematology; Spontaneous remission; Internal medicine; Oncology; Pathology; Alternative medicine","score_opus":0.014648414883871719,"score_gpt":0.2689435423935965,"score_spread":0.2542951275097248,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4407499244","genre_codex":"commentary","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.15097487,0.08551263,0.00025058095,0.68866223,0.0098746065,0.00006706665,0.00084583013,0.000035358193,0.06377676],"genre_scores_gemma":[0.758012,0.020896949,0.00037052826,0.17479143,0.014706942,0.00008556035,0.00054969924,0.000018022036,0.030568868],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9993174,0.00037691617,0.000063620006,0.00003564997,0.00014106186,0.00006542729],"domain_scores_gemma":[0.9982664,0.0011174747,0.00022001048,0.000057108213,0.00010263492,0.00023647817],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000998696,0.00007827209,0.00034217042,0.00042293017,0.0007471175,0.00040458466,0.0002605136,0.003408204,0.0037166572],"category_scores_gemma":[0.004779596,0.00009214375,0.00018958088,0.0005434314,0.00034879643,0.00041463083,0.0002596774,0.0019220547,0.0007600004],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0077188388,0.0008751797,0.06610465,0.0010025802,0.00013475958,0.04633392,0.00084498536,0.00049755623,0.004547833,0.018499482,0.57603085,0.27740943],"study_design_scores_gemma":[0.0026008138,0.0021704081,0.29731643,0.0012607492,0.00015962787,0.08169389,0.0010007914,0.0011418818,0.0012713835,0.03266644,0.5786315,0.00008607132],"about_ca_topic_score_codex":0.0020126307,"about_ca_topic_score_gemma":0.005625307,"teacher_disagreement_score":0.0037166572,"about_ca_system_score_codex":0.00088671147,"about_ca_system_score_gemma":0.0004509713,"threshold_uncertainty_score":0.01243341},"labels":[],"label_agreement":null},{"id":"W4408162287","doi":"10.1111/bjh.20038","title":"A low lymphocyte‐to‐monocyte ratio is independently associated with early relapse (POD24) in high tumour burden follicular lymphoma: A RELEVANCE subanalysis","year":2025,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Jewish General Hospital","funders":"Celgene","keywords":"Follicular lymphoma; Lymphoma; Medicine; Follicular phase; Lymphocyte; Immunology; Monocyte; Oncology; Internal medicine","score_opus":0.006197750062904729,"score_gpt":0.23811405283016207,"score_spread":0.23191630276725733,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4408162287","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99797636,0.0012587924,0.00015002041,0.000032213327,0.000007576026,0.00003180474,0.0003047793,0.0000063560906,0.00023212073],"genre_scores_gemma":[0.9991592,0.0001332834,0.00008326898,0.000024325222,0.000023766828,0.00003224265,0.000350282,0.000003825039,0.00018977675],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99915636,0.00033476175,0.00007477149,0.00017412669,0.00014038345,0.00011955711],"domain_scores_gemma":[0.99915385,0.0002754225,0.00023827374,0.00013270242,0.00008176526,0.000118093405],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0019750982,0.0004640124,0.001006414,0.00049726776,0.00026757488,0.00080390356,0.0006137684,0.0003913168,0.0012522927],"category_scores_gemma":[0.0016017791,0.00031690064,0.0017668919,0.0007376967,0.00026975368,0.00033255733,0.00071663695,0.00068127824,0.00016237386],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.012765845,0.00012553194,0.9732021,0.00018318657,0.0028181258,0.00019667095,0.00010104462,0.00023859974,0.001820345,0.000050942625,0.00048995134,0.008007639],"study_design_scores_gemma":[0.00044052384,0.0009170965,0.9948997,0.000013660958,0.0018074845,0.00031053406,0.000055067943,0.0006202812,0.00024911194,0.00007202682,0.0006066097,0.000007908852],"about_ca_topic_score_codex":0.0011452329,"about_ca_topic_score_gemma":0.0012823811,"teacher_disagreement_score":0.0019750982,"about_ca_system_score_codex":0.00023819512,"about_ca_system_score_gemma":0.0002524427,"threshold_uncertainty_score":0.010445476},"labels":[],"label_agreement":null},{"id":"W4408956531","doi":"10.1111/bjh.20055","title":"The wider perspective: Barriers and recommendations for transfusion support for patients with sickle cell disease in low‐ and middle‐income countries","year":2025,"lang":"en","type":"review","venue":"British Journal of Haematology","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; Kingston Health Sciences Centre; Queen's University","funders":"National Heart, Lung, and Blood Institute; National Institutes of Health; U.S. Department of Defense","keywords":"Medicine; Disease; Intensive care medicine; Blood transfusion; Low and middle income countries; Adverse effect; Disease burden; Immunology; Developing country; Internal medicine","score_opus":0.007139800407600179,"score_gpt":0.2768393549863169,"score_spread":0.2696995545787167,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4408956531","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00009767597,0.98534125,0.00010847211,0.012177003,0.00089049904,0.000008696844,0.000039429677,0.00000900803,0.0013280651],"genre_scores_gemma":[0.0011906403,0.9925392,0.00041910357,0.004557836,0.00057341345,0.000019452855,0.00006905396,0.0000028990214,0.00062843267],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9988619,0.00052845327,0.00018788839,0.00008259275,0.0002515949,0.0000875402],"domain_scores_gemma":[0.99719524,0.0015690251,0.00038670425,0.000040386265,0.00061658653,0.00019203665],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0024469912,0.00067546195,0.0012841191,0.001654139,0.00042412302,0.0023188232,0.0014093677,0.0028549766,0.008704634],"category_scores_gemma":[0.008070542,0.00023963429,0.0009759133,0.0017966374,0.00061100564,0.0028319533,0.0010509528,0.0033292861,0.0019879814],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000079821446,0.00006517758,0.00044447437,0.042894267,0.00020193141,0.00035661017,0.00045497916,0.0003401917,0.00024246518,0.0089989025,0.20202398,0.74389726],"study_design_scores_gemma":[0.000033867404,0.000041121395,0.0010490367,0.06595573,0.00021364416,0.00091123336,0.0007651662,0.00008199325,0.00005779116,0.004185887,0.9266781,0.000026381824],"about_ca_topic_score_codex":0.0044322438,"about_ca_topic_score_gemma":0.0065044207,"teacher_disagreement_score":0.008704634,"about_ca_system_score_codex":0.0013572101,"about_ca_system_score_gemma":0.0057009887,"threshold_uncertainty_score":0.029119909},"labels":[],"label_agreement":null},{"id":"W4408957618","doi":"10.1111/bjh.20061","title":"CD19 chimeric antigen receptor‐T cell therapy in murine immune thrombocytopenia","year":2025,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"Natural Science Foundation of Shandong Province; National Natural Science Foundation of China","keywords":"Chimeric antigen receptor; Immunology; CD19; Antigen; Immune thrombocytopenia; Medicine; Immune system; Receptor; Virology; T cell; Antibody; Internal medicine","score_opus":0.017159117864516304,"score_gpt":0.3131646132022168,"score_spread":0.2960054953377005,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4408957618","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.973684,0.0075828875,0.00936171,0.00046001966,0.00029873961,0.00039794017,0.0005946696,0.00054316316,0.007076972],"genre_scores_gemma":[0.99169815,0.002158873,0.0024486578,0.00010652026,0.000045161407,0.00020502634,0.00041316924,0.00003124357,0.0028932476],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9997789,0.000067426714,0.000013811117,0.000029758106,0.000048976523,0.000061095554],"domain_scores_gemma":[0.9999056,0.000021900625,0.000023535635,0.000015822912,0.000008879177,0.00002440427],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00027130562,0.0005668914,0.0004353574,0.0005178299,0.00014512977,0.00029642077,0.0002952759,0.0005888619,0.0015464688],"category_scores_gemma":[0.00012502108,0.000117539756,0.00028399407,0.00016983079,0.00025188323,0.00018020438,0.0001801276,0.00091728684,0.00038272984],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001820377,0.001321004,0.00034552263,0.00031122772,0.00005725694,0.0005146566,0.000074228956,0.0023207206,0.9584009,0.0018392635,0.0011921468,0.03180282],"study_design_scores_gemma":[0.001099376,0.014144405,0.0014686212,0.000032517084,0.00012589211,0.0013036383,0.000021960861,0.005139313,0.9559018,0.00030098332,0.020448992,0.000012404125],"about_ca_topic_score_codex":0.00055054104,"about_ca_topic_score_gemma":0.00049788004,"teacher_disagreement_score":0.0015464688,"about_ca_system_score_codex":0.00034051892,"about_ca_system_score_gemma":0.00026909276,"threshold_uncertainty_score":0.0051734447},"labels":[],"label_agreement":null},{"id":"W4409948315","doi":"10.1111/bjh.20092","title":"Anti‐<scp>PF4</scp> mediated thrombocytopenia and thrombosis associated with acute cytomegalovirus infection displays both <scp>HIT</scp>‐like and <scp>VITT</scp>‐like characteristics","year":2025,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Heparin-Induced Thrombocytopenia and Thrombosis","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hamilton Health Sciences; McMaster University","funders":"Public Health Agency; Canadian Institutes of Health Research; National Institute for Health and Care Research; Public Health Agency of Canada; British Heart Foundation; Heart and Stroke Foundation of Canada","keywords":"Medicine; Platelet factor 4; Immunology; Immune system; Thrombosis; Platelet; Hematology; Vaccination; Cytomegalovirus; Viral disease; Internal medicine; Herpesviridae; Virus","score_opus":0.01383163468911153,"score_gpt":0.26601613440405797,"score_spread":0.25218449971494644,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409948315","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9672866,0.003275035,0.0024733348,0.00082513195,0.00006207718,0.00007100032,0.00019845233,0.00013851034,0.025669893],"genre_scores_gemma":[0.9972109,0.0006165477,0.00057252677,0.00027779795,0.000066943685,0.000006388551,0.00013443606,0.000010655961,0.0011037375],"study_design_codex":"case_report","study_design_gemma":"observational","domain_scores_codex":[0.99974924,0.00004485825,0.000024249133,0.000031776854,0.00007114281,0.00007883011],"domain_scores_gemma":[0.99939966,0.00023773534,0.00017038386,0.000037963793,0.00005082196,0.00010335526],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017849616,0.0004069178,0.000293405,0.00073051726,0.00029438204,0.0004679644,0.00021670783,0.0007191861,0.0030645996],"category_scores_gemma":[0.0012055661,0.00016943224,0.00022255193,0.00051677076,0.00057852664,0.00030371928,0.0002860907,0.0005981566,0.00047990092],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00056699076,0.0001291802,0.2645692,0.0003123335,0.00008640634,0.63665897,0.00051054166,0.00038804603,0.044431355,0.0014235332,0.0032102505,0.04771316],"study_design_scores_gemma":[0.000025661584,0.0004112943,0.10343082,0.00003470271,0.000038509046,0.8867846,0.00013012778,0.0003915237,0.005205906,0.00038769553,0.0031471066,0.000012007802],"about_ca_topic_score_codex":0.0013301217,"about_ca_topic_score_gemma":0.0012528754,"teacher_disagreement_score":0.0030645996,"about_ca_system_score_codex":0.00023349021,"about_ca_system_score_gemma":0.00024018831,"threshold_uncertainty_score":0.010252118},"labels":[],"label_agreement":null},{"id":"W4409979015","doi":"10.1111/bjh.20131","title":"Acute splenomegaly, haemolysis, and thrombocytopenia following luspatercept initiation in a patient with transfusion‐dependent thalassaemia: A case report","year":2025,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Haemolysis; Medicine; Splenectomy; Blood transfusion; Intensive care medicine; Internal medicine; Immunology; Spleen","score_opus":0.005748460627671056,"score_gpt":0.2516875209674015,"score_spread":0.24593906033973043,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409979015","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95711845,0.011606723,0.004254926,0.009747382,0.00078973186,0.0003223375,0.0005582489,0.00032071723,0.01528141],"genre_scores_gemma":[0.99160635,0.0027664849,0.0011976081,0.0017201001,0.0011101677,0.000022617436,0.00012921123,0.000034640485,0.0014128414],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.9993369,0.000089468114,0.00008704607,0.00017659615,0.00010563014,0.00020420521],"domain_scores_gemma":[0.9982886,0.00050721155,0.0003556119,0.00008679254,0.0000832461,0.0006785409],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003920416,0.0017405719,0.0014894982,0.0026480476,0.0020559495,0.0022181598,0.0012220575,0.0052542714,0.0020978893],"category_scores_gemma":[0.0025558455,0.001282049,0.0013999388,0.0017795338,0.001654284,0.0022855296,0.0014885964,0.0050473604,0.00081515696],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000022499471,0.000025223891,0.0024450724,0.000018891442,0.000005996653,0.99624395,0.00012000136,0.000046554145,0.00025688283,0.00006139225,0.00023255571,0.0005209595],"study_design_scores_gemma":[0.000006612701,0.000051824372,0.0022008582,0.000012036567,0.000009873486,0.9970367,0.000088595414,0.0001369139,0.00014370886,0.000066692606,0.00023818259,0.000008115536],"about_ca_topic_score_codex":0.003148802,"about_ca_topic_score_gemma":0.0032638484,"teacher_disagreement_score":0.0052542714,"about_ca_system_score_codex":0.0016788227,"about_ca_system_score_gemma":0.0008706005,"threshold_uncertainty_score":0.012180805},"labels":[],"label_agreement":null},{"id":"W4410110295","doi":"10.1111/bjh.20115","title":"An international real‐world study of primary vitreoretinal lymphoma from the Australasian lymphoma alliance and collaborators","year":2025,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"CNS Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"Celgene; Gilead Sciences; AstraZeneca; Bristol-Myers Squibb","keywords":"Medicine; Internal medicine; Hazard ratio; Oncology; Lymphoma; Retrospective cohort study; Primary central nervous system lymphoma; Systemic therapy; Cumulative incidence; Cohort; Cancer","score_opus":0.0103177385679048,"score_gpt":0.28765248607657906,"score_spread":0.27733474750867426,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4410110295","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9952429,0.0006354933,0.00017494509,0.00014075452,0.000010874264,0.00008746233,0.0026931665,0.0000037046261,0.0010107073],"genre_scores_gemma":[0.99604475,0.00028288207,0.00020241557,0.0000865225,0.000025545143,0.000086226864,0.0029577336,0.000006508959,0.0003073785],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981395,0.0007590327,0.00018547807,0.00039899116,0.00028123797,0.00023563817],"domain_scores_gemma":[0.9934556,0.0009935763,0.0028518836,0.00096034375,0.00082892197,0.00090972526],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003614368,0.00040367545,0.00044138817,0.0008336588,0.00058645196,0.0010957984,0.00048927777,0.00042620627,0.001439561],"category_scores_gemma":[0.0075078593,0.00034384272,0.00044240546,0.001971402,0.0003464395,0.00068225997,0.0011551518,0.00069531525,0.00045696253],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007302446,0.00011479565,0.9931536,0.000066545406,0.00020875469,0.00022737042,0.0005658623,0.00009158227,0.0001893816,0.000082004066,0.0009255588,0.003644196],"study_design_scores_gemma":[0.00014871416,0.00041968163,0.99416035,0.000051654468,0.00021937964,0.0012178795,0.00060893974,0.00018122527,0.0000881784,0.000075457225,0.0028090987,0.000019367008],"about_ca_topic_score_codex":0.017520586,"about_ca_topic_score_gemma":0.014741678,"teacher_disagreement_score":0.017520586,"about_ca_system_score_codex":0.0009331982,"about_ca_system_score_gemma":0.0011058542,"threshold_uncertainty_score":0.034837186},"labels":[],"label_agreement":null},{"id":"W4410110360","doi":"10.1111/bjh.20132","title":"Distinct characteristics and social determinants in adult T‐cell leukaemia/lymphoma patients at a tertiary cancer centre in Canada","year":2025,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"T-cell and Retrovirus Studies","field":"Immunology and Microbiology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"Canadian Cancer Society; Princess Margaret Cancer Foundation","keywords":"Medicine; Lymphoma; Cohort; Internal medicine; Cancer; Young adult; Malignancy; Transplantation; Population; Cohort study; Pediatrics","score_opus":0.0036334587930831486,"score_gpt":0.19961964798549622,"score_spread":0.19598618919241306,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4410110360","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9989421,0.000120745586,0.000017897457,0.00009070998,0.0000022938234,0.000009866059,0.00020717751,0.0000022690635,0.00060700136],"genre_scores_gemma":[0.999605,0.000080563455,0.000020899051,0.000035794987,0.0000025862946,0.0000033195447,0.00011154631,0.0000012809829,0.00013904793],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.999539,0.0000418851,0.000029950694,0.000048435315,0.00010659922,0.00023413493],"domain_scores_gemma":[0.99895465,0.00008341094,0.0002700031,0.000018294822,0.00022275798,0.00045085163],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016507284,0.00020602469,0.00024960874,0.0009389906,0.0020316183,0.0010917011,0.00059401296,0.00036660006,0.0020711825],"category_scores_gemma":[0.0010622734,0.00020442758,0.00017296412,0.0022280791,0.0008428716,0.00023903372,0.0007171493,0.0005196822,0.00018905938],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000044711243,0.000020898658,0.9968027,0.000011235791,0.000008553952,0.00038482147,0.0009035732,0.000030448808,0.00024401443,0.000037706555,0.0001956473,0.0013157405],"study_design_scores_gemma":[0.0000031286454,0.00003554742,0.9954786,0.0000114135155,0.0000064659525,0.0003894728,0.0035588446,0.000111918765,0.000040125793,0.000020839772,0.00033701595,0.0000066958773],"about_ca_topic_score_codex":0.8909662,"about_ca_topic_score_gemma":0.9148863,"teacher_disagreement_score":0.10903382,"about_ca_system_score_codex":0.008059216,"about_ca_system_score_gemma":0.0076846615,"threshold_uncertainty_score":0.21935183},"labels":[],"label_agreement":null},{"id":"W4410380473","doi":"10.1111/bjh.20153","title":"Real‐world outcomes of vacuoles, E1 enzyme, X‐linked, autoinflammatory, somatic syndrome at a tertiary referral centre","year":2025,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Otitis Media and Relapsing Polychondritis","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Dalhousie University; University of British Columbia","funders":"","keywords":"Tertiary referral centre; Referral; Medicine; Tertiary care; Vacuole; Internal medicine; Dermatology; Family medicine; Biology; Biochemistry","score_opus":0.009101618304577837,"score_gpt":0.2677795649325124,"score_spread":0.2586779466279346,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4410380473","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9829145,0.0026309018,0.0006607146,0.0030821078,0.00018572577,0.0001533247,0.0012200207,0.00007190298,0.009080815],"genre_scores_gemma":[0.99571383,0.00067315646,0.00038079653,0.0014037683,0.0002820582,0.000033007767,0.00063536427,0.00002328352,0.0008548012],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99913365,0.0001210867,0.00011684663,0.00019732138,0.00016800323,0.0002630755],"domain_scores_gemma":[0.9966905,0.00033543413,0.000641311,0.000115960196,0.00029886756,0.0019179041],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00047755832,0.00043873137,0.00048388,0.0005657624,0.0020727236,0.0014379437,0.0007066113,0.0014122933,0.008058576],"category_scores_gemma":[0.0023519727,0.00024592315,0.0003719463,0.0010627776,0.00084889325,0.0009586977,0.0012749303,0.0017831849,0.0011010347],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00083817536,0.00083664083,0.6914368,0.00045320689,0.00015494782,0.2677519,0.0019696702,0.00085379364,0.0029236744,0.0013253712,0.014017477,0.017438324],"study_design_scores_gemma":[0.00020646372,0.002416612,0.4841298,0.00076604134,0.00014135908,0.49263173,0.0053204545,0.0016823083,0.00088777725,0.001827815,0.009834156,0.00015547319],"about_ca_topic_score_codex":0.0072140833,"about_ca_topic_score_gemma":0.011392624,"teacher_disagreement_score":0.008058576,"about_ca_system_score_codex":0.0033458997,"about_ca_system_score_gemma":0.0018430399,"threshold_uncertainty_score":0.026958644},"labels":[],"label_agreement":null},{"id":"W4410544331","doi":"10.1111/bjh.20058","title":"Long‐term efficacy and safety of mitapivat in non‐transfusion‐dependent α‐ or β‐thalassaemia: An open‐label phase 2 study","year":2025,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"Agios Pharmaceuticals","keywords":"Medicine; Haemolysis; Adverse effect; Pyruvate kinase; Pyruvate kinase deficiency; Internal medicine; Anemia; Erythropoiesis; Ineffective erythropoiesis; Gastroenterology; Immunology; Metabolism; Glycolysis","score_opus":0.019596948676217314,"score_gpt":0.34064619538657837,"score_spread":0.32104924671036106,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4410544331","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9920696,0.003865971,0.00057185825,0.00025289014,0.00009792686,0.0009587968,0.0008546025,0.000111047804,0.0012172995],"genre_scores_gemma":[0.99096537,0.0024381857,0.0009557237,0.0007524848,0.00020278366,0.0011595781,0.0015602803,0.000029148801,0.0019364215],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9996505,0.0001478852,0.000025522035,0.00006254565,0.00005116169,0.000062493185],"domain_scores_gemma":[0.9992461,0.0001708523,0.00021468403,0.000071226925,0.00007246356,0.00022469807],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014442586,0.00089901296,0.001740615,0.00026507027,0.00033143058,0.00095906405,0.0005787668,0.000976783,0.0035765027],"category_scores_gemma":[0.0011732879,0.00035627096,0.0010893123,0.00024537885,0.0005342135,0.00087919435,0.00021200762,0.0023373833,0.0007340235],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.65936935,0.06707695,0.00760416,0.002245041,0.0029105681,0.00066067127,0.0004615797,0.0023147538,0.07256975,0.0002550897,0.0056367517,0.1788953],"study_design_scores_gemma":[0.3548708,0.59972155,0.029305942,0.000140538,0.0011514915,0.0009904426,0.00010089005,0.0018814987,0.006443135,0.0003027199,0.005024606,0.000066367415],"about_ca_topic_score_codex":0.0002073674,"about_ca_topic_score_gemma":0.00048797758,"teacher_disagreement_score":0.0035765027,"about_ca_system_score_codex":0.00035971965,"about_ca_system_score_gemma":0.00051224447,"threshold_uncertainty_score":0.011964619},"labels":[],"label_agreement":null},{"id":"W4411041284","doi":"10.1111/bjh.20178","title":"Risk factors for immediate postpartum sickle cell disease‐specific maternal morbidity","year":2025,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Lunenfeld-Tanenbaum Research Institute; Mount Sinai Hospital; University of Toronto; University Health Network","funders":"","keywords":"Medicine; Acute chest syndrome; Pregnancy; Complication; Hypoxia (environmental); Univariate analysis; Obstetrics; Postpartum period; Incidence (geometry); Retrospective cohort study; Vaso-occlusive crisis; Disease; Surgery; Multivariate analysis; Internal medicine; Sickle cell anemia","score_opus":0.009967978040826959,"score_gpt":0.24674437538190394,"score_spread":0.23677639734107697,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411041284","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9983998,0.00063197,0.000103319326,0.00007547356,0.000009069363,0.000005607416,0.00021895346,0.0000049810888,0.00055081706],"genre_scores_gemma":[0.99958616,0.00015280434,0.00006414375,0.000012571421,0.0000075930093,0.0000032548492,0.000091032256,7.304421e-7,0.00008178294],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99980205,0.00006246077,0.00002320344,0.00003409072,0.00003536918,0.000042783777],"domain_scores_gemma":[0.99925905,0.0001737052,0.0003695395,0.000047067515,0.000042629348,0.000108009895],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003294481,0.00011116779,0.00016403617,0.00025518786,0.00015958185,0.0002486368,0.00018966007,0.00020766577,0.001589247],"category_scores_gemma":[0.0018483873,0.00013259765,0.0002264415,0.0003267758,0.00014103188,0.00012319283,0.00018172713,0.00034895638,0.0000822251],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000025310368,0.000006379087,0.99891233,0.0000053957274,0.000016864473,0.00008493915,0.000014961671,0.000016527485,0.000069129834,0.000010953826,0.0000500936,0.0007869812],"study_design_scores_gemma":[0.000001365484,0.000039804716,0.99918026,0.000009074367,0.0000143850975,0.00044150537,0.00005062608,0.0001090263,0.0000373099,0.000017352088,0.00009792618,0.0000014447936],"about_ca_topic_score_codex":0.00267945,"about_ca_topic_score_gemma":0.0028363236,"teacher_disagreement_score":0.00267945,"about_ca_system_score_codex":0.00014175048,"about_ca_system_score_gemma":0.00023956646,"threshold_uncertainty_score":0.005327761},"labels":[],"label_agreement":null},{"id":"W4411391466","doi":"10.1111/bjh.20203","title":"Efficacy and safety of oral decitabine/cedazuridine in the chronic myelomonocytic leukaemia subpopulations from phase 2 and 3 studies","year":2025,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Queen Elizabeth II Health Sciences Centre; McMaster University; Health Sciences Centre; Sunnybrook Health Science Centre","funders":"Taiho Oncology","keywords":"Decitabine; Chronic myelomonocytic leukemia; Medicine; Internal medicine; Myelodysplastic syndromes; Oncology; Azacitidine; Prospective cohort study; Clinical trial; International Prognostic Scoring System; Gastroenterology; Bone marrow","score_opus":0.03687991850905249,"score_gpt":0.38576371445286745,"score_spread":0.34888379594381497,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411391466","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99010766,0.007586098,0.0002714164,0.0001046092,0.000015780455,0.0002189557,0.00032914063,0.000014877291,0.001351496],"genre_scores_gemma":[0.996997,0.0015429651,0.00030584307,0.00010971338,0.000016727337,0.00011764287,0.00042204492,0.0000047873827,0.0004832642],"study_design_codex":"design_other","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99957365,0.00019960768,0.000040877756,0.000055320266,0.00007545364,0.000055063723],"domain_scores_gemma":[0.99948347,0.00016398473,0.00016204751,0.000039689192,0.000056611218,0.00009418494],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012518776,0.000264471,0.00092941156,0.0002729227,0.00021055757,0.00048623062,0.00014663821,0.00029855676,0.0015377165],"category_scores_gemma":[0.00097281084,0.00013261825,0.0004896295,0.00026110915,0.00023353743,0.00025285725,0.0002145663,0.0005253497,0.00016704526],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.2532169,0.006148482,0.0919023,0.0017342359,0.0015693401,0.0007976811,0.00046876192,0.0037183564,0.19993994,0.0005320411,0.0021443053,0.43782774],"study_design_scores_gemma":[0.0447953,0.45977712,0.34622496,0.00046076532,0.003321987,0.003978375,0.0003545305,0.0038031999,0.10248952,0.0006122222,0.034061704,0.00012024035],"about_ca_topic_score_codex":0.00043989977,"about_ca_topic_score_gemma":0.0012238427,"teacher_disagreement_score":0.0015377165,"about_ca_system_score_codex":0.00041791052,"about_ca_system_score_gemma":0.0004076042,"threshold_uncertainty_score":0.0066206455},"labels":[],"label_agreement":null},{"id":"W4411531910","doi":"10.1111/bjh.20221","title":"Lamotrigine and anti‐seizure medications in <scp>HLH</scp>: A systematic review","year":2025,"lang":"en","type":"review","venue":"British Journal of Haematology","topic":"Autoimmune and Inflammatory Disorders Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; Dalhousie University","funders":"","keywords":"Lamotrigine; Pathological; Medicine; Histiocytosis; Bone marrow; Pathology; Immunology; Epilepsy; Disease; Psychiatry","score_opus":0.02125405717224143,"score_gpt":0.35235695176816223,"score_spread":0.3311028945959208,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411531910","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0002531963,0.9992488,0.000027904487,0.00009445641,0.000045805427,0.00002231995,0.00013108946,0.000003494362,0.00017304024],"genre_scores_gemma":[0.0020140107,0.997497,0.00008297734,0.00016407842,0.000034702047,0.000031057298,0.00008689385,0.0000014500058,0.0000878066],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9991579,0.00018725885,0.00032710668,0.00008722075,0.00019044153,0.000050071903],"domain_scores_gemma":[0.9965957,0.0022510237,0.0007047796,0.000040259532,0.00033966405,0.00006859273],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013151203,0.0009297375,0.0040601743,0.004999091,0.00032134217,0.0012159743,0.0012388062,0.0011112441,0.008061854],"category_scores_gemma":[0.005833486,0.00046337614,0.0034312115,0.0055231745,0.00032130236,0.0010606332,0.00082710723,0.00060233945,0.00062123826],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002534976,0.00002218386,0.00044429113,0.8474103,0.0035355089,0.00013896618,0.000115155366,0.00011064925,0.00026123086,0.0003108629,0.006858581,0.1405387],"study_design_scores_gemma":[0.00028325786,0.00027526863,0.0053989585,0.8418246,0.046984714,0.0012298049,0.00024917495,0.00009004727,0.00024553842,0.0005044282,0.102868415,0.000045888777],"about_ca_topic_score_codex":0.005451149,"about_ca_topic_score_gemma":0.015049646,"teacher_disagreement_score":0.008061854,"about_ca_system_score_codex":0.0010866977,"about_ca_system_score_gemma":0.0036933005,"threshold_uncertainty_score":0.026969612},"labels":[],"label_agreement":null},{"id":"W4411966677","doi":"10.1111/bjh.20239","title":"Therapeutic advances and gradual improvement in overall survival in mantle cell lymphoma over four decades","year":2025,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"Incyte; BeiGene; AstraZeneca; Celgene; Gilead Sciences; Eli Lilly and Company","keywords":"Mantle cell lymphoma; Lymphoma; Medicine; Mantle (geology); Cancer research; Oncology; Internal medicine; Intensive care medicine; Geology; Geochemistry","score_opus":0.010890812951829193,"score_gpt":0.2748953398795863,"score_spread":0.2640045269277571,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411966677","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.6258573,0.27595636,0.003906338,0.041453965,0.0017529681,0.00006702516,0.010976273,0.00032219823,0.03970763],"genre_scores_gemma":[0.9630318,0.027664615,0.0007693566,0.002670319,0.000510101,0.000034288896,0.002760274,0.0000392118,0.002520154],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9993297,0.00021416617,0.00006640015,0.00012150344,0.000123328,0.00014497705],"domain_scores_gemma":[0.99773693,0.0007169124,0.00072089536,0.00015880416,0.00035806175,0.00030844615],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016309354,0.00011192021,0.00029350657,0.0005445482,0.00021182376,0.0008777534,0.00028285888,0.00052560086,0.0045104222],"category_scores_gemma":[0.0063222293,0.00007038725,0.00035781713,0.0010891219,0.0002616664,0.00068834657,0.00045976893,0.00092084997,0.00089561095],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005293334,0.00018211668,0.18143724,0.002052327,0.00060911546,0.0013759185,0.0011708381,0.0027723305,0.005974279,0.0065454277,0.029253932,0.7633332],"study_design_scores_gemma":[0.00016904219,0.0018689855,0.7706983,0.001582567,0.0008778039,0.005100007,0.0011704304,0.0009466113,0.003238548,0.0066721584,0.20762165,0.000053910753],"about_ca_topic_score_codex":0.0017749936,"about_ca_topic_score_gemma":0.0020614746,"teacher_disagreement_score":0.0045104222,"about_ca_system_score_codex":0.00080109475,"about_ca_system_score_gemma":0.0011059121,"threshold_uncertainty_score":0.015088916},"labels":[],"label_agreement":null},{"id":"W4412055944","doi":"10.1111/bjh.20246","title":"Laboratory assessment of fetomaternal haemorrhage and Rh immune globulin management: Canadian practice and scoping review","year":2025,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Blood groups and transfusion","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Alberta; University Health Network; University of Toronto; Mount Sinai Hospital; Health Sciences Centre; Queen's University; Sunnybrook Health Science Centre","funders":"Health Canada; University of Toronto; Canadian Blood Services; Australian Government","keywords":"Medicine; Flow cytometry; Immunology; Antibody; Test (biology); Obstetrics; Biology","score_opus":0.004839632321260927,"score_gpt":0.30907197856505975,"score_spread":0.3042323462437988,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412055944","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0004428044,0.9945263,0.00024438536,0.0020758072,0.00023950131,0.0001547089,0.00042340282,0.000013281318,0.0018798055],"genre_scores_gemma":[0.0059932163,0.99106795,0.0011916218,0.0007590867,0.00009283842,0.00018317155,0.0004397671,0.000008542198,0.0002638868],"study_design_codex":"design_other","study_design_gemma":"systematic_review","domain_scores_codex":[0.9910226,0.0020862476,0.0038815804,0.00059709814,0.0020811814,0.00033136024],"domain_scores_gemma":[0.9375317,0.031338967,0.007881041,0.00083454396,0.02127577,0.0011380026],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.012473854,0.0012792497,0.003811567,0.031521384,0.001643257,0.0047322684,0.0034912345,0.002889606,0.00488637],"category_scores_gemma":[0.07057914,0.0012395574,0.0032596318,0.037781753,0.0016500022,0.0029834884,0.0024727958,0.0016572507,0.00065445737],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013557004,0.000036535115,0.0047925934,0.4570413,0.0014841318,0.0007936821,0.0017425258,0.0006919174,0.00027972175,0.00248097,0.03465785,0.4958632],"study_design_scores_gemma":[0.00003779569,0.000035053643,0.0077304756,0.8542985,0.0036004763,0.0008369661,0.0007547944,0.00022616939,0.00011007752,0.000742957,0.13156357,0.000063135325],"about_ca_topic_score_codex":0.3189309,"about_ca_topic_score_gemma":0.3989775,"teacher_disagreement_score":0.68106914,"about_ca_system_score_codex":0.018861365,"about_ca_system_score_gemma":0.06698774,"threshold_uncertainty_score":0.634149},"labels":[],"label_agreement":null},{"id":"W4412184701","doi":"10.1111/bjh.70000","title":"Feasibility, safety and efficacy of intranasal fentanyl in the treatment of acute pain episodes among adults with sickle cell disease: A retrospective single‐centre study","year":2025,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Centre Hospitalier de l’Université de Montréal; Université de Montréal","funders":"","keywords":"Medicine; Retrospective cohort study; Nasal administration; Fentanyl; Disease; Acute pain; Anesthesia; Internal medicine; Pediatrics; Pharmacology","score_opus":0.005163710993248907,"score_gpt":0.23991376985284754,"score_spread":0.23475005885959863,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412184701","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9965783,0.0022386322,0.00025150567,0.000042093427,0.000019160758,0.00023755824,0.00033598763,0.0000032310566,0.0002935966],"genre_scores_gemma":[0.9983518,0.00066985545,0.00030626246,0.000094480936,0.000047601963,0.00010994222,0.00033339916,0.000004476482,0.000082114326],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.995572,0.0011297676,0.0010887523,0.0008351623,0.0011161962,0.00025806276],"domain_scores_gemma":[0.9903501,0.0021546762,0.0045288326,0.00063567597,0.0015572221,0.00077344896],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004192888,0.00037962478,0.0012593745,0.00094112457,0.00055194076,0.0013450461,0.000651092,0.0008008433,0.0015598773],"category_scores_gemma":[0.009292859,0.0005919893,0.0014416813,0.0012029279,0.0006907834,0.0008964429,0.0006086679,0.0008202615,0.000448322],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016632482,0.00042287525,0.9928041,0.00032436667,0.0004083381,0.00034758472,0.00052020146,0.000050319857,0.0003983262,0.000028377763,0.00013605799,0.0028962146],"study_design_scores_gemma":[0.00030604008,0.0072721336,0.9879177,0.00012707488,0.000538601,0.0015926005,0.0009575727,0.0003296279,0.00018153488,0.000029609359,0.0007090649,0.000038464575],"about_ca_topic_score_codex":0.0023130379,"about_ca_topic_score_gemma":0.002273334,"teacher_disagreement_score":0.004192888,"about_ca_system_score_codex":0.00077411154,"about_ca_system_score_gemma":0.001124902,"threshold_uncertainty_score":0.022174358},"labels":[],"label_agreement":null},{"id":"W4412461972","doi":"10.1111/bjh.70012","title":"Distinct patient, tumour and chimeric antigen receptor T‐cell characteristics are associated with initiating versus sustaining responses to idecabtagene vicleucel in relapsed and refractory multiple myeloma","year":2025,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Bristol-Myers Squibb Canada","keywords":"Chimeric antigen receptor; Cytokine release syndrome; Multiple myeloma; Antigen; Medicine; Cancer research; Refractory (planetary science); Immunology; T cell; Oncology; Biology; Immune system","score_opus":0.019908754751251426,"score_gpt":0.2897263368892645,"score_spread":0.2698175821380131,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412461972","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9995939,0.0001419788,0.00003764594,0.000008306968,0.0000011109462,0.0000043090477,0.000042442964,0.0000031373904,0.00016720755],"genre_scores_gemma":[0.99970573,0.000028694756,0.000035707828,0.00001119687,0.0000028836075,0.000004303132,0.000093625065,0.0000015671847,0.00011629347],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9997366,0.00007548839,0.000029833736,0.000051434934,0.00005248913,0.000054194268],"domain_scores_gemma":[0.9991897,0.00030375095,0.00027525093,0.00005223217,0.000035697256,0.00014332029],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00058653334,0.00014000204,0.0003926973,0.0002786089,0.00014333337,0.00034760416,0.00014815881,0.000305197,0.0011053965],"category_scores_gemma":[0.0011105705,0.000099375546,0.00022015144,0.00028553916,0.00021549896,0.00024425422,0.00016261108,0.0003854829,0.00016539614],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.020957991,0.0007908362,0.82399803,0.00007702422,0.00020382185,0.0012830589,0.00032694373,0.0010803987,0.11686478,0.00013072656,0.00026264333,0.03402378],"study_design_scores_gemma":[0.0001019264,0.0062014763,0.9846747,0.0000041092053,0.00008247987,0.0019965728,0.00009617966,0.0007713917,0.0054589515,0.00007511769,0.00052686,0.000010342822],"about_ca_topic_score_codex":0.0002484747,"about_ca_topic_score_gemma":0.0005088312,"teacher_disagreement_score":0.0011053965,"about_ca_system_score_codex":0.00026596594,"about_ca_system_score_gemma":0.00019961793,"threshold_uncertainty_score":0.0036979318},"labels":[],"label_agreement":null},{"id":"W4412522403","doi":"10.1111/bjh.70006","title":"Impact of graft‐versus‐host disease prophylaxis on second primary malignancies after allogeneic haematopoietic stem cell transplantation","year":2025,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Medicine; Cumulative incidence; Hazard ratio; Internal medicine; Transplantation; Graft-versus-host disease; Incidence (geometry); Hematopoietic stem cell transplantation; Population; Cyclophosphamide; Anti-thymocyte globulin; Immunosuppression; Gastroenterology; Complication; Immunology; Chemotherapy; Confidence interval","score_opus":0.010243267193849872,"score_gpt":0.2603578642506921,"score_spread":0.2501145970568422,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412522403","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9929818,0.0061553055,0.00011515921,0.00005748976,0.0000256675,0.0000054587276,0.000044565266,0.0000059049944,0.00060864113],"genre_scores_gemma":[0.9991161,0.00066791434,0.000035537098,0.000024328627,0.000024420351,0.0000016671626,0.000053108564,0.0000010281206,0.00007582895],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99952006,0.00021800335,0.00003686635,0.00004600811,0.000100682424,0.000078478726],"domain_scores_gemma":[0.99874425,0.00051574316,0.0004002008,0.000053162206,0.00005850063,0.00022824248],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006318023,0.00016330315,0.00045327816,0.00017963586,0.00010636414,0.00036292188,0.000101014186,0.00013346976,0.0007501481],"category_scores_gemma":[0.0016425406,0.00004108565,0.00054806616,0.00018289895,0.00013391122,0.00013298701,0.00019299131,0.00035331261,0.000082319246],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.012755841,0.000671386,0.7659062,0.00040515035,0.0013784758,0.0008444792,0.0000723562,0.0019037139,0.006762031,0.00015114997,0.00053055113,0.20861867],"study_design_scores_gemma":[0.00019928592,0.014677393,0.97779435,0.000075517586,0.00074277027,0.0018506666,0.000048166065,0.0006809702,0.0025062594,0.00008223744,0.0013341564,0.0000082951665],"about_ca_topic_score_codex":0.0003014521,"about_ca_topic_score_gemma":0.00082177337,"teacher_disagreement_score":0.0007501481,"about_ca_system_score_codex":0.00017600719,"about_ca_system_score_gemma":0.0002710913,"threshold_uncertainty_score":0.0033413768},"labels":[],"label_agreement":null},{"id":"W4412809101","doi":"10.1111/bjh.70040","title":"A new unstable haemoglobin, Hb Alger, causes a transfusion‐dependent anaemia in early childhood","year":2025,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Hemoglobin structure and function","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Pediatrics","score_opus":0.003846316004248597,"score_gpt":0.2218219087832292,"score_spread":0.2179755927789806,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412809101","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97246855,0.013249978,0.0027796372,0.0008583685,0.00030882,0.00013123822,0.0006900758,0.00021063972,0.0093026925],"genre_scores_gemma":[0.99223137,0.0030481382,0.0013247449,0.00035175937,0.00019286296,0.000013762784,0.00025951065,0.000026691918,0.0025510506],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.9997125,0.000029366187,0.000030577503,0.00006311532,0.00007893561,0.00008546883],"domain_scores_gemma":[0.999529,0.00013623414,0.00015914039,0.000017720871,0.00004659647,0.000111336536],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016250568,0.0008149469,0.00057544286,0.001355563,0.001040044,0.00057665573,0.00034594542,0.0008063337,0.00210155],"category_scores_gemma":[0.0009632972,0.00024858656,0.00025311534,0.0008291273,0.000656184,0.00046681648,0.00052402564,0.0007696519,0.00031766534],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010893177,0.00008632387,0.092218086,0.00023509272,0.000032801865,0.8794936,0.0009928547,0.00013691474,0.009882345,0.001205624,0.0019725398,0.013634767],"study_design_scores_gemma":[0.0000045571496,0.00008930703,0.06619479,0.00005578037,0.00003208134,0.9274507,0.00025224764,0.00009349323,0.0016245411,0.00016657944,0.0040258523,0.000010135328],"about_ca_topic_score_codex":0.0039780904,"about_ca_topic_score_gemma":0.004923111,"teacher_disagreement_score":0.0039780904,"about_ca_system_score_codex":0.00063190196,"about_ca_system_score_gemma":0.00051553565,"threshold_uncertainty_score":0.007909894},"labels":[],"label_agreement":null},{"id":"W4413035574","doi":"10.1111/bjh.70066","title":"Blood donor populations reveal a clear association between ferritin and change in haemoglobin levels","year":2025,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Iron Metabolism and Disorders","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"AABB Foundation; Stichting Sanquin Bloedvoorziening","keywords":"Ferritin; Iron deficiency; Serum ferritin; Iron status; Population; Blood donor; Medicine; Whole blood; Hemoglobin; Blood donations; Physiology; Immunology; Anemia; Internal medicine; Environmental health","score_opus":0.03860780220432686,"score_gpt":0.3182051715922488,"score_spread":0.27959736938792196,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4413035574","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9965249,0.0009342491,0.0009651149,0.00009585787,0.000012762425,0.00001177075,0.00024830515,0.000013267633,0.0011939255],"genre_scores_gemma":[0.99935573,0.00009621052,0.00016920936,0.000052458425,0.00000746623,0.000004557395,0.000114571,0.0000043746777,0.0001953958],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984976,0.00064670644,0.00016423236,0.00033014728,0.00023671165,0.00012453478],"domain_scores_gemma":[0.9961702,0.0018320546,0.00096963986,0.0005192326,0.00034334484,0.00016561046],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0028121541,0.00016284056,0.00040496278,0.00070754054,0.00022894415,0.00075723446,0.00023439425,0.00043675888,0.0018959704],"category_scores_gemma":[0.0056219287,0.00016824751,0.0002907812,0.00080865243,0.00061544485,0.00040105128,0.0005964729,0.0005481769,0.00031401677],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00038998012,0.000037372025,0.98577476,0.000035070323,0.00011670536,0.00010290994,0.00065581285,0.000106914544,0.0014316888,0.00018045986,0.00019454595,0.010973716],"study_design_scores_gemma":[0.000005869818,0.00016733768,0.99721044,0.000013768451,0.000043493776,0.0006536526,0.0003730482,0.00014597984,0.00036148867,0.00025441885,0.0007629011,0.000007636733],"about_ca_topic_score_codex":0.0012853874,"about_ca_topic_score_gemma":0.0013026511,"teacher_disagreement_score":0.0028121541,"about_ca_system_score_codex":0.00018003333,"about_ca_system_score_gemma":0.00014247342,"threshold_uncertainty_score":0.014872253},"labels":[],"label_agreement":null},{"id":"W4413666823","doi":"10.1111/bjh.70123","title":"Outcomes and risk factors for complications in deletional haemoglobin H disease: A retrospective longitudinal cohort study in British Columbia, Canada","year":2025,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"St. Paul's Hospital; BC Children's Hospital; University of British Columbia","funders":"BC Children's Hospital","keywords":"Medicine; Retrospective cohort study; Cohort; Pediatrics; Disease; Thalassemia; Cohort study; Internal medicine","score_opus":0.0079451962729693,"score_gpt":0.2585228237179897,"score_spread":0.2505776274450204,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4413666823","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.985609,0.002319062,0.00022403606,0.0005180978,0.000039135102,0.00016051147,0.008883856,0.000019600899,0.002226721],"genre_scores_gemma":[0.99275184,0.0016687555,0.00038584822,0.0004221402,0.000016643933,0.00010128302,0.0033473289,0.000014244881,0.0012918734],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985031,0.00013459436,0.00013121242,0.00034348082,0.0004122599,0.00047547813],"domain_scores_gemma":[0.9963547,0.00016583681,0.0004981782,0.00018577978,0.0016956362,0.0010999244],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009791175,0.00061617733,0.0007740304,0.001905567,0.004348852,0.002087409,0.0025695416,0.0010152637,0.0022527324],"category_scores_gemma":[0.0021661157,0.000837315,0.0007320382,0.0058239866,0.001032082,0.00070276926,0.0014607009,0.0014396165,0.00057555834],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012539771,0.0000699558,0.99580044,0.000040261064,0.00009715458,0.00022248006,0.0006945951,0.000069773974,0.00016595064,0.000059183487,0.0012472385,0.00140754],"study_design_scores_gemma":[0.000020843017,0.00004470982,0.9968413,0.000078179255,0.000059762544,0.00015555914,0.0016221364,0.00027380403,0.000037615275,0.000031523297,0.00081302796,0.000021411945],"about_ca_topic_score_codex":0.9904358,"about_ca_topic_score_gemma":0.99415034,"teacher_disagreement_score":0.026196228,"about_ca_system_score_codex":0.026196228,"about_ca_system_score_gemma":0.02698494,"threshold_uncertainty_score":0.19006783},"labels":[],"label_agreement":null},{"id":"W4413764907","doi":"10.1111/bjh.70124","title":"A decade of experience using <scp>ATG</scp> and <scp>PTCy</scp> for graft‐versus‐host disease prophylaxis in matched unrelated donor allogeneic haematopoietic cell transplantation","year":2025,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Graft-versus-host disease; Immunology; Transplantation; Haematopoiesis; Medicine; Host (biology); Disease; Hematopoietic cell; Stem cell; Biology; Internal medicine; Genetics","score_opus":0.019430612450783393,"score_gpt":0.28822424252731255,"score_spread":0.2687936300765292,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4413764907","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96988153,0.025095128,0.0018120107,0.0006295722,0.000060643284,0.000024945222,0.000051422692,0.000022422424,0.0024223274],"genre_scores_gemma":[0.9820531,0.014792568,0.0012336107,0.00086349313,0.00023853067,0.000017553219,0.00013236786,0.000017389963,0.0006514027],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985802,0.0006713295,0.00023085295,0.00019117004,0.00019796187,0.00012849197],"domain_scores_gemma":[0.9971125,0.001389527,0.0007413992,0.00020413245,0.00020862385,0.00034378615],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0026392797,0.00028034244,0.00024438842,0.00041586586,0.00022139213,0.0006607591,0.00041517607,0.00045589937,0.0009392053],"category_scores_gemma":[0.0034654865,0.00019491401,0.00039869547,0.0010079944,0.0006503481,0.00037984576,0.00043152375,0.000596803,0.00040834662],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001039439,0.0005268869,0.6769752,0.00032097794,0.00031345294,0.005536355,0.00089538784,0.00080987776,0.0049080215,0.00039838452,0.0013374974,0.30693862],"study_design_scores_gemma":[0.00025819315,0.010317512,0.79017246,0.00063914934,0.0007026564,0.13278931,0.0018023317,0.0016116246,0.00966813,0.0007885019,0.051156677,0.0000935242],"about_ca_topic_score_codex":0.00081471395,"about_ca_topic_score_gemma":0.001057623,"teacher_disagreement_score":0.0026392797,"about_ca_system_score_codex":0.0004223778,"about_ca_system_score_gemma":0.00053969974,"threshold_uncertainty_score":0.013957977},"labels":[],"label_agreement":null},{"id":"W4413806777","doi":"10.1111/bjh.70131","title":"Outcomes following exposure to drug interactions with ibrutinib in patients with chronic lymphocytic leukaemia","year":2025,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Princess Margaret Cancer Centre; Sunnybrook Hospital; Health Sciences Centre; Queen's University; Institute for Clinical Evaluative Sciences; Sunnybrook Health Science Centre; University Health Network; University of Toronto","funders":"Canadian Institutes of Health Research","keywords":"Ibrutinib; Medicine; Odds ratio; Internal medicine; Concomitant; Population; CYP3A; Oncology; Pharmacology; Chronic lymphocytic leukemia; Leukemia; Cytochrome P450","score_opus":0.005669862241993579,"score_gpt":0.2795223042852576,"score_spread":0.27385244204326403,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4413806777","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9988619,0.0003941757,0.00002077244,0.00007840424,0.000005134817,0.0000084589565,0.0003332147,0.0000016119219,0.00029640857],"genre_scores_gemma":[0.99927574,0.00014963339,0.000019787156,0.000044157663,0.000016088867,0.0000078562225,0.0003976669,6.155682e-7,0.00008856367],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9992231,0.00015620573,0.00007630966,0.00013577072,0.00018192368,0.00022668121],"domain_scores_gemma":[0.9974769,0.00024125831,0.0015140678,0.00009411309,0.00026900013,0.00040472095],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00061001995,0.00021591195,0.0004384688,0.00054995,0.0006536928,0.00072250754,0.0003696178,0.00049740355,0.0009817319],"category_scores_gemma":[0.002832069,0.00020679303,0.00066870207,0.0013883335,0.0003338302,0.00042723355,0.0005722615,0.00077366055,0.00010103702],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017893253,0.00002197274,0.99874216,0.000010097099,0.000042349853,0.000090638736,0.000050962317,0.000017237593,0.00005056505,0.000004701125,0.00006255399,0.0007279354],"study_design_scores_gemma":[0.000012556352,0.00008494169,0.9994873,0.00000602427,0.000028129118,0.0001322215,0.00008535421,0.000043377106,0.000012389466,0.000009874881,0.00009521178,0.0000027508013],"about_ca_topic_score_codex":0.060316898,"about_ca_topic_score_gemma":0.08191496,"teacher_disagreement_score":0.060316898,"about_ca_system_score_codex":0.0016440103,"about_ca_system_score_gemma":0.0011506984,"threshold_uncertainty_score":0.11993164},"labels":[],"label_agreement":null},{"id":"W4413962157","doi":"10.1111/bjh.70120","title":"Impact of red blood cell exchange on echocardiographic parameters among adults with sickle cell disease","year":2025,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Université de Montréal; Centre Hospitalier de l’Université de Montréal","funders":"Fonds de Recherche du Québec - Santé","keywords":"Medicine; Cell; Disease; Red blood cell; Internal medicine; Cardiology; Red Cell; Pediatrics; Genetics; Biology","score_opus":0.0038739884766896622,"score_gpt":0.22030098693837355,"score_spread":0.2164269984616839,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4413962157","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9865806,0.0069761924,0.00029749077,0.0021000162,0.0004579145,0.000050862112,0.0022584312,0.00002141233,0.0012570361],"genre_scores_gemma":[0.99453884,0.0016298599,0.00021440671,0.0010313009,0.0013418258,0.000029966905,0.0009758356,0.000008769062,0.0002292194],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99918944,0.00017752577,0.00016309146,0.00017181101,0.00018809253,0.00011011362],"domain_scores_gemma":[0.99304444,0.0020451462,0.0026896491,0.00042054112,0.0010885629,0.0007117922],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011662929,0.00026416176,0.00055914384,0.00084345933,0.00038061678,0.0007918872,0.00044221405,0.0010797422,0.0016702389],"category_scores_gemma":[0.0076253186,0.00020826321,0.00033085883,0.0010087586,0.0002591533,0.0009431981,0.00041926262,0.00094103796,0.00032294012],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00023130949,0.00008410752,0.99181,0.00007213843,0.000068167064,0.0009013581,0.00010263328,0.000030047462,0.00013269934,0.000025097957,0.0016523009,0.004890193],"study_design_scores_gemma":[0.000031841617,0.00039993165,0.99014974,0.000121605,0.000113397415,0.006162248,0.0003054742,0.0003803545,0.00011971798,0.000059045473,0.0021324002,0.000024232722],"about_ca_topic_score_codex":0.0013949954,"about_ca_topic_score_gemma":0.0016121744,"teacher_disagreement_score":0.0016702389,"about_ca_system_score_codex":0.00023219771,"about_ca_system_score_gemma":0.00026926445,"threshold_uncertainty_score":0.0061680675},"labels":[],"label_agreement":null},{"id":"W4414002743","doi":"10.1111/bjh.70041","title":"Assessment and treatment of frail patients living with multiple myeloma. A guideline on behalf of the <scp>UK</scp> Myeloma Research Alliance Frailty Group","year":2025,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Medicine; Guideline; Quality of life (healthcare); Gerontology; Polypharmacy; Population; Multiple myeloma; Cancer; Disease; Intensive care medicine; Internal medicine; Pathology; Environmental health","score_opus":0.04191771513113096,"score_gpt":0.3634831112193089,"score_spread":0.3215653960881779,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414002743","genre_codex":"review","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0051889624,0.60916907,0.017647902,0.20002419,0.011765958,0.011106128,0.020211851,0.0012645274,0.12362135],"genre_scores_gemma":[0.037718896,0.60287607,0.09374759,0.13440005,0.0077478606,0.01777377,0.041382093,0.00041499417,0.06393869],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9965294,0.0009826773,0.0011209595,0.00015261887,0.0009983617,0.00021604105],"domain_scores_gemma":[0.9946689,0.0015260556,0.0009108267,0.00010856417,0.002399902,0.00038559403],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0040885163,0.0009833988,0.0018999332,0.0023269188,0.0007284651,0.0016899261,0.002510373,0.004021903,0.0045946506],"category_scores_gemma":[0.013003863,0.0005193714,0.0024381133,0.0015575005,0.000563868,0.0013825861,0.0017681649,0.0042414763,0.004144293],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000099561665,0.00008686896,0.00081820064,0.0067957705,0.0001092111,0.0004766966,0.00027696957,0.00057394354,0.0004938147,0.0018166577,0.61656225,0.37189007],"study_design_scores_gemma":[0.00023225517,0.00017615993,0.0060213176,0.039835222,0.00020107834,0.0011938793,0.0001442141,0.00044025894,0.0002831565,0.0033634505,0.9480569,0.000052167867],"about_ca_topic_score_codex":0.021144232,"about_ca_topic_score_gemma":0.0411586,"teacher_disagreement_score":0.021144232,"about_ca_system_score_codex":0.0024177835,"about_ca_system_score_gemma":0.006429796,"threshold_uncertainty_score":0.042042315},"labels":[],"label_agreement":null},{"id":"W4414085806","doi":"10.1111/bjh.70061","title":"<scp>UK</scp> recommendations for chimerism testing and monitoring following allogeneic haematopoietic stem cell transplantation <scp>(HSCT</scp> ): Best practice consensus guidelines from the British Society for Blood and Marrow Transplant and Cellular Therapies ( <scp>BSBMTCT</scp> ), <scp>NHS</scp> England Genomic Laboratory Hub ( <scp>GLH</scp> ) Haematological Malignancies Working Group, <scp>UK</scp> Cancer Genetics Group ( <scp>UKCGG</scp> ) and the <scp>UK</scp> National External Quality Assessment Service for Leucocyte Immunophenotyping ( <scp>UK NEQAS LI</scp> )","year":2025,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Thomas Hospital","funders":"","keywords":"Transplantation; Minimal residual disease; Disease; Stem cell; Hematopoietic stem cell transplantation; Audit; Clinical Practice; Dosing","score_opus":0.048372120973216054,"score_gpt":0.3135522715974631,"score_spread":0.26518015062424705,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414085806","genre_codex":"commentary","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0095318975,0.19085644,0.07051303,0.43446112,0.02292574,0.005576367,0.019624008,0.005110151,0.24140133],"genre_scores_gemma":[0.07458728,0.19293995,0.26264104,0.22113284,0.009112927,0.010525497,0.050246216,0.0042968313,0.1745174],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.97894394,0.0073739924,0.005923384,0.0007597073,0.0060963416,0.00090257445],"domain_scores_gemma":[0.9377664,0.016620623,0.006118851,0.002523196,0.034002263,0.0029687136],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0153928865,0.00087137276,0.0014336469,0.0031129331,0.0012161921,0.003627604,0.0046003526,0.006745606,0.021452801],"category_scores_gemma":[0.046137013,0.0007171551,0.0027023533,0.0028246026,0.0020667699,0.0020589435,0.0031240776,0.0054260064,0.016547572],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012373064,0.00012318457,0.0014300424,0.0028214203,0.00004851322,0.000533592,0.00061545667,0.0005924275,0.001776498,0.0034037044,0.81385195,0.17467941],"study_design_scores_gemma":[0.00008417797,0.00008595316,0.005990603,0.0069449614,0.0000607156,0.00094734505,0.0004562057,0.00030033579,0.0013059692,0.002751905,0.9810144,0.000057531426],"about_ca_topic_score_codex":0.029368596,"about_ca_topic_score_gemma":0.03959856,"teacher_disagreement_score":0.029368596,"about_ca_system_score_codex":0.0035056067,"about_ca_system_score_gemma":0.013068417,"threshold_uncertainty_score":0.081406355},"labels":[],"label_agreement":null},{"id":"W4414160795","doi":"10.1111/bjh.70150","title":"‘Raise the Bar’, a Canadian intervention to combat disparities in the recognition and management of iron deficiency: Development of the intervention, feasibility and implementation","year":2025,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Iron Metabolism and Disorders","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"The Scarborough Hospital; Brampton Civic Hospital; Hospital for Sick Children; Centre for Addiction and Mental Health; Toronto Public Health; Queen's University; McMaster University; Thrombosis and Atherosclerosis Research Institute; Public Health Ontario; Trillium Health Centre; University Health Network; Health Sciences Centre; St. Michael's Hospital; Sunnybrook Health Science Centre; Sinai Health System; University of Toronto","funders":"","keywords":"Iron deficiency; Ferritin; Anemia; Concomitant; Intervention (counseling); Socioeconomic status; Pregnancy; Health care","score_opus":0.02318509927061853,"score_gpt":0.3091752351083233,"score_spread":0.2859901358377048,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414160795","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.28350136,0.021222794,0.034521777,0.38241968,0.01117162,0.089310475,0.013712385,0.0013690917,0.16277093],"genre_scores_gemma":[0.56426823,0.012670126,0.2211639,0.1137892,0.0016327283,0.054447427,0.003368845,0.00027841332,0.0283811],"study_design_codex":"design_other","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.98889416,0.00592382,0.0003445659,0.00059840246,0.0022042198,0.0020348972],"domain_scores_gemma":[0.98343164,0.002624563,0.0007578927,0.0006583185,0.0055403975,0.0069872006],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.015781406,0.0009245366,0.0011538299,0.0010708388,0.0082463715,0.0021360961,0.0039899563,0.002958869,0.019615542],"category_scores_gemma":[0.034911662,0.0005851954,0.0018052729,0.001333015,0.0018739454,0.0023017237,0.0064124707,0.0043287305,0.0011576562],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002673615,0.010609996,0.026847847,0.006241344,0.00037283002,0.0005094957,0.012010122,0.0008286898,0.0008191634,0.024253108,0.22060102,0.6942328],"study_design_scores_gemma":[0.017436938,0.013002584,0.21917169,0.040804286,0.0023643381,0.0005913186,0.042721815,0.010945834,0.0022868032,0.03250481,0.61746407,0.0007054959],"about_ca_topic_score_codex":0.8147678,"about_ca_topic_score_gemma":0.90073603,"teacher_disagreement_score":0.18523222,"about_ca_system_score_codex":0.03489923,"about_ca_system_score_gemma":0.2767624,"threshold_uncertainty_score":0.37264615},"labels":[],"label_agreement":null},{"id":"W4414168132","doi":"10.1111/bjh.70146","title":"Endothelial activation and stress index ( <scp>EASIX</scp> ) as a biomarker to predict ruxolitinib failure for steroid‐refractory acute graft‐versus‐host disease treatment","year":2025,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Saskatchewan Cancer Agency; University of British Columbia; Ottawa Hospital; BC Cancer Agency; Princess Margaret Cancer Centre; Centre hospitalier universitaire de Québec; Alberta University of the Arts; University of Toronto","funders":"","keywords":"Ruxolitinib; Biomarker; Disease; Transplantation; Clinical endpoint; Confidence interval","score_opus":0.015403724167790659,"score_gpt":0.2954711320915568,"score_spread":0.2800674079237661,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414168132","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9990269,0.00036520633,0.00011158156,0.00002986019,0.0000040369423,0.00001468724,0.000108014465,0.000004856793,0.00033484798],"genre_scores_gemma":[0.9996123,0.00006297011,0.00009482051,0.000012290683,0.00000531343,0.000006273308,0.0001384836,6.7149506e-7,0.000066870365],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9996866,0.00006948572,0.000020304517,0.000047512392,0.000093882736,0.000082261766],"domain_scores_gemma":[0.999114,0.0001457981,0.0003023465,0.00003895645,0.00015769526,0.00024118068],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00078802335,0.0003753808,0.0004788805,0.0004966387,0.00026804802,0.0008656313,0.00028104385,0.00033073366,0.00063129433],"category_scores_gemma":[0.0011422504,0.000106662854,0.00035279797,0.00059764314,0.00031035594,0.0001653039,0.00032212585,0.0005873003,0.000116630166],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006134263,0.000040606417,0.9932341,0.000012523597,0.00004667365,0.000036863454,0.000039728275,0.00022180301,0.0005850038,0.000016718564,0.00015318359,0.00499931],"study_design_scores_gemma":[0.000021737156,0.00024621128,0.99746644,0.000007989556,0.00004897203,0.00012164455,0.000062378786,0.0015046827,0.00029027413,0.000021639054,0.00020159943,0.0000064120545],"about_ca_topic_score_codex":0.017599253,"about_ca_topic_score_gemma":0.019834487,"teacher_disagreement_score":0.017599253,"about_ca_system_score_codex":0.0009297565,"about_ca_system_score_gemma":0.00080764556,"threshold_uncertainty_score":0.03499365},"labels":[],"label_agreement":null},{"id":"W4414191963","doi":"10.1111/bjh.70157","title":"Incidence and impact of prior history of serious infection in paediatric lymphoma: A population‐based study","year":2025,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Immunodeficiency and Autoimmune Disorders","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Toronto; SickKids Foundation; Institute for Clinical Evaluative Sciences; Hospital for Sick Children","funders":"","keywords":"Incidence (geometry); Lymphoma; Odds ratio; Hazard ratio; Confidence interval; Intensive care unit; Epidemiology; Cohort","score_opus":0.005588518299444807,"score_gpt":0.2467060650357208,"score_spread":0.24111754673627597,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414191963","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9992204,0.00013744796,0.000015459165,0.00002145263,0.0000014665861,0.0000062073855,0.00034830856,0.0000016405808,0.00024760223],"genre_scores_gemma":[0.99949956,0.00011344805,0.000021983198,0.000012430307,0.0000027592243,0.000004816957,0.00029461397,8.5860853e-7,0.000049561877],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9995641,0.000069299735,0.00004649428,0.00009743217,0.00013218577,0.000090512585],"domain_scores_gemma":[0.99882454,0.00009416801,0.0006072924,0.00007222529,0.00016550865,0.00023628725],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003571975,0.0001838126,0.00024945577,0.0006343875,0.0003680668,0.0007233101,0.00042924203,0.00032639378,0.0011442547],"category_scores_gemma":[0.0015461206,0.00030674713,0.00037507943,0.0013518571,0.00040110783,0.00039522914,0.00044011176,0.000452965,0.00014388647],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00000858021,0.000005136212,0.9996871,0.0000025306974,0.000008754573,0.000032008516,0.000038610415,0.0000063916373,0.000026890892,0.000002945091,0.000027005926,0.00015402849],"study_design_scores_gemma":[0.0000010060566,0.00001618142,0.99973387,0.0000019591034,0.0000043937553,0.00009354987,0.00008079021,0.00001930472,0.0000054270326,0.000001370521,0.000041527946,5.985193e-7],"about_ca_topic_score_codex":0.13664411,"about_ca_topic_score_gemma":0.1763411,"teacher_disagreement_score":0.13664411,"about_ca_system_score_codex":0.0012957014,"about_ca_system_score_gemma":0.0010882284,"threshold_uncertainty_score":0.27169752},"labels":[],"label_agreement":null},{"id":"W4414370964","doi":"10.1111/bjh.70170","title":"Can we move beyond myeloablative conditioning ( <scp>MAC</scp> )? A comparison of <scp>MAC</scp> versus reduced intensity conditioning ( <scp>RIC</scp> ) in patients aged younger than 65 years undergoing allogeneic haematopoietic cell transplantation using <scp>ATG</scp> ‐ <scp>PTCy</scp> ‐ <scp>CSA</scp> for <scp>GVHD</scp> prophylaxis","year":2025,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"","keywords":"Context (archaeology); Conditioning; Transplantation; Cyclophosphamide; Incidence (geometry); Regimen; Concomitant; Propensity score matching; Hematology","score_opus":0.020394561358424927,"score_gpt":0.28085985196928825,"score_spread":0.2604652906108633,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414370964","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99276674,0.0064931153,0.00009914844,0.0002478112,0.00007166857,0.000018460667,0.000046830435,0.0000020638786,0.000254172],"genre_scores_gemma":[0.99763274,0.0015433793,0.00010825884,0.00038922558,0.00011788067,0.000015589681,0.000116597024,0.0000012312198,0.0000750755],"study_design_codex":"observational","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.99967265,0.00012781542,0.00004335558,0.000052046835,0.000043393302,0.000060778395],"domain_scores_gemma":[0.9992798,0.00020669588,0.00027014303,0.00003639607,0.000034289882,0.00017264094],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010133123,0.00015162159,0.0004555308,0.00020126306,0.00014440725,0.0004331242,0.00024420093,0.00048666785,0.0010170451],"category_scores_gemma":[0.0015535871,0.00006863892,0.0009321963,0.00032739135,0.00028261388,0.0004393757,0.0003140548,0.0004425122,0.00015548489],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.1411086,0.0025206776,0.5407856,0.0016392214,0.0032177053,0.00055674877,0.00048782432,0.0017534898,0.0063626748,0.0009652131,0.0017633741,0.29883885],"study_design_scores_gemma":[0.005456094,0.11246894,0.8623206,0.00074182247,0.0044385153,0.001310722,0.0007672091,0.0016114515,0.0013646741,0.00116461,0.008312694,0.000042690317],"about_ca_topic_score_codex":0.0004972308,"about_ca_topic_score_gemma":0.0010541485,"teacher_disagreement_score":0.0010170451,"about_ca_system_score_codex":0.00024102979,"about_ca_system_score_gemma":0.00043222503,"threshold_uncertainty_score":0.0053589344},"labels":[],"label_agreement":null},{"id":"W4415075029","doi":"10.1111/bjh.70194","title":"Confronting medical grifting: Fraudulent and unproven products and interventions in apheresis, transfusion and biotherapies","year":2025,"lang":"en","type":"review","venue":"British Journal of Haematology","topic":"Blood donation and transfusion practices","field":"Business, Management and Accounting","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Blood Services; University of Toronto","funders":"","keywords":"Psychological intervention; Apheresis; Medical care; MEDLINE; Medical literature; Therapeutic plasma exchange","score_opus":0.03134231137536264,"score_gpt":0.30920026584264876,"score_spread":0.2778579544672861,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4415075029","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00009271338,0.998796,0.00004316732,0.0006025204,0.000088884735,0.0000028893396,0.0000039581687,0.0000010803132,0.0003688654],"genre_scores_gemma":[0.0014923462,0.99770385,0.0001320513,0.00040444726,0.00013421613,0.0000050368144,0.000006310223,6.6738056e-7,0.00012117199],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99809915,0.0008124286,0.00034239655,0.00011771071,0.000555915,0.00007238831],"domain_scores_gemma":[0.9925292,0.005845407,0.0010213146,0.00008159892,0.0004336421,0.00008876633],"candidate_categories":["research_integrity"],"consensus_categories":[],"category_scores_codex":[0.002813109,0.000632752,0.00136093,0.0034904962,0.0005534991,0.0025279003,0.0008075494,0.00249227,0.0030257024],"category_scores_gemma":[0.009034459,0.00030585704,0.000964572,0.0043136273,0.001228937,0.0024094447,0.0010754879,0.0019503828,0.0004488931],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000050309398,0.000041787778,0.0002803727,0.0664985,0.00023258482,0.00017577515,0.000396774,0.00027094717,0.0001402486,0.008788029,0.013796002,0.9093287],"study_design_scores_gemma":[0.000034813886,0.00011950527,0.0027216852,0.16679758,0.0007270331,0.0021884034,0.0011082802,0.00020163388,0.00022799814,0.009745163,0.81607676,0.000051166604],"about_ca_topic_score_codex":0.0031948374,"about_ca_topic_score_gemma":0.008098057,"teacher_disagreement_score":0.99750775,"about_ca_system_score_codex":0.001388865,"about_ca_system_score_gemma":0.0036027536,"threshold_uncertainty_score":0.014877379},"labels":[],"label_agreement":null},{"id":"W4415421445","doi":"10.1111/bjh.70215","title":"Real‐world efficacy and safety of immunochemotherapy in cold agglutinin‐mediated autoimmune haemolytic anaemia","year":2025,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Blood groups and transfusion","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Infection and Immunity","funders":"Stichting Sanquin Bloedvoorziening","keywords":"Cold agglutinin disease; Rituximab; Cold Agglutinin; Autoantibody; Antibody; Monoclonal; Autoimmune hemolytic anemia; Autoimmune disease; Bone marrow","score_opus":0.007119306655546533,"score_gpt":0.264375483618945,"score_spread":0.2572561769633984,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4415421445","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9637616,0.030735662,0.00076137757,0.00039504305,0.00014759935,0.00031275046,0.0008952166,0.000056202196,0.0029345255],"genre_scores_gemma":[0.99569017,0.0025572106,0.0003009202,0.00036202036,0.00014216076,0.00015606727,0.0004951947,0.00000919083,0.0002870286],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99833554,0.00090806413,0.00015359084,0.0002518987,0.0002485033,0.00010236294],"domain_scores_gemma":[0.9970777,0.0010065197,0.0011598793,0.00022213261,0.00022131344,0.00031244446],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0020562822,0.00028784992,0.0009802614,0.00022871987,0.00020935405,0.0006738225,0.00033337538,0.0005785895,0.0020243474],"category_scores_gemma":[0.0037336072,0.00012464623,0.0007716321,0.00050899806,0.00054529455,0.00053849403,0.00018407975,0.0012432412,0.0004195561],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.449316,0.010465321,0.031527504,0.0023654469,0.0026294298,0.00033163195,0.00034883953,0.0043205917,0.017970897,0.0005102769,0.0035352325,0.47667876],"study_design_scores_gemma":[0.07098683,0.621642,0.25862256,0.00061767455,0.0034588352,0.0015881624,0.00022780281,0.004946825,0.016805438,0.0009719071,0.019995948,0.00013604788],"about_ca_topic_score_codex":0.00046797062,"about_ca_topic_score_gemma":0.000481518,"teacher_disagreement_score":0.0020562822,"about_ca_system_score_codex":0.0009845115,"about_ca_system_score_gemma":0.00032002054,"threshold_uncertainty_score":0.010874808},"labels":[],"label_agreement":null},{"id":"W4415567510","doi":"10.1111/bjh.70220","title":"New cases expand the genotype, phenotype and therapeutic landscape of H syndrome","year":2025,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Vascular Malformations and Hemangiomas","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Centre Hospitalier de l’Université de Montréal; Hôpital Charles-Le Moyne; Centre Hospitalier Universitaire Sainte-Justine","funders":"CHU Sainte-Justine Foundation; Wallonie-Bruxelles International","keywords":"Hypertrichosis; Lipodystrophy; Phenotype; Etiology; Camptodactyly; Genodermatosis; Histiocyte; Targeted therapy","score_opus":0.011754095478576298,"score_gpt":0.26188175275523307,"score_spread":0.25012765727665676,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4415567510","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9394123,0.015816376,0.0047850744,0.0030712364,0.00023750098,0.000138987,0.00050391955,0.00040328986,0.035631247],"genre_scores_gemma":[0.98968667,0.0049226345,0.002276293,0.0008460851,0.00056160847,0.000027214017,0.0002980832,0.000054162945,0.0013272251],"study_design_codex":"case_report","study_design_gemma":"observational","domain_scores_codex":[0.99957603,0.000051474664,0.000041106236,0.000097863194,0.00010998921,0.00012351404],"domain_scores_gemma":[0.99949336,0.00018890039,0.00009107017,0.000059437196,0.000060551545,0.00010674419],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00036041322,0.00079874176,0.0004441504,0.0010645372,0.00076057855,0.0010197058,0.00061966083,0.0012255984,0.0022297215],"category_scores_gemma":[0.0014103613,0.00021774489,0.0005094208,0.00093008525,0.0010437508,0.00076644175,0.00080115855,0.00061836466,0.00061360607],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021511113,0.0001079432,0.129475,0.0001903937,0.000058413927,0.74003583,0.0015360073,0.000732686,0.015557594,0.002671205,0.004653995,0.10476584],"study_design_scores_gemma":[0.000011988702,0.00006014817,0.033013873,0.000056840367,0.00002364716,0.95555174,0.00034020297,0.00033149464,0.0011557743,0.0007835099,0.008653667,0.000017218614],"about_ca_topic_score_codex":0.0029924603,"about_ca_topic_score_gemma":0.005174931,"teacher_disagreement_score":0.0029924603,"about_ca_system_score_codex":0.00065337546,"about_ca_system_score_gemma":0.0003687573,"threshold_uncertainty_score":0.0074591637},"labels":[],"label_agreement":null},{"id":"W4416306788","doi":"10.1111/bjh.70257","title":"Return to employment outcomes in patients with multiple myeloma","year":2025,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hotel Dieu Hospital","funders":"","keywords":"Multiple myeloma; MEDLINE; Immunopathology; Hematology","score_opus":0.010825367374835684,"score_gpt":0.2904119371044533,"score_spread":0.2795865697296176,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416306788","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99134225,0.0016169547,0.00003948238,0.0014803474,0.000092823124,0.000009559139,0.0010460233,0.000006652811,0.004366061],"genre_scores_gemma":[0.9979395,0.00036114836,0.000016367403,0.00013890486,0.000048086524,0.000009094555,0.00058674946,0.0000026490247,0.0008974643],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99932134,0.00014279055,0.00006168687,0.000054258413,0.00012707397,0.0002928545],"domain_scores_gemma":[0.9979208,0.00030449824,0.00075443863,0.0000728642,0.00019150402,0.0007559194],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007171657,0.0001453921,0.00035977198,0.000975858,0.00074671186,0.0007689719,0.000369099,0.00056223146,0.006359664],"category_scores_gemma":[0.0050048223,0.00011763685,0.00042172923,0.0011529794,0.00027702522,0.0006783873,0.0011067626,0.0012718114,0.0011271997],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004963195,0.00015344442,0.98670816,0.000047010282,0.000068609996,0.00052878854,0.00043617652,0.00013277658,0.000070835245,0.000102768754,0.0021782657,0.009076848],"study_design_scores_gemma":[0.0000148870895,0.00016919625,0.9971506,0.00005010278,0.000019497757,0.00041237895,0.0008457481,0.000074283125,0.000020210597,0.00018393109,0.0010509136,0.000008248549],"about_ca_topic_score_codex":0.0073810345,"about_ca_topic_score_gemma":0.008443092,"teacher_disagreement_score":0.0073810345,"about_ca_system_score_codex":0.0005120448,"about_ca_system_score_gemma":0.00042754094,"threshold_uncertainty_score":0.021275222},"labels":[],"label_agreement":null},{"id":"W4417017262","doi":"10.1111/bjh.70275","title":"Real‐world experience with <scp>CPX</scp> ‐351 for secondary acute myeloid leukaemia: Comparison with <scp>FLAG</scp> ‐ <scp>IDA</scp> in a propensity score matching analysis","year":2025,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Saskatchewan Cancer Agency; Hôpital Maisonneuve-Rosemont; London Health Sciences Centre; Princess Margaret Cancer Centre; University of Calgary; University of British Columbia; Juravinski Cancer Centre; McGill University Health Centre; Jewish General Hospital; Sunnybrook Health Science Centre; University of Alberta; University of Toronto","funders":"","keywords":"Cytarabine; Daunorubicin; Propensity score matching; Induction chemotherapy; Hematopoietic stem cell transplantation; Transplantation; Myeloid leukemia; Clinical trial; Randomized controlled trial","score_opus":0.02457374611780042,"score_gpt":0.3081901246744311,"score_spread":0.28361637855663063,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417017262","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9952573,0.0014365213,0.001615059,0.00024194633,0.000066955996,0.00021458698,0.00041111442,0.000012277923,0.00074423506],"genre_scores_gemma":[0.9972275,0.00054950593,0.0008265302,0.00012990591,0.000086129665,0.00008550579,0.0008928953,0.0000098935125,0.00019202619],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.997382,0.0013421898,0.00033186917,0.0004811857,0.00032175775,0.00014101816],"domain_scores_gemma":[0.9962393,0.00093729224,0.0013795078,0.00045950012,0.00022693626,0.0007574554],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005938366,0.00041423953,0.00074837916,0.00041207488,0.0003416932,0.0010252944,0.00044873866,0.00041462114,0.0030734085],"category_scores_gemma":[0.0077935862,0.00021178194,0.0017683374,0.00080580945,0.00044441552,0.0007720245,0.0009521559,0.0007376559,0.00064571353],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.08861515,0.0037602724,0.7382949,0.0006068534,0.005956288,0.00054007093,0.000830975,0.003905909,0.0020617575,0.0013722678,0.0047254898,0.14932993],"study_design_scores_gemma":[0.011624147,0.066851184,0.8766802,0.0002968859,0.0052767387,0.0027518314,0.00094952446,0.019108184,0.0015651205,0.0023752241,0.01231994,0.00020100751],"about_ca_topic_score_codex":0.0006017224,"about_ca_topic_score_gemma":0.00072082056,"teacher_disagreement_score":0.005938366,"about_ca_system_score_codex":0.00094839,"about_ca_system_score_gemma":0.00066450465,"threshold_uncertainty_score":0.03140545},"labels":[],"label_agreement":null},{"id":"W4417027289","doi":"10.1111/bjh.70269","title":"Impact of graft‐versus‐host disease prophylaxis strategies on <scp>GvHD</scp> ‐free/relapse‐free survival in young adults undergoing unrelated donor allogeneic haematopoietic cell transplantation: A propensity score‐matched analysis","year":2025,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"National Institute of Allergy and Infectious Diseases; Health Resources and Services Administration; Office of Naval Research; National Heart, Lung, and Blood Institute; National Cancer Institute; Medical College of Wisconsin; National Marrow Donor Program","keywords":"Calcineurin; Methotrexate; Cyclophosphamide; Retrospective cohort study; Young adult; Propensity score matching; Transplantation; Population; Group B","score_opus":0.01763336043075995,"score_gpt":0.26739148718702355,"score_spread":0.2497581267562636,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417027289","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.999329,0.00023520392,0.00012312579,0.000017064263,0.00000782593,0.000009260662,0.00019332426,0.0000012699472,0.00008402874],"genre_scores_gemma":[0.99955374,0.00006749902,0.000060594368,0.000017432032,0.000009093113,0.000008092281,0.00024252868,0.0000011556285,0.000039896495],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99939156,0.00017103204,0.000118024655,0.00016352367,0.00007557678,0.000080220605],"domain_scores_gemma":[0.998798,0.00028646906,0.0005755402,0.00011302675,0.000059522412,0.00016736928],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011862381,0.0002188647,0.0004227083,0.0004735633,0.00022264996,0.00044615814,0.00022356873,0.00029514168,0.001168537],"category_scores_gemma":[0.0019416765,0.00016550864,0.0014530462,0.0006187724,0.00021895446,0.00030501664,0.0004306357,0.00037245566,0.0001304384],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014456533,0.000040520186,0.9947659,0.000023630842,0.00070648384,0.000060394366,0.000044440414,0.00020598603,0.00022418887,0.000041422863,0.00015965757,0.002281752],"study_design_scores_gemma":[0.000100376295,0.0010009072,0.9955434,0.000016213035,0.0006744871,0.00024361275,0.00017143437,0.0015499241,0.00012106133,0.00009709061,0.00047323038,0.000008209018],"about_ca_topic_score_codex":0.0012972709,"about_ca_topic_score_gemma":0.0020384446,"teacher_disagreement_score":0.0012972709,"about_ca_system_score_codex":0.00021488241,"about_ca_system_score_gemma":0.00028656432,"threshold_uncertainty_score":0.006273508},"labels":[],"label_agreement":null},{"id":"W4417291333","doi":"10.1111/bjh.70278","title":"Plasma proteomic profiles of patients during oral anti‐coagulant treatment with vitamin K antagonists","year":2025,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Advanced Proteomics Techniques and Applications","field":"Chemistry","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McGill University; Jewish General Hospital; McGill University Health Centre; University of Victoria","funders":"Trombosestichting Nederland; Center for Translational Molecular Medicine; Hartstichting","keywords":"Contraindication; Adverse effect; Cohort; Cohort study; Proteomics; Vitamin k; Atrial fibrillation; Etiology; Epidemiology","score_opus":0.006310400691612768,"score_gpt":0.25042620549429795,"score_spread":0.2441158048026852,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417291333","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99889684,0.00030206182,0.00017207401,0.00002266812,0.0000062444137,0.000014658184,0.0003578814,0.0000044163044,0.00022326168],"genre_scores_gemma":[0.9985488,0.000252611,0.0002808855,0.00007753895,0.000017108048,0.000026384345,0.00054400513,0.0000030600931,0.0002494583],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9996867,0.00005778727,0.00003105639,0.00010825684,0.0000639537,0.00005213535],"domain_scores_gemma":[0.9996414,0.00006905643,0.00013817326,0.000023483191,0.00006223623,0.000065737],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002801888,0.00024136876,0.00046865363,0.00069187867,0.00038373325,0.00079493155,0.0001653479,0.00041136154,0.00052065274],"category_scores_gemma":[0.0011178353,0.00015953573,0.00026011252,0.0007976583,0.00020137632,0.00027550888,0.00031643992,0.00038343814,0.00019153519],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010452531,0.00012844057,0.98123896,0.000040400246,0.000099525576,0.00043225737,0.00040820468,0.00011563406,0.01171821,0.000048733156,0.00022303208,0.004501243],"study_design_scores_gemma":[0.000012466235,0.0003951801,0.99712354,0.000007726699,0.00003865469,0.00057743175,0.0002554211,0.0002632422,0.0008597655,0.000034245273,0.00042394275,0.000008311703],"about_ca_topic_score_codex":0.0016841006,"about_ca_topic_score_gemma":0.0010354858,"teacher_disagreement_score":0.0016841006,"about_ca_system_score_codex":0.0002456644,"about_ca_system_score_gemma":0.0001665889,"threshold_uncertainty_score":0.0033486485},"labels":[],"label_agreement":null},{"id":"W7117297153","doi":"10.1111/bjh.70304","title":"Opportunities for improving platelet transfusion practice: A large retrospective audit across 22 hospitals","year":2025,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Blood transfusion and management","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary; St. Michael's Hospital; Canadian Blood Services; University Health Network; University of Toronto; McMaster University; Queen's University","funders":"Canadian Blood Services","keywords":"Platelet transfusion; Subspecialty; Guideline; Transfusion medicine; Retrospective cohort study; Context (archaeology); Blood product; Audit","score_opus":0.01646508079470564,"score_gpt":0.31165165381882454,"score_spread":0.2951865730241189,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7117297153","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99729174,0.0009056189,0.00025437848,0.00023036738,0.000009900077,0.000042201285,0.00086393004,0.00001296392,0.0003888423],"genre_scores_gemma":[0.99878305,0.0003192285,0.00019709044,0.00010874127,0.000011036825,0.00003246094,0.0005086535,0.000005045707,0.000034720644],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.98562336,0.0053739734,0.0035068917,0.0017459895,0.0028028486,0.0009469777],"domain_scores_gemma":[0.9452892,0.009975239,0.036080923,0.003091327,0.0035212417,0.0020420668],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0061167195,0.00032624725,0.00054997485,0.0020162486,0.00047172984,0.0018853463,0.0007488229,0.00055931124,0.0005721107],"category_scores_gemma":[0.02110409,0.00066540163,0.00048182305,0.005162135,0.00070521573,0.00086437224,0.001344535,0.0006715136,0.00014252885],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000025313611,0.000008740537,0.99843174,0.00002973014,0.000033583638,0.000065428416,0.00012463862,0.000029033135,0.000040458446,0.000015379317,0.00018324306,0.0010126382],"study_design_scores_gemma":[0.000006569245,0.000048408212,0.99831116,0.0000531714,0.000034542187,0.00035604107,0.00048113975,0.00027831114,0.000082910774,0.000015807418,0.0003251107,0.0000067872447],"about_ca_topic_score_codex":0.009398879,"about_ca_topic_score_gemma":0.011207622,"teacher_disagreement_score":0.009398879,"about_ca_system_score_codex":0.001434497,"about_ca_system_score_gemma":0.002405822,"threshold_uncertainty_score":0.032348692},"labels":[],"label_agreement":null},{"id":"W7117317284","doi":"10.1111/bjh.70288","title":"Philadelphia chromosome‐positive acute lymphoblastic leukaemia in children and adolescents: A changing treatment landscape and a methodological challenge","year":2025,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Centre Hospitalier Universitaire Sainte-Justine","funders":"National Cancer Institute; National Institutes of Health; Pennsylvania Department of Health; Ministero della Salute; Agentura Pro Zdravotnický Výzkum České Republiky; Deutsche Krebshilfe; U.S. Department of Defense","keywords":"Chemoimmunotherapy; Chemotherapy; Transplantation; Hematopoietic stem cell transplantation; Clinical trial; Disease; Acute lymphocytic leukemia; MEDLINE","score_opus":0.017691652082967444,"score_gpt":0.3135956183861634,"score_spread":0.29590396630319593,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7117317284","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.01200022,0.43516356,0.027227294,0.4912673,0.025998255,0.0011121985,0.001939126,0.00013529802,0.0051567974],"genre_scores_gemma":[0.19941257,0.37471572,0.073336616,0.24316055,0.095559455,0.008741481,0.0022252349,0.00056613813,0.0022822255],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.86985826,0.108207546,0.011162177,0.0032109122,0.0069691795,0.00059190585],"domain_scores_gemma":[0.78862906,0.1394465,0.017183607,0.012343687,0.03960898,0.0027881332],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.14202097,0.00059205585,0.0020140824,0.0021765344,0.0007868884,0.0055432627,0.0024887563,0.0025502052,0.002949543],"category_scores_gemma":[0.24841468,0.0004016001,0.0010495746,0.002975897,0.0029560935,0.0038854894,0.0031449103,0.0044385456,0.0010052909],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001543948,0.00016594602,0.023036141,0.025881894,0.0014982707,0.0007545106,0.0038796787,0.0007489128,0.0011345914,0.027554078,0.17606696,0.73773503],"study_design_scores_gemma":[0.0007364002,0.0013002204,0.026423078,0.04668647,0.0019896615,0.003411181,0.005178681,0.0020905402,0.0014444386,0.07645074,0.83404994,0.0002385841],"about_ca_topic_score_codex":0.0021202464,"about_ca_topic_score_gemma":0.0041946783,"teacher_disagreement_score":0.14202097,"about_ca_system_score_codex":0.0027595034,"about_ca_system_score_gemma":0.008548362,"threshold_uncertainty_score":0.75108767},"labels":[],"label_agreement":null}]}